Lectin compositions and methods for modulating an immune response to an antigen
The present invention also relates to a method of reducing metastases in a subject comprising administering to the subject a composition comprising a multifunctional molecule comprising a first part which is capable of binding to an antigen bearing target and a second part which is capable of binding to a cell.
Latest Patents:
The present application is a divisional application to U.S. Utility Application with Ser. No. 10/645,000, filed Aug. 20, 2003, which claims priority to U.S. Provisional application 60/404,823, filed Aug. 20, 2002 and 60/487,407, filed Jul. 15, 2003, the entirety of each is hereby incorporated by reference.
BACKGROUND OF THE INVENTIONTypically, the specific modulation of an immune response to an antigen in a subject requires the administration of another substance, e.g. an adjuvant, in admixture with the antigen in order to initiate and/or direct the modulation. Traditional adjuvants, though, have a number of weaknesses. For example, many are crude, heterogeneous preparations. In addition, many are relatively weak immunomodulators, and some cause severe local inflammation that is unacceptable in humans. Purified soluble polypeptides, such as cytokines, have some advantages over crude adjuvants, but their value is limited because they diffuse away from the antigen upon administration. While certain cell-surface molecules may be potential immunomdulators as components of cell-based vaccines, their application generally involves gene transfer into the cells, which is often problematic.
The invention therefore fills heretofore unmet needs by providing molecules that can bind to antigen bearing targets, such as cells, viruses, and isolated antigens, and that can serve as immunomodulators when administered with an antigen bearing target. In addition, the invention provides compositions comprising these molecules and related methods. The compositions and methods of the invention are also useful for other applications, e.g. any application in which it is desirable to attach a biological effeector, such as a polypeptide ligand for a cell surface receptor, to a target structure, such as a virus or a cell.
SUMMARY OF THE INVENTIONThe present invention relates to a multifunctional molecule, e.g. a fusion polypeptide, comprising a first part which is capable of binding to an antigen bearing target and a second part which is capable of binding to a cell. In a preferred embodiment, the first part is a first cell surface binding moiety and the second part is a second cell surface binding moiety. In this embodiment, the first cell surface binding moiety can attach to a virus or cell, e.g. a tumor cell, which comprises an antigen. It is also particularly preferred that the second cell surface binding moiety can bind to a cell-surface polypeptide, e.g. a non-immunoglobulin polypeptide, of an antigen presenting cell (APC). Thus, in some embodiments, a multifunctional molecule of the invention can serve as a bridge or link between an antigen bearing target and an APC.
As used herein an “antigen bearing target” is an entity which comprises an antigen. As used herein an “antigen bearing target” includes, for example, a whole cell which expresses an antigen a cell fraction comprising an antigen, a membrane fraction comprising an antigen, a virus comprising an antigen, a viral particle comprising an antigen, or an antigen, e.g. a polypeptide antigen, which may be free of any other cell-derived or virus-derived material. Cellular fractions may be prepared using methods known to those of skill in the art such as those taught in Cell Biology A Laboratory Handbook (Academic Press 1994 Editor J. E. Celis ISBN 0-12-164715-3)
The term “antigen” as used herein refers to a molecule against which a subject can initiate a humoral and/or cellular immune response. Antigens can be any type of biologic molecule including, for example, simple intermediary metabolites, sugars, lipids, and hormones as well as macromolecules such as complex carbohydrates, phospholipids, nucleic acids and proteins. Common categories of antigens include, but are not limited to, viral antigens, bacterial antigens, fungal antigens, protozoa and other parasitic antigens, tumor antigens, antigens involved in autoimmune disease, allergy and graft rejection, and other miscellaneous antigens. In the compositions and methods of the invention, it is preferred that the antigen is a polypeptide, e.g., one comprising at least seven amino acids.
As used herein, “antigen presenting cell” or “APC” refers to cells that ingest and present antigen to T cells. These cells include phagocytic leukocytes, macrophages, and dendritic cells, B lymphocytes, and endothelial cells. A “professional APC” is an APC that is constitutively able to activate a T lymphocyte. Professional APCs typically constitutively express class II major histocompatibility molecules and costimulatory molecules such as B7-1 and/or B7-2.
In one embodiment, the invention encompasses a multifunctional molecule, the first part of which is a lectin. Thus, the multifunctional molecule can bind to one or more carbohydrates of an antigen bearing target. In a preferred embodiment of the invention, the first part of the multifunctional molecule is a lectin and the second portion is a ligand for a cell surface protein (e.g., a ligand for a cell surface receptor). Preferably, the cell surface protein is a cell surface receptor of an APC. Ligands for a cell surface receptor include any ligand which will bind to a cell surface protein, and preferably include, but are not limited to, an opsonin, cytokine, adhesion molecule, counterreceptor of a T cell costimulatory molecule, a defensin, a ligand for a CD40 molecule, or a heat shock protein, or a portion of any of these ligands, including about (or at least about) 5, 8, 10, 12, 15, 20, 25, 35, 50, 60, 70, 80, 100, or 120 contiguous amino acids of such a ligand. Preferably, the multifunctional molecule which comprises first and second parts comprises an amino acid sequence which can bind to a cell surface protein (e.g., a cell surface receptor) including, but not limited to an adhesion molecule, a costimulatory molecule for a T cell, or a receptor for at least one of the following types of molecules: a cytokine, a defensin, a heat shock protein, a CD40 molecule, or an opsonin.
A cell surface protein (e.g., a cell surface receptor) useful in the present invention is any cell surface molecule which can bind the ligand portion of a multifunctional molecule of the invention. Preferably, the cell surface receptor is a CD40 molecule, a T cell costimulatory molecule, an adhesion molecule, or a receptor for a cytokine, a defensin, a heat shock protein, an opsonin, or an adhesion molecule. Cell surface proteins, useful in the invention include, but are not limited to the cell surface molecules identified by GenBank Accession number in Appendix I and II, or those cell surface molecules which are encoded by a nucleic acid molecule identified by GenBank Accession number in Appendix I or II.
The term “cytokine” as used herein refers to a polypeptide molecule that is naturally secreted by mammalian cells and that binds to a cell surface protein on a leukocyte, inducing a change (e.g., a change in the proliferative state, a change in the transcriptional profile or a change in the propensity to migrate) in the leukocyte (other than mere occupancy of the leukocyte's receptors for the cytokine). “Change” refers to at least about a 5% increase or decrease as compared to in the absence of a cytokine. The term “cytokine” also refers herein to a polypeptide molecule that is a ligand for a receptor for a naturally occurring cytokine.
Examples of cytokines which are useful in the methods and compositions of the invention include the following: GM-CSF, Il-2, IL-4, IL-6, IL-12, ligands for hematopoietin receptors, ligands for immunoglobulin superfamily receptors, ligands for interferon receptors, ligands for TNF receptors, and ligands for chemokine receptors. An antibody against a cytokine receptor can also be a cytokine.
In one embodiment of the invention, it is preferred that a cytokine comprised by a composition of the invention promote a Th1 immune response, i.e., the generation of T cells that express Th1 cytokines such as IL-2 and IFN-γ. In another embodiment, it is preferred that a cytokine comprised by a composition of the invention promote a Th2 immune response, i.e., the generation of T cells that express Th2 cytokines such as IL-4 and IL-10.
“Engineered cytokines” as described herein are cytokines which comprise a heterologous cell surface binding moiety.
The term “opsonin” as used herein refers to naturally occurring and non-naturally occurring molecules which are capable, by virtue of being contemporaneously bound or attached to both an antigen-containing cell and an antigen-presenting cell (APC), of acting as a link or coupling agent (an adapter) between the antigen and the APC to allow more efficient binding, engulfment, and internalization of the antigen-containing cell by the APC. An opsonin useful according to the invention, also includes non-naturally occurring opsonins capable of binding to APCs via receptors that can bind naturally occurring opsonins.
The term “opsonin” as used herein can also refer to molecules which can be processed such that at least one product of the processing step or steps is capable of, by virtue of being contemporaneously bound or attached to both an antigen-containing cell and an APC, acting as a link or coupling agent to allow more efficient binding, engulfment, and internalization of other antigen-containing cells by the APC. An opsonin can also be any polypeptide chain of a multichain opsonin.
Examples of opsonins which are useful in the methods and compositions of the invention include the following: vitronectin, fibronectin, complement components such as C1q (including any of its component polypeptide chains A, B and C), complement fragments such as C3d, C3b and C4b, mannose binding protein, conglutinin, surfactant proteins A and D, C-reactive protein (CRP), alpha-2-macroglobulin, and immunoglobulins, for example, the Fc portion of an immunoglobulin.
“Innate opsonins” are opsonins of the innate immune system and are known in the art as secreted polypeptide molecules of the innate immune system and are believed to bind contemporaneously to an antigen and to the surface of an APC. They can thus act as “bridges”, and are thought, by virtue of this property, to promote internalization of antigens by APCs. The mode in which opsonins bind to antigens varies among opsonins, and can be covalent or noncovalent. In general, the antigen-binding moieties of innate opsonins differ from the antigen-binding moieties of immunoglobulins in that the former are relatively invariant among members of the same species, and do not undergo diversification during the ontogeny of an individual.
A molecule containing a naturally occurring APC-binding moiety shall be considered an opsonin if it contains a moiety through which it can be stably bound or attached to a cell such that the APC-binding moiety is located in the extracellular space, whether or not the opsonin molecule contains its natural antigen-binding domain.
“Engineered opsonins”, as described herein, include molecules in which a cell surface binding moiety is substituted for the natural antigen-binding domain of an opsonin or where a cell surface binding moiety is linked to the opsonin without modification or removal of the natural antigen-binding domain of the opsonin.
A “cell surface binding moiety” is a moiety through which a molecule can be stably bound to a cell surface, e.g. a cell wall, a polysaccharide capsule, or the lipid or protein component of a plasma membrane, or to the surface of a virus. Such moieties include but are not limited to crosslinking moieties and lipid moieties. It is preferred that the cell surface binding moiety bind to a cell by a means other than interaction of a polypeptide with its cognate cell-surface polypeptide. It is further preferred that the cell surface binding moiety comprise a non-polypeptide moiety. In a preferred embodiment, a lipid moiety is linked to the engineered molecule via a glycosylphosphatidylinositol (GPI) moiety. In another preferred embodiment, the lipid comprises a fatty acid, e.g. palmitate. In yet another preferred embodiment of the invention, the cell surface binding moiety is linked to an opsonin or an antigen-binding domain-truncated opsonin at the antigen-binding end of the opsonin. In another preferred embodiment, the multifunctional molecule comprises an idiotypic portion of an immunoglobulin which can bind to an APC. Preferably, the opsonin of an opsonin-enhanced cell is one of alpha′ chain C3b or mannose binding protein.
If the opsonin is a fragment of C3, it is preferred hat it bind to CR1 with a greater affinity than to CR2. It is further preferred that the fragment of C3 not be a ligand for CR2. Preferably, the opsonin is neither C3bi, C3d, nor C3dg.
It is preferred that the opsonins bind to receptors that trigger phagocytosis and that are non-clonotypic and thus do not vary from cell to cell as, for example, clonotypic receptors do. Non-clonotypic receptors are present on cells which play a role in innate immunity, and include, e.g., non-idiotypic receptors. Examples of such receptors include CR1, CR2, CR3, CR4, and C1q receptor, receptors containing a component of the C1q receptor, collectin receptors, receptors for α2m, receptors for CRP, and Fc receptors for immunoglobulins.
“Exogenous” refers to something which is introduced from or produced outside the cell.
“Endogenous” refers to something which is expressed or present naturally in a cell.
“Heterologous” refers to something which is not naturally expressed in a cell.
Preferably, the multifunctional molecule which comprises first and second parts can bind, via the second part, to the surface or plasma membrane of an antigen presenting cell (APC), i.e. a cell that can present antigen to a T cell, e.g. a cell that can activate a T cell, at least in part by presenting antigen to the T cell. The APC may be a leukocyte, e.g. a cell of monocytic lineage and/or a dendritic cell. Preferably, binding of the multifunctional molecule is independent of expression of an idiotype, e.g. a clonotypic determinant of an immunoglobulin, on the APC. Most preferably, the multifunctional molecule comprises a first end which can bind to a cell that comprises an antigen and a second end which can bind to a APC.
The multifunctional molecule may bind to an antigen bearing target cell by, e.g., inserting into the lipid portion of a cell membrane or by binding to a structure, e.g. a polypeptide or a carbohydrate, that is physically associated with the lipid portion of the membrane. The structure need not be directly in contact with the lipid portion of the membrane, but may be indirectly attached, e.g. a carbohydrate that is part of a cell-surface glycoprotein. Preferably the multifunctional molecule can bind via a first part to an antigen bearing target, preferably a mammalian cell that comprises an antigen, and via a second part to an APC. The invention also encompasses the use of a molecule that can bind via a first part to a virus or to a non-mammalian cell, e.g. a fungal or bacterial cell, and via a second part to an APC. In the latter cases, the first part may bind, e.g., to a component of a cell wall or a capsule.
In a preferred embodiment, the multifunctional molecule which comprises first and second parts comprises a first part which comprises a lectin and a second part that can bind to a leukocyte, e.g. an APC, e.g. a cell of monocytic lineage or a dendritic cell (which may itself be of monocytic lineage). A “lectin”, according to the invention, is a molecule or part of a molecule, e.g. an amino acid sequence, which can bind to a carbohydrate, e.g. a polysaccharide. Families of naturally occurring lectins include:
- 1) Galectins, a rapidly growing family of animal lectins. All of them share galactose-specificity.
- 2) Calcium-dependent (C-type) animal lectins, an extremely large family composed of members having diverse structures and functions.
- 3) Among this C-type lectin family, selectins form a distinguishable subfamily by their specific function in leukocyte adhesion to endothelial cells through sialyl-Lewis X recognition.
- 4) Collectins, another subfamily of C-type lectins specific for mannose, which have a unique structure consisting of a C-type lectin domain and a collagen-like domain. They are involved in innate immunity.
- 5) Invertebrates are known to contain various lectins in their body fluids, probably as body-protection factors. Recently, some lectins from an echinoderm were found to show hemolytic activity.
- 6) Annexins, a group of proteins having affinity to lipids that were recently shown to be lectins showing binding to glycosaminoglycans.
- 7) The legume lectin family, which consists of a large number of members, such as ConA, with variable saccharide specificity comparable to C-type lectins.
- 8) Ricin, the first lectin investigated in Russia more than 100 years ago. It is now evident that the ricin family has many other homologous members which differ in either toxicity or sugar-binding specificities.
Thus, a multifunctional molecule of the invention may bind to one or more carbohydrates. Carbohydrates to which lectins may bind also include, for example, carbohydrates comprising lactose, D-mannose, D-glucose, D-fucose, L-fucose (e.g. alpha-L-fucose), D-galactose, blood group A oligosaccharides, blood group B oligosaccharides, saccharides comprising alpha-D-Gal(1->3)[alpha-Lfuc(1->2)]-beta-D-Gal(1->3/4-beta-D-GlcNAc, saccharides comprising alpha-sialyl [2->3]-lactose, alpha-D-mannosyl glycoconjugates, alpha-NeuNAc-[2->6]-Gal, alpha-NeuNAc-[2->6]-GalNAc, alpha-NeuNAc-[2->3]-Gal, N-acetyl-beta-D-glucosamine, terminal alpha-D-galactosyl residues, terminal beta-D-galactosyl residues, N-acetyllactosamine, terminal alpha-D-mannosyl residues, N-acetyl-beta-D-glucosamine, terminal N-acetyl-D-galactosamine, N-acetylneuraminic acid, and terminal alpha-D-galactosaminyl residues.
The multifunctional molecule which comprises a lectin may comprise, for example, the whole of a naturally occurring lectin or a portion of a naturally occurring lectin, e.g about (or at least about) 5, 8, 10, 12, 15, 20, 25, 35, 50, 60, 70, 80, 100, or 120 contiguous amino acids of a naturally occurring polypeptide lectin. In one embodiment the multifunctional molecule comprises a carbohydrate-binding domain of a naturally occurring lectin, i.e., a portion of a lectin that can bind to a carbohydrate in the absence of the remainder of the lectin. In another embodiment the lectin may be non-naturally occurring, e.g. identified from an artificial library of molecules or designed by modifying the structure of a naturally occurring lectin.
Lectins known as “hemagglutinins” bind to carbohydrates on erythrocytes, e.g. blood group antigens, and when incubated with these cells cause them to aggregate. The influenza virus hemagglutinin, for example, binds to sialic acid (as does the human parainfluenza virus 3 hemagglutinin/neuraminidase). There are at least 15 known influenza hemagglutinin subtypes, defined by their distinct antigenic properties. Any of these subtypes, designated, e.g., H1, H2, H3, H4, H5, H6, H7, H8, H9, H10, H11, H12, H13, H14, and H15, may provide amino acid sequences useful in the compositions and methods of the invention. In one embodiment of the invention, the hemagglutinin is of a subtype from a virus that infects humans, e.g. H1, H2, or H3. In another embodiment, the hemagglutinin is of a subtype from a virus that does not infect humans, e.g. one of H4 through H15. Amino acid sequences can vary up to about 20% for influenza hemagglutinins within a given subtype, and can vary between about 30% and about 70% for influenza hemagglutinins from different subtypes.
Influenza hemagglutinin is expressed as a single polypeptide chain, designated HA0, which trimerizes post-translationally. HA0 is proteolytically cleaved to yield two domains, HA1 and HA2, which are disulfide-bonded to each other. HA1 comprises significant sialic acid binding activity, while HA2 is anchored to the viral membrane and facilitates fusion of this membrane with a host cell membrane. In preferred embodiments of the invention, the multifunctional molecule comprising first and second parts comprises an amino acid sequence of an HA1 domain.
The molecule may be a fusion polypeptide which comprises one or more amino acids interposed between the first and second parts which bind to cells, e.g. a fusion polypeptide which comprises a first amino acid sequence which can bind to an antigen bearing target and a second amino acid sequence which can bind to a leukocyte, and which further comprises at least one amino acid interposed between the first and second parts. The interposed amino acids may comprise, e.g., a linker sequence intended to lessen steric hindrance or other undesirable interactions between the aforementioned first and second parts. For, example, one such type of sequence takes the form (Gly3Ser)n. Additional useful linkers include, but are not limited to (Arg-Ala-Arg-Asp-Pro-Arg-Val-Pro-Val-Ala-Thr)1-5 (Xu et al., 1999, Proc. Natl. Acad. Sci. U.S.A. 96: 151-156), (Gly-Ser)n (Shao et al., 2000, Bioconjug. Chem. 11: 822-826), (Thr-Ser-Pro), (Kroon et al., 2000, Eur. J. Biochem. 267: 6740-6752), (Gly-Gly-Gly)n (Kluczyk et al., 2000, Peptides 21: 1411-1420), and (Glu-Lys), (Klyczyk et al., 2000, supra), wherein n is 1 to 15 (each of the preceding references is also incorporated herein by reference). In another embodiment, no amino acids are interposed between the first and second parts.
The present invention further provides a nucleic acid molecule, preferably a recombinant nucleic acid molecule which encodes a multifunctional polypeptide of the present invention. The nucleic acid molecule may be, for example, DNA, RNA, cDNA, or mRNA. The nucleic acid molecule may be naturally occuring or may be partially or wholly synthesized using techniques known to those of skill in the art. In a preferred embodiment, the nucleic acid molecule is a DNA molecule comprising a first nucleic acid sequence encoding a first amino acid sequence which can bind to an antigen bearing target, and a second nucleic acid sequence encoding a second amino acid sequence which can bind to a cell surface receptor on an APC.
The present invention still further provides a vector comprising the nucleic acid molecule encoding a multifunctional polypeptide of the invention, e.g. an expression vector suitable for expressing in a host cell, wherein the host cell is preferably a eukaryotic cell, more preferably an animal cell, more preferably a mammalian cell, and still more preferably a human cell. In another preferred embodiment the host cell is a yeast cell, e.g. Saccharomyces cerevesiae.
The invention also provides a host cell comprising a nucleic acid vector which comprises a sequence encoding the multifunctional molecule of the present invention. Preferably, the host cell is a eukaryotic cell, such as a yeast cell- or an animal cell, preferably a human cell. The host cell may also be a prokaryotic cell.
The invention also encompasses a molecule, e.g. a polypeptide, e.g. a fusion polypeptide, which comprises a first part that can bind to an antigen bearing target, e.g. a cell, e.g. a cell that comprises an antigen, and a second part that can bind to a cell, e.g. a leukocyte, e.g. an APC. The molecule may have any of the characteristics taught in the descriptions of methods and compositions herein. Preferably the first and second parts are heterologous to each other. The molecule may be, e.g., a recombinant polypeptide expressed in a mammalian cell, an insect cell, a plant cell, a yeast cell, or a bacterial cell.
The invention also encompasses a method of modulating an immune response in an animal comprising the step of expressing in an animal, e.g. expressing in a host cell of the animal, a multifunctional molecule of the invention, e.g. a polypeptide which comprises a first part that can bind to a antigen bearing target and a second part that can bind to a cell. According to the invention, “expressing in an animal” means “causing to be present in an animal”. When the molecule is a polypeptide, it is preferably expressed by introducing into the host cell, in vivo or ex vivo, a nucleic acid encoding the polypeptide. If the nucleic acid is introduced into the host cell ex vivo, the host cell may subsequently be administered to the animal. In a preferred embodiment, the method further comprises administering to the animal the antigen to which the immune response is modulated. For example, the antigen may be administered to the animal as part of a composition which further comprises a nucleic acid that encodes the multifunctional molecule. In another preferred embodiment, the antigen is already present in the animal at the time the multifunctional molecule is expressed. In yet another preferred embodiment, the antigen is administered to the animal after administration of the multifunctional molecule. In still other preferred embodiments, the antigen is expressed in the animal, e.g. by administering to the animal a composition comprising a nucleic acid encoding the antigen, either before or after expression of the multifunctional molecule in the animal. In another embodiment, nucleic acid sequences encoding the multifunctional molecule and the antigen are introduced into one or more host cells of the animal, e.g. by administering to the animal a composition comprising those nucleic acid sequences.
As used herein, the term “modulating an immune response” to a selected antigen using the methods and compositions of the invention means rendering the response more or less efficient, more or less rapid, greater or lesser in magnitude, and/or more or less easily induced than the response obtained from administration of a composition which is identical in every respect except that it does not comprise a multifunctional molecule of the invention. In a preferred embodiment, the response is between about 5 and 100%, or preferably between about 5 and 50% or more preferably between about 5 and 25% more or less efficient, more or less rapid, greater or lesser in magnitude, and/or more or less easily induced than the response obtained from administration of a composition which is identical in every respect except that it does not comprise a multifunctional molecule of the invention.
The term “modulate the immune response” may refer to stimulation/activation of an immune response to a selected antigen, or it may refer to suppression, elimination, or attenuation of an immune response to a selected antigen. In a preferred embodiment, modulating the immune response results in stimulation/activation of an immune response to a selected antigen by about at least 5%, or preferably between 5 and 50% or more preferably between 50 and 100%, as compared to an immune response in the absence of vaccination, or it may result in suppression, elimination, or attenuation of an immune response to a selected antigen by about at least 5%, or preferably between 5 and 50% or more preferably between 50 and 100%, as compared to an immune response in the absence of vaccination. In some cases, one immune response to an antigen (e.g. a Th1 response) may be increased while another immune response to the same antigen (e.g. a Th2 response) may be diminished.
The invention also encompasses a composition comprising a multifunctional molecule of the invention and antigen bearing target, e.g. a virus, a prion, or a cell. Preferably, when the antigen bearing target is a cell, the multifunctional molecule is exogenous to the cell. The multifunctional molecule may be heterologous to the cell. In one embodiment, the multifunctional molecule is expressed within the cell, e.g. from a recombinant nucleic acid within the cell. The invention also encompasses a cell comprising a nucleic acid encoding a multifunctional molecule of the invention. The multifunctional molecule may have any of the characteristics set forth herein. An antigen bearing target (e.g., a cell) useful in the invention includes, for example, malignant cells, benign tumor cells, lymphocytes, e.g. B or T lymphocytes which may be pathogenic and/or autoreactive, cells expressing an antigen from an exogenously introduced nucleic acid molecule, eukaryotic cells such as mammalian cells, human cells, fibroblasts, insect and fungal cells, and prokaryotic cells such as bacterial cells. Examples of viruses useful in the invention include, e.g., retroviruses such as human immunodeficiency viruses 1 and 2; herpesviruses such as herpes simplex viruses 1 and 2, cytomegalovirus, and varicella zoster virus; human papilloma virus; rabies virus; rotavirus; influenza viruses A, B, and C; hepatitis viruses A, B, C, and E or delta agent; adenoviruses; measles virus; mumps virus; polio virus; rubella virus; parainflunza viruses; coxsackie viruses A and B; variola virus; yellow fever virus; dengue and other hemorrhagic fever viruses; West Nile fever virus; Eastern equine encephalitis virus; Western equine encephalitis virus; Venezuelan equine encephalitis virus; Japanese encephalitis virus; rhinoviruses; and foot and mouth disease virus. Prions include the agents of scrapie, kuru, and bovine spongiform encephalitis. The cell, virus, or prion may be attenuated, i.e. rendered non-pathogenic, by, e.g, killing, irradiation, chemical fixation, passaging in culture with selection for diminished pathogenicity, or genetic manipulation. Preferably, the composition further comprises a leukocyte, e.g. a monocyte, a cell of monocytic lineage, a macrophage, or a dendritic cell or another APC.
Preferably, in the inventive methods and compositions, the cell is substantially unable to divide in vitro. “Substantially unable to divide in vitro” means that the cell divides at a rate that is less than about 50% of the rate of division of corresponding cells which are not treated to prevent cell division. In a preferred embodiment, the cell divides at a rate that is less than about 30-50% of the rate of division of corresponding cells which are not treated to prevent cell division.
Preferably, the composition is substantially free of culture medium. As used herein, “culture medium” refers to medium that is used in cell culture containing at least 2% animal serum, such as fetal calf serum.
More particularly, the present invention provides a multifunctional molecule which is a fusion polypeptide comprising: a lectin which comprises at least about 10 contiguous amino acids of an influenza virus hemagglutinin, and at least about 5 contiguous amino acids of a naturally occurring GM-CSF molecule.
In one embodiment, the lectin is N-terminal to the contiguous amino acids of a naturally occurring GM-CSF molecule.
In an alternate embodiment, the lectin is C-terminal to the contiguous amino acids of a naturally occurring GM-CSF molecule.
In one embodiment, the lectin comprises at least about 10 contiguous amino acids of the HA1 domain of an influenza virus hemagglutinin.
In one embodiment, the lectin is the HA1 domain of an influenza virus hemagglutinin.
Preferably, the influenza virus hemagglutinin is a hemagglutinin of an influenza A virus. In other preferred embodiments the influenza virus hemagglutinin is a hemagglutinin of an influenza B or influenza C virus.
In one embodiment, the influenza virus hemagglutinin is of a subtype from a virus that infects humans. Preferably, the influenza virus hemagglutinin is of an H1 subtype. Still more preferably, the influenza virus hemagglutinin is from the influenza A strain PR/8/34.
In one embodiment, the influenza virus hemagglutinin is of an H2 subtype.
In one embodiment, the influenza virus hemagglutinin is of an H3 subtype.
In one embodiment, the influenza virus hemagglutinin is of a subtype from a virus that does not infect humans.
In one embodiment the fusion polypeptide comprises the entire amino acid sequence of a naturally occurring GM-CSF molecule.
Preferably, the GM-CSF molecule is a murine GM-CSF. Still more preferably, the GM-CSF molecule is a human GM-CSF.
In one aspect, the invention encompasses a method of reducing the number of metastases, e.g. tumor metastases, in a subject, e.g. a mammal, e.g. a human, comprising the step of administering to the subject any of the compositions described herein, e.g. a composition comprising a multifunctional molecule of the invention or a nucleic acid molecule encoding a multifunctional molecule of the invention. Typically, such a composition will further comprise an antigen associated with the disease, or a nucleic acid encoding such an antigen. The method may comprise any of the methods of administering a composition, modulating an immune response, or treating a disease described herein.
The invention provides, a method of reducing the number of metastasis in an animal comprising administering to said animal a composition comprising a cell comprising an antigen, said composition further comprising a fusion protein comprising a lectin and a ligand for a cell surface protein.
As used herein, a “metastasis” refers to a focus of disease that is caused by a malignent cell or infectious organism which has traveled from one site in a host to a second site in the host (e.g., from one site to a non-contiguous site; e.g., from a first organ to a second organ). More specifically, “metastasis” refers to a detectable focus of malignant tumor or infection that is derived from, and spread from, and is distinct from the primary site of disease. Accordingly, “metastases” refers to a plurality of foci either in a single organ or tissue in a subject, or in two or more organs or tissues in a subject. A “focus” as used herein may be at least a single malignant or infectious cell, or may be a detectable focus, which is detectable by one or more of the methods described hereinbelow. Metastases is said to be detected where a metastases is able to be detected by one of skill in the art using one or more of the assay methods described hereinbelow.
According to the invention, “reducing the number of metastases” may mean either causing there to be fewer (e.g., at least 10% fewer, 20%, 30%, 50%, 70%, 90%, and up to at least 100% fewer) metastases than expected (where the number or severity of metastases expected is based on the observations made in a set (e.g., more than one) or similar subjects which has not received the multifunctional molecule of the invention). In one embodiment “reducing the number of metastases” may encompass preventing metastases (e.g. a subject does not develop any detectable foci of disease), e.g. in a subject with a tumor, or causing one or more preexisting metastases to become undetectable, e.g. by radiologic, non-invasive imaging techniques, or other techniques as described herein. Those skilled in the art will recognize that a metastasis itself may become undetectable even though residual scarring or fibrosis may be detectable. Metastases may be, for example, to bone, brain, liver, lung, or spinal cord, or any other organ or tissue.
In another aspect, the invention encompasses a method of reducing the number of metastases in a population of subjects comprising the step of administering to one or more subjects any of the compositions described herein e.g. a composition comprising a multifunctional molecule of the invention or a nucleic acid molecule encoding a multifunctional molecule of the invention. Typically, such a composition will further comprise an antigen associated with the disease, or a nucleic acid encoding such an antigen. The method may comprise any of the methods of administering a composition, modulating an immune response, or treating a disease described herein.
In another aspect, the invention encompasses a method of reducing the size of a metastasis in a subject comprising the step of administering to the subject any of the compositions described herein, e.g. a composition comprising a multifunctional molecule of the invention or a nucleic acid molecule encoding a multifunctional molecule of the invention. Typically, such a composition will further comprise an antigen associated with the disease, or a nucleic acid encoding such an antigen. The method may comprise any of the methods of administering a composition, modulating an immune response, or treating a disease described herein. The “size” of a metastasis, as used herein refers to the one, two or three dimensional area encompassed by a metastasis, or alternatively, refers to the number of malignant or infectious cells present in a metastasis. The size of the metastasis, which may be measured by direct visualization or by noninvasive imaging, may be reduced by, e.g., at least about 10%, at least about 20%, 30%, 50%, 70%, 90%, and up to at least 100%.
The invention provides a method of reducing the size of a metastasis in an animal comprising administering to said animal a composition comprising a cell comprising an antigen, said composition further comprising a fusion protein comprising a lectin and a ligand for a cell surface protein.
In another aspect, the invention encompasses a method of reducing the average size of metastases in a subject comprising the step of administering to the subject any of the compositions described herein. The method may comprise any of the methods of administering a composition, modulating an immune response, or treating a disease described herein. According to the invention, “reducing the average size of metastases” may mean either causing metastases to be smaller on average than expected, e.g. by preventing one or more of them from growing to the expected size, or causing one or more preexisting metastases to become smaller, thus decreasing the mean size of the metastases. The average size of the metastases, which may be determined by direct visualization or by noninvasive imaging, may be reduced by, e.g., at least about 10%, at least about 20%, 30%, 50%, 70%, 90%, and up to at least 100%.
In another aspect, the invention encompasses a method of reducing the average size of metastases in a population comprising the step of administering to one or more subjects any of the compositions described herein, e.g. a composition comprising a multifunctional molecule of the invention or a nucleic acid molecule encoding a multifunctional molecule of the invention. The method may comprise any of the methods of administering a composition, modulating an immune response, or treating a disease described herein.
Thus, in another aspect the invention encompasses preventing or treating a disease in a subject by administering to the subject any of the compositions described herein, e.g. a composition comprising a multifunctional molecule of the invention or a nucleic acid molecule encoding a multifunctional molecule of the invention. Typically, such a composition will further comprise an antigen associated with the disease, or a nucleic acid encoding such an antigen. The disease may be, for example, a benign or malignant tumor, an infectious disease, an allergy, or an autoimmune disease. “Treating a disease” means decreasing morbidity or mortality associated with the disease in a patient or population afflicted with the disease. For example, survival, relapse-free survival, or disease-free survival may be prolonged by, e.g., at least about 10%, at least about 20%, 30%, 50%, 70%, 90%, and up to at least 100%, or the number of metastases may be reduced by, e.g., at least about 10%, at least about 20%, 30%, 50%, 70%, 90%, and up to at least 100%. For preventive applications, the incidence of the targeted disease may be reduced by, e.g., at least about 10%, at least about 20%, 30%, 50%, 70%, 90%, and up to at least 100%.
In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising the antigen and further comprising a multifunctional molecule of the invention and 2) administering to the subject a composition comprising the antigen and not comprising (i.e. free of) the multifunctional molecule administered in step 1. Generally, the two steps will be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or at least 1 month apart, or at least 6 months apart, or at least 1 year apart. In one embodiment, the composition comprising the multifunctional molecule is administered to the subject prior to the composition which is free of the multifunctional molecule. In another embodiment, the composition which is free of the multifunctional molecule is administered to the subject prior to the composition which comprises the multifunctional molecule. The antigen of the composition may be comprised by an antigen bearing target such as a cell, a cell fraction, a virus, or a viral particle.
In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising the antigen and further comprising a nucleic acid molecule encoding a multifunctional molecule of the invention and 2) administering to the subject a composition comprising the antigen and not comprising (i.e. free of) the nucleic acid molecule administered in step 1. Again, the two steps will generally be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or at least 1 month apart, or at least 6 months apart, or at least 1 year apart. In one embodiment, the composition comprising the nucleic acid molecule is administered to the subject prior to the composition which is free of the nucleic acid molecule. In another embodiment, the composition which is free of the nucleic acid molecule is administered to the subject prior to the composition which comprises the nucleic acid molecule. The antigen of the composition may be comprised by an antigen bearing target such as a cell, a cell fraction, a virus, or a viral particle. The nucleic acid molecule may be comprised by an expression vector.
In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and further comprising a multifunctional molecule of the invention and 2) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and not comprising (i.e. free of) the multifunctional molecule administered in step 1. Generally, the two steps will be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or at least 1 month apart, or at least 6 months apart, or at least 1 year apart. In one embodiment, the composition comprising the multifunctional molecule is administered to the subject prior to the composition which is free of the multifunctional molecule. In another embodiment, the composition which is free of the multifunctional molecule is administered to the subject prior to the composition which comprises the multifunctional molecule. The antigen of the composition may be comprised by an antigen bearing target such as a cell, a cell fraction, a virus, or a viral particle. One or more of the nucleic acid molecules may be comprised by an expression vector.
In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising the antigen and further comprising a multifunctional molecule of the invention and 2) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and not comprising (i.e. free of) the multifunctional molecule administered in step 1. Generally, the two steps will be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or at least 1 month apart, or at least 6 months apart, or at least 1 year apart. In one embodiment, the composition comprising the multifunctional molecule is administered to the subject prior to the composition which is free of the multifunctional molecule. In another embodiment, the composition which is free of the multifunctional molecule is administered to the subject prior to the composition which comprises the multifunctional molecule. The antigen of the composition may be comprised by an antigen bearing target such as a cell, a cell fraction, a virus, or a viral particle. The nucleic acid molecule may be comprised by an expression vector.
In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and further comprising a multifunctional molecule of the invention and 2) administering to the subject a composition comprising the antigen and not comprising (i.e. free of) the multifunctional molecule administered in step 1. Generally, the two steps will be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or at least 1 month apart, or at least 6 months apart, or a least 1 year apart. In one embodiment, the composition comprising the multifunctional molecule is administered to the subject prior to the composition which is free of the multifunctional molecule. In another embodiment, the composition which is free of the multifunctional molecule is administered to the subject prior to the composition which comprises the multifunctional molecule. The antigen of the composition may be comprised by an antigen bearing target such as a cell, a cell fraction, a virus, or a viral particle. The nucleic acid molecule may be comprised by an expression vector.
In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and further comprising a nucleic acid molecule encoding a multifunctional molecule of the invention and 2) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and not comprising (i.e. free of) the nucleic acid molecule encoding the multifunctional molecule, which was administered in step 1. Again, the two steps will generally be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or at least 1 month apart, or at least 6 months apart, or at least 1 year apart. In one embodiment, the composition comprising the nucleic acid molecule is administered to the subject prior to the composition which is free of the nucleic acid molecule encoding the multifunctional molecule. In another embodiment, the composition which is free of the nucleic acid molecule encoding the multifunctional molecule is administered to the subject prior to the composition which comprises the nucleic acid molecule encoding the multifunctional molecule. One or more of the nucleic acid molecules may be comprised by an expression vector.
In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and further comprising a nucleic acid molecule encoding a multifunctional molecule of the invention and 2) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and further comprising a multifunctional molecule of the invention. The multifunctional molecules of step 1 and step 2 may be the same or different. Again, the two steps will generally be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or a least 1 month apart, or at least 6 months apart, or at least 1 year apart. In one embodiment, the composition comprising the nucleic acid molecule is administered to the subject prior to the composition which is free of the nucleic acid molecule encoding the multifunctional molecule. In another embodiment, the composition which is free of the nucleic acid molecule encoding the multifunctional molecule is administered to the subject prior to the composition which comprises the nucleic acid molecule encoding the multifunctional molecule. One or more of the nucleic acid molecules may be comprised by an expression vector.
In yet another aspect, the invention encompasses a method of modulating an immune response to an antigen in a subject, e.g. a mammal, e.g. a human, comprising the steps of 1) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and further comprising a multifunctional molecule of the invention and 2) administering to the subject a composition comprising a nucleic acid molecule encoding the antigen and further comprising a nucleic acid molecule encoding a multifunctional molecule of the invention. The multifunctional molecules of step 1 and step 2 may be the same or different. Again, the two steps will generally be performed sequentially, e.g. at least 1 day apart, or at least 1 week apart, or at least 1 month apart, or at least 6 months apart, or at least 1 year apart. In one embodiment, the composition comprising the nucleic acid molecule is administered to the subject prior to the composition which is free of the nucleic acid molecule encoding the multifunctional molecule. In another embodiment, the composition which is free of the nucleic acid molecule encoding the multifunctional molecule is administered to the subject prior to the composition which comprises the nucleic acid molecule encoding the multifunctional molecule. One or more of the nucleic acid molecules may be comprised by an expression vector.
The present invention encompasses a method of modulating an immune response in an animal comprising the step of administering a composition comprising a multifunctional molecule, e.g. a polypeptide, e.g. a fusion polypeptide, which comprises a first part that can bind to a antigen bearing target and a second part that can bind to a cell. In a preferred embodiment, the composition further comprises an antigen, an immune response to which is modulated by administration of the composition. The antigen may be, for example, a polypeptide (e.g. a recombinant polypeptide), a lipid (e.g. a glycolipid), or a carbohydrate (e.g. a polysaccharide or a component of a bacterial or fungal cell wall). The composition therefore comprises an antigen bearing target, whether, e.g., a homogeneous antigen or a heterogeneous structure such as a cell or a virus. When the antigen bearing target is a cell, it may be autologous, syngeneic, allogeneic, or xenogeneic to the animal. In other preferred embodiments, the antigen is already present in the animal at the time the molecule is administered, and/or the antigen is administered to the animal prior to administration of the molecule. In yet another preferred embodiment, the antigen is administered to the animal after administration of the molecule.
Preferably, the composition comprises multifunctional molecules which are not bound to an antigen bearing target. In a preferred embodiment, the composition further comprises an antigen bearing target, e.g. a cell. In one embodiment of the invention, the composition comprises multifunctional molecules, some of which are bound to a antigen bearing target, e.g. to the surface of a cell, and some of which are external to and not bound to any target. In another embodiment, the composition comprises a multifunctional molecule and further comprises a portion of a cell, e.g. a membrane fraction of a cell (i.e., an antigen bearing target). In yet another embodiment, the composition comprises a multifunctional molecule and further comprises a multiplicity of different molecules derived from a cell, as is found, e.g., in a cell lysate. Cells may be lysed, for example, by freezing and thawing, preferably repeatedly. In a preferred embodiment, the composition is cell-free.
The present invention further encompasses a method of vaccinating a mammal to a selected antigen comprising administering to the animal a vaccine composition comprising a multifunctional molecule of the invention comprising a first part which is a lectin, and a second part which is a ligand for a cell surface protein, e.g. a cell surface receptor of an APC. Preferably, the lectin can bind to an antigen bearing target which comprises the antigen.
In one embodiment, the invention provides a method of vaccinating a mammal to a selected antigen comprising removing at least one cell from the mammal, wherein the cell comprises the antigen, contacting the cell ex vivo with a multifunctional molecule comprising a first part which is a lectin and is capable of binding to at least one carbohydrate molecule on the surface of the antigen bearing cell, and a second part which is a ligand for a cell surface protein of an APC, so as to form an antigen bearing cell/multifunctional molecule complex; and placing the complex back into the mammal.
In a preferred embodiment, the composition comprises an antigen, an immune response to which is modulated by administration of the composition.
The invention provides a method of modulating an immune response to a selected antigen in a mammal comprising administering to said animal a composition comprising a cell comprising said antigen, and a multifunctional molecule comprising a lectin and a ligand for a cell surface protein.
The invention also relates to a method of vaccinating an animal to a selected antigen comprising removing at least one cell from said animal, wherein the cell comprises said antigen; contacting said cell ex vivo with a fusion polypeptide comprising a lecting and a ligand for a cell surface protein of an antigen presenting cell so as to form a complex; and placing said complex back in said animal.
The present invention provides a method for juxtaposing an APC with an antigen bearing target comprising: contacting an APC and antigen bearing target with a multifunctional molecule comprising a first part comprising a lectin which is able to bind to at least one carbohydrate moiety on the antigen bearing target and a second part comprising a ligand for a cell surface protein on the APC. Preferably, the multifunctional molecule is first contacted with the antigen bearing target and the resulting antigen bearing target/multifunctional molecule complex is subsequently contacted with the APC. In one embodiment the antigen bearing target is a cell from an animal comprising an antigen, and is contacted with the multifunctional molecule ex vivo under conditions which permit the binding of the lectin to at least one carbohydrate moiety of the cell. The resulting multifunctional molecule/antigen bearing cell complex is then administered back to the animal from which the antigen bearing cell was derived wherein it is able to bind to a cell surface receptor on an APC via the ligand portion of the multifunctional molecule, thereby juxtaposing the antigen bearing target and the APC.
“Juxtaposition”, in the context of the present invention, includes but is not limited to physical contact. An APC and antigen bearing target are “juxtaposed” with one another if they are sufficiently close for the APC to internalize the antigen bearing target. An APC and antigen bearing target are also “juxtaposed” if they are separated by no more that 20 μm, preferably no more than 10 μm, and still more preferably no more than 5 μm, and more preferably no more than 1 μm.
As used herein, “contacting” refers to admixing in vitro or in vivo.
The invention also encompasses a method of modulating an immune response to an antigen comprising contacting in vitro an antigen bearing target, a multifunctional molecule of the invention, and an APC and administering the resultant composition to a subject. In one embodiment the antigen bearing target/multifunctional molecule complex is contacted with an APC for a time sufficient to permit internalization of the antigen bearing target by the APC. In other embodiments the antigen bearing target/multifunctional molecule complex is contacted with an APC for a time that allows internalization of less than about 80%, less than about 60%, less than about 40%, less than about 20%, less than about 10%, or less than about 5% of the antigen bearing target by the APC. Methods for determining the amount of target internalized, e.g. by measuring the amount remaining outside the APC and subtracting from the starting amount, are well-known in the art. Preferably, the antigen bearing target/multifunctional molecule complex is contacted with an APC for less than about 10 minutes, less than about 30 minutes, less than about 60 minutes, less than about 90 minutes, less than about 120 minutes, or less than about 180 minutes.
As used herein, “time sufficient to permit internalization” refers to a period of time that is of a sufficient duration to allow internalization of the selected antigen or antigen bearing targtet by the APC (for example, no more than about fourteen days, or seven days, or five or three days, or as little as about 24, 12, 6, 3, 2 or 1 hour, or even as little as about 30, 20, 10, 5, or 1 minute).
The invention also encompasses a method of attaching a ligand for a cell surface polypeptide to an antigen bearing target comprising admixing the antigen bearing target with a multifunctional molecule which comprises the ligand. The invention also encompasses a method of attaching an amino acid sequence to an antigen bearing target comprising admixing the antigen bearing target with a fusion polypeptide which comprises the amino acid sequence and further comprises a lectin. The invention also encompasses a composition comprising an antigen bearing target admixed with a fusion polypeptide which comprises a first amino acid sequence which is not a lectin and a second amino acid sequence which comprises a lectin.
The invention also comprises methods of producing a multifunctional molecule of the invention in each of the following cell types: a yeast cell, a mammalian cell, a bacterial cell, an insect cell. Each of these methods comprises the step of introducing a nucleic acid encoding a multifunctional molecule into the respective cell type, as taught hereinbelow.
The invention also encompasses methods of detecting or quantifying a multifunctional molecule of the invention comprising contacting the multifunctional molecule with an antibody or other ligand that binds to the multfunctional molecule. Such methods include ELISA assays and flow cytometry, as described hereinbelow. Preferably, the multifunctional molecule to be detected or quantitated is bound to an antigen bearing target.
DETAILED DESCRIPTIONThe present invention is based, in part, on the discovery that a multifunctional fusion protein comprising a first polypeptide which is a lectin and a second polypeptide which is a ligand of a cell surface receptor of an APC, can effectively target an antigen bearing target, such as a cell bearing an antigen of interest, to an APC, wherein the antigen is engulfed by the APC, and an appropriate immune response to the antigen is mounted by an animal to which the multifunctional molecule is administered.
Accordingly, the present invention provides a method for vaccinating a mammal comprising administering to the animal a vaccine composition comprising a multifunctional molecule of the invention comprising a first part which is a lectin and which can bind to a target bearing the antigen, and a second part which is a ligand for a cell surface protein of an APC. In one embodiment, the method comprises removing at least one cell from the mammal, wherein the cell comprises the antigen, contacting the cell ex vivo with a multifunctional molecule comprising a first part which is a lectin and is capable of binding to at lease one carbohydrate molecule on the surface of the antigen bearing cell, and a second part which is a ligand for a cell surface protein of an APC, so as to form an antigen bearing cell/multifunctional molecule complex; and placing the complex back into the mammal.
Multifunctional Molecules
The present invention encompasses a multifunctional molecule comprising a first part which can bind to an antigen bearing target, and a second part which is a ligand for a cell surface protein of a cell, e.g. an antigen presenting cell. Preferably, the first part which can bind to an antigen bearing target is a lectin which binds to at least one carbohydrate molecule present on the antigen bearing target. Preferably the lectin is an influenza hemagglutinin and binds to sialic acid residues present on the antigen bearing target. Preferably, the ligand of a cell surface protein of an antigen presenting cell is selected from an opsonin, a cytokine, a ligand for a CD40 molecule, an adhesion molecule, a defensin, a heat shock protein, or a counterreceptor for a T cell costimulatory molecule. Cell surface molecules which can act as receptors for the second part of the multifunctional molecule include CD40 molecules and specific receptors for an opsonin, a cytokine, an adhesion molecule, a defensin, a heat shock protein, or a counterreceptor for a T cell costimulatory molecule, and also include, but are not limited to the cell surface molecules listed in Apendix I and II.
Lectins
The multifunctional molecule which comprises first and second parts can comprise a first part which comprises a lectin and a second part that can bind to a leukocyte, e.g. an APC, e.g. a cell of monocytic lineage or a dendritic cell (which may itself be of monocytic lineage). A “lectin”, according to the invention, is a molecule or part of a molecule, e.g. an amino acid sequence, which can bind to a carbohydrate, e.g. a polysaccharide. Families of naturally occurring lectins include:
- 1) Galectins, a rapidly growing family of animal lectins. All of them share galactose-specificity.
- 2) Calcium-dependent (C-type) animal lectins, an extremely large family composed of members having diverse structures and functions.
- 3) Among this C-type lectin family, selectins form a distinguishable subfamily by their specific function in leukocyte adhesion to endothelial cells through sialyl-Lewis X recognition.
- 4) Collectins, another subfamily of C-type lectins specific for mannose, which have a unique structure consisting of a C-type lectin domain and a collagen-like domain. They are involved in innate immunity.
- 5) Invertebrates are known to contain various lectins in their body fluids, probably as body-protection factors. Recently, some lectins from an echinoderm were found to show hemolytic activity.
- 6) Annexins, a group of proteins having affinity to lipids that were recently shown to be lectins showing binding to glycosaminoglycans.
- 7) The legume lectin family, which consists of a large number of members, such as ConA, with variable saccharide specificity comparable to C-type lectins.
- 8) Ricin, the first lectin investigated in Russia more than 100 years ago. It is now evident that the ricin family has many other homologous members which differ in either toxicity or sugar-binding specificities.
Thus, a multifunctional molecule of the invention may bind to one or more carbohydrates. Carbohydrates to which lectins may bind also include, for example, carbohydrates comprising lactose, D-mannose, D-glucose, D-fucose, L-fucose (e.g. alpha-L-fucose), D-galactose, blood group A oligosaccharides, blood group B oligosaccharides, saccharides comprising alpha-D-Gal(1->3)[alpha-Lfuc(1->2)]-beta-D-Gal(1->3/4-beta-D-GlcNAc, saccharides comprising alpha-sialyl-[2->3]-lactose, alpha-D-mannosyl glycoconjugates, alpha-NeuNAc-[2->6]-Gal, alpha-NeuNAc-[2->6]-GalNAc, alpha-NeuNAc-[2->3]-Gal, N-acetyl-beta-D-glucosamine, terminal alpha-D-galactosyl residues, terminal beta-D-galactosyl residues, N-acetyllactosamine, terminal alpha-D-mannosyl residues, N-acetyl-beta-D-glucosamine, terminal N-acetyl-D-galactosamine, N-acetylneuraminic acid, and terminal alpha-D-galactosaminyl residues.
The multifunctional molecule which comprises a lectin may comprise, for example, the whole of a naturally occurring lectin or a portion of a naturally occurring lectin, e.g about (or at least about) 5, 8, 10, 12, 15, 20, 25, 35, 50, 60, 70, 80, 100, or 120 contiguous amino acids of a naturally occurring polypeptide lectin. In one embodiment the multifunctional molecule comprises a carbohydrate-binding domain of a naturally occurring lectin, i.e., a portion of a lectin that can bind to a carbohydrate in the absence of the remainder of the lectin. In another embodiment the lectin may be non-naturally occurring, e.g. identified from an artificial library of molecules or designed by modifying the structure of a naturally occurring lectin.
Lectins known as “hemagglutinins” bind to carbohydrates on erythrocytes, e.g. blood group antigens, and when incubated with these cells cause them to aggregate. The influenza virus hemagglutinin, for example, binds to sialic acid. There are at least 15 known influenza hemagglutinin subtypes, defined by their distinct antigenic properties. Any of these subtypes, designated, e.g., H1, H2, H3, H4, H5, H6, H7, H8, H9, H10, H11, H12, H13, H14, and H15, may provide amino acid sequences useful in the compositions and methods of the invention. In one embodiment of the invention, the hemagglutinin is of a subtype from a virus that infects humans, e.g. H1, H2, or H3. In another embodiment, the hemagglutinin is of a subtype from a virus that does not infect humans, e.g. one of H4 through H15. Amino acid sequences can vary up to about 20% for influenza hemagglutinins within a given subtype, and can vary between about 30% and about 70% for influenza hemagglutinins from different subtypes. Methods for determining amino acid sequence homology are known to those of skill in the art. Examples of other software that can perform sequence comparisons to determine the % identity between hemagglutanin variants (or variants of any portion of the multifunctional molecules disclosed herein) include, but are not limited to, the BLAST package (Ausubel et al., 1995, Short Protocols in Molecular Biology, 3rd Edition, John Wiley & Sons), FASTA (Atschul et al., 1990, J. Mol. Biol., 403-410) and the GENEWORKS suite of comparison tools. Both BLAST and FASTA are available for offline and online searching.
Although the final % homology can be measured in terms of identity, the alignment process itself is typically not based on an all-or-nothing pair comparison. Instead, a scaled similarity score matrix is generally used that assigns scores to each pairwise comparison based on chemical similarity or evolutionary distance. An example of such a matrix commonly used is the BLOSUM62 matrix the default matrix for the BLAST suite of programs. GCG Wisconsin programs generally use either the public default values or a custom symbol comparison table if supplied. It is preferred to use the public default values for the GCG package, or in the case of other software, the default matrix, such as BLOSUM62.
Advantageously, the BLAST algorithm is employed, with parameters set to default values. The BLAST algorithm is described in detail in Altschul et al., (1990) J. Mol. Biol. 215:403-410, which is incorporated herein by reference. The search parameters are defined as follows, and can be advantageously set to the defined default parameters.
Advantageously, “substantial identity” when assessed by BLAST equates to sequences which match with an EXPECT value of at least about 7, preferably at least about 9 and most preferably 10 or more. The default threshold for EXPECT in BLAST searching is usually 10.
BLAST (Basic Local Alignment Search Tool) is the heuristic search algorithm employed by the programs blastp, blastn, blastx, tblastn, and tblastx; these programs ascribe significance to their findings using the statistical methods of Karlin and Altschul (Karlin and Altschul 1990, Proc. Natl. Acad. Sci. USA 87:2264-68; Karlin and Altschul, 1993, Proc. Natl. Acad. Sci. USA 90:5873-7) with a few enhancements. The BLAST programs are tailored for sequence similarity searching, for example to identify homologues to a query sequence. For a discussion of basic issues in similarity searching of sequence databases, see Altschul et al (1994) Nature Genetics 6:119-129.
The five BLAST programs available through the National Institutes of Health (NIII; Bethesda, Md.) perform the following tasks: blastp compares an amino acid query sequence against a protein sequence database; blastn compares a nucleotide query sequence against a nucleotide sequence database; blastx compares the six-frame conceptual translation products of a nucleotide query sequence (both strands) against a protein sequence database; tblastn compares a protein query sequence against a nucleotide sequence database dynamically translated in all six reading frames (both strands); tblastx compares the six-frame translations of a nucleotide query sequence against the six-frame translations of a nucleotide sequence database.
BLAST uses the following search parameters:
HISTOGRAM—Display a histogram of scores for each search; default is yes. (See parameter H in the BLAST Manual).
DESCRIPTIONS—Restricts the number of short descriptions of matching sequences reported to the number specified; default limit is 100 descriptions. (See parameter V in the manual page).
EXPECT—The statistical significance threshold for reporting matches against database sequences; the default value is 10, such that 10 matches are expected to be found merely by chance, according to the stochastic model of Karlin and Altschul (1990). If the statistical significance ascribed to a match is greater than the EXPECT threshold, the match will not be reported. Lower EXPECT thresholds are more stringent, leading to fewer chance matches being reported. Fractional values are acceptable. (See parameter E in the BLAST Manual).
CUTOFF—Cutoff score for reporting high-scoring segment pairs. The default value is calculated from the EXPECT value (see above). HSPs are reported for a database sequence only if the statistical significance ascribed to them is at least as high as would be ascribed to a lone HSP having a score equal to the CUTOFF value. Higher CUTOFF values are more stringent, leading to fewer chance matches being reported. (See parameter S in the BLAST Manual). Typically, significance thresholds can be more intuitively managed using EXPECT.
ALIGNMENTS—Restricts database sequences to the number specified for which high-scoring segment pairs (HSPs) are reported; the default limit is 50. If more database sequences than this happen to satisfy the statistical significance threshold for reporting (see EXPECT and CUTOFF below), only the matches ascribed the greatest statistical significance are reported. (See parameter B in the BLAST Manual).
MATRIX—Specify an alternate scoring matrix for BLASTP, BLASTX, TBLASTN and TBLASTX. The default matrix is BLOSUM62 (Henikoff & Henikoff, 1992). The valid alternative choices include: PAM40, PAM120, PAM250 and IDENTITY. No alternate scoring matrices are available for BLASTN; specifying the MATRIX directive in BLASTN requests returns an error response.
STRAND—Restrict a TBLASTN search to just the top or bottom strand of the database sequences; or restrict a BLASTN, BLASTX or TBLASTX search to just reading frames on the top or bottom strand of the query sequence.
FILTER—Mask off segments of the query sequence that have low compositional complexity, as determined by the SEG program of Wootton & Federhen (1993) Computers and Chemistry 17:149-163, or segments consisting of short-periodicity internal repeats, as determined by the XNU program of Clayerie & States (1993) Computers and Chemistry 17:191-201, or, for BLASTN, by the DUST program of Tatusov and Lipman (NIH). Filtering can eliminate statistically significant but biologically uninteresting reports from the blast output (e.g., hits against common acidic-, basic- or proline-rich regions), leaving the more biologically interesting regions of the query sequence available for specific matching against database sequences.
Low complexity sequence found by a filter program is substituted using the letter “N” in nucleotide sequence (e.g., “NNNNNNNNNNN”) and the letter “X” in protein sequences (e.g., “XXXXXXXXX”).
Filtering is only applied to the query sequence (or its translation products), not to database sequences. Default filtering is DUST for BLASTN, SEG for other programs.
It is not unusual for nothing at all to be masked by SEG, XNU, or both, when applied to sequences in SWISS-PROT, so filtering should not be expected to always yield an effect. Furthermore, in some cases, sequences are masked in their entirety, indicating that the statistical significance of any matches reported against the unfiltered query sequence should be suspect.
NCBI-gi—Causes NCBI gi identifiers to be shown in the output, in addition to the accession and/or locus name.
Most preferably, sequence comparisons are conducted using the simple BLAST search algorithm provided by the NIH. In some embodiments of the present invention, no gap penalties are used when determining sequence identity.
Influenza hemagglutinin is expressed as a single polypeptide chain, designated HA0, which trimerizes post-translationally. HA0 is proteolytically cleaved to yield two domains, HA1 and HA2, which are disulfide-bonded to each other. HA1 comprises significant sialic acid binding activity, while HA2 is anchored to the viral membrane and facilitates fusion of this membrane with a host cell membrane. In preferred embodiments of the invention, the
multifunctional molecule comprising first and second parts comprises an amino acid sequence of an HA1 domain.
Additional examples of lectin molecules useful in the present invention include, but are not limited to, those lectins shown in Table 1, and variants thereof having at least 50%, 70%, 90%, and up to 99% sequence homology with the sequences of the lectins shown in Table 1.
Lectin codes take the following form:
An explanation of each index variable follows.
LLL refers to the general category of agglutinin. At this point six general categories are recognized: lectins (LEC), integrins (INT), cadherins (CDH), annexins (ANN), selectins (SEL) and galectins (GLT). The x value refers to the taxonomic groups of the agglutinin, Table 1 summarizes these categories:
- Ggg stands for the three first letters of the plant genus name (in Latin).
- Sss stands for the three first letters of the plant species name (in Latin).
ti refers to the tissue from which the lectin has been isolated. Table 2 summarizes the indices used for the various tissues:
- T refers to the lectin subtype. Hololectins, merolectins, chimerolectins and superlectins are indicated by the letters H, M, C and S, respectively.
sp refers to the specificity group. Each group is indicated by the index given in Table 3:
Lipids
A multifunctional molecule of the invention can also be a molecule that comprises a first part which comprises a lipid and a second part which comprises an amino acid sequence which can bind to a cell surface molecule, e.g. a cell surface molecule of an APC. The attachment of a lipid, e.g. a long-chain fatty acid, to a molecule, e.g. a polypeptide, can permit the complex to become stably associated with the plasma membrane when the complex is admixed with a cell (Nagarajan et al, 1995, J Immunol Methods 184:241-51; McHugh et al, 1995, PNAS 92:8059-63; van den Berg et al, 1995, J Cell Biol, 131:669-77). This is believed to occur through intercalation of the lipid into the membrane. A convenient method of producing a lipid-associated polypeptide comprises expressing, in a suitable host cell, a nucleic acid encoding, in part, a signal sequence directing the post-translational addition of a GPI moiety. Using recombinant DNA technology, a naturally non-GPI linked protein can be expressed as a GPI-linked protein by constructing a nucleic acid that encodes the protein linked to a heterologous GPI signal sequence. Nucleotide sequences encoding GPI signal sequences useful for this purpose include, for example, those comprised by decay accelerating factor (e.g., sequences encoding amino acid sequence “22” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32; sequences encoding signal sequences disclosed in Caras et al, U.S. Pat. No. 5,109,113); brevican (e.g., nt 1982-2047 of Genbank accession number X86406), mesothelin (e.g., nt 1858-1983 of Genbank U40434), coccidioides immitis antigen 2 (e.g., sequences encoding amino acids 172-194 of NCBI Entrez protein database accession #1256444, Zhu et al, 1996, Gene 181:121-5), acetylcholinesterase (e.g., sequences encoding the peptide “HC” as described in Duval et al, 1992, EMBO J. 11:3255-61; (e.g., sequences encoding amino acid sequence “19” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32)), human folate receptors alpha and beta (e.g., sequences encoding amino acids 230-257 of NCBI Entrez protein database accession #182416 or amino acids 228-255 of NCBI Entrez protein database accession #1655592, Yan and Ratnam, 1995, Biochemistry 34:14594-600), 5′ nucleotidase (e.g., sequences encoding amino acids 547-570 or 547-574 of NCBI Entrez protein database accession #404502, Furukawa et al, 1994, Biochim Biophys Acta 1190:273-8; (e.g., sequences encoding amino acid sequences “5” or “6” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32)), CD59 (e.g. encoded by nt 393-473 of Genbank U48255; sequences encoding amino acid sequence “20” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32; sequences encoding amino acids 74-101 of FIG. 2 of Powell et al, 1997, J Immunol 158:1692-1702), T-cadherin (e.g., sequences encoding the 76 C-terminal amino acids of chick T cadherin as described by Koller and Ranscht, 1996, J Biol Chem 271:30061-7), aminopeptidase P (e.g., sequences encoding amino acids 649-673 of NCBI Entrez protein database accession #1517942, Hyde et al, 1996, Biochem J 319:197-201), carboxypeptidase M, CD16B, Thy 1, carbonic anhydrase IV (e.g., sequences encoding amino acids 284-312 of NCBI Entrez protein database accession #179791, Okuyama et al, 1995, Arch Biochem Biophys 320:315-22), placental alkaline phosphatase (e.g., sequences encoding amino acids 498-529 of NCBI Entrez protein database accession #178464, Oda et al, 1994, Biochem J 301:577-83), neuronal glycoprotein F3, carcinoembryonic antigen (e.g., sequences encoding amino acid sequence “28” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), MRC-OX45 (e.g., sequences encoding amino acid sequence “2” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), RT 6.2 (e.g., sequences encoding amino acid sequence “3” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), D. discoideum prespore-specific antigen (e.g., sequences encoding amino acid sequence “4” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), microsomal dipeptidase (e.g., sequences encoding amino acid sequence “8” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), CAMPATH-1 (e.g., sequences encoding amino acid sequence “9” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei PARP (e.g., sequences encoding amino acid sequence “10” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei VSG Mit 118a (e.g., sequences encoding amino acid sequence “11” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei VSG Mit 117a (e.g., sequences encoding amino acid sequence “12” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei VSG MITat 1.1000 BC (e.g., sequences encoding amino acid sequence “13” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei VSG MITat 1.5b (e.g., sequences encoding amino acid sequence “14” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei VSG ILTat 1.1 (e.g., sequences encoding amino acid sequence “15” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei VSG TxTat 1 (e.g., sequences encoding amino acid sequence “16” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. brucei VSG Mit 221 (e.g., sequences encoding amino acid sequence “17” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), prion proteins (e.g., sequences encoding amino acid sequence “18” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), urokinase receptor (e.g., sequences encoding amino acid sequence “21” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), T. congolense VSG YNat 1.1 (e.g., sequences encoding amino acid sequence “23” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), S. cerevesiae GAS-1 (e.g., sequences encoding amino acid sequence “24” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), Thy-1 (e.g., sequences encoding amino acid sequences “25” or “26” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), L. major PSP (e.g., sequences encoding amino acid sequence “29” in Table 1 of Bucht and Hjalmarsson, 1996, Biochim Biophys Acta 1292:223-32), D. discoideum contact site A glycoprotein (e.g., sequences encoding the 25 C-terminal amino acids as described in Barth et al, 1996, Biochem J 317:533-40) CD24, and synthetic sequences (e.g. as described by Coyne et al, 1993, J Biol Chem 268:6689-93).
GPI-linked polypeptides can be extracted from cells using the following method. 5×106 cells are spun down and frozen at −80° C. The pellet is thawed in 14 ml of 0.15M NaCl/10 mM Tris 7.4/0.1 mM primaquine/2% Trito X-114 with stirring at 0° C. for 1 h, then centrifuged at 8800 g at 0° C. for 10 min. The supernatant is maintained at −20° C. overnight, thawed at room temperature, and then placed at 32° C. for 12 min. It is then centrifuged at 3000 g for 3 min at 32° C. The top layer is decanted and 11 ml of cold Buffer A (0.15M NaCl/10 mM Tris 7.4/0.1 mM primaquine/0.06% Triton X-114) is added to the bottom layer. This is incubated on ice for 10 min. The 12 min 32° C. incubation 32° C. 30002 centrifugation, decanting of top layer, and addition of 11 ml cold Buffer A to bottom layer are repeated. The solution is centrifuged at 18000 g for 10 min at 0° C. The 12 min 32° C. incubation, 32° C. 3000 g centrifugation, and decanting of top layer are repeated. 3 vol of cold acetone are added to the final bottom phase. The solution is centrifuged at 12, 000 RPM for 30 min, the supernatant removed, and the protein pellet containing the GPI fraction dried under vacuum. Specific proteins can be purified by methods well-known to those skilled in the art, e.g. immunoaffinity purification.
Another method of producing a lipid-linked polypeptide is to chemically link the polypeptide to a fatty acid such as palmitate. 1.5 mg/ml of the polypeptide is suspended in PBS, pH 7.8, containing 0.3% deeoxycholic acid, 0.1% sodium bicarbonate, and 0.1% sodium azide. The optimal final pH of the solution is 7.6-8.0. The mixture is warmed to 37° C. and the N-hydroxysuccinimide ester of palmitic acid (Research Organics, Cleveland, Ohio) is added to a final concentration of 0.1 mg/ml. The solution is incubated overnight at room temperature. The polypeptide is purified by passage through a 16×250 mm Sephadex G-75 chromatography column equilibrated with 0.15% deoxycholic acid in PBS, pH 7.6.
Crosslinking Moieties Useful According to the Invention
Another convenient method of linking a ligand to an antigen bearing target is to use a crosslinking agent. A “crosslinking agent” is a chemical entity that can react with functional groups on at least two other molecules, e.g. two polypeptides or a polypeptide and a lipid, such that upon reaction with the crosslinking agent the two molecules become covalently linked. Thus, a ligand for CD40 can be crosslinked to a molecule on the surface of a cell.
A wide variety of crosslinking agents, both bifunctional and polyfunctional, are known in the art and are commercially available, e.g. from Sigma (St. Louis, Mo.). These include, for example, S-acetylmercaptosuccinic anhydride, 5-acetylthioglycolic acid N-hydroxysuccinimide ester, S-acetylthiopropionic acid N-hydroxysuccinimide ester, adipic acid dihydrazide, 4-azidobenzoic acid N-hydroxysuccinimide ester, N-(5-azido-2-nitrobenzyloxy)succinimide, 6-(4-azido-2-nitrophenylamino)hexanoic acid N-hydroxysuccinimide ester, p-azidophenacyl bromide, N-(4-azidophenylthio)phthalimide, 4-azidosalicylic acid N-hydroxysuccinimide ester, bromoacetic acid N-hydroxysuccinimide ester, 1,4-butanediol diglycidyl ether, carbonyl-bis(L-methionine p-nitrophenyl ester), 2-diazo-3,3,3-trifluoropropionic acid p-nitrophenyl ester, diethyl malonimidate, 1,5-difluoro-2,4-dinitrobenzene, 4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid, dimethyl adipimidate, dimethyl 3,3′-dithiobispropionimidate, dimethyl pimelimidate, dimethyl suberimidate, 4,4′-dithiobisphenyl azide, dithiobis(propionic acid N-hydroxysuccinimide ester), ethylene glycol bis-(succinic acid N-hydroxysuccinimide ester), 4-fluoro-3-nitrophenyl azide, bis-(4-fluoro-3-nitrophenyl) sulfone, p-formylbenzoic acid N-hydroxysuccinimide ester, glutaraldehyde, 2-iminothiolane, 6-(iodoacetamido)caproic acid N-hydroxysuccinimide ester, iodoacetic acid N-hydroxysuccinimide ester, 3-malemidoacetic acid N-hydroxysuccinimide ester, 3-malemidobenzoic acid N-hydroxysuccinimide ester, 4-(N-malemido)benzophenone, gamma-malemidobutyric acid N-hydroxysuccinimide ester, epsilon-malemidocaproic acid N-hydroxysuccinimide ester, 4-(N-malemidomethyl)cyclohexanecarboxylic acid N-hydroxysuccinimide ester, 4-(N-malemidomethyl)cyclohexanecarboxylic acid 3-sulfo-N-hydroxysuccinimide ester, beta-malemidopropionic acid N-hydroxysuccinimide ester, N,N′-bis(3-malemidopropionyl)-2-hydroxy-1,3-propanediamine, 1,4-phenylene diisothiocyanate, N,N′-o-phenylene dimalemide, N,N′-p-phenylene dimalemide, polyoxyethylene bis(glycidyl ether), bis(polyoxyethylene bis(glycidyl ether)), polyoxyethylene bis(imidazolylcarbonyl), bis(polyoxyethylene bis(imidazolylcarbonyl)), polyoxyethylene bis(p-nitrophenyl carbonate), 3-(2-pyridyldithio)propionic acid N-hydroxysuccinimide ester, suberic acid bis(N-hydroxysuccinimide) ester, succinic acid malemidoethyl N-hydroxysuccinimide ester, 1, 5 bis(succinimidooxycarbonyloxy)-pentane, and bis(N-succinimidyl) carbonate.
Ligands of a Cell Surface Protein
The multifunctional molecules of the present invention comprise one part which is a lectin and is capable of binding to at least one carbohydrate molecule on an antigen bearing target, and a second part comprising a ligand for a cell surface protein of an antigen presenting cell. The ligand can be any ligand which binds to one or more of the cell surface molecules indicated by GenBank Accession number in Appendix I or II. More preferably, however, the ligand includes, but is not limited to an opsonin, a cytokine, a heat shock protein, an adhesion molecule. a defensin, or a counterreceptor for a T cell costimulatory molecule; or a portion of any of these molecules, e.g., about (or at least about) 5, 8, 10, 12, 15, 20, 25, 35, 40, 50, 60, 70, 80, 100, or 120 contiguous amino acid residues, up to the full length of such a molecule.
Cytokines Useful According to the Invention
The term “cytokine” as defined hereinabove refers to a polypeptide molecule that is naturally secreted by mammalian cells and that binds to a cell surface receptor on a leukocyte. The term “cytokine” also refers herein to a polypeptide molecule that is a ligand for a receptor for a naturally occurring cytokine. Unlike an opsonin, a cytokine does not naturally contemporaneously bind an antigen and a cell-surface receptor.
Leukocytes which bear receptors for cytokines include, for example, monocytes, macrophages, dendritic cells, neutrophils, eosinophils, basophils, platelets, lymphocytes, T lymphocytes, B lymphocytes, NK cells, myeloma cells, lymphoma cells, and leukemic cells.
Without being bound by any one mechanism, it is believed that cell-surface associated cytokines provide an advantage over freely diffusible cytokines by allowing stable juxtaposition of the cytokine to the cell, thus increasing the concentration of cytokine in the vicinity of the cell.
Preferred cytokines are non-rodent cytokines, e.g primate, e.g. human cytokines.
Some cytokines can be regarded as belonging to one or more families of cytokines based on structural and/or functional properties. One such family consists of the interleukins. Interleukins are structurally diverse, but share the property of both being expressed by and acting on leukocytes. Examples of interleukins include IL-1 (e.g. polypeptides encoded by Genbank Accession No. M15330, M28983, E04743, M15131) IL-2 (e.g. polypeptides encoded by Genbank Accession No. E01108, K02797), IL-3 (e.g. polypeptides encoded by Genbank Accession No. A02046, M14743), IL-4 (e.g. polypeptides encoded by M13982, M25892), IL-5 (e.g. polypeptides encoded by X06270, J03478), IL-6 (e.g. polypeptides encoded by E02772, M20572), IL-7 (e.g. polypeptides encoded by J04156, M29054-29057), IL-8 (e.g. polypeptides encoded by M28130), IL-9 (e.g. sequences disclosed in Kelleher et al, Blood. 1991; 77: 1436-1441, Immunogenetics 1990;31(4):265-270), IL-10 (e.g. polypeptides encoded by M84340, U16720), IL-11 (e.g. sequences disclosed in Paul et al, Proc Natl Acad Sci USA. 1990; 87: 7512-7516, Morris et al, Exp Hematol. 1996; 24: 1369-1376), IL-12 (e.g. polypeptides encoded by Genbank Accession No. M86671, S82412; Genbank protein P29459, P29460), IL-13 (e.g. polypeptides encoded by U31120, L13028), 1L-14 (e.g. sequences disclosed in Ambrus et al, Proceedings of the National Academy of Science (USA) 1993; 90: 6330-4), IL-15 (e.g. polypeptides encoded by AF031167, U22339), 1L-16 (e.g. polypeptides encoded by AF006001, M90391), IL-17 (e.g. polypeptides encoded by U32659, U43088), IL-18 (e.g. polypeptides encoded by D49949, D49950), IL-19 (e.g. polypeptides encoded by AY040367), IL-20 (e.g. polypeptides encoded by NM02130, NM018724), IL-21 (e.g. polypeptides encoded by AF254069, AF254070), IL-22 (e.g. polypeptides encoded by AF279437), IL-23 (e.g. polypeptides encoded by AF301619, AF301620, AY055379 [p19 alpha chain combines with IL-12 p40 chain to form IL-23]), IL-24 (e.g. polypeptides encoded by AF276916, NM053095), IL-25 (e.g. polypeptides encoded by NM080837), TNF-alpha (e.g. polypeptides encoded by M16441, Y00467), and GM-CSF (e.g. polypeptides encoded by X03019, M11220) and their homologues among species. Nucleotide sequences encoding homologues will hybridize to each other under moderate- to high-stringency conditions.
Another family consists of the hematopoietins. Members of this family comprise helical regions, known as helices A, B, C, and D. Helices A and B and helices C and D run roughly parallel to each other, respectively. Examples of hematopoietins include IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-11, IL-12, IL-13, IL-15, GM-CSF, G-CSF (e.g. polypeptides encoded by Genbank Accession No. E01219, M13926), oncostatin M (e.g. polypeptides encoded by Genbank Accession No. D31942, sequences disclosed in Malik et al, Mol Cell Biol 1989, 9:2847-2853), LIF (e.g. polypeptides encoded by Genbank Accession No. X13967, X06381), CNTF (e.g. polypeptides encoded by Genbank Accession No. U05342, X60542), and their homologues among species. Nucleotide sequences encoding homologues will hybridize to each other under moderate- to high-stringency conditions.
Human IL2 is a protein of 133 amino acids (15.4 kDa) with a slightly basic pI. Murine and human IL2 display a homology of approximately 65%. IL2 is synthesized as a precursor protein of 153 amino acids with the first 20 amino-terminal amino acids functioning as a hydrophobic secretory signal sequence. The protein contains a single disulfide bond (positions Cys58/105) essential for biological activity.
IL2 is O-glycosylated at threonine at position 3. Variants with different molecular masses and charges are due to variable glycosylation. Non-glycosylated IL2 is also biologically active. Glycosylation appears to promote elimination of the factor by hepatocytes.
A dimeric form of human IL2, produced by the action of a transglutaminase isolated from regenerating fish optic nerves, has been shown to be a cytotoxic factor for rat brain oligodendrocytes in culture.
The human IL2 gene contains four exons. The IL2 gene maps to human chromosome 4q26-28 (murine chromosome 3). The homology of murine and human IL2 is 72% at the nucleotide level in the coding region.
The biological activities of IL2 are mediated by a membrane receptor that is expressed almost exclusively on activated, but not on resting, T-cells at densities of 4-12×13 receptors/cell. Activated B-cells and resting mononuclear leukocytes rarely express this receptor. The expression of the IL2 receptor is modulated by IL5 and IL6. Three different types of IL2 receptors are distinguished that are expressed differentially and independently. The high affinity IL2 receptor (Kdis ˜10 pM) constitutes approximately 10% of all IL2 receptors expressed by a cells. This receptor is a membrane receptor complex consisting of the two subunits IL2R-alpha (TAC antigen=T-cell activation antigen; p55) and IL2R-beta (p75; CD122) as the ligand binding domains and a gamma chain as a signaling component. p75 is expressed constitutively on resting T-lymphocytes, NK-cells, and a number of other cell types while the expression of p55 is usually observed only after cell activation. p55 is, however, synthesized constitutively by a number of tumor cells and by HTLV-1-infected cells.
IL2 receptor expression of monocytes is induced by IFN-gamma, so that these cells become tumor-cytotoxic. In T-cells the expression of p75 can be reduced by IL3. An intermediate affinity IL2 receptor (Kdis=100 pM) consists of the p75 subunit and a gamma chain (see below) while a low affinity receptor (Kdis=10 nM) is formed by p55 alone.
p55 (e.g. polypeptides encoded by Genbank Accession No. X01057) has a length of 251 amino acids with an extracellular domain of 219 amino acids an a very short cytoplasmic domain of 13 amino acids. The p55 gene maps to human chromosome 10p14-p15.
p75 (e.g. polypeptides encoded by Genbank Accession No. M26062, M28052) has a length of 525 amino acids with an extracellular domain of 214 amino acids and a cytoplasmic domain of 286 amino acids. The p75 gene contains 10 exons and has a length of approximately 24 kb. It maps to human chromosome 22q11.2-q12 and to murine chromosome 15 (band E).
A third 64 kDa subunit of the IL2 receptor, designated gamma, has been described (e.g. polypeptides encoded by Genbank Accession No. D13821, D11086). Murine and human gamma subunits of the receptor have approximately 70% sequence identity at the nucleotide and amino acid levels. This subunit is required for the generation of high and intermediate affinity IL2 receptors but does not bind IL2 by itself. These two receptor types consist of an alpha-beta-gamma heterotrimer and a beta-gamma heterodimer, respectively. The gene encoding the gamma subunit of the IL2 receptor maps to human chromosome Xq13, spans approximately 4.2 kb and contains eight exons. The gamma subunit of the IL2 receptor has been shown recently to be a component of the receptors for IL4 and IL7. It is also believed to be a component of the IL13 receptor.
The amino acids at positions 267-317 lying directly adjacent to the transmembrane region of p75 are involved in IL2-mediated signal transduction. In addition the IL2 receptor is associated with a number of other proteins (p22, p40, p100) which are thought to be involved in mediating conformational changes in the receptor chains, receptor-mediated endocytosis, and further signal transduction processes. One of the identified proteins is the 95 kDa cell adhesion molecule ICAM-1 which probably focuses IL2 receptors at regions of cell-to-cell contacts and thus may mediate paracrine activities, for example, during IL2-mediated stimulation of T-cells. Another protein associated with p75 is a tyrosine-specific protein kinase called lck. The observation that proliferation of cells induced by IL2 is inhibited by specific inhibitors of protein tyrosine kinases in an lck negative cell line suggests that other kinases may also be associated with IL2 receptors. Two such kinases, called fyn and lyn, have been identified. In addition, IL2 receptor signaling may also be mediated by vav.
Activated lymphocytes continuously secrete a 42 kDa fragment of the TAC antigen. This fragment circulates in the serum and plasma and functions as a soluble IL2 receptor (sIL2R). The concentrations of this soluble receptor vary markedly in different pathological situations, for example, infections, autoimmune diseases, leukemias, or after organ transplantation. Levels may increase up to 100-fold. The levels of sIL2R appear to correlate with the severity of HIV-induces diseases and may be of diagnostic value also in other settings.
Mouse and human IL2 both cause proliferation of T-cells of the homologous species at high efficiency. Human IL2 also stimulates proliferation of mouse T-cells at similar concentrations, whereas mouse IL2 stimulates human T-cells at a lower (sixfold to 170-fold) efficiency.
IL2 is a growth factor for all subpopulations of T-lymphocytes. It is an antigen-unspecific proliferation factor for T-cells that induces cell cycle progression in resting cells and thus allows clonal expansion of activated T-lymphocytes. This effect is modulated by hormones such as prolactin.
IL2 also promotes the proliferation of activated B-cells also this requires the presence of additional factors, for example, IL4.
Due to its effects on T-cells and B-cells IL2 is a central regulator of immune responses. It also plays a role in anti-inflammatory reactions, in hematopoiesis and in tumor surveillance. IL2 stimulates the synthesis of IFN-gamma in peripheral leukocytes and also induces the secretion of IL1, TNF-alpha and TNF-beta.
It is believed that he induction of the secretion of tumoricidal cytokines apart from the activity in the expansion of LAK cells (lymphokine-activated killer cells) are probably the main factors responsible for the antitumor activity of IL2.
IL2 can be assayed in bioassays employing cell lines that respond to the factor (e.g., ATH8, CT6, CTLL-2, FDCPmix, HT-2, NKC3, TALL-103). Specific ELISA assays for IL2 and enzyme immunoassays for the soluble receptor are also available. The soluble receptor can be detected also by employing biotinylated IL2 and flow-through cytometry or ELISA assays.
IL2 displays significant anti-tumor activity for a variety of tumor cell types since it supports the proliferation and clonal expansion of T-cells that specifically attack certain tumors. IL2 is increasingly used to treat patients with cancers refractory to conventional treatment. Combination therapy with systemically administered IL2 has resulted in long-term remissions in 30% of patients with metastatic renal cell carcinoma, for which there is no standard treatment. Objective and long-lived clinical responses have been documented also in a proportion of patients with melanoma or acute myeloid leukemia.
High dose systemic IL2 therapy is also associated with a great number of unwanted toxic side-effects. IL2 has additional effects on other components of the cellular immune system, including B-cells and macrophages, and induces the secretion of other soluble mediators, including TNF-alpha, TNF-beta, and IFN-gamma. These effects may contribute to the antitumor activity of IL2 as well as to its dose-related toxicity.
The transduction of murine tumor cells with a functional IL2 gene has been shown to lead to the rejection of the genetically modified cells by syngeneic hosts. Altered tumor cells expressing IL2 also increase systemic immunity.
Human IL4 is a protein of 129 amino acids (20 kDa) that is synthesized as a precursor containing a hydrophobic secretory signal sequence of 24 amino acids. IL4 is glycosylated at two arginine residues (positions 38 and 105) and contains six cysteine residues involved in disulfide bond formation. The disulfide bonds are essential for biological activity. Some glycosylation variants of IL4 have been described that differ in their biological activities. A comparison of murine and human IL4 shows that both proteins only diverge at positions 91-128.
An IL4 variant, Y124D, in which Tyr124 of the recombinant human protein is substituted by an aspartic acid residue, binds with high affinity to the IL4 receptor (Kd=310 pM). This variant is a powerful antagonist for the IL4 receptor system. It retains no detectable proliferative activity for T-cells and competitively inhibits IL4-dependent T-cell proliferation (K(i)=620 pM). The existence of this mutant demonstrates that high affinity binding and signal generation can be uncoupled efficiently in a ligand. Y124D also acts as a powerful antagonist for the IL13 receptor.
The human IL4 gene contains four exons and has a length of approximately 10 kb. It maps to chromosome 5q23-31. The murine gene maps to chromosome 11. The IL4 gene is in close proximity to other genes encoding hematopoietic growth factors (e.g., GM-CSF, M-CSF, IL3, IL5). The distance between the IL4 and the IL5 gene is approximately 90-240 kb.
At the nucleotide level the human and the murine IL4 gene display approximately 70% homology. The 5′ region of the IL4 contains several sequence elements, designated CLE (conserved lymphokine element), that are binding sites for transcription factors controlling the expression of this and other genes. A sequence motif, called P sequence (CGAAAATTTCC; SEQ ID NO: 1) in the 5′ region of the human IL4 gene (positions −79-−69) is the binding site for a nuclear factor, called NF(P), mediating the response to T-cell activation signals.
The biological activities of IL4 are mediated by a specific receptor (Kdis=20-100 pM) which is expressed at densities of 100-5000 copies/cell (e.g. polypeptides encoded by Genbank Accession No. M29854, X52425). The extracellular domain of the IL4 receptor is related to the receptors for erythropoietin (Epo), IL6, and the beta chain of the IL2 receptor. It has been given the name CD124.
The cDNA for the murine IL4 receptor encodes a transmembrane protein of 810 amino acids (including a secretory signal sequence). This receptor has a large intracellular domain of 553 amino acids. The human receptor has an extracellular domain of 207 amino acids, a transmembrane domain of 24 residues, and a large intracellular domain of 569 amino acids.
The IL4 receptor has been shown recently to contain the gamma subunit of the IL2 receptor as a signaling component. This gamma subunit is also associated with the receptors for IL4 and IL7 and probably also of IL13. Two forms of the receptor have been described, one of which is secreted. The secreted receptor only contains the extracellular IL4 binding domain and is capable of blocking IL4 activities. An IL4 binding protein (IL4-BP) that binds IL4 with the same affinity as the IL4 receptor has been shown also to be a soluble IL4 receptor variant. These soluble receptors probably function as physiological regulators of cytokine activities by inhibiting receptor binding or act as transport proteins. Soluble receptors or binding proteins have been described also for IL1 (IL1 receptor antagonist), IL2, IL6, IL7, TNF-alpha, IGF, and IFN-gamma.
The biological activities of IL4 are species-specific; mouse IL4 is inactive on human cells and human IL4 is inactive on murine cells. IL4 promotes the proliferation and differentiation of activated B-cells, the expression of class II MHC antigens, and of low-affinity IgE receptors in resting B-cells. IL4 enhances expression of class II MHC antigens on B-cells. It can promote their capacity to respond to other B-cell stimuli and to present antigens for T-cells. This may be one way to promote the clonal expansion of specific B-cells and the immune system may thus be able to respond to very low concentrations of antigens. The production of IL4 by non-B non-T-cells is stimulated if these cells interact with other cells via their Fc receptors for IgE or IgG. This effect can be enhanced by IL3. IL2 and PAF (platelet activating factor) induce the synthesis of IL4 while TGF-beta inhibits it.
IL3 antagonizes the IL2-induced effects in B-cells and causes a slow decrease of the expression of IL2 receptors, thus inhibiting the proliferation of human B-cells stimulated by IL2. In activated B-cells IL4 stimulates the synthesis of IgG1 and IgE and inhibits the synthesis of IgM, IgG3, IgG2a and IgG2b. This isotype switching induced by IL4 in B-cells is antagonized by IFN-gamma. The growth of multiple myelomas can be suppressed by IL4 which inhibits the synthesis of IL6, a myeloma growth factor. IL4 also inhibits the synthesis of IL6 in human alveolar macrophages.
Pretreatment of macrophages with IL4 prevents the production of IL1, TNF-alpha and prostaglandins in response to activation of the cells by bacterial endotoxins or IFN-gamma.
IL4 synergises with Epo and G-CSF/Epo in the generation of colonies containing granulocytes or erythroid progenitor cells in a colony formation assay.
The classical detection method for IL4 is a B-cell costimulation assay measuring the enhanced proliferation of stimulated purified B-cells. IL4 can be detected also in bioassays, employing IL4-responsive cells (e.g., BALM-4; BCL1; CT.4S; CTL44; CTLL-2; Da; FDCPmix; HT-2; L4; L138.8A; M07E; MC/9; NFS-60; Ramos, Sez627, TF-1; TS1). A specific detection method for human IL4 is the induction of CD23 in a number of B-cell lines with CD23 detected either by flow-through cytometry or by a fluorescence immunoassay. An immunoassay that allows rapid determination of the rate of IN production under conditions preventing consumption/degradation is cytokine immunotrapping.
IL4 inhibits the growth of colon and mammary carcinomas. It has been shown to augment the development of LAK cells. The transduction of murine tumor cells with a functional IL4 gene has been shown to lead to the rejection of the genetically modified cells by syngeneic hosts. Altered tumor cells expressing IL4 also increase systemic immunity. Mice vaccinated with transduced cells reject a subsequent challenge of non-transduced cells, and, in some cases, a pre-existing tumor.
Human IL6 is a protein of 185 amino acids glycosylated at positions 73 and 172. It is synthesized as a precursor protein of 212 amino acids. Monocytes express at least five different molecular forms of IL6 with molecular masses of 21.5-28 kDa. They mainly differ by post-translational alterations such as glycosylation and phosphorylation.
IL6 isolated from various cell types shows some microheterogeneity in its N terminus. A 42-45 kDa form has been observed in plasma that is probably complexed with a carrier protein, alpha-2-macroglobulin (α2M). Murine and human IL6 show 65% sequence homology at the DNA level and 42% homology at the protein level.
IL6 is a member of a family of cytokines which also includes LIF, CNTF, Oncostatin M, IL11, and CT-1. All known members of the IL6 cytokine family induce hepatic expression of acute phase proteins.
A stable and highly bioactive designer cytokine consisting of a fusion protein between IL6 and a soluble IL6 receptor, designated H-IL6, has been used for human hematopoietic progenitor cell expansion and is useful in cases in which cells do not respond to IL6 but require a stable complex consisting of IL6 and a soluble IL6 receptor.
The human IL6 gene has a length of approximately 5 kb and contains five exons. It maps to human chromosome 7p21-p14 between the markers D7S135 and D7S370. The murine gene maps to chromosome 5. The nucleotide sequences of IL6 and G-CSF genes resemble each other in a way suggesting a possible evolutionary relationship.
The IL6 receptor (e.g. polypeptides encoded by Genbank Accession No. M20566, E03515) is expressed on T-cells, mitogen-activated B-cells, peripheral monocytes and some macrophage- and B-cell-derived tumor cell types. It is not expressed in resting B-cells but is in resting T-cells. In hepatocytes the IL6 receptor expression is enhanced after treatment with IL6 or IL1. In several cell types the expression of the IL6 receptor is also enhanced by glucocorticoids. The IL6 receptor gene maps to human chromosome 1q21.
The IL6 receptor is a strongly glycosylated protein of 80 kDa and a length of 449 amino acids. It has been designated CD126. It is synthesized as a precursor of 468 amino acids. The molecular structure resembles that of receptors for M-CSF, PDGF and IL1 in that the receptor contains an immunoglobulin-like sequence domain in the aminoterminal region of the extracellular receptor domain.
The intracellular domain of the IL6 receptor has a length of approximately 82 amino acids and does not show any homology to other proteins involved in intracellular signal transduction. Two different forms of the receptor have been described that bind IL6 with different affinities (Kdis=10−9 and 10−11 M) and most likely arise by post-translational modification of the same receptor protein. Biological activities of IL6 have been found also at concentrations of 10−13-10−15 M suggesting either the existence of other high-affinity receptor conformations or the existence of further receptor molecules with higher affinities.
IL6 receptor-mediated signal transduction involves protein kinase C and also adenylate cyclase.
The complex formed between IL6 and its receptor associates with a transmembrane glycoprotein, gp130 (918 amino acids; cytoplasmic domain of 277 amino acids), that is involved in signal transduction. Binding of IL6 to its receptor leads to disulfide-linked homodimerization of gp130 and the associated activation of a tyrosine kinase as the first step of signal transduction. gp130 is expressed also in cells that do not express IL6 receptors. It has been found to be a component of other receptors, including those for IL11, LIF, Oncostatin M, and CNTF, and CT-1. This explains why LIF, CNTF, and IL6 share many biological activities although the factors themselves are not related to each other. A factor resembling STAT proteins, termed LIL factor, has been found to be involved in signaling pathways of IL6, and also of IL1 and bacterial lipopolysaccharides.
A soluble form of the IL6 receptor (IL6R-SUP (IL6 receptor soluble urinary protein)) has been described also that also interacts with gp130. These soluble receptors probably function as physiological regulators of cytokine activities by inhibiting receptor binding or act as transport proteins. Similar soluble receptors or binding proteins have been described also for IL1 (IL1ra, IL1 receptor antagonist), IL2, IL4, IL7, TNF-alpha, IGF, and IFN-gamma.
Some cells, including hematopoietic progenitor cells and neuronal cells, are only responsive towards a combination of IL6 and soluble IL6 receptor but not to IL6 alone.
Human IL6 is biologically active in monkeys, rats, and mice. Murine IL6 is not active in human cells. The plethora of biological activities is exemplified by the many different acronyms under which IL6 has been described. IL6 is a pleiotropic cytokine influencing antigen-specific immune responses and inflammatory reactions. It is one of the major physiological mediators of cute phase reaction. In hepatocytes IL6 in combination with glucocorticoids induces the synthesis of metallothioneins and increases intracellular zinc levels, thus preventing CCL4-induced hepatotoxicity. IL6 is a neurotrophic factor for cholinergic neurons that promotes their survival in culture. Some neuronal cell lines can be induced to differentiate by IL6.
IL6, like IL1, stimulates the synthesis of ACTH (Corticotropin) in the pituitary. Glucocorticoids synthesized in response to ACTH inhibit the production of IL6, IL1 and TNF in vivo, thus establishing a sort of negative feedback loop between the immune system and neuroendocrine functions. In astrocytes IL6 induces the synthesis of Nerve Growth Factor (NGF).
IL6 is a B-cell differentiation factor in vivo and in vitro and an activation factor for T-cells. In the presence of IL2 IL6 induces the differentiation of mature and immature T-cells into cytotoxic T-cells. IL6 also induces the proliferation of thymocytes and probably plays a role in the development of thymic T-cells.
IL6 is capable of inducing the final maturation of B-cells into immunoglobulin-secreting plasma cells if the cells have been pre-activated by IL4. In B-cells IL6 stimulates the secretion of antibodies to such a degree that serum IgG1 levels can rise 120-400-fold.
IL6 at concentrations of only 0.002 ng/mL is one of the major autocrine growth modulator for many human myelomas. The growth of these cells can be inhibited by monoclonal antibodies directed against IL6. It can be inhibited also by the introduction of antisense oligonucleotides against IL6 or by IL4. The growth-inhibitory effects of corticosteroids on myeloma cells is probably due to the steroid-induced reduction in the expression of IL6. The growth of human IL6 dependent myeloma cells can be inhibited also by IFN-gamma. IL6 may also function as an autocrine growth modulator for other tumor types, some of which have been found to secrete IL6 constitutively. IL6 has been shown to be an autocrine modulator of growth for in vitro cervical tumor cell growth. On the other hand IL6 blocks the growth of some solid tumors such as mammary carcinomas, cervical carcinomas, human lung cancer cell lines, histiocytic lymphomas, and melanomas.
IL6 and IL3 synergise in vitro in promoting the proliferation of multipotent hematopoietic progenitor cells. IL6 is also a thrombopoietin that induces the maturation of megakaryocytes in vitro and increases platelet counts in vivo. In murine, but not in human bone marrow cultures IL6 shows activities resembling those of GM-CSF.
Plasmacytoma cells produce IL6 and also the IL6 receptor. It has been suggested that these cells are stimulated in an autocrine fashion. A paracrine mechanism involving the presence of two different cell populations, one producing the factor and the other expressing the receptor, has been described also.
IL6 can be detected in bioassays employing IL6 responsive cell lines (e.g., 7TD1; B19; CESS, KPMM2, KT-3; M1, MH60-BSF-2, M07E; Mono Mac 6; NFS-60; PIL-6; SKW6-C14; T1165; XG-1). IL6 can be assayed also by its activity as a hybridoma growth factor. Sensitive immunoassays and colorimetric tests are also available. An ELISA assay exists for detecting the receptor-associated gp130 protein.
In combination with other cytokines (for example, IL2) IL6 may be useful in the treatment of some tumor types. The transduction of murine tumor cells with a functional IL6 gene has been shown to lead to the rejection of the genetically modified cells by syngeneic hosts. Altered tumor cells expressing IL6 also increase systemic immunity. Mice vaccinated with transduced cells reject a subsequent challenge of non-transduced cells, and, in some cases, a pre-existing tumor.
Human IL10 is a homodimeric protein with subunits having a length of 160 amino acids. Human IL10 shows 73% amino acid homology with murine IL10. The human IL10 contains four exons. It is closely related to the product of the BCRF-1 gene (Bam HI C fragment rightward reading frame) of Epstein-Barr virus (84% homology at the protein level). These two proteins are more closely related to each other than human and murine IL10. BCRF-1 has therefore also been called viral IL10 (vIL10). The human IL10 gene maps to chromosome 1. The human IL10 shows 81% homology with murine IL10 at the nucleotide level.
A receptor has been identified on murine and human cells by using radiolabeled IL10 (e.g. polypeptides encoded by Genbank Accession No. L12120, U00672). Mouse IL10 is capable of blocking binding of human IL10 to mouse but not human cells. The murine IL10 receptor has been cloned. This receptor is a protein of approximately 110 kDa that binds murine IL10 specifically. This receptor is structurally related to receptors for IFN.
IL10 inhibits the synthesis of a number of cytokines such as IFN-gamma, IL2 and TNF-beta in Th1 subpopulations of T-cells but not of Th2 cells. This activity is antagonized by IL4. The inhibitory effect on IFN-gamma production is indirect and appears to be the result of a suppression of IL12 synthesis by accessory cells. In the human system, IL10 is produced by, and down-regulates the function of, Th1 and Th2 cells. In macrophages stimulated by bacterial lipopolysaccharides IL10 inhibits the synthesis of IL1, IL6 and TNF-alpha by promoting, among other things, the degradation of cytokine mRNA. It also leads to an inhibition of antigen presentation. In human monocytes IFN-gamma and IL1 antagonize each other's production and function. IL10 has been shown also to be a physiologic antagonist of IL12.
IL10 also inhibits mitogen- or anti-CD3-induced proliferation of T-cells in the presence of accessory cells and reduces the production of IFN-gamma and IL2. Exogenous 1L2 and IL4 inhibit the proliferation-inhibitory effect but do not influence the production of IFN-gamma. In LPS-stimulated macrophages IFN-gamma increases the synthesis of IL6 by inhibiting the production of IL10. IL10 appears to be responsible for most or all of the ability of Th2 supernatants to inhibit cytokine synthesis by Th1 cells.
IL10 inhibits secretion of Ig by T-cell-independent antigens induced by IL5 but not that induced by IL2.
Murine Ly-1 B cells are the principal source of IL10. In contrast to other B-cells, Ly-1 B-cells express greatly elevated constitutive and inducible levels of IL10. These cells also have the distinctive property of continuous self-replenishment. The continuous treatment of newborn mice with anti-IL10 antibodies leads to a depletion of the Ly-1 B-cells while maintaining a normal population of splenic B-cells. These mice also contain greatly reduced serum immunoglobulin M levels and are also impaired in their antibody responses to specific antigens. IL10 is therefore a regulator of Ly-1 B-cell development. The mechanism of Ly-1 B-cell depletion appears to involve the increased production of IFN-gamma since co-administration of neutralizing anti-IFN-gamma antibodies substantially restores the number of peritoneal-resident Ly-1 B-cells in these mice.
IL10 is also a costimulator for the growth of mature and immature thymocytes (together with IL2, IL4 and IL7) and functions as a cytotoxic T-cell differentiation factor, promoting a higher number of IL2-activated cytotoxic T-lymphocyte precursors to proliferate and differentiate into cytotoxic effector cells. IL10 sustains viability of B-cells in vitro and also stimulates B-cells and promotes their differentiation. It enhances the expression of MHC class II antigens on B-cells whereas it inhibits MHC class II expression on monocytes. In B-cells activated via their antigen receptors or via CD40 IL10 induces the secretion of IgG, IgA and IgM. This effect is synergised by IL4 while the synthesis of immunoglobulins induced by IL10 is antagonized by TGF-beta. The activation of macrophages can be prevented by IL10.
It has been shown that human IL10 is a potent and specific chemoattractant for human T-lymphocytes. The chemotactic activity is directed towards cells expressing CD8 and not towards CD4 (+)cells. IL10 also inhibits the chemotactic response of CD4 (+)cells, but not of CD8 (+)cells, towards IL8. IL10 can be detected with a sensitive ELISA assay. The murine mast cell line D36 can be used to bioassay human IL10. The intracellular factor can be detected also by flow cytometry.
The introduction of an IL10 expression vector into CHO cells has been used to analyze the consequences of local IL10 production in vivo. These altered cells were no longer tumorigenic in nude mice or severe combined immunodeficient SCID mice and also suppressed the growth of equal numbers of co-injected normal CHO cells. While normal CHO tumors are usually substantially infiltrated by macrophages, these were virtually absent within CHO-IL10 tumor tissues, suggesting that IL10 indirectly suppresses tumor growth of certain tumors by inhibiting infiltration of macrophages which may provide tumor growth promoting activity.
Human IL12 is a heterodimeric 70 kDa glycoprotein consisting of a 40 kDa subunit (p40, 306 amino acids; 10% carbohydrate) and a 35 kDa subunit (p35, 197 amino acids; 20% carbohydrate) linked by disulfide bonds that are essential for the biological activity of IL12. p40 contains 10 cysteines and a binding site for heparin; p35 contains 7 cysteines.
The two subunits of IL12 are not related to any other known proteins. p40 shows some homology with the extracellular domain of the receptor for IL6, and p35 appears to be a homologue of IL6.
Bioactive murine and human IL12 fusion proteins combining the two IL12 subunits in a single molecule have been described. This designer cytokine retains antitumor activity in vivo. Flexi 12, a single chain protein retaining all of the biological characteristics of the dimeric recombinant IL12, has also been described.
The gene encoding the p40 subunit of IL12 (IL12B) maps to human chromosome 5q31-q33 in the same region that also harbors other cytokine genes. The gene encoding the p35 subunit of IL12 (IL12A) maps to human chromosome 3p 12-q 13.2. The expression of the two genes is regulated independently of each other.
The IL12 receptor appears to be a single protein of approximately 110 kDa (e.g. polypeptides encoded by Genbank Accession No. U03187, U23922, U64198, U64199). Up to 1000-9000 high affinity IL12 receptors/cell are expressed on peripheral blood mononuclear cells activated by various T-cell mitogens or by IL2. IL12 receptors are present on activated T-cells expressing CD4 and CD8 and on activated CD56 positive natural killer cells. Resting peripheral blood mononuclear cells, tonsillar B-cells, or tonsillar B-cells activated by anti-IgM/Dx, anti-IgM/Dx+IL2, or SAC+IL2 do not express the receptor. High affinity IL12 receptors are expressed constitutively on a transformed marmoset NK-like cell line, HVS.SILVA 40.
Binding of IL12 to its receptor can be prevented by monoclonal antibodies directed against the p40 subunit which therefore contains the binding site. The p40 subunit of IL12 shows homology with the extracellular domain of the IL6 receptor. A virus-encoded homologue of the p40 subunit is EBV-induced gene-3.
Human IL12 is not active in murine lymphocytes. Hybrid heterodimers consisting of murine p35 and human p40 subunits retain bioactivity on murine cells; however, the combination of human p35 and murine p40 is completely inactive on murine cells. Murine IL12 is active on both murine and human lymphocytes. The p40 subunit of murine IL12 subunit p40 (IL12p40) has been shown to specifically antagonize the effects of the IL12 heterodimer in different assay systems and to function as an endogenous specific inhibitor for the IL12 heterodimer.
IL12 stimulates the proliferation of human lymphoblasts activated by phytohemagglutinin. IL12 activates NK-cells positive for CD56, and this activity is blocked by antibodies specific for TNF-alpha. IL12 promotes specific allogenic CTL reactions. IL12 synergizes also with anti-CD3 antibodies and with allogeneic stimulation in mixed lymphocyte cultures in inducing T-cell proliferation.
In peripheral lymphocytes of the Th1 type IL12 induces the synthesis of IFN-gamma and IL2, and TNF. TNF-alpha also appears to be involved in mediating the effects of IL12 on natural killer cells since the effects of IL12 are inhibited by an antibody directed against TNF-alpha. IL12 and TNF-alpha are costimulators for IFN-gamma production with IL12 maximizing the IFN-gamma response; the production of IL12, TNF, and IFN-gamma is inhibited by IL10. In Th2 helper cells IL12 reduces the synthesis of IL4, IL5, and IL10.
IL12 synergises with suboptimal amounts of IL2 in promoting the proliferation of mononuclear cells in the peripheral blood and in promoting the generation of LAK cells (lymphokine activated killer cells). Picomolar concentrations of IL12 are as effective as nanomolar concentrations of IL2 in augmenting the cytolytic activity of natural killer cells expanded in vivo by IL2. IL12 also acts as a co-mitogen and potentiates the proliferation of resting peripheral cells induced by IL2.
IL12 enhances myelopoiesis of primitive bone marrow progenitor cells induced by SCF (stem cell factor) and synergizes with colony stimulating factors to induce proliferation. IL12 also has synergistic effects on more committed bone marrow progenitors, synergising with IL3, IL11, or IL3 plus SCF.
IL12 is potential clinical interest since it allows the reduction of doses of IL2 required for the generation of LAK cells (lymphokine-activated killer cells). IL12 has been shown to inhibit the growth of a variety of experimental tumors in vivo and to have antiangiogenic effects in vivo, which are, at least in part, mediated by IFN-gamma. IL12 therefore seems to be a potential candidate also for the treatment of angiogenesis-dependent malignancies.
IL19 and IL10 share 21 percent amino acid identity and are probably homologs. In monocytes treatment with bacterial lipopolysaccharides induces the synthesis of IL19 and this effect is potentiated in the presence of IL4 or IL13 but is unaffected by IFN-gamma. GM-CSF directly induces IL19 gene expression in monocytes. IL19 has been shown to bind to the IL20 receptor complex (Dumoutier L et al Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. Journal of Immunology 167(7): 3545-9 (2001); Gallagher G et al Cloning, expression and initial characterization of interleukin-19 (IL-i 9), a novel homologue of human interleukin-10 (IL-10). Genes Immun 1(7): 442-50 (2000)).
IL20 is structurally related to IL10. IL20 appears to be an autocrine factor for keratinocytes that regulates their participation in inflammation. Overexpression of IL20 in transgenic mice causes neonatal lethality with skin abnormalities characterized by an impairment of epidermal differentiation (Blumberg H et al Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104(1): 9-19 (2001); Dumoutier L et al Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. Journal of Immunology 167(7): 3545-9 (2001); Rich BE and Kupper TS Cytokines: IL-20-a new effector in skin inflammation. Current Biology 11(13): R531-4 (2001)).
An IL20 receptor has been identified to consist of two orphan class 2 cytokine receptor subunits. The receptor is expressed in skin and its expression is upregulated dramatically in psoriatic skin. Engagement of the receptor in a keratinocyte cell line involves signaling by one member of the STAT proteins, STAT3.
The IL20 receptor complex has been shown to bind also IL19 and IL24.
IL21 has been isolated by Parrish-Novak et al from a cDNA library derived from activated CD3 (+)T-cells in a search for the ligand of a type-I cytokine receptor isolated previously. The cDNA encodes a secreted protein of 131 amino acids protein most closely related to IL2 and IL15. The IL21 gene maps to human chromosome 4q26-q27 near the IL2 gene. IL21 mRNA is expressed in CD4 (+) but not in CD8 (+) T-cells after cell activation. It is not expressed also in B-cells and monocytes (Asao H et al Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. Journal of Immunology 167(1):1-5 (2001); Ozaki K et al Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proceedings of the National Academy of Science (USA) 97: 11439-11444 (2000); Parrish-Novak J et al Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63 (2000)).
IL21 stimulates proliferation of B-cell stimulated by crosslinking of the CD40 antigen. It inhibits proliferation stimulated by IL4 plus anti-IgM. IL21 augments stimulation of the proliferation of naive (CD45RA (+)) but not memory (CD45RO (+)) T-cells mediated by engagement of CD3. IL21 stimulates the proliferation of bone marrow progenitor cells and the expression of the NK-cell marker CD56 in the presence of IL15.
The IL21 receptor has been isolated by Parrish-Novak et al and found to be expressed by CD23 (+)B-cells, B-cell lines, a T-cell leukemia line, and NK-cell lines. The receptor gene has been mapped to human chromosome 16p12. The same receptor has been isolated by Ozaki et al, who called it NILR (novel interleukin receptor). The receptor (538 amino acids) is most closely related to human IL2 beta receptor. The receptor contains a WSXWS motif in the extracellular region, typical of type-1 cytokine receptors. The receptor is expressed on NK-cells, T-cells, and B-cell lines.
The common gamma chain, which is an indispensable subunit of the functional receptor complexes for IL2, IL4, 1L7, IL9, and IL15 has been shows also to be part of the IL21 receptor complex. The functional signalling complex activates Janus kinases JAK1, JAK3, and the STAT proteins STAT1, and STAT3 (Asao et al).
IL22 (180 amino acids including a signal sequence; 25 kDa; also called IL-TIF) was identified by a cDNA subtraction method as a gene induced specifically by IL9 in mouse T lymphocytes. The protein shows limited homology with IL10 (22 percent amino acid identity). Human and murine IL-TIF proteins share 79 percent amino acid identity.
The murine and human IL-TIF genes both consist of 6 exons. The human single-copy gene maps to chromosome 12q15 (90 Kb from the IFN-gamma gene, and 27 Kb from the AK155 gene encoding another IL10-related cytokine. In mice the gene is located also in the same region as the IFN-gamma gene. In BALB/c and DBA/2 mice the gene is a single copy gene. In C57B1/6, FVB and 129 mice the gene is duplicated. The two copies, termed IL-TIF-alpha and IL-TIF-beta show 98 percent nucleotide identity in the coding region and differ by a deletion of 658 nucleotide in IL-TIF-beta. This gene may be inactive.
Expression of IL-TIF is induced by IL9 in thymic lymphomas, T-cells, and mast cells, and by lectins in freshly isolated splenocytes. IL-TIF expression in T-cells does not require protein synthesis, and depends on the activation Janus kinases and STAT proteins. IL-TIF is expressed constitutively in thymus and brain.
In HepG2 human hepatoma cells IL-TIF up-regulates the production of acute phase proteins. IL-TIF also acts as a pro-inflammatory cytokine in vivo because injection of the protein also induces the synthesis of acute phase proteins. Synthesis of IL-TIF is induced rapidly after injection of bacterial lipopolysaccharides. In contrast to IL10, IL22 does not inhibit the production of pro-inflammatory cytokines by monocytes in response to bacterial lipopolysaccharides. It also does not impair IL10 function on monocytes. IL-TIF has some inhibitory effects on IL4 production from Th2 T-helper cells.
IL10 and IL-TIF utilise a common receptor subunit. Antibodies directed against the beta chain of the IL10 receptor block the induction of acute phase proteins by IL-TIF. The functional IL-TIF receptor complex consists of two receptor chains. One chain has been identified as the orphan receptor CRF2-4 that is expressed in normal liver and kidney. The other chain is the L10 receptor-2, the second chain of the IL10 receptor complex. Monkey COS expressing CRF2-9 alone respond to IL-TIF. In hamster cells both chains must be expressed to yield functional IL-TIF receptors. Although both receptor chains can bind IL-TIF independently binding of IL-TIF to the receptor complex is greater. This sharing of receptor subunits is similar to the shared use of the common gamma chain by cytokines such as IL2, IL4, IL7, IL9, and IL15. Some cell lines that do not respond to IL10 respond to IL-TIF by activation of STAT-1, STAT-3, and STAT-5.
A soluble secreted receptor (231 amino acids), designated IL22BP [IL22 binding protein] has been described (Kotenko et al). The protein demonstrates 34 percent amino acid identity with the extracellular domain of the IL22R1 chain and is known also as CRF2-10. The gene maps to human chromosome 6q24, 35 kb from the IFN-gamma R1 gene. It is expressed in various tissues with maximal expression in breast, lungs, and colon. The protein binds IL-TIF and inhibits its activity, blocking its interaction with the cell surface IL22 receptor complex and thus acting as a natural cytokine antagonist. IL22BP also blocks induction of the suppressors of cytokine signaling-3 (SOCS-3) gene expression by IL22 in HepG2 cells (Dumoutier L et al Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. Journal of Immunology 164(4): 1814-1819 (2000); Dumoutier L et al Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proceedings of the National Academy of Science (USA) 97(18): 10144-9 (2000); Dumoutier L et al IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun 1(8): 488-494 (2000); Dumoutier L et al Cloning and characterization of il-22 binding protein, a natural antagonist of il-10-related t cell-derived inducible factor/il-22. Journal of Immunology 166(12): 7090-5 (2001); Kotenko S V et al Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. Journal of Immunology 166(12): 7096-7103 (2001); Kotenko S V et al Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. Journal of Biological Chemistry 276(4): 2725-32 (2001); Xie M H et al Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. Journal of Biological Chemistry 275(40): 31335-9 (2000)).
IL-23 is the name given to a factor that is composed of the p40 subunit of IL12 (IL12B) and another protein of 19 kDa, designated p19. p19 is structurally related to IL6, G-CSF, and the p35 subunit of IL12. In databanks the p19 subunit is found also under the acronym SGRF (IL6 G-CSF related factor).
p19 by itself is biologically inactive while the complex of p19 with p40 is active. The active complex is secreted by dendritic cells after cell activation.
Mouse memory T-cells (CD4 (+) CD45 Rb(low)) proliferate in response to IL23 but not in response to IL12. Human IL23 has been shown to stimulate the production of IFN-gamma by PHA blast T-cells and memory T-cells. It also induces proliferation of both cell types.
IL23 binds to the beta-1 subunit but not to the beta-2 subunit of the IL12 receptor, activating one of the STAT proteins, STAT4, in PHA blast T-cells.
Expression of p19 in transgenic mice leads to runting, systemic inflammation, infertility, and death before 3 months of age. The animals show high serum concentrations of the pro-inflammatory cytokines TNF-alpha and IL1. The number of circulating neutrophils is increased. Acute phase proteins are expressed constitutively. Animals expressing p19 specifically in the liver do not show these abnormalities. Expression of p19 is most likely due to hematopoietic cells as bone marrow transplantation of cells expressing p19 causes the same phenotype as that observed in the transgenic animals (Oppmann B et al Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13(5): 715-25 (2000); Wiekowski M T et al Ubiquitous Transgenic Expression of the IL-23 Subunit p 19 Induces Multiorgan Inflammation, Runting, Infertility, and Premature Death. Journal of Immunology 166(12): 7563-70 (2001)).
IL24 is a name given to a protein that is known also as ST16 [suppression of tumorigenicity-16] and MDA-7 [melanoma differentiation-associated gene 7]. The rat counterpart of IL24 has been identified as mob-5 or C49a. The murine counterpart is FISP.
MDA-7 protein (206 amino acids) was identified initially as a melanoma differentiation-associated cDNA in a study using cultured human melanoma cells that lose proliferative capacity and terminally differentiate in response to human IFN-beta and mezerein. The expression of MDA-7 is upregulated as a consequence of terminal differentiation. H0-1 and C8161 human melanoma cells engineered to express MDA-7 show reduces growth and do not form colonies in a colony formation assay. MDA-7 selectively suppresses the growth of human breast cancer cells by promoting cell death by apoptosis. Ectopic expression of MDA-7 by means of a replication defective adenovirus results in growth suppression and induction of apoptosis in a broad spectrum of additional cancers, including melanoma, glioblastoma multiforme, osteosarcoma and carcinomas of the breast, cervix, colon, lung, nasopharynx and prostate. No apparent harmful effects are observed after expression of MDA-7 in normal epithelial or fibroblast cells.
In human hematopoietic cells MDA-7 expression is induced during megakaryocyte differentiation in response to treatment with TPA (12-O-tetradecanoyl-phorbol-13-acetate).
The human MDA-7 gene maps to chromosome 1q32 and is tightly linked (within a region of 195 kb) to the genes encoding IL10, IL19, and IL20.
The receptor for IL24 has been identified as the IL20 receptor complex. This receptor also binds to IL19 (Blumberg H et al Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104(1): 9-19 (2001); Dumoutier L et al Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. Journal of Immunology 167(7): 3545-9 (2001); Huang E Y et al Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene 20(48): 7051-63 (2001); Jiang H et al Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11: 2477-2486 (1995); Jiang H et al The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proceedings of the National Academy of Science (USA) 93: 9160-9165 (1996); Su Z et al The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proceedings of the National Academy of Science (USA) 95: 14400-14405 (1998)).
IL25 (also known as SF20) has been identified in a search for factors that stimulate cell proliferation. The factor is secreted by bone marrow stromal cells
The IL25 receptor has been identified as mouse thymic shared antigen-1 (TSA-1). Enforced expression of the receptor in one of the factor-dependent cell lines, BaF3, which does not express the receptor, causes cell proliferation. FDCP2 cells, which express the receptor, also proliferate in response to SF20/IL25. In both cases proliferation is abolished by specific blocking antibodies directed against the receptor.
SF20/IL-25 has no detectable myelopoietic activity but supports proliferation of cells in the lymphoid lineage (Tulin E E et al SF20/IL-25, a Novel Bone Marrow Stroma-Derived Growth Factor That Binds to Mouse Thymic Shared Antigen-1 and Supports Lymphoid Cell Proliferation. Journal of Immunology 167(11): 6338-47 (2001)).
The members of the TNF ligand superfamily (TNFalpha, TNF-beta, LT beta, CD27 ligand, CD30 ligand, CD40 ligand, CD95 ligand, 41BB, OX40 ligand, TRAIL) share common biological activities, but some properties are shared by only some ligands, while others are unique. Human TNF-alpha is a non-glycosylated protein of 17 kDa and a length of 157 amino acids. Murine TNF-alpha is N-glycosylated. Homology with TNF-beta is approximately 30%. TNF-alpha forms dimers and trimers. The 17 kDa form of the factor is produced by processing of a precursor protein of 233 amino acids. A TNF-alpha converting enzyme has been shown to mediate this conversion. A transmembrane form of 26 kDa has been described also.
TNF-alpha contains a single disulfide bond that can be destroyed without altering the biological activity of the factor. Mutations Ala84 to Val and Val91 to Ala reduce the cytotoxic activity of the factor almost completely. These sites are involved in receptor binding. The deletion of 7 N-terminal amino acids and the replacement of Pro8Ser9Asp10 by ArgLysArg yields a mutated factor with an approximately 10-fold enhanced antitumor activity and increased receptor binding, as demonstrated by the L-M cell assay, while at the same time reducing the toxicity.
The gene has a length of approximately 3.6 kb and contains four exons. The primary transcript has a length of 2762 nucleotides and encodes a precursor protein of 233 amino acids. The aminoterminal 78 amino acids function as a presequence. The human gene maps to chromosome 6p23-6q12. It is located between class I HLA region for HLA-B and the gene encoding complement factor C. The gene encoding TNF-beta is approximately 1.2 kb downstream of the TNF-alpha gene. However, both genes are regulated independently. The two genes also lie close to each other on murine chromosome 17.
Approximately 500-10000 high-affinity receptors (Ka=2.5×10−9 M) for ‘I’ N-alpha are expressed on all somatic cell types with the exception of erythrocytes. Two receptors of 55 kDa (TNF-R1; new designation: CD120a) (e.g. polypeptides encoded by Genbank Accession No. X55313) and 75 kDa (TNF-R2; new designation: CD120b) (e.g. as described in Goodwin R G et al (1991) Molecular Cellular Biology 11: 3020-6) have been described. One receptor is a glycosylated protein of 455 amino acids that contains an extracellular domain of 171 and a cytoplasmic domain of 221 amino acids. Sequence homologies in the cysteine-rich domains of the extracellular portion reveal that the receptor is related to the low-affinity receptor of NGF and to human cell surface antigen CD40.
Deletion analysis in the C-terminal intracellular region of the 55 kDa receptor, TNF-R1 has revealed the existence of a so-called death domain, which is involved in signaling processes leading to programmed cell death. The death domain of TNF-R1 interacts with a variety of other signaling adaptor molecules, including TRADD, and RIP.
The two known receptors bind both TNF-alpha and TNF-beta. p55 is expressed particularly on cells susceptible to the cytotoxic action of TNF. p75 is also present on many cell types, especially those of myeloid origin (a virus-encoded homologue of the receptor subunit is EBV-induced gene-6). It is strongly expressed on stimulated T-cells and B-lymphocytes. The differential activities of TNF on various cell types, i.e. growth-promoting and growth-inhibiting activities, are probably mediated by the differential expression and/or regulation of multiple receptors in combination with other distinct receptor-associated proteins. p55 appears to play a critical role in host defenses against microorganisms and their pathogenic factors.
A third receptor subtype is expressed in normal human liver. It binds TNF-alpha but not TNF-beta. Some viruses contain genes encoding secreted proteins with TNF binding properties that are closely homologous to the p55 and p75 TNF receptors. Differential effects of the two receptor subtypes have been found also in TNF-mediated adhesion of leukocytes to the endothelium. It appears that engagement of the p55 receptor specifically leads to the induction of the cellular adhesion molecules ICAM-1, E-selectin, V-CAM-1, and CD44, while engagement of both the p55 and the p75 receptor induces expression of alpha-2 integrin.
Truncated soluble forms of the receptor have been found also. The soluble forms, in particular the soluble extracellular domain of the p60 receptor, block the antiproliferative effects of TNF and, therefore, may modulate the harmful effects of TNF.
Receptor densities are reduced by IL1 and tumor promoters such as phorbol esters. The expression of TNF-alpha receptor density is induced by IFN-alpha, IFN-beta, and IFN-gamma.
Signal transducers that associate with the cytoplasmic domains of members of the TNF receptor superfamily comprise TRAF (Tumor necrosis factor receptor-associated factors).
Human TNF-alpha is active on murine cells with a slightly reduced specific activity. In general, TNF-alpha and TNF-beta display similar spectra of biological activities in in-vitro systems, although TNF-beta is often less potent or displays apparent partial agonist activity.
TNF-alpha shows a wide spectrum of biological activities. It causes cytolysis and cytostasis of many tumor cell lines in vitro. Sensitive cells die within hours after exposure to picomolar concentrations of the factor and this involves, at least in part, mitochondria-derived second messenger molecules serving as common mediators of TNF cytotoxic and gene-regulatory signaling pathways. The factor induces hemorrhagic necrosis of transplanted tumors. Within hours after injection TNF-alpha leads to the destruction of small blood vessels within malignant tumors. The factor also enhances phagocytosis and cytotoxicity in neutrophilic granulocytes and also modulates the expression of many other proteins, including fos, myc, IL1 and IL6.
The 26 kDa form of TNF is found predominantly on activated monocytes and T-cells. It is also biologically active and mediates cell destruction by direct cell-to-cell contacts.
The chemotactic properties of fMLP (Formyl-Met-Leu-Phe) for neutrophils are enhanced by TNF-alpha. TNF-alpha induces the synthesis of a number of chemoattractant cytokines, including IP-10, JE, KC, in a cell-type and tissue-specific manner.
TNF-alpha is a growth factor for normal human diploid fibroblasts. It promotes the synthesis of collagenase and prostaglandin E2 in fibroblasts. It may also function as an autocrine growth modulator for human chronic lymphocytic leukemia cells in vivo and has been described to be an autocrine growth modulator for neuroblastoma cells. The autocrine growth-promoting activity is inhibited by IL4.
In resting macrophages TNF induces the synthesis of IL1 and prostaglandin E2. It also stimulates phagocytosis and the synthesis of superoxide dismutase in macrophages. TNF activates osteoclasts and thus induces bone resorption.
In leukocyte and lymphocyte progenitors TNF stimulates the expression of class I and II HLA and differentiation antigens, and the production of IL1, colony stimulating factors, IFN-gamma, and arachidonic acid metabolism. It also stimulates the biosynthesis of collagenases in endothelial cells and synovial cells.
IL6 suppresses the synthesis of IL1 induced by bacterial endotoxins and TNF, and the synthesis of TNF induced by endotoxins.
The neurotransmitter SP (substance P) induces the synthesis of TNF and IL1 in macrophages. IL1, like IL6, stimulates the synthesis of ACTH (corticotropin) in the pituitary. Glucocorticoids synthesized in response to ACTH in turn inhibit the synthesis of IL6, IL1 and TNF in vivo, thus establishing a negative feedback loop between the immune system and neuroendocrine functions.
TNF-alpha enhances the proliferation of T-cells induced by various stimuli in the absence of IL2. Some subpopulations of T-cells only respond to IL2 in the presence of TNF-alpha. In The presence of IL2 TNF-alpha promotes the proliferation and differentiation of B-cells.
The functional capacities of skin Langerhans cells are also influenced by TNF-alpha. These cells are not capable of initiating primary immune responses such as contact sensibilisation. They are converted into immunostimulatory dendritic cells by GM-CSF and also IL1. These cells therefore are a reservoir for immunologically immature lymphoid dendritic cells. The enhanced ability of maturated Langerhans cells to process antigens is significantly reduced by TNF-alpha.
Although TNF-alpha is also required for normal immune responses the overexpression has severe pathological consequences. TNF-alpha is the major mediator of cachexia observed in tumor patients (hence its name, cachectin). TNF is also responsible for some of the severe effects during Gram-negative sepsis.
TNF-alpha can be detected in bioassays involving cell lines that respond to it (e.g., BT-20, CT6, EL4; PK15; L929; L-M; M07E; T1165; WEHI-3B). TNF-alpha can be detected also by a sensitive sandwich enzyme immunoassay, ELISA, an immunoradiometric assay (IRMA), and by an assay designated RELAY (receptor-mediated label-transfer assay). Intracellular factor is detected by two color immunofluorescence flow cytometry. Higuchi et al have described an assay based on the release of tritiated thymidine from cells undergoing apoptosis after treatment with either TNF-alpha or TNF-beta. IFN-alpha, IFN-beta, IFN-gamma, TGF-beta, IL4, LIF and GM-CSF have been shown not to interfere with this assay.
In contrast to chemotherapeutic drugs TNF specifically attacks malignant cells. Extensive preclinical studies have documented a direct cytostatic and cytotoxic effect of TNF-alpha against subcutaneous human xenografts and lymph node metastases in nude mice, as well as a variety of immunomodulatory effects on various immune effector cells, including neutrophils, macrophages, and T-cells. Single- and multiple-dose phase I studies have confirmed that TNF can be administered safely to patients with advanced malignancies in a dose range associated with anticancer effect without concomitant serious toxicities such as shock and cachexia. However, clinical trials on the whole have unfortunately so far failed to demonstrate significant improvements in cancer treatment, with TNF-induced systemic toxicity being a major limitation for the use of TNF as an antineoplastic agent in most cases. The combined use of TNF and cytotoxic or immune modulatory agents, particularly IFN-gamma and possibly IL2, may be of advantage in the treatment of some tumors. In some cases intratumoral application of TNF has been found to be of advantage in tumor control.
Some mutant forms of TNF-beta with selective activity on the p55 receptor have been described recently. It has been shown that activation of the p55 receptor is sufficient to trigger cytotoxic activity towards transformed cells. Some of these mutants have been described to retain their antitumor activity in nude mice carrying transplanted human tumors.
TNF can also be used to increase the aggressiveness of lymphokine-activated killer cells. Studies with an experimental fibrosarcoma metastasis model have shown that TNF induces significant enhancement of the number of metastases in the lung. It has been suggested that low doses of endogenous TNF or administration of TNF during cytokine therapy may enhance the metastatic potential of circulating tumor cells. The transduction of murine tumor cells with a functional TNF-alpha gene has been shown to lead to the rejection of the genetically modified cells by syngeneic hosts.
The interferons are a family of cytokines that induce a virus-nonspecific antiviral state in target cells. Binding of an interferon to its receptor induces new protein synthesis which, in turn, results in the inactivation of initiation factor eIF-2. The inactivation is thought to contribute to the antiviral state induced by the interferons. Interferons also induce pathways that activate intracellular endonucleases which degrade viral mRNA. Many interferons also possess immunomodulatory activities, such as activation of macrophages and lymphocytes. Examples of interferons include IFN-gamma (e.g. polypeptides encoded by Genbank Accession No. K01900, J00209, M12350, J00213, J00216, J00214, M11003, M11026, M34913, M54886, X01974, L38698, M13710, K01238, M13660, M68944, X01972, X01971, X01973, X01969), IFN-gamma (e.g. polypeptides encoded by Genbank Accession No.M28622, X14029, X14455, K00020, J00218, E00171, X04430, A09363, M27327, M16656, M25460, K03196), IFN-gamma e.g. polypeptides encoded by Genbank Accession No. A34532, X87308, E00756, K00083), IFN-gamma e.g. polypeptides encoded by Genbank Accession No. X58822, A12140), bovine trophoblast protein-1 (IFN-gamma) e.g. polypeptides encoded by Genbank Accession No. M31556, M31557, M31558), and their homologues among species. Human IFN-gamma and IFN-gamma are thought to bind to a common receptor (e.g. polypeptides encoded by Genbank Accession No. X60459, M89641) which is distinct from the receptor for IFN-gamma (e.g. polypeptides encoded by Genbank Accession No. J03143, M28233).
At least 23 different variants of IFN-alpha are known. The individual proteins have molecular masses between 19-26 kDa and consist of proteins with lengths of 156-166 and 172
amino acids. All IFN-alpha subtypes possess a common conserved sequence region between amino acid positions 115-151 while the amino-terminal ends are variable. Many IFN-alpha subtypes differ in their sequences at only one or two positions. Naturally occurring variants also include proteins truncated by 10 amino acids at the carboxy-terminal end. Disulfide bonds are formed between cysteines at positions 1/98 and 29/138. The disulfide bond 29/138 is essential for biological activity while the 1/98 bond can be reduces without affecting bioactivity.
Human IFN-beta is a glycoprotein (approximately 20% sugar moiety) of 20 kDa and has a length of 166 amino acids. Glycosylation is not required for biological activity in vitro. The protein contains a disulfide bond Cys31/141) required for biological activity. At the DNA level IFN-beta displays 34% sequence homology with IFN-beta-2 and approximately 30% homology with other IFN-alpha subtypes. In contrast to IFN-gamma IFN-beta is stable at pH2.
Human IFN-gamma is a dimeric protein with subunits of 146 amino acids. The protein is glycosylated at two sites. The pI is 8.3-8.5. IFN-gamma is synthesized as a precursor protein of 166 amino acids including a secretory signal sequence of 23 amino acids. Two molecular forms of the biologically active protein of 20 and 25 kDa have been described. Both of them are glycosylated at position 25. The 25 kDa form is also glycosylated at position 97. The observed differences of natural IFN-gamma with respect to molecular mass and charge are due to variable glycosylation patterns. 40-60 kDa forms observed under non-denaturing conditions are dimers and tetramers of IFN-gamma.
Members of the CSF family of cytokines allow the growth and differentiation of bone marrow cells immobilized on soft agar or methylcellulose. While hematopoietic progenitor cells can be maintained only for short periods of time in the absence of such factors, their presence allows the development of colonies containing erythroid cells, neutrophils, eosinophils, macrophages, and/or megakaryocytes, depending on the particular factor. The biochemical analysis of various activities stimulating colony formation supporting the growth and development of these cell types revealed that there existed many different and distinct factors of this sort.
Many of these factors are either N- or O-glycosylated. Glycosylation has been shown to enhance the solubility, stability and resistance to proteolytic enzymes. It does not appear to be required for the full spectrum of biological activities of these factors. The genes encoding many of the human colony stimulating factors have been cloned and mapped. Some of the genes are in close vicinity but they do not show great homology among each other with the exception of some conserved regions.
Colony stimulating factors are produced by many different cell types, including, for example, B-lymphocytes, epithelial cells, fibroblasts, endothelial cells, macrophages, Stromal cell line, T-lymphocytes. They are synthesized as precursor molecules containing a classical hydrophobic secretory signal sequence of approximately 25-32 amino acids. The secreted factors have an extremely high specific biological activity are active at very low concentrations (1-100 pM). These factors are absolutely required for the proliferation of hematopoietic progenitor cells. The concentrations required for mere maintenance of viability are usually orders of magnitude lower than those required to induce cell proliferation or to elicit specific functional activities of the cells.
The names of the individual factors usually indicate the cell types that respond to these factors. The classical colony stimulating factors include M-CSF (e.g. polypeptides encoded by Genbank Accession No. E03235, M64592, U22386, X05010) (macrophage-specific), G-CSF (granulocyte-specific), GM-CSF (macrophage/granulocyte-specific), IL3 (multifunctional) and MEG-CSF (e.g. polypeptides encoded by Genbank Accession No.D86370, U70136) (megakaryocyte-specific). G-CSF and M-CSF are lineage-specific while GM-CSF and IL3 are multifunctional hematopoietic growth factors acting on earlier stages of differentiation of hematopoietic progenitor cells.
Human GM-CSF is a monomeric protein of 127 amino acids with two glycosylation sites. The protein is synthesized as a precursor of 144 amino acids, which included a hydrophobic secretory signal sequence at the aminoterminal end. The sugar moiety is not required for the full spectrum of biological activities. Non-glycosylated and glycosylated GM-CSF show the same activities in vitro. Fully glycosylated GM-CSF is biologically more active in vivo than the non-glycosylated protein. The different molecular weight forms of GM-CSF (14 kDa, 35 kDa) described in the literature are the result of varying degrees of glycosylation. GM-CSF contains four cysteine residues (positions 54/96 and 88/121).
A comparison of the protein sequence of GM-CSF with those of the other colony stimulating factors reveals that they are not strongly homologous to each other. Human and murine GM-CSF display 60% homology at the protein level and 70% at the nucleotide level. The two factors do not, however, cross-react immunologically. GM-CSF can be associated with the extracellular matrix of cells as a complex with heparan sulfate proteoglycans. This allows storage of the factor in a biologically inactive form. The exact mechanism by which the factor is eventually released from these depots is not known.
The human gene has a length of approximately 2.5 kb and contains four exons. The distance between the GM-CSF gene and the IL3 gene is approximately 9 kb. The human GM-CSF gene maps to chromosome 5q22-31 in the vicinity of other genes encoding hematopoietic growth factors (M-CSF, IL3, IL4, IL5) and the gene encoding the M-CSF receptor. The 5′ region of the GM-CSF gene contains several sequence elements known as CLE (conserved lymphokine element). They function as binding sites for transcription factors, modulating the expression of the GM-CSF gene.
GM-CSF receptors are expressed at densities of several 100 to several 1000 copies/cell on the cell surface of myeloid cells. The receptor is expressed also on non-hematopoietic cells such as endothelial cells and small cell lung carcinoma cells. In receptor-positive cell lineages the receptor density decreases with increasing degrees of maturation.
The receptor shows significant homologies with other receptors for hematopoietic growth factors, including IL2-beta, IL3, IL6, IL7, Epo and the prolactin receptors. One cloned subunit of the GM-CSF receptor (GM-R alpha, 45 kDa) binds GM-CSF with low affinity (e.g. polypeptides encoded by Genbank Accession No. SEG_HUMGRAS). The second subunit (GM-R beta, 120 kDa) does not bind GM-CSF. GM-R alpha is a protein of 400 amino acids that contains only a short cytoplasmic domain of 54 amino acids. The high affinity GM-CSF receptor is formed by the aggregation of the two receptor subunits. The GM-R beta subunit of the receptor (e.g. polypeptides encoded by Genbank Accession No. SEG_MUSAIC2B, M59941) is also a constituent of other cytokine receptor systems. It is a component of the high affinity receptors for IL3 and IL5, both of which also contain a cytokine-specific subunit (AIC2A).
Human GM-CSF is not active on murine cells and vice versa. GM-CSF was isolated initially as a factor stimulating the growth of macrophage/granulocyte-containing colonies in soft agar cultures (colony formation assay). GM-CSF is indispensable for the growth and development of granulocyte and macrophage progenitor cells. It stimulates myeloblasts and monoblasts and triggers irreversible differentiation of these cells. GM-CSF synergises with Epo in the proliferation of erythroid and megakaryocytic progenitor cells. In combination with another colony stimulating factor, M-CSF, one observes the phenomenon of synergistic suppression, i.e., the combination of these two factors leads to a partial suppression of the generation of macrophage-containing cell colonies.
For some types of blast cells from patients with acute myeloid leukemia GM-CSF acts as an autocrine mediator of growth. GM-CSF is a strong chemoattractant for neutrophils. It enhances microbicidal activity, oxidative metabolism, and phagocytotic activity of neutrophils and macrophages. It also improves the cytotoxicity of these cells. GM-CSF displays a less pronounced specificity than, for example, G-CSF. It stimulates the proliferation and differentiation of neutrophilic, eosinophilic, and monocytic lineages. It also functionally activates the corresponding mature forms, enhancing, for example, the expression of certain cell surface adhesion proteins (CD-11A, CD-11C). The overexpression of these proteins could be one explanation for the observed local accumulation of granulocytes at sites of inflammation. In addition, GM-CSF also enhances expression of receptors for fMLP (Formyl-Met-Leu-Phe) which is a stimulator of neutrophil activity.
At pico to nanomolar concentrations GM-CSF is chemotactic for eosinophils and also influences the chemotactic behavior of these cells in response to other chemotactic factors.
In granulocytes GM-CSF stimulates the release of arachidonic acid metabolites and the increased generation of reactive oxygen species. The activation of the Na+/H+ antiport system leads to a rapid alkalization of the cytosol. Phagocytotic activities of neutrophil granulocytes and the cytotoxicity of eosinophils is also enhanced considerably by GM-CSF. Since GM-CSF is produced by cells (T-lymphocytes, tissue macrophages, endothelial cells, mast cells) present at sites of inflammatory responses it can be assumed that it is an important mediator for inflammatory reactions.
The functional state of Langerhans cells of the skin is also influenced by GM-CSF. These cells are not capable of initiating primary immune responses, for example, contact sensibilization. They are converted to highly potent immunostimulatory dendritic cells by GM-CSF (and also IL1). Langerhans cells therefore form an in situ reservoir for immunologically immature lymphoid dendritic cells. The maturation of these cells which is seen as an increased ability to process antigens, can be down-regulated by TNF-alpha.
At nanomolar concentrations GM-CSF induces the expression of complement C3a receptors on basophils. Cells which normally do not respond to C3a and which have been activated by GM-CSF degranulate in response to the C3a stimulus. This is accompanied by the release of histamine and leukotriene C4. This process may be of significance in hypersensitivity reactions associated with inflammatory responses (T-lymphocytes, tissue macrophages, endothelial cells, mast cells). GM-CSF has been shown also to be a potent inducer of trophoblast interferon (TP-1).
GM-CSF synergises with some other cytokines, including IL1, IL3 and G-CSF. GM-CSF and G-CSF must act in concert to allow the development of neutrophil-containing colonies in vitro.
IL3 by itself only negligibly expands the number of circulating blood cells; a subsequent dose of GM-CSF, however, significantly increases cell numbers, probably because IL3 first leads to an expansion of those cells capable of responding to GM-CSF.
The observations that most IL3-dependent cell lines can also grow in the presence of GM-CSF and IL4 and that several synergistic effects are observed between GM-CSF and IL4 suggest that these three factors perform similar functions in controlling the growth of cells. There are some indications that the mechanism of signal transduction contains at least some common factors.
Experiments with tyrosine-specific protein kinases encoded by an oncogene have shown that the expression of this kinase activity in factor-dependent cells abolishes their dependence on GM-CSF, IL3 and IL4. The exact mechanism by which these factors regulate the proliferation and differentiation of cells is still unknown.
The consequences of a deregulated expression of GM-CSF have been studied in transgenic mice harboring a constitutively expressed GM-CSF gene. The overexpression of the transgene encoding GM-CSF leads to pathological alterations in the retina and causes blindness and also causes muscle deterioration. These mice are characterized by a very pronounced increase in activated macrophages. In addition, the overexpression of GM-CSF leads to the activation of mature macrophages secreting large amounts of IL1 and TNF, suggesting that these cytokines may be responsible for some aspects of the transgenic mouse disease.
Histopathological examination demonstrates a pronounced increase in the progenitor cell population of the monocytic lineage. GM-CSF-transgenic animals usually die within months from the massive tissue damage resulting from the overexpression of these factors. Similar results have been obtained with mice possessing a bone marrow manipulated to overexpress GM-CSF by transformation with suitable retrovirus vectors. These findings do not seem to be of clinical significance, though. The long-term treatment of primates and mice with GM-CSF has shown that life-threatening complications do not occur.
The biological consequences of GM-CSF gene disruption have been studied in mice generated from ES cells carrying a targeted deletion of the gene. Mice homozygous for a targeted disruption of the GM-CSF gene are characterized by an unimpaired steady-state hematopoiesis, demonstrating that GM-CSF is not essential for maintaining normal levels of the major types of mature hematopoietic cells and their precursors in blood, marrow, and spleen.
Most GM-CSF-deficient mice are superficially healthy and fertile but develop abnormal lungs. GM-CSF-deficient mice develop a progressive accumulation of surfactant lipids and proteins in the alveolar space, the defining characteristics of the idiopathic human disorder pulmonary alveolar proteinosis. Extensive lymphoid hyperplasia associated with lung airways and blood vessels is found also. These results demonstrate an unexpected, critical role for GM-CSF in pulmonary homeostasis.
Transgenic mice homozygous for null mutations of the gene encoding the common beta subunit (beta C) of the GM-CSF, IL3, and IL5 receptor complexes exhibit normal development and survive to young adult life. They develop pulmonary peribroncnovascular lymphoid infiltrates and areas resembling alveolar proteinosis. Eosinophil numbers in peripheral blood and bone marrow of homozygous deletion mutants are reduced, while other hematological parameters are normal. Bone marrow cells from homozygous deletion mutants do not show high-affinity binding of GM-CSF, while cells from heterozygous animals show an intermediate number of high-affinity receptors. In clonal cultures of bone marrow cells derived from homozygous deletion mutants, even high concentrations of GM-CSF and IL5 do not stimulate colony formation in the colony formation assay. Differences in the systemic clearance and distribution of GM-CSF between mutant and wild-type littermates are not observed.
Nishinakamura et al have crossed beta-c mutant mice with mice deficient for IL3. The double-mutant mice lacking all IL3, GM-CSF, and IL5 functions are apparently normally fertile. The animals show the same reduced numbers of eosinophils and a lack of eosinophilic response to parasites as beta-c mutant mice. The immune response of the double mutant mice to Listeria monocytogenes is normal. Hematopoietic recovery after treatment with fluorouracil is also normal. These findings suggest the existence of alternative mechanism to produce blood cells that do not depend on the presence of IL3, GM-CSF, and IL5.
GM-CSF can be assayed in a colony formation assay by the development of colonies containing macrophages, neutrophils, eosinophils, and megakaryocytes. GM-CSF is also detected in specific bioassays with cells lines that depend in their growth on the presence of GM-CSF or that respond to this factor (e.g., AML-193; B6SUt-A; BAC1.2F5; BCL1; Da; FDCP1; GF-D8; GM/SO; IC-2; M07E; NFS-60; PT-18; TALL-103; TF-1; UT-7).
GM-CSF can be employed for the physiological reconstitution of hematopoiesis in all diseases characterized either by an aberrant maturation of blood cells or by a reduced production of leukocytes. The main and most important clinical application of GM-CSF is probably the treatment of life-threatening neutropenia following chemo and/or radiotherapy, which is markedly reduced under GM-CSF treatment. GM-CSF can be used also to correct chemotherapy-induced cytopenias and to counteract cytopenia-related predisposition to infections and hemorrhages.
In order to avoid potential complications following the administration of GM-CSF careful clinical monitoring is required in certain patient groups, for example those with myelodysplastic syndrome, acute myeloid leukemia, inflammatory disease, autoimmune thrombocytopenia or malfunctional immunological responsiveness.
Several studies have demonstrated that the use of GM-CSF enhances tolerance to cytotoxic drug treatment and can be used to prevent dose reductions necessitated by the side effects of cytotoxic drug treatment. GM-CSF treatment frequently permits to increase the doses of cytotoxic drugs per course. These studies have also revealed a significantly reduced morbidity under GM-CSF treatment.
The transduction of murine tumor cells with a functional GM-CSF gene has been shown to lead to the rejection of the genetically modified cells by syngeneic hosts. Moreover, vaccination with GM-CSF transduced tumor cells prevents growth of a subsequent inoculum of wild-type syngeneic tumor cells.
The chemokine family of cytokines consists of relatively small, structurally similar polypeptides that induce chemotaxis in leukocytes. Chemokines have molecular masses of 8-10 kDa and show approximately 20-50% sequence homology among each other at the protein level. The proteins also share common gene structures and tertiary structures. All chemokines possess a number of conserved cysteine residues involved in intramolecular disulfide bond formation.
According to the chromosomal locations of individual genes two different subfamilies of chemokines are distinguished. Members of the alpha-chemokines are referred to also as the 4q chemokine family because the genes encoding members of this family map to human chromosome 4q12-21. The first two cysteine residues of members of this family are separated by a single amino acids and these proteins, therefore, are called also C-X-C chemokines. This subfamily includes 9E3 (e.g. Genbank protein P08317), AMCF (e.g. polypeptides encoded by Genbank Accession No. M99367, M99368), beta-thromboglobulin (e.g. as disclosed in Begg G S et al (1978), Biochemistry 17: 1739-44), CINC family members (e.g. polypeptides encoded by Genbank Accession No. D21095), ENA-78 (e.g. polypeptides encoded by Genbank Accession No. X78686), eotaxin (e.g. polypeptides encoded by Genbank Accession No. U46572, U40672), GCP-2 (e.g. polypeptides encoded by Genbank Accession No. Y08770, U83303), IL8, IP-10 (e.g. polypeptides encoded by Genbank Accession No. L07417, X02530), KC (e.g. polypeptides encoded by Genbank Accession No. J04596), LIX (e.g. polypeptides encoded by Genbank Accession No. U27267), mig (e.g. polypeptides encoded by Genbank Accession No. M34815, Z24725), MGSA (e.g. polypeptides encoded by Genbank Accession No. X12510), mob-1 (e.g. polypeptides encoded by Genbank Accession No. U17035), NAP-2 (as described in Clark-Lewis I et al (1991) Biochemistry 30: 3128-35, Cohen A B et al (1992) American Journal of Physiology 263: L249-56), NAP-3 (as described in: Schröder J M et al (1991) Journal of Experimental Medicine 171: 1091-100), NAP-4 (as described in Schröder T M et al (1990) Biochemical zui Biophysical Research Communications 172: 898-904), PBSF (SDF) (e.g. polypeptides encoded by Genbank Accession No. D21072, U16752, D50645), and PF4 (e.g. polypeptides encoded by Genbank Accession No. M25897).
IL8, MGSA, mouse KC, MIP-2 (e.g. polypeptides encoded by Genbank Accession No. X65647 and as described in Blum S et al Three human homologues of a murine gene encoding an inhibitor of stem cell proliferation. DNA Cell Biol. 9: 589-602 (1990); Clements J M et al Biological and structural properties of MIP-1 alpha expressed in yeast. Cytokine 4: 76-82 (1992); Devatelis G et al Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties. Journal of Experimental Medicine 167: 1939-44 (1988) (erratum in JEM 170: 2189 (1989)); Farber J M A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. Proceedings of the National Academy of Science (USA) 87: 5238-42 (1990); Haskill S et al Identification of three related human GRO genes encoding cytokine functions. Proceedings of the National Academy of Science (USA) 87: 7732-6 (1990); Poltorak A N et al (1995) Journal of Inflammation 45(3): 207-19; Rossi D L et al (1997) Journal of Immunology 158(3): 1033-1036; Sherry B et al (1988) Journal of Experimental Medicine 168: 2251-9; Tekamp-Olson P et al (1990) Journal of Experimental Medicine 172: 911-9; Wolpe S D et al (1989) Proceedings of the National Academy of Science (USA) 86: 612-16; Wolpe S D et al (1989) FASEB Journal 3: 2565-73), NAP-2, ENA-78, and GCP-2 comprise a subgroup of the human C-X-C-chemokines defined by the conserved ELR sequence motif (glutamic acid-leucine-arginine) immediately preceding the first cysteine residue near the amino-terminal end. Chemokines with an ELR sequence motif have been found to chemoattract and activate primarily neutrophils. Chemokines without the ELR sequence motif appear to chemoattract and activate monocytes, dendritic cells, T-cells, NK-cells, B-lymphocytes, basophils, and eosinophils.
Members of the beta-chemokines or 17q chemokine family map to human chromosome 17q11-32 (murine chromosomel 1). The first two cysteine residues are adjacent and, therefore, these proteins are called also C-C chemokines. This subfamily includes ACT-2 (e.g. polypeptides encoded by Genbank Accession No. J04130), CdO (e.g. as described in Berger M S et al (1993) DNA Cell Biol. 12: 839-47. Berger M S et al (1996) δ: 439-447), CCF18 (e.g. as described in Hara T et al (1995) Journal of Immunology 155: 5352-8), DC-CK1 (e.g. as described in Adema G J et al (1997) Nature 387: 713-717), ELC (e.g. polypeptides encoded by Genbank Accession No. AB000887, AF059208), Eotaxin-2 (e.g. as described in Forssmann U et al (1997) Journal of Experimental Medicine 185: 2171-2176), Exodus (e.g. polypeptides encoded by Genbank Accession No. U64197, U88320, U88321, U88322), FIC (e.g. polypeptides encoded by Genbank Accession No. L04694), GDCF and GDCF-2 (e.g. as described in Kuratsu J et al (1989) Journal of the National Cancer Institute 81: 347-51; Yoshimura T et al (1989) Journal of Experimental Medicine 169: 1449-59; Yoshimura T et al (1989) Journal of Immunology 142: 1956-62), HC-21 (e.g. as described in Chang H C & Reinherz E L (1989) European Journal of Immunology 19:1045-1051), HCC-1 (e.g. polypeptides encoded by Genbank Accession No. Z49270), I-309 (e.g. polypeptides encoded by Genbank Accession No. M57502), JE (e.g. polypeptides encoded by Genbank Accession No. AF058786, M28226), LAG-1 (lymphocyte activation gene-1) (e.g. polypeptides encoded by Genbank Accession No. X53683), LARC D86955), LD78 E03130, E03131, MARC (e.g. as described in Thirion S et al (1994) Biochemical and Biophysical Research Communications 201: 493-499), MCAF M24545 and as described in Apella E et al (1990) Progress in Clinical and Biological Research 349: 405-17), MCP-1 (e.g. polypeptides encoded by Genbank Accession No. X14768), MCP-2 (e.g. polypeptides encoded by Genbank Accession No. Y16645), MCP-3 (e.g. polypeptides encoded by Genbank Accession No. X72308, S71251), MCP-4 (e.g. polypeptides encoded by Genbank Accession No. X98306), MCP-5 (e.g. polypeptides encoded by Genbank Accession No. U50712), MIP (macrophage inflammatory protein) (e.g. polypeptides encoded by Genbank Accession No. U77180, U77035, U49513, M35590), MRP-2 (e.g. as described in Youn B S et al (1995) Journal of Immunology 155: 2661-7), RANTES SDF (e.g. polypeptides encoded by Genbank Accession No. M21121, M77747), TARC (e.g Genbank protein Accession No. Q92583).
In addition there are several other factors that are related to chemokines but that either have not been assigned yet to one of the two chemokine groups or that do not possess the classical features of either of the two chemokine groups (for example, ATAC (e.g. polypeptides encoded by Genbank Accession No. X86474), Ltn (e.g. polypeptides encoded by Genbank Accession No. U15607, U23772), SCM-1 (e.g. polypeptides encoded by Genbank Accession No. D63789, D637090, D43769). These have been referred to as C-type chemokines or gamma-chemokines.
Yet another group of chemokines has been identified that comprises neurotactin (e.g. polypeptides encoded by Genbank Accession No. AF010586, which is characterized by a CX(3)C cysteine signature motif. The existence of clearly defined subgroups of chemokines on the basis of structural and functional properties illustrates the importance of chemoattractant diversity in the regulation of leukocyte movement through the body.
The biological activities of chemokines are mediated by specific receptors and also by receptors with overlapping ligand specificities that bind several of these proteins which always belong either to the C-C-chemokines or the group of C-X-C-chemokines. Chemokine receptors belong to the large group of G-protein-coupled seven transmembrane domain receptors which contain seven hydrophobic alpha-helical segments that transverse the membrane. These receptors form a structurally related group within the superfamily of G-protein-coupled receptors which mediate signalling via heterotrimeric G-proteins.
The receptors that bind C-X-C chemokines are designated CXCR followed by a number (e.g., CXCR-1 (e.g. polypeptides encoded by Genbank Accession No. L19591), CXCR-2 (e.g. polypeptides encoded by Genbank Accession No. M94582), CXCR-3 (e.g. polypeptides encoded by Genbank Accession No. X95876), CXCR-4 (e.g. polypeptides encoded by Genbank Accession No. D87747, AF025375) while those binding C-C chemokines are designated CCR followed by a number (e.g., CCR-1 (e.g. polypeptides encoded by Genbank Accession No.L09230, U29678), CCR-2 (e.g. polypeptides encoded by Genbank Accession No. U29677, U95626), CCR-3 (e.g. polypeptides encoded by Genbank Accession No. U51241), CCR-4 (e.g. polypeptides encoded by Genbank Accession No. X90862, X85740), CCR-5 (e.g. polypeptides encoded by Genbank Accession No. U54994, U83327), CCR-6 (e.g. polypeptides encoded by Genbank Accession No. U95626), CCR-7 (e.g. polypeptides encoded by Genbank Accession No. L31581), CCR-8 (e.g. polypeptides encoded by Genbank Accession No. Z98206, U45983). Viral chemokine receptor homologues include ECRF-3, EBI-1 (EBV-induced gene-1), and US28.
It is now assumed that the combinatorial effects of multiple chemokines and other mediators are responsible for the cellular composition at inflammatory sites. In addition, many chemokines also directly activate cells. Some of them activate granulocytes and/or monocytes and cause respiratory bursts, degranulation, and the release of lysosomal enzymes. Others prime immune cells to respond to sub-optimal amounts of other inflammatory mediators. Yet others have been shown to be potent histamine releasing factors for basophils. It has been proposed that erythrocytes through their promiscuous chemokine receptor play an important role in regulating the chemokine network. Chemokines bound to the erythrocyte receptor are known to be inaccessible to their normal target cells. This appears to provide a sink for superfluous chemokines and may serve to limit the systemic effects of these mediators without disrupting localized processes taking place at the site of inflammation.
Certain C-C chemokines exhibit biological activities other than mere chemotaxis. Some chemokines have been shown to be capable of inducing the proliferation and activation of killer cells known as CHAK (C-C-chemokine-activated killer), which are similar to cells activated by IL2.
Another particularly useful cytokine according to the invention is flt-3 ligand (e.g., polypeptides encoded by Genbank Accession Nos. U04806, U04807, U03858, L23636, U29874, U29875, U44024). This cytokine binds to the flt-3 tyrosine kinase (e.g., polypeptides encoded by Genbank Accession Nos. Z26652, X59398). The human flt-3 ligand also stimulates the proliferation of cells expressing murine flt-3 receptors.
The effects of flt-3 ligand are synergized by coexpression of G-C SF, GM-C SF, M-CSF, IL3, PIXY-321, and SCF. In combination with SCF and IL3 flt-3 ligand can cause expansion of cells with the marker spectrum CD34 (+)CD38 (−). Alone flt-3 ligand supports the survival of precursor cell types in the lineage of blood-forming cells such as CFU-GM, CFU-GEMM, and the very primitive high proliferative potential colony-forming cells. flt-3 ligand only has marginal effects on erythroid and megakaryocyte progenitor cells.
In the mouse, flt-3 ligand potently enhances growth of various types of progenitor/precursor cells in synergy with G-CSF, GM-CSF, M-CSF, IL3, IL6, IL7, IL11, IL12 and SCF. flt-3 ligand supports growth of LTC-IC (long-term culture-initiating cells). The ability of flt-3 ligand to promote the survival of hematopoietic progenitor cells is abrogated by TGF-beta and counteracted by TNF-alpha.
A study of the expression of functional flt-3 receptor and the responses to the ligand in AML (acute myeloid leukemia) and ALL (acute lymphoblastic leukemia) shows a considerable heterogeneity. BCP-ALL in particular fails to proliferate in the presence of flt-3 ligand despite strong expression of surface flt-3 receptor.
It has been shown that in patients with aplastic anemia and in cancer patients with chemotherapy-induced transient suppression of hematopoiesis, serum levels of flt-3 ligand fluctuate in an inverse relationship to the degree of bone marrow failure. flt-3 ligand levels in serum inversely correlate with the colony forming ability in vitro of bone marrow precursors from patients with aplastic anemia. flt-3 ligand treatment of mice challenged with syngeneic fibrosarcoma cells has been shown to result in complete tumor regression and in decreased tumor growth rates.
Antitumor cytokines are especially useful in the methods and compositions of the invention. According to the invention, an “antitumor cytokine” is a cytokine that can limit the growth or metastasis of tumor cells in vitro or in vivo, or can prolong the survival of a tumor-bearing animal, when either admixed with the cells or administered to the animal. The cytokine can be formulated as a solution in a biologically compatible buffer, e.g. PBS, and admixed with tumor cells in vitro. The concentration of cytokine may be from about the picomolar range to about the micromolar range. An antitumor cytokine will, for example, reduce the growth rate of the cells, e.g. by at least 10% compared to buffer alone, or inhibit metastatic properties of the cells, as may be evidenced by, e.g., increased cell adhesiveness or decreased ability to invade an extracellular matrix substrate, such as an artificial basement membrane. Alternatively, an antitumor cytokine may inhibit the growth or metastasis of a tumor in vivo, or may prolong the survival of a tumor-bearing animal. To evaluate the in vivo antitumor effects of a cytokine, the cytokine may be formulated in a pharmaceutically acceptable carrier and administered, e.g., by intravenous, intratumoral, or intraperitoneal injection. The cytokine may also be administered in association with cells, such as tumor cells that express or are coated with the cytokine.
Assays for Bioactivity
According to the invention, it is preferred that a cytokine be “bioactive”, “highly bioactive”, “extremely bioactive”, “natively bioactive”, or “suprabioactive”. Different levels of bioactivity relate to the ability to induce a change in a leukocyte (other than mere occupancy of the leukocyte's receptors for the cytokine). According to the invention, all naturally occuring cytokines are natively bioactive. Many types of assay can demonstrate the bioactivity of a non-naturally occurring cytokine. For example, a cytokine may be shown to induce survival and/or proliferation of a particular cell type. As another example, a cytokine may change the concentration of an intracellular second messenger, such as cAMP, arachidonic acid, calcium ions, or inositol triphosphate. The following are examples of assays for bioactivity:
Assay 1
Each well of one or more 60-well Lux microtiter trays is loaded with 200 FDC-P1 cells in 10 ul Dulbecco's modified Eagle's medium with a final concentration of 10% newborn calf serum. Cytokine in a concentration in at most the micromolar range is added to each well in a volume of 5 ul. The tray is incubated for 48 h at 37° C. in 10% CO2. Viable cell counts are performed. The average number of viable cells/well is counted. This assay is useful, for example, for identifying bioactivity mediated through a murine GM-CSF receptor.
Assay 2
Cytokine sample and a recombinant standard identical to a naturally occurring cytokine are each diluted serially in complete RPM1-10 in 96-well flat-bottom microtiter plates. Each dilution is plated in triplicate. CT.4S cells in active log-phase growth are collected, washed at least twice in complete RPM1-10, and resuspended in complete RPM1-10 at 1×105 cells/ml. 50 ul of the cell suspension is added to each well of the plate, which is then incubated for 24 h at 37° C. in 5% CO2 Tritiated thymidine is added to each well and the plate is incubated for an additional 24 h. The cells are then harvested and tritium incorporation is measured by liquid scintillation counting. This assay is useful, for example, for identifying bioactivity mediated through an IL-4 receptor.
Assay 3 (Colony Formation Assay)
Agar (4% w/v) is melted in sterile water by boiling 3 min. The agar is then cooled to 42° C. and added to 42° C. RPM1-15 to a final concentration of 0.4%. The solution is maintained at 42° C. Femurs are removed from young mice using sterile technique. Marrow is collected by flushing the opened ends of the bones with sterile Hank's Balanced Salt Solution (HBSS) using a syringe equipped with a 23G needle. Marrow is placed in a 15 ml tissue culture tube and vortexed into a cell suspension. Bone fragments are allowed to settle for 5 min, and the supernatant suspension is removed. The suspension is adjusted to 7.5×106 nucleated cells/ml and diluted 1:100 by adding the 42° C. RPMI with 0.4% agar. 2-fold serial dilutions of cytokine are added to 35 mm tissue culture dishes in a volume<=0.2 ml. Control dishes have no cytokine added. 1 ml warm cell suspension is added to each dish and the agar is allowed to set at room temperature. The cultures are incubated for 5-7 days at 37° C. in 5% CO2. Colony formation is then evaluated by microscopy. The average number of colonies of a given type (or aggregate number of colonies of given different types) on the cytokine plates and the average number on the control plates is counted. This assay is useful, for example, for identifying bioactivity mediated through CSF receptors.
Assay 4
Cytokine is diluted serially in RPMI 1640/25 mM HEPES/1% BSA. 25 ul of each dilution is plated in triplicate in a multiwell chemotaxis chamber bottom. Wells containing medium alone serve as negative controls and wells containing chemotaxis-inducing naturally occurring cytokine serve as positive controls. A polycarbonate membrane is placed over the chamber bottom and the chamber is assembled. 50 ul of peripheral blood mononuclear cells at 1.5×106 cells/ml in the RPMI/HEPES/BSA is added to each of the upper wells of the chamber. The chamber is incubated for 90 min at 37° C. in 5% CO2. The membrane is removed, washed, and stained. Migrated cells in 3-5 random fields of each well are counted by microscopy.
Assay 5
Naturally-occurring cytokine reference standard is diluted to 2 ng/ml in a 17×100 mm tube using supplemented medium. 3 further 5-fold serial dilutions are also prepared. Serial dilutions of cytokine are prepared in 17×100 mm tubes from 2 ng/ml to 20 pg/ml. 50 ul of PHA-activated human lymphoblasts 4×105 cells/ml in supplemental medium is added to each well of a 96-well flat-bottom microtiter plate. 50 ul of each dilution of reference standard or cytokine is added to triplicate wells. Negative control wells receive 50 ul of supplemented media alone. The plate is incubated for 48 h at 37° C. in 5% CO2 and the cells are labeled with tritiated thymidine. Incorporation is measured by liquid scintillation counting. This assay is useful, for example, for identifying bioactivity mediated through an IL-12 receptor.
Assay 6
In another assay for bioactivity, an immunocompetent animal is vaccinated with on the order of 104-108 irradiated cytokine-transduced or cytokine-coated tumor cells, and challenged with on the order of 104-108 live wild-type tumor cells (in any temporal sequence). Readouts of the assay are survival, tumor onset, or number of metastases.
Further examples of cytokine assays can be found, e.g., in: Callard R E et al Assay for human B cell growth and differentiation factors. in: Clemens M J et al (eds) Lymphokines and Interferons. A practical Approach, pp. 345-64, IRL Press, Oxford 1987; Coligan J E et al Current protocols in immunology. Grene and Wiley-Interscience, New York 1991); Dotsika E N Assays for mediators affecting cellular immune functions. Current Opinion in Immunology 2: 932-5 (1989); Feldmann M et al Cytokine assays: role in evaluation of the pathogenesis of autoimmunity. Immunological Reviews 119: 105-123 (1991); Guiguet M et al Misinterpretation of the biological activity of cytokine-containing preparations attributable to unrecognized interacting components. Analytical Biochemistry 247(2): 441-442 (1997); Hamblin A S & O'Garra A Assays for interleukins and other related factors. In: Lymphocytes, a practical approach, Klaus G G B (edt), pp. 209-28, IRL Press, Oxford, (1987); Laska E M & Meisner M J Statistical methods and applications of bioassay. Annu. Rev. Pharmacol. Toxicol. 27: 385-97 (1987); Mosman T R & Fong T A T Specific assays for cytokine production by T cells Journal of Immunological Methods 116: 151-8 (1989); Newton R C & Uhl J Assays relevant to the detection and quantitation of cytokines and their inhibitors. Modem Methods in Pharmacol. 5: 83-99 (1989); Thorpe R et al Detection and measurement of cytokines. Blood Rev. 6: 133-48 (1992); van Zoelen E J The use of biological assays for detection of polypeptide growth factors. Progress in Growth Factor Research 2: 131-52 (1990); Winstanley F P Cytokine bioassay. In: Gallagher G et al (eds) Tumor Immunobiology, A practical Approach. Oxford University Press, pp. 179-303 (1993); Wadha M et al Quantitative biological assays for individual cytokines. In: Balkwill F R (edt) Cytokines, A practical approach. Oxford University press, pp. 309-330 (1991)
According to the invention, if a non-naturally occurring cytokine gives a readout in a bioactivity assay that is at least 10% but not more than 29% (to the nearest 1%) of the readout yielded by an equimolar amount of a naturally occurring cytokine (the latter giving a positive result in the assay), then the non-naturally occurring cytokine is “bioactive”. According to the invention, if a non-naturally occurring cytokine gives a readout in a bioactivity assay that is at least 30% but not more than 49% (to the nearest 1%) of the readout yielded by an equimolar amount of a naturally occurring cytokine (the latter giving a positive result in the assay), then the non-naturally occurring cytokine is “highly bioactive”. According to the invention, if a non-naturally occurring cytokine gives a readout in a bioactivity assay that is at least 50% but not more than 69% (to the nearest 1%) of the readout yielded by an equimolar amount of a naturally occurring cytokine (the latter giving a positive result in the assay), then the non-naturally occurring cytokine is “extremely bioactive”. According to the invention, if a non-naturally occurring cytokine gives a readout in a bioactivity assay that is at least 70% but not more than 100% (to the nearest 1%) of the readout yielded by an equimolar amount of a naturally occurring cytokine (the latter giving a positive result in the assay), then the non-naturally occurring cytokine is “natively bioactive”. According to the invention, if a non-naturally occurring cytokine gives a readout in a bioactivity assay that is greater than 100% of the readout yielded by an equimolar amount of a naturally occurring cytokine (the latter giving a positive result in the assay), then the non-naturally occurring cytokine is “suprabioactive”.
Ligands for CD40 Useful According to the Invention
Nucleotide sequences encoding the CD40 proteins of various species are provided by, e.g. Genbank Accession Nos. Y10507, M83312, and U57745. Human CD40 is a transmembrane glycoprotein with a length of 277 amino acids (48 kDa). CD40 is a phosphoprotein and can be expressed as a homodimer. A soluble form of CD40 (28 kDa) has also been described. CD40 protein is expressed on all B-lymphocytes during various stages of development, activated T-cells and monocytes, follicular dendritic cells, thymic epithelial cells, and various carcinoma cell lines. It is expressed on most mature B-cell malignancies and on some early B-cell acute lymphocytic leukemias. CD40 has been demonstrated on the majority of myeloma cell lines and myeloma cells from patients with plasma cell dyscrasia.
Induction of CD40 mRNA and enhancement of cell surface protein expression in primary human monocytes is observed after treatment with GM-CSF, IL3, or IFN-gamma. The human CD40 gene maps to chromosome 20.
CD40 has been proposed to play a role in the development of memory cells. It also plays a role in cell activation, functioning as a competence factor and progression factor. Crosslinking of the CD40 antigen (in combination with cytokines such as IL4 and IL5) leads to B-cell proliferation and induces immunoglobulin class switching from IgM to the synthesis of IgG, IgA, and IgE in the absence of activated T-cells. CD40 is one of the obligatory signals required for commitment of naive B-cells to IgA secretion; the mechanism of IgA induction requires the cooperation of IL10 and TGF-beta. Soluble CD40 inhibits T-cell-dependent B-cell proliferation.
Monoclonal antibodies against CD40 mediate a variety of effects on B-lymphocytes, including induction of intercellular adhesion (via CD11a/CD18 (LFA-1)), short- and long-term proliferation, differentiation and enhanced tyrosine phosphorylation of proteins. Germinal center centrocytes are prevented from undergoing cell death by apoptosis by activation through CD40 and antigen receptors.
In human resting B-cells expression of CD40 is induced by IL4. Treatment of human B-cells with IL6 leads to the phosphorylation of the intracellular CD40 domain. CD40 does not, however, function as a receptor for IL6. In activated human B-cells the synthesis of IL6 is induced by treatment of the cells with monoclonal antibodies directed against CD40, suggesting that CD40 participates in signal transduction mechanisms dependent on IL6.
Some limited sequence homologies have been found with receptors for Nerve Growth Factor, TNF-alpha and CD27 and it has been assumed that CD40 may be involved also in modulating the biological activity of these and other cytokines.
CD40 has biological functions also in non-immune cells although these are still largely unknown. CD40 ligation has been shown to induce cell death by apotosis in transformed cells of mesenchymai and epithelial origin. In part these processes are mediated through the death domain present in the cytoplasmic domain of CD40.
A particularly useful ligand for CD40 is CD154. CD154 (“CD40 ligand”; human protein 29.3 kDa, 261 amino acids) is a member of the TNF family of proteins. The human protein shows 82.8% and 77.4% identity at the cDNA and protein level, respectively, with a similar protein isolated from murine EL4 thymoma cells. Both proteins are the ligands for the CD40 cell surface antigen expressed on resting B-cells. The human gene encoding CD154 maps to chromosome Xq26.3-q27. Nucleotide sequences encoding the native CD40 ligands of various species are provided by, e.g., Genbank Accession Nos. X67878, X96710, X68550, X65453, Z48469, and L07414. Amino acid sequences of the CD154 molecules of various species are provided, e.g., by Entrez protein database Accession Nos. 1705713, 231718, 560693, 3047129, 116000, 1518170, 38412, 109639, 1083014, 38484, and 37270.
CD154 is naturally synthesized as a transmembrane polypeptide. Nevertheless, a biologically active soluble fragment of human CD154 has been described (Pietravalle et al, 1996, J Biol Chem 271:5965-5967.) Mazzei et al (1995, J Biol Chem 270:7025-7028) identified a biologically active soluble fragment of CD154 as a homotrimer of polypeptides consisting of amino acids Glu 108 through Leu 261 of intact transmembrane CD154. Graf et al (1995, Eur J Immunol 25:1749) describe another active fragment consisting of the C-terminal fragment produced by proteolyttic cleavage at Met 113. Aruffo et al disclose soluble forms of CD154 and their use to stimulate B cells in vitro in U.S. Pat. No. 5,540,926. In the present invention, particularly useful ligands for CD40 include polypeptides that comprise a sequence as set forth in SEQ ID NO. 2 of the '926 patent, from amino acid residues 47 to 261. These residues are comprised by the extracellular domain of human CD154.
Another particularly useful type of ligand for CD40 is an antibody to CD40. Examples of such antibodies include the monoclonal antibodies designated product numbers MCA1143 and MCA1590 of Harlan Bioproducts for Science (Indianapolis, Ind.); monoclonal antibodies designated catalog numbers P61640F (produced by clone 14G7), P42374M (produced by clone MAB89), P61046M (produced by clone BL-C4), and P54486M (produced by clone B-B20) of Biodesign International (Kennebunk, Me.); monoclonal antibody designated catalog number 05-422 (produced by clone 626.1) of Upstate Biotechnology (Lake Placid, N.Y.); monoclonal antibody designated catalog number 3601 (produced by clone S2C6) of Mabtech (Nacka, Sweden); monoclonal antibodies designated catalog numbers RDI-CBL486 (produced by clone BB20), RDI-M1691clb (produced by clone CLB-14G7), RDI-mCD40-323 (produced by clone 3/23) of Research Diagnostics (Flanders, N.J.); monoclonal antibodies described in Schwabe et al, 1997, Hybridoma 16:217-226; monoclonal antibodies described in Bjorck et al, 1994, Immunology 83:430-437; monoclonal antibody G28-5 described by Ledbetter et al, 1994, Circ Shock 44:67-72; and monoclonal antibodies described in Buske et al, 1997, Exp Hematol 25:329-337.
Opsonins Useful According to the Invention
As defined hereinabove, “opsonin” refers to naturally occurring and non-naturally occurring molecules which bind to both antigens and antigen presenting cells (APCs), such as, for example, phagocytic leukocytes (including monocytes and macrophages), dendritic cells (for example, Langerhans cells of the skin), B lymphocytes and, in humans, endothelial cells, or molecules which can be processed such that at least one product of the processing step or steps can bind to both antigens and antigen presenting cells (APCs), such as, for example, phagocytic leukocytes, dendritic cells, B lymphocytes, and, in humans, endothelial cells.
Without being bound to any one mechanism of action, it is believed that opsonin-enhanced cells provide a beneficial effect according to the invention because the opsonin portion acts as a link or coupling agent between the antigen and the APC to allow more efficient binding, engulfment, and internalization of the antigen. In addition, the opsonin itself can be internalized with the antigen. “Internalization” refers to the cellular uptake of a molecule such that it is brought into the cytoplasm or a compartment within the cytoplasm of the cell. Phagocytosis is a process by which a molecule is internalized by a cell.
Preferred opsonins are non-rodent opsonins, e.g., primate, e.g., human, opsonins. Opsonins useful according to the invention bind to receptors on APCs (e.g., phagocytic leukocytes, e.g., macrophages and other cells of the phagocytic system) such as receptors on cells which play a role in innate immunity, as described herein.
Some sets of opsonins can be regarded as structurally and functionally similar. For example, one family comprises fragments of complement components C3 and C4. These two components are highly structurally homologous, and each possesses an intramolecular thiolester bond that is broken when a peptide (C3a or C4a respectively) is proteolytically cleaved from the native molecule. Disruption of the thiolester makes available a chemical structure that can form an ester linkage with an antigen. The moiety of C3 on which this ester bond resides, i.e. the non-C3a moiety, is designated C3b, and C4b is the analogous product of C4 cleavage. C3b can be further proteolysed by proteins such as factor I to yield fragments such as C3bi and C3d, which also remain linked to the antigen via the ester bond.
There are four structurally unique proteins that are known to function as high affinity receptors for biologically active, membrane-bound fragments of C3 and/or C4. CR1 is the major receptor for the C3b fragment of C3 and C4b fragment of C4. It is expressed on monocytes and monocyte-derived APCs, among other cell types. CR2 is the major receptor for the fragment of C3 known as C3d, and is expressed on, e.g., mature B lymphocytes, but not on cells of monocytic lineage. The major role of CR2 on B lymphocytes is believed to be direct costimulation of B cells in concert with their cognate antigens.
CR3 is expressed primarily by neutrophils and monocytes and is also expressed on FDC, Kupffer cells, and NK cells. CR3 is a C3 fragment receptor with a primary specificity for C3bi. CR3 has been proposed as an important organizer of cytoskeletal events necessary for adhesive interactions and membrane reorganization during processes such as phagocytosis.
CR4 is a member of the beta2 integrin family, and its alpha chain is structurally similar to the alpha chain of CR3 and LFA-1. Its primary physiologic ligands are believed to be C3d and C3d,g;, however, its biologic activities are less well understood than CR3.
Another example of a family of innate opsonins is the collectins, a group of collagenous C-type lectins that comprises complement component C1q, mannose binding protein, surfactant proteins A and D, and conglutinin. Each molecule comprises a lectin domain that can bind to an antigen, and a collagenous domain that can bind to receptors on phagocytic mononuclear cells, including receptors that are wholly or partially identical to the C1q receptor (Nepomuceno et al, Immunity 6:11'9-29; Tenner et al, Immunity 3:485-93; Guan et al, J Immunol 152:4005-16; Geertsma et al, Am J Physiol 267:L578-84; Miyamura et al, Biochem J 300:237-42; Malhotra et al, J Exp Med 172:955-9; Malhotra et al, Biochem J 293:15-19). Most known collectins comprise multiple polypeptide chains, in some cases homomeric and in others heteromeric, that are assembled post-translationally, in part by covalent cross-linkage of hydroxyproline and hydroxylysine residues. Collectins are demonstrated to be opsonins in, for example, Pikaar et al, J Infect Dis 172:481-9; Alvarez-Dominguez et al, Infection & Immunity 61:3664-72; Kuhlman et al, J Exp Med 169:1733-45; and Geertsma et al, op cit.
Among the other innate opsonins useful according to the invention are C-reactive protein (CRP), alpha-2 macroglobulin, and fibronectin. CRP, a member of the pentraxin family of molecules, binds to receptors on cells of monocytic lineage and has been shown to be an opsonin (Tebo and Mortenson, J Immunol 144:231-8; Holzer et al, J Immunol 133:1424-30). Alpha-2 macroglobulin, like C3 and C4, comprises an internal thiolester bond that can be disrupted when the molecule is proteolysed. Such disruption allows covalent binding of the molecule to an antigen, and binding of alpha-2 macroglobulin to an APC can promote uptake of the conjugate. Fibronectin binds to the alpha 5 beta 1 integrin and can also bind to various antigens, allowing it to function as an opsonin (Cosio, J Lab Clin Med 103:613-9; Czop and Austen, J Immunol 129:2678-81).
Immunoglobulins (antibodies) can function as opsonins by binding antigens via their variable regions and APCs via their constant regions. Typically, an immunoglobulin comprises two heavy chains which are covalently bound to each other and each of which is bound to one light chain. These heterotetramers can further assemble into higher-order structures, such as the pentamers of IgM. Both heavy and light chain variable regions can contribute to the structure of the antigen binding site, whereas the APC binding site is located on the heavy chain constant region. Recombinant single-chain antibodies have also been described. APC receptors for immunoglobulins include Fc alpha, Fc gamma, Fc epsilon, and Fc mu receptors for IgA, IgG, IgE, and IgM, respectively.
Opsonins that are naturally expressed by multicellular eukaryotic organisms are secreted. The latter characteristic distinguishes opsonins from adhesion molecules. A non-naturally occurring molecule containing a naturally occurring APC-binding moiety shall be considered an opsonin if it contains a moiety through which it can be stably bound or attached to a cell such that the APC-binding moiety is located in the extracellular space, whether or not the molecule contains an antigen-binding moiety of a naturally occurring antigen. Moieties through which molecules can be stably bound to a cell include crosslinking moieties, transmembrane sequences, and lipid moieties. The preparation of proteins containing these sequences or moieties is well-known to one of skill in the art.
An “APC binding moiety of an opsonin” is a sequence or domain of an opsonin which when included in a chimeric molecule permits binding of the chimeric molecule to a receptor that is physiologically expressed on an APC with an affinity at least in the nanomolar range.
There are a number of examples of opsonin fragments that comprise APC binding moieties. Such a fragment may be any length so long as it retains an APC binding function; for example, it may be about 40 amino acids, 100 amino acids, 150 amino acids, 500 amino acids, 800 amino acids, or even as long as 3000 amino acids. For example, Las Holtet et al, 1994, FEBS Lett 344:242 describe a carboxy-terminal fragment of human α2m (val1299-ala1451) that binds with high affinity to the α2m receptor. Fragments comprising amino acids 1314-1451 of human α2m and the corresponding domain of rat α2m also bind to α2m receptors, albeit with 1-2% of the affinities of native α2m (Van Leuven et al, 1986, J Biol Chem 261:11369; Enghild et al, 1989, Biochemistry 28:1406; Salvesen et al, 1992, FEBS Lett 313:198; Sottrup-Jensen et al, 1986, FEBS Lett 205:20).
Becherer and Lambris, 1988, J Biol Chem 263:14586 describe fragments of C3b that bind to CR1, e.g., C3c, fragments of C3 generated by elastase treatment and comprising the N-terminal of the alpha′ chain of C3b, and a synthetic peptide comprising the 42 N-terminal amino acids of the C3b alpha′ chain. A binding sequence in C3 for CR3 has also been described (Wright et al, 1987, PNAS 84:4235).
“Collagen stalks” of C1q, which are N-terminal fragments obtained by pepsin digestion, bind to the C1q receptor (Reid, 1981, Methods Enzymol 80:16; Malhotra et al, 1993, Biochem J 293:15). Malhotra et al, ibid., also provide evidence that an APC binding moiety of conglutinin is comprised by its 55 N-terminal amino acids. Ezekowitz (U.S. Pat. No. 5,270,199) offers a putative APC binding site in human mannose binding protein consisting of nucleotides 370-438 of FIG. 2 in the '199 patent. In addition, by homology with conglutinin, exon 1 disclosed in the '199 patent may comprise an APC binding moiety.
An APC binding moiety of IgG comprises the CH2 domain and the lower hinge region, including residues 234-237, as described by Canfield and Morrison, 1991, J Exp Med 173:1483-91; Lund et al, 1991, J Immunol 147:2657-62; and Sarmay et al, 1992, Mol Immunol, 29:633-9.
Examples of opsonins which can be used in the compositions and methods of the invention include fibronectin (e.g., Genbank accessions X02761, K00799, K02273, X82402, X00307, X00739), CRP (e.g., Genbank accessions X17496, M11880, M11881, M11882), complement components such as C1q (e.g., Genbank accessions X66295, M22531, X03084, X58861, and Swiss-Prot accessions P02747, P02745), complement fragments such as C3b and C3d (e.g., Genbank accessions K02782, K02765), mannose binding protein (e.g., Genbank accessions S42292, S42294, X15422), conglutinin (e.g., Genbank accession X71774), alpha-2-macroglobulin (e.g., Genbank accessions M93264, M11313), and surfactant proteins A (e.g., Genbank accessions M68519, S48768) and D (e.g., Genbank accessions L40156, X65018, S38981), immunoglobulins, and their homologues among species.
Determination of Opsonicity According to the Invention
A given naturally occurring opsonin is considered useful according to the invention if it is determined to possess opsonicity according to one or more of the following assays, and if it is a secreted molecule.
Assay 1
In one assay of opsonicity, as described by O'Rear and Ross in Current Protocols in Immunology, 1994, John Wiley & Sons, pp. 13.4.5-9, SRBC bound via a physiologically occurring linkage to the candidate opsonin molecule are obtained. APCs from the species to which the candidate opsonin is native are suspended at 4×106/ml in ice-cold HBSS with 1% (w/v) Cohn fraction of BSA. If the candidate opsonin is a fragment of C3, the APCs are freshly drawn, uncultivated peripheral blood monocytes. SRBC linked to the candidate opsonin or control SRBC (identical to the former but not linked to the candidate opsonin) are suspended in the same solution at 2×108/ml. 100 ul of SRBC suspension and 100 ul of APC suspension are mixed in a 10×75 mm plastic tube. The tube is rotated at 40 rpm at 37° C. for 2-20 min. A small drop of the suspension is placed on a slide, covered with a coverslip, and allowed to stand for 5-10 min. Excess fluid can be removed by pressure on the coverslip, and the coverslip can be sealed to the slide, e.g. with clear nail polish. The slide is examined microscopically, and the percentage of APCs visibly adherent to 4 or more SRBCs is determined. If the percentage is 50% or greater when there are up to 4×104 candidate opsonin molecules/SRBC′, the candidate opsonin can be an opsonin.
Assay 2 (For Protease-Activated Candidate Opsonin)
Candidate opsonin or radiolabeled Candidate opsonin is treated with a 1.5-3 fold molar excess of protease (0.05 M triethanolamine-0.1 M NaCl, pH 8.0, room temperature overnight). In this assay, the protease can serve as the antigen or an excess of another antigen can be added. Prior to binding studies, the candidate opsonin-antigen complex is dialyzed against HBSS (4° C.).
Candidate opsonin-antigen complex binding to monocytes is measured by incubating labeled ligand at a concentration up to 1.0 M with (1.5-4.0)×106 monocytes in 200 ml volume on ice. Nonspecific binding of radiolabeled ligands is determined in the presence of a 100-fold molar excess labeled candidate opsonin-antigen complex. The unbound ligand is separated from the cells and cell-bound ligand by rapid vacuum filtration on glass fiber filters. Studies are performed on ice to avoid potential complications due to endocytosis. Binding constarts and the number of sites per cell are determined by analysis and by nonlinear curve fit. If candidate opsonin-antigen complex affinity for a monocyte binding site is in at least the nanomolar range, the candidate opsonin is an opsonin.
Assay 3
Part I
To directly evaluate whether candidate opsonin is bound to the surface of P. carinii, immunoelectron microscopy is performed. P. carinii are isolated from bronchoaveolar lavage (BAL) of moribund infected rats using TBS with 1 mM calcium to preserve surface-bound candidate opsonin. Isolated organisms are fixed in periodate-lysine-paraformaldehyde buffer and embedded in Lowacryl mounting medium (Ted Pella, Inc., Redding, Calif.). Ultrathin sections are obtained, blocked with normal goat serum (2%) for 1 h, and incubated with either rabbit anti-candidate opsonin or nonimmune rabbit IgG (25 mg/ml) overnight. After washing, the sections are subsequently incubated with goat and rabbit IgG conjugated to 15 nM colloidal gold (Amersham Corp., Arlington Heights, Ill.). The sections are washed again and examined on a transmission electron microscope (model 6400:JEOL USA, Inc., Peabody, Mass.).
Part II
The attachment of P. carinii to cultured alveolar macrophages in the presence or absence of antibody to the candidate opsonin or with the addition of purified candidate is quantified as follows. Adherence of P. carinii to alveolar macrophages is assayed by 51Cr-labeling the organisms. P. carinii are isolated from infected rats with TBS containing 1 mM calcium to prevent loss of surface-bound candidate opsonin. The organisms are radiolabeled by incubation for 8 h at 37° C. in 2 ml of DME containing 20% FCS and 200 mCi of 51Cr-sodium chromate (New England Nuclear). Normal alveolar macrophages are lavaged from healthy rats and plated in tissue culture plates (1×105) cells/well) which are been precoated with normal rat IgG (100 mg/ml×60 min) in order to ensure firm adherence of the macrophages. After 1 h, the macrophages are gently washed with HBSS to remove nonadherent cells. >95% of macrophages are adherent after this wash. 51Cr-P. carinii (1×106) containing surface-associated candidate opsonin are added to the macrophages and incubated at 37° C. for an additional hour. Subsequently, nonadherent P. carinii are removed by washing. The macrophage monolayers containing adherent P. carinii are solubilized in 1 N NaOH and quantified. Adherence of P. carinii is defined as: percentage of adherence=(A/A+B)×100, where A=51Cr-P. carinii associated with the monolayer, and B=unattached 51Cr-P. carinii. To assess the effect of candidate opsonin on the attachment of P. carinii to alveolar macrophage lung cells in culture, P. carinii adherence assays are conducted in the presence or absence of a polyclonal rabbit antibody generated against the candidate opsonin (100 mg/ml).
If candidate opsonin binding to P. carinii is apparent in Part I and if, in Part II, % adherence is diminished in the presence of anti-candidate opsonin with statistical significance of P<0.05, the candidate opsonin is an opsonin.
Assay 4
Association of bacteria with adherent monocytes is measured as follows. Endotoxin level in the modified PBS and in all buffers used is below 50 pg/ml as determined by the Limulus assay. 5×103 monocytes in modified PBS are allowed to adhere to the wells of a Terasaki plate for 2 h at 37° C. After nonadherent cells are removed by three washes with PBS, 5×104 FITC-labeled bacteria in 0.5 ml buffer with or without 10-50 micrograms/ml of candidate opsonin are added. A bacteria-to-monocyte ratio of 10:1 to 50:1 is used. After 30 min of incubation at 37° C. in the dark, the nonadherent bacteria are removed by five washes with warm PBS. Assays are performed in quadruplicate; in each well, the number of bacteria associated with 3 100 monocytes is counted under a flourescence microscope using ×400 magnification. Results are expressed as the number of bacteria associated with 100 monocytes. If this number with candidate opsonin can be at least twice that without candidate opsonin, the candidate opsonin is an opsonin.
Assay 5
Part I
About 1×107 to 6×107 bacteria per ml are incubated (20 min, 0° C.) with 10 mcg/ml of 125I-candidate opsonin in a total volume of 0.7 ml. of PBS aliquots, 100 ml, of the reaction mixtures are layered over 150 ml of an oil cushion (60% dibutyl phthalate, 40% dioctyl phthalate [Eastman Kodak Co., Rochester, N.Y.]), and the mixtures are centrifuged (10,000×g, 60 s, 4° C.). The tip of the tube, containing the cell pellet, is cut with a Mozart razor blade, and the radioactivity is counted.
Part II
APCs are plated in 96-well tissue culture plates (Costar, Cambridge, Mass.) at 2×105 cells per ml the evening before use. 2×106 bacteria per well (0.1 ml per well) are added to the culture plates with or without 100 mcg/ml of candidate opsonin. The plates are then centrifuged at 1,000×g for 7 min. After 15 min at 37° C. to allow the uptake of bacteria, free bacteria are removed by several washes with cold PBS. They are then incubated (45 min, 37° C.) in RPMI 1640 plus an amount of antibiotic that, when present in the culture for 45 min, kills all extracellular bacteria. The end of this incubation period is considered time zero. Monolayers are washed three times with Hanks' balanced saline solution, and the same volume of RPMI 1640 (R0) is added. The cells are lysed by using several cycles of freezing and thawing. The number (CFU) of viable bacteria per well is determined by quantitative plate counts on blood agar plates (Columbia blood agar; Becton Dickinson, San Jose, Calif.) after 24 h of incubation. Each result is given as the mean of three determinations.
If, in Part I, candidate opsonin-treated bacterial pellet has >75 KCPM and this incorporation can be inhibited by unlabeled candidate opsonin, and if in Part II the CFU with candidate opsonin is greater than without (P<0.05), the candidate opsonin can be an opsonin.
Assay 6
200 μl of GHBSS (Hanks Balanced Salt Solution)+0.1% of gelatin containing 10 m mol CaCl2) containing 107 bacteria is prepared. The bacteria are then incubated at 4° C. with 20-100 μg/ml of candidate opsonin. Binding assays are done in the presence or absence of a competitive inhibitor. After incubation for 30 minutes, the bacteria are washed five times in a GHBSS+10 mmol CaCl2 at room temperature in a microfuge at 1,300 g for 3 minutes. Thereafter, a 1:1,000 dilution of rabbit anti-candidate opsonin antiserum is incubated with the bacteria for 1 h in PBS+5% FCS and 10 mmol CaCl2 and then the bacteria are washed three times in GHBSS+10 mmol CaCl2 plus 0.05% Tween 20. Binding of anti-serum to bacteria is detected by a 1:1,000 dilution of goat anti-rabbit IgG conjugated to rhodamine (Fisher Pharmaceuticals, Orangeburg, N.Y.). After incubation, the bacteria are washed five times in GHBSS+10 mmol CaCl2 plus 0.05% Tween 20, smeared onto glass slides and allowed to air dry. Thereafter bacteria are fixed with 100% ice cold methanol for 5 minutes. Negative controls included the absence of candidate opsonin and no first step antibody. Numerous fields of triplicate assays are examined by fluorescence microscopy.
Part II Association of Radiolabeled Bacteria with Cells.
107 radiolabeled bacteria are resuspended in 200 μl of GHBSS+10 mmol CaCl2 and are incubated with or without candidate opsonin ranging from 2 μg/ml to 40 μg/ml at 4° C. for 30 min. The bacteria are then washed three times in GHBSS+10 mmol CaCl2 for 3 min at room temperature in a microfuge at 1,300 g, resuspended in 50 μl of GHBSS and added to a 1-ml suspension containing on the order of 106 APCs (GHBSS). The bacteria and APCs are gently rocked at 37° C. for 20 min and thereafter the unattached bacteria are removed by five washes using differential centrifugation at 82 g in a microfuge. Before the last wash, an aliquot from each sample is plated on a Labtek slide and cells are adhered for 10 min, fixed in methanol, stained with Giemsa, and scored by light microscopy. To score the cells plated on the Labtek slides, at least 400 cells are counted. The phagocytic index represented the number of attached or ingested particles per 100 PMNs. The pellet from above containing cells and radiolabeled bacteria is then lysed in 100 μl PBS+0.5% Triton X-100 and the radioactivity is measured in a scintillation counter. If, in Part I, specific binding of candidate opsonin to bacteria is evident, and in Part II the specific uptake of bacteria, in cpm, is more than three times greater with candidate opsonin than without, the candidate opsonin can be an opsonin.
Assay 7
Part I
To investigate binding to L donovani promastigotes cultures are seeded at 5×105 parasites ml. At regular time points up to 9 days, a fraction of parasites are counted, washed, and resuspended in 1% BSA, 0.5 mM Ca2+. 0.05% NaN3, Tris-buffered saline (TBS), (10 mM Tris-HCl, 0.15 M NaCl, pH 8.0) (diluent) to 2×105 ml−1. Fifty microliters of this suspension are then added to 200-μl microfuge tubes containing 70 μl 5 μg/ml radiolabled candidate opsonin (0.12 μCi/μg) in diluent without EDTA, which had been layered over 150 μl of a dinonyl phthalate/dibutyl phthalate (40:60 v/v) oil mixture. Parasites are incubated for 1 h and centrifuged through the oil layer, the cell pellet is cut off, and associated candidate is detected by gamma counting. Each assay is performed in triplicate. The concentration dependency of candidate binding to promastigotes is also measured as above, using an activity of 0.045 μCi/μg and a twofold dilution series from 60 to 0.015 μg/ml candidate.
Part II
APCs are plated out at 1×106 cells/well on glass coverslips in a 24-well tissue culture plate. Cells are incubated in RPMI 1640 (Life Technologies) supplemented with 10% PCS, 1 mM glutamine, 200 U/ml penicillin and 200 μg/ml streptomycin in a humidified incubator at 37° C. After 24 h, nonadherent cells are removed and remaining cells are used after 6 days. Promastigotes are incubated with or without candidate at 30 μg/ml in RPMI 1640 for 1 h and then washed three times before adding to the APC cultures at 106/well. Promastigotes are allowed to infect APCs for 1 h, then cells are washed, fixed with methanol, and Geimsa stained (BDH, Poole, Dorset, U.K.) before counting. The percentage of APCs infected and the number of parasites/100 macrophages is determined from quadruplicate cultures.
If in Part I the affinity of candidate opsonin for parasites is at least in the nanomolar range and in Part II the number of parasites taken up/100 APCs is, with candidate opsonin, at least twice that without candidate opsonin, the candidate opsonin can be an opsonin.
Assay 8
Part I
Portions (0.5 ml) of [35S] methionine-labeled culture medium containing 5 percent fetal calf serum and the candidate opsonin are incubated for 30 minutes at room temperature with 0.1 ml or 0.2 ml of a 10 percent suspension of a microorganism). The microorganisms tested may include, for example, Salmonella typhimurium, Bacillus subtilis, Staphylococcus aureus, Escherichia coli, and Saccharomyces cerevisiae. Bound proteins are released by boiling in buffer containing 2 percent SDS and 0.1 M dithiothreitol and are analyzed on a 5 percent SDS gel.
Part II
Fixed bacteria (0.1 ml; 10 percent by volume; 1010 organisms per millileter), labeled with [3H]thymidine, are incubated with 0.1 ml of serum with or without depletion of the candidate opsonin. After being washed with PBS, the bacteria are incubated with on the order of 1×107 APCs in a final volume of 0.9 ml PBS containing divalent cations. At intervals 0.2 ml is removed to ice-cold PBS with N-ethylmaleimide (2 mM) to block further endocytosis, and the cells are washed (at about 100 g for 10 seconds)
If in Part I a band corresponding to the candidate opsonin is apparent, and if in Part II the CPM after 6-10 min of incubation is at least three times greater for undepleted samples with serum than with depleted serum, the candidate opsonin can be an opsonin.
In lieu of results form Parts I of assays 3, 5, 6, 7, 8, a candidate opsonin that satisfies Part II of an assay can be an opsonin if it can bind to the antigen of the assay with an affinity in at least the nanomolar range.
Assay 9
SRBC coated with at least 1.2×104 molecules/cell of a fragment of C3 are prepared as described by O'Rear and Ross in Current Protocols in Immunology, 1994, John Wiley & Sons, pp. 13.4.5-9. 250 ul of monocytes at 2×105 cells/ml of RPMI with 10% fetal calf serum are added to each well of an 8-well glass tissue culture plate and incubated at 37° C., 5% CO2 for 3 h. The monocytes are washed twice with HBSS, and 50 ul of the SRBC at 1.5×108/ml of DVBS2+ are added to each well. The plate is centrifuged at 50 g for 5 min and then incubated at 37° C., 5% CO2 for 3 h. The walls are washed twice with HBSS, fixed with 0.5% glutaraldehyde, and stained with Giemsa stain. If >40% of the monocytes form rosettes with at least 1 SRBC as determined by light microscopy, the candidate can be an opsonin.
Heat Shock Proteins Useful in the Invention
Heat shock proteins (HSPs) are associated in cells with a broad spectrum of peptides, polypeptides, denatured proteins and antigens with which they form complexes. Such HSP-peptide complexes have been described as being useful in vaccines against cancers and infectious diseases by Srivastava et al., “Heat shock protein-peptide complexes in cancer immunotherapy” in Current Opinion in Immunology (1994), 6:728-732; Srivastava, “Peptide-Binding Heat Shock Proteins in the Endoplasmic Reticulum” in Advances in Cancer Research (1993), 62:153-177. The HSP-peptide complexes appear to work as vaccines, because they may function as antigen carrying and presentation molecules. The development of vaccines using such antigens has been described by Baltz, “Vaccines in the treatment of Cancer” in Am. J. Health-Syst. Pharm. (1995), 52:2574-2585. The antigenicity of heat shock proteins appears to derive not from the heat shock protein itself, but from the associated peptides, see Udono et al., “Heat Shock Protein 70-associated Peptides Elicit Specific Cancer Immunity” in J. Exp. Med. (1993), 178:1391-1396; Srivastava et al., “Heat shock proteins transfer peptides during antigen processing and CTL priming” in Immunogenetics (1994), 39:93-98; Srivastava, “A Critical Contemplation on the Roles of Heat Shock Proteins in Transfer of Antigenic Peptides During Antigen Presentation” in Behring Inst. Mitt. (1994), 94:37-47. HSPs appear to be part of the process by which peptides are transported to the Major Histocompatibility Complex (MHC) molecules for surface presentation.
A number of different HSPs have been shown to exhibit immunogenicity, and are useful in the present invention, including, but not limited to: gp96, hsp90, hsp100, hsp60, hsp 25 and hsp70, see Udono et al., supra. and Udono et al., “Comparison of Tumor-Specific Immunogenicities of Stress-Induced Proteins gp96, hsp90, and hsp 70” in Journal of Immunology (1994), 5398-5403; gp96 and grp94, Li et al., “Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation” in The EMBO Journal, Vol. 12, No. 8 (1993), 3143-3151; and gp96, hsp90 and hsp70, Blachere et al., “Heat Shock Protein Vaccines Against Cancer” in Journal Of Immunotherapy (1993), 14:352-356.
Heat shock proteins may be purified for use in the present invention using a procedure employing DE52 ionexchange chromatography followed by affinity chromatography on ATP-agarose, see Welch et al., “Rapid Purification of Mammalian 70,000-Dalton Stress Proteins: Affinity of the Proteins for Nucleotides” in Molecular and Cellular Biology (June 1985), 1229-1237.
Adhesion Molecules Useful in the Invention
Adhesion molecules useful in the present invention include any cell-surface protein which is involved in bediating the recognition and adhesion of cell sto their substrate and to other cells. Cellular adhesion molecules can be divided into two primary classes: Ca2+ dependent (cadherins) and Ca2+ independent.
There are over a dozen different types of Ca2+ dependent adhesion molecules called cadherins. Most cadherins are single-pass transmembrane glycoproteins composed of about 700-750 amino acid residues. The large extracellular part of the molecule is usually folded into five domains, each containing about 100 amino acid residues. Four of these domains contain presumptive Ca2+ binding sites. Cadherins are often present in the cell membrane as dimers.
Cadherens useful in the present invention include, but are not limited to cadherin E, cadherin N, cadherin BR, cadherin P, cadherin R, cadherin M, cadherin VE, cadherin T&H, cadherin OB, cadherin K, cadherin 7, cadherin 8, cadherin KSP, cadherin LI, cadherin 18, fibroblast 1, cadherin, fibroblast 2, cadherin, fibroblast 3, cadherin 23, desmocollin 1, desmocollin 2, desmoglein 1, desmoglein 2, desmoglein 3, and protocadherin 1, 2, 3, 7, 8, and 9.
The remaining adhesion molecules are Ca2+ independent, and, like the cadherins, may be used as ligands of a cell surface protein on an APC in the present invention. General classes of adhesion molecules as well as specific adhesion molecules useful in the present invention are shown below in Table 3.
Defensins Useful in the Invention
In one embodiment, the portion of the multifunctional molecule which is a ligand of a cell surface protein of an APC is a defensin. Defensins are a large family of broad-spectrum antimicrobial peptides, identified originally in leukocytes of rabbits and humans. Defensins, cationic, polar peptides (30-35 aa, 3-4 kDa), are distinguished by a conserved tri-disulfide and largely beta sheet structure. When expressed at the cell surface, defensins have been hypothesized to function as a biocheical barrier against microbial invection by inhibiting colonization of the epithelium by a wide range of pathogenic microorganisms. Defensins useful in the present invention include, but are not limited to human alpha defensins 1-6, human neutrophil peptides 1-4, human beta defensin 1 and 2, and rat beta defeinsin 1 and 2.
Counter-Receptors of T Cell Co-Stimulatory Molecules of the Invention
In one embodiment of the invention the portion of the multifunctional molecule which is a ligand of a cell surface protein of an APC is a counter-receptor of a T cell co-stimulatory molecule. Costimulation is defined as a signaling pathway that does more than simply augment antigen receptor-proximal activation events, but that intersects with antigen-specific signals synergistically to allow lymphocyte activation. Accordingly, a counter-receptor of a co-stimulatory molecule, useful in the present invention includes, but is not limited to a receptor for one or more of B7-1, B7-2, ICOS:B7h, PD-1:PD-L1/PD-L2, CD48, CD40 ligand, and OX40. Counter-receptors useful in the present invention include, but are not limited to CD28, CTLA-4, ICOS, PD-1, members of the TNF receptor family, CD40, the major B cell costimulatory molecule, as well as OX-40, 4-1BB, CD30, and CD27.
Peptide Linkers
In one embodiment, the multifunctional molecule is a fusion polypeptide which comprises one or more amino acids interposed between the first and second parts which bind to cells, e.g. a fusion polypeptide which comprises a first amino acid sequence which can bind to an antigen bearing target and a second amino acid sequence which can bind to a leukocyte, and which further comprises at least one amino acid interposed between the first and second parts. The interposed amino acids may comprise, e.g., a linker sequence intended to lessen steric hindrance or other undesirable interactions between the aforementioned first and second parts. For, example, one such type of sequence takes the form (GlyxSer)n, wherein n is an integer from between 1 and 15, and x is an integer betewen 1 and 10. Additional useful linkers include, but are not limited to (Arg-Ala-Arg-Asp-Pro-Arg-Val-Pro-Val-Ala-Thr)1-5 (Xu et al., 1999, Proc. Natl. Acad. Sci. U.S.A. 96: 151-156), (Gly-Ser), (Shao et al., 2000, Bioconjug. Chem. 11: 822-826), (Thr-Ser-Pro)n (Kroon et al., 2000, Eur. J. Biochem. 267: 6740-6752), (Gly-Gly-Gly), (Kluczyk et al., 2000, Peptides 21: 1411-1420), and (Glu-Lys)n (Klyczyk et al., 2000, supra), wherein n is 1 to 15 (each of the preceding references is also incorporated herein by reference). In another embodiment, no amino acids are interposed between the first and second parts.
Antigens Useful According to the Invention
1. Viral Antigens
Examples of viral antigens include, but are not limited to, retroviral antigens such as retroviral antigens from the human immunodeficiency virus (HIV) antigens such as gene products of the gag, pol, and env genes, the Nef protein, reverse transcriptase, and other HIV components; hepatitis viral antigens such as the S. M, and L proteins of hepatitis B virus, the pre-S antigen of hepatitis B virus, and other hepatitis, e.g., hepatitis A, B. and C, viral components such as hepatitis C viral RNA; influenza viral antigens such as hemagglutinin and neuraminidase and other influenza viral components; measles viral antigens such as the measles virus fusion protein and other measles virus components; rubella viral antigens such as proteins E1 and E2 and other rubella virus components; rotaviral antigens such as VP7sc and other rotaviral components; cytomegaloviral antigens such as envelope glycoprotein B and other cytomegaloviral antigen components; respiratory syncytial viral antigens such as the RSV fusion protein, the M2 protein and other respiratory syncytial viral antigen components; herpes simplex viral antigens such as immediate early proteins, glycoprotein D, and other herpes simplex viral antigen components; varicella zoster viral antigens such as gpI, gpII, and other varicella zoster viral antigen components; Japanese encephalitis viral antigens such as proteins E, M-E, M-E-NS 1, NS 1, NS 1-NS2A, 80% E, and other Japanese encephalitis viral antigen components; rabies viral antigens such as rabies glycoprotein, rabies nucleoprotein and other rabies viral antigen components. See Fundamental Virology, Second Edition, e's. Fields, B. N. and Knipe, D. M. (Raven Press, New York, 1991) for additional examples of viral antigens.
2. Bacterial Antigens
Bacterial antigens which can be used in the compositions and methods of the invention include, but are not limited to, pertussis bacterial antigens such as pertussis toxin, filamentous hemagglutinin, pertactin, FIM2, FIM3, adenylate cyclase and other pertussis bacterial antigen components; diptheria bacterial antigens such as diptheria toxin or toxoid and other diphtheria bacterial antigen components; tetanus bacterial antigens such as tetanus toxin or toxoid and other tetanus bacterial antigen components; streptococcal bacterial antigens such as M proteins and other streptococcal bacterial antigen components; grarn-negative bacilli bacterial antigens such as lipopolysaccharides and other gram-negative bacterial antigen components; Mycobacterium tuberculosis bacterial antigens such as mycolic acid, heat shock protein 65 (HSP65), the 30 kDa major secreted protein, antigen 85A and other mycobacterial antigen components; Helicobacter pylori bacterial antigen components; pneumococcal bacterial antigens such as pneumolysin, pneumococcal capsular polysaccharides and other pneumococcal bacterial antigen components; hemophilus influenza bacterial antigens such as capsular polysaccharides and other hemophilus influenza bacterial antigen components; anthrax bacterial antigens such as anthrax protective antigen and other anthrax bacterial antigen components; rickettsiae bacterial antigens such as romps and other rickettsiae bacterial antigen component. Also included with the bacterial antigens described herein are any other bacterial, mycobacterial, mycoplasmal, rickettsial, or chlamydial antigens.
3. Fungal Antigens
Fungal antigens which can be used in the compositions and methods of the invention include, but are not limited to, candida fungal antigen components; histoplasma fungal antigens such as heat shock protein 60 (HSP60) and other histoplasma fungal antigen components; cryptococcal fungal antigens such as capsular polysaccharides and other cryptococcal fungal antigen components; coccidiodes fungal antigens such as spherule antigens and other coccidiodes fungal antigen components; and tinea fungal antigens such as trichophytin and other coccidiodes fungal antigen components.
4. Parasite Antigens
Examples of protozoa and other parasitic antigens include, but are not limited to, plasmodium falciparum antigens such as merozoite surface antigens, sporozoite surface antigens, circumsporozoite antigens, gametocyte/gamete surface antigens, blood-stage antigen pf 1 55/RESA and other plasmodial antigen components; toxoplasma antigens such as SAG-1, p30 and other toxoplasma antigen components; schistosomae antigens such as glutathione-S-transferase, paramyosin, and other schistosomal antigen components; leishmania major and other leishmaniae antigens such as gp63, lipophosphoglycan and its associated protein and other leishmanial antigen components; and trypanosoma cruzi antigens such as the 75-77 kDa antigen, the 56 kDa antigen and other trypanosomal antigen components.
5. Tumor Antigens.
Tumor antigens which can be used in the compositions and methods of the invention include, but are not limited to, telomerase components; multidrug resistance proteins such as P-glycoprotein; MAGE-1, alpha fetoprotein, carcinoembryonic antigen, mutant p53, immunoglobulins of B-cell derived malignancies, fusion polypeptides expressed from genes that have been juxtaposed by chromosomal translocations, human chorionic gonadotrpin, calcitonin, tyrosinase, papillomavirus antigens, gangliosides or other carbohydrate-containing components of melanoma or other tumor cells. It is contemplated by the invention that antigens from any type of tumor cell can be used in the compositions and methods described herein.
6. Antigens Relating to Autoimmunity.
Antigens involved in autoimmune diseases, allergy, and graft rejection can be used in the compositions and methods of the invention. For example, an antigen involved in any one or more of the following autoimmune diseases or disorders can be used in the present invention: diabetes mellitus, arthritis (including rheumatoid arthritis, juvenile rheumatoid arthritis, osteoarthritis, psoriatic arthritis), multiple sclerosis, myasthenia gravis, systemic lupus erythematosis, autoimmune thyroiditis, dermatitis (including atopic dermatitis and eczematous dermatitis), psoriasis, Sjogren's Syndrome, including keratoconjunctivitis sicca secondary to Sjogren's Syndrome, alopecia areata, allergic responses due to arthropod bite reactions, Crohn's disease, aphthous ulcer, iritis, conjunctivitis, keratoconjunctivitis, ulcerative colitis, asthma, allergic asthma, cutaneous lupus erythematosus, scleroderma, vaginitis, proctitis, drug eruptions, leprosy reversal reactions, erythema nodosum leprosum, autoimmune uveitis, allergic encephalomyelitis, acute necrotizing hemorrhagic encephalopathy, idiopathic bilateral progressive sensorineural hearing loss, aplastic anemia, pure red cell anemia, idiopathic thrombocytopenia, polychondritis, Wegener's granulomatosis, chronic active hepatitis, Stevens-Johnson syndrome, idiopathic sprue, lichen planus, Crohn's disease, Graves ophthalmopathy, sarcoidosis, primary biliary cirrhosis, uveitis posterior, and interstitial lung fibrosis. Examples of antigens involved in autoimmune disease include glutamic acid decarboxylase 65 (GAD 65), native DNA, myelin basic protein, myelin proteolipid protein, acetylcholine receptor components, thyroglobulin, and the thyroid stimulating hormone (TSH) reception. Examples of antigens involved in allergy include pollen antigens such as Japanese cedar pollen antigens, ragweed pollen antigens, rye grass pollen antigens, animal derived antigens such as dust mite antigens and feline antigens, histocompatiblity antigens, and penicillin and other therapeutic drugs. Examples of antigens involved in graft rejection include antigenic components of the graft to be transplanted into the graft recipient such as heart, lung, liver, pancreas, kidney, and neural graft components. An antigen can also be an altered peptide ligand useful in treating an autoimmune disease.
Examples of miscellaneous antigens which can be can be used in the compositions and methods of the invention include endogenous hormones such as luteinizing hormone, follicular stimulating hormone, testosterone, growth hormone, prolactin, and other hormones, drugs of addiction such as cocaine and heroin, and idiotypic fragments of antigen receptors such as Fab-containing portions of an anti-leptin receptor antibody.
Determination of Binding of a Multifunctional Molecule to a Antigen Bearing Target or APC
Multiple techniques are known to those of skill in the art for detecting protein-protein binding. That is, the binding of a multifunctional molecule of the invention to either or both of an antigen bearing target and an APC.
The association between the multifunctional molecule and an antigen bearing target and/or an APC may be measured for example by Fluorescent Resonance Energy Transfer (FRET), wherein one peptide (i.e., the multifunctional molecule) comprises a fluorescent label moiety, and the antigen bearing target or APC harbours a second such moiety, and where excitation at an appropriate wavelength may result in absorption of photons by one label, followed by FRET, and emission at a second wavelength characteristic of the second fluorophore, this emission being measured and corresponding to the amount of antigen bearing target or APC which is associated with the multifunctional molecule. Alternatively, this association may be measured in one of many other ways which are described more fully below.
A “fluorescent tag” or “fluorescent group” refers to either a fluorophore or a fluorescent protein or fluorescent fragment thereof, or refers to a fluorescent amino acid such as tryptophan which may be incorporated into a polypeptide. “Fluorescent protein” refers to any protein which fluoresces when excited with appropriate electromagnetic radiation. This includes proteins whose amino acid sequences are either natural or engineered.
It is additionally preferred that the fluorophores comprise fluorescein and tetramethylrhodamine or another suitable pair. In another preferred embodiment, the label comprises two different fluorescent proteins. It is preferred that fluorescent proteins comprise any protein selected from the group consisting of green fluorescent protein (GFP), blue fluorescent protein, red fluorescent protein and other engineered forms of GFP.
Preferably, the polypeptide comprises a cysteine amino acid through which the label is attached via a covalent bond. More preferably, the label may be attached via a primary amine group such as via a lysine residue. As will be apparent to a person skilled in the art, it is preferable to avoid using the same chemistry for both labelling and immobilising polypeptides of the invention. For example, if the polypeptide is immobilised via cysteine residues, the label is advantageously attached via lysine residues.
Preferably, the measuring is performed by fluorescent resonance energy transfer (FRET), fluorescence anisotropy or fluorescence correlation spectroscopy, or by measuring the binding of a fluorescent partner polypeptide to an immobilised polypeptide. Techniques for performing such measurements are well known to those of skill in the art.
It is preferred that the fluorescence emitting means comprise two different fluorophores, and particularly preferred that the fluorophores comprise fluorescein and tetramethylrhodamine or another suitable pair.
As used herein with regard to fluorescent labels for use in FRET, the term “appropriate combination” refers to a choice of reporter labels such that the emission wavelength spectrum of one (the “donor” moiety) is within the excitation wavelength spectrum of the other (the “acceptor” moiety).
Methods of detection without use of label are known in the art. These include detection using surface plasmon resonance to detect changes in the mass of, for example the multifunctional molecule, which would occur if binding of the partner polypeptide increased or decreased. Such measurements may be made for example using a BIACORE machine. In this embodiment, the multifunctional molecule is immobilized on a solid support prior to contacting the molecule with the antigen bearing moiety and/or APC.
In addition to the above methods, one technique for determing the binding of a multifunctional molecule of the invention to an antigen bearing moiety and/or and APC involves the use of antibodies specifically directed to the multifunctional molecule. Briefly, antigen bearing cells, for example, are incubated with the multifunctional molecule of the invention in RPMI 1640, or other suitable buffer, for 1-4 hours at 37° C. with shaking. The cells are then washed in PBS containing 2% FBS, or other cell culture serum. The antigen bearing cells are then incubated with, for example, an FITC labeled anti-multifunctional molecule antibody for 1 hour at 4° C. After additional washing in PBS, the cells are analyzed by flow cytometry, wherein the identification of labeled cells is indicative of the binding of the multifunctional molecule of the invention to the antigen bearing cell.
Preparation of a Cell Containing a Recombinant Nucleic Acid According to the Invention
In one embodiment of the present invention, a nucleic acid molecule encoding a multifunctional molecule of the present invention is introduced into a host cell capable of expressing the nucleic acid molecule so as to produce the multifunctional molecule. In one embodiment, the host cell is permitted to express the nucleic acid ex vivo. In an alternate embodiment, the host cell is transfected with the nucleic acid molecule encoding the multifunctional molecule, and then placed back into the host animal from which it was obtained, wherein the multifunctional polypeptide molecule is expressed in vivo in the host animal.
Host cells are transfected, as taught herein, via conventional methods well-known in the art. Suitable methods for transforming or transfecting host cells can be found in Sambrook et al. (Molecular Cloning: A Laboratory Manual, 2nd Edition, Cold Spring Harbor Laboratory press (1989)), and other laboratory manuals. Additional examples of methods of introducing nucleic acid molecules encoding multifunctional molecules are described below. The cells containing the introduced nucleic acid molecules encoding, for example, multifunctional molecule and/or an antigen, can themselves be administered to a subject (as the antigen) according to the methods of the invention, e.g., in a vaccine composition.
A. Introduction of Naked Nucleic Acid into Cells
1. Transfection mediated by DEAE-dextran: Naked nucleic acid can be introduced into cells by forming a mixture of the nucleic acid and DEAE-dextran and incubating the mixture with the cells. A dimethylsulfoxide or chloroquine shock step can be added to increase the amount of nucleic acid uptake. DEAE-dextran transfection is only applicable to in vitro modification of cells and can be used to introduce nucleic acid transiently into cells but is not preferred for creating stably transfected cells. Thus, this method can be used for short term production of a gene product but is not a method of choice for long-term production of a gene product. Protocols for DEAE-dextran-mediated transfection can be found in Current Protocols in Molecular Biology, Ausubel, F. M. et al. (e's.) Greene Publishing Associates, (1989), Section 9.2 and in Molecular Cloning: A Laboratory Manual. 2nd Edition. Sambrook et al. Cold Spring Harbor Laboratory Press, (1989), Sections 16.41-16.46 or other standard laboratory manuals.
2. Electroporation: Naked nucleic acid can also be introduced into cells by incubating the cells and the nucleic acid together in an appropriate buffer and subjecting the cells to a high-voltage electric pulse. The efficiency with which nucleic acid is introduced into cells by electroporation is influenced by the strength of the applied field, the length of the electric pulse, the temperature, the conformation and concentration of the nucleic acid and the ionic composition of the media. Electroporation can be used to stably (or transiently) transfect a wide variety of cell types and is only applicable to in vitro modification of cells. Protocols for electroporating cells can be found in Current Protocols in Molecular Biology, Ausubel, F. M. et al. (e's.) Greene Publishing Associates, (1989), Section 9.3 and in Molecular Cloning: A Laboratory Manual, 2nd Edition, Sambrook et al. Cold Spring Harbor Laboratory Press, (1989), Sections 16.54-16.55 or other standard laboratory manuals.
3. Liposome-mediated transfection (“lipofection”): Naked nucleic acid can be introduced into cells by mixing the nucleic acid with a liposome suspension containing cationic lipids. The nucleic acid/liposome complex is then incubated with cells. Liposome mediated transfection can be used to stably (or transiently) transfect cells in culture in vitro. Protocols can be found in Current Protocols in Molecular Biology, Ausubel, F. M. et al. (e's.) Greene Publishing Associates, (1989), Section 9.4 and other standard laboratory manuals. Additionally, gene delivery in vivo has been accomplished using liposomes. See for example Nicolau et al. (1987) Meth. Enz. 149:157-176; Wang and Huang (1987) Proc. Natl. Acad. Sci. SA 84:7851-785S; Brigham et al. (1989) Am. J. Med. Sci. 298:278; and Gould-Fogerite et al. (1989) Gene 84:429-438.
4. Direct Injection: Naked nucleic acid can be introduced into cells by directly injecting the nucleic acid into the cells. For an in vitro culture of cells, nucleic acid can be introduced by microinjection. Since each cell is microinjected individually, this approach is very labor intensive when modifying large numbers of cells. However, a situation wherein microinjection is a method of choice is in the production of transgenic animals (discussed in greater detail below). In this situation, the nucleic acid is stably introduced into a fertilized oocyte which is then allowed to develop into an animal. The resultant animal contains cells carrying the nucleic acid introduced into the oocyte. Direct injection has also been used to introduce naked nucleic acid into cells in vivo (see e.g., Acsadi et al. (1991) Nature 332: 815-818; Wolff et al. (1990) Science 247:1465-1468). A delivery apparatus (e.g., a “gene gun”) for injecting DNA into cells in vivo can be used. Such an apparatus is commercially available (e.g., from BioRad).
5. Receptor-Mediated DNA Uptake: Naked nucleic acid can also be introduced into cells by complexing the nucleic acid to a cation, such as polylysine, which is coupled to a ligand for a cell-surface receptor (see for example Wu, G. and Wu, C. H. (1988) J. Biol. Chem 263:14621; Wilson et al. (1992) J. Biol. Chem. 267:963-967; and U.S. Pat. No. 5,166,320). Binding of the nucleic acid-ligand complex to the receptor facilitates uptake of the nucleic acid by receptor-mediated endocytosis. Receptors to which a nucleic acid-ligand complex have targeted include the transferrin receptor and the asialoglycoprotein receptor. A nucleic acid-ligand complex linked to adenovirus capsids which naturally disrupt endosomes, thereby releasing material into the cytoplasm can be used to avoid degradation of the complex by intracellular lysosomes (see for example Curiel et al. (1991) Proc. Natl. Acad. Sci. USA 88:8850; Cristiano et al. (1993) Proc. Natl. Acad. Sci USA 90:2122-2126). Receptor-mediated nucleic acid uptake can be used to introduce nucleic acid into cells either in vitro or in vivo and, additionally, has the added feature that nucleic acid can be selectively targeted to a particular cell type by use of a ligand which binds to a receptor selectively expressed on a target cell of interest.
Generally, when naked nucleic acid is introduced into cells in culture (e.g., by one of the transfection techniques described above) only a small fraction of cells (about 1 out of 105) typically integrate the transfected nucleic acid into their genomes (i.e., the nucleic acid is maintained in the cell episomally). Thus, in order to identify cells which have taken up exogenous nucleic acid, it is advantageous to transfect nucleic acid encoding a selectable marker into the cell along with the nucleic acid(s) of interest. Preferred selectable markers include those which confer resistance to drugs such as G418, hygromycin and methotrexate. Alternatively, a selectable marker maybe one which emits a detectable signal upon expression such as green fluorescen protein or blue fluorescent protein. Selectable markers may be introduced on the same plasmid as the gene(s) of interest or may be introduced on a separate plasmid.
B. Viral-Mediated Gene Transfer
A preferred approach for introducing nucleic acid encoding a gene product into a cell is by use of a viral vector containing nucleic acid, e.g. a cDNA, encoding the gene product. Infection of cells with a viral vector has the advantage that a large proportion of cells receive the nucleic acid, which can obviate the need for selection of cells which have received the nucleic acid. Additionally, molecules encoded within the viral vector, e.g., by a cDNA contained in the viral vector, are expressed efficiently in cells which have taken up viral vector nucleic acid and viral vector systems can be used either in vitro or in vivo.
1. Retroviruses: Defective retroviruses are well characterized for use in gene transfer for gene therapy purposes (for a review see Miller, A. D. (1990) Blood 76:271). A recombinant retrovirus can be constructed having a nucleic acid encoding a gene product of interest inserted into the retroviral genome. Additionally, portions of the retroviral genome can be removed to render the retrovirus replication defective. The replication defective retrovirus is then packaged into virions which can be used to infect a target cell through the use of a helper virus by standard techniques. Protocols for producing recombinant retroviruses and for infecting cells in vitro or in vivo with such viruses can be found in Current Protocols in Molecular Biology, Ausubel, F. M. et al. (eds.) Greene Publishing Associates, (1989), Sections 9.10-9.14 and other standard laboratory manuals. Examples of suitable retroviruses include pLJ, pZIP, pWE and pEM which are well known to those skilled in the art. Examples of suitable packaging virus lines include φCrip, φCre, —2, and_Am. Retroviruses have been used to introduce a variety of genes into many different cell types, including epithelial cells, endothelial cells, lymphocytes, myoblasts, hepatocytes, bone marrow cells, in vitro and/or in vivo (see for example Eglitis, et al. (1985) Science 230:1395-1398; Danos and Mulligan (1988) Proc. Natl. Acad. Sci. USA 85:6460-6464; Wilson et al. (1988) Proc. Natl. Acad. Sci. USA 85:3014-3018; Armentano et al. (1990) Proc. Natl. Acad. Sci. USA 87:6141-6145; Huber et al. (1991) Proc. Natl. Acad. Sci. USA 88:8039-8043; Ferry et al. (1991) Proc. Natl. Acad. Sci. USA 88:8377-8381; Chowdhury et al. (1991) Science 254:1802-1805; van Beusechem et al. (1992) Proc. Natl. Acad. Sci. USA 89:7640-7644; Kay et al. (1992) Human Gene Therapy 3:641-647; Dai et al. (1992) Proc. Natl. Acad. Sci. USA 89:10892-10895; Hwu et al. (1993) J. Immunol. 150:4104-115; U.S. Pat. No. 4,868,116; U.S. Pat. No. 4,980,286; PCT Application WO 89/07136; PCT Application WO 89/02468; PCT Application WO 89/05345; and PCT Application WO 92/07573). Retroviral vectors require target cell division in order for the retroviral genome (and foreign nucleic acid inserted into it) to be integrated into the host genome to stably introduce nucleic acid into the cell. Thus, it may be necessary to stimulate replication of the target cell.
2. Adenoviruses: The genome of an adenovirus can be manipulated such that it encodes and expresses a gene product of interest but is inactivated in terms of its ability to replicate in a normal lytic viral life cycle. See for example Berkner et al. (1988) BioTechniques 6:616; Rosenfeld et al. (1991) Science 252:431-434; and Rosenfeld et al. (1992) Cell 68:143-155. Suitable adenoviral vectors derived from the adenovirus strain Ad type 5 d1324 or other strains of adenovirus (e.g., Adz, Ad3, Ad7 etc.) are well known to those skilled in the art. Recombinant adenoviruses are advantageous in that they do not require dividing cells to be effective gene delivery vehicles and can be used to infect a wide variety of cell types, including airway epithelium (Rosenfeld et al. (1992) cited supra), endothelial cells (Lemarchand et al. (1992) Proc. Natl. Acad. Sci. USA 89:6482-6486), hepatocytes (Herz and Gerard (1993) Proc. Natl. Acad. Sci. USA 90:2812-2816) and muscle cells (Quantin et al. (1992) Proc. Natl. Acad. Sci. USA 89:2581-2584). Additionally, introduced adenoviral nucleic acid (and foreign DNA contained therein) is not integrated into the genome of a host cell but remains episomal, thereby avoiding potential problems that can occur as a result of insertional mutagenesis in situations where introduced nucleic acid becomes integrated into the host genome (e.g., retroviral DNA). Moreover, the carrying capacity of the adenoviral genome for foreign DNA is large (up to 8 kilobases) relative to other gene delivery vectors (Berkner et al. cited supra; Haj-Ahmand and Graham (1986) J. Virol. 57:267). Most replication-defective adenoviral vectors currently in use are deleted for all or parts of the viral E1 and E3 genes but retain as much as 80% of the adenoviral genetic material.
3. Adeno-Associated Viruses: Adeno-associated virus (AAV) is a naturally occurring defective virus that requires another virus, such as an adenovirus or a herpes virus, as a helper virus for efficient replication and a productive life cycle. (For a review see Muzyczka et al. Curr. Topics in Micro. and Immunol. (1992) 158:97-129). It is also one of the few viruses that may integrate its DNA into non-dividing cells, and exhibits a high frequency of stable integration (see for example Flotte et al. (1992) Am. J. Respir. Cell. Mol. Biol. 7:349-356; Samulski et al. (1989) J. Virol. 63:3822-3828; and McLaughlin et al. (1989) J. Virol 62:1963-1973). Vectors containing as little as 300 base pairs of AAV can be packaged and can integrate. Space for exogenous nucleic acid is limited to about 4.5 kb. An AAV vector such as that described in Tratschin et al. (1985) Mol. Cell. Biol. 5:3251-3260 can be used to introduce nucleic acid into cells. A variety of nucleic acids have been introduced into different cell types using AAV vectors (see for example Hermonat et al. (1984) Proc. Natl. Acad. Sci. USA 81 :6466-6470; Tratschin et al. (1985) Mol. Cell. Biol. 4:2072-2081; Wondisford et al. (1988) Mol. Endocrinol. 2:32-39; Tratschin et al. (1984) J. Virol.51:611-619; and Flotte et al. (1993) J. Biol. Chem. 268:3781-3790).
The efficacy of a particular expression vector system and method of introducing nucleic acid into a cell can be assessed by standard approaches routinely used in the art. For example, nucleic acid introduced into a cell can be detected by a filter hybridization technique (e.g., Southern blotting) and RNA produced by transcription of introduced nucleic acid can be detected, for example, by Northern blotting, RNase protection or reverse transcriptase-polymerase chain reaction (RI-PCR). The gene product can be detected by an appropriate assay, for example by immunological detection of a produced protein, such as with a specific antibody, or by a functional assay to detect a functional activity of the gene product, such as an enzymatic assay. If the gene product of interest to be expressed by a cell is not readily assayable, an expression system can first be optimized using a reporter gene linked to the regulatory elements and vector to be used. The reporter gene encodes a gene product which is easily detectable and, thus, can be used to evaluate the efficacy of the system. Standard reporter genes used in the art include genes encoding beta-galactosidase, chloramphenicol acetyl transferase, luciferase and human growth hormone.
Cells Useful According to the Invention
The invention provides for host cells transfected with nucleic acid constructs encoding a multifunctional molecule of the invention. Host cells useful in the invention include but are not limited to the following.
A host cell can be any cell which is able to act as a carrier for an antigen according to the invention and thus may be a nucleated cell or a procaryotic cell into which nucleic acid can be artificially introduced. Procaryotic cells useful according to the invention include bacterial cells. Eucaryotic (nucleated) cells useful according to the invention include cells of a yeast, fungus, cells of a parasite and mammalian cells. Mammalian cells useful according to the invention include but are not limited to fibroblasts, including specialized mesenchymal cells such as a synoviocytes; keratinocytes, epithelial cells, endothelial cells, leukocytes and tumor cells.
Cell lines useful according to the invention include but are not limited to B16, CMS-5 fibrosarcoma cells, Cos1 cells and CHO cells, TS/A, Lewis lung carcinoma, RENCA, Dunning rat prostate carcinoma, and cell lines included in the catalogue of the American Type Culture Collection (Manassas, Va.).
Host cells comprising a nucleic acid molecule encoding a multifunctional molecule of the invention can be prepared from pathogenic cells according to the invention. Pathogenic cells include tumor cells (e.g. B16 cells, CMS-5 fibrosarcoma cells, and cells derived from the tumors included in the section entitled “Tumors for which the Invention is Useful”), and cells derived from pathogenic bacterium, pathogenic fungus, pathogenic virus, pathogenic parasite, or a pathogenic arthropod.
Methods of Detecting Expression From an Artificially Introduced Recombinant Nucleic Acid Sequence
The invention provides for methods of detecting a protein (e.g., a multifunctional molecule) that is expressed from a recombinant nucleic acid molecule that has been artificially introduced into a cell.
Preparation of Antibodies
Antibodies specific for a protein useful according to the invention (e.g., a multifunctional molecule) are useful for protein purification, and for the detection of expression of these proteins from cells into which a recombinant nucleic acid molecule expressing these proteins has been artificially introduced. By antibody, we include constructions using the binding (variable) region of such an antibody, and other antibody modifications. Thus, an antibody useful in the invention may comprise a whole antibody, an antibody fragment, a polyfunctional antibody aggregate, or in general a substance comprising one or more specific binding sites from an antibody. The antibody fragment may be a fragment such as an Fv, Fab or F(ab′)2 fragment or a derivative thereof, such as a single chain Fv fragment. The antibody or antibody fragment may be non-recombinant, recombinant or humanized. The antibody may be of an immunoglobulin isotype, e.g., IgG, IgM, and so forth. In addition, an aggregate, polymer, derivative and conjugate of an immunoglobulin or a fragment thereof can be used where appropriate.
Although a protein product (or fragment or oligopeptide thereof) of a protein according to the invention (e.g., a multifunctional molecule according to the invention) that is useful for the production of antibodies does not require biological activity, it must be antigenic. Antibodies may be directed to any portion of the multifunctional molecule of the invention. For example, an antibody may be directed to the lecting portion of the multifunctional molecule or to the ligand portion of the multifunctional molecule. Peptides used to induce specific antibodies may have an amino acid sequence consisting of at least five amino acids and preferably at least 10 amino acids. Preferably, they should be identical to a region of the natural protein and may contain the entire amino acid sequence of a small, naturally occurring molecule. Short stretches of amino acids corresponding to the protein product of a recombinant nucleic acid encoding a protein useful according to the invention (e.g., a multifunctional molecule according to the invention) may be fused with amino acids from another protein such as keyhole limpet hemocyanin or GST, and antibody will be produced against the chimeric molecule. Procedures well known in the art can be used for the production of antibodies to the protein products of recombinant nucleic acids of the invention.
For the production of antibodies, various hosts including goats, rabbits, rats, mice etc. may be immunized by injection with the protein products (or any portion, fragment, or oligonucleotide thereof which retains immunogenic properties) of the recombinant nucleic acid molecules encoding proteins useful according to the invention. Depending on the host species, various adjuvants may be used to increase the immunological response. Such adjuvants include but are not limited to Freund's, mineral gels such as aluminum hydroxide, and surface active substances such as lysolecithin, pluronic polyols, polyanions, peptides, oil emulsions, keyhole limpet hemocyanin, and dinitrophenol. BCG (bacilli Calmette-Guerin) and Corynebacterium parvum are potentially useful human adjuvants.
I. Polyclonal Antibodies.
The antigen protein may be conjugated to a conventional carrier in order to increase its immunogenicity, and an antiserum to the peptide-carrier conjugate will be raised. Coupling of a peptide to a carrier protein and immunizations may be performed as described (Dymecki et al., 1992, J. Biol. Chem., 267: 4815). The serum can be titered against protein antigen by ELISA (below) or alternatively by dot or spot blotting (Boersma and Van Leeuwen, 1994, J. Neurosci. Methods, 51: 317). At the same time, the antiserum may be used in tissue sections prepared as described. A useful serum will react strongly with the appropriate peptides by ELISA, for example, following the procedures of Green et al., 1982, Cell, 28: 477.
2. Monoclonal Antibodies.
Techniques for preparing monoclonal antibodies are well known, and monoclonal antibodies may be prepared using a candidate antigen (e.g., a mulispecific molecule or a lectin whose level is to be measured or which is to be either inactivated or affinity-purified, preferably bound to a carrier, as described by Arnheiter et al., 1981, Nature, 294;278.
Monoclonal antibodies are typically obtained from hybridoma tissue cultures or from ascites fluid obtained from animals into which the hybridoma tissue was introduced.
Monoclonal antibody-producing hybridomas (or polyclonal sera) can be screened for antibody binding to the target protein.
3. Antibody Detection Methods
Particularly preferred immunological tests rely on the use of either monoclonal or polyclonal antibodies and include enzyme-linked immunoassays (ELISA), immunoblotting and immunoprecipitation (see Voller, 1978, Diagnostic Horizons, 2:1, Microbiological Associates Quarterly Publication, Walkersville, Md.; Voller et al., 1978, J. Clin. Pathol., 31: 507; U.S. Reissue Pat. No. 31,006; UK Patent 2,019,408; Butler, 1981, Methods Enzymol., 73: 482; Maggio, E. (ed.), 1980, Enzyme Immunoassay, CRC Press, Boca Raton, Fla.) or radioimmunoassays (RIA) (Weintraub, B., Principles of radioimmunoassays, Seventh Training Course on Radioligand Assay Techniques, The Endocrine Society, March 1986, pp. 1-5, 46-49 and 68-78). For analysing tissues for the presence or absence of a protein produced by a recombinant nucleic acid encoding a protein useful according to the invention (e.g., multifunctional molecule or portion thereof), immunohistochemistry techniques may be used. It will be apparent to one skilled in the art that the antibody molecule may have to be labelled to facilitate easy detection of a target protein. Techniques for labelling antibody molecules are well known to those skilled in the art (see Harlow and Lane, 1989, Antibodies, Cold Spring Harbor Laboratory).
Determining Whether an Immune Response is Modulated According to the Invention
The multifunctional molecules described herein are useful according to the invention to modulate an immune response in a mammalian, preferably a human, to an antigen or antigens contained in the antigen bearing target which is bound to the lectin portion of the multifunctional molecule. In one embodiment, a composition comprising a multifunctional molecule bound to an antigen bearing target is administered to an animal, preferably a human. The second portion of the multifunctional molecule comprising a ligand for a cell-surface molecule of an APC targets the composition to antigen presenting cells in the animal to which the composition has been administered. The antigen bearing target is taken up (i.e., ingested or phagocytosed) by antigen presenting cells. Alternatively, the multifunctional molecule/antigen bearing target complex is contacted with antigen presenting cells in vitro under conditions which allow phagocytosis, wherein the APCs are subsequently returned to the host organinsm from which they were derived.
The present invention thus provides a method for modulating an immune response in an mammal comprising administering to the mammal a composition comprising at least a multifunctional molecule as described herein. In one embodiment, the composition further comprises an antigen bearing target. In a further embodiment, the composition still further comprises an APC.
An “immune response” refers to stimulation/activation of a selected response involving the immune system, or suppression, elimination, or attenuation of a selected response. In a preferred embodiment, an immune response refers to stimulation/activation of a selected response involving the immune system by about at least 5%, or preferably between 5 and 50% or more preferably between 50 and 100% or at least 100% or greater, or suppression, elimination, or attenuation of a selected response by about at least 5%, or preferably between 5 and 50% or more preferably between 50 and 100% or at least 100% or greater, as compared to control cells that are not CD 40-ligand enhanced cells. Thus, to modulate an immune response means that the desired response is more efficient, more rapid, greater in magnitude, and/or more easily induced than when an antigen bearing target is contacted with an APC in the absence of a multifunctional molecule. Different immune responses in the subject may be modulated differentially, e.g., the cellular immune response may be selectively enhanced while the humoral response may be selectively attenuated, and vice versa.
The following in vitro and in vivo assays are useful for determining whether an immune response is modulated according to the invention. The assays described in detail below measure stimulation or suppression of cellular or humoral immune responses to an antigen. The antigens referred to in the following assays are representative. It will be apparent to one of skill in the art that an immune response to a selected antigen useful according to the invention may be measured using one or more of the following assays by adapting the assay to that antigen.
I. Detection of Increased Phagocytosis
The following assay may be used in order to determine whether opsonin-enhanced cells stimulate phagocytosis by antigen presenting cells.
Phagocytosis is examined using monocytes that have been adhered at 37° for 30 min in RPMI without added FCS. Sheep erythrocytes are incubated with an opsonin, or its precursor, under conditions such that there are no more than 300 of such molecules, on average, are deposited on each erythrocyte. If a precursor is used, coated erythrocytes are then processed to convert all precursors to the actual candidate molecule (e.g., See Carlo et al., J. Immunol. 123:523-8(1979)). Fresh monocytes are isolated from the subject, and 5×-1×105 of these cells suspended in 0.25-0.5 ml of RPMI medium with 1% BSA. This aliquot is placed in a tissue culture well and incubated for 30 min at 37° C. An excess of coated erythrocytes, suspended at 1.2×108 cells/ml, is overlain on the monocytes, the plate is centrifuged for 5 min at 50 g, and incubated for 30 min at 37° C. Non-ingested material is removed in two hypotonic lysis steps using ice-cold lysing buffer before fixing and staining the adherent cells, and examining the cells under light microscopy. Phagocytosis is quantified by determining the percentage of 100 monocytes ingesting one or more target cells, and the total number of ingested E/100 monocyptes (PI) is recorded. Stimulation of phagocytosis according to the invention is indicated by a phagocytic index of equal to or greater than 40.
Another assay for phagocytosis is as follows: Cells of the murine macrophage line are harvested and suspended in DMEM-10 at 4×105/ml. 2.0 ml of this suspension is aliquoted into individual 3.5 cm cell culture plates, and the dishes incubated at 37° C. in 5% CO2 overnight. Target cells, as well as control cells, are harvested on the same day as the macrophages, washed in PBS, and resuspended 2 min in PKH26 dye (a 2 μM solution in 1 ml of the supplied diluent) at 5×106 cells/ml. The fluorescent PKH26 dye emits in the red spectrum when excited, whereas the FITC label that is used for the phagocytes emits in the green spectrum. PKH26 is stable in the endosomal/lysosomal compartment of phagocytes. The dyed target cells are washed 3 times with PBS and cultured overnight to allow leaching of PKH26 out into the medium. This minimizes leakage of dye during the assay. The following day the target cells are harvested, washed 3 times with PBS, and resuspended in serum-free DMEM at 5×105/ml. The phagocytic cells are rinsed vigorously with PBS on the culture plates in order to remove serum, and 2 ml of target cells is added to each plate After 0, 2, 4, or 8 h, the plates are rinsed 3 times with PBS to remove all non-adhered cells and the remaining cells are incubated with 2 mM EDTA to release them from the plate. The released cells are washed with 1% FBS/PBS, and suspending in 100 μl of the same buffer. 2 μg anti-phagocyte (e.g. anti-CR3) antibody is added and the cells placed on ice for 25 min. The cells are washed 3 times with 1% FBS/PBS, resuspended in 100 μl of this solution, and stained with a 1:25 dilution of FITC-conjugated secondary IgG for 25 min on ice. Cells are washed 3 times and resuspended in 500 μl 1% FBS/PBS, then analyzed on a Becton Dickinson FACScan with CellQuest software.
FL-1 (green) fluorescence is used to gate phagocytes. The FL-2 (red) fluorescence of these cells, which reflects internalization of PKH26-labeled target cells, is then measured. Phagocytosis induced by, e.g., an opsonin is indicated by the difference between mean FL-2 fluorescence of macrophages incubated with opsonin-coated versus non-opsonin-coated target cells. Use of an opsonin will increase mean FL-2 fluorescence by, e.g. at least 10%., or enough to obtain ap value less than or equal to 0.05 by student t-test.
II. Amplification of the Immune Response Usually Involves Proliferation of Particular Subpopulations of Lymphoid Cells that are Normally in the Resting State.
Proliferative assays have the following applications in clinical studies: (1) Assessment of overall immunologic competence of T cells or B cells as manifested in their ability to respond to polyclonal proliferation signals such as mitogens or anti-CD3 antibodies. Defects in the proliferation may be indicative of fundamental cellular immunologic defect. Low proliferation is often found as a nonspecific secondary effect of chronic disease. (2) Assessment of an individual's response to specific antigens, where low responses are indicative of general or specific immunologic defect. (3) Determination of MHC compatibility by the mixed lymphocyte reaction (MLR).
In addition, proliferative assays are useful for estimating lymphokine production, investigating signal transduction, and assessing growth factor requirements (e.g., lymphokines) for T or B cells. The procedure outlined here measures incorporation of [3H]thymidine into DNA, which usually correlates well with cell growth as measured by changes in cell number. However, when the activation stimulus is toxic, as with chemical activators such as ionomycin plus phorbol myristate acetate (PMA), the burst of new DNA synthesis following activation may not be accompanied with a net increase in viable cells, and, in fact, a decline in cell number may be observed. In this instance, [3H]thymidine incorporation in DNA is more indicative of initial cell stimulation than estimation of cell number. In addition, [3H]thymidine incorporation provides information on cell populations, not on individual cells. Alternate methods, such as flow cytometry may be used for studies requiring that type of information.
Assay for Antigen-Induced T Cell Proliferation
This protocol is designed to test the proliferation of T cells in response to a specific antigen—tetanus toxoid. It can be modified to test T cell proliferation in response to any protein or polysaccharide antigen. Materials: (T cell suspension, autologous antigen-presenting cell suspension (non-T cells), Tetanus toxoid solution (Connaught or State Laboratory Institute of Massachusetts)). (1) Count T cells and adjust to 1×106 cells/ml with complete RPM1-10 AB. (2) Treat antigen-presenting cells with mitomycin C (or irradiate with 2500 rad) as in step 2 of one-way MLR protocol. Adjust concentration of antigen-presenting cells to 2×105 cells/ml. Antigen-presenting cells can consist of autologous non-T cells or autologous monocytes/macrophages. (3) Add 100 ul T cell suspension and 50 ul antigen-presenting cell population to wells; mix just before dispensing. (4) Add 50 ul tetanus toxoid solution to give final concentrations of 0, 1, 5, 10, and 20 ug/ml. Prepare three wells for each dilution. (5) Incubate 6 days in a humidified 37° C., 5% CO2 incubator. (6) Pulse with [3H]thymidine and harvest as described in support protocol.
Assay for Lymphokine-Dependent Cell Proliferation
This protocol assays the lymphokine-dependent proliferation of a lymphocyte population, in this case, the IL-4 dependent proliferation of B cells. Materials: (Tonsil B cell suspension, Anti-Img cross-linked to Sepharose beads (Bio-Rad), 10,000 U/ml human rIL-4 (Genzyme) in complete RPM1-10). (1) Count tonsil B cells and adjust concentration to 1×106 cells/ml with complete RPM1-10. (2) Dispense 100 ul of tonsil B cells into each well. Prepare three wells for each experimental condition. (3) Dilute 10,000 U/ml rIL-4 solution 1:10, 1:100, and 1:1000. Add 20 ul of the stock or dilution to appropriate wells to yield 1000 U/ml, 100 U/ml, 10 U/ml, and 1 U/ml. Include a control well with no rIL-4. (4) Pipet anti-IgM beads into appropriate wells.
Determine the optimal concentration of beads with pilot experiments. It is best to include several concentrations of beads in each experiment to “bracket” the optimal dose. Prepare wells with tonsil B cells and IL-4 dilutions alone, anti-IgM beads alone, culture medium alone, and all the combinations of IL-4 and anti-IgM bead dilutions. (5) Increase the volume of each well to 200 ul with complete RPM1-10 as necessary. (6) Culture 5 days in a humidified 37° C., 5% CO2 incubator. (7) Pulse with [3H]thymidine and harvest as described in support protocol.
[3H]Thymidine Pulse and Harvest of Cell Cultures
This protocol is used in conjunction with the preceding protocols to complete the [3H] thymidine incorporation assay. (1) Add 20 ul of 50 uCi/ml [3H]thymidine to each culture (1.0 uCi) at a fixed time before terminating the culture (usually 6 or 18 hr). (2) Harvest cell cultures using an automated multiwell harvester that aspirates cells, lyses cells, and transfers DNA onto filter paper, while allowing unincorporated [3H]thymidine to wash out. Fill and aspirate each row of the microtiter plate ten times to ensure complete cell transfer and complete removal of unincorporated thymidine. Wash each filter strip with 100% ethanol to facilitate drying. Transfer to scintillation vials. For semiautomated harvester, transfer filter dots for each well into scintillation counting vials. For manual transfer, dry filters under lamp and transfer to scintillation vial with forceps. Add scintillation fluid to each vial. (3) Count samples in scintillation counter until standard deviation is less than 2%. Calculate mean cpm for background cultures and for each experimental condition. There should be less than 20% variation in replicate cultures.
III. Induction and Measurement of In Vitro Antibody Responses
The capacity of the human immune system to mount an antibody response following in vivo immunization with a protein or polysaccharide antigen is a revealing indication of the overall integrity of both the B and T cell arms of the immune system. As such, in vivo immunization followed by measurement of the antibody response is an appropriate test of immune function in the various acquired and congenital immunodeficiencies and in a host of other conditions affecting the immune system. The following procedures are for in vivo immunization and for the measurement of the subsequent immune response using an ELISA technique.
Immuno-Enzymetric Assay for Cytokines Using NIP- and HRPO-Labeled Antibodies
This protocol describes an immunonoenzymetric assay for cytokines using a heterogeneous, noncompetitive immunoassay reaction in which the cytokine is immobilized by a coating antibody bound to a microtiter plate. Unbound material is washed free, and detection is carried out using a different anti-cytokine antibody labeled with the hapten nitroiodophenyl (NIP). This is in turn detected by a horseradish peroxidase (HRPO) conjugate of an anti-NIP antibody, which is revealed with the chromogenic substrate ABTS. In this noncompetitive immunoassay, the immunoassay signal (A405) increases as a direct function of the amount of cytokine present in the sample. Antibodies are prepared as described in Current Protocols in Immunology, 1995, 6.20.2-6.20.10.
Coat assay plate. (1) Using a multichannel pipettor, transfer 100 ul of an appropriate dilution of coating antibody into all wells of the assay plate that are to be used. (2) Seal plates with microtiter plate sealer or Parafilm and incubate 2 hr. At 37° C. Prepare samples and standards in preparation plate. (3) Dilute each sample (or aliquot of conditioned medium) to be assayed with an equal volume of immunoassay diluent. (4) Pipet less than or equal to 1 ml of each diluted sample to be assayed into the upper chamber of a separate Spin-X microfiltration device. Microcentifuge 5 min. At 10,000 rpm and save the filtrates that collect in the lower chambers. (5) Add 65 ul of each diluted sample to the appropriate well of a preparation plate (i.e., a separate 96-well microtiter plate). (6) Thaw an aliquot of cytokine standard at room temperature and make sure that it is well mixed. Pipet 130 ul into the well of the preparation plate representing the highest concentration on the standard curve. Transfer 65 ul from this well into the next, then continue performing serial 1:1 dilutions in immunoassay diluent so that 65 ul of each concentration represented on the standard curve is placed in appropriate well of the preparation plate. (7) Thaw an aliquot of calibrator at room temperature (if used). Dilute with an equal volume of immunoassay diluent, then pipet 65 ul of diluted calibrator into appropriate well or wells of preparation plate.
Incubate with coating antibody. (8) Remove coated assay plate from incubator. Dip in 2-liter beaker filled with 1× with buffer, then invert over sink and flick to remove liquid. Repeat two more times, then bang dry on paper towel. (9) Transfer 50 ul of solution from each well of preparation plate to corresponding well of the assay plate using multichannel pipettor. (10) Seal plate with microtiter plate sealer or Parafilm and incubate 2 hr. at room temperature.
Incubate with detecting antibody. (11) Dilute NIP-labeled detecting antibody specific to cytokine of interest to 1 ug/ml in detecting buffer. (12) Wash assay plate as in step 8. (13) Add 75 ul diluted detecting antibody from step 11 to all wells of assay plate, including unused outer walls. (14) Reseal plate with microtiter plate sealer or Parafilm and incubate 1 hr. at room temperature.
Incubate with HRPO-conjugated anti-NIP antibody. (15) Dilute HRPO-conjugated anti-NIP Mab 1:3000 in detecting buffer. (16) Wash assay plate as in step 8. (17) Add 75 ul of diluted HRPO-labeled anti-NIP antibody from step 15 to all wells of assay plate. (18) Reseal plate with microtiter plate sealer or Parafilm and incubate 1 hr. at room temperature.
Incubate with chromogenic substrate. (19) Wash assay plate as in step 8. (20) Add 100 ul ABTS substrate working solutions to all wells of assay plate. Cover plate and incubate at room temperature until color development reaches desired level (generally until A405 for wells containing the highest concentration of standard is between 1.5 and 2). This protocol usually produces an assay that can be read after 30 to 60 min.
Read plate and analyze data. (21) Using microtiter plate reader with computer interface, measure absorbance in all wells at 405 nm in single-wavelength mode or at 405 and 650 nm in dual-wavelength mode. (22) Fit standard data to a curve described by a first-degree (linear), second degree (quadratic), or four-parameter (nonlinear) mathematical function using curve-fitting software. (23) Interpolate absorbance data from unknown cytokine samples to fitted standard curve, and calculate cytokine concentrations.
IV. Induction of an In Vivo Antibody Response Provides an Approach to the Evaluation of the Overall Integrity of the Immune System.
In the protocols presented here, diptheria and tetanus toxoids are used as representative protein antigens and pneumococcal polysaccharides are used as representative polysaccharide antigens because of their safety and availability. It should be noted, however, that the responses elicited by these antigens are likely to be secondary responses because of past vaccination or natural exposure. To obtain a primary response, an unusual antigen such as keyhole limpet hemocyanin should be used.
When antigens are administered by the intramuscular or subcutaneous route, as they are here, a “systemic” immune response is induced and measurement of circulating antibody is most appropriate. It is, however, sometimes of interest to evaluate “local” or mucosal immune responses. In this case, the antigen is given either intranasally to stimulate respiratory lymphoid tissue or orally to stimulate gastrointestinal lymphoid tissue and bronchial washings or intestinal fluids, rather than blood, is assayed for antibody content; in addition, antigens are used that are more appropriate for stimulation of the local/mucosal response (i.e., influenza virus antigen for respiratory responses and cholera toxin for gastrointestinal responses).
In assaying the in vivo antibody response, it is important to determine responses to both protein and polysaccharide antigens because these antigens stimulate different components of the immune system. In this regard, the major antibody response to protein antigen is composed of IgG1 and IgG3 subclass antibodies, whereas the major antibody response to polysaccharide antigen is composed of IgG2 subclass antibody.
A variety of immunoassay techniques have been used to measure antibody responses in materials obtained after in vivo immunization. Of these, the ELISA assay is perhaps the most useful because it yields a stable, easily measurable, reproducible, and safe readout.
Induction of In Vivo Antibody Responses to Protein/Polysaccharide Antigens
In this protocol antigens are administered by the intramuscular or subcutaneous route and serum is collected for measurement of responses. (1) Draw preimmunized blood sample, allow blood to clot, and separate serum from clot by centrifugation. Store serum at −20° C. to −70° C. in appropriately labeled plastic tubes. (2) Inject 0.5 ml of toxoid mixture into an appropriately prepared intramuscular site (deltoid or thigh), taking care not to inject material intravenously. (3) Inject 0.5 ml polyvalent pneumococcal vaccine into an appropriately prepared subcutaneous site, taking care not to inject material intravenously. (4) Draw post-immunization blood samples at desired intervals, usually at 1, 2, and 3 weeks. Separate serum and store at −20° C. to −70° C. (5) After all serum samples are collected, assay samples for presence of antibodies using ELISA.
The ELISA offers a rapid, sensitive, reproducible, nonradioactive method for measuring in vivo antibody responses to a variety of antigens, including protein and polysaccharide antigens in sera obtained from individuals vaccinated with tetanus and diphtheria boosters and the polyvalent pneumococcal polysaccharide vaccine. Assays specific for tetanus, diphtheria and the pneumococcal polysaccharide types I, II, and III are detailed in Current Protocols in Immunology, 1995, Vols. 6 and 7.
Assay Using Tumor Rejection
In another assay for immunomodulation, an immunocompent animal is vaccinated with on the order of 104-108 irradiated cytokine-coated tumor cells, and challenged with on the order of 104-108 live wild-type tumor cells (in any temporal sequence). If survival or tumor onset in these animals differs from that of animal vaccinated, using identical parameters, with irradiated non-cytokine coated cells instead of opsonin-enhanced cells, immunomodulation has occurred. For example, if at least 10% of the animals in the test group survive 100% longer than mean survival in the control group, the test is positive. As another example, onset of tumors in 20% of the test animals might be 50% later than mean onset in the control animals.
Dosage and Administration
The invention encompasses methods of modulating an immune response in a mammal to a selected antigen, the method comprising administering to a mammal a therapeutic amount of a composition comprising a multifunctional molecule as described herein, or a composition comprising a multifunctional molecule of the invention and an antigen bearing target, or administering a composition comprising a therapeutic amount of APCs which have been contacted with a multifunctional molecule and antigen bearing target in vitro.
Compositions described herein may be prepared as injectables, either as liquid solutions or suspensions; solid forms suitable for solution in or suspension in, liquid prior to infection can also be prepared. The preparation can also be emulsified, or encapsulated in liposomes. The active immunogenic ingredients are often mixed with carriers which are pharmaceutically acceptable and compatible with the active ingredient. The term “pharmaceutically acceptable carrier” refers to a carrier that does not cause an allergic reaction or other untoward effect in subjects to whom it is administered. As used herein, a “pharmaceutically acceptable carrier” does not include culture medium, or any solution containing about 0.2-2% serum or greater. Suitable pharmaceutically acceptable carriers include, for example, one or more of water, saline, phosphate buffered saline, dextrose, glycerol, ethanol, or the like and combinations thereof. In addition, if desired, the vaccine can contain minor amounts of auxiliary substances such as wetting or emulsifying agents, pH buffering agents, and/or adjuvants which enhance the effectiveness of the vaccine. Examples of adjuvants which may be effective include but are not limited to: aluminum hydroxide, N-acetyl-muramyl-L-threonyl-D-isoglutamine (thr-MDP), N-acetyl-nor-muramyl-L-alanyl-D-isoglutamine (CGP 11637, referred to as nor-MDP), N-acetylmuramyl-L-alanyl-D-isoglutaminyl-alanine-2-1′-2′-dipalmitoyl-sn-glycero-3-hydroxyphosphoryloxy)-ethylamine (COP) 19835A, referred to as MTP-PE), and RIBI, which contains three components extracted from bacteria, monophosporyl lipid A, trehalose dimycolate and cell wall skeleton (MPL+TDM+CWS) in a 2% squalene/Tween 80 emulsion. Other examples of adjuvants include DDA (dimethyldioctadecylammonium bromide), Freund's complete and incomplete adjuvants and QuilA. In addition, immune modulating substances such as lymphokines (e.g., IFN-, IL-2 and IL-12) or synthetic IFN-inducers such as poly I:C can be used in combination with adjuvants described herein.
Compositions of the invention can be administered parenterally, by injection, for example, either subcutaneously or intramuscularly. Additional formulations which are suitable for other modes of administration include suppositories, and in some cases, oral formulations or formulations suitable for distribution as aerosols. In the case of the oral formulations, the manipulation of T-cell subsets employing adjuvants, antigen packaging, or the addition of individual cytokines to various formulations can result in improved oral vaccines with optimized immune responses. For suppositories, traditional binders and carriers may include, for example, polyalkylene glycols or triglycerides; such suppositories may be formed from mixtures containing the active ingredient in the range of 0.5% to 10%, preferably 1%-2%. Oral formulations include such normally employed excipients as, for example, pharmaceutical grades of mannitol, lactose, starch magnesium stearate, sodium saccharine, cellulose, magnesium carbonate, and the like. These compositions take the form of solutions, suspensions, tablets, pills, capsules, sustained release formulations or powders and contain 10%-95% of active ingredient, preferably 25-70%.
The compositions of the invention can be formulated into the vaccine compositions as neutral or salt forms. Pharmaceutically acceptable salts include the acid addition salts (formed with free amino groups of the peptide) and which are formed with inorganic acids such as, for example, hydrochloric or phosphoric acids, or with organic acids such as acetic, oxalic, tartaric, maleic, and the like. Salts formed with the free carboxyl groups can also be derived from inorganic bases such as, for example, sodium, potassium, ammonium, calcium, or ferric hydroides, and such organic bases as isopropylamine, trimethylamine, 2-ethylamino ethanol, histidine, procaine, and the like.
Any cellular component of such vaccine compositions can, in preparation for inclusion in such compositions, be subjected to treatments which involve attenuation or inactivation of the cells of the vaccine, including, for example, exposure to ionizing radiation, which can inhibit cell division, antiproliferative agents such as cyclophosphamide, cytochalasin D, or colchicine, or killing with or without fixation.
The compositions, including antigen bearing targets and APCs are administered in a manner compatible with the dosage formulation, and in such amount as will be prophylactically and/or therapeutically effective. The quantity to be administered depends on the subject to be treated, including, e.g., capacity of the subject's immune system to synthesize antibodies, and the degree of protection desired. Suitable dose ranges are on the order of several hundred micrograms active ingredient per vaccination with a preferred range from about 0.1 μg to 1000 μg, such as in the range from about 1 μg to 300 μg, and preferably in the range from about 10 μg to 50 μg. Suitable regiments for initial administration and booster shots are also variable but are typified by an initial administration followed by subsequent inoculations or other administrations. Precise amounts of active ingredient required to be administered depend on the judgment of the practitioner and may be peculiar to each subject. It will be apparent to those of skill in the art that the therapeutically effective amount of cells of this invention will depend, inter alia, upon the administration schedule, the unit dose of antigen administered, whether the cells are administered in combination with other therapeutic agents, the immune status and health of the recipient, and the therapeutic activity of the particular composition.
The compositions can be given in a single dose schedule, or preferably in a multiple dose schedule. A multiple dose schedule is one in which a primary course of vaccination can include 1-10 separate doses, followed by other doses given at subsequent time intervals required to maintain and or reinforce the immune response, for example, at 1-4 months for a second dose, and if needed, a subsequent dose(s) after several months. Periodic boosters at intervals of 1-5 years, usually 3 years, are preferable to maintain the desired levels of protective immunity. The course of the immunization can be followed by in vitro proliferation assays of peripheral blood lymphocytes (PBLs) co-cultured with ESAT6 or ST-CF, and by measuring the levels of IFN-released from the primed lymphocytes. The assays can be performed using conventional labels, such as radionucleotides, enzymes, fluorescent labels and the like. These techniques are known to one skilled in the art and can be found in U.S. Pat. Nos. 3,791,932, 4,174,384 and 3,949,064, which are hereby incorporated by reference.
Tumors for Which the Invention is Applicable
The invention contemplates treatment of tumors including but not limited to the following:
Melanomas, squamous cell tumors, basal cell carcinomas, astrocytomas, gliomas, glioblastoma multiforme, meningiomas, ependymomas, schwannomas, neuroblastomas, retinoblastomas, meningiomas, glomus tumors, sarcomas, including, e.g., osteosarcomas, Ewing's sarcomas, chondrosarcomas, myosarcomas, synovial cell sarcomas, fibrosarcomas, spindle cell tumors, angiosarcomas, primitive neuroectodermal cell tumors, and Kaposi's sarcomas, lymphomas, acute and chronic leukemias, tumors of the head and neck, nasopharyngeal carcinomas, carcinomas of the pharynx, laryngeal carcinomas, carcinomas of the thyroid, carcinomas of the parathyroids, thymomas, esophageal carcinomas, gastric carcinomas, tumors of the small bowel, carcinomas of the colon and rectum, mesotheliomas, lung carcinomas, including adenocarcinomas, squamous cell carcinomas, bronchoalveolar carcinomas, and small cell tumors, pancreatic carcinomas, islet cell and non-islet cell tumors, carcinomas of the breast, cardiac myxomas, pituitary tumors, carcinoid tumors, nepatomas, cholangiocarcinomas, hepatoblastomas, renal cell carcinomas, nephroblastomas, Wilms' tumors, adrenal carcinomas, pheochromocytomas, germ cell tumors, choriocarcinomas, ovarian carcinomas, testicular tumors, seminomas, endometrial tumors, carcinomas of the prostate, carcinomas of the seminal vesicles, vaginal tumors, carcinomas of the penis, hydatiform moles, carcinomas of the gall bladder, and carcinomas of the urinary bladder.
Subjects for Treatment According to the Invention
The present invention provides a method for reducing the size and/or number of metastases in a subject. The method comprises administering to the subject a vaccine composition comprising a multifunctional molecule of the invention. A “subject” as used herein, may refer to an organism of the Kingdom animalia, preferably a mammal, and still more preferably a human. A “subject”, according to the invention may also be an animal in need of anti-metastases therapy, e.g., a patient with malignant metastases to one or more organs or tissues, e.g., a human patient with lung or lymph node metastases. A “subject”, according to the invention may also be an animal model of metastases, in which the animal is manipulated, either genetically, or by injection of malignant cells, or by other methods known to those of skill in the art, to simulate the appearance of foci of malignant cells or infected cells which are observed in a similar animal with naturally occurring metastases. The generation of animal models of metastasis is well known in the art, and examples of such models may be found in, for example, Ryan M H et al., J. Immunol. 2001;167:4286-92; Specht J M et al., J Exp Med. 1997;186:1213-21; Nakanishi et al., Tumour Biol. 2003 24:70-6; Wang et al., Int J Gastrointest Cancer, 2001;29(1):37-46; Muralidharan et al., J Clin Laser Med Surg. 2003 21(2):75-83; Tanaka et al., Chest 2003, 123(4):1248-53; Huang et al., Clin Exp Metastasis 2002;19(4):359; and Irvine K R et al., J. Immunol. 1996;156:238-45. One of skill in the art would be able to readily adapt the animal models of metastasis known in the art to generate a metastasis model of interest for any given application.
Detection of Metastases
The present invention provides a method of reducing the number and/or size of metastases in a subject comprising administering to a subject, a multifunctional molecule as described herein. One of skill in the art will recognize that the detection and measurement of metastases is routine in the art and may be accomplished using well established methods. For example, metastases may be detected using gross examination of a subject, such as exploratory surgery (e.g., laparotomy). Alternatively, metastases may be detected, measure, and/or observed using less invasive techniques and methods such as thorascopy, mediastinoscopy, and laparoscopy. One of skill in the art may also detect the presence of metastases using imaging techniques known to those of skill in the art. Such techniques include, but are not limited to radiographic imaging, computerized tomography (CT scan), magnetic resonance imaging (MRI), positron emission tomography (PET scan), single photon excitation (SPECT), and radionuclide scintigraphy (e.g., bone scan). The sensitivity of many of the above imaging methods may be enhanced, as known by those of skill in the art by injection or IV administration of contrast agents (e.g., iodine or barium) to a subject to be imaged. Additional methods for assessing the presence of, or detecting, or measuring metastasis is through the use of gross or histological pathologic examination (i.e., in which a tissue sample is removed from a subject an examined at eaither or both of the gross anatomical level, or at the histological or ultrastructural level according to methods which are well known in the art). The above methods for the detection, measurement, and imaging of metastases are known to those of skill in the art and may be adapted according to the knowledge in the art to particular tissues, organs, or cells which one of skill in the art wishes to asses according to the methods of the invention. More detailed descriptions of such methods may be found in the art, for example, the Oxford Textbook of Oncology, 2nd Ed., New York, Oxford University Press, 2002.
According to the invention, metastasis is detected if any amount of metastasis is detected in a subject. That is, upon the detection of even a single foci in a subject, metastasis may be said to have been detected. Preferably, metastasis is detected as plural metastatic foci, in one or preferably one or more organs in a subject.
Transgenic Animals According to the Invention
A nucleic acid molecule encoding a multifunctional molecule as described herein can be used to produce nonhuman transgenic animals, and cells of such transgenic animals can be isolated and used in a vaccine formulation in animal or human vaccination.
For example, in one embodiment, a nucleic acid molecule is introduced into a fertilized oocyte or an embryonic stem cell. Such cells can then be used to create non-human transgenic animals in which exogenous nucleic acid molecules encoding the polypeptides of the invention have been introduced into their genome or homologous recombinant animals in which endogenous nucleic acid molecules have been altered. Such animals are useful for studying the function and/or activity of the molecules of the invention and for identifying and/or evaluating modulators of the activity of the molecules of the invention. As used herein, a “transgenic animal” is a non-human animal, prefers mammal, more preferably a mouse, in which one or more of the cells of the animal includes a transgene. A transgene is exogenous nucleic acid which is integrated into the genome of a cell from which a transgenic animal develops and which remains in the genome of the mature animal, thereby directing the expression of an encoded gene product in one or more cell types or tissues of the transgenic animal.
A transgenic animal of the invention can be created by introducing nucleic acid molecules encoding the polypeptides described herein (i.e., a multifunctional molecule) into the male pronuclei of a fertilized oocyte, e.g., by microinjection, and allowing the oocyte to develop in a pseudopregnant female foster animal. Intronic sequences and polyadenylation signals can also be included in the transgene to increase the efficiency of expression of the transgene. A tissue-specific regulatory sequence(s) can be operably linked to the transgene to direct expression of a polypeptide of the invention to particular cells. Methods for generating transgenic animals via embryo manipulation and microinjection, particularly animals such as mice, have become conventional in the art and are described, for example, in U.S. Pat. Nos. 4,736,866 and 4,870,009, both by Leder et al., U.S. Pat. No. 4,873,191 by Wagner et al. and in Hogan, B., Manipulating the Mouse Embryo, (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1986). Similar methods are used for production of other transgenic animals. A transgenic founder animal can be identified based upon the presence of the nucleic acid molecule of the invention, e.g., the transgene in its genome and/or expression of the transgene mRNA in tissues or cells of the animals. A transgenic founder animal can then be used to breed additional animals carrying the transgene. Moreover, transgenic animals carrying a transgene encoding polypeptides of the invention can further be bred to other transgenic animals carrying other transgenes.
The invention is further illustrated by the following exemplifications which should not be construed as being further limiting.
EXAMPLES Example 1 Cloning of a Murine GM-CSF Fused to the S. cerevesiae Gas1 GPI Modification Signal Sequence The starting point for producing a yeast expression vector was the pUC 19-GM-CSF-mammalian GPI signal sequence plasmid (pUC19-GM-CSF-GPI). This plasmid encodes murine GM-CSF (upstream) fused in-frame to the human Thy-1 GPI modification signal sequence (downstream). The following two oligonucleotides were purchased from Midland Certified Reagent Company (Midland, Tex.):
GTX-5 comprises:
- a. Sequences at the 5′ end suitable for ligating to an EcoRI site (bases 1-5)
- b. An NgoM1 site for creating an in-frame chimeric coding sequence (bases 9-14)
- c. The coding sequence for the GPI modification sequence of human Thy-1 (Genbank Accession No. M11749) (bases 15-137)
- d. A termination codon (bases 138-140)
e. Sequences at the 3′ end for ligating to a KpnI site (bases 144-148)
This oligonucleotide is complementary to GTX-5, except for staggered ends.
GTX-5 and GTX-6 were dissolved in individual tubes in sterile water at a final concentration of 1 microgram/lambda. GTX-5 and GTX-6 were mixed at a final concentration of 100 ng/lambda and allowed to anneal for 60 minutes at room temperature.
The GTX-5:GTX-6 double stranded oligonucleotide was then cloned into the plasmid pUC19. Four micrograms of pUC19 DNA was digested with EcoRI and KpnI. After electrophoresis, the linear DNA was purified from a 0.7% agarose gel using a Qiagen (Santa Clarita, Calif.) gel purification kit according to instructions provided by the manufacturer. 100 ng of the GTX-5:GTX-6 oligonucleotide was ligated to 200 ng of the EcoRI-KpnI digested pUC19 in a final volume of 20 microliters at room temperature for 60 minutes.
The plasmid was transformed into competent AG-1 cells, which were purchased from Stratagene. Transformed E. coli were inoculated onto LB-amp plates. Bacterial colonies grown on LB plates containing ampicillin (100 micrograms/ml) were picked and inoculated into one ml of LB with amp and grown overnight at 37° with shaking.
Plasmid DNA was isolated using a standard alkaline lysis miniprep protocol and DNA was digested with EcoRI and KpnI. DNA was electrophoresed on 1.6% agarose gels stained with ethidium bromide, and colonies containing an EcoRI-KpnI fragment of approximately 148 bp were thus identified. Positive colonies were inoculated into 100 ml of LB with ampicillin and grown overnight. Plasmid DNA was again purified using kits purchased from Qiagen.
The nucleotide sequence of a Thy-GPI positive clone, designated pUC-GPI 21, was sequenced, confirming its identity.
The GM-CSF coding sequence was amplified by PCR from a mouse lung cDNA library purchased from Clontech. PCR was performed for 35 cycles using pfu polymerase and the following primers:
PCR parameters were denaturation at 90° for 1 minute, annealing at 60° for 1 minute, and extension at 720 for 1 minute.
The GM-CSF chain PCR product was purified after electrophoresis through a 1% agarose gel. The DNA band was excised and the DNA fragment purified using a kit purchased from Qiagen.
The purified GM-CSF DNA fragment was digested with EcoRI and NgoM1. After digestion, the reaction mix was extracted with phenol:chloroform (1:1) followed by chloroform. The aqueous phase was adjusted to 0.3M sodium acetate pH 5.2 and the DNA was precipitated with 2 volumes of ethanol at −80° for 2 hours. The DNA was pelleted by centrifugation, ethanol was removed, and the pellet was rinsed with 70% ethanol. The pellet was dried under vacuum.
The GM-CSF DNA was resuspended in sterile water and ligated to pUC19-GPI 21 that had been digested with EcoRI-NgoM1. Ligation was for one hour at room temperature. PUC19 GPI 21 ligated to GM-CSF DNA was used to transform competent AG-1 cells. Transformed AG-1 cells were selected on LB plates with ampicillin. Plasmid DNA was isolated and analyzed as above. Restriction digests were performed to confirm the pUC 19 GPI-GM-CSF chimeric construct. The DNA from several positive clones was isolated and sequenced.
This plasmid was digested with NgoMIV and KpnI, and the larger resulting fragment isolated after electrophoresis through a 1% agarose gel.
The 280 bp GPI modification signal sequence from the yeast protein Gas1 was amplified by PCR from the yeast cosmid clone C9952 (ATCC). This PCR employed pfu polymerase and the primers:
These primers add a 5′ NgoMIV site and a 3′ KpnI site to the Gas I fragment.
Conditions for PCR were:
The PCR product was purified after electrophoresis through a 1% agarose gel and digested with NgoM IV and KpnI. The Gas1 GPI signal sequence was then ligated into the pUC19-GM-CSF-GPI plasmid prepared above so that the Gas1 signal sequence was fused in-frame downstream of the GM-CSF sequence, replacing the Thy-1 sequence. This vector is termed pUC19-GMCSF-Gas1.1. The resultant plasmid was then transformed into AG-1 competent E. coli (Stratagene) and plasmid clones were isolated by alkaline lysis mini-prep. Plamids were then screened for inserts by restriction digest. DNA from a positive clone was sequenced to confirm the identity of the GAS1 coding region.
A yeast expression plasmid for GPI-GM-CSF was then generated utilizing the pITY-4 vector, which was kindly provided by Dr. K. Dane Wittrup (University of Illinois). This plasmid stably integrates into the yeast genome and allows high-level expression of heterologous genes. Features of pITY-4 include: a delta sequence (LTR of Ty element) that enables multiple integration events by homologous recombination; a neo/kanamycin resistance gene that provides for selection in E. coli and tunable selection in yeast; the Gal1 promoter for high-level inducible transcription; a unique EagI cloning site; a synthetic Pre-Pro sequence optimized for efficient secretion of expressed genes; the alpha factor termination sequence; and an origin of replication for propagation in E. coli. In this system, yeast are grown in dextrose-containing media for 3 days, then are switched to media containing galactose to induce transcription of genes inserted downstream of the Gal1 promoter.
The GMCSF-Gas1 insert described above was amplified by PCR from pUC 19-GMCSF-Gas1.1 using pfu polymerase and the primers:
These primers add EagI sites at both ends for cloning into the pITY-4 plasmid.
Conditions for PCR were:
The PCR product was purified after electrophoresis through a 1% agarose gel and digested with EagI. The EagI-flanked GMCSF-Gas1 fragment was ligated into EagI-digested pITY-4 and used to transform E. coli AG1 cells. E. coli were then grown on kanamycin-containing LB plates (100 ug/ml). Plasmids from kanamycin resistant colonies were purified by mini-prep and mapped by restriction digests for presence and correct orientation of inserts. The identity of a positive clone was confirmed by sequencing. This plasmid is termed pITY-GMCSF-Gas1.1.
Example 2 Expression of Murine GM-CSF Fused to the Gas1 GPI Modification Signal Sequence in YeastA 50 ml culture of the E. coli clone containing pITY-GMCSF-Gas1.1 was grown in LB with 100 ug/ml kanamycin and the plasmid purified using a Midi-Prep Kit from Qiagen. The S. cerevesiae strain BJ5464 (ATCC) was then transformed with pITY-GMCSF-Gas 1.1 using a lithium acetate (LiAc) protocol. A 10 ml overnight culture of BJ5464 in YPD (Per liter: 20 g Bactotryptone, 10 g yeast extract, 20 g dextrose) was used to inoculate a 100 ml flask. Yeast were grown for 3 hours at 30° and then harvested by centrifugation at 12,000×g for 2 minutes at room temperature. Cells were washed with sterile water and centrifuged again. The cells were resuspended in 1.0 ml of 100 mM LiAc, transferred to a 1.5 ml microfuge tube and centrifuged in an Eppendorf microfuge at top speed for 15 seconds. The cells were then resuspended in 0.5 ml of 100 mM LiAc and 50 uL samples were aliquoted to individual tubes. The cells were pelleted. 240 uL of PEG (50% w/v), 36 uL 1.0M LiAc, 5 uL (10 mg/ml) boiled carrier DNA (salmon sperm DNA, Sigma), and 2 ug plasmid in 75 uL water, were then added in that order. After the addition of plasmid, the tube was vortexed, incubated at 30° for 30 minutes and heat-shocked at 42° for 15 minutes. The cells were then pelleted, resuspended in sterile water and plated on YPD plates containing 1 mg/ml G418.
Individual colonies of G418-resistant yeast were picked and grown in one ml of YPD with 1 mg/ml G418 for 3 days. The cells were then pelleted by centrifugation in a microfuge and the YPD (dextrose-containing, galactose-free) media was replaced with YPG (20 g bactotryptone, 10 g yeast extract, 20 g galactose per liter) with 1 mg/ml G418. Yeast were grown in YPG for 3 days to allow full induction of transcription from the Gal1 promoter. After induction, cells were pelleted, washed with TN (0.15M NaCl, 25 mM Tris pH 7.4) and lysed in TN containing 20 mM octyl glucopyranoside (OGP), 1 mM PMSF, and lug/ml each aprotinin, leupeptin and pepstatin. Yeast were lysed by vortexing with acid-washed glass beads (425-600 microns, Sigma). Insoluble material was pelleted and the supernatant assayed using a murine GM-CSF ELISA (Endogen). A colony expressing high levels of GPI-GM-CSF was identified. Based on standard curve of soluble GMCSF, we estimate expression to be approximately 25 ug/L, a significant improvement over mammalian expression and sufficient for in vivo experiments. This yeast clone is designated SC-GM-GPI.
One of the advantages of stably integrating vectors for expression in yeast is that, after the initial cloning and colony isolation, antibiotic maintenance is no longer required. To confirm this, cells were grown with and without G418 and tested for GPI-GM-CSF expression. We have seen no decrease in expression levels in the absence of G418 over 8 months.
To produce GPI-GM-CSF on a scale suitable for in vitro and in vivo functional characterization, 500 ml of YPD was inoculated with SC-GM-GPI and grown for three days at 300 with shaking. Cells were pelleted by centrifugation at 12,000×g for 2 minutes at room temperature and transferred to an equal volume of YPG for an additional three days of growth. Cells were then pelleted, washed with TN and lysed in 25 ml of TN containing 20 mM OGP, 1 mM PMSF, and lug/ml each aprotinin, leupeptin and pepstatin. Cells were then lysed by vortexing with acid washed glass beads, 20 g/500 ml culture, (425-600 microns, Sigma). Insoluble material was pelleted at 8,000×g for 10 minutes at room temperature and the soluble material was applied to an immunoaffinity column of anti-murine GMCSF monoclonal antibody (Endogen) linked to cyanogen bromide-activated Sepharose 4B (Sigma). Coupling of the monoclonal to the Sepharose was performed according to the manufacturer's instructions. Efficiency of coupling was monitored using OD280 and binding of murine GM-CSF to immobolized antibody was confirmed using commercially available, recombinant cytokine.
Soluble yeast-derived material was applied to the column and allowed to flow by gravity. The column was washed sequentially with: (a) 20 volumes of TN with 1% Triton X-100; (b) 5 volumes of 50 mM Tris pH 8.0, 1 mM OGP; (c) 20 volumes TN with 1 mM OGP. Bound material was then eluted with 10 volumes of 0.15M NaCl, 25 mM Tris pH 2.5 with 1 mM OGP. Eluted material was neutralized with {fraction (1/200)} volume of 1.5M Tris pH8.8. The purified material was concentrated using a Microsep 3K centrifugal device (Pall Gelman Laboratory). Yields of GPI-GM-CSF were determined by ELISA (Endogen) to be 25 ug/L of culture. Final concentration was adjusted to 40 ug/ml by addition of 0.15M NaCl, 25 mM Tris pH 7.4 with 1 mM OGP.
Purified GPI-GM-CSF was analyzed by stained gel and western blot. Approximately lug of purified GPI-GM-CSF or recombinant soluble murine GM-CSF per lane were electrophoresed. Gels were then stained with silver nitrate using the Sigma silver staining kit according to the manufacturer's directions (Sigma). For western blots, gels were transferred to Protran BA83 (Schleicher and Schuell) using an Owl Scientific electric transblotter and blocked with TBS (Tris Buffered Saline) containing 0.05% Tween 20 and 2% nonfat dry milk overnight at room temperature. The blot was then incubated with primary antibody (rat monoclonal anti-murine GMCSF, Endogen) at 1:5000 dilution in blocking buffer for 2 hours at room temperature. The blot was washed with TBS-0.05% Tween 20, and incubated with a secondary antibody, alkaline phosphatase conjugated goat anti-rat IgG (Sigma) at 1:10,000 for 1 hour at room temperature. After washing, color was developed with NBT-BCIP (Sigma). A single dominant band migrating at approximately the same rate as a recombinant soluble GM-CSF standard was clearly present on both the gel and the blot (the molecular weight of the GPI moiety is only approximately 1500 compared to approximately 14,000 for the protein moiety]. Given the immunoreactivity with anti-GM-CSF and the ability of this material to bind to tumor cell membranes, these bands appear to represent GPI-GM-CSF. While some high molecular weight material, possibly representing aggregates, is visible in the blot, this material is not visible in the less sensitive silver stain, indicating that it is present in lower amount than the dominant band.
Example 3 Attachment of Murine GM-CSF Fused to the Gas1 GPI Modification Signal Sequence to CellsWild type CMS-5 murine fibrosarcoma cells grown in DMEM, 10% FBS, Pen-Strep were harvested, washed twice with RPMI 1640 (Life Technologies) and resuspended in RPMI 1640 at a concentration of 5×105 cells/ml. 0.9 ml aliquots of the cell suspension were dispensed to Eppendorf siliconized microfuge tubes. Each aliquot received either 1 ug of purified GPI-GM-CSF prepared as in Example 2, 1 ug of soluble recombinant murine GM-CSF (Intergen, supplied as lyophilized powder and reconstituted at 40 ug/ml in the same buffer as GPI-GM-CSF), or media alone. Cells were then incubated for 3 hours at 37° C. with shaking and then washed 3 times with PBS containing 2% FBS.
For detection of GPI-GM-CSF by flow cytometry, cells were incubated with a rat anti-murine GM-CSF monoclonal antibody (Endogen) for one hour at 4° C. The cells were then washed 3 times with PBS containing 2% FBS, and incubated with FITC-labeled goat anti-rat IgG antibody (Sigma) for one hour at 4° C., and again washed 3 times with PBS containing 2% FBS. The cells were analyzed by flow cytometry on a Becton-Dickinson Facscalibur. Decoration with GPI-GM-CSF caused an approximately 10-fold increase in peak and mean FL-1 fluorescence relative to cells incubated with media alone. In contrast, cells incubated with soluble GM-CSF had virtually the same profile as the negative control cells. This data indicates that GPI-GM-CSF, but not soluble recombinant GM-CSF, can bind to tumor cells.
GPI-GM-CSF attached to CMS-5 cells was also detected and quantitated by ELISA. CMS-5 cells were harvested and washed as described above. 1×106 cells in 1 ml of RPMI 1640 were incubated with 1 ug of purified GPI-GM-CSF. After incubation for 2 hours at 37° C., the cells were washed 3 times with PBS containing 2% FBS. The cell pellet was lysed with 50 microliters of PBS containing 0.15% deoxycholate and the detergent subsequently diluted by the addition of 200 microliters of PBS. The material was serially diluted with PBS and amounts of GM-CSF determined using an ELISA kit (Endogen) against a soluble, recombinant GM-CSF standard provided by the manufacturer. Based on this data, the mean number of GPI-GM-CSF molecules incorporated/cell over five experiments was 37,000+/−33,000. The large standard deviation was due to one experiment in which the number of molecules/cell was 66,000. Excluding this experiment, the mean was 29,500+/−4,500.
“Decoration” of B16 murine melanoma cells with GPI-GM-CSF was also quantitated by ELISA. Decoration and ELISA were performed exactly as described for CMS-5 cells. The mean number of molecules/cell over three experiments was 21,000+/−11,500.
Example 4 Stability of Murine GM-CSF Fused to the Gas1 GPI Modification Signal Sequence on CellsTo study the stability of incorporated GPI-GM-CSF on cells, CMS-5 cells were harvested and decorated as described above in Example 3. After decoration, the cells were washed 3 times with PBS containing 2% FBS and then resuspended at 4×106 cells/ml in RPMI 1640. The cells were irradiated at 3500 rads from a 137CS source. The cells were then incubated at 37° C. in 5% CO2 and aliquots were removed at hourly intervals, washed three times, and lysed in 50 ul PBS with 0.15% deoxycholate. 200 ul of PBS was then added to dilute the deoxycholate. Cell-associated GM-CSF was measured by ELISA. Even at 6 hours, cells showed only about a 20% loss of cell-surface GPI-GM-CSF. After 6 hours, viability of irradiated cells (both decorated and non-decorated) as measured by microscopic inspection with trypan blue staining was significantly compromised. However, in vivo data (see below) indicates that both cell-surface retention of GPI-GM-CSF and post-irradiation cellular viability are sufficient to sustain a biological effect.
Example 5 Bioactivity of Murine GM-CSF Fused to the Gas I GPI Modification Signal Sequence to CellsThe bioactivity of GPI-GM-CSF was assayed by determining the molecule's ability to support the proliferation of the FDC-P1 cell line, a murine bone-marrow derived, GM-CSF dependent cell line. Proliferation of FDC cells was measured with the Biotrak Cell Proliferation ELISA (Amersham Pharmacia), an assay that utilizes the thymidine analogue 5-bromo-2′-deoxyuridine (BrdU). WEHI cells (ATCC) were grown in Iscove MEM, 10% FBS, Penicillin-streptomycin, as a source of conditioned media for FDC-P1 cells. FDC-P1 cells were grown in DMEM, 10% FBS, Penicillin-streptomycin with 25% WEHI conditioned media, harvested, and washed 3 times with DMEM, 10% FBS, Penicillin-streptomycin. The cells were resuspended at 1×105/ml in DMEM, 10% FBS, Penicillin-streptomycin and 100 uL was aliquoted to individual wells of a 96 well microtitre plate. Groups, done in triplicate, were as follows:
-
- A. Media—No Cells
- B. FDC-P1 Cells-Unstimulated
- C. FDC-P1 Cells+10 ng soluble GM-CSF
- D. FDC-P1 Cells+10 ng GM-CSF as GPI-GM-CSF (as determined by ELISA against GM-CSF standard)
- E. FDC-P1 Cells+10 ng GPI-GM-CSF (as in “D”) denatured by extraction of the protein with chloroform:methanol (3:1) followed by acetone precipitation and resuspension.
All protein solutions were diluted to 100 ng/ml in 0.15M NaCl, 25 mM Tris pH 7.4 with 1 mM OGP, so that the volume added to each well was 100 uL.
The non-isotopic proliferation assay was performed according to the manufacturer's instructions. The plated cells were grown for two days at 37° C. in 5% CO2. On day 3, 10 ul of the BrdU solution was added to individual wells and the cells incubated for 3 more hours. The plate was then centrifuged at 300×g for 10 minutes and the supernatant removed. The plate was dried by incubating at 60° C. for one hour. The plate was then fixed and blocked according to the manufacturer's instructions. The fixed cells were then incubated with peroxidase-labelled anti-BrdU for 90 minutes. The wells were then washed and color developed with TMB according to the manufacturer's instructions. In two experiments, GPI-GM-CSF consistently sustained proliferation at a level somewhat (about 25%) higher than did soluble recombinant GM-CSF, indicating that GPI-GM-CSF is suprabioactive. The effect of GPI-GM-CSF was not due to the GPI moiety alone, since denatured GPI-GM-CSF did not support proliferation. The GPI moiety remained linked to the protein after denaturation, since the protein was still able to decorate cells as demonstrated by ELISA, which recognizes linear epitopes on GM-CSF.
Example 6 Effective Immunization with Cells Admixed with GPI-GM-CSFThese experiments included mice vaccinated with:
- (a) Wild-type cells (WT)
- (b) Cells incubated with soluble GM-CSF—Unwashed (total GM-CSF in dose: 1 microgram)
- (c) Cells decorated with GPI-GM-CSF—Unbound GPI-GM-CSF Washed off Following Incubation (total GPI-GM-CSF in dose: 0.74 nanograms by ELISA [mean of 2 experiments; 73 and 75 ng individually]
- (d) Cells decorated with GPI-GM-CSF-Unwashed (total GM-CSF in dose: 1 microgram)
GPI-GM-CSF mass and concentration values are expressed in terms of equivalence to GM-CSF as determined by ELISA against a soluble GM-CSF standard.
CMS-5 cells were grown to 70% confluence in DMEM, 10% FBS, Penicillin-streptomycin, harvested trypsinization, and washed 3 times with RPMI 1640. Viability was determined by trypan blue staining of an aliquot and the cells were then resuspended at a concentration of 4×106 cells/ml a 1 ul aliquots dispensed into siliconized microfuge tubes. The cells were incubated with 1 ug GPI-GM-CSF or 1 ug soluble recombinant murine GM-CSF per 106 cells for 3 hours at 37° C. “Washed” groups were then washed 3 times with PBS, 2% FBS and resuspended at 4×106 cells/ml in RPMI 1640. An aliquot of the washed GPI-GM-CSF decorated cells was removed and the amount of cell-associated GM-CSF measured by ELISA as described above. There were approximately 31,000 and 32,000 GPI-GM-CSF molecules/cell in the washed decorated groups in the two experiments, respectively.
The cells were irradiated at 3500 rads from a 137CS source. 8-10 week-old female Balb/c mice (which are syngeneic for CMS-5) were anesthetized by metofane inhalation and vaccinated subcutaneously in the left inguinal fold with 1×106 cells in 0.25 ml. Seven days later, wild-type CMS-5 cells at 70% confluence were harvested and washed 3 times in HBSS. Viability was determined by trypan blue staining of an aliquot and cells were adjusted to 4×106/ml in HBSS. The previously vaccinated mice were then injected subcutaneously behind the neck, under metofane anesthesia, with 2×106 live, wild-type CMS-5 cells in 0.5 ml HBSS.
Tumor development was assessed daily by palpation and visual inspection. “Onset” was defined as the first day on which a tumor mass was both palpable and visible. The observer was blinded to the vaccine received by each set of mice to ensure against bias. Mice were sacrificed by CO2 asphyxiation when tumors become unwieldy. Experiments were terminated 70 days after tumor challenge, as planned in advance.
Data is pooled from three experiments for GPI-GM-CSF unwashed, soluble GM-CSF, and wild-type vaccine groups. Data for these groups includes that from undepleted controls in a lymphocyte subset depletion experiment. Data for the GPI-GM-CSF washed group is pooled from two experiments, since this group was not included in the initial depletion experiment. The depletion experiment had 4 mice/group, and the other experiments had 5/group. In terms of total mouse numbers, n=14 for GPI-GM-CSF unwashed; 10 for GPI-GM-CSF washed; 14 for soluble GM-CSF unwashed; and 14 for WT. Approximate percentages of mice surviving tumor-free to day 70 after challenge were: WT, 15%; soluble GM-CSF, 50%; GPI-GM-CSF washed, 60%; GPI-GM-CSF unwashed, 85%. Thus, even though the GPI-GM-CSF washed vaccine contained over a thousand-fold less GM-CSF than the unwashed soluble, administration of cells decorated with GPI-GM-CSF was more effective. Furthermore, the GPI-GM-CSF unwashed vaccine, in which some molecules were not attached to a cell, was even more effective.
Example 7 Cloning and Expression of Human GM-CSF Fused to the Gas1 GPI Modification Signal Sequence Human GM-CSF is amplified by PCR from a human T cell cDNA library (Clontech) using Pfu polymerase (Stratagene). The following primers are used:
The upstream primer contains EcoR1 and Eag1 restriction sites immediately preceding the first amino acid found in the mature human GM-CSF protein. Since expression in S. cerevisiae utilizes a yeast leader sequence, cloning of the human GM-CSF begins at the N terminus of the mature protein. Each downstream primer omits the native stop codon to allow in-frame ligation to the sequence encoding the Gas1 GPI modification signal. The downstream primer contains an NgoM IV restriction site, consistent with restriction sites used in other constructs.
PCR parameters are denaturation at 97° C for 1 minute,
-
- annealing at 56° C for 1 minute, and
- extension at 72° C for 2 minutes.
PCR is performed for the least number of cycles yielding a visible band on agarose gel electrophoresis. After amplification, the reaction mix is allowed to cool at 4° for 10 minutes.
The PCR product is isolated by electrophoresis through a 1% agarose gel and eluted from the excised agarose band using a commercially available kit (Qiagen). The purified hGM-CSF DNA fragment is digested with EcoR1 and NgoM IV and ligated to the (murine) pUC19 GM-CSF-GPI plasmid that has been digested with EcoR1 and NgoM IV. This replaces the murine GM-CSF with its human counterpart. The pUC19-hGM-CSF GPI plasmid is then transformed into competent AG-1 E. coli cells, 30 colonies are picked for mini-culture, and plasmid clones are isolated and purified using commercially available kits (Qiagen). Positive clones are identified by restriction enzyme test digest and agarose gel electrophoresis. Positive E. coli colonies are grown overnight in maxi-culture and their plasmids purified using Qiagen maxi-prep kits. Inserts are sequenced.
To clone GM-CSF GAS1g into the pITY-4 expression vector, PCR of this construct from the pUC19 vector is performed. The primers are:
The upstream primer has an EagI site immediately preceding the first codon of the mature GM-CSF. This removes the mammalian secretion signal and allows for in-frame ligation to the yeast signal sequence. The same restriction site can be used as for the mouse construct because it is absent in the human sequence. The downstream primer appends an EagI site at the 3′ end. PCR is performed using Pfu polymerase for 25 cycles. Conditions for PCR are: denaturation 90° one minute, annealing 60° one minute, extension 720 one minute. After amplification, the reaction mix is allowed to cool at 4° for 10 minutes.
The PCR product is isolated by electrophoresis through a 1% agarose gel and eluted from the excised agarose band using a commercially available kit (Qiagen). The purified GM-CSF GAS1g DNA fragment is digested with EagI, ligated to pITY-4, and transformed into AG-1 chemically competent bacteria (Stratagene). 30 colonies are picked for mini-culture and plasmid clones are isolated and purified using commercially available kits (Qiagen). Positive clones are identified by restriction enzyme test digest and agarose gel electrophoresis. Positive E. coli colonies are grown overnight in maxi-culture and their plasmids purified using Qiagen maxi-prep kits. Inserts are sequenced.
The GPI-human GM-CSF molecule is expressed in S. cerevesiae as described for the murine molecule in Example 2. Immunoaffinity purification is performed as described in Example 2, substituting an anti-human GM-CSF antibody for the anti-murine GM-CSF antibody. ELISA to detect and quantitate the molecule, whether in isolation or bound to an antigen bearing target, is performed using an anti-human GM-CSF monoclonal antibody, as is flow cytometry on cells decorated with the molecule.
Example 8 Cloning of GM-CSF/Influenza Hemagglutinin Chimeric ProteinspUC19 GMCSF-K-GAS1.1
pUC19 GM-CSF-K-HA was cloned starting with pUC19 GM-CSF-K-Gas1.1, which we produced in our laboratory. This plasmid includes a sequence that encodes murine GM-CSF fused to a downstream glycosylphosphatidylinositol modification sequence derived from the yeast GAS 1 protein (the latter obtained from Dr. D. Wittrup, University of Illinois). A linker sequence is interposed between the GM-CSF and GAS 1 portions. To insert the linker sequence, the plasmid pUC19 GMCSF-Gas1.1, also previously produced in our lab, was digested with NgoM IV and NheI. These restriction enzymes cut at the 3′ end of the GM-CSF molecule and at the 5′ end of the Gas 1.1 sequence, respectively. The resulting plasmid was purified after electrophoresis through agarose gel using a kit manufactured by Qiagen. The following oligonucleotides were purchased:
The synthetic oligonucleotides contain:
-
- 1. 5′ overhang that anneals to NgoM IV digested plasmid DNA
- 2. 3′ overhang that anneals to Nhe I digested plasmid DNA
- 3. DNA sequence coding for the peptide GGGGSGGGGS where G stands for glycine and S stands for serine. This 10 amino acid sequence (G4S)2 is designed to insert a kink/spacer in the protein between the GMCSF and the Gas 0.1 moieties.
- 4. SpeI site to allow confirmation of cloning of the small fragment and for further manipulations.
The two oligonucleotides were mixed in equimolar concentrations, boiled for 2 minutes and allowed to anneal at room temperature. The oligonucelotide was ligated into the NgoM IV-Nhe I digested plasmid and the plasmid was used to transform the E. coli strain AG-1. Transformants were selected on LB plates containing 100 ug/ml ampicillin. Plasmid DNA was isolated, digested with Spe I, and electrophoresed on agarose gels to confirm the presence of the (G4S)2 sequence.
pUC19 GM-CSF-K-hemagglutinin (HA)
The plasmid pUC19 GM-CSF-K-HA was produced, which encodes a chimeric protein containing (from amino terminal to carboxy terminal): (1) murine GM-CSF; (2) the (G4S)2 linker described above; and (3) the HA1 domain of the H1 HA from the A/PR/8/34 influenza A isolate. The HA1 sequence used (amino acids 18 to 344 of the HA precursor) omits the N-terminal leader sequence and the downstream HA2 domain. A termination codon was added after amino acid 344.
pUC 19 GM-CSF-K-Gas 1.1. was digested with Nhe I and Kpn L. Nhe I cuts at the 5′ end of the Gas 1.1 coding sequence and Kpn I cuts at the 3′ end of the Gas 1.1 coding sequence, respectively. The resulting plasmid with the GPI coding region removed, was purified after electrophoresis through agarose gel using a kit manufactured by Qiagen. The HA1 coding sequence was cloned by PCR from a plasmid encoding the HA gene of the A/PR/8/34 strain of influenza. The HA1 sequence used begins at amino acid 18, the start of the mature protein, i.e. lacking the secretion signal sequence. The 3′ end corresponds to amino acid 344, eliminating the transmembrane region and substituting a termination codon. Primers for PCR of the HA1 sequence were as follows:
Conditions for PCR were:
PCR was performed for 20 cycles using vent polymerase.
Following PCR, the product was electrophoresed through a 1.0% agarose gel and the HA1 cDNA was extracted from the gel using a Qiagen kit according to the manufacturer's instructions. The purified HA1 DNA fragment was digested with Nhe I and Kpn I. To make the fusion protein, the purified Nhe 1-Kpn I HA fragment was ligated into the pUC 19 GM-CSF-K-Gas1.1 vector that had been digested with Nhe I and Kpn I to remove the Gas1.1 coding region. The DNA was used to transform E. coli AG1 and transformants selected on LB-ampicillin plates. Plasmid DNA from individual colonies was isolated and digested with restriction enzymes. Restriction digests identified a pUC19 GM-CSF-K-HA plasmid.
The pUC19 GM-CSF-K-HA plasmid was purified according to the manufacturer's instructions using a kit purchased from Qiagen.
Example 9 Cloning of GM-CSF-K-HA into Yeast Expression Vector PCR of pUC19 GM-CSF-K-HA was used to isolate a DNA fragment encoding GM-CSF-K-HA for cloning into a yeast expression vector. The PCR product contains Eag I cloning sites for in frame insertion into the yeast expression vector.
Conditions for PCR were:
PCR was performed for 20 cycles using vent polymerase.
Following PCR, the product was electrophoresed through a 1.0% agarose gel and the GM-CSF-K-HA gene was extracted from the gel using a Qiagen kit according to the manufacturers instructions. The purified DNA fragment was digested with Fag I and ligated to the yeast expression vector ITK that had been digested with Eag I. The ITK vector is designed for (1) replication in E. coli and (2) expression of genes in the yeast Saccharomyces cerevisiae after stable integration using homologous recombination. The vector contains:
-
- 1. Sequences for replication of the plasmid in E. coli
- 2. Yeast Gal promoter for expression of heterologous genes in yeast grown in media containing galactose.
- 3. PrePro—Synthetic DNA sequence, optimized for secretion and signal sequence cleavage of distal genes in yeast.
- 4. Unique Eag I site for cloning genes to be expressed.
- 5. Alpha terminator—DNA sequence for efficient termination of proximal genes.
- 6. Delta sequence that allows for stable integration of the plasmid by recombination with endogenous delta sequences in the yeast chromosome.
- 7. Antibiotic resistance gene allowing for selection in E. coli with kanamycin and selection in yeast with G418.
This plasmid was used to transform E. coli strain AG-1. Transformants were selected by growth on LB plates containing 100 ug/ml kanamycin. Individual colonies were grown in LB media containing kanamycin and plasmids were purified. Restriction digests determined orientation of inserts. The resulting plasmid ITK GM-CSF-K-HA was purified using a kit purchased from Qiagen according to the manufacturer's instructions.
Example 10 Expression of GM-CSF-K-HA in YeastThe purified plasmid was linearized with Mfe 1 and used to transform the yeast strain Saccharomyces cerevisiae WDHY131 using lithium acetate (LiAc). A 10 ml culture of S. cerevisiae grown to saturation at 30° in YPD media (per liter/20 g Bactotryptone; 20 g dextrose: 10 g yeast extract) was used to inoculate 100 ml of YPD. The culture was grown at 300 with shaking for 3 hours. The yeast were harvested by centrifugation at 11,000×g for 2 minutes and resuspended in 25 ml of sterile water. The yeast were centrifuged as above and resuspended in 1.0 ml of 100 mM lithium acetate and transferred to a 1.5 ml microfuge tube. The yeast were pelleted by centrifugation at 12,000×g for 15 seconds and the supernatant removed. The cells were resuspended in 0.5 ml of 100 mM LiAc. 50 uL of cell suspension was added to individual microfuge tubes and centrifuged as above. Supernatant was removed.
Transformation mix added to the yeast pellet consisted of: 240 uL PEG (50% w/v); 36 uL 1.0 M LiAc; 5 uL single stranded DNA (10 mg/ml) and 1 ug of linearized ITK GM-CSF-K-HA in 75 uL of water. The mixture was vortexed to resuspend the cell pellet and incubated at 30° for 30 minutes. The cells were then shocked at 42° for 15 minutes, centrifuged to pellet cells and resuspended in 0.5 ml of YPD. Yeast were incubated in YPD media for 3 hours and plated on YPD plates containing 2 mg/ml G418. Plates were grown at 30° for 3 days until individual colonies appeared. To screen for expression of GM-CSF-K-HA, individual colonies were grown in 1 ml of YPD media at 300 for 2 days. The cells were centrifuged at 8,000×g for 2 minutes and the YPD media removed and replaced with 1 ml of YPG media (per liter/20 g Bactotryptone; 20 g galactose; 10 g yeast extract) for induction from the gal promoter. Yeast were grown in YPG media for 2 days. At this time, an aliquot was removed and cells were pelleted. The supernatant was tested for GM-CSF expression using an ELISA kit purchased from Endogen. Protocol was according to the manufacturer. A high-expressing yeast clone secreting the chimeric protein GM-CSF-K-HA was identified. Based on standard curve of soluble GMCSF, expression level was approximately 2.4 mg/L of GM-CSF moiety.
Example 11 Production of pUC 19 HA (hemagglutinin)-K-GM-CSFThe plasmid pUC19 HA-K-GM-CSF was also produced, which encodes a chimeric protein containing (from amino terminal to carboxy terminal): (1) an HA1 domain (2) K, the (G4S)2 linker described above, and (3) murine GM-CSF, The HA1 begins at the amino terminus of the mature protein, amino acid 18, eliminating the leader sequence. The 3′ end terminates at amino acid 344. The (G4S)2 has been added to supply a flexible linker. The GM-CSF begins at amino acid 18 of the GM-CSF protein, corresponding to the first amino acid of the mature protein.
The HA-K sequence was first cloned by PCR of the HA1 coding sequence from a plasmid encoding the HA gene of the A/PR/8134 strain of influenza.
The oligonucleotides for PCR generate a nucleic acid with:
- 1. A 5′ EcoRI site at the amino terminus of the mature HA
- 2. The (G4S)2 linker at the carboxy terminus of the HA1 domain (amino acid 344 of the HA precursor)
- 3. A Kpn I site distal to the end of the (G4S)2 sequence
Conditions for PCR were:
PCR was performed for 20 cycles using vent polymerase.
Following PCR, the product was electrophoresed through a 1.0% agarose gel and the HA1-K DNA was extracted from the gel using a Qiagen kit according to the manufacturer's instructions. The purified HA-K DNA fragment was digested with EcoRI and Kpn I and the fragment was cloned into pUC19 that had been digested with EcoRI and KpnI. The plasmid was used to transform E. coli AG-1 to ampr. Individual colonies were picked and grown in LB-amp. The identity of plasmids with the correct insert was determined by restriction mapping. The resulting plasmid termed pUC19 HA-K was purified using a Qiagen kit according to the manufacturer's instructions.
The PCR primers generate a GM-CSF fragment with
- 1. 5′ KpnI site that allows in frame translation from the (G4S)2 portion of the HA-K molecule to the start of the mature GM-CSF molecule at amino acid 18.
- 2. A termination codon at the 3′ end of the GM-CSF
- 3. 3′ BamHI site
Conditions for PCR were:
PCR was performed for 20 cycles using vent polymerase.
Following PCR, the product was electrophoresed through a 1.0% agarose gel and the GM-CSF gene was extracted from the gel using a Qiagen kit according to the manufacturer's instructions. The purified fragment was digested with Kpn I and BamHI and the fragment was ligated into pUC19 HA-K plasmid that had been digested with KpnI and BamHI. The plasmid was used to transform E. coli AG-1 to ampr. Individual colonies were picked and grown in LB-amp. The identity of plasmids with the correct insert was determined by restriction mapping. The resulting plasmid termed pUC19 HA-K-GM-CSF was purified using a Qiagen kit according to the manufacturer's instructions.
Example 12 Cloning of HA-K-GM-CSF into Yeast Expression Vector PCR of pUC19 HA-K-GM-CSF was used to generate a DNA fragment encoding HA-K-GM-CSF for cloning into a yeast expression vector. The PCR product contains Eag I cloning sites for in-frame insertion into the yeast expression vector.
Conditions for PCR were:
PCR was performed for 20 cycles using vent polymerase.
Following PCR, the product was electrophoresed through a 1.0% agarose gel and the HA-K-GM-CSF gene was extracted from the gel using a Qiagen kit according to the manufacturers instructions. The purified DNA fragment was digested with Eag I and ligated to the yeast expression vector ITK, that had been digested with Eag I. The ITK vector is designed for (1) replication in E. coli and (2) expression of genes in the yeast Saccharomyces cerevisiae after stable integration using homologous recombination. The vector contains:
-
- 1. Sequences for replication of the plasmid in E. coli
- 2. Yeast Gal promoter for expression of heterologous genes in media containing galactose.
- 3. PrePro—Synthetic DNA sequence, optimized for secretion and signal sequence cleavage of distal genes in yeast.
- 4. Unique Eag I site for cloning genes to be expressed.
- 5. Alpha terminator—DNA sequence for efficient termination of proximal genes.
- 6. Delta sequence that allows for stable integration of the plasmid by recombination with endogenous delta sequences in the yeast chromosome.
- 7. Antibiotic resistance gene allowing for selection in E. coli with kanamycin and selection in yeast with G418.
This plasmid was used to transform E. coli strain AG-1. Transformants were selected by growth on LB plates containing 100 ug/ml kanamycin. Individual colonies were grown in LB media containing kanamycin and plasmids were purified. Restriction digests determined orientation of inserts. The resulting plasmid ITK HA-K-GM-CSF was purified using a kit purchased from Qiagen according to the manufacturer's instructions.
The purified plasmid was linearized with Mfe 1 and used to transform the yeast strain Saccharomyces cerevisiae WDHY131 using lithium acetate (LiAc). A 10 ml culture of S. cerevisiae grown to saturation at 30° C. in YPD media (per liter/20 g Bactotryptone; 20 g dextrose; 10 g yeast extract) was used to inoculate 100 ml of YPD. The culture was grown at 30° C. with shaking for 3 hours. The yeast were harvested by centrifugation at 11,000×g for 2 minutes and resuspended in 25 ml of sterile water. The yeast were centrifuged as above and resuspended in 1.0 ml of 100 mM lithium acetate and transferred to a 1.5 ml microfuge tube. The yeast were pelleted by centrifugation at 12,000×g for 15 seconds and the supernatant removed. The cells were resuspended in 0.5 ml of 100 mM LiAc. 50 uL of cell suspension was added to individual microfuge tubes and centrifuged as above. Supernatant was removed. Transformation mix added to the yeast pellet consisted of: 240 uL PEG (50% w/v); 36 uL 1.0 M LiAc; 5 uL single stranded DNA (10 mg/ml) and 1 ug of linearized ITK HA-K-GM-CSF in 75 uL of water. The mixture was vortexed to resuspend the cell pellet and incubated at 300 for 30 minutes. The cells were then shocked at 42° C. for 15 minutes, centrifuged to pellet cells and resuspended in 0.5 ml of YPD. Yeast were incubated in YPD media for 3 hours and plated on YPD plates containing 2 mg/ml G418. Plates were grown at 30° C. for 3 days until individual colonies appeared. To screen for expression of HA-K-GM-CSF, individual colonies were grown in 1 ml of YPD media at 30° C. for 2 days. The cells were centrifuged at 8,000×g for 2 minutes and the YPD media removed and replaced with 1 ml of YPG media (per liter/20 g Bactotryptone; 20 g galactose; 10 g yeast extract) for induction from the gal promoter. Yeast were grown in YPG media for 2 days. At this time, an aliquot was removed and cells were pelleted. The supernatant was tested for GM-CSF expression using an ELISA kit purchased from Endogen. The protocol was according to the manufacturer.
A colony expressing high levels of the chimeric protein was identified. Based on standard curve of soluble GMCSF, expression level is approximately 2.0 mg/L of soluble material. There is no decrease in expression levels in the absence of G418.
Example 13 Scale Up Purification of GM-CSF-K-HAFor scaled-up purification of the chimeric protein, yeast were inoculated into 500 ml of YPD and grown for three days at 30° C. Cells were pelleted by centrifugation at 12,000×g for 2 minutes and transferred to an equal volume of YPG for an additional three days of growth. The cells were then pelleted by centrifugation at 12,000×g for 2 minutes and the supernatant collected. The soluble material was applied to an immunoaffinity column of anti-murine GMCSF monoclonal antibody (Endogen) linked to cyanogen bromide-activated Sepharose 4B (Sigma). Coupling of the monoclonal to the Sepharose was performed according to the manufacturer. Efficiency of coupling was monitored using OD280 and of binding of GMCSF to immobolized antibody was tested using soluble, commercially available material.
Soluble yeast-derived material was applied to the column and allowed to flow by gravity. The column was washed with: (a) 20 volumes of 0.15M NaCl, 25 mM Tris pH 7.4 (TN) (b) 5 volumes of 50 mM Tris pH 8.0 (c) 20 volumes TN. Bound material was then eluted with 10 volumes of 0.15M NaCl, 25 mM Tris pH 2.5. Eluted material was neutralized with 1/200 volume of 1.5M Tris pH8.8. The purified material was concentrated using a Microsep 3K centrifugal devise (Pall Gelman Laboratory). Yields of chimeric protein were determined by ELISA (Endogen) according to the manufacturer's instructions.
Purified GM-CSF-K-HA
Purified GM-CSF-K-HA was analyzed by western blot. Approximately lug of GM-K-HA per lane was electrophoresed along with soluble GMCSF. For western blot, gels were transferred to Protran BA83 (Schleicher and Schuell), blocked with TBS (Tris Buffered Saline) containing 0.05% Tween 20 and 2% Nonfat Dry Milk. The blot was incubated with primary antibody (rat monoclonal anti-murine GMCSF, Endogen) at 1:5000 dilution in blocking buffer for 2 hours at room temperature. The blot was washed with TBS-0.05% Tween 20. Secondary antibody, alkaline phosphatase conjugated anti-rat IgG (Sigma) was incubated at 1:10,000 for 1 hour at room temperature.
Example 14 Decoration of Cells with GM-K-HAPurified GM-CSF-K-HA was used to decorate CMS 5 murine fibrosarcoma cells. CMS 5 cells were grown in DMEM, 10% FBS, Penicillin-streptomycin, harvested by trypsinization and washed 3 times with RPMI 1640 (Gibco). Cells were diluted to 1×106/ml in RPMI 1640 and 0.9 ml were aliquoted to siliconized tubes. Cells were incubated for 2 hours at 37° C. with shaking and then washed 3 times with PBS containing 2% FBS. Primary antibody, rat anti-murine GMCSF monoclonal, was incubated for one hour at 4° C. Cells were washed as above, treated with FITC labeled anti-rat antibody (Sigma), and incubated for one hour at 4° C. After additional washing, the cells were analyzed by flow cytometry, which confirmed the presence of GM-CSF-K-HA on the surface of the tumor cells.
Example 15 Quantitation of GM-CSF-K-HA on the Cell Surface of CMS 5 Cells After DecorationCMS 5 cells were harvested and washed as described above. 1×106 cells in 1 ml of RPMI 1640 were incubated with 1 ug of purified GM-K-HA. After incubation for 15 min, 30 min, 1 hour, or 2 hours at 4° C., room temperature, or 37° C., the cells were washed 3 times with PBS containing 2% FBS. The cell pellet was lysed with 50 microliters of PBS containing 0.15% deoxycholate and the detergent subsequently diluted by the addition of 200 microliters of PBS. The material was serially diluted with PBS and tested by ELISA (Endogen). Based on the amount of GM-CSF detected in the cell lysates, it was possible to quantitate the average number of GM-CSF molecules associated with each cell. For example, after a 15 min incubation at 4° C., 58,700 molecules were present per cell. After a 15 min incubation at room temperature, 25,700 molecules were present per cell. After a 15 min incubation at 37° C., 17,200 molecules were present per cell.
Example 16 Effective Immunization with Tumor Cells Admixed with GM-CSF/Hemagglutinin Fusion PolypeptidesCMS-5 murine fibrosarcoma cells were grown to 70% confluence in DMEM, 10% FBS, Penicillin-streptomycin, harvested by trypsinization, and washed 3 times with RPMI 1640. Viability was determined by trypan blue staining of an aliquot and the cells were then resuspended at a concentration of 4×106 cells/ml and 1 ml aliquots dispensed into siliconized microfuge tubes. The cells were incubated with 1 ug (microgram) murine GM-CSF-K-HA or 10 ng (nanograms) HA-K-murine GM-CSF per 106 cells for 3 hours at 37° C. Cells were then washed 3 times with RPMI 1640 and resuspended at 4×106 cells/ml in RPMI 1640. An aliquot of the cells was removed and the amount of cell-associated GM-CSF measured by ELISA as described above. There were approximately 20,240 and 18,000 molecules/cell in the GM-CSF-K-HA and HA-K-GM-CSF groups, respectively. Cells for a control vaccine, to be administered without a molecule of the invention (or any other immunomodulator), were prepared in parallel.
The cells were irradiated at 3500 rads from a 137Cs source. 8 week-old female Balb/c mice (which are syngeneic for CMS-5) were anesthetized by metofane inhalation and vaccinated subcutaneously in the left inguinal fold with 1×106 cells in 0.25 ml. Each mouse received cells from only one vaccine type. Seven days later, wild-type CMS-5 cells at 70% confluence were harvested and washed 3 times in HBSS. Viability was determined by trypan blue staining of an aliquot and cells were adjusted to 4×106/ml in HBSS. The previously vaccinated mice were then injected subcutaneously behind the neck, under metofane anesthesia, with 2×106 live, wild-type CMS-5 cells in 0.5 ml HBSS. The groups receiving the HA-K-GM-CSF and control vaccines each consisted of 5 mice, whereas the group receiving the GM-CSF-K-HA vaccine consisted of 4 mice because 1 mouse failed to awaken from anesthesia.
Tumor development was assessed daily by palpation and visual inspection. The observer was blinded to the vaccine received by each set of mice to ensure against bias. Mice were sacrificed by CO2 asphyxiation when tumors become unwieldy. All mice that had received the control vaccine developed tumors within 18 days after challenge with live tumor cells. In contrast, 100% of mice that had received the GM-CSF-K-HA vaccine and 60% of mice that had received the HA-K-GM-CSF vaccine remained tumor-free at the end of the experiment, 40 days after challenge. Thus, immunization with a composition comprising tumor cells and a molecule of the invention confers significantly longer tumor-free survival than immunization with a composition comprising tumor cells but not comprising a molecule of the invention.
Example 17 Cloning of Human GM-CSF-K-HA pUC19 human GM-CSF-K-HA (hGM-CSF-K-HA) is cloned starting with pUC19 GM-CSF-K-HA. pUC19 GM-CSF-K-HA. is digested with EcoRI and NgoM IV. EcoRI cuts at the 5′ end of the murine GM-CSF coding sequence and Ngo M IV cuts at the 3′ end of the murine GM-CSF molecule. The resulting plasmid with the murine GM-CSF coding region removed is purified after electrophoresis through agarose gel using a kit manufactured by Qiagen. The human GM-CSF coding segment is generated by PCR from a commercially available human cDNA library (Clontech). The human sequence begins at amino acid 18, the start of the mature protein, i.e. lacking the secretory signal sequence. The 3′ end corresponds to amino acid 144, eliminating the endogenous termination codon.
Conditions for PCR were:
PCR is performed for 20 cycles using vent polymerase.
Following PCR, the product is electrophoresed through a 1.0% agarose gel and the hGM-CSF gene is extracted from the gel using a Qiagen kit according to the manufacturer's instructions. The purified hGM-CSF DNA fragment is digested with Eco RI and NgoM IV and ligated into the pUC 19 murine GM-CSF-K-HA vector that has been digested with EcoRI and NgoM IV to remove the murine GM-CSF sequence. The DNA is used to transform E. coli AG1 and transformants are selected on LB-ampicillin plates. Plasmid DNA from individual colonies is isolated and digested with restriction enzymes to identify clone harboring a pUC19 hGM-CSF-K-HA plasmid.
The pUC19 hGM-CSF-K-HA plasmid is purified according to the manufacturer's instructions using a kit purchased from Qiagen. PCR of pUC19 hGM-CSF-K-HA is used to generate a DNA fragment encoding hGM-CSF-K-HA for cloning into a yeast expression vector. The PCR product contains Eag I cloning sites for in frame insertion into the yeast expression vector.
Conditions for PCR were:
PCR is performed for 20 cycles using vent polymerase.
Following PCR the product is electrophoresed through a 1.0% agarose gel and the hGM-CSF-K-HA gene is extracted from the gel using a Qiagen kit according to the manufacturer's instructions. The purified DNA fragment is digested with Eag I and ligated to the yeast expression vector ITK that has been digested with Eag I. The ITK vector is designed for (1) replication in E. coli and (2) expression of genes in the yeast Saccharomyces cerevisiae after stable integration using homologous recombination. The vector contains:
-
- 1. Sequences for replication of the plasmid in E. coli
- 2. Yeast Gal promoter for expression of heterologous genes in yeast grown in media containing galactose.
- 3. PrePro—Synthetic DNA sequence, optimized for secretion and signal sequence cleavage of distal genes in yeast.
- 4. Unique Eag I site for cloning genes to be expressed.
- 5. Alpha terminator—DNA sequence for efficient termination of proximal genes.
- 6. Delta sequence that allows for stable integration of the plasmid by recombination with endogenous delta sequences in the yeast chromosome.
- 7. Antibiotic resistance gene allowing for selection in E. coli with kanamycin and selection in yeast with G418.
This plasmid is used to transform E. coli strain AG-1. Transformants are selected by growth on LB plates containing 100 ug/ml kanamycin. Individual colonies are grown in LB media containing kanamycin and plasmids are purified. Restriction digests determine orientation of inserts. The resulting plasmid ITK hGM-CSF-K-HA is purified using a kit purchased from Qiagen according to the manufacturer's instructions.
The purified plasmid is linearized with Mfe 1 and used to transform the yeast strain Saccharomyces cerevisiae WDHY131 using lithium acetate (LiAc). A 10 ml culture of S. cerevisiae grown to saturation at 30° in YPD media (per liter/20 g Bactotryptone; 20 g dextrose; 10 g yeast extract) is used to inoculate 100 ml of YPD. The culture is grown at 30° with shaking for 3 hours. The yeast are harvested by centrifugation at 11,000×g for 2 minutes and resuspended in 25 ml of sterile water. The yeast are centrifuged as above and resuspended in 1.0 ml of 100 mM lithium acetate and transferred to a 1.5 ml microfuge tube. The yeast are pelleted by centrifugation at 12,000×g for 15 seconds and the supernatant removed. The cells are resuspended in 0.5 ml of 100 mM LiAc. 50 uL of cell suspension is added to individual microfuge tubes and centrifuged as above. Supernatant is removed. Transformation mix added to the yeast pellet consists of: 240 uL PEG (50% w/v); 36 uL 1.0 M LiAc; 5 uL single stranded DNA (10 mg/ml) and 1 ug of linearized ITK hGM-CSF-K-HA in 75 uL of water. The mixture is vortexed to resuspend the cell pellet and incubated at 30° for 30 minutes. The cells are then shocked at 42° for 15 minutes, centrifuged to pellet, and resuspended in 0.5 ml of YPD. Yeast are incubated in YPD media for 3 hours and plated on YPD plates containing 2 mg/ml G418. Plates are grown at 30° for 3 days until individual colonies appear.
To screen for expression of hGM-CSF-K-HA, individual colonies are grown in 1 ml of YPD media at 30° for 2 days. The cells are centrifuged at 8,000×g for 2 minutes and the YPD media removed and replaced with 1 ml of YPG media (per liter/20 g Bactotryptone; 20 g galactose; 10 g yeast extract) for induction from the gal promoter. Yeast are grown in YPG media for 2 day. An aliquot is then removed and the cells are pelleted. The supernatant is tested for hGM-CSF expression using an ELISA kit purchased from Endogen. Protocol is according to the manufacturer.
Example 18 Reduction of Metastases in a Mouse ModelB16F10 murine melanoma cells were harvested and washed three times in PBS. Cells were then suspended at 5×105 viable cells/ml in PBS, with viability determined by staining an aliquot of cells with Trypan blue. 100 ul of this suspension was injected into the tail veins of 8-10 week old female C57BL/6 mice. On day 1 or day 3 after tumor challenge, mice were immunized with 1×106 irradiated B16F10 cells subcutaneously in the left inguinal fold. Groups (3 mice each) received either cells alone, cells mixed with 1 ug soluble recombinant murine GM-CSF (Serologicals Corp.), or cells mixed with 1 ug of a multifunctional molecule of the invention comprising murine GM-CSF at the N terminus, a (Gly4Ser)2 flexible linker, and the HA1 domain of influenza A/PR/8/34 hemagglutinin at the C terminus. The latter composition comprised both free and cell-bound multifunctional molecule.
Mice were sacrificed on day 12, the thoracic cavity opened with dissecting scissors, and the lungs removed en bloc by tracheal transection. Metastases were enumerated with a hand lens. In the mice immunized 1 day after challenge, the average number of metastases/mouse was as follows:
In the mice immunized 3 days after challenge, the average number of metastases/mouse was as follows:
Thus, administration of the composition comprising a multifunctional molecule of the invention was able to effectively reduce metastases and treat disease.
Example 19 GM-CSF-HA1-Mediated Protection Against Tumor Challenge In VivoAs an allogeneic tumor vaccine model, C57BL/6 mice (haplotype b) were immunized with C3H (haplotype k)-derived K1735 melanoma cells, followed by challenge with C57BL/6-derived B16F10 melanoma cells. K1735 cells were grown to 70% confluence in DMEM with 10% FBS and penicillin-streptomycin, harvested by trypsinization, and washed 3 times with RPMI 1640. Viability was determined by trypan blue staining of an aliquot and the cells were then resuspended at a concentration of 4×106 cells/ml for K1735. One ml aliquots were then dispensed into siliconized microfuge tubes. The cells were incubated with 1 ug mGM-CSF-HA1 (a fusion polypeptide consisting of murine GM-CSF at the N terminus, a (Gly4Ser)2 linker, and the HA1 domain of influenza AIPR/8/34) per 106 cells for 2 hours at 4° C. An aliquot of the cells was removed for measurement of cell-associated GM-CSF by ELISA. Mean cell-associated GM-CSF across two experiments was approximately 60,000. Cells that were not admixed with any polypeptide and, in one experiment, cells mixed with 1 ug soluble murine GM-CSF (Serologicals Corp.) were prepared in parallel as control vaccines.
The cells were irradiated at 3500 rads from a 137CS source. 8 week-old female C57BL/6 mice were anesthetized by metofane inhalation and vaccinated subcutaneously in the left inguinal fold with or 1×106 cells in 0.25 ml RPMI, along with a total of 1 ug GM-CSF-HA1 (including bound and free fusion polypeptide). Each mouse received cells from only one vaccine type. Seven days later, B16F10 cells, as appropriate, at 70% confluence were harvested and washed 3 times in HBSS. Viability was determined by trypan blue staining of an aliquot and cells were adjusted in HBSS to 1×105/ml. The previously vaccinated mice were then challenged subcutaneously behind the neck, under metofane anesthesia, with 0.5 ml of the B16F10 cell suspension.
Tumor development was assessed daily by palpation and visual inspection. “Onset” was defined as the first day on which a tumor mass was both palpable and visible. The observer was blinded to the vaccine received by each set of mice to ensure against bias. Mice were sacrificed by CO2 asphyxiation when tumors become unwieldy. Experiments were terminated 70 days after tumor challenge, as planned in advance.
In pooled results from two experiments, 70 days after challenge, 7/10 mice that had been vaccinated with cells admixed with fusion polypeptide remained tumor-free. In contrast, 10/10 mice that had been vaccinated with cells alone developed tumors, as did 4/5 mice vaccinated with cells admixed with soluble murine GM-CSF.
Other Embodiments
The foregoing examples demonstrate experiments performed and contemplated by the present inventors in making and carrying out the invention. It is believed that these examples include a disclosure of techniques which serve to both apprise the art of the practice of the invention and to demonstrate its usefulness. It will be appreciated by those of skill in the art that the techniques and embodiments disclosed herein are preferred embodiments only that in general numerous equivalent methods and techniques may be employed to achieve the same result.
All of the references identified hereinabove, are hereby expressly incorporated herein by reference to the extent that they describe, set forth, provide a basis for or enable compositions and/or methods which may be important to the practice of one or more embodiments of the present inventions.
Appendix I
- 4: BC025704 Homo sapiens, leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5, clone MGC:34418 IMAGE:5223581, mRNA, complete cds
gi|19344005|gb|BC025704.1|[19344005] - 5: BC025713 Homo sapiens, T-cell receptor interacting molecule, clone MGC:34314 IMAGE:5227396, mRNA, complete cds
gi|19343996|gb|BC025713.1|[19343996] - 6: BC025722 Homo sapiens, adenosine A2b receptor, clone MGC:34640 IMAGE:5198898, mRNA, complete cds
gi|19343938|gb|BC025722.1|[19343938] - 7: BC025717 Homo sapiens, chemokine (C-C motif) receptor-like 2, clone MGC:34104 IMAGE:5228561, mRNA, complete cds
gi|19343936|gb|BC025717.1|[19343936] - 8: BC025695 Homo sapiens, endothelial differentiation, lysophosphatidic acid
G-protein-coupled receptor, 4, clone MGC:34227 IMAGE:5209267, mRNA, complete cds
gi|19343926|gb|BC025695.1|[19343926] - 9: BC025727 Homo sapiens, Similar to T cell receptor alpha locus, clone MGC:34712 IMAGE:5201547, mRNA, complete cds
gi|19343616|gb|BC025727.1|[19343616] - 10: BC025691 Homo sapiens, interleukin 2 receptor, beta, clone MGC:34584 IMAGE:5207833, mRNA, complete cds
gi|19343610|gb|BC025691.1|[19343610] - 11: AF474992 Homo sapiens G protein-coupled receptor SNSR6 gene, complete cds
gi|19338917|gb|AF474992.1|[19338917] - 12: AF474991 Homo sapiens G protein-coupled receptor SNSR5 gene, complete cds
gi|19338915|gb|AF474991.1|[19338915] - 13: AF474990 Homo sapiens G protein-coupled receptor SNSR4 gene, complete cds
gi|19338913|gb|AF474990.1|[19338913] - 14: AF474989 Homo sapiens G protein-coupled receptor SNSR3 gene, complete cds
gi|19338911|gb|AF474989.1|[19338911] - 15: AF474988 Homo sapiens G protein-coupled receptor SNSR2 gene, complete cds
gi|19338909|gb|AF474988.1|[19338909] - 71: AF453877 Homo sapiens neuronal nicotinic receptor beta 4 subunit precursor, gene, exon 1 and partial cds
gi|18042122|gb|AF453877.1|[18042122] - 73: U62556 Homo sapiens chemokine receptor-like protein (TER1) gene, complete cds
gi|1468978|gb|U62556.1|HSU62556[1468978] - 74: AF449218 Homo sapiens 43 kDa acetylcholine receptor-associated protein (RAPSN) mRNA, complete cds
gi|19310212|gb|AF449218.1|[19310212] - 84: AJ437349 Homo sapiens partial mRNA for T-cell receptor beta chain (V14-D-J-C) (TCRB gene), clone 11
gi|19262919|emb|AJ437349.1|HSA437349[19262919] - 85: AJ011371 Homo sapiens mRNA for serotonin 4 receptor, splice variant h5-HT4(e)
gi|3646277|emb|AJ011371.1|HSAJ1371[3646277] - 88: BC025294 Homo sapiens, Similar to toll-like receptor 4, clone IMAGE:4868078, mRNA
gi|19263693|gb|BC025294.1|[19263693] - 89: BM875542 ij54d02.y1 Human insulinoma Homo sapiens cDNA clone IMAGE:5634842 5′ similar to TR:O00559 O00559 RECEPTOR-BINDING CANCER ANTIGEN EXPRESSED ON SISO CELLS;, mRNA sequence
gi|19243208|gb|BM875542.1|BM875542[19243208] - 99: AY059419 Homo sapiens killer-cell immunoglobulin-like receptor (KIR3DL1) mRNA, KIR3DL1*011 allele, partial cds
gi|19224338|gb|AY059419.1|[19224338] - 100: AY059418 Homo sapiens killer-cell immunoglobulin-like receptor (KIR3DL2) mRNA, KIR3DL2*010 allele, partial cds
gi|19224336|gb|AY059418.1|[19224336] - 101: AY059417 Homo sapiens killer-cell immunoglobulin-like receptor KIR3DL1/2v mRNA, partial cds
gi|19224334|gb|AY059417.1|[19224334] - 102: AY059420 Homo sapiens killer-cell immunoglobulin-like receptor (KIR3DL2) mRNA, KIR3DL2*012 allele, partial cds
gi|19224332|gb|AY059420.1|[19224332] - 103: AC079385 Homo sapiens 12q BAC RP11-482D24 (Roswell Park Cancer Institute Human BAC Library) complete sequence
gi|14670063|gb|AC079385.18|[14670063] - 104: AC078889 Homo sapiens 12q BAC RP11-33512 (Roswell Park Cancer Institute Human BAC Library) complete sequence
gi|11072039|gb|AC078889.20|[11072039] - 105: AC010168 Homo sapiens 12 p12-31.7-32.2 BAC RP11-174G6 (Rosewell Park Cancer Institute Human Bac Library) complete sequence
gi|6855156|gb|AC010168.61[6855156] - 106: U14188 Homo sapiens LERK-4 (EPLG4) mRNA, complete cds
gi|642834|gb|U14188.1|HSU14188[642834] - 107: U14187 Homo sapiens LERK-3 (EPLG3) mRNA, complete cds
gi|642832|gb|U14187.1|HSU14187[642832] - 108: U15637 Homo sapiens CD40 binding protein (CD40BP) mRNA, complete cds
gi|595910|gb|U15637.1|HSU15637[595910] - 109; AF262304 Homo sapiens clone 6 CC chemokine receptor 3-like mRNA, partial sequence, alternatively spliced
gi|19171650|gb|AF262304.1|[19171650] - 110: AF262303 Homo sapiens clone 6 CC chemokine receptor 3 (CCR3) mRNA, partial cds
gi|19171648|gb|AF262303.1|[19171648] - 111: AF262302 Homo sapiens clone 5 CC chemokine receptor 3 (CCR3) mRNA, partial cds
gi|19171646|gb|AF262302.1|[19171646] - 112: AF262301 Homo sapiens clone 4 CC chemokine receptor 3 (CCR3) mRNA, partial cds
gi|19171644|gb|AF262301.1|[19171644] - 113: AF262300 Homo sapiens clone 2 CC chemokine receptor 3 (CCR3) mRNA, partial cds
gi|19171642|gb|AF262300.1|[19171642] - 114: AF262299 Homo sapiens clone 1 CC chemokine receptor 3 (CCR3) mRNA, partial cds
gi|19171640|gb|AF262299.1|[19171640] - 118: AF247361 Homo sapiens CC chemokine receptor 3 (CCR3) gene, complete cds
gi|19110542|gb|AF247361.1|[19110542] - 122: AF416619 Homo sapiens prolactin receptor short isoform 1a (PRLR) mRNA, complete cds, alternatively spliced
gi|16506717|gb|AF416619.1|[16506717] - 123: AF416618 Homo sapiens prolactin receptor short isoform 1b (PRLR) mRNA, complete cds, alternatively spliced
gi|16506715|gb|AF416618.1|[16506715] - 125: AJ303165 Homo sapiens partial gene for putative transmembrane receptor
gi|13162199|emb|AJ303165.1|HSA303165[13162199] - 126: NM—017451 Homo sapiens BA11-associated protein 2 (BAIAP2) transcript variant 2, mRNA
gi|9257198|ref|NM—017451.1|[9257198] - 127: NM—017450 Homo sapiens BA11-associated protein 2 (BAIAP2) transcript variant 1, mRNA
gi|9257196|ref|NM—017450.1|[9257196] - 128: NM—006340 Homo sapiens BA11-associated protein 2 (BAIAP2) transcript variant 3, mRNA
gi|5453564|ref|NM—006340.1|[5453564] - 131: AF350881 Homo sapiens channel kinase 2 (CHAK2) mRNA, complete cds
gi|18860923|gb|AF350881.2|[18860923] - 132: AF022044 Homo sapiens natural killer cell receptor KIR3D51 variant mRNA, complete cds
gi|2760894|gb|AF022044.1|[2760894] - 133: AF034773 Homo sapiens natural killer cell inhibitory receptor (KIR2DL4) mRNA, variant 3, complete cds
gi|2739181|gb|AF034773.1|[2739181] - 134: AF034772 Homo sapiens natural killer cell inhibitory receptor (KIR2DL4) mRNA, variant 2, complete cds
gi|2739179|gb|AF034772.1|[2739179] - 135: AF034771 Homo sapiens natural killer cell inhibitory receptor (KIR2DL4) mRNA, variant 1, complete cds
gi|2739177|gb|AF034771.1|[2739177] - 136: AF022047 Homo sapiens natural killer cell inhibitory receptor KIR2D53 variant mRNA, complete cds
gi|2738966|gb|AF022047.1|[2738966] - 137: AF022046 Homo sapiens natural killer cell inhibitory receptor KIR2D51 variant mRNA, complete cds
gi|2738964|gb|AF022046.1|[2738964] - 138: AF022045 Homo sapiens natural killer cell receptor KIR2DL1 variant mRNA, complete cds
gi|2738962|gb|AF022045.1|[2738962] - 139: U56255 Homo sapiens CW-1 mRNA, complete cds
gi|1399688|gb|U56255.1|HSU56255[1399688] - 140: AJ422056 Homo sapiens partial GRM5 gene for metabotrophic glutamate receptor, exon 1A
gi|19069804|emb|AJ422056.1|HSA422056[19069804] - 141: AY028912 Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 7 and complete cds, alternatively spliced
gi|19067944|gb|AY028912.1|AY028906S7[19067944] - 142: AY028911 Homo sapiens ectodysplasin A receptor associated death domain (ED.hD)T ene, exon 6
gi|19067943|gb|AY028911.1|AY028906S6[19067943] - 143: AY028910 Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 5
gi|19067942|gb|AY028910.1|AY028906S5[19067942] - 144: AY028909 Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 4
gi|19067941|gb|AY028909.1|AY028906S4[19067941] - 145: AY028908 Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 3
gi|19067940|gb|AY028908.1|AY028906S3[19067940] - 146: AY028907 Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 2
gi|19067939|gb|AY028907.1|AY028906S2[19067939] - 147: AY028906 Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 1
gi|9067938|gb|AY028906.1|AY028906S1[19067938] - 148: AH010677 Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, complete cds, alternatively spliced
gi|19067937|gb|AH010677.1|SEG_AY028906S[19067937] - 149: AY028913 Homo sapiens ectodysplasia A receptor associated death domain A (EDARADD) mRNA, complete cds; alternatively spliced
gi|19067935|gb|AY028913.1|[19067935] - 150: BM735809 06E08 Canine Brain cDNA Library Canis familiaris cDNA 5′ similar to Homo sapiens glycine receptor, beta, mRNA sequence
gi|19057142|gb|BM735809.1|BM735809[19057142] - 151: BM735756 06A09 Canine Brain cDNA Library Canis familiaris cDNA 5′ similar to Homo sapiens glycine receptor, beta subunit, mRNA sequence
gi|19057089|gb|BM735756.1|BM735756[19057089] - 152: BM735711 10E11 Canine Brain cDNA Library Canis familiaris cDNA 5′ similar to Homo sapiens protein tyrosine phosphatase, receptor-type, Z polypeptide 1, mRNA sequence
gi|19057044|gb|BM735711.1|BM735711[19057044] - 155: AC007165 Homo sapiens BAC clone RP11-451C2 from 2, complete sequence
gi|19033999|gb|AC007165.4|[19033999] - 156: AF245699 Homo sapiens type 1 angiotensin II receptor (AGTR1) gene, complete cds
gi|7862074|gb|AF245699.1|[7862074] - 157: BC024229 Homo sapiens, prostaglandin E receptor 3 (subtype EP3), clone MGC:27302 IMAGE:4660371, mRNA, complete cds
gi|18999476|gb|BC024229.1|[18999476] - 176: AJ417555 Homo sapiens partial mRNA for killer cell immunoglobulin receptor (KIR2D54 gene), strain 4053
gi|18958228|emb|AJ417555.1|HSA417555[18958228] - 177: AJ417554 Homo sapiens partial mRNA for killer cell immunoglobulin receptor (KIR2D54 gene), strain 3321
gi|18958226|emb|AJ417554.1|HSA417554[18958226] - 179: NM—003877 Homo sapiens STAT induced STAT inhibitor-2 (STAT12), mRNA
gi|18921206|ref|NM—003877.2|[18921206] - 180: NM—017662 Homo sapiens transient receptor potential cation channel, subfamily M, member 6(TRPM6), mRNA
gi|18921092|ref|NM—017662.3|[18921092] - 191: NM—016148 Homo sapiens SH3 and multiple ankyrin repeat domains 1 (SHANK1), mRNA
gi|11968151|ref|NM—016148.1|[11968151] - 193: NM—017729 Homo sapiens epidermal growth factor receptor pathway substrate 8 related protein 1 (EPS8R1), mRNA
gi|8923231|ref|NM—017729.1|[8923231] - 195: M13824 Homo sapiens T cell receptor gamma chain variable region (TCRG) gene, partial cds
gi|339169|gb|M13824.1|HUMTCGXL[339169] - 196: M12960 Homo sapiens T-cell receptor gamma-chain J1, partial cds
gi|339144|gb|M12960.1|HUMTCGJB[339144] - 197: M13823 Homo sapiens T cell receptor gamma chain (TCRG) gene, partial cds
gi|292736|gb|M13823.1|HUMTCGXK[292736] - 198: L12398 Homo sapiens dopamine receptor D4 (DRD4) mRNA, complete cds
gi|291945|gb|L12398.1|HUMD4C[291945] - 199: M86383 Homo sapiens nicotinic acetylcholine receptor alpha 3 subunit precursor, mRNA, complete cds
gi|177897|gb|M86383.1|HUMA3NARSP[177897] - 202: NM—012245 Homo sapiens SKI-interacting protein (SNW1), mRNA
gi|18860912|ref|NM—012245.2|[18860912] - 203: NM—006750 Homo sapiens syntrophin, beta 2 (dystrophin-associated protein A1, 59 kD, basiccomponent 2) (SNTB2), transcript variant 1, mRNA
gi|18860911|ref|NM—006750.2|[18860911] - 204: NM—130845 Homo sapiens syntrophin, beta 2 (dystrophin-associated protein A1, 59 kD, basic component 2) (SNTB2), transcript variant 2, mRNA
gi|18860909|ref|NM—130845.1|[18860909] - 205: NM—002846 Homo sapiens protein tyrosine phosphatase, receptor type, N (PTPRN), mRNA
gi|18860905|ref|NM—002846.2|[18860905] - 206: NM—002845 Homo sapiens protein tyrosine phosphatase, receptor type, M (PTPRM), mRNA
gi|18860903|ref|NM—002845.2|[18860903] - 207: NM—002844 Homo sapiens protein tyrosine phosphatase, receptor type, K (PTPRK), mRNA
gi|18860901|ref|NM—002844.2|[18860901] - 208: NM—002843 Homo sapiens protein tyrosine phosphatase, receptor type, J (PTPRJ), mRNA
gi|18860899|ref|NM—002843.2|[18860899] - 209: NM—002841 Homo sapiens protein tyrosine phosphatase, receptor type, G (PTPRG), mRNA
gi|18860897|ref|NM—002841.2|[18860897] - 210: NM—130440 Homo sapiens protein tyrosine phosphatase, receptor type, F (PTPRF), transcript variant 2, mRNA
gi|18860895|ref|NM—130440.1|[18860895] - 211: NM—130393 Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript variant 4, mRNA
gi|18860893|ref|NM—130393.1|[18860893] - 212: NM—130392 Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript variant 3, mRNA
gi|18860891|ref|NM—130392.1|[18860891] - 213: NM—130391 Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript variant 2, mRNA
gi|18860889|ref|NM—130391.1|[18860889] - 214: NM—003682 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 4, mRNA
gi|18860876|ref|NM—003682.2|[18860876] - 215: NM—130476 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 8, mRNA
gi|18860874|ref|NM—130476.1|[18860874] - 216: NM—130475 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 7,
mRNA
gi|18860872|ref|NM—130475.1|[18860872] - 217: NM—002840 Homo sapiens protein tyrosine phosphatase, receptor type, F (PTPRF), transcript variant 1, mRNA
gi|18860871|ref|NM—002840.2|[18860871] - 218: NM—130474 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 6, mRNA
gi|18860869|ref|NM—130474.1|[18860869] - 219: NM—130473 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 5, mRNA
gi|18860867|ref|NM—130473.1|[18860867] - 220: NM—130472 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 3, mRNA
gi|18860865|ref|NM—130472.1|[18860865] - 221: NM—130471 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 2, mRNA
gi|18860863|ref|NM—130471.1|[18860863] - 222: NM—130470 Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 1, mRNA
gi|18860861|ref|NM—130470.1|[18860861] - 223: NM—006504 Homo sapiens protein tyrosine phosphatase, receptor type, E (PTPRE), transcript variant 1, mRNA
gi|18860861|ref|NM—006504.2|[18860860] - 224: NM—130435 Homo sapiens protein tyrosine phosphatase, receptor type, E (PTPRE), transcript variant 2, mRNA
gi|18860858|ref|NM—130435.1|[18860858] - 225: AJ431177 Homo sapiens mRNA for WIRE protein
gi|18857713|emb|AJ431177.1|HSA431177[18857713] - 226: NM—006474 Homo sapiens lung type-I cell membrane-associated glycoprotein (T1A-2), mRNA
gi|18767663|ref|NM—006474.2|[18767663] - 228: NM—006794 Homo sapiens G protein-coupled receptor 75 (GPR75), mRNA
gi|5803024|ref|NM—006794.1|[5803024] - 229: NM—002842 Homo sapiens protein tyrosine phosphatase, receptor type, H (PTPRH), mRNA
gi|4506312|ref|NM—002842.1|[4506312] - 230: NM—002839 Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript variant 1, mRNA
gi|4506308|ref|NM—002839.1|[4506308] - 231: BC024145 Homo sapiens, TNF receptor-associated factor 1, clone MGC:10353 IMAGE:3832475, mRNA, complete cds
gi|18848176|gb|BC024145.1|[18848176] - 232: AF469756 Homo sapiens clone S9 interleukin-1 receptor type I (IL1R1) gene, partial sequence
gi|18846656|gb|AF469756.1|[18846656] - 233: AF469755 Homo sapiens clone S8 interleukin-1 receptor type I (IL1R1) gene, partial sequence
gi|18846655|gb|AF469755.1|[18846655] - 234: AF469754 Homo sapiens clone S7 interleukin-1 receptor type I (IL1R1) gene, partial
sequence
gi|18845036|gb|AF469754.1|[18845036] - 237: AF416711 Homo sapiens Fc-gamma receptor IIc5 mRNA, partial cds
gi|18765992|gb|AF416711.1|[18765992] - 238: NM—023068 Homo sapiens sialoadhesin (SN), mRNA
gi|18765743|ref|NM—023068.2|[18765743] - 239: NM—004782 Homo sapiens synaptosomal-associated protein, 29 kD (SNAP29), mRNA
gi|18765736|ref|NM—004782.2|[18765736] - 240: NM—130798 Homo sapiens synaptosomal-associated protein, 23 kD (SNAP23), transcript variant 2, mRNA
gi|18765730|ref|NM—130798.1|[18765730] - 241: NM—003825 Homo sapiens synaptosomal-associated protein, 23 kD (SNAP23), transcript variant 1, mRNA
gi|18765728|ref|NM—003825.2|[18765728] - 245: AF439409 Homo sapiens G-protein-coupled receptor kinase 7 (GRK7) mRNA, GRK7-S allele, complete cds
gi|17933258|gb|AF439409.1|[17933258] - 246: NM—032211 Homo sapiens lysyl oxidase-like 4 (LOXL4), mRNA
gi|16933522|ref|NM—032211.4|[16933522] - 247: AF411122 Homo sapiens importin 4 mRNA, complete cds
gi|18700634|gb|AF411122.1|[18700634] - 289: NM—130441 Homo sapiens C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 11 (CLECSF11), mRNA
gi|18466805|ref|NM—130441.1|[18466805] - 290: NM—030876 Homo sapiens olfactory receptor, family 5, subfamily V, member 1 (OR5V1), mRNA
gi|14495550|ref|NM—030876.2|[14495550] - 291: NM—032732 Homo sapiens hypothetical protein MGC10763 (IL17RL), mRNA
gi|14249349|ref|NM—032732.1|[14249349] - 292: NM—030959 Homo sapiens olfactory receptor, family 12, subfamily D, member 3 (OR12D3), mRNA
gi|13624334|ref|NM—030959.1|[13624334] - 294: NM—018844 Homo sapiens B-cell receptor-associated protein BAP29 (BAP29), mRNA
gi|9994198|ref|NM—018844.1|[9994198] - 295: NM—002825 Homo sapiens pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1) (PTN), mRNA
gi|18656935|ref|NM—002825.2|[18656935] - 299: NM—016372 Homo sapiens seven transmembrane domain orphan receptor (TPRA40), mRNA
gi|7705964|ref|NM—016372.1|[7705964] - 300: NM—014288 Homo sapiens integrin beta 3 binding protein (beta3-endonexin) (ITGB3BP), mRNA
gi|7657205|ref|NM—014288.1|[7657205] - 301: L43588 Homo sapiens T cell antigen receptor mRNA, partial cds
gi|18654191|gb|L43588.1|HUMTCARF[18654191] - 318: U77589 Homo sapiens MHC class II HLA-DQ-alpha chain (HLA-DQA1) mRNA, HLA-DQA1*0104 allele, complete cds
gi|1916744|gb|U77589.1|HSU77589[1916744] - 319: AF410465 Homo sapiens importin 9 mRNA, complete cds
gi|15529702|gb|AF410465.1|[15529702] - 320: AF332759 Homo sapiens partially duplicated CHRNA7 gene, hybrid intron A/4 and partial exon 5
gi|13345792|gb|AF332759.1|[13345792] - 321: AF332758 Homo sapiens alpha-7 nicotinic cholinergic receptor subunit (CHRNA7) gene, partial intron 4 and partial cds
gi|13345790|gb|AF332758.1|[13345790] - 322: NM—003744 Homo sapiens numb homolog (Drosophila) (NUMB), mRNA
gi|18644887|ref|NM—003744.2|[18644887] - 323: NM—003681 Homo sapiens pyridoxal (pyridoxine, vitamin B6) kinase (PDXK), mRNA
gi|18644884|ref|NM—003681.2|[18644884] - 324: NM—080706 Homo sapiens transient receptor potential cation channel, subfamily V, member 1(TRPV1), transcript variant 3, mRNA
gi|18375670|ref|NM—080706.1|[18375670] - 325: NM—080705 Homo sapiens transient receptor potential cation channel, subfamily V, member 1(TRPV1), transcript variant 4, mRNA
gi|18375668|ref|NM—080705.1|[18375668] - 326: NM—080704 Homo sapiens transient receptor potential cation channel, subfamily V, member 1(TRPV1), transcript variant 1, mRNA
gi|18375666|ref|NM—080704.1|[18375666] - 327: NM—018727 Homo sapiens transient receptor potential cation channel, subfamily V, member 1(TRPV1), transcript variant 2, mRNA
gi|18375664|ref|NM—018727.3|[18375664] - 328: NM—080819
Homo sapiens G protein-coupled receptor 78 (GPR78), mRNA
gi|18201873|ref|NM—080819.1|[18201873] - 329: NM—080738
Homo sapiens EDAR-associated death domain (EDARADD), mRNA
gi|18152768|ref|NM—080738.1|[18152768] - 330: NM—080491 Homo sapiens GRB2-associated binding protein 2 (GAB2), transcript variant 1, mRNA
gi|18105041|ref|NM—080491.1|[18105041] - 331: NM—012296 Homo sapiens GRB2-associated binding protein 2 (GAB2), transcript variant 2, mRNA
gi|18105040|ref|NM—012296.2|[18105040] - 332: NM—032027 Homo sapiens beta-amyloid binding protein precursor (BBP), mRNA
gi|17738309|ref|NM—032027.2|[17738309] - 333: NM—057159 Homo sapiens endothelial differentiation, lysophosphatidic acid
G-protein-coupled receptor, 2 (EDG2), transcript variant 2, mRNA
gi|16950637|ref|NM—057159.1|[16950637] - 334: NM—001401 Homo sapiens endothelial differentiation, lysophosphatidic acid
G-protein-coupled receptor, 2 (EDG2), transcript variant 1, mRNA
gi|16950635|ref|NM—001401.2|[16950635] - 335: NM—007070 Homo sapiens FKBP-associated protein (FAP48), transcript variant 2, mRNA
gi|16933538|ref|NM—007070.2|[16933538] - 336: NM—053274 Homo sapiens FKBP-associated protein (FAP48), transcript variant 1, mRNA
gi|16933536|ref|NM—053274.1|[16933536] - 337: NM—003726 Homo sapiens src family associated phosphoprotein 1 (SCAP1), mRNA
gi|16753209|ref|NM—003726.2|[16753209] - 338: NM—033632 Homo sapiens F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila) (FBXW7), transcript variant 1, mRNA
gi|16117780|ref|NM—033632.1|[16117780] - 339: NM—018315 Homo sapiens F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila) (FBXW7), transcript variant 2, mRNA
gi|16117778|ref|NM—018315.2|[16117778] - 340: NM—021203 Homo sapiens APMCF1 protein (APMCF1), mRNA
gi|14917112|ref|NM—021203.2|[14917112] - 341: NM—002927 Homo sapiens regulator of G-protein signalling 13 (RGS13), mRNA
gi|14589857|ref|NM—002927.2|[14589857] - 344: NM—020167 Homo sapiens neuromedin U receptor 2 (NMU2R), mRNA
gi|9910461|ref|NM—020167.1|[9910461] - 346: AF190052 Homo sapiens interleukin 1 receptor type I (IL1R1) gene, exon 1C sequence
gi|9719300|gb|AF190052.1|[9719300] - 347: NM—018965 Homo sapiens triggering receptor expressed on myeloid cells 2 (TREM2), mRNA
gi|9507202|ref|NM—018965.1|[9507202] - 348: NM—018643 Homo sapiens triggering receptor expressed on myeloid cells 1 (TREM1), mRNA
gi|8924261|ref|NM—018643.1|[8924261] - 349: NM—018647 Homo sapiens tumor necrosis factor receptor superfamily, member 19 (TNFRSF19), mRNA
gi|8924251|ref|NM—018647.1|[8924251] - 350: NM—018695 Homo sapiens erbb2 interacting protein (ERBB2IP), mRNA
gi|8923908|ref|NM—018695.1|[8923908] - 351: NM—017636 Homo sapiens transient receptor potential cation channel, subfamily M, member 4(TRPM4), mRNA
gi|8923048|ref|NM—017636.1|[8923048] - 353: NM—016559 Homo sapiens PXR2b protein (PXR2b), mRNA
gi|7706670|ref|NM—016559.1|[7706670] - 354: NM—016382 Homo sapiens natural killer cell receptor 2B4 (CD244), mRNA
gi|7706528|ref|NM—016382.1|[7706528] - 357: NM—015986 Homo sapiens cytokine receptor-like factor 3 (CRLF3), mRNA
gi|7705331|ref|NM—015986.1|[7705331] - 358: NM—014815 Homo sapiens KIAA0130 gene product (KIAA0130), mRNA
gi|7661929|ref|NM—014815.1|[7661929] - 359: NM—014053 Homo sapiens FLVCR protein (FLVCR), mRNA
gi|7661707|ref|NM—014053.1|[7661707] - 360: NM—014478 Homo sapiens calcitonin gene-related peptide-receptor component protein
(CGRP-RCP), mRNA
gi|7656976|ref|NM—014478.1|[7656976] - 361: NM—012470 Homo sapiens transportin-SR (TRN-SR), mRNA
gi|6912733|ref|NM—012470.1|[6912733] - 362: NM—007357 Homo sapiens low density lipoprotein receptor defect C complementing (LDLC), mRNA
gi|6678675|ref|NM—007357.1|[6678675] - 366: NM—005162 Homo sapiens angiotensin receptor-like 2 (AGTRL2), mRNA
gi|6031157|ref|NM—005162.2|[6031157] - 367: NM—005501 Homo sapiens integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) (ITGA3), transcript variant b, mRNA
gi|6006010|ref|NM—005501.1|[6006010] - 370: NM—007053 Homo sapiens natural killer cell receptor, immunoglobulin superfamily member (BY55), mRNA
gi|5901909|ref|NM—007053.1|[5901909] - 371: NM—006653 Homo sapiens suc1-associated neurotrophic factor target 2 (FGFR signalling adaptor) (SNT-2), mRNA
gi|5730058|ref|NM—006653.1|[5730058] - 374: NM—005761 Homo sapiens plexin C1 (PLXNC1), mRNA
gi|5032222|ref|NM—005761.1|[5032222] - 375: NM—005866 Homo sapiens sigma receptor (SR31747 binding protein 1) (SR-BP1), mRNA
gi|5032116|ref|NM—005866.1|[5032116] - 377: NM—005506 Homo sapiens CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane protein II) (CD36L2), mRNA
gi|5031630|ref|NM—005506.1|[5031630] - 379: NM—004799 Homo sapiens MAD, mothers against decapentaplegic homolog (Drosophila) interacting protein, receptor activation anchor (MADHIP), transcript variant 3, mRNA
gi|4759059|ref|NM—004799.1|[4759059] - 380: NM—004292 Homo sapiens ras inhibitor (RIN1), mRNA
gi|4759039|ref|NM—004292.1|[4759039] - 381: NM—004828 Homo sapiens lymphocyte antigen 95 (activating NK-receptor; NK-p44) (LY95), mRNA
gi|4758693|ref|NM—004828.1|[4758693] - 382: NM—004767 Homo sapiens endothelin type b receptor-like protein 2 (ET(B)R-LP-2), mRNA
gi|4758309|ref|NM—004767.1|[4758309] - 383: NM—004440 Homo sapiens EphA7 (EPHA7), mRNA
gi|4758281|ref|NM—004440.1|[4758281] - 384: NM—003999 Homo sapiens oncostatin M receptor (OSMR), mRNA
gi|4557039|ref|NM—003999.1|[4557039] - 386: NM—003305 Homo sapiens transient receptor potential cation channel, subfamily C, member 3(TRPC3), mRNA
gi|4507686|ref|NM—003305.1|[4507686] - 388: NM—003626 Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 (PPFIA1), mRNA
gi|4505982|ref|NM—003626.1|[4505982] - 389: NM—003876 Homo sapiens putative receptor protein (PMI), mRNA
gi|4505900|ref|NM—003876.1|[4505900] - 390: NM—003559 Homo sapiens phosphatidylinositol-4-phosphate 5-kinase, type II, beta (PIP5K2B), mRNA
gi|4505818|ref|NM—003559.1|[4505818] - 391: NM—003629 Homo sapiens phosphoinositide-3-kinase, regulatory subunit, polypeptide 3 (p55, gamma) (PIK3R3), mRNA
gi|4505804|ref|NM—003629.1|[4505804] - 392: NM—003676 Homo sapiens degenerative spermatocyte homolog, lipid desaturase (Drosophila) (DEGS), mRNA
gi|4505192|ref|NM—003676.1|[4505192] - 393: NM—002270 Homo sapiens karyopherin (importin) beta 2 (KPNB2), mRNA
gi|4504906|ref|NM—002270.1|[4504906] - 394: NM—002204 Homo sapiens integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) (ITGA3), transcript variant a, mRNA
gi|4504746|ref|NM—002204.1|[4504746] - 395: NM—001560 Homo sapiens interleukin 13 receptor, alpha 1 (IL13RA1), mRNA
gi|4504646|ref|NM—001560.1|[4504646] - 396: NM—000842 Homo sapiens glutamate receptor, metabotropic 5 (GRM5), mRNA
gi|4504142|ref|NM—000842.1|[4504142] - 397: NM—001883 Homo sapiens corticotropin releasing hormone receptor 2 (CRHR2), mRNA
gi|4503044|ref|NM—001883.1|[4503044] - 398: NM—001873 Homo sapiens carboxypeptidase E (CPE), mRNA
gi|4503008|ref|NM—001873.1|[4503008] - 400: L29395 Homo sapiens v-erbB-related protein gene, partial cds
gi|459807|gb|L29395.1|HUMERBB[459807] - 401: L08584 Homo sapiens T cell receptor beta chain (TCRB) mRNA, partial cds
gi|307497|gb|L08584.1|HUMTCVB7A[307497] - 403: NM—015638 Homo sapiens chromosome 20 open reading frame 188 (C20orf188), mRNA
gi|18158415|ref|NM—015638.1|[18158415] - 405: NM—054032 Homo sapiens G protein-coupled receptor MRGX4 (MRGX4), mRNA
gi|16876454|ref|NM—054032.1|[16876454] - 406: NM—054031 Homo sapiens G protein-coupled receptor MRGX3 (MRGX3), mRNA
gi|16876452|ref|NM—054031.1|[16876452] - 407: NM—054030 Homo sapiens G protein-coupled receptor MRGX2 (MRGX2), mRNA
gi|16876450|ref|NM—054030.1|[16876450] - 408: NM—052931 Homo sapiens activating NK receptor (KALI), mRNA
gi|16418406|ref|NM—052931.1|[16418406] - 409: NM—032871 Homo sapiens tumor necrosis factor receptor superfamily, member 19-like (TNFRSF19L), mRNA
gi|14249611|ref|NM—032871.1|[14249611] - 410: NM—032553 Homo sapiens putative purinergic receptor (FKSG79), mRNA
gi|14211848|ref|NM—032553.1|[14211848] - 411: NM—025179 Homo sapiens plexin A2 (PLXNA2), mRNA
gi|13378152|ref|NM—025179.1|[13378152] - 413: NM—021249 Homo sapiens sorting nexin 6 (SNX6), mRNA
gi|13027619|ref|NM—021249.1|[13027619] - 414: NM—014045 Homo sapiens DKFZP564C1940 protein (DKFZP564C1940), mRNA
gi|13027587|ref|NM—014045.1|[13027587] - 415: NM—080923 Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript variant 4, mRNA
gi|18641365|ref|NM—080923.1|[18641365] - 416: NM—080922 Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript variant 3, mRNA
gi|18641363|ref|NM—080922.1|[18641363] - 417: NM—080921 Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript variant 2, mRNA
gi|18641361|ref|NM—080921.1|[18641361] - 418: NM—130386 Homo sapiens collectin sub-family member 12 (COLEC12), transcript variant I, mRNA
gi|18641359|ref|NM—130386.1|[18641359] - 419: NM—030781 Homo sapiens collectin sub-family member 12 (COLEC12), transcript variant II, mRNA
gi|18641357|ref|NM—030781.2|[18641357] - 420: NM—002838 Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript variant 1, mRNA
gi|18641346|ref|NM—002838.2|[18641346] - 421: NM—130770 Homo sapiens 5-hydroxytryptamine receptor 3 subunit C (HTR3C), mRNA gi|18640739|ref|NM—130770.1|[18640739]
- 430: BD010218 Novel hemopoietin receptor protein, NR12
gi|18638591|dbj|BD010218.1|[18638591] - 431: BD010217 Novel hemopoietin receptor protein, NR12
gi|18638590|dbj|BD010217.1|[18638590] - 432: BD010216 Novel hemopoietin receptor protein, NR12
gi|18638589|dbj|BD010216.1|[18638589] - 433: BD010215 Novel hemopoietin receptor protein, NR12
gi|18638588|dbj|BD010215.1|[18638588] - 434: BD010214 Novel hemopoietin receptor protein, NR12
gi|18638587|dbj|BD010214.1|[18638587] - 435: BD010125 Peptide leukotriene receptor
gi|18638498|dbj|BD010125.1|[18638498] - 436: BD010114 Novel receptor and gene encoding the same
gi|18638487|dbj|BD010114.1|[18638487] - 437: BD010057 Novel G protein coupled receptor protein and its DNA
gi|18638430|dbj|BD010057.1|[18638430] - 438: BD010056 Novel G protein coupled receptor protein and its DNA
gi|18638429|dbj|BD010056.1|[18638429] - 439: BD010055 Novel G protein coupled receptor protein and its DNA
gi|18638428|dbj|BD010055.1|[18638428] - 440: BD010054 Novel G protein coupled receptor protein and its DNA
gi|18638427|dbj|BD010054.1|[18638427] - 441: BD010053 Novel G protein coupled receptor protein and its DNA
gi|18638426|dbj|BD010053.1|[18638426] - 442: BD010052 Novel G protein coupled receptor protein and its DNA
gi|18638425|dbj|BD010052.1|[18638425] - 443: BD010051 Novel G protein coupled receptor protein and its DNA
gi|18638424|dbj|BD010051.1|[18638424] - 444: BD010050 Novel G protein coupled receptor protein and its DNA
gi|18638423|dbj|BD010050.1[18638423] - 445: BD010049 Novel G protein coupled receptor protein and its DNA
gi|18638422|dbj|BD010049.1|[18638422] - 446: BD010046 Novel G protein coupled receptor protein and its DNA
gi|18638419|dbj|BD010046.1|[18638419] - 447: BD010035 Novel G protein coupled receptor protein and its DNA
gi|18638408|dbj|BD010035.1|[18638408] - 448: BD010034 Novel G protein coupled receptor protein and its DNA
gi|18638407|dbj|BD010034.1|[18638407] - 449: BD010028 Novel G protein coupled receptor protein and its DNA
gi|18638401|dbj|BD010028.1|[18638401] - 450: BD010022 Novel G protein coupled receptor protein and its DNA
gi|18638395|dbj|BD010022.1|[18638395] - 451: BD009263 GABAA receptor subunit epsilon-related protein
gi|18637636|dbj|BD009263.1|[18637636] - 452: BD009262 GABAA receptor subunit epsilon-related protein
gi|18637635|dbj|BD009262.1|[18637635] - 453: BD009261 GABAA receptor subunit epsilon-related protein
gi|18637634|dbj|BD009261.1|[18637634] - 454: BD009260 GABAA receptor subunit epsilon-related protein
gi|18637633|dbj|BD009260.1|[18637633] - 455: BD006753 Human G protein chemokine receptor HDGNR10
gi|18635124|dbj|BD006753.1|[18635124] - 460: E51301 Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
gi|18633577|dbj|E51301.1|[18633577] - 461: E51300 Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
gi|18633576|dbj|E51300.1|[18633576] - 462: E51299 Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein gi|18633575|dbj|E51299.1|[18633575]
- 463: E51298 Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein gi|18633574|dbj|E51298.1|[18633574]
- 464: E51297 Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein gi|18633573|dbj|E51297.1|[18633573]
- 465: E51296 Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein gi|18633572|dbj|E51296.1|[18633572]
- 466: E50838 Novel G protein-coupled receptor
gi|18633543|dbj|E50838.1|[18633543] - 467: E50837 Novel G protein-coupled receptor
gi|18633542|dbj|E50837.1|[18633542] - 468: E50836 Novel G protein-coupled receptor
gi|18633541|dbj|E50836.1|[18633541] - 469: E50835 Novel G protein-coupled receptor
gi|18633540|dbj|E50835.1|[18633540] - 470: E50834 Novel G protein-coupled receptor
gi|18633539|dbj|E50834.1|[18633539] - 471: E50833 Novel G protein-coupled receptor
gi|18633538|dbj|E50833.1|[18633538] - 490: BD003056 Novel G protein-coupled receptor protein and DNA thereof
gi|18631017|dbj|BD003056.1|[18631017] - 491: E55122 Novel G protein-coupled receptor and the G protein-coupled receptor gene gb|18629753|dbj|E55122.1|[18629753]
- 492: E55121 Novel G protein-coupled receptor and the G protein-coupled receptor gene gi|18629752|dbj|E55121.1|[18629752]
- 493: E55120 Novel G protein-coupled receptor and the G protein-coupled receptor gene gi|18629751|dbj|E55120.1|[18629751]
- 494: E55119 Novel G protein-coupled receptor and the G protein-coupled receptor gene gi|18629750|dbj|E55119.1|[18629750]
- 495: E55118 Novel G protein-coupled receptor and the G protein-coupled receptor gene gi|18629749|dbj|E55118.1|[18629749]
- 496: E55117 Novel G protein-coupled receptor and the G protein-coupled receptor gene gi|18629748|dbj|E55117.1|[18629748]
- 497: E49128 Novel G protein-conjugated receptor protein
gi|18629265|dbj|E49128.1|[18629265] - 498: E49127 Novel G protein-conjugated receptor protein
gi|18629264|dbj|E49127.1|[18629264] - 499: E49126 Novel G protein-conjugated receptor protein
gi|18629263|dbj|E49126.1|[18629263] - 500: E49125 Novel G protein-conjugated receptor protein
gi|18629262|dbj|E49125.1|[18629262] - 501: D21847
Human mRNA for T cell receptor alpha chain TcHST2Va7, V segment, J segment and C region
gi|431140|dbj|D21847.1|HUMTCHST24[431140] - 502: D21846
Human mRNA for T cell receptor beta chain HPBL3xVb20, V segment, D segment, J segment and C region
gi|431139|dbj|D21846.1|HUMHPBL3X3[431139] - 503: D21845
Human mRNA for T cell receptor alpha chain HPBL3xVa7, V segment, J segment and C region
gi|431138|dbj|D521845.1|HUMHPBL3X2[431138] - 504: D21844
Human mRNA for T cell receptor alpha chain HPBL(−)Va7, V segment, J segment and
C region
gi|431137|dbj|D521844.1|HUMCHPBL1[431137] - 505: D13083
Human mRNA for T-cell receptor beta-chain V region, partial cds, clone WBDM19C
gi|407766|dbj|D13083.1|HUMVB73B[407766] - 506: D13085
Human mRNA for T-cell receptor beta-chain V region, partial cds, clone WBDM28A
gi|407764|dbj|D513085.1|HUMVB69B[407764] - 507: D13088
Human TCRBV2.3a mRNA for T-cell receptor beta-chain V region, partial cds
gi|407762|dbj|D13088.1|HUMVB23A[407762] - 508: D13087
Human TCRBV2.1c mRNA for T-cell receptor beta-chain V region, partial cds
gi|407760|dbj|D13087.1|HUMVB21C[407760] - 509: D13082
Human mRNA for T-cell receptor beta-chain V region, partial cds, clone WBDM17A
gi|407758|dbj|D13082.1|HUMVB21AA[407758] - 510: D13086
Human TCRBV20.1a mRNA for T-cell receptor beta-chain V region, partial cds
gi|407756|dbj|D13086.1HUMVB201A[407756] - 511: D13084
Human TCRBV12.5a mRNA for T-cell receptor beta-chain V region, partial cds
gi|407754|dbj|D513084.1|HUMVB125A[407754] - 512: D13073
Human TCRAVN1 mRNA for T-cell receptor alpha-chain V region, partial cds
gi|407752|dbj|D13073.1|HUMVAN1[407752] - 513: D13079
Human TCRAV8.1a mRNA for T-cell receptor alpha-chain V region, partial cds
gi|407750|dbj|D13079.1|HUMVA81A[407750] - 514: D13069
Human TCRAV5.1a mRNA for T-cell receptor alpha-chain V region, partial cds
gi|407748|dbj|D13069.1HUMVA51A[407748] - 515: D13078
Human TCRAV2.5a mRNA for T-cell receptor alpha-chain V region, partial cds
gi|407746|dbj|D13078.1|HUMVA25A[407746] - 516: D13072
Human mRNA for T-cell receptor alpha-chain V-J-C, partial cds, clone WADM13D
gi|407744|dbj|D13072.1|HUMVA221AJ[407744] - 517: D13076
Human TCRAV21.1a mRNA for T-cell receptor alpha-chain V region, partial cds
gi|407742|dbj|D13076.1|HUMVA211A[407742] - 518: D13071
Human mRNA for T-cell receptor alpha-chain V region, partial cds, clone WADM11H
gi|407740|dbj|D13071.1|HUMVA171A[407740] - 519: D13074
Human TCRAV14.1a mRNA for T-cell receptor alpha-chain V region, partial cds
gi|407738|dbj|D13074.1|HUMVA141A[407738] - 520: D13070
Human TCRAV1.3a mRNA for T-cell receptor alpha-chain V region, partial cds
gi|407736|dbj|D13070.1|HUMVA13A[407736] - 521: D13077
Human TCRAV1.2a mRNA for T-cell receptor alpha-chain V region, partial cds
gi|407734|dbj|D13077.1|HUMVA12A[407734] - 522: D13075
Human TCRAV10.1a mRNA for T-cell receptor alpha-chain V region, partial cds
gi|407732|dbj|D13075.1|HUMVA101A[407732] - 523: D13081
Human mRNA for T-cell receptor alpha-chain J segment, partial cds, clone WADM36G
gi|407730|dbj|D13081.1|HUMJAAC17[407730] - 524: D13080
Human mRNA for T-cell receptor alpha-chain J segment, partial cds, clone WADM36A
gi|407728|dbj|D13080.1|HUMJAAB19[407728] - 525: D16584
Homo sapiens mRNA for T cell receptor beta chain, N-terminal
gi|391732|dbj|D16584.1|HUMTCRB17[391732] - 526: D16586
Homo sapiens mRNA for T cell receptor alpha chain, N-terminal
gi|391731|dbj|D16586.1|HUMTCRB17[391731] - 527: D16585
Homo sapiens mRNA for T cell receptor alpha chain, N-terminal
gi|391730|dbj|D16585.1|HUMTCRA32[391730] - 528: NM—003268
Homo sapiens toll-like receptor 5 (TLR5), mRNA
gi|19718736|ref|NM—003268.3|[19718736] - 529: NM—003265
Homo sapiens toll-like receptor 3 (TLR3), mRNA
gi|19718735|ref|NM—003265.2|[19718735] - 530: NM—003264
Homo sapiens toll-like receptor 2 (TLR2), mRNA
gi|19718733|ref|NM—003264.2|[19718733] - 531: NM—003263
Homo sapiens toll-like receptor 1 (TLR1), mRNA
gi|19718732|ref|NM—003263.2|[19718732] - 534: NM—020350
Homo sapiens angiotensin II, type I receptor-associated protein (ATRAP), mRNA
gi|19705427|ref|NM—020350.2|[19705427] - 535: AY081843
Homo sapiens GnRH receptor II 5TM mRNA, complete cds
gi|19697895|gb|AY081843.1|[19697895] - 539: NM—016511
Homo sapiens C-type lectin-like receptor-1 (LOC51267), mRNA
gi|7706062|ref|NM—016511.1|[7706062] - 540: NM—016509
Homo sapiens C-type lectin-like receptor-2 (LOC51266), mRNA
gi|7706060|ref|NM—016509.1|[7706060] - 546: AL713657
Homo sapiens mRNA; cDNA DKFZp547G1215 (from clone DKFZp547G1215)
gi|19584339|emb|AL713657.1|HSM802985[19584339] - 547: AJ438313
Homo sapiens partial mRNA for KIT protein
gi|19571549|emb|AJ438313.1|HSA438313[19571549] - 575: AF390036
Homo sapiens FCRLd mRNA, partial cds
gi|16611715|gb|AF390036.1|[16611715] - 576: AF329495
Homo sapiens FCRLe mRNA, complete cds
gi|16506270|gb|AF329495.1|[16506270] - 577: AF329494
Homo sapiens FCRLc1 mRNA, complete cds
gi|16506268|gb|AF329494.1|[16506268] - 578: AF329493
Homo sapiens FCRLb mRNA, complete cds
gi|16506266|gb|AF329493.1|[16506266] - 579: AF329491
Homo sapiens FCRLc2 mRNA, complete cds
gi|16506262|gb|AF329491.1|[16506262] - 580: AF329489
Homo sapiens FCRLa mRNA, complete cds
gi|16506258|gb|AF329489.1|[16506258] - 582: AB060695
Homo sapiens TLR5 mRNA for Toll-like receptor 5, complete cds
gi|13810567|dbj|AB060695.1|[13810567] - 583: AJ276429
Homo sapiens mRNA for 19A protein
gi|12619176|emb|AJ276429.2|HSA276429[12619176] - 584: AL136801
Homo sapiens mRNA; cDNA DKFZp434K0220 (from clone DKFZp434K0220); complete cds
gi|12053114|emb|AL136801.1|HSM801769[12053114] - 585: AL136652
Homo sapiens mRNA; cDNA DKFZp56401762 (from clone DKFZp56401762); complete cds
gi|12052829|emb|AL136652.1|HSM801622[12052829] - 587: AB012911
Homo sapiens mRNA for Frizzled-6, complete cds
gi|3062802|dbj|AB012911.1|[3062802] - 589: AY071862
Homo sapiens crinkled (CR) mRNA, complete cds
gi|19568064|gb|AY071862.1|[19568064] - 596: NM—133169
Homo sapiens osteoclast-associated receptor (OSCAR), transcript variant 2, mRNA
gi|19557667|ref|NM—133169.1|[19557667] - 597: NM—133168
Homo sapiens osteoclast-associated receptor (OSCAR), transcript variant 3, mRNA
gi|19557663|ref|NM—133168.1|[19557663] - 598: NM—130771
Homo sapiens osteoclast-associated receptor (OSCAR), transcript variant 1, mRNA
gi|19557659|ref|NM—130771.1|[19557659] - 599: AF426461
Homo sapiens FREB mRNA, complete cds
gi|18056674|gb|AF426461.1|[18056674] - 600: AF428134
Homo sapiens T-cell receptor beta-chain (TCRVb13.1-Jb1.5) mRNA, partial cds
gi|16566700|gb|AF428134.1|[16566700] - 601: AF428133
Homo sapiens T-cell receptor beta-chain (TCRVb13.1-Jb1.2) mRNA, partial cds
gi|16566697|gb|AF428133.1|[16566697] - 602: AF428132
Homo sapiens T-cell receptor beta-chain (TCRVb8.1-Jb2.3) mRNA, partial cds
gi|16566694|gb|AF428132.1|[16566694] - 603: AF428131
Homo sapiens T-cell receptor beta-chain (TCRVb8.2-Jb2.7) mRNA, partial cds
gi|16566691|gb|AF428131.1|[16566691] - 604: AF428130
Homo sapiens T-cell receptor beta-chain (TCRVb8.1-Jb2.3) mRNA, partial cds
gi|16566688|gb|AF428130.1|[16566688] - 605: AF428129
Homo sapiens T-cell receptor beta-chain (TCRVb7.1-Jb1.2) mRNA, partial cds
gi|16566685|gb|AF428129.1|[16566685] - 606: AF428128
Homo sapiens T-cell receptor beta-chain (TCRVb7.2-Jb1.6) mRNA, partial cds
gi|16566682|gb|AF428128.1|[16566682] - 607: AF428127
Homo sapiens T-cell receptor beta-chain (TCRVb7.1-Jb1.2) mRNA, partial cds
gi|16566679|gb|AF428127.1|[16566679] - 608: AF428126
Homo sapiens T-cell receptor beta-chain (TCRVb7.2-Jb1.2) mRNA, partial cds
gi|16566676|gb|AF428126.1|[16566676] - 609: AF428125
Homo sapiens T-cell receptor beta-chain (TCRVb7.1-Jb1.5) mRNA, partial cds
gi|16566673|gb|AF428125.1|[16566673] - 611: AF242456
Homo sapiens interleukin 13 receptor alpha 1-binding protein-1 mRNA, complete cds
gi|19548138|gb|AF242456.1|[19548138] - 616: S57283
Homo sapiens endothelin ET-B receptor mRNA, complete cds
gi|298321|gb|S57283.1|[298321] - 617: L14854
Homo sapiens T cell receptor TCR-beta D38 (TCRB) mRNA, partial cds
gi|292794|gb|L14854.1|HUMTCRD38[292794] - 618: NM—024080
Homo sapiens transient receptor potential cation channel, subfamily M, member 8
(TRPM8), mRNA
gi|13129071|ref|NM—024080.1|[13129071] - 619: AY069961
Homo sapiens lymphocyte effector toxicity activation ligand (LETAL) mRNA, complete cds
gi|19525539|gb|AY069961.1|[19525539] - 620: U43901
Homo sapiens 37 kD laminin receptor precursor/p40 ribosome associated protein (LAMR1) gene, complete cds; and E2 small nuclear RNA gene, complete sequence
gi|19483807|gb|U43901.2|HSU43901[19483807] - 621: NM—021044
Homo sapiens desert hedgehog homolog (Drosophila) (DHH), mRNA
gi|19482157|ref|NM—021044.1|[19482157] - 622: AC078860
Homo sapiens 12q BAC RP11-186F10 (Roswell Park Cancer Institute Human BAC Library) complete sequence
gi|13491193|gb|AC078860.19|[13491193] - 623: AC003683
Homo sapiens x BAC RP1-147H15 (Roswell Park Cancer Institute Human BAC Library)
complete sequence
gi|13489135|gb|AC003683.2|[13489135] - 624: AC007397
Homo sapiens 12 p13 BAC RPCI11-439G16 (Roswell Park Cancer Institute Human BAC Library) complete sequence
gi|5685879|gb|AC007397.21|[5685879] - 625: AC007784
Homo sapiens 12 p13 BAC RPCI11-1092P21 (Roswell Park Cancer Library Human BAC Library) complete sequence
gi|5597031|gb|AC007784.7|[5597031] - 627: AF451730
Homo sapiens isolate R5255 T cell receptor delta chain (TRD@) mRNA, partial cds
gi|19401669|gb|AF451730.1|[19401669] - 628: AF451729
Homo sapiens isolate Q5252 T cell receptor delta chain (TRD@) mRNA, partial cds
gi|19401667|gb|AF451729.1|[19401667] - 629: AF451728
Homo sapiens isolate P5739 T cell receptor delta chain (TRD@) mRNA, partial cds
gi|19401665|gb|AF451728.1|[19401665] - 630: AF451727
Homo sapiens isolate P5742 T cell receptor delta chain (TRD@) mRNA, partial cds
gi|19401663|gb|AF451727.1|[19401663] - 631: AF451726
Homo sapiens isolate P5738 T cell receptor delta chain (TRD@) mRNA, partial cds
gi|19401661|gb|AF451726.1|[19401661] - 632: AF451725
Homo sapiens isolate 0581 T cell receptor delta chain (TRD@) mRNA, partial cds
gi|19401658|gb|AF451725.1|[19401658] - 633: AF451724
Homo sapiens isolate N505 T cell receptor delta chain (TRD@) mRNA, partial cds
gi|19401656|gb|AF451724.1|[19401656] - 634: AF451723
Homo sapiens isolate N504 T cell receptor delta chain (TRD@) mRNA, partial cds
gi|19401653|gb|AF451723.1|[19401653] - 635: AF451722
Homo sapiens isolate P5729 T cell receptor delta chain (TRD@) mRNA, partial cds
gi|19401650|gb|AF451722.1|[19401650] - 636: AF451721
Homo sapiens isolate P5728 T cell receptor delta chain (TRD@) mRNA, partial cds
gi|19401647|gb|AF451721.1|[19401647] - 637: AF451720
Homo sapiens isolate 0268 T cell receptor delta chain (TRD@) mRNA, partial cds
gi|19401645|gb|AF451720.1|[19401645] - 638: AF451719
Homo sapiens isolate 038 T cell receptor delta chain (TRD@) mRNA, partial cds
gi|19401642|gb|AF451719.1|[19401642] - 639: AF451718
Homo sapiens isolate 037 T cell receptor delta chain (TRD@) mRNA, partial cds
gi|19401640|gb|AF451718.1|[19401640] - 640: AF449218
Homo sapiens 43 kDa acetylcholine receptor-associated protein (RAPSN) mRNA, complete cds
gi|19310212|gb|AF449218.1|[19310212] - 644: BC025704
Homo sapiens, leukocyte immunoglobulin-like receptor, subfamily B (with TM and
ITIM domains), member 5, clone MGC:34418 IMAGE:5223581, mRNA, complete cds
gi|19344005|gb|BC025704.1|[19344005] - 645: BC025713
Homo sapiens, T-cell receptor interacting molecule, clone MGC:34314 IMAGE:5227396, mRNA, complete cds
gi|19343996|gb|BC025713.1|[19343996] - 646: BC025722
Homo sapiens, adenosine A2b receptor, clone MGC:34640 IMAGE:5198898, mRNA, complete cds
gi|19343938|gb|BC025722.1|[19343938] - 647: BC025717
Homo sapiens, chemokine (C-C motif) receptor-like 2, clone MGC:34104 IMAGE:5228561, mRNA, complete cds
gi|19343936|gb|BC025717.1|[19343936] - 648: BC025695
Homo sapiens, endothelial differentiation, lysophosphatidic acid
G-protein-coupled receptor, 4, clone MGC:34227 IMAGE:5209267, mRNA, complete cds
gi|19343926|gb|BC025695.1|[19343926] - 650: BC025691
Homo sapiens, interleukin 2 receptor, beta, clone MGC:34584 IMAGE:5207833, mRNA,
complete cds
gi|19343610|gb|BC025691.1|[19343610] - 651: AF474992
Homo sapiens G protein-coupled receptor SNSR6 gene, complete cds
gi|19338917|gb|AF474992.1|[19338917] - 652: AF474991
Homo sapiens G protein-coupled receptor SNSR5 gene, complete cds
gi|19338915|gb|AF474991.1|[19338915] - 653: AF474990
Homo sapiens G protein-coupled receptor SNSR4 gene, complete cds
gi|19338913|gb|AF474990.1|[19338913] - 654: AF474989
Homo sapiens G protein-coupled receptor SNSR3 gene, complete cds
gi|19338911|gb|AF474989.1|[19338911] - 655: AF474988
Homo sapiens G protein-coupled receptor SNSR2 gene, complete cds
gi|19338909|gb|AF474988.1|[19338909] - 656: AF474987
Homo sapiens G protein-coupled receptor SNSR1 gene, complete cds
gi|19338907|gb|AF474987.1|[19338907] - 695: AF453877
Homo sapiens neuronal nicotinic receptor beta 4 subunit precursor, gene, exon 1
and partial cds
gi|18042122|gb|AF453877.1|[18042122] - 697: U62556
Homo sapiens chemokine receptor-like protein (TER1) gene, complete cds
gi|1468978|gb|U62556.1|HSU62556[1468978] - 698: AJ011371
Homo sapiens mRNA for serotonin 4 receptor, splice variant h5-HT4(e)
gi|3646277|emb|AJ011371.1|HSAJ1371[3646277] - 712: AY059419
Homo sapiens killer-cell immunoglobulin-like receptor (KIR3DL1) mRNA, KIR3DL1*011 allele, partial cds
gi|19224338|gb|AY059419.1|[19224338] - 713: AY059418
Homo sapiens killer-cell immunoglobulin-like receptor (KIR3DL2) mRNA, KIR3DL2*010 allele, partial cds
gi|19224336|gb|AY059418.1|[19224336] - 714: AY059417
Homo sapiens killer-cell immunoglobulin-like receptor KIR3DL1/2v mRNA, partial
cds
gi|19224334|gb|AY059417.1|[19224334] - 715: AY059420
Homo sapiens killer-cell immunoglobulin-like receptor (KIR3DL2) mRNA, KIR3DL2*012 allele, partial cds
gi|19224332|gb|AY059420.1|[19224332] - 716: AC079385
Homo sapiens 12q BAC RP11-482D24 (Roswell Park Cancer Institute Human BAC Library) complete sequence
gi|14670063|gb|AC079385.18|[14670063] - 717: AC078889
Homo sapiens 12q BAC RP11-335112 (Roswell Park Cancer Institute Human BAC Library) complete sequence
gi|11072039|gb|AC078889.20|[11072039] - 718: AC010168
Homo sapiens 12 p12-31.7-32.2 BAC RP11-174G6 (Rosewell Park Cancer Institute Human Bac Library) complete sequence
gi|6855156|gb|AC010168.6|[6855156] - 719: U14188
Homo sapiens LERK-4 (EPLG4) mRNA, complete cds
gi|642834|gb|U14188.1|HSU14188[642834] - 720: U14187
Homo sapiens LERK-3 (EPLG3) mRNA, complete cds
gi|642832|gb|U14187.1|HSU14187[642832] - 721: U15637
Homo sapiens CD40 binding protein (CD40BP) mRNA, complete cds
gi|595910 gb|U15637.1|HSU15637[595910] - 722: AF262304
Homo sapiens clone 7 CC chemokine receptor 3-like mRNA, partial sequence, alternatively spliced
gi|19171650|gb|AF262304.1|[19171650] - 723: AF262303
Homo sapiens clone 6 CC chemokine receptor 3 (CCR3) mRNA, partial cds
gi|19171648|gb|AF262303.1|[19171648] - 724: AF262302
Homo sapiens clone 5 CC chemokine receptor 3 (CCR3) mRNA, partial cds
gi|19171646|gb|AF262302.1|[19171646] - 725: AF262301
Homo sapiens clone 4 CC chemokine receptor 3 (CCR3) mRNA, partial cds
gi|19171644|gb|AF262301.1|[19171644] - 726: AF262300
Homo sapiens clone 2 CC chemokine receptor 3 (CCR3) mRNA, partial cds
gi|19171642|gb|AF262300.1|[19171642] - 727: AF262299
Homo sapiens clone 1 CC chemokine receptor 3 (CCR3) mRNA, partial cds
gi|19171640|gb|AF262299.1|[19171640] - 729: AF247361
Homo sapiens CC chemokine receptor 3 (CCR3) gene, complete cds
gi|19110542|gb|AF247361.1|[19110542] - 730: AF247360
Homo sapiens CC chemokine receptor 3 (CCR3) gene, promoter region and partial sequence
gi|1911054|gb|AF247360.1|[19110541] - 731: AF247359
Homo sapiens CC chemokine receptor 3 (CCR3) gene, promoter region and partial sequence
gi|19110540|gb|AF247359.1|[19110540] - 733: AF416619
Homo sapiens prolactin receptor short isoform 1a (PRLR) mRNA, complete cds, alternatively spliced
gi|16506717|gb|AF416619.1|[16506717] - 734: AF416618
Homo sapiens prolactin receptor short isoform 1b (PRLR) mRNA, complete cds, alternatively spliced
gi|16506715|gb|AF416618.1[16506715] - 736: AJ303165
Homo sapiens partial gene for putative transmembrane receptor
gi|13162199|emb|AJ303165.1|HSA303165[13162199] - 738: AF350881
Homo sapiens channel kinase 2 (CHAK2) mRNA, complete cds
gi|18860923|gb|AF350881.2|[18860923] - 739: AF022044
Homo sapiens natural killer cell receptor KIR3D51 variant mRNA, complete cds
gi|2760894|gb|AF022044.1|[2760894] - 740: AF034773
Homo sapiens natural killer cell inhibitory receptor (KIR2DL4) mRNA, variant 3, complete cds
gi|2739181|gb|AF034773.1|[2739181] - 741: AF034772
Homo sapiens natural killer cell inhibitory receptor (KIR2DL4) mRNA, variant 2,
complete cds
gi|2739179|gb|AF034772.1([2739179] - 742: AF034771
Homo sapiens natural killer cell inhibitory receptor (KIR2DL4) mRNA, variant 1, complete cds
gi|2739177|gb|AF034771.1|[2739177] - 743: AF022047
Homo sapiens natural killer cell inhibitory receptor KIR2D53 variant mRNA, complete cds
gi|2738966|gb|AF022047.1|[2738966] - 744: AF022046
Homo sapiens natural killer cell inhibitory receptor KIR2D51 variant mRNA, complete cds
gi|2738964|gb|AF022046.1|[2738964] - 745: AF022045
Homo sapiens natural killer cell receptor KIR2DL1 variant mRNA, complete cds
gi|2738962|gb|AF022045.1|[2738962] - 746: U56255
Homo sapiens CW-1 mRNA, complete cds
gi|1399688|gb|U56255.1|HSU56255[1399688] - 747: AJ422056
Homo sapiens partial GRM5 gene for metabotrophic glutamate receptor, exon 1A
gi|19069804|emb|AJ422056.1|HSA422056[19069804] - 748: AY028912
Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 7 and complete cds, alternatively spliced
gi|19067944|gb|AY028912.1|AY028906S7[19067944] - 749: AY028911
Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 6
gi|19067943|gb|AY028911.1|AY028906S6[19067943] - 750: AY028910
Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 5
gi|19067942|gb|AY028910.1|AY028906S5[19067942] - 751: AY028909
Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 4
gi|1906794|gb|AY028909.1|AY028906S4[19067941] - 752: AY028908
Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 3
gi|19067940|gb|AY028908.1|AY028906S3[19067940] - 753: AY028907
Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 2
gi|19067939|gb|AY028907.1|AY028906S2[19067939] - 754: AY028906
Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, exon 1
gi|19067938|gb|AY028906.1|AY028906S1[19067938] - 755: AH010677
Homo sapiens ectodysplasin A receptor associated death domain (EDARADD) gene, complete cds, alternatively spliced
gi|19067937|gb|AH010677.1|SEG_AY028906S[19067937] - 756: AY028913
Homo sapiens ectodysplasia A receptor associated death domain A (EDARADD) mRNA,
complete cds; alternatively spliced
gi|9067935|gb|AY028913.1|[19067935] - 757: BM735809
06E08 Canine Brain cDNA Library Canis familiaris cDNA 5′ similar to Homo sapiens
glycine receptor, beta, mRNA sequence
gi|19057142|gb|BM735809.1|BM735809[19057142] - 758: BM735756
06A09 Canine Brain cDNA Library Canis familiaris cDNA 5; similar to Homo sapiens
glycine receptor, beta subunit, mRNA sequence
gi|19057089|gb|BM735756.1|BM735756[19057089] - 759: BM735711
10E11 Canine Brain cDNA Library Canis familiaris cDNA 5′ similar to Homo sapiens
protein tyrosine phosphatase, receptor-type, Z polypeptide 1, mRNA sequence
gi|19057044|gb|BM735711.1|BM735711[19057044] - 762: AC007165
Homo sapiens BAC clone RP11-451C2 from 2, complete sequence
gi|19033999|gb|AC007165.4|[19033999] - 763: AF245699
Homo sapiens type 1 angiotensin II receptor (AGTR1) gene, complete cds
gi|7862074|gb|AF245699.1|[7862074] - 764: BC024229
Homo sapiens, prostaglandin E receptor 3 (subtype EP3), clone MGC:27302 IMAGE:4660371, mRNA, complete cds
gi|18999476|gb|BC024229.1|[18999476] - 783: AJ417555
Homo sapiens partial mRNA for killer cell immunoglobulin receptor (KIR2D54 gene), strain 4053
gi|18958228|emb|AJ417555.1|HSA417555[18958228] - 784: AJ417554
Homo sapiens partial mRNA for killer cell immunoglobulin receptor (KIR2D54 gene), strain 3321
gi|18958226|emb|AJ417554.1|HSA417554[18958226] - 786: NM—003877
Homo sapiens STAT induced STAT inhibitor-2 (STAT12), mRNA
gi|18921206|ref|NM—003877.2|[18921206] - 787: NM—017662
Homo sapiens transient receptor potential cation channel, subfamily M, member 6
(TRPM6), mRNA
gi|18921092|ref|NM—017662.3|[18921092]
- 788: NM—133181
Homo sapiens epidermal growth factor receptor pathway substrate 8 related protein 3 (EPS8R3), mRNA
gi|18874727|ref|NM—133181.1|[18874727] - 802: M13823
Homo sapiens T cell receptor gamma chain (TCRG) gene, partial cds
gi|292736|gb|M13823.1|HUMTCGXK[292736] - 803: L12398
Homo sapiens dopamine receptor D4 (DRD4) mRNA, complete cds
gi|291945|gb|L12398.1|HUMD4C[291945] - 804: M86383
Homo sapiens nicotinic acetylcholine receptor alpha 3 subunit precursor, mRNA,
complete cds
gi|177897|gb|M86383.1|HUMA3NARSP[177897] - 805: NG—000019
Homo sapiens chorionic gonadotropin beta region (CGB@) on chromosome 19
gi|18860921|ref|NG—000019.2|[18860921] - 807: NM—012245
Homo sapiens SKI-interacting protein (SNW1), mRNA
gi|18860912|ref|NM—012245.2|[18860912] - 808: NM—006750
Homo sapiens syntrophin, beta 2 (dystrophin-associated protein A1, 59 kD, basic
component 2) (SNTB2), transcript variant 1, mRNA
gi|18860911|ref|NM—006750.2|[18860911] - 809: NM—130845
Homo sapiens syntrophin, beta 2 (dystrophin-associated protein A1, 59 kD, basic
component 2) (SNTB2), transcript variant 2, mRNA
gi|18860909|ref|NM—130845.1|[18860909] - 810: NM—002846
Homo sapiens protein tyrosine phosphatase, receptor type, N (PTPRN), mRNA
gi|18860905|ref|NM—002846.2|[18860905] - 811: NM—002845
Homo sapiens protein tyrosine phosphatase, receptor type, M (PTPRM), mRNA
gi|18860903|ref|NM—002845.2|[18860903] - 812: NM—002844
Homo sapiens protein tyrosine phosphatase, receptor type, K (PTPRK), mRNA
gi|18860901|ref|NM—002844.2|[18860901] - 813: NM—002843
Homo sapiens protein tyrosine phosphatase, receptor type, J (PTPRJ), mRNA
gi|18860899|ref|NM—002843.2|[18860899] - 814: NM—002841
Homo sapiens protein tyrosine phosphatase, receptor type, G (PTPRG), mRNA
gi|18860897|ref|NM—002841.2|[18860897] - 815: NM—130440
Homo sapiens protein tyrosine phosphatase, receptor type, F (PTPRF), transcript
variant 2, mRNA
gi|18860895|ref|NM—130440.1|[18860895] - 816: NM—130393
Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
variant 4, mRNA
gi|18860893|ref|NM—130393.1|[18860893] - 817: NM—130392
Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
variant 3, mRNA
gi|18860891|ref|NM—130392.1|[18860891] - 818: NM—130391
Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
variant 2, mRNA
gi|18860889|ref|NM—130391.1|[18860889] - 819: NM—003682
Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 4, mRNA
gi|18860876|ref|NM—003682.2|[18860876] - 820: NM—130476
Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 8, mRNA
gi|18860874|ref|NM—130476.1|[18860874] - 821: NM—130475
Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 7, mRNA
gi|18860872|ref|NM—130475.1|[18860872] - 822: NM—002840
Homo sapiens protein tyrosine phosphatase, receptor type, F (PTPRF), transcript
variant 1, mRNA
gi|18860871|ref|NM—002840.2|[18860871] - 823: NM—130474
Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 6, mRNA
gi|18860869|ref|NM—130474.2|[18860869] - 824: NM—130473
Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 5, mRNA
gi|18860867|ref|NM—130473.1|[18860867] - 825: NM—130472
Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 3, mRNA
gi|18860865|ref|NM—130472.1|[18860865] - 826: NM—130471
Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 2, mRNA
gi|18860863|ref|NM—130471.1|[18860863] - 827: NM—130470
Homo sapiens MAP-kinase activating death domain (MADD), transcript variant 1, mRNA
gi|18860861|ref|NM—130470.1|[18860861] - 828: NM—006504
Homo sapiens protein tyrosine phosphatase, receptor type, E (PTPRE), transcript
variant 1, mRNA
gi|18860860|ref|NM—006504.2|[18860860] - 829: NM—130435
Homo sapiens protein tyrosine phosphatase, receptor type, E (PTPRE), transcript
variant 2, mRNA
gi|18860858|ref|NM—130435.1|[18860858] - 830: AJ431177
Homo sapiens mRNA for WIRE protein
gi|18857713|emb|AJ431177.1|HSA431177[18857713] - 831: NM—006474
Homo sapiens lung type-I cell membrane-associated glycoprotein (T1A-2), mRNA
gi|18767663|ref|NM—006474.2|[18767663] - 833: NM—006794
Homo sapiens G protein-coupled receptor 75 (GPR75), mRNA
gi|5803024|ref|NM—006794.1|[5803024] - 834: NM—002842
Homo sapiens protein tyrosine phosphatase, receptor type, H (PTPRH), mRNA
gi|4506312|ref|NM—002842.1|[4506312] - 835: NM—002839
Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
variant 1, mRNA
gi|4506308|ref|NM—002839.1|[4506308] - 836: BC024145
Homo sapiens, TNF receptor-associated factor 1, clone MGC:10353 IMAGE:3832475, mRNA, complete cds
gi|18848176|gb|BC024145.1|[18848176] - 837: AF469756
Homo sapiens clone S9 interleukin-1 receptor type I (IL1R1) gene, partial sequence
gi|18846656|gb|AF469756.1|[18846656] - 838: AF469755
Homo sapiens clone S8 interleukin-1 receptor type I (IL1R1) gene, partial sequence
gi|18846655|gb|AF469755.1|[18846655] - 839: AF469754
Homo sapiens clone S7 interleukin-1 receptor type I (IL1R1) gene, partial sequence
gi|18845036|gb|AF469754.1|[18845036] - 841: BM565570
ih27b03.x1 Human insulinoma Homo sapiens cDNA clone IMAGE: 3′ similar to SW:FCEG_HUMAN P30273 HIGH AFFINITY IMMUNOGLOBULIN EPSILON RECEPTOR GAMMA-SUBUNIT
PRECURSOR; mRNA sequence
gi|18825852|gb|BM565570.1|BM565570[18825852] - 842: AF416711
Homo sapiens Fc-gamma receptor IIc5 mRNA, partial cds
gi|18765992|gb|AF416711.1|[18765992] - 843: NM—023068
Homo sapiens sialoadhesin (SN), mRNA
gi|18765743|ref|NM—023068.2|[18765743] - 844: NM—004782
Homo sapiens synaptosomal-associated protein, 29 kD (SNAP29), mRNA
gi|18765736|ref|NM—004782.2|[18765736] - 845: NM—130798
Homo sapiens synaptosomal-associated protein, 23 kD (SNAP23), transcript variant
2, mRNA
gi|18765730|ref|NM—130798.1|[18765730] - 846: NM—003825
Homo sapiens synaptosomal-associated protein, 23 kD (SNAP23), transcript variant
1, mRNA
gi|18765728|ref|NM—003825.2|[18765728] - 850: AF439409
Homo sapiens G-protein-coupled receptor kinase 7 (GRK7) mRNA, GRK7-S allele,
complete cds
gi|17933258|gb|AF439409.1|[17933258] - 851: NM—032211
Homo sapiens lysyl oxidase-like 4 (LOXL4), mRNA
gi|16933522|ref|NM—032211.4|[16933522] - 852: AF411122
Homo sapiens importin 4 mRNA, complete cds
gi|18700634|gb|AF411122.1|[18700634] - 894: NM—130441
Homo sapiens C-type (calcium dependent, carbohydrate-recognition domain) lectin,
superfamily member 11 (CLECSF11), mRNA
gi|18466805|ref|NM—130441.1|[18466805] - 895: NM—030876
Homo sapiens olfactory receptor, family 5, subfamily V, member 1 (OR5V1), mRNA
gi|14495550|ref|NM—030876.2|[14495550] - 896: NM—032732
Homo sapiens hypothetical protein MGC10763 (IL17RL), mRNA
gi|14249349|ref|NM—032732.1|[14249349] - 897: NM—030959
Homo sapiens olfactory receptor, family 12, subfamily D, member 3 (OR12D3), mRNA
gi|13624334|ref|NM—030959.1|[13624334] - 898: NM—018842
Homo sapiens insulin receptor tyrosine kinase substrate (LOC55971), mRNA
gi|10047119|ref|NM—018842.1|[10047119] - 899: NM—018844
Homo sapiens B-cell receptor-associated protein BAP29 (BAP29), mRNA
gi|9994198|ref|NM—018844.1|[9994198] - 900: NM—002825
Homo sapiens pleiotrophin (heparin binding growth factor 8, neurite growth-promoting factor 1) (PTN), mRNA
gi|18656935|ref|NM—002825.2|[18656935] - 904: NM—016372
Homo sapiens seven transmembrane domain orphan receptor (TPRA40), mRNA
gi|7705964|ref|NM—016372.1|[7705964] - 905: NM—014288
Homo sapiens integrin beta 3 binding protein (beta3-endonexin) (ITGB3BP), mRNA
gi|7657205|ref|NM—014288.1|[7657205] - 906: L43588
Homo sapiens T cell antigen receptor mRNA, partial cds
gi|18654191|gb|L43588.1|HUMTCARF[18654191] - 907: AB050954
Homo sapiens irs-2 gene for insulin receptor substrate-2, partial cds
gi|18652856|dbj|AB050954.1|[18652856] - 923: U77589
Homo sapiens MHC class II HLA-DQ-alpha chain (HLA-DQA1) mRNA, HLA-DQA1*0104 allele, complete cds
gi|1916744|gb|U77589.1|HSU77589[1916744] - 924: AF410465
Homo sapiens importin 9 mRNA, complete cds
gi|15529702|gb|AF410465.1|[15529702] - 925: AF332759
Homo sapiens partially duplicated CHRNA7 gene, hybrid intron A/4 and partial exon 5
gi|13345792|gb|AF332759.1|[13345792] - 926: AF332758
Homo sapiens alpha-7 nicotinic cholinergic receptor subunit (CHRNA7) gene, partial intron 4 and partial cds
gi|13345790|gb|AF332750.1|[13345790] - 927: NM—003744
Homo sapiens numb homolog (Drosophila) (NUMB), mRNA
gi|18644887|ref|NM—003744.2|[18644887] - 928: NM—003681
Homo sapiens pyridoxal (pyridoxine, vitamin B6) kinase (PDXK), mRNA
gi|18644884|ref|NM—003681.2|[18644884] - 929: NM—080706
Homo sapiens transient receptor potential cation channel, subfamily V, member 1
(TRPV1), transcript variant 3, mRNA
gi|18375670|ref|NM—080706.1|[18375670] - 930: NM—080705
Homo sapiens transient receptor potential cation channel, subfamily V, member 1
(TRPV1), transcript variant 4, mRNA
gi|18375668|ref|NM—080705.1|[18375668] - 931: NM—080704
Homo sapiens transient receptor potential cation channel, subfamily V, member 1
(TRPV1), transcript variant 1, mRNA
gi|18375666|ref|NM—080704.1|[18375666] - 932: NM—018727
Homo sapiens transient receptor potential cation channel, subfamily V, member 1
(TRPV1), transcript variant 2, mRNA
gi|18375664|ref|NM—018727.3|[18375664] - 933: NM—080819
Homo sapiens G protein-coupled receptor 78 (GPR78), mRNA
gi|18201873|ref|NM—080819.1|[18201873] - 934: NM—080738
Homo sapiens EDAR-associated death domain (EDARADD), mRNA
gi|18152768|ref|NM—080738.1|[18152768] - 935: NM—080491 Homo sapiens GRB2-associated binding protein 2 (GAB2), transcript variant 1, mRNA gi|18105041|ref|NM—080491.1|[18105041]
- 936: NM—012296 Homo sapiens GRB2-associated binding protein 2 (GAB2), transcript variant 2, mRNA gi|18105040|ref|NM—012296.2|[18105040]
- 937: NM—032027 Homo sapiens beta-amyloid binding protein precursor (BBP), mRNA gi|17738309|ref|NM—032027.2|[17738309]
- 938: NM—057159 Homo sapiens endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2 (EDG2), transcript variant 2, mRNA
gi|16950637|ref|NM—057159.1|[16950637] - 939: NM—001401 Homo sapiens endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2 (EDG2), transcript variant 1, mRNA
gi|16950635|ref|NM—001401.2|[16950635] - 940: NM—007070 Homo sapiens FKBP-associated protein (FAP48), transcript variant 2, mRNA gi|16933538|ref|NM—007070.2|[16933538]
- 941: NM—053274 Homo sapiens FKBP-associated protein (FAP48), transcript variant 1, mRNA gi|16933536|ref|NM—053274.1|[16933536]
- 942: NM—003726 Homo sapiens src family associated phosphoprotein 1 (SCAP1), mRNA gi|16753209|ref|NM—003726.2|[16753209]
- 943: NM—033632 Homo sapiens F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila) (FBXW7), transcript variant 1, mRNA
gi|16117780|ref|NM—033632.1|[16117780] - 944: NM—018315 Homo sapiens F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila) (FBXW7), transcript variant 2, mRNA
gi|16117778|ref|NM—018315.2|[16117778] - 945: NM—021203 Homo sapiens APMCF1 protein (APMCF1), mRNA
gi|14917112|ref|NM—021203.2|[14917112] - 946: NM—002927 Homo sapiens regulator of G-protein signalling 13 (RGS13), mRNA gi|14589857|ref|NM—002927.2|[14589857]
- 949: NM—020167 Homo sapiens neuromedin U receptor 2 (NMU2R), mRNA
gi|9910461|ref|NM—020167.1|[9910461] - 950: NM—020149 Homo sapiens Meis1, myeloid ecotropic viral integration site 1 homolog 2 (mouse) (MEIS2), mRNA
gi|9910355|ref|NM—020149.1|[9910355] - 951: AF190052 Homo sapiens interleukin 1 receptor type I (IL1R1) gene, exon 1C sequence gi|9719300|gb|AF190052.1|[9719300]
- 952: NM—018965 Homo sapiens triggering receptor expressed on myeloid cells 2 (TREM2), mRNA gi|9507202|ref|NM—018965.1|[9507202]
- 953: NM—018643 Homo sapiens triggering receptor expressed on myeloid cells 1 (TREM1), mRNA gi|8924261|ref|NM—018643.1|[8924261]
- 954: NM—018647 Homo sapiens tumor necrosis factor receptor superfamily, member 19 (TNFRSF19), mRNA gi|8924251|ref|NM—018647.1|[8924251]
- 955: NM—018695 Homo sapiens erbb2 interacting protein (ERBB2IP), mRNA
gi|8923908|ref|NM—018695.1|[8923908] - 956: NM—017636 Homo sapiens transient receptor potential cation channel, subfamily M, member 4(TRPM4), mRNA gi|8923048|ref|NM—017636.1|[8923048]
- 958: NM—016559 Homo sapiens PXR2b protein (PXR2b), mRNA
gi|7706670|ref|NM—016559.1|[7706670] - 959: NM—016382 Homo sapiens natural killer cell receptor 2B4 (CD244), mRNA
gi|7706528|ref|NM—016382.1|[7706528] - 962: NM—015986 Homo sapiens cytokine receptor-like factor 3 (CRLF3), mRNA
gi|7705331|ref|NM—015986.1|[7705331] - 963: NM—014815 Homo sapiens KIAA0130 gene product (KIAA0130), mRNA
gi|7661929|ref|NM—014815.1|[7661929] - 964: NM—014053 Homo sapiens FLVCR protein (FLVCR), mRNA
gi|7661707|ref|NM—014053.1|[7661707] - 965: NM—014478 Homo sapiens calcitonin gene-related peptide-receptor component protein (CGRP-RCP), mRNA gi|7656976|ref|NM—014478.1|[7656976]
- 966: NM—012470
Homo sapiens transportin-SR (TRN-SR), mRNA
gi|6912733|ref|NM—012470.1|[6912733] - 967: NM—007357 Homo sapiens low density lipoprotein receptor defect C complementing (LDLC), mRNA gi|6678675|ref|NM—007357.1|[6678675]
- 969: NM—007324 Homo sapiens MAD, mothers against decapentaplegic homolog (Drosophila) interacting protein, receptor activation anchor (MADHIP), transcript variant 1, mRNA gi|6552338|ref|NM—007324.1|[6552338]
- 970: NM—007323 Homo sapiens MAD, mothers against decapentaplegic homolog (Drosophila) interacting protein, receptor activation anchor (MADHIP), transcript variant 2, mRNA gi|6552336|ref|NM—007323.1|[6552336]
- 971: NM—005162 Homo sapiens angiotensin receptor-like 2 (AGTRL2), mRNA
gi|6031157|ref|NM—005162.21[6031157] - 972: NM—005501 Homo sapiens integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) (ITGA3), transcript variant b, mRNA
gi|6006010|ref|NM—005501.1|[6006010] - 975: NM—007053 Homo sapiens natural killer cell receptor, immunoglobulin superfamily member (BY55), mRNA gi|5901909|ref|NM—007053.1|[5901909]
- 978: NM—006254 Homo sapiens protein kinase C, delta (PRKCD), mRNA
gi|5453969|ref|NM—006254.1|[5453969] - 979: NM—005761 Homo sapiens plexin C1 (PLXNC1), mRNA
gi|5032222|ref|NM—005761.1|[5032222] - 980: NM—005866 Homo sapiens sigma receptor (SR31747 binding protein 1) (SR-BP1), mRNA gi|5032116|ref|NM—005866.1|[5032116]
- 982: NM—005506 Homo sapiens CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane protein II) (CD36L2), mRNA gi|5031630|ref|NM—005506.1|[5031630]
- 984: NM—004799 Homo sapiens MAD, mothers against decapentaplegic homolog (Drosophila) interacting protein, receptor activation anchor (MADHIP), transcript variant 3, mRNA gi|4759059|ref|NM—004799.1|[4759059]
- 985: NM—004292 Homo sapiens ras inhibitor (RIN1), mRNA
gi|4759039|ref|NM—004292.1|[4759039] - 986: NM—004828 Homo sapiens lymphocyte antigen 95 (activating NK-receptor; NK-p44) (LY95), mRNA gi|4758693|ref|NM—004828.1|[4758693]
- 987: NM—004767 Homo sapiens endothelin type b receptor-like protein 2 (ET(B)R-LP-2), mRNA gi|4758309|ref|NM—004767.1|[4758309]
- 988: NM—004440 Homo sapiens EphA7 (EPHA7), mRNA
gi|4758281|ref|NM—004440.1|[4758281] - 989: NM—003999 Homo sapiens oncostatin M receptor (OSMR), mRNA
gi|4557039|ref|NM—003999.1|[4557039] - 990: NM—003904 Homo sapiens zinc finger protein 259 (ZNF259), mRNA
gi|4508020|ref|NM—003904.1|[4508020] - 991: NM—003305 Homo sapiens transient receptor potential cation channel, subfamily C, member 3(TRPC3), mRNA gi|4507686|ref|NM—003305.1|[4507686]
- 992: NM—003804 Homo sapiens receptor (TNFRSF)-interacting serine-threonine kinase 1 (RIPK1), mRNA gi|4506538|ref|NM—003804.1|[4506538]
- 993: NM—003626 Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 (PPFIA1), mRNA
gi|4505982|ref|NM—003626.1|[4505982] - 994: NM—003876 Homo sapiens putative receptor protein (PMI), mRNA
gi|4505900|ref|NM—003876.1|[4505900] - 995: NM—003559 Homo sapiens phosphatidylinositol-4-phosphate 5-kinase, type II, beta (PIP5K2B), mRNA gi|4505818|ref|NM—003559.1|[4505818]
- 996: NM—003629 Homo sapiens phosphoinositide-3-kinase, regulatory subunit, polypeptide 3 (p55, gamma) (PIK3R3), mRNA gi|4505804|ref|NM—003629.1|[4505804]
- 997: NM—003676 Homo sapiens degenerative spermatocyte homolog, lipid desaturase (Drosophila) (DEGS), mRNA gi|4505192|ref|NM—003676.1|[4505192]
- 998: NM—002270 Homo sapiens karyopherin (importin) beta 2 (KPNB2), mRNA
gi|4504906|ref|NM—002270.1|[4504906] - 999: NM—002204 Homo sapiens integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) (ITGA3), transcript variant a, mRNA
gi|4504746|ref|NM—002204.1|[4504746] - 1000: NM—001560 Homo sapiens interleukin 13 receptor, alpha 1 (IL13RA1), mRNA
gi|4504646|ref|NM—001560.1|[4504646]
sapiens AND receptor NOT similar NOT non-receptor NOT nuclear NOT receptor-associated NOT “thyroid hormone” NOT “steroid receptor” - 779: NM—000842
Homo sapiens glutamate receptor, metabotropic 5 (GRM5), mRNA
gi|4504142|ref|NM—000842.1|[4504142] - 780: NM—001883
Homo sapiens corticotropin releasing hormone receptor 2 (CRHR2), mRNA
gi|4503044|ref|NM—001883.1|[4503044] - 781: NM—001873
Homo sapiens carboxypeptidase E (CPE), mRNA
gi|4503008|ref|NM—001873.1|[4503008] - 783: L29395
Homo sapiens v-erbB-related protein gene, partial cds
gi|459807|gb|L29395.1|HUMERBB[459807] - 784: L08584
Homo sapiens T cell receptor beta chain (TCRB) mRNA, partial cds
gi|307497|gb|L08584.1|HUMTCVB7A[307497] - 786: NM—015638
Homo sapiens chromosome 20 open reading frame 188 (C20orf188), mRNA
gi|18158415|ref|NM—015638.1|[18158415] - 787: NM—058167
Homo sapiens ubiquitin conjugating enzyme 6 (Ubc6p), mRNA
gi|17157996|ref|NM—058167.1|[17157996] - 788: NM—054032
Homo sapiens G protein-coupled receptor MRGX4 (MRGX4), mRNA
gi|16876454|ref|NM—054032.1|[16876454] - 789: NM—054031
Homo sapiens G protein-coupled receptor MRGX3 (MRGX3), mRNA
gi|16876452|ref|NM—054031.1|[16876452] - 790: NM—054030
Homo sapiens G protein-coupled receptor MRGX2 (MRGX2), mRNA
gi|16876450|ref|NM—054030.1|[16876450] - 791: NM—052931
Homo sapiens activating NK receptor (KALI), mRNA
gi|16418406|ref|NM—052931.1|[16418406] - 792: NM—032871
Homo sapiens tumor necrosis factor receptor superfamily, member 19-like (TNFRSF19L), mRNA
gi|14249611|ref|NM—032871.1|[14249611] - 793: NM—032553
Homo sapiens putative purinergic receptor (FKSG79), mRNA
gi|14211848|ref|NM—032553.1|[14211848] - 794: NM—025179
Homo sapiens plexin A2 (PLXNA2), mRNA
gi|13378152|ref|NM—025179.1|[13378152] - 795: NM—024419
Homo sapiens Phosphatidylglycerophosphate Synthase (PGS1), mRNA
gi|13259369|ref|NM—024419.1|[13259369] - 796: NM—021249
Homo sapiens sorting nexin 6 (SNX6), mRNA
gi|13027619|ref|NM—021249.1|[13027619] - 797: NM—014045
Homo sapiens DKFZP564C1940 protein (DKFZP564C1940), mRNA
gi|13027587|ref|NM—014045.1|[13027587] - 798: NM—080923
Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
variant 4, mRNA
gi|18641365|ref|NM—080923.1|[18641365] - 799: NM—080922
Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
variant 3, mRNA
gi|18641363|ref|NM—080922.1|[18641363] - 800: NM—080921
Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
variant 2, mRNA
gi|18641361|ref|NM—080921.1|[18641361] - 801: NM—130386
Homo sapiens collectin sub-family member 12 (COLEC12), transcript variant I, mRNA
gi|18641359|ref|NM—130386.1|[18641359] - 802: NM—030781
Homo sapiens collectin sub-family member 12 (COLEC12), transcript variant II, mRNA
gi|18641357|ref|NM—030781.2|[18641357] - 803: NM—002838
Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
variant 1, mRNA
gi|18641346|ref|NM—002838.2|[18641346] - 804: NM—130770
Homo sapiens 5-hydroxytryptamine receptor 3 subunit C (HTR3C), mRNA
gi|18640739|ref|NM—130770.1|[18640739] - 813: BD010218
Novel hemopoietin receptor protein, NR12
gi|18638591|dbj|BD010218.1|[18638591] - 814: BD010217
Novel hemopoietin receptor protein, NR12
gi|18638590|dbj|BD010217.1|[18638590] - 815: BD010216
Novel hemopoietin receptor protein, NR12
gi|18638589|dbj|BD010216.1|[18638589] - 816: BD010215
Novel hemopoietin receptor protein, NR12
gi|18638588|dbj|BD010215.1|[18638588] - 817: BD010214
Novel hemopoietin receptor protein, NR12
gi|18638587|dbj|BD010214.1|[18638587] - 818: BD010125
Peptide leukotrien receptor
gi|18638498|dbj|BD010125.1|[18638498] - 819: BD010114
Novel receptor and gene encoding the same
gi|18638487|dbj|BD010114.1|[18638487] - 820: BD010057
Novel G protein coupled receptor protein and its DNA
gi|18638430|dbj|BD010057.1|[18638430] - 821: BD010056
Novel G protein coupled receptor protein and its DNA
gi|18638429|dbj|BD010056.1|[18638429] - 822: BD010055
Novel G protein coupled receptor protein and its DNA
gi|18638428|dbj|BD010055.1|[18638428] - 823: BD010054
Novel G protein coupled receptor protein and its DNA
gi|18638427|dbj|BD010054.1|[18638427] - 824: BD010053
Novel G protein coupled receptor protein and its DNA
gi|18638426|dbj|BD010053.1|[18638426] - 825: BD010052
Novel G protein coupled receptor protein and its DNA
gi|18638425|dbj|BD010052.1|[18638425] - 826: BD010051
Novel G protein coupled receptor protein and its DNA
gi|18638424|dbj|BD010051.1|[18638424] - 827: BD010050
Novel G protein coupled receptor protein and its DNA
gi|18638423|dbj|BD010050.1|[18638423] - 828: BD010049
Novel G protein coupled receptor protein and its DNA
gi|18638422|dbj|BD010049.1|[18638422] - 829: BD010046
Novel G protein coupled receptor protein and its DNA
gi|18638419|dbj|BD010046.1|[18638419] - 830: BD010035
Novel G protein coupled receptor protein and its DNA
gi|18638408|dbj|BD010035.1|[18638408] - 831: BD010034
Novel G protein coupled receptor protein and its DNA
gi|18638407|dbj|BD010034.1|[18638407] - 832: BD010028
Novel G protein coupled receptor protein and its DNA
gi|18638401|dbj|BD010028.1|[18638401] - 833: BD010022
Novel G protein coupled receptor protein and its DNA
gi|18638395|dbj|BD010022.1|[18638395] - 834: BD009263
GABAA receptor subunit epsilon-related protein
gi|18637636|dbj|BD009263.1|[18637636] - 835: BD009262
GABAA receptor subunit epsilon-related protein
gi|18637635|dbj|BD009262.1|[18637635] - 836: BD009261
GABAA receptor subunit epsilon-related protein
gi|18637634|dbj|BD009261.1|[18637634] - 837: BD009260
GABAA receptor subunit epsilon-related protein
gi|18637633|dbj|BD009260.1|[18637633] - 838: BD006753
Human G protein chemokine receptor HDGNR10
gi|18635124|dbj|BD006753.1|[18635124] - 843: E51301
Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
gi|18633577|dbj|E51301.1|[18633577] - 844: E51300
Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
gi|18633576|dbj|E51300.1|[18633576] - 845: E51299
Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
gi|18633575|dbj|E51299.1|[18633575] - 846: E51298
Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
gi|18633574|dbj|E51298.1|[18633574] - 847: E51297
Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
gi|18633573|dbj|E51297.1|[18633573] - 848: E51296
Novel G protein-coupled receptor protein and gene of said G protein-coupled receptor protein
gi|18633572|dbj|E51296.1|[18633572] - 849: E50838
Novel G protein-coupled receptor
gi|18633543|dbj|E50838.1|[18633543] - 850: E50837
Novel G protein-coupled receptor
gi|18633542|dbj|E50837.1|[18633542] - 851: E50836
Novel G protein-coupled receptor
gi|18633541|dbj|E50836.1|[18633541] - 852: E50835
Novel G protein-coupled receptor
gi|18633540|dbj|E50835.1|[18633540] - 853: E50834
Novel G protein-coupled receptor
gi|18633539|dbj|E50834.1|[18633539] - 854: E50833
Novel G protein-coupled receptor
gi|18633538|dbj|E50833.1|[18633538] - 873: BD003056
Novel G protein-coupled receptor protein and DNA thereof
gi|18631017|dbj|BD003056.1|[18631017] - 874: E55122
Novel G protein-coupled receptor and the G protein-coupled receptor gene
gi|18629753|dbj|E55122.1|[18629753] - 875: E55121
Novel G protein-coupled receptor and the G protein-coupled receptor gene
gi|18629752|dbj|E55121.1|[18629752] - 876: E55120
Novel G protein-coupled receptor and the G protein-coupled receptor gene
gi|18629751|dbj|E55120.1|[18629751] - 877: E55119
Novel G protein-coupled receptor and the G protein-coupled receptor gene
gi|18629750|dbj|E55119.1|[18629750] - 878: E55118
Novel G protein-coupled receptor and the G protein-coupled receptor gene
gi|18629749|dbj|E55118.1|[18629749] - 879: E55117
Novel G protein-coupled receptor and the G protein-coupled receptor gene
gi|18629748|dbj|E55117.1|[18629748] - 880: E49128
Novel G protein-conjugated receptor protein
gi|18629265|dbj|E49128.1|[18629265] - 881: E49127
Novel G protein-conjugated receptor protein
gi|18629264|dbj|E49127.1|[18629264] - 882: E49126
Novel G protein-conjugated receptor protein
gi|18629263|dbj|E49126.1|[18629263] - 883: E49125
Novel G protein-conjugated receptor protein
gi|18629262|dbj|E49125.1|[18629262] - 884: E49124
Novel G protein-conjugated receptor protein
gi|18629261|dbj|E49124.1|[18629261] - 885: E49123
Novel G protein-conjugated receptor protein
gi|18629260|dbj|E49123.1|[18629260] - 887: E58499
Novel G protein-coupled receptor protein, DNA and utilization thereof
gi|18628416|dbj|E58499.1|[18628416] - 888: E58495
Novel G protein-coupled receptor protein, DNA and utilization thereof
gi|18628412|dbj|E58495.1|[18628412] - 889: E58494
Novel G protein-coupled receptor protein, DNA and utilization thereof
gi|18628411|dbj|E58494.1|[18628411] - 890: E58488
Novel G protein-coupled receptor protein, DNA and utilization thereof
gi|18628405|dbj|E58488.1|[18628405] - 891: E58485
Novel G protein-coupled receptor protein, DNA and utilization thereof
gi|18628402|dbj|E58485.1|[18628402] - 892: E58484
Novel G protein-coupled receptor protein, DNA and utilization thereof
gi|18628401|dbj|E58484.1|[18628401] - 893: E58479
Novel G protein-coupled receptor protein, DNA and utilization thereof
gi|18628396|dbj|E58479.1|[18628396] - 902: E43451
Novel protein G-coupled receptor protein and DNA thereof
gi|18627717|dbj|E43451.1|[18627717] - 903: E43450
Novel protein G-coupled receptor protein and DNA thereof
gi|18627716|dbj|E43450.1|[18627716] - 904: E41270
Novel G protein-conjugate receptor protein and its DNA
gi|18627502|dbj|E41270.1|[18627502] - 905: E41269
Novel G protein-conjugate receptor protein and its DNA
gi|18627501|dbj|E41269.1|[18627501] - 906: E41268
Novel G protein-conjugate receptor protein and its DNA
gi|18627500|dbj|E41268.1|[18627500] - 907: E40003
Novel G protein-conjugate receptor protein and its DNA
gi|18627119|dbj|E40003.1|[18627119] - 908: E40000
Novel G protein-conjugate receptor protein and its DNA
gi|18627116|dbj|E40000.1|[18627116] - 909: E39999
Novel G protein-conjugate receptor protein and its DNA
gi|18627115|dbj|E39999.1|[18627115] - 910: E39824
Novel guanosine triphospate (GTP)-binding protein-conjugate receptor protein
gi|18627105|dbj|E39824.1|[18627105] - 911: E39817
Novel guanosine triphospate (GTP)-binding protein-conjugate receptor protein
gi|18627098|dbj|E39817.1|[18627098] - 912: E39816
Novel guanosine triphospate (GTP)-binding protein-conjugate receptor protein
gi|18627097|dbj|E39816.1|[18627097] - 913: E39815
Novel guanosine triphospate (GTP)-binding protein-conjugate receptor protein
gi|18627096|dbj|E39815.1|[18627096] - 929: E34464
Novel Toll-like receptor and gene thereof
gi|18624350|dbj|E34464.1|[18624350] - 930: E33807
Human splice mutant CXCR4B of CXCR4 chemokine receptor
gi|18624164|dbj|E33807.1|[18624164] - 931: E33806
Human splice mutant CXCR4B of CXCR4 chemokine receptor
gi|18624163|dbj|E33806.1)[18624163] - 941: E63757
Human nurse cell receptor gene
gi|18622844|dbj|E63757.1|[18622844] - 942: E63756
Human nurse cell receptor gene
gi|18622843|dbj|E63756.1|[18622843] - 943: E63754
Human nurse cell receptor gene
gi|18622841|dbj|E63754.1|[18622841] - 944: E49275
Novel G protein-conjugated receptor protein and DNA thereof
gi|18622037|dbj|E49275.1|[18622037] - 945: E44151
Novel G protein-coupled receptor protein and DNA thereof
gi|18622012|dbj|E44151.1|[18622012] - 946: E44032
Novel G protein-coupled receptor protein and DNA and ligand of the same
gi|18621998|dbj|E44032.1|[18621998] - 947: AX350990
Sequence 24 from Patent WO0190358
gi|18616366|emb|AX350990.1|[18616366] - 948: AX350988
Sequence 22 from Patent WO0190358
gi|18616364|emb|AX350988.1|[18616364] - 949: AX350984
Sequence 18 from Patent WO0190358
gi|18616360|emb|AX350984.1|[18616360] - 950: AX350982
Sequence 16 from Patent WO0190358
gi|18616358|emb|AX350982.1|[18616358] - 951: AX350981
Sequence 15 from Patent WO0190358
gi|18616357|emb|AX350981.1|[18616357] - 952: AX350979
Sequence 13 from Patent WO0190358
gi|18616355|emb|AX350979.1|[18616355] - 953: AX350975
Sequence 9 from Patent WO0190358-
gi|18616351|emb|AX350975.1|[18616351] - 954: AX350973
Sequence 7 from Patent WO0190358
gi|18616349|emb|AX350973.1|[18616349] - 955: AX350969
Sequence 3 from Patent WO0190358
gi|18616345|emb|AX350969.1|[18616345] - 956: AX350967
Sequence 1 from Patent WO0190358
gi|18616343|emb|AX350967.1|[18616343] - 957: NM—005608
Homo sapiens protein tyrosine phosphatase, receptor type, C-associated protein
(PTPRCAP), mRNA
gi|5032004|ref|NM—005608.1|[5032004] - 958: XM—012097
Homo sapiens olfactory receptor, family 6, subfamily A, member 1 (OR6A1), mRNA
gi|18605332|ref|XM—012097.3|[18605332] - 959: XM—090173
Homo sapiens olfactory receptor, family 5, subfamily L, member 2 (OR5L2), mRNA
gi|1860518|ref|XM—090173.1|[18605181] - 960: XM—055369
Homo sapiens pro-oncosis receptor inducing membrane injury gene (PORIMIN), mRNA
gi|18604484|ref|XM—055369.2|[18604484] - 961: XM—041961
Homo sapiens PYK2 N-terminal domain-interacting receptor 1 (NIR1), mRNA
gi|18604126|ref|XM—041961.2|[18604126] - 962: XM—040037
Homo sapiens adrenergic, beta, receptor kinase 1 (ADRBK1), mRNA
gi|18604053|ref|XM—040037.3|[18604053] - 963: XM—045532
Homo sapiens olfactory receptor, family 51, subfamily E, member 2 (OR51E2), mRNA
gi|18603788|ref|XM—045532.2|[18603788] - 964: XM—091465
Homo sapiens olfactory receptor, family 4, subfamily D, member 1 (OR4D1), mRNA
gi|18603196|ref|XM—091465.1|[18603196] - 965: XM—036784
Homo sapiens phosphatidylserine receptor (KIAA0585), mRNA
gi|18603024|ref|XM—036784.3|[18603024] - 966: XM—036728
Homo sapiens ryanodine receptor 3 (RYR3), mRNA
gi|18602746|ref|XM—036728.3|[18602746] - 967: XM—084025
Homo sapiens complement component 5 receptor 1 (C5a ligand) (C5R1), mRNA
gi|18601827|ref|XM—084025.1|[18601827] - 968: XM—009107
Homo sapiens KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 (KDELR1), mRNA
gi|18601740|ref|XM—009107.6|[18601740] - 969: XM—027883
Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF),
interacting protein (liprin), alpha 3 (PPFIA3), mRNA
gi|18601690|ref|XM—027883.2|[18601690] - 970: XM—027904
Homo sapiens Fc fragment of IgG, receptor, transporter, alpha (FCGRT), mRNA
gi|18601656|ref|XM—027904.4|[18601656] - 971: XM—049229
Homo sapiens dopamine receptor interacting protein (DRIP78), mRNA
gi|18601498|ref|XM—049229.3|[18601498] - 972: XM—040709
Homo sapiens prostaglandin F2 receptor negative regulator (PTGFRN), mRNA
gi|186011300ref|XM—040709.2|[18601130] - 973: XM—003091
Homo sapiens G protein-coupled receptor 105 (GPR105), mRNA
gi|18600688|ref|XM—003091.5|[18600688] - 975: XM—010533
Homo sapiens interleukin 12 receptor, beta 2 (IL12RB2), mRNA
gi|18600602|ref |XM—010533.4|[18600602] - 976: NT—006318
Homo sapiens chromosome 4 working draft sequence segment
gi|18600353|ref|NT—006318.7|Hs4—6475[18600353] - 977: XM—039145
Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 3 (CHRNA3), mRNA
gi|18597785|ref|XM—039145.3|[18597785] - 978: XM—039151
Homo sapiens cholinergic receptor, nicotinic, beta polypeptide 4 (CHRNB4), mRNA
gi|18597777|ref|XM—039151.2|[18597777] - 979: XM—007392
Homo sapiens G protein-coupled receptor 65 (GPR65), mRNA
gi|8597722|ref|XM—007392.4|[18597722] - 980: XM—007315
Homo sapiens receptor-interacting serine-threonine kinase 3 (RIPK3), mRNA
gi|18597625|ref|XM—007315.2|[18597625] - 981: NT—024675
Homo sapiens chromosome 15 working draft sequence segment
gi|18597616|ref|NT—024675.7|Hs15—24831[18597616] - 982: XM—051711
Homo sapiens prostaglandin D2 receptor (DP) (PTGDR), mRNA
gi|18597012|ref|XM—051711.2|[18597012] - 983: XM—007337
Homo sapiens kinectin 1 (kinesin receptor) (KTN1), mRNA
gi|18596970|ref|XM—007337.7|[18596970] - 984: XM—096782
Homo sapiens putative leukocyte platelet-activating factor receptor (HUMNPIIY20), mRNA
gi|18596920|ref|XM—096782.1|[18596920] - 985: XM—055898
Homo sapiens nerve growth factor receptor (TNFRSF16) associated protein 1 (NGFRAP1), mRNA
gi|18596422|ref|XM—055898.3|[18596422] - 986: XM—018505
Homo sapiens G protein-coupled receptor 23 (GPR23), mRNA
gi|18594906|ref|XM—018505.3|[18594906] - 987: XM—096288
Homo sapiens G protein-coupled receptor 64 (GPR64), mRNA
gi|18594854|ref|XM—096288.1|[18594854] - 988: XM—096154
Homo sapiens angiotensin receptor-like 2 (AGTRL2), mRNA
gi|18593950|ref|XM—096154.1|[18593950] - 989: XM—015620
Homo sapiens nogo receptor (NOGOR), mRNA
gi|18593698|ref|XM—015620.5|[18593698] - 990: XM—048563
Homo sapiens interferon gamma receptor 2 (interferon gamma transducer 1) (IFNGR2), mRNA
gi|18593096|ref|XM—048563.2|[18593096] - 991: XM—086754
Homo sapiens coxsackie virus and adenovirus receptor (CXADR), mRNA
gi|18592977|ref|XM—086754.1|[18592977] - 992: XM—056242
Homo sapiens protein C receptor, endothelial (EPCR) (PROCR), mRNA
gi|18592822|ref|XM—056242.3|[18592822] - 993: XM—097415
Homo sapiens leukocyte receptor cluster (LRC) member 8 (LENG8), mRNA
gi|18591238|ref|XM—097415.1|[18591238] - 994: XM—044314
Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 4 (ILT7), mRNA
gi|18591234|ref|XM—044314.4|[18591234] - 995: XM—092068
Homo sapiens olfactory receptor, family 7, subfamily C, member 1 (OR7C1), mRNA
gi|18591224|ref|XM—092068.1|[18591224] - 996: XM—084042
Homo sapiens egf-like module containing, mucin-like, hormone receptor-like sequence 2 (EMR2), mRNA
gi|18591222|ref|XM—084042.1|[18591222] - 997: XM—012893
Homo sapiens endothelial differentiation, lysophosphatidic acid
G-protein-coupled receptor, 4 (EDG4), mRNA
gi|18591032|ref|XM—012893.5|[18591032] - 998: XM—103288
Homo sapiens polycythemia rubra vera 1; cell surface receptor (PRV1), mRNA
gi|18590882|ref|XM—103288.1|[18590882] - 999: XM—046103
Homo sapiens protein tyrosine phosphatase, receptor type, S (PTPRS), mRNA
gi|18590850|ref|XM—046103.3|[18590850] - 1000: XM—047633
Homo sapiens thromboxane A2 receptor (TBXA2R), mRNA
gi|18590817|ref|XM—047633.2|[18590817] - 1001: XM—030637
Homo sapiens G protein-coupled receptor kinase 7 (GPRK7), mRNA
gi|18590749|ref|XM—030637.3|[18590749] - 1002: XM—086017
Homo sapiens plasminogen activator, urokinase receptor (PLAUR), mRNA
gi|18590707|ref|XM—086017.1|[18590707] - 1003: XM—029455
Homo sapiens ryanodine receptor 1 (skeletal) (RYR1), mRNA
gi|18590460|ref|XM—029455.2|[18590460] - 1004: XM—085976
Homo sapiens leukocyte receptor cluster (LRC) member 3 (LENG3), mRNA
gi|18590428|ref|XM—085976.1|[18590428] - 1005: XM—084028
Homo sapiens killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 (KIR3DL1), mRNA
gi|18590419|ref|XM—084028.1|[18590419] - 1006: XM—097304
Homo sapiens leukocyte receptor cluster (LRC) member 1 (LENG1), mRNA
gi|18590235|ref|XM—097304.1|[18590235] - 1007: XM—050582
Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM, domains), member 3 (LILRB3), mRNA
gi|18590233|ref|XM—050582.3|[18590233] - 1008: XM—041258
Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 (LILRB2), mRNA
gi|18590231|ref|XM—041258.3|[18590231] - 1009: XM—050236
Homo sapiens leukocyte receptor cluster (LRC) member 4 (LENG4), mRNA
gi|18590224|ref|XM—050236.3|[18590224] - 1010: XM—048346
Homo sapiens insulin receptor (INSR), mRNA
gi|18590185|ref|XM—048346.3|[18590185] - 1011: XM—044591
Homo sapiens G protein-coupled receptor 108 (GPR108), mRNA
gi|18590160|ref|XM—044591.3|[18590160] - 1012: XM—085864
Homo sapiens endothelial differentiation, sphingolipid G-protein-coupled receptor, 8 (EDG8), mRNA
gi|18589990|ref|XM—085864.1|[18589990] - 1013: XM—044320
Homo sapiens poliovirus receptor-related 2 (herpesvirus entry mediator B) (PVRL2), mRNA
gi|18589873|ref|XM—044320.4|[18589873] - 1014: XM—012671
Homo sapiens olfactory receptor, family 1, subfamily E, member 2 (OR1E2), mRNA
gi|18588331|ref|XM—012671.5|[18588331] - 1015: XM—085745
Homo sapiens somatostatin receptor 2 (SSTR2), mRNA
gi|18588314|ref|XM—085745.1|[18588314] - 1016: XM—008646
Homo sapiens cytokine receptor-like factor 3 (CRLF3), mRNA
gi|18588105|ref|XM—008646.5|[18588105] - 1017: XM—008509
Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 5 (P2RX5), mRNA
gi|18587692|ref|XM—008509.6|[18587692] - 1018: XM—030851
Homo sapiens G protein-coupled receptor kinase-interactor 1 (GIT1), mRNA
gi|18587652|ref|XM—030851.2|[18587652] - 1019: XM—048233
Homo sapiens autocrine motility factor receptor (AMFR), mRNA
gi|18585872|ref|XM—048233.3|[18585872] - 1020: NT—010280
Homo sapiens chromosome 15 working draft sequence segment
gi|18584150|ref|NT—010280.8|Hs15—10437[18584150] - 1021: XM—039208
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, gamma 3 (GABRG3), mRNA
gi|18584141|ref|XM—039208.5|[18584141] - 1022: XM—030709
Homo sapiens transient receptor potential cation channel, subfamily M, member 7
(TRPM7), mRNA
gi|18583756|ref|XM—030709.3|[18583756] - 1023: XM—085103
Homo sapiens G protein-coupled receptor (G2A), mRNA
gi|18583332|ref|XM—085103.1|[18583332] - 1024: XM—040854
Homo sapiens bradykinin receptor B2 (BDKRB2), mRNA
gi|18582977|ref|XM—040854.2|[18582977] - 1025: XM—007275
Homo sapiens bradykinin receptor B1 (BDKRB1), mRNA
gi|18582976|ref|XM—007275.4|[18582976] - 1027: XM—083897
Homo sapiens Epstein-Barr virus induced gene 2 (lymphocyte-specific G protein-coupled receptor) (EBI2), mRNA
gi|18581588|ref|XM—083897.1|[18581588] - 1029: XM—062656
Homo sapiens C-type lectin-like receptor (CLEC-6), mRNA
gi|18580484|ref|XM—062656.2|[18580484] - 1031: XM—084785
Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF),
interacting protein (liprin), alpha 2 (PPFIA2), mRNA
gi|18579245|ref|XM—084785.1|[18579245] - 1032: XM—043322
Homo sapiens peroxisome receptor 1 (PXR1), mRNA
gi|18579222|ref|XM—043322.3|[18579222] - 1033: XM—090117
Homo sapiens olfactory receptor, family 8, subfamily G, member 2 (OR8G2), mRNA
gi|18578560|ref|XM—090117.1|[18578560] - 1034: XM—090109
Homo sapiens olfactory receptor, family 8, subfamily G, member 1 (OR8G1), mRNA
gi|18578546|ref|XM—090109.1[18578546] - 1035: XM—035095
Homo sapiens cortical thymocyte receptor (X. laevis CTX) like (CTXL), mRNA
gi|18578508|ref|XM—035095.4|[18578508] - 1036: XM—084690
Homo sapiens olfactory receptor, family 8, subfamily B, member 8 (OR8B8), mRNA
gi|18578501|ref|XM—084690.1|[18578501] - 1037: XM—012064
Homo sapiens glutamate receptor, ionotropic, kainate 4 (GRIK4), mRNA
gi|18578454|ref|XM—012064.6|[18578454] - 1039: XM—031348
Homo sapiens glutamate receptor, metabotropic 5 (GRM5), mRNA
gi|18577875|ref|XM—031348.2|[18577875] - 1040: XM—089965
Homo sapiens olfactory receptor, family 10, subfamily A, member 3 (OR10A3), mRNA
gi|18577828|ref|XM—089965.1|[18577828] - 1041: NT—030791
Homo sapiens chromosome 11 working draft sequence segment
gi|18577645|ref|NT—030791.2|Hs11—31047[18577645] - 1042: XM—006549
Homo sapiens G protein-coupled receptor 48 (GPR48), mRNA
gi|18577644|ref|XM—006549.5|[18577644] - 1043: XM—054215
Homo sapiens purinergic receptor P2Y, G-protein coupled, 2 (P2RY2), mRNA
gi|18577261|ref|XM—054215.4|[18577261] - 1044: XM—038024
Homo sapiens protein tyrosine phosphatase, receptor type, J (PTPRJ), mRNA
gi|18577179|ref|XM—038024.4|[18577179] - 1045: XM—049296
Homo sapiens GDNF family receptor alpha 1 (GFRA1), mRNA
gi|18576832|ref|XM—049296.4|[18576832] - 1046: XM—005781
Homo sapiens protein tyrosine phosphatase, receptor type, E (PTPRE), mRNA
gi|18576581|ref|XM—005781.5|[18576581] - 1047: XM—011904
Homo sapiens cubilin (intrinsic factor-cobalamin receptor) (CUBN), mRNA
gi|18576082|ref|XM—011904.6|[18576082] - 1048: XM—005969
Homo sapiens G protein-coupled receptor kinase 5 (GPRK5), mRNA
gi|18575440|ref|XM—005969.6|[18575440] - 1049: XM—089569
Homo sapiens VPS10 domain receptor protein SORCS1 (SORCS1), mRNA
gi|18574995|ref|XM—089569.1|[18574995] - 1050: XM—005830
Homo sapiens mannose receptor, C type 1 (MRC1), mRNA
gi|18574297|ref|XM—005830.7|[18574297] - 1051: XM—005747
Homo sapiens tachykinin receptor 2 (TACR2), mRNA
gi|18574167|ref |XM—005747.5|[18574167] - 1052: XM—043613
Homo sapiens glutamate receptor, ionotropic, delta 1 (GRID1), mRNA
gi|18574031|ref|XM—043613.4|[18574031] - 1053: XM—028830
Homo sapiens transient receptor potential cation channel, subfamily M, member 6
(TRPM6), mRNA
gi|18573768|ref|XM—028830.3|[18573768] - 1054: XM—095961
Homo sapiens olfactory receptor, family 2, subfamily K, member 2 (OR2K2), mRNA
gi|18573486|ref|XM—095961.1|[18573486] - 1055: XM—096286
Homo sapiens receptor tyrosine kinase-like orphan receptor 2 (ROR2), mRNA
gi|18573067|ref|XM—096286.1|[18573067] - 1056: XM—095815
Homo sapiens olfactory receptor, family 1, subfamily J, member 5 (OR1J5), mRNA
gi|18572435|ref|XM—095815.1|[18572435] - 1057: XM—095814
Homo sapiens olfactory receptor, family 1, subfamily J, member 4 (OR1J4), mRNA
gi|18572433|ref|XM—095814.1|[18572433] - 1059: XM—011695
Homo sapiens leptin receptor overlapping transcript-like 1 (LEPROTL1), mRNA
gi|18570296|ref|XM—011695.3|[18570296] - 1061: XM—088035
Homo sapiens transient receptor potential cation channel, subfamily V, member 6
(TRPV6), mRNA
gi|18565882|ref|XM—088035.1|[18565882] - 1062: XM—004696
Homo sapiens EphB6 (EPHB6), mRNA
gi|18565881|ref|XM—004696.5|[18565881] - 1063: XM—096245
Homo sapiens olfactory receptor, family 2, subfamily H, member 3 (OR2H3), mRNA
gi|18564780|ref|XM—096245.1|[18564780] - 1064: XM—084200
Homo sapiens olfactory receptor, family 11, subfamily A, member 1 (OR11A1), mRNA
gi|18563692|ref|XM—084200.1|[18563692] - 1065: XM—084190
Homo sapiens olfactory receptor, family 2, subfamily A, member 4 (OR2A4), mRNA
gi|18563106|ref|XM—084190.1|[18563106] - 1066: XM—004341
Homo sapiens opioid receptor, mu 1 (OPRM1), mRNA
gi|18562969|ref|XM—004341.6|[18562969] - 1067: XM—084185
Homo sapiens dopamine receptor D1 (DRD1), mRNA
gi|18561988|ref|XM—084185.1|[18561988] - 1069: XM—049570
Homo sapiens dioxin receptor repressor (AHRR), mRNA
gi|18560847|ref|XM—049570.4|[18560847] - 1070: XM—084176
Homo sapiens coagulation factor II (thrombin) receptor-like 1 (F2RL1), mRNA
gi|18560787|ref|XM—084176.1|[18560787] - 1071: NT—029289
Homo sapiens chromosome 5 working draft sequence segment
gi|18560495|ref|NT—029289.4|Hs5—29448[18560495] - 1072: XR—000069
Homo sapiens neuropeptide Y receptor Y6 (psuedogene) (NPY6R), misc RNA
gi|18560235|ref|XR—000069.1|[18560235] - 1073: NT—025716
Homo sapiens chromosome 5 working draft sequence segment
gi|18560224|ref|NT—025716.6|Hs5—25872[18560224] - 1074: XM—094306
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 1 (GABRA1), mRNA
gi|18560222|ref|XM—094306.1|[18560222] - 1075: XM—096226
Homo sapiens interleukin 7 receptor (IL7R), mRNA
gi|18560176|ref|XM—096226.1|[18560176] - 1076: XM—031131
Homo sapiens leukemia inhibitory factor receptor (LIFR), mRNA
gi|18559952|ref|XM—031131.2|[18559952] - 1077: XM—011222
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 2 (GABRB2), mRNA
gi|18559788|ref|XM—011222.6|[18559788]
- 1078: XM—003519
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 1 (GABRB1), mRNA
gi|18558473|ref|XM—003519.3|[18558473] - 1079: XM—038446
Homo sapiens melatonin receptor 1A (MTNR1A), mRNA
gi|18558343|ref|XM—038446.2|[18558343] - 1080: XM—084160
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 2 (GABRA2), mRNA
gi|18558328|ref|XM—084160.1|[18558328] - 1081: XM—011169
Homo sapiens neuropeptide Y receptor Y2 (NPY2R), mRNA
gi|18558281|ref|XM—011169.3|[18558281] - 1082: XM—044120
Homo sapiens fibroblast growth factor receptor 3 (achondroplasia, thanatophoric
dwarfism) (FGFR3), mRNA
gi|18558241|ref|XM—044120.2|[18558241] - 1083: NT—030654
Homo sapiens chromosome 4 working draft sequence segment
gi|18557828|ref|NT—030654.2|Hs4—30910[18557828] - 1084: NT—030650
Homo sapiens chromosome 4 working draft sequence segment
gi|18557822|ref|NT—030650.2|Hs4—30906[18557822] - 1085: XM—011173
Homo sapiens glutamate receptor, ionotropic, delta 2 (GRID2), mRNA
gi|18557816|ref|XM—011173.4|[18557816] - 1086: NT—029955
Homo sapiens chromosome 4 working draft sequence segment
gi|18557687|ref|NT—029955.3|Hs4—30210[18557687] - 1087: NT—025693
Homo sapiens chromosome 4 working draft sequence segment
gi|18557505|ref|NT—025693.3|Hs4—25849[18557505] - 1088: NM—019841
Homo sapiens transient receptor potential nation channel, subfamily V, member 5
(TRPV5), mRNA
gi|17505199|ref|NM—019841.2|[17505199] - 1089: NT—030778
Homo sapiens chromosome 10 working draft sequence segment
gi|17489667|ref|NT—030778.1|Hs10—31034[17489667] - 1090: NT—010591
Homo sapiens chromosome 16 working draft sequence segment
gi|17487829|ref|NT—010591.6|Hs16—10748[17487829] - 1091: NT—030889
Homo sapiens chromosome X working draft sequence segment
gi|17486981|ref|NT—030889.1|HsX—31145[17486981] - 1092: XM—066104
Homo sapiens G protein-coupled receptor 73-like 1 (GPR73L1), mA
gi|17484462|ref|XM—066104.1|[17484462] - 1093: XM—056414
Homo sapiens killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 (KIR2DL4), mRNA
gi|17483039|ref|XM—056414.2|[17483039] - 1094: XM—053166
Homo sapiens somatostatin receptor-interacting protein (SSTRIP), mRNA
gi|17482811|ref|XM—053166.3|[17482811] - 1096: XM—008489
Homo sapiens acetyl LDL receptor; SREC=scavenger receptor expressed by endothelial cells (SREC), mRNA
gi|17481055|ref|XM—008489.7|[17481055] - 1097: XM—044091
Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 7 (CHRNA7), mRNA
gi|17477913|ref|XM—044091.2|[17477913] - 1098: NT—010258
Homo sapiens chromosome 15 working draft sequence segment
gi|17477780|ref|NT—010258.7|Hs15—10415[17477780] - 1099: XM—038336
Homo sapiens neurotrophic tyrosine kinase, receptor, type 3 (NTRK3), mRNA
gi|17477779|ref|XM—038336.2|[17477779] - 1101: XM—027181
Homo sapiens transient receptor potential cation channel, subfamily V, member 4
(TRPV4), mRNA
gi|17475007|ref|XM—027181.2|[17475007] - 1102: XM—047362
Homo sapiens Glutamate receptor interacting protein (GRIP1), mRNA
gi|17474492|ref|XM—047362.3|[17474492] - 1104: XM—006372
Homo sapiens aryl hydrocarbon receptor interacting protein (AIP), mRNA
gi|17472888|ref|XM—006372.4|[17472888] - 1105: XM—004893
Homo sapiens receptor (calcitonin) activity modifying protein 3 (RAMP3), mRNA
gi|17464777|ref|XM—004893.4|[17464777] - 1107: XM—004559
Homo sapiens discoidin domain receptor family, member 1 (DDR1), mRNA
gi|17464405|ref|XM—004559.5|[17464405] - 1108: XM—004237
Homo sapiens insulin-like growth factor 2 receptor (IGF2R), mRNA
gi|17463326|ref|XM—004237.4|[17463326] - 1109: XM—051214
Homo sapiens type 1 tumor necrosis factor receptor shedding aminopeptidase regulator (ARTS-1), mRNA
gi|17462792|ref|XM—051214.2|[17462792] - 1110: XM—059645
Homo sapiens neuropeptide Y receptor Y1 (NPY1R), mRNA
gi|17462720|ref|XM—059645.1|[17462720] - 1111: XM—044493
Homo sapiens cholecystokinin B receptor (CCKBR), mRNA
gi|17461537|ref|XM—044493.2|[17461537] - 1112: XM—048562
Homo sapiens interferon (alpha, beta and omega) receptor 1 (IFNAR1), mRNA
gi|17460140|ref|XM—048562.3|[17460140] - 1113: XM—040307
Homo sapiens low density lipoprotein receptor defect B complementing (LDLB), mRNA
gi|17459160|ref|XM—040307.2|[17459160] - 1114: XM—046949
Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2C (GRIN2C),
mRNA
gi|17457940|ref|XM—046949.3|[17457940] - 1115: XM—050937
Homo sapiens galanin receptor 1 (GALR1), mRNA
gi|17457665|ref|XM—050937.2|[17457665] - 1116: XM—058224
Homo sapiens protein tyrosine phosphatase, receptor type, M (PTPRM), mRNA
gi|17457059|ref|XM—058224.1|[17457059] - 1117: XM—059877
Homo sapiens scavenger receptor cysteine rich domain containing, group B (4 domains) (SRCRB4D), mRNA
gi|17452620|ref|XM—059877.1|[17452620] - 1118: XM—030074
Homo sapiens corticotropin releasing hormone receptor 2 (CRHR2), mRNA
gi|17451624|ref|XM—030074.2|[17451624] - 1119: XM—036899
Homo sapiens paired immunoglobulin-like receptor alpha (PILR(ALPHA)), mRNA
gi|17450024|ref|XM—036899.2|[17450024] - 1120: XM—040292
Homo sapiens glutamate receptor, ionotropic, AMPA 1 (GRIA1), mRNA
gi|17447971|ref|XM—040292.3|[17447971] - 1121: XM—003913
Homo sapiens integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) (ITGA2), mRNA
gi|17447767|ref|XM—003913.5|[17447767] - 1122: XM—052621
Homo sapiens VPS10 domain receptor protein (SORCS2), mRNA
gi|17447359|ref|XM—052621.2|[17447359] - 1123: XM—011186
Homo sapiens platelet-derived growth factor receptor, alpha polypeptide (PDGFRA), mRNA
gi|17446713|ref|XM—011186.5|[17446713] - 1124: XM—037260
Homo sapiens coagulation factor II (thrombin) receptor (F2R), mRNA
gi|17446698|ref|XM—037260.3|[17446698] - 1125: XM—068231
Homo sapiens G protein-coupled receptor 78 (GPR78), mRNA
gi|17446518|ref|XM—068231.1|[17446518] - 1126: XM—003896
Homo sapiens growth hormone receptor (GHR), mRNA
gi|17446516|ref|XM—003896.5|[17446516] - 1127: XM—003883
Homo sapiens prolactin receptor (PRLR), mRNA
gi|17446302|ref|XM—003883.4|[17446302] - 1128: XM—003423
Homo sapiens toll-like receptor 6 (TLR6), mRNA
gi|17443462|ref|XM—003423.5|[17443462] - 1129: XM—050674
Homo sapiens kinase insert domain receptor (a type III receptor tyrosine kinase)
(KDR), mRNA
gi|17443063|ref|XM—050674.2|[17443063] - 1130: XM—016537
Homo sapiens low density lipoprotein receptor-related protein 8, apolipoprotein
e receptor (LRP8), mRNA
gi|17438001|ref|XM—016537.4|[17438001] - 1131: XM—050512
Homo sapiens activin A receptor, type I (ACVR1), mRNA
gi|17437640|ref|XM—050512.3|[17437640] - 1132: XM—011248
Homo sapiens adrenergic, alpha-1B-, receptor (ADRA1B), mRNA
gi|17437111|ref|XM—011248.5|[17437111] - 1133: XM—057299
Homo sapiens very large G protein-coupled receptor 1 (VLGR1), mRNA
gi|17436651|ref|XM—057299.2|[17436651] - 1134: XM—042825
Homo sapiens luteinizing hormone/choriogonadotropin receptor (LHCGR), mRNA
gi|17433844|ref|XM—042825.3|[17433844] - 1135: XM—039993
Homo sapiens fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (FLT1), mRNA
gi|16188964|ref|XM—039993.2|[16188964] - 1136: XM—028642
Homo sapiens integrin, alpha 5 (fibronectin receptor, alpha polypeptide) (ITGA5), mRNA
gi|16186750|ref|XM—028642.2|[16186750] - 1137: XM—057337
Homo sapiens cholinergic receptor, muscarinic 1 (CHRM1), mRNA
gi|16184321|ref|XM—057337.1|[16184321] - 1138: XM—006447
Homo sapiens interleukin 10 receptor, alpha (IL10RA), mRNA
gi|16183626|ref|XM—006447.5|[16183626] - 1139: XM—057984
Homo sapiens G protein-coupled receptor 51 (GPR51), mRNA
gi|16181083|ref|XM—057984.1|[16181083] - 1140: XM—057452
Homo sapiens toll-like receptor 4 (TLR4), mRNA
gi|16179752|ref|XM—057452.1|[16179752] - 1141: XM—051505
Homo sapiens opioid receptor, kappa 1 (OPRK1), mRNA
gi|16179331|ref|XM—051505.2|[16179331] - 1142: XM—027651
Homo sapiens tumor necrosis factor receptor superfamily, member 10b (TNFRSF10B),
mRNA
gi|16178146|ref|XM—027651.2|[16178146] - 1144: XM—028141
Homo sapiens killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 (KIR3DL2), mRNA
gi|16176785|ref|XM—028141.2|[16176785] - 1145: XM—004872
Homo sapiens atrophin-1 interacting protein 1; activin receptor interacting protein 1 (KIAA0705), mRNA
gi|16175845|ref|XM—004872.6|[16175845] - 1146: XM—057372
Homo sapiens tumor necrosis factor receptor superfamily, member 5 (TNFRSF5), mRNA
gi|16174074|ref|XM—057372.1|[16174074] - 1147: XM—056391
Homo sapiens BAFF receptor (BAFFR), mRNA
gi|16168558|ref|XM—056391.1|[16168558] - 1148: XM—054949
Homo sapiens transient receptor potential cation channel, subfamily V, member 2
(TRPV2), mRNA
gi|16165271|ref|XM—054949.1|[16165271] - 1149: XM—009219
Homo sapiens endothelial differentiation, G-protein-coupled receptor 6 (EDG6),
mRNA
gi|16163259|ref|XM—009219.5|[16163259] - 1150: XM—057188
Homo sapiens transient receptor potential cation channel, subfamily M, member 4
(TRPM4), mRNA
gi|16162857|ref|XM—057188.1|[16162857] - 1151: XM—033762
Homo sapiens growth factor receptor-bound protein 10 (GRB10), mRNA
gi|16162156|ref|XM—033762.2|[16162156] - 1152: XM—037256
Homo sapiens protein tyrosine phosphatase, receptor type, N polypeptide 2 (PTPRN2), mRNA
gi|16162004|ref|XM—037256.2|[16162004] - 1153: XM—007662
Homo sapiens transient receptor potential cation channel, subfamily M, member 1
(TRPM1), mRNA
gi|16161643|ref|XM—007662.6|[16161643] - 1154: XM—011327
Homo sapiens hepatitis A virus cellular receptor 1 (HAVCR-1), mRNA
gi|16159892|ref|XM—011327.4|[16159892] - 1155: XM—034331
Homo sapiens endothelin receptor type A (EDNRA), mRNA
gi|16158485|ref|XM—034331.2|[16158485] - 1156: XM—002212
Homo sapiens follicle stimulating hormone receptor (FSHR), mRNA
gi|16158251|ref|XM—002212.4|[16158251] - 1157: XM—003736
Homo sapiens G protein-coupled receptor kinase 6 (GPRK6), mRNA
gi|16157601|ref|XM—003736.4|[16157601] - 1158: XM—038350
Homo sapiens platelet-derived growth factor receptor, beta polypeptide (PDGFRB),
mRNA
gi|16157449|ref|XM—038350.21[16157449] - 1159: XM—003789
Homo sapiens colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog (CSF1R), mRNA
gi|16157447|ref|XM—003789.4|[16157447] - 1160: XM—054659
Homo sapiens olfactory receptor, family 3, subfamily A, member 3 (OR3A3), mRNA
gi|15314104|ref|XM—054659.1|[15314104] - 1161: XM—054658
Homo sapiens olfactory receptor, family 1, subfamily E, member 1 (OR1E1), mRNA
gi|15314100|ref|XM—054658.1|[15314100] - 1162: XM—006275
Homo sapiens membrane-spanning 4-domains, subfamily A, member 1 (MS4A2), mRNA
gi|15311761|ref|XM—006275.4|[15311761] - 1163: XM—012695
Homo sapiens growth factor receptor-bound protein 7 (GRB7), mRNA
gi|15310219|ref|XM—012695.4|[15310219] - 1164: XM—045812
Homo sapiens G protein-coupled receptor 72 (GPR72), mRNA
gi|15308293|ref|XM—045812.2|[15308293] - 1165: XM—033995
Homo sapiens histamine H4 receptor (HRH4), mRNA
gi|15305825|ref|XM—033995.2|[15305825] - 1166: XM—036978
Homo sapiens tumor necrosis factor receptor superfamily, member 11a, activator
of NFKB (TNFRSF11A), mRNA
gi|15305343|ref|XM—036978.2|[15305343] - 1167: XM—015355
Homo sapiens protein tyrosine phosphatase, receptor type, R (PTPRR), mRNA
gi|15304370|ref|XM—015355.2|[15304370] - 1168: XM—006738
Homo sapiens CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 1 (CD36L1), mRNA
gi|15303296|ref|XM—006738.5|[15303296] - 1169: XM—049255
Homo sapiens Fc fragment of IgE, low affinity II, receptor for (CD23A) (FCER2),
mRNA
gi|15302967|ref|XM—049255.2|[15302967] - 1170: XM—008930
Homo sapiens coagulation factor II (thrombin) receptor-like 3 (F2RL3), mRNA
gi|15302724|ref|XM—008930.4|[15302724] - 1171: NT—029418
Homo sapiens chromosome 12 working draft sequence segment
gi|15302021|ref|NT—029418.1|Hs12—29577[15302021] - 1173: XM—054004
Homo sapiens glutamate receptor, metabotropic 1 (GRM1), mRNA
gi|15299786|ref|XM—054004.1|[15299786] - 1174: XM—046588
Homo sapiens G protein-coupled receptor slt (SLT), mRNA
gi|15299770|ref|XM—046588.2|[15299770] - 1175: XM—032592
Homo sapiens VPS10 domain receptor protein SORCS 3 (SORCS3), mRNA
gi|15299687|ref|XM—032592.2|[15299687] - 1176: XM—054157
Homo sapiens G protein-coupled receptor 35 (GPR35), mRNA
gi|15298180|ref|XM—054157.1|[15298180] - 1177: XM—042907
Homo sapiens bone morphogenetic protein receptor, type IB (BMPR1B), mRNA
gi|15296528|ref|XM—042907.2|[15296528] - 1178: XM—033031
Homo sapiens peroxisome proliferative activated receptor, gamma, coactivator 1
(PPARGC1), mRNA
gi|15295682|ref|XM—033031.2|[15295682] - 1179: XM—003708
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, pi (GABRP), mRNA
gi|15294866|ref|XM—003708.5|[15294866] - 1180: XM—008189
Homo sapiens CMRF35 leukocyte immunoglobulin-like receptor (CMRF35), mRNA
gi|14785569|ref|XM—008189.4|[14785569] - 1182: XM—033305
Homo sapiens lymphotoxin beta receptor (TNFR superfamily, member 3) (LTBR), mRNA
gi|14784387|ref|XM—033305.1|[14784387] - 1183: XM—004350
Homo sapiens cannabinoid receptor 1 (brain) (CNR1), mRNA
gi|14783266|ref|XM—004350.4|[14783266] - 1184: XM—004285
Homo sapiens peroxisome proliferative activated receptor, delta (PPARD), mRNA
gi|14782955|ref|XM—004285.4|[14782955] - 1185: XM—042636
Homo sapiens inositol 1,4,5-triphosphate receptor, type 3 (ITPR3), mRNA
gi|14782869|ref|XM—042636.1|[14782869] - 1187: XM—050142
Homo sapiens integrin, alpha M (complement component receptor 3, alpha; also known as CD11b (p170), macrophage antigen alpha polypeptide) (ITGAM), mRNA
gi|14779440|ref|XM—050142.1|[14779440] - 1188: XM—037826
Homo sapiens adrenergic, beta, receptor kinase 2 (ADRBK2), mRNA
gi|14777914|ref|XM—037826.1|[14777914] - 1189: XM—036497
Homo sapiens olfactory receptor, family 1, subfamily F, member 2 (OR1F2), mRNA
gi|14777865|ref|XM—036497.1|[14777865] - 1190: XM—036891
Homo sapiens purinergic receptor P2X-like 1, orphan receptor (P2RXL1), mRNA
gi|14777537|ref|XM—036891.1|[14777537] - 1191: XM—007986
Homo sapiens apolipoprotein B48 receptor (APOB48R), mRNA
gi|14777420|ref|XM—007986.4|[14777420] - 1192: XM—047456
Homo sapiens melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) (MC1R), mRNA
gi|14776693|ref|XM—047456.1|[14776693] - 1193: XM—030214
Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A),
mRNA
gi|14776459|ref|XM—030214.1|[14776459] - 1194: XM—049959
Homo sapiens chemokine (C-C motif) receptor 7 (CCR7), mRNA
gi|14775963|ref|XM—049959.1|[14775963] - 1196: XM—048049
Homo sapiens G protein-coupled receptor 56 (GPR56), mRNA
gi|14775189|ref|XM—048049.1|[14775189] - 1197: XM—046488
Homo sapiens glucagon receptor (GCGR), mRNA
gi|14775175|ref|XM—046488.1|[14775175] - 1198: XM—040635
Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 1 (P2RX1), mRNA
gi|14774341|ref|XM—040635.1|[14774341] - 1199: XM—018451
Homo sapiens cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) (CHRNB1), mRNA
gi|14773487|ref|XM—018451.2|[14773487] - 1201: XM—008432
Homo sapiens integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) (ITGA3), mRNA
gi|14773206|ref|XM—008432.4|[14773206]
- 1202: XM—047339
Homo sapiens opiate receptor-like 1 (OPRL1), mRNA
gi|14772199|ref|XM—047339.1|[14772199] - 1203: XM—006349
Homo sapiens angiotensin receptor-like 1 (AGTRL1), mRNA
gi|14771894|ref|XM—006349.2|[14771894] - 1204: XM—046182
Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 3 (P2RX3), mRNA
gi|14771633|ref|XM—046182.1|[14771633] - 1205: XM—006312
Homo sapiens sortilin-related receptor, L (DLR class) A repeats-containing (SORL1), mRNA
gi|14771251|ref|XM—006312.4|[14771251] - 1206: XM—012936
Homo sapiens protein tyrosine phosphatase, receptor type, T (PTPRT), mRNA
gi|14770881|ref|XM—012936.3|[14770881] - 1207: XM—040842
Homo sapiens cullin 5 (CUL5), mRNA
gi|14770334|ref|XM—040842.1|[14770334] - 1208: XM—045103
Homo sapiens G protein coupled receptor interacting protein, complement-c1q tumor necrosis factor-related (ZSIG37), mRNA
gi|14770190|ref|XM—045103.1|[14770190] - 1209: XM—040699
Homo sapiens transient receptor potential cation channel, subfamily C, member 6
(TRPC6), mRNA
gi|14770156|ref|XM—040699.1|[14770156] - 1210: XM—040922
Homo sapiens interleukin 13 receptor, alpha 2 (IL13RA2), mRNA
gi|14769890|ref|XM—040922.1|[14769890] - 1211: XM—028854
Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 4 (CHRNA4), mRNA
gi|14769881|ref|XM—028854.1|[14769881] - 1212: XM—028783
Homo sapiens opioid growth factor receptor (OGFR), mRNA
gi|14769761|ref|XM—028783.1|[14769761] - 1213: XM—050577
Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 7 (ILT11), mRNA
gi|14769454|ref|XM—050577.1|[14769454] - 1215: XM—045929
Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 4 (P2RX4), mRNA
gi|14768232|ref|XM—045929.1|[14768232] - 1216: XM—006929
Homo sapiens complement component 3a receptor 1 (C3AR1), mRNA
gi|14765892|ref|XM—006929.2|[14765892] - 1217: XM—030897
Homo sapiens angiotensin receptor 2 (AGTR2), mRNA
gi|14765825|ref|XM—030897.1|[14765825] - 1218: XM—037563
Homo sapiens G protein-coupled receptor 54 (GPR54), mRNA
gi|14765555|ref|XM—037563.1|[14765555] - 1219: XM—045549
Homo sapiens FGF receptor activating protein 1 (FRAG1), mRNA
gi|4765112|ref|XM—045549.1|[14765112] - 1220: XM—045706
Homo sapiens toll-like receptor 8 (TLR8), mRNA
gi|14764423|ref|XM—045706.1|[14764423] - 1221: XM—013100
Homo sapiens G protein-coupled receptor 34 (GPR34), mRNA
gi|14764061|ref|XM—013100.3|[14764061] - 1222: XM—012862
Homo sapiens cargo selection protein (mannose 6 phosphate receptor binding protein) (TIP47), mRNA
gi|14764025|ref|XM—012862.3|[14764025] - 1223: XM—035037
Homo sapiens low density lipoprotein receptor-related protein 4 (LRP4), mRNA
gi|14763920|ref|XM—035037.1|[14763920] - 1224: XM—050707
Homo sapiens activin A receptor type II-like 1 (ACVRL1), mRNA
gi|14763806|ref|XM—050707.1|[14763806] - 1225: XM—036573
Homo sapiens low density lipoprotein receptor-related protein 3 (LRP3), mRNA
gi|14763070|ref|XM—036573.1|[14763070] - 1226: XM—012843
Homo sapiens protein tyrosine phosphatase, receptor type, H (PTPRH), mRNA
gi|14762603|ref|XM—012843.3|[14762603] - 1227: XM—006789
Homo sapiens protein tyrosine phosphatase, receptor type, B (PTPRB), mRNA
gi|14762249|ref|XM—006789.4|[14762249] - 1229: XM—034808
Homo sapiens interleukin 1 receptor accessory protein-like 2 (IL1RAPL2), mRNA
gi|14760985|ref|XM—034808.1|[14760985] - 1230: XM—006747
Homo sapiens inositol 1,4,5-triphosphate receptor, type 2 (ITPR2), mRNA
gi|14760648|ref|XM—006747.4|[14760648] - 1231: XM—015921
Homo sapiens putative chemokine receptor; GTP-binding protein (HM74), mRNA
gi|14760439|ref|XM—015921.2|[14760439] - 1232: XM—009008
Homo sapiens egf-like module containing, mucin-like, hormone receptor-like sequence 1 (EMR1), mRNA
gi|14759169|ref|XM—009008.4|[14759169] - 1233: XM—028274
Homo sapiens prostaglandin 12 (prostacyclin) receptor (IP) (PTGIR), mRNA
gi|14758807|ref|XM—028274.1|[14758807] - 1234: XM—007123
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A), mRNA
gi|14757796|ref|XM—007123.4|[14757796] - 1235: XM—049518
Homo sapiens intercellular adhesion molecule 1 (CD54), human rhinovirus receptor
(ICAM1), mRNA
gi|14756651|ref|XM—049518.1|[14756651] - 1236: XM—049496
Homo sapiens purinergic receptor P2Y, G-protein coupled, 11 (P2RY11), mRNA
gi|14756601|ref|XM—049496.1|[14756601] - 1237: XM—007577
Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 5 (CHRNA5), mRNA
gi|14756537|ref|XM—007577.2|[14756537] - 1238: XM—006636
Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2B (GRIN2B),
mRNA
gi|14756111|ref|XM—006636.4|[14756111] - 1239: XM—044309
Homo sapiens poliovirus receptor (PVR), mRNA
gi|14755769|ref|XM—044309.1|[14755769] - 1240: XM—004134
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1E (HTR1E), mRNA
gi|14755675|ref|XM—004134.4|[14755675] - 1241: XM—033838
Homo sapiens chemokine (C-C motif) receptor 6 (CCR6), mRNA
gi|14755122|ref|XM—033838.1|[14755122] - 1242: XM—031082
Homo sapiens formyl peptide receptor-like 1 (FPRL1), mRNA
gi|14754918|ref|XM—031082.1|[14754918] - 1243: XM—028205
Homo sapiens glucagon-like peptide 1 receptor (GLP1R), mRNA
gi|14754205|ref|XM—028205.1|[14754205] - 1244: XM—051710
Homo sapiens prostaglandin E receptor 2 (subtype EP2), 53 kD (PTGER2), mRNA
gi|14753577|ref|XM—051710.1|[14753577] - 1245: XM—048918
Homo sapiens met proto-oncogene (hepatocyte growth factor receptor) (MET), mRNA
gi|14753543|ref|XM—048918.1|[14753543] - 1246: XM—045352
Homo sapiens receptor-interacting serine-threonine kinase 2 (RIPK2), mRNA
gi|14751723|ref|XM—045352.1|[14751723] - 1247: XM—049463
Homo sapiens fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2,
Pfeiffer syndrome) (FGFR1), mRNA
gi|14750712|ref|XM—049463.1|[14750712] - 1248: XM—033240
Homo sapiens leukotriene b4 receptor (chemokine receptor-like 1) (LTB4R), mRNA
gi|14750696|ref|XM—033240.1|[14750696] - 1249: XM—046720
Homo sapiens gamma-aminobutyric acid (GABA) receptor, rho 1 (GABRR1), mRNA
gi|14750531|ref|XM—046720.1|[14750531] - 1250: XM—050434
Homo sapiens interferon gamma receptor 1 (IFNGR1), mRNA
gi|14750131|ref|XM—050434.1|[14750131] - 1251: XM—035832
Homo sapiens cholinergic receptor, nicotinic, beta polypeptide 3 (CHRNB3), mRNA
gi|14749978|ref|XM—035832.1|[14749978] - 1252: XM—034142
Homo sapiens CD36 antigen (collagen type I receptor, thrombospondin receptor) (CD36), mRNA
gi|14749875|ref|XM—034142.1|[14749875] - 1253: XM—030066
Homo sapiens growth hormone releasing hormone receptor (GHRHR), mRNA
gi|14749610|ref|XM—030066.1|[14749610] - 1254: XM—007383
Homo sapiens G protein-coupled receptor 68 (GPR68), mRNA
gi|14748827|ref|XM—007383.2|[14748827] - 1255: XM—004117
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1B (HTR1B), mRNA
gi|14747779|ref|XM—004117.2|[14747779] - 1256: XM—036123
Homo sapiens transient receptor potential cation channel, subfamily M, member 3
(TRPM3), mRNA
gi|14743665|ref|XM—036123.1|[14743665] - 1257: XM—011817
Homo sapiens muscle, skeletal, receptor tyrosine kinase (MUSK), mRNA
gi|14742818|ref|XM—011817.3|[14742818] - 1258: XM—044653
Homo sapiens epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) (EGFR), mRNA
gi|14741797|ref|XM—044653.1|[14741797] - 1259: XM—033529
Homo sapiens G protein-coupled receptor 85 (GPR85), mRNA
gi|14741568|ref|XM—033529.1|[14741568] - 1260: XM—011916
Homo sapiens pancreatic polypeptide receptor 1 (PPYR1), mRNA
gi|14740172|ref|XM—011916.2|[14740172] - 1261: XM—005486
Homo sapiens neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), mRNA
gi|14740022|ref|XM—005486.4|[14740022] - 1262: XM—042740
Homo sapiens region containing Sulfonylurea receptor; KIAA1674 (LOC142781), mRNA
gi|14739341|ref|XM—042740.1|[14739341] - 1263: XM—045386
Homo sapiens very low density lipoprotein receptor (VLDLR), mRNA
gi|14736403|ref|XM—045386.1|[14736403] - 1264: XM—004002
Homo sapiens hyaluronan-mediated motility receptor (RHAMM) (HMMR), mRNA
gi|14734503|ref|XM—004002.4|[14734503] - 1265: XM—034451
Homo sapiens olfactory receptor, family 7, subfamily A, member 120 (OR7E120), mRNA
gi|14733406|ref|XM—034451.1|[14733406] - 1266: XM—029284
Homo sapiens cholecystokinin A receptor (CCKAR), mRNA
gi|14733138|ref|XM—029284.1|[14733138] - 1267: XM—052171
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 4 (HTR4), mRNA
gi|14732310|ref|XM—052171.1|[14732310] - 1268: XM—042695
Homo sapiens fibroblast growth factor receptor-like 1 (FGFRL1), mRNA
gi|14728655|ref|XM—042695.1|[14728655] - 1269: XM—041933
Homo sapiens Ig superfamily receptor LNIR (LNIR), mRNA
gi|14723974|ref|XM—041933.1|[14723974] - 1270: XM—032738
Homo sapiens glycine receptor, alpha 1 (startle disease/hyperekplexia, stiff man
syndrome) (GLRA1), mRNA
gi|14722750|ref|XM—032738.1|[14722750] - 1271: XM—032682
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 6 (GABRA6), mRNA
gi|14722636|ref|XM—032682.1|[14722636] - 1272: XM—017228
Homo sapiens low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor) (LRP1), mRNA
gi|13654580|ref|XM—017228.1|[13654580] - 1273: XM—008538
Homo sapiens aryl hydrocarbon receptor interacting protein-like 1 (AIPL1), mRNA
gi|13653245|ref|XM—008538.3|[13653245] - 1274: XM—007046
Homo sapiens vitamin D (1,25-dihydroxyvitamin D3) receptor (VDR), mRNA
gi|13653215|ref|XM—007046.3|[13653215] - 1275: XM—007751
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 3 (GABRB3), mRNA
gi|13653090|ref|XM—007751.3|[13653090] - 1276: XM—007719
Homo sapiens paired basic amino acid cleaving enzyme (furin, membrane associated
receptor protein) (PACE), mRNA
gi|1365250|ref|XM—007719.2|[13652501] - 1277: XM—010296
Homo sapiens transient receptor potential cation channel, subfamily C, member 5
(TRPC5), mRNA
gi|13652451|ref|XM—010296.2|[13652451] - 1278: XM—006950
Homo sapiens tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A),
mRNA
gi|13652420|ref|XM—006950.3|[13652420] - 1279: XM—008206
Homo sapiens receptor (calcitonin) activity modifying protein 2 (RAMP2), mRNA
gi|13652390|ref|XM—008206.3|[13652390] - 1280: XM—013114
Homo sapiens interleukin 1 receptor accessory protein-like 1 (IL1RAPL1), mRNA
gi|13652318|ref|XM—013114.2|[13652318] - 1281: XM—015989
Homo sapiens interleukin 9 receptor (IL9R), mRNA
gi|13652206|ref|XM—015989.1|[13652206] - 1282: XM—006934
Homo sapiens arginine vasopressin receptor 1A (AVPR1A), mRNA
gi|13652044|ref|XM—006934.3|[13652044] - 1283: XM—012441
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 5 (GABRA5), mRNA
gi|13651536|ref|XM—012441.2|[13651536] - 1284: XM—008193
Homo sapiens putative receptor protein (PMI), mRNA
gi|13650873|ref|XM—008193.2|[13650873] - 1285: XM—009108
Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2D (GRIN2D),
mRNA
gi|13650682|ref|XM—009108.3|[13650682] - 1286: XM—015505
Homo sapiens AXL receptor tyrosine kinase (AXL), mRNA
gi|13650099|ref|XM—015505.1|[13650099] - 1287: XM—006145
Homo sapiens dopamine receptor D4 (DRD4), mRNA
gi|13647063|ref|XM—006145.2|[13647063] - 1288: XM—009803
Homo sapiens transient receptor potential cation channel, subfamily M, member 2
(TRPM2), mRNA
gi|13646881|ref|XM—009803.3|[13646881] - 1289: XM—004030
Homo sapiens adrenergic, beta-2-, receptor, surface (ADRB2), mRNA
gi|13645597|ref|XM—004030.2|[13645597] - 1290: XM—011703
Homo sapiens tumor necrosis factor receptor superfamily, member 10a (TNFRSF10A),
mRNA
gi|13644652|ref|XM—011703.2|[13644652] - 1291: XM—003986
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, gamma 2 (GABRG2), mRNA
gi|13643024|ref|XM—003986.2|[13643024] - 1292: XM—004253
Homo sapiens gamma-aminobutyric acid (GABA) receptor, rho 2 (GABRR2), mRNA
gi|13642452|ref|XM—004253.2|[13642452] - 1293: XM—006233
Homo sapiens glutamate receptor, ionotrophic, AMPA 4 (GRIA4), mRNA
gi|13639643|ref|XM—006233.3|[13639643] - 1294: XM—005384
Homo sapiens RAR-related orphan receptor B (RORB), mRNA
gi|13639481|ref|XM—005384.3|[13639481] - 1295: XM—004988
Homo sapiens aryl hydrocarbon receptor (AHR), mRNA
gi|13631520|ref|XM—004988.2|[13631520] - 1296: XM—011364
Homo sapiens lymphocyte antigen 95 (activating NK-receptor; NK-p44) (LY95), mRNA
gi|3630600|ref|XM—011364.2|[13630600] - 1297: XM—009612
Homo sapiens neurotensin receptor 1 (high affinity) (NTSR1), mRNA
gi|13630500|ref|XM—009612.2|[13630500] - 1298: XM—003417
Homo sapiens CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane protein II) (CD36L2), mRNA
gi|13630130|ref|XM—003417.3|[13630130] - 1299: XM—007817
Homo sapiens tumor necrosis factor receptor superfamily, member 17 (TNFRSF17),
mRNA
gi|13627219|ref|XM—007817.3|[13627219] - 1300: XM—012949
Homo sapiens complement component 1, q subcomponent, receptor 1 (C1QR1), mRNA
gi|12742414|ref|XM—012949.1|[12742414] - 1301: XM—009594
Homo sapiens somatostatin receptor 4 (SSTR4), mRNA
gi|12742412|ref|XM—009594.2|[12742412] - 1302: XM—008512
Homo sapiens vanilloid receptor subtype 1 (VR1), mRNA
gi|12740624|ref|XM—008512.2|[12740624] - 1303: XM—006931
Homo sapiens oxidised low density lipoprotein (lectin-like) receptor 1 (OLR1),
mRNA
gi|12737735|ref|XM—006931.2|[12737735] - 1304: XM—006933
Homo sapiens C-type lectin-like receptor-1 (LOC51267), mRNA
gi|12737731|ref|XM—006933.2|[12737731] - 1305: XM—004438
Homo sapiens interleukin 20 receptor, alpha (IL20RA), mRNA
gi|12732139|ref|XM—004438.2|[12732139] - 1306: XM—003692
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1A (HTR1A), mRNA
gi|12731011|ref|XM—003692.2|[12731011] - 1307: XM—010228
Homo sapiens G protein-coupled receptor 50 (GPR50), mRNA
gi|12719157|ref|XM—010228.2|[12719157] - 1308: XM—009082
Homo sapiens low density lipoprotein receptor (familial hypercholesterolemia) (LDLR), mRNA
gi|1525992|ref|XM—009082.1|[11525992] - 1309: XM—006296
Homo sapiens cholinergic receptor, muscarinic 4 (CHRM4), mRNA
gi|11437838|ref|XM—006296.1|[11437838] - 1310: NT—009784
Homo sapiens chromosome 12 working draft sequence segment
gi|11436706|ref|NT—009784.1|Hs12—9941[11436706] 131I: XM—003386
Homo sapiens gonadotropin-releasing hormone receptor (GNRHR), mRNA
gi|11435615|ref|XM—003386.1|[11435615] - 1312: NT—024131
Homo sapiens chromosome 10 working draft sequence segment
gi|11430625|ref|NT—024131.1|Hs10—24287[11430625] - 1313: XM—009373
Homo sapiens formyl peptide receptor-like 2 (FPRL2), mRNA
gi|11426996|ref|XM—009373.1|[11426996] - 1314: XM—008520
Homo sapiens cholinergic receptor, nicotinic, epsilon polypeptide (CHRNE), mRNA
gi|11426945|ref|XM—008520.1|[11426945] - 1315: XM—009140
Homo sapiens G protein-coupled receptor 4 (GPR4), mRNA
gi|11425489|ref|XM—009140.1|[11425489] - 1316: XM—008279
Homo sapiens adenosine A2b receptor (ADORA2B), mRNA
gi|11425432|ref|XM—008279.1|[11425432] - 1317: XM—010321
Homo sapiens glycine receptor, alpha 2 (GLRA2), mRNA
gi|11421007|ref|XM—010321.1|[11421007] - 1318: XM—004808
Homo sapiens taste receptor, type 2, member 4 (TAS2R4), mRNA
gi|11420322|ref|XM—004808.1|[11420322] - 1319: XM—004807
Homo sapiens taste receptor, type 2, member 5 (TAS2R5), mRNA
gi|11420320|ref|XM—004807.1|[11420320] - 1320: XM—011092
Homo sapiens glycine receptor, alpha 3 (GLRA3), mRNA
gi|18556859|ref|XM—011092.4|[18556859] - 1321: XM—003324
Homo sapiens transient receptor potential cation channel, subfamily C, member 3
(TRPC3), mRNA
gi|18556760|ref|XM—003324.5|[18556760] - 1322: XM—011068
Homo sapiens macrophage stimulating 1 receptor (c-met-related tyrosine kinase)
(MST1R), mRNA
gi|18556611|ref|XM—011068.4|[18556611] - 1323: XM—011064
Homo sapiens protein tyrosine phosphatase, receptor type, G (PTPRG), mRNA
gi|18556526|ref|XM—011064.7|[18556526] - 1324: XM—003207
Homo sapiens glutamate receptor, metabotropic 2 (GRM2), mRNA
gi|18556346|ref|XM—003207.5|[18556346] - 1325: XM—036436
Homo sapiens interleukin 1 receptor accessory protein (IL1RAP), mRNA
gi|18555803|ref|XM—036436.4|[18555803] - 1326: XM—031246
Homo sapiens roundabout, axon guidance receptor, homolog 2 (Drosophila) (ROBO2),
mRNA
gi|18555796|ref|XM—031246.2|[18555796] - 1327: XM—003226
Homo sapiens vasoactive intestinal peptide receptor 1 (VIPR1), mRNA
gi|18555693|ref|XM—003226.7|[18555693] - 1328: NT—005824
Homo sapiens chromosome 3 working draft sequence segment
gi|18555677|ref|NT—005824.7|Hs3—5981[18555677] - 1329: XM—093692
Homo sapiens RYK receptor-like tyrosine kinase (RYK), mRNA
gi|18555675|ref|XM—093692.1|[18555675] - 1332: NT—005564
Homo sapiens chromosome 3 working draft sequence segment
gi|18555104|ref|NT—005564.8|Hs3—5721[18555104] - 1333: XM—010943
Homo sapiens inositol 1,4,5-triphosphate receptor, type 1 (ITPR1), mRNA
gi|18554594|ref|XM—010943.7|[18554594] - 1334: XM—052730
Homo sapiens transferrin receptor (p90, CD71) (TFRC), mRNA
gi|18553906|ref|XM—052730.3|[18553906] - 1335: XM—032666
Homo sapiens calcium-sensing receptor (hypocalciuric hypercalcemia 1, severe neonatal hyperparathyroidism) (CASR), mRNA
gi|18553576|ref|XM—032666.3|[18553576] - 1336: XM—002686
Homo sapiens interleukin 1 receptor, type I (IL1R1), mRNA
gi|18553052|ref|XM—002686.6|[18553052] - 1337: XM—002596
Homo sapiens protein tyrosine phosphatase, receptor type, N (PTPRN), mRNA
gi|18552617|ref|XM—002596.6|[18552617] - 1338: XM—087110
Homo sapiens macrophage receptor with collagenous structure (MARCO), mRNA
gi|18552038|ref|XM—087110.1|[18552038] - 1340: XM—087047
Homo sapiens G protein-coupled receptor 66 (GPR66), mRNA
gi|18551251|ref|XM—087047.1|[18551251] - 1341: XM—086954
Homo sapiens G protein-coupled receptor 45 (GPR45), mRNA
gi|18549982|ref|XM—086954.1|[18549982] - 1342: XM—029434
Homo sapiens toll-like receptor 5 (TLR5), mRNA
gi|18549454|ref|XM—029434.2|[18549454] - 1344: XM—089355
Homo sapiens LDL receptor adaptor protein (ARH), mRNA
gi|18549097|ref|XM—089355.1|[18549097] - 1346: XM—086483
Homo sapiens Fc fragment of IgG, low affinity IIa, receptor for (CD32) (FCGR2A),
mRNA
gi|18548731|ref|XM—086483.1|[18548731] - 1347: XM—046751
Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF),
interacting protein (liprin), alpha 4 (PPFIA4), mRNA
gi|18548679|ref|XM—046751.3|[18548679] - 1348: XM—001821
Homo sapiens glutamate receptor, ionotropic, kainate 3 (GRIK3), mRNA
gi|18548332|ref|XM—001821.7|[18548332] - 1349: XM—002205
Homo sapiens colony stimulating factor 3 receptor (granulocyte) (CSF3R), mRNA
gi|18548330|ref|XM—002205.2|[18548330] - 1350: XM—033690
Homo sapiens protein tyrosine phosphatase, receptor type, U (PTPRU), mRNA
gi|18548204|ref|XM—033690.2|[18548204] - 1351: XM—001795
Homo sapiens lamin B receptor (LBR), mRNA
gi|18548051|ref|XM—001795.6|[18548051] - 1352: XM—058179
Homo sapiens natural killer cell receptor 2B4 (CD244), mRNA
gi|18547600|ref|XM—058179.3|[18547600] - 1353: XM—086356
Homo sapiens cannabinoid receptor 2 (macrophage) (CNR2), mRNA
gi|18547399|ref|XM—086356.1|[18547399] - 1354: XM—001499
Homo sapiens endothelial differentiation, sphingolipid G-protein-coupled receptor, 1 (EDG1), mRNA
gi|18547249|ref|XM—001499.1|[18547249] - 1355: NT—031737
Homo sapiens chromosome 1 working draft sequence segment
gi|18547126|ref|NT—031737.1|Hs1—31908[18547126] - 1356: XM—010608
Homo sapiens G-protein coupled receptor 88 (GPR88), mRNA
gi|18547116|ref|XM—010608.6|[18547116] - 1357: XM—089029
Homo sapiens olfactory receptor, family 2, subfamily L, member 2 (OR2L2), mRNA
gi|18547000|ref|XM—089029.1|[18547000] - 1358: XM—089028
Homo sapiens olfactory receptor, family 2, subfamily L, member 1 (OR2L1), mRNA
gi|18546996|ref|XM—089028.1|[18546996] - 1359: XM—089016
Homo sapiens olfactory receptor, family 1, subfamily C, member 1 (OR1C1), mRNA
gi|18546895|ref|XM—089016.1|[18546895] - 1360: XM—001289
Homo sapiens xenotropic and polytropic retrovirus receptor (XPR1), mRNA
gi|18546688|ref|XM—001289.7|[18546688] - 1361: XM—049849
Homo sapiens tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) (TNFRSF14), mRNA
gi|18546661|ref|XM—049849.3|[18546661] - 1362: XM—001667
Homo sapiens natural killer cell receptor, immunoglobulin superfamily member (BY55), mRNA
gi|18546631|ref|XM—001667.5|[18546631] - 1364: XM—086285
Homo sapiens leucine-rich repeat-containing G protein-coupled receptor 6 (LGR6),
mRNA
gi|18546477|ref|XM—086285.1|[18546477] - 1365: XM—016748
Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), mRNA
gi|18546353|ref|XM—016748.4|[18546353] - 1366: XM—088942
Homo sapiens olfactory receptor, family 2, subfamily M, member 4 (OR2M4), mRNA
gi|18546222|ref|XM—088942.1|[18546222] - 1367: XM—086242
Homo sapiens receptor tyrosine kinase-like orphan receptor 1 (ROR1), mRNA
gi|18546174|ref|XM—086242.1|[18546174] - 1368: XM—086232
Homo sapiens G protein-coupled receptor 61 (GPR61), mRNA
gi|18546070|ref|XM—086232.1|[18546070] - 1369: XM—042739
Homo sapiens cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog,
Drosophila) (CELSR2), mRNA
gi|18546045|ref|XM—042739.2|[18546045] - 1370: XM—002008
Homo sapiens complement component (3d/Epstein Barr virus) receptor 2 (CR2), mRNA
gi|18545768|ref|XM—002008.6|[18545768] - 1371: XM—052013
Homo sapiens polymeric immunoglobulin receptor (PIGR), mRNA
gi|18545758|ref|XM—052013.2|[18545758] - 1372: XM—001320
Homo sapiens low density lipoprotein receptor defect C complementing (LDLC), mRNA
gi|18545223|ref|XM—001320.4|[18545223] - 1373: NT—030585
Homo sapiens chromosome 1 working draft sequence segment
gi|18544898|ref|NT—030585.2|Hs1—30841[18544898] - 1374: XM—084053
Homo sapiens complement component (3b/4b) receptor 1, including Knops blood group system (CR1), mRNA
gi|18544845|ref|XM—084053.1|[18544845] - 1376: XM—039685
Homo sapiens putative G-protein coupled receptor (SH120), mRNA
gi|17488963|ref|XM—039685.3|[17488963] - 1377: XM—001687
Homo sapiens adenosine A1 receptor (ADORA1), mRNA
gi|17488879|ref|XM—001687.5|[17488879] - 1378: XM—002700
Homo sapiens cytochrome c oxidase subunit VIIa polypeptide 2 like (COX7A2L), mRNA
gi|17462137|ref|XM—002700.3|[17462137] - 1379: XM—002673
Homo sapiens calcitonin receptor-like (CALCRL), mRNA
gi|17447546|ref|XM—002673.5|[17447546] - 1380: XM—001924
Homo sapiens transforming growth factor, beta receptor III (betaglycan, 300 kD)
(TGFBR3), mRNA
gi|17446897|ref|XM—001924.6|[17446897] - 1381: XM—001744
Homo sapiens tumor necrosis factor receptor superfamily, member 8 (TNFRSF8), mRNA
gi|17444362|ref|XM—001744.6|[17444362] - 1382: XM—054837
Homo sapiens tumor necrosis factor receptor superfamily, member 1B, (TNFRSF1B),
mRNA
gi|17444359|ref|XM—054837.2|[17444359] - 1383: XM—037011
Homo sapiens T-cell receptor interacting molecule (TRIM), mRNA
gi|17438759|ref|XM—037011.2|[17438759] - 1384: NT—022773
Homo sapiens chromosome 4 working draft sequence segment
gi|17438611|ref|NT—022773.6|Hs4—22929[17438611] - 1385: XM—051522
Homo sapiens G protein-coupled receptor (RDC1), mRNA
gi|17437231|ref|XM—051522.2|[17437231] - 1386: NT—029249
Homo sapiens chromosome 2 working draft sequence segment
gi|17436701|ref|NT—029249.2|Hs2—29408[17436701] - 1387: XM—050043
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 4 (GABRA4), mRNA
gi|17436698|ref|XM—050043.2|[17436698] - 1388: XM—001857
Homo sapiens platelet-activating factor receptor (PTAFR), mRNA
gi|17435918|ref|XM—001857.3|[17435918] - 1389: XM—001630
Homo sapiens prostaglandin F receptor (FP) (PTGFR), mRNA
gi|17434349|ref|XM—001630.5|[17434349] - 1390: XM—058183
Homo sapiens activating NK receptor (KALI), mRNA
gi|16165765|ref|XM—058183.1|[16165765] - 1391: XM—003177
Homo sapiens oxytocin receptor (OXTR), mRNA
gi|16164840|ref|XM—003177.5|[16164840] - 1392: XM—001778
Homo sapiens ryanodine receptor 2 (cardiac) (RYR2), mRNA
gi|16161568|ref|XM—001778.6|[16161568] - 1393: XM—039118
Homo sapiens phospholipase A2 receptor 1, 180 kD (PLA2R1), mRNA
gi|16160858|ref|XM—039118.2|[16160858] - 1394: NT—005791
Homo sapiens chromosome 3 working draft sequence segment
gi|16159942|ref|NT—005791.5|Hs3—5948[16159942] - 1395: NT—029941
Homo sapiens chromosome 3 working draft sequence segment
gi|16158541|ref|NT—029941.1|Hs3—30196[16158541] - 1396: XM—056760
Homo sapiens tumor necrosis factor receptor superfamily, member 9 (TNFRSF9), mRNA
gi|16158007|ref|XM—056760.1|[16158007] - 1397: XM—010871
Homo sapiens adrenergic, alpha-2B-, receptor (ADRA2B), mRNA
gi|16157882|ref|XM—010871.5|[16157882] - 1398: XM—055737
Homo sapiens interleukin 6 receptor (IL6R), mRNA
gi|16157271|ref|XM—055737.1|[16157271] - 1399: XM—043563
Homo sapiens insulin receptor-related receptor (INSRR), mRNA
gi|15299156|ref|XM—043563.2|[15299156] - 1400: XM—001466
Homo sapiens protein tyrosine phosphatase, receptor type, F (PTPRF), mRNA
gi|15299050|ref|XM—001466.5|[15299050] - 1401: XM—002888
Homo sapiens activin A receptor, type IIB (ACVR2B), mRNA
gi|15298060|ref|XM—002888.3|[15298060] - 1402: XM—049427
Homo sapiens interleukin 5 receptor, alpha (IL5RA), mRNA
gi|15297287|ref|XM—049427.2|[15297287] - 1404: XM—047502
Homo sapiens chemokine (C-X3-C) receptor 1 (CX3CR1), mRNA
gi|15295593|ref|XM—047502.2|[15295593] - 1405: XM—041048
Homo sapiens chemokine (C-C motif) receptor 8 (CCR8), mRNA
gi|15295589|ref|XM—041048.2|[15295589] - 1406: XM—052155
Homo sapiens adenosine A3 receptor (ADORA3), mRNA
gi|14739381|ref|XM—052155.1|[14739381] - 1407: XM—002926
Homo sapiens chemokine (C-C motif) receptor-like 2 (CCRL2), mRNA
gi|14736663|ref|XM—002926.3|[14736663] - 1408: XM—030397
Homo sapiens chemokine (C-C motif) receptor 5 (CCR5), mRNA
gi|14736645|ref|XM—030397.1|[14736645] - 1409: XM—040605
Homo sapiens interleukin 17B receptor (IL17BR), mRNA
gi|14735848|ref|XM—040605.1|[14735848] - 1410: XM—033199
Homo sapiens growth hormone secretagogue receptor (GHSR), mRNA
gi|14735283|ref|XM—003199.4|[14735283] - 1411: XM—041399
Homo sapiens glutamate receptor, metabotropic 7 (GRM7), mRNA
gi|14734683|ref|XM—041399.1|[14734683] - 1412: XM—039011
Homo sapiens integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) (ITGA4), mRNA
gi|14733147|ref|XM—039011.1|[14733147] - 1413: XM—033709
Homo sapiens opioid receptor, delta 1 (OPRD1), mRNA
gi|14732044|ref|XM—033709.1|[14732044] - 1414: XM—033469
Homo sapiens transforming growth factor, beta receptor II (70-80 kD) (TGFBR2), mRNA
gi|14732004|ref|XM—033469.1|[14732004] - 1415: XM—017782
Homo sapiens ectodysplasin 1, anhidrotic receptor (EDAR), mRNA
gi|14731094|ref|XM—017782.2|[14731094] - 1416: XM—002475
Homo sapiens insulin receptor substrate 1 (IRS1), mRNA
gi|14730385|ref|XM—002475.4|[14730385] - 1417: XM—051470
Homo sapiens angiotensin receptor 1 (AGTR1), mRNA
gi|14729512|ref|XM—051470.1|[14729512] - 1418: XM—001542
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1D (HTR1D), mRNA
gi|14726872|ref|XM—001542.4|[14726872]
- 1419: XM—052382
Homo sapiens histamine receptor H1 (HRH1), mRNA
gi|14726259|ref|XM—052382.1|[14726259] - 1420: XM—032349
Homo sapiens interleukin 22 receptor (IL22R), mRNA
gi|14725224|ref|XM—032349.1|[14725224] - 1421: XM—002792
Homo sapiens APMCF1 protein (APMCF1), mRNA
gi|14720925|ref|XM—002792.4|[14720925] - 1422: XM—045070
Homo sapiens immunoglobulin superfamily receptor translocation associated 2 (IRTA2), mRNA
gi|14720460|ref|XM—045070.1|[14720460] - 1423: XM—045067
Homo sapiens immunoglobulin superfamily receptor translocation associated 1 (IRTA1), mRNA
gi|14720452|ref|XM—045067.1|[14720452] - 1425: XM—002685
Homo sapiens interleukin 1 receptor-like 2 (IL1RL2), mRNA
gi|12728885|ref|XM—002685.2|[12728885] - 1426: XM—002624
Homo sapiens G protein-coupled receptor 75 (GPR75), mRNA
gi|11430331|ref|XM—002624.1|[11430331] - 1427: XM—001907
Homo sapiens G protein-coupled receptor 25 (GPR25), mRNA
gi|11425714|ref|XM—001907.1|[11425714] - 1428: XM—001543
Homo sapiens G protein-coupled receptor 52 (GPR52), mRNA
gi|11423045|ref|XM—001543.1|[11423045] - 1429: NM—016113
Homo sapiens transient receptor potential cation channel, subfamily V, member 2
(TRPV2), mRNA
gi|7706766|ref|NM—016113.1|[7706766] - 1430: NM—002837
Homo sapiens protein tyrosine phosphatase, receptor type, B (PTPRB), mRNA
gi|18491009|ref|NM—002837.2|[18491009] - 1431: NM—017625
Homo sapiens intelectin (ITLN), mRNA
gi|8923027|ref|NM—017625.1|[8923027] - 1432: NM—000651
Homo sapiens complement component (3b/4b) receptor 1, including Knops blood group system (CR1), transcript variant S, mRNA
gi|18490997|ref|NM—000651.2|[18490997] - 1433: NM—000573
Homo sapiens complement component (3b/4b) receptor 1, including Knops blood group system (CR1), transcript variant F, mRNA
gi|18490996|ref|NM—000573.2|[18490996] - 1435: BC022501
Homo sapiens, neurotensin receptor 2, clone MGC:26447 IMAGE:4792730, mRNA, complete cds
gi|18490911|gb|BC022501.1)[18490911] - 1436: BC022447
Homo sapiens, angiotensin receptor 1, clone MGC:25987 IMAGE:4799755, mRNA, complete cds
gi|18490885|gb|BC022447.1|[18490885] - 1437: BC022317
Homo sapiens, T cell receptor delta diversity 3, clone MGC:22624 IMAGE:4732634, mRNA, complete cds
gi|18490613|gb|BC022317.1|[18490613] - 1438: BC022304
Homo sapiens, receptor (calcitonin) activity modifying protein 3, clone MGC:22548 IMAGE:4717934, mRNA, complete cds
gi|18490610|gb|BC022304.1|[18490610] - 1439: BC022496
Homo sapiens, glutamate receptor, metabotropic 3, clone MGC:26392 IMAGE:4792430,
mRNA, complete cds
gi|18490393|gb|BC022496.1|[18490393] - 1440: BC022511
Homo sapiens, endothelin receptor type A, clone MGC:26548 IMAGE:4812050, mRNA,
complete cds
gi|18490297|gb|BC022511.1|[18490297] - 1441: BC022502
Homo sapiens, glycine receptor, beta, clone IMAGE:4792516, mRNA
gi|18490294|gb|BC022502.1|[18490294] - 1442: BC022449
Homo sapiens, gamma-aminobutyric acid (GABA) A receptor, beta 1, clone MGC:25991
IMAGE:4797401, mRNA, complete cds
gi|18490266|gb|BC022449.1|[18490266] - 1443: BC022295
Homo sapiens, oxidised low density lipoprotein (lectin-like) receptor 1, clone
MGC:22491 IMAGE:4722086, mRNA, complete cds
gi|18490152|gb|BC022295.1|[18490152] - 1444: BC022279
Homo sapiens, CMRF35 leukocyte immunoglobulin-like receptor, clone MGC:22395 IMAGE:4692025, mRNA, complete cds
gi|18490142|gb|BC022279.1|[18490142] - 1448: AH011463
Homo sapiens chromosome 7 map 7q22
gi|18483169|gb|AH011463.1|SEG_AF461188S[18483169] - 1449: AF453828
Homo sapiens G protein-coupled receptor affecting testicular descent (GREAT) mRNA, complete cds
gi|18483167|gb|AF453828.1|[18483167] - 1450: AY072912
Homo sapiens coxsackie-adenovirus-receptor isoform CAR4/7 (CXADR) mRNA, complete
cds; alternatively spliced
gi|18482481|gb|AY072912.1|[18482481] - 1451: AY072911
Homo sapiens coxsackie-adenovirus-receptor isoform CAR3/7 (CXADR) mRNA, complete
cds; alternatively spliced
gi|18482479|gb|AY072911.1|[18482479] - 1452: AY072910
Homo sapiens soluble coxsackie-adenovirus-receptor isoform CAR2/7 (CXADR) mRNA,
complete cds; alternatively spliced
gi|18482477|gb|AY072910.1|[18482477] - 1453: NM—020399
Homo sapiens PDZ/coiled-coil domain binding partner for the rho-family GTPase TC10 (PIST), mRNA
gi|9966876|ref|NM—020399.1|[9966876] - 1454: NM—017935
Homo sapiens hypothetical protein FLJ20706 (BANK), mRNA
gi|8923635|ref|NM—017935.1|[8923635] - 1455: NM—002438
Homo sapiens mannose receptor, C type 1 (MRC1), mRNA
gi|4505244|ref|NM—002438.1|[4505244] - 1456: AF321913
Homo sapiens histamine H3 receptor isoform 4 (HRH3) mRNA, complete cds, alternatively spliced
gi|18461386|gb|AF321913.1|[18461386] - 1457: AF321912
Homo sapiens histamine H3 receptor isoform 3 (HRH3) mRNA, complete cds, alternatively spliced
gi|18461384|gb|AF321912.1|[18461384] - 1458: AF321911
Homo sapiens histamine H3 receptor isoform 2 (HRH3) mRNA, complete cds, alternatively spliced
gi|18461382|gb|AF321911.1|[18461382] - 1459: AF321910
Homo sapiens histamine H3 receptor isoform 1 (HRH3) mRNA, complete cds, alternatively spliced
gi|18461380|gb|AF321910.1|[18461380] - 1460: NM—080841
Homo sapiens protein tyrosine phosphatase, receptor type, A (PTPRA), transcript
variant 3, mRNA
gi|18450370|ref|NM—080841.1|[18450370] - 1461: NM—080840
Homo sapiens protein tyrosine phosphatase, receptor type, A (PTPRA), transcript
variant 2, mRNA
gi|18450368|ref|NM—080840.1|[18450368] - 1462: NM—002836
Homo sapiens protein tyrosine phosphatase, receptor type, A (PTPRA), transcript
variant 1, mRNA
gi|18450367|ref|NM—002836.2|[18450367] - 1463: NM—023915
Homo sapiens G protein-coupled receptor 87 (GPR87), mRNA
gi|13236505|ref|NM—023915.1|[13236505] - 1464: NM—003029
Homo sapiens SHC (Src homology 2 domain containing) transforming protein 1 (SHC1), mRNA
gi|10835030|ref|NM—003029.1|[10835030] - 1465: NM—018490
Homo sapiens G protein-coupled receptor 48 (GPR48), mRNA
gi|8923700|ref|NM—018490.1|[8923700] - 1466: NM—006065
Homo sapiens signal-regulatory protein beta 1 (SIRPB1), mRNA
gi|5174678|ref|NM—006065.1|[5174678] - 1467: NM—003667
Homo sapiens G protein-coupled receptor 49 (GPR49), mRNA
gi|4504378|ref|NM—003667.1|[4504378] - 1468: NM—080816
Homo sapiens signal-regulatory protein beta 2 (SIRPB2), transcript variant 2, mRNA
gi|18426908|ref|NM—080816.1|[18426908] - 1469: NM—018556
Homo sapiens signal-regulatory protein beta 2 (SIRPB2), transcript variant 1, mRNA
gi|18426907|ref|NM—018556.2|[18426907] - 1470: NM—080914
Homo sapiens asialoglycoprotein receptor 2 (ASGR2), transcript variant 3, mRNA
gi|18426876|ref|NM—080914.1|[18426876] - 1471: NM—080913
Homo sapiens asialoglycoprotein receptor 2 (ASGR2), transcript variant 2, mRNA
gi|18426874|ref|NM—080913.1|[18426874] - 1472: NM—080912
Homo sapiens asialoglycoprotein receptor 2 (ASGR2), transcript variant H2′, mRNA
gi|18426872|ref|NM—080912.1|[18426872] - 1473: NM—001181
Homo sapiens asialoglycoprotein receptor 2 (ASGR2), transcript variant 1, mRNA
gi|18426871|ref|NM—001181.2|[18426871] - 1474: NM—001671
Homo sapiens asialoglycoprotein receptor 1 (ASGR1), mRNA
gi|18426870|ref|NM—001671.2|[18426870] - 1475: NM—014978
Homo sapiens VPS10 domain receptor protein SORCS 3 (SORCS3), mRNA
gi|18379345|ref|NM—014978.1|[18379345] - 1476: NM—021625
Homo sapiens transient receptor potential cation channel, subfamily V, member 4
(TRPV4), mRNA
gi|13699862|ref|NM—021625.2|[13699862] - 1477: NM—020960
Homo sapiens G protein-coupled receptor 107 (GPR107), mRNA
gi|13470087|ref|NM—020960.1|[13470087] - 1478: NM—021634
Homo sapiens leucine-rich repeat-containing G protein-coupled receptor 7 (LGR7),
mRNA
gi|11056007|ref|NM—021634.1|[11056007] - 1479: NM—016179
Homo sapiens transient receptor potential cation channel, subfamily C, member 4
(TRPC4), mRNA
gi|7706746|ref|NM—016179.1|[7706746] - 1480: NM—004621
Homo sapiens transient receptor potential cation channel, subfamily C, member 6
(TRPC6), mRNA
gi|5730101|ref|NM—004621.21[5730101] - 1481: NM—003304
Homo sapiens transient receptor potential cation channel, subfamily C, member 1
(TRPC1), mRNA
gi|4507684|ref|NM—003304.1|[4507684] - 1485: NM—016235
Homo sapiens G protein-coupled receptor, family C, group 1, member B (GPRC5B),
mRNA
gi|7706450|ref|NM—016235.1|[7706450] - 1487: AF024642
Homo sapiens luteinizing hormone receptor gene, exon 1 and partial cds
gi|2655113|gb|AF024642.1|AF024642[2655113] - 1488: NM—007128
Homo sapiens pre-B lymphocyte gene 1 (VPREB1), mRNA
gi|18379350|ref|NM—007128.2|[18379350] - 1489: NM—020777
Homo sapiens VPS10 domain receptor protein (SORCS2), mRNA
gi|18379343|ref|NM—020777.1|[18379343] - 1490: NM—052918
Homo sapiens VPS10 domain receptor protein SORCS 1 (SORCS1), mRNA
gi|8379341|ref|NM—052918.2|[18379341] - 1491: AF391164
Homo sapiens osteoclast-associated receptor hOSCAR-M3 (OSCAR) mRNA, complete cds
gi|18376830|gb|AF391164.1|AF391164[18376830] - 1492: AF391163
Homo sapiens osteoclast-associated receptor hOSCAR-M2 (OSCAR) mRNA, complete cds
gi|18376828|gb|AF391163.1|AF391163[18376828] - 1493: AF391162
Homo sapiens osteoclast-associated receptor hOSCAR-M1 (OSCAR) mRNA, complete cds
gi|18376826|gb|AF391162.1|AF391162[18376826] - 1494: AJ421783
Homo sapiens mRNA for short transient receptor potential channel 7 (TRP7 gene)
gi|18376628|emb|AJ421783.1|HSA421783[18376628] - 1497: AF410902
Homo sapiens neurotrophin receptor tyrosine kinase type 2 (NTRK2) gene, promoter
region and partial cds; alternatively spliced
gi|18369868|gb|AF410902.1|AF410902[18369868] - 1498: AF410901
Homo sapiens neurotrophin receptor tyrosine kinase type 2 truncated isoform (NTRK2) mRNA, complete cds; alternatively spliced
gi|18369866|gb|AF410901.1|AF410901[18369866] - 1499: AF410900
Homo sapiens neurotrophin receptor tyrosine kinase type 2 truncated isoform (NTRK2) mRNA, complete cds; alternatively spliced
gi|18369864|gb|AF410900.1|AF410900[18369864] - 1500: AF410899
Homo sapiens neurotrophin receptor tyrosine kinase type 2 (NTRK2) mRNA, complete
cds; alternatively spliced
gi|18369862|gb|AF410899.1|AF410899[18369862] - 1501: AF410898
Homo sapiens clone DKFZp547L014 neurotrophin receptor tyrosine kinase type 2 truncated isoform (NTRK2) mRNA, partial cds; alternatively spliced
gi|18369860|gb|AF410898.1|AF410898[18369860] - 1502: AY071830
Homo sapiens interleukin 9 receptor (IL9R) gene, complete cds
gi|18071671|gb|AY071830.1|[18071671] - 1503: AF421362
Homo sapiens transient receptor potential channel 4 zeta splice variant (TRPC4)
mRNA, complete cds; alternatively spliced
gi|16517177|gb|AF421362.1|AF421362[16517177] - 1504: AF421361
Homo sapiens transient receptor potential channel 4 eta splice variant (TRPC4)
mRNA, complete cds; alternatively spliced
gi|16517175|gb|AF421361.1|AF421361[16517175] - 1505: AF421360
Homo sapiens transient receptor potential channel 4 epsilon splice variant (TRPC4) mRNA, complete cds; alternatively spliced
gi|16517173|gb|AF421360.1|AF421360[16517173] - 1506: AF421359
Homo sapiens transient receptor potential channel 4 beta splice variant (TRPC4)
mRNA, complete cds; alternatively spliced
gi|16517171|gb|AF421359.1|AF421359[16517171] - 1507: AF421358
Homo sapiens transient receptor potential channel 4 alpha splice variant (TRPC4)
mRNA, complete cds; alternatively spliced
gi|16517169|gb|AF421358.1|AF421358[16517169] - 1508: AF359246
Homo sapiens fibroblast growth factor receptor 4 variant mRNA, complete cds
gi|13991617|gb|AF359246.1|AF359246[13991617] - 1509: NM—022349
Homo sapiens membrane-spanning 4-domains, subfamily A, member 6A (MS4A6A), mRNA
gi|11641258|ref|NM—022349.1|[11641258] - 1510: NM—006055
Homo sapiens LanC lantibiotic synthetase component C-like 1 (bacterial) (LANCL1), mRNA
gi|5174444|ref|NM—006055.1|[5174444] - 1511: NM—005716
Homo sapiens regulator of G-protein signalling 19 interacting protein 1 (RGS19IP1), mRNA
gi|5031714|ref|NM—005716.1|[5031714] - 1512: NM—003307
Homo sapiens transient receptor potential cation channel, subfamily M, member 2
(TRPM2), mRNA
gi|4507688|ref|NM—003307.1|[4507688] - 1513: NM—003807
Homo sapiens tumor necrosis factor (ligand) superfamily, member 14 (TNFSF14), mRNA
gi|4507600|ref|NM—003807.1|[4507600] - 1514: NM—002984
Homo sapiens small inducible cytokine A4 (SCYA4), mRNA
gi|4506844|ref|NM—002984.1|[4506844] - 1515: NM—021181
Homo sapiens 19A24 protein (CRACC), mRNA
gi|12711663|ref|NM—021181.2|[12711663] - 1516: BC021892
Homo sapiens, CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane protein II), clone MGC:9392 IMAGE:3872778, mRNA, complete cds
gi|18257311|gb|BC021892.1|BC021892[18257311] - 1517: AF459285
Homo sapiens 5-hydroxytryptamine receptor 3 subunit C (HTR3C) mRNA, complete cds
gi|18251965|gb|AF459285.1|AF459285[18251965] - 1518: BC021553
Homo sapiens, G protein coupled receptor interacting protein, complement-c1q tumor necrosis factor-related, clone MGC:31795 IMAGE:4622952, mRNA, complete cds
gi|18204860|gb|BC021553.1|BC021553[18204860] - 1519: BC021195
Homo sapiens, dopamine receptor D2, clone MGC:10521 IMAGE:3939741, mRNA, complete cds
gi|18203702|gb|BC021195.1|BC021195[18203702] - 1520: BC020752
Homo sapiens, Epstein-Barr virus induced gene 2 (lymphocyte-specific G protein-coupled receptor), clone MGC:22599 IMAGE:4722289, mRNA, complete cds
gi|18089130|gb|BC020752.1|BC020752[18089130] - 1521: BC020614
Homo sapiens, G protein-coupled receptor 84, clone MGC:22224 IMAGE:4279185, mRNA, complete cds
gi|18089044|gb|BC020614.1|BC020614[18089044] - 1522: BC021104
Homo sapiens, apelin; peptide ligand for APJ receptor, clone MGC:31846 IMAGE:4586949, mRNA, complete cds
gi|18088893|gb|BC021104.1|BC021104[18088893] - 1523: BC020805
Homo sapiens, leukocyte receptor cluster (LRC) member 5, clone MGC:23828 IMAGE:4277870, mRNA, complete cds
gi|18088780|gb|BC020805.1|BC020805[18088780] - 1524: BC020742
Homo sapiens, complement component 3a receptor 1, clone MGC:22570 IMAGE:4690283,
mRNA, complete cds
gi|18088764|gb|BC020742.1|BC020742[18088764] - 1525: BC020815
Homo sapiens, putative receptor protein, clone MGC:23860 IMAGE:4296149, mRNA, complete cds
gi|18088747|gb|BC020815.1|BC020815[18088747] - 1526: BC020768
Homo sapiens, olfactory receptor, family 51, subfamily E, member 2, clone MGC:22638 IMAGE:4249775, mRNA, complete cds
gi|18088468|gb|BC020768.1|BC020768[18088468] - 1527: BC020739
Homo sapiens, interleukin 13 receptor, alpha 2, clone MGC:22566 IMAGE:4807603,
mRNA, complete cds
gi|18088440|gb|BC020739.1|BC020739[18088440] - 1528: BC020678
Homo sapiens, G protein-coupled receptor 34, clone MGC:22389 IMAGE:4770479, mRNA, complete cds
gi|18088371|gb|BC020678.1|BC020678[18088371] - 1529: BC020669
Homo sapiens, advanced glycosylation end product-specific receptor, clone MGC:22357 IMAGE:4718076, mRNA, complete cds
gi|18088362|gb|BC020669.1|BC020669[18088362] - 1530: BC020968
Homo sapiens, chemokine (C-X-C motif), receptor 4 (fusin), clone MGC:9199 IMAGE:3846345, mRNA, complete cds
gi|18088082|gb|BC020968.1|BC020968[18088082] - 1531: BC019610
Homo sapiens, somatostatin receptor 2, clone MGC:24950 IMAGE:3875163, mRNA, complete cds
gi|18043108|gb|BC019610.1|BC019610[18043108] - 1532: BC020079
Homo sapiens, lamin B receptor, clone MGC:9041 IMAGE:3925138, mRNA, complete cds
gi|18042833|gb|BC020079.1|BC020079[18042833] - 1715: NM—001364
Homo sapiens discs, large homolog 2, chapsyn-110 (Drosophila) (DLG2), mRNA
gi|4557526|ref|NM—001364.1|[4557526] - 1716: NM—080744
Homo sapiens scavenger receptor cysteine rich domain containing, group B (4 domains) (SRCRB4D), mRNA
gi|18152778|ref|NM—080744.1|[18152778] - 1717: AB063170
Homo sapiens mRNA for BANK, complete cds
gi|17646091|dbj|AB063170.1|AB063170[17646091] - 1718: NM—022760
Homo sapiens chromosome 20 open reading frame 81 (C20orf81), mRNA
gi|16163672|ref|NM—022760.2|[16163672] - 1719: NM—032554
Homo sapiens G protein-coupled receptor 81 (GPR81), mRNA
gi|14211850|ref|NM—032554.1|[14211850] - 1720: AB054004
Homo sapiens DR5 gene for death receptor 5, promoter and partial cds
gi|13429873|dbj|AB054004.1|AB054004[13429873] - 1721: NM—000668
Homo sapiens alcohol dehydrogenase IB (class I), beta polypeptide (ADH1B), mRNA
gi|11496887|ref|NM—000668.2|[11496887] - 1722: NM—018697
Homo sapiens LanC lantibiotic synthetase component C-like 2 (bacterial) (LANCL2), mRNA
gi|8923910|ref|NM—018697.1|[8923910] - 1723: NM—016610
Homo sapiens toll-like receptor 8 (TLR8), mRNA
gi|7706147|ref|NM—016610.1|[7706147] - 1725: NM—015833
Homo sapiens adenosine deaminase, RNA-specific, B1 (RED1 homolog rat) (ADARB1),
transcript variant DRABA2b, mRNA
gi|7669476|ref|NM—015833.1|[7669476] - 1727: NM—007184
Homo sapiens nischarin (NISCH), mRNA
gi|6005787|ref|NM—007184.1|[6005787] - 1728: NM—000139
Homo sapiens membrane-spanning 4-domains, subfamily A, member 1 (MS4A2), mRNA
gi|4503676|ref|NM—000139.1|[4503676] - 1730: NM—080681
Homo sapiens collagen, type XI, alpha 2 (COL11A2), transcript variant 2, mRNA
gi|18201918|ref|NM—080681.1|[18201918] - 1731: NM—080680
Homo sapiens collagen, type XI, alpha 2 (COL11A2), transcript variant 1, mRNA
gi|18201916|ref|NM—080680.1|[18201916] - 1732: NM—080679
Homo sapiens collagen, type XI, alpha 2 (COL11A2), transcript variant 3, mRNA
gi|18201914|ref|NM—080679.1|[18201914] - 1733: NM—006115
Homo sapiens preferentially expressed antigen in melanoma (PRAME), mRNA
gi|18201906|ref|NM—006115.2|[18201906] - 1734: NM—020526
Homo sapiens EphA8 (EPHA8), mRNA
gi|18201903|ref|NM—020526.2|[18201903] - 1735: NM—080818
Homo sapiens G protein-coupled receptor 80 (GPR80), mRNA
gi|18201871|ref|NM—080818.1[18201871] - 1736: NM—080817
Homo sapiens G protein-coupled receptor 82 (GPR82), mRNA
gi|18201869|ref|NM—080817.1|[18201869] - 1737: AF400075
Homo sapiens coagulation factor II (thrombin) receptor-like 1 (F2RL1) gene, complete cds
gi|15021772|gb|AF400075.1|AF400075[15021772] - 1738: NM—024021
Homo sapiens membrane-spanning 4-domains, subfamily A, member 4 (MS4A4A), mRNA
gi|13430865|ref|NM—024021.1|[13430865] - 1739: A1B066218
Homo sapiens RYR1 gene for ryanodine receptor type1, partial cds, clone: 4-101
gi|18181961|dbj|AB066218.1|AB066218[18181961] - 1740: AB066217
Homo sapiens RYR1 gene for ryanodine receptor type1, partial cds, clone: 4-96
gi|18181959|dbj|AB066217.1|AB066217[18181959] - 1741: NM—021950
Homo sapiens membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of
IgE, high affinity I, receptor for; beta polypeptide) (MS4A1), mRNA
gi|11386186|ref|NM—021950.1|[11386186] - 1742: NM—012323
Homo sapiens v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) (MAFF), mRNA
gi|6912489|ref|NM—012323.1|[6912489] - 1743: AJ298292
Homo sapiens mRNA for histamine receptor H4 (HRH4 gene)
gi|18152452|emb|AJ298292.1|HSA298292[18152452] - 1744: AB070621
Homo sapiens HTR4 gene for 5-hydroxytryptamine 4 receptor, promoter and exon 1
gi|18149171|dbj|AB070621.1|AB070621[18149171] - 1745: AB070620
Homo sapiens HTR4 mRNA for 5-hydroxytryptamine 4 receptor, partial cds
gi|18149169|dbj|AB070620.1|AB070620[18149169] - 1746: AB050774
Homo sapiens N27C7-4 gene, complete cds
gi|8147104|dbj|AB050774.1|AB050774[18147104] - 1747: AB048946
Homo sapiens PrRPR gene for prolactin releasing peptide receptor, complete cds
gi|18147078|dbj|AB048946.1|AB048946[18147078] - 1748: NM—030760
Homo sapiens endothelial differentiation, sphingolipid G-protein-coupled receptor, 8 (EDG8), mRNA
gi|18141314|ref|NM—030760.2|[18141314] - 1749: NM—032556
Homo sapiens interleukin-1 HY2 (IL1HY2), mRNA
gi|18141307|ref|NM—032556.2|[18141307] - 1750: AF459634
Homo sapiens immunoglobulin superfamily receptor translocation associated 5 mRNA, complete cds
gi|18140080|gb|AF459634.1|AF459634[18140080] - 1751: AF459633
Homo sapiens immunoglobulin superfamily receptor translocation associated 4 mRNA, complete cds
gi|18140078|gb|AF459633.1|AF459633[18140078] - 1752: AY046529
Homo sapiens melanocortin 1 receptor mutant V122M (MC1R) gene, complete cds
gi|1813824|gb|AY046529.1|[18138241] - 1753: AY046528
Homo sapiens melanocortin 1 receptor mutant 140T (MC1R) gene, complete cds
gi|18138239|gb|AY046528.1|[18138239] - 1754: AX338549
Sequence 1 from Patent WO0185790
gi|18128949|emb|AX338549.1|AX338549[18128949] - 1755: NM—001745
Homo sapiens calcium modulating ligand (CAMLG), mRNA
gi|18105008|ref|NM—001745.2|[18105008] - 1756: NM—001128
Homo sapiens adaptor-related protein complex 1, gamma 1 subunit (AP1G1), mRNA
gi|18104997|ref|NM—001128.2|[18104997] - 1757: NM—080545
Homo sapiens adaptor-related protein complex 1, gamma 2 subunit (AP1G2), transcript variant 2, mRNA
gi|18104995|ref|NM—080545.1|[18104995] - 1758: NM—003917
Homo sapiens adaptor-related protein complex 1, gamma 2 subunit (AP1G2), transcript variant 1, mRNA
gi|18104994|ref|NM—003917.2|[18104994] - 1759: AF459027
Homo sapiens immunoglobulin superfamily receptor translocation associated protein 3 mRNA, complete cds
gi|18092654|gb|AF459027.1|AF459027[18092654] - 1760: AY069943
Homo sapiens TCP11b protein mRNA, complete cds
gi|18091790|gb|AY069943.1|[18091790] - 1761: AY063126
Homo sapiens Fc alpha/mu receptor mRNA, partial cds; alternatively spliced
gi|18032043|gb|AY063126.1[18032043] - 1762: AY063125
Homo sapiens Fc alpha/mu receptor mRNA, complete cds; alternatively spliced
gi|18032041|gb|AY063125.1|[18032041] - 1763: AF395264
Homo sapiens clone EIII48 bpVNTR55 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063763|gb|AF395264.1|AF395264[17063763] - 1764: AF395263
Homo sapiens clone EIII48 bpVNTR54 dopamine receptor D4 (DRD4) gene, partial cds
gi|1706376|gb|AF395263.1|AF395263[17063761] - 1765: AF395262
Homo sapiens clone EIII48 bpVNTR53 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063759|gb|AF395262.1|AF395262[17063759] - 1766: AF395261
Homo sapiens clone EIII48 bpVNTR52 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063757|gb|AF395261.1|AF395261[17063757] - 1767: AF395260
Homo sapiens clone EIII48 bpVNTR51 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063755|gb|AF395260.1|AF395260[17063755] - 1768: AF395259
Homo sapiens clone EIII48 bpVNTR50 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063753|gb|AF395259.1|AF395259[17063753] - 1769: AF395258
Homo sapiens clone EIII48 bpVNTR49 dopamine receptor D4 (DRD4) gene, partial cds
gi|1706375|gb|AF395258.1|AF395258[17063751] - 1770: AF395257
Homo sapiens clone EIII48 bpVNTR48 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063749|gb|AF395257.1|AF395257[17063749] - 1771: AF395256
Homo sapiens clone EIII48 bpVNTR47 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063747|gb|AF395256.1|AF395256[17063747] - 1772: AF395255
Homo sapiens clone EIII48 bpVNTR46 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063745|gb|AF395255.1|AF395255[17063745] - 1773: AF395254
Homo sapiens clone EIII48 bpVNTR45 dopamine receptor D4 (DRD4) gene, partial cds
gi|7063743|gb|AF395254.1|AF395254[17063743] - 1774: AF395253
Homo sapiens clone EIII48 bpVNTR44 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063741|gb|AF395253.1|AF395253[17063741] - 1775: AF395252
Homo sapiens clone EIII48 bpVNTR43 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063739|gb|AF395252.1|AF395252[17063739] - 1776: AF395251
Homo sapiens clone EIII48 bpVNTR42 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063737|gb|AF395251.1|AF395251[17063737] - 1777: AF395250
Homo sapiens clone EIII48 bpVNTR41 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063735|gb|AF395250.1|AF395250[17063735] - 1778: AF395249
Homo sapiens clone EIII48 bpVNTR40 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063733|gb|AF395249.1|AF395249[17063733] - 1779: AF395248
Homo sapiens clone EIII48 bpVNTR39 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063731|gb|AF395248.1|AF395248[17063731] - 1780: AF395247
Homo sapiens clone EIII48 bpVNTR38 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063729|gb|AF395247.1|AF395247[17063729] - 1781: AF395246
Homo sapiens clone EIII48 bpVNTR37 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063727|gb|AF395246.1|AF395246[17063727] - 1782: AF395245
Homo sapiens clone EIII48 bpVNTR36 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063725|gb|AF395245.1|AF395245[17063725] - 1783: AF395244
Homo sapiens clone EIII48 bpVNTR35 dopamine receptor D4 (DRD4) gene, partial cds
gi|7063723|gb|AF395244.1|AF395244[17063723] - 1784: AF395243
Homo sapiens clone EIII48 bpVNTR34 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063721|gb|AF395243.1|AF395243[17063721] - 1785: AF395242
Homo sapiens clone EIII48 bpVNTR33 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063719|gb|AF395242.1|AF395242[17063719] - 1786: AF395241
Homo sapiens clone EIII48 bpVNTR32 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063717|gb|AF395241.1|AF395241[17063717] - 1787: AF395240
Homo sapiens clone EIII48 bpVNTR31 dopamine receptor D4 (DRD4) gene, partial cds
gi|7063715|gb|AF395240.1|AF395240[17063715] - 1788: AF395239
Homo sapiens clone EIII48 bpVNTR30 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063713|gb|AF395239.1|AF395239[17063713] - 1789: AF395238
Homo sapiens clone EIII48 bpVNTR29 dopamine receptor D4 (DRD4) gene, partial cds
gi|1706371|gb|AF395238.1|AF395238[17063711] - 1790: AF395237
Homo sapiens clone EIII48 bpVNTR28 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063709|gb|AF395237.1|AF395237[17063709] - 1791: AF395236
Homo sapiens clone EIII48 bpVNTR27 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063707|gb|AF395236.1|AF395236[17063707] - 1792: AF395235
Homo sapiens clone EIII48 bpVNTR26 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063705|gb|AF395235.1|AF395235[17063705] - 1793: AF395234
Homo sapiens clone EIII48 bpVNTR25 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063703|gb|AF395234.1|AF395234[17063703] - 1794: AF395233
Homo sapiens clone EIII48 bpVNTR24 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063701|gb|AF395233.1|AF395233[17063701] - 1795: AF395232
Homo sapiens clone EIII48 bpVNTR23 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063699|gb|AF395232.1|AF395232[17063699] - 1796: AF395231
Homo sapiens clone EIII48 bpVNTR22 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063697|gb|AF395231.1|AF395231[17063697] - 1797: AF395230
Homo sapiens clone EIII48 bpVNTR21 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063695|gb|AF395230.1|AF395230[17063695] - 1798: AF395229
Homo sapiens clone EIII48 bpVNTR20 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063693|gb|AF395229.1|AF395229[17063693] - 1799: AF395228
Homo sapiens clone EIII48 bpVNTR19 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063691|gb|AF395228.1|AF395228[17063691] - 1800: AF395227
Homo sapiens clone EIII48 bpVNTR18 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063689|gb|AF395227.1|AF395227[170636891] - 1801: AF395226
Homo sapiens clone EIII48 bpVNTR17 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063687|gb|AF395226.1|AF395226[17063687] - 1802: AF395225
Homo sapiens clone EIII48 bpVNTR16 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063685|gb|AF395225.1|AF395225[17063685] - 1803: AF395224
Homo sapiens clone EIII48 bpVNTR15 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063683|gb|AF395224.1|AF395224[17063683] - 1804: AF395223
Homo sapiens clone EIII48 bpVNTR14 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063681|gb|AF395223.1|AF395223[17063681] - 1805: AF395222
Homo sapiens clone EIII48 bpVNTR13 dopamine receptor D4 (DRD4) gene, partial cds
gi|7063679|gb|AF395222.1|AF395222[17063679] - 1806: AF395221
Homo sapiens clone EIII48 bpVNTR12 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063677|gb|AF395221.1|AF395221[17063677] - 1807: AF395220
Homo sapiens clone EIII48 bpVNTR11 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063675|gb|AF395220.1|AF395220[17063675] - 1808: AF395219
Homo sapiens clone EIII48 bpVNTR10 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063673|gb|AF395219.1|AF395219[17063673] - 1809: AF395218
Homo sapiens clone EIII48 bpVNTR9 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063671|gb|AF395218.1|AF395218[17063671] - 1810: AF395217
Homo sapiens clone EIII48 bpVNTR8 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063669|gb|AF395217.1|AF395217[17063669] - 1811: AF395216
Homo sapiens clone EIII48 bpVNTR7 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063667|gb|AF395216.1|AF395216[17063667] - 1812: AF395215
Homo sapiens clone EIII48 bpVNTR6 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063665|gb|AF395215.1|AF395215[17063665] - 1813: AF395214
Homo sapiens clone EIII48 bpVNTR5 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063663|gb|AF395214.1|AF395214[17063663] - 1814: AF395213
Homo sapiens clone EIII48 bpVNTR4 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063661|gb|AF395213.1|AF395213[17063661] - 1815: AF395212
Homo sapiens clone EIII48 bpVNTR3 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063659|gb|AF395212.1|AF395212[17063659] - 1816: AF395211
Homo sapiens clone EIII48 bpVNTR2 dopamine receptor D4 (DRD4) gene, partial cds
gi|17063657|gb|AF395211.1|AF395211[17063657] - 1817: AF395210
Homo sapiens clone EIII48 bpVNTR1 dopamine receptor D4 (DRD4) gene, partial cds
gi|7063655|gb|AF395210.1|AF395210[17063655] - 1818: AF258342
Homo sapiens biogenic amine receptor-like protein mRNA, complete cds
gi|15428321|gb|AF258342.1|AF258342[15428321] - 1819: AJ278982
Homo sapiens mRNA for 5-hydroxytryptamine4 receptor (HTR4 gene), splice variant
h5-HT4(n)
gi|12274905|emb|AJ278982.1|HSA278982[12274905] - 1820: AJ278981
Homo sapiens mRNA for 5-hydroxytryptamine4 receptor (HTR4 gene), splice variant
h5-HT4(g)
gi|12274903|emb|AJ278981.1|HSA278981[12274903] - 1821: AJ278980
Homo sapiens mRNA for 5-hydroxytryptamine4 receptor (HTR4 gene), splice variant
h5-HT4(b)
gi|12274901|emb|AJ278980.1|HSA278980[12274901] - 1822: AJ278979
Homo sapiens mRNA for 5-hydroxytryptamine4 receptor (HTR4 gene), splice variant
h5-HT4(a)
gi|12274899|emb|AJ278979.1|HSA278979[12274899] - 1823: NM—014555
Homo sapiens transient receptor potential cation channel, subfamily M, member 5
(TRPM5), mA
gi|11225265|ref|NM—014555.1|[11225265] - 1824: AF200627
Homo sapiens putative catecholamine receptor gene, complete cds
gi|10441576|gb|AF200627.1|AF200627[10441576] - 1825: AF257789
Homo sapiens urokinase-type plasminogen activator receptor mRNA, partial cds
gi|8050814|gb|AF257789.1|AF257789[8050814] - 1826: NM—002335
Homo sapiens low density lipoprotein receptor-related protein 5 (LRP5), mRNA
gi|4505018|ref|NM—002335.1|[4505018] - 1827: Y00508
H. sapiens M1 gene for muscarinic acetylcholine receptor
gi|297405|emb|Y00508.1|HSMIMAR[297405] - 1828: AF457599
Homo sapiens killer cell immunoglobulin-like receptor (KIR3DL1) gene, KIR3DL1-NKB1-like allele, promoter region and exon 1
gi|18087432|gb|AF457599.1|AF457599[18087432] - 1829: AF457598
Homo sapiens killer cell immunoglobulin-like receptor (KIR3DL1) gene, KIR3DL1-NKB1-like allele, promoter region and exon 1
gi|18087431|gb|AF457598.1|AF457598[18087431] - 1830: AF457597
Homo sapiens killer cell immunoglobulin-like receptor (KIR3DL1) gene, KIR3DL1-NKAT3-like allele, promoter region and exon 1
gi|18087430|gb|AF457597.1|AF457597[18087430] - 1831: AJ312755
Homo sapiens mRNA for scavenger receptor cysteine-rich protein SRCRB-S4D, (SRCRB-S4D gene)
gi|18073905|emb|AJ312755.1|HSA312755[18073905] - 1832: AF331842
Homo sapiens SPPR-2 mRNA, complete cds, alternatively spliced
gi|18033260|gb|AF331842.1|AF331842[18033260] - 1833: AF331841
Homo sapiens SPPR-1 mRNA, complete cds, alternatively spliced
gi|18033258|gb|AF331841.1|AF331841[18033258] - 1834: AF331840
Homo sapiens SPPR mRNA, complete cds, alternatively spliced
gi|18033256|gb|AF331840.1|AF331840[18033256] - 1835: AF284756
Homo sapiens VPS10 domain receptor S or CS mRNA, complete cds
gi|18032274|gb|AF284756.1|AF284756[18032274] - 1836: AF328684
Homo sapiens Fc-epsilon receptor III mRNA, complete cds
gi|8028292|gb|AF328684.1|AF328684[18028292] - 1837: AY029413
Homo sapiens interleukin-1 receptor antagonist-like FIL1 theta (FIL1-theta) mRNA, complete cds
gi|18025343|gb|AY029413.1|[18025343] - 1838: AF126470
Homo sapiens KOR-3D (KOR-3) mRNA, complete cds
gi|18000078|gb|AF126470.1|AF126470[18000078] - 1839: AF435925
Homo sapiens very large G protein-coupled receptor 1b (VLGR1) mRNA, complete cds
gi|16904207|gb|AF435925.1|AF435925[16904207] - 1840: G67431
D7S3125 GRB10 Homo sapiens STS genomic, sequence tagged site
gi|12025489|gb|G67431.1|G67431[12025489] - 1841: AF260136
Homo sapiens NK cell receptor D (NKG2-D) mRNA, NKG2-D*03 allele, complete cds
gi|9295444|gb|AF260136.1|AF260136[9295444] - 1842: AF260135
Homo sapiens NK cell receptor D (NKG2-D) mRNA, NKG2-D*02 allele, complete cds
gi|9295442|gb|AF260135.1|AF260135[9295442] - 1843: AF260134
Homo sapiens NK cell receptor C (NKG2-C) mRNA, NKG2-C*02 allele, complete cds
gi|9295440|gb|AF260134.1|AF260134[9295440] - 1844: NM—015891
Homo sapiens pre-mRNA splicing factor 17 (PRP17), mRNA
gi|7706656|ref|NM—015891.1|[7706656] - 1845: L12397
Homo sapiens Dopamine D4 receptor (DRD4) gene, partial cds
gi|291947|gb|L12397.1|HUMD4G[291947] - 1846: NM—019888
Homo sapiens melanocortin 3 receptor (MC3R), mRNA
gi|17986278|ref|NM—019888.2|[17986278] - 1847: NM—000795
Homo sapiens dopamine receptor D2 (DRD2), transcript variant 1, mRNA
gi|17986271|ref|NM—000795.2|[17986271] - 1848: NM—016574
Homo sapiens dopamine receptor D2 (DRD2), transcript variant 2, mRNA
gi|17986269|ref|NM—016574.2|[17986269] - 1849: AY070269
Homo sapiens hypocretin receptor 1 (HCRTR1) gene, complete cds
gi|17979217|gb|AY070269.1|[17979217] - 1850: NM—052945
Homo sapiens BAFF receptor (BAFFR), mRNA
gi|17978517|ref|NM—052945.2|[17978517] - 1851: NM—054026
Homo sapiens CCR4—NOT transcription complex, subunit 7 (CNOT7), transcript variant 2, mRNA
gi|17978499|ref|NM—054026.1|[17978499] - 1852: NM—013354
Homo sapiens CCR4—NOT transcription complex, subunit 7 (CNOT7), transcript variant 1, mRNA
gi|17978498|ref|NM—013354.3|[17978498] - 1853: NM—004444
Homo sapiens EphB4 (EPHB4), mRNA
gi|17975769|ref|NM—004444.2|[17975769] - 1854: NM—004443
Homo sapiens EphB3 (EPHB3), mRNA
gi|17975767|ref|NM—004443.2|[17975767] - 1855: NM—004442
Homo sapiens EphB2 (EPHB2), transcript variant 1, mRNA
gi|17975766|ref|NM—004442.2|[17975766] - 1856: NM—017449
Homo sapiens EphB2 (EPHB2), transcript variant 2, mRNA
gi|17975764|ref|NM—017449.1|[17975764] - 1857: BC019278
Homo sapiens, cargo selection protein (mannose 6 phosphate receptor binding protein), clone MGC:3816 IMAGE:2905275, mRNA, complete cds
gi|17939468|gb|BC019278.1|BC019278[17939468] - 1858: NM—080387
Homo sapiens C-type lectin-like receptor (CLEC-6), mRNA
gi|17933769|ref|NM—080387.1|[17933769] - 1859: NM—007200
Homo sapiens A kinase (PRKA) anchor protein 13 (AKAP13), mRNA
gi|17933491|ref|NM—007200.1|[17933491] - 1861: AF373878
Homo sapiens herpesvirus entry mediator (TNFRSF14) mRNA, TNFRSF14-V241I allele,
complete cds
gi|17901872|gb|AF373878.1|AF373878[17901872] - 1862: AF373877
Homo sapiens herpesvirus entry mediator (TNFRSF14) mRNA, TNFRSF14-R17K allele,
complete cds
gi|17901869|gb|AF373877.1|AF373877[17901869] - 1863: AF373876
Homo sapiens nectin-1 (PVRL1) gene, PVRL1-R199W allele, partial cds
gi|17901866|gb|AF373876.1|AF373876[17901866] - 1864: AY065844
Homo sapiens truncated receptor tyrosine kinase TrkC mRNA, partial cds
gi|17887448|gb|AY065844.1|[17887448] - 1865: AY062295
Homo sapiens prolactin receptor (PRLR) mRNA, partial cds; alternatively spliced
gi|7887307|gb|AY062295.1|[17887307] - 1866: NM—078474
Homo sapiens BBP-like protein 2 (BLP2), transcript variant 1, mRNA
gi|17865799|ref|NM—078474.1|[17865799] - 1867: NM—025141
Homo sapiens BBP-like protein 2 (BLP2), transcript variant 2, mRNA
gi|17865798|ref|NM—025141.2|[17865798] - 1868: NM—078473
Homo sapiens BBP-like protein 1 (BLP1), transcript variant 1, mRNA
gi|17865796|ref|NM—078473.1|[17865796] - 1869: NM—020749
Homo sapiens AT2 receptor-interacting protein 1 (ATIP1), mRNA
gi|17865631|ref|NM—020749.1|[17865631] - 1870: NM—002088
Homo sapiens glutamate receptor, ionotropic, kainate 5 (GRIK5), mRNA
gi|17864085|ref|NM—002088.2|[17864085] - 1871: AY064474
Homo sapiens interleukin 21 receptor (IL21R) gene, complete cds
gi|17863086|gb|AY064474.1|[17863086] - 1872: AY036093
Homo sapiens lysyl oxidase-like 4 mRNA, complete cds
gi|1786137|gb|AY036093.1|[17861371] - 1873: AF369653
Homo sapiens corticotropin releasing hormone receptor variant 1 g (CRHR1) mRNA,
partial cds, alternatively spliced
gi|17834100|gb|AF369653.1|AF369653[17834100] - 1874: AF369652
Homo sapiens corticotropin releasing hormone receptor variant lf (CRHR1) mRNA,
partial cds, alternatively spliced
gi|17834097|gb|AF369652.1|AF369652[17834097] - 1875: AF369651
Homo sapiens corticotropin releasing hormone receptor variant le (CRHRL) mRNA,
partial cds, alternatively spliced
gi|17834094|gb|AF369651.1|AF369651[17834094] - 1876: NM—001239
Homo sapiens cyclin H(CCNH), mRNA
gi|17738313|ref|NM—001239.2|[17738313] - 1877: NM—014286
Homo sapiens frequenin homolog (Drosophila) (FREQ), mRNA
gi|17738307|ref|NM—014286.2|[17738307] - 1878: NM—006650
Homo sapiens complexin 2 (CPLX2), mRNA
gi|17738306|ref|NM—006650.2|[17738306] - 1879: NM—006651
Homo sapiens complexin 1 (CPLX1), mRNA
gi|17738305|ref|NM—006651.2|[17738305] - 1880: AF416558
Homo sapiens N-methyl-D-aspartate receptor 3A (GRIN3A) mRNA, complete cds
gi|17530176|gb|AF416558.1|AF416558[17530176] - 1882: BC018926
Homo sapiens, vanilloid receptor-like protein, clone MGC:12549 IMAGE:4298484, mRNA, complete cds
gi|17511937|gb|BC018926.1|BC018926[17511937] - 1883: BC018778
Homo sapiens, KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1, clone MGC:32075 IMAGE:4870476, mRNA, complete cds
gi|17511855|gb|BC018778.1|BC018778[17511855] - 1884: NM—004625
Homo sapiens wingless-type MMTV integration site family, member 7A (WNT7A), mRNA
gi|17505190|ref|NM—004625.2|[17505190] - 1885: L78805
Homo sapiens G protein-coupled receptor gene, partial cds
gi|17466993|gb|L78805.1|HUMGPCRE[17466993] - 1886: NM—003602
Homo sapiens FK506 binding protein 6 (36 kD) (FKBP6), mRNA
gi|17149848|ref|NM—003602.2|[17149848] - 1887: NM—000801
Homo sapiens FK506 binding protein 1A (12 kD) (FKBP1A), transcript variant 12B,
mRNA
gi|17149837|ref|NM—000801.2|[17149837] - 1888: NM—054014
Homo sapiens FK506 binding protein 1A (12 kD) (FKBP1A), transcript variant 12A,
mRNA
gi|17149835|ref|NM—054014.1|[17149835] - 1889: AF411044
Homo sapiens DnaJ protein Tid-1 mRNA, complete cds
gi|17066574|gb|AF411044.1|AF411044[17066574] - 1890: NM—003728
Homo sapiens unc-5 homolog B (C. elegans) (UNC5C), mRNA
gi|16933524|ref|NM—003728.2|[16933524] - 1891: NM—005633
Homo sapiens son of sevenless homolog 1 (Drosophila) (SOS1), mRNA
gi|15529995|ref|NM—005633.2|[15529995] - 1892: AJ308539
Homo sapiens partial mRNA for T-cell receptor beta chain V-D-J region (TCRBV7BJ2S4 gene)
gi|4787781|emb|AJ308539.1|HSA308539[14787781] - 1893: AJ308538
Homo sapiens partial mRNA for T-cell receptor beta chain V-D-J region (TCRBV14BJ1S1 gene)
gi|14787779|emb|AJ308538.1|HSA308538[14787779] - 1894: AJ308537
Homo sapiens partial mRNA for T-cell receptor beta chain V-D-J region (TCRBV17BJ2S7 gene)
gi|14787777|emb|AJ308537.1|HSA308537[14787777] - 1895: AJ308536
Homo sapiens partial mRNA for T-cell receptor beta chain V-D-J region (TCRBV23BJ2S2 gene)
gi|14787775|emb|AJ308536.1|HSA308536[14787775] - 1896: AJ308535
Homo sapiens partial mRNA for T-cell receptor beta chain V-D-J region (TCRBV12BJ1S5 gene)
gi|14787773|emb|AJ308535.1|HSA308535[14787773] - 1897: AJ308534
Homo sapiens partial mRNA for T-cell receptor beta chain, V-D-J region (TCRBV1BJ2S1 gene)
gi|14787771|emb|AJ308534.1|HSA308534[14787771] - 1898: AJ308533
Homo sapiens partial mRNA for T-cell receptor beta chain, V-D-J region (TCRBV25BJ2S7 gene)
gi|14787769|emb|AJ308533.1|HSA308533[14787769] - 1899: AJ308532
Homo sapiens partial mRNA for T-cell receptor beta chain, V-D-J region (TCRBV22BJ2S7 gene)
gi|14787767|emb|AJ308532.1|HSA308532[14787767] - 1900: NM—014459
Homo sapiens protocadherin 17 (PCDH17), mRNA
gi|14589926|ref|NM—014459.2|[14589926] - 1901: NM—032961
Homo sapiens protocadherin 10 (PCDH10), transcript variant 1, mRNA
gi|14589915|ref|NM—032961.1|[14589915] - 1902: NM—020815
Homo sapiens protocadherin 10 (PCDH10), transcript variant 2, mRNA
gi|14589913|ref|NM—020815.1|[14589913] - 1903: NM—032966
Homo sapiens Burkitt lymphoma receptor 1, GTP binding protein (BLR1), transcript
variant 2, mRNA
gi|145 - 2001: AF011513
Homo sapiens isolate MwCCR5-1553 CCR5 receptor (CCR5) mRNA, partial cds
gi|2305143|gb|AF011513.1|AF011513[2305143] - 2002: AF011512
Homo sapiens isolate MwCCR5-107 CCR5 receptor (CCR5) mRNA, partial cds
gi|2305141|gb|AF011512.1|AF011512[2305141] - 2003: AF011511
Homo sapiens isolate KeCCR5-3b CCR5 receptor (CCR5) mRNA, partial cds
gi|2305139|gb|AF011511.1|AF011511[2305139] - 2004: AF011510
Homo sapiens isolate KeCCR5-3a CCR5 receptor (CCR5) mRNA, partial cds
gi|2305137|gb|AF011510.1|AF011510[2305137] - 2005: AF011509
Homo sapiens isolate KeCCR5-116 CCR5 receptor (CCR5) mRNA, partial cds
gi|2305135|gb|AF011509.1|AF011509[2305135] - 2006: AF011508
Homo sapiens isolate KeCCR5-111 CCR5 receptor (CCR5) mRNA, partial cds
gi|2305133|gb|AF011508.1|AF011508[2305133] - 2007: AF011507
Homo sapiens isolate InCCR5-72a CCR5 receptor (CCR5) mRNA, partial cds
gi|2305131|gb|AF011507.1|AF011507[2305131] - 2008: AF011506
Homo sapiens isolate InCCR5-71b CCR5 receptor (CCR5) mRNA, partial cds
gi|2305129|gb|AF011506.1|AF011506[2305129] - 2009: AF011505
Homo sapiens isolate InCCR5-71a CCR5 receptor (CCR5) mRNA, partial cds
gi|2305127|gb|AF0115050.1|AF011505[2305127] - 2010: AF011504
Homo sapiens isolate InCCR5-46 CCR5 receptor (CCR5) mRNA, partial cds
gi|2305125|gb|AF011504.1|AF011504[2305125] - 2011: AF011503
Homo sapiens isolate InCCR5-467 CCR5 receptor (CCR5) mRNA, partial cds
gi|2305123|gb|AF011503.1|AF011503[2305123] - 2012: AF011502
Homo sapiens isolate InCCR5-463 CCR5 receptor (CCR5) mRNA, partial cds
gi|2305121|gb|AF011502.1|AF011502[2305121] - 2013: AF011501
Homo sapiens isolate InCCR5-45c CCR5 receptor (CCR5) mRNA, partial cds
gi|2305119|gb|AF011501.1|AF011501[2305119] - 2014: AF011500
Homo sapiens isolate HtCCR5-104 CCR5 receptor (CCR5) mRNA, partial cds
gi|2305117|gb|AF011500.1|AF011500[2305117] - 2015: U77732
Homo sapiens glycine receptor alpha 1 subunit gene, partial cds
gi|1718390|gb|U77732.1|HSU77732[1718390] - 2016: NM—033519
Homo sapiens olfactory receptor sdolf (sdolf), mRNA
gi|15723373|ref|NM—033519.1|[15723373] - 2017: NM—032192
Homo sapiens hypothetical protein FLJ20940 (FLJ20940), mRNA
gi|14149882|ref|NM—032192.1|[14149882] - 2018: NM—032152
Homo sapiens PRAM-1 protein (PRAM-1), mRNA
gi|14149826|ref|NM—032152.1|[14149826] - 2019: NM—032142
Homo sapiens hypothetical protein FLJ10352 (FLJ10352), mRNA
gi|14149808|ref|NM—032142.1|[14149808] - 2020: NM—004801
Homo sapiens neurexin 1 (NRXN1), mRNA
gi|14149612|ref|NM—004801.1|[14149612] - 2021: NM—031936
Homo sapiens G protein-coupled receptor 61 (GPR61), mRNA
gi|13994319|ref|NM—031936.1|[13994319] - 2022: NM—030901
Homo sapiens olfactory receptor, family 7, subfamily A, member 17 (OR7A17), mRNA
gi|13775161|ref|NM—030901.1|[13775161] - 2023: NM—024681
Homo sapiens hypothetical protein FLJ12242 (FLJ12242), mRNA
gi|13489098|ref|NM—024681.1|[13489098] - 2024: NM—022571
Homo sapiens putative leukocyte platelet-activating factor receptor (HUMNPIIY20), mRNA
gi|12007653|ref|NM—022571.1|[12007653] - 2025: NM—022065
Homo sapiens hypothetical protein FLJ21877 (FLJ21877), mRNA
gi|11545774|ref|NM—022065.1|[11545774] - 2026: NM—020806
Homo sapiens gephyrin (GPHN), mRNA
gi|10880982|ref|NM—020806.1|[10880982] - 2027: NM—021258
Homo sapiens interleukin 22 receptor (IL22R), mRNA
gi|10864066|ref|NM—021258.1|[10864066] - 2029: NM—020400
Homo sapiens G protein-coupled receptor 92 (GPR92), mRNA
gi|9966878|ref|NM—020400.1|[9966878] - 2030: NM—000888
Homo sapiens integrin, beta 6 (ITGB6), mRNA
gi|9966771|ref|NM—000888.31[9966771] - 2032: NM—018113
Homo sapiens lipocalin-interacting membrane receptor (LIMR), mRNA
gi|8922462|ref|NM—018113.1|[8922462] - 2033: NM—018423
Homo sapiens hypothetical protein DKFZp761P1010 (DKFZp761P1010), mRNA
gi|8922178|ref|NM—018423.1|[8922178] - 2034: AF257182
Homo sapiens G-protein-coupled receptor 48 (GPR48) mRNA, complete cds
gi|7739736|gb|AF257182.1|AF257182[7739736] - 2035: NM—016442
Homo sapiens type 1 tumor necrosis factor receptor shedding aminopeptidase regulator (ARTS-1), mRNA
gi|7706544|ref|NM—016442.1|[7706544]
- 2036: NM—015364
Homo sapiens MD-2 protein (MD-2), mRNA
gi|7702503|ref|NM—015364.1|[7702503] - 2037: NM—014380
Homo sapiens nerve growth factor receptor (TNFRSF16) associated protein 1 (NGFRAP1), mRNA
gi|7657043|ref|NM—014380.1|[7657043] - 2038: NM—013308
Homo sapiens platelet activating receptor homolog (H963), mRNA
gi|7019400|ref|NM—013308.1|[7019400] - 2039: NM—013333
Homo sapiens EH domain-binding mitotic phosphoprotein (EPSIN), mRNA
gi|7019368|ref|NM—013333.1|[7019368] - 2040: NM—007369
Homo sapiens G-protein coupled receptor (RE2), mRNA
gi|6677700|ref|NM—007369.1|[6677700] - 2041: NM—002673
Homo sapiens plexin B1 (PLXNB1), mRNA
gi|6631105|ref|NM—002673.1|[6631105] - 2042: NM—007115
Homo sapiens tumor necrosis factor, alpha-induced protein 6 (TNFAIP6), mRNA
gi|6005905|ref|NM—007115.1|[6005905] - 2044: NM—007223
Homo sapiens putative G protein coupled receptor (GPR), mRNA
gi|6005771|ref|NM—007223.1|[6005771] - 2045: NM—006748
Homo sapiens Src-like-adaptor (SLA), mRNA
gi|5803170|ref|NM—006748.1|[5803170] - 2046: NM—006681
Homo sapiens neuromedin U (NMU), mRNA
gi|5729946|ref|NM—006681.1|[5729946] - 2047: NM—006068
Homo sapiens toll-like receptor 6 (TLR6), mRNA
gi|5174720|ref|NM—006068.1|[5174720] - 2048: NM—006018
Homo sapiens putative chemokine receptor; GTP-binding protein (HM74), mRNA
gi|5174460|ref|NM—006018.1|[5174460] - 2049: NM—006098
Homo sapiens guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 (GNB2L1), mRNA
gi|5174446|ref|NM—006098.1|[5174446] - 2050: NM—005879
Homo sapiens TRAF interacting protein (TRIP), mRNA
gi|5032194|ref|NM—005879.1|[5032194] - 2051: NM—005843
Homo sapiens signal transducing adaptor molecule (SH3 domain and ITAM motif) 2
(STAM2), mRNA
gi|5032126|ref|NM—005843.1|[5032126] - 2052: NM—005505
Homo sapiens CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 1 (CD36L1), mRNA
gi|5031628|ref|NM—005505.1|[5031628] - 2053: NM—005795
Homo sapiens calcitonin receptor-like (CALCRL), mRNA
gi|5031620|ref|NM—005795.1|[5031620] - 2054: NM—005400
Homo sapiens protein kinase C, epsilon (PRKCE), mRNA
gi|4885562|ref|NM—005400.1|[4885562] - 2057: NM—004488
Homo sapiens glycoprotein V (platelet) (GP5), mRNA
gi|4758459|ref|NM—004488.1|[4758459] - 2058: NM—004122
Homo sapiens growth hormone secretagogue receptor (GHSR), mRNA
gi|4758433|ref|NM—004122.1|[4758433] - 2059: NM—004438
Homo sapiens EphA4 (EPHA4), mRNA
gi|4758279|ref|NM—004438.1|[4758279] - 2060: NM—004198
Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 6 (CHRNA6), mRNA
gi|4757981|ref|NM—004198.1|[4757981] - 2061: NM—004054
Homo sapiens complement component 3a receptor 1 (C3AR1). mRNA
gi|4757887|ref|NM—004054.1|[4757887] - 2062: NM—003955
Homo sapiens STAT induced STAT inhibitor 3 (SSI-3), mRNA
gi|4507234|ref|NM—003955.1|[4507234] - 2063: NM—003693
Homo sapiens acetyl LDL receptor; SREC=scavenger receptor expressed by endothelial cells (SREC), mRNA
gi|4507202|ref|NM—003693.1|[4507202] - 2064: NM—003625
Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF),
interacting protein (liprin), alpha 2 (PPFIA2), mRNA
gi|4505984|ref|NM—003625.1|[4505984] - 2065: NM—000286
Homo sapiens peroxisomal biogenesis factor 12 (PEX12), mRNA
gi|4505720|ref|NM—000286.1|[4505720] - 2066: NM—002563
Homo sapiens purinergic receptor P2Y, G-protein coupled, 1 (P2RY1), mRNA
gi|4505556|ref|NM—002563.1|[4505556] - 2067: NM—000913
Homo sapiens opiate receptor-like 1 (OPRL1), mRNA
gi|4505512|ref|NM—000913.1|[4505512] - 2068: NM—002333
Homo sapiens low density lipoprotein receptor-related protein 3 (LRP3), mRNA
gi|4505014|ref|NM—002333.1|[4505014] - 2069: NM—001957
Homo sapiens endothelin receptor type A (EDNRA), mRNA
gi|4503464|ref|NM—001957.1|[4503464] - 2070: L34726
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100206|gb|L34726.1|HUMTCRBZ[1100206] - 2071: L34725
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
gi|1100204|gb|L34725.1|HUMTCRBY[1100204] - 2072: L34724
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100202|gb|L34724.1|HUMTCRBU[1100202] - 2073: L34723
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100200|gb|L34723.1|HUMTCRBT[1100200] - 2074: L34722
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
gi|1100198|gb|L34722.1|HUMTCRBS[1100198] - 2075: L34721
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7). partial cds
gi|1100196|gb|L34721.1|HUMTCRBQ[1100196] - 2076: L34719
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
gi|1100192|gb|L34719.1|H1MTCRBO[1100192] - 2077: L34737
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR2, 7), partial cds
gi|1100188|gb|L34737.1|HUMTCRBAO[1100188] - 2078: L34736
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR2, 7), partial cds
gi|1100186|gb|L34736.1|HUMTCRBAN[1100186] - 2079: L34735
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
gi|1100184|gb|L34735.1|HUMTCRBAM[1100184] - 2080: L34733
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1001179|gb|L34733.1|HUMTCRBAK[1100179] - 2081: L34732
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29: B7, 44; DR 2, 7), partial cds
gi|1100177|gb|L34732.1|HUMTCRBAJ[1100177] - 2082: L34731
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100175|gb|L34731.1|HUMTCRBAI[1100175] - 2083: L34730
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
gi|1100173|gb|L34730.1|HUMTCRBAH[1100173] - 2084: L34728
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100169|gb|L34728.1|HUMTCRBAF[1100169] - 2085: L34727
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100167|gb|L34727.1|HUMTCRBAE[1100167] - 2086: L34703
Homo sapiens T-cell receptor alpha chain (TCRA) mRNA (HLA-A1, 24; B7, 8; DR 1,
3), complete cds
gi|110065|gb|L34703.1|HUMTCRAZ[1100165] - 2087: L34702
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100163|gb|L34702.1|HUMTCRAY[1100163] - 2088: L34701
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100161|gb|L34701.1|HUMTCRAV[1100161] - 2089: L34700
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1001159|gb|L34700.1|HUMTCRAU[1100159] - 2090: L34699
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A1, 24; B7, 8; C7; DR 1, 3),
partial cds
gi|1001157|gb|L34699.1|HUMTCRAT[1100157] - 2091: L34698
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), complete cds
gi|1100155|gb|L34698.1|HUMTCRAQ[1100155] - 2092: L34695
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR2, 7), partial cds
gi|1001153|gb|L34695.1|HUMTCRAP[1100153] - 2093: L34694
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A1, 24; B7, 8; C7; DR 1, 3),
partial cds
gi|1100151|gb|L34694.1|HUMTCRAO[1100151] - 2094: L34738
Homo sapiens T-cell receptor beta (TCRB) mRNA (HLA-A1, 24; B7, 8; C7; DR 1, 3),
partial cds
gi|1100149|gb|L34738.1|HUMTCRAAX[1100149] - 2095: L34718
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100147|gb|L34718.1|HUMTCRAAW[1100147] - 2096: L34717
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|100145|gb|L34717.1|HUMTCRAAV[1100145] - 2097: L34716
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
gi|100143|gb|L34716.1|HUMTCRAAU[1100143] - 2098: L34715
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
gi|1100141|gb|L34715.1|HUMTCRAAT[1100141] - 2099: L34714
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A1, 24; B7, 8; DR 1, 3), partial cds
gi|1100139|gb|L34714.1|HUMTCRAAT[1100139] - 2100: L34713
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100137|gb|L34713.1|HUMTCRAAR[1100137] - 2101: L34712
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100135|gb|L34712.1|HUMTCRAAQ[1100135] - 2102: L34711
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100133|gb|L34711.1|HUMTCRAAP[1100133] - 2103: L34710
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100131|gb|L34710.1|HUMTCRAAO[1100131] - 2104: L34709
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100129|gb|L34709.1|HUMTCRAAN[1100129] - 2105: L34708
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A1, 24; B7, 8; DR1, 3), partial cds
gi|1100127|gb|L34708.1|HUMTCRAAM[1100127] - 2106: L34707
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100125|gb|L34707.1|HUMTCRAAL[1100125] - 2107: L34706
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100123|gb|L34706.1HUMTCRAAK[1100123] - 2108: L34705
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100121|gb|L34705.1|HUMTCRAAJ[1100121] - 2109: L34704
Homo sapiens T-cell receptor alpha (TCRA) mRNA (HLA-A3, 29; B7, 44; DR 2, 7), partial cds
gi|1100119|gb|L34704.1|HUMTCRAAI[1100119] - 2110: L29037
Human T-cell antigen receptor mRNA
gi|517066|gb|L29037.1|HUMTCRBW[517066] - 2111: L29038
Human T-cell antigen receptor mRNA
gi|456432|gb|L29038.1|HUMTCRBX[456432] - 2112: L29036
Human T-cell antigen receptor mRNA
gi|456431|gb|L29036.1|HUMTCRAX[456431] - 2113: L29035
Human T-cell antigen receptor mRNA
gi|456430|gb|L29035.1|HUMTCRAW[456430] - 2114: AF106913
Homo sapiens CRL3 protein (CRL3) mRNA, complete cds
gi|7221662|gb|AF106913.1|AF106913[17221662] - 2115: AB055881
Homo sapiens NKp30 mRNA for natural killer cell receptor, complete cds
gi|17221621|dbj|AB055881.1|AB055881[17221621] - 2116: AJ417149
Homo sapiens partial mRNA for T cell receptor beta chain (TCRB gene), clone 21
gi|17154680|emb|AJ417149.1|HSA417149[17154680] - 2117: AJ417148
Homo sapiens partial mRNA for T cell receptor beta chain (TCRB gene), clone 17
gi|17148484|emb|AJ417148.1|HSA417148[17148484] - 2118: NM—054021
Homo sapiens G protein-coupled receptor 101 (GPR101), mRNA
gi|16876434|ref|NM—054021.1|[16876434] - 2119: NM—052939
Homo sapiens Fc receptor-like protein 3 (FCRH3), mRNA
gi|16418420|ref|NM—052939.1|[16418420] - 2120: NM—052938
Homo sapiens Fc receptor-like protein 1 (FCRH1), mRNA
gi|16418418|ref|NM—052938.1|[16418418] - 2121: NM—003823
Homo sapiens tumor necrosis factor receptor superfamily, member 6b, decoy (TNFRSF6B), transcript variant M68E, mRNA
gi|14790166|ref|NM—003823.2|[14790166] - 2122: NM—006470
Homo sapiens tripartite motif-containing 16 (TRIM16), mRNA
gi|14577927|ref|NM—006470.2|[14577927] - 2123: NM—031918
Homo sapiens Kruppel-like factor 16 (KLF16), mRNA
gi|13994286|ref|NM—031918.1|[13994286] - 2124: NM—023945
Homo sapiens membrane-spanning 4-domains, subfamily A, member 5 (MS4A5), mRNA
gi|12965204|ref|NM—023945.1|[12965204] - 2125: NM—018485
Homo sapiens G protein-coupled receptor C5L2 (LOC55868), mRNA
gi|8923872|ref|NM—018485.1|[8923872] - 2126: NM—016562
Homo sapiens toll-like receptor 7 (TLR7), mRNA
gi|7706092|ref|NM—016562.1|[7706092] - 2130: NM—006138
Homo sapiens membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) (MS4A3), mRNA
gi|5453608|ref|NM—006138.1|[5453608] - 2131: AF447176
Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exon 20 and complete cds
gi|17432420|gb|AF447176.1|F447157S11[17432420] - 2132: AF447175
Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exon 19
gi|17432419|gb|AF447175.1|F447157S10[17432419] - 2133: AF447174
Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exon 18
gi|17432418|gb|AF447174.1|F447157S09[17432418] - 2134: AF447173
Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exon 17
gi|17432417|gb|AF447173.1|F447157S08[17432417] - 2135: AF447171
Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exons 15 and 16
gi|17432416|gb|AF447171.1|F447157S07[17432416] - 2136: AF447170
Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exon 14
gi|174324155gb|AF447170.1|F447157S06[17432415] - 2137: AF447167
Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exons 11, 12, and 13
gi|17432414|gb|AF447167.1|F447157S05[17432414] - 2138: AF447164
Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exons 8, 9, and 10
gi|17432413|gb|AF447164.1|F447157S04[17432413] - 2139: AF447162
Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exons 6 and 7
gi|17432412|gb|AF447162.1|F447157S03[17432412] - 2140: AF447158
Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exons 2, 3, 4, and 5
gi|17432411|gb|AF447158.1F447157S02[17432411] - 2141: AF447157
Homo sapiens protein tyrosine kinase-7 (PTK7) gene, exon 1
gi|17432410|gb|AF447157.1|F447157S01[17432410] - 2142: AH011239
Homo sapiens protein tyrosine kinase-7 (PTK7) gene, complete cds
gi|17432409|gb|AH011239.1|SEG_F447157S[17432409] - 2143: AF374231
Homo sapiens corticotropin releasing hormone receptor variant 1 h mRNA, partial
cds, alternatively spliced
gi|17432316|gb|AF374231.1|AF374231[17432316] - 2145: AY013309
Homo sapiens clone FM1-3.3.12A immunoglobulin heavy chain variable region gene,
partial cdc
gi|17220530|gb|AY013309.1|[17220530] - 2146: AY013308
Homo sapiens clone FL1-2.4.2G immunoglobulin heavy chain variable region gene,
partial cds
gi|17220528|gb|AY013308.1|[17220528] - 2147: AY013307
Homo sapiens clone FL1-2.4.12A immunoglobulin heavy chain variable region gene,
partial cds
gi|17220526|gb|AY013307.1|[17220526] - 2148: AY013306
Homo sapiens clone FL3-3.4.4G immunoglobulin heavy chain variable region gene,
partial cds
gi|17220524|gb|AY013306.1|[17220524] - 2149: AB062787
Homo sapiens mRNA for triggering receptor TREM-2V, complete cds
gi|17425161|dbj|AB062787.1|AB062787[17425161] - 2150: NM—003392
Homo sapiens wingless-type MMTV integration site family, member 5A (WNT5A), mRNA
gi|17402917|ref|NM—003392.2|[17402917] - 2152: AJ421518
Homo sapiens mRNA for tumor necrosis factor-stimulated gene 6 (TSG-6) protein,
G431 allele
gi|17402491|emb|A1|AJ421518.1|HSA421518[17402491] - 2153: NM—053049
Homo sapiens stresscopin (SPC), mRNA
gi|16596691|ref|NM—053049.1|[16596691] - 2154: AF430697
Homo sapiens T cell receptor beta variable region, Vbeta 13S3-KRGAYETQYF-Jbeta
2.5 mRNA, partial cds
gi|16566919|gb|AF430697.1|AF430697[16566919] - 2155: AF430696
Homo sapiens T cell receptor beta variable region, Vbeta 13S2A1T-SEVRETQYF-Jbeta
2.5 mRNA, partial cds
gi|16566916|gb|AF430696.1|AF430696[16566916] - 2156: AF430695
Homo sapiens T cell receptor beta variable region, Vbeta 13S3-EKVTGGETQYF-Jbeta
2.5 mRNA, partial cds
gi|16566913|gb|AF430695.1|AF430695[16566913] - 2157: AF430694
Homo sapiens T cell receptor beta variable region, Vbeta
13S2A1T-QGRTSVIETQYF-Jbeta 2.5 mRNA, partial cds
gi|16566910|gb|AF430694.1|AF430694[16566910] - 2158: AF430693
Homo sapiens T cell receptor beta variable region, Vbeta
13S2A1T-RSDRRKTRYF-Jbeta2.5 mRNA, partial cds
gi|16566907|gb|AF430693.1|AF430693[16566907] - 2159: AF430692
Homo sapiens T cell receptor beta variable region, Vbeta 13S3-GRGAQETQYF-Jbeta
2.5 mRNA, partial cds
gi|16566904|gb|AF430692.1|AF430692[16566904] - 2160: AF430691
Homo sapiens T cell receptor beta variable region, Vbeta 13S2A1T-GGQTYF-Jbeta 2.5 mRNA, partial cds
gi|1656690|gb|AF430691.1|AF430691[16566901] - 2161: AF430690
Homo sapiens T cell receptor beta variable region, Vbeta 1S1A1N1-SGLTPNTGELFF-Jbeta 2.2 mRNA, partial cds
gi|16566898|gb|AF430690.1|AF430690[16566898] - 2162: AF430689
Homo sapiens T cell receptor beta variable region, Vbeta 13S6A1N1-TSPVPIGTDTQYF-Jbeta 2.3 mRNA, partial cds
gi|16566895|gb|AF430689.1|AF430689[16566895] - 2163: AF430688
Homo sapiens T cell receptor beta variable region, Vbeta 13S3-MFGGSTGELFF-Jbeta
2.2 mRNA, partial cds
gi|16566892|gb|AF430688.1|AF430688[16566892] - 2164: AF430687
Homo sapiens T cell receptor beta variable region, Vbeta 13S3-AQGKGTQYF-Jbeta 2.5 mRNA, partial cds
gi|16566889|gb|AF430687.1|AF430687[16566889] - 2165: AF430686
Homo sapiens T cell receptor beta variable region, Vbeta 13 S3-EQGLLSTDTQYF-Jbeta 2.3 mRNA, partial cds
gi|16566886|gb|AF430686.1|AF430686[16566886] - 2166: AF430685
Homo sapiens T cell receptor beta variable region, Vbeta 13S5-ETPGQGAGELFF-Jbeta
2.2 mRNA, partial cds
gi|16566883|gb|AF430685.1|AF430685[16566883] - 2167: AF430684
Homo sapiens T cell receptor beta variable region, Vbeta 13S5-RLAGASYNEQYF-Jbeta
2.1 mRNA, partial cds
gi|16566880|gb|AF430684.1|AF430684[16566880] - 2168: AF430683
Homo sapiens T cell receptor beta variable region, Vbeta 13S5-DTAGSTDTQYF-Jbeta
2.3 mRNA, partial cds
gi|16566877|gb|AF430683.1|AF430683[16566877] - 2169: AF430682
Homo sapiens T cell receptor beta variable region, Vbeta 13S5-EVASGTDTQYF-Jbeta
2.3 mRNA, partial cds
gi|16566874|gb|AF430682.1|AF430682[16566874] - 2170: AF430681
Homo sapiens T cell receptor beta variable region, Vbeta S6A3N2T-ASSGGYEQYF-Jbeta 2.7 mRNA, partial cds
gi|16566871|gb|AF430681.1|AF430681[16566871] - 2171: AF430680
Homo sapiens T cell receptor beta variable region, Vbeta 5 S3A1T/S1A1T-RRSDTQYF-Jbeta 2.3 mRNA, partial cds
gi|16566868|gb|AF430680.1|AF430680[16566868] - 2172: AF430679
Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-FGGEDTDTQYF-Jbeta 2.3 mRNA, partial cds
gi|16566865|gb|AF430679.1|AF430679[16566865] - 2173: AF430678
Homo sapiens T cell receptor beta variable region, Vbeta 5 S2-FGTRGNEQFF-Jbeta
2.7 mRNA, partial cds
gi|16566862|gb|AF430678.1|AF430678[16566862] - 2174: AF430677
Homo sapiens T cell receptor beta variable region, Vbeta 5-FQGARETQYF-Jbeta 2.5
mRNA, partial cds
gi|16566859|gb|AF430677.1|AF430677[16566859] - 2175: AF430676
Homo sapiens T cell receptor beta variable region, Vbeta 5S6A3N2T-FTGTGIYGYTF-Jbeta 1.2 mRNA, partial cds
gi|16566856|gb|AF430676.1|AF430676[16566856] - 2176: AF430675
Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-APLTGDSGNTIYF-Jbeta 1.3 mRNA, partial cds
gi|16566853|gb|AF430675.1|AF430675[16566853] - 2177: AF430674
Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1TSDLSGANVLTF-Jbeta
2.6 mRNA, partial cds
gi|16566850|gb|AF430674.1|AF430674[16566850] - 2178: AF430673
Homo sapiens T cell receptor beta variable region, Vbeta 5S6A3N2T-GQGKGTF-Jbeta
1.2 mRNA, partial cds
gi|16566847|gb|AF430673.1|AF430673[16566847] - 2179: AF430672
Homo sapiens T cell receptor beta variable region, Vbeta 5S6A3N2T-YTGGVWRNQYF-Jbeta 2.5 mRNA, partial cds
gi|16566844|gb|AF430672.1|AF430672[16566844] - 2180: AF430671
Homo sapiens T cell receptor beta variable region, Vbeta 5S2-FSGGAHTQYF-Jbeta 2.3 mRNA, partial cds
gi|16566841|gb|AF430671.1|AF430671[16566841] - 2181: AF430670
Homo sapiens T cell receptor beta variable region, Vbeta 5S2/S6A3N2T-SGQGKTEAFF-Jbeta 1.1 mRNA, partial cds
gi|16566838|gb|AF430670.1|AF430670[16566838] - 2182: AF430669
Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-FSKGVTEAFF-Jbeta
1.1 mRNA, partial cds
gi|16566835|gb|AF430669.1|AF430669[16566835] - 2183: AF430668
Homo sapiens T cell receptor beta variable region, Vbeta 5S2-SSPTGRSGNTIYF-Jbeta
1.3 mRNA, partial cds
gi|16566832|gb|AF430668.1|AF430668[16566832] - 2184: AF430667
Homo sapiens T cell receptor beta variable region, Vbeta 5S4A2T-PLLGQGRDEQFF-Jbeta 2.1 mRNA, partial cds
gi|16566829|gb|AF430667.1|AF430667[16566829] - 2185: AF430666
Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-FDFPGELFF-Jbeta
2.2 mRNA, partial cds
gi|16566827|gb|AF430666.1|AF430666[16566827] - 2186: AF430665
Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-DPSGGYNEQFF-Jbeta 2.1 mRNA, partial cds
gi|16566824|gb|AF430665.1|AF430665[16566824] - 2187: AF430664
Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-DATGNLNEQYF-Jbeta 2.7 mRNA, partial cds
gi|16566821|gb|AF430664.1|AF430664[16566821] - 2188: AF430663
Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-SGQVTGELFF-Jbeta
2.2 mRNA, partial cds
gi|16566818|gb|AF430663.1|AF430663[16566818] - 2189: AF430662
Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-AWWGAGYEGYF-Jbeta 2.7 mRNA, partial cds
gi|16566815|gb|AF430662.1|AF430662[16566815] - 2190: AF430661
Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-RRLAGVYNEQFF-Jbeta 2.1 mRNA, partial cds
gi|16566812|gb|AF430661.1|AF430661[16566812] - 2191: AF430660
Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-EFQAPYGYTF-Jbeta 1.2 mRNA, partial cds
gi|6566809|gb|AF430660.1|AF430660[16566809] - 2192: AF430659
Homo sapiens T cell receptor beta variable region, Vbeta 5S6A3N2T-TGTESPDTQYF-Jbeta 2.3 mRNA, partial cds
gi|16566806|gb|AF430659.1|AF430659[16566806] - 2193: AF430658
Homo sapiens T cell receptor beta variable region, Vbeta 5S6A3N2T-TFGTPTYNEQFF-Jbeta 2.1 mRNA, partial cds
gi|16566803|gb|AF430658.1|AF430658[16566803] - 2194: AF430657
Homo sapiens T cell receptor beta variable region, Vbeta 5-SGPSTDTQYF-Jbeta 2.3
mRNA, partial cds
gi|16566800|gb|AP430657.1|AF430657[16566800] - 2195: AF430656
Homo sapiens T cell receptor beta variable region, Vbeta 5S2-NPGGNYGYTF-Jbeta 1.2 mRNA, partial cds
gi|16566797|gb|AF430656.1|AF430656[16566797] - 2196: AF430655
Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-VIGTYEQYF-Jbeta
2.7 mRNA, partial cds
gi|6566794|gb|AF430655.1|AF430655[16566794] - 2197: AF430654
Homo sapiens T cell receptor beta variable region, Vbeta 5S2-AGGETQYF-J beta
2.5
mRNA, partial cds
gi|16566791|gb|AF430654.1|AF430654[16566791] - 2198: AF430653
Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-VSGRGSYEQYF-Jbeta 2.7 mRNA, partial cds
gi|16566788|gb|AF430653.1|AF430653[16566788] - 2199: AF430652
Homo sapiens T cell receptor beta variable region, Vbeta 5S2-VRSEAFF-JBeta 1.1
mRNA, partial cds
gi|16566785|gb|AF430652.1|AF430653[16566785] - 2200: AF430651
Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-RTRTGETNTGELFF-JBeta2.2 mRNA, partial cds
gi|16566782|gb|AF430651.1|AF430651[16566782] - 2201: AF430650
Homo sapiens T cell receptor beta variable region, Vbeta 5S6A3N2T-GAGPSGELFF-JBeta 2.2 mRNA, partial cds
gi|16566779|gb|AF430650.1|AF430650[16566779] - 2202: AF430649
Homo sapiens T cell receptor beta variable region, Vbeta 5S1A1T-GGGTGELFF-Jbeta2.2 mRNA, partial cds
gi|16566776(gb|AF430649.1|AF430649[16566776] - 2203: AF430648
Homo sapiens T cell receptor beta variable region, Vbeta 5S1AT-PGQGAYEQYF-2.7 mRNA, partial cds
gi|16566773|gb|AF430648.1|AF430648[16566773] - 2204: AF430647
Homo sapiens T cell receptor beta variable region, Vbeta 5S2-RPDSGYTF-Jeta1.2 mRNA, partial cds
gi|6566770|gb|AF430647.1|AF430647[16566770] - 2205: AF411117
Homo sapiens G protein-coupled receptor (GPR103) mRNA, complete cds
gi|16566346|gb|AF411117.1|AF411117[16566346] - 2206: AF411116
Homo sapiens G protein-coupled receptor (GPR102) gene, complete cds
gi|16566343|gb|AF411116.1|AF411116[16566343] - 2207: AF411115
Homo sapiens G protein-coupled receptor (GPR101) gene, complete cds
gi|16566340|gb|AF411115.1|AF411115[16566340] - 2208: AF411114
Homo sapiens G protein-coupled receptor (GPR95) mRNA, complete cds
gi|16566337|gb|AF411114.1|AF411114[16566337] - 2209: AF411113
Homo sapiens G protein-coupled receptor (GPR94) gene, complete cds
gi|16566334|gb|AF411113.1|AF411113[16566334] - 2210: AF411112
Homo sapiens G protein-coupled receptor (GPR93) gene, complete cds
gi|16566331|gb|AF411112.1|AF411112[16566331] - 2211: AF411111
Homo sapiens G protein-coupled receptor (GPR82) gene, complete cds
gi|16566328|gb|AF411111.1|AF411111[16566328] - 2212: AF411110
Homo sapiens G protein-coupled receptor (GPR81) gene, complete cds
gi|16566325|gb|AF411110.1|AF411110[16566325] - 2213: AF411109
Homo sapiens G protein-coupled receptor (GPR80) gene, complete cds
gi|16566322|gb|AF411109.1|AF411109[16566322] - 2215: AF411107
Homo sapiens G protein-coupled receptor (GPR78) mRNA, complete cds
gi|1656631B|gb|AF411107.1|AF411107[16566318] - 2216: AF406692
Homo sapiens G protein-coupled receptor GPR86 mRNA, complete cds
gi|5487985|gb|AF406692.1|AF406692[15487985] - 2217: NM—019035
Homo sapiens protocadherin 18 (PCDH18), mRNA
gi|14589928|ref|NM—019035.1|[14589928] - 2218: AF214012
Homo sapiens prolactin receptor gene, exon 11 and partial sequence
gi|14328908|gb|AF214012.1|AF214012[14328908] - 2219: NM—030943
Homo sapiens amnionless protein (AMN), mRNA
gi|13569914|ref|NM—030943.1|[13569914] - 2220: NM—023922
Homo sapiens taste receptor, type 2, member 14 (TAS2R14), mRNA
gi|12965181|ref|NM—023922.1|[12965181] - 2221: NM—023921
Homo sapiens taste receptor, type 2, member 10 (TAS2R10), mRNA
gi|12965179|ref|NM—023921.1|[12965179] - 2222: NM—023920
Homo sapiens taste receptor, type 2, member 13 (TAS2R13), mRNA
gi|12965177|ref|NM—023920.1|[12965177] - 2223: NM—023919
Homo sapiens taste receptor, type 2, member 7 (TAS2R7), mRNA
gi|12965175|ref|NM—023919.1|[12965175] - 2224: NM—023918
Homo sapiens taste receptor, type 2, member 8 (TAS2R8), mRNA
gi|12965173|ref|NM—023918.1|[12965173] - 2225: NM—023917
Homo sapiens taste receptor, type 2, member 9 (TAS2R9), mRNA
gi|12965171|ref|NM—023917.1|[12965171] - 2226: AF206696
Homo sapiens interleukin-1 epsilon (IL1E) mRNA, complete cds
gi|11493847|gb|AF206696.1|AF206696[11493847] - 2227: AF230377
Homo sapiens interleukin-1 delta mRNA, complete cds
gi|9651788|gb|AF230377.1|AF230377[9651788] - 2228: BC018284
Homo sapiens, triggering receptor expressed on myeloid cells 2, clone IMAGE:4151400, mRNA
gi|17390669|gb|BC018284.1|BC018284[17390669] - 2229: BC018130
Homo sapiens, coagulation factor II (thrombin) receptor-like 1, clone MGC:9298
IMAGE:3895653, mRNA, complete cds
gi|17390291|gb|BC018130.1|BC018130[17390291] - 2230: BC017898
Homo sapiens, Purinergic receptor P2Y, G protein-coupled, 12, clone MGC:23802 IMAGE:4251263, mRNA, complete cds
gi|17389766|gb|BC017898.1|BC017898[17389766] - 2231: BC017865
Homo sapiens, Fc fragment of IgG, low affinity 111a, receptor for (CD16), clone
MGC:22630 IMAGE:4690249, mRNA, complete cds
gi|17389687|gb|BC017865.1|BC017865[17389687] - 2232: BC017852
Homo sapiens, tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain, clone IMAGE:4700855, mRNA
gi|17389657|gb|BC017852.1|BC017852[17389657] - 2233: BC017784
Homo sapiens, killer cell lectin-like receptor subfamily C, member 4, clone MGC:22279 IMAGE:4619154, mRNA, complete cds
gi|17389488|gb|BC017784.1|BC017784[17389488] - 2234: BC017773
Homo sapiens, triggering receptor expressed on myeloid cells 1, clone MGC:22242
IMAGE:4692680, mRNA, complete cds
gi|17389458|gb|BC017773.1|BC017773[17389458] - 2235: BC017730
Homo sapiens, tumor necrosis factor receptor superfamily, member 21, clone MGC:21476 IMAGE:3847246, mRNA, complete cds
gi|17389378|gb|BC017730.1|BC017730[17389378] - 2237: AJ252246
Homo sapiens mRNA for kainate receptor subunit (GRIK2 gene)
gi|17384623|emb|AJ252246.1|HSA252246[17384623] - 2238: AJ249210
Homo sapiens mRNA for glutamate/kainate receptor subtype GluR7 (GRIK3 gene)
gi|17384612|emb|AJ249210.1|HSA249210[17384612] - 2239: AJ249209
Homo sapiens mRNA for glutamate/kainate receptor subunit KA2a (GRIK5 gene)
gi|17384610|emb|AJ249209.1|HSA249209[17384610] - 2240: AJ249208
Homo sapiens mRNA for glutamate receptor subunit GluR5 (GRIK1 gene)
gi|17384608|emb|AJ249208.1|HSA249208[17384608] - 2241: AJ415410
Homo sapiens partial IGVK1-O14 gene for immunoglobulin kappa chain variable region, donor MF, cell24
gi|17384019|emb|AJ415410.2|HSA415410[17384019] - 2242: AJ415291
Homo sapiens partial IGVH3-33 gene for immunoglobulin heavy chain variable region, donor TG, cell46
gi|17384018|emb|AJ415291.2|HSA415291[17384018] - 2243: AJ414840
Homo sapiens partial IGVKA30 gene for immunoglobulin kappa chain variable region, donor MF, cell2
gi|17384017|emb|AJ414840.2|HSA414840[17384017] - 2244: NM—000623
Homo sapiens bradykinin receptor B2 (BDKRB2), mRNA
gi|17352499|ref|NM—000623.2|[17352499] - 2246: AJ347709
Homo sapiens mRNA for FKBP-associated protein
gi|15620770|emb|AJ347709.1|HSA347709[15620770] - 2247: AF356518
Homo sapiens junctional adhesion molecule 3 precursor, mRNA, complete cds
gi|13448824|gb|AF356518.1|AF356518[13448824] - 2248: NM—021201
Homo sapiens membrane-spanning 4-domains, subfamily A, member 7 (MS4A7), mRNA
gi|11139298|ref|NM—021201.1|[11139298] - 2249: NM—015344
Homo sapiens leptin receptor overlapping transcript-like 1 (LEPROTL1), mRNA
gi|7662509|ref|NM—015344.1|[7662509] - 2250: AF411850
Homo sapiens C-type lectin-like receptor CLEC-6 mRNA, complete cds
gi|17226267|gb|AF411850.1|AF411850[17226267] - 2251: AF325460
Homo sapiens dendritic lectin b isoform (CLECSF11) mRNA, complete cds, alternatively spliced
gi|17225338|gb|AF325460.1|AF325460[17225338] - 2252: AF325459
Homo sapiens dendritic lectin (CLECSF11) mRNA, complete cds, alternatively spliced
gi|17225336|gb|AF325459.1|AF325459[17225336] - 2253: AF293357
Homo sapiens AT2 receptor-interacting protein 1 mRNA, complete cds
gi|17224595|gb|AF293357.1|AF293357[17224595] - 2254: AF283988
Homo sapiens leukocyte immunoglobulin-like receptor-5 (LILRB5) mRNA, LILRB5-v1
allele, complete cds
gi|17224473|gb|AF283988.1|AF283988[17224473] - 2255: AF283987
Homo sapiens leukocyte immunoglobulin-like receptor-2 (LILRB2) mRNA, LILRB2-v2
allele, complete cds
gi|17224471|gb|AF283987.1|AF283987[17224471] - 2256: AF283986
Homo sapiens leukocyte immunoglobulin-like receptor-2 (LILRB2) mRNA, LILRB2-v1
allele, complete cds
gi|17224469|gb|AF283986.1|AF283986[17224469] - 2257: AF283985
Homo sapiens leukocyte immunoglobulin-like receptor-1 (LILRB1) mRNA, LILRB1-v2
allele, complete cds
gi|17224467|gb|AF283985.1|AF283985[17224467] - 2258: AF283984
Homo sapiens leukocyte immunoglobulin-like receptor-1 (LILRB1) mRNA, LILRB1-v1
allele, complete cds
gi|17224465|gb|AF283984.1|AF283984[17224465] - 2259: NM—057170
Homo sapiens G protein-coupled receptor kinase-interactor 2 (GIT2), transcript
variant 2, mRNA
gi|17149831|ref|NM—057170.1|[17149831] - 2260: NM—057169
Homo sapiens G protein-coupled receptor kinase-interactor 2 (GIT2), transcript
variant 1, mRNA
gi|17149829|ref|NM—057169.1|[17149829] - 2261: AJ417151
Homo sapiens partial mRNA for T cell receptor beta chain (TCRB gene), clone 25
gi|17148488|emb|AJ417151.1|HSA417151[17148488] - 2262: AJ417150
Homo sapiens partial mRNA for T cell receptor beta chain (TCRB gene), clone 27
gi|17148486|emb|AJ417150.1|HSA417150[17148486] - 2263: NM—014776
Homo sapiens G protein-coupled receptor kinase-interactor 2 (GIT2), transcript
variant 3, mRNA
gi|7661943|ref|NM—014776.1|[7661943] - 2264: AJ239326
Homo sapiens chromosome 21 clone cosmid LLNLc116 32E2 map 21q22.3, *** SEQUENCING IN PROGRESS ***, 4 ordered pieces
gi|6982097|emb|AJ239326.3|HSS171M[6982097] - 2265: NM—000675
Homo sapiens adenosine A2a receptor (ADORA2A), mRNA
gi|17136146|ref|NM—000675.3|[17136146] - 2266: AF035374
Homo sapiens Cys-rich protein (RAMP) mRNA, complete cds
gi|2665702|gb|AF035374.1|AF035374[2665702] - 2267: AF282269
Homo sapiens G protein-coupled receptor kinase 7 mRNA, complete cds
gi|17026317|gb|AF282269.1|AF282269[17026317] - 2268: AF437510
Homo sapiens T-cell receptor beta-chain mRNA, partial cds
gi|16974744|gb|AF437510.1|AF437510[16974744] - 2269: AX286800
Sequence 35 from Patent WO0178796
gi|17048833|emb|AX286800.1|AX286800[17048833] - 2270: AX286799
Sequence 34 from Patent WO0178796
gi|17048832|emb|AX286799.1|AX286799[17048832] - 2271: AB005145
Homo sapiens CL-P1 mRNA for collectin placenta 1, complete cds
gi|17026100|dbj|AB005145.1|AB005145[17026100] - 2272: SEG_HUMIL3RA
Homo sapiens gene for interleukin 3 receptor alpha subunit
gi|1345401|dbj||SEG_HUMIL3RA[1345401] - 2273: L34720
Homo sapiens T-cell receptor beta (TCRB) mRNA, partial cds
gi|1100194|gb|L34720.1|HUMTCRBP[1100194] - 2274: L34734
Homo sapiens T-cell receptor beta (TCRB) mRNA, complete cds
gi|1100181|gb|L34734.1|HUMTCRBAL[1100181] - 2275: L34729
Homo sapiens T-cell receptor beta (TCRB) mRNA, partial cds
gi|110017|gb|L34729.1|HUMTCRBAG[1100171] - 2276: D49412
Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 11
gi|684969|dbj|D49412.1|HUMIL3RA11[684969] - 2277: D49410
Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 12 and partial
cds
gi|684968|dbj|D49410.1|HUMIL3RA12[684968] - 2278: D49408
Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 10
gi|684967|dbj|D49408.1|HUMIL3RA10[684967] - 2279: D49409
Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 6
gi|684966|dbj|D549409.1|HUMIL3RA06[684966] - 2280: D49407
Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 4
gi|684965|dbj|D549407.1|HUMIL3RA04[684965] - 2281: D49406
Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 2
gi|684964|dbj|D549406.1|HUMIL3RA02[684964] - 2282: D49404
Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 7
gi|684963|dbj|D549404.1|HUMIL3RA07[684963] - 2283: D49403
Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 5
gi|684962|dbj|D549403.1|HUMIL3RA05[684962] - 2284: D49402
Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 3
gi|684961|dbj|D549402.1|HUMIL3RA03[684961] - 2285: D49401
Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 1
gi|684960|dbj|D549401.1|HUMIL3RA01[684960] - 2286: D49411
Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 9
gi|684959|dbj|D549411.1|HUMIL3RA09[684959] - 2287: D49405
Homo sapiens gene for interleukin 3 receptor alpha subunit, exon 8
gi|684958|dbj|D49405.1|HUMIL3RA08[684958] - 2288: SEG_HUMGRAS
Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
receptor alpha subunit
gi|522101|dbj||SEG_HUMGRAS[522101] - 2289: D26625
Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
receptor alpha subunit, exon 10
gi|467508|dbj|D526625.1|HUMGRAS10[467508] - 2290: D26624
Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
receptor alpha subunit, exon 9
gi|467507|dbj|D526624.1|HUMGRAS09[467507] - 2291: D26623
Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
receptor alpha subunit, exon 8
gi|467506|dbj|D526623.1|HUMGRAS08[467506] - 2292: D26622
Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
receptor alpha subunit, exon 7
gi|467505|dbj|D526622.1|HUMGRAS07[467505] - 2293: D26621
Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
receptor alpha subunit, exon 6
gi|467504|dbj|D526621.1|HUMGRAS06[467504] - 2294: D26628
Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
receptor alpha subunit, exon 13 and partial cds
gi|456594|dbj|D526628.1|HUMGRAS13[456594] - 2295: D26627
Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
receptor alpha subunit, exon 12
gi|456593|dbj|D526627.1|HUMGRAS12[456593] - 2296: D26626
Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
receptor alpha subunit, exon 11
gi|456592|dbj|D526626.1|HUMGRAS11[456592] - 2297: D26620
Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
receptor alpha subunit, exon 5
gi|456591|dbj|D526620.1|HUMGRAS05[456591] - 2298: D26619
Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
receptor alpha subunit, exon 4
gi|456590|dbj|D526619.1|HUMGRAS04[456590] - 2299: D26618
Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
receptor alpha subunit, exon 3
gi|456589|dbj|D526618.1|HUMGRAS03[456589] - 2300: D26617
Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
receptor alpha subunit, exon 2
gi|456588|dbj|D526617.1|HUMGRAS02[456588] - 2301: D26616
Homo sapiens gene for granulocyte-macrophage colony stimulating factor (GM-CSF)
receptor alpha subunit, exon 1
gi|456587|dbj|D526616.1|HUMGRAS01[456587] - 2307; AF324499
Homo sapiens olfactory-like receptor mRNA, complete cds
gi|17016397|gb|AF324499.1|AF324499[17016397] - 2308: AF308814
Homo sapiens olfactory receptor-like protein (JCG10) mRNA, partial cds
gi|17016395|gb|AF308814.1|AF308814[17016395] - 2309: AF238488
Homo sapiens olfactory-like receptor JCG8 (JCG8) mRNA, complete cds
gi|17016318|gb|AF238488.1JAF238488[17016318] - 2310: AF238487
Homo sapiens olfactory-like receptor PJCG2 (PJCG2) mRNA, partial cds
gi|17016316|gb|AF238487.1|AF238487[17016316] - 2311: AF220494
Homo sapiens olfactory receptor-like protein JCG4 (JCG4) mRNA, partial cds
gi|17016314|gb|AF220494.1|AF220494[17016314] - 2312: AF220493
Homo sapiens olfactory receptor-like protein PJCG1 (PJCG1) mRNA, partial cds
gi|17016312|gb|AF220493.1|AF220493[17016312] - 2313: AF209507
Homo sapiens olfactory receptor-like protein mRNA, complete sequence
gi|17016311|gb|AF209507.1|AF209507[17016311] - 2314: AF403014
Homo sapiens type II gonadotropin-releasing hormone receptor gene, partial cds
gi|16589055|gb|AF403014.1|AF403014[16589055] - 2316: AF403012
Homo sapiens ribonucleoprotein RBM8 gene, complete cds
gi|1658905|gb|AF403012.1|AF403012[16589051] - 2317: AY011601
Homo sapiens cannabinoid receptor 1 (CNR1) gene, partial cds
gi|12699807|gb|AY011601.1|[12699807] - 2318: AY011231
Homo sapiens adenosine A3 receptor (ADORA3) gene, partial cds
gi|12699245|gb|AY011231.1|[12699245] - 2319: AF400602
Homo sapiens beta-glucan receptor isoform H (BGR) mRNA, complete cds, alternatively spliced
gi|15986713|gb|AF400602.1|AF400602[15986713] - 2320: AF400601
Homo sapiens beta-glucan receptor isoform G (BGR) mRNA, complete cds, alternatively spliced
gi|15986711|gb|AF400601.1|AF400601[15986711] - 2321: AF400600
Homo sapiens beta-glucan receptor isoform F (BGR) mRNA, complete cds, alternatively spliced
gi|15986709|gb|AF400600.1|AF400600[15986709] - 2322: AF400599
Homo sapiens beta-glucan receptor isoform E (BGR) mRNA, complete cds, alternatively spliced
gi|15986707|gb|AF400599.1|AF400599[15986707] - 2323: AF400598
Homo sapiens beta-glucan receptor isoform D (BGR) mRNA, complete cds, alternatively spliced
gi|15986705|gb|AF400598.1|AF400598[15986705] - 2324: AF400597
Homo sapiens beta-glucan receptor isoform C (BGR) mRNA, complete cds, alternatively spliced
gi|15986703|gb|AF400597.1|AF400597[15986703] - 2325: AF400596
Homo sapiens beta-glucan receptor isoform B (BGR) mRNA, complete cds, alternatively spliced
gi|15986701|gb|AF400596.1|AF400596[15986701] - 2326: AF400595
Homo sapiens beta-glucan receptor isoform A (BGR) mRNA, complete cds, alternatively spliced
gi|15986699|gb|AF400595.1|AF400595[15986699] - 2329: AF162669
Homo sapiens olfactory receptor-like protein JCG2 (JCG2) gene, complete cds
gi|12002783|gb|AF162669.1|AF162669[12002783] - 2330: NM—004895
Homo sapiens cold autoinflammatory syndrome 1 (CIAS1), mRNA
gi|4757727|ref|NM—004895.1|[4757727] - 2331: AF409103
Homo sapiens T-cell receptor VB3 CDR3 region mRNA, partial cds
gi|15425973|gb|AF409103.1|AF409103[15425973] - 2332: NM—033181
Homo sapiens cannabinoid receptor 1 (brain) (CNR1), transcript variant 3, mRNA
gi|15208647|ref|NM—033181.1|[15208647] - 2333: AF373846
Homo sapiens BAFF receptor mRNA, complete cds
gi|15208474|gb|AF373846.1|AF373846[15208474] - 2334: AF361108
Homo sapiens CRHF2 receptor beta-isoform mRNA, partial sequence, aberrantly spliced
gi|14586959|gb|AF361108.1|AF361108[14586959] - 2335: NM—005755
Homo sapiens Epstein-Barr virus induced gene 3 (EBI3), mRNA
gi|14577916|ref|NM—005755.2|[14577916] - 2336: AF369794
Homo sapiens B cell crosslinked IgM-activating sequence protein (BXMAS1) mRNA,
complete cds
gi|14278718|gb|AF369794.2|AF369794[14278718] - 2337: AF376725
Homo sapiens lung seven transmembrane receptor 1 (LUSTR1) mRNA, complete cds
gi|14248996|gb|AF376725.1|AF376725[14248996] - 2343: AF352324
Homo sapiens killer cell Ig-like receptor KIR3DL7 (KIRC1) mRNA, complete cds
gi|13560903|gb|AF352324.1|AF352324[13560903] - 2344: AJ249131
Homo sapiens partiel mPR gene for progesterone membrane binding protein
gi|6688178|emb|AJ249131.1|HSA249131[6688178] - 2345: S73474
Homo sapiens folate receptor alpha isoform mRNA, partial cds
gi|688233|gb|S73474.1|S73490S2[688233] - 2346: S73490
Homo sapiens folate receptor alpha isoform mRNA, partial cds
gi|688232|gb|S73490.1|S73490S1[688232] - 2347: S69142
Homo sapiens T-cell receptor alpha-chain (TcR V alpha) mRNA, partial cds
gi|545977|gb|S69142.1|S69142[545977] - 2348: S67401
Homo sapiens T-cell receptor beta chain VDJ region (TCR Vbeta 7.1 Jbeta 2.3) mRNA, partial cds
gi|455870gb|S67401.1|S67401[455870] - 2349: S62797
Homo sapiens T cell receptor beta chain VDJ region (TcrVbeta 6) mRNA, TcrVbeta
6.7a allele, partial cds
gi|385951|gb|S62797.1|S62797[385951] - 2350: AF310685
Homo sapiens ADP-glucose receptor gene, complete cds
gi|16973448|gb|AF310685.1|AF310685[16973448] - 2351: NM—057160
Homo sapiens artemin (ARTN), transcript variant 3, mRNA
gi|16950644|ref|NM—057160.1|[16950644] - 2352: NM—057091
Homo sapiens artemin (ARTN), transcript variant 2, mRNA
gi|16950642|ref|NM—057091.1|[16950642] - 2353: NM—057090
Homo sapiens artemin (ARTN), transcript variant 4, mRNA
gi|16950640|ref|NM—057090.1|[16950640] - 2354: NM—003976
Homo sapiens artemin (ARTN), transcript variant 1, mRNA
gi|16950639|ref|NM—003976.2|[16950639] - 2355: NM—053032
Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 8, mRNA
gi|16950624|ref|NM—053032.1|[16950624] - 2356: NM—053031
Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 7, mRNA
gi|16950622|ref|NM—053031.1|[16950622] - 2357: NM—053030
Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 5, mRNA
gi|16950620|ref|NM—053030.1|[16950620] - 2358: NM—053029
Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 4, mRNA
gi|16950618|ref|NM—053029.1|[16950618] - 2359: NM—053028
Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 3B, mRNA
gi|16950616|ref|NM—053028.1|[16950616] - 2360: NM—053027
Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 3A, mRNA
gi|16950614|ref|NM—053027.1|[16950614] - 2361: NM—053026
Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 2, mRNA
gi|16950612|ref|NM—053026.1|[16950612] - 2362: NM—053025
Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 1, mRNA
gi|16950610|ref|NM—053025.1|[16950610] - 2363: NM—005965
Homo sapiens myosin, light polypeptide kinase (MYLK), transcript variant 6, mRNA
gi|16950600|ref|NM—005965.2|[16950600] - 2364: AF106202
Homo sapiens endothelial cell protein C receptor precursor (EPCR) gene, promoter
region and complete cds
gi|16950557|gb|AF106202.2|AF106202[16950557] - 2365: AY033942
Homo sapiens prostate-specific G protein-coupled receptor (PSGR) mRNA, complete
cds
gi|16943640|gb|AY033942.1|[16943640] - 2366: AF369708
Homo sapiens prostate-specific G-protein coupled receptor mRNA, complete cds
gi|13752563|gb|AF369708.1|AF369708[13752563] - 2368: AJ276204
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-8
gi|9968287|emb|AJ276204.1|HSA276204[9968287] - 2369: AJ276203
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-7
gi|9968285|emb|AJ276203.1|HSA276203[9968285] - 2370: AJ276202
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-6
gi|9968266|emb|AJ276202.1|HSA276202[9968266] - 2371: AJ276201
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-5
gi|9968264|emb|AJ276201.1|HSA276201[9968264]
- 2372: AJ276200
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-4
gi|9968262|emb|AJ276200.1|HSA276200[9968262] - 2373: AJ276199
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-3
gi|9968260|emb|AJ276199.1|HSA276199[9968260] - 2374: AJ276198
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-2
gi|9968258|emb|AJ276198.1|HSA276198[9968258] - 2375: AJ276197
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-C-1
gi|9968256|emb|AJ276197.1|HSA276197[9968256] - 2376: AJ276196
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Gel-C
gi|9968254|emb|AJ276196.1|HSA276196[9968254] - 2377: AJ276195
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-11
gi|9968252|emb|AJ276195.1|HSA276195[9968252] - 2378: AJ276194
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-10
gi|9968250|emb|AJ276194.1|HSA276194[9968250] - 2379: AJ276193
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-9
gi|9968248|emb|AJ276193.1|HSA276193[9968248] - 2380: AJ276192
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-8
gi|9968246|emb|AJ276192.1|HSA276192[9968246] - 2381: AJ276191
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-7
gi|9968244|emb|AJ276191.1|HSA276191[9968244] - 2382: AJ276190
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-6
gi|9968242|emb|AJ276190.1|HSA276190[9968242] - 2383: AJ276189
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-5
gi|9968240|emb|AJ276189.1|HSA276189[9968240] - 2384: AJ276188
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-4
gi|9968238|emb|AJ276188.1|HSA276188[9968238] - 2385: AJ276187
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-3
gi|9968236|emb|AJ276187.1|HSA276187[9968236] - 2386: AJ276186
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-2
gi|9968234|emb|AJ276186.1|HSA276186[9968234] - 2387: AJ276185
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Plasmid-B-1
gi|9968232|emb|AJ276185.1|HSA276185[9968232] - 2388: AJ276184
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Gel-A2
gi|9968230|emb|AJ276184.1|HSA276184[9968230] - 2389: AJ276183
Homo sapiens partial mRNA for T-cell receptor beta-chain (TCRB gene) Gel-A1
gi|9968228|emb|AJ276183.1|HSA276183[9968228] - 2390: NM—005086
Homo sapiens sarcospan (Kras oncogene-associated gene) (SSPN), mRNA
gi|16933560|ref|NM—005086.3|[16933560] - 2391: NM—018153
Homo sapiens tumor endothelial marker 8 (TEM8), transcript variant 3, mRNA
gi|16933552|ref|NM—018153.2|[16933552] - 2392: NM—053034
Homo sapiens tumor endothelial marker 8 (TEM8), transcript variant 2, mRNA
gi|16933550|ref|NM—053034.1|[16933550] - 2393: NM—005929
Homo sapiens antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 (MFI2), transcript variant 1, mRNA
gi|16933549|ref|NM—005929.3|[16933549] - 2394: NM—033316
Homo sapiens antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 (MFI2), transcript variant 2, mRNA
gi|16933548|ref|NM—033316.2|[16933548] - 2395: AF361473
Homo sapiens magic roundabout mRNA, complete cds
gi|16930357|gb|AF361473.1|AF361473[16930357] - 2396: NM—032208
Homo sapiens tumor endothelial marker 8 (TEM8), transcript variant 1, mRNA
gi|14149903|ref|NM—032208.1|[14149903] - 2397: NM—007346
Homo sapiens opioid growth factor receptor (OGFR), mRNA
gi|6671492|ref|NM—007346.1|[6671492] - 2398: BC017412
Homo sapiens, leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2, clone MGC:27265 IMAGE:4618777, mRNA, complete cds
gi|16924270|gb|BC017412.1|BC017412[16924270] - 2401: AF435588
Homo sapiens melatonin receptor Me11a (MTNR1A) mRNA, partial cds
gi|16904202|gb|AF435588.1|AF435588[16904202] - 2402: AF421380
Homo sapiens anthrax toxin receptor mRNA, complete cds
gi|16566412|gb|AF421380.1|AF421380[16566412] - 2403: AF291815
Homo sapiens NK cell receptor (CS1) mRNA, complete cds
gi|113021809 gb|AF291815.1|AF291815[13021809] - 2404: AF117899
Homo sapiens LDLR-FUT fusion protein (LDLR-FUT) mRNA, complete cds
gi|6739499|gb|AF117899.1|AF117899[6739499] - 2405: AF054013
Homo sapiens lipoxin A4 receptor mRNA, complete cds
gi|3047268|gb|AF054013.1|AF054013[3047268] - 2406: AF013250
Homo sapiens leukocyte-associated Ig-like receptor-2 (LAIR-2) mRNA, complete cds
gi|2352942|gb|AF013250.1|AF013250[2352942] - 2407: AF013249
Homo sapiens leukocyte-associated Ig-like receptor-1 (LAIR-1) mRNA, complete cds
gi|2352940gb|AF013249.1|AF013249[2352940] - 2409: AF326353
Homo sapiens Src-like adapter protein-2 mRNA, complete cds
gi|16797891|gb|AF326353.1|AF326353[16797891] - 2411: BC017065
Homo sapiens, tumor necrosis factor receptor superfamily, member 6b, decoy, clone MGC:9587 IMAGE:3886635, mRNA, complete cds
gi|16877637|gb|BC017065.1|BC017065[16877637] - 2412: BC016938
Homo sapiens, neuromedin U receptor 2, clone MGC:21396 IMAGE:3852151, mRNA, complete cds
gi|16877376|gb|BC016938.1|BC016938[16877376] - 2413: BC016860
Homo sapiens, G protein-coupled receptor, family C, group 5, member C, clone MGC:17384 IMAGE:3904655, mRNA, complete cds
gi|16877192|gb|BC016860.1|BC016860[16877192] - 2414: BC016692
Homo sapiens, progesterone receptor membrane component 2, clone MGC:22407 IMAGE:4067832, mRNA, complete cds
gi|16876813|gb|BC016692.1|BC016692[16876813] - 2415: AY026949
Homo sapiens stresscopin mRNA, complete cds
gi|15026913|gb|AY026949.1|[15026913] - 2416: AF285092
Homo sapiens Bcl-2-like protein 10 mRNA, complete cds
gi|9837265|gb|AF285092.1|AF285092[9837265] - 2417: D78579
Homo sapiens NOR-1 mRNA for neuron derived orphan receptor, complete cds
gi|1651190|dbj|D78579.1|D78579[1651190] - 2418: D38044
Homo sapiens gene for Ah-receptor, partial cds, exons 7-9
gi|532672|dbj|D538044.1|HUMAHRA[532672] - 2419: NM—053278
Homo sapiens G protein-coupled receptor 102 (GPR102), mRNA
gi|16751916|ref|NM—053278.1|[16751916] - 2420: NM—030916
Homo sapiens Ig superfamily receptor LNIR (LNIR), mRNA
gi|16716338|ref|NM—030916.1|[16716338] - 2421: AF403479
Homo sapiens EWS/FLI1 activated transcript 2 protein mRNA, complete cds
gi|16611777|gb|AF403479.1|AF403479[16611777] - 2422: NM—053036
Homo sapiens G protein-coupled receptor 74 (GPR74), mRNA
gi|16604257|gb|BC053036.1|BC016004[16604257] - 2431: BC016004
Homo sapiens, macrophage receptor with collagenous structure, clone MGC:27263 IMAGE:4618447, mRNA, complete cds
gi|16359078|gb|BC016004.1|BC016004[16359078] - 2432: BC013827
Homo sapiens, laminin receptor 1 (67 kD, ribosomal protein SA), clone MGC:17122
IMAGE:3446816, mRNA, complete cds
gi|16307601|gb|BC013827.1|BC013827[16307601] - 2433: BC001590
Homo sapiens, cargo selection protein (mannose 6 phosphate receptor binding protein), clone MGC:2012 IMAGE:2987965, mRNA, complete cds
gi|16306788|gb|BC001590.1|BC001590[16306788] - 2434: BC001492
Homo sapiens, ciliary neurotrophic factor receptor, clone MGC:1774 IMAGE:3510004, mRNA, complete cds
gi|16306633|gb|BC001492.1|BC001492[16306633] - 2435: BC015768
Homo sapiens, interleukin 13 receptor, alpha 1, clone MGC:23204 IMAGE:4868206,
mRNA, complete cds
gi|16041774|gb|BC015768.1|BC015768[16041774] - 2436: BC015731
Homo sapiens, leukocyte immunoglobulin-like receptor, subfamily B (with TM and
ITIM domains), member 1, clone MGC:22968 IMAGE:4878915, mRNA, complete cds
gi|16041710|gb|BC015731.1|BC015731[16041710] - 2437: BC015542
Homo sapiens, poliovirus receptor, clone MGC:9603 IMAGE:3902226, mRNA, complete
cds
gi|15930222|gb|BC015542.1|BC015542[15930222] - 2439: BC015195
Homo sapiens, Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide, clone MGC:14717 IMAGE:4251469, mRNA, complete cds
gi|15929529|gb|BC015195.1|BC015195[15929529] - 2440: BC014972
Homo sapiens, interleukin 2 receptor, gamma (severe combined immunodeficiency),
clone MGC:23116 IMAGE:4878734, mRNA, complete cds
gi|15929027|gb|BC014972.1|BC014972[15929027] - 2441: BC014962
Homo sapiens, GDNF family receptor alpha 1, clone MGC:23045 IMAGE:4874042, mRNA,
complete cds
gi|15929001|gb|BC014962.1|BC014962[15929001] - 2442: BC014960
Homo sapiens, low density lipoprotein receptor defect C complementing, clone MGC:23019 IMAGE:4876271, mRNA, complete cds
gi|15928995|gb|BC014960.1|BC014960[15928995] - 2443: BC013816
Homo sapiens, platelet-activating factor receptor, clone MGC:17210 IMAGE:4343214, mRNA, complete cds
gi|15489458|gb|BC013816.1|BC013816[15489458] - 2444: BC013780
Homo sapiens, adenosine A2a receptor, clone MGC:21342 IMAGE:4385637, mRNA, complete cds
gi|15489369|gb|BC013780.1|BC013780[15489369] - 2445: NM—032551
Homo sapiens G protein-coupled receptor 54 (GPR54), mRNA
gi|14211846|ref|NM—032551.1|[14211846] - 2446: AF329490
Homo sapiens IFGP2 mRNA, complete cds
gi|16506260|gb|AF329490.1|AF329490[16506260] - 2447: AF329488
Homo sapiens IFGP1 mRNA, complete cds
gi|16506256|gb|AF329488.1|AF329488[16506256] - 2448: NM—000798
Homo sapiens dopamine receptor D5 (DRD5), mRNA
gi|16445405|ref|NM—000798.2|[16445405] - 2449: NM—000794
Homo sapiens dopamine receptor D1 (DRD1), mRNA
gi|16445404|ref|NM—000794.2|[16445404] - 2450: NM—000796
Homo sapiens dopamine receptor D3 (DRD3), transcript variant a, mRNA
gi|16445403|ref|NM—000796.2|[16445403] - 2451: NM—033663
Homo sapiens dopamine receptor D3 (DRD3), transcript variant e, mRNA
gi|16445401|ref|NM—033663.1|[16445401] - 2452: NM—033660
Homo sapiens dopamine receptor D3 (DRD3), transcript variant d, mRNA
gi|16445399|ref|NM—033660.1|[16445399] - 2453: NM—033659
Homo sapiens dopamine receptor D3 (DRD3), transcript variant c, mRNA
gi|16445397|ref|NM—033659.1|[16445397] - 2454: NM—033658
Homo sapiens dopamine receptor D3 (DRD3), transcript variant b, mRNA
gi|16445395|ref|NM—033658.1|[16445395] - 2455: AJ298918
Homo sapiens t(8;22) (p11;q11) translocation breakpoint, BCR/FGFR gene
gi|16444915|emb|AJ298918.1|HSA298918[16444915] - 2456: AJ298917
Homo sapiens partial mRNA for FGFR1/BCR chimaeric fusion peptide
gi|16444913|emb|AJ298917.1|HSA298917[16444913] - 2457: AJ298916
Homo sapiens partial mRNA for BCR/FGFR1 chimaeric fusion protein
gi|16444911|emb|AJ298916.1|HSA298916[16444911] - 2458: AF325925
Homo sapiens tandem motif downstream of INSRR gene, allele 2
gi|13374363|gb|AF325925.1|AF325925[13374363] - 2459: AF325924
Homo sapiens tandem motif downstream of INSRR gene, allele 1
gi|13374362|gb|AF325924.1|AF325924[13374362] - 2460: NM—014879
Homo sapiens G protein-coupled receptor 105 (GPR105), mRNA
gi|7661847|ref|NM—014879.1|[7661847] - 2461: NM—000797
Homo sapiens dopamine receptor D4 (DRD4), mRNA
gi|4503388|ref|NM—000797.1|[4503388] - 2462: NM—052962
Homo sapiens class II cytokine receptor (IL22RA2), mRNA
gi|16418458|ref|NM—052962.1|[16418458] - 2463: NM—052932
Homo sapiens pro-oncosis receptor inducing membrane injury gene (PORIMIN), mRNA
gi|16418408|ref|NM—052932.1|[16418408] - 2464: NM—052887
Homo sapiens Toll-interleukin 1 receptor (TIR) domain-containing adapter protein
(TIRAP), mRNA
gi|16418398|ref|NM—052887.1|[16418398] - 2465: NM—018835
Homo sapiens olfactory receptor, family 1, subfamily K, member 1 (OR1K1), mRNA
gi|9256536|ref|NM—018835.1|[9256536] - 2466: BC016141
Homo sapiens, interleukin 1 receptor accessory protein, clone IMAGE:3920152, mRNA
gi|16359373|gb|BC016141.1|BC016141[16359373] - 2467: AF177765
Homo sapiens toll-like receptor 4 (TLR4) gene, TLR4A allele, complete cds
gi|6175872|gb|AF177765.1|AF177765[6175872] - 2468: U11813
Homo sapiens hepatocyte growth factor receptor precursor, mRNA, partial cds; alternatively spliced
gi|530799|gb|U11813.1|HSU11813[530799] - 2469: BC009540
Homo sapiens, G protein-coupled receptor 87, clone MGC:10065 IMAGE:3894333, mRNA, complete cds
gi|16306940 gb|BC009540.1|BC009540[16306940] - 2474: AJ313162
Homo sapiens mRNA for soluble cytokine class II receptor, long isoform (CRF2-S1
gene)
gi|16304592|emb|AJ313162.1|HSA313162[16304592] - 2475: AJ313161
Homo sapiens mRNA for soluble cytokine class II receptor, short isoform (CRF2-S1
gene)
gi|16304590|emb|AJ313161.1|HSA313161[16304590] - 2476: AY048757
Homo sapiens ATP-binding cassette transporter G1 (ABCG1) mRNA, complete cds, alternatively spliced
gi|16304310|gb|AY048757.1|[16304310] - 2501: AJ313161
Homo sapiens mRNA for soluble cytokine class II receptor, short isoform (CRF2-S1 gene)
gi|16304590|emb|AJ313161.1|HSA313161[16304590] - 2502: AY048757
Homo sapiens ATP-binding cassette transporter G1 (ABCG1) mRNA, complete cds, alternatively spliced
gi|16304310|gb|AY048757.1|[16304310] - 2626: NM—012068
Homo sapiens activating transcription factor 5 (ATF5), mRNA
gi|12597624|ref|NM—012068.2|[12597624] - 2627: AF055084
Homo sapiens very large G-protein coupled receptor-1 (VLGR1) mRNA, complete cds
gi|5902965|gb|AF055084.1|AF055084[5902965] - 2629: AJ414821
Homo sapiens partial IGVKL12 gene for immunoglobulin kappa chain variable region, donor TG, cell84
gi|16215495|emb|AJ414821.2|HSA414821[16215495] - 2630: AY056048
Homo sapiens receptor protein tyrosine kinase variant EphB4v1 (EPHB4) mRNA, complete cds, alternatively spliced
gi|16209619|gb|AY056048.1|[16209619] - 2631: AY056047
Homo sapiens receptor protein tyrosine kinase EphB4 (EPHB4) gene, complete cds,
alternatively spliced
gi|16209617|gb|AY056047.1|[16209617] - 2632: AY052490
Homo sapiens NK cell receptor (KIR2DL4) mRNA, KIR2DL4-10A allele, partial cds
gi|16209550|gb|AY052498.1|[16209550] - 2633: AY052497
Homo sapiens NK cell receptor (KIR2DL4) mRNA, KIR2DL4-9A allele, partial cds
gi|16209510|gb|AY052497.1|[16209510] - 2634: AY052496
Homo sapiens truncated NK cell receptor (KIR2DL4) mRNA, KIR2DL4-9A allele, partial cds
gi|16209507|gb|AY052496.1|[16209507] - 2635: AF267245
Homo sapiens killer cell lectin-like receptor KLRF1-S3 (KLRF1) mRNA, complete cds., alternatively spliced
gi|16151842|gb|AF267245.1|AF267245[16151842] - 2636: AF267244
Homo sapiens killer cell lectin-like receptor KLRF1-S2 (KLRF1) mRNA, complete cds., alternatively spliced
gi|16151840|gb|AF267244.1|AF267244[16151840] - 2637: NM—033637
Homo sapiens beta-transducin repeat containing (BTRC), transcript variant 1, mRNA
gi|16117782|ref|NM—033637.1|[16117782] - 3563: NM—033050
Homo sapiens G protein-coupled receptor 91 (GPR91), mRNA
gi|14780893|ref|NM—033050.1|[14780893] - 3564: NM—023914
Homo sapiens G protein-coupled receptor 86 (GPR86), mRNA
gi|13194202|ref|NM—023914.1|[13194202] - 3565: NM—020402
Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 10 (CHRNA10), mRNA
gi|11138122|ref|NM—020402.2|[11138122] - 3566: NM—020370
Homo sapiens G protein-coupled receptor 84 (GPR84), mRNA
gi|9966838|ref|NM—020370.1|[9966838] - 3567: NM—012301
Homo sapiens atrophin-1 interacting protein 1; activin receptor interacting protein 1 (KIAA0705), mRNA
gi|6912461|ref|NM—012301.1|[6912461] - 3568: AF208541
Homo sapiens V1-vascular vasopressin receptor AVPRLA gene, promoter region and
partial cds
gi|658112|gb|AF208541.1|AF208541[6581121] - 3569: NM—005756
Homo sapiens G protein-coupled receptor 64 (GPR64), mRNA
gi|5031732|ref|NM—005756.1|[5031732] - 3570: NM—003939
Homo sapiens beta-transducin repeat containing (BTRC), transcript variant 2, mRNA
gi|4502476|ref|NM—003939.1|[4502476] - 3571: AH003597
Homo sapiens A3 adenosine receptor (ADORA3) gene
gi|1387984|gb|AH003597.1|SEG_HUMADOR0[1387984] - 3572: L77730
Homo sapiens A3 adenosine receptor (ADORA3) gene, exon 2
gi|387983|gb|L77730.1[HUMADOR02[1387983] - 3573: L77729
Homo sapiens A3 adenosine receptor (ADORA3) gene, exon 1
gi|1387982|gb|L77729.1|HUMADOR01[1387982] - 3574: AF000381
Homo sapiens folate binding protein mRNA, partial cds
gi|16041647|gb|AF000381.2|AF000381[16041647] - 3583: AY054974
Homo sapiens RAE-1-like transcript 4 mRNA, complete cds
gi|15990603|gb|AY054974.1|[15990603] - 3584: AF421855
Homo sapiens interleukin 4 receptor (IL4R) gene, complete cds
gi|15987825|gb|AF421855.1|AF421855[15987825] - 3585: AF359241
Homo sapiens soluble truncated fibroblast growth factor receptor 4 (FGFR4) mRNA,
complete cds
gi|3877134|gb|AF359241.1|AF359241[13877134] - 3586: NM—022148
Homo sapiens cytokine receptor-like factor 2 (CRLF2), mRNA
gi|13375623|ref|NM—022148.1|[13375623] - 3587: AF179770
Homo sapiens olfactory receptor (HSA8) gene, partial cds
gi|7211542|gb|AF179770.1|AF179770[7211542] - 3590: AF179767
Homo sapiens olfactory receptor (HSA5) gene, partial cds
gi|7211538|gb|AF179767.1|AF179767[7211538] - 3591: AF179766
Homo sapiens olfactory receptor (HSA3) gene, partial cds
gi|7211536|gb|AF179766.1|AF179766[7211536] - 3596: AF179761
Homo sapiens olfactory receptor (HSA12) gene, partial cds
gi|7211530|gb|AF179761.1|AF179761[7211530] - 3597: AF179760
Homo sapiens olfactory receptor (HSA10) gene, partial cds
gi|7211528|gb|AF179760.1|AF179760[7211528] - 3598: AF179759
Homo sapiens olfactory receptor (HSA1) gene, partial cds
gi|7211526|gb|AF179759.1|AF179759[7211526] - 3599: D86962
Human mRNA for KIAA0207 gene, complete cds
gi|1503997|dbj|D86962.1D86962[1503997] - 3600: D13626
Human mRNA for KIAA0001 gene, complete cds
gi|285994|dbj|D13626.1|HUMRSC338[285994] - 3601: AY026770
Homo sapiens lectin-like receptor 1B (DECTIN1) mRNA, complete cds, alternatively
spliced
gi|15967098|gb|AY026770.2|[15967098] - 3602: AY026769
Homo sapiens lectin-like receptor 1 (DECTIN1) mRNA, complete cds
gi|15967096|gb|AY026769.2|[15967096] - 3605: AJ344142
Homo sapiens mRNA for putative MCP-1 chemokine receptor (CCR11 gene)
gi|15919090|emb|AJ344142.1|HSA344142[15919090] - 3606: AY029770
Homo sapiens CCK-B/gastrin receptor variant mRNA, complete cds, alternatively spliced
gi|15911832|gb|AY029770.1|[15911832] - 3607: NM—002821
Homo sapiens PTK7 protein tyrosine kinase 7 (PTK7), mRNA
gi|15826839|ref|NM—002821.2|[15826839] - 3608: AF303576
Homo sapiens G protein-coupled receptor 75 (GPR75) gene, exon 1
gi|15824419|gb|AF303576.1|AF303576[15824419] - 3609: AB032427
Homo sapiens VRL-2 mRNA for vanilloid receptor like channel-2, complete cds
gi|15822824|dbj|AB032427.1|AB032427[15822824] - 3610: AY008280
Homo sapiens histamine receptor H4 (H4) mRNA, complete cds
gi|15822540|gb|AY008280.1|[15822540] - 3611: U40271
Homo sapiens transmembrane receptor precursor (PTK7) mRNA, complete cds
gi|15808058|gb|U40271.2|HSU40271[15808058] - 3612: NM—000575
Homo sapiens interleukin 1, alpha (IL1A), mRNA
gi|13236493|ref|NM—000575.1|[13236493] - 3615: NM—014312
Homo sapiens cortical thymocyte receptor (X. laevis CTX) like (CTXL), mRNA
gi|7657000|ref|NM—014312.1|[7657000] - 3616: AB032738
Homo sapiens gene for chemokine receptor CXCR3, partial cds
gi|7209698|dbj|AB032738.1|AB032738[7209698] - 3617: AB032737
Homo sapiens gene for chemokine receptor CXCR3, partial cds
gi|7209696|dbj|AB032737.1|AB032737[7209696] - 3618: AB032736
Homo sapiens gene for chemokine receptor CXCR3, partial cds
gi|7209694|dbj|AB032736.1|AB032736[7209694] - 3619: AB032735
Homo sapiens gene for chemokine receptor CXCR3, partial cds
gi|7209692|dbj|AB032735.1|AB032735[7209692] - 3620: AB032734
Homo sapiens CXCR2 gene for IL-8 receptor type B, partial cds
gi|7209690|dbj|AB032734.1|AB032734[7209690] - 3621: AB032733
Homo sapiens CXCR2 gene for IL-8 receptor type B, partial cds
gi|7209688|dbj|AB032733.1|AB032733[7209688] - 3622: AB032732
Homo sapiens CXCR1 gene for IL-8 receptor type A, partial cds
gi|7209686|dbj|AB032732.1|AB032732[7209686] - 3623: AB032731
Homo sapiens CXCR1 gene for IL-8 receptor type A, partial cds
gi|7209684|dbj|AB032731.1|AB032731[7209684] - 3624: AB032730
Homo sapiens CXCR1 gene for IL-8 receptor type A, partial cds
gi|7209682|dbj|AB032730.1|AB032730[7209682] - 3625: AB032729
Homo sapiens CXCR1 gene for IL-8 receptor type A, partial cds
gi|7209680|dbj|AB032729.1|AB032729[7209680] - 3626: AB032728
Homo sapiens CXCR1 gene for IL-8 receptor type A, partial cds
gi|7209678|dbj|AB032728.1|A]B032728[7209678] - 3628: AB030952
Homo sapiens TNFR2 gene for tumor necrosis factor receptor 2, partial cds
gi|6683135|dbj|AB030952.1|AB030952[6683135] - 3629: AB030951
Homo sapiens TNFR2 gene for tumor necrosis factor receptor 2, partial cds
gi|6683133|dbj|AB030951.1|AB030951[6683133] - 3630: AB030950
Homo sapiens TNFR2 gene for tumor necrosis factor receptor 2, partial cds
gi|6683131|dbj|AB030950.1|AB030950[6683131] - 3631: AB030949
Homo sapiens TNFR2 gene for tumor necrosis factor receptor 2, partial cds
gi|6683129|dbj|AB030949.1|AB030949[6683129] - 3632: AB023892
Homo sapiens gene for b-chemokine receptor CCR4, complete cds
gi|6467142|dbj|AB023892.1|AB023892[6467142] - 3633: AB023891
Homo sapiens gene for b-chemokine receptor CCR4, complete cds
gi|6467140|dbj|AB023891.1|AB023891[6467140] - 3634: AB023890
Homo sapiens gene for b-chemokine receptor CCR4, complete cds
gi|6467138|dbj|AB023890.1|AB023890[6467138] - 3635: AB023889
Homo sapiens gene for b-chemokine receptor CCR4, complete cds
gi|6467136|dbj|AB023889.1|AB023889[6467136] - 3636: AB023888
Homo sapiens gene for b-chemokine receptor CCR4, complete cds
gi|6467134|dbj|AB023888.1|AB023888[6467134] - 3637: AB023887
Homo sapiens gene for b-chemokine receptor CCR3, complete cds
gi|6467132|dbj|AB023887.1|AB023887[6467132] - 3638: AH008153
Homo sapiens IL-1RI gene, complete sequence
gi|5823144|gb|AH008153.1|SEG_HSAIL1R[5823144] - 3639: AF146427
Homo sapiens interleukin-1 receptor type I (IL1R1) gene, exon 1c
gi|5823143|gb|AF146427.1|HSAIL1R2[5823143] - 3640: AF146426
Homo sapiens interleukin-1 receptor type I (IL1R1) gene, exon 1b and intron 1b
gi|5823142|gb|AF146426.1|HSAIL1R1[5823142] - 3641: NM—006691
Homo sapiens extracellular link domain-containing 1 (XLKD1), mRNA
gi|5729910|ref|NM—006691.1|[5729910] - 3642: Z99761
Homo sapiens gonadotrophin-releasing hormone receptor gene exon 2
gi|5514748|emb|Z99761.2|HSGRHRX2[5514748] - 3643: Z99760
Homo sapiens gonadotropin-releasing hormone receptor gene exon 1 variant 1
gi|5514747|emb|Z99760.2|HSGRHRX1[5514747] - 3644: NM—001250
Homo sapiens tumor necrosis factor receptor superfamily, member 5 (TNFRSF5), mRNA
gi|4507580|ref|NM—001250.1|[4507580] - 3645: NM—000406
Homo sapiens gonadotropin-releasing hormone receptor (GNRHR), mRNA
gi|4504058|ref|NM—000406.1|[4504058] - 3646: Z99995
Homo sapiens partial gonadotropin releasing hormone receptor gene
gi|3334762|emb|Z99995.1|HSZ99995[3334762] - 3647: G16069
928H1R CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 928H1 right arm, sequence tagged site
gi|1825444|gb|G16069.1|G16069[1825444] - 3648: G16077
817D6L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 817D6 left arm, sequence tagged site
gi|1592357|gb|G16077.1|G16077[1592357] - 3649: G16076
807B6L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 807B6 left arm, sequence tagged site
gi|1592356|gb|G16076.1|G16076[1592356] - 3650: G16075
940H12L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 940H12 left arm, sequence tagged site
gi|1592355|gb|G16075.1|G16075[1592355] - 3651: G16074
706A2L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 706A2 left arm, sequence tagged site
gi|1592354|gb|G16074.1G16074[1592354] - 3652: G16073
967A10L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 967A10 left arm, sequence tagged site
gi|1592353|gb|G16073.1|G16073[1592353] - 3653: G16072
816C10L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 816C10 left arm, sequence tagged site
gi|1592352|gb|G16072.1G16072[1592352] - 3654: G16071
765B8R CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 765B8 right arm, sequence tagged site
gi|1592351|gb|G16071.1G16071[1592351] - 3655: G16070
622F2R CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 622F2 right arm, sequence tagged site
gi|1592350|gb|G16070.1|G16070[1592350] - 3656: G16068
868H11L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 868H11 left arm, sequence tagged site
gi|1592349|gb|G16068.1|G16068[1592349] - 3657: G16067
662F2L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 662F2 left arm, sequence tagged site
gi|1592348|gb|G16067.1|G16067[1592348] - 3658: G16066
918D7R CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 918D7 right arm, sequence tagged site
gi|1592347|gb|G16066.1|G16066[1592347] - 3659: G16065
758C4R CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 758C4 right arm, sequence tagged site
gi|1592346|gb|G16065.1|G16065[1592346] - 3660: G16064
677D7L CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 677D7 left arm, sequence tagged site
gi|1592345|gb|G16064.1|G16064[1592345] - 3663: L11238
Homo sapiens platelet membrane glycoprotein V mRNA; complete cds
gi|388759|gb|L11238.1|HUMGLYCOPR[388759] - 3665: AF406652
Homo sapiens MyD88 adapter-like protein mRNA, complete cds
gi|15528826|gb|AF406652.1|AF406652[15528826] - 4053: NM—022059
Homo sapiens chemokine (C-X-C motif) ligand 16 (CXCL16), mRNA
gi|11545764|ref|NM—022059.1|[11545764] - 4054: NM—030956
Homo sapiens toll-like receptor 10 (TLR10), mRNA
gi|13569929|ref|NM—030956.1|[13569929] - 4055: NM—033358
Homo sapiens caspase 8, apoptosis-related cysteine protease (CASP8), transcript
variant E, mRNA
gi|15718711|ref|NM—033358.1|[15718711] - 4056: NM—033357
Homo sapiens caspase 8, apoptosis-related cysteine protease (CASP8), transcript
variant D, mRNA
gi|15718709|ref|NM—033357.1|[15718709] - 4057: NM—033356
Homo sapiens caspase 8, apoptosis-related cysteine protease (CASP8), transcript
variant C, mRNA
gi|15718707|ref|NM—033356.1|[15718707] - 4058: NM—033355
Homo sapiens caspase 8, apoptosis-related cysteine protease (CASP8), transcript
variant B, mRNA
gi|15718705|ref|NM—033355.1|[15718705] - 4059: NM—001228
Homo sapiens caspase 8, apoptosis-related cysteine protease (CASP8), transcript
variant A, mRNA
gi|15718703|ref|NM—001228.2|[15718703] - 4061: NM—000024
Homo sapiens adrenergic, beta-2-, receptor, surface (ADRB2), mRNA
gi|15718673|ref|NM—000024.3|[15718673] - 4062: NM—000683
Homo sapiens adrenergic, alpha-2C—, receptor (ADRA2C), mRNA
gi|15718672|ref|NM—000683.2|[15718672] - 4063: NM—000682
Homo sapiens adrenergic, alpha-2B-, receptor (ADRA2B), mRNA
gi|5718671|ref|NM—000682.2|[15718671] - 4064: NM—000681
Homo sapiens adrenergic, alpha-2A-, receptor (ADRA2A), mRNA
gi|15718669|ref|NM—000681.2|[15718669] - 4065: NM—006179
Homo sapiens neurotrophin 5 (neurotrophin 4/5) (NTF5), mRNA
gi|15718666|ref|NM—006179.2|[15718666] - 4066: L26458
Homo sapiens T-cell receptor mRNA, partial sequence
gi|432477|gb|L26458.1|HUMEBSH[432477] - 4067: L26457
Homo sapiens T-cell receptor mRNA, partial sequence
gi|432476|gb|L26457.1|HUMEBSG[432476] - 4068: L26456
Homo sapiens T-cell receptor mRNA, partial sequence
gi|432475|gb|L26456.1|HUMEBSF[432475] - 4069: L26455
Homo sapiens T-cell receptor mRNA, partial sequence
gi|432474|gb|L26455.1|HUMEBSE[432474] - 4070: L26454
Homo sapiens T-cell receptor mRNA, partial sequence
gi|432473|gb|L26454.1|HUMEBSD[432473] - 4071: L26453
Homo sapiens T-cell receptor mRNA, partial sequence
gi|432472|gb|L26453.1|HUMEBSC[432472] - 4072: L26452
Homo sapiens T-cell receptor mRNA, partial sequence
gi|432471|gb|L26452.1|HUMEBSB[432471] - 4073: L26451
Homo sapiens T-cell receptor mRNA, partial sequence
gi|432470|gb|L26451.1|HUMEBSA[432470] - 4074: AH009839
Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
partial cds, alternatively spliced
gi|15706245|gb|AH009839.2|[15706245] - 4075: AJ301610
Homo sapiens mRNA for GluR6 kainate receptor (GRIK2 gene), isoform-b
gi|15485591|emb|AJ301610.1|HSA301610[15485591] - 4076: AJ301609
Homo sapiens partial mRNA for GluR6 kainate receptor (GRIK2 gene), exons 10, and 13
gi|15485589|emb|AJ301609.1|HSA301609[15485589] - 4077: AJ301608
Homo sapiens partial mRNA for GluR6 kainate receptor (GRIK2 gene), exons 11, and 14
gi|15485587|emb|AJ301608.1|HSA301608[15485587] - 4078: AF196774
Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
exon 8 and partial cds, alternatively spliced
gi|10312084|gb|AF196774.1|AH009839S8[10312084] - 4079: AF196773
Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
exon 7
gi|10312083|gb|AF196773.1|AH009839S7[10312083] - 4080: AF196772
Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
exon 6
gi|10312082|gb|AF196772.1|AH009839S6[10312082] - 4081: AF252867
Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
exon 6A and partial cds, alternatively spliced
gi|10312081|gb|AF252867.1|AH009839S5[10312081] - 4082: AF196771
Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
exon 5
gi|10312080|gb|AF196771.1|AH009839S4[10312080] - 4083: AF196770
Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
exon 4
gi|10312079|gb|AF196770.1|AH009839S3[10312079] - 4084: AF196769
Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
exon 3
gi|10312078|gb|AF196769.1|AH009839S2[10312078] - 4085: AF196768
Homo sapiens HVEC cell-cell adhesion molecule/herpesvirus receptor (HVEC) gene,
exon 2
gi|10312077|gb|AF196768.1|AH009839S1[10312077] - 4086: AF399937
Homo sapiens melanin-concentrating hormone receptor MCH-R2 mRNA, complete cds
gi|15667842|gb|AF399937.1|AF399937[15667842] - 4087: NM—032405
Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant D,
mRNA
gi|14602456|ref|NM—032405.1|[14602456] - 4088: NM—032404
Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant C,
mRNA
gi|14602454|ref|NM—032404.1|[14602454] - 4089: NM—032401
Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant B,
mRNA
gi|14602452|ref|NM—032401.1|[14602452] - 4090: NM—024022
Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant A,
mRNA
gi|13173470|ref|NM—024022.1|[13173470] - 4091: AY046418
Homo sapiens brain immunoglobulin receptor precursor, mRNA, complete cds
gi|15636797|gb|AY046418.1|[15636797] - 4092: AF069333
Homo sapiens insulin-like growth factor II receptor (IGF2R) gene, partial cds
gi|15628184|gb|AF069333.2|AF069333115628184] - 4093: AY029541
Homo sapiens putative G protein-coupled receptor mRNA, complete cds
gi|15626067|gb|AY029541.1|[15626067] - 4094: AF117819
Homo sapiens bradykinin B1 receptor mRNA, partial cds and 3′-untranslated region
gi|4325046|gb|AF117819.1|AF117819[4325046] - 4095: NM—004624
Homo sapiens vasoactive intestinal peptide receptor 1 (VIPR1), mRNA
gi|15619005|ref|NM—004624.2|[15619005] - 4096: AY042216
Homo sapiens G protein-coupled receptor (MRGX4) gene, complete cds
gi|15546067|gb|AY042216.1|[15546067] - 4097: AY042215
Homo sapiens G protein-coupled receptor (MRGX3) gene, complete cds
gi|15546065|gb|AY042215.1|[15546065] - 4098: AY042214
Homo sapiens G protein-coupled receptor (MRGX2) gene, complete cds
gi|15546063|gb|AY042214.1|[15546063] - 4099: AY042213
Homo sapiens G protein-coupled receptor (MRGX1) gene, complete cds
gi|1554606|gb|AY042213.1|[15546061] - 4100: Y11395
Homo sapiens mRNA for lanthionine synthetase C-like protein 1 (LANCL1 gene)
gi|2894085|emb|Y11395.1|HSRNAP40[2894085] - 4101: BC014108
Homo sapiens, Fc fragment of IgE, low affinity II, receptor for (CD23A), clone
MGC:20696 IMAGE:4309266, mRNA, complete cds
gi|15559484|gb|BC014108.1|BC014108[15559484] - 4102: AF306329
Homo sapiens neuronal nicotinic acetylcholine receptor beta 4 subunit (CHRNB4)
gene, exon 6 and complete cds
gi|15558964|gb|AF306329.1|AF306325S5[15558964] - 4103: AF306328
Homo sapiens neuronal nicotinic acetylcholine receptor beta 4 subunit (CHRNB4)
gene, exon 5
gi|15558963|gb|AF306328.1|AF306325S4[15558963] - 4104: AF306327
Homo sapiens neuronal nicotinic acetylcholine receptor beta 4 subunit (CHRNB4)
gene, exons 3, 4, and 4a, alternatively spliced
gi|15558962|gb|AF306327.1|AF306325S3[15558962] - 4105: AF306326
Homo sapiens neuronal nicotinic acetylcholine receptor beta 4 subunit (CHRNB4)
gene, exon 2
gi|15558961|gb|AF306326.1|AF306325S2[15558961] - 4106: AF306325
Homo sapiens neuronal nicotinic acetylcholine receptor beta 4 subunit (CHRNB4)
gene, exon 1
gi|15558960|gb|AF306325.1|AF306325S1[15558960] - 4107: AH011061
Homo sapiens neuronal nicotinic acetylcholine receptor beta 4 subunit (CHRNB4)
gene, complete cds
gi|15558959|gb|AH011061.1|SEG_AF306325S[15558959] - 4108: AJ316282
Homo sapiens partial TCRB gene for T cell receptor beta chain, allele TCRBV1J2S3, isolate P15SF, clone 9
gi|15558855|emb|AJ316282.1|HSA316282[15558855] - 4109: AJ316281
Homo sapiens partial TCRB gene for T cell receptor beta chain, allele TCRBV1J2S3, patient P22SF, clone 3
gi|5558853|emb|AJ316281.1|HSA316281[15558853] - 4110: AJ316280
Homo sapiens partial TCRB gene for T cell receptor beta chain, allele TCRBV1J2S3, patient P14SF, clone 1
gi|15558851|emb|AJ316280.1|HSA316280[15558851] - 4111: NM—001954
Homo sapiens discoidin domain receptor family, member 1 (DDR1), transcript variant 2, mRNA
gi|7669486|ref|NM—001954.21[7669486] - 4112: NM—013994
Homo sapiens discoidin domain receptor family, member 1 (DDR1), transcript variant 3, mRNA
gi|7669484|ref|NM—013994.1|[7669484] - 4113: NM—013993
Homo sapiens discoidin domain receptor family, member 1 (DDR1), transcript variant 1, mRNA
gi|7669482|ref|NM—013993.1|[7669482] - 4114: AF325356
Homo sapiens histamine receptor H4 (AXOR35) mRNA, complete cds
gi|15553202|gb|AF325356.1|AF325356[15553202] - 4115: AF349574
Homo sapiens interleukin 12 receptor beta 2 (IL12RB2) gene, partial sequence
gi|15088551|gb|AF349574.1|AF349574[15088551] - 4116: NM—014395
Homo sapiens dual adaptor of phosphotyrosine and 3-phosphoinositides (DAPP1), mRNA
gi|7657006|ref|NM—014395.1|[7657006] - 4117: AY043466
Homo sapiens Fc receptor-like protein 3 (FCRH3) mRNA, complete cds
gi|15528834|gb|AY043466.1|[15528834] - 4118: AY043465
Homo sapiens Fc receptor-like protein 2 (FCRH2) mRNA, complete cds
gi|15528832|gb|AY043465.1|[15528832] - 4119: AY043464
Homo sapiens Fc receptor-like protein 1 (FCRH1) mRNA, complete cds
gi|15528830|gb|AY043464.1|[15528830] - 4120: AJ344350
Homo sapiens partial IGDH3-9 gene segment, isolate case6-cell520
gi|15528515|emb|AJ344350.1|HSA344350[15528515] - 4121: AJ344349
Homo sapiens partial IGDH3-9 gene segment, isolate case5-cell49
gi|15528514|emb|AJ344349.1|HSA344349[15528514] - 4122: AJ344348
Homo sapiens partial IGDH6-25 gene segment, isolate case4-cell89
gi|15528513|emb|AJ344348.1|HSA344348[15528513] - 4125: NM—033135
Homo sapiens spinal cord-derived growth factor-B (SCDGF-B), transcript variant
2, mRNA
gi|15451920|ref|NM—033135.1|[15451920] - 4126: NM—025208
Homo sapiens spinal cord-derived growth factor-B (SCDGF-B), transcript variant
1, mRNA
gi|15451919|ref|NM—025208.2|[15451919] - 4127: NM—033346
Homo sapiens bone morphogenetic protein receptor, type II (serine/threonine kinase) (BMPR2), transcript variant 2, mRNA
gi|15451917|ref|NM—033346.1|[15451917] - 4128: NM—001204
Homo sapiens bone morphogenetic protein receptor, type II (serine/threonine kinase) (BMPR2), transcript variant 1, mRNA
gi|15451915|ref|NM—001204.3|[15451915] - 4129: NM—003933
Homo sapiens BA11-associated protein 3 (BAIAP3), mRNA
gi|15451913|ref|NM—003933.3|[15451913] - 4130: NM—002006
Homo sapiens fibroblast growth factor 2 (basic) (FGF2), mRNA
gi|15451897|ref|NM—002006.2|[15451897] - 4131: NM—000647
Homo sapiens chemokine (C-C motif) receptor 2 (CCR2), transcript variant A, mRNA
gi|15451896|ref|NM—000647.2|[15451896] - 4132: NM—004631
Homo sapiens low density lipoprotein receptor-related protein 8, apolipoprotein
e receptor (LRP8), transcript variant 1, mRNA
gi|15451869|ref|NM—004631.2|[15451869] - 4133: NM—033300
Homo sapiens low density lipoprotein receptor-related protein 8, apolipoprotein
e receptor (LRP8), transcript variant 2, mRNA
gi|15451867|ref|NM—033300.1|[15451867] - 4134: NM—017522
Homo sapiens low density lipoprotein receptor-related protein 8, apolipoprotein
e receptor (LRP8), transcript variant 3, mRNA
gi|15451865|ref|NM—017522.2|[15451865] - 4135: NM—033337
Homo sapiens caveolin 3 (CAV3), transcript variant 1, mRNA
gi|15451859|ref|NM—033337.1|[15451859] - 4136: NM—001234
Homo sapiens caveolin 3 (CAV3), transcript variant 2, mRNA
gi|15451858|ref|NM—001234.3|[15451858] - 4137: NM—002609
Homo sapiens platelet-derived growth factor receptor, beta polypeptide (PDGFRB),
mRNA
gi|15451788|ref|NM—002609.2|[15451788] - 4138: NM—006206
Homo sapiens platelet-derived growth factor receptor, alpha polypeptide (PDGFRA), mRNA
gi|15451787|ref|NM—006206.2|[15451787] - 4139: NM—000679
Homo sapiens adrenergic, alpha-1B-, receptor (ADRA1B), mRNA
gi|15451783|ref|NM—000679.2|[15451783] - 4140: AY026771
Homo sapiens lectin-like receptor 1C (DECTIN1) mRNA, complete cds, alternatively
spliced
gi|14278822|gb|AY026771.1|[14278822] - 4142: NM—000648
Homo sapiens chemokine (C-C motif) receptor 2 (CCR2), transcript variant B, mRNA
gi|4757937|ref|NM—000648.1|[4757937] - 4143: AB041403
Homo sapiens HTR1A gene for serotonin receptor 1A, complete cds
gi|7592996|dbj|AB041403.1|AB041403[7592996] - 4144: NM—015722
Homo sapiens calcyon; D1 dopamine receptor-interacting protein (CALCYON), mRNA
gi|9257200|ref|NM—015722.2|[9257200] - 4145: AY044429
Homo sapiens class II cytokine receptor (IL22RA2) mRNA, complete cds
gi|15419022|gb|AY044429.1|[15419022] - 4148: AJ306388
Homo sapiens mRNA for NTB-A receptor (KALI b gene)
gi|15384842|emb|AJ306388.1|HSA306388[15384842] - 4149: AJ277141
Homo sapiens mRNA for activating NK receptor (KALI gene)
gi|15384840|emb|AJ277141.1|HSA277141[15384840] - 4150: NM—033199
Homo sapiens stresscopin-related peptide (SRP), mRNA
gi|15082239|ref|NM—033199.1|[15082239] - 4151: AB052684
Homo sapiens mRNA for G1-coupled ADP receptor HORK3, complete cds
gi|14422409|dbj|AB052684.1|AB052684[14422409] - 4152: AF227732
Homo sapiens nicotinic acetylcholine receptor alpha 9 subunit mRNA, partial cds
gi|7407124|gb|AF227732.1|AF227732[7407124] - 4153: NM—005849
Homo sapiens immunoglobulin superfamily, member 6 (IGSF6), mRNA
gi|5031672|ref|NM—005849.1|[5031672] - 4154: AF317654
Homo sapiens G protein-coupled receptor (GPR63) gene, complete cds
gi|15321723|gb|AF317654.2|AF317654[15321723] - 4155: AF399637
Homo sapiens clone OR5B16 olfactory receptor gene, partial cds
gi|15293858|gb|AF399637.1|AF399637[15293858] - 4156: AF399636
Homo sapiens clone OR5B2 olfactory receptor gene, partial cds
gi|15293856|gb|AF399636.1|AF399636[15293856] - 4157: AF399635
Homo sapiens clone OR5AU1 olfactory receptor gene, partial cds
gi|15293854|gb|AF399635.1|AF399635[15293854] - 4158: AF399634
Homo sapiens clone OR10A3 olfactory receptor gene, partial cds
gi|15293852|gb|AF399634.1|AF399634[15293852] - 4159: AF399633
Homo sapiens clone OR13H1 olfactory receptor gene, partial cds
gi|15293850|gb|AF399633.1|AF399633[15293850] - 4160: AF399632
Homo sapiens clone OR2B3 olfactory receptor gene, partial cds
gi|15293848|gb|AF399632.1|AF399632[15293848] - 4161: AF399631
Homo sapiens clone OR2H2 olfactory receptor gene, partial cds
gi|15293846|gb|AF399631.1|AF399631[15293846] - 4162: AF399630
Homo sapiens clone OR2J3 olfactory receptor gene, partial cds
gi|15293844|gb|AF399630.1|AF399630[15293844] - 4163: AF399629
Homo sapiens clone OR2Y1 olfactory receptor gene, partial cds
gi|15293842|gb|AF399629.1|AF399629[15293842] - 4164: AF399628
Homo sapiens clone OR2W1 olfactory receptor gene, partial cds
gi|15293840 gb|AF399628.1|AF399628[15293840] - 4165: AF399627
Homo sapiens clone OR10C2 olfactory receptor gene, partial cds
gi|5293838|gb|AF399627.1|AF399627[15293838] - 4166: AF399626
Homo sapiens clone OR10A7 olfactory receptor gene, partial cds
gi|15293836|gb|AF399626.1|AF399626[15293836] - 4167: AF399625
Homo sapiens clone OR10A4 olfactory receptor gene, partial cds
gi|15293834|gb|AF399625.1|AF399625[15293834] - 4168: AF399624
Homo sapiens clone OR10A1 olfactory receptor gene, partial cds
gi|15293832|gb|AF399624.1|AF399624[15293832] - 4169: AF399623
Homo sapiens clone OR10A5 olfactory receptor gene, partial cds
gi|15293830 gb|AF399623.1|AF399623[15293830] - 4170: AF399622
Homo sapiens clone OR1K1 olfactory receptor gene, partial cds
gi|15293828|gb|AF399622.1|AF399622[15293828] - 4171: AF399621
Homo sapiens clone OR3A4 olfactory receptor gene, partial cds
gi|5293826|gb|AF399621.1|AF399621[15293826] - 4172: AF399620
Homo sapiens clone OR3A3 olfactory receptor gene, partial cds
gi|15293824|gb|AF399620.1|AF399620[15293824] - 4173: AF399619
Homo sapiens clone OR2Z2 olfactory receptor gene, partial cds
gi|5293822|gb|AF399619.1|AF399619[15293822] - 4174: AF399618
Homo sapiens clone OR2AG1 olfactory receptor gene, partial cds
gi|15293820|gb|AF399618.1|AF399618[15293820] - 4175: AF399617
Homo sapiens clone OR2M4 olfactory receptor gene, partial cds
gi|5293818|gb|AF399617.1|AF399617[15293818] - 4176: AF399616
Homo sapiens clone OR2M2 olfactory receptor gene, partial cds
gi|15293816|gb|AF399616.1|AF399616[15293816] - 4177: AF399615
Homo sapiens clone OR2M2 olfactory receptor gene, partial cds
gi|15293814|gb|AF399615.1|AF399615[15293814] - 4178: AF399614
Homo sapiens clone OR2V2 olfactory receptor gene, partial cds
gi|15293812|gb|AF399614.1|AF399614[15293812] - 4179: AF399613
Homo sapiens clone OR2T1 olfactory receptor gene, partial cds
gi|15293810|gb|AF399613.1|AF399613[15293810] - 4180: AF399612
Homo sapiens clone OR2T3 olfactory receptor gene, partial cds
gi|15293808|gb|AF399612.1|AF399612[15293808] - 4181: AF399611
Homo sapiens clone OR11H1 olfactory receptor gene, partial cds
gi|5293806|gb|AF399611.1|AF399611[15293806] - 4182: AF399610
Homo sapiens clone OR11G2 olfactory receptor gene, partial cds
gi|15293804|gb|AF399610.1|AF399610[15293804] - 4183: AF399609
Homo sapiens clone OR6Q1 olfactory receptor gene, partial cds
gi|15293802|gb|AF399609.1|AF399609[15293802] - 4184: AF399608
Homo sapiens clone OR6N1 olfactory receptor gene, partial cds
gi|5293800|gb|AF399608.1|AF399608[15293800] - 4185: AF399607
Homo sapiens clone OR6W1 olfactory receptor gene, partial cds
gi|15293798|gb|AF399607.1|AF399607[15293798] - 4186: AF399606
Homo sapiens clone OR6M1 olfactory receptor gene, partial cds
gi|15293796|gb|AF399606.1|AF399606[15293796] - 4187: AF399605
Homo sapiens clone OR6B1 olfactory receptor gene, partial cds
gi|5293794|gb|AF399605.1|AF399605[15293794] - 4188: AF399604
Homo sapiens clone OR6F1 olfactory receptor gene, partial cds
gi|15293792|gb|AF399604.1|AF399604[15293792] - 4189: AF399603
Homo sapiens clone OR13J1 olfactory receptor gene, partial cds
gi|15293790|gb|AF399603.1|AF399603[15293790] - 4190: AF399602
Homo sapiens clone OR13C4 olfactory receptor gene, partial cds
gi|15293788|gb|AF399602.1|AF399602[15293788] - 4191: AF399601
Homo sapiens clone OR2S2 olfactory receptor gene, partial cds
gi|15293786|gb|AF399601.1|AF399601[15293786] - 4192: AF399600
Homo sapiens clone OR13C7 olfactory receptor gene, partial cds
gi|15293784|gb|AF399600.1|AF399600[15293784] - 4193: AF399599
Homo sapiens clone OR13C8 olfactory receptor gene, partial cds
gi|15293782|gb|AF399599.1|AF399599[15293782] - 4194: AF399598
Homo sapiens clone OR2A7 olfactory receptor gene, partial cds
gi|15293780|gb|AF399598.1|AF399598[15293780]
- 4195: AF399597
Homo sapiens clone OR2A1 olfactory receptor gene, partial cds
gi|15293778|gb|AF399597.1|AF399597[15293778] - 4196: AF399596
Homo sapiens clone OR2A6 olfactory receptor gene, partial cds
gi|15293776|gb|AF399596.1|AF399596[15293776] - 4197: AF399595
Homo sapiens clone OR2A5 olfactory receptor gene, partial cds
gi|15293774|gb|AF399595.1|AF399595[15293774] - 4198: AF399594
Homo sapiens clone OR2F1 olfactory receptor gene, partial cds
gi|15293772|gb|AF399594.1|AF399594[15293772] - 4199: AF399593
Homo sapiens clone OR10V1 olfactory receptor gene, partial cds
gi|15293770|gb|AF399593.1|AF399593[15293770] - 4200: AF399592
Homo sapiens clone OR2D3 olfactory receptor gene, partial cds
gi|15293768|gb|AF399592.1|AF399592[15293768] - 4201: AF399591
Homo sapiens clone OR2D2 olfactory receptor gene, partial cds
gi|15293766|gb|AF399591.1|AF399591[15293766] - 4202: AF399590
Homo sapiens clone OR5AY1 olfactory receptor gene, partial cds
gi|15293764|gb|AF399590.1|AF399590[15293764] - 4203: AF399589
Homo sapiens clone OR5AX1 olfactory receptor gene, partial cds
gi|15293762|gb|AF399589.1|AF399589[15293762] - 4204: AF399588
Homo sapiens clone OR10J6 olfactory receptor gene, partial cds
gi|15293760|gb|AF399588.1|AF399588[15293760] - 4205: AF399587
Homo sapiens clone OR10J1 olfactory receptor gene, partial cds
gi|15293758|gb|AF399587.1|AF399587[15293758] - 4206: AF399586
Homo sapiens clone OR10H4 olfactory receptor gene, partial cds
gi|15293756|gb|AF399586.1|AF399586[15293756] - 4207: AF399585
Homo sapiens clone OR10H2 olfactory receptor gene, partial cds
gi|15293754|gb|AF399585.1|AF399585[15293754] - 4208: AF399584
Homo sapiens clone OR10H1 olfactory receptor gene, partial cds
gi|15293752|gb|AF399584.1|AF399584[15293752] - 4209: AF399583
Homo sapiens clone OR10H5 olfactory receptor gene, partial cds
gi|15293750|gb|AF399583.1|AF399583[15293750] - 4210: AF399582
Homo sapiens clone OR10R2 olfactory receptor gene, partial cds
gi|15293748|gb|AF399582.1|AF399582[15293748] - 4211: AF399581
Homo sapiens clone OR4E2 olfactory receptor gene, partial cds
gi|15293746|gb|AF399581.1|AF399581[15293746] - 4212: AF399580
Homo sapiens clone OR4X2 olfactory receptor gene, partial cds
gi|15293744|gb|AF399580.1|AF399580[15293744] - 4213: AF399579
Homo sapiens clone OR4B1 olfactory receptor gene, partial cds
gi|5293742|gb|AF399579.1|AF399579[15293742] - 4214: AF399578
Homo sapiens clone OR4A15 olfactory receptor gene, partial cds
gi|15293740|gb|AF399578.1|AF399578[15293740] - 4215: AF399577
Homo sapiens clone OR4A4 olfactory receptor gene, partial cds
gi|15293738|gb|AF399577.1|AF399577[15293738] - 4216: AF399576
Homo sapiens clone OR4C12 olfactory receptor gene, partial cds
gi|15293736|gb|AF399576.1|AF399576[15293736] - 4217: AF399575
Homo sapiens clone OR4C13 olfactory receptor gene, partial cds
gi|15293734|gb|AF399575.1|AF399575[15293734] - 4218: AF399574
Homo sapiens clone OR4F4 olfactory receptor gene, partial cds
gi|15293732|gb|AF399574.1|AF399574[15293732] - 4219: AF399573
Homo sapiens clone OR4F15 olfactory receptor gene, partial cds
gi|15293730|gb|AF399573.1|AF399573[15293730] - 4220: AF399572
Homo sapiens clone OR4K14 olfactory receptor gene, partial cds
gi|5293728|gb|AF399572.1|AF399572[15293728] - 4221: AF399571
Homo sapiens clone OR4K3 olfactory receptor gene, partial cds
gi|15293726|gb|AF399571.1|AF399571[15293726] - 4222: AF399570
Homo sapiens clone OR4K1 olfactory receptor gene, partial cds
gi|15293724|gb|AF399570.1|AF399570[15293724] - 4223: AF399569
Homo sapiens clone OR4D6 olfactory receptor gene, partial cds
gi|15293722|gb|AF399569.1|AF399569[15293722] - 4224: AF399568
Homo sapiens clone OR4D2 olfactory receptor gene, partial cds
gi|15293720|gb|AF399568.1|AF399568[15293720] - 4225: AF399567
Homo sapiens clone OR4D1 olfactory receptor gene, partial cds
gi|15293718|gb|AF399567.1|AF399567[15293718] - 4226: AF399566
Homo sapiens clone OR10G3 olfactory receptor gene, partial cds
gi|15293716|gb|AF399566.1|AF399566[15293716] - 4227: AF399565
Homo sapiens clone OR10S1 olfactory receptor gene, partial cds
gi|15293714|gb|AF399565.1|AF399565[15293714] - 4228: AF399564
Homo sapiens clone OR1L8 olfactory receptor gene, partial cds
gi|5293712|gb|AF399564.1|AF399564[15293712] - 4229: AF399563
Homo sapiens clone OR1L6 olfactory receptor gene, partial cds
gi|15293710|gb|AF399563.1|AF399563[15293710] - 4230: AF399562
Homo sapiens clone OR1L4 olfactory receptor gene, partial cds
gi|15293708|gb|AF399562.1|AF399562[15293708] - 4231: AF399561
Homo sapiens clone ORIQI olfactory receptor gene, partial cds
gi|15293706|gb|AF399561.1|AF399561[15293706] - 4232: AF399560
Homo sapiens clone OR1C1 olfactory receptor gene, partial cds
gi|15293704|gb|AF399560.1|AF399560[15293704] - 4233: AF399559
Homo sapiens clone OR1F1 olfactory receptor gene, partial cds
gi|15293702|gb|AF399559.1|AF399559[15293702] - 4234: AF399558
Homo sapiens clone OR1F2 olfactory receptor gene, partial cds
gi|15293700|gb|AF399558.1|AF399558[15293700] - 4235: AF399557
Homo sapiens clone OR1S2 olfactory receptor gene, partial cds
gi|15293698|gb|AF399557.1|AF399557[15293698] - 4236: AF399556
Homo sapiens clone OR1A2 olfactory receptor gene, partial cds
gi|15293696|gb|AF399556.1|AF399556[15293696] - 4237: AF399555
Homo sapiens clone OR1A1 olfactory receptor gene, partial cds
gi|15293694|gb|AF399555.1|AF399555[15293694] - 4238: AF399554
Homo sapiens clone OR1J1 olfactory receptor gene, partial cds
gi|15293692|gb|AF399554.1|AF399554[15293692] - 4239: AF399553
Homo sapiens clone OR1J4 olfactory receptor gene, partial cds
gi|5293690|gb|AF399553.1|AF399553[15293690] - 4240: AF399552
Homo sapiens clone OR1J2 olfactory receptor gene, partial cds
gi|15293688|gb|AF399552.1|AF399552[15293688] - 4241: AF399551
Homo sapiens clone OR1E2 olfactory receptor gene, partial cds
gi|15293686|gb|AF399551.1|AF399551[15293686] - 4242: AF399550
Homo sapiens clone OR1E1 olfactory receptor gene, partial cds
gi|15293684|gb|AF399550.1|AF399550[15293684] - 4243: AF399549
Homo sapiens clone OR1M1 olfactory receptor gene, partial cds
gi|15293682|gb|AF399549.1|AF399549[15293682] - 4244: AF399548
Homo sapiens clone OR1I1 olfactory receptor gene, partial cds
gi|5293680|gb|AF399548.1|AF399548[15293680] - 4245: AF399547
Homo sapiens clone OR1N3 olfactory receptor gene, partial cds
gi|15293678|gb|AF399547.1|AF399547[15293678] - 4246: AF399546
Homo sapiens clone OR7C1 olfactory receptor gene, partial cds
gi|15293676|gb|AF399546.1|AF399546[15293676] - 4247: AF399545
Homo sapiens clone OR7C2 olfactory receptor gene, partial cds
gi|15293674|gb|AF399545.1|AF399545[15293674] - 4248: AF399544
Homo sapiens clone OR7A2 olfactory receptor gene, partial cds
gi|15293672|gb|AF399544.1|AF399544[15293672] - 4249: AF399543
Homo sapiens clone OR7A5 olfactory receptor gene, partial cds
gi|15293670|gb|AF399543.1|AF399543[15293670] - 4250: AF399542
Homo sapiens clone OR7A10 olfactory receptor gene, partial cds
gi|15293668|gb|AF399542.1|AF399542[15293668] - 4251: AF399541
Homo sapiens clone OR7A17 olfactory receptor gene, partial cds
gi|15293666|gb|AF399541.1|AF399541[15293666] - 4252: AF399540
Homo sapiens clone OR7G3 olfactory receptor gene, partial cds
gi|15293664|gb|AF399540.1|AF399540[15293664] - 4253: AF399539
Homo sapiens clone OR7G2 olfactory receptor gene, partial cds
gi|15293662|gb|AF399539.1|AF399539[15293662] - 4254: AF399538
Homo sapiens clone OR7G1 olfactory receptor gene, partial cds
gi|15293660|gb|AF399538.1|AF399538[15293660] - 4255: AF399537
Homo sapiens clone OR7D2 olfactory receptor gene, partial cds
gi|15293658|gb|AF399537.1|AF399537[15293658] - 4256: AF399536
Homo sapiens clone OR1N2 olfactory receptor gene, partial cds
gi|15293656|gb|AF399536.1|AF399536[15293656] - 4257: AF399535
Homo sapiens clone OR1D2 olfactory receptor gene, partial cds
gi|15293654|gb|AF399535.1|AF399535[15293654] - 4258: AF399534
Homo sapiens clone OR1D4 olfactory receptor gene, partial cds
gi|15293652|gb|AF399534.1|AF399534[15293652] - 4259: AF399533
Homo sapiens clone OR1D5 olfactory receptor gene, partial cds
gi|15293650|gb|AF399533.1|AF399533[15293650] - 4260: AF399532
Homo sapiens clone OR9Q1 olfactory receptor gene, partial cds
gi|15293648|gb|AF399532.1|AF399532[15293648] - 4261: AF399531
Homo sapiens clone OR9I1 olfactory receptor gene, partial cds
gi|15293646|gb|AF399531.1|AF399531[15293646] - 4262: AF399530
Homo sapiens clone OR9G4 olfactory receptor gene, partial cds
gi|15293644|gb|AF399530.1|AF399530[15293644] - 4263: AF399529
Homo sapiens clone OR5A2 olfactory receptor gene, partial cds
gi|15293642|gb|AF399529.1|AF399529[15293642] - 4264: AF399528
Homo sapiens clone OR5A1 olfactory receptor gene, partial cds
gi|15293640|gb|AF399528.1|AF399528[15293640] - 4265: AF399527
Homo sapiens clone OR5F1 olfactory receptor gene, partial cds
gi|15293638|gb|AF399527.1|AF399527[15293638] - 4266: AF399526
Homo sapiens clone OR5L2 olfactory receptor gene, partial cds
gi|15293636|gb|AF399526.1|AF399526[15293636] - 4267: AF399525
Homo sapiens clone OR5D18 olfactory receptor gene, partial cds
gi|15293634|gb|AF399525.1|AF399525[15293634] - 4268: AF399524
Homo sapiens clone OR5D16 olfactory receptor gene, partial cds
gi|15293632|gb|AF399524.1|AF399524[15293632] - 4269: AF399523
Homo sapiens clone OR5D14 olfactory receptor gene, partial cds
gi|15293630|gb|AF399523.1|AF399523[15293630] - 4270: AF399522
Homo sapiens clone OR5M1 olfactory receptor gene, partial cds
gi|15293628|gb|AF399522.1|AF399522[15293628] - 4271: AF399521
Homo sapiens clone OR5M11 olfactory receptor gene, partial cds
gi|15293626|gb|AF399521.1|AF399521[15293626] - 4272: AF399520
Homo sapiens clone OR5 MB olfactory receptor gene, partial cds
gi|15293624|gb|AF399520.1|AF399520[15293624] - 4273: AF399519
Homo sapiens clone OR5M9 olfactory receptor gene, partial cds
gi|15293622|gb|AF399519.1|AF399519[15293622] - 4274: AF399518
Homo sapiens clone OR5M3 olfactory receptor gene, partial cds
gi|15293620|gb|AF399518.1|AF399518[15293620] - 4275: AF399517
Homo sapiens clone OR8K1 olfactory receptor gene, partial cds
gi|15293618|gb|AF399517.1|AF399517[15293618] - 4276: AF399516
Homo sapiens clone OR8J3 olfactory receptor gene, partial cds
gi|15293616|gb|AF399516.1|AF399516[15293616] - 4277: AF399515
Homo sapiens clone OR8J1 olfactory receptor gene, partial cds
gi|15293614|gb|AF399515.1|AF399515[15293614] - 4278: AF399514
Homo sapiens clone OR5C1 olfactory receptor gene, partial cds
gi|15293612|gb|AF399514.1|AF399514[15293612] - 4279: AF399513
Homo sapiens clone OR8I2 olfactory receptor gene, partial cds
gi|15293610|gb|AF399513.1|AF399513[15293610] - 4280: AF399512
Homo sapiens clone OR8A1 olfactory receptor gene, partial cds
gi|15293608|gb|AF399512.1|AF399512[15293608] - 4281: AF399511
Homo sapiens clone OR8B12 olfactory receptor gene, partial cds
gi|15293606|gb|AF399511.1|AF399511[15293606] - 4282: AF399510
Homo sapiens clone OR8B8 olfactory receptor gene, partial cds
gi|15293604|gb|AF399510.1|AF399510[15293604] - 4283: AF399509
Homo sapiens clone OR8B4 olfactory receptor gene, partial cds
gi|15293602|gb|AF399509.1|AF399509[15293602] - 4284: AF399508
Homo sapiens clone OR8B2 olfactory receptor gene, partial cds
gi|15293600|gb|AF399508.1|AF399508[15293600] - 4285: AF399507
Homo sapiens clone OR8G1 olfactory receptor gene, partial cds
gi|15293598|gb|AF399507.1|AF399507[15293598] - 4286: AF399506
Homo sapiens clone OR6C1 olfactory receptor gene, partial cds
gi|15293596|gb|AF399506.1|AF399506[15293596] - 4287: AF399505
Homo sapiens clone OR52B2 olfactory receptor gene, partial cds
gi|15293594|gb|AF399505.1|AF399505[15293594] - 4288: AF399504
Homo sapiens clone OR52E6 olfactory receptor gene, partial cds
gi|15293592|gb|AF399504.1|AF399504[15293592] - 4289: AF399503
Homo sapiens clone OR51B2 olfactory receptor gene, partial cds
gi|15293590|gb|AF399503.1|AF399503[15293590] - 4290: AF244813
Homo sapiens platelet-derived growth factor C mRNA, complete cds
gi|8886883|gb|AF244813.1|AF244813[8886883] - 4291: AF169650
Homo sapiens high mobility group 1 protein (HMG1) gene, exon 5
gi|14522864|gb|AF169650.1|AF169650[14522864] - 4451: AF330055
Homo sapiens neuropeptide NPVF receptor mRNA, complete cds
gi|15281399|gb|AF330055.1|AF330055[15281399] - 4452: AF330053
Homo sapiens neuropeptide NPFF receptor mRNA, complete cds
gi|15281395|gb|AF330053.1|AF330053[15281395] - 4453: AF402318
Homo sapiens differentiation-related DIF14 long form (DIF14) mRNA, complete cds,
alternatively spliced
gi|15278166|gb|AF402318.1|AF402318[15278166] - 4454: AF397453
Homo sapiens Fc receptor-like protein 5 (FCRH5) mRNA, complete cds
gi|15277745|gb|AF397453.1|AF397453[15277745] - 4455: AF397452
Homo sapiens Fc receptor-like protein 4 (FCRH4) mRNA, complete cds
gi|15277740|gb|AF397452.1|AF397452[15277740] - 4456: AF400441
Homo sapiens neurotrophic tyrosine kinase receptor type 2 (NTRK2) mRNA, complete
cds
gi|15217076|gb|AF400441.1|AF400441[15217076] - 4462: NM—020535
Homo sapiens killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5 (KIR2DL5), mRNA
gi|11968153|ref|NM—020535.1|[11968153] - 4463: AP000511
Homo sapiens genomic DNA, chromosome 6p21.3, HLA Class I region, section 10/20
gi|5926698|dbj|AP000511.1|AP000511[5926698] - 4465: L20295
Homo sapiens vasoactive intestinal peptide receptor mRNA, partial cds
gi|403461|gb|L20295.1|HUMVAIPR[403461] - 4466: AY040568
Homo sapiens interleukin 22-binding protein CRF2-10S (IL22BP) mRNA, complete cds, alternatively spliced
gi|5212829|gb|AY040568.1|[15212829] - 4467: AY040567
Homo sapiens interleukin 22-binding protein CRF2-10L (IL22BP) mRNA, complete cds, alternatively spliced
gi|15212827|gb|AY040567.1|[15212827] - 4468: AY040566
Homo sapiens interleukin 22-binding protein CRF2-10 (IL22BP) mRNA, complete cds
gi|15212825|gb|AY040566.1|[15212825] - 4471: AX193708
Sequence 30 from Patent WO0136467
gi|15211557|emb|AX193708.1|AX193708[15211557] - 4472: AX193705
Sequence 27 from Patent WO0136467
gi|15211554|emb|AX193705.1|AX193705[15211554] - 4473: AX193702
Sequence 24 from Patent WO0136467
gi|15211551|emb|AX193702.1|AX193702[15211551] - 4474: AX193682
Sequence 4 from Patent WO0136467
gi|15211548|emb|AX193682.1|AX193682[15211548] - 4475: AX193679
Sequence 1 from Patent WO0136467
gi|15211545|emb|AX193679.1|AX193679[15211545] - 4476: NM—005675
Homo sapiens DiGeorge syndrome critical region gene 6 (DGCR6), mRNA
gi|15208653|ref|NM—005675.2|[15208653] - 4477: NM—016083
Homo sapiens cannabinoid receptor 1 (brain) (CNR1), transcript variant 2, mRNA
gi|15208646|ref|NM—016083.2|[15208646] - 4478: NM—016205
Homo sapiens platelet derived growth factor C (PDGFC), mRNA
gi|9994186|ref|NM—016205.1|[9994186] - 4479: AF159056
Homo sapiens T-cell gamma receptor locus, complete sequence
gi|5566238|gb|AF159056.1|AF159056[5566238] - 4480: NM—006207
Homo sapiens platelet-derived growth factor receptor-like (PDGFRL), mRNA
gi|5453871|ref|NM—006207.1|[5453871] - 4481: NM—004986
Homo sapiens kinectin 1 (kinesin receptor) (KTN1), mRNA
gi|4826813|ref|NM—004986.1|[4826813] - 4482: NM—001840
Homo sapiens cannabinoid receptor 1 (brain) (CNR1), transcript variant 1, mRNA
gi|4502926|ref|NM—001840.1|[4502926] - 4483: NM—033223
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, gamma 3 (GABRG3), mRNA
gi|15193297|ref|NM—033223.1|[15193297] - 4484: AY008283
Homo sapiens porimin mRNA, complete cds
gi|15192138|gb|AY008283.1|[15192138] - 4485: NM—015906
Homo sapiens tripartite motif-containing 33 (TRIM33), transcript variant alpha,
mRNA
gi|14971412|ref|NM—015906.2|[14971412] - 4486: NM—033020
Homo sapiens tripartite motif-containing 33 (TRIM33), transcript variant beta,
mRNA
gi|14971410|ref|NM—033020.1|[14971410] - 4487: AH006431
Homo sapiens glycine receptor alpha 2 subunit, complete cds
gi|3598700|gb|AH006431.1|SEG_HSGLRA2G[3598700] - 4488: AF053495
Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 9 and complete
cds
gi|3598699|gb|AF053495.1|HSGLRA2G9[3598699] - 4489: AF053494
Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 8
gi|3598698|gb|AF053494.1|HSGLRA2G8[3598698] - 4490: AF053493
Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 7
gi|3598697|gb|AF053493.1|HSGLRA2G7[3598697] - 4491: AF053492
Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 6
gi|3598696|gb|AF053492.1|HSGLRA2G6[3598696] - 4492: AF053491
Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 5
gi|3598695|gb|AF053491.1|HSGLRA2G5[3598695] - 4493: AF053490
Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 4
gi|3598694|gb|AF053490.1|HSGLRA2G4[3598694] - 4494: AF053489
Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exons 3a and 3b
gi|3598693|gb|AF053489.1|HSGLRA2G3[3598693] - 4495: AF053488
Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 2
gi|3598692|gb|AF053488.1|HSGLRA2G2[3598692] - 4496: AF053487
Homo sapiens glycine receptor alpha 2 subunit (GLRA2) gene, exon 1
gi|3598691|gb|AF053487.1|HSGLRA2G1[3598691] - 4499: AF344654
Homo sapiens growth hormone receptor variant gene, partial cds
gi|15186845|gb|AF344654.1|[15186845] - 4501: AF179680
Homo sapiens apelin gene, complete cds
gi|6708145|gb|AF179680.1|AF179680[6708145] - 4502: AJ296652
Homo sapiens HRH3 gene for histamine h3 receptor, exons 1-3
gi|15149878|emb|AJ296652.1|HSA296652[15149878] - 4503: NM—006707
Homo sapiens butyrophilin-like 3 (BTNL3), mRNA
gi|5729747|ref|NM—006707.1|[5729747] - 4504: NM—002009
Homo sapiens fibroblast growth factor 7 (keratinocyte growth factor) (FGF7), mRNA
gi|15147344|ref|NM—002009.2|[15147344] - 4505: AF190501
Homo sapiens leucine-rich repeat-containing G protein-coupled receptor 6 (LGR6)
mRNA, partial cds
gi|10441731|gb|AF190501.1|AF190501[10441731] - 4506: AF190500
Homo sapiens leucine-rich repeat-containing G protein-coupled receptor 7 (LGR7)
mRNA, complete cds
gi|10441729|gb|AF190500.1|AF190500[10441729] - 4507: NM—016543
Homo sapiens sialic acid binding Ig-like lectin 7 (SIGLEC7), mRNA
gi|7706570|ref|NM—016543.1|[7706570] - 4508: NM—014385
Homo sapiens sialic acid binding Ig-like lectin 7 (SIGLEC7), mRNA
gi|7657569|ref|NM—014385.1|[7657569] - 4509: AC005153
Homo sapiens PAC clone RP4-537P9 from 7p11.2-p12, complete sequence
gi|3242766|gb|AC005153.1|AC005153[3242766] - 4528: AJ309020
Homo sapiens mRNA for G protein-coupled receptor (AXOR12 gene)
gi|14330412|emb|AJ309020.1|HSA309020[14330412] - 4529: AJ243297
Homo sapiens partial RET gene, exons 2 to 20
gi|5419752|emb|AJ243297.1|HSA243297[5419752] - 4530: X57019
H. sapiens mRNA for tyrosine kinase receptor
gi|37592|emb|X57019.1|HSUF025[37592] - 4585: AF166361
Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 9 and complete cds
gi|10086249|gb|AF166361.1|AF165901S9[10086249] - 4586: AF166360
Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 8
gi|10086248|gb|AF166360.1|AF165901S8[10086248] - 4587: AF166359
Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 7
gi|10086247|gb|AF166359.1|AF165901S7[10086247] - 4588: AF165906
Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 6
gi|10086246|gb|AF165906.1|AF165901S6[10086246] - 4589: AF165905
Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 5
gi|10086245|gb|AF165905.1|AF165901S5[10086245] - 4590: AF165904
Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 4
gi|10086244|gb|AF165904.1|AF165901S4[10086244] - 4591: AF165903
Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 3
gi|0086243|gb|AF165903.1|AF165901S3[10086243] - 4592: AF165902
Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 2
gi|10086242|gb|AF165902.1|AF165901S2[10086242] - 4593: AF165901
Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, exon 1
gi|10086241|gb|AF165901.1|AF165901S1[10086241] - 4594: AH009803
Homo sapiens GABA receptor subunit alpha 3 (GABRA3) gene, complete cds
gi|10086240|gb|AH009803.1|SEG_AF165901S[10086240] - 4595: AF167332
Homo sapiens glutamate receptor subunit 3 flip and flop isoforms (GRIA3) gene,
exon 16 and partial cds, alternatively spliced
gi|9738978|gb|AF167332.1|F166362S15[9738978] - 4596: AF166375
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 15
gi|9738977|gb|AF166375.1|F166362S14[9738977] - 4597: AF166374
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 14
gi|9738976|gb|AF166374.1|F166362S13[9738976] - 4598: AF166373
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 13
gi|9738975|gb|AF166373.1F166362S12[9738975] - 4599: AF166372
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 12
gi|9738974|gb|AF166372.1|F166362S11[9738974] - 4600: AF166371
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 11
gi|9738973|gb|AF166371.1|F166362S10[9738973] - 4601: AF166370
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 10
gi|9738972|gb|AF166370.1|F166362S09[9738972] - 4602: AF166369
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 9
gi|9738971|gb|AF166369.1F166362S08[9738971] - 4603: AF166368
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 8
gi|9738970|gb|AF166368.1|F166362S07[9738970] - 4604: AF166367
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 7
gi|9738969|gb|AF166367.1|F166362S06[9738969] - 4605: AF166366
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 6
gi|9738968|gb|AF166366.1|F166362S05[9738968] - 4606: AF166365
Homo sapiens glutamate receptor subunit 3 flip and flop isoforms (GRIA3) gene,
exon 4 and partial cds
gi|9738967|gb|AF166365.1|F166362S04[9738967] - 4607: AF166364
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 3
gi|9738966|gb|AF166364.1|F166362S03[9738966] - 4608: AF166363
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 2
gi|9738965|gb|AF166363.1|F166362S02[9738965] - 4609: AF166362
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 1
gi|9738964|gb|AF166362.1|F166362S01[9738964] - 4610: AH009704
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, partial cds; and glutamate receptor subunit 3 (GRIA3) gene, partial cds, alternatively spliced
gi|9738963|gb|AH009704.1|SEG_F166362S[9738963] - 4611: AF272389
Homo sapiens natural killer cell immunoglobulin-like receptor (KIR2D55) mRNA, partial cds
gi|15080894|gb|AF272389.1|AF272389[15080894] - 4612: BC011847
Homo sapiens, fibroblast growth factor receptor 4, clone MGC:20292 IMAGE:4121396, mRNA, complete cds
gi|15080147|gb|BC011847.1|BC011847[15080147] - 4613: BC011787
Homo sapiens, nogo receptor, clone MGC:19831 IMAGE:4040540, mRNA, complete cds
gi|15080004|gb|BC011787.1|BC011787[15080004] - 4614: AF353942
Homo sapiens lantibiotic synthetase C-like protein 2 (LANCL2) mRNA, complete cds
gi|15077638|gb|AF353942.1|AF353942[15077638] - 4615: AF343725
Homo sapiens G-protein-coupled receptor GPR54 (GPR54) mRNA, complete cds
gi|15077535|gb|AF343725.1|AF343725[15077535] - 4617: AJ272063
Homo sapiens mRNA for vanilloid receptor 1 (VR1 gene)
gi|15028818|emb|AJ272063.2|HSA272063[15028818] - 4618: AF133266
Homo sapiens cysteinyl leukotriene receptor mRNA, complete cds
gi|5359717|gb|AF133266.1|AF133266[5359717] - 4619: NM—033130
Homo sapiens sialic acid binding Ig-like lectin 10 (SIGLEC10), mRNA
gi|15055512|ref|NM—033130.1|[15055512] - 4620: NM—033180
Homo sapiens olfactory receptor, family 51, subfamily B, member 2 (OR51B2), mRNA
gi|15042966|ref|NM—033180.1|[15042966] - 4621: NM—033179
Homo sapiens olfactory receptor, family 51, subfamily B, member 4 (OR51B4), mRNA
gi|15042964|ref|NM—033179.1|[15042964] - 4622: AF380193
Homo sapiens trace amine receptor 5 (TA5) gene, complete cds
gi|14600089|gb|AF380193.1|AF380193[14600089] - 4623: AF380192
Homo sapiens trace amine receptor 4 (TA4) gene, complete cds
gi|14600087|gb|AF380192.1|AF380192[14600087] - 4624: AF380189
Homo sapiens trace amine receptor 3 (TA3) gene, complete cds
gi|14600081|gb|AF380189.1|AF380189[14600081] - 4625: AF380185
Homo sapiens trace amine receptor 1 (TA1) gene, complete cds
gi|14600073|gb|AF380185.1|AF380185[14600073] - 4626: AF313468
Homo sapiens dendritic cell-associated C-type lectin-1 mRNA, complete cds
gi|13649707|gb|AF313468.1|AF313468[13649707] - 4627: NM—007096
Homo sapiens clathrin, light polypeptide (Lca) (CLTA), transcript variant brain-specific, mRNA
gi|6005992|ref|NM—007096.1|[6005992] - 4628: NM—001833
Homo sapiens clathrin, light polypeptide (Lca) (CLTA), transcript variant nonbrain, mRNA
gi|4502898|ref|NM—001833.1|[4502898] - 4629: NM—005292
Homo sapiens G protein-coupled receptor 18 (GPR18), mRNA
gi|15029527|ref|NM—005292.1|[15029527] - 4630: NM—012276
Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 4 (ILT7), mRNA
gi|15029521|ref|NM—012276.1|[15029521] - 4631: AJ299451
Homo sapiens mRNA for glutamate receptor 7 (GRIK3 gene)
gi|5028906|emb|AJ299451.1|HSA299451[15028906] - 4632: AY033606
Homo sapiens fused in glioblastoma mRNA, complete cds
gi|14289128|gb|AY033606.1|[14289128] - 4633: AF190696
Homo sapiens bile salt export pump (ABCB11) gene, promoter region and partial sequence
gi|14280234|gb|AF190696.1|AF190696[14280234] - 4634: NM—018558
Homo sapiens gamma-aminobutyric acid (GABA) receptor, theta (GABRQ), mRNA
gi|8924257|ref|NM—018558.1|[8924257] - 4635: NM—014452
Homo sapiens tumor necrosis factor receptor superfamily, member 21 (TNFRSF21),
mRNA
gi|7657038|ref|NM—014452.1|[7657038] - 4637: AF320560
Homo sapiens stresscopin-related protein mRNA, complete cds
gi|14029393|gb|AF320560.1|AF320560[14029393] - 4638: NM—007368
Homo sapiens RAS p21 protein activator (GTPase activating protein) 3 (Ins(1,3,4,5)P4-binding protein) (GAP1IP4BP), mRNA
gi|12545409|ref|NM—007368.1|[12545409] - 4639: NM—016109
Homo sapiens angiopoietin-like 4 (ANGPTL4), mRNA
gi|7705828|ref|NM—016109.1|[7705828] - 4640: NM—006667
Homo sapiens progesterone receptor membrane component 1 (PGRMC1), mRNA
gi|6857798|ref|NM—006667.2|[6857798] - 4641: NM—006320
Homo sapiens progesterone receptor membrane component 2 (PGRMC2), mRNA
gi|5453915|ref|NM—006320.1|[5453915] - 4662: AF319553
Homo sapiens TNFRSF19L mRNA, complete cds
gi|15011026|gb|AF319553.1|AF319553[15011026] - 4663: AF395806
Homo sapiens adrenergic receptor alpha-1a (ADRA1A) mRNA, complete cds
gi|15004693|gb|AF395806.1|AF395806[15004693] - 4664: AF388194
Homo sapiens PML/RARA fusion mRNA, partial sequence
gi|15004544|gb|AF388194.1|AF388194[15004544] - 4665: AF388193
Homo sapiens PML/RARA fusion mRNA, partial sequence
gi|15004543|gb|AF388193.1|AF388193[15004543] - 4666: AF334818
Homo sapiens sodium-dependent neutral amino acid transporter type 2 truncated isoform (ASCT2) mRNA, partial cds
gi|15004316|gb|AF334818.1|AF334818[15004316] - 4667: NM—022788
Homo sapiens Purinergic receptor P2Y, G protein-coupled, 12 (P2RY12), mRNA
gi|12232482|ref|NM—022788.1|[12232482] - 4668: NM—016523
Homo sapiens killer cell lectin-like receptor subfamily F, member 1 (KLRF1), mRNA
gi|7705573|ref|NM—016523.1|[7705573] - 4669: NM—002558
Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 1 (P2RX1), mRNA
gi|4505544|ref|NM—002558.1|[4505544] - 4670: AF391809
Homo sapiens coagulation factor II (thrombin) receptor (F2R) gene, complete cds
gi|14971463|gb|AF391809.2|AF391809[14971463] - 4671: NM—016930
Homo sapiens syntaxin 18 (STX18), mRNA
gi|8394375|ref|NM—016930.1|[8394375] - 4672: NM—032957
Homo sapiens tumor necrosis factor receptor superfamily, member 6b, decoy (TNFRSF6B), transcript variant 1, mRNA
gi|14790173|ref|NM—032957.1|[14790173] - 4673: NM—032945
Homo sapiens tumor necrosis factor receptor superfamily, member 6b, decoy (TNFRSF6B), transcript variant M68C, mRNA
gi|14790169|ref|NM—032945.1|[14790169] - 4674: NM—015647
Homo sapiens tumor necrosis factor receptor superfamily, member 6b, decoy (TNFRSF6B), transcript variant 3, mRNA
gi|14790156|ref|NM—015647.2|[14790156] - 4675: NM—005409
Homo sapiens small inducible cytokine subfamily B (Cys-X-Cys), member 11 (SCYB11), mRNA
gi|14790145|ref|NM—005409.3|[14790145] - 4676: NM—001305
Homo sapiens claudin 4 (CLDN4), mRNA
gi|14790131|ref|NM—001305.2|[14790131] - 4677: NM—004346
Homo sapiens caspase 3, apoptosis-related cysteine protease (CASP3), transcript
variant alpha, mRNA
gi|14790118|ref|NM—004346.2|[14790118] - 4678: NM—032991
Homo sapiens caspase 3, apoptosis-related cysteine protease (CASP3), transcript
variant beta, mRNA
gi|14790114|ref|NM—032991.1|[14790114] - 4679: NM—033057
Homo sapiens olfactory receptor, family 2, subfamily B, member 2 (OR2B2), mRNA
gi|14780899|ref|NM—033057.1|[14780899] - 4680: NM—020137
Homo sapiens GRIP-associated protein 1 (GRASP1), mRNA
gi|14719405|ref|NM—020137.1|[14719405] - 4681: NM—032503
Homo sapiens G protein-coupled receptor slt (SLT), mRNA
gi|14210483|ref|NM—032503.1|[14210483] - 4682: AF260738
Homo sapiens platelet-derived growth factor C (PDGFC) mRNA, complete cds
gi|14009503|gb|AF260738.1|AF260738[14009503] - 4683: AF326275
Homo sapiens melanocortin 1 receptor (MC1R) gene, complete cds
gi|12658397|gb|AF326275.1|AF326275[12658397] - 4684: NM—016434
Homo sapiens tumor necrosis factor receptor superfamily, member 6b, decoy (TNFRSF6B), transcript variant 2, mRNA
gi|7706540|ref|NM—016434.1|[7706540] - 4685: NM—013314
Homo sapiens B-cell linker (BLNK), mRNA
gi|7019534|ref|NM—013314.1|[7019534] - 4686: NM—005817
Homo sapiens cargo selection protein (mannose 6 phosphate receptor binding protein) (TIP47), mRNA
gi|5032182|ref|NM—005817.1|[5032182] - 4687: NM—003110
Homo sapiens Sp2 transcription factor (SP2), mRNA
gi|4507166|ref|NM—003110.1|[4507166] - 4688: NM—002704
Homo sapiens pro-platelet basic protein (includes platelet basic protein, beta-thromboglobulin, connective tissue-activating peptide III, neutrophil-activating peptide-2) (PPBP), mRNA
gi|4505980|ref|NM—002704.1|[4505980] - 4689: AF064083
Homo sapiens T-cell receptor beta chain variable region (TCRBV28) mRNA, TCRBV28*S2 allele, partial cds
gi|3859856|gb|AF064083.1|AF064083[3859856] - 4690: BC010641
Homo sapiens, gamma-aminobutyric acid (GABA) A receptor, beta 3, clone MGC:9051
IMAGE:3871111, mRNA, complete cds
gi|14714964|gb|BC010641.1|BC010641[14714964] - 4691: BC010574
Homo sapiens, glutamate receptor, ionotropic, AMPA2 (alpha 2), clone MGC:17079
IMAGE:4215347, mRNA, complete cds
gi|14714845|gb|BC010574.1|BC010574[14714845] - 4692: BC010536
Homo sapiens, coxsackie virus and adenovirus receptor, clone MGC:17118 IMAGE:3456544, mRNA, complete cds
gi|14714774|gb|BC010536.1|BC010536[14714774] - 4693: BC010423
Homo sapiens, Ig superfamily receptor LNIR, clone MGC:15117 IMAGE:3610849, mRNA,
complete cds
gi|14714573|gb|BC010423.1|BC010423[14714573] - 4694: BC010418
Homo sapiens, laminin receptor 1 (67 kD, ribosomal protein SA), clone MGC:16557
IMAGE:4079845, mRNA, complete cds
gi|14714563|gb|BC010418.1|BC010418[14714563] - 4695: NM—020168
Homo sapiens p21(CDKN1A)-activated kinase 6 (PAK6), mRNA
gi|14670348|ref|NM—020168.2|[14670348] - 4696: BC010140
Homo sapiens, tumor necrosis factor receptor superfamily, member 1A, clone MGC:19588 IMAGE:4131360, mRNA, complete cds
gi|14603367|gb|BC010140.1|BC010140[14603367] - 4697: BC010054
Homo sapiens, laminin receptor 1 (67 kD, ribosomal protein SA), clone MGC:19795
IMAGE:3845335, mRNA, complete cds
gi|14603183|gb|BC010054.1|BC010054[14603183] - 4698: BC009974
Homo sapiens, laminin receptor 1 (67 kD, ribosomal protein SA), clone MGC:16607
IMAGE:4110990, mRNA, complete cds
gi|14602973|gb|BC009974.1|BC009974[14602973] - 4699: BC009960
Homo sapiens, interleukin 13 receptor, alpha 1, clone MGC:15228 IMAGE:4300487, mRNA, complete cds
gi|14602931|gb|BC009960.1|BC009960[14602931] - 4701: BC009877
Homo sapiens, purinergic receptor P2Y, G-protein coupled, 11, clone MGC:16468 IMAGE:3953307, mRNA, complete cds
gi|14602717|gb|BC009877.1|BC009877[14602717] - 4702: BC009861
Homo sapiens, super conserved receptor expressed in brain 3, clone MGC:16375 IMAGE:3936037, mRNA, complete cds
gi|14602675|gb|BC009861.1|BC009861[14602675] - 4703: BC009748
Homo sapiens, dopamine receptor D5, clone MGC:10601 IMAGE:3928370, mRNA, complete cds
gi|14602484|gb|BC009748.1|BC009748[14602484] - 4705: BC009391
Homo sapiens, pyrimidinergic receptor P2Y, G-protein coupled, 6, clone MGC:15335
IMAGE:4128941, mRNA, complete cds
gi|14424757|gb|BC009391.1|BC009391[14424757] - 4707: BC009237
Homo sapiens, thyroid stimulating hormone receptor, clone MGC:2216 IMAGE:2989823, mRNA, complete cds
gi|14328043|gb|3BC009237.1|BC009237[14328043] - 4708: BC008982
Homo sapiens, complement component 5 receptor 1 (C5a ligand), clone MGC:17119 IMAGE:4177114, mRNA, complete cds
gi|14290435|gb|BC008982.1|BC008982[14290435] - 4709: BC008867
Homo sapiens, laminin receptor 1 (67 kD, ribosomal protein SA), clone MGC:16750
IMAGE:4130936, mRNA, complete cds
gi|14250793|gb|BC008867.1|BC008867[14250793] - 4710: BC008786
Homo sapiens, integrin, alpha 5 (fibronectin receptor, alpha polypeptide), clone
MGC:3697 IMAGE:3629647, mRNA, complete cds
gi|14250643|gb|BC008786.1|BC008786[14250643] - 4711: BC008770
Homo sapiens, G protein-coupled receptor 56, clone MGC:1409 IMAGE:3139174, mRNA,
complete cds
gi|14250619|gb|BC008770.1|BC008770[14250619] - 4712: BC008734
Homo sapiens, Fc fragment of IgG, receptor, transporter, alpha, clone MGC:1506
IMAGE:3163446, mRNA, complete cds
gi|14250560|gb|BC008734.1|BC008734[14250560] - 4714: BC008716
Homo sapiens, discoidin domain receptor family, member 1, clone MGC:8681 IMAGE:2964574, mRNA, complete cds
gi|14250529|gb|BC008716.1|BC008716[14250529] - 4715: BC008406
Homo sapiens, CD36 antigen (collagen type I receptor, thrombospondin receptor),
clone MGC:14530 IMAGE:4244251, mRNA, complete cds
gi|14250019|gb|BC008406.1|BC008406[14250019] - 4716: NM—032571
Homo sapiens EGF-like module-containing mucin-like receptor EMR3 (EMR3), mRNA
gi|14211882|ref|NM—032571.1|[14211882] - 4717: AF345568
Homo sapiens putative chemokine receptor (FKSG80) mRNA, complete cds
gi|13517963|gb|AF345568.1|AF345568[13517963] - 4718: AF345567
Homo sapiens putative purinergic receptor (FKSG79) mRNA, complete cds
gi|13517961|gb|AF345567.1|AF345567[13517961] - 4719: AF345566
Homo sapiens putative G-protein-coupled receptor FKSG78 (FKSG78) mRNA, complete
cds
gi|3517959|gb|AF345566.1|AF345566[13517959] - 4720: AF345565
Homo sapiens putative G-protein-coupled receptor FKSG77 (FKSG77) mRNA, complete
cds
gi|13517957|gb|AF345565.1|AF345565[13517957] - 4722: NM—013447
Homo sapiens egf-like module containing, mucin-like, hormone receptor-like sequence 2 (EMR2), mRNA
gi|7305024|ref|NM—013447.1|[7305024] - 4724: BC007720
Homo sapiens, 5-hydroxytryptamine (serotonin) receptor 1D, clone MGC:12645 IMAGE:4299633, mRNA, complete cds
gi|14043458|gb|BC007720.1|BC007720[14043458] - 4725: BC007713
Homo sapiens, protein tyrosine phosphatase, receptor type, N, clone MGC:12646 IMAGE:4130827, mRNA, complete cds
gi|14043446|gb|BC007713.1|BC007713[14043446] - 4727: BC007566
Homo sapiens, cargo selection protein (mannose 6 phosphate receptor binding protein), clone MGC:15516 IMAGE:3028104, mRNA, complete cds
gi|14043156|gb|BC007566.1|BC007566[14043156] - 4728: BC007408
Homo sapiens, low density lipoprotein receptor-related protein 3, clone MGC:2428
IMAGE:3009711, mRNA, complete cds
gi|13938518|gb|BC007408.1|BC007408[13938518] - 4729: BC006196
Homo sapiens, tumor necrosis factor receptor superfamily, member 9, clone MGC:2172 IMAGE:2924109, mRNA, complete cds
gi|13623200|gb|BC006196.1|BC006196[13623200] - 4730: BC005912
Homo sapiens, Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide, clone MGC:14507 IMAGE:4294467, mRNA, complete cds
gi|13543505|gb|BC005912.1|BC005912[13543505] - 4731: BC005818
Homo sapiens, cargo selection protein (mannose 6 phosphate receptor binding protein), clone MGC:11117 IMAGE:3833411, mRNA, complete cds
gi|13543306|gb|BC005818.1|BC005818[13543306] - 4732: BC005391
Homo sapiens, laminin receptor 1 (67 kD, ribosomal protein SA), clone MGC:12521
IMAGE:3997019, mRNA, complete cds
gi|13529268|gb|BC005391.1|BC005391[13529268] - 4733: BC005333
Homo sapiens, interferon gamma receptor 1, clone MGC:12420 IMAGE:3950528, mRNA,
complete cds
gi|13529118|gb|BC005333.1|BC005333[13529118] - 4734: BC005315
Homo sapiens, formyl peptide receptor 1, clone MGC:12392 IMAGE:3829614, mRNA, complete cds
gi|13529064|gb|BC005315.1|BC005315[13529064] - 4735: BC005268
Homo sapiens, putative receptor protein, clone MGC:12310 IMAGE:4051155, mRNA, complete cds
gi|13528953|gb|BC005268.1|BC005268[13528953] - 4737: BC004555
Homo sapiens, G protein-coupled receptor, clone MGC:10314 IMAGE:4054377, mRNA,
complete cds
gi|13528716|gb|BC004555.1|BC004555[13528716] - 4738: BC004553
Homo sapiens, receptor-interacting serine-threonine kinase 2, clone MGC:10684 IMAGE:4026156, mRNA, complete cds
gi|13528713|gb|BC004553.1|BC004553[13528713] - 4739: BC004545
Homo sapiens, leukotriene b4 receptor (chemokine receptor-like 1), clone MGC:10388 IMAGE:3946189, mRNA, complete cds
gi|13528695|gb|BC004545.1|BC004545[13528695] - 4740: BC004899
Homo sapiens, sigma receptor (SR31747 binding protein 1), clone MGC:3851 IMAGE:3529352, mRNA, complete cds
gi|13436169|gb|BC004899.1|BC004899[13436169] - 4741: BC004348
Homo sapiens, interleukin 21 receptor, clone MGC:10967 IMAGE:3634520, mRNA, complete cds
gi|13279298|gb|BC004348.1|BC004348[13279298] - 4742: BC003684
Homo sapiens, coxsackie virus and adenovirus receptor, clone MGC:5086 IMAGE:3463613, mRNA, complete cds
gi|13277551|gb|BC003684.1|BC003684[13277551] - 4743: BC003624
Homo sapiens, interferon gamma receptor 2 (interferon gamma transducer 1), clone
MGC:2193 IMAGE:2967074, mRNA, complete cds
gi|13177681|gb|BC003624.1|BC003624[13177681] - 4744: BC003187
Homo sapiens, putative G-protein coupled receptor, clone MGC:688 IMAGE:3537949, mRNA, complete cds
gi|13112026|gb|BC003187.1|BC003187[13112026] - 4745: BC003142
Homo sapiens, vesicle-associated soluble NSF attachment protein receptor (v-SNARE; homolog of S. cerevisiae VTI1), clone MGC:3767 IMAGE:2958320, mRNA, complete cds
gi|13111940|gb|BC003142.1|BC003142[13111940] - 4746: BC003110
Homo sapiens, interleukin 11 receptor, alpha, clone MGC:2146 IMAGE:3502059, mRNA, complete cds
gi|13111884|gb|BC003110.1|BC003110[13111884] - 4747: BC003091
Homo sapiens, poliovirus receptor-related 2 (herpesvirus entry mediator B), clone MGC:1349 IMAGE:3503222, mRNA, complete cds
gi|13111848|gb|BC003091.1|BC003091[13111848] - 4748: BC000181
Homo sapiens, putative G protein-coupled receptor, clone MGC:5003 IMAGE:3048193,
mRNA, complete cds
gi|13111815|gb|BC000181.2|BC000181[13111815] - 4751: BC003005
Homo sapiens, unactive progesterone receptor, 23 kD, clone MGC:4004 IMAGE:2821965, mRNA, complete cds
gi|12804292|gb|BC003005.1|BC003005[12804292] - 4752: BC002996
Homo sapiens, cholinergic receptor, nicotinic, alpha polypeptide 3, clone MGC:3862 IMAGE:2822768, mRNA, complete cds
gi|12804274|gb|BC002996.1|BC002996[12804274] - 4753: BC002947
Homo sapiens, folate receptor 1 (adult), clone MGC:10473 IMAGE:3956659, mRNA, complete cds
gi|12804178|gb|BC002947.1|BC002947[12804178] - 4754: BC002819
Homo sapiens, putative receptor protein, clone MGC:3676 IMAGE:3636199, mRNA, complete cds
gi|12803944|gb|BC002819.1|BC002819[12803944] - 4755: BC002794
Homo sapiens, tumor necrosis factor receptor superfamily, member 14 (herpesvirus
entry mediator), clone MGC:3753 IMAGE:3614650, mRNA, complete cds
gi|12803894|gb|BC002794.1|BC002794[12803894] - 4756: BC002793
Homo sapiens, interferon (alpha, beta and omega) receptor 2, clone MGC:3873 IMAGE:3626374, mRNA, complete cds
gi|12803892|gb|BC002793.1|BC002793[12803892] - 4757: BC002788
Homo sapiens, plasminogen activator, urokinase receptor, clone MGC:3905 IMAGE:3617894, mRNA, complete cds
gi|12803884|gb|BC002788.1|BC002788[12803884] - 4758: BC002635
Homo sapiens, colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage), clone MGC:3848 IMAGE:3606186, mRNA, complete cds
gi|12803600|gb|BC002635.1|BC002635[12803600] - 4759: BC002537
Homo sapiens, fibroblast growth factor receptor-like 1, clone IMAGE:3140874, mRNA
gi|12803426|gb|BC002537.1|BC002537[12803426] - 4760: BC002464
Homo sapiens, coagulation factor II (thrombin) receptor, clone MGC:1197 IMAGE:3343051, mRNA, complete cds
gi|12803296|gb|BC002464.1|BC002464[12803296] - 4761: BC002443
Homo sapiens, putative T1/ST2 receptor binding protein, clone MGC:1270 IMAGE:3346273, mRNA, complete cds
gi|12803256|gb|BC002443.1|BC002443[12803256] - 4762: BC002354
Homo sapiens, 5-hydroxytryptamine (serotonin) receptor 3A, clone MGC:8469 IMAGE:2821710, mRNA, complete cds
gi|12803100|gb|BC002354.1|BC002354[12803100] - 4763: BC001379
Homo sapiens, G protein-coupled receptor kinase-interactor 2, clone MGC:760 IMAGE:3051069, mRNA, complete cds
gi|12655058|gb|BC001379.1|BC001379[12655058] - 4764: BC001281
Homo sapiens, tumor necrosis factor receptor superfamily, member lob, clone MGC:5144 IMAGE:3458466, mRNA, complete cds
gi|12654874|gb|BC001281.1|BC001281[12654874] - 4766: BC001188
Homo sapiens, transferrin receptor (p90, CD71), clone MGC:3151 IMAGE:3354176, mRNA, complete cds
gi|12654696|gb|BC001188.1|BC001188[12654696] - 4769: BC001110
Homo sapiens, benzodiazapine receptor (peripheral), clone MGC:1184 IMAGE:2989070, mRNA, complete cds
gi|12654552|gb|BC001110.1|BC001110[12654552] - 4770: BC000740
Homo sapiens, cholecystokinin B receptor, clone MGC:2199 IMAGE:3504160, mRNA, complete cds
gi|12653894|gb|BC000740.1|BC000740[12653894] - 4772: BC000571
Homo sapiens, pyrimidinergic receptor P2Y, G-protein coupled, 6, clone MGC:2067
IMAGE:3162734, mRNA, complete cds
gi|12653590|gb|BC000571.1|BC000571[12653590] - 4773: BC000548
Homo sapiens, receptor (calcitonin) activity modifying protein 1, clone MGC:1996
IMAGE:3163522, mRNA, complete cds
gi|12653550|gb|BC000548.1|BC000548[12653550] - 4774: BC000513
Homo sapiens, cholinergic receptor, nicotinic, alpha polypeptide 3, clone MGC:8545 IMAGE:2822768, mRNA, complete cds
gi|12653482|gb|BC000513.1|BC000513[12653482] - 4776: BC000254
Homo sapiens, activin A receptor, type IB, clone MGC:2177 IMAGE:3352720, mRNA,
complete cds
gi|12652986|gb|BC000254.1|BC000254[12652986] - 4780: AF037351
Homo sapiens macrophage scavenger receptor type III (SR-A) mRNA, complete cds
gi|3004959|gb|AF037351.1|AF037351[3004959] - 4781: BC009277
Homo sapiens, G protein-coupled receptor kinase 6, clone IMAGE:4053197, mRNA
gi|14627273|gb1BC009277.1|BC009277[14627273] - 4782: AF369786
Homo sapiens growth hormone secretagogue receptor gene, complete cds, alternatively spliced
gi|14625865|gb|AF369786.1|AF369786[14625865] - 4784: U35877
Homo sapiens (−) genotype B2 bradykinin receptor gene, exon 1
gi|1353393|gb|U35877.1|HSU35877[1353393] - 4785: U35876
Homo sapiens (+) genotype B2 bradykinin receptor gene, exon 1
gi|1353392|gb|U35876.1|HSU35876[1353392] - 4786: NM—005656
Homo sapiens transmembrane protease, serine 2 (TMPRSS2), mRNA
gi|14602458|ref|NM—005656.2|[14602458] - 4787: NM—004167
Homo sapiens small inducible cytokine subfamily A (Cys-Cys), member 15 (SCYA15),
transcript variant 2, mRNA
gi|14602450|ref|NM—004167.2|[14602450] - 4788: NM—032965
Homo sapiens small inducible cytokine subfamily A (Cys-Cys), member 15 (SCYA15),
transcript variant 3, mRNA
gi|14602448|ref|NM—032965.1|[14602448] - 4789: NM—032964
Homo sapiens small inducible cytokine subfamily A (Cys-Cys), member 15 (SCYA15),
transcript variant 1, mRNA
gi|14602446|ref|NM—032964.1|[14602446] - 4790: AJ312373
Homo sapiens mRNA for DECTIN-1 receptor, splice variant 2
gi|14599395|emb|AJ312373.1|HSA312373[14599395] - 4791: AJ312372
Homo sapiens mRNA for DECTIN-1 receptor, splice variant 1
gi|14599393|emb|AJ312372.1|HSA312372[14599393] - 4792: AJ307885
Homo sapiens mRNA for T-cell receptor beta chain, clone 83
gi|14595016|emb|AJ307885.1|HSA307885[14595016] - 4793: NM—001987
Homo sapiens ets variant gene 6 (TEL oncogene) (ETV6), mRNA
gi|14589947|ref|NM—001987.2|[14589947] - 4794: NM—020403
Homo sapiens protocadherin 9 (PCDH9), mRNA
gi|14589940|ref|NM—020403.2|[14589940] - 4795: NM—022843
Homo sapiens protocadherin 20 (PCDH20), mRNA
gi|14589938|ref|NM—022843.1|[14589938] - 4797: NM—020164
Homo sapiens aspartate beta-hydroxylase (ASPH), transcript variant 5, mRNA
gi|14589858|ref|NM—020164.2|[14589858] - 4798: AF361107
Homo sapiens CRHF2 receptor beta-isoform mRNA, partial sequence, aberrantly spliced
gi|14586958|gb|AF361107.1|AF361107[14586958] - 4799: AF361106
Homo sapiens CRHF2 receptor beta-isoform mRNA, partial sequence, aberrantly spliced
gi|14586957|gb|AF361106.1|AF361106[14586957]
- 4800: AF284768
Homo sapiens laminin receptor-like protein LAMRL5 mRNA, complete cds
gi|14583013|gb|AF284768.1|AF284768[14583013] - 4801: AF343090
Homo sapiens HSF-27 protein mRNA, complete cds
gi|14582809|gb|AF343090.1|AF343090[14582809] - 4802: AF286696
Homo sapiens olfactory receptor sdolf mRNA, complete cds
gi|14582606|gb|AF286696.1|AF286696[14582606] - 4803: AF279673
Homo sapiens vanilloid receptor-like protein 2 (VRL2) mRNA, complete cds
gi|14582397|gb|AF279673.1|AF279673[14582397] - 4804: AF279611
Homo sapiens cysteinyl leukotriene receptor type 2 (CYSLT2) gene, complete cds
gi|14582393|gb|AF2796711.1|AF279611[14582393] - 4806: NM—005111
Homo sapiens crystallin, zeta (quinone reductase)-like 1 (CRYZL1), mRNA
gi|14577924|ref|NM—005111.2|[14577924] - 4807: NM—000592
Homo sapiens complement component 4B (C4B), mRNA
gi|14577920|ref|NM—000592.3|[14577920] - 4809: NM—016557
Homo sapiens orphan seven-transmembrane receptor, chemokine related (VSHK1), mRNA
gi|7706768|ref|NM—016557.1|[7706768] - 4810: NM—006850
Homo sapiens interleukin 24 (IL24), mRNA
gi|5803085|ref|NM—006850.1|[5803085] - 4811: NM—000029
Homo sapiens angiotensinogen (serine (or cysteine) proteinase inhibitor, clade A
(alpha-1 antiproteinase, antitrypsin), member 8) (AGT), mRNA
gi|4557286|ref|NM—000029.1|[4557286] - 4812: AF385591
Homo sapiens m5 muscarinic cholinergic receptor (CHRM5) mRNA, complete cds
gi|14573544|gb|AF385591.1|AF385591[14573544] - 4813: AF385590
Homo sapiens m4 muscarinic cholinergic receptor (CHRM4) mRNA, complete cds
gi|14573542|gb|AF385590.1|AF385590[14573542] - 4814: AF385589
Homo sapiens m3 muscarinic cholinergic receptor (CHRM3) mRNA, partial cds
gi|14573540|gb|AF385589.1|AF385589[14573540] - 4815: AF385588
Homo sapiens m2 muscarinic cholinergic receptor (CHRM2) mRNA, complete cds
gi|14573538|gb|AF385588.1|AF385588[14573538] - 4816: AF385587
Homo sapiens ml muscarinic cholinergic receptor (CHRM1) mRNA, complete cds
gi|14573536|gb|AF385587.1|AF385587[14573536] - 4817: AF385585
Homo sapiens nicotinic cholinergic receptor alpha 7 (CHRNA7) mRNA, complete cds
gi|14573533|gb|AF385585.1|AF385585[14573533] - 4818: AF385584
Homo sapiens nicotinic cholinergic receptor alpha 3 (CHRNA3) mRNA, partial cds
gi|4573531|gb|AF385584.1|AF385584[14573531] - 4819: AF361943
Homo sapiens urocortin III (UCNIII) gene, complete cds
gi|14571921|gb|AF361943.1|AF361943[14571921] - 4825: NM—031282
Homo sapiens immunoglobulin superfamily receptor translocation associated 1 (IRTA1), mRNA
gi|14550415|ref|NM—031282.1|[14550415] - 4826: NM—031281
Homo sapiens immunoglobulin superfamily receptor translocation associated 2 (IRTA2), mRNA
gi|14550413|ref|NM—031281.1|[14550413] - 4827: NM—020404
Homo sapiens tumor endothelial marker 1 precursor (TEM1), mRNA
gi|9966884|ref|NM—020404.1|[9966884] - 4830: AF338733
Homo sapiens thymic stromal lymphopoietin protein receptor TSLPR mRNA, complete
cds
gi|14335439|gb|AF338733.1|AF338733[14335439] - 4831: AF338732
Homo sapiens thymic stromal lymphopoietin protein TSLP mRNA, complete cds
gi|14335437|gb|AF338732.1|AF338732[14335437] - 4832: AJ272324
Homo sapiens mRNA for PRAM-1 protein
gi|11558108|emb|AJ272324.1|HSA272324[11558108] - 4833: AF281043
Homo sapiens high mobility group 1 protein (HMG1) gene, promoter and partial cds
gi|14522873|gb|AF281043.1|AF281043[14522873] - 4834: NM—024298
Homo sapiens malignant cell expression-enhanced gene/tumor progression-enhance (LENG4), mRNA
gi|13236521|ref|NM—024298.1|[13236521] - 4835: AB051580
Homo sapiens gene for IgG receptor IIIB, complete cds
gi|11344590|dbj|AB051580.1|AB051580[11344590] - 4836: NM—006134
Homo sapiens chromosome 21 open reading frame 4 (C21orf4), mRNA
gi|8659558|ref|NM—006134.2|[8659558] - 4837: NM—015927
Homo sapiens transforming growth factor beta 1 induced transcript 1 (TGFB1I1),
mRNA
gi|7706249|ref|NM—015927.1|[7706249] - 4838: NM—000956
Homo sapiens prostaglandin E receptor 2 (subtype EP2), 53 kD (PTGER2), mRNA
gi|4506254|ref|NM—000956.1|[4506254] - 4839: AF019381
Homo sapiens corticotropin releasing hormone receptor type 2 gamma isoform (CRH2R) mRNA, complete cds
gi|2738888|gb|AF019381.1|AF019381[2738888] - 4840: AB043702
Homo sapiens FZD5 mRNA for seven-transmembrane receptor Frizzled-5, complete cds
gi|14495150|dbj|AB043702.1|AB043702[14495150] - 4841: AF384819
Homo sapiens coagulation factor II receptor-like 3 (F2RL3) gene, complete cds
gi|14488403|gb|AF384819.2|AF384819[14488403] - 4842: AF343666
Homo sapiens translocation associated fusion protein IRTA1/IGA1 (IRTA1/IGHA1) mRNA, complete cds
gi|13591717|gb|AF343666.1|AF343666[13591717] - 4843: AF343665
Homo sapiens immunoglobulin superfamily receptor translocation associated protein 2d (IRTA2) mRNA, partial cds, alternatively spliced
gi|13591715|gb|AF343665.1|AF343665[13591715] - 4844: AF343664
Homo sapiens immunoglobulin superfamily receptor translocation associated protein 2c (IRTA2) mRNA, complete cds, alternatively spliced
gi|13591713|gb|AF343664.1|AF343664[13591713] - 4845: AF343663
Homo sapiens immunoglobulin superfamily receptor translocation associated protein 2b (IRTA2) mRNA, complete cds, alternatively spliced
gi|13591711|gb|AF343663.1|AF343663[13591711] - 4846: AF343662
Homo sapiens immunoglobulin superfamily receptor translocation associated protein 2a (IRTA2) mRNA, complete cds, alternatively spliced
gi|13591709|gb|AF343662.1|AF343662[13591709] - 4847: AF343661
Homo sapiens immunoglobulin superfamily receptor translocation associated protein 1a (IRTA1) mRNA, complete cds, alternatively spliced
gi|13591707|gb|AF343661.1|AF343661[13591707] - 4848: AF343660
Homo sapiens immunoglobulin superfamily receptor translocation associated protein 1b (IRTA1) mRNA, complete cds, alternatively spliced
gi|13591705|gb|AF343660.1|AF343660[13591705] - 4849: AF343659
Homo sapiens immunoglobulin superfamily receptor translocation associated protein 1c (IRTA1) mRNA, complete cds, alternatively spliced
gi|13591703|gb|AF343659.1|AF343659[13591703] - 4850: AF321237
Homo sapiens chromosome 11p15.4 clone RPC11-610i20 P2-containing olfactory receptor gene cluster, complete sequence
gi|12007433|gb|AF321237.1|AF321237[12007433] - 4851: NM—005567
Homo sapiens lectin, galactoside-binding, soluble, 3 binding protein (LGALS3BP),
mRNA
gi|6006016|ref|NM—005567.21[6006016] - 4852: AF351620
Homo sapiens lipocalin-1 interacting membrane receptor (LIMR) gene, complete cds
gi|14485746|gb|AF351620.1|AF351620[14485746] - 4853: AF366519
- 4890: AB063174
Homo sapiens SLC-1 mRNA for somatostatin receptor-like protein, complete cds
gi|14475646|dbj|AB063174.1|AB063174[14475646] - 4891: AF238470
Homo sapiens natural killer cell receptor NKG2F gene, partial cds
gi|11023178|gb|AF238470.1|AF238470[11023178] - 4892: AF238469
Homo sapiens natural killer cell receptor NKG2E gene, partial cds
gi|11023176|gb|AF238469.1|AF238469[11023176] - 4893: AF238468
Homo sapiens natural killer cell receptor NKG2C gene, partial cds
gi|11023174|gb|AF238468.1|AF238468[11023174] - 4894: AE000662
Homo sapiens T-cell receptor alpha delta locus from bases 1000498 to 1071650 (section 5 of 5) of the Complete Nucleotide Sequence
gi|2358068|gb|AE000662.1|HUAE000662[2358068] - 4895: AE000661
Homo sapiens T-cell receptor alpha delta locus from bases 752679 to 1000555 (section 4 of 5) of the Complete Nucleotide Sequence
gi|2358060|gb|AE000661.1|HUAE000661[2358060] - 4896: AE000660
Homo sapiens T-cell receptor alpha delta locus from bases 501613 to 752736 (section 3 of 5) of the Complete Nucleotide Sequence
gi|2358042|gb|AE000660.1|HUAE000660[2358042] - 4897: AE000659
Homo sapiens T-cell receptor alpha delta locus from bases 250472 to 501670 (section 2 of 5) of the Complete Nucleotide Sequence
gi|2358025|gb|AE000659.1|HUAE000659[2358025] - 4898: AE000658
Homo sapiens T-cell receptor alpha delta locus from bases 1 to 250529 (section 1 of 5) of the Complete Nucleotide Sequence
gi|2358019|gb|AE000658.1|HUAE000658[2358019] - 4899: AF364129
Homo sapiens tandem repeat region 76.3 kb upstream of BMPR1A exon 1
gi|14423333|gb|AF364129.1|AF364129[14423333] - 4900: AF364128
Homo sapiens tandem repeat region 49.4 kb upstream of BMPR1A exon 1
gi|14423332|gb|AF364128.1|AF364128[14423332] - 4901: AF261083
Homo sapiens polymeric immunoglobulin receptor (PIGR) gene, partial cds
gi|8099662|gb|AF261083.1|AF261083[8099662] - 4902: AF243129
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 67 and partial cds
gi|14388671|gb|AF243129.1|F243081S49[14388671] - 4903: AF243128
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 66
gi|14388670 gb|AF243128.1|F243081S48[14388670] - 4904: AF243127
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 65
gi|14388669|gb|AF243127.1|F243081S47[14388669] - 4905: AF243126
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 63 and
gi|14388668|gb|AF243126.1|F243081S46[14388668] - 4906: AF243125
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 61 and
gi|14388667|gb|AF243125.1|F243081S45[14388667] - 4907: AF243124
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 60
gi|14388666|gb|AF243124.1|F243081S44[14388666] - 4908: AF243123
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 59
gi|14388665|gb|AF243123.1|F243081S43[14388665] - 4909: AF243122
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 58
gi|14388664|gb|AF243122.1|F243081S42[14388664] - 4910: AF243121
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 57
gi|14388663|gb|AF243121.1|F243081S41[14388663] - 4911: AF243120
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 56
gi|14388662|gb|AF243120.1|F243081S40[14388662] - 4912: AF243119
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 55
gi|4388661|gb|AF243119.1F243081S39[14388661] - 4913: AF243118
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 54
gi|14388660|gb|AF243118.1F243081S38[14388660] - 4914: AF243117
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 52 and
gi|14388659|gb|AF243117.1|F243081S37[14388659] - 4915: AF243116
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 51
gi|14388658|gb|AF243116.1|F243081S36[14388658] - 4916: AF243115
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 49 and
gi|14388657|gb|AF243115.1|F243081S35[14388657] - 4917: AF243114
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 48
gi|14388656|gb|AF243114.1|F243081S34[14388656] - 4918: AF243113
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 47
gi|14388655|gb|AF243113.1F243081S33[14388655] - 4919: AF243112
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 46
gi|14388654|gb|AF243112.1F243081S32[14388654] - 4920: AF243111
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 45
gi|4388653|gb|AF243111.1F243081S31[14388653] - 4921: AF243110
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 44
gi|14388652|gb|AF243110.1|F243081S30[14388652] - 4922: AF243109
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 42 and
gi|14388651|gb|AF243109.1|F243081S29[14388651] - 4923: AF243108
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 41
gi|14388650|gb|AF243108.1|F243081S28[14388650] - 4924: AF243107
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 40
gi|14388649|gb|AF243107.1F243081S27[14388649] - 4925: AF243106
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 39
gi|4388648|gb|AF243106.1F243081S26[14388648] - 4926: AF243105
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 37 and
gi|14388647|gb|AF243105.1|F243081S25[14388647] - 4927: AF243104
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 35 and
gi|14388646|gb|AF243104.1|F243081S24[14388646] - 4928: AF243103
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 34
gi|14388645|gb|AF243103.1F243081S23[14388645] - 4929: AF243102
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 33
gi|14388644|gb|AF243102.1F243081S22[14388644] - 4930: AF243101
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 32
gi|14388643|gb|AF243101.1F243081S21[14388643] - 4931: AF243100
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 31
gi|14388642|gb|AF243100.1F243081S20[14388642] - 4932: AF243099
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 30
gi|1438864|gb|AF243099.1F243081S19[14388641] - 4933: AF243098
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 29
gi|14388640|gb|AF243098.1F243081S18[14388640] - 4934: AF243097
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 28
gi|14388639|gb|AF243097.1F243081S17[14388639] - 4935: AF243096
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 27
gi|14388638|gb|AF243096.1F243081S16[14388638] - 4936: AF243095
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 26
gi|14388637|gb|AF243095.1|F243081S15[14388637] - 4937: AF243094
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 23, 24, and 25
gi|14388636|gb|AF243094.1|F243081S14[14388636] - 4938: AF243093
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 22
gi|14388635|gb|AF243093.1|F243081S13[14388635] - 4939: AF243092
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 20 and
gi|14388634|gb|AF243092.1|F243081S12[14388634] - 4940: AF243091
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 18 and
gi|4388633|gb|AF243091.1|F243081S11[14388633] - 4941: AF243090
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 16 and
gi|14388632|gb|AF243090.1|F243081S10[14388632] - 4942: AF243089
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 15
gi|14388631|gb|AF243089.1|F243081S09[14388631] - 4943: AF243088
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 14
gi|14388630|gb|AF243088.1|F243081S08[14388630] - 4944: AF243087
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 11, 12, and 13
gi|14388629|gb|AF243087.1|F243081S07[14388629] - 4945: AF243086
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 9 and
gi|14388628|gb|AF243086.1|F243081S06[14388628] - 4946: AF243085
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 8
gi|14388627|gb|AF243085.1|F243081S05[14388627] - 4947: AF243084
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 7
gi|14388626|gb|AF243084.1|F243081S04[14388626] - 4948: AF243083
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 5 and 6
gi|14388625|gb|AF243083.1|F243081S03[14388625] - 4949: AF243082
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exon 3 and partial cds
gi|14388624|gb|AF243082.1|F243081S02[14388624] - 4950: AF243081
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) gene, exons 1 and 2
gi|14388623|gb|AF243081.1|F243081S01[14388623] - 4951: AH010855
Homo sapiens intrinsic factor-vitamin B12 receptor (CUBN) and intrinsic factor-vitamin B12 receptor (CUBN) genes, partial cds
gi|14388622|gb|AH010855.1|SEG_F243081S[14388622] - 4952: AY029596
Homo sapiens melanin-concentrating hormone 2 receptor mRNA, complete cds
gi|14388165|gb|AY029596.1|[14388165] - 4953: AF233349
Homo sapiens neuronal phosphoprotein DARPP-32 mRNA, partial cds
gi|7243754|gb|AF233349.1|AF233349[7243754] - 4954: AF208690
Homo sapiens clone 24 p70 killer cell inhibitory receptor mRNA, partial cds
gi|6851353|gb|AF208690.1|AF208690[6851353] - 4955: AF208689
Homo sapiens clone 22 p70 killer cell inhibitory receptor mRNA, partial cds
gi|6851351|gb|AF208689.1|AF208689[6851351] - 4956: AF208688
Homo sapiens clone 3 p70 killer cell inhibitory receptor mRNA, partial cds
gi|6851349|gb|AF208688.1|AF208688[6851349] - 4957: AF208687
Homo sapiens clone 25 p70 killer cell inhibitory receptor mRNA, partial cds
gi|6851347|gb|AF208687.1|AF208687[6851347] - 4958: AF208686
Homo sapiens clone 23 p70 killer cell inhibitory receptor mRNA, partial cds
gi|6851345|gb|AF208686.1|AF208686[6851345] - 4959: AF208685
Homo sapiens clone 21 p70 killer cell inhibitory receptor mRNA, partial cds
gi|6851343|gb|AF208685.1|AF208685[6851343] - 4960: AF208684
Homo sapiens clone 6 p70 killer cell inhibitory receptor mRNA, partial cds
gi|6851341|gb|AF208684.1|AF208684[6851341] - 4961: AF208683
Homo sapiens clone 1 p70 killer cell inhibitory receptor mRNA, partial cds
gi|6851339|gb|AF208683.1|AF208683[6851339] - 4962: AB052639
Homo sapiens mRNA for IL-XR, complete cds
gi|14349288|dbj|AB052639.1|AB052639[14349288] - 4963: AF366364
Homo sapiens interleukin-1 receptor type 1 (IL1R1) gene, exon 1A, partial sequence
gi|1434887|gb|AF366364.1|AF366364[14348871] - 4967: AF260728
Homo sapiens lipocalin-interacting protein mRNA, complete cds
gi|14335227|gb|AF260728.1|AF260728[14335227] - 4968: AJ308526
Homo sapiens partial GRIK3 gene for glutamate receptor 7, exon 18
gi|14329723|emb|AJ308526.1|HSA308526[14329723] - 4969: AJ308525
Homo sapiens partial GRIK3 gene for glutamate receptor 7, exon 16
gi|14329720|emb|AJ308525.1|HSA308525[14329720] - 4970: AF165124
Homo sapiens chromosome 5q31.1-q33.1 clone BAC djn082c10 containing GABRG2 gene,
complete sequence
gi|5738137|gb|AF165124.1|AF165124[5738137] - 4971: AF353733
Homo sapiens leukocyte immunoglobulin-like receptor A3 (LILRA3) gene, exon 3 and
partial cds
gi|4280086|gb|AF353733.1|AF353733[14280086] - 4972: AF236083
Homo sapiens G-protein-coupled receptor 74 (GPR74) mRNA, complete cds
gi|14279164|gb|AF236083.1|AF236083[14279164] - 4973: AF375468
Homo sapiens endothelial protein C receptor (PROCR) gene, complete cds
gi|1427871|gb|AF375468.2|AF375468[14278711] - 4974: AF374726
Homo sapiens coagulation factor II receptor-like 2 (F2RL2) gene, complete cds
gi|14278710|gb|AF374726.2|AF374726[14278710] - 4975: AF378542
Homo sapiens bradykinin receptor B2 (BDKRB2) gene, complete cds
gi|14278705|gb|AF378542.2|AF378542[14278705] - 4976: AB051065
Homo sapiens hot7t175 mRNA for G protein-coupled receptor, complete cds
gi|14041797|dbj|AB051065.1|AB051065[14041797] - 4977: AF347063
Homo sapiens G protein-coupled receptor MCH2 mRNA, complete cds
gi|13604341|gb|AF347063.1|AF347063[13604341] - 4978: AJ278250
Homo sapiens HRH3 gene for histamine H3 receptor, exons 1-3
gi|14270360|emb|AJ278250.1|HSA278250[14270360] - 4979: AF297616
Homo sapiens natural killer cell receptor 2B4 gene, partial cds
gi|14268841|gb|AF297616.1|AF297616[14268841] - 4980: AJ271068
Homo sapiens mRNA for transient receptor potential channel 6, variant delta377-431 (TRP6 gene)
gi|9716912|emb|AJ271068.1|HSA271068[9716912] - 4981: AJ271067
Homo sapiens mRNA for transient receptor potential channel 6, variant delta316-431 (TRP6 gene)
gi|9716910|emb|AJ271067.1|HSA271067[9716910] - 4982: AJ271066
Homo sapiens mRNA for transient receptor potential channel 6 (TRP6 gene)
gi|9716908|emb|AJ271066.1|HSA271066[9716908] - 4983: X91852
H. sapiens P2Y4 gene
gi|1124904|emb|X91852.1|HSP2Y4[1124904] - 4984: NM—032565
Homo sapiens emopamil binding related protein, delta8-delta7 sterol isomerase related protein (EBRP), mRNA
gi|4211872|ref|NM—032565.1|[14211872] - 4986: AY029539
Homo sapiens soluble nectin1 gamma mRNA, complete cds
gi|1419622|gb|AY029539.1|[14196221] - 4987: NM—006986
Homo sapiens melanoma antigen, family D, 1 (MAGED1), mRNA
gi|14195633|ref|NM—006986.2|[14195633] - 4988: AF351784
Homo sapiens dopamine receptor interacting protein mRNA, partial cds
gi|14194056|gb|AF351784.1|AF351784[14194056] - 4989: AF336376
Homo sapiens platelet-derived growth factor D (PDGFD) mRNA, complete cds
gi|14193795|gb|AF336376.1|AF336376[14193795] - 4992: AH010778
Homo sapiens CHRNA3 gene, partial sequence
gi|14190789|gb|AH010778.1|SEG_AY027913S[14190789] - 4995: AH010779
Homo sapiens CHRNB4 gene, partial sequence
gi|14190786|gb|AH010779.1|SEG_AY027915S[14190786] - 4996: AF310234
Homo sapiens sialic acid binding immunoglobulin-like lectin 8 (SIGLEC8) mRNA, complete cds, alternatively spliced
gi|14164614|gb|AF310234.1|AF310234[14164614] - 4997: AF310233
Homo sapiens sialic acid binding immunoglobulin-like lectin 10 (SIGLEC10) mRNA,
complete cds
gi|14164612|gb|AF310233.1|AF310233[14164612] - 4998: AB060151
Homo sapiens slt mRNA for G protein-coupled receptor, complete cds
gi|14164382|dbj|AB060151.1|AB060151[14164382] - 4999: AF239764
Homo sapiens EGF-like module-containing mucin-like receptor EMR3 mRNA, complete
cds
gi|13183148|gb|AF239764.1|AF239764[13183148] - 5000: AF199235
Homo sapiens nicotinic acetylcholine receptor subunit alpha 10 mRNA, complete cds
gi|11128455|gb|AF199235.2|AF199235[11128455] - 5001: AF054176
Homo sapiens angiotensin/vasopressin receptor AII/AVP mRNA, complete cds
gi|3341995|gb|AF054176.1|AF054176[3341995] - 5002: AF369213
Homo sapiens fibroblast growth factor receptor 3 IIIc isoform (FGFR3) mRNA, partial cds
gi|14161391|gb|AF369213.1|AF369213[14161391] - 5003: AF369212
Homo sapiens fibroblast growth factor receptor 3 IIIc isoform (FGFR3) mRNA, partial cds
gi|14161389|gb|AF369212.1|AF369212[14161389] - 5004: AF369211
Homo sapiens fibroblast growth factor receptor 3 IIIc isoform (FGFR3) mRNA, partial cds
gi|14161387|gb|AF369211.1|AF369211[14161387] - 5005: AF274714
Homo sapiens oxysterol-binding protein-related protein (ORP1) mRNA, complete cds
gi|13183326|gb|AF274714.1|AF274714[13183326] - 5034: NM—005959
Homo sapiens melatonin receptor 1B (MTNR1B), mRNA
gi|14141172|ref|NM—005959.2|[14141172] - 5035: NM—005958
Homo sapiens melatonin receptor 1A (MTNR1A), mRNA
gi|14141171|ref|NM—005958.2|[14141171] - 5036: AF366903
Homo sapiens MER receptor tyrosine kinase gene, exon 1 and partial cds
gi|14133725|gb|AF366903.1|AF366903[14133725] - 5037: NM—002226
Homo sapiens jagged 2 (JAG2), mRNA
gi|4504800|ref|NM—002226.1|[4504800] - 5039: NM—009585
Homo sapiens angiotensin receptor 1 (AGTR1), transcript variant 2, mRNA
gi|14043067|ref|NM—009585.2|[14043067] - 5040: NM—032049
Homo sapiens angiotensin receptor 1 (AGTR1), transcript variant 5, mRNA
gi|14043065|ref|NM—032049.1|[14043065] - 5041: NM—031850
Homo sapiens angiotensin receptor 1 (AGTR1), transcript variant 4, mRNA
gi|14043063|ref|NM—031850.1|[14043063] - 5042: NM—004835
Homo sapiens angiotensin receptor 1 (AGTR1), transcript variant 3, mRNA
gi|14043061|ref|NM—004835.2|[14043061] - 5043: NM—000685
Homo sapiens angiotensin receptor 1 (AGTR1), transcript variant 1, mRNA
gi|14043060|ref|NM—000685.3|[14043060] - 5044: NM—003965
Homo sapiens chemokine (C-C motif) receptor-like 2 (CCRL2), mRNA
gi|14043058|ref|NM—003965.2|[14043058] - 5045: AJ298334
Homo sapiens mRNA for P2Y11 receptor (P2Y11 gene)
gi|12964589|emb|AJ298334.1|HSA298334[12964589] - 5046: NM—000323
Homo sapiens ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) (RET), transcript variant 1, mRNA
gi|10862704|ref|NM—000323.1|[10862704] - 5047: NM—020975
Homo sapiens ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) (RET), transcript variant 2, mRNA
gi|10862702|ref|NM—020975.1|[10862702] - 5048: NM—020630
Homo sapiens ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) (RET), transcript variant 4, mRNA
gi|10862700|ref|NM—020630.1|[10862700] - 5049: NM—020629
Homo sapiens ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) (RET), transcript variant 3, mRNA
gi|10862698|ref|NM—020629.1|[10862698] - 5050: NM—002342
Homo sapiens lymphotoxin beta receptor (TNFR superfamily, member 3) (LTBR), mRNA
gi|4505038|ref|NM—002342.1|[4505038] - 5051: AY032736
Homo sapiens alpha-2A adrenergic receptor (ADR2AR) gene, complete cds
gi|14029162|gb|AY032736.1|[14029162] - 5052: AF322014
Homo sapiens growth hormone receptor gene, partial sequence
gi|14028657|gb|AF322014.1|AF322014S1[14028657] - 5053: AF283321
Homo sapiens low density lipoprotein receptor-related protein 5 (LRP5) gene, exons 10 through 23 and complete cds
gi|14028617|gb|AF283321.1|AF283320S2[14028617] - 5054: AF283320
Homo sapiens low density lipoprotein receptor-related protein 5 (LRP5) gene, exons 1 through 9
gi|14028616|gb|AF283320.1|AF283320S1[14028616] - 5055: AH010745
Homo sapiens low density lipoprotein receptor-related protein 5 (LRP5) gene, complete cds
gi|14028615|gb|AH010745.1|SEG_AF283320S[14028615] - 5056: NM—017934
Homo sapiens pleckstrin homology domain interacting protein (PHIP), mRNA
gi|8923633|ref|NM—017934.1|[8923633] - 5057: AF203386
Homo sapiens beta-2 adrenergic receptor (ADRB2) gene, complete cds
gi|6636495|gb|AF203386.1|AF203386[6636495] - 5058: AF202305
Homo sapiens beta-2 andrenergic receptor gene, complete cds
gi|6573152|gb|AF202305.1|AF202305[6573152] - 5059: AF169225
Homo sapiens beta-2-adrenergic receptor gene, complete cds
gi|5714687|gb|AF169225.1|AF169225[5714687] - 5060: AF063657
Homo sapiens vascular endothelial growth factor receptor (FLT1) mRNA, complete
cds
gi|3132830|gb|AF063657.1|AF063657[3132830] - 5061: AF022049
Homo sapiens natural killer cell inhibitory receptor KIR3DL1 variant mRNA, complete cds
gi|2760898|gb|AF022049.1|AF022049[2760898] - 5062: AF022048
Homo sapiens natural killer cell inhibitory receptor KIR2DL3 variant mRNA, complete cds
gi|2760896|gb|AF022048.1|AF022048[2760896] - 5066: AF361880
Homo sapiens neurokinin-2 receptor gene, partial cds
gi|1400294|gb|AF361880.1|AF361880[14010294] - 5068: AF209923
Homo sapiens orphan G-protein coupled receptor (GPRC5D) mRNA, complete cds
gi|8118039|gb|AF209923.1|AF209923[8118039] - 5069: AF207989
Homo sapiens orphan G-protein coupled receptor (GPRC5C) mRNA, complete cds
gi|8118031|gb|AF207989.1|AF207989[8118031] - 5070: AB018076
Homo sapiens hedgehog gene, exon 3 and complete cds
gi|13990993|dbj|AB018076.2|AB010092S3[13990993] - 5071: SEG_AB010092S
Homo sapiens hedgehog gene
gi|13990992|dbj|SEG_AB010092S[13990992] - 5072: NM—018980
Homo sapiens taste receptor, type 2, member 5 (TAS2R5), mRNA
gi|9507172|ref|NM—018980.1|[9507172] - 5073: NM—016945
Homo sapiens taste receptor, type 2, member 16 (TAS2R16), mRNA
gi|8394394|ref|NM—016945.1|[8394394] - 5074: AB018075
Homo sapiens hedgehog gene, exon 2
gi|3702725|dbj|AB018075.1|AB010092S2[3702725] - 5075: AB010092
Homo sapiens hedgehog gene, exon 1
gi|2810977|dbj|AB010092.1|AB010092S1[2810977] - 5076: AF130867
Homo sapiens smoothened mRNA, partial cds
gi|4732138|gb|AF130867.1|AF130867[4732138] - 5077: AF363791
Homo sapiens histamine receptor H3S(HRH3) mRNA, complete cds
gi|13937081|gb|AF363791.1|AF363791[13937081] - 5078: AF363452
Homo sapiens NK cell type I receptor protein 2B4 (CD244) mRNA, partial cds, alternatively spliced
gi|13937022|gb|AF363452.1|AF363452[13937022] - 5079: AY029486
Homo sapiens G protein gamma subunit 13 mRNA, complete cds
gi|13936268|gb|AY029486.1|[13936268] - 5080: AF224497
Homo sapiens CC chemokine receptor 3 (CCR3) gene, exon 2 and partial cds
gi|13924486|gb|AF224497.1|AF224496S2[13924486] - 5081: AF224496
Homo sapiens CC chemokine receptor 3 (CCR3) gene, exon 1
gi|13924485|gb|AF224496.1|AF224496S1[13924485] - 5082: AH010691
Homo sapiens CC chemokine receptor 3 (CCR3) gene, partial cds
gi|13924484|gb|AH010691.1|SEG_AF224496S[13924484] - 5083: AF224495
Homo sapiens CC chemokine receptor 3 (CCR3) mRNA, partial cds
gi|13924481|gb|AF224495.1|AF224495[13924481] - 5084: AF251120
Homo sapiens interleukin-1-related protein short isoform mRNA, complete cds; alternatively spliced
gi|10185739|gb|AF251120.1|AF251120[10185739] - 5085: AF251119
Homo sapiens interleukin-1-related protein long isoform mRNA, complete cds; alternatively spliced
gi|10185737|gb|AF251119.1|AF251119[10185737] - 5086: AF251118
Homo sapiens interleukin-1-related protein long isoform a mRNA, complete cds; alternatively spliced
gi|10185735|gb|AF251118.1|AF251118[10185735] - 5087: AF103013
Homo sapiens JME clone 4 KIR3DL1-like natural killer cell receptor mRNA, complete cds
gi|3983423|gb|AF103013.1|AF103013[3983423] - 5088: AF103012
Homo sapiens JME clone 3 KIR3DL1-like natural killer cell receptor mRNA, complete cds
gi|3983421|gb|AF103012.1|AF103012[3983421] - 5089: AF103011
Homo sapiens JME clone 2 KIR3DL1-like natural killer cell receptor mRNA, complete cds
gi|3983419|gb|AF103011.1|AF103011[3983419] - 5090: AF103010
Homo sapiens JME clone 1 KIR3DL1-like natural killer cell receptor mRNA, complete cds
gi|3983417|gb|AF103010.1|AF103010[3983417] - 5091: AF353183
Homo sapiens discoidin domain receptor DDR1e (DDR1) mRNA, partial cds, alternatively spliced
gi|13898644|gb|AF353183.1|AF353183[13898644] - 5092: AF353182
Homo sapiens discoidin domain receptor DDR1d (DDR1) mRNA, partial cds, alternatively spliced
gi|13898642|gb|AF353182.1|AF353182[13898642] - 5096: AF014112
Homo sapiens phenol UDP-glucuronosyltransferase (UGT1A6) gene, partial cds
gi|2645490|gb|AF014112.1|AF014112[2645490] - 5097: AJ293654
Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
ARSPRV allele
gi|12054061|emb|AJ293654.1|HSA293654[12054061] - 5098: AJ293653
Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
ACSPRV allele
gi|12054059|emb|AJ293653.1|HSA293653[12054059] - 5099: AJ293652
Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
ACSSRI allele
gi|12054057|emb|AJ293652.1|HSA293652[12054057] - 5100: AJ293651
Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
ECLPRV allele
gi|12054055|emb|AJ293651.1|HSA293651[12054055] - 5101: AJ293650
Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
ECSPRV allele
gi|12054053|emb|AJ293650.1|HSA293650[12054053] - 5102: AJ293649
Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
ECSSRV allele
gi|12054051|emb|AJ293649.1|HSA293649[12054051] - 5103: AJ293648
Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
ECSPQV allele
gi|12054049|emb|AJ293648.1|HSA293648[12054049] - 5104: AJ293647
Homo sapiens partial IL4RA gene for interleukin-4 receptor alfa chain, exon 11,
ECSSQV allele
gi|12054047|emb|AJ293647.1|HSA293647[12054047] - 5105: AF329449
Homo sapiens histamine receptor H4 mRNA, complete cds
gi|13876643|gb|AF329449.1|AF329449[13876643] - 5106: AF276893
Homo sapiens p21-activated protein kinase 6 (PAK6) mRNA, complete cds
gi|9082305|gb|AF276893.1|AF276893[9082305] - 5107: AY029324
Homo sapiens mRNA sequence
gi|13752242|gb|AY029324.1|[13752242] - 5108: AF307337
Homo sapiens ALPP, ALPPL2, ALPI, XCE, CHRND, and CHRNG genes, complete sequence
gi|10732831|gb|AF307337.1|AF307337[10732831] - 5109: Z75190
H. sapiens mRNA for apolipoprotein E receptor 2
gi|1834533|emb|Z75190.1|HSZ75190[1834533] - 5110: NM—004523
Homo sapiens kinesin-like 1 (KNSL1), mRNA
gi|13699823|ref|NM—004523.2|[13699823] - 5111: NM—006646
Homo sapiens WAS protein family, member 3 (WASF3), mRNA
gi|13699802|ref|NM—006646.2|[13699802] - 5112: NM—030667
Homo sapiens protein tyrosine phosphatase, receptor type, O (PTPRO), transcript
variant 1, mRNA
gi|13677213|ref|NM—030667.1|[13677213] - 5113: NM—002848
Homo sapiens protein tyrosine phosphatase, receptor type, O (PTPRO), transcript
variant 2, mRNA
gi|13677212|ref|NM—002848.2|[13677212] - 5114: NM—006990
Homo sapiens WAS protein family, member 2 (WASF2), mRNA
gi|11386182|ref|NM—006990.1|[11386182] - 5115: AF250309
Homo sapiens putative cytokine receptor CRL4 precusor mRNA, complete cds
gi|13649476|gb|AF250309.1|AF250309[13649476] - 5116: AY029180
Homo sapiens soluble urokinase plasminogen activator receptor precursor (SUPAR)
mRNA, complete cds
gi|13641308|gb|AY029180.1|[13641308] - 5117: AF346711
Homo sapiens G-protein couple receptor (GPR48) gene, exons 3 through 18, and complete cds
gi|13569576|gb|AF346711.1|AF346709S3[13569576] - 5118: AF346710
Homo sapiens G-protein couple receptor (GPR48) gene, exon 2
gi|13569575|gb|AF346710.1|AF346709S2[13569575] - 5119: AF346709
Homo sapiens G-protein couple receptor (GPR48) gene, exon 1
gi|13569574|gb|AF346709.1|AF346709S1[13569574] - 5120: AH010608
Homo sapiens G-protein couple receptor (GPR48) gene, complete cds
gi|13569573|gb|AH010608.1|SEG_AF346709S[13569573] - 5121: AF251059
Homo sapiens FGF receptor 4b mRNA, complete cds
gi|13625179|gb|AF251059.1|AF251059[13625179] - 5122: AF251055
Homo sapiens 5-HT receptor mRNA, complete cds
gi|1362517|gb|AF251055.1|AF251055[13625171] - 5123: NM—030905
Homo sapiens olfactory receptor, family 2, subfamily J, member 2 (OR2J2), mRNA
gi|13624330|ref|NM—030905.1|[13624330] - 5124: NM—012377
Homo sapiens olfactory receptor, family 7, subfamily C, member 2 (OR7C2), mRNA
gi|13624324|ref|NM—012377.1|[13624324] - 5125: AB043703
Homo sapiens FZD8 mRNA for seven-transmembrane receptor Frizzled-8, complete cds
gi|13623798|dbj|AB043703.1|AB043703[13623798] - 5126: AB051851
Homo sapiens DR3 gene for death receptor 3, complete cds, mutant DR3 sequnce
gi|13537362|dbj|AB051851.1|AB051851[13537362] - 5127: AB051850
Homo sapiens DR3 gene for death receptor 3, complete cds
gi|13537360|dbj|AB051850.1|AB051850[13537360] - 5128: AF349939
Homo sapiens prolactin receptor isoform delta S1 precursor, mRNA, complete cds
gi|13605397|gb|AF349939.1|AF349939[13605397] - 5130: AF346629
Homo sapiens channel-kinase 1 (CHAK1) mRNA, complete cds
gi|13562152|gb|AP346629.2|AF346629[13562152] - 5131: NM—012373
Homo sapiens olfactory receptor, family 3, subfamily A, member 3 (OR3A3), mRNA
gi|13562103|ref|NM—012373.1|[13562103] - 5132: AF056979
Homo sapiens clone YAN1 interferon-gamma receptor mRNA, complete cds
gi|13562048|gb|AF056979.1|AF056979[13562048] - 5133: NM—017506
Homo sapiens olfactory receptor family 7, subfamily C, member 1 (OR7C1), mRNA
gi|9506798|ref|NM—017506.1|[9506798] - 5134: AF222689
Homo sapiens protein arginine N-methyltransferase 1 (HRMT1L2) gene, complete cds, alternatively spliced
gi|7453574|gb|AF222689.1|AF222689[7453574] - 5135: NM—005137
Homo sapiens DiGeorge syndrome critical region gene 2 (DGCR2), mRNA
gi|4826693|ref|NM—005137.1|[4826693] - 5136: AC002533
Homo sapiens clone SCb-24C13 from 7q31.3, complete sequence
gi|2388587|gb|AC002533.1|AC002533[2388587] - 5139: AF263617
Homo sapiens killer cell immunoglobulin-like receptor 3DL2 (KIR3DL2) mRNA, KIR3DL2*00901 allele, complete cds
gi|13560454|gb|AF263617.1|AF263617[13560454] - 5140: AF262974
Homo sapiens killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) mRNA, KIR3DL1*00801 allele, complete cds
gi|13560452|gb|AF262974.1|AF262974[13560452] - 5141: AF262973
Homo sapiens killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) mRNA, KIR3DL1*00701 allele, complete cds
gi|13560450|gb|AF262973.1|AF262973[13560450] - 5142: AF262972
Homo sapiens killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) mRNA, KIR3DL1*00601 allele, partial cds
gi|13560448|gb|AF262972.1|AF262972[13560448] - 5143: AF262971
Homo sapiens killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) mRNA, KIR3DL1*00501 allele, partial cds
gi|13560446|gb|AF262971.1|AF262971[13560446] - 5144: AF262970
Homo sapiens killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) mRNA, KIR3DL1*00402 allele, partial cds
gi|13560444|gb|AF262970.1|AF262970[13560444] - 5145: AF262969
Homo sapiens killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) mRNA, KIR3DL1*00401 allele, partial cds
gi|13560442|gb|AF262969.1|AF262969[13560442] - 5146: AF262968
Homo sapiens killer cell immunoglobulin-like receptor 3DL1 (KIR3DL1) mRNA, KIR3DL1*00102 allele, partial cds
gi|13560440|gb|AF262968.1|AF262968[13560440] - 5147: AF262967
Homo sapiens killer cell immunoglobulin-like receptor 3DL2 (KIR3DL2) mRNA, KIR3DL2*00801 allele, complete cds
gi|13560438|gb|AF262967.1|AF262967[13560438] - 5148: AF262966
Homo sapiens killer cell immunoglobulin-like receptor 3DL2 (KIR3DL2) mRNA, KIR3DL2*00601 allele, partial cds
gi|13560436|gb|AF262966.1|AF262966[13560436] - 5149: AF262965
Homo sapiens killer cell immunoglobulin-like receptor 3DL2 (KIR3DL2) mRNA, KIR3DL2*00701 allele, partial cds
gi|13560434|gb|AF262965.1|AF262965[13560434] - 5150: AF348491
Homo sapiens chemokine receptor CXCR4 mRNA, complete cds
gi|13549089|gb|AF348491.1|AF348491[13549089] - 5151: AF295368
Homo sapiens G-protein coupled receptor GPR86 (GPR86) mRNA, complete cds
gi|12711484|gb|AF295368.1|AF295368[12711484] - 5152: AF237763
Homo sapiens orphan G protein-coupled receptor 87 (GPR87) mRNA, complete cds
gi|12711472|gb|AF237763.1|AF237763[12711472] - 5153: AF237762
Homo sapiens orphan G protein-coupled receptor 84 (GPR84) mRNA, complete cds
gi|12711470|gb|AF237762.1|AF237762[12711470] - 5154: NM—004248
Homo sapiens G protein-coupled receptor 10 (GPR10), mRNA
gi|4758473|ref|NM—004248.1|[4758473] - 5155: AC000099
Homo sapiens chromosome 7 map 7q31.3 cosmid g0771a003, complete sequence
gi|1764159|emb|AC99.1|HSAC000099[1764159] - 5156: NM—030784
Homo sapiens brain expressed G-protein-coupled receptor PSP24 beta (PSP24B), mRNA
gi|13540556|ref|NM—030784.1|[13540556] - 5157: NM—030774
Homo sapiens prostate specific G-protein coupled receptor (PSGR), mRNA
gi|13540538|ref|NM—030774.1|[13540538] - 5158: NM—030764
Homo sapiens SH2 domain-containing phosphatase anchor protein 1 (SPAP1), mRNA
gi|13540524|ref|NM—030764.1)[13540524] - 5160: AJ249921
Homo sapiens intergenic region between apoE and apoCI genes
gi|6006507|emb|AJ249921.1|HSA249921[6006507] - 5161: AF050737
Homo sapiens dopamine D2 receptor (DRD2) gene, complete cds
gi|382049|gb|AF050737.1|AF050737[3820491] - 5162: NM—004987
Homo sapiens LIM and senescent cell antigen-like domains 1 (LIMS1), mRNA
gi|13518025|ref|NM—004987.2|[13518025] - 5163: AF348078
Homo sapiens G-protein coupled receptor 91 (GPR91) mRNA, complete cds
gi|13517982|gb|AF348078.1|AF348078[13517982] - 5164: AJ276125
Homo sapiens mRNA for inhibitory NK receptor (kir3d gene)
gi|13516222|emb|AJ276125.1|HSA276125[13516222] - 5165: AF246999
Homo sapiens TRADEbeta mRNA, complete cds
gi|13506909|gb|AF246999.1|AF246999[13506909] - 5166: AF246998
Homo sapiens TRADEalpha mRNA, complete cds
gi|13506907|gb|AF246998.1|AF246998[13506907] - 5167: AF263450
Homo sapiens dopamine D3 receptor (DRD3) gene, exon 2 and partial cds
gi|13506728|gb|AF263450.1|AF148807S2[13506728] - 5168: AF148807
Homo sapiens dopamine D3 receptor (DRD3) gene, exon 1
gi|13506727|gb|AF148807.1|AF148807S1[13506727] - 5169: AH010591
Homo sapiens dopamine D3 receptor (DRD3) gene, partial cds
gi|13506726|gb|AH010591.1|SEG_AF148807S[13506726] - 5170: Y18388
Homo sapiens CD163 gene, exon 1 and joined CDS
gi|5107944|emb|Y18388.1|HSA118388[5107944] - 5171: NM—002183
Homo sapiens interleukin 3 receptor, alpha (low affinity) (IL3RA), mRNA
gi|13324709|ref|NM—002183.1|[13324709] - 5172: AF142570
Homo sapiens cytokine receptor CRL2 precusor (CRL2) mRNA, complete cds
gi|11055018|gb|AF142570.1|AF142570[11055018] - 5173: NM—006140
Homo sapiens colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) (CSF2RA), mRNA
gi|5453626|ref|NM—006140.1|[5453626] - 5174: NM—002186
Homo sapiens interleukin 9 receptor (IL9R), mRNA
gi|4504684|ref|NM—002186.1|[4504684] - 5175: AF296673
Homo sapiens toll-like receptor 10 mRNA, complete cds
gi|13447752|gb|AF296673.1|AF296673[13447752] - 5176: AF284095
Homo sapiens alpha-2A adrenergic receptor mRNA, complete cds
gi|13447750|gb|AF284095.1|AF284095[13447750] - 5177: AF279689
Homo sapiens fibroblast growth factor receptor 5 (FGFR5) mRNA, complete cds
gi|13447748|gb|AF279689.1|AF279689[13447748] - 5178: NM—000861
Homo sapiens histamine receptor H1 (HRH1), mRNA
gi|13435403|ref|NM—000861.2|[13435403] - 5179: NM—001514
Homo sapiens general transcription factor IIB (GTF2B), mRNA
gi|13435384|ref|NM—001514.2|[13435384] - 5180: NM—022845
Homo sapiens core-binding factor, beta subunit (CBFB), transcript variant 1, mRNA
gi|13124880|ref|NM—022845.1|[13124880] - 5181: AF213460
Homo sapiens ephrin receptor EPHA3 secreted form (EPHA3) mRNA, complete cds
gi|12003436|gb|AF213460.1|AF213460[12003436] - 5182: AF213459
Homo sapiens ephrin receptor EPHA3 complete form (EPHA3) mRNA, complete cds
gi|12003434|gb|AF213459.1|AF213459[12003434] - 5183: NM—019599
Homo sapiens taste receptor, type 2, member 1 (TAS2R1), mRNA
gi|9625042|ref|NM—019599.1|[9625042] - 5184: NM—017579
Homo sapiens deleted in malignant brain tumors 1 (DMBT1), transcript variant 3,
mRNA
gi|8923739|ref|NM—017579.1|[8923739] - 5185: AJ306481
Homo sapiens partial CHRNA5 gene for neuronal nicotinic acetylcholine receptor
alpha-5 subunit, exon 1 and joined CDS
gi|13400975|emb|AJ306481.1|HSA306481[13400975] - 5186: AJ306454
Homo sapiens partial CHRNB4 gene for neuronal nicotinic acetylcholine receptor
beta-4 subunit, exon 1 and joined CDS
gi|13400963|emb|AJ306454.1|HSA306454[13400963] - 5187: NM—024317
Homo sapiens immunoglobulin-like transcript 10 (ILT10), mRNA
gi|13399319|ref|NM—024317.1|[13399319] - 5188: NM—020070
Homo sapiens immunoglobulin lambda-like polypeptide 1 (IGLL1), mRNA
gi|13399297|ref|NM—020070.1|[13399297] - 5189: NM—002383
Homo sapiens MYC-associated zinc finger protein (purine-binding transcription factor) (MAZ), mRNA
gi|13399295|ref|NM—002383.1|[13399295] - 5190: AJ306486
Homo sapiens partial CHRNA5 gene for neuronal nicotinic acetylcholine receptor
alpha-5 subunit, exon 6
gi|13399189|emb|AJ306486.1|HSA306486[13399189] - 5191: AJ306485
Homo sapiens partial CHRNA5 gene for neuronal nicotinic acetylcholine receptor
alpha-5 subunit, exon 5
gi|13399188|emb|AJ306485.1|HSA306485[13399188] - 5192: AJ306484
Homo sapiens partial CHRNA5 gene for neuronal nicotinic acetylcholine receptor
alpha-5 subunit, exon 4
gi|13399187|emb|AJ306484.1|HSA306484[13399187] - 5193: AJ306483
Homo sapiens partial CHRNA5 gene for neuronal nicotinic acetylcholine receptor
alpha-5 subunit, exon 3
gi|13399186|emb|AJ306483.1|HSA306483[13399186] - 5194: AJ306482
Homo sapiens partial CHRNA5 gene for neuronal nicotinic acetylcholine receptor
alpha-5 subunit, exon 2
gi|13399185|emb|AJ306482.1|HSA306482[13399185] - 5195: AJ306459
Homo sapiens partial CHRNB4 gene for neuronal nicotinic acetylcholine receptor
beta-4 subunit, exon 6
gi|13399184|emb|AJ306459.1|HSA306459[13399184] - 5196: AJ306458
Homo sapiens partial CHRNB4 gene for neuronal nicotinic acetylcholine receptor
beta-4 subunit, exon 5
gi|13399183|emb|AJ306458.1|HSA306458[13399183] - 5197: AJ306457
Homo sapiens partial CHRNB4 gene for neuronal nicotinic acetylcholine receptor
beta-4 subunit, exon 4
gi|13399182|emb|AJ306457.1|HSA306457[13399182] - 5198: AJ306456
Homo sapiens partial CHRNB4 gene for neuronal nicotinic acetylcholine receptor
beta-4 subunit, exon 3
gi|13399181|emb|AJ306456.1|HSA306456[13399181] - 5199: AJ306455
Homo sapiens partial CHRNB4 gene for neuronal nicotinic acetylcholine receptor
beta-4 subunit, exon 2
gi|13399180|emb|AJ306455.1|HSA306455[13399180] - 5200: AJ291675
Homo sapiens mRNA for putative GDNF family receptor alpha 4, secreted isoform c
(GFRA4 gene)
gi|12038960|emb|AJ291675.1|HSA291675[12038960] - 5201: AJ291674
Homo sapiens mRNA for putative GDNF family receptor alpha 4, GPI anchored isoform b (GFRA4 gene)
gi|12038958|emb|AJ291674.1|HSA291674[12038958] - 5202: AJ291673
Homo sapiens mRNA for GDNF family receptor alpha 4, GPI anchored isoform (GFRA4 gene)
gi|12038956|emb|AJ291673.1|HSA291673[12038956] - 5203: AF245704
Homo sapiens toll-like receptor 9 (TLR9) mRNA, complete cds
gi|8575528|gb|AF245704.1|AF245704[8575528] - 5204: AF245703
Homo sapiens toll-like receptor 8 (TLR8) mRNA, complete cds
gi|8575526|gb|AF245703.1|AF245703[8575526] - 5205: AF245702
Homo sapiens toll-like receptor 7 (TLR7) mRNA, complete cds
gi|8575524|gb|AF245702.1|AF245702[8575524] - 5206: NM—016944
Homo sapiens taste receptor, type 2, member 4 (TAS2R4), mRNA
gi|8394401|ref|NM—016944.1|[8394401] - 5207: NM—016943
Homo sapiens taste receptor, type 2, member 3 (TAS2R3), mRNA
gi|8394397|ref|NM—016943.1|[8394397] - 5209: AF307776
Homo sapiens beta-1 adrenergic receptor gene, 5′ UTR and partial cds
gi|11837864|gb|AF307776.1|AF307776[11837864] - 5210: AB026043
Homo sapiens mRNA for MS4A7, complete cds
gi|11559249|dbj|AB026043.1|AB026043[11559249] - 5211: AB013104
Homo sapiens mRNA for MS4A6, complete cds
gi|11559215|dbj|AB013104.1|AB013104[11559215] - 5212: AB013103
Homo sapiens mRNA for MS4A5, complete cds
gi|11559213|dbj|AB013103.1|AB013103[11559213] - 5213: AB013102
Homo sapiens mRNA for MS4A4, complete cds
gi|11559211|dbj|AB013102.1|AB013102[11559211] - 5215: NM—003789
Homo sapiens TNFRSF1A-associated via death domain (TRADD), mRNA
gi|13378136|ref|NM—003789.1|[13378136] - 5216: NM—025218
Homo sapiens UL16-binding protein 1 (ULBP1), mRNA
gi|13376825|ref|NM—025218.1|[13376825]
- 5217: NM—025217
Homo sapiens UL16-binding protein 2 (ULBP2), mRNA
gi|13376823|ref|NM—025217.1|[13376823] - 5218: NM—024518
Homo sapiens UL16-binding protein 3 (ULBP3), mRNA
gi|13375655|ref|NM—024518.1|[13375655] - 5220: AB052103
Homo sapiens SRCL mRNA for scavenger receptor with C-type lectin type II, complete cds
gi|13365552|dbj|AB052103.1|AB052103[13365552] - 5221: AB038518
Homo sapiens SRCL mRNA for scavenger receptor with C-type lectin type I, complete cds
gi|13365514|dbj|AB038518.1|AB038518[13365514] - 5222: NM—021708
Homo sapiens leukocyte-associated Ig-like receptor 1 (LAIR1), transcript variant
d, mRNA
gi|11231178|ref|NM—021708.1|[11231178] - 5223: NM—021706
Homo sapiens leukocyte-associated Ig-like receptor 1 (LAIR1), transcript variant
b, mRNA
gi|11231176|ref|NM—021706.1|[11231176] - 5224: NM—002287
Homo sapiens leukocyte-associated Ig-like receptor 1 (LAIR1), transcript variant
a, mRNA
gi|11231175|ref|NM—002287.2|[11231175] - 5225: AB038237
Homo sapiens mRNA for G protein-coupled receptor C5L2, complete cds
gi|7707800|dbj|AB038237.1|AB038237[7707800] - 5226: S82756
Homo sapiens T cell receptor (Vbeta8.2-N1DbetaN2-Jbeta1.6) mRNA, partial cds
gi|1835847|gb|S82756.1|S82756[1835847] - 5227: S82754
Homo sapiens T cell receptor mRNA, partial cds
gi|1835843|gb|S82754.1|S82754[1835843] - 5233: NM—024318
Homo sapiens immunoglobulin-like transcript 8 (ILT8), mRNA
gi|13324689|ref|NM—024318.1|[13324689] - 5234: AF178982
Homo sapiens putative G protein-coupled receptor GPCR1 precursor, mRNA, complete
cds
gi|13324450|gb|AF178982.1|AF178982[13324450] - 5236: NM—021956
Homo sapiens glutamate receptor, ionotropic, kainate 2 (GRIK2), mRNA
gi|11386136|ref|NM—021956.1|[11386136] - 5237: NM—018724
Homo sapiens interleukin 20 (IL20), mRNA
gi|11036633|ref|NM—018724.1|[11036633] - 5238: AJ295846
Homo sapiens mRNA for endosialin protein
gi|13277300|emb|AJ295846.1|HSA295846[13277300] - 5242: AF310249
Homo sapiens peroxisome proliferator activated receptor gamma 2 gene, upstream
sequence
gi|13274397|gb|AF310249.1|AF310249[13274397] - 5243: AF321815
Homo sapiens G-protein coupled receptor SP1999 mRNA, complete cds
gi|12656597|gb|AF321815.1|AF321815[12656597] - 5244: AL136818
Homo sapiens mRNA; cDNA DKFZp434F1726 (from clone DKFZp434F1726)
gi|12053146|emb|AL136818.1|HSM801786[12053146] - 5245: AF285440
Homo sapiens clone KIR2D54v1 killer-cell Ig-like receptor mRNA, complete cds
gi|11385699|gb|AF285440.1|AF285440[11385699] - 5246: AF285439
Homo sapiens clone KIR2D52v2 killer-cell Ig-like receptor mRNA, complete cds
gi|11385697|gb|AF285439.1|AF285439[11385697] - 5247: AF285438
Homo sapiens clone KIR2D52v1 killer-cell Ig-like receptor mRNA, partial cds
gi|11385695|gb|AF285438.1|AF285438[11385695] - 5248: AF285437
Homo sapiens clone KIR2DS1v2 killer-cell Ig-like receptor mRNA, partial cds
gi|11385693|gb|AF285437.1|AF285437[11385693] - 5249: AF285436
Homo sapiens clone KIR2DL4v4 killer-cell Ig-like receptor mRNA, complete cds
gi|11385691|gb|AF285436.1|AF285436[11385691] - 5250: AF285435
Homo sapiens clone KIR2DL3v2 killer-cell Ig-like receptor mRNA, partial cds
gi|11385689|gb|AF285435.1|AF285435[11385689] - 5251: AF285434
Homo sapiens clone KIR2DL2v2 killer-cell Ig-like receptor mRNA, partial cds
gi|11385687|gb|AF285434.1|AF285434[11385687] - 5252: AF285433
Homo sapiens clone KIR2DL2v1 killer-cell Ig-like receptor mRNA, partial cds
gi|11385685|gb|AF285433.1|AF285433[11385685] - 5253: AF285432
Homo sapiens clone KIR2DL1v3 killer-cell Ig-like receptor mRNA, partial cds
gi|11385683|gb|AF285432.1|AF285432[11385683] - 5254: AF285431
Homo sapiens clone KIR2DL1v2 killer-cell Ig-like receptor mRNA, complete cds
gi|11385681|gb|AF285431.1|AF285431[11385681] - 5255: AJ245872
Homo sapiens mRNA for putative truncated metabotropic glutamatereceptor 6 form
b, partial (tr-mGluR6 b)
gi|6688173|emb|AJ245872.1|HSA245872[6688173] - 5256: AJ245871
Homo sapiens mRNA for putative truncated metabotropic glutamatereceptor 6 form
a, partial (tr-mGluR6 a)
gi|6688171|emb|AJ245871.1|HSA245871[6688171] - 5258: AL050262
Homo sapiens mRNA; cDNA DKFZp56410682 (from clone DKFZp56410682); complete cds
gi|4886482|emb|AL050262.1|HSM800268[4886482] - 5259: AF308820
Homo sapiens adrenocorticotropin receptor gene, upstream sequence
gi|13272368|gb|AF308820.1|AF308820[13272368] - 5260: NM—014432
Homo sapiens interleukin 20 receptor, alpha (IL20RA), mRNA
gi|7657690|ref|NM—014432.1|[7657690] - 5261: NM—004967
Homo sapiens integrin-binding sialoprotein (bone sialoprotein, bone sialoprotein
II) (IBSP), mRNA
gi|13259536|ref|NM—004967.2|[13259536] - 5270: AF348323
Homo sapiens nociceptin receptor (ORL1) mRNA, complete cds
gi|13022242|gb|AF348323.1|AF348323[13022242] - 5272: S79217
Homo sapiens Ca(2+)-sensing receptor mRNA, partial cds
gi|1050985|gb|S79217.1|S79217[1050985] - 5273: S78723
Homo sapiens serotonin 5-HT2A receptor (5-HT2A R) gene, partial cds
gi|1042173|gb|S78723.1|S78723[1042173] - 5274: S78505
Homo sapiens prolactin receptor mRNA, partial cds
gi|999114|gb|S78505.1S78505[999114] - 5277: S77555
Homo sapiens corticotropin receptor/ACTH receptor gene, partial cds
gi|957294|gb|S77555.1|S77555[957294] - 5278: NM—024012
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 5A (HTR5A), mRNA
gi|13236496|ref|NM—024012.1|[13236496] - 5279: NM—021904
Homo sapiens gamma-aminobutyric acid (GABA) B receptor, 1 (GABBR1), transcript
variant 3, mRNA
gi|11497613|ref|NM—021904.1|[11497613] - 5280: NM—021903
Homo sapiens gamma-aminobutyric acid (GABA) B receptor, 1 (GABBR1), transcript
variant 2, mRNA
gi|11497611|ref|NM—021903.1|[11497611] - 5281: NM—001470
Homo sapiens gamma-aminobutyric acid (GABA) B receptor, 1 (GABBR1), transcript
variant 1, mRNA
gi|10835014|ref|NM—001470.1|[10835014] - 5282: NM—007329
Homo sapiens deleted in malignant brain tumors 1 (DMBT1), transcript variant 2,
mRNA
gi|6633800|ref|NM—007329.1|[6633800] - 5283: S71404
Homo sapiens interleukin-9 receptor mRNA, partial cds
gi|551356|gb|S71404.1|S71404[551356] - 5356: NM—023031
Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
13, mRNA
gi|13186272|ref|NM—023031.1|[13186272] - 5357: NM—023030
Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
12, mRNA
gi|13186270|ref|NM—023030.1|[13186270] - 5358: NM—023028
Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
10, mRNA
gi|13186268|ref|NM—023028.1|[13186268] - 5359: NM—022976
Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
9, mRNA
gi|13186266|ref|NM—022976.1|[13186266] - 5360: NM—022975
Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
8, mRNA
gi|13186264|ref|NM—022975.1|[13186264] - 5361: NM—022974
Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
7, mRNA
gi|13186262|ref|NM—022974.1|[13186262] - 5362: NM—022973
Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
6, mRNA
gi|13186260|ref|NM—022973.1|[13186260] - 5363: NM—022972
Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
5, mRNA
gi|13186258|ref|NM—022972.1|[13186258] - 5364: NM—022971
Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
4, mRNA
gi|13186256|ref|NM—022971.1|[13186256] - 5365: NM—022970
Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
3, mRNA
gi|13186254|ref|NM—022970.1|[13186254] - 5366: NM—022969
Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
2, mRNA
gi|13186252|ref|NM—022969.1|[13186252] - 5367: NM—023029
Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
11, mRNA
gi|13186242|ref|NM—023029.1|[13186242] - 5368: NM—000141
Homo sapiens fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome) (FGFR2), transcript variant
1, mRNA
gi|13186239|ref|NM—000141.2|[13186239] - 5369: AF312678
Homo sapiens FGF homologous factor receptor (FHFR) mRNA, complete cds
gi|13183617|gb|AF312678.1|AF312678[13183617] - 5370: AF243385
Homo sapiens beta-2 syntrophin mRNA, complete cds, alternatively spliced
gi|13183299|gb|AF243385.1|AF243385[13183299] - 5371: M97191
Homo sapiens Sp3 protein mRNA, partial cds
gi|13162672|gb|M97191.2|HUMSP3A[13162672] - 5474: NM—024075
Homo sapiens LENG5 protein (LENG5), mRNA
gi|13129061|ref|NM—024075.1|[13129061] - 5475: AF304379
Homo sapiens ULBP3 protein mRNA, complete cds
gi|13128926|gb|AF304379.1|AF304379[13128926] - 5476: AF304378
Homo sapiens ULBP2 protein mRNA, complete cds
gi|13128924|gb|AF304378.1|AF304378[13128924] - 5477: AF304377
Homo sapiens ULBP1 protein mRNA, complete cds
gi|13128922|gb|AF304377.1|AF304377[13128922] - 5481: AF000549
AF000549 Human Homo sapiens genomic clone P1 clone DMPC-HFF#1-1075-D9, genomic
survey sequence
gi|2232072|gb|AF000549.1|AF000549[2232072] - 5482: NM—001755
Homo sapiens core-binding factor, beta subunit (CBFB), transcript variant 2, mRNA
gi|13124872|ref|NM—001755.1|[13124872] - 5483: AF172398
Homo sapiens junctional adhesion molecule-1 mRNA, complete cds
gi|13124448|gb|AF172398.2|AF172398[13124448] - 5484: AF317655
Homo sapiens G protein-coupled receptor (GPR77) gene, complete cds
gi|13122466|gb|AF317655.1|AF317655[13122466] - 5485: AF317653
Homo sapiens G protein-coupled receptor (GPR62) gene, complete cds
gi|13122462|gb|AF317653.1|AF317653[13122462] - 5486: AF317652
Homo sapiens G protein-coupled receptor (GPR61) mRNA, complete cds
gi|13122460|gb|AF317652.1|AF317652[13122460] - 5487: NM—022036
Homo sapiens G protein-coupled receptor, family C, group 5, member C (GPRC5C),
transcript variant 1, mRNA
gi|13112058|ref|NM—022036.1|[13112058] - 5488: NM—018653
Homo sapiens G protein-coupled receptor, family C, group 5, member C (GPRC5C),
transcript variant 2, mRNA
gi|13112056|ref|NM—018653.2|[13112056] - 5489: NM—000707
Homo sapiens arginine vasopressin receptor 1B (AVPR1B), mRNA
gi|13112055|ref|NM—000707.2|[13112055] - 5490: NM—000706
Homo sapiens arginine vasopressin receptor 1A (AVPR1A), mRNA
gi|13112054|ref|NM—000706.2|[13112054] - 5491: NM—021923
Homo sapiens fibroblast growth factor receptor-like 1 (FGFRL1), mRNA
gi|13112053|ref|NM—021923.2|[13112053] - 5492: NM—002011
Homo sapiens fibroblast growth factor receptor 4 (FGFR4), transcript variant 1,
mRNA
gi|13112051|ref|NM—002011.2|[13112051] - 5493: NM—022963
Homo sapiens fibroblast growth factor receptor 4 (FGFR4), transcript variant 2,
mRNA
gi|13112049|ref|NM—022963.1|[13112049] - 5494: NM—022965
Homo sapiens fibroblast growth factor receptor 3 (achondroplasia, thanatophoric
dwarfism) (FGFR3), transcript variant 2, mRNA
gi|13112047|ref|NM—022965.1|[13112047] - 5495: NM—000142
Homo sapiens fibroblast growth factor receptor 3 (achondroplasia, thanatophoric
dwarfism) (FGFR3), transcript variant 1, mRNA
gi|13112046|ref|NM—000142.2|[13112046] - 5496: NM—022336
Homo sapiens ectodysplasin 1, anhidrotic receptor (EDAR), mRNA
gi|11641230|ref|NM—022336.1|[11641230] - 5497: NM—018654
Homo sapiens G protein-coupled receptor, family C, group 5, member D (GPRC5D),
mRNA
gi|8923704|ref|NM—018654.1|[8923704] - 5498: AF312230
Homo sapiens histamine receptor H4 subtype mRNA, complete cds
gi|13094918|gb|AF312230.1|AF312230[13094918] - 5504: AY016370
Homo sapiens hnRNPA1 pseudogene, complete sequence; and CC chemokine receptor 8
(CCR8) and CX3C chemokine receptor 1 (CX3CR1) genes, complete cds
gi|13027668|gb|AY016370.1|[13027668] - 5505: E32517
Scavenger receptor-like protein
gi|13026764|dbj|E32517.1E32517[13026764] - 5506: E32511
Scavenger receptor-like protein
gi|13026758|dbj|E32511.1|E32511[13026758] - 5507: E32510
Scavenger receptor-like protein
gi|3026757|dbj|E32510.1|E32510[13026757] - 5508: E32509
Scavenger receptor-like protein
gi|13026756|dbj|E32509.1|E32509[13026756] - 5509: E32504
Scavenger receptor-like protein
gi|13026751|dbj|E32504.1|E32504[13026751] - 5510: E32503
Scavenger receptor-like protein
gi|13026750|dbj|E32503.1|E32503[13026750] - 5511: E60222
Melatonin receptor expressing cell and utilization thereof
gi|13025812|dbj|E60222.1|E60222[13025812] - 5512: E36078
cDNA clone HNEAA81 encoding human seven-pass transmembrane receptor
gi|13022480|dbj|E36078.1|E36078[13022480] - 5522: AJ309545
Homo sapiens mRNA for T-cell receptor alpha chain, clone 57LSK10 (Va2, Ja45)
gi|13016702|emb|AJ309545.1|HSA309545[13016702] - 5523: AF323176
Homo sapiens death receptor-interacting protein mRNA, complete cds
gi|12964787|gb|AF323176.1|AF323176[12964787] - 5524: AF329496
Homo sapiens immunoglobulin kappa light chain gene, partial cds
gi|12963392|gb|AF329496.1|AF329496[12963392] - 5529: NM—015717
Homo sapiens Langerhans cell specific c-type lectin (LANGERIN), mRNA
gi|7657290|ref|NM—015717.1|[7657290] - 5530: NM—012329
Homo sapiens monocyte to macrophage differentiation-associated (MMD), mRNA
gi|6912507|ref|NM—012329.1|[6912507] - 5571: AH009956
Homo sapiens chromosome 12 clone pacHRARg map 12q13
gi|12746591|gb|AH009956.2|SEG_AF311283S[12746591] - 5573: AF230330
Homo sapiens angiopoietin-related protein 5 (ARP5) mRNA, complete cds
gi|12743935|gb|AF230330.1|AF230330[12743935] - 5574: AF316895
Homo sapiens alpha 2B adrenergic receptor (ADRA2B) gene, complete cds
gi|12698669|gb|AF316895.1|AF316895[12698669] - 5575: NM—021905
Homo sapiens gamma-aminobutyric acid (GABA) B receptor, 1 (GABBR1), transcript
variant 4, mRNA
gi|11497615|ref|NM—021905.1|[11497615] - 5578: NM—016730
Homo sapiens folate receptor 1 (adult) (FOLR1), transcript variant 3, mRNA
gi|9257214|ref|NM—016730.1|[9257214] - 5579: NM—016729
Homo sapiens folate receptor 1 (adult) (FOLR1), transcript variant 4, mRNA
gi|9257212|ref|NM—016729.1|[9257212] - 5580: NM—016725
Homo sapiens folate receptor 1 (adult) (FOLR1), transcript variant 1, mRNA
gi|9257206|ref|NM—016725.1|[9257206] - 5581: NM—016724
Homo sapiens folate receptor 1 (adult) (FOLR1), transcript variant 7, mRNA
gi|9257204|ref|NM—016724.1|[9257204] - 5582: NM—004406
Homo sapiens deleted in malignant brain tumors 1 (DMBT1), transcript variant 1,
mRNA
gi|4758169|ref|NM—004406.1|[4758169] - 5583: L27609
Homo sapiens T-cell receptor beta gene, partial cds
gi|457265|gb|L27609.1|HUMTCRBD[457265] - 5584: U65905
U65905 Human Homo sapiens genomic, genomic survey sequence
gi|1743863|gb|U65905.1|U65905[1743863] - 5585: U65904
U65904 Human Homo sapiens genomic, genomic survey sequence
gi|1743862|gb|U65904.1|U65904[1743862] - 5586: U65903
U65903 Human Homo sapiens genomic, genomic survey sequence
gi|1743861|gb|U65903.1|U65903[1743861] - 5587: NM—016731
Homo sapiens folate receptor 1 (adult) (FOLR1), transcript variant 8, mRNA
gi|12719454|ref|NM—016731.2|[12719454] - 5588: AF316870
Homo sapiens T cell receptor beta chain variable region mRNA, partial cds
gi|12711595|gb|AF316870.1|AF316870[12711595] - 5589: AX074315
Sequence 29 from Patent WO0104310
gi|12710501|emb|AX074315.1|AX074315[12710501] - 5590: AX074314
Sequence 28 from Patent WO0104310
gi|12710500|emb|AX074314.1|AX074314[12710500] - 5591: NM—022113
Homo sapiens kinesin family member 13A (KIF13A), mRNA
gi|11545828|ref|NM—022113.1|[11545828] - 5592: AF283296
Homo sapiens interleukin-15 receptor alpha gene, 5′ regulatory region and exon
1, partial sequence
gi|9965299|gb|AF283296.1|AF283296[9965299] - 5593: NM—014688
Homo sapiens related to the N terminus of tre (RNTRE), mRNA
gi|7661863|ref|NM—014688.1|[7661863] - 5594: NM—000916
Homo sapiens oxytocin receptor (OXTR), mRNA
gi|12707575|ref|NM—000916.2|[12707575] - 5595: NM—000915
Homo sapiens oxytocin, prepro-(neurophysin I) (OXT), mRNA
gi|12707574|ref|NM—000915.2|[12707574] - 5596: NM—004961
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, epsilon (GABRE), transcript variant 1, mRNA
gi|12707559|ref|NM—004961.2|[12707559] - 5597: NM—021990
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, epsilon (GABRE), transcript variant 4, mRNA
gi|12707557|ref|NM—021990.1|[12707557] - 5598: NM—021987
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, epsilon (GABRE), transcript variant 3, mRNA
gi|12707555|ref|NM—021987.1|[12707555] - 5599: NM—021984
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, epsilon (GABRE), transcript variant 2, mRNA
gi|12707553|ref|NM—021984.1|[12707553] - 5600: AY011291
Homo sapiens beta-2 adrenergic receptor (ADRB2) gene, partial cds
gi|12699005|gb|AY011291.1|[12699005] - 5601: AF316894
Homo sapiens alpha 2A adrenergic receptor (ADRA2A) gene, complete cds
gi|12698667|gb|AF316894.1|AF316894[12698667] - 5602: AJ300340
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 1 and joined complete CDS
gi|11878410|emb|AJ300340.1|HSA300340[11878410] - 5603: AF063605
Homo sapiens brain my047 protein mRNA, complete cds
gi|4071360|gb|AF063605.1|AF063605[4071360] - 5604: AF319440
Homo sapiens SH2 domain-containing phosphatase anchor protein 1c (SPAP1) mRNA,
complete cds, alternatively spliced
gi|12667355|gb|AF319440.1|AF319440[12667355] - 5605: AF319439
Homo sapiens SH2 domain-containing phosphatase anchor protein 1b (SPAP1) mRNA,
complete cds, alternatively spliced
gi|12667353|gb|AF319439.1|AF319439[12667353] - 5606: AF319438
Homo sapiens SH2 domain-containing phosphatase anchor protein 1a (SPAP1) mRNA,
complete cds, alternatively spliced
gi|12667351|gb|AF319438.1|AF319438[12667351] - 5607: NM—021912
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 3 (GABRB3), transcript variant 2, mRNA
gi|12548787|ref|NM—021912.1|[12548787] - 5608: NM—021911
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 2 (GABRB2), transcript variant 1, mRNA
gi|12548784|ref|NM—021911.1|[12548784] - 5609: NM—000814
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 3 (GABRB3), transcript variant 1, mRNA
gi|12548782|ref|NM—000814.2|[12548782] - 5610: NM—000812
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 1 (GABRB1), mRNA
gi|12548775|ref|NM—000812.2|[12548775] - 5611: NM—006786
Homo sapiens urotensin 2 (UTS2), transcript variant 2, mRNA
gi|12056480|ref|NM—006786.2|[12056480] - 5612: NM—021995
Homo sapiens urotensin 2 (UTS2), transcript variant 1, mRNA
gi|12056478|ref|NM—021995.1|[12056478] - 5613: AJ300444
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 105
gi|1863669|emb|AJ300444.1|HSA300444[11863669] - 5614: AJ300443
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 104
gi|11863668|emb|AJ300443.1|HSA300443[11863668] - 5615: AJ300442
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 103
gi|11863667|emb|AJ300442.1|HSA300442[11863667] - 5616: AJ300441
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 102
gi|11863666|emb|AJ300441.1|HSA300441[11863666] - 5617: AJ300440
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 101
gi|11863665|emb|AJ300440.1|HSA300440[11863665] - 5618: AJ300439
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 100
gi|11863664|emb|AJ300439.1|HSA300439[11863664] - 5619: AJ300438
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 99
gi|11863663|emb|AJ300438.1|HSA300438[11863663] - 5620: AJ300437
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 98
gi|11863662|emb|AJ300437.1|HSA300437[11863662] - 5621: AJ300436
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 97
gi|11863661|emb|AJ300436.1|HSA300436[11863661] - 5622: AJ300435
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 96
gi|11863660|emb|AJ300435.1|HSA300435[11863660] - 5623: AJ300434
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 95
gi|11863659|emb|AJ300434.1|HSA300434[11863659] - 5624: AJ300433
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 94
gi|11863658|emb|AJ300433.1|HSA300433[11863658] - 5625: AJ300432
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 93
gi|11863657|emb|AJ300432.1|HSA300432[11863657] - 5626: AJ300431
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 92
gi|11863656|emb|AJ300431.1|HSA300431[11863656] - 5627: AJ300430
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 91
gi|11863655|emb|AJ300430.1|HSA300430[11863655] - 5628: AJ300429
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 90
gi|11863654|emb|AJ300429.1|HSA300429[11863654] - 5629: AJ300428
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 89
gi|11863653|emb|AJ300428.1|HSA300428[11863653] - 5630: AJ300427
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 88
gi|11863652|emb|AJ300427.1|HSA300427[11863652] - 5631: AJ300426
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 87
gi|11863651|emb|AJ300426.1|HSA300426[11863651] - 5632: AJ300425
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 86
gi|11863650|emb|AJ300425.1|HSA300425[11863650] - 5633: AJ300424
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 85
gi|11863649|emb|AJ300424.1|HSA300424[11863649] - 5634: AJ300423
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 84
gi|11863648|emb|AJ300423.1|HSA300423[11863648] - 5635: AJ300422
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 83
gi|11863647|emb|AJ300422.1|HSA300422[11863647] - 5636: AJ300421
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 82
gi|11863646|emb|AJ300421.1|HSA300421[11863646] - 5637: AJ300420
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 81
gi|11863645|emb|AJ300420.1|HSA300420[11863645] - 5638: AJ300419
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 80
gi|11863644|emb|AJ300419.1|HSA300419[11863644] - 5639: AJ300418
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 79
gi|11863643|emb|AJ300418.1|HSA300418[11863643] - 5640: AJ300417
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 78
gi|11863642|emb|AJ300417.1|HSA300417[11863642] - 5641: AJ300416
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 77
gi|11863641|emb|AJ300416.1|HSA300416[11863641] - 5642: AJ300415
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 76
gi|1863640|emb|AJ300415.1|HSA300415[11863640] - 5643: AJ300414
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 75
gi|11863639|emb|AJ300414.1|HSA300414[11863639] - 5644: AJ300413
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 74
gi|11863638|emb|AJ300413.1|HSA300413[11863638] - 5645: AJ300412
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 73
gi|11863637|emb|AJ300412.1|HSA300412[11863637] - 5646: AJ300411
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 72
gi|11863636|emb|AJ300411.1|HSA300411[11863636] - 5647: AJ300410
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 71
gi|11863635|emb|AJ300410.1|HSA300410[11863635] - 5648: AJ300409
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 70
gi|11863634|emb|AJ300409.1|HSA300409[11863634] - 5649: AJ300408
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 69
gi|11863633|emb|AJ300408.1|HSA300408[11863633] - 5650: AJ300407
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 68
gi|11863632|emb|AJ300407.1|HSA300407[11863632] - 5651: AJ300406
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 67
gi|11863631|emb|AJ300406.1|HSA300406[11863631] - 5652: AJ300405
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 66
gi|11863630|emb|AJ300405.1|HSA300405[11863630] - 5653: AJ300404
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 65
gi|11863629|emb|AJ300404.1|HSA300404[11863629] - 5654: AJ300403
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 64
gi|11863628|emb|AJ300403.1|HSA300403[11863628] - 5655: AJ300402
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 63
gi|11863627|emb|AJ300402.1|HSA300402[11863627] - 5656: AJ300401
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 62
gi|11863626|emb|AJ300401.1|HSA300401[11863626] - 5657: AJ300400
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 61
gi|11863625|emb|AJ300400.1|HSA300400[11863625] - 5658: AJ300399
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 60
gi|11863624|emb|AJ300399.1|HSA300399[11863624] - 5659: AJ300398
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 59
gi|11863623|emb|AJ300398.1|HSA300398[11863623] - 5660: AJ300397
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 58
gi|11863622|emb|AJ300397.1|HSA300397[11863622] - 5661: AJ300396
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 57
gi|11863621|emb|AJ300396.1|HSA300396[11863621] - 5662: AJ300395
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 56
gi|11863620|emb|AJ300395.1|HSA300395[11863620] - 5663: AJ300394
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 55
gi|11863619|emb|AJ300394.1|HSA300394[11863619] - 5664: AJ300393
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 54
gi|11863618|emb|AJ300393.1|HSA300393[11863618] - 5665: AJ300392
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 53
gi|11863617|emb|AJ300392.1|HSA300392[11863617] - 5666: AJ300391
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 52
gi|11863616|emb|AJ300391.1|HSA300391[11863616] - 5667: AJ300390
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 51
gi|11863615|emb|AJ300390.1|HSA300390[11863615] - 5668: AJ300389
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 50
gi|11863614|emb|AJ300389.1|HSA300389[11863614] - 5669: AJ300388
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 49
gi|11863613|emb|AJ300388.1|HSA300388[11863613] - 5670: AJ300387
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 48
gi|11863612|emb|AJ300387.1|HSA300387[11863612] - 5671: AJ300386
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 47
gi|11863611|emb|AJ300386.1|HSA300386[11863611] - 5672: AJ300385
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 46
gi|11863610|emb|AJ300385.1|HSA300385[11863610] - 5673: AJ300384
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 45
gi|11863609|emb|AJ300384.1HSA300384[11863609] - 5674: AJ300383
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 44
gi|11863608|emb|AJ300383.1|HSA300383[11863608] - 5675: AJ300382
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 43
gi|11863607|emb|AJ300382.1|HSA300382[11863607] - 5676: AJ300381
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 42
gi|11863606|emb|AJ300381.1|HSA300381[11863606] - 5677: AJ300380
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 41
gi|11863605|emb|AJ300380.1|HSA300380[11863605] - 5678: AJ300379
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 40
gi|11863604|emb|AJ300379.1|HSA300379[11863604] - 5679: AJ300378
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 39
gi|1863603|emb|AJ300378.1|HSA300378[11863603] - 5680: AJ300377
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 38
gi|11863602|emb|AJ300377.1|HSA300377[11863602] - 5681: AJ300376
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 37
gi|1863601|emb|AJ300376.1|HSA300376[11863601] - 5682: AJ300375
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 36
gi|1863600|emb|AJ300375.1|HSA300375[11863600] - 5683: AJ300374
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 35
gi|11863599|emb|AJ300374.1|HSA300374[11863599] - 5684: AJ300373
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 34
gi|11863598|emb|AJ300373.1|HSA300373[11863598] - 5685: AJ300372
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 33
gi|11863597|emb|AJ300372.1|HSA300372[11863597] - 5686: AJ300371
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 32
gi|11863596|emb|AJ300371.1|HSA300371[11863596] - 5687: AJ300370
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 31
gi|11863595|emb|AJ300370.1|HSA300370[11863595] - 5688: AJ300369
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 30
gi|11863594|emb|AJ300369.1|HSA300369[11863594] - 5689: AJ300368
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 29
gi|11863593|emb|AJ300368.1|HSA300368[11863593] - 5690: AJ300367
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 28
gi|11863592|emb|AJ300367.1|HSA300367[11863592] - 5691: AJ300366
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 27
gi|11863591|emb|AJ300366.1|HSA300366[11863591] - 5692: AJ300365
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 26
gi|11863590|emb|AJ300365.1|HSA300365[11863590] - 5693: AJ300364
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 25
gi|11863589|emb|AJ300364.1|HSA300364[11863589] - 5694: AJ300363
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 24
gi|11863588|emb|AJ300363.1|HSA300363[11863588] - 5695: AJ300362
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 23
gi|11863587|emb|AJ300362.1|HSA300362[11863587] - 5696: AJ300361
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 22
gi|11863586|emb|AJ300361.1|HSA300361[11863586] - 5697: AJ300360
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 21
gi|11863585|emb|AJ300360.1|HSA300360[11863585] - 5698: AJ300359
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 20
gi|11863584|emb|AJ300359.1|HSA300359[11863584] - 5699: AJ300358
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 19
gi|11863583|emb|AJ300358.1|HSA300358[11863583] - 5700: AJ300357
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 18
gi|11863582|emb|AJ300357.1|HSA300357[11863582] - 5701: AJ300356
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 17
gi|11863581|emb|AJ300356.1|HSA300356[11863581] - 5702: AJ300355
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 16
gi|11863580|emb|AJ300355.1|HSA300355[11863580] - 5703: AJ300354
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 15
gi|11863579|emb|AJ300354.1|HSA300354[11863579] - 5704: AJ300353
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 14
gi|11863578|emb|AJ300353.1|HSA300353[11863578] - 5705: AJ300352
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 13
gi|11863577|emb|AJ300352.1|HSA300352[11863577] - 5706: AJ300351
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 12
gi|11863576|emb|AJ300351.1|HSA300351[11863576] - 5707: AJ300350
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 11
gi|11863575|emb|AJ300350.1|HSA300350[11863575] - 5708: AJ300349
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 10
gi|11863574|emb|AJ300349.1|HSA300349[11863574] - 5709: AJ300348
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 9
gi|11863573|emb|AJ300348.1|HSA300348[11863573] - 5710: AJ300347
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 8
gi|11863572|emb|AJ300347.1|HSA300347[11863572] - 5711: AJ300346
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 7
gi|11863571|emb|AJ300346.1|HSA300346[11863571] - 5712: AJ300345
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 6
gi|11863570|emb|AJ300345.1|HSA300345[11863570] - 5713: AJ300344
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 5
gi|11863569|emb|AJ300344.1|HSA300344[11863569] - 5714: AJ300343
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 4
gi|11863568|emb|AJ300343.1|HSA300343[11863568] - 5715: AJ300342
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 3
gi|11863567|emb|AJ300342.1|HSA300342[11863567] - 5716: AJ300341
Homo sapiens partial RYR2 gene for ryanodine receptor 2, exon 2
gi|11863566|emb|AJ300341.1|HSA300341[11863566] - 5717: NM—000832
Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 1 (GRIN1), transcript variant NR1-1, mRNA
gi|11496970|ref|NM—000832.4|[11496970] - 5718: NM—021709
Homo sapiens CD27-binding (Siva) protein (SIVA), transcript variant 2, mRNA - 5719: NM—006427
Homo sapiens CD27-binding (Siva) protein (SIVA), transcript variant 1, mRNA
gi|11277467|ref|NM—006427.2|[11277467] - 5720: NM—016232
Homo sapiens interleukin 1 receptor-like 1 (IL1RL1), mRNA
gi|11136631|ref|NM—016232.2|[11136631] - 5721: AF202091
Homo sapiens hypocretin receptor-2 (HCRTR2) gene, exon 7 and complete cds
gi|11055242|gb|AF202091.1|F202078S14[11055242] - 5722: AF202090
Homo sapiens hypocretin receptor-2 (HCRTR2) gene, exon 6
gi|11055241|gb|AF202090.1|F202078S13[11055241] - 5723: AF202089
Homo sapiens hypocretin receptor-2 (HCRTR2) gene, exon 5
gi|110552400gb|AF202089.1|F202078S12[11055240] - 5724: AF202088
Homo sapiens hypocretin receptor-2 (HCRTR2) gene, exon 4
gi|11055239|gb|AF202088.1|F202078S11[11055239] - 5725: AF202087
Homo sapiens hypocretin receptor-2 (HCRTR2) gene, exon 3
gi|11055238|gb|AF202087.1|F202078S10[11055238] - 5726: AF202086
Homo sapiens hypocretin receptor-2 (HCRTR2) gene, exon 2
gi|11055237|gb|AF202086.1|F202078S09[11055237] - 5727: AF202085
Homo sapiens hypocretin receptor-2 (HCRTR2) gene, exon 1
gi|11055236|gb|AF202085.1|F202078S08[11055236] - 5728: AF202084
Homo sapiens hypocretin receptor-1 (HCRTR1) gene, exon 7 and complete cds
gi|11055235|gb|AF202084.1|F202078S07[11055235] - 5729: AF202083
Homo sapiens hypocretin receptor-1 (HCRTR1) gene, exon 6
gi|11055234|gb|AF202083.1|F202078S06[11055234] - 5730: AF202082
Homo sapiens hypocretin receptor-1 (HCRTR1) gene, exon 5
gi|11055233|gb|AF202082.1|F202078S05[11055233] - 5731: AF202081
Homo sapiens hypocretin receptor-1 (HCRTR1) gene, exon 4
gi|11055232|gb|AF202081.1|F202078S04[11055232] - 5732: AF202080
Homo sapiens hypocretin receptor-1 (HCRTR1) gene, exon 3
gi|11055231|gb|AF202080.1|F202078S03[11055231] - 5733: AF202079
Homo sapiens hypocretin receptor-1 (HCRTR1) gene, exon 2
gi|110552300gb|AF202079.1|F202078S02[11055230] - 5734: AF202078
Homo sapiens hypocretin receptor-1 (HCRTR1) gene, exon 1
gi|11055229|gb|AF202078.1|F202078S01[11055229] - 5735: AH009943
Homo sapiens hypocretin receptor-1 (HCRTR1) and hypocretin receptor-2 (HCRTR2)
genes, complete cds
gi|11055228|gb|AH009943.1|SEG_F202078S[11055228] - 5736: NM—021602
Homo sapiens CD79B antigen (immunoglobulin-associated beta) (CD79B), transcript
variant 2, mRNA
gi|11038675|ref|NM—021602.1|[11038675] - 5737: NM—000626
Homo sapiens CD79B antigen (immunoglobulin-associated beta) (CD79B), transcript
variant 1, mRNA
gi|11038673|ref|NM—000626.1|[11038673] - 5738: NM—021601
Homo sapiens CD79A antigen (immunoglobulin-associated alpha) (CD79A), transcript
variant 2, mRNA
gi|11038671|ref|NM—021601.1|[11038671] - 5739: NM—007327
Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 1 (GRIN1), transcript variant NR1-3, mRNA
gi|11038636|ref|NM—007327.1|[11038636] - 5740: NM—021569
Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 1 (GRIN1), transcript variant NR1-2, mRNA
gi|11038634|ref|NM—021569.1|[11038634] - 5743: NM—021270
Homo sapiens leukocyte-associated Ig-like receptor 2 (LAIR2), transcript variant
2, mRNA
gi|10947102|ref|NM—021270.1|[10947102] - 5744: NM—002288
Homo sapiens leukocyte-associated Ig-like receptor 2 (LAIR2), transcript variant
1, mRNA
gi|10947100|ref|NM—002288.2|[10947100] - 5745: NM—004041
Homo sapiens arrestin, beta 1 (ARRB1), transcript variant 1, mRNA
gi|10880135|ref|NM—004041.2|[10880135] - 5746: NM—020251
Homo sapiens arrestin, beta 1 (ARRB1), transcript variant 2, mRNA
gi|10880133|ref|NM—020251.1|[10880133] - 5747: NM—000872
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) (HTR7), transcript variant a, mRNA
gi|10880132|ref|NM—000872.2|[10880132] - 5748: NM—019860
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) (HTR7), transcript variant b, mRNA
gi|10880130|ref|NM—019860.1|[10880130] - 5749: NM—019859
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) (HTR7), transcript variant d, mRNA
gi|10880128|ref|NM—019859.1|[10880128] - 5750: NM—004302
Homo sapiens activin A receptor, type IB (ACVR1B), transcript variant 1, mRNA
gi|10862695|ref|NM—004302.2|[10862695] - 5751: NM—020328
Homo sapiens activin A receptor, type IB (ACVR1B), transcript variant 3, mRNA
gi|10862693|ref|NM—020328.1|[10862693] - 5752: NM—020327
Homo sapiens activin A receptor, type IB (ACVR1B), transcript variant 2, mRNA
gi|10862691|ref|NM—020327.1|[10862691] - 5753: NM—020525
Homo sapiens interleukin 22 (IL22), mRNA
gi|10092624|ref|NM—020525.1|[10092624] - 5754: NM—000407
Homo sapiens glycoprotein Ib (platelet), beta polypeptide (GP1BB), mRNA
gi|9945387|ref|NM—000407.31[9945387] - 5755: NM—018971
Homo sapiens G protein-coupled receptor 27 (GPR27), mRNA
gi|9506746|ref|NM—018971.1|[9506746] - 5756: NM—017455
Homo sapiens stromal cell derived factor receptor 1 (SDFR1), transcript variant
alpha, mRNA
gi|9257239|ref|NM—017455.1|[9257239] - 5757: NM—002197
Homo sapiens aconitase 1, soluble (ACO1), mRNA
gi|8659554|ref|NM—002197.1|[8659554] - 5758: NM—005242
Homo sapiens coagulation factor II (thrombin) receptor-like 1 (F2RL1), mRNA
gi|8051581|ref|NM—005242.2|[8051581] - 5759: NM—016388
Homo sapiens T-cell receptor interacting molecule (TRIM), mRNA
gi|7706744|ref|NM—016388.1|[7706744] - 5760: NM—016334
Homo sapiens putative G-protein coupled receptor (SH120), mRNA
gi|7706703|ref|NM—016334.1|[7706703] - 5761: NM—016318
Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 2 (P2RX2), mRNA
gi|7706628|ref|NM—016318.1|[7706628] - 5762: NM—016602
Homo sapiens G protein-coupled receptor 2 (GPR2), mRNA
gi|7705315|ref|NM—016602.1|[7705315] - 5763: NM—013964
Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-alpha, mRNA
gi|7669525|ref|NM—013964.1|[7669525] - 5764: NM—013962
Homo sapiens neuregulin 1 (NRG1), transcript variant GGF2, mRNA
gi|7669523|ref|NM—013962.1|[7669523] - 5765: NM—013961
Homo sapiens neuregulin 1 (NRG1), transcript variant GGF, mRNA
gi|7669521|ref|NM—013961.1|[7669521] - 5766: NM—013960
Homo sapiens neuregulin 1 (NRG1), transcript variant ndf43, mRNA
gi|7669519|ref|NM—013960.1|[7669519] - 5767: NM—013959
Homo sapiens neuregulin 1 (NRG1), transcript variant SMDF, mRNA
gi|7669517|ref|NM—013959.1|[7669517] - 5768: NM—013958
Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-beta3, mRNA
gi|7669515|ref|NM—013958.1|[7669515] - 5769: NM—013957
Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-beta2, mRNA
gi|7669513|ref|NM—013957.1|[7669513] - 5770: NM—013956
Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-beta1, mRNA
gi|7669511|ref|NM—013956.1|[7669511] - 5771: NM—007334
Homo sapiens killer cell lectin-like receptor subfamily D, member 1 (KLRD1), transcript variant 2, mRNA
gi|7669498|ref|NM—007334.1|[7669498] - 5772: NM—002262
Homo sapiens killer cell lectin-like receptor subfamily D, member 1 (KLRD1), transcript variant 1, mRNA
gi|7669497|ref|NM—002262.21[7669497] - 5773: NM—007319
Homo sapiens presenilin 1 (Alzheimer disease 3) (PSEN1), transcript variant I-374., mRNA
gi|7549814|ref|NM—007319.1|[7549814] - 5774: NM—007318
Homo sapiens presenilin 1 (Alzheimer disease 3) (PSEN1), transcript variant I-463, mRNA
gi|7549812|ref|NM—007318.1|[7549812] - 5775: NM—007333
Homo sapiens killer cell lectin-like receptor subfamily C, member 3 (KLRC3), transcript variant NKG2-H, mRNA
gi|7262385|ref|NM—007333.1|[7262385] - 5776: NM—007328
Homo sapiens killer cell lectin-like receptor subfamily C, member 1 (KLRC1), transcript variant NKG2-B, mRNA
gi|7262383|ref|NM—007328.1|[7262383] - 5777: NM—002259
Homo sapiens killer cell lectin-like receptor subfamily C, member 1 (KLRC1), transcript variant NKG2-A, mRNA
gi|7262382|ref|NM—002259.2|[7262382] - 5778: NM—006350
Homo sapiens follistatin (FST), transcript variant FST317, mRNA
gi|7242223|ref|NM—006350.2|[7242223] - 5779: NM—013409
Homo sapiens follistatin (FST), transcript variant FST344, mRNA
gi|7242221|ref|NM—013409.1|[7242221] - 5780: NM—012486
Homo sapiens presenilin 2 (Alzheimer disease 4) (PSEN2), transcript variant 2,
mRNA
gi|7108359|ref|NM—012486.1|[7108359] - 5781: NM—012485
Homo sapiens hyaluronan-mediated motility receptor (RHAMM) (HMMR), transcript variant 2, mRNA
gi|7108350|ref|NM—012485.1|[7108350] - 5782: NM—012484
Homo sapiens hyaluronan-mediated motility receptor (RHAMM) (HMMR), transcript variant 1, mRNA
gi|7108348|ref|NM—012484.1|[7108348] - 5783: NM—012428
Homo sapiens stromal cell derived factor receptor 1 (SDFR1), transcript variant
beta, mRNA
gi|6912645|ref|NM—012428.1|[6912645] - 5784: NM—012226
Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 2 (P2RX2), mRNA
gi|6912565|ref|NM—012226.1|[6912565] - 5785: NM—012369
Homo sapiens olfactory receptor, family 2, subfamily F, member 1 (OR2F1), mRNA
gi|6912557|ref|NM—012369.1|[6912557] - 5786: NM—007325
Homo sapiens glutamate receptor, ionotrophic, AMPA 3 (GRIA3), transcript variant
flip, mRNA
gi|6598324|ref|NM—007325.1|[6598324] - 5787: NM—000632
Homo sapiens integrin, alpha M (complement component receptor 3, alpha; also known as CD11b (p170), macrophage antigen alpha polypeptide) (ITGAM), mRNA
gi|6006013|ref|NM—000632.21[6006013] - 5788: NM—007097
Homo sapiens clathrin, light polypeptide (Lcb) (CLTB), mRNA
gi|6005994|ref|NM—007097.1|[6005994] - 5789: NM—000655
Homo sapiens selectin L (lymphocyte adhesion molecule 1) (SELL), mRNA
gi|5713320|ref|NM—000655.2|[5713320] - 5790: NM—005751
Homo sapiens A kinase (PRKA) anchor protein (yotiao) 9 (AKAP9), mRNA
gi|5032230|ref|NM—005751.1|[5032230] - 5791: NM—005691
Homo sapiens ATP-binding cassette, sub-family C(CFTR/MRP), member 9 (ABCC9), transcript variant SUR2A, mRNA
gi|5032134|ref|NM—005691.1|[5032134] - 5792: NM—005534
Homo sapiens interferon gamma receptor 2 (interferon gamma transducer 1) (IFNCR2), mRNA
gi|5031782|ref|NM—005534.1|[5031782] - 5793: NM—005682
Homo sapiens G protein-coupled receptor 56 (GPR56), mRNA
gi|5031724|ref|NM—005682.1|[5031724] - 5794: NM—005446
Homo sapiens purinergic receptor P2X-like 1, orphan receptor (P2RXL1), mRNA
gi|4885534|ref|NM—005446.1|[4885534] - 5795: NM—004958
Homo sapiens FK506 binding protein 12-rapamycin associated protein 1 (FRAP1), mRNA
gi|4826729|ref|NM—004958.1|[4826729]
- 5796: NM—004495
Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-gamma, mRNA
gi|4758525|ref|NM—004495.1|[4758525] - 5797: NM—003995
Homo sapiens natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) (NPR2), mRNA
gi|4580421|ref|NM—003995.2|[4580421] - 5798: NM—003994
Homo sapiens KIT ligand (KITLG), mRNA
gi|4580419|ref|NM—003994.2|[4580419] - 5799: NM—000115
Homo sapiens endothelin receptor type B (EDNRB), transcript variant 1, mRNA
gi|4557546|ref|NM—000115.1|[4557546] - 5800: NM—000734
Homo sapiens CD3Z antigen, zeta polypeptide (TiT3 complex) (CD3Z), mRNA
gi|4557430|ref|NM—000734.1|[4557430] - 5801: NM—003856
Homo sapiens interleukin 1 receptor-like 1 (IL1RL1), mRNA
gi|4507244|ref|NM—003856.1|[4507244] - 5802: NM—002980
Homo sapiens secretin receptor (SCTR), mRNA
gi|4506824|ref|NM—002980.1|[4506824] - 5803: NM—000447
Homo sapiens presenilin 2 (Alzheimer disease 4) (PSEN2), transcript variant 1,
mRNA
gi|4506164|ref|NM—000447.1|[4506164] - 5804: NM—000021
Homo sapiens presenilin 1 (Alzheimer disease 3) (PSEN1), transcript variant I-467, mRNA
gi|4506162|ref|NM—000021.1|[4506162] - 5805: NM—000907
Homo sapiens natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) (NPR2), mRNA
gi|4505436|ref|NM—000907.1|[4505436] - 5806: NM—000899
Homo sapiens KIT ligand (KITLG), mRNA
gi|4505174|ref|NM—000899.1|[4505174] - 5807: NM—002353
Homo sapiens tumor-associated calcium signal transducer 2 (TACSTD2), mRNA
gi|4505056|ref|NM—002353.1|[4505056] - 5808: NM—002261
Homo sapiens killer cell lectin-like receptor subfamily C, member 3 (KLRC3), transcript variant NKG2-E, mRNA
gi|4504884|ref|NM—002261.1|[4504884] - 5809: NM—000836
Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2D (GRIN2D),
mRNA
gi|4504130|ref|NM—000836.1|[4504130] - 5810: NM—000828
Homo sapiens glutamate receptor, ionotrophic, AMPA 3 (GRIA3), transcript variant
flop, mRNA
gi|4504114|ref|NM—000828.1|[4504114] - 5811: NM—000813
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, beta 2 (GABRB2), transcript variant 2, mRNA
gi|4503864|ref|NM—000813.1|[4503864] - 5812: NM—003991
Homo sapiens endothelin receptor type B (EDNRB), transcript variant 2, mRNA
gi|4503466|ref|NM—003991.1|[4503466] - 5813: NM—001337
Homo sapiens chemokine (C-X3-C) receptor 1 (CX3CR1), mRNA
gi|4503170|ref|NM—001337.1|[4503170] - 5814: NM—001834
Homo sapiens clathrin, light polypeptide (Lcb) (CLTB), transcript variant nonbrain, mRNA
gi|4502900|ref|NM—001834.1|[4502900] - 5815: NM—001783
Homo sapiens CD79A antigen (immunoglobulin-associated alpha) (CD79A), transcript
variant 1, mRNA
gi|4502684|ref|NM—001783.1|[4502684] - 5816: AF277897
Homo sapiens truncated epidermal growth factor receptor (EGFR) mRNA, partial cds; alternatively spliced
gi|12658300|gb|AF277897.1|AF277897[12658300] - 5817: AF192403
Homo sapiens ETL protein (ETL) mRNA, complete cds
gi|11225482|gb|AF192403.1|AF192403[11225482] - 5818: AF259263
Homo sapiens toll-like receptor 9 form B (TLR9) mRNA, complete cds; alternatively spliced
gi|8099653|gb|AF259263.1|AF259263[8099653] - 5819: AF259262
Homo sapiens toll-like receptor 9 form A (TLR9) mRNA, complete cds; alternatively spliced
gi|8099651|gb|AF259262.1|AF259262[8099651] - 5820: AF246971
Homo sapiens Toll-like receptor 8 (TLR8) mRNA, complete cds
gi|7576932|gb|AF246971.1|AF246971[7576932] - 5821: AF240467
Homo sapiens toll-like receptor 7 (TLR7) mRNA, complete cds
gi|7330280|gb|AF240467.1|AF240467[7330280] - 5822: AF230073
Homo sapiens sialoadhesin mRNA, complete cds
gi|12656129|gb|AF230073.1|AF230073[12656129] - 5823: BC000783
Homo sapiens, calcitonin gene-related peptide-receptor component protein, clone
MGC:804, mRNA, complete cds
gi|12653974|gb|BC000783.1|BC000783[12653974] - 5824: NM—016184
Homo sapiens C-type (calcium dependent, carbohydrate-recognition domain) lectin,
superfamily member 6 (CLECSF6), mRNA
gi|7705337|ref|NM—016184.1|[7705337] - 5825: AF242540
Homo sapiens NK cell type I receptor protein 2B4 (2B4) mRNA, complete cds, alternatively spliced
gi|12642415|gb|AF242540.1|AF242540[12642415] - 5826: NM—020979
Homo sapiens adaptor protein with pleckstrin homology and src homology 2 domains
(APS), mRNA
gi|10280625|ref|NM—020979.1|[10280625] - 5827: NM—018557
Homo sapiens low density lipoprotein-related protein 1B (deleted in tumors) (LRP1B), mRNA
gi|9055269|ref|NM—018557.1|[9055269] - 5828: NM—012452
Homo sapiens transmembrane activator and CAML interactor (TACI), mRNA
gi|6912693|ref|NM—012452.1|[6912693] - 5829: NM—005338
Homo sapiens huntingtin interacting protein 1 (HIP1), mRNA
gi|12545385|ref|NM—005338.3|[12545385] - 5830: AF321238
Homo sapiens T-cell receptor variable beta-chain 15 mRNA, partial cds
gi|2484115|gb|AF321238.1|AF321238[12484115] - 5831: AF125253
Homo sapiens truncated epidermal growth factor receptor precursor (EGFR) mRNA,
complete cds
gi|1200221|gb|AF125253.1|AF125253[12002211] - 5832: NM—014211
Homo sapiens gamma aminobutyric acid (GABA) A receptor, pi (GABRP), mRNA
gi|7657105|ref|NM—014211.1|[7657105] - 5833: AF283463
Homo sapiens Nogo receptor mRNA, complete cds
gi|12407652|gb|AF283463.1|AF283463[12407652] - 5834: AF224266
Homo sapiens four alpha helix cytokine (ZCYTO10) mRNA, ZCYTO10-1 allele,
complete cds
gi|7109206|gb|AF224266.1|AF224266[7109206] - 5837: AB045370
Homo sapiens mRNA for histamine H4 receptor HH4R, complete cds
gi|12248411|dbj|AB045370.1|AB045370[12248411] - 5838: AB045369
Homo sapiens mRNA for histamine H3 receptor HH3R, complete cds
gi|12248409|dbj|AB045369.1|AB045369[12248409] - 5840: NM—016363
Homo sapiens glycoprotein VI (platelet) (GP6), mRNA
gi|7705956|ref|NM—016363.1|[7705956] - 5841: NM—022139
Homo sapiens GDNF family receptor alpha 4 (GFRA4), mRNA
gi|11545874|ref|NM—022139.1|[11545874] - 5842: NM—004403
Homo sapiens deafness, autosomal dominant 5 (DFNA5), mRNA
gi|4758153|ref|NM—004403.1|[4758153] - 5847: AF308156
Homo sapiens HERV-E LTR/leader long terminal repeat, complete sequence; and endothelin B receptor mRNA, partial cds
gi|12239519|gb|AF308156.1|AF308156[12239519] - 5850: NM—022789
Homo sapiens interleukin 17E (IL17E), mRNA
gi|12232484|ref|NM—022789.1|[12232484] - 5851: AX054991
Sequence 3 from Patent WO0073451
gi|12228357|emb|AX054991.1|AX054991[12228357] - 5852: AX054989
Sequence 1 from Patent WO0073451
gi|12228355|emb|AX054989.1|AX054989[12228355] - 5853: AJ278581
Homo sapiens DREV gene and IGSF6 gene for immunoglobulin superfamily 6 protein
gi|12053852|emb|AJ278581.1|HSA278581[12053852] - 5854: AJ302556
Homo sapiens 6M1-3*02 gene for olfactory receptor, cell line OLGA olfactory receptor
gi|12140483|emb|AJ302556.1|HSA302556[12140483] - 5855: AJ302555
Homo sapiens 6M1-3*02 gene for olfactory receptor, cell line SA olfactory receptor
gi|12140479|emb|AJ302555.1|HSA302555[12140479] - 5856: AJ302554
Homo sapiens 6M1-3*02 gene for olfactory receptor, cell line KR3598 olfactory receptor
gi|12140476|emb|AJ302554.1|HSA302554[12140476] - 5857: AJ302553
Homo sapiens 6M1-3*02 gene for olfactory receptor, cell line BM19.7 olfactory receptor
gi|12140472|emb|AJ302553.1|HSA302553[12140472] - 5858: AJ302552
Homo sapiens 6M1-3*02 gene for olfactory receptor, cell line BM28.7 olfactory receptor
gi|12140468|emb|AJ302552.1|HSA302552[12140468] - 5859: AF209481
Homo sapiens probable mannose binding C-type lectin DC-SIGNR gene, exons 3-8, and complete cds
gi|12084794|gb|AF209481.2|AF209480S2[12084794] - 5860: AH009824
Homo sapiens chromosome 19 probable mannose binding C-type lectin DC-SIGNR (abc)
gene, complete cds
gi|12084793|gb|AH009824.2|SEG_AF209480S[12084793] - 5861: AF313449
Homo sapiens P2Y12 platelet ADP receptor mRNA, complete cds
gi|1208390|gb|AF313449.1|AF313449[12083901] - 5884: AH009659
Homo sapiens RON gene, partial sequence
gi|9621821|gb|AH009659.1|SEG_HSRONPO[9621821] - 5885: NM—002351
Homo sapiens SH2 domain protein 1A, Duncan's disease (lymphoproliferative syndrome) (SH2D1A), mRNA
gi|4506922|ref|NM—002351.1|[4506922] - 5886: NM—000171
Homo sapiens glycine receptor, alpha 1 (startle disease/hyperekplexia, stiff man
syndrome) (GLRA1), mRNA
gi|4504018|ref|NM—000171.1|[4504018] - 5887: NM—000569
Homo sapiens Fc fragment of IgG, low affinity 111a, receptor for (CD16) (FCGR3A), mRNA
gi|12056966|ref|NM—000569.2|[12056966] - 5888: NM—000802
Homo sapiens folate receptor 1 (adult) (FOLR1), transcript variant 2, mRNA
gi|12056965|ref|NM—000802.2|[12056965] - 5889: NM—003979
Homo sapiens retinoic acid induced 3 (RA13), mRNA
gi|12056470|ref|NM—003979.2|[12056470] - 5900: AJ302633
Homo sapiens 6M1-02P*02 gene for olfactory receptor, cell line BM28.7
gi|12054481|emb|AJ302633.1|HSA302633[12054481] - 5910: AJ302623
Homo sapiens 6M1-18*02 gene for olfactory receptor, cell line KR3598
gi|12054470|emb|AJ302623.1|HSA302623[12054470] - 5911: AJ302622
Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line AMAI
gi|12054468|emb|AJ302622.1|HSA302622[12054468] - 5912: AJ302621
Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line OLGA
gi|12054466|emb|AJ302621.1|HSA302621[12054466] - 5913: AJ302620
Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line YAR
gi|12054464|emb|AJ302620.1|HSA302620[12054464] - 5914: AJ302619
Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line SA
gi|2054462|emb|AJ302619.1|HSA302619[12054462] - 5915: AJ302618
Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line WT51
gi|12054460|emb|AJ302618.1|HSA302618[12054460] - 5916: AJ302617
Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line H2LCL
gi|12054458|emb|AJ302617.1|HSA302617[12054458] - 5917: AJ302616
Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line LG2
gi|2054456|emb|AJ302616.1|HSA302616[12054456] - 5918: AJ302615
Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line BM19.7
gi|12054454|emb|AJ302615.1|HSA302615[12054454] - 5919: AJ302614
Homo sapiens 6M1-18*01 gene for olfactory receptor, cell line BM28.7
gi|12054452|emb|AJ302614.1|HSA302614[12054452] - 5920: AJ302613
Homo sapiens 6M1-16*03 gene for olfactory receptor, cell line AMAI
gi|12054450|emb|AJ302613.1|HSA302613[12054450] - 5921: AJ302612
Homo sapiens 6M1-16*03 gene for olfactory receptor, cell line BM19.7
gi|12054448|emb|AJ302612.1|HSA302612[12054448] - 5922: AJ302611
Homo sapiens 6M1-16*02 gene for olfactory receptor, cell line BM28.7
gi|12054446|emb|AJ302611.1|HSA302611[12054446] - 5923: AJ302610
Homo sapiens 6M1-16*01 gene for olfactory receptor, cell line OLGA
gi|12054444|emb|AJ302610.1|HSA302610[12054444] - 5924: AJ302609
Homo sapiens 6M1-16*01 gene for olfactory receptor, cell line YAR
gi|12054442|emb|AJ302609.1|HSA302609[12054442] - 5925: AJ302608
Homo sapiens 6M1-16*01 gene for olfactory receptor, cell line SA
gi|12054440|emb|AJ302608.1|HSA302608[12054440] - 5926: AJ302607
Homo sapiens 6M1-16*01 gene for olfactory receptor, cell line WT51
gi|12054438|emb|AJ302607.1|HSA302607[12054438] - 5927: AJ302606
Homo sapiens 6M1-16*01 gene for olfactory receptor, cell line H2LCL
gi|12054436|emb|AJ302606.1|HSA302606[12054436] - 5928: AJ302605
Homo sapiens 6M1-16*01 gene for olfactory receptor, cell line KR3598
gi|12054434|emb|AJ302605.1|HSA302605[12054434] - 5929: AJ302604
Homo sapiens 6M1-16*01 gene for olfactory receptor, cell line LG2
gi|2054432|emb|AJ302604.1|HSA302604[12054432] - 5930: AJ302603
Homo sapiens 6M1-15*03 gene for olfactory receptor, cell line AMAI
gi|12054430|emb|AJ302603.1|HSA302603[12054430] - 5931: AJ302602
Homo sapiens 6M1-15*02 gene for olfactory receptor, cell line WT51
gi|12054428|emb|AJ302602.1|HSA302602[12054428] - 5932: AJ302601
Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line OLGA
gi|12054426|emb|AJ302601.1|HSA302601[12054426] - 5933: AJ302600
Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line YAR
gi|12054424|emb|AJ302600.1|HSA302600[12054424] - 5934: AJ302599
Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line SA
gi|12054422|emb|AJ302599.1|HSA302599[12054422] - 5935: AJ302598
Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line H2LCL
gi|12054420|emb|AJ302598.1|HSA302598[12054420] - 5936: AJ302597
Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line KR3598
gi|12054418|emb|AJ302597.1|HSA302597[12054418] - 5937: AJ302596
Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line LG2
gi|12054416|emb|AJ302596.1|HSA302596[12054416] - 5938: AJ302595
Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line BM19.7
gi|12054414|emb|AJ302595.1|HSA302595[12054414] - 5939: AJ302594
Homo sapiens 6M1-15*01 gene for olfactory receptor, cell line BM28.7
gi|12054412|emb|AJ302594.1|HSA302594[12054412] - 5940: AJ302593
Homo sapiens 6M1-10*02 gene for olfactory receptor, cell line KR3598
gi|12054410|emb|AJ302593.1|HSA302593[12054410] - 5941: AJ302592
Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line AMAI
gi|12054408|emb|AJ302592.1|HSA302592[12054408] - 5942: AJ302591
Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line OLGA
gi|12054406|emb|AJ302591.1|HSA302591[12054406] - 5943: AJ302590
Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line YAR
gi|12054404|emb|AJ302590.1|HSA302590[12054404] - 5944: AJ302589
Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line SA
gi|12054402|emb|AJ302589.1|HSA302589[12054402] - 5945: AJ302588
Homo sapiens 6M-10*01 gene for olfactory receptor, cell line WT51
gi|12054400|emb|AJ302588.1|HSA302588[12054400] - 5946: AJ302587
Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line H2LCL
gi|12054398|emb|AJ302587.1|HSA302587[12054398] - 5947: AJ302586
Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line LG2
gi|12054396|emb|AJ302586.1|HSA302586[12054396] - 5948: AJ302585
Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line BM19.7
gi|12054394|emb|AJ302585.1|HSA302585[12054394] - 5949: AJ302584
Homo sapiens 6M1-10*01 gene for olfactory receptor, cell line BM28.7
gi|12054392|emb|AJ302584.1|HSA302584[12054392] - 5950: AJ302583
Homo sapiens 6M1-6*03 gene for olfactory receptor, cell line WT51
gi|12054390|emb|AJ302583.1|HSA302583[12054390] - 5951: AJ302582
Homo sapiens 6M1-6*02 gene for olfactory receptor, cell line OLGA
gi|12054388|emb|AJ302582.1|HSA302582[12054388] - 5952: AJ302581
Homo sapiens 6M1-6*02 gene for olfactory receptor, cell line KR3598
gi|12054386|emb|AJ3025810.1HSA302581[12054386] - 5953: AJ302580
Homo sapiens 6M1-6*02 gene for olfactory receptor, cell line SA
gi|12054384|emb|AJ302580.1|HSA302580[12054384] - 5954: AJ302579
Homo sapiens 6M1-6*02 gene for olfactory receptor, cell line AMAI
gi|12054382|emb|AJ302579.1|HSA302579[12054382] - 5955: AJ302578
Homo sapiens 6M1-6*02 gene for olfactory receptor, cell line BM28.7
gi|12054380|emb|AJ302578.1|HSA302578[12054380] - 5956: AJ302577
Homo sapiens 6M1-6*02 gene for olfactory receptor, cell line BM19.7
gi|112054378|emb|AJ302577.1|HSA302577[12054378] - 5957: AJ302576
Homo sapiens 6M1-6*01 gene for olfactory receptor, cell line OLGA
gi|12054376|emb|AJ302576.1|HSA302576[12054376] - 5958: AJ302575
Homo sapiens 6M1-6*01 gene for olfactory receptor, cell line YAR
gi|2054374|emb|AJ302575.1|HSA302575[12054374] - 5959: AJ302574
Homo sapiens 6M1-6*01 gene for olfactory receptor, cell line SA
gi|12054372|emb|AJ302574.1|HSA302574[12054372] - 5960: AJ302573
Homo sapiens 6M1-6*01 gene for olfactory receptor, cell line H2LCL
gi|12054370|emb|AJ302573.1|HSA302573[12054370] - 5961: AJ302572
Homo sapiens 6M1-6*01 gene for olfactory receptor, cell line KR3598
gi|12054368|emb|AJ302572.1|HSA302572[12054368] - 5962: AJ302571
Homo sapiens 6M1-6*01 gene for olfactory receptor, cell line LG2
gi|12054366|emb|AJ302571.1|HSA302571[12054366] - 5963: AJ302570
Homo sapiens 6M1-4P*05 gene for olfactory receptor, cell line BM19.7
gi|12054364|emb|AJ302570.1|HSA302570[12054364] - 5964: AJ302569
Homo sapiens 6M1-4P*05 gene for olfactory receptor, cell line BM28.7
gi|12054362|emb|AJ302569.1|HSA302569[12054362] - 5965: AJ302568
Homo sapiens 6M1-4P*04 gene for olfactory receptor, cell line AMAI
gi|12054360|emb|AJ302568.1|HSA302568[12054360] - 5966: AJ302567
Homo sapiens 6M1-4P*03 gene for olfactory receptor, cell line WT51
gi|12054358|emb|AJ302567.1|HSA302567[12054358] - 5967: AJ302566
Homo sapiens 6M1-4P*02 gene for olfactory receptor, cell line OLGA
gi|2054356|emb|AJ302566.1|HSA302566[12054356] - 5968: AJ302565
Homo sapiens 6M1-4P*02 gene for olfactory receptor, cell line KR3598
gi|12054354|emb|AJ302565.1|HSA302565[12054354] - 5975: AJ302558
Homo sapiens 6M1-3*04 gene for olfactory receptor, cell line AMAI
gi|12054346|emb|AJ302558.1|HSA302558[12054346] - 5976: AJ302557
Homo sapiens 6M1-3*03 gene for olfactory receptor, cell line WT51
gi|12054344|emb|AJ302557.1|HSA302557[12054344] - 5977: AJ302551
Homo sapiens 6M1-3*01 gene for olfactory receptor, cell line OLGA
gi|12054342|emb|AJ302551.1|HSA302551[12054342] - 5978: AJ302550
Homo sapiens 6M1-3*01 gene for olfactory receptor, cell line YAR
gi|12054340|emb|AJ302550.1|HSA302550[12054340] - 5979: AJ302549
Homo sapiens 6M1-3*01 gene for olfactory receptor, cell line SA
gi|12054338|emb|AJ302549.1|HSA302549[12054338] - 5980: AJ302548
Homo sapiens 6M1-3*01 gene for olfactory receptor, cell line H2LCL
gi|12054336|emb|AJ302548.1|HSA302548[12054336] - 5981: AJ302547
Homo sapiens 6M1-3*01 gene for olfactory receptor, cell line LG2
gi|2054334|emb|AJ302547.1|HSA302547[12054334] - 5982: AJ302546
Homo sapiens 6M1-1*02 gene for olfactory receptor, cell line BM19.7
gi|12054332|emb|AJ302546.1|HSA302546[12054332] - 5983: AJ302545
Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line KR3598
gi|12054330|emb|AJ302545.1|HSA302545[12054330] - 5984: AJ302544
Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line YAR
gi|12054328|emb|AJ302544.1|HSA302544[12054328] - 5985: AJ302543
Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line OLGA
gi|12054326|emb|AJ302543.1|HSA302543[12054326] - 5986: AJ302542
Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line SA
gi|12054324|emb|AJ302542.1|HSA302542[12054324] - 5987: AJ302541
Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line AMAI
gi|12054322|emb|AJ302541.1|HSA302541[12054322] - 5988: AJ302540
Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line WT51
gi|12054320|emb|AJ302540.1|HSA302540[12054320] - 5989: AJ302539
Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line H2LCL
gi|12054318|emb|AJ302539.1|HSA302539[12054318] - 5990: AJ302538
Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line BM28.7
gi|12054316|emb|AJ302538.1|HSA302538[12054316] - 5991: AJ302537
Homo sapiens 6M1-1*01 gene for olfactory receptor, cell line LG2
gi|12054314|emb|AJ302537.1|HSA302537[12054314] - 5993: AJ131724
Homo sapiens mRNA for serotonin receptor 5-HT4 (splice variant h5-HT4(b))
gi|12053629|emb|AJ131724.1|HSA131724[12053629] - 5994: AF305200
Homo sapiens interleukin 17E (IL17E) mRNA, complete cds
gi|11878209|gb|AF305200.1|AF305200[11878209] - 5995: AH003378
Homo sapiens ciliary neurotrophic factor alpha receptor gene
gi|608655|gb|AH003378.1|SEG_HUMCNFAR0[608655] - 5996: L38025
Homo sapiens ciliary neurotrophic factor alpha receptor gene, exons 8-10, complete cds
gi|608654|gb|L38025.1|HUMCNFAR06[608654] - 5997: L38024
Homo sapiens ciliary neurotrophic factor alpha receptor gene, exons 5-7
gi|608653|gb|L38024.1|HUMCNFAR05[608653] - 5998: L38023
Homo sapiens ciliary neurotrophic factor alpha receptor gene, exon 4
gi|608652|gb|L38023.1|HUMCNFAR04[608652] - 5999: L38022
Homo sapiens ciliary neurotrophic factor alpha receptor gene, exon 3
gi|608651|gb|L380220.1HUMCNFAR03[608651] - 6000: L38021
Homo Sapiens ciliary neurutrophic factor alpha receptor gene, exon 2
gi|608650|gb|L38021.1|HUMCNFAR02[608650] - 6001: L38020
Homo sapiens ciliary neurotrophic factor alpha receptor gene, exon 1
gi|608649|gb|L380200.1HUMCNFAR01[608649] - 6050: NM—012152
Homo sapiens endothelial differentiation, lysophosphatidic acid
G-protein-coupled receptor, 7 (EDG7), mRNA
gi|6912347|ref|NM—012152.1|[6912347] - 6051: NM—007360
Homo sapiens DNA segment on chromosome 12 (unique) 2489 expressed sequence (D12S2489E), mRNA
gi|6679051|ref|NM—007360.1|[6679051] - 6054: AF263029
Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 14
and complete cds
gi|12043771|gb|AF263029.1|F263016S14[12043771] - 6055: AF263028
Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 13
gi|12043770|gb|AF263028.1|F263016S13[12043770] - 6056: AF263027
Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 12
gi|12043769|gb|AF263027.1|F263016S12[12043769] - 6057: AF263026
Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 11----
gi|12043768|gb|AF263026.1|F263016S11[12043768] - 6058: AF263025
Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 10
gi|12043767|gb|AF263025.1|F263016S10[12043767] - 6059: AF263024
Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 9
gi|12043766|gb|AF263024.1|F263016S09[12043766] - 6060: AF263023
Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 8
gi|12043765|gb|AF263023.1|F263016S08[12043765] - 6061: AF263022
Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 7
gi|12043764|gb|AF263022.1|F263016S07[12043764] - 6062: AF263021
Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 6
gi|12043763|gb|AF263021.1F263016S06[12043763] - 6063: AF263020
Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 5
gi|12043762|gb|AF263020.1|F263016S05[12043762] - 6064: AF263019
Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon
gi|12043761|gb|AF263019.1|F263016S04[12043761] - 6065: AF263018
Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 3
gi|12043760|gb|AF263018.1|F263016S03[12043760] - 6066: AF263017
Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 2
gi|12043759|gb|AF263017.1|F263016S02[12043759] - 6067: AF263016
Homo sapiens protein tyrosine phosphatase receptor type R (PTPRR) gene, exon 1
gi|12043758|gb|AF263016.1|F263016S01[12043758] - 6068: AH010208
Homo sapiens chromosome 12 map 12q15
gi|12043757|gb|AH010208.1|SEG_F263016S[12043757] - 6069: AF310676
Homo sapiens E3 ubiquitin ligase SMURF2 mRNA, complete cds
gi|112018150gb|AF310676.1|AF310676[12018150] - 6070: AF310250
Homo sapiens IRS-1 PH domain binding protein PHIP mRNA, complete cds
gi|12007333|gb|AF310250.1|AF310250[12007333] - 6071: AF276292
Homo sapiens killer cell immunoglobulin-like receptor KIR2DL4 mRNA, complete cds
gi|12006296|gb|AF276292.1|AF276292[12006296] - 6072: AF272157
Homo sapiens killer cell immunoglobulin-like receptor precursor (KIR2DLX) gene,
complete cds
gi|12006228|gb|AF272157.1|AF272157[12006228] - 6073: AF271608
Homo sapiens clone 3 killer cell immunoglobulin-like receptor KIR2DLX (KIR2DLX)
mRNA, complete cds
gi|12006190|gb|AF271608.1|AF271608[12006190] - 6074: AF271607
Homo sapiens clone 13 killer cell immunoglobulin-like receptor KIR2DLX (KIR2DLX)
mRNA, complete cds
gi|2006188|gb|AF271607.1|AF271607[12006188] - 6075: AF223941
Homo sapiens complement receptor 2 (CR2) gene, promoter region and partial sequence
gi|12004993|gb|AF223941.1|AF223941[12004993] - 6076: AF196176
Homo sapiens capsaicin receptor variant mRNA, complete cds
gi|12003147|gb|AF196176.1|AF196176[12003147] - 6077: AF196175
Homo sapiens capsaicin receptor mRNA, complete cds
gi|12003145|gb|AF196175.1|AF196175[12003145] - 6078: AF125539
Homo sapiens epidermal growth factor receptor (EGFR) gene, alternative exons, exons 16 and 17 and partial cds, alternatively spliced
gi|12002219|gb|AF125539.1|AF125538S2[12002219] - 6079: AF125538
Homo sapiens epidermal growth factor receptor (EGFR) gene, exon 15
gi|2002218|gb|AF125538.1|AF125538S1[12002218] - 6080: AH010139
Homo sapiens epidermal growth factor receptor (EGFR) gene, partial cds, alternatively spliced
gi|12002217|gb|AH010139.1|SEG_AF125538S[12002217] - 6081: AF308571
Homo sapiens hepatointestinal leukotriene B4 receptor mRNA, complete cds
gi|11878227|gb|AF308571.1|AF308571[11878227] - 6082: AF275260
Homo sapiens SRPSOX (SRPSOX) mRNA, complete cds
gi|11139543|gb|AF275260.1|AF275260[11139543] - 6083: NM—007161
Homo sapiens DNA segment on chromosome 6 (unique) 49 expressed sequence, NK cell
triggering receptor, p30 (D6S49E), mRNA
gi|6005740|ref|NM—007161.1|[6005740] - 6090: AF289204
Homo sapiens odorant receptor HOR3′beta4 and odorant receptor HOR3′beta5 genes,
complete cds
gi|1991862|gb|AF289204.1|AF289203S2[11991862] - 6091: AF289203
Homo sapiens odorant receptor HOR3′beta1, odorant receptor HOR3′beta2, and odorant receptor HOR3′beta3 genes, complete cds
gi|11991861|gb|AF289203.1|AF289203S1[11991861] - 6092: AH010109
Homo sapiens odorant receptor HOR3′beta1, odorant receptor HOR3′beta4, odorant
receptor HOR3′beta2, odorant receptor HOR3′beta5, and odorant receptor HOR3′beta3 genes, complete cds
gi|11991860|gb|AH010109.1|SEG_AF289203S[11991860] - 6093: AF217689
Homo sapiens nociceptin receptor ORL1 (ORL1) gene, exons 1b and 2, and partial
cds, alternatively spliced
gi|11991833|gb|AF217689.1|AF217688S2[11991833] - 6094: AF217688
Homo sapiens G alpha interacting protein (GAIP) gene, partial cds, alternatively
spliced; and nociceptin receptor ORL1 (ORL1) gene, exon 1a
gi|11991832|gb|AF217688.1|AF217688S1[11991832] - 6095: AH010108
Homo sapiens G alpha interacting protein (GAIP) and nociceptin receptor ORL1 (ORL1) genes, partial cds
gi|1199183|gb|AH010108.1|SEG_AF217688S[11991831] - 6096: AB045011
Homo sapiens hmGluR2 gene for metabotropic glutamate receptor type 2, complete
cds
gi|11990938|dbj|AB045011.1|AB045011[11990938] - 6097: AF281074
Homo sapiens neuropilin 2 (NRP2) gene, complete cds, alternatively spliced
gi|11934947|gb|AF281074.1|AF281074[11934947] - 6098: AJ400846
Homo sapiens mRNA for immunoglobulin-like cell surface receptor FDFACT1, activating counterpart allele 1
gi|11932154|emb|AJ400846.1|HSA400846[11932154] - 6099: AJ400845
Homo sapiens mRNA for immunoglobulin-like cell surface receptor FDFACT2, activating counterpart allele 2
gi|11932151|emb|AJ400845.1|HSA400845[11932151] - 6100: AB024327
Homo sapiens pt-wd mRNA for WD-40 repeat protein, complete cds
gi|4519416|dbj|AB024327.1|AB024327[4519416] - 6102: AF280547
Homo sapiens neuropilin-1 soluble isoform 11 (NRP1) mRNA, complete cds, alternatively spliced
gi|11907931|gb|AF280547.1|AF280547[11907931] - 6103: AF280546
Homo sapiens neuropilin-2 soluble isoform 9 (NRP2) mRNA, complete cds, alternatively spliced
gi|11907929|gb|AF280546.1|AF280546[11907929] - 6104: AF280545
Homo sapiens neuropilin-2b(5) (NRP2) mRNA, complete cds, alternatively spliced
gi|11907927|gb|AF280545.1|AF280545[11907927] - 6105: AF280544
Homo sapiens neuropilin-2b(O) (NRP2) mRNA, complete cds, alternatively spliced
gi|11907925|gb|AF280544.1|AF280544[11907925] - 6106: AF268899
Homo sapiens neuropeptide FF receptor 2 (NPFF2) mRNA, complete cds
gi|11907914|gb|AF268899.1|AF268899[11907914] - 6107: AF268898
Homo sapiens neuropeptide FF receptor 1 (NPFF1) mRNA, complete cds
gi|11907912|gb|AF268898.1|AF268898[11907912] - 6111: Y19228
Homo sapiens partial GIR gene for glucocorticoid induced receptor, exons and joined CDS
gi|11878425|emb|Y19228.1|HSY19228[11878425] - 6118: Y19231
Homo sapiens partial GIR gene for glucocorticoid induced receptor, exon 4
gi|11877264|emb|Y19231.1|HSY19231[11877264] - 6119: Y19230
Homo sapiens partial GIR gene for glucocorticoid induced receptor, exon 3
gi|11877263|emb|Y19230.1|HSY19230[11877263] - 6120: Y19229
Homo sapiens partial GIR gene for glucocorticoid induced receptor, exon 2
gi|11877262|emb|Y19229.1|HSY19229[11877262] - 6121: AX047952
Sequence 19 from Patent WO0070045
gi|11876875|emb|AX047952.1|AX047952[11876875] - 6122: AX047940
Sequence 7 from Patent WO0070045
gi|11876863|emb|AX047940.1|AX047940[11876863] - 6123: AX047936
Sequence 3 from Patent WO0070045
gi|11876859|emb|AX047936.1|AX047936[11876859] - 6124: AJ272207
Homo sapiens mRNA for putative G protein-coupled receptor 92 (GPR92 gene)
gi|9843745|emb|AJ272207.1|HSA272207[9843745] - 6125: AF311306
Homo sapiens prostate specific G-protein coupled receptor gene, complete cds
gi|11875777|gb|AF311306.1|AF311306[11875777] - 6126: NM—022146
Homo sapiens neuropeptide FF 1; RFamide-related peptide receptor (OT7T022), mRNA
gi|11545886|ref|NM—022146.1|[11545886] - 6127: NM—004885
Homo sapiens neuropeptide G protein-coupled receptor; neuropeptide FF 2 (NPGPR),
mRNA
gi|4758819|ref|NM—004885.1|[4758819] - 6128: NM—002958
Homo sapiens RYK receptor-like tyrosine kinase (RYK), mRNA
gi|11863158|ref|NM—002958.1|[11863158] - 6129: AF217485
Homo sapiens KIR3D51 gene, partial sequence; and killer cell Ig-like receptor KIR2DL5.1 (KIR2DL5.1) gene, complete cds
gi|1761705|gb|AF217485.1|AF217485[11761705] - 6130: NM—005856
Homo sapiens receptor (calcitonin) activity modifying protein 3 (RAMP3), mRNA
gi|5032022|ref|NM—005856.1|[5032022] - 6131: NM—005854
Homo sapiens receptor (calcitonin) activity modifying protein 2 (RAMP2), mRNA
gi|5032020|ref|NM—005854.1|[5032020] - 6132: NM—005855
Homo sapiens receptor (calcitonin) activity modifying protein 1 (RAMP1), mRNA
gi|5032018|ref|NM—005855.1|[5032018] - 6133: NM—000025
Homo sapiens adrenergic, beta-3-, receptor (ADRB3), mRNA
gi|4557266|ref|NM—000025.1|[4557266] - 6134: AF245390
Homo sapiens GREB1c (GREB1) mRNA, complete cds, alternatively spliced
gi|11611737|gb|AF245390.1|AF245390[11611737] - 6135: AF245389
Homo sapiens GREB1b (GREB1) mRNA, complete cds, alternatively spliced
gi|11611735|gb|AF245389.1|AF245389[11611735] - 6136: AF245388
Homo sapiens GREB1a (GREB1) mRNA, partial cds, alternatively spliced
gi|11611733|gb|AF245388.1|AF245388[11611733] - 6137: AF292402
Homo sapiens neuromedin U receptor-type 2 mRNA, complete cds
gi|9944989|gb|AF292402.1|AF292402[9944989] - 6138: NM—002855
Homo sapiens poliovirus receptor-related 1 (herpesvirus entry mediator C; nectin) (PVRL1), mRNA
gi|11602905|ref|NM—002855.2|[11602905] - 6143: AH010043
Homo sapiens
gi|1155957|gb|AH010043.1|SEG_AF260138S[11559571] - 6144: AF260137
Homo sapiens killer-cell immunoglobulin-like receptor KIR2DL5.3 (KIR2DL5) gene,
exon 1 and partial cds
gi|11559569|gb|AF260137.1|AF260137[11559569] - 6145: X76400
Homo sapiens mRNA for nectin 1 (PRR1 gene)
gi|11558774|emb|X76400.2|HSPRR[11558774] - 6147: NM—022159
Homo sapiens ETL protein (ETL), mRNA
gi|11545907|ref|NM—022159.1|[11545907] - 6148: NM—022150
Homo sapiens RFamide-related peptide precursor (RFRP), mRNA
gi|11545893|ref|NM—022150.1|[11545893] - 6149: NM—022049
Homo sapiens G-protein coupled receptor 88 (GPR88), mRNA
gi|11545752|ref|NM—022049.1|[11545752] - 6219: AF281308
Homo sapiens alpha 2A adrenergic receptor (ADRA2A) gene, complete cds
gi|9652209|gb|AF281308.1|AF281308[9652209] - 6241: AF217487
Homo sapiens killer cell Ig-like receptor KIR2DL5.3 (KIR2DL5.3) mRNA, complete
cds
gi|11528059|gb|AF217487.1|AF217487[11528059] - 6242: NM—003553
Homo sapiens olfactory receptor, family 1, subfamily E, member 1 (OR1E1), mRNA
gi|11496274|ref|NM—003553.1|[11496274] - 6243: AF208054
Homo sapiens non-inhibitory killer-cell Ig-like receptor KIR (KIR2D55) mRNA, complete cds
gi|11493968|gb|AF208054.1|AF208054[11493968] - 6244: NM—018690
Homo sapiens apolipoprotein B48 receptor (APOB48R), mRNA
gi|8922078|ref|NM—018690.1|[8922078] - 6245: AB044934
Homo sapiens H4R mRNA for histamine H4 receptor, complete cds
gi|10241846|dbj|AB044934.1|AB044934[10241846] - 6246: NM—003555
Homo sapiens olfactory receptor, family 1, subfamily G, member 1 (OR1G1), mRNA
gi|11415033|ref|NM—003555.1|[11415033] - 6247: NM—003552
Homo sapiens olfactory receptor, family 1, subfamily D, member 4 (OR1D4), mRNA
gi|11415031|ref|NM—003552.1|[11415031] - 6248: NM—003554
Homo sapiens olfactory receptor, family 1, subfamily E, member 2 (OR1E2), mRNA
gi|11386152|ref|NM—003554.1|[11386152] - 6390: AF264014
Homo sapiens scavenger receptor cysteine-rich type 1 protein M160 precursor, mRNA, complete cds, alternatively spliced
gi|9652086|gb|AF264014.1|AF264014[9652086] - 6391: AF169007
Homo sapiens beta-1-adrenergic receptor (ADRB1) gene, complete cds
gi|5833816|gb|AF169007.1|AF169007[5833816] - 6392: AF169006
Homo sapiens beta-1-adrenergic receptor (ADRB1) gene, complete cds
gi|5833814|gb|AF169006.1|AF169006[5833814] - 6393: AF159854
Homo sapiens cytokine signaling suppressor (SOCS3) mRNA, complete cds
gi|5353755|gb|AF159854.1|AF159854[5353755] - 6394: AF032124
Homo sapiens RET proto-oncogene (RET) gene, 5′ flanking region and partial cds
gi|2795879|gb|AF032124.1|AF032124[2795879] - 6395: NM—002644
Homo sapiens polymeric immunoglobulin receptor (PIGR), mRNA
gi|11342673|ref|NM—002644.1|[11342673] - 6396: AJ249248
Homo sapiens mRNA for putative G protein-coupled Receptor
gi|5834594|emb|AJ249248.1|HSA249248[5834594] - 6397: AJ277028
Homo sapiens mRNA for vanilloid receptor 1 (VR1 gene)
gi|8977865|emb|AJ277028.1|HSA277028[8977865] - 6398: AF072872
Homo sapiens frizzled 1 mRNA, complete cds
gi|5305406|gb|AF072872.1|AF072872[5305406] - 6399: AF073727
Homo sapiens EH domain-binding mitotic phosphoprotein (EPSIN) mRNA, complete cds
gi|5051635|gb|AF073727.1|AF073727[5051635] - 6400: NM—002551
Homo sapiens olfactory receptor, family 3, subfamily A, member 2 (OR3A2), mRNA
gi|11321568|ref|NM—002551.1|[11321568] - 6401: NM—000870
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 4 (HTR4), mRNA
gi|11321562|ref|NM—000870.1|[11321562] - 6419: AB042411
Homo sapiens strg gene for striatum-specific G potein-coupled receptor, complete
cds
gi|11275369|dbj|AB042411.1|AB042411[11275369] - 6420: AB042410
Homo sapiens strg mRNA for striatum-specific G protein-coupled receptor, complete cds
gi|1275367|dbj|AB042410.1|AB042410[11275367] - 6434: AJ289159
Homo sapiens CD30 gene for cytokine receptor CD30, exons 1-8
gi|11230634|emb|AJ289159.1|HSA289159[11230634] - 6435: AF279762
Homo sapiens ROR2 (ROR2) gene, exon 9 and partial cds
gi|11228720|gb|AF279762.1|AF279755S8[11228720] - 6436: AF279761
Homo sapiens ROR2 (ROR2) gene, exon 8
gi|11228719|gb|AF279761.1|AF279755S7[11228719] - 6437: AF279760
Homo sapiens ROR2 (ROR2) gene, exon 7
gi|11228718|gb|AF279760.1|AF279755S6[11228718] - 6438: AF279759
Homo sapiens ROR2 (ROR2) gene, exon 6
gi|11228717|gb|AF279759.1|AF279755S5[11228717] - 6439: AF279758
Homo sapiens ROR2 (ROR2) gene, exon 5
gi|11228716|gb|AF279758.1|AF279755S4[11228716] - 6440: AF279757
Homo sapiens ROR2 (ROR2) gene, exon 4
gi|11228715|gb|AF279757.1|AF279755S3[11228715] - 6441: AF279756
Homo sapiens ROR2 (ROR2) gene, exon 3
gi|11228714|gb|AF279756.1|AF279755S2[11228714] - 6442: AF279755
Homo sapiens ROR2 (ROR2) gene, exon 2
gi|11228713|gb|AF279755.1|AF279755S1[11228713] - 6443: AH010002
Homo sapiens ROR2 (ROR2) gene, partial cds
gi|11228712|gb|AH010002.1|SEG AF279755S[11228712] - 6444: AF260529
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 19 and partial cds
gi|11228705|gb|AF260529.1|F260514S16[11228705] - 6445: AF260528
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exons 17 and 18
gi|11228704|gb|AF260528.1|F260514S15[11228704] - 6446: AF260527
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 16
gi|11228703|gb|AF260527.1|F260514S14[11228703] - 6447: AF260526
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 15
gi|11228702|gb|AF260526.1|F260514S13[11228702] - 6448: AF260525
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 14
gi|11228701|gb|AF260525.1|F260514S12[11228701] - 6449: AF260524
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exons 12 and 13
gi|11228700|gb|AF260524.1|F260514S11[11228700] - 6450: AF260523
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 11
gi|11228699|gb|AF260523.1|F260514S10[11228699] - 6451: AF260522
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 10
gi|11228698|gb|AF260522.1|F260514S09[11228698] - 6452: AF260521
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 9 - 6453: AF260520
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 8
gi|11228696|gb|AF260520.1|F260514S07[11228696] - 6454: AF260519
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 7
gi|11228695|gb|AF260519.1|F260514S06[11228695] - 6455: AF260518
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 6
gi|11228694|gb|AF260518.1|F260514S05[11228694] - 6456: AF260517
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 5
gi|11228693|gb|AF260517.1|F260514S04[11228693] - 6457: AF260516
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 4
gi|11228692|gb|AF260516.1|F260514S03[11228692] - 6458: AF260515
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 3
gi|11228691|gb|AF260515.1|F260514S02[11228691] - 6459: AF260514
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, exon 2
gi|11228690|gb|AF260514.1|F260514S01[11228690] - 6460: AH010001
Homo sapiens MER receptor tyrosine kinase (MERTK) gene, partial cds
gi|11228689|gb|AH010001.1|SEG_F260514S[11228689] - 6461: AF175406
Homo sapiens transient receptor potential 4 (TRP4) mRNA, complete cds
gi|5802614|gb|AF175406.1|AF175406[5802614] - 6462: NM—017416
Homo sapiens interleukin 1 receptor accessory protein-like 2 (IL1RAPL2), mRNA
gi|11225606|ref|NM—017416.1|[11225606] - 6463: AJ295237
Homo sapiens mRNA for neuronal nicotinic acetylcholine receptor subunit alpha 10
(NACHR alpha 10 gene)
gi|11182127|emb|AJ295237.1|HSA295237[11182127] - 6464: NM—004720
Homo sapiens endothelial differentiation, lysophosphatidic acid
G-protein-coupled receptor, 4 (EDG4), mRNA
gi|11038657|ref|NM—004720.3|[11038657] - 6465: AF298770
Homo sapiens Smac/DIABLO-S protein mRNA, complete cds
gi|107196531|gb|AF298770.1|AF298770[10719653] - 6562: NM—005226
Homo sapiens endothelial differentiation, sphingolipid G-protein-coupled receptor, 3 (EDG3), mRNA
gi|4885194|ref|NM—005226.1|[4885194] - 6563: NM—021803
Homo sapiens interleukin 21 (IL21), mRNA
gi|11141874|ref|NM—021803.1|[11141874] - 6564: NM—021798
Homo sapiens interleukin 21 receptor (IL21R), mRNA
gi|11141868|ref|NM—021798.1|[11141868] - 6565: AF307973
Homo sapiens histamine H4 receptor mRNA, complete cds
gi|11141732|gb|AF307973.1|AF307973[11141732] - 6566: X06026
Homo sapiens partial CD3G gene, exon 1 (and joined CDS)
gi|36809|emb|X06026.1|HSTCR3G1[36809] - 6567: AF200220
Homo sapiens FcRn alpha chain (FCGRT) gene, exons 5, 6, 7, and complete cds
gi|11138512|gb|AF200220.1|AF200219S2[11138512] - 6568: AF200219
Homo sapiens FcRn alpha chain (FCGRT) gene, exons 1 through 4
gi|11138511|gb|AF200219.1|AF200219S1[1113851l] - 6569: AH009974
Homo sapiens FcRn alpha chain (FCGRT) gene, exons 1 through 4
gi|11138510|gb|AH009974.1|SEG_AF200219S[11138510] - 6570: NM—017581
Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 9 (CHRNA9), mRNA
gi|8923741|ref|NM—017581.1|[8923741] - 6571: AB040290
Homo sapiens RFRP mRNA for RFamide-related peptide precursor, complete cds
gi|11125707|dbj|AB040290.1|AB040290[11125707] - 6572: AB040104
Homo sapiens OT7T022 mRNA for RFamide-related peptide receptor, complete cds
gi|11125701|dbj|AB040104.1|AB040104[11125701] - 6598: AF308542
Homo sapiens clone ST1L_G11 immunoglobulin heavy chain mRNA, partial cds
gi|11119124|gb|AF308542.1|AF308542[11119124] - 6599: AJ271338
Homo sapiens IL1L1 gene for interleukin-1 like protein 1, exons 1-6
gi|6729586|emb|AJ271338.1|HSA271338[6729586] - 6600: AJ242738
Homo sapiens mRNA for interleukin-1-like protein 1 (IL1L1 gene) transcript 2
gi|6165335|emb|AJ242738.1|HSA242738[6165335] - 6601: AJ242737
Homo sapiens mRNA for interleukin-1-like protein-1 (IL1L gene), transcript 1
gi|6165333|emb|AJ242737.1|HSA242737[6165333] - 6602: NM—005508
Homo sapiens chemokine (C-C motif) receptor 4 (CCR4), mRNA
gi|5031626|ref|NM—005508.1|[5031626] - 6603: NM—005283
Homo sapiens chemokine (C motif) XC receptor 1 (CCXCR1), mRNA
gi|4885338|ref|NM—005283.1|[4885338] - 6604: AJ238419
Homo sapiens mRNA for HIV-specific T-cell receptor beta chain, clone R1, partial
gi|4691321|emb|AJ238419.1|HSA238419[4691321] - 6605: AJ238418
Homo sapiens mRNA for HIV-specific T-cell receptor beta chain, clone MA, partial
gi|4691319|emb|AJ238418.1|HSA238418[4691319] - 6606: AJ238417
Homo sapiens mRNA for HIV-specific T-cell receptor beta chain, clone HA, partial
gi|4691317|emb|AJ238417.1|HSA238417[4691317] - 6607: AJ238416
Homo sapiens mRNA for HIV-specific T-cell receptor alpha chain, clone R1, partial
gi|4691315|emb|AJ238416.1|HSA238416[4691315] - 6608: AJ238415
Homo sapiens mRNA for HIV-specific T-cell receptor alpha chain, clone MA, partial
gi|4691313|emb|AJ238415.1|HSA238415[4691313] - 6609: AJ238414
Homo sapiens mRNA for HIV-specific T-cell receptor alpha chain, clone HA, partial
gi|4691311|emb|AJ238414.1|HSA238414[4691311] - 6610: AF074042
AF074042 Human Homo sapiens genomic clone pTWB15.69 T7, genomic survey sequence
gi|3342086|gb|AF074042.1|AF074042[3342086] - 6611: AF074041
AF074041 Human Homo sapiens genomic clone pTWB15.69 SP6, genomic survey sequence
gi|3342085|gb|AF074041.1|AF074041[3342085] - 6612: AF074040
AF074040 Human Homo sapiens genomic clone pTWB15.53 T7, genomic survey sequence
gi|3342084|gb|AF074040.1|AF074040[3342084] - 6613: AF074039
AF074039 Human Homo sapiens genomic clone pTWB15.53 SP6, genomic survey sequence
gi|3342083|gb|AF074039.1|AF074039[3342083] - 6614: AF074038
AF074038 Human Homo sapiens genomic clone pTWB15.43 T7, genomic survey sequence
gi|3342082|gb|AF074038.1|AF074038[3342082] - 6615: AF074037
AF074037 Human Homo sapiens genomic clone pTWB15.43 SP6, genomic survey sequence
gi|3342081|gb|AF074037.1|AF074037[3342081] - 6616: AF074036
AF074036 Human Homo sapiens genomic clone pTWB15.42, genomic survey sequence
gi|3342080|gb|AF074036.1|AF074036[3342080] - 6617: AF074034
AF074034 Human Homo sapiens genomic clone pTWB15.32 T7, genomic survey sequence
gi|3342079|gb|AF074034.1|AF074034[3342079] - 6618: AF074033
AF074033 Human Homo sapiens genomic clone pTWB15.32 SP6, genomic survey sequence
gi|3342078|gb|AF074033.1|AF074033[3342078] - 6619: AF074032
AF074032 Human Homo sapiens genomic clone pTWB15.31 T7, genomic survey sequence
gi|3342077|gb|AF074032.1|AF074032[3342077] - 6620: AF074031
AF074031 Human Homo sapiens genomic clone pTWB15.31 SP6, genomic survey sequence
gi|3342076|gb|AF074031.1|AF074031[3342076] - 6621: AF074030
AF074030 Human Homo sapiens genomic clone pTWB15.28 T7, genomic survey sequence
gi|3342075|gb|AF074030.1|AF074030[3342075] - 6622: AF074028
AF074028 Human Homo sapiens genomic clone pTWB15.21, genomic survey sequence
gi|3342074|gb|AF074028.1|AF074028[3342074] - 6623: AF074027
AF074027 Human Homo sapiens genomic clone pTWB15.12, genomic survey sequence
gi|3342073|gb|AF074027.1|AF074027[3342073] - 6624: AF074026
AF074026 Human Homo sapiens genomic clone pTWB15.09, genomic survey sequence
gi|3342072|gb|AF074026.1|AF074026[3342072] - 6625: AF074025
AF074025 Human Homo sapiens genomic clone pTWB15.08, genomic survey sequence
gi|3342071|gb|AF074025.1|AF074025[3342071] - 6626: AF074024
AF074024 Human Homo sapiens genomic clone pTWB15.07, genomic survey sequence
gi|3342070|gb|AF074024.1|AF074024[3342070] - 6627: AF074023
AF074023 Human Homo sapiens genomic clone pTWB15.04, genomic survey sequence
gi|3342069|gb|AF074023.1|AF074023[3342069] - 6628: AF074022
AF074022 Human Homo sapiens genomic clone pTWB15.04 SP6, genomic survey sequence
gi|3342068|gb|AF074022.1|AF074022[3342068] - 6629: NM—000450
Homo sapiens selectin E (endothelial adhesion molecule 1) (SELE), mRNA
gi|4506870|ref|NM—000450.1|[4506870] - 6630: AF254069
Homo sapiens interleukin 21 (IL21) mRNA, complete cds
gi|11093535|gb|AF254069.1|AF254069[11093535]
- 6631: AF254067
Homo sapiens interleukin 21 receptor (IL21R) mRNA, complete cds
gi|1093531|gb|AF254067.1|AF254067[11093531] - 6632: AF251510
Homo sapiens leukocyte-associated Ig-like receptor 1D isoform mRNA, complete cds
gi|1090865|gb|AF251510.2|AF251510[11090865] - 6633: AF251509
Homo sapiens leukocyte-associated Ig-like receptor 1C isoform mRNA, complete cds
gi|11090859|gb|AF251509.2|AF251509[11090859] - 6634: AB3043943
Homo sapiens GPVI gene for platelet glycoprotein VI, partial cds
gi|9955915|dbj|AB043943.1|AB043943[9955915] - 6635: AB043821
Homo sapiens GPVI mRNA for platelet glycoprotein VI-3, complete cds
gi|9955913|dbj|AB3043821.1|AB043821[9955913] - 6636: AB043820
Homo sapiens GPVI mRNA for platelet glycoprotein VI-2, complete cds
gi|9955911|dbj|AB043820.1|AB043820[9955911] - 6637: AB043819
Homo sapiens GPVI mRNA for platelet glycoprotein VI-1, complete cds
gi|9955909|dbj|AB043819.1|AB043819[9955909] - 6638: NM—000527
Homo sapiens low density lipoprotein receptor (familial hypercholesterolemia) (LDLR), mRNA
gi|8051613|ref|NM—000527.2|[8051613] - 6639: NM—012407
Homo sapiens protein kinase C, alpha binding protein (PRKCABP), mRNA
gi|7110696|ref|NM—012407.1|[7110696] - 6640: NM—005232
Homo sapiens EphA1 (EPHA1), mRNA
gi|4885208|ref|NM—005232.1|[4885208] - 6641: NM—000214
Homo sapiens jagged 1 (Alagille syndrome) (JAG1), mRNA
gi|4557678|ref|NM—000214.1|[4557678] - 6642: NM—000875
Homo sapiens insulin-like growth factor 1 receptor (IGF1R), mRNA
gi|11068002|ref|NM—000875.2|[11068002] - 6643: AF298812
Homo sapiens X-linked ectodysplasin-A2 receptor (XEDAR) mRNA, complete cds
gi|11066914|gb|AF298812.1|AF298812[11066914] - 6644: AF197929
Homo sapiens short form lysophosphatidic acid receptor EDG4 (EDG4) mRNA, complete cds
gi|11066253|gb|AF197929.1|AF197929[11066253] - 6645: NM—021642
Homo sapiens Fc fragment of IgG, low affinity IIa, receptor for (CD32) (FCGR2A),
mRNA
gi|11056051|ref|NM—021642.1|[11056051] - 6646: AF280400
Homo sapiens alpha 2C adrenergic receptor variant (ADRA2C) gene, complete cds
gi|11055420|gb|AF280400.1|AF280400[11055420] - 6647: AF280399
Homo sapiens alpha 2C adrenergic receptor (ADRA2C) gene, complete cds
gi|11055418|gb|AF280399.1|AF280399[11055418] - 6648: AF263523
Homo sapiens vanilloid receptor-related osmotically activated channel (VROAC) mRNA, complete cds
gi|11055321|gb|AF263523.1|AF263523[11055321] - 6649: NM—001117
Homo sapiens adenylate cyclase activating polypeptide 1 (pituitary) (ADCYAP1),
mRNA
gi|10947062|ref|NM—001117.2|[10947062] - 6650: NM—002355
Homo sapiens mannose-6-phosphate receptor (cation dependent) (M6PR), mRNA
gi|10947032|ref|NM—002355.2|[10947032] - 6651: NM—000541
Homo sapiens S-antigen; retina and pineal gland (arrestin) (SAG), mRNA
gi|10880124|ref|NM—000541.2|[10880124] - 6652: NM—021130
Homo sapiens peptidylprolyl isomerase A (cyclophilin A) (PPIA), mRNA
gi|10863926|ref|NM—021130.1|[10863926] - 6653: NM—001106
Homo sapiens activin A receptor, type IIB (ACVR2B), mRNA
gi|10862697|ref|NM—001106.2|[10862697] - 6654: NM—001616
Homo sapiens activin A receptor, type II (ACVR2), mRNA
gi|10862696|ref|NM—001616.2|[10862696] - 6655: NM—001105
Homo sapiens activin A receptor, type I (ACVR1), mRNA
gi|10862690|ref|NM—001105.2|[10862690] - 6656: NM—001136
Homo sapiens advanced glycosylation end product-specific receptor (AGER), mRNA
gi|10835202|ref|NM—001136.1|[10835202] - 6657: NM—000866
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1F (HTR1F), mRNA
gi|10835196|ref|NM—000866.1|[10835196] - 6658: NM—000629
Homo sapiens interferon (alpha, beta and omega) receptor 1 (IFNAR1), mRNA
gi|10835182|ref|NM—000629.1|[10835182] - 6659: NM—000621
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A), mRNA
gi|10835174|ref|NM—000621.1|[10835174] - 6660: NM—000610
Homo sapiens CD44 antigen (homing function and Indian blood group system) (CD44), mRNA
gi|10835162|ref|NM—000610.1|[10835162] - 6661: NM—000585
Homo sapiens interleukin 15 (IL15), mRNA
gi|10835152|ref|NM—000585.1|[10835152] - 6662: NM—000586
Homo sapiens interleukin 2 (IL2), mRNA
gi|10835148|ref|NM—000586.1|[10835148] - 6663: NM—000577
Homo sapiens interleukin 1 receptor antagonist (IL1RN), mRNA
gi|10835146|ref|NM—000577.1|[10835146] - 6664: NM—000576
Homo sapiens interleukin 1, beta (IL1B), mRNA
gi|10835144|ref|NM—000576.1|[10835144] - 6665: NM—000570
Homo sapiens Fc fragment of IgG, low affinity 111b, receptor for (CD16) (FCGR3B), mRNA
gi|10835138|ref|NM—000570.1|[10835138] - 6666: NM—000566
Homo sapiens Fc fragment of IgG, high affinity Ia, receptor for (CD64) (FCGR1A),
mRNA
gi|10835132|ref|NM—000566.1|[10835132] - 6667: NM—000564
Homo sapiens interleukin 5 receptor, alpha (IL5RA), mRNA
gi|10835130|ref|NM—000564.1|[10835130] - 6668: NM—000525
Homo sapiens potassium inwardly-rectifying channel, subfamily J, member 11
gi|10835116|ref|NM—000525.1|[10835116] - 6669: NM—003841
Homo sapiens tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain (TNFRSF10C), mRNA
gi|10835042|ref|NM—003841.1|[10835042] - 6672: NM—001307
Homo sapiens claudin 7 (CLDN7), mRNA
gi|10835007|ref|NM—001307.1[10835007] - 6673: NM—000640
Homo sapiens interleukin 13 receptor, alpha 2 (IL13RA2), mRNA
gi|10834991|ref|NM—000640.1|[10834991] - 6674: NM—001993
Homo sapiens coagulation factor III (thromboplastin, tissue factor) (F3), mRNA
gi|10518499|ref|NM—001993.2|[10518499] - 6675: NM—013252
Homo sapiens C-type (calcium dependent, carbohydrate-recognition domain) lectin,
superfamily member 5 (CLECSF5), mRNA
gi|10281668|ref|NM—013252.1|[10281668] - 6676: NM—020547
Homo sapiens anti-Mullerian hormone receptor, type II (AMHR2), mRNA
gi|10198655|ref|NM—020547.1|[10198655] - 6677: NM—018970
Homo sapiens G protein-coupled receptor 85 (GPR85), mRNA
gi|10190654|ref|NM—018970.2|[10190654] - 6678: NM—014292
Homo sapiens chromobox homolog 6 (CBX6), mRNA
gi|10140848|ref|NM—014292.1|[10140848] - 6679: NM—019897
Homo sapiens olfactory receptor, family 2, subfamily S, member 2 (OR2S2), mRNA
gi|10092668|ref|NM—019897.1|[10092668] - 6680: NM—014499
Homo sapiens putative purinergic receptor (P2Y10), mRNA
gi|10092632|ref|NM—014499.1|[10092632] - 6681: NM—017572
Homo sapiens G protein-coupled receptor kinase 7 (GPRK7), mRNA
gi|9994196|ref|NM—017572.1|[9994196] - 6682: NM—020406
Homo sapiens polycythemia rubra vera 1; cell surface receptor (PRV1), mRNA
gi|9966888|ref|NM—020406.1|[9966888] - 6683: NM—020377
Homo sapiens cysteinyl leukotriene CysLT2 receptor; cDNA: PSEC0146 from clone PLACE1006979 (LOC57105), mRNA
gi|9966850|ref|NM—020377.1|[9966850] - 6686: NM—002295
Homo sapiens laminin receptor 1 (67 kD, ribosomal protein SA) (LAMR1), mRNA
gi|9845501|ref|NM—002295.2|[9845501] - 6687: NM—019839
Homo sapiens seven transmembrane receptor BLTR2; leukotriene B4 receptor BLT2 (BLTR2), mRNA
gi|9789896|ref|NM—019839.1|[9789896] - 6688: NM—018969
Homo sapiens super conserved receptor expressed in brain 3 (SREB3), mRNA
gi|9507142|ref|NM—018969.1|[9507142] - 6689: NM—018949
Homo sapiens G protein-coupled receptor 14 (GPR14), mRNA
gi|9506744|ref|NM—018949.1|[9506744] - 6690: NM—000804
Homo sapiens folate receptor 3 (gamma) (FOLR3), mRNA
gi|9257219|ref|NM—000804.2|[9257219] - 6691: NM—000803
Homo sapiens folate receptor 2 (fetal) (FOLR2), mRNA
gi|9257218|ref|NM—000803.2|[9257218] - 6692: NM—017526
Homo sapiens leptin receptor gene-related protein (HSOBRGRP), mRNA
gi|8923784|ref|NM—017526.1|[8923784] - 6693: NM—017532
Homo sapiens p65 protein (HSAJ2425), mRNA
gi|8923776|ref|NM—017532.1|[8923776] - 6694: NM—017442
Homo sapiens toll-like receptor 9 (TLR9), mRNA
gi|8394455|ref|NM—017442.1|[8394455] - 6695: NM—016946
Homo sapiens junctional adhesion molecule (JAM), mRNA
gi|8393637|ref|NM—016946.1|[8393637] - 6697: NM—013280
Homo sapiens fibronectin leucine rich transmembrane protein 1 (FLRT1), mRNA
gi|8051591|ref|NM—013280.2|[8051591] - 6698: NM—013431
Homo sapiens killer cell lectin-like receptor subfamily C, member 4 (KLRC4), mRNA
gi|7710123|ref|NM—013431.1|[7710123] - 6699: NM—016568
Homo sapiens G-protein coupled receptor SALPR; somatostatin and angiotensin-like
peptide receptor (LOC51289), mRNA
gi|7706102|ref|NM—016568.1|[7706102] - 6700: NM—015863
Homo sapiens surfactant protein B (LOC51041), mRNA
gi|7705659|ref|NM—015863.1|[7705659] - 6702: NM—015868
Homo sapiens NK-receptor (KIR-023 GB), mRNA
gi|7705567|ref|NM—015868.1|[7705567] - 6703: NM—016540
Homo sapiens G protein-coupled receptor 72 (GPR72), mRNA
gi|7705384|ref|NM—016540.1|[7705384] - 6704: NM—001059
Homo sapiens tachykinin receptor 3 (TACR3), mRNA
gi|7669547|ref|NM—001059.1|[7669547] - 6705: NM—014030
Homo sapiens G protein-coupled receptor kinase-interactor 1 (GIT1), mRNA
gi|7661711|ref|NM—014030.1|[7661711] - 6706: NM—014521
Homo sapiens SH3-domain binding protein 4 (SH3BP4), mRNA
gi|7657561|ref|NM—014521.1|[7657561] - 6707: NM—014285
Homo sapiens homolog of Yeast RRP4 (ribosomal RNA processing 4), 3′-5′-exoribonuclease (RRP4), mRNA
gi|7657527|ref|NM—014285.1|[7657527] - 6708: NM—014566
Homo sapiens olfactory receptor, family 1, subfamily D, member 5 (OR1D5), mRNA
gi|7657422|ref|NM—014566.1|[7657422] - 6709: NM—014565
Homo sapiens olfactory receptor, family 1, subfamily A, member 1 (OR1A1), mRNA
gi|7657420|ref|NM—014565.1|[7657420] - 6710: NM—014221
Homo sapiens mature T-cell proliferation 1 (MTCP1), mRNA
gi|7657348|ref|NM—014221.1|[7657348] - 6711: NM—014387
Homo sapiens linker for activation of T cells (LAT), mRNA
gi|7657292|ref|NM—014387.1|[7657292] - 6712: NM—014514
Homo sapiens killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1 (KIR3D51), mRNA
gi|7657280|ref|NM—014514.1|[7657280] - 6713: NM—014513
Homo sapiens killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5 (KIR2D55), mRNA
gi|7657278|ref|NM—014513.1|[7657278] - 6714: NM—014512
Homo sapiens killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1 (KIR2D51), mRNA
gi|7657276|ref|NM—014512.1|[7657276] - 6715: NM—014511
Homo sapiens killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 (KIR2DL3), mRNA
gi|7657274|ref|NM—014511.1|[7657274] - 6716: NM—014219
Homo sapiens killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 (KIR2DL2), mRNA
gi|7657272|ref|NM—014219.1|[7657272] - 6717: NM—014218
Homo sapiens killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 (KIR2DL1), mRNA
gi|7657270|ref|NM—014218.1|[7657270] - 6718: NM—014271
Homo sapiens interleukin 1 receptor accessory protein-like 1 (IL1RAPL1), mRNA
gi|7657231|ref|NM—014271.1|[7657231] - 6719: NM—014339
Homo sapiens interleukin 17 receptor (IL17R), mRNA
gi|7657229|ref|NM—014339.1|[7657229] - 6720: NM—014619
Homo sapiens glutamate receptor, ionotropic, kainate 4 (GRIK4), mRNA
gi|7657143|ref|NM—014619.1|[7657143] - 6721: NM—014626
Homo sapiens G protein-coupled receptor 58 (GPR58), mRNA
gi|7657141|ref|NM—014626.1|[7657141] - 6722: NM—014627
Homo sapiens G protein-coupled receptor 57 (GPR57), mRNA
gi|7657139|ref|NM—014627.1|[7657139] - 6723: NM—014373
Homo sapiens putative G protein-coupled receptor (GPCR150), mRNA
gi|7657135|ref|NM—014373.1|[7657135] - 6724: NM—005529
Homo sapiens heparan sulfate proteoglycan 2 (perlecan) (HSPG2), mRNA
gi|7427516|ref|NM—005529.2|[7427516] - 6727: NM—005415
Homo sapiens solute carrier family 20 (phosphate transporter), member 1 (SLC20A1), mRNA
gi|7382462|ref|NM—005415.2|[7382462] - 6728: NM—005199
Homo sapiens cholinergic receptor, nicotinic, gamma polypeptide (CHRNG), mRNA
gi|7382453|ref|NM—005199.3|[7382453] - 6729: NM—013940
Homo sapiens olfactory receptor, family 10, subfamily H, member 1 (OR10H1), mRNA
gi|7363438|ref|NM—013940.1|[7363438] - 6730: NM—013440
Homo sapiens paired immunoglobulin-like receptor beta (PILR(BETA)), mRNA
gi|7305386|ref|NM—013440.1|[7305386] - 6731: NM—013439
Homo sapiens paired immunoglobulin-like receptor alpha (PILR(ALPHA)), mRNA
gi|7305384|ref|NM—013439.1|[7305384] - 6732: NM—002260
Homo sapiens killer cell lectin-like receptor subfamily C, member 2 (KLRC2), mRNA
gi|7108353|ref|NM—002260.2|[7108353] - 6733: NM—012125
Homo sapiens cholinergic receptor, muscarinic 5 (CHRM5), mRNA
gi|7108335|ref|NM—012125.1|[7108335] - 6734: NM—013378
Homo sapiens pre-B lymphocyte gene 3 (VPREB3), mRNA
gi|7019566|ref|NM—013378.1|[7019566] - 6735: NM—013261
Homo sapiens peroxisome proliferative activated receptor, gamma, coactivator (PPARGC1), mRNA
gi|7019498|ref|NM—013261.1|[7019498] - 6736: NM—013269
Homo sapiens lectin-like NK cell receptor (LLT1), mRNA
gi|7019446|ref|NM—013269.1|[7019446] - 6737: NM—013289
Homo sapiens killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 (KIR3DL1), mRNA
gi|7019440|ref|NM—013289.1|[7019440] - 6738: NM—013281
Homo sapiens fibronectin leucine rich transmembrane protein 3 (FLRT3), mRNA
gi|7019382|ref|NM—013281.1|[7019382] - 6739: NM—013231
Homo sapiens fibronectin leucine rich transmembrane protein 2 (FLRT2), mRNA
gi|7019380|ref|NM—013231.1|[7019380] - 6740: NM—012410
Homo sapiens type I transmembrane receptor (seizure-related protein) (PSK-1), mRNA
gi|6912611|ref|NM—012410.1|[6912611] - 6741: NM—012391
Homo sapiens prostate epithelium-specific Ets transcription factor (PDEF), mRNA
gi|6912579|ref|NM—012391.1|[6912579] - 6742: NM—012375
Homo sapiens olfactory receptor, family 52, subfamily A, member 1 (OR52A1), mRNA
gi|6912559|ref|NM—012375.1|[6912559] - 6743: NM—012368
Homo sapiens olfactory receptor, family 2, subfamily C, member 1 (OR2C1), mRNA
gi|6912555|ref|NM—012368.1|[6912555] - 6744: NM—012360
Homo sapiens olfactory receptor, family 1, subfamily F, member 8 (OR1F8), mRNA
gi|6912553|ref|NM—012360.1|[6912553] - 6745: NM—012352
Homo sapiens olfactory receptor, family 1, subfamily A, member 2 (OR1A2), mRNA
gi|6912551|ref|NM—012352.1|[6912551] - 6746: NM—012351
Homo sapiens olfactory receptor, family 10, subfamily J, member 1 (OR10J1), mRNA
gi|6912549|ref|NM—012351.1|[6912549] - 6747: NM—012344
Homo sapiens neurotensin receptor 2 (NTSR2), mRNA
gi|6912537|ref|NM—012344.1|[6912537] - 6748: NM—012314
Homo sapiens killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4 (KIR2D54), mRNA
gi|6912475|ref|NM—012314.1|[6912475] - 6749: NM—012313
Homo sapiens killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3 (KIR2D53), mRNA
gi|6912473|ref|NM—012313.1|[6912473] - 6750: NM—012312
Homo sapiens killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2 (KIR2D52), mRNA
gi|6912471|ref|NM—012312.1|[6912471] - 6751: NM—012211
Homo sapiens integrin, alpha 11 (ITGA11), mRNA
gi|6912435|ref|NM—012211.1|[6912435] - 6752: NM—012275
Homo sapiens interleukin-1 receptor antagonist homolog 1 (IL1HY1), mRNA
gi|6912431|ref|NM—012275.1|[6912431] - 6753: NM—004525
Homo sapiens low density lipoprotein-related protein 2 (LRP2), mRNA
gi|6806918|ref|NM—004525.1|[6806918] - 6754: NM—004304
Homo sapiens anaplastic lymphoma kinase (Ki-1) (ALK), mRNA
gi|6715586|ref|NM—004304.2|[6715586] - 6755: NM—000686
Homo sapiens angiotensin receptor 2 (AGTR2), mRNA
gi|6715584|ref|NM—000686.2|[6715584] - 6756: NM—007366
Homo sapiens phospholipase A2 receptor 1, 180 kD (PLA2R1), mRNA
gi|6679370|ref|NM—007366.1|[6679370] - 6757: NM—005385
Homo sapiens natural killer-tumor recognition sequence (NKTR), mRNA
gi|6631099|ref|NM—005385.2|[6631099] - 6758: NM—005266
Homo sapiens gap junction protein, alpha 5, 40 kD (connexin 40) (GJA5), mRNA
gi|6631082|ref|NM—005266.2|[6631082] - 6759: NM—000827
Homo sapiens glutamate receptor, ionotropic, AMPA 1 (GRIA1), mRNA
gi|6552333|ref|NM—000827.21[6552333] - 6760: NM—001619
Homo sapiens adrenergic, beta, receptor kinase 1 (ADRBK1), mRNA
gi|6138971|ref|NM—001619.2|[6138971] - 6761: NM—000810
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 5 (GABRA5), mRNA
gi|6031207|ref|NM—000810.2|[6031207] - 6762: NM—003006
Homo sapiens selectin P ligand (SELPLG), mRNA
gi|6031197|ref|NM—003006.2|[6031197] - 6763: NM—001480
Homo sapiens galanin receptor 1 (GALR1), mRNA
gi|6031165|ref|NM—001480.21[6031165] - 6764: NM—001992
Homo sapiens coagulation factor II (thrombin) receptor (F2R), mRNA
gi|6031164|ref|NM—001992.2|[6031164] - 6765: NM—000677
Homo sapiens adenosine A3 receptor (ADORA3), mRNA
gi|6031156|ref|NM—000677.21[6031156] - 6766: NM—001526
Homo sapiens hypocretin (orexin) receptor 2 (HCRTR2), mRNA
gi|6006037|ref|NM—001526.2|[6006037] - 6767: NM—000885
Homo sapiens integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) (ITGA4), mRNA
gi|6006032|ref|NM—000885.2|[6006032] - 6768: NM—002377
Homo sapiens MAS1 oncogene (MAS1), mRNA
gi|6006022|ref|NM—002377.21[6006022] - 6769: NM—000887
Homo sapiens integrin, alpha X (antigen CD11C (p150), alpha polypeptide) (ITGAX), mRNA
gi|6006014|ref|NM—000887.2|[6006014] - 6770: NM—000419
Homo sapiens integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex,
antigen CD41B) (ITGA2B), mRNA
gi|6006009|ref|NM—000419.2|[6006009] - 6771: NM—002203
Homo sapiens integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) (ITGA2), mRNA
gi|6006008|ref|NM—002203.21[6006008] - 6772: NM—000843
Homo sapiens glutamate receptor, metabotropic 6 (GRM6), mRNA
gi|6006006|ref|NM—000843.2|[6006006] - 6773: NM—000838
Homo sapiens glutamate receptor, metabotropic 1 (GRM1), mRNA
gi|6006005|ref|NM—000838.2|[6006005] - 6774: NM—000835
Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2C (GRIN2C),
mRNA
gi|6006004|ref|NM—000835.2|[6006004] - 6775: NM—000834
Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2B (GRIN2B),
mRNA
gi|6006003|ref|NM—000834.2|[6006003] - 6776: NM—000833
Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A),
mRNA
gi|6006002|ref|NM—000833.2|[6006002] - 6777: NM—007155
Homo sapiens zona pellucida glycoprotein 3A (sperm receptor) (ZP3A), mRNA
gi|6005983|ref|NM—007155.1|[6005983] - 6778: NM—007124
Homo sapiens utrophin (homologous to dystrophin) (UTRN), mRNA
gi|6005937|ref|NM—007124.1|[6005937] - 6779: NM—007114
Homo sapiens TATA element modulatory factor 1 (TMF1), mRNA
gi|6005903|ref|NM—007114.1|[6005903] - 6780: NM—007273
Homo sapiens B-cell associated protein (REA), mRNA
gi|6005853|ref|NM—007273.1|[6005853] - 6781: NM—007160
Homo sapiens olfactory receptor, family 2, subfamily H, mer-er 3 (OR2H3), mRNA
gi|6005821|ref|NM—007160.1|[6005821] - 6782: NM—007227
Homo sapiens G protein-coupled receptor 45 (GPR45), mRNA
gi|6005769|ref|NM—007227.1|[6005769] - 6783: NM—006934
Homo sapiens solute carrier family 6 (neurotransmitter transporter, glycine), member 9 (SLC6A9), mRNA
gi|5902093|ref|NM—006934.1|[5902093] - 6785: NM—007011
Homo sapiens putative transmembrane protein (HS1-2), mRNA
gi|5901977|ref|NM—007011.1|[5901977] - 6786: NM—007045
Homo sapiens FGFR1 oncogene partner (FOP), mRNA
gi|5901953|ref|NM—007045.1|[5901953] - 6787: NM—006889
Homo sapiens CD86 antigen (CD28 antigen ligand 2, B7-2 antigen) (CD86), mRNA
gi|5901919|ref|NM—006889.1|[5901919] - 6788: NM—006749
Homo sapiens solute carrier family 20 (phosphate transporter), member 2 (SLC20A2), mRNA
gi|5803172|ref|NM—006749.1|[5803172] - 6789: NM—006770
Homo sapiens macrophage receptor with collagenous structure (MARCO), mRNA
gi|5803079|ref|NM—006770.1|[5803079] - 6790: NM—006840
Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 (LILRB5), mRNA
gi|5803069|ref|NM—006840.1|[5803069] - 6791: NM—006866
Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 (LILRA2), mRNA
gi|5803067|ref|NM—006866.1|[5803067] - 6792: NM—006863
Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 (LILRA1), mRNA
gi|5803065|ref|NM—006863.1|[583065] - 6793: NM—006847
Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 (LILRB4), mRNA
gi|5803063|ref|NM—006847.1|[5803063] - 6794: NM—006865
Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 (LILRA3), mRNA
gi|5803061|ref|NM—006865.1|[5803061] - 6795: NM—006864
Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 (LILRB3), mRNA
gi|5803059|ref|NM—006864.1|[5803059] - 6796: NM—006738
Homo sapiens lymphoid blast crisis oncogene (LBC), mRNA
gi|5803057|ref|NM—006738.1|[5803057] - 6797: NM—006737
Homo sapiens killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 (KIR3DL2), mRNA
gi|5803051|ref|NM—006737.1|[5803051] - 6799: NM—006564
Homo sapiens G protein-coupled receptor (TYMSTR), mRNA
gi|5730105|ref|NM—006564.1|[5730105] - 6800: NM—001561
Homo sapiens tumor necrosis factor receptor superfamily, member 9 (TNFRSF9), mRNA
gi|5730094|ref|NM—001561.2|[5730094] - 6801: NM—006664
Homo sapiens small inducible cytokine subfamily A (Cys-Cys), member 27 (SCYA27),
mRNA
gi|5730034|ref|NM—006664.1|[5730034] - 6802: NM—006583
Homo sapiens retinal pigment epithelium-derived rhodopsin homolog (RRH), mRNA
gi|5730018|ref|NM—006583.1|[5730018] - 6803: NM—006505
Homo sapiens poliovirus receptor (PVR), mRNA
gi|5729994ref|NM—006505.1|[5729994] - 6804: NM—006637
Homo sapiens olfactory receptor, family 5, subfamily I, member 1 (OR5I1), mRNA
gi|5729959|ref|NM—006637.1|[5729959] - 6805: NM—006669
Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 (LILRB1), mRNA
gi|5729926|ref|NM—006669.1|[5729926] - 6806: NM—006611
Homo sapiens killer cell lectin-like receptor subfamily A, member 1 (KLRA1), mRNA
gi|5729898|ref|NM—006611.1|[5729898] - 6807: NM—006496
Homo sapiens guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 (GNA13), mRNA
gi|5729849|ref|NM—006496.1|[5729849] - 6808: NM—006529
Homo sapiens glycine receptor, alpha 3 (GLRA3), mRNA
gi|5729843|ref|NM—006529.1|[5729843] - 6809: NM—006639
Homo sapiens cysteinyl leukotriene receptor 1 (CYSLT1), mRNA
gi|5729797|ref|NM—006639.1|[5729797] - 6810: NM—006293
Homo sapiens TYRO3 protein tyrosine kinase (TYRO3), mRNA
gi|5454141|ref|NM—006293.1|[5454141] - 6813: NM—006238
Homo sapiens peroxisome proliferative activated receptor, delta (PPARD), mRNA
gi|5453939|ref|NM—006238.1|[5453939] - 6814: NM—006189
Homo sapiens olfactory marker protein (OMP), mRNA
gi|5453827|ref|NM—006189.1|[5453827] - 6815: NM—006182
Homo sapiens discoidin domain receptor family, member 2 (DDR2), mRNA
gi|5453813|ref|NM—006182.1|[5453813] - 6816: NM—006180
Homo sapiens neurotrophic tyrosine kinase, receptor, type 2 (NTRK2), mRNA
gi|5453811|ref|NM—006180.1|[5453811] - 6817: NM—006403
Homo sapiens enhancer of filamentation 1 (cas-like docking; Crk-associated substrate related) (HEF1), mRNA
gi|5453679|ref|NM—006403.1|[5453679] - 6818: NM—006143
Homo sapiens G protein-coupled receptor 19 (GPR19), mRNA
gi|5453665|ref|NM—006143.1|[5453665] - 6819: NM—006404
Homo sapiens protein C receptor, endothelial (EPCR) (PROCR), mRNA
gi|5453645|ref|NM—006404.1|[5453645] - 6820: NM—006419
Homo sapiens small inducible cytokine B subfamily (Cys-X-Cys motif), member (B-cell chemoattractant) (SCYB13), mRNA
gi|5453576|ref|NM—006419.1|[5453576] - 6821: NM—005954
Homo sapiens metallothionein 3 (growth inhibitory factor (neurotrophic)) (MT3),
mRNA
gi|5174761|ref|NM—005954.1|[5174761] - 6822: NM—006006
Homo sapiens zinc finger protein 145 (Kruppel-like, expressed in promyelocytic
leukemia) (ZNF145), mRNA
gi|5174752|ref|NM—006006.1|[5174752] - 6823: NM—006072
Homo sapiens small inducible cytokine subfamily A (Cys-Cys), member 26 (SCYA26),
mRNA
gi|5174670|ref|NM—006072.1|[5174670] - 6824: NM—005972
Homo sapiens pancreatic polypeptide receptor 1 (PPYR1), mRNA
gi|5174638|ref|NM—005972.1|[5174638] - 6825: NM—005913
Homo sapiens melanocortin 5 receptor (MC5R), mRNA
gi|5174534|ref|NM—005913.1|[5174534] - 6826: NM—005912
Homo sapiens melanocortin 4 receptor (MC4R), mRNA
gi|5174532|ref|NM—005912.1|[5174532] - 6827: NM—006028
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 3B (HTR3B), mRNA
gi|5174468|ref|NM—006028.1|[5174468] - 6828: NM—005628
Homo sapiens solute carrier family 1 (neutral amino acid transporter), member 5
(SLC1A5), mRNA
gi|5032092|ref|NM—005628.1|[5032092] - 6829: NM—005767
Homo sapiens purinergic receptor (family A group 5) (P2Y5), mRNA
gi|5031968|ref|NM—005767.1|[5031968] - 6830: NM—005592
Homo sapiens muscle, skeletal, receptor tyrosine kinase (MUSK), mRNA
gi|5031926|ref|NM—005592.1|[5031926] - 6831: NM—005874
Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 (LILRB2), mRNA
gi|5031910|ref|NM—005874.1|[5031910] - 6832: NM—005810
Homo sapiens killer cell lectin-like receptor subfamily G, member 1 (KLRG1), mRNA
gi|5031900|ref|NM—005810.1|[5031900] - 6833: NM—005544
Homo sapiens insulin receptor substrate 1 (IRS1), mRNA
gi|5031804|ref|NM—005544.1|[5031804] - 6834: NM—005535
Homo sapiens interleukin 12 receptor, beta 1 (IL12RB1), mRNA
gi|5031784|ref|NM—005535.1|[5031784] - 6835: NM—005683
Homo sapiens G protein-coupled receptor 55 (GPR55), mRNA
gi|5031722|ref|NM—005683.1|[5031722] - 6836: NM—005684
Homo sapiens G protein-coupled receptor 52 (GPR52), mRNA
gi|5031720|ref|NM—005684.1|[5031720] - 6837: NM—001621
Homo sapiens aryl hydrocarbon receptor (AHR), mRNA
gi|5016091|ref|NM—001621.2|[5016091] - 6838: NM—005429
Homo sapiens vascular endothelial growth factor C (VEGFC), mRNA
gi|4885652|ref|NM—005429.1|[4885652] - 6839: NM—005424
Homo sapiens tyrosine kinase with immunoglobulin and epidermal growth factor homology domains (TIE), mRNA
gi|4885630|ref|NM—005424.1|[4885630] - 6840: NM—005408
Homo sapiens small inducible cytokine subfamily A (Cys-Cys), member 13 (SCYA13),
mRNA
gi|4885586|ref|NM—005408.1|[4885586] - 6841: NM—005328
Homo sapiens hyaluronan synthase 2 (HAS2), mRNA
gi|4885390|ref|NM—005328.1|[4885390] - 6842: NM—005314
Homo sapiens gastrin-releasing peptide receptor (GRPR), mRNA
gi|4885360|ref|NM—005314.1|[4885360] - 6843: NM—005311
Homo sapiens growth factor receptor-bound protein 10 (GRB10), mRNA
gi|4885352|ref|NM—005311.1|[4885352] - 6844: NM—005308
Homo sapiens G protein-coupled receptor kinase 5 (GPRK5), mRNA
gi|4885348|ref|NM—005308.1|[4885348] - 6845: NM—005286
Homo sapiens G protein-coupled receptor 8 (GPR8), mRNA
gi|4885344|ref|NM—005286.1|[4885344] - 6846: NM—005285
Homo sapiens G protein-coupled receptor 7 (GPR7), mRNA
gi|4885342|ref|NM—005285.1|[4885342] - 6847: NM—005284
Homo sapiens G protein-coupled receptor 6 (GPR6), mRNA
gi|4885340|ref|NM—005284.1|[4885340] - 6848: NM—005458
Homo sapiens G protein-coupled receptor 51 (GPR51), mRNA
gi|4885336|ref|NM—005458.1|[4885336] - 6849: NM—005282
Homo sapiens G protein-coupled receptor 4 (GPR4), mRNA
gi|4885334|ref|NM—005282.1|[4885334] - 6850: NM—005306
Homo sapiens G protein-coupled receptor 43 (GPR43), mRNA
gi|4885332|ref|NM—005306.1|[4885332] - 6851: NM—005305
Homo sapiens G protein-coupled receptor 42 (GPR42), mRNA
gi|4885330|ref|NM—005305.1|[4885330] - 6852: NM—005304
Homo sapiens G protein-coupled receptor 41 (GPR41), mRNA
gi|4885328|ref|NM—005304.1|[4885328] - 6853: NM—005303
Homo sapiens G protein-coupled receptor 40 (GPR40), mRNA
gi|4885326|ref|NM—005303.1|[4885326] - 6854: NM—005281
Homo sapiens G protein-coupled receptor 3 (GPR3), mRNA
gi|4885324|ref|NM—005281.1|[4885324] - 6855: NM—005302
Homo sapiens G protein-coupled receptor 37 (endothelin receptor type B-like) (GPR37), mRNA
gi|4885322|ref|NM—005302.1|[4885322] - 6856: NM—005301
Homo sapiens G protein-coupled receptor 35 (GPR35), mRNA
gi|4885320|ref|NM—005301.1|[4885320] - 6857: NM—005300
Homo sapiens G protein-coupled receptor 34 (GPR34), mRNA
gi|4885318|ref|NM—005300.1|[4885318] - 6858: NM—005299
Homo sapiens G protein-coupled receptor 31 (GPR31), mRNA
gi|4885316|ref|NM—005299.1|[4885316] - 6859: NM—005298
Homo sapiens G protein-coupled receptor 25 (GPR25), mRNA
gi|4885314|ref|NM—005298.1|[4885314] - 6860: NM—005297
Homo sapiens G protein-coupled receptor 24 (GPR24), mRNA
gi|4885312|ref|NM—005297.1|[4885312] - 6861: NM—005296
Homo sapiens G protein-coupled receptor 23 (GPR23), mRNA
gi|4885310|ref|NM—005296.1|[4885310] - 6862: NM—005295
Homo sapiens G protein-coupled receptor 22 (GPR22), mRNA
gi|4885308|ref|NM—005295.1|[4885308] - 6863: NM—005294
Homo sapiens G protein-coupled receptor 21 (GPR21), mRNA
gi|4885306|ref|NM—005294.1|[4885306] - 6864: NM—005293
Homo sapiens G protein-coupled receptor 20 (GPR20), mRNA
gi|4885304|ref|NM—005293.1|[4885304] - 6865: NM—005279
Homo sapiens G protein-coupled receptor 1 (GPR1), mRNA
gi|4885302|ref|NM—005279.1|[4885302] - 6866: NM—005291
Homo sapiens G protein-coupled receptor 17 (GPR17), mRNA
gi|4885300|ref|NM—005291.1|[4885300] - 6867: NM—005290
Homo sapiens G protein-coupled receptor 15 (GPR15), mRNA
gi|4885298|ref|NM—005290.1|[4885298] - 6868: NM—005288
Homo sapiens G protein-coupled receptor 12 (GPR12), mRNA
gi|4885294|ref|NM—005288.1|[4885294] - 6869: NM—005264
Homo sapiens GDNF family receptor alpha 1 (GFRA1), mRNA
gi|4885268|ref|NM—005264.1|[4885268] - 6870: NM—005246
Homo sapiens fer (fps/fes related) tyrosine kinase (phosphoprotein NCP94) (FER),
mRNA
gi|4885230|ref|NM—005246.1|[4885230] - 6871: NM—005233
Homo sapiens EphA3 (EPHA3), mRNA
gi|4885210|ref|NM—005233.1|[4885210] - 6872: NM—005227
Homo sapiens ephrin-A4 (EFNA4), mRNA
gi|4885196|ref|NM—005227.1|[4885196] - 6873: NM—005211
Homo sapiens colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog (CSF1R), mRNA
gi|4885158|ref|NM—005211.1|[4885158] - 6875: NM—005161
Homo sapiens angiotensin receptor-like 1 (AGTRL1), mRNA
gi|4885056|ref|NM—005161.1|[4885056] - 6876: NM—005092
Homo sapiens tumor necrosis factor (ligand) superfamily, member 18 (TNFSF18), mRNA
gi|4827033|ref|NM—005092.1|[4827033] - 6877: NM—005118
Homo sapiens tumor necrosis factor (ligand) superfamily, member 15 (TNFSF15), mRNA
gi|4827031|ref|NM—005118.1|[4827031] - 6878: NM—005048
Homo sapiens parathyroid hormone receptor 2 (PTHR2), mRNA
gi|4826953|ref|NM—005048.1|[4826953] - 6879: NM—004963
Homo sapiens guanylate cyclase 2C (heat stable enterotoxin receptor) (GUCY2C),
mRNA
gi|4826751|ref|NM—004963.1|[4826751] - 6880: NM—005145
Homo sapiens guanine nucleotide binding protein (G protein), gamma 7 (GNG7), mRNA
gi|4826745|ref|NM—005145.1|[4826745] - 6881: NM—004952
Homo sapiens ephrin-A3 (EFNA3), mRNA
gi|4826707|ref|NM—004952.1|[4826707] - 6882: NM—004736
Homo sapiens xenotropic and polytropic retrovirus receptor (XPR1), mRNA
gi|4759333|ref|NM—004736.1|[4759333] - 6883: NM—004664
Homo sapiens Vertebrate LIN7 homolog 1, Tax interaction protein 33 (VELI1), mRNA
gi|4759305|ref|NM—004664.1|[4759305] - 6884: NM—004195
Homo sapiens tumor necrosis factor receptor superfamily, member 18 (TNFRSF18),
mRNA
gi|4759245|ref|NM—004195.1|[4759245] - 6885: NM—004612
Homo sapiens transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53 kD) (TGFBR1), mRNA
gi|4759225|ref|NM—004612.1|[4759225] - 6887: NM—004154
Homo sapiens pyrimidinergic receptor P2Y, G-protein coupled, 6 (P2RY6), mRNA
gi|4758863|ref|NM—004154.1|[4758863] - 6888: NM—004244
Homo sapiens CD163 antigen (CD163), mRNA
gi|4758721|ref|NM—004244.1|[4758721] - 6889: NM—002332
Homo sapiens low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor) (LRP1), mRNA
gi|4758685|ref|NM—002332.1|[4758685] - 6890: NM—004514
Homo sapiens interleukin enhancer binding factor 1 (ILF1), mRNA
gi|4758599|ref|NM—004514.1|[4758599] - 6891: NM—004633
Homo sapiens interleukin 1 receptor, type II (IL1R2), mRNA
gi|4758597|ref|NM—004633.1|[4758597] - 6892: NM—004512
Homo sapiens interleukin 11 receptor, alpha (IL11RA), mRNA
gi|4758593|ref|NM—004512.1|[4758593] - 6894: NM—000826
Homo sapiens glutamate receptor, ionotropic, AMPA 2 (GRIA2), mRNA
gi|4758479|ref|NM—000826.1|[4758479] - 6896: NM—004224
Homo sapiens G protein-coupled receptor 50 (GPR50), mRNA
gi|4758467|ref|NM—004224.1|[4758467] - 6898: NM—004246
Homo sapiens glucagon-like peptide 2 receptor (GLP2R), mRNA
gi|4758437|ref|NM—004246.1|[4758437] - 6899: NM—004293
Homo sapiens guanine deaminase (GDA), mRNA
gi|4758425|ref|NM—004293.1|[4758425] - 6900: NM—002030
Homo sapiens formyl peptide receptor-like 2 (FPRL2), mRNA
gi|4758401|ref|NM—002030.2|[4758401] - 6901: NM—004469
Homo sapiens c-fos induced growth factor (vascular endothelial growth factor D)
(FIGF), mRNA
gi|4758377|ref|NM—004469.1|[4758377] - 6902: NM—004107
Homo sapiens Fc fragment of IgG, receptor, transporter, alpha (FCGRT), mRNA
gi|4758345|ref|NM—004107.1|[4758345] - 6903: NM—004101
Homo sapiens coagulation factor II (thrombin) receptor-like 2 (F2RL2), mRNA
gi|4758325|ref|NM—004101.1|[4758325] - 6904: NM—004447
Homo sapiens epidermal growth factor receptor pathway substrate 8 (EPS8), mRNA
gi|4758295|ref|NM—004447.1|[4758295] - 6905: NM—004431
Homo sapiens EphA2 (EPHA2), mRNA
gi|4758277|ref|NM—004431.1|[4758277] - 6906: NM—004093
Homo sapiens ephrin-B2 (EFNB2), mRNA
gi|4758249|ref|NM—004093.1|[4758249] - 6907: NM—004429
Homo sapiens ephrin-B1 (EFNB1), mRNA
gi|4758247|ref|NM—004429.1|[4758247] - 6908: NM—004428
Homo sapiens ephrin-A1 (EFNA1), mRNA
gi|4758245|ref|NM—004428.1|[4758245] - 6909: NM—004393
Homo sapiens dystroglycan 1 (dystrophin-associated glycoprotein 1) (DAG1), mRNA
gi|4758115|ref|NM—004393.1|[4758115] - 6910: NM—004383
Homo sapiens c-src tyrosine kinase (CSK), mRNA
gi|4758077|ref|NM—004383.1|[4758077] - 6911: NM—004778
Homo sapiens G protein-coupled receptor 44 (GPR44), mRNA
gi|4758069|ref|NM—004778.1|[4758069] - 6912: NM—004382
Homo sapiens corticotropin releasing hormone receptor 1 (CRHR1), mRNA
gi|4758059|ref|NM—004382.1|[4758059] - 6913: NM—004072
Homo sapiens chemokine-like receptor 1 (CMKLR1), mRNA
gi|4758013|ref|NM—004072.1|[4758013] - 6914: NM—004329
Homo sapiens bone morphogenetic protein receptor, type IA (BMPR1A), mRNA
gi|4757853|ref|NM—004329.1|[4757853] - 6915: NM—004313
Homo sapiens arrestin, beta 2 (ARRB2), mRNA
gi|4757779|ref|NM—004313.1|[4757779] - 6916: NM—004039
Homo sapiens annexin A2 (ANXA2), mRNA
gi|4757755|ref|NM—004039.1|[4757755] - 6917: NM—000806
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 1 (GABRA1), mRNA
gi|4585862|ref|NM—000806.2|[4585862] - 6918: NM—002529
Homo sapiens neurotrophic tyrosine kinase, receptor, type 1 (NTRK1), mRNA
gi|4585711|ref|NM—002529.2|[4585711] - 6919: NM—000395
Homo sapiens colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) (CSF2RB), mRNA
gi|4559407|ref|NM—000395.1|[4559407] - 6920: NM—000211
Homo sapiens integrin, beta 2 (antigen CD18 (p95), lymphocyte function-associated antigen 1; macrophage antigen 1 (mac-1) beta subunit) (ITGB2), mRNA
gi|4557885|ref|NM—000211.1|[4557885] - 6921: NM—000208
Homo sapiens insulin receptor (INSR), mRNA
gi|4557883|ref|NM—000208.1|[4557883] - 6922: NM—000206
Homo sapiens interleukin 2 receptor, gamma (severe combined immunodeficiency) (IL2RG), mRNA
gi|4557881|ref|NM—000206.1|[4557881] - 6923: NM—000416
Homo sapiens interferon gamma receptor 1 (IFNGR1), mRNA
gi|4557879|ref|NM—000416.1|[4557879] - 6924: NM—000201
Homo sapiens intercellular adhesion molecule 1 (CD54), human rhinovirus receptor
(ICAM1), mRNA
gi|4557877|ref|NM—000201.1|[4557877] - 6925: NM—000459
Homo sapiens TEK tyrosine kinase, endothelial (venous malformations, multiple cutaneous and mucosal) (TEK), mRNA
gi|4557868|ref|NM—000459.1|[4557868] - 6926: NM—001053
Homo sapiens somatostatin receptor 5 (SSTR5), mRNA
gi|4557864|ref|NM—001053.1|[4557864] - 6927: NM—001052
Homo sapiens somatostatin receptor 4 (SSTR4), mRNA
gi|4557862|ref|NM—001052.1|[4557862] - 6928: NM—001051
Homo sapiens somatostatin receptor 3 (SSTR3), mRNA
gi|4557860|ref|NM—001051.1|[4557860] - 6929: NM—001050
Homo sapiens somatostatin receptor 2 (SSTR2), mRNA
gi|4557858|ref|NM—001050.1|[4557858] - 6930: NM—001049
Homo sapiens somatostatin receptor 1 (SSTR1), mRNA
gi|4557856|ref|NM—001049.1|[4557856] - 6931: NM—000245
Homo sapiens met proto-oncogene (hepatocyte growth factor receptor) (MET), mRNA
gi|4557746|ref|NM—000245.1|[4557746] - 6932: NM—000242
Homo sapiens mannose-binding lectin (protein C) 2, soluble (opsonic defect) (MBL2), mRNA
gi|4557738|ref|NM—000242.1|[4557738] - 6933: NM—000237
Homo sapiens lipoprotein lipase (LPL), mRNA
gi|4557726|ref|NM—000237.1|[4557726] - 6934: NM—000236
Homo sapiens lipase, hepatic (LIPC), mRNA
gi|4557722|ref|NM—000236.1|[4557722] - 6935: NM—000233
Homo sapiens luteinizing hormone/choriogonadotropin receptor (LHCGR), mRNA
gi|4557716|ref|NM—000233.1|[4557716] - 6936: NM—000222
Homo sapiens v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT), mRNA
gi|4557694|ref|NM—000222.1|[4557694] - 6937: NM—000212
Homo sapiens integrin, beta 3 (platelet glycoprotein 111a, antigen CD61) (ITGB3), mRNA
gi|4557676|ref|NM—000212.1|[4557676] - 6939: NM—000418
Homo sapiens interleukin 4 receptor (IL4R), mRNA
gi|4557668|ref|NM—000418.1|[4557668] - 6940: NM—000417
Homo sapiens interleukin 2 receptor, alpha (IL2RA), mRNA
gi|4557666|ref|NM—000417.1|[4557666] - 6941: NM—001551
Homo sapiens immunoglobulin (CD79A) binding protein 1 (IGBP1), mRNA
gi|4557662|ref|NM—001551.1|[4557662] - 6942: NM—000859
Homo sapiens 3-hydroxy-3-methylglutaryl-Coenzyme A reductase (HMGCR), mRNA
gi|4557642|ref|NM—000859.1|[4557642] - 6943: NM—001525
Homo sapiens hypocretin (orexin) receptor 1 (HCRTR1), mRNA
gi|4557636|ref|NM—001525.1|[4557636] - 6944: NM—001510
Homo sapiens glutamate receptor, ionotropic, delta 2 (GRID2), mRNA
gi|4557632|ref|NM—001510.1|[4557632] - 6945: NM—000829
Homo sapiens glutamate receptor, ionotrophic, AMPA 4 (GRIA4), mRNA
gi|4557630|ref|NM—000829.1|[4557630] - 6946: NM—001496
Homo sapiens GDNF family receptor alpha 3 (GFRA3), mRNA
gi|4557622|ref|NM—001496.1|[4557622] - 6947: NM—000820
Homo sapiens growth arrest-specific 6 (GAS6), mRNA
gi|4557616|ref|NM—000820.1|[4557616] - 6948: NM—000155
Homo sapiens galactose-1-phosphate uridylyltransferase (GALT), mRNA
gi|4557614|ref|NM—000155.1|[4557614] - 6949: NM—000816
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, gamma 2 (GABRG2), mRNA
gi|4557610|ref|NM—000816.1|[4557611] - 6950: NM—000815
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, delta (GABRD), mRNA
gi|4557608|ref|NM—000815.1|[4557608] - 6951: NM—000811
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 6 (GABRA6), mRNA
gi|4557606|ref|NM—000811.1|[4557606] - 6952: NM—000809
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 4 (GABRA4), mRNA
gi|4557604|ref|NM—000809.1|[4557604] - 6953: NM—000808
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 3 (GABRA3), mRNA
gi|4557602|ref|NM—000808.1|[4557602] - 6954: NM—000807
Homo sapiens gamma-aminobutyric acid (GABA) A receptor, alpha 2 (GABRA2), mRNA
gi|4557600|ref|NM—000807.1|[4557600] - 6955: NM—000121
Homo sapiens erythropoietin receptor (EPOR), mRNA
gi|4557561|ref|NM—000121.2|[4557561] - 6956: NM—000118
Homo sapiens endoglin (Osler-Rendu-Weber syndrome 1) (ENG), mRNA
gi|4557554|ref|NM—000118.1|[4557554] - 6957: NM—000114
Homo sapiens endothelin 3 (EDN3), mRNA
gi|4557544|ref|NM—000114.1|[4557544] - 6958: NM—001365
Homo sapiens discs, large (Drosophila) homolog 4 (DLG4), mRNA
gi|4557528|ref|NM—001365.1|[4557528] - 6959: NM—000080
Homo sapiens cholinergic receptor, nicotinic, epsilon polypeptide (CHRNE), mRNA
gi|4557462|ref|NM—000080.1|[4557462] - 6960: NM—000751
Homo sapiens cholinergic receptor, nicotinic, delta polypeptide (CHRND), mRNA
gi|4557460|ref|NM—000751.1|[4557460] - 6961: NM—000747
Homo sapiens cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) (CHRNB1), mRNA
gi|4557458|ref|NM—000747.1|[4557458) b6Y2: NM—000079
Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) (CHRNA1), mRNA
gi|4557456|ref|NM—000079.1|[4557456] - 6963: NM—000074
Homo sapiens tumor necrosis factor (ligand) superfamily, member 5 (hyper-IgM syndrome) (TNFSF5), mRNA
gi|4557432|ref|NM—000074.1|[4557432] - 6964: NM—000073
Homo sapiens CD3G antigen, gamma polypeptide (TiT3 complex) (CD3G), mRNA
gi|4557428|ref|NM—000073.1|[4557428] - 6965: NM—000072
Homo sapiens CD36 antigen (collagen type I receptor, thrombospondin receptor) (CD36), mRNA
gi|4557418|ref|NM—000072.1|[4557418] - 6966: NM—000388
Homo sapiens calcium-sensing receptor (hypocalciuric hypercalcemia 1, severe neonatal hyperparathyroidism) (CASR), mRNA
gi|4557410|ref|NM—000388.1|[4557410] - 6967: NM—000069
Homo sapiens calcium channel, voltage-dependent, L type, alpha 1S subunit (CACNA1S), mRNA
gi|4557400|ref|NM—000069.1|[4557400] - 6968: NM—000041
Homo sapiens apolipoprotein E (APOE), mRNA
gi|4557324|ref|NM—000041.1|[4557324] - 6969: NM—000684
Homo sapiens adrenergic, beta-1-, receptor (ADRB1), mRNA
gi|4557264|ref|NM—000684.1|[4557264] - 6970: NM—001116
Homo sapiens adenylate cyclase 9 (ADCY9), mRNA
gi|4557258|ref|NM—001116.1|[4557258] - 6971: NM—001115
Homo sapiens adenylate cyclase 8 (brain) (ADCY8), mRNA
gi|4557256|ref|NM—001115.1|[4557256] - 6972: NM—004001
Homo sapiens Fc fragment of IgG, low affinity IIb, receptor for (CD32) (FCGR2B),
mRNA
gi|4557021|ref|NM—004001.1|[4557021] - 6975: NM—003931
Homo sapiens WAS protein family, member 1 (WASF1), mRNA
gi|4507912|ref|NM—003931.1|[4507912] - 6976: NM—003383
Homo sapiens very low density lipoprotein receptor (VLDLR), mRNA
gi|4507900|ref|NM—003383.1|[4507900]
- 6977: NM—003382
Homo sapiens vasoactive intestinal peptide receptor 2 (VIPR2), mRNA
gi|4507898|ref|NM—003382.1|[4507898] - 6978: NM—000376
Homo sapiens vitamin D (1,25-dihydroxyvitamin D3) receptor (VDR), mRNA
gi|4507882|ref|NM—000376.1|[4507882] - 6979: NM—003329
Homo sapiens thioredoxin (TXN), mRNA
gi|4507744|ref|NM—003329.1|[4507744] - 6980: NM—000369
Homo sapiens thyroid stimulating hormone receptor (TSHR), mRNA
gi|4507700|ref|NM—000369.1|[4507700] - 6981: NM—003301
Homo sapiens thyrotropin-releasing hormone receptor (TRHR), rRNA
gi|4507680|ref|NM—003301.1|[4507680] - 6982: NM—001244
Homo sapiens tumor necrosis factor (ligand) superfamily, member 8 (TNFSF8), mRNA
gi|4507606|ref|NM—001244.1|[4507606] - 6983: NM—003809
Homo sapiens tumor necrosis factor (ligand) superfamily, member 12 (TNFSF12), mRNA
gi|4507596|ref|NM—003809.1|[4507596] - 6984: NM—001243
Homo sapiens tumor necrosis factor receptor superfamily, member 8 (TNFRSF8), mRNA
gi|4507588|ref|NM—001243.1|[4507588] - 6985: NM—001242
Homo sapiens tumor necrosis factor receptor superfamily, member 7 (TNFRSF7), mRNA
gi|4507586|ref|NM—001242.1|[4507586] - 6986: NM—000043
Homo sapiens tumor necrosis factor receptor superfamily, member 6 (TNFRSF6), mRNA
gi|4507582|ref|NM—000043.1|[4507582] - 6987: NM—003327
Homo sapiens tumor necrosis factor receptor superfamily, member 4 (TNFRSF4), mRNA
gi|4507578|ref|NM—003327.1|[4507578] - 6988: NM—001065
Homo sapiens tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A),
mRNA
gi|4507574|ref|NM—001065.1|[4507574] - 6989: NM—001192
Homo sapiens tumor necrosis factor receptor superfamily, member 17 (TNFRSF17),
mRNA
gi|4507572|ref|NM—001192.1|[4507572] - 6990: NM—003820
Homo sapiens tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) (TNFRSF14), mRNA
gi|4507570|ref|NM—003820.1|[4507570] - 6991: NM—003790
Homo sapiens tumor necrosis factor receptor superfamily, member 12 (translocating chain-association membrane protein) (TNFRSF12), mRNA
gi|4507568|ref|NM—003790.1|[4507568] - 6992: NM—002546
Homo sapiens tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) (TNFRSF11B), mRNA
gi|4507566|ref|NM—002546.1|[4507566] - 6993: NM—003839
Homo sapiens tumor necrosis factor receptor superfamily, member lla, activator
of NFKB (TNFRSF11A), mRNA
gi|4507564|ref|NM—003839.1|[4507564] - 6994: NM—003840
Homo sapiens tumor necrosis factor receptor superfamily, member 10d, decoy with
truncated death domain (TNFRSF10D), mRNA
gi|4507562|ref|NM—003840.1|[4507562] - 6995: NM—003842
Homo sapiens tumor necrosis factor receptor superfamily, member 10b (TNFRSF10B),
mRNA
gi|4507560|ref|NM—003842.1|[4507560] - 6996: NM—003844
Homo sapiens tumor necrosis factor receptor superfamily, member 10a (TNFRSF10A),
mRNA
gi|4507558|ref|NM—003844.1|[4507558] - 6997: NM—003692
Homo sapiens transmembrane protein with EGF-like and two follistatin-like domains 1 (TMEFF1), mRNA
gi|4507548|ref|NM—003692.1|[4507548] - 6998: NM—003273
Homo sapiens transmembrane 7 superfamily member 2 (TM7SF2), mRNA
gi|4507546|ref|NM—003273.1|[4507546] - 6999: NM—003272
Homo sapiens transmembrane 7 superfamily member 1 (upregulated in kidney) (TM7SF1), mRNA
gi|4507544|ref|NM—003272.1|[4507544] - 7000: NM—000460
Homo sapiens thrombopoietin (myeloproliferative leukemia virus oncogene ligand,
megakaryocyte growth and development factor) (THPO), mRNA
gi|4507492|ref|NM—000460.1|[4507492] - 7001: NM—003844
Homo sapiens tumor necrosis factor receptor superfamily, member 10a (TNFRSF10A),
mRNA
gi|4507558|ref|NM—003844.1|[4507558] - 7002: NM—003692
Homo sapiens transmembrane protein with EGF-like and two follistatin-like domains 1 (TMEFF1), mRNA
gi|4507548|ref|NM—003692.1|[4507548] - 7003: NM—003273
Homo sapiens transmembrane 7 superfamily member 2 (TM7SF2), mRNA
gi|4507546|ref|NM—003273.1|[4507546] - 7004: NM—003272
Homo sapiens transmembrane 7 superfamily member 1 (upregulated in kidney) (TM7SF1), mRNA
gi|4507544|ref|NM—003272.1|[4507544] - 7005: NM—000460
Homo sapiens thrombopoietin (myeloproliferative leukemia virus oncogene ligand,
megakaryocyte growth and development factor) (THPO), mRNA
gi|4507492|ref|NM—000460.1|[4507492] - 7006: NM—000361
Homo sapiens thrombomodulin (THBD), mRNA
gi|4507482|ref|NM—000361.1|[4507482] - 7007: NM—003243
Homo sapiens transforming growth factor, beta receptor III (betaglycan, 300 kD)
(TGFBR3), mRNA
gi|4507470|ref|NM—003243.1|[4507470] - 7008: NM—003234
Homo sapiens transferrin receptor (p90, CD71) (TFRC), mRNA
gi|4507456|ref|NM—003234.1|[4507456] - 7009: NM—003608
Homo sapiens G protein-coupled receptor 65 (GPR65), mRNA
gi|4507420|ref|NM—003608.1|[4507420] - 7010: NM—001060
Homo sapiens thromboxane A2 receptor (TBXA2R), mRNA
gi|4507380|ref|NM—001060.1|[4507380] - 7012: NM—001057
Homo sapiens tachykinin receptor 2 (TACR2), mRNA
gi|4507344|ref|NM—001057.1|[4507344] - 7013: NM—003177
Homo sapiens spleen tyrosine kinase (SYK), mRNA
gi|4507328|ref|NM—003177.1|[4507328] - 7015: NM—003070
Homo sapiens SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2), mRNA
gi|4507068|ref|NM—003070.1|[4507068] - 7016: NM—003045
Homo sapiens solute carrier family 7 (cationic amino acid transporter, y+system), member 1 (SLC7A1), mRNA
gi|4507046|ref|NM—003045.1|[4507046] - 7017: NM—003037
Homo sapiens signaling lymphocytic activation molecule (SLAM), mRNA
gi|4506968|ref|NM—003037.1|[4506968] - 7019: NM—001036
Homo sapiens ryanodine receptor 3 (RYR3), mRNA
gi|4506758|ref|NM—001036.1|[4506758] - 7020: NM—001035
Homo sapiens ryanodine receptor 2 (cardiac) (RYR2), mRNA
gi|4506756|ref|NM—001035.1|[4506756] - 7023: NM—002921
Homo sapiens retinal G protein coupled receptor (RGR), mRNA
gi|4506502|ref|NM—002921.1|[4506502] - 7026: NM—002852
Homo sapiens pentaxin-related gene, rapidly induced by IL-1 beta (PTX3), mRNA
gi|4506332|ref|NM—002852.1|[4506332] - 7027: NM—002851
Homo sapiens protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (PTPRZ1), mRNA
gi|4506328|ref|NM—002851.1|[4506328] - 7028: NM—000316
Homo sapiens parathyroid hormone receptor 1 (PTHR1), mRNA
gi|4506270|ref|NM—000316.1|[4506270] - 7029: NM—000960
Homo sapiens prostaglandin 12 (prostacyclin) receptor (IP) (PTGIR), mRNA
gi|4506262|ref|NM—000960.1|[4506262] - 7030: NM—000959
Homo sapiens prostaglandin F receptor (FP) (PTGFR), mRNA
gi|4506260|ref|NM—000959.1|[4506260] - 7031: NM—000958
Homo sapiens prostaglandin E receptor 4 (subtype EP4) (PTGER4), mRNA
gi|4506258|ref|NM—000958.1|[4506258] - 7032: NM—000957
Homo sapiens prostaglandin E receptor 3 (subtype EP3) (PTGER3), mRNA
gi|4506256|ref|NM—000957.1|[4506256] - 7033: NM—000955
Homo sapiens prostaglandin E receptor 1 (subtype EP1), 42 kD (PTGER1), mRNA
gi|4506252|ref|NM—000955.1|[4506252] - 7034: NM—000952
Homo sapiens platelet-activating factor receptor (PTAFR), mRNA
gi|4506240|ref|NM—000952.1|[4506240] - 7035: NM—002769
Homo sapiens protease, serine, 1 (trypsin 1) (PRSS1), mRNA
gi|4506144|ref|NM—002769.1|[4506144] - 7036: NM—000949
Homo sapiens prolactin receptor (PRLR), mRNA
gi|4506106|ref|NM—000949.1|[4506106] - 7037: NM—002745
Homo sapiens mitogen-activated protein kinase 1 (MAPK1), mRNA
gi|4506086|ref|NM—002745.1|[4506086] - 7038: NM—002702
Homo sapiens POU domain, class 6, transcription factor 1 (POU6F1), mRNA
gi|4505968|ref|NM—002702.1|[4505968] - 7039: NM—003967
Homo sapiens putative neurotransmitter receptor (PNR), mRNA
gi|4505924|ref|NM—003967.1|[4505924] - 7040: NM—002659
Homo sapiens plasminogen activator, urokinase receptor (PLAUR), mRNA
gi|4505864|ref|NM—002659.1|[4505864] - 7041: NM—000926
Homo sapiens progesterone receptor (PGR), mRNA
gi|4505766|ref|NM—000926.1|[4505766] - 7042: NM—000288
Homo sapiens peroxisomal biogenesis factor 7 (PEX7), mRNA
gi|4505730|ref|NM—000288.1|[4505730] - 7043: NM—000287
Homo sapiens peroxisomal biogenesis factor 6 (PEX6), mRNA
gi|4505728|ref|NM—000287.1|[4505728] - 7044: NM—002618
Homo sapiens peroxisome biogenesis factor 13 (PEX13), mRNA
gi|4505722|ref|NM—002618.1|[4505722] - 7045: NM—002591
Homo sapiens phosphoenolpyruvate carboxykinase 1 (soluble) (PCK1), mRNA
gi|4505638|ref|NM—002591.1|[4505638] - 7046: NM—002586
Homo sapiens pre-B-cell leukemia transcription factor 2 (PBX2), mRNA
gi|4505624|ref|NM—002586.1|[4505624] - 7047: NM—002569
Homo sapiens paired basic amino acid cleaving enzyme (furin, membrane associated
receptor protein) (PACE), mRNA
gi|4505578|ref|NM—002569.11 4505578] - 7048: NM—002565
Homo sapiens pyrimidinergic receptor P2Y, G-protein coupled, 4 (P2RY4), mRNA
gi|4505560|ref|NM—002565.1)[4505560] - 7049: NM—002566
Homo sapiens purinergic receptor P2Y, G-protein coupled, 11 (P2RY11), mRNA
gi|4505554|ref|NM—002566.1|[4505554] - 7050: NM—002562
Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 7 (P2RX7), mRNA
gi|4505552|ref|NM—002562.1|[4505552] - 7051: NM—002561
Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 5 (P2RX5), mRNA
gi|4505550|ref|NM—002561.1|[4505550] - 7052: NM—002560
Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 4 (P2RX4), mRNA
gi|4505548|ref|NM—002560.1|[4505548] - 7053: NM—002559
Homo sapiens purinergic receptor P2X, ligand-gated ion channel, 3 (P2RX3), mRNA
gi|4505546|ref|NM—002559.1|[4505546] - 7054: NM—002556
Homo sapiens oxysterol binding protein (OSBP), mRNA
gi|4505530|ref|NM—002556.1|[4505530] - 7055: NM—003696
Homo sapiens olfactory receptor, family 6, subfamily A, member 1 (OR6A1), mRNA
gi|4505520|ref|NM—003696.1|[4505520] - 7056: NM—002550
Homo sapiens olfactory receptor, family 3, subfamily A, member 1 (OR3A1), mRNA
gi|4505518|ref|NM—002550.1|[4505518] - 7057: NM—002548
Homo sapiens olfactory receptor, family 1, subfamily D, member 2 (OR1D2), mRNA
gi|4505516|ref|NM—002548.1|[4505516] - 7058: NM—000914
Homo sapiens opioid receptor, mu 1 (OPRM1), mRNA
gi|4505514|ref|NM—000914.1|[4505514] - 7059: NM—000912
Homo sapiens opioid receptor, kappa 1 (OPRK1), mRNA
gi|4505510|ref|NM—000912.1|[4505510] - 7060: NM—000911
Homo sapiens opioid receptor, delta 1 (OPRD1), mRNA
gi|4505508|ref|NM—000911.1|[4505508] - 7061: NM—002543
Homo sapiens oxidised low density lipoprotein (lectin-like) receptor 1 (OLR1),
mRNA
gi|4505500|ref|NM—002543.1|[4505500] - 7062: NM—003485
Homo sapiens G protein-coupled receptor 68 (GPR68), mRNA
gi|4505496|ref|NM—003485.1|[4505496] - 7063: NM—002531
Homo sapiens neurotensin receptor 1 (high affinity) (NTSR1), mRNA
gi|4505476|ref|NM—002531.1|[4505476] - 7064: NM—002530
Homo sapiens neurotrophic tyrosine kinase, receptor, type 3 (NTRK3), mRNA
gi|4505474|ref|NM—002530.1|[4505474] - 7065: NM—003580
Homo sapiens neutral sphingomyelinase (N-SMase) activation associated factor (NSMAF), mRNA
gi|4505464|ref|NM—003580.1|[4505464] - 7066: NM—003872
Homo sapiens neuropilin 2 (NRP2), mRNA
gi|4505458|ref|NM—003872.1|[4505458] - 7067: NM—003873
Homo sapiens neuropilin 1 (NRP1), mRNA
gi|4505456|ref|NM—003873.1|[4505456] - 7068: NM—000910
Homo sapiens neuropeptide Y receptor Y2 (NPY2R), mRNA
gi|4505446|ref|NM—000910.1|[4505446] - 7069: NM—000909
Homo sapiens neuropeptide Y receptor Y1 (NPY1R), mRNA
gi|4505444|ref|NM—000909.1|[4505444] - 7070: NM—000908
Homo sapiens natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) (NPR3), mRNA
gi|4505440|ref|NM—000908.1|[4505440] - 7071: NM—000906
Homo sapiens natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) (NPR1), mRNA
gi|4505434|ref|NM—000906.1|[4505434] - 7072: NM—002511
Homo sapiens neuromedin B receptor (NMBR), mRNA
gi|4505406|ref|NM—002511.1|[4505406] - 7073: NM—003954
Homo sapiens mitogen-activated protein kinase kinase kinase 14 (MAP3K14), mRNA
gi|4505396|ref|NM—003954.1|[4505396] - 7074: NM—002507
Homo sapiens nerve growth factor receptor (TNFR superfamily, member 16) (NGFR),
mRNA
gi|4505392|ref|NM—002507.1|[4505392] - 7075: NM—002447
Homo sapiens macrophage stimulating 1 receptor (c-met-related tyrosine kinase)
(MST1R), mRNA
gi|4505264|ref|NM—002447.1|[4505264] - 7076: NM—002445
Homo sapiens macrophage scavenger receptor 1 (MSR1), mRNA
gi|4505258|ref|NM—002445.1|[4505258] - 7077: NM—000529
Homo sapiens melanocortin 2 receptor (adrenocorticotropic hormone) (MC2R), mRNA
gi|4505126|ref|NM—000529.1|[4505126] - 7078: NM—002386
Homo sapiens melanocortin I receptor (alpha melanocyte stimulating hormone receptor) (MC1R), mRNA
gi|4505124|ref|NM—002386.1[4505124] - 7079: NM—002349
Homo sapiens lymphocyte antigen 75 (LY75), mRNA
gi|4505052|ref|NM—002349.1|[4505052] - 7080: NM—002344
Homo sapiens leukocyte tyrosine kinase (LTK), mRNA
gi|4505044|ref|NM—002344.1|[4505044] - 7081: NM—000752
Homo sapiens leukotriene b4 receptor (chemokine receptor-like 1) (LTB4R), mRNA
gi|4505032|ref|NM—000752.1[4505032] - 7082: NM—002336
Homo sapiens low density lipoprotein receptor-related protein 6 (LRP6), mRNA
gi|4505016|ref|NM—002336.1|[4505016] - 7083: NM—002319
Homo sapiens leucine-rich neuronal protein (LRN), mRNA
gi|4505012|ref|NM—002319.1|[4505012] - 7084: NM—002303
Homo sapiens leptin receptor (LEPR), mRNA
gi|4504978|ref|NM—002303.1|[4504978] - 7085: NM—002291
Homo sapiens laminin, beta 1 (LAMB1), mRNA
gi|4504950|ref|NM—002291.1[4504950] - 7086: NM—002258
Homo sapiens killer cell lectin-like receptor subfamily B, member 1 (KLRB1), mRNA
gi|4504878|ref|NM—002258.1|[4504878] - 7087: NM—002255
Homo sapiens killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 (KIR2DL4), mRNA
gi|4504870|ref|NM—002255.1|[4504870] - 7088: NM—002227
Homo sapiens Janus kinase 1 (a protein tyrosine kinase) (JAK1), mRNA
gi|4504802|ref|NM—002227.1|[4504802] - 7091: NM—002210
Homo sapiens integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen
CD51) (ITGAV), mRNA
gi|4504762|ref|NM—002210.1|[4504762] - 7092: NM—002205
Homo sapiens integrin, alpha 5 (fibronectin receptor, alpha polypeptide) (ITGA5), mRNA
gi|4504750|ref|NM—002205.1|[4504750] - 7094: NM—001565
Homo sapiens small inducible cytokine subfamily B (Cys-X-Cys), member 10 (SCYB10), mRNA
gi|4504700|ref|NM—001565.1|[4504700] - 7095: NM—001557
Homo sapiens interleukin 8 receptor, beta (IL8RB), mRNA
gi|4504682|ref|NM—001557.1|[4504682] - 7096: NM—000634
Homo sapiens interleukin 8 receptor, alpha (IL8RA), mRNA
gi|4504680|ref|NM—000634.1|[4504680] - 7097: NM—002185
Homo sapiens interleukin 7 receptor (IL7R), mRNA
gi|4504678|ref|NM—002185.1|[4504678] - 7098: NM—002184
Homo sapiens interleukin 6 signal transducer (gp130, oncostatin M receptor) (IL6ST), mRNA
gi|4504674|ref|NM—002184.1|[4504674] - 7099: NM—000565
Homo sapiens interleukin 6 receptor (IL6R), mRNA
gi|4504672|ref|NM—000565.1|[4504672] - 7100: NM—000878
Homo sapiens interleukin 2 receptor, beta (IL2RB), mRNA
gi|4504664|ref|NM—000878.1|[4504664] - 7101: NM—003854
Homo sapiens interleukin 1 receptor-like 2 (IL1RL2), mRNA
gi|4504662|ref|NM—003854.1|[4504662] - 7102: NM—000877
Homo sapiens interleukin 1 receptor, type I (IL1R1), mRNA
gi|4504658|ref|NM—000877.1|[4504658] - 7103: NM—003853
Homo sapiens interleukin 18 receptor accessory protein (IL18RAP), mRNA
gi|4504656|ref|NM—003853.1|[4504656] - 7104: NM—002189
Homo sapiens interleukin 15 receptor, alpha (IL15RA), mRNA
gi|4504648|ref|NM—002189.1|[4504648] - 7105: NM—001559
Homo sapiens interleukin 12 receptor, beta 2 (IL12RB2), mRNA
gi|4504642|ref|NM—001559.1|[4504642] - 7106: NM—001558
Homo sapiens interleukin 10 receptor, alpha (IL10RA), mRNA
gi|4504632|ref|NM—001558.1|[4504632] - 7107: NM—000876
Homo sapiens insulin-like growth factor 2 receptor (IGF2R), mRNA
gi|4504610|ref|NM—000876.1|[4504610] - 7108: NM—000871
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 6 (HTR6), mRNA
gi|4504544|ref|NM—000871.1|[4504544] - 7109: NM—000869
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 3A (HTR3A), mRNA
gi|4504542|ref|NM—000869.1|[4504542] - 7110: NM—000868
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 2C (HTR2C), mRNA
gi|4504540|ref|NM—000868.1|[4504540] - 7111: NM—000867
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 2B (HTR2B), mRNA
gi|4504538|ref|NM—000867.1|[4504538] - 7112: NM—000865
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1E (HTR1E), mRNA
gi|4504536|ref|NM—000865.1|[4504536] - 7113: NM—000863
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1B (HTR1B), mRNA
gi|4504532|ref|NM—000863.1|[4504532] - 7114: NM—000524
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1A (HTR1A), mRNA
gi|4504530|ref|NM—000524.1|[4504530] - 7115: NM—000186
Homo sapiens H factor 1 (complement) (HF1), mRNA
gi|4504374|ref|NM—000186.1|[4504374] - 7116: NM—001523
Homo sapiens hyaluronan synthase 1 (HAS1), mRNA
gi|4504338|ref|NM—001523.1|[4504338] - 7117: NM—000845
Homo sapiens glutamate receptor, metabotropic 8 (GRM8), mRNA
gi|4504148|ref|NM—000845.1|[4504148] - 7118: NM—000844
Homo sapiens glutamate receptor, metabotropic 7 (GRM7), mRNA
gi|4504146|ref|NM—000844.1|[4504146] - 7119: NM—000841
Homo sapiens glutamate receptor, metabotropic 4 (GRM4), mRNA
gi|4504140|ref|NM—000841.1|[4504140] - 7120: NM—000840
Homo sapiens glutamate receptor, metabotropic 3 (GRM3), mRNA
gi|4504138|ref|NM—000840.1|[4504138] - 7121: NM—000831
Homo sapiens glutamate receptor, ionotropic, kainate 3 (GRIK3), mRNA
gi|4504118|ref|NM—000831.1|[4504118] - 7122: NM—000830
Homo sapiens glutamate receptor, ionotropic, kainate 1 (GRIK1), mRNA
gi|4504116|ref|NM—000830.1|[4504116] - 7123: NM—002086
Homo sapiens growth factor receptor-bound protein 2 (GRB2), mRNA
gi|4504110|ref|NM—002086.1|[4504110] - 7124: NM—002082
Homo sapiens G protein-coupled receptor kinase 6 (GPRK6), mRNA
gi|4504100|ref|NM—002082.1|[4504100] - 7125: NM—001504
Homo sapiens G protein-coupled receptor 9 (GPR9), mRNA
gi|4504098|ref|NM—001504.1|[4504098] - 7126: NM—001508
Homo sapiens G protein-coupled receptor 39 (GPR39), mRNA
gi|4504096|ref|NM—001508.1|[4504096] - 7127: NM—001507
Homo sapiens G protein-coupled receptor 38 (GPR38), mRNA
gi|4504094|ref|NM—001507.1|[4504094] - 7128: NM—001506
Homo sapiens G protein-coupled receptor 32 (GPR32), mRNA
gi|4504092|ref|NM—001506.1|[4504092] - 7129: NM—001505
Homo sapiens G protein-coupled receptor 30 (GPR30), mRNA
gi|4504090|ref|NM—001505.1|[4504090] - 7130: NM—000173
Homo sapiens glycoprotein Ib (platelet), alpha polypeptide (GP1BA) mRNA
gi|4504070|ref|NM—000173.1|[4504070] - 7131: NM—000824
Homo sapiens glycine receptor, beta (GLRB), mRNA
gi|4504022|ref|NM—000824.1|[4504022] - 7132: NM—002063
Homo sapiens glycine receptor, alpha 2 (GLRA2), mRNA
gi|4504020|ref|NM—002063.1|[4504020] - 7133: NM—000164
Homo sapiens gastric inhibitory polypeptide receptor (GIPR), mRNA
gi|4503998|ref|NM—000164.1|[4503998] - 7134: NM—000823
Homo sapiens growth hormone releasing hormone receptor (GHRHR), mRNA
gi|4503996|ref|NM—000823.1|[4503996] - 7135: NM—000163
Homo sapiens growth hormone receptor (GHR), mRNA
gi|4503992|ref|NM—000163.1|[4503992] - 7136: NM—000160
Homo sapiens glucagon receptor (GCGR), mRNA
gi|4503946|ref|NM—000160.1|[4503946] - 7137: NM—003614
Homo sapiens galanin receptor 3 (GALR3), mRNA
gi|4503906|ref|NM—003614.1|[4503906] - 7138: NM—002043
Homo sapiens gamma-aminobutyric acid (GABA) receptor, rho 2 (GABRR2), mRNA
gi|4503870|ref|NM—002043.1|[4503870] - 7139: NM—002042
Homo sapiens gamma-aminobutyric acid (GABA) receptor, rho 1 (GABRR1), mRNA
gi|4503868|ref|NM—002042.1|[4503868] - 7140: NM—002036
Homo sapiens Duffy blood group (FY), mRNA
gi|4503818|ref|NM—002036.1|[4503818] - 7141: NM—001462
Homo sapiens formyl peptide receptor-like 1 (FPRL1), mRNA
gi|4503780|ref|NM—001462.1|[4503780] - 7142: NM—002029
Homo sapiens formyl peptide receptor 1 (FPR1), mRNA
gi|4503778|ref|NM—002029.1|[4503778] - 7143: NM—001461
Homo sapiens flavin containing monooxygenase 5 (FMO5), mRNA
gi|4503760|ref|NM—001461.1|[4503760] - 7144: NM—002020
Homo sapiens fms-related tyrosine kinase 4 (FLT4), mRNA
gi|4503752|ref|NM—002020.1|[4503752] - 7145: NM—001459
Homo sapiens fms-related tyrosine kinase 3 ligand (FLT3LG), mRNA
gi|4503750|ref|NM—001459.1|[4503750] - 7146: NM—002019
Homo sapiens fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (FLT1), mRNA
gi|4503748|ref|NM—002019.1|[4503748] - 7147: NM—002002
Homo sapiens Fc fragment of IgE, low affinity II, receptor for (CD23A) (FCER2),
mRNA
gi|4503678|ref|NM—002002.1|[4503678] - 7148: NM—002001
Homo sapiens Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide (FCER1A), mRNA
gi|4503674|ref|NM—002001.1|[4503674] - 7149: NM—003950
Homo sapiens coagulation factor II (thrombin) receptor-like 3 (F2RL3), mRNA
gi|4503638|ref|NM—003950.1|[4503638] - 7150: NM—001981
Homo sapiens epidermal growth factor receptor pathway substrate 15 (EPS15), mRNA
gi|4503592|ref|NM—001981.1|[4503592] - 7151: NM—001974
Homo sapiens egf-like module containing, mucin-like, hormone receptor-like sequence 1 (EMR1), mRNA
gi|4503564|ref|NM—001974.1|[4503564] - 7152: NM—001423
Homo sapiens epithelial membrane protein 1 (EMP1), mRNA
gi|4503558|ref|NM—001423.1|[4503558] - 7153: NM—003757
Homo sapiens eukaryotic translation initiation factor 3, subunit 2 (beta, 36 kD)
(EIF3S2), mRNA
gi|4503512|ref|NM—003757.1|[4503512] - 7154: NM—001406
Homo sapiens ephrin-B3 (EFNB3), mRNA
gi|4503488|ref|NM—001406.1|[4503488] - 7155: NM—001962
Homo sapiens ephrin-A5 (EFNA5), mRNA
gi|4503486|ref|NM—001962.1|[4503486] - 7156: NM—001405
Homo sapiens ephrin-A2 (EFNA2), mRNA
gi|4503484|ref|NM—001405.1|[4503484] - 7157: NM—003775
Homo sapiens endothelial differentiation, G-protein-coupled receptor 6 (EDG6),
mRNA
gi|4503458|ref|NM—003775.1|[4503458] - 7158: NM—001945
Homo sapiens diphtheria toxin receptor (heparin-binding epidermal growth factor-like growth factor) (DTR), mRNA
gi|4503412|ref|NM—001945.1|[4503412] - 7159: NM—001360
Homo sapiens 7-dehydrocholesterol reductase (DHCR7), mRNA
gi|4503320|ref|NM—001360.1|[4503320] - 7160: NM—003467
Homo sapiens chemokine (C-X-C motif), receptor 4 (fusin) (CXCR4), mRNA
gi|4503174|ref|NM—003467.1|[4503174] - 7161: NM—001338
Homo sapiens coxsackie virus and adenovirus receptor (CXADR), mRNA
gi|4503172|ref|NM—001338.1|[4503172] - 7162: NM—003478
Homo sapiens cullin 5 (CUL5), mRNA
gi|4503166|ref|NM—003478.1|[4503166] - 7163: NM—001330
Homo sapiens cardiotrophin 1 (CTF1), mRNA
gi|4503120|ref|NM—001330.1|[4503120] - 7164: NM—000760
Homo sapiens colony stimulating factor 3 receptor (granulocyte) (CSF3R), mRNA
gi|4503080|ref|NM—000760.1|[4503080] - 7165: NM—003805
Homo sapiens CASP2 and RIPK1 domain containing adaptor with death domain (CRADD), mRNA
gi|4503030|ref|NM—003805.1|[4503030] - 7166: NM—001877
Homo sapiens complement component (3d/Epstein Barr virus) receptor 2 (CR2), mRNA
gi|4503026|ref|NM—001877.1|[4503026] - 7167: NM—001842
Homo sapiens ciliary neurotrophic factor receptor (CNTFR), mRNA
gi|4502930|ref|NM—001842.1|[4502930] - 7168: NM—001281
Homo sapiens cytoskeleton-associated protein 1 (CKAP1), mRNA
gi|4502848|ref|NM—001281.1|[4502848] - 7169: NM—000750
Homo sapiens cholinergic receptor, nicotinic, beta polypeptide 4 (CHRNB4), mRNA
gi|4502836|ref|NM—000750.1|[4502836] - 7170: NM—000749
Homo sapiens cholinergic receptor, nicotinic, beta polypeptide 3 (CHRNB3), mRNA
gi|4502834|ref|NM—000749.1|[4502834] - 7171: NM—000748
Homo sapiens cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) (CHRNB2), mRNA
gi|4502832|ref|NM—000748.1|[4502832] - 7172: NM—000746
Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 7 (CHRNA7),
gi|4502830|ref|NM—000746.1|[4502830] - 7173: NM—000745
Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 5 (CHRNA5), mRNA
gi|4502828|ref|NM—000745.1|[4502828] - 7174: NM—000744
Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 4 (CHRNA4), mRNA
gi|4502826|ref|NM—000744.1|[4502826] - 7175: NM—000742
Homo sapiens cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal) (CHRNA2), mRNA
gi|4502822|ref|NM—000742.1|[4502822] - 7176: NM—000741
Homo sapiens cholinergic receptor, muscarinic 4 (CHRM4), mRNA
gi|4502820|ref|NM—000741.1|[4502820] - 7177: NM—000740
Homo sapiens cholinergic receptor, muscarinic 3 (CHRM3), mRNA
gi|4502818|ref|NM—000740.1|[4502818] - 7178: NM—000739
Homo sapiens cholinergic receptor, muscarinic 2 (CHRM2), mRNA
gi|4502816|ref|NM—000739.1|[4502816] - 7179: NM—000738
Homo sapiens cholinergic receptor, muscarinic 1 (CHRM1), mRNA
gi|4502814|ref|NM—000738.1|[4502814] - 7181: NM—001768
Homo sapiens CD8 antigen, alpha polypeptide (p32) (CD8A), mRNA
gi|4502688|ref|NM—001768.1|[4502688] - 7182: NM—001781
Homo sapiens CD69 antigen (p60, early T-cell activation antigen) (CD69), mRNA
gi|4502680|ref|NM—001781.1|[4502680] - 7183: NM—001779
Homo sapiens CD58 antigen, (lymphocyte function-associated antigen 3) (CD58), mRNA
gi|4502676|ref|NM—001779.1|[4502676] - 7184: NM—000733
Homo sapiens CD3E antigen, epsilon polypeptide (TiT3 complex) (CD3E), mRNA
gi|4502670|ref|NM—000733.1|[4502670] - 7185: NM—000732
Homo sapiens CD3D antigen, delta polypeptide (TiT3 complex) (CD3D), mRNA
gi|4502668|ref|NM—000732.1|[4502668] - 7186: NM—001775
Homo sapiens CD38 antigen (p45) (CD38), mRNA
gi|4502664|ref|NM—001775.1|[4502664] - 7187: NM—001767
Homo sapiens CD2 antigen (p50), sheep red blood cell receptor (CD2), mRNA
gi|4502652|ref|NM—001767.1|[4502652] - 7188: NM—001837
Homo sapiens chemokine (C-C motif) receptor 3 (CCR3), mRNA
gi|4502636|ref|NM—001837.1|[4502636] - 7189: NM—000731
Homo sapiens cholecystokinin B receptor (CCKBR), mRNA
gi|4502608|ref|NM—000731.1|[4502608] - 7190: NM—000730
Homo sapiens cholecystokinin A receptor (CCKAR), mRNA
gi|4502606|ref|NM—000730.1|[4502606] - 7191: NM—001742
Homo sapiens calcitonin receptor (CALCR), mRNA
gi|4502546|ref|NM—001742.1|[4502546] - 7192: NM—001737
Homo sapiens complement component 9 (C9), mRNA
gi|4502510|ref|NM—001737.1|[4502510] - 7193: NM—001736
Homo sapiens complement component 5 receptor 1 (C5a ligand) (C5R1), mRNA
gi|4502508|ref|NM—001736.1|[4502508] - 7194: NM—001732
Homo sapiens butyrophilin, subfamily 1, member A1 (BTN1A1), mRNA
gi|4502474|ref|NM—001732.1|[4502474] - 7195: NM—001729
Homo sapiens betacellulin (BTC), mRNA
gi|4502460|ref|NM—001729.1|[4502460] - 7196: NM—001727
Homo sapiens bombesin-like receptor 3 (BRS3), mRNA
gi|4502454|ref|NM—001727.1|[4502454] - 7197: NM—001203
Homo sapiens bone morphogenetic protein receptor, type IB (BMPR1B), mRNA
gi|4502430|ref|NM—001203.1|[4502430] - 7198: NM—000710
Homo sapiens bradykinin receptor B1 (BDKRB1), mRNA
gi|4502390|ref|NM—000710.1|[4502390] - 7199: NM—003921
Homo sapiens B-cell CLL/lymphoma 10 (BCL10), mRNA
gi|4502378|ref|NM—003921.1|[4502378] - 7200: NM—001168
Homo sapiens baculoviral IAP repeat-containing 5 (survivin) (BIRC5), mRNA
gi|4502144|ref|NM—001168.1|[4502144] - 7201: NM—001150
Homo sapiens alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase
M, microsomal aminopeptidase, CD13, p150) (ANPEP), mRNA
gi|4502094|ref|NM—001150.1|[4502094] - 7202: NM—001146
Homo sapiens angiopoietin 1 (ANGPT1), mRNA
gi|4502086|ref|NM—001146.1|[4502086] - 7203: NM—000676
Homo sapiens adenosine A2b receptor (ADORA2B), mRNA
gi|4501950|ref|NM—000676.1|[4501950] - 7204: NM—000674
Homo sapiens adenosine A1 receptor (ADORA1), mRNA
gi|4501946|ref|NM—000674.1-|[4501946] - 7205: NM—001118
Homo sapiens adenylate cyclase activating polypeptide 1 (pituitary) receptor type I (ADCYAP1R1), mRNA
gi|4501922|ref|NM—001118.1|[4501922] - 7206: AF287270
Homo sapiens mucolipin (MCOLN1) gene, complete cds
gi|9844925|gb|AF287270.1|AF287270[9844925] - 7207: AF287269
Homo sapiens mucolipin (MCOLN1) mRNA, complete cds
gi|9844923|gb|AF287269.1|AF287269[9844923] - 7208: AF307080
Homo sapiens lectomedin-3 (LEC3) mRNA, complete cds
gi|11037015|gb|AF307080.1|AF307080[11037015] - 7209: AF307079
Homo sapiens lectomedin-2 (LEC2) mRNA, complete cds
gi|1037013|gb|AF307079.1|AF307079[11037013] - 7216: AF265242
Homo sapiens type-I T cell cytokine receptor mRNA, complete cds
gi|103679|gb|AF265242.1|AF265242[11036791] - 7217: AF018284
Homo sapiens P2Y1 receptor (P2YR1) mRNA, partial cds
gi|2738815|gb|AF018284.1|AF018284[2738815] - 7218: AF017307
Homo sapiens Ets-related transcription factor (ERT) mRNA, complete cds
gi|2338755|gb|AF017307.1|AF017307[2338755] - 7219: AF106912
Homo sapiens CRL1 protein (CRL1) mRNA, complete cds
gi|1022746|gb|AF106912.1|AF106912[11022746] - 7220: AB042033
Homo sapiens FCER1B gene for high affinity IgE receptor beta subunit, 5′ flanking sequence and partial cds
gi|11022658|dbj|AB042033.1|AB042033[11022658] - 7221: AB019000
Homo sapiens mRNA for G-protein coupled receptor, complete cds
gi|11022652|dbj|AB019000.1|AB019000[11022652] - 7222: AH007076
Homo sapiens chromosome 13 map 13q34
gi|3955190|gb|AH007076.1|SEG_HSGRKIN[3955190] - 7223: AF019765
Homo sapiens G protein-coupled receptor kinase 1 and G protein-coupled receptor
kinase 1b (GRK1) gene, alternatively spliced, alternative exon 6, exon 7, and partial cds
gi|3955189|gb|AF019765.1|HSGRKIN2[3955189] - 7224: AF019764
Homo sapiens G protein-coupled receptor kinase 1 and G protein-coupled receptor
kinase 1b (GRK1) gene, alternatively spliced, exon 6, alternative exon 6, and partial cds
gi|3955188|gb|AF019764.1|HSGRKIN1[3955188] - 7225: AF035819
Homo sapiens macrophage receptor MARCO mRNA, complete cds
gi|3002790|gb|AF035819.1|AF035819[3002790] - 7227: AF253318
Homo sapiens GFR receptor alpha 4 protein (GFRA4) mRNA, complete cds
gi|10998399|gb|AF253318.1|AF253318[10998399] - 7228: AF077186
Homo sapiens neuronal nicotinic acetylcholine receptor beta 2 (CHRNB2) gene, complete cds
gi|10947140|gb|AF077186.2|[10947140] - 7229: AF272363
Homo sapiens neuromedin U receptor 2 (NMUR2) mRNA, complete cds
gi|10946202|gb|AF272363.1|AF272363[10946202] - 7230: AF272362
Homo sapiens neuromedin U receptor 1 (NMUR1) mRNA, complete cds
gi|10946200|gb|AF272362.1|AF272362[10946200] - 7231: AJ277437
Homo sapiens mRNA for fibroblast growth factor receptor-like protein 1, (FGFRL1 gene)
gi|10944886|emb|AJ277437.1|HSA277437[10944886] - 7232: G64264
Alk4/3′ Human Chromosome 12 Homo sapiens STS genomic, sequence tagged site
gi|9802476|gb|G64264.1|G64264[9802476] - 7233: G64261
AMHR2/ex1-2 Human Chromosome 12 Homo sapiens STS genomic, sequence tagged site
gi|9802473|gb|G64261.1|G64261[9802473] - 7234: G64251
Alk4/ex1 Human Chromosome 12 Homo sapiens STS genomic, sequence tagged site
gi|9802463|gb|G64251.1|G64251[9802463] - 7235: G64250
Alk1/ex10 Human Chromosome 12 Homo sapiens STS genomic, sequence tagged site
gi|9802462|gb|G64250.1|G64250[9802462] - 7236: G64249
Alk1/ex2 Human Chromosome 12 Homo sapiens STS genomic, sequence tagged site
gi|9802461|gb|G64249.1|G64249[9802461] - 7237: AF301005
Homo sapiens gamma-aminobutyric acid receptor GABA-B1e mRNA, complete cds
gi|10863757|gb|AF301005.1|AF301005[10863757] - 7238: AF269133
Homo sapiens novel interleukin receptor (NILR) mRNA, complete cds
gi|10801191|gb|AF269133.1|AF269133[10801190] - 7239: AF127670
Homo sapiens hyaluronic acid receptor (HAR) mRNA, complete cds
gi|10800121|gb|AF127670.2|AF127670[10800121] - 7241: AF284436
Homo sapiens TIGIRR-1 mRNA, complete cds
gi|10644689|gb|AF284436.1|AF284436[10644689] - 7242: AF284435
Homo sapiens TIGIRR-2 mRNA, complete cds
gi|10644687|gb|AF284435.1|AF284435[10644687] - 7243: AF284434
Homo sapiens IL-1Rrp2 mRNA, complete cds
gi|10644685|gb|AF284434.1|AF284434[10644685] - 7244: M35198
Homo sapiens integrin beta-subunit mRNA, complete cds
gi|9961228|gb|M35198.3|HUMINTB6A[9961228] - 7245: AF302903
Homo sapiens vomeronasal receptor 1 (VNR19I1) mRNA, complete cds
gi|10732801|gb|AF302903.1|AF302903[10732801] - 7246: AF286095
Homo sapiens IL-22 receptor (IL22R) mRNA, complete cds
gi|10719607|gb|AF286095.1|AF286095[10719607] - 7248: AF239668
Homo sapiens CCK-B/gastrin receptor mRNA, complete cds; alternatively spliced
gi|7677459|gb|AF239668.1|AF239668[7677459] - 7249: AF029759
Homo sapiens mutant G protein-coupled receptor STRL33 (STRL33) gene, STRL33-3K allele, complete cds
gi|10716827|gb|AF029759.1|AF029759[10716827] - 7250: AB041644
Homo sapiens gene for cysteinyl leukotriene receptor like receptor, complete cds
gi|10716135|dbj|AB041644.1|AB041644[10716135] - 7251: AF237381
Homo sapiens CCR3 gene and exon 3
gi|10643653|gb|AF237381.1|AF237380S2[10643653] - 7252: AF237380
Homo sapiens CCR3 gene, promotor and exon 1
gi|10643652|gb|AF237380.1|AF237380S1[10643652] - 7253: AH009867
Homo sapiens
gi|10643651|gb|AH009867.1|SEG_AF237380S[10643651] - 7254: AF233516
Homo sapiens PD-1-ligand precursor, mRNA, complete cds
gi|10567621|gb|AF233516.1|AF233516[10567621] - 7255: AJ297688
Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 1 and joined CDS
gi|0445329|emb|AJ297688.1|HSA297688[10445329] - 7256: AJ297701
Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exons 16-gi|10443220|emb|AJ297701.1|HSA297701[10443220] - 7257: AJ297700
Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 15
gi|10443219|emb|AJ297700.1|HSA297700[10443219] - 7258: AJ297699
Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 14
gi|10443218|emb|AJ297699.1|HSA297699[10443218] - 7259: AJ297698
Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 13
gi|0443217|emb|AJ297698.1HSA297698[10443217] - 7260: AJ297697
Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 12
gi|10443216|emb|AJ297697.1|HSA297697[10443216] - 7261: AJ297696
Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 11
gi|10443215|emb|AJ297696.1|HSA297696[10443215] - 7262: AJ297695
Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 10
gi|10443214|emb|AJ297695.1|HSA297695[10443214] - 7263: AJ297694
Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 9
gi|10443213|emb|AJ297694.1|HSA297694[10443213] - 7264: AJ297693
Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 8
gi|10443212|emb|AJ297693.1|HSA297693[10443212] - 7265: AJ297692
Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exons 6-7
gi|0443211|emb|AJ297692.1|HSA297692[10443211] - 7266: AJ297691
Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 5
gi|0443210|emb|AJ297691.1|HSA297691[10443210] - 7267: AT2976910
Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exon 4
gi|10443209|emb|AJ297690.1|HSA297690[10443209] - 7268: AJ297689
Homo sapiens partial IL-12RB1 gene for IL-12 receptor beta1 chain, exons 2-3
gi|10443208|emb|AJ297689.1|HSA297689[10443208] - 7269: AJ276452
Homo sapiens partial pIgR gene for polymeric immunoglobulin receptor, partial intron 1 and partial exon 2
gi|10303247|emb|AJ276452.1|HSA276452[10303247] - 7271: AF254664
Homo sapiens cysteinyl leukotriene receptor CYSLT2 gene, complete cds
gi|10442007|gb|AF254664.1|AF254664[10442007] - 7273: AC005330
Homo sapiens chromosome 19, cosmid R34047 and overlapping PCR product, complete
sequence
gi|10305189|gb|AC005330.2|AC005330[10305189] - 7517: AF176039
Homo sapiens high mobility group protein-R mRNA, complete cds
gi|5834272|gb|AF176039.1|AF176039[5834272] - 7518: AB041228
Homo sapiens mRNA for G protein-coupled receptor TGR-1, complete cds
gi|10257380|dbj|AB041228.1|AB041228[10257380] - 7519: AF282262
Homo sapiens GHRH receptor splice variant 4 mRNA, complete cds
gi|10242297|gb|AF282262.1|AF282262[10242297] - 7520: AF282261
Homo sapiens GHRH receptor splice variant 3 mRNA, complete cds
gi|10242295|gb|AF282261.1|AF282261[10242295] - 7521: AF282260
Homo sapiens GHRH receptor splice variant 2 mRNA, complete cds
gi|10242293|gb|AF282260.1|AF282260[10242293] - 7522: AF282259
Homo sapiens GHRH receptor splice variant 1 mRNA, complete cds
gi|10242291|gb|AF282259.1|AF282259[10242291] - 7523: X80389
H. sapiens platelet-derived growth factor alpha receptor DNA
gi|10241726|emb|X80389.2|HSPDGFAD[10241726] - 7524: AF177761
Homo sapiens herstatin (HER-2) mRNA, alternatively spliced, complete cds
gi|10181232|gb|AF177761.2|AF177761[10181232] - 7525: AF005058
Homo sapiens chemokine receptor (CXCR-4) gene, complete cds
gi|2735718|gb|AF005058.1|AF005058[2735718] - 7526: AF264716
Homo sapiens complement receptor type 1 (CR1) gene, CR1*SCR25-HUM1 allele, partial cds
gi|10185787|gb|AF264716.1|AF264716[10185787] - 7527: AF264715
Homo sapiens complement receptor type 1 (CR1) gene, CR1*SCR25-HUM2 allele, partial cds
gi|10185785|gb|AF264715.1|AF264715[10185785] - 7528: AF250237
Homo sapiens orphan G protein-coupled receptor 85 (GPR85) mRNA, complete cds
gi|10181092|gb|AF250237.2|AF250237[10181092] - 7533: AF189277
Homo sapiens leukocyte immunoglobulin-like receptor 1 (LIR1) gene, complete cds
gi|9954209|gb|AF189277.1|AF189277[9954209] - 7534: AB010994
Homo sapiens hedgehog gene, exon 3 and complete cds
gi|10047225|dbj|AB010994.2|AB010581S3[10047225] - 7535: AB010993
Homo sapiens hedgehog gene, exon 2
gi|10047224|dbj|AB010993.2|AB010581S2[10047224] - 7536: AB010581
Homo sapiens hedgehog gene, exon 1
gi|10047223|dbj|AB010581.2|AB010581S1[10047223] - 7537: SEG_AB010581S
Homo sapiens hedgehog gene
gi|0047222|dbj|SEG_AB010581S[10047222] - 7538: AX015117
Sequence 8 from Patent WO9952943
gi|10041220|emb|AX015117.1|AX015117[10041220] - 7539: AX015116
Sequence 7 from Patent WO9952943
gi|10041219|emb|AX015116.1|AX015116[10041219] - 7540: AX015115
Sequence 6 from Patent WO9952943
gi|10041218|emb|AX015115.1|AX015115[10041218] - 7541: AX015114
Sequence 5 from Patent WO9952943
gi|10041217|emb|AX015114.1|AX015114[10041217] - 7542: AX015113
Sequence 4 from Patent WO9952943
gi|10041216|emb|AX015113.1|AX015113[10041216] - 7543: AX015112
Sequence 3 from Patent WO9952943
gi|10041215|emb|AX015112.1|AX015112[10041215] - 7544: AX015111
Sequence 2 from Patent WO9952943
gi|10041214|emb|AX015111.1|AX015111[10041214] - 7545: AX015110
Sequence 1 from Patent WO9952943
gi|10041213|emb|AX015110.1|AX015110[10041213] - 7546: AF042080
Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
mRNA, complete cds
gi|2801556|gb|AF042080.1|AF042080[2801556] - 7547: AF255342
Homo sapiens putative pheromone receptor V1RL1 long form (V1RL1) mRNA, complete
cds
gi|9988584|gb|AF255342.1|AF255342[9988584] - 7548: AF254747
Homo sapiens ROR2 protein (ROR2) gene, exon 2
gi|9664303|gb|AF254747.1|AF254747S1[9664303] - 7550: AJ295613
Homo sapiens partial GHR gene for growth hormone receptor, exon 2
gi|9968301|emb|AJ295613.1|HSA295613[9968301] - 7551: AJ278681
Homo sapiens partial GHR gene for growth hormone receptor, exons 8-10
gi|9968297|emb|AJ278681.1|HSA278681[9968297] - 7553: AF217963
Homo sapiens NRAGE mRNA, complete cds
gi|9963809|gb|AF217963.1|AF217963[9963809] - 7554: AF169970
Homo sapiens complement receptor 1 (CR1) gene, CR1*SCR25-HUM5 allele, exon 29 and partial cds
gi|9956947|gb|AF169970.1|AF169970[9956947] - 7555: AF169969
Homo sapiens complement receptor 1 (CR1) gene, CR1*SCR25-HUM4 allele, exon 29 and partial cds
gi|9956945|gb|AF169969.1|AF169969[9956945] - 7556: AB044402
Homo sapiens mRNA for LTB4 receptor JULF2, complete cds
gi|9081802|dbj|AB044402.1|AB044402[9081802] - 7557: U96190
Homo sapiens p58 NK cell inhibitory receptor NKR-K7 mRNA, partial cds
gi|2088618|gb|U96190.1|HSU96190[2088618] - 7558: U96189
Homo sapiens p58 NK cell inhibitory receptor NKR-K6 mRNA, partial cds
gi|2088616|gb|U96189.1|HSU96189[2088616] - 7559: U96188
Homo sapiens p50 cell activatory receptor NKR-K1 mRNA, partial cds
gi|2088614|gb|U96188.1|HSU96188[2088614] - 7560: AF251841
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exons 29, 30, and complete cds
gi|9944844|gb|AF251841.1|F251818S24[9944844] - 7561: AF251840
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exons 27 and
gi|9944843|gb|AF251840.1F251818S23[9944843] - 7562: AF251839
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 26
gi|99448421|gb|AF251839.1|F251818S22[9944842] - 7563: AF251838
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 25
gi|9944841|gb|AF251838.1|F251818S21[9944841] - 7564: AF251837
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exons 23 and
gi|9944840|gb|AF251837.1F251818S20[9944840] - 7565: AF251836
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 22
gi|9944839|gb|AF251836.1|F251818S19[9944839] - 7566: AF251835
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exons 20 and
gi|9944838|gb|AF251835.1|F251818S18[9944838] - 7567: AF251834
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 19
gi|9944837|gb|AF251834.1F251818S17[9944837] - 7568: AF251833
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 18
gi|9944836|gb|AF251833.1|F251818S16[9944836] - 7569: AF251832
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 17
gi|9944835|gb|AF251832.1|F251818S15[9944835] - 7570: AF251831
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 16
gi|9944834|gb|AF251831.1|F251818S14[9944834] - 7571: AF251830
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 15
gi|9944833|gb|AF251830.1|F251818S13[9944833] - 7572: AF251829
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 14
gi|9944832|gb|AF251829.1|F251818S12[9944832] - 7573: AF251828
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 13
gi|9944831|gb|AF251828.1|F251818S11[9944831]
- 7574: AF251827
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exons 11 and
gi|9944830|gb|AF251827.1|F251818S10[9944830] - 7575: AF251826
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exons 9 and
gi|9944829|gb|AF251826.1|F251818S09[9944829] - 7576: AF251825
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 8
gi|9944828|gb|AF251825.1|F251818S08[9944828] - 7577: AF251824
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 7
gi|9944827|gb|AF251824.1F251818S07[9944827] - 7578: AF251823
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 6
gi|9944826|gb|AF251823.1|F251818S06[9944826] - 7579: AF251822
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 5
gi|9944825|gb|AF251822.1|F251818S05[9944825] - 7580: AF251821
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 4
gi|9944824|gb|AF251821.1|F251818S04[9944824] - 7581: AF251820
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 3
gi|9944823|gb|AF251820.1|F251818S03[9944823] - 7582: AF251819
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, exon 2
gi|9944822|gb|AF251819.1|F251818S02[9944822] - 7583: AF251818
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, promoter region and exon 1
gi|9944821|gb|AF251818.1|F251818S01[9944821] - 7584: AH009773
Homo sapiens vitronectin receptor alpha polypeptide (ITGAV) gene, complete cds
gi|9944820|gb|AH009773.1|SEG_F251818S[9944820] - 7585: AF189768
Homo sapiens leukocyte immunoglobulin-like receptor 5 (LIR5) gene, complete cds
gi|9930102|gb|AF189768.1|AF189768[9930102] - 7600: AJ245377
Homo sapiens mRNA for 2B4 NK receptor homologue (h2B4 gene)
gi|9621661|emb|AJ245377.1|HSA245377[9621661] - 7601: X07206
H. sapiens TRGV10 gene, allele V10*A1
gi|1848182|emb|X07206.1|HSTRGV10[1848182] - 7603: AF246974
Homo sapiens toll-like receptor 9 (TLR9) mRNA, partial cds, alternatively spliced
gi|9887086|gb|AF246974.1|AF246974[9887086] - 7604: AF246973
Homo sapiens toll-like receptor 9 (TLR9) mRNA, partial cds, alternatively spliced
gi|9887084|gb|AF246973.1|AF246973[9887084] - 7605: AF246972
Homo sapiens toll-like receptor 9 (TLR9) mRNA, partial cds
gi|9887082|gb|AF246972.1|AF246972[9887082] - 7606: AF215826
Homo sapiens killer-cell Ig-like receptor KIR2DL4v1 (KIR2DL4) gene, KIR2DL4v1 allele, exon 3 and partial cds
gi|9886965|gb|AF215826.1|AF215826[9886965] - 7607: AF215825
Homo sapiens killer-cell Ig-like receptor KIR3DL1v (KIR3DL1) gene, KIR3DL1v allele, exon 3 and partial cds
gi|9886963|gb|AF215825.1|AF215825[9886963] - 7608: AB008193
Homo sapiens genes for leukotriene B4 receptor BLT2, leukotriene B4 receptor BLT1, complete cds
gi|9229835|gb|AF008193.1|AF008193[9229835] - 7609: AB029892
Homo sapiens hBLT2 mRNA for Leukotriene B4 receptor BLT2, complete cds
gi|9186899|dbj|AB029892.1|AB029892[9186899] - 7610: AF211978
Homo sapiens LENG11 mRNA, partial sequence
gi|9885308|gb|AF211978.1|AF211978[9885308] - 7611: AF211977
Homo sapiens LENG10 mRNA, partial sequence
gi|9885307|gb|AF211977.1|AF211977[9885307] - 7612: AF211976
Homo sapiens LENG9 mRNA, partial sequence
gi|9885306|gb|AF211976.1|AF211976[9885306] - 7613: AF211975
Homo sapiens LENG8 mRNA, variant C, partial sequence
gi|9885305|gb|AF211975.1|AF211975[9885305] - 7614: AF211974
Homo sapiens LENG8 mRNA, variant B, partial sequence
gi|9885304|gb |AF211974.1|AF211974[9885304] - 7615: AF211973
Homo sapiens LENG8 mRNA, variant A, partial sequence
gi|9885303|gb|AF211973.1|AF211973[9885303] - 7616: AF211972
Homo sapiens LENG7 mRNA, partial sequence
gi|9885302|gb|AF211972.1|AF211972[9885302] - 7617: AF211971
Homo sapiens LENG6 mRNA, partial sequence
gi|9885301|gb|AF211971.1|AF211971[9885301] - 7618: AF211970
Homo sapiens LENG5 mRNA, partial sequence
gi|9885300|gb|AF211970.1|AF211970[9885300] - 7619: AF211969
Homo sapiens LENG4 mRNA, partial sequence
gi|9885299|gb|AF211969.1|AF211969[9885299] - 7620: AF211968
Homo sapiens LENG3 mRNA, partial sequence
gi|9885298|gb|AF211968.1|AF211968[9885298] - 7621: AF211967
Homo sapiens LENG2 mRNA, partial sequence
gi|9885297|gb|AF211967.1|AF211967[9885297] - 7622: AF211966
Homo sapiens LENG1 protein (LENG1) mRNA, partial cds
gi|9885295|gb|AF211966.1|AF211966[9885295] - 7624: AF262016
Homo sapiens adrenergic receptor alpha-2A gene, complete cds
gi|986478|gb|AF262016.2|AF262016[9864781] - 7626: AF242865
Homo sapiens coxsackie virus and adenovirus receptor (CXADR) gene, exon 7 and complete cds
gi|9858570|gb|AF242865.1|AF242862S4[9858570] - 7627: AF242864
Homo sapiens coxsackie virus and adenovirus receptor (CXADR) gene, exons 2 through 6
gi|9858569|gb|AF242864.1|AF242862S3[9858569] - 7629: AF242862
Homo sapiens coxsackie virus and adenovirus receptor (CXADR) gene, exon 1
gi|9858567|gb|AF242862.1|AF242862S1[9858567] - 7630: AH009718
Homo sapiens coxsackie virus and adenovirus receptor (CXADR) gene, complete cds
gi|9858566|gb|AH009718.1|SEG_AF242862S[9858566] - 7631: AF257210
Homo sapiens G-protein coupled receptor HLWAR77 mRNA, complete cds
gi|9309468|gb|AF257210.1|AF257210[9309468] - 7632: AF292403
Homo sapiens type B natriuretic peptide receptor gene, promoter region and partial cds
gi|9858187|gb|AF292403.1|AF292403[9858187] - 7633: AF288571
Homo sapiens lymphoid enhancer factor-1 (LEF1) mRNA, complete cds
gi|9858157|gb|AF288571.1|AF288571[9858157] - 7634: AF146747
Homo sapiens cell surface receptor (PRV1) mRNA, complete cds
gi|9857660|gb|AF146747.1|AF146747[9857660] - 7862: AF233092
Homo sapiens lysophosphatidic acid G protein-coupled receptor 4 (EDG4) mRNA, complete cds
gi|7243675|gb|AF233092.1|AF233092[7243675] - 7863: AF269144
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 10 and complete
cds
gi|9802369|gb|AF269144.1|F269135S10[9802369] - 7864: AF269143
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 9
gi|9802368|gb|AF2691430.1F269135S09[9802368] - 7865: AF269142
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 8
gi|9802367|gb|AF269142.1|F269135S08[9802367] - 7866: AF269141
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 7
gi|9802366|gb|AF269141.1F269135S07[9802366] - 7867: AF269140
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 6
gi|9802365|gb|AF269140.1|F269135S06[9802365] - 7868: AF269139
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 5
gi|9802364|gb|AF269139.1|F269135S05[9802364] - 7869: AF269138
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 4
gi|9802363|gb|AF269138.1F269135S04[9802363] - 7870: AF269137
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 3
gi|9802362|gb|AF269137.1|F269135S03[9802362] - 7871: AF269136
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 2
gi|980236|gb|AF269136.1|F269135S02[9802361] - 7872: AF269135
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 1
gi|9802360|gb|AF269135.1|F269135S01[9802360] - 7873: AH009710
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, complete cds
gi|9802359|gb|AH009710.1|SEG_F269135S[9802359] - 7874: AF211942
Homo sapiens haplotype 1089 olfactory receptor (OR2H3) gene, partial cds
gi|9798923|gb|AF211942.1|AF211942[9798923] - 7875: AF211941
Homo sapiens haplotype 1037 olfactory receptor (OR2H3) gene, partial cds
gi|9798921|gb|AF211941.1|AF211941[9798921] - 7876: AF211940
Homo sapiens haplotype 1012 olfactory receptor (OR2H3) gene, partial cds
gi|9798919|gb|AF211940.1|AF211940[9798919] - 7877: AF211939
Homo sapiens haplotype 1013 olfactory receptor (OR2H3) gene, partial cds
gi|9798917|gb|AF211939.1|AF211939[9798917] - 7878: AJ272029
Homo sapiens partial CD30 gene for cytokine receptor CD30 and promoter region
gi|9798449|emb|AJ272029.1|HSA272029[9798449] - 7880: AF101726
Homo sapiens vasopressin receptor subtype 1b mRNA, complete cds
gi|4336681|gb|AF101726.1|AF101726[4336681] - 7881: AF101725
Homo sapiens vasopressin receptor subtype 1a mRNA, complete cds
gi|4336679|gb|AF101725.1|AF101725[4336679] - 7882: AF101728
Homo sapiens truncated vasopressin receptor type 2 mRNA, complete cds
gi|4323606|gb|AF101728.1|AF101728[4323606] - 7883: AF101727
Homo sapiens vasopressin receptor type 2 mRNA, complete cds
gi|4323604|gb|AF101727.1|AF101727[4323604] - 7884: AF064078
Homo sapiens insulin receptor-related receptor (INSRR) mRNA, partial cds
gi|3152883|gb|AF064078.1|AF064078[3152883] - 7885: S82307
Homo sapiens p65 mRNA, partial cds
gi|1839613|gb|S82307.1|S82307[1839613] - 7886: S83176
Homo sapiens calcium-sensing receptor long isoform (CASR) mRNA, partial cds
gi|1836093|gb|S83176.1|S83176[1836093] - 7887: S82755
Homo sapiens T cell receptor mRNA, partial cds
gi|1835845|gb|S82755.1|S82755[1835845] - 7888: S82612
Homo sapiens 5-hydroxytryptamine type 3AS receptor subunit mRNA, complete cds
gi|1699437|gb|S82612.1|S82612[1699437] - 7891: AF238374
Homo sapiens mutant fibroblast growth factor receptor 3 (FGFR3) mRNA, partial cds
gi|9719331|gb|AF2383740.1|AF238374[9719331] - 7894: AJ400843
Homo sapiens partial mRNA for immunoglobulin-like cell surface receptor FDF03-M14, soluble alternative form
gi|9715838|emb|AJ400843.1|HSA400843[9715838] - 7895: AJ400842
Homo sapiens partial mRNA for immunoglobulin-like cell surface receptor FDF03-dtm, soluble form
gi|9715835|emb|AJ400842.1|HSA400842[9715835] - 7896: AJ400841
Homo sapiens mRNA for immunoglobulin-like cell surface receptor FDF03
gi|9715833|emb|AJ400841.1|HSA400841[9715833] - 8061: AJ005205
Homo sapiens 5HT3 gene for serotonin 3 receptor
gi|7019744|emb|AJ005205.2|HSA005205[7019744] - 8062: AB038269
Homo sapiens mRNA for cysteinyl leukotriene CysLT2 receptor, complete cds; cDNA:
PSEC0146 from clone PLACE1006979
gi|9663957|dbj|AB038269.1|AB038269[9663957] - 8063: AJ278476
Homo sapiens partial mRNA for transport-secretion protein 2.2, (TTS-2.2 gene)
gi|9663152|emb|AJ278476.1|HSA278476[9663152] - 8064: AJ278475
Homo sapiens partial mRNA for transport-secretion protein 2.1 (TTS-2.1 gene)
gi|9663150|emb|AJ278475.1|HSA278475[9663150] - 8065: AF282693
Homo sapiens inflammation-related G protein-coupled receptor EX33 (EX33) mRNA,
complete cds
gi|9652260|gb|AF282693.1|AF282693[9652260] - 8066: AF254409
Homo sapiens scavenger receptor class B type III SR-BIII mRNA, partial cds
gi|9651987|gb|AF254409.1|AF254409[9651987] - 8067: AF236117
Homo sapiens G-protein coupled receptor EDG-7 mRNA, complete cds
gi|9651838|gb|AF236117.1|AF236117[9651838] - 8068: AF287008
Homo sapiens triggering receptor expressed on monocytes 1 (TREML) mRNA, complete
cds
gi|9624485|gb|AF287008.1|AF287008[9624485] - 8069: AF172171
Homo sapiens toll-like receptor 4 (TLR4) gene, exon 4 and complete cds
gi|9622356|gb|AF172171.1|HSTLR3[9622356] - 8070: AF172170
Homo sapiens toll-like receptor 4 (TLR4) genie, exons 2 and 3
gi|9622355|gb|AF172170.1|HSTLR2[9622355] - 8071: AF172169
Homo sapiens toll-like receptor 4 (TLR4) gene, exon 1
gi|9622354|gb|AF172169.1|HSTLR1[9622354] - 8072: AH009665
Homo sapiens toll-like receptor 4 (TLR4) gene, complete cds
gi|9622353|gb|AH009665.1|SEG_HSTLR[9622353] - 8073: AF165312
Homo sapiens pre-T-cell receptor alpha chain (PTA) mRNA, alternatively spliced,
complete cds
gi|9621867|gb|AF165312.1|AF165312[9621867] - 8074: AJ245375
Homo sapiens mRNA for PP35 act (h2B4 gene)
gi|9621657|emb|AJ245375.1|HSA245375[9621657] - 8075: AF277230
Homo sapiens seven transmembrane receptor BLTR2 (BLTR2) mRNA, complete cds
gi|8896158|gb|AF277230.1|AF277230[8896158] - 8076: AF114491
Homo sapiens EGF-like module EMR2 (EMR2) mRNA, complete cds
gi|6650688|gb|AF114491.1|AF114491[6650688] - 8077: AF107259
Homo sapiens chromosome 21q22.1 cosmid clone ICRFcA0552D2, complete sequence, containing part of the glutamate receptor gene GLUR5
gi|4154320|gb|AF107259.1|AF107259[4154320] - 8078: AF107257
Homo sapiens chromosome 21q22.1 PAC L12209, complete sequence
gi|4106881|gb|AF107257.1|AF107257[4106881] - 8079: AZ081535
p133B6#4 RPCI-6 Homo sapiens genomic, genomic survey sequence
gi|9587541|gb|AZ081535.1|AZ081535[9587541] - 8081: AF285168
Homo sapiens GABA-A receptor beta 1 subunit (GABRB1) gene, promoter and partial
cds
gi|9502261|gb|AF285168.1|AF285168[9502261] - 8126: AC018755
Homo sapiens chromosome 19, BAC BC330783 (CIT-HSPC—470E3), complete sequence
gi|9454515|gb|AC018755.3|AC018755[9454515] - 8159: AF246303
Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, exon 9 and complete cds
gi|7417394|gb|AF246303.1|AF246296S8[7417394] - 8160: AF246302
Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, exons 7 and 8
gi|7417393|gb|AF246302.1|AF246296S7[7417393] - 8161: AF246301
Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, exon 6
gi|7417392|gb|AF246301.1|AF246296S6[7417392] - 8162: AF246300
Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, exon 5
gi|741739|gb|AF246300.1|AF246296S5[7417391] - 8163: AF246299
Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, exon 4
gi|7417390|gb|AF246299.1|AF246296S4[7417390] - 8164: AF246298
Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, exon 3
gi|7417389|gb|AF246298.1|AF246296S3[7417389] - 8165: AF246297
Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, exon 2
gi|7417388|gb|AF246297.1|AF246296S2[7417388] - 8166: AF246296
Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, promoter and exon 1
gi|7417387|gb|AF246296.1|AF246296S1[7417387] - 8167: AH009223
Homo sapiens peroxisome proliferative activated receptor delta (PPARD) gene, complete cds
gi|7417386|gb|AH009223.1|SEG_AF246296S[7417386] - 8168: U94888
Homo sapiens CC-chemokine-binding receptor JAB61 mRNA, complete cds
gi|2213808|gb|U94888.1|HSU94888[2213808] - 8169: AB040434
Homo sapiens mRNA for hTROY, complete cds
gi|9392329|dbj|AB040434.1|AB040434[9392329] - 8170: AJ272427
Homo sapiens mRNA for frizzled homolog 3 (FZD3 gene)
gi|7649448|emb|AJ272427.1|HSA272427[7649448] - 8173: U88356
Homo sapiens receptor tyrosine kinase ErbB-3 (c-erbB-3) gene, exons 12, 13, 14, and partial cds
gi|9294704|gb|U88356.1|HSCERBR3[9294704] - 8174: U88355
Homo sapiens receptor tyrosine kinase ErbB-3 (c-erbB-3) gene, exon 10 and partial cds
gi|9294703|gb|U88355.1|HSCERBR2[9294703] - 8175: U88354
Homo sapiens receptor tyrosine kinase ErbB-3 (c-erbB-3) gene, exons 8 and 9
gi|9294702|gb|U88354.1|HSCERBR1[9294702] - 8176: AB037533
Homo sapiens HTR1F gene for 5-hydroxytryptamine (serotonin) receptor 1F, partial
cds
gi|6815236|dbj|AB037533.1|AB037533[6815236] - 8177: AB037513
Homo sapiens HTR2A gene for 5-hydroxytryptamine (serotonin) receptor 2A, partial
cds
gi|6815196|dbj|AB037513.1|AB037513[6815196] - 8178: AF180301
Homo sapiens corticotropin-releasing factor receptor variant id (CRHR1) mRNA, alternative splice product, complete cds
gi|5815472|gb|AF180301.1|AF180301[5815472] - 8181: AF208111
Homo sapiens truncated IL-17 receptor homolog precursor (EVI27) mRNA, complete
cds
gi|9246434|gb|AF208111.1|AF208111[9246434] - 8182: AF208110
Homo sapiens IL-17 receptor homolog precursor (EVI27) mRNA, complete cds
gi|9246432|gb|AF208110.1|AF208110[9246432] - 8183: M15222
Homo sapiens T-cell receptor (TCRB) mRNA, partial cds
gi|338893|gb|M15222.1|HUMTCBVO[338893] - 8189: AF263279
Homo sapiens CD164 mRNA, complete cds
gi|9230740|gb|AF263279.1|AF263279[9230740] - 8192: AF242874
Homo sapiens neuromedin U receptor 2 (NMU2R) mRNA, complete cds
gi|9082155|gb|AF242874.1|AF242874[9082155] - 8193: AF160477
Homo sapiens Ig superfamily receptor LNIR precursor, mRNA, complete cds
gi|9049507|gb|AF160477.1|AF160477[9049507] - 8194: AF058290
Homo sapiens imidazoline receptor antisera-selected protein mRNA, partial cds
gi|3493224|gb|AF058290.1|AF058290[3493224] - 8195: AF082516
Homo sapiens I-1 receptor candidate protein mRNA, complete cds
gi|3462806|gb|AF082516.1|AF082516[3462806] - 8211: X06031
Homo sapiens partial T-cell receptor CD3-gamma gene, exon 6
gi|36818|emb|X06031.1|HSTCR3G6[36818] - 8212: X06030
Homo sapiens partial T-cell receptor CD3-gamma gene, exon 5
gi|36816|emb|X06030.1|HSTCR3G5[36816] - 8213: X06029
Homo sapiens partial T-cell receptor CD3-gamma gene exon 4
gi|36814|emb|X06029.1|HSTCR3G4[36814] - 8214: X06027
Homo sapiens partial CD3G gene, exon 2 (and joined mature peptide)
gi|36811|emb|X06027.1|HSTCR3G2[36811] - 8216: Z30426
H. sapiens gene for early lymphocyte activation antigen CD69, exon 1
gi|525242|emb|Z30426.1|HSLACD691[525242] - 8302: AJ278605
Homo sapiens BLT-2R gene for leukotriene B4 receptor 2
gi|8919627|emb|AJ278605.1|HSA278605[8919627] - 8444: AF246925
Homo sapiens haplotype 28 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|880984|gb|AF246925.1|AF246925[8809841] - 8445: AF246924
Homo sapiens haplotype 27 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809840|gb|AF246924.1|AF246924[8809840] - 8446: AF246923
Homo sapiens haplotype 26 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809839|gb|AF246923.1|AF246923[8809839] - 8447: AF246922
Homo sapiens haplotype 24 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809838|gb|AF246922.1|AF246922[8809838] - 8448: AF246921
Homo sapiens haplotype 23 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809837|gb|AF246921.1|AF246921[8809837] - 8449: AF246920
Homo sapiens haplotype 22 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809836|gb|AF246920.1|AF246920[8809836] - 8450: AF246919
Homo sapiens haplotype 21 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809835|gb|AF246919.1|AF246919[8809835] - 8451: AF246918
Homo sapiens haplotype 20 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809834|gb|AF246918.1|AF246918[8809834] - 8452: AF246917
Homo sapiens haplotype 19 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809833|gb|AF246917.1|AF246917[8809833] - 8452: AF246917
- 8453: AF246916
Homo sapiens haplotype 18 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809832|gb|AF246916.1|AF246916[8809832] - 8454: AF246915
Homo sapiens haplotype 17 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809831|gb|AF246915.1|AF246915[8809831] - 8455: AF246914
Homo sapiens haplotype 16 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809830|gb|AF246914.1|AF246914[8809830] - 8456: AF246913
Homo sapiens haplotype 15 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809829|gb|AF246913.1|AF246913[8809829] - 8457: AF246912
Homo sapiens haplotype 14 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809828|gb|AF246912.1|AF246912[8809828] - 8458: AF246911
Homo sapiens haplotype 13 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809827|gb|AF246911.1|AF246911[8809827] - 8459: AF246910
Homo sapiens haplotype 12 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809826|gb|AF246910.1|AF246910[8809826] - 8460: AF246909
Homo sapiens haplotype 11 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809825|gb|AF246909.1|AF246909[8809825] - 8461: AF246908
Homo sapiens haplotype 10 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809824|gb|AF246908.1|AF246908[8809824] - 8462: AF246907
Homo sapiens haplotype 9 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809823|gb|AF246907.1|AF246907[8809823] - 8463: AF246906
Homo sapiens haplotype 8 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809822|gb|AF246906.1|AF246906[8809822] - 8464: AF246905
Homo sapiens haplotype 7 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809821|gb|AF246905.1|AF246905[8809821] - 8465: AF246904
Homo sapiens haplotype 6 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809820|gb|AF246904.1|AF246904[8809820] - 8466: AF246903
Homo sapiens haplotype 5 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809819|gb|AF246903.1|AF246903[8809819] - 8467: AF246902
Homo sapiens haplotype 4 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809818|gb|AF246902.1|AF246902[8809818] - 8468: AF246901
Homo sapiens haplotype 1 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809817|gb|AF246901.1|AF246901[8809817] - 8469: AF246900
Homo sapiens haplotype 2 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809816|gb|AF246900.1|AF246900[8809816] - 8470: AF246899
Homo sapiens haplotype 3 CC chemokine receptor 5 (CCR5) gene, partial sequence
gi|8809815|gb|AF246899.1|AF246899[8809815] - 8471: AF210633
Homo sapiens growth hormone receptor (GHR) gene, GHR-d3 allele, partial sequence
gi|8809760|gb|AF210633.1|AF210633[8809760] - 8472: M22057
Homo sapiens T-cell receptor epsilon (CD3E) gene, exon 5 and partial cds
gi|339220|gb|M22057.1|HUMTCR3E[339220] - 8476: AF212311
Homo sapiens interleukin 20 (IL20) mRNA, complete cds
gi|8705219|gb|AF2123110.1|AF212311[8705219] - 8477: AF141334
Homo sapiens placenta apolipoprotein B48 receptor type 2 (APOB48R) mRNA, complete cds
gi|8699629|gb|AF141334.1|AF141334[8699629] - 8478: AF277379
Homo sapiens vitamin D receptor-interacting protein complex component DRIP100 (DRIP100) mRNA, complete cds
gi|8699627|gb|AF277379.1|AF277379[8699627] - 8480: AJ251962
Homo sapiens partial TGF-beta III receptor gene
gi|6634455|emb|AJ251962.1|HSA251962[6634455] - 8481: AJ251961
Homo sapiens partial mRNA for betaglycan (TBR III gene)
gi|6634453|emb|AJ251961.1|HSA251961[6634453] - 8483: AF062039
Homo sapiens integrin alpha-2 subunit (ITGA2) gene, ITGA2-1 allele, partial cds
gi|8574452|gb|AF062039.1|AF062039[8574452] - 8485: AF141333
Homo sapiens apolipoprotein B48 receptor (APOB48R) gene, complete cds
gi|8547065|gb|AF141333.1|AF141333[8547065] - 8486: AF141332
Homo sapiens apolipoprotein B48 receptor (APOB48R) mRNA, complete cds
gi|8547063|gb|AF141332.1|AF141332[8547063] - 8488: X56253
Homo sapiens partial MPR46 gene for 46 kd mannose 6-phosphate receptor, exon 1 and join mRNA
gi|34727|emb|X56253.1|HSMPR461[34727] - 8489: AF155912
Homo sapiens growth hormone receptor (GHR) gene, exon 3 and partial cds
gi|8037572|gb|AF155912.1|AF155912[8037572] - 8490: AF263744
Homo sapiens erbb2-interacting protein ERBIN mRNA, complete cds
gi|8572220|gb|AF263744.1|AF263744[8572220] - 8501: X56254
Homo sapiens partial MPR46 gene for 46 kd mannose 6-phosphate receptor, exon 2 join CDS
gi|34729|emb|X56254.1|HSMPR462[34729] - 8503: AB040801
Homo sapiens mRNA for SREB3, complete cds
gi|8467969|dbj|AB040801.1|AB040801[8467969] - 8504: AB040800
Homo sapiens mRNA for SREB2, complete cds
gi|8467967|dbj|AB040800.1|AB040800[8467967] - 8505: AB040799
Homo sapiens mRNA for SREB1, complete cds
gi|8467965|dbj|AB040799.1|AB040799[8467965] - 8506: AF187064
Homo sapiens p75NTR-associated cell death executor (NADE) mRNA, complete cds
gi|8452893|gb|AF187064.1|AF187064[8452893] - 8507: AF045606
Homo sapiens C21orf4 mRNA, complete cds
gi|8277249|gb|AF045606.2|AF045606[8277249] - 8508: AF204920
Homo sapiens killer cell Ig-like receptor (KIR48) gene, KIR48b variant, exon 5
gi|8248132|gb|AF204920.1|AF204918S3[8248132] - 8509: AF204919
Homo sapiens killer cell Ig-like receptor (KIR48) gene, KIR48b variant, exon 4
gi|8248131|gb|AF204919.1|AF204918S2[8248131] - 8510: AF204918
Homo sapiens killer cell Ig-like receptor (KIR48) gene, KIR48b variant, exons 4
and 3
gi|8248130|gb|AF204918.1|AF204918S1[8248130] - 8511: AH009422
Homo sapiens
gi|8248129|gb|AH009422.1|SEG_AF204918S[8248129] - 8512: AF204917
Homo sapiens killer cell Ig-like receptor (KIR48) gene, KIR48a variant, exon 5
gi|8248128|gb|AF204917.1|AF204915S3[8248128] - 8513: AF204916
Homo sapiens killer cell Ig-like receptor (KIR48) gene, KIR48a variant, exon 4
gi|8248127|gb|AF204916.1|AF204915S2[8248127] - 8514: AF204915
Homo sapiens killer cell Ig-like receptor (KIR48) gene, KIR48a variant, exons 2
and 3
gi|8248126|gb|AF204915.1|AF204915S1[8248126] - 8515: AH009421
Homo sapiens
gi|8248125|gb|AH009421.1|SEG_AF204915S[8248125] - 8516: AF204914
Homo sapiens killer cell Ig-like receptor (KIR44) gene, KIR44b variant, exon 5
gi|8248124|gb|AF204914.1|AF204912S3[8248124] - 8517: AF204913
Homo sapiens killer cell Ig-like receptor (KIR44) gene, KIR44b variant, exon 4
gi|8248123|gb|AF204913.1|AF204912S2[8248123] - 8518: AF204912
Homo sapiens killer cell Ig-like receptor (KIR44) gene, KIR44b variant, exons 2
and 3
gi|8248122|gb|AF204912.1|AF204912S1[8248122] - 8519: AH009420
Homo sapiens
gi|8248121|gb|AH009420.1|SEG_AF204912S[8248121] - 8520: AF204911
Homo sapiens killer cell Ig-like receptor (KIR44) gene, KIR44a variant, exon
5
gi|8248120|gb|AF204911.1|AF204909S3[8248120] - 8521: AF204910
Homo sapiens killer cell Ig-like receptor (KIR44) gene, KIR44a variant, exon 4
gi|8248119|gb|AF204910.1|AF204909S2[8248119] - 8522: AF204909
Homo sapiens killer cell Ig-like receptor (KIR44) gene, KIR44a variant, exons
2
and 3
gi|8248118|gb|AF204909.1|AF204909S1[8248118] - 8523: AH009419
Homo sapiens
gi|8248117|gb|AH009419.1|SEG_AF204909S[8248117] - 8524: AF204905
Homo sapiens killer cell Ig-like receptor (KIR2DL5) gene, KIR2DL5.2 variant, partial sequence
gi|8248112|gb|AF204905.1|AF204905[8248112] - 8525: AF204904
Homo sapiens killer cell Ig-like receptor (KIR2DL5) gene, KIR2DL5.1 variant, partial cds
gi|8248110|gb|AF204904.1|AF204904[8248110] - 8607: AF212842
Homo sapiens immunoglobulin-like transcript 11 protein (ILT11) mRNA, partial cds
gi|8163785|gb|AF212842.1|AF212842[8163785] - 8608: AF208237
Homo sapiens 7-transmembrane G-protein coupled receptor 2 (GPR2) mRNA, complete
cds
gi|8118034|gb|AF208237.1|AF208237[8118034] - 8609: AF204903
Homo sapiens killer-cell immunoglobulin-like receptor KIR2DL5.1 (KIR2DL5) mRNA,
complete cds
gi|8117976|gb|AF204903.1|AF204903[8117976] - 8610: AP001716
Homo sapiens genomic DNA, chromosome 21q, section 60/105
gi|7768717|dbj|AP001716.1|AP001716[7768717] - 8611: AP001705
Homo sapiens genomic DNA, chromosome 21q, section 49/105
gi|7768711|dbj|AP001705.1|AP001705[7768711] - 8612: AP001670
Homo sapiens genomic DNA, chromosome 21q, section 14/105
gi|7768690|dbj|AP001670.1|AP001670[7768690] - 8613: AP001717
Homo sapiens genomic DNA, chromosome 21q, section 61/105
gi|7768678|dbj|AP001717.1|AP001717[7768678] - 8616: AJ012074
Homo sapiens VPAC1 receptor gene, 5′ end and promoter region
gi|3758828|emb|AJ012074.1|HSA012074[3758828] - 8617: AF039906
Homo sapiens cosmid D16B8, chromosome 21 3′ of IFNGR2
gi|2914756|gb|AF039906.1|AF039906[2914756] - 8619: S77335
Homo sapiens growth hormone receptor gene, partial cds
gi|999143|gb|S77335.1|S77335[999143] - 8621: S75765
Homo sapiens delta CCK-B gene, partial cds
gi|913754|gb|S75765.1|S75765[913754] - 8624: S78717
Homo sapiens ryanodine receptor (RYR1) gene, partial cds
gi|244183|gb|S78717.1|S78717[244183] - 8625: X15266
Homo sapiens gene for muscarinic acetylcholine receptor HM3
gi|32323|emb|X15266.1|HSACM3[32323] - 8626: X15265
Homo sapiens gene for muscarinic acetylcholine receptor M4
gi|32321|emb|X15265.1|HSACM4[32321] - 8627: AF220542
Homo sapiens FCRN protein gene, complete cds
gi|8101614|gb|AF220542.1|AF220542[8101614] - 8629: AF073924
Homo sapiens putative taste receptor HTR2 mRNA, partial cds
gi|8100088|gb|AF073924.1|AF073924[8100088] - 8630: D88437
Homo sapiens mRNA for G-protein coupled receptor SALPR, complete cds
gi|7340885|dbj|D88437.1|D88437[7340885] - 8631: AB032369
Homo sapiens MIST mRNA, partial cds
gi|8099156|dbj|AB032369.1|AB032369[8099156] - 8632: AF167555
Homo sapiens TAJ-alpha mRNA, complete cds
gi|8071643|gb|AF167555.1|AF167555[8071643] - 8633: AF002982
Homo sapiens killer cell receptor (KIR103) mRNA, allele ASD2, complete cds
gi|2443483|gb|AF002982.1|AF002982[2443483] - 8634: AF002981
Homo sapiens killer cell receptor (KIR103) mRNA, allele ASD1, complete cds
gi|2443481|gb|AF002981.1|AF002981[2443481] - 8635: AF002980
Homo sapiens killer cell receptor (KIR103) mRNA, allele AS, complete cds
gi|2443479|gb|AF002980.1|AF002980[2443479] - 8636: AF002979
Homo sapiens killer cell receptor (KIR103) mRNA, allele LP, complete cds
gi|2443477|gb|AF002979.1|AF002979[2443477] - 8637: AH005453
Homo sapiens chromosome 19 clone 4 map 19q13.4
gi|2228790|gb|AH005453.1|SEG_HSKIR[2228790] - 8638: AF003123
Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 8 and complete cds
gi|2228789|gb|AF003123.1|HSKIR8[2228789] - 8639: AF003122
Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 7
gi|2228788|gb|AF003122.1|HSKIR7[2228788] - 8640: AF003121
Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 6
gi|2228787|gb|AF003121.1|HSKIR6[2228787] - 8641: AF003120
Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 5
gi|2228786|gb|AF003120.1|HSKIR5[2228786] - 8642: AF003119
Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 4
gi|2228785|gb|AF003119.1|HSKIR4[2228785] - 8643: AF003118
Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 3
gi|2228784|gb|AF003118.1|HSKIR3[2228784] - 8644: AF003117
Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 2
gi|2228783|gb|AF003117.1|HSKIR2[2228783] - 8645: AF003116
Homo sapiens killer cell inhibitory receptor (KIR-103AS) gene, exon 1
gi|2228782|gb|AF003116.1|HSKIR1[2228782] - 8646: AF196329
Homo sapiens triggering receptor expressed on monocytes 1 mRNA, complete cds
gi|8050526|gb|AF196329.1|AF196329[8050526] - 8647: AF167342
Homo sapiens membrane interleukin 1 receptor accessory protein (IL1RAP) gene, exon 12 and complete cds, alternatively spliced
gi|8050498|gb|AF167342.1|F167333S10[8050498] - 8648: AF167341
Homo sapiens membrane interleukin 1 receptor accessory protein (IL1RAP) gene, exons 10 and 11
gi|8050497|gb|AF167341.1|F167333S09[8050497] - 8649: AF167340
Homo sapiens soluble interleukin 1 receptor accessory protein (IL1RAP) gene, exon 8, alternative exons 9 and complete cds, alternatively spliced
gi|8050496|gb|AF167340.1|F167333S08[8050496] - 8650: AF167339
Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, exon 7
gi|8050495|gb|AF167339.1|F167333S07[8050495] - 8651: AF167338
Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, exon 6
gi|8050494|gb|AF167338.1|F167333S06[8050494] - 8652: AF167337
Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, exon 5
gi|8050493|gb|AF167337.1|F167333S05[8050493] - 8653: AF167336
Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, exon 4
gi|8050492|gb|AF167336.1F167333S04[8050492] - 8654: AF167335
Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, exon 3
gi|8050491|gb|AF167335.1|F167333S03[8050491] - 8655: AF167334
Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, exon 2
gi|8050490|gb|AF167334.1|F167333S02[8050490] - 8656: AF167333
Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, exon 1
gi|8050489|gb|AF167333.1|F167333S01[8050489] - 8657: AH009309
Homo sapiens interleukin 1 receptor accessory protein (IL1RAP) gene, complete cds, alternatively spliced
gi|8050488|gb|AH009309.1|SEG_F167333S[8050488] - 8658: AF167343
Homo sapiens soluble interleukin-1 receptor accessory protein (IL1RAP) mRNA, complete cds
gi|8050486|gb|AF167343.1|AF167343[8050486] - 8659: AF213457
Homo sapiens triggering receptor expressed on myeloid cells 2 mRNA, complete cds
gi|7800156|gb|AF213457.1|AF213457[7800156] - 8661: AF233281
Homo sapiens CC chemokine receptor (CCBP2) gene, complete cds
gi|7274391|gb|AF233281.1|AF233281[7274391] - 8662: AF189259
Homo sapiens GABA-A receptor theta subunit (THETA) mRNA, complete cds
gi|7861735|gb|AF189259.1|AF189259[7861735] - 8663: AF176832
Homo sapiens low density lipoprotein receptor related protein-deleted in tumor
(LRPDIT) mRNA, complete cds
gi|7861732|gb|AF176832.1|AF176832[7861732] - 8664: AH001455
Homo sapiens protooncogene protein (c-erb-2) gene, partial cds
gi|182164|gb|AH001455.1|SEG_HUMERB2[182164] - 8665: M11767
Homo sapiens protooncogene protein (c-erb-2) gene, exon 7 and partial cds
gi|182163|gb|M11767.1|HUMERB27[182163] - 8666: M11766
Homo sapiens protooncogene protein (c-erb-2) gene, exon 6
gi|182162|gb|M11766.1|HUMERB26[182162] - 8667: M11765
Homo sapiens protooncogene protein (c-erb-2) gene, exon 5
gi|118216|gb|M11765.1|HUMERB25[182161] - 8668: M11764
Homo sapiens protooncogene protein (c-erb-2) gene, exon 4
gi|182160|gb|M11764.1|HUMERB24[182160] - 8669: M11763
Homo sapiens protooncogene protein (c-erb-2) gene, exon 3
gi|182159|gb|M11763.1|HUMERB23[182159] - 8670: M11762
Homo sapiens protooncogene protein (c-erb-2) gene, exon 2
gi|182158|gb|M11762.1|HUMERB22[182158] - 8671: M11761
Homo sapiens protooncogene protein (c-erb-2) gene, exon 1
gi|182157|gb|M11761.1|HUMERB21[182157] - 8674: AC068948
Homo sapiens chromosome 19, cosmid R28371 (LLNL-R—244D7), complete sequence
gi|7798735|gb|AC068948.1|AC068948[7798735] - 8675: AF060231
Homo sapiens herpesvirus entry protein C (HVEC) mRNA, complete cds
gi|3242792|gb|AF060231.1|AF060231[3242792] - 8676: Z24459
H. sapiens MTCP1 gene, exons 2A to 7 (and joined mRNA)
gi|2252491|emb|Z24459.1|HSMTCP12A[2252491] - 8677: AB006200
Homo sapiens gene for parathyroid hormone/parathyroid hormone-related protein receptor, exon1, partial sequence
gi|7770088|dbj|AB006200.1|AB006200[7770088] - 8693: AB023493
Homo sapiens mRNA for preproapelin, complete cds
gi|6009585|dbj|AB023493.1|AB023493[6009585] - 8697: M55336
Homo sapiens oncogene tyrosine protein kinase receptor (trk2) mRNA, partial cds
gi|339913|gb|M55336.1|HUMTRK2[339913] - 8701: AB028741
Homo sapiens mRNA for syntaxin 18, complete cds
gi|7707423|dbj|AB028741.1|AB028741[7707423] - 8702: U27478
Homo sapiens angiotensin II type 2 receptor (AT2) gene, partial cds
gi|1143833|gb|U27478.1|HSU27478[1143833] - 8707: M81774
Homo sapiens T-cell receptor alpha (TCRB) mRNA, partial cds
gi|186224|gb|M81774.1|HUMIGTCACA[186224] - 8708: S70782
Homo sapiens alpha adrenergic receptor subtype alpha 1a mRNA, complete cds
gi|547219|gb|S70782.1|S70782[547219] - 8709: S70057
Homo sapiens cholecystokinin B receptor mRNA, complete cds
gi|546748|gb|S70057.1|S70057[546748] - 8711: S70123
Homo sapiens low density lipoprotein receptor mRNA, partial cds
gi|546107|gb|S70123.1|S70123[546107] - 8712: S56143
Homo sapiens A1 adenosine receptor mRNA, complete cds
gi|298327|gb|S56143.1|S56143[298327] - 8715: S57793
Homo sapiens luteinizing hormone receptor mRNA, complete cds
gi|236050|gb|S57793.1|S57793[236050] - 8722: AF202640
Homo sapiens orphan G-protein coupled receptor (GPRC5B) mRNA, complete cds
gi|7682556|gb|AF202640.1|AF202640[7682556] - 8723: AF211154
AF211154 Clontech HL1008b Homo sapiens cDNA, mRNA sequence
gi|7677996|gb|AF211154.1|AF211154[7677996] - 8724: AF211153
AF211153 Clontech HL1008b Homo sapiens cDNA, mRNA sequence
gi|7677995|gb|AF211153.1|AF211153[7677995] - 8729: AF145440
Homo sapiens CC chemokine receptor 9B (CCR9) mRNA, alternatively spliced, complete cds
gi|7673010|gb|AF145440.1|AF145440[7673010] - 8730: AF145439
Homo sapiens CC chemokine receptor 9A (CCR9) mRNA, alternatively spliced, complete cds
gi|7673008|gb|AF145439.1|AF145439[7673008] - 8731: AF129170
Homo sapiens apolipoprotein E receptor 2 gene, exon 6b and partial cds, alternatively spliced
gi|7672339|gb|AF129170.1|AF129169S2[7672339] - 8732: AF129169
Homo sapiens apolipoprotein E receptor 2 gene, exon 6a and partial cds, alternatively spliced
gi|7672338|gb|AF129169.1|AF129169S1[7672338] - 8733: AH009264
Homo sapiens apolipoprotein E receptor 2 and apolipoprotein E receptor 2 genes,
partial cds
gi|7672337|gb|AH009264.1|SEG_AF129169S[7672337] - 8812: AB039723
Homo sapiens FZD3 mRNA for WNT receptor frizzled-3, complete cds
gi|7670051|dbj|AB039723.1|AB039723[7670051] - 8813: AL353940
Homo sapiens mRNA; cDNA DKFZp761P1010 (from clone DKFZp761P1010)
gi|7669978|emb|AL353940.1|HSM802647[7669978] - 8814: AC067969
Homo sapiens chromosome 19, cosmid R26839 (LLNL-R—228D1), complete sequence
gi|7656699|gb|AC067969.1|AC067969[7656699] - 8815: AF236081
Homo sapiens orphan G-protein coupled receptor GPR72 (GPR72) mRNA, complete cds
gi|7248881|gb|AF236081.1|AF236081[7248881] - 8819: AC004416
Homo sapiens BAC clone CTB-13N12 from 7q31.2, complete sequence
gi|2979585|gb|AC004416.1|AC004416[2979585] - 8820: AF056020
Homo sapiens chemokine receptor CCR5 (CCR5) gene, CCR5-delta32 allele, partial
cds
gi|7648496|gb|AF056020.1|AF056020[7648496] - 8821: AF056019
Homo sapiens mutant chemokine receptor CCR5 (CCR5) gene, CCR5-delta32 allele, partial cds
gi|7648494|gb|AF056019.1|AF056019[7648494] - 8822: AF052244
Homo sapiens mutant chemokine receptor CCR5 (CCR5) gene, CCR5-delta32 allele, partial cds
gi|7648492|gb|AF052244.1|AF052244[7648492] - 8824: AF068288
Homo sapiens HDCME31P mRNA, complete cds
gi|7643783|gb|AF068288.1|AF068288[7643783] - 8825: AF186022
Homo sapiens B lymphocyte adapter protein BAM32 (BAM32) mRNA, complete cds
gi|6503077|gb|AF186022.1|AF186022[6503077] - 8826: AB002168
Homo sapiens gene for vitamin D receptor, exon 9 and complete cds
gi|5736651|dbj|AB002168.1|AB00215S12[5736651] - 8827: AB002167
Homo sapiens gene for vitamin D receptor, exon 8
gi|5736591|dbj|AB002167.1|AB00215S11[5736591] - 8828: AB002166
Homo sapiens gene for vitamin D receptor, exon 7
gi|5736588|dbj|AB002166.1|AB00215S10[5736588] - 8829: AB002165
Homo sapiens gene for vitamin D receptor, exon 6
gi|5736585|dbj|AB002165.1|AB00215S09[5736585] - 8830: AB002164
Homo sapiens gene for vitamin D receptor, exon 5
gi|5736582|dbj|AB002164.1|AB00215S08[5736582] - 8831: AB002163
Homo sapiens gene for vitamin D receptor, exon 4
gi|5736579|dbj|AB002163.1|AB00215S07[5736579] - 8832: AB002162
Homo sapiens gene for vitamin D receptor, exon 3
gi|5736575|dbj|AB002162.1|AB00215S06[5736575] - 8833: AB002161
Homo sapiens gene for vitamin D receptor, exon 2
gi|5736571|dbj|AB002161.1|AB00215S05[5736571] - 8834: AB002160
Homo sapiens gene for vitamin D receptor, exon 1c, 5′ non-coding region
gi|5736566|dbj|AB002160.1|AB00215S04[5736566] - 8835: AB002159
Homo sapiens gene for vitamin D receptor, exon 1b, 5′ non-coding region
gi|5736562|dbj|AB002159.1|AB00215S03[5736562] - 8839: AB005647
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 22 and complete cds
gi|5139788|dbj|AB005647.1|AB00562S23[5139788] - 8840: AB005646
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 21
gi|5139787|dbj|AB005646.1|AB00562S22[5139787] - 8841: AB005645
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 20
gi|5139786|dbj|AB005645.1|AB00562S21[5139786] - 8842: AB005644
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 19
gi|5139785|dbj|AB005644.1|AB00562S20[5139785] - 8843: AB005643
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 18
gi|5139784|dbj|AB005643.1|AB00562S19[5139784] - 8844: AB005642
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 17
gi|5139783|dbj|AB005642.1|AB00562S18[5139783] - 8845: AB005641
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 16
gi|5139782|dbj|AB005641.1|AB00562S17[5139782] - 8846: AB005640
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 15
gi|5139781|dbj||AB005640.1|AB00562S16[5139781] - 8847: AB005639
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 14
gi|5139780|dbj|AB005639.1|AB00562S15[5139780] - 8848: AB005638
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 13
gi|5139779|dbj|AB005638.1|AB00562S14[5139779] - 8849: AB005637
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 12
gi|5139778|dbj|AB005637.1|AB00562S13[5139778] - 8850: AB005636
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 11
gi|5139777|dbj|AB005636.1|AB00562S12[1L39777] - 8851: AB005635
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 10
gi|5139776|dbj|AB005635.1|AB00562S11[5139776] - 8852: AB005634
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 9
gi|5139775|dbj|AB005634.1|AB00562S10[5139775] - 8853: AB005633
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 8
gi|5139774|dbj|AB005633.1|AB00562S09[5139774] - 8854: AB005632
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 7
gi|5139773|dbj|AB005632.1|AB00562S08[5139773] - 8855: AB005631
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 6
gi|5139772|dbj|AB005631.1|AB00562S07[5139772] - 8856: AB005630
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 5
gi|5139771|dbj|AB005630.1|AB00562S06[5139771] - 8857: AB005629
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 4
gi|5139770|dbj|AB005629.1|AB00562S05[5139770] - 8858: AB005628
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 3
gi|5139769|dbj|AB005628.1|AB00562S04[5139769] - 8859: AB005627
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 2
gi|5139768|dbj|AB005627.1|AB00562S03[5139768] - 8860: AB005626
Homo sapiens gene for atrial natriuretic peptide Btype receptor, exon 1
gi|5139767|dbj|AB005626.1|AB00562S02[5139767] - 8862: AF030335
Homo sapiens purinergic P2Y11 receptor (P2Y11) mRNA, complete cds
gi|2674119|gb|AF030335.1|AF030335[2674119] - 8863: AF003522
Homo sapiens Delta mRNA, complete cds
gi|2197068|gb|AF003522.1|AF003522[2197068] - 8864: AF003521
Homo sapiens Jagged 2 mRNA, complete cds
gi|2197066|gb|AF003521.1|AF003521[2197066] - 8865: AF068292
Homo sapiens HDCMA39P mRNA, partial cds
gi|7634778|gb|AF068292.1|AF068292[7634778] - 8868: AH007819
Homo sapiens 5-hydroxytryptamine 2B receptor (HTR2B) gene, complete cds
gi|5442455|gb|AH007819.2|SEG_HSHTR2B[5442455] - 8869: AF156158
Homo sapiens 5-hydroxytryptamine 2B receptor (HTR2B) gene, exon 1
gi|5442454|gb|AF156158.2|HSHTR2B1[5442454] - 8870: AF156160
Homo sapiens 5-hydroxytryptamine 2B receptor (HTR2B) gene, exon 3 and complete
cds
gi|5070703|gb|AF156160.1|HSHTR2B3[5070703] - 8871: AF156159
Homo sapiens 5-hydroxytryptamine 2B receptor (HTR2B) gene, exon 2
gi|5070702|gb|AF156159.1|HSHTR2B2[5070702] - 8872: AB041713
Homo sapiens fp gene for prostaglandin F2alpha receptor, exon 1 and 2, partial
cds
gi|7619988|dbj|AB041713.1|AB041713[7619988] - 8873: AF041811
Homo sapiens ETS related protein-growth factor receptor tyrosine kinase fusion
proteins (ETV6-NTRK3 fusion) mRNA, partial cds
gi|6274523|gb|AF041811.2|AF041811[6274523] - 8874: AF172453
Homo sapiens opioid growth factor receptor mRNA, complete cds
gi|7595306|gb|AF172453.1|AF172453[7595306] - 8875: AF172452
Homo sapiens opioid growth factor receptor mRNA, complete cds
gi|7595304|gb|AF172452.1|AF172452[7595304] - 8876: AF172451
Homo sapiens opioid growth factor receptor mRNA, complete cds
gi|7595302|gb|AF172451.1|AF172451[7595302] - 8877: AF172450
Homo sapiens opioid growth factor receptor mRNA, complete cds
gi|7595300|gb|AF172450.1|AF172450[7595300]
- 8878: AF172449
Homo sapiens clone 127 opioid growth factor receptor mRNA, complete cds
gi|7595298|gb|AF172449.1|AF172449[7595298] - 8879: D49394
Homo sapiens mRNA for serotonin 5-HT3 receptor, complete cds
gi|681913|dbj|D49394.1|HUMS5HT3RA[681913] - 8880: AB041395
Homo sapiens CHRM3 gene for muscarinic acetylcholine receptor m3, complete cds
gi|7592980|dbj|AB041395.1|AB041395[7592980] - 8881: AB041391
Homo sapiens CHRM2 gene for muscarinic acetylcholine receptor m2, partial cds
gi|7592971|dbj|AB041391.1|AB041391[7592971] - 8882: AB041384
Homo sapiens gene for histamine H2 receptor, complete cds
gi|7592957|dbj|AB041384.1|AB041384[7592957] - 8883: AB041380
Homo sapiens gene for histamine H1 receptor, complete cds
gi|7592949|dbj|AB041380.1|AB041380[7592949] - 8884: AB041373
Homo sapiens HTR1E gene for 5-hydroxytryptamine (serotonin) receptor 1E, partial
cds
gi|7592934|dbj|AB041373.1|AB041373[7592934] - 8885: AB041370
Homo sapiens HTR1B gene for 5-hydroxytryptamine (serotonin) receptor 1B, complete cds
gi|7592928|dbj|AB041370.1|AB041370[7592928] - 8887: AB033598
Homo sapiens gene for melatonin 1b receptor, exon 2 and complete cds
gi|7209599|dbj|AB033598.1|AB033597S2[7209599] - 8888: AB033597
Homo sapiens gene for melatonin 1b receptor, exon 1
gi|7209598|dbj|AB033597.1|AB033597S1[7209598] - 8889: SEG_AB033597S
Homo sapiens gene for melatonin 1b receptor
gi|7209597|dbj|SEG_AB033597S[7209597] - 8890: D85606
Homo sapiens gene for cholecystokinin type-A receptor, complete cds
gi|7008026|dbj|D85606.1D85606[7008026] - 8891: SEG_AB019480S
Homo sapiens NTRK1 gene for TRKA
gi|6492387|dbj|SEG_AB019480S[6492387] - 8892: AB019485
Homo sapiens NTRK1 gene for TRKA, exon 8-14
gi|6492386|dbj|AB019485.2|AB019480S6[6492386] - 8893: SEG_AB029932S
Homo sapiens hMel1a gene for melatonin 1a receptor
gi|6045084|dbj|SEG_AB029932S[6045084] - 8894: AB029933
Homo sapiens hMel1a gene for melatonin 1a receptor, exon 2 and complete cds
gi|6045083|dbj|AB029933.1|AB029932S2[6045083] - 8895: AB029932
Homo sapiens hMel1a gene for melatonin 1a receptor, exon 1
gi|6045082|dbj|AL029932.1|AB029932S1[6045082] - 8896: AB026584
Homo sapiens gene for endothelial protein C receptor, complete cds
gi|5837963|dbj|AB026584.2|AB026584[5837963] - 8897: AB017444
Homo sapiens gene for lectin-like oxidized LDL receptor, exon 6
gi|5821166|dbj|AB017444.1|AB017444[5821166] - 8898: AB017443
Homo sapiens gene for lectin-like oxidized LDL receptor, exon 5
gi|5821165|dbj|AB017443.1|AB017443[5821165] - 8899: AB017442
Homo sapiens gene for lectin-like oxidized LDL receptor, exon 4
gi|5821164|dbj|AB017442.1|AB017442[5821164] - 8900: AB017441
Homo sapiens gene for lectin-like oxidized LDL receptor, exon 3
gi|5821163|dbj|AB017441.1|AB017441[5821163] - 8901: AB017440
Homo sapiens gene for lectin-like oxidized LDL receptor, exon 2
gi|5821162|dbj|AB017440.1|AB017440[5821162] - 8902: AB017439
Homo sapiens gene for lectin-like oxidized LDL receptor, exon 1
gi|5821161|dbj|AB017439.1|AB017439[5821161] - 8903: AB019488
Homo sapiens NTRK1 gene for TRKA, exon 17 and complete cds
gi|3869111|dbj|AB019488.1|AB019480S9[3869111] - 8904: AB019487
Homo sapiens NTRK1 gene for TRKA, exon 16
gi|3869110|dbj|AB019487.1|AB019480S8[3869110] - 8905: AB019486
Homo sapiens NTRK1 gene for TRKA, exon 15
gi|3869109|dbj|AB019486.1|AB019480S7[3869109] - 8906: AB019484
Homo sapiens NTRK1 gene for TRKA, exon 7
gi|3869107|dbj|AB019484.1|AB019480S5[3869107] - 8907: AB019483
Homo sapiens NTRK1 gene for TRKA, exon 5 and 6
gi|3869106|dbj|AB019483.1|AB3019480S4[3869106] - 8908: AB019482
Homo sapiens NTRK1 gene for TRKA, exon 4
gi|3869105|dbj|AB019482.1|AB019480S3[3869105] - 8909: AB019481
Homo sapiens NTRK1 gene for TRKA, exon 2,3
gi|3869104|dbj|AB019481.1|AB019480S2[3869104] - 8910: AB019480
Homo sapiens NTRK1 gene for TRKA, exon 1
gi|3869103|dbj|AB019480.1|AB019480S1[3869103] - 8911: SEG_AB01471S
Homo sapiens DR5 gene
gi|3721877|dbj|SEG_AB01471S[3721877] - 8912: AB014718
Homo sapiens DR5 gene, exon 9 and complete cds
gi|3721876|dbj|AB014718.1|AB01471S9[3721876] - 8913: AB014717
Homo sapiens DR5 gene, exon 8
gi|3721875|dbj|AB014717.1|AB301471S8[3721875] - 8914: AB014716
Homo sapiens DR5 gene, exon 7
gi|3721874|dbj|AB014716.1|AB01471S7[3721874] - 8915: AB014715
Homo sapiens DR5 gene, exon 6
gi|3721873|dbj|AB014715.1|AB01471S6[3721873] - 8916: AB3014714
Homo sapiens DR5 gene, exon 5
gi|3721872|dbj|AB014714.1|AB01471S5[3721872] - 8917: AB014713
Homo sapiens DR5 gene, exon 4
gi|3721871|dbj|AB014713.1|AB01471S4[3721871] - 8918: AB014712
Homo sapiens DR5 gene, exon 3
gi|3721870|dbj|AB014712.1|AB01471S3[3721870] - 8919: AB014711
Homo sapiens DR5 gene, exon 2
gi|3721869|dbj|AB014711.1|AB01471S2[3721869] - 8920: AB014710
Homo sapiens DR5 gene, exon 1, partial sequence
gi|3721868|dbj|AB014710.1|AB01471S1[3721868] - 8921: SEG_AB01047S
Homo sapiens gene for natriuretic peptide A type receptor
gi|3297985|dbj|SEG_AB01047S[3297985] - 8922: AB010491
Homo sapiens gene for natriuretic peptide A type receptor, exon 22 and complete
cds
gi|3297984|dbj|AB010491.1|AB01047S22[3297984] - 8923: AB010490
Homo sapiens gene for natriuretic peptide A type receptor, exon 21
gi|3297983|dbj|AB010490.1|AB01047S21[3297983] - 8924: AB010489
Homo sapiens gene for natriuretic peptide A type receptor, exon 20
gi|3297982|dbj|AB010489.1|AB01047S20[3297982] - 8925: AB010488
Homo sapiens gene for natriuretic peptide A type receptor, exon 19
gi|3297981|dbj|AB010488.1|AB01047S19[3297981] - 8926: AB010487
Homo sapiens gene for natriuretic peptide A type receptor, exon 18
gi|3297980|dbj|AB010487.1|AB01047S18[3297980] - 8927: AB010486
Homo sapiens gene for natriuretic peptide A type receptor, exon 17
gi|3297979|dbj|AB010486.1|AB01047S17[3297979] - 8928: AB010485
Homo sapiens gene for natriuretic peptide A type receptor, exon 16
gi|3297978|dbj|AB010485.1|AB01047S16[3297978] - 8929: AB010484
Homo sapiens gene for natriuretic peptide A type receptor, exon 15
gi|3297977|dbj|AB010484.1|AB01047S15[3297977] - 8930: AB010483
Homo sapiens gene for natriuretic peptide A type receptor, exon 14
gi|3297976|dbj|AB010483.1|AB01047S14[3297976] - 8931: AB010482
Homo sapiens gene for natriuretic peptide A type receptor, exon 13
gi|3297975|dbj|AB010482.1|AB01047S13[3297975] - 8932: AB010481
Homo sapiens gene for natriuretic peptide A type receptor, exon 12
gi|3297974|dbj|AB010481.1|AB01047S12[3297974] - 8933: AB010480
Homo sapiens gene for natriuretic peptide A type receptor, exon 11
gi|3297973|dbj|AB010480.1|AB01047S11[3297973] - 8934: AB010479
Homo sapiens gene for natriuretic peptide A type receptor, exon 10
gi|3297972|dbj|AB010479.1|AB01047S10[3297972] - 8935: AB010478
Homo sapiens gene for natriuretic peptide A type receptor, exon 9
gi|3297971|dbj|AB010478.1|AB01047S09[3297971] - 8936: AB010477
Homo sapiens gene for natriuretic peptide A type receptor, exon 8
gi|3297970|dbj|AB010477.1|AB01047S08[3297970] - 8937: AB010476
Homo sapiens gene for natriuretic peptide A type receptor, exon 7
gi|3297969|dbj|AB010476.1|AB01047S07[3297969] - 8938: AB010475
Homo sapiens gene for natriuretic peptide A type receptor, exon 6
gi|3297968|dbj|AB010475.1|AB01047S06[3297968] - 8939: AB010474
Homo sapiens gene for natriuretic peptide A type receptor, exon 5
gi|3297967|dbj|AB010474.1|AB01047S05[3297967] - 8940: AB010473
Homo sapiens gene for natriuretic peptide A type receptor, exon 4
gi|3297966|dbj|AB010473.1|AB01047S04[3297966] - 8941: AB010472
Homo sapiens gene for natriuretic peptide A type receptor, exon 3
gi|3297965|dbj|AB010472.1|AB01047S03[3297965] - 8942: AB010471
Homo sapiens gene for natriuretic peptide A type receptor, exon 2
gi|3297964|dbj|AB010471.1|AB01047S02[3297964] - 8943: AB010470
Homo sapiens gene for natriuretic peptide A type receptor, exon 1, partial sequence
gi|3297963|dbj|AB010470.1|AB01047S01[3297963] - 8944: AB008681
Homo sapiens gene for activin receptor type IIB, complete cds
gi|2760152|dbj|AB008681.1|AB008681[2760152] - 8945: SEG_AB005521S
Homo sapiens ppar gamma gene for peroxisome proliferator activated-receptor gamma
gi|2605496|dbj|SEG_AB005521S[2605496] - 8946: AB005526
Homo sapiens ppar gamma gene for peroxisome proliferator activated-receptor gamma, eoxn 6 and complete cds
gi|2605495|dbj|AB005526.1|AB005521S6[2605495] - 8947: AB005525
Homo sapiens ppar gamma gene for peroxisome proliferator activated-receptor gamma, exon 5
gi|2605494|dbj|AB005525.1|AB005521S5[2605494] - 8948: AB005524
Homo sapiens ppar gamma gene for peroxisome proliferator activated-receptor gamma, exon 4
gi|2605493|dbj|AB005524.1|AB005521S4[2605493] - 8949: AB005523
Homo sapiens ppar gamma gene for peroxisome proliferator activated-receptor gamma, exon 3
gi|2605492|dbj|AB005523.1|AB005521S3[2605492] - 8950: AB005522
Homo sapiens ppar gamma gene for peroxisome proliferator activated-receptor gamma, exon 2
gi|2605491|dbj|AB005522.1|AB005521S2[2605491] - 8951: AB005521
Homo sapiens ppar gamma gene for peroxisome proliferator activated-receptor gamma, exon 1
gi|2605490|dbj|AB005521.1|AB005521S1[2605490] - 8954: AB002059
Homo sapiens DNA for Human P2XM, complete cds
gi|2350848|dbj|AB002059.1|AB002059[2350848] - 8955: SEG_D86389S
- 8955: D86407
Homo sapiens DNA for apoER2
gi|2344801|dbj||SEG_D86389S[2344801] - 8956: D86407
Homo sapiens DNA for apoER2, complete cds, and exon 19
gi|2344800|dbj|D86407.1|D86389S19[2344800] - 8957: D86406
Homo sapiens DNA for apoER2, exon 18
gi|2344799|dbj|D86406.1|D86389S18[2344799] - 8958: D86405
Homo sapiens DNA for apoER2, exon 17
gi|2344798|dbj|D86405.1|D86389S17[2344798] - 8959: D86404
Homo sapiens DNA for apoER2, exon 16
gi|2344797|dbj|D586404.1|D8.6389S16[2344797] - 8960: D86403
Homo sapiens DNA for apoER2, exon 15
gi|2344796|dbj|D86403.1|D86389S15[2344796] - 8961: D86402
Homo sapiens DNA for apoER2, exon 14
gi|2344795|dbj|D586402.1D86389S14[2344795] - 8962: D86401
Homo sapiens DNA for apoER2, exon 13
gi|2344794|dbj|D586401.1|D86389S13[2344794] - 8963: D86400
Homo sapiens DNA apoER2, exon 12
gi|2344793|dbj|D86400.1|D86389S12[2344793] - 8964: D86399
Homo sapiens DNA for apoER2, exon 11
gi|2344792|dbj|D586399.1|D86389S11[2344792] - 8965: D86398
Homo sapiens DNA for apoER2, exon 10
gi|2344791|dbj|D586398.1|D86389S10[2344791] - 8966: D86397
Homo sapiens DNA for apoER2, exon 9
gi|2344790|dbj|D586397.1|D86389S09[2344790] - 8967: D86396
Homo sapiens DNA for apoER2, exon 8
gi|2344789|dbj|D86396.1|D86389S08[2344789] - 8968: D86395
Homo sapiens DNA for apoER2, exon 7
gi|2344788|dbj|D586395.1|D86389S07[2344788] - 8969: D86394
Homo sapiens DNA for apoER2, exon 6
gi|2344787|dbj|D86394.1|D86389S06[2344787] - 8970: D86393
Homo sapiens DNA for apoER2, exon 5
gi|2344786|dbj|D86393.1|D86389S05[2344786] - 8971: D86392
Homo sapiens DNA for apoER2, exon 4
gi|2344785|dbj|D86392.1|D86389S04[2344785] - 8972: D86391
Homo sapiens DNA for apoER2, exon 3
gi|2344784|dbj|D586391.1|D86389S03[2344784] - 8973: D86390
Homo sapiens DNA for apoER2, exon 2
gi|2344783|dbj|D86390.1|D86389S02[2344783] - 8974: D86389
Homo sapiens DNA for apoER2, exon 1
gi|2344782|dbj|D86389.1|D86389S01[2344782] - 8975: D86096
Human DNA for prostaglandin EP3 receptor subtype, complete cds
gi|2114186|dbj|D86096.1|D86087S10[2114186] - 8976: D86095
Human DNA for prostaglandin E receptor EP3 subtype, exon 9
gi|2114185|dbj|D86095.1|D86087S09[2114185] - 8977: D86094
Human DNA for prostaglandin E receptor EP3 subtype, exon 8
gi|2114184|dbj|D86094.1|D86087S08[2114184] - 8978: D86093
Human DNA for prostaglandin E receptor EP3 subtype, exon 7
gi|2114183|dbj|D586093.1|D86087S07[2114183] - 8979: D86092
Human DNA for prostaglandin E receptor EP3 subtype, exon 6
gi|2114182|dbj|D586092.1|D86087S06[2114182] - 8980: D86091
Human DNA for prostaglandin E receptor EP3 subtype, exon 5
gi|2114181|dbj|D86091.1|D86087S05[2114181] - 8981: D86090
Human DNA for prostaglandin E receptor EP3 subtype, exon 4
gi|21141800 dbj|D86090.1|D86087S04[2114180] - 8982: D86089
Human DNA for prostaglandin E receptor EP3 subtype, exon 3
gi|2114179|dbj|D86089.1|D86087S03[2114179] - 8983: D86088
Human DNA for prostaglandin E receptor EP3 subtype, exon 2
gi|2114178|dbj|D86088.1|D86087S02[2114178] - 8984: D86087
Human DNA for prostaglandin E receptor EP3 subtype, exon 1
gi|2114177|dbj|D586087.1|D86087S01[2114177] - 8985: SEG_D49555S
Homo sapiens DNA for gastric inhibitory polypeptide receptor
gi|1805368|dbj||SEG_D49555S[1805368] - 8986: D85376
Human DNA for thyrotropin-releasing hormone receptor, exon 3 and copmplete cds
gi|1616933|dbj|D585376.1|D85375S2[1616933] - 8987: D85375
Human DNA for thyrotropin-releasing hormon receptor, exon 1, 2
gi|1616932|dbj|D585375.1D85375S1[1616932] - 8988: D49559
Human DNA for gastric inhibitory polypeptide receptor, exon 13 and 14, complete
cds
gi|1088442|dbj|D549559.1|D49555S5[1088442] - 8989: D49558
Human DNA for gastric inhibitory polypeptide receptor, exon 5, 6, 7, 8, 9, 10,
11 and 12
gi|1088441|dbj|D549558.1|D49555S4[1088441] - 8990: D49557
Human DNA for gastric inhibitory polypeptide receptor, exon 3 and 4
gi|1088440|dbj|D549557.1D49555S3[1088440] - 8991: D49556
Homo sapiens DNA for gastric inhibitory polypeptide receptor, exon 2
gi|1088439|dbj|D549556.1D49555S2[1088439] - 8992: D49555
Homo sapiens DNA for gastric inhibitory polypeptide receptor, exon 1
gi|1088438|dbj|D549555.1|D49555S1[1088438] - 8993: D64016
Human gene for vascular endothelial growth factor receptor, promoter and exon 1
gi|1088437|dbj|D564016.1|HUMES[1088437] - 8994: D38128
Homo sapiens IP gene for prostacyclin receptor, exon 3
gi|1019364|dbj|D538128.1|HUMIP2[1019364] - 8995: D38127
Human IP gene for prostacyclin receptor, exon 1 and exon 2
gi|1019362|dbj|D538127.1|HUMIP1[1019362] - 8996: D37965
Human mRNA for PDGF receptor beta-like tumor suppressor (PRLTS), complete cds
gi|807818|dbj|D537965.1|HUMPRLTS[807818] - 8997: D50017
Human DNA for alpha-platelet-derived growth factor receptor, exon 23
gi|767797|dbj|D550017.1|D50001S17[767797] - 8998: D50016
Human DNA for alpha-platelet-derived growth factor receptor, exon 22
gi|767796|dbj|D550016.1|D50001S16[767796] - 8999: DS0015
Human DNA for alpha-platelet-derived growth factor receptor, exon 20 and 21
gi|767795|dbj|D50015.1|D50001S15[767795] - 9000: D50014
Human DNA for alpha-platelet-derived growth factor receptor, exon 19
gi|767794|dbj|D550014.1|D50001S14[767794] - 9001: D50013
Human DNA for alpha-platelet-derived growth factor receptor, exon 18
gi|767793|dbj|D550013.1|D50001S13[767793] - 9002: D50012
Human DNA for alpha-platelet-derived growth factor receptor, exon 17
gi|767792|dbj|D550012.1D50001S12[767792] - 9003: D50011
Human DNA for alpha-platelet-derived growth factor receptor, exon 16
gi|767791|dbj|D550011.1|D50001S11[767791] - 9004: D50010
Human DNA for alpha-platelet-derived growth factor receptor, exon 15
gi|767790|dbj|D550010.1|D50001S10[767790] - 9005: D50009
Human DNA for alpha-platelet-derived growth factor receptor, exon 14
gi|767789|dbj|D550009.1|D50001S09[767789] - 9006: D50008
Human DNA for alpha-platelet-derived growth factor receptor, exon 13
gi|767788|dbj|D550008.1|D50001S08[767788] - 9007: D50007
Human DNA for alpha-platelet-derived growth factor receptor, exon 11 and 12
gi|767787|dbj|D550007.1|D50001S07[767787] - 9008: D50006
Human DNA for alpha-platelet-derived growth factor receptor, exon 6-10
gi|767786|dbj|D550006.1|D50001S06[767786] - 9009: D50005
Human DNA for alpha-platelet-derived growth factor receptor, exon 5
gi|767785|dbj|D550005.1|D50001S05[767785] - 9010: D50004
Human DNA for alpha-platelet-derived growth factor receptor, exon 4
gi|767784|dbj|D550004.1D50001S04[767784] - 9011: D50003
Human DNA for alpha-platelet-derived growth factor receptor, exon 3
gi|767783|dbj|D550003.1|D50001S03[767783] - 9012: D50002
Human DNA for alpha-platelet-derived growth factor receptor, exon 2
gi|767781|dbj|D550002.1D50001S02[767781] - 9013: D50001
Human DNA for alpha-platelet-derived growth factor receptor, exon 1
gi|767780|dbj|D550001.1|D50001S01[767780] - 9014: D31793
Human CD40 ligand (CD40L) gene, 5′ flanking region and exon 1
gi|662386|dbj|D531793.1|HUMCD40L1[662386] - 9015: D28768
Homo sapiens leukocyte DNA for Ah receptor, exon 1
gi|567941|dbj|D528768.1|HUMAHRP[567941] - 9016: D28769
Human HOX12 and RAGE genes, complete cds
gi|561657|dbj|D528769.1|HUMHOXRAGE[561657] - 9017: D31708
Human DNA for Ah-receptor, exon 1
gi|538228|dbj|D531708.1|HUMAHR[538228] - 9019: D26535
Human gene for dihydrolipoamide succinyltransferase, complete cds (exon 1-15)
gi|537349|dbj|D26535.1|HUMDS[537349] - 9020: SEG_HUMTA2R
Homo sapiens gene for thromboxane A2 receptor
gi|488600|dbj|SEGHUMTA2R[488600] - 9021: D15056
Homo sapiens gene for thromboxane A2 receptor, exon 3
gi|441173|dbj|D515056.1|HUMTA2R4[441173] - 9022: D15055
Homo sapiens gene for thromboxane A2 receptor, exon 2
gi|441172|dbj|D515055.1|HUMTA2R3[441172] - 9023: D15054
Homo sapiens gene for thromboxane A2 receptor, exon 1b (promoter region II)
gi|441171|dbj|D515054.1|HUMTA2R2[441171] - 9024: D15053
Homo sapiens gene for thromboxane A2 receptor, exon 1 (promoter region I)
gi|441170|dbj|D515053.1|HUMTA2R1[441170] - 9025: D21219
Human CCKBR gene for cholecystokinin-B receptor/gastrin receptor, exon 2-5, partial cds
gi|416225|dbj|D521219.1|HUMCCKBR2[416225] - 9026: D21218
Human CCKBR gene for cholecystokinin-B receptor/gastrin receptor, exon 1
gi|416224|dbj|D21218.1|HUMCCKBR1[416224] - 9027: D16532
Human gene for very low density lipoprotein receptor, exon 19
gi|407219|dbj|D16532.1|HUMVLDLR19[407219] - 9028: D16531
Human gene for very low density lipoprotein receptor, exon 18
gi|407218|dbj|D16531.1|HUMVLDLR18[407218] - 9029: D16530
Huma gene for very low density lipoprotein receptor, exon 17
gi|407217|dbj|D16530.1|HUMVLDLR17[407217] - 9030: D16529
Human gene for very low density lipoprotein receptor, exon 16
gi|407216|dbj|D516529.1|HUMVLDLR16[407216] - 9031: D16528
Human gene for very low density lipoprotein receptor, exon 15
gi|407215|dbj|D516528.1|HUMVLDLR15[407215] - 9032: D16527
Human gene for very low density lipoprotein receptor, exon 14
gi|407214|dbj|D516527.1|HUMVLDLR14[407214] - 9033: D16526
Human gene for very low density lipoprotein receptor, exon 13
gi|407213|dbj|D516526.1|HUMVLDLR13[407213] - 9034: D16525
Human gene for very low density lipoprotein receptor, exon 12
gi|407212|dbj|D516525.1|HUMVLDLR12[407212] - 9035: D16524
Human gene for very low density lipoprotein receptor, exon 11
gi|407211|dbj|D516524.1|HUMVLDLR11[407211] - 9036: D16523
Human gene for very low density lipoprotein receptor, exon 10
gi|407210|dbj|D516523.1|HUMVLDLR10[407210] - 9037: D16522
Human gene for very low density lipoprotein receptor, exon 9
gi|407209|dbj|D516522.1|HUMVLDLR09[407209] - 9038: D16520
Human gene for very low density lipoprotein receptor, exon 8
gi|407208|dbj|D516520.1|HUMVLDLR08[407208] - 9039: D16518
Human gene for very low density lipoprotein receptor, exon 7
gi|407207|dbj|D516518.1|HUMVLDLR07[407207] - 9040: D16516
Human gene for very low density lipoprotein receptor, exon 6
gi|407206|dbj|D516516.1|HUMVLDLR06[407206] - 9041: D16514
Human gene for very low density lipoprotein receptor, exon 5
gi|407205|dbj|D516514.1|HUMVLDLR05[407205] - 9042: D16512
Human gene for very low density lipoprotein receptor, exon 4
gi|407204|dbj|D516512.1|HUMVLDLR04[407204] - 9043: D16510
Human gene for very low density lipoprotein receptor, exon 3
gi|407203|dbj|D516510.1|HUMVLDLR03[407203] - 9044: D16508
Human gene for very low density lipoprotein receptor, exon 2
gi|407202|dbj|D516508.1|HUMVLDLR02[407202] - 9045: D16495
Human gene for very low density lipoprotein receptor, 5′flanking and exon 1
gi|407201|dbj|D516495.1|HUMVLDLR01[407201] - 9046: D13168
Human gene for endothelin-B receptor (hET-BR), exon 7
gi|285924|dbj|D513168.1|HUMHETBR7[285924] - 9047: D13167
Human gene for endothelin-B receptor (hET-BR), exon 6
gi|285923|dbj|D513167.1|HUMHETBR6[285923] - 9048: D13166
Human gene for endothelin-B receptor (hET-BR), exon 5
gi|285922|dbj|D513166.1|HUMHETBR5[285922] - 9049: D13165
Human gene for endothelin-B receptor (hET-BR), exon 4
gi|285921|dbj|D513165.1|HUMHETBR4[285921] - 9050: D13164
Human gene for endothelin-B receptor (hET-BR), exon 3
gi|285920|dbj|D513164.1|HUMHETBR3[285920] - 9051: D13163
Human gene for endothelin-B receptor (hET-BR), exon 2
gi|285919|dbj|D13163.1|HUMHETBR2[285919] - 9052: D13162
Human gene for endothelin-B receptor (hET-BR), exon 1
gi|285918|dbj|D13162.1|HUMHETBR1[285918] - 9053: D10604
Human midkine gene, complete cds
gi|219928|dbj|D10604.1|HUMMK[219928] - 9054: D11151
Human DNA for endothelin-A receptor, exon 8 and 3′ flanking region
gi|219628|dbj|D511151.1|HUMETAR8[219628] - 9055: D11150
Human DNA for endothelin-A receptor, exon 7
gi|219627|dbj|D511150.1|HUMETAR7[219627] - 9056: D11149
Human DNA for endothelin-A receptor, exon 6
gi|219626|dbj|D511149.1|HUMETAR6[219626] - 9057: D11148
Human DNA for endothelin-A receptor, exon 5
gi|219625|dbj|D511148.1|HUMETAR5[219625] - 9058: D11147
Human DNA for endothelin-A receptor, exon 4
gi|219624|dbj|D511147.1|HUMETAR4[219624] - 9059: D11146
Human DNA for endothelin-A receptor, exon 3
gi|219623|dbj|D511146.1|HUMETAR3[219623] - 9060: D11145
Human DNA for endothelin-A receptor, exon 2
gi|219622|dbj|D511145.1|HUMETAR2[219622] - 9061: D11144
Human DNA for endothelin-A receptor, 5′ flanking region and exon 1
gi|219621|dbj|D511144.1|HUMETAR1[219621] - 9063: AF215981
Homo sapiens CC chemokine receptor 10 (CCR10) mRNA, complete cds
gi|7546844|gb|AF215981.1|AF215981[7546844] - 9066: AF065440
Homo sapiens low density lipoprotein receptor-related protein II (LRP2) gene, exon 1 and partial cds
gi|7534311|gb|AF065440.2|AF065440[7534311] - 9068: AF228458
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 10 and partial
cds
gi|7530451|gb|AF228458.1|AF228450S9[7530451] - 9069: AF228457
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 9
gi|7530450|gb|AF228457.1|AF228450S8[7530450] - 9070: AF228456
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 8
gi|7530449|gb|AF228456.1|AF228450S7[7530449] - 9071: AF228455
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 7
gi|7530448|gb|AF228455.1|AF228450S6[7530448] - 9072: AF228454
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 6
gi|7530447|gb|AF228454.1|AF228450S5[7530447] - 9073: AF228453
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 5
gi|7530446|gb|AF228453.1|AF228450S4[7530446] - 9074: AF228452
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 4
gi|7530445|gb|AF228452.1|AF228450S3[7530445] - 9075: AF228451
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 3
gi|7530444|gb|AF228451.1|AF228450S2[7530444] - 9076: AF228450
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, exon 2
gi|7530443|gb|AF228450.1|AF228450S1[7530443] - 9077: AH009226
Homo sapiens GABAA receptor gamma 3 subunit (GABRG3) gene, partial cds
gi|7530442|gb|AH009226.1|SEG_AF228450S[7530442] - 9078: AJ272208
Homo sapiens mRNA for IL-1 receptor accessory protein-like 2 (IL1RAPL-2 gene)
gi|7530096|emb|AJ272208.1|HSA272208[7530096] - 9081: AF056085
Homo sapiens GABA-B receptor mRNA, complete cds
gi|3719225|gb|AF056085.1|AF056085[3719225] - 9083: AF161081
Homo sapiens activating receptor PILRbeta mRNA, complete cds
gi|5817856|gb|AF161081.1|AF161081[5817856] - 9084: AF161080
Homo sapiens inhibitory receptor PILRalpha mRNA, complete cds
gi|5817854|gb|AF161080.1|AF161080[5817854] - 9085: AF228449
Homo sapiens gamma-aminobutyric acid receptor alpha 5 subunit (GABRA5) gene, exon 10 and partial cds
gi|7417243|gb|AF228449.1|AF228447S3[7417243] - 9086: AF228448
Homo sapiens gamma-aminobutyric acid receptor alpha 5 subunit (GABRA5) gene, exon 8 and partial cds
gi|7417242|gb|AF228448.1|AF228447S2[7417242] - 9087: AF228447
Homo sapiens gamma-aminobutyric acid receptor alpha 5 subunit (GABRA5) gene, exons 5, 6, and partial cds
gi|7417241|gb|AF228447.1|AF228447S1[7417241] - 9088: AH009221
Homo sapiens gamma-aminobutyric acid receptor alpha 5 subunit (GABRA5), gamma-aminobutyric acid receptor alpha 5 subunit (GABRA5), and gamma-aminobutyric acid receptor alpha 5 subunit (GABRA5) genes, partial cds
gi|7417240|gb|AH009221.1|SEG_AF228447S[7417240] - 9089: AF198052
Homo sapiens EVH1 domain binding protein mRNA, complete cds
gi|7416992|gb|AF198052.1|AF198052[7416992] - 9091: AF159278
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 17
gi|7406946|gb|AF159278.1F159262S17[7406946] - 9092: AF159277
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 16 and complete cds, alternatively spliced
gi|7406945|gb|AF159277.1|F159262S16[7406945] - 9093: AF159276
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 15
gi|7406944|gb|AF159276.1|F159262S15[7406944] - 9094: AF159275
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 14
gi|7406943|gb|AF159275.1|F159262S14[7406943] - 9095: AF159274
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 13
gi|7406942|gb|AF159274.1|F159262S13[7406942] - 9096: AF159273
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 12
gi|7406941|gb|AF159273.1F159262S12[7406941] - 9097: AF159272
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 11
gi|7406940|gb|AF159272.1|F159262S11[7406940] - 9098: AF159271
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 10
gi|7406939|gb|AF159271.1|F159262S10[7406939] - 9099: AF159270
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 9
gi|7406938|gb|AF159270.1|F159262S09[7406938] - 9100: AF159269
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 8
gi|7406937|gb|AF159269.1F159262S08[7406937] - 9101: AF159268
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 7
gi|7406936|gb|AF159268.1|F159262S07[7406936] - 9102: AF159267
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 6
gi|7406935|gb|AF159267.1|F159262S06[7406935] - 9103: AF159266
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 5
gi|7406934|gb|AF159266.1|F159262S05[7406934] - 9104: AF159265
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 4
gi|7406933|gb|AF159265.1|F159262S04[7406933] - 9105: AF159264
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 3
gi|7406932|gb|AF159264.1F159262S03[7406932] - 9106: AF159263
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 2
gi|7406931|gb|AF159263.1|F159262S02[7406931] - 9107: AF159262
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, exon 1
gi|7406930|gb|AF159262.1|F159262S01[7406930] - 9108: AH009217
Homo sapiens glutamate receptor subunit 3 (GRIA3) gene, complete cds, alternatively spliced
gi|7406929|gb|AH009217.1|SEG_F159262S[7406929] - 9109: AF176812
Homo sapiens dopamine receptor D2longer mRNA, complete cds
gi|7381415|gb|AF176812.1|AF176812[7381415] - 9112: AF193507
Homo sapiens chemokine receptor (CCR11) gene, complete cds
gi|736334|gb|AF193507.1|AF193507[7363341] - 9113: AF105239
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 9
and complete cds
gi|7363319|gb|AF105239.1|KIR3DL9[7363319] - 9114: AF105238
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 8
gi|7363318|gb|AF105238.1|KIR3DL8[7363318] - 9115: AF105237
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 7
gi|7363317|gb|AF105237.1|KIR3DL7[7363317] - 9116: AF105236
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 6
gi|7363316|gb|AF105236.1|KIR3DL6[7363316] - 9117: AF105235
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 5
gi|7363315|gb|AF105235.1|KIR3DL5[7363315] - 9118: AF105234
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 4
gi|7363314|gb|AF105234.1|KIR3DL4[7363314] - 9119: AF105233
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 3
gi|7363313|gb|AF105233.1|KIR3DL3[7363313] - 9120: AF105232
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 2
gi|7363312|gb|AF105232.1|KIR3DL2[7363312] - 9121: AF105231
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, exon 1
gi|736331|gb|AF105231.1|KIR3DL1[7363311] - 9122: AH009212
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL) gene, complete
cds
gi|7363310|gb|AH009212.1|SEG_KIR3DL[7363310] - 9123: AF104856
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 9
and complete cds
gi|7363308|gb|AF104856.1|HSKCIRV9[7363308] - 9124: AF104855
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 8
gi|7363307|gb|AF104855.1|HSKCIRV8[7363307] - 9125: AF104854
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 7
gi|7363306|gb|AF104854.1|HSKCIRV7[7363306] - 9126: AF104853
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 6
gi|7363305|gb|AF104853.1|HSKCIRV6[7363305] - 9127: AF104852
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 5
gi|7363304|gb|AF104852.1|HSKCIRV5[7363304] - 9128: AF104851
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 4
gi|7363303|gb|AF104851.1|HSKCIRV4[7363303] - 9129: AF104850
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 3
gi|7363302|gb|AF104850.1|HSKCIRV3[7363302] - 9130: AF104849
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon 2
gi|7363301|gb|AF104849.1|HSKCIRV2[7363301] - 9131: AF104848
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, exon
1
gi|7363300|gb|AF104848.1|HSKCIRV1[7363300] - 9132: AH009211
Homo sapiens killer cell immunoglobulin receptor variant (KIR3DL1) gene, complete cds
gi|7363299|gb|AH009211.1|SEG_HSKCIRV[7363299] - 9136: AF130742
AF130742 Homo sapiens LNCaP prostate cancer Homo sapiens cDNA, mRNA sequence
gi|7330628|gb|AF130742.1|AF130742[7330628] - 9137: AF130741
AF130741 Homo sapiens LNCaP prostate cancer Homo sapiens cDNA, mRNA sequence
gi|7330627|gb|AF130741.1|AF130741[7330627] - 9138: AF130740
AF130740 Homo sapiens LNCaP prostate cancer Homo sapiens cDNA, mRNA sequence
gi|7330626|gb|AF130740.1|AF130740[7330626] - 9139: AF130739
AF130739 Homo sapiens LNCaP prostate cancer Homo sapiens cDNA, mRNA sequence
gi|7330625|gb|AF130739.1|AF130739[7330625] - 9140: AF130738
AF130738 Homo sapiens LNCaP prostate cancer Homo sapiens cDNA, mRNA sequence
gi|7330624|gb|AF130738.1|AF130738[7330624] - 9141: AF130737
AF130737 Homo sapiens LNCaP prostate cancer Homo sapiens cDNA, mRNA sequence
gi|7330623|gb|AF130737.1|AF130737[7330623] - 9142: AF130743
AF130743 Homo sapiens LNCaP prostate cancer Homo sapiens cDNA, mRNA sequence - 9143: AB032593
Homo sapiens mRNA for PXR2b, complete cds
gi|7328930|dbj|AB3032593.1|AB032593[7328930] - 9144: AB032592
Homo sapiens mRNA for PXR2a, complete cds
gi|7328928|dbj|AB032592.1|AB032592[7328928] - 9145: AF110640
Homo sapiens orphan seven-transmembrane receptor (VSHK1) mRNA, complete cds
gi|7328551|gb|AF110640.1|AF110640[7328551] - 9147: AF181286
Homo sapiens mutant dystrophin mRNA, partial cds
gi|7321332|gb|AF181286.1|AF181286[7321332] - 9148: AF181285
Homo sapiens X-linked interleukin-1 receptor accessory protein-like 2 (IL1RAPL2)
mRNA, partial cds
gi|7321330|gb|AF181285.1|AF181285[7321330] - 9149: AF181284
Homo sapiens X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL1)
mRNA, complete cds
gi|7321328|gb|AF181284.1|AF181284[7321328] - 9150: G64286
34 Human Homo sapiens STS cDNA, sequence tagged site
gi|7274484|gb|G64286.1G64286[7274484] - 9151: AF145712
Homo sapiens soluble neuropilin-1 mRNA, complete cds
gi|7271464|gb|AF145712.1|AF145712[7271464] - 9180: AB031325
Homo sapiens gene for calcium-sensing receptor, exons, promoter region
gi|7023984|dbj|AB031325.1|AB031325[7023984] - 9183: AF112461
Homo sapiens G protein-coupled receptor 57 (GPR57) gene, complete cds
gi|6739495|gb|AF112461.1|AF112461[6739495] - 9184: AF112460
Homo sapiens G protein-coupled receptor 58 (GPR58) gene, complete cds
gi|6739493|gb|AF112460.1|AF112460[6739493] - 9185: AF184174
Homo sapiens somatostatin receptor 2 (SSTR2) gene, complete cds, alternatively
spliced
gi|7229402|gb|AF184174.1|AF184174[7229402] - 9227: AF175207
Homo sapiens lectin-like receptor F1, splice variant 1 KLRF1-s1 (KLRF1) mRNA, complete cds
gi|7188568|gb|AF175207.1|AF175207[7188568] - 9228: AF175206
Homo sapiens lectin-like receptor F1 (KLRF1) mRNA, complete cds
gi|7188566|gb|AF175206.1|AF175206[7188566] - 9229: AJ271348
Homo sapiens partial DRD3 gene for dopamine D3 receptor, exon 1
gi|7159738|emb|AJ271348.2|HSA271348[7159738] - 9236: AF180814
Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exon 10 and complete cds
gi|7157949|gb|AF180814.1|HSPEX7NB9[7157949] - 9237: AF180813
Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exon 9
gi|7157948|gb|AF180813.1|HSPEX7NB8[7157948] - 9238: AF180812
Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exon 8
gi|7157947|gb|AF180812.1|HSPEX7NB7[7157947] - 9239: AF180811
Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exon 7
gi|7157946|gb|AF180811.1|HSPEX7NB6[7157946] - 9240: AF180810
Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exon 6
gi|7157945|gb|AF180810.1|HSPEX7NB5[7157945] - 9241: AF180809
Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exons 4 and 5
gi|7157944|gb|AF180809.1|HSPEX7NB4[7157944] - 9242: AF180808
Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exon 3
gi|7157943|gb|AF180808.1|HSPEX7NB3[7157943] - 9243: AF180807
Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, exon 2
gi|7157942|gb|AF180807.1|HSPEX7NB2[7157942] - 9244: AF180806
Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, 5′ region and exon 1
gi|715794|gb|AF180806.1|HSPEX7NB1[7157941] - 9245: AH009157
Homo sapiens peroxisomal PTS2 receptor (PEX7) gene, complete cds
gi|7157940|gb|AH009157.1|SEG_HSPEX7NB[7157940] - 9246: AF087930
Homo sapiens olfactory receptor 17-228 (OR3A2) gene, complete cds
gi|714464|gb|AF087930.1|AF087930[7144641] - 9248: AF087928
Homo sapiens olfactory receptor 17-209 (OR1G1) gene, complete cds
gi|7144638|gb|AF087928.1|AF087928[7144638] - 9250: AF087926
Homo sapiens olfactory receptor 17-201 (OR3A3) gene, complete cds
gi|7144635|gb|AF087926.1|AF087926[7144635] - 9251: AF087925
Homo sapiens olfactory receptor 17-93 (OR1E2) gene, complete cds
gi|7144633|gb|AF087925.1|AF087925[7144633] - 9252: AF087924
Homo sapiens olfactory receptor 17-40 (OR3A1) gene, complete cds
gi|7144631|gb|AF087924.1|AF087924[7144631] - 9253: AF087923
Homo sapiens olfactory receptor 17-31 (OR1D5) gene, complete cds
gi|7144629|gb|AF087923.1|AF087923[7144629] - 9254: AF087922
Homo sapiens olfactory receptor 17-30 (OR1D4) gene, complete cds
gi|7144627|gb|AF087922.1|AF087922[7144627] - 9258: AF087918
Homo sapiens olfactory receptor 17-7 (OR1A1) gene, complete cds
gi|7144622|gb|AF087918.1|AF087918[7144622] - 9259: AF087917
Homo sapiens olfactory receptor 17-4 (OR1D2) gene, complete cds
gi|7144620|gb|AF087917.1|AF087917[7144620] - 9260: AF087916
Homo sapiens olfactory receptor 17-2 (OR1E1) gene, complete cds
gi|7144618|gb|AF087916.1|AF087916[7144618] - 9262: AC010582
Homo sapiens chromosome 14 clone CTD-2547F10, complete sequence
gi|6721135|gb|AC010582.6|AC010582[6721135] - 9263: AC010072
Homo sapiens chromosome 14q31 clone CTD-217314 containing TSHR gene, partial cds; and unknown gene, complete sequence
gi|6453843|gb|AC010072.5|AC010072[6453843] - 9264: AF155225
Homo sapiens olfactory receptor 17-6 (OR1A2) gene, complete cds
gi|5081803|gb|AF155225.1|AF155225[5081803] - 9265: AC007262
Homo sapiens chromosome 14 clone containing gene for thyroid stimulating hormone
receptor, partial CDS, complete sequence
gi|4883585|gb|AC007262.4|AC007262[4883585] - 9266: AC002085
Homo sapiens Chromosome 17 p13 Cosmid Clone cos26, complete sequence
gi|4835805|gb|AC002085.2|AC002085[4835805] - 9267: AC006531
Homo sapiens chromosome 16 clone 113K5, complete sequence
gi|4235137|gb|AC006531.1|AC006531[4235137] - 9268: AC004164
Homo sapiens chromosome 19, cosmid R26450, complete sequence
gi|2905827|gb|AC004164.1|AC004164[2905827] - 9269: AF200949
Homo sapiens C-type lectin-like receptor-1 mRNA, complete cds
gi|7110215|gb|AF200949.1|AF200949[7110215] - 9277: AF124841
Homo sapiens C-type lectin-like receptor-2 mRNA, complete cds
gi|7109730|gb|AF124841.1|AF124841[7109730] - 9278: AF210818
Homo sapiens SWAP-70 mRNA, complete cds
gi|6691098|gb|AF210818.1|AF210818[6691098] - 9281: AF134838
Homo sapiens endocytic receptor Endo180 (ENDO180) mRNA, complete cds
gi|4835877|gb|AF134838.1|AF134838[4835877] - 9282: U89326
Homo sapiens bone morphogenetic protein receptor type I ALK-6 mRNA, complete cds
gi|3377788|gb|U89326.1|HSU89326[3377788] - 9283: AJ003080
Homo sapiens mRNA for serotonin receptor (short isoform)
gi|3115225|emb|AJ003080.1|HSAJ3080[3115225] - 9284: AJ003079
Homo sapiens mRNA for 5-hydroxytryptamine3 receptor
gi|3115223|emb|AJ003079.1|HSAJ3079[3115223] - 9285: AJ003078
Homo sapiens mRNA for 5-HT3 serotonin receptor (long isoform)
gi|3115221|emb|AJ003078.1|HSAJ3078[3115221] - 9286: AC024126
Homo sapiens chromosome 11 clone cosmid f-o-8180 map 11q13, *** SEQUENCING IN PROGRESS ***, 2 ordered pieces
gi|7025812|gb|AC024126.1|AC024126[7025812] - 9287: AC024124
Homo sapiens chromosome 11 clone cosmid b-o-7185 map 11q13, *** SEQUENCING IN PROGRESS ***, 4 ordered pieces
gi|7025810|gb|AC024124.1|AC024124[7025810] - 9288: AC024123
Homo sapiens chromosome 11 clone bac67-m-5 map 11q13, *** SEQUENCING IN PROGRESS ***, 3 ordered pieces
gi|7025809|gb|AC024123.1|AC024123[7025809] - 9289: AF226728
Homo sapiens somatostatin receptor-interacting protein splice variant b (SSTRIP)
mRNA, complete cds
gi|7025450|gb|AF226728.1|AF226728[7025450] - 9290: AL157442
Homo sapiens mRNA; cDNA DKFZp586P1424 (from clone DKFZp586P1424); partial cds
gi|7018558|emb|AL157442.1|HSM802508[7018558] - 9291: AF217796
Homo sapiens SCG10 like-protein, helicase-like protein NHL, M68, and ADP-ribosylation factor related protein 1 (ARFRP1) genes, complete cds
gi|7012928|gb|AF217796.1|AF217796[7012928] - 9293: AL137719
Homo sapiens mRNA; cDNA DKFZp434K1831 (from clone DKFZp434K1831); partial cds
gi|6808155|emb|AL137719.1|HSM802224[6808155] - 9294: AL137432
Homo sapiens mRNA; cDNA DKFZp761E1824 (from clone DKFZp761E1824); partial cds
gi|6807990|emb|AL137432.1|HSM802135[6807990] - 9295: AL137375
Homo sapiens mRNA; cDNA DKFZp43411926 (from clone DKFZp43411926); partial cds
gi|6807903|emb|AL137375.1|HSM802063[6807903] - 9296: AL137288
Homo sapiens mRNA; cDNA DKFZp434F1516 (from clone DKFZp434F1S16); partial cds
gi|6807745|emb|AL137288.1|HSM801953[6807745] - 9297: AL137651
Homo sapiens mRNA; cDNA DKFZp43400213 (from clone DKFZp43400213); partial cds
gi|6807717|emb|AL137651.1|HSM801924[6807717] - 9298: AL133666
Homo sapiens mRNA; cDNA DKFZp434C1418 (from clone DKFZp434C1418); partial cds
gi|6599298|emb|AL133666.1|HSM801500[6599298] - 9299: AL133097
Homo sapiens mRNA; cDNA DKFZp434N1928 (from clone DKFZp434N1928)
gi|6453551|emb|AL133097.1|HSM801374[6453551] - 9300: AL133058
Homo sapiens mRNA; cDNA DKFZp434K0615 (from clone DKFZp434K0615); partial cds
gi|6453479|emb|AL133058.1|HSM801329[6453479] - 9301: AL133030
Homo sapiens mRNA; cDNA DKFZp434H177 (from clone DKFZp434H177); partial cds
gi|6453431|emb|AL133030.1|HSM801297[6453431] - 9304: AL117432
Homo sapiens mRNA; cDNA DKFZp434E066 (from clone DKFZp434E066); partial cds
gi|5911868|emb|AL117432.1|HSM800941[5911868] - 9305: AL096753
Homo sapiens mRNA; cDNA DKFZp434C192 (from clone DKFZp434C192); partial cds
gi|5419889|emb|AL096753.1|HSM800719[5419889] - 9306: AL080164
Homo sapiens mRNA; cDNA DKFZp564C1940 (from clone DKFZp564C1940); partial cds
gi|5262628|emb|AL080164.1|HSM800683[5262628] - 9307: AL050071
Homo sapiens mRNA; cDNA DKFZp566B0846 (from clone DKFZp566B0846); partial cds
gi|4884302|emb|AL050071.1|HSM800396[4884302] - 9308: AL049924
Homo sapiens mRNA; cDNA DKFZp564G1182 (from clone DKFZp564G1182); partial cds
gi|4884170|emb|AL049924.1|HSM800265[4884170] - 9309: X68559
Homo sapiens partial FGFR-4 gene for acidic fibroblast growth factor
gi|556841|emb|X68559.1|HSFGRF[556841] - 9310: AF228312
Homo sapiens T-cell receptor zeta chain precursor, mRNA, partial cds
gi|6984206|gb|AF228312.1|AF228312[6984206] - 9311: AF199028
Homo sapiens B7-like protein (GL50) mRNA, complete cds
gi|6983943|gb|AF199028.1|AF199028[6983943] - 9315: AF225903
Homo sapiens D1 dopamine receptor interacting protein calcyon mRNA, complete cds
gi|6980075|gb|AF225903.1|AF225903[6980075] - 9316: AF222340
Homo sapiens type 1 tumor necrosis factor receptor shedding aminopeptidase regulator mRNA, complete cds
gi|6979942|gb|AF222340.1|AF222340[6979942] - 9317: AF201349
Homo sapiens glutamate receptor C gene, partial cds
gi|6690029|gb|AF201349.1|AF201349[6690029] - 9318: AF201343
Homo sapiens glutamate receptor B flop isoform and glutamate receptor B flip isoform genes, partial cds
gi|6690023|gb|AF201343.1|AF201343[6690023] - 9319: AJ271729
Homo sapiens mRNA for glucose-regulated protein (HSPA5 gene)
gi|6900103|emb|AJ271729.1|HSA271729[6900103] - 9320: AF217794
Homo sapiens M68E mRNA, alternatively spliced, complete cds
gi|6969262|gb|AF217794.1|AF217794[6969262] - 9321: AF217793
Homo sapiens M68C mRNA, alternatively spliced, complete cds
gi|6969260|gb|AF217793.1|AF217793[6969260] - 9322: AF152238
Homo sapiens V1b vasopressin receptor (VPR3) gene, complete cds
gi|6969252|gb|AF152238.1|AF152238[6969252]
- 9325: X89271
H. sapiens mRNA for HG11 orphan receptor
gi|6911643|emb|X89271.1|HSHG11ORP[6911643] - 9328: AJ240085
Homo sapiens mRNA for T-cell receptor interacting molecule protein, splice variant (TRIM gene)
gi|6911580|emb|AJ240085.1|HSA240085[6911580] - 9330: AJ271684
Homo sapiens mRNA for myeloid DAP12-associating lectin (MDL-1 gene)
gi|6900101|emb|AJ271684.1|HSA271684[6900101] - 9331: AJ243213
Homo sapiens partial 5-HT4 receptor gene, exons 2 to 5
gi|6900061|emb|AJ243213.1|HSA243213[6900061] - 9332: AC003075
Human PAC clone RP4-658N5 from 7p21, complete sequence
gi|2588637|gb|AC003075.1|AC003075[2588637] - 9333: AC003078
Human BAC clone GS1-117010 from 7q21-q22, complete sequence
gi|258863|gb|AC003078.1|AC003078[2588631] - 9334: AC002381
Human BAC clone CTB-20D2 from 7q22, complete sequence
gi|2275186|gb|AC002381.1|AC002381[2275186] - 9335: AC005155
Homo sapiens PAC clone RP5-877J2 from 7 p14-p15, complete sequence
gi|3242760|gb|AC005155.1|AC005155[3242760] - 9338: D50678
Human mRNA for apolipoprotein E receptor 2, complete cds
gi|1321643|dbj|D50678.1|D50678[1321643] - 9339: D31770
Human osteosarcoma mRNA for activin typeII A receptor, complete cds
gi|1321631|dbj|D31770.1|HUMACTRIIA[1321631] - 9340: D50516
Human mRNA for type II receptor for bone morphogenetic protein-4, complete cds
gi|807712|dbj|D50516.1|HUMBMP4A[807712] - 9341: D31661
Human mRNA for tyrosine kinase, complete cds
gi|495677|dbj|D31661.1|HUMERKA[495677] - 9342: D17516
Homo sapiens mRNA for PACAP receptor, complete cds
gi|457562|dbj|D17516.1|HUMPACAPR[457562] - 9343: D16105
Human mRNA for leukocyte tyrosine kinase, complete cds
gi|440854|dbj|D516105.1|HUMLTKLP2[440854] - 9344: D16494
Human mRNA for very low density lipoprotein receptor, complete cds
gi|391735|dbj|D516494.1|HUMVLDLRB[391735] - 9345: D16493
Human mRNA for very low density lipoprotein receptor, complete cds
gi|391733|dbj|D516493.1|HUMVLDLRA[391733] - 9346: G63891
GRM7 Human Homo sapiens STS genomic 3′, sequence tagged site
gi|6842052|gb|G63891.1|G63891[6842052] - 9347: G63890
GRM4 Human Homo sapiens STS genomic 5′, sequence tagged site
gi|6842051|gb|G63890.1|G63890[6842051] - 9471: AF148806
Homo sapiens dopamine receptor D2 (DRD2) gene, 5′-flanking region and exon 1
gi|6759904|gb|AF148806.1|AF148806[6759904] - 9473: AF189251
Homo sapiens cytomegalovirus partial fusion receptor mRNA, partial cds
gi|6760349|gb|AF189251.1|AF189251[6760349] - 9474: AF202063
Homo sapiens fibroblast growth factor receptor 4, soluble-form splice variant (FGFR4) mRNA, complete cds
gi|6739817|gb|AF202063.1|AF202063[6739817] - 9475: AF201951
Homo sapiens high affinity immunoglobulin epsilon receptor beta subunit mRNA, complete cds
gi|6563299|gb|AF201951.1|AF201951[6563299] - 9476: AB037108
Homo sapiens mRNA for seven transmembrane domain orphan receptor, complete cds
gi|6729335|dbj|AB037108.1|AB037108[6729335] - 9478: AF209721
Homo sapiens IgG Fc receptor locus, partial sequence
gi|6715394|gb|AF209721.1|AF209721[6715394] - 9480: AJ238323
Homo sapiens mRNA for NK inhibitory receptor (IRC2)
gi|6707798|emb|AJ238323.1|HSA238323[6707798] - 9481: AB036432
Homo sapiens RAGE mRNA for advanced glycation endproducts receptor, complete cds
gi|6691625|dbj|AB036432.1|AB036432[6691625] - 9482: AF192548
Homo sapiens tumor necrosis factor receptor-like protein ZTNFR9 (ZTNFR9) mRNA,
complete cds
gi|6319129|gb|AF192548.1|AF192548[6319129] - 9483: AF184971
Homo sapiens class II cytokine receptor ZCYTOR7 (ZCYTOR7) mRNA, complete cds
gi|6013324|gb|AF184971.1|AF184971[6013324] - 9484: AJ012288
Homo sapiens mRNA for GABA-BR1
gi|4186035|emb|AJ012288.1|HSA012288[4186035] - 9485: AB035073
Homo sapiens mRNA for platelet glycoprotein VI, complete cds
gi|6691622|dbj|AB035073.1|AB035073[6691622] - 9486: AF217403
Homo sapiens low density lipoprotein receptor (LDLR) gene, partial cds
gi|6691160|gb|AF217403.1|AF217403[6691160] - 9487: AF200465
Homo sapiens coxsackievirus and adenovirus receptor (CXADR) gene, complete cds;
and ANA gene, partial cds
gi|6690789|gb|AF200465.1|AF200465[6690789] - 9509: AJ243342
Homo sapiens mRNA for nicotinic acetylcholine receptor alpha 9 subunit (NACHRA9 gene)
gi|6688135|emb|AJ243342.1|HSA243342[6688135] - 9510: AJ223183
Homo sapiens mRNA for DORA protein
gi|3925598|emb|AJ223183.1|HSAJ3183[3925598] - 9512: AF006265
Homo sapiens cancer associated surface antigen (RCAS1) mRNA, complete cds
gi|2213933|gb|AF006265.1|AF006265[2213933] - 9513: AF159570
Homo sapiens regulator of G-protein signalling 5 (RGS5) mRNA, complete cds
gi|5230675|gb|AF159570.1|AF159570[5230675] - 9515: D29952
Human DNA for alpha1A/D adrenergic receptor, complete cds
gi|914933|dbj|D29952.1|HUMA1ADAR[914933] - 9516: NM—004441
Homo sapiens EphB1 (EPHB1) mRNA
gi|4758283|ref|NM—004441.1|[4758283] - 9532: AF133299
Homo sapiens lectin-like NK cell receptor LLT1 (LLT1) mRNA, complete cds
gi|6651064|gb|AF133299.1|AF133299[6651064] - 9533: AF110265
Homo sapiens epidermal growth factor receptor substrate EPS15R mRNA, complete cds
gi|6650598|gb|AF110265.1|AF110265[6650598] - 9535: AF061779
Homo sapiens cosmid 25, complete sequence
gi|6650204|gb|AF061779.1|AF061779[6650204] - 9537: AF118224
Homo sapiens matriptase mRNA, complete cds
gi|6647301|gb|AF118224.2|AF118224[6647301] - 9538: AF125809
Homo sapiens neurotrophic receptor tyrosine kinase-ETS related protein fusion protein (NTRK3-ETV6 fusion) mRNA, partial cds
gi|6635288|gb|AF125809.1|AF125809[6635288] - 9539: AF125808
Homo sapiens ETS related protein-neurotrophic receptor tyrosine kinase fusion protein (ETV6-NTRK3 fusion) mRNA, partial cds
gi|6635286|gb|AF125808.1|AF125808[6635286] - 9540: AJ000542
Homo sapiens partial p58 gene for NK receptor
gi|6624934|emb|AJ000542.2|HSP58NKRC[6624934] - 9541: AF190826
Homo sapiens P2X2A receptor (P2X2) gene, complete cds
gi|6606329|gb|AF190826.1|AF190826[6606329] - 9542: AF190825
Homo sapiens P2X2D receptor (P2X2) mRNA, complete cds
gi|6606327|gb|AF190825.1|AF190825[6606327] - 9543: AF190824
Homo sapiens P2X2C receptor (P2X2) mRNA, complete cds
gi|6606325|gb|AF190824.1|AF190824[6606325] - 9544: AF190823
Homo sapiens P2X2B receptor (P2X2) mRNA, complete cds
gi|6606323|gb|AF190823.1|AF190823[6606323] - 9545: AF190822
Homo sapiens P2X2A receptor (P2X2) mRNA, complete cds
gi|660632|gb|AF190822.1|AF190822[6606321] - 9546: AH008809
Homo sapiens FGF receptor activating protein 1 (FRAG1) gene, complete cds
gi|6606289|gb|AH008809.1|SEG_AF159616S[6606289] - 9547: AF159621
Homo sapiens FGF receptor activating protein 1 (FRAG1) gene, exon 6 and complete
cds
gi|6606288|gb|AF159621.1|AF159616S6[6606288] - 9548: AF159620
Homo sapiens FGF receptor activating protein 1 (FRAG1) gene, exon 5
gi|6606287|gb|AF159620.1|AF159616S5[6606287] - 9549: AF159619
Homo sapiens FGF receptor activating protein 1 (FRAG1) gene, exon 4
gi|6606286|gb|AF159619.1|AF159616S4[6606286] - 9550: AF159618
Homo sapiens FGF receptor activating protein 1 (FRAG1) gene, exon 3
gi|6606285|gb|AF159618.1|AF159616S3[6606285] - 9551: AF159617
Homo sapiens FGF receptor activating protein 1 (FRAG1) gene, exon 2
gi|6606284|gb|AF159617.1|AF159616S2[6606284] - 9552: AF159616
Homo sapiens FGF receptor activating protein 1 (FRAG1) gene, exon 1
gi|6606283|gb|AF159616.1|AF159616S1[6606283] - 9553: AH008808
Homo sapiens PPAR gamma coactivator (PPAR gamma coactivator) gene, complete cds
gi|6606153|gb|AH008808.1|SEG_F108193S[6606153] - 9554: AF108205
Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 13 and complete cds
gi|6606152|gb|AF108205.1|F108193S13[6606152] - 9555: AF108204
Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 12
gi|6606151|gb|AF108204.1|F108193S12[6606151] - 9556: AF108203
Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 11
gi|6606150|gb|AF108203.1|F108193S11[6606150] - 9557: AF108202
Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 10
gi|6606149|gb|AF108202.1|F108193S10[6606149] - 9558: AF108201
Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 9
gi|6606148|gb|AF108201.1|F108193S09[6606148] - 9559: AF108200
Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 8
gi|6606147|gb|AF108200.1|F108193S08[6606147] - 9560: AF108199
Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 7
gi|6606146|gb|AF108199.1|F108193S07[6606146] - 9561: AF108198
Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 6
gi|6606145|gb|AF108198.1|F108193S06[6606145] - 9562: AF108197
Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 5
gi|6606144|gb|AF108197.1|F108193S05[6606144] - 9563: AF108196
Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 4
gi|6606143|gb|AF108196.1F108193S04[6606143] - 9564: AF108195
Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 3
gi|6606142|gb|AF108195.1|F108193S03[6606142] - 9565: AF108194
Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 2
gi|6606141|gb|AF108194.1|F108193S02[6606141] - 9566: AF108193
Homo sapiens PPAR gamma coactivator-1 (PPARGC1) gene, exon 1
gi|6606140|gb|AF108193.1|F108193S01[6606140] - 9567: AC005009
Homo sapiens BAC clone GS1-67A24 from 7q21.q21.2, complete sequence
gi|4156150|gb|AC005009.1|AC005009[4156150] - 9568: AF047487
Homo sapiens Nck-2 (NCK2) mRNA, complete cds
gi|3930216|gb|AF047487.1|AF047487[3930216] - 9569: AC004822
Homo sapiens PAC clone RP1-170D19 from Xq23, complete sequence
gi|3845420|gb|AC004822.1|AC004822[3845420] - 9570: AC002543
Homo sapiens BAC clone CTA-300C3 from 7q31.2, complete sequence
gi|3645947|gb|AC002543.1|AC002543[3645947] - 9571: AC002081
Homo sapiens BAC clone CTA-331C24 from 7q21, complete sequence
gi|2078453|gb|AC002081.1|AC002081[2078453] - 9572: AF106698
Homo sapiens PPAR gamma coactivator-1 (PPARGC1) mRNA, complete cds
gi|6594644|gb|AF106698.1|AF106698[6594644] - 9574: AH002552
Homo sapiens CHRNG gene, complete sequence; and acetylcholine receptor gamma-subunit (ACHR) gene, partial cds
gi|6579185|gb|AH002552.2|SEG_HUMACHRG[6579185] - 9575: L29197
Homo sapiens acetylcholine receptor gamma-subunit (ACHR) gene, exons 10 and 11
gi|457433|gb|L29197.1|HUMACHRG7[457433] - 9576: M11811
Homo sapiens acetylcholine receptor gamma-subunit (ACHR) gene, exon 12 and partial cds
gi|177984|gb|M11811.1|HUMACHRG8[177984] - 9580: AF119666
Homo sapiens insulin receptor tyrosine kinase substrate mRNA, complete cds
gi|6563257|gb|AF119666.1|AF119666[6563257] - 9581: AF109683
Homo sapiens leukocyte-associated Ig-like receptor 1b mRNA, complete cds
gi|6563041|gb|AF109683.1|AF109683[6563041] - 9582: AH008758
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, complete cds
gi|6561205|gb|AH008758.1|SEG_HSILGFR[6561205] - 9583: AF109291
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 48 and complete cds
gi|6561204|gb|AF109291.1|HSILGFR48[6561204] - 9584: AF109290
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 47
gi|6561203|gb|AF109290.1|HSILGFR47[6561203] - 9585: AF109289
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 46
gi|6561202|gb|AF109289.1|HSILGFR46[6561202] - 9586: AF109288
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 45
gi|656120|gb|AF109288.1|HSILGFR45[6561201] - 9587: AF109287
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 44
gi|6561200|gb|AF109287.1|HSILGFR44[6561200] - 9588: AF109286
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 43
gi|6561199|gb|AF109286.1|HSILGFR43[6561199] - 9589: AF109285
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 42
gi|6561198|gb|AF109285.1|HSILGFR42[6561198] - 9590: AF109284
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 41
gi|6561197|gb|AF109284.1|HSILGFR41[6561197] - 9591: AF109283
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 40
gi|6561196|gb|AF109283.1|HSILGFR40[6561196] - 9592: AF109282
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 39
gi|6561195|gb|AF109282.1|HSILGFR39[6561195] - 9593: AF109281
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 38
gi|6561194|gb|AF109281.1|HSILGFR38[6561194] - 9594: AF109280
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 37
gi|6561193|gb|AF109280.1|HSILGFR37[6561193] - 9595: AF109279
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 36
gi|6561192|gb|AF109279.1|HSILGFR36[6561192] - 9596: AF109278
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 35
gi|6561191|gb|AF109278.1|HSILGFR35[6561191] - 9597: AF109277
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 34
gi|6561190|gb|AF109277.1|HSILGFR34[6561190] - 9598: AF109276
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 33
gi|6561189|gb|AF109276.1|HSILGFR33[6561189] - 9599: AF109275
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 32
gi|6561188|gb|AF109275.1|HSILGFR32[6561188] - 9600: AF109274
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 31
gi|6561187|gb|AF109274.1|HSILGFR31[6561187] - 9601: AF109273
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 30
gi|6561186|gb|AF109273.1|HSILGFR30[6561186] - 9602: AF109272
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 29
gi|6561185|gb|AF109272.1|HSILGFR29[6561185] - 9603: AF109271
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 28
gi|6561184|gb|AF109271.1|HSILGFR28[6561184] - 9604: AF109270
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 27
gi|6561183|gb|AF109270.1|HSILGFR27[6561183] - 9605: AF109269
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 26
gi|6561182|gb|AF109269.1|HSILGFR26[6561182] - 9606: AF109268
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 25
gi|6561181|gb|AF109268.1|HSILGFR25[6561181] - 9607: AF109267
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 24
gi|6561180gb|AF109267.1|HSILGFR24[6561180] - 9608: AF109266
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 23
gi|6561179|gb|AF109266.1|HSILGFR23[6561179] - 9609: AF109265
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 22
gi|6561178|gb|AF109265.1|HSILGFR22[6561178] - 9610: AF109264
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 21
gi|6561177|gb|AF109264.1|HSILGFR21[6561177] - 9611: AF109263
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 20
gi|6561176|gb|AF109263.1|HSILGFR20[6561176] - 9612: AF109262
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 19
gi|6561175|gb|AF109262.1|HSILGFR19[6561175] - 9613: AF109261
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 18
gi|6561174|gb|AF109261.1|HSILGFR18[6561174] - 9614: AF109260
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 17
gi|6561173|gb|AF109260.1|HSILGFR17[6561173] - 9615: AF109259
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 16
gi|6561172|gb|AF109259.1|HSILGFR16[6561172] - 9616: AF109258
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 15
gi|6561171|gb|AF109258.1|HSILGFR15[6561171] - 9617: AF109257
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 14
gi|6561170gb|AF109257.1|HSILGFR14[6561170] - 9618: AF109256
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 13
gi|6561169|gb|AF109256.1|HSILGFR13[6561169] - 9619: AF109255
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 12
gi|6561168|gb|AF109255.1|HSILGFR1 2[6561168] - 9620: AF109254
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 11
gi|6561167|gb|AF109254.1|HSILGFR11[6561167] - 9621: AF109253
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 10
gi|6561166|gb|AF109253.1|HSILGFR10[6561166] - 9622: AF109252
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 9
gi|6561165|gb|AF109252.1|HSILGFR09[6561165] - 9623: AF109251
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 8
gi|6561164|gb|AF109251.1|HSILGFR08[6561164] - 9624: AF109250
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 7
gi|6561163|gb|AF109250.1|HSILGFR07[6561163] - 9625: AF109249
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 6
gi|6561162|gb|AF109249.1|HSILGFR06[6561162] - 9626: AF109248
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 5
gi|6561161|gb|AF109248.1HSILGFR05[6561161] - 9627: AF109247
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 4
gi|6561160gb|AF109247.1|HSILGFR04[6561160] - 9628: AF109246
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 3
gi|6561159|gb|AF109246.1|HSILGFR03[6561159] - 9629: AF109245
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 2
gi|6561158|gb|AF109245.1|HSILGFR02[6561158] - 9630: AF109244
Homo sapiens insulin-like growth factor 2 receptor (IGF2R) gene, exon 1
gi|6561157|gb|AF109244.1|HSILGFR01[6561157] - 9631: AF178684
Homo sapiens class I cytokine receptor (zcytor5) mRNA, complete cds
gi|5853247|gb|AF178684.1|AF178684[5853247] - 9632: AQ917583
hxa18 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552294|gb|AQ917583.1|AQ917583[6552294] - 9633: AQ917582
hxa17 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552293|gb|AQ917582.1|AQ917582[6552293] - 9634: AQ917581
hxa16 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552292|gb|AQ917581.1|AQ917581[6552292] - 9635: AQ917580
hxa15 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552291|gb|AQ917580.1|AQ917580[6552291] - 9636: AQ917579
hxa14 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552290|gb|AQ917579.1|AQ917579[6552290] - 9637: AQ917578
hxa13 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552289|gb|AQ917578.1|AQ917578[6552289] - 9638: AQ917577
hxa12 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552288|gb|AQ917577.1|AQ917577[6552288] - 9639: AQ917576
Hxa11 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552287|gb|AQ917576.1|AQ917576[6552287] - 9640: AQ917575
hxa10 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552286|gb|AQ917575.1|AQ917575[6552286] - 9641: AQ917574
hxa9 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552285|gb|AQ917574.1|AQ917574[6552285] - 9642: AQ917573
hxa8 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552284|gb|AQ917573.1|AQ917573[6552284] - 9643: AQ917572
hxa7 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552283|gb|AQ917572.1|AQ917572[6552283] - 9644: AQ917571
hxa6 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552282|gb|AQ917571.1|AQ917571[6552282] - 9645: AQ917570
hxa5 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552281|gb|AQ917570.1|AQ917570[6552281] - 9646: AQ917569
hxa4 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552280|gb|AQ917569.1|AQ917569[6552280] - 9647: AQ917568
hxa3 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552279|gb|AQ917568.1|AQ917568[6552279] - 9648: AQ917567
hxa2 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552278|gb|AQ917567.1|AQ917567[6552278] - 9649: AQ917566
hxa1 Bac Human I Homo sapiens genomic, genomic survey sequence
gi|6552277|gb|AQ917566.1|AQ917566[6552277] - 9650: AH008470
Homo sapiens somatostatin receptor subtype 2 gene, partial cds
gi|6531649|gb|AH008470.1|SEG_AF182397S[6531649] - 9652: AF182397
Homo sapiens somatostatin receptor subtype 2 gene, promoter region and patial
cds
gi|6531647|gb|AF182397.1|AF182397S1[6531647] - 9654: AF068757
Homo sapiens somatostatin receptor subtype 3 (SSTR3) gene, 5′ flanking region and partial cds
gi|6523784|gb|AF068757.1|AF068757[6523784] - 9656: AF166329
Homo sapiens intermediate prolactin receptor isoform mRNA, complete cds
gi|5734139|gb|AF166329.1|AF166329[5734139] - 9658: AJ251595
Homo sapiens mRNA for transmembrane glycoprotein (CD44 gene)
gi|6491738|emb|AJ251595.1|HSA251595[6491738] - 9659: AF100772
Homo sapiens tenascin-M1 (TNM1) mRNA, complete cds
gi|6165844|gb|AF100772.1|AF100772[6165844] - 9660: AF100634
Homo sapiens Duffy antigen/Receptor for chemokines (DARC) gene, DARC-Fya allele,
partial cds
gi|6048958|gb|AF100634.1|AF100634[6048958] - 9661: AH008438
Homo sapiens outer membrane receptor Tom20 (TOM20) gene, complete cds
gi|6469611|gb|AH008438.1|SEG_HS20TOM[6469611] - 9662: AF019638
Homo sapiens nedasin s-form mRNA, complete cds
gi|6469319|gb|AF019638.1|AF019638[6469319] - 9663: AB3010445
Homo sapiens mRNA for CC chemokine ILC, complete cds
gi|6469037|dbj|AB010445.1|AB010445[6469037] - 9664: AF119330
Synthetic construct from Homo sapiens dopamine receptor D4-7 mRNA, partial cds
gi|4325159|gb|AF119330.1|AF119330[4325159] - 9665: AF119329
Synthetic construct from Homo sapiens dopamine receptor D4-4 mRNA, partial cds
gi|4325157|gb|AF119329.1|AF119329[4325157] - 9666: AF119328
Synthetic construct from Homo sapiens dopamine receptor D4-2 mRNA, partial cds
gi|4325155|gb|AF119328.1|AF119328[4325155] - 9667: AL021940
Homo sapiens DNA sequence from PAC 117P20 on chromosome 1q24. Contains the LNHR
(SELL) gene coding for Lymph Node Homing Receptor (L-Selectin precursor, LAM-1
Leukocyte Adhesion Molecule, Leukocyte surface antigen Leu-8, TQ1, GP90-MEL, LECAM1 Leukocyte-Endothelial Cell Adhesion Molecule 1, CD62L). Contains the SELE
gene coding for E-Selectin precursor (CD62E, ELAM-1 Endothelial Leukocyte Adhesion Molecule 1, LECAM-2 Leukocyte-Endothelial Cell Adhesion Molecule 2).
Contains an unknown gene with homology to predicted yeast. plant and worm proteins. Contains ESTs and STSs, complete sequence
gi|3115962|emb|AL021940.1|HS117P20[3115962] - 9668: AF152113
Homo sapiens perforin gene, IL-2 responsive enhancer sequence
gi|6467393|gb|AF152113.1|AF152113[6467393] - 9669: AB022178
Homo sapiens mRNA for calcitonin receptor, complete cds, isolate from bone marrow osteoclast
gi|6456431|dbj|AB022178.1|AB022178[6456431] - 9670: AB022177
Homo sapiens mRNA for calcitonin receptor, complete cds, isolate from breast carcinoma
gi|6456429|dbj|AB022177.1|AB022177[6456429] - 9671: AJ251004
Homo sapiens ITGB4 gene for integrin beta 4, exons 1-2 and joined CDS
gi|6453379|emb|AJ251004.1|HSA251004[6453379] - 9672: AJ133822
Homo sapiens mRNA for receptor for Advanced Glycation End Product, secreted isoform (RAGEsec gene)
gi|4877290|emb|AJ133822.1|HSA133822[4877290] - 9673: Y18994
Homo sapiens GABRR3 gene, partial
gi|6434194|emb|Y18994.1|HSP18994[6434194] - 9676: AF177766
Homo sapiens human toll-like receptor 4 (TLR4) gene, TLR4B allele, partial cds
gi|6403466|gb|AF177766.1|AF177766[6403466] - 9677: AH008297
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, complete
cds
gi|6090614|gb|AH008297.1|SEG_HSDRA2S[6090614] - 9678: AF083854
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 40
and complete cds
gi|6090613|gb|AF083854.1|HSDRA2S38[6090613] - 9679: AF083853
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 39
gi|6090612|gb|AF083853.1|HSDRA2S37[6090612] - 9680: AF083852
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 38
gi|6090611|gb|AF083852.1|HSDRA2S36[6090611] - 9681: AF083851
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 37
gi|6090610gb|AF083851.1|HSDRA2S35[6090610] - 9682: AF083850
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 36
gi|6090609|gb|AF083850.1|HSDRA2S34[6090609] - 9683: AF083849
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exons 34
and 35
gi|6090608|gb|AF083849.1|HSDRA2S33[6090608] - 9684: AF083848
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 33
gi|6090607|gb|AF083848.1|HSDRA2S32[6090607] - 9685: AF083847
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 32
gi|6090606|gb|AF083847.1|HSDRA2S31[6090606] - 9686: AF083846
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 31
gi|6090605|gb|AF083846.1|HSDRA2S30[6090605] - 9687: AF083845
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 30
gi|6090604|gb|AF083845.1|HSDRA2S29[6090604] - 9688: AF083844
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 29
gi|6090603|gb|AF083844.1|HSDRA2S28[6090603] - 9689: AF083843
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 28
gi|6090602|gb|AF083843.1|HSDRA2S27[6090602] - 9690: AF083842
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 27
gi|6090601|gb|AF083842.1|HSDRA2S26[6090601] - 9691: AF083841
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 26
gi|6090600|gb|AF083841.1|HSDRA2S25[6090600] - 9692: AF083840
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 25
gi|6090599|gb|AF083840.1|HSDRA2S24[6090599] - 9693: AF083839
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 24
gi|6090598|gb|AF083839.1|HSDRA2S23[6090598] - 9694: AF083838
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 23
gi|6090597|gb|AF083838.1|HSDRA2S22[6090597] - 9695: AF083837
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 22
gi|6090596|gb|AF083837.1|HSDRA2S21[6090596] - 9696: AF083836
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 21
gi|6090595|gb|AF083836.1|HSDRA2S20[6090595] - 9697: AF083835
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 20
gi|6090594|gb|AF083835.1|HSDRA2S19[6090594] - 9698: AF083834
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 19
gi|6090593|gb|AF083834.1|HSDRA2S18[6090593] - 9699: AF083833
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exons 17
and 18
gi|6090592|gb|AF083833.1|HSDRA2S17[6090592] - 9700: AF083832
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 16
gi|6090591|gb|AF083832.1|HSDRA2S16[6090591] - 9701: AF083831
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 15
gi|6090590|gb|AF083831.1|HSDRA2S15[6090590] - 9702: AF083830
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 14
gi|6090589|gb|AF083830.1|HSDRA2S14[6090589] - 9703: AF083829
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 13
gi|6090588|gb|AF083829.1|HSDRA2S13[6090588] - 9704: AF083828
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 12
gi|6090587|gb|AF083828.1|HSDRA2S12[6090587] - 9705: AF083827
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 11
gi|6090586|gb|AF083827.1|HSDRA2S11[6090586] - 9706: AF083826
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 10
gi|6090585|gb|AF083826.1|HSDRA2S10[6090585] - 9707: AF083825
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 9
gi|6090584|gb|AF083825.1|HSDRA2S09[6090584] - 9708: AF083824
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 8
gi|6090583|gb|AF083824.1|HSDRA2S08[6090583] - 9709: AF083823
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 7
gi|6090582|gb|AF083823.1|HSDRA2S07[6090582] - 9710: AF083822
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 6
gi|6090581|gb|AF083822.1|HSDRA2S06[6090581] - 9711: AF083821
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 5
gi|6090580|gb|AF083821.1|HSDRA2S05[6090580] - 9712: AF083820
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 4
gi|6090579|gb|AF083820.1|HSDRA2S04[6090579] - 9713: AF083819
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 3
gi|60905781|gb|AF083819.1|HSDRA2S03[6090578] - 9714: AF083818
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 2
gi|6090577|gb|AF083818.1|HSDRA2S02[6090577] - 9715: AF083817
Homo sapiens dihydropyridine receptor alpha 2 subunit (CACNA2D1) gene, exon 1
gi|6090576|gb|AF083817.1|HSDRA2S01[6090576] - 9716: U68492
Homo sapiens 5-hydroxytryptamine 7 receptor isoform B gene, alternatively spliced, partial cds
gi|1857150|gb|U68492.1|HS5HTSEV01[1857150] - 9717: AB032417
Homo sapiens FZD4 mRNA for WNT receptor Frizzled-4, complete cds
gi|6277265|dbj|AB032417.1|AB032417[6277265] - 9718: AF191093
Homo sapiens P2X4 purinoceptor gene, complete cds
gi|6274470|gb|AF191093.1|AF191093[6274470] - 9719: AJ130713
Homo sapiens mRNA for QA79 membrane protein, splice product airm-1
gi|5541875|emb|AJ130713.1|HSA130713[5541875] - 9720: AJ130712
Homo sapiens mRNA for QA79 membrane protein, splice product airm-3
gi|5541873|emb|AJ130712.1|HSA130712[5541873] - 9721: AJ130711
Homo sapiens mRNA for QA79 membrane protein, splice product airm-2
gi|5541871|emb|AJ130711.1|HSA130711[5541871] - 9722: AJ130710
Homo sapiens mRNA for QA79 membrane protein, allelic variant airm-1b
gi|5541869|emb|AJ130710.1|HSA130710[5541869] - 9723: AJ007395
Homo sapiens mRNA for QA79 membrane protein
gi|5295849|emb|AJ007395.1|HSA7395[5295849] - 9724: X95097
Homo sapiens mRNA for VIP receptor 2
gi|4837717|emb|X95097.2|HSVIP2R[4837717] - 9725: Y18423
Homo sapiens VIP2R gene, exons 1-2 (and joined CDS)
gi|4753150|emb|Y18423.1|HA18423[4753150] - 9726: Y18431
Homo sapiens VIP2R gene, exon 13
gi|4741409|emb|Y18431.1|HA18431[4741409] - 9727: Y18430
Homo sapiens VIP2R gene, exons 9-12
gi|4741408|emb|Y18430.1|HA18430[4741408] - 9728: Y18429
Homo sapiens VIP2R gene, exon 8
gi|4741407|emb|Y18429.1|HA18429[4741407] - 9729: Y18428
Homo sapiens VIP2R gene, exon 7
gi|4741406|emb|Y18428.1|HA18428[4741406] - 9730: Y18427
Homo sapiens VIP2R gene, exon 6
gi|4741405|emb|Y18427.1|HA18427[4741405] - 9731: Y18426
Homo sapiens VIPR2 gene exon 5
gi|4741404|emb|Y18426.1|HA18426[4741404] - 9732: Y18425
Homo sapiens VIPR2 gene exon 4
gi|4741403|emb|Y18425.1|HA18425[4741403] - 9733: Y18424
Homo sapiens VIPR2 gene exon 3
gi|4741402|emb|Y18424.1|HA18424[4741402] - 9734: X57250
H. sapiens C5aR mRNA for C5 anaphylatoxin receptor
gi|29569|emb|X57250.1|HSC5AR[29569] - 9735: AF200348
Homo sapiens melanoma-associated antigen MG50 mRNA, partial cds
gi|6273398|gb|AF200348.1|AF200348[6273398] - 9736: AH008357
Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 1
gi|6224699|gb|AH008357.1|SEG_HSCXADR[6224699] - 9737: AF169366
Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 7 and complete cds
gi|6224698|gb|AF169366.1|HSCXADR7[6224698] - 9738: AF169365
Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 6
gi|6224697|gb|AF169365.1|HSCXADR6[6224697] - 9739: AF169364
Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 5
gi|6224696|gb|AF169364.1|HSCXADR5[6224696] - 9740: AF169363
Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 4
gi|6224695|gb|AF169363.1|HSCXADR4[6224695] - 9741: AF169362
Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 3
gi|6224694|gb|AF169362.1|HSCXADR3[6224694] - 9742: AF169361
Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 2
gi|6224693|gb|AF169361.1|HSCXADR2[6224693] - 9743: AF169360
Homo sapiens coxsackievirus B-adenovirus receptor (CAR) gene, exon 1
gi|6224692|gb|AF169360.1|HSCXADR1[6224692] - 9744: AF181862
Homo sapiens G protein-coupled receptor mRNA, complete cds
gi|6175912|gb|AF181862.1|AF181862[6175912] - 9745: AF178632
Homo sapiens FEM-1-like death receptor binding protein mRNA, complete cds
gi|6175868|gb|AF178632.1|AF178632[6175868] - 9755: X80763
Homo sapiens gene for 5-hydroxytrptamine 2C receptor, exons 1 to 4
gi|602872|emb|X80763.1|HS5HT2C[602872] - 9756: X68149
Homo sapiens BLR1 gene for Burkitt's lymphoma receptor 1
gi|29459|emb|X68149.1|HSBLR1A[29459] - 9757: AF187320
Homo sapiens transferrin receptor (TFRC) gene, complete cds
gi|6164847|gb|AF187320.1|AF187320[6164847] - 9758: AF154673
Homo sapiens olfactory receptor HPFH1OR (HPFH1OR) gene, complete cds
gi|5764388|gb|AF154673.1|AF154673[5764388] - 9760: AF169255
Homo sapiens 5-hydroxytryptamine 3 receptor B subunit (5-HTR3B) mRNA, complete
cds
gi|6103620|gb|AF169255.1|AF169255[6103620] - 9762: AJ133107
Homo sapiens CD163 gene, exon 17
gi|5102659|emb|AJ133107.1|HSA133107[5102659] - 9763: Y18403
Homo sapiens CD163 gene, exon 16
gi|5102656|emb|Y18403.1|HSA118403[5102656] - 9764: Y18402
Homo sapiens CD163 gene, exon 15
gi|5102655|emb|Y18402.1|HSA118402[5102655] - 9765: Y18401
Homo sapiens CD163 gene, exon 14
gi|5102654|emb|Y18401.1|HSA118401[5102654] - 9766: Y18400
Homo sapiens CD163 gene, exon 13
gi|5102653|emb|Y18400.1|HSA118400[5102653] - 9767: Y18399
Homo sapiens CD163 gene, exon 12
gi|5102652|emb|Y18399.1|HSA118399[5102652] - 9768: Y18398
Homo sapiens CD163 gene, exon 11
gi|5102651|emb|Y18398.1|HSA118398[5102651] - 9769: Y18397
Homo sapiens CD163 gene, exon 10
gi|5102650|emb|Y18397.1|HSA118397[5102650] - 9770: Y18396
Homo sapiens CD163 gene, exon 9
gi|5102649|emb|Y18396.1|HSA118396[5102649] - 9771: Y18395
Homo sapiens CD163 gene, exon 8
gi|5102648|emb|Y18395.1|HSA118395[5102648] - 9772: Y18394
Homo sapiens CD163 gene, exon 7
gi|5102647|emb|Y18394.1|HSA118394[5102647] - 9773: Y18393
Homo sapiens CD163 gene, exon 6
gi|5102646|emb|Y18393.1|HSA118393[5102646] - 9774: Y18392
Homo sapiens CD163 gene, exon 5
gi|5102645|emb|Y18392.1|HSA118392[5102645] - 9775: Y18391
Homo sapiens CD163 gene, exon 4
gi|5102644|emb|Y18391.1|HSA118391[5102644] - 9776: Y18390
Homo sapiens CD163 gene, exon 3
gi|5102643|emb|Y18390.1|HSA118390[5102643] - 9777: Y18389
Homo sapiens CD163 gene, exon 2
gi|5102642|emb|Y18389.1|HSA118389[5102642] - 9791: AF095725
Homo sapiens PAC LLNLP704E02527Q3 olfactory receptor 17-1 (OR17-1), olfactory receptor 17-2 (OR17-2), olfactory receptor 17-201 (OR17-201), and olfactory receptor 17-93 (OR17-93) genes, complete cds
gi|6090622|gb|AF095725.1|AF095725[6090622] - 9792: AH007997
Homo sapiens prostaglandin E2 receptor EP2 subtype (PTGER2) gene, complete cds
gi|5524234|gb|AH007997.1|SEG_HSPTGER2G[5524234] - 9793: AF134202
Homo sapiens prostaglandin E2 receptor EP2 subtype (PTGER2) gene, alternatively
spliced exons and complete cds
gi|5524233|gb|AF134202.1|HSPTGER2G2[5524233] - 9794: AF134201
Homo sapiens prostaglandin E2 receptor EP2 subtype (PTGER2) gene, exon 1
gi|5524232|gb|AF134201.1|HSPTGER2G1[5524232] - 9797: AF139768
Homo sapiens type II transmembrane protein MDL-1 (MDL1) mRNA, complete cds
gi|6049175|gb|AF139768.1|AF139768[6049175] - 9799: X75318
H. sapiens ITIH1 gene (exon 22) and ITIH3 gene (exon 1 and joining features)
gi|575256|emb|X75318.1|HSITIH[575256] - 9800: AJ245822
Homo sapiens mRNA for type I transmembrane receptor (psk-3 gene)
gi|6018463|emb|AJ245822.1|HSA245822[6018463] - 9801: AJ245820
Homo sapiens mRNA for type I transmembrane receptor (psk-1 gene)
gi|6018459|emb|AJ245820.1|HSA245820[6018459] - 9802: L46722
Homo sapiens BTG1 binding factor 1 (CAF1) mRNA, complete cds
gi|6016011|gb|L46722.1|L46722[6016011] - 9803: X87831
Homo sapiens mRNA for partial OCT/plexin-A2 protein
gi|6010214|emb|X87831.2|HSOCTPROT[6010214] - 9804: AJ000994
Homo sapiens DNA for p58 NK receptor gene
gi|2764562|emb|AJ000994.1|HSP58NK[2764562] - 9805: X84761
H. sapiens LHCGR gene, exon 9
gi|1225992|emb|X84761.1|HSLHCGRX9[1225992] - 9806: X84760
H. sapiens LHCGR gene, exon 8
gi|1225991|emb|X84760.1|HSLHCGRX8[1225991] - 9807: X84759
H. sapiens LHCGR gene, exon 7
gi|1225990|emb|X84759.1|HSLHCGRX7[1225990] - 9808: X84758
H. sapiens LHCGR gene, exon 6
gi|1225989|emb|X84758.1|HSLHCGRX6[1225989] - 9809: X84757
H. sapiens LHCGR gene, exon 5
gi|1225988|emb|X84757.1|HSLHCGRX5[1225988] - 9810: X84756
H. sapiens LHCGR gene, exon 4
gi|1225987|emb|X84756.1|HSLHCGRX4[1225987] - 9811: X84754
H. sapiens LHCGR gene, exon 2
gi|1225985|emb|X84754.1|HSLHCGRX2[1225985] - 9812: X84753
H. sapiens LHCGR gene, exon 1
gi|1225983|emb|X84753.1|HSLHCGRX1[1225983] - 9813: X84763
H. sapiens LHCGR gene, exon 11
gi|1225982|emb|X84763.1|HSLHCGR111[1225982] - 9814: X84762
H. sapiens LHCGR gene, exon 10
gi|1225981|emb|X84762.1|HSLHCGR10[1225981] - 9815: AF140631
Homo sapiens G-protein coupled receptor 14 (GPR14) gene, complete cds
gi|5902615|gb|AF140631.1|AF140631[5902615] - 9816: AF140630
Homo sapiens urotensin-II mRNA, complete cds
gi|5902613|gb|AF140630.1|AF140630[5902613] - 9817: AF040752
Homo sapiens G protein-coupled receptor kinase 6, splice variant C (GRK6) mRNA,
complete cds
gi|3005017|gb|AF040752.1|AF040752[3005017] - 9818: AF040751
Homo sapiens G protein-coupled receptor kinase 6, splice variant B (GRK6) mRNA,
complete cds
gi|3005015|gb|AF040751.1|AF040751[3005015] - 9819: AF040753
Homo sapiens G protein-coupled receptor kinase 6 (GRK6) gene, partial cds
gi|3004990|gb|AF040753.1|AF040753[3004990] - 9820: X87832
Homo sapiens mRNA for partial NOV/plexin-A1 protein
gi|6010216|emb|X87832.2|HSNOVPROT[6010216] - 9821: X87904
Homo sapiens mRNA for semaphorin receptor (plexin-B1/SEP gene)
gi|6010210|emb|X87904.2|HSRNASEP[6010210] - 9822: AJ011415
Homo sapiens mRNA for plexin-B1 plasma membrane receptor, splice variant R (plexin-B1/SEP gene)
gi|5918166|emb|AJ011415.1|HSA011415[5918166] - 9823: AJ011414
Homo sapiens mRNA for plexin-B1 plasma membrane receptor, truncated splice variant (plexin-B1/SEP gene)
gi|5918164|emb|AJ011414.1|HSA011414[5918164] - 9824: X07019
Homo sapiens partial TRDC gene for T-cell receptor delta chain, exon 1
gi|29766|emb|X07019.1|HSCD1G[29766] - 9825: X54559
Homo sapiens mRNA for met proto-oncogene
gi|34557|emb|X54559.1|HSMETPRO[34557] - 9826: AF186380
Homo sapiens calcium-mobilizing lysophosphatidic acid receptor LP-A3/Edg-7 mRNA,
complete cds
gi|6003655|gb|AF186380.1|AF186380[6003655] - 9827: AF147204
Homo sapiens chemokine receptor CXCR4-Lo (CXCR4) mRNA, alternatively spliced, complete cds
gi|6002763|gb|AF147204.1|AF147204[6002763] - 9828: AF029213
Homo sapiens IL-1 receptor accessory protein mRNA, complete cds
gi|2599126|gb|AF029213.1|AF029213[2599126] - 9829: Z24462
H. sapiens MTCP-1 gene
gi|406858|emb|Z24462.1|HSMTCP1B[406858] - 9830: Z24455
H. sapiens MTCP-1 gene
gi|406857|emb|Z24455.1|HSMTCP1A[406857] - 9832: AF124598
Homo sapiens coxsackie and adenovirus receptor protein (HCAR2) mRNA, partial cds
gi|4884701|gb|AF124598.1|AF124598[4884701] - 9833: AF124145
Homo sapiens autocrine motility factor receptor (AMFR) mRNA, complete cds
gi|5931954|gb|AF124145.1|AF124145[5931954] - 9835: AF118637
Homo sapiens feline leukemia virus subgroup C receptor FLVCR(C10) mRNA, complete cds
gi|5565871|gb|AF118637.1|AF118637[5565871] - 9836: AF127138
Homo sapiens lysophosphatidic acid G protein-coupled receptor (EDG7) mRNA, complete cds
gi|5922724|gb|AF127138.1|AF127138[5922724] - 9837: AF104939
Homo sapiens lectomedin-1 gamma (LEC1) mRNA, complete cds
gi|5880493|gb|AF104939.1|AF104939[5880493] - 9838: AF104266
Homo sapiens lectomedin-1 alpha (LEC1) mRNA, complete cds
gi|5880489|gb|AF104266.1|AF104266[5880489] - 9839: X51646
Homo sapiens DRD2 gene for dopamine receptor D2
gi|30868|emb|X51646.1|HSDOPD2GE[30868] - 9840: X51645
Homo sapiens mRNA for dopamine receptor D2 (DRD2 gene)
gi|30867|emb|X51645.1|HSDOPD2[30867] - 9841: AB010447
Homo sapiens mRNA for CC chemokine eotaxin3, complete cds
gi|5921130|dbj|AB010447.1|AB010447[5921130] - 9844: AF137378
Homo sapiens integrin alpha 11 subunit precursor (ITGA11) mRNA, complete cds
gi|5915661|gb|AF137378.2|AF137378[5915661] - 9845: AJ243212
Homo sapiens mRNA for DMBT1 protein 8 kb transcript variant 2 (DMBT1/8 kb.2)
gi|5912463|emb|AJ243212.1|HSA243212[5912463] - 9846: AJ243874
Homo sapiens mRNA for oligophrenin-4 (OPHN4 gene)
gi|5911829|emb|AJ243874.1|HSA243874[5911829] - 9847: AF091352
Homo sapiens vascular permeability factor 148 mRNA, complete cds
gi|5901560|gb|AF091352.1|AF091352[5901560] - 9848: AF159456
Homo sapiens gp-340 variant protein (DMBT1) mRNA, complete cds
gi|5733597|gb|AF159456.1|AF159456[5733597] - 9948: AB023486
Homo sapiens gene for histamine H2 receptor, promoter region and complete cds
gi|5881575|dbj|AB023486.1|AB023486[5881575] - 9949: AF104938
Homo sapiens lectomedin-1 beta (LEC1) mRNA, complete cds
gi|588049|gb|AF104938.1|AF104938[5880491] - 9950: U81379
Homo sapiens interleukin-13 receptor mRNA, complete cds
gi|5870850|gb|U81379.3|HSU81379[5870850] - 9951: AH008056
Homo sapiens galanin receptor (GALR3) gene, complete cds
gi|5870844|gb|AH008056.2|SEG_HSGALR3S[5870844] - 9952: AF129514
Homo sapiens galanin receptor (GALR3) gene, exon 2 and complete cds
gi|5870843|gb|AF129514.2|HSGALR3S2[5870843] - 9953: AF129513
Homo sapiens galanin receptor (GALR3) gene, exon 1
gi|5870842|gb|AF129513.2|HSGALR3S1[5870842] - 9954: AF101472
Homo sapiens G protein-coupled receptor 75 (GPR75) gene, complete cds
gi|4558866|gb|AF101472.1|AF101472[4558866] - 9955: AF072693
Homo sapiens G protein-coupled receptor 75 (GPR75) mRNA, complete cds
gi|4406084|gb|AF072693.1|AF072693[4406084] - 9957: AJ246000
Homo sapiens mRNA for leucocyte adhesion receptor, L-selectin
gi|5852071|emb|AJ246000.1|HSA246000[5852071] - 9959: AJ224864
Homo sapiens mRNA for IRC1 protein
gi|5834585|emb|AJ224864.1|HSA224864[5834585] - 9960: AJ132948
Homo sapiens mRNA for rfg7 protein, partial
gi|5834581|emb|AJ132948.1|HSA132948[5834581] - 9961: AB027464
Homo sapiens FZD10 mRNA for Frizzled-10, complete cds
gi|5834487|dbj|AB027464.1|AB027464[5834487] - 9963: AJ133532
Homo sapiens mRNA for dendritic cell immunoreceptor
gi|5823973|emb|AJ133532.1|HSA133532[5823973] - 9964: AJ223153
Homo sapiens mRNA for activating NK-A1 receptor
gi|5823969|emb|AJ223153.1|HSAJ3153[5823969] - 9965: AB025257
Homo sapiens FCER1B gene for high affinity IgE receptor beta chain, promoter region, partial sequence
gi|5821396|dbj|AB025257.1|AB025257[5821396]
- 9970: Y16434
Homo sapiens mRNA for T-cell receptor beta, clone PPN82
gi|2879843|emb|Y16434.1|HSTCRB82[2879843] - 9971: Y16433
Homo sapiens mRNA for T-cell receptor alpha, clone PPN82
gi|2879842|emb|Y16433.1|HSTCRA82[2879842] - 9972: AF144648
Homo sapiens GABA-A receptor theta (theta) mRNA, complete cds
gi|5764186|gb|AF144648.1|AF144648[5764186] - 9973: AF151104
Homo sapiens T-cell receptor gamma gene sequence
gi|5758137|gb|AF151104.1|AF151104[5758137] - 9974: AF039686
Homo sapiens G-protein coupled receptor GPR34 (GPR34) mRNA, complete cds
gi|5757633|gb|AF039686.1|AF039686[5757633] - 9975: AF000548
Homo sapiens P1 clone DMPC-HFF#1-1075-D9, repeat region
gi|223207|gb|AF000548.1|HSAF000548[2232071] - 9976: X83701
Homo sapiens IGF2R gene (subclone pE3UP)
gi|929648|emb|X83701.1|HSIGF2RX3[929648] - 9977: X83700
Home sapiens IGF2R gene (subclone pEX2)
gi|929646|emb|X83700.1|HSIGF2RX2[929646] - 9978: X83702
Homo sapiens IGF2R gene (subclone pEX3)
gi|929644|emb|X83702.1|HSIGF2R1 3[929644] - 9979: G16210
967A10R CEPH YAC and mega-YAC libraries (DBThompson) Homo sapiens STS genomic clone 967A10, sequence tagged site
gi|1592382|gb|G16210.1|G16210[1592382] - 9980: AH008077
Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, complete cds
gi|5737745|gb|AH008077.1|SEG_HSEDAR[5737745] - 9981: AF130996
Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exon 12 and complete
cds
gi|5737744|gb|AF130996.1|HSEDAR8[5737744] - 9982: AF130995
Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exon 11
gi|5737743|gb|AF130995.1|HSEDAR7[5737743] - 9983: AF130994
Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exon 10
gi|5737742|gb|AF130994.1|HSEDAR6[5737742] - 9984: AF130993
Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exons 7, 8, and 9
gi|573774|gb|AF130993.1|HSEDAR5[5737741] - 9985: AF130992
Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exon 6
gi|5737740|gb|AF130992.1|HSEDAR4[5737740] - 9986: AF130991
Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exon 5
gi|5737739|gb|AF130991.1|HSEDAR3[5737739] - 9987: AF130990
Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exons 2, 3, and 4
gi|5737738|gb|AF130990.1|HSEDAR2[5737738] - 9988: AF130989
Homo sapiens ectodysplasin-A receptor protein (EDAR) gene, exon 1
gi|5737737|gb|AF130989.1|HSEDAR1[5737737] - 9989: AF130988
Homo sapiens ectodysplasin-A receptor protein (EDAR) mRNA, complete cds
gi|5737735|gb|AF130988.1|AF130988[5737735] - 9990: AF033111
Homo sapiens Siva-2 mRNA, complete cds
gi|5737690|gb|AF033111.1|AF033111[5737690] - 9992: AJ238044
Homo sapiens mRNA for bradykinin B1 receptor (BLBKR gene)
gi|5139485|emb|AJ238044.1|HSA238044[5139485] - 9993: X95425
H. sapiens mRNA for EHK-1 receptor tyrosine kinase
gi|1177465|emb|X95425.1|HSEHK1[1177465] - 9995: AF135562
Homo sapiens p58 killer cell inhibitory receptor KIR-K78 (KIR-K78) mRNA, partial
cds
gi|5730925|gb|AF135562.1|AF135562[5730925] - 9996: AF135561
Homo sapiens p58 killer cell inhibitory receptor KIR-K65 (KIR-K65) mRNA, partial
cds
gi|5730923|gb|AF135561.1(AF135561[5730923] - 9997: AF135560
Homo sapiens p58 killer cell inhibitory receptor KIR-K64 (KIR-K64) mRNA, partial
cds
gi|5730921|gb|AF135560.1|AF135560[5730921] - 9998: AF135559
Homo sapiens p58 killer cell inhibitory receptor KIR-K61 (KIR-K61) mRNA, partial
cds
gi|5730919|gb|AF135559.1|AF135559[5730919] - 9999: AF135558
Homo sapiens p58 killer cell inhibitory receptor KIR-K39 (KIR-K39) mRNA, partial
cds
gi|5730917|gb|AF135558.1|AF135558[5730917] - 10000: AF135557
Homo sapiens p58 killer cell inhibitory receptor KIR-K36 (KIR-K36) mRNA, partial
cds
gi|5730915|gb|AF135557.1|AF135557[5730915] - 10001: AF135556
Homo sapiens p58 killer cell inhibitory receptor KIR-K15 (KIR-K15) mRNA, partial
cds
gi|5730913|gb|AF135556.1|AF135556[5730913] - 10002: AF135555
Homo sapiens p58 killer cell inhibitory receptor KIR-K9 (KIR-K9) mRNA, partial
cds
gi|5730911|gb|AF135555.1|AF135555[5730911] - 10003: AF135554
Homo sapiens p58 killer cell inhibitory receptor KIR-K3 (KIR-K3) mRNA, partial
cds
gi|5730909|gb|AF135554.1|AF135554[5730909] - 10004: AF135567
Homo sapiens p58 killer cell inhibitory receptor KIR-K7c mRNA, alternatively spliced, partial cds
gi|5730907|gb|AF135567.1|AF135567[5730907] - 10005: AF135566
Homo sapiens p58 killer cell inhibitory receptor KIR-K7b mRNA, alternatively spliced, partial cds
gi|5730905|gb|AF135566.1|AF135566[5730905] - 10006: AF135565
Homo sapiens p58 killer cell inhibitory receptor KIR-K7a mRNA, alternatively spliced, partial cds
gi|5730903|gb|AF135565.1|AF135565[5730903] - 10007: AF135564
Homo sapiens p50 killer cell activating receptor KAR-K1d mRNA, alternatively spliced, partial cds
gi|5730901|gb|AF135564.1|AF135564[5730901] - 10008: AF135563
Homo sapiens p50 killer cell activating receptor KAR-K1a mRNA, alternatively spliced, partial cds
gi|5730899|gb|AF135563.1|AF135563[5730899] - 10009: AF172932
Homo sapiens MIS type II receptor (MISRII) mRNA, complete cds
gi|5726642|gb|AF172932.1|AF172932[5726642] - 10010: AF162790
Homo sapiens Fc gamma receptor III-A gene, partial cds
gi|5726469|gb|AF162790.1|AF162790[5726469] - 10012: AF161921
Homo sapiens clone G7 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
gi|5712813|gb|AF161921.1|[5712813] - 10013: AF161920
Homo sapiens clone G6 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
gi|5712812|gb|AF161920.1|[5712812] - 10014: AF161919
Homo sapiens clone F4 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
gi|5712811|gb|AF161919.1|[5712811] - 10015: AF161918
Homo sapiens clone F3 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
gi|5712810|gb|AF161918.1|[5712810] - 10016: AF161917
Homo sapiens clone F1.1 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
gi|5712809|gb|AF161917.1|[5712809] - 10017: AF161916
Homo sapiens clone H-JM-2 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
gi|5712808|gb|AF161916.1|[5712808] - 10018: AF161915
Homo sapiens clone JM-1 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
gi|5712807|gb|AF161915.1|[5712807] - 10019: AF161914
Homo sapiens clone 9/8.2 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
gi|5712806|gb|AF161914.1|[5712806] - 10020: AF161913
Homo sapiens clone 6-53 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
gi|5712805|gb|AF161913.1|[5712805] - 10021: AF161912
Homo sapiens clone 5-53 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
gi|5712804|gb|AF161912.1|[5712804] - 10022: AF161911
Homo sapiens clone 4-55 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
gi|5712803|gb|AF161911.1|[5712803] - 10023: AF161910
Homo sapiens clone 4-53 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
gi|5712802|gb|AF161910.1|[5712802] - 10024: AF161909
Homo sapiens clone 3-55 C-C chemokine receptor 5 (CCR5) mRNA, partial cds
gi|5712801|gb|AF161909.1|[5712801] - 10025: E17202
Human cDNA for JEG18 complete cds
gi|5711885|dbj|E17202.1|E17202[5711885] - 10026: E17201
Human mRNA for JEG18 complete cds
gi|5711884|dbj|E17201.1|E17201[5711884] - 10027: E16188
cDNA encoding G protein-coupled receptor
gi|5710871|dbj|E16188.1|E16188[5710871] - 10028: E16187
Partial sequence of cDNA encoding G protein-coupled receptor
gi|5710870|dbj|E16187.1|E16187[5710870] - 10029: E16186
Partial sequence of cDNA encoding G protein-coupled receptor
gi|5710869|dbj|E16186.1|E16186[5710869] - 10030: E16000
EST sequence containing human G protein-coupling receptor gene
gi|5710683|dbj|E6000.1|E16000[5710683] - 10031: E15999
EST sequence containing human G protein-coupling receptor gene
gi|5710682|dbj|E15999.1|E15999[5710682] - 10032: E15998
cDNA encoding G protein-coupling receptor protein
gi|5710681|dbj|E15998.1|E15998[5710681] - 10033: E15997
cDNA encoding human G protein-coupling receptor protein
gi|5710680|dbj|E15997.1|E15997[5710680] - 10034: E15919
cDNA encoding prostaglandin EP3-6 receptor
gi|5710602|dbj|E15919.1|E15919[5710602] - 10035: E15918
cDNA encoding prostaglandin EP3-5 receptor
gi|5710601|dbj|E15918.1|E15918[5710601] - 10037: E15242
Human mRNA for endothelin B receptor, complete cds
gi|5709925|dbj|E15242.1|E15242[5709925] - 10038: E14946
Human mRNA for adrenaline beta 3 receptor
gi|5709629|dbj|E14946.1|E14946[5709629] - 10039: E14587
Human mRNA isoform fragment for Vitamin D receptor
gi|5709270|dbj|E14587.1|E14587[5709270] - 10040: E14586
Human mRNA isoform fragment for Vitamin D receptor
gi|5709269|dbj|E14586.1|E14586[5709269] - 10041: E14585
Human mRNA isoform for Vitamin D receptor
gi|5709268|dbj|E14585.1|E14585[5709268] - 10042: E14219
Partial sequence of human cDNA encoding a G protein-coupled receptor, 63A2full
gi|5708902|dbj|E14219.1|E14219[5708902] - 10043: E14218
Partial sequence of human cDNA encoding a G protein-coupled receptor, 63A2full
gi|5708901|dbj|E14218.1|E14218[5708901] - 10044: E14217
Human mRNA for a G protein-coupled receptor, 63A2full, complete cds
gi|5708900|dbj|E14217.1|E14217[5708900] - 10046: X83699
Homo sapiens IGF2R gene (subclone pEX1-P)
gi|1006660|emb|X83699.1|HSIGF2RX1[1006660] - 10048: AF007790
Homo sapiens ICERE-1 mRNA, complete cds
gi|5670325|gb|AF007790.2|AF007790[5670325] - 10054: AF036718
Homo sapiens FGFR signalling adaptor SNT-2 mRNA, complete cds
gi|2708629|gb|AF036718.1|AF036718[2708629] - 10056: AF099033
Homo sapiens gamma-aminobutyric acid type B receptor 2 (GABABR2) mRNA, complete
cds
gi|5639666|gb|AF099033.1|AF099033[5639666] - 10057: AF009221
Homo sapiens leucocyte immunoglobulin-like receptor-1 mRNA, complete cds
gi|2267169|gb|AF009221.1|AF009221[2267169] - 10058: AF009220
Homo sapiens leucocyte immunoglobulin-like receptor-1 mRNA, complete cds
gi|2267167|gb|AF009220.1|AF009220[2267167] - 10059: AF067864
Homo sapiens transferrin receptor 2 alpha (TFR2) mRNA, complete cds
gi|5596369|gb|AF067864.1|AF067864[5596369] - 10061: AF040257
Homo sapiens TNF receptor homolog mRNA, partial cds
gi|3170220|gb|AF040257.1|AF040257[3170220] - 10062: AF026245
Homo sapiens yotiao mRNA, complete cds
gi|2623067|gb|AF026245.1|AF026245[2623067] - 10064: AF163302
Homo sapiens somatostatin receptor interacting protein splice variant a (SSTRIP)
mRNA, complete cds
gi|5533304|gb|AF163302.1|AF163302[5533304] - 10065: AF153500
Homo sapiens mu opioid receptor (MOR1) gene, partial cds
gi|5524612|gb|AF153500.1|AF153500[5524612] - 10066: AH007996
Homo sapiens NK receptor Ly-49L gene, complete cds
gi|5524171|gb|AH007996.1|SEG_HSLY49L[5524171] - 10067: AF126038
Homo sapiens NK receptor Ly-49L gene, pseudoexon 7
gi|5524170|gb|AF126038.1|HSLY49L3[5524170] - 10068: AF126037
Homo sapiens NK receptor Ly-49L gene, exon 5, pseudoexon 6, and complete cds
gi|5524169|gb|AF126037.1|HSLY49L2[5524169] - 10069: AF126036
Homo sapiens NK receptor Ly-49L gene, exons 1 through 4
gi|5524168|gb|AF126036.1|HSLY49L1[5524168] - 10070: AF081675
Homo sapiens ITIM-containing receptor MAFA-L mRNA, complete cds
gi|3421400|gb|AF081675.1|AF081675[3421400] - 10071: AF145782
Homo sapiens 2B4 type I transmembrane protein mRNA, complete cds
gi|5059179|gb|AF145782.1|AF145782[5059179] - 10072: AH007960
Homo sapiens receptor tyrosine kinase (EPHAL) gene, complete cds
gi|5453121|gb|AH007960.1|SEG_HSEPHAI[5453121] - 10073: AF101171
Homo sapiens receptor tyrosine kinase (EPHAL) gene, exon 18 and complete cds
gi|5453120|gb|AF101171.1|HSEPHA17[5453120] - 10074: AF101170
Homo sapiens receptor tyrosine kinase (EPHAL) gene, exon 17
gi|5453119|gb|AF101170.1|HSEPHA16[5453119] - 10075: AF101169
Homo sapiens receptor tyrosine kinase (EPHAL) gene, exons 12 through 16
gi|5453118|gb|AF101169.1|HSEPHA15[5453118] - 10076: AF101168
Homo sapiens receptor tyrosine kinase (EPHAL) gene, exons 4 through 11
gi|5453117|gb|AF101168.1|HSEPHA14[5453117] - 10077: AF101167
Homo sapiens receptor tyrosine kinase (EPHAL) gene, exon 3
gi|5453116|gb|AF101167.1|HSEPHA13[5453116] - 10078: AF101166
Homo sapiens receptor tyrosine kinase (EPHAL) gene, exon 2
gi|5453115|gb|AF101166.1|HSEPHA12[5453115] - 10079: AF101165
Homo sapiens receptor tyrosine kinase (EPHAL) gene, exon 1
gi|5453114|gb|AF101165.1|HSEPHA11[5453114] - 10080: AF107761
Homo sapiens NK cell receptor (2B4) mRNA, complete cds
gi|5442467|gb|AF107761.2|AF107761[5442467] - 10081: AF109127
Homo sapiens stromal cell-derived receptor-1 alpha mRNA, complete cds
gi|5442037|gb|AF109127.1|AF109127[5442037] - 10082: AF109126
Homo sapiens stromal cell-derived receptor-1 beta mRNA, complete cds
gi|5442035|gb|AF109126.1|AF109126[5442035] - 10084: Y17131
Homo sapiens FGFR2 gene, exon 7 and exon 8 (partial)
gi|3077606|emb|Y17131.1|HSY17131[3077606] - 10085: X57829
H. sapiens serotonin 5-HT1a receptor gene
gi|36428|emb|X57829.1|HSSERR51[36428] - 10086: AF100762
Homo sapiens thyroid receptor interactor trip15 mRNA, complete cds
gi|5410309|gb|AF100762.1|TRIP15[5410309] - 10087: AF109388
Homo sapiens P2X2B receptor mRNA, complete cds
gi|5381338|gb|AF109388.1|AF109388[5381338] - 10088: AF109387
Homo sapiens P2X2A receptor mRNA, complete cds
gi|5381336|gb|AF109387.1|AF109387[5381336] - 10089: AF118108
Homo sapiens lymphatic endothelium-specific hyaluronan receptor LYVE-1 mRNA, complete cds
gi|5359672|gb|AF118108.1|AF118108[5359672] - 10090: AF119711
Homo sapiens cysLT1 LTD4 receptor (CYSLT1) mRNA, complete cds
gi|5353886|gb|AF119711.1|AF119711[5353886] - 10091: X72861
H. sapiens gene for beta-3-adrenergic receptor
gi|298094|emb|X72861.1|HSB3A[298094] - 10092: AF103906
Homo sapiens vanilloid receptor-like protein (VRL) mRNA, complete cds
gi|5305597|gb|AF103906.1|AF103906[5305597] - 10093: AF072873
Homo sapiens frizzled 6 mRNA, complete cds
gi|5305408|gb|AF072873.1|AF072873[5305408] - 10095: AF153437
Homo sapiens haplotype val92met/A942G melanocortin 1 receptor (MC1R) gene, complete cds
gi|5257473|gb|AF153437.1|AF153437[5257473] - 10096: AF153436
Homo sapiens haplotype A942G melanocortin 1 receptor (MC1R) gene, complete cds
gi|5257472|gb|AF153436.1|AF153436[5257472] - 10097: AF153435
Homo sapiens haplotype arg67gln/arg163gln melanocortin 1 receptor (MC1R) gene,
complete cds
gi|525747|gb|AF153435.1|AF153435[5257471] - 10098: AF153434
Homo sapiens haplotype arg163gln melanocortin 1 receptor (MC1R) gene, complete
cds
gi|5257470|gb|AF153434.1|AF153434[5257470] - 10099: AF153433
Homo sapiens haplotype arg151cys melanocortin 1 receptor (MC1R) gene, complete
cds
gi|5257469|gb|AF153433.1|AF153433[5257469] - 10100: AF153432
Homo sapiens haplotype asp84glu melanocortin 1 receptor (MC1R) gene, complete cds
gi|5257468|gb|AF153432.1|AF153432[5257468] - 10101: AF153431
Homo sapiens melanocortin 1 receptor (MC1R) gene, complete cds
gi|5257467|gb|AF153431.1|AF153431[5257467] - 10103: AH007879
Homo sapiens macrophage receptor (MARCO) gene, complete cds
gi|5231091|gb|AH007879.1|SEG_HSMARCO[5231091] - 10104: AF128186
Homo sapiens macrophage receptor (MARCO) gene, exon 17 and complete cds
gi|5231090gb|AF128186.1|HSMARCO15[5231090] - 10105: AF128185
Homo sapiens macrophage receptor (MARCO) gene, exon 16
gi|5231089|gb|AF128185.1|HSMARCO14[5231089] - 10106: AP128184
Homo sapiens macrophage receptor (MARCO) gene, exon 15
gi|5231088|gb|AF128184.1|HSMARCO13[5231088] - 10107: AF128183
Homo sapiens macrophage receptor (MARCO) gene, exon 14
gi|5231087|gb|AF128183.1|HSMARCO12[5231087] - 10108: AF128182
Homo sapiens macrophage receptor (MARCO) gene, exon 13
gi|5231086|gb|AF128182.1|HSMARCO11[5231086] - 10109: AF128181
Homo sapiens macrophage receptor (MARCO) gene, exons 11 and 12
gi|5231085|gb|AF128181.1|HSMARCO10[5231085] - 10110: AF128180
Homo sapiens macrophage receptor (MARCO) gene, exons 9 and 10
gi|5231084|gb|AF128180.1|HSMARCO09[5231084] - 10111: AF128179
Homo sapiens macrophage receptor (MARCO) gene, exon 8
gi|5231083|gb|AF128179.1|HSMARCO08[5231083] - 10112: AF128178
Homo sapiens macrophage receptor (MARCO) gene, exon 7
gi|5231082|gb|AF128178.1|HSMARCO07[5231082] - 10113: AF128177
Homo sapiens macrophage receptor (MARCO) gene, exon 6
gi|5231081|gb|AF128177.1|HSMARCO06[5231081] - 10114: AF128176
Homo sapiens macrophage receptor (MARCO) gene, exon 5
gi|5231080|gb|AF128176.1|HSMARCO05[5231080] - 10115: AF128175
Homo sapiens macrophage receptor (MARCO) gene, exon 4
gi|5231079|gb|AF128175.1|HSMARCO04[5231079] - 10116: AF128174
Homo sapiens macrophage receptor (MARCO) gene, exon 3
gi|5231078|gb|AF128174.1|HSMARCO03[5231078] - 10117: AF128173
Homo sapiens macrophage receptor (MARCO) gene, exon 2
gi|5231077|gb|AF128173.1|HSMARCO02[5231077] - 10118: AF128172
Homo sapiens macrophage receptor (MARCO) gene, exon 1
gi|5231076|gb|AF128172.1|HSMARCO01[5231076] - 10140: D50855
Human mRNA for Ca-sensing receptor, complete cds
gi|904209|dbj|D50855.1|HUMCASR[904209] - 10141: D49783
Human gene for histamine H2 receptor, complete cds
gi|728495|dbj|D49783.1|HUMHH2R[728495] - 10142: D16826
Human gene for fourth somatostatin receptor subtype
gi|693907|dbj|D16826.1|HUMSSTR4[693907] - 10143: D29984
Human mRNA for monocyte chemoattractant protein 1 receptor (MCP-1 receptor), complete cds
gi|531246|dbj|D529984.1|HUMMCP1R[531246] - 10144: D14436
Human gene for histamine H1-receptor, complete cds
gi|506335|dbj|D514436.1|HUMHH1RE[506335] - 10145: D16827
Human gene for fifth somatostatin receptor subtype
gi|487683|dbj|D516827.1|HUMSSTR5[487683] - 10146: D14717
Human mRNA for large erk kinase
gi|285916|dbj|D514717.1|HUMERK[285916] - 10147: AF073515
Homo sapiens cytokine type 1 receptor CRLP-1 precursor, mRNA, complete cds
gi|5106394|gb|AF073515.1|AF073515[5106394] - 10148: AH007696
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, partial cds; fibroblast growth factor receptor 2 Ksam IV secreted isoform (FGFR2) gene, complete cds; fibroblast growth factor receptor (FGFR2) gene, alternative splice
products, partial cds; and fibroblast growth factor receptor 2 (FGFR2) gene, partial cds
gi|4808621|gb|AH007696.1|SEG_HSFGFR2A[4808621] - 10149: AF097354
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 20, alternative splice products and partial cds
gi|4808620|gb|AF097354.1|HSFGFR2A19[4808620] - 10150: AF097353
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 19, alternative splice products and partial cds
gi|4808619|gb|AF097353.1|HSFGFR2A18[4808619] - 10151: AF097352
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 18
gi|4808618|gb|AF097352.1|HSFGFR2A17[4808618] - 10152: AF097351
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 17
gi|4808617|gb|AF097351.1|HSFGFR2A16[4808617] - 10153: AF097350
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 16
gi|4808616|gb|AF097350.1|HSFGFR2A15[4808616] - 10154: AF097349
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 15
gi|4808615|gb|AF097349.1|HSFGFR2A14[4808615] - 10155: AF097348
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 14
gi|4808614|gb|AF097348.1|HSFGFR2A13[4808614] - 10156: AF097347
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 13
gi|4808613|gb|AF097347.1|HSFGFR2A12[4808613] - 10157: AF097346
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 12
gi|4808612|gb|AF097346.1|HSFGFR2A11[4808612] - 10158: AF097345
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exons 11 and 11′
gi|4808611|gb|AF097345.1|HSFGFR2A10[4808611] - 10159: AF097344
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 10
gi|4808610|gb|AF097344.1|HSFGFR2A09[4808610] - 10160: AF097343
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 9
gi|4808609|gb|AF097343.1|HSFGFR2A08[4808609] - 10161: AF097342
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 8
gi|4808608|gb|AF097342.1|HSFGFR2A07[4808608] - 10162: AF097341
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exons 6 and 7, alternative splice products and partial cds
gi|4808607|gb|AF097341.1|HSFGFR2A06[4808607] - 10163: AF097340
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 5, alternative splice products and partial cds
gi|4808606|gb|AF097340.1|HSFGFR2A05[4808606] - 10164: AF097339
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 4
gi|4808605|gb|AF097339.1|HSFGFR2A04[4808605] - 10165: AF097338
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 3
gi|4808604|gb|AF097338.1|HSFGFR2A03[4808604] - 10166: AF097337
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 2
gi|4808603|gb|AF097337.1|HSFGFR2A02[4808603] - 10167: AF097336
Homo sapiens fibroblast growth factor receptor 2 (FGFR2) gene, exon 1
gi|4808602|gb|AF097336.1|HSFGFR2A01[4808602] - 10168: U58146
Homo sapiens alternatively spliced interleukin-6 receptor beta chain mRNA, partial cds
gi|2253597|gb|U58146.1|HSU58146[2253597] - 10169: AF134395
Homo sapiens CARD-like apoptotic protein (CLAP) mRNA, complete cds
gi|5070371|gb|AF134395.1|AF134395[5070371] - 10170: AF015044
Homo sapiens EH-binding protein mRNA, partial cds
gi|4102712|gb|AF015044.1|AF015044[4102712] - 10171: AF015043
Homo sapiens EH-binding protein mRNA, partial cds
gi|4102710|gb|AF015043.1|AF015043[4102710] - 10172: AF145207
Homo sapiens CCR9 chemokine receptor (CCR9) mRNA, partial cds
gi|5052417|gb|AF145207.1|AF145207[5052417] - 10173: AB018549
Homo sapiens MD-2 mRNA, complete cds
gi|5051739|dbj|AB018549.1|AB018549[5051739] - 10174: AH007443
Homo sapiens chromosome 19 clone cosmid R31931 map 19q13.4
gi|4322573|gb|AH007443.1|SEG_HSCD89S[4322573] - 10175: AF091544
Homo sapiens myeloid FcalphaRI (CD89) gene, 3′ sequence
gi|4322572|gb|AF091544.1|HSCD89S2[4322572] - 10177: AF152962
Homo sapiens somatostatin receptor type 5 (SSTR5) gene, promoter region and partial cds
gi|5031446|gb|AF152962.1|AF152962[5031446] - 10178: AF140538
Homo sapiens histamine H3 receptor mRNA, complete cds
gi|5031290|gb|AF140538.1|AF140538[5031290] - 10179: AJ238896
Homo sapiens partial RAGE gene, exons 9 to 11
gi|4867820|emb|AJ238896.1|HSA238896[4867820] - 10180: AF039904
Homo sapiens cosmid D56B10, chromosome 21 5′ of IFNAR1
gi|2853622|gb|AF039904.1|AF039904[2853622] - 10181: AF039905
Homo sapiens cosmid Q95D4, chromosome 21 5′ of IFNAR2
gi|2766549|gb|AF039905.1|AF039905[2766549] - 10182: AF039907
Homo sapiens cosmid Q50G2, chromosome 21 3′ of IFNAR1
gi|2754858|gb|AF039907.1|AF039907[2754858] - 10183: AB020807
Homo sapiens mRNA for TLR6, complete cds
gi|5006247|dbj|AB020807.1|AB020807[5006247] - 10184: AF144308
Homo sapiens putative G protein-coupled receptor (DL1R) mRNA, complete cds
gi|4959876|gb|AF144308.1|AF144308[4959876] - 10185: AF107262
Homo sapiens central cannabinoid receptor (CB1K5) mRNA, complete cds
gi|4959366|gb|AF107262.1|AF107262[4959366] - 10263: AH007742
Homo sapiens neuronal acetylcholine receptor beta-3 subunit precursor (CHRNB3)
gene, complete cds
gi|4927249|gb|AH007742.1|SEG_HSCHRNB[4927249] - 10264: AF140765
Homo sapiens neuronal acetylcholine receptor beta-3 subunit precursor (CHRNB3)
gene, exon 6 and complete cds
gi|4927248|gb|AF140765.1|HSCHRNB6[4927248] - 10265: AF140764
Homo sapiens neuronal acetylcholine receptor beta-3 subunit precursor (CHRNB3)
gene, exon 5
gi|4927247|gb|AF140764.1|HSCHRNB5[4927247] - 10266: AF140763
Homo sapiens neuronal acetylcholine receptor beta-3 subunit precursor (CHRNB3)
gene, exon 4
gi|4927246|gb|AF140763.1|HSCHRNB4[4927246] - 10267: AF140762
Homo sapiens neuronal acetylcholine receptor beta-3 subunit precursor (CHRNB3)
gene, exon 3
gi|4927245|gb|AF140762.1|HSCHRNB3[4927245] - 10268: AF140761
Homo sapiens neuronal acetylcholine receptor beta-3 subunit precursor (CHRNB3)
gene, exon 2
gi|49272441gb|AF140761.1|HSCHRNB2[4927244] - 10269: AF140760
Homo sapiens neuronal acetylcholine receptor beta-3 subunit precursor (CHRNB3)
gene, exon 1
gi|4927243|gb|AF140760.1|HSCHRNB1[4927243] - 10270: U19261
Homo sapiens Epstein-Barr virus-induced protein mRNA, complete cds
gi|675461|gb|U19261.1|HSU19261[675461] - 10272: AF105261
Homo sapiens natural killer cell receptor 2B4 mRNA, complete cds
gi|4894519|gb|AF105261.1|AF105261[4894519] - 10273: AH007727
Homo sapiens prolactin receptor gene, complete cds
gi|4886767|gb|AH007727.1|SEG_HSPLR[4886767] - 10274: AF091870
Homo sapiens prolactin receptor gene, alternatively spliced, exon 10 and complete cds
gi|4886766|gb|AF091870.1|HSPLR12[4886766] - 10275: AF091869
Homo sapiens prolactin receptor gene, exon 9
gi|4886765|gb|AF091869.1|HSPLR11[4886765] - 10276: AF091868
Homo sapiens prolactin receptor gene, exon 8
gi|4886764|gb|AF091868.1|HSPLR10[4886764] - 10277: AF091867
Homo sapiens prolactin receptor gene, exon 7
gi|4886763|gb|AF091867.1|HSPLR09[4886763] - 10278: AF091866
Homo sapiens prolactin receptor gene, exon 6
gi|4886762|gb|AF091866.1|HSPLR08[4886762] - 10279: AF091865
Homo sapiens prolactin receptor gene, exon 5
gi|4886761|gb|AF091865.1|HSPLR07[4886761] - 10280: AF091864
Homo sapiens prolactin receptor gene, exon 4
gi|4886760|gb|AF091864.1|HSPLR06[4886760] - 10281: AF091863
Homo sapiens prolactin receptor gene, exon 3
gi|4886759|gb|AF091863.1|HSPLR05[4886759] - 10282: AF091862
Homo sapiens prolactin receptor gene, exon 2
gi|4886758|gb|AF091862.1|HSPLR04[4886758] - 10283: AF091859
Homo sapiens prolactin receptor gene, promoter region and alternative exons 1
gi|4886757|gb|AF091859.1|HSPLR01[4886757] - 10284: AJ132337
Homo sapiens mRNA for chemokine receptor CCR9
gi|4886431|emb|AJ132337.1|HSA132337[4886431] - 10285: AF120152
Mus musculus cytokine receptor-like molecule 9 (Creme9) mRNA, complete cds
gi|4884628|gb|AF120152.1|AF120152[4884628] - 10286: AF120151
Homo sapiens cytokine receptor-like molecule 9 (CREME9) mRNA, complete cds
gi|4884626|gb|AF120151.1|AF120151[4884626] - 10287: D13814
Homo sapiens mRNA for angiotensin II type 1b receptor, complete cds
gi|471120|dbj|D13814.1|HUMAGRT1B[471120] - 10288: AJ236922
Homo sapiens mRNA for metabotropic glutamate receptor 8c
gi|4456479|emb|AJ236922.1|HSA236922[4456479] - 10289: AJ236921
Homo sapiens mRNA for metabotropic glutamate receptor 8b
gi|4456477|emb|AJ236921.1HSA236921[4456477] - 10478: AF106858
Homo sapiens G-protein-coupled receptor (GPR56) mRNA, complete cds
gi|4836764|gb|AF106858.1|AF106858[4836764] - 10479: AF095784
Homo sapiens GABA-B receptor R2 (GABBR2) mRNA, complete cds
gi|4836217|gb|AF095784.1|AF095784[4836217] - 10500: AJ006520
Homo sapiens mRNA for m1 muscarinic acetylcholine receptor protein, partial
gi|3292964|emb|AJ006520.1|HSA6520[3292964] - 10693: AF110907
Homo sapiens TNF-receptor associated factor-3 (TRAF-3) gene, exons 1a and 1b, complete sequence
gi|4761208|gb|AF110907.1|AF110907[4761208] - 10694: AJ002425
Homo sapiens mRNA for p65 protein
gi|4753767|emb|AJ002425.2|HSAJ2425[4753767] - 10697: Y15220
Homo sapiens mRNA for chemokine IP-9
gi|4225953|emb|Y15220.1|HSCHIP9RN[4225953] - 10698: AJ005282
Homo sapiens mRNA for NPR-B1
gi|3059110|emb|AJ005282.1|HSAJ5282[3059110] - 10699: AJ012188
Homo sapiens mRNA for GABAB receptor, subunit 2
gi|3776097|emb|AJ012188.1|HSA012188[3776097] - 10700: AJ012187
Homo sapiens mRNA for GABAB receptor, subunit 1c,
gi|3776095|emb|AJ012187.1|HSA012187[3776095] - 10701: AJ012186
Homo sapiens mRNA for GABAB receptor, subunit 1b
gi|3776093|emb|AJ012186.1|HSA012186[3776093] - 10702: AJ012185
Homo sapiens mRNA for GABAB-receptor, subunit 1a
gi|3776072|emb|AJ012185.1|HSA012185[3776072] - 10704: AF129112
Homo sapiens vanilloid receptor-like protein 1 (VRL-1) mRNA, complete cds
gi|4589140|gb|AF129112.1|AF129112[4589140] - 10705: AF068265
Homo sapiens monocyte chemoattractant protein 1 receptor (CCR2) gene promoter and mRNA, partial sequence
gi|4587865|gb|AF068265.1|AF068265[4587865] - 10706: AB020625
Homo sapiens mRNA for butyrophilin like receptor, complete cds
gi|4587208|dbj|AB020625.1|AB020625[4587208] - 10709: AH007576
Homo sapiens killer cell inhibitory receptor G9P gene, complete cds
gi|4581764|gb|AH007576.1|SEG_HSKIRG9P[4581764] - 10710: AF110035
Homo sapiens killer cell inhibitory receptor G9P gene, complete cds
gi|4581763|gb|AF110035.1|HSKIRG9P4[4581763] - 10711: AF110034
Homo sapiens killer cell inhibitory receptor G9P gene, partial sequence
gi|4581762|gb|AF110034.1|HSKIRG9P3[4581762] - 10712: AF110033
Homo sapiens killer cell inhibitory receptor G9P gene, partial sequence
gi|4581761|gb|AF110033.1HSKIRG9P2[4581761] - 10713: AF110032
Homo sapiens killer cell inhibitory receptor G9P gene, partial sequence
gi|4581760|gb|AF110032.1|HSKIRG9 P1[4581760] - 10714: AF114165
Homo sapiens endothelin receptor B delta 3 mRNA, complete cds
gi|4580923|gb|AF114165.1|AF114165[4580923] - 10717: AF105999
Homo sapiens acetylcholine receptor epsilon subunit (CHRNE) gene, complete cds
gi|4580858|gb|AF105999.1|AF105999[4580858] - 10718: AH007573
Homo sapiens killer inhibitory receptor 1 (KIR1) gene, complete cds; and kill inhibitory receptor 2 (KIR2) gene, partial cds
gi|4580703|gb|AH007573.1|SEG_HS2KIR[4580703] - 10720: AF134316
Homo sapiens killer inhibitory receptor 4-1-2 (KIR412) gene, exon 5 and partial
cds
gi|4580701|gb|AF134316.1|SEG_HS2KIR7[4580701] - 10721: AF134315
Homo sapiens killer inhibitory receptor 4-1-2 (KIR412) gene, exon 4
gi|4580700|gb|AF134315.1|SEG_HS2KIR6[4580700] - 10723: AF134313
Homo sapiens killer inhibitory receptor 4-1-2 (KIR412) gene, exon 2 and pseudoexon 3
gi|4580698|gb|AF134313.1|SEG_HS2KIR4[4580698] - 10724: AF134312
Homo sapiens killer inhibitory receptor 4-1-1 (KIR411) gene, exons 7, 8 and 9
and partial cds; killer inhibitory receptor 4-1-2 (KIR412) gene, exon 1
gi|4580697|gb|AF134312.1|SEG_HS2KIR3[4580697] - 10725: AF134311
Homo sapiens killer inhibitory receptor 4-1-1 (KIR411) gene, exon 6
gi|4580696|gb|AF134311.1|SEG_HS2KIR2[4580696] - 10727: AH007572
Homo sapiens killer inhibitory receptor (KIR) gene, partial cds
gi|4580693|gb|AH007572.1|SEG_HSKIRP[4580693] - 10728: AF133900
Homo sapiens killer inhibitory receptor cl 2-3 (KIRCL23) gene, exons 7, 8, and 9
and partial cds
gi|4580692|gb|AF133900.1|HSKIRP5[4580692] - 10729: AF133899
Homo sapiens killer inhibitory receptor cl 2-3 (KIRCL23) gene, exon 6
gi|4580691|gb|AF133899.1|HSKIRP4[4580691] - 10730: AF133898
Homo sapiens killer inhibitory receptor cl 2-3 (KIRCL23) gene, exon 5
gi|4580690|gb|AF133898.1|HSKIRP3[4580690] - 10731: AF133897
Homo sapiens killer inhibitory receptor cl 2-3 (KIRCL23) gene, exon 4
gi|4580689|gb|AF133897.1|HSKIRP2[4580689] - 10732: AF133896
Homo sapiens killer inhibitory receptor cl 2-3 (KIRCL23) gene, pseudoexon 3
gi|4580688|gb|AF133896.1|HSKIRP1[4580688] - 10733: AF133901
Homo sapiens killer inhibitory receptor 2-2-1 (KIR221) and killer inhibitory receptor 2-2-2 (KIR222) genes, partial cds
gi|4580682|gb|AF133901.1|AF133901[4580682] - 10736: AF069755
Homo sapiens orphan G protein-coupled receptor HG20 (HG20) mRNA, complete cds
gi|4091932|gb|AF069755.1|AF069755[4091932] - 10738: AC007229
Homo sapiens chromosome 19, cosmid R34187, complete sequence
gi|4567173|gb|AC007229.1|AC007229[4567173] - 10740: AF125303
Homo sapiens glucocorticoid-induced TNFR-related protein ligand (TNFSF18) mRNA,
complete cds
gi|4558500|gb|AF125303.1|AF125303[4558500] - 10742: AF058762
Homo sapiens galanin receptor subtype 2 (GALNR2) gene, complete cds
gi|3170598|gb|AF058762.1|AF058762[3170598] - 10743: AF096786
Homo sapiens chromosome 2 G protein-coupled receptor (GPR55) gene, complete cds
gi|4545136|gb|AF096786.1|AF096786[4545136] - 10745: AF096784
Homo sapiens chromosome 1 G protein-coupled receptor (GPR52) gene, complete cds
gi|4545133|gb|AF096784.1|AF096784[4545133] - 10746: AF119815
Homo sapiens G-protein coupled receptor (NPGPR) mRNA, complete cds
gi|4530468|gb|AF119815.1|AF119815[4530468] - 10749: AF098664
Homo sapiens olfactory receptor-like protein (OR2C1) gene, complete cds
gi|3982606|gb|AF098664.1|AF098664[3982606] - 10752: AF090131
Homo sapiens clone b312C2EN9 LDL receptor-related protein 6 gene, partial cds,
and CpG island sequence
gi|4494988|gb|AF090131.1|AF090131[4494988] - 10778: X95583
H. sapiens mRNA for monocyte chemotactic protein-1 (MCP-1) receptor
gi|4468944|emb|X95583.1|HSMCP1REC[4468944] - 10791: AJ131757
Homo sapiens olr1 gene
gi|4468343|emb|AJ131757.1|HSA131757[4468343] - 10792: X58674
H. sapiens RNA for receptor for C5a anaphylatoxin
gi|29568|emb|X58674.1|HSC5ANAPL[29568] - 10793: U51134
Homo sapiens calcitonin gene-related peptide receptor component protein mRNA, complete cds
gi|4097252|gb|U51134.1|HSU51134[4097252] - 10794: Y13464
Homo sapiens mRNA for cholecystokinin B receptor
gi|3287189|emb|Y13464.1|HSY13464[3287189] - 10795: Z66558
H. sapiens FAS/Apo1 gene (Del B1 mutation; partial)
gi|150414|embo Z66558.1|HSFASAPOC[1150414] - 10796: Z66557
H. sapiens of FAS/Apo1 gene (partial)
gi|150413|emb|Z66557.1|HSFASAPOB[1150413] - 10797: Z66556
H. sapiens FASExo8Del mRNA
gi|11150412emb|Z66556.1|HSFASAPOA[1150412] - 10825: AF118266
Homo sapiens orphan G protein-coupled receptor GPR45 (GPR45) gene, complete cds
gi|4455062|gb|AF118266.1|AF118266[4455062] - 10826: AF118265
Homo sapiens orphan G protein-coupled receptor GPR44 (GPR44) gene, complete cds
gi|4455060|gb|AF118265.1|AF118265[4455060] - 10827: Y18046
Homo sapiens mRNA for FOP (FGFR1 oncogene partner)
gi|4454262|emb|Y18046.1|HSAY18046[4454262] - 10828: AJ006276
Homo sapiens mRNA for transient receptor potential protein TRP6
gi|4454260|emb|AJ006276.1|HSAJ6276[4454260] - 10829: M13918
Homo sapiens fibronectin receptor alpha-subunit precursor (ITGA5) mRNA, partial
cds
gi|4464190|gb|M13918.2|HUMFNRAS[4464190] - 10831: D13515
Homo sapiens mRNA for key subunit of N-methyl-D-aspartate receptor, complete cds
gi|219919|dbj|D13515.1|HUMMARR[219919] - 10832: D10583
Homo sapiens mRNA for IgE receptor beta subunit, complete cds
gi|219881|dbj|D10583.1|HUMIGERB[219881] - 10834: AH007490
Homo sapiens gibbon ape leukemia virus receptor 1 (SLC20A1) gene, partial cds
gi|4416260|gb|AH007490.1|SEG_HSGLVR1G[4416260] - 10835: AF102063
Homo sapiens gibbon ape leukemia virus receptor 1 (SLC20A1) gene, exon 11 and complete cds
gi|4416259|gb|AF102063.1|HSGLVR1G5[4416259] - 10836: AF102062
Homo sapiens gibbon ape leukemia virus receptor 1 (SLC20A1) gene, exons 7 through 10
gi|4416258|gb|AF102062.1|HSGLVR1G4[4416258] - 10837: AF102061
Homo sapiens gibbon ape leukemia virus receptor 1 (SLC20A1) gene, exon 6
gi|4416257|gb|AF102061.1|HSGLVR1G3[4416257] - 10838: AF102060
Homo sapiens gibbon ape leukemia virus receptor 1 (SLC20A1) gene, exon 5
gi|4416256|gb|AF102060.1|HSGLVR1G2[4416256] - 10839: AF102059
Homo sapiens gibbon ape leukemia virus receptor 1 (SLC20A1) gene, exons 1 through 4
gi|4416255|gb|AF102059.1|HSGLVR1G1[4416255] - 10840: AF098798
Homo sapiens unknown mRNA
gi|4416073|gb|AF098798.1|AF098798[4416073] - 10841: AF118670
Homo sapiens orphan G protein-coupled receptor (GPR34) gene, complete cds
gi|4325085|gb|AF118670.1|AF118670[4325085] - 10842: AF053072
Homo sapiens GABA subunit A receptor alpha 6 precursor, gene, partial cds
gi|4405812|gb|AF053072.1|AF053072[4405812] - 10843: AF052539
Homo sapiens chemokine receptor 5 (CCR5) gene, CCR5—CYS allele, complete cds
gi|4337455|gb|AF052539.1|AF052539[4337455] - 10844: AF117713
Homo sapiens AITR ligand (TL6) mRNA, complete cds
gi|4378801|gb|AF117713.1|AF117713[4378801] - 10845: AF117297
Homo sapiens TNF receptor superfamily activation-inducible protein mRNA, complete cds
gi|4378799|gb|AF117297.1|AF117297[4378799] - 10974: Z29585
H. sapiens gene for high affinity IgE receptor alpha chain
gi|452350|emb|Z29585.1|HSHAIGER[452350] - 10975: AF050154
Homo sapiens clone F19374 APO E-C2 gene cluster, complete sequence
gi|4105701|gb|AF050154.1|AF050154[4105701] - 10981: X97881
H. sapiens mRNA for G protein coupled receptor kinase, GRK4D
gi|1770427|emb|X97881.1|HSGRK4D[1770427] - 10982: X97880
H. sapiens mRNA for G protein coupled receptor kinase, GRK4C
gi|1770425|emb|X97880.1|HSGRK4C[1770425] - 10983: X97879
H. sapiens mRNA for G protein coupled receptor kinase, GRK4B
gi|1770423|emb|X97879.1|HSGRK4B[1770423] - 10984: AJ007787
Homo sapiens CHRNA3 gene, exon 6, partial
gi|4164387|emb|AJ007787.1|HSA7787[4164387] - 10985: AJ007786
Homo sapiens CHRNA3 gene, exon 5
gi|4164386|emb|AJ007786.1|HSA7786[4164386] - 10986: AJ007785
Homo sapiens CHRNA3 gene, exon 4
gi|4164383|emb|AJ007785.1|HSA7785[4164383] - 10987: AJ007784
Homo sapiens CHRNA3 gene, exons 2 to 3
gi|4164382|emb|AJ007784.1|HSA7784[4164382] - 10988: AJ007783
Homo sapiens CHRNA3 gene, exon 1 and joined CDS
gi|4164380|emb|AJ007783.1|HSA7783[4164380] - 10989: AJ001939
Homo sapiens CHRNB2 gene, exon 6
gi|3766463|emb|AJ001939.1|HSAJ1939[3766463] - 10990: AJ001938
Homo sapiens CHRNB2 gene, exon 5
gi|3766454|emb|AJ001938.1|HSAJ1938[3766454] - 10991: AJ001937
Homo sapiens CHRNB2 gene, exon 4
gi|3766453|emb|AJ001937.1|HSAJ1937[3766453] - 10992: AJ001936
Homo sapiens CHRNB2 gene, exon 2 and exon 3
gi|3766452|emb|AJ001936.1|HSAJ1936[3766452] - 10993: AJ001935
Homo sapiens CHRNB2 gene, exon 1 (and joined CDS)
gi|3766450|emb|AJ001935.1|HSAJ1935[3766450] - 10998: AJ003147
Homo sapiens complete genomic sequence between D16S3070 and D16S3275, containing
Familial Mediterranean Fever gene disease
gi|2808656|emb|AJ003147.1|HSAJ03147[2808656] - 11000: AJ225029
Homo sapiens mRNA for GABA-B R1b receptor
gi|3892873|emb|AJ225029.1|HSA225029[3892873] - 11004: AJ003147
Homo sapiens complete genomic sequence between D16S3070 and D16S3275, containing
Familial Mediterranean Fever gene disease
gi|2808656|emb|AJ003147.1|HSAJ03147[2808656] - 11006: AJ225029
Homo sapiens mRNA for GABA-B R1b receptor
gi|3892873|emb|AJ225029.1|HSA225029[3892873] - 11007: AJ225028
Homo sapiens mRNA for GABA-B R1a receptor
gi|3892593|emb|AJ225028.1|HSA225028[3892593] - 11092: AJ132194
Homo sapiens olfr89 gene
gi|4160227|emb|AJ132194.1|HSA132194[4160227] - 11093: AJ012753
Homo sapiens RAGE gene (partial), exon 2
gi|4034482|emb|AJ012753.1|HSA012753[4034482] - 11094: AJ012332
Homo sapiens IL-1R gene cluster PAC contig, centromeric STS, sequence tagged site
gi|4128031|emb|AJ012332.1|HSA012332[4128031] - 11095: AJ012331
Homo sapiens IL-1R gene cluster PAC contig, telomeric STS, sequence tagged site
gi|4128030|emb|AJ012331.1|HSA012331[4128030] - 11097: AJ011701
Homo sapiens TRHR gene promoter and exons 1-2, partial
gi|4128016|emb|AJ011701.1|HSA011701[4128016] - 11098: AJ010191
Homo sapiens gababr1 receptor gene, exon 18
gi|3980509|emb|AJ010191.1|HSA010191[3980509] - 11099: AJ010190
Homo sapiens gababr1 receptor gene, exon 17
gi|3980507|emb|AJ010190.1|HSA010190[3980507] - 11100: AJ010189
Homo sapiens gababr1 receptor gene, exon 16
gi|3980504|emb|AJ010189.1|HSA010189[3980504] - 11101: AJ010188
Homo sapiens gababr1 receptor gene, exon 15
gi|3980502|emb|AJ010188.1|HSA010188[3980502] - 11102: AJ010187
Homo sapiens gababr1 receptor gene, exon 14
gi|3980500|emb|AJ010187.1|HSA010187[3980500] - 11103: AJ010186
Homo sapiens gababr1 receptor gene, exon 13
gi|3980498|emb|AJ010186.1|HSA010186[3980498] - 11104: AJ010185
Homo sapiens gababr1 receptor gene, exon 12
gi|3980496|emb|AJ010185.1|HSA010185[3980496] - 11105: AJ010184
Homo sapiens gababr1 receptor gene, exon 11
gi|3980494|emb|AJ010184.1|HSA010184[3980494] - 11106: AJ010183
Homo sapiens gababr1 receptor gene, exon 10
gi|3980492|emb|AJ010183.1|HSA010183[3980492] - 11107: AJ010182
Homo sapiens gababr1 receptor gene, exon 9
gi|3980490|emb|AJ010182.1|HSA010182[3980490] - 11108: AJ010181
Homo sapiens gababr1 receptor gene, exon 8
gi|3980488|emb|AJ010181.1|HSA010181[3980488] - 11109: AJ010180
Homo sapiens gababr1 receptor gene, exon 7
gi|3980486|emb|AJ010180.1|HSA010180[3980486] - 11110: AJ010179
Homo sapiens gababr1 receptor gene, exon 6
gi|3980484|emb|AJ010179.1|HSA010179[3980484] - 11111: AJ010178
Homo sapiens gababr1 receptor gene, exon 5
gi|3980482|emb|AJ010178.1|HSA010178[3980482] - 11112: AJ010177
Homo sapiens gababr1 receptor gene, exon 4
gi|3980481|emb|AJ010177.1|HSA010177[3980481] - 11113: AJ010176
Homo sapiens gababr1 receptor gene, exon 3
gi|3980480|emb|AJ010176.1|HSA010176[3980480] - 11114: AJ010175
Homo sapiens gababr1 receptor gene, exon 2
gi|3980479|emb|AJ010175.1|HSA010175[3980479] - 11115: AJ010174
Homo sapiens gababr1 receptor gene, exon 1
gi|3980477|emb|AJ010174.1|HSA010174[3980477] - 11116: AJ010173
Homo sapiens gababr1 receptor gene, exon 1a4
gi|3980475|emb|AJ010173.1|HSA010173[3980475] - 11117: AJ010172
Homo sapiens gababr1 receptor gene, exon 1a3
gi|3980472|emb|AJ010172.1|HSA010172[3980472] - 11118: AJ010171
Homo sapiens gababr1 receptor gene, exon 1a2
gi|3980469|emb|AJ010171.1|HSA10171[3980469] - 11119: AJ010170
Homo sapiens gababr1 receptor gene, exon 1a1
gi|3980465|emb|AJ010170.1|HSA10170[3980465] - 11121: AF061022
Homo sapiens CTH gene, complete cds
gi|4335930|gb|AF061022.1|AF061022[4335930] - 11122: AF052041
Homo sapiens olfactory receptor gene cluster, complete sequence
gi|4335873|gb|AF052041.1|AF052041[4335873] - 11124: AC006953
Homo sapiens chromosome 19, cosmid R28316, complete sequence
gi|4335701|gb|AC006953.1|AC006953[4335701]
- 11125: AF105367
Homo sapiens glucagon-like peptide-2 receptor precursor (GLP2R) mRNA, complete
cds
gi|4324490|gb|AF105367.1|AF105367[4324490] - 11434: AH007439
Homo sapiens chromosome X
gi|4322454|gb|AH007439.1|SEG_HSIL2RGIN[4322454] - 11435: AF085452
Homo sapiens interleukin-2 receptor gamma chain (IL2RG) gene, intron 5, partial
sequence
gi|4322453|gb|AF085452.1|HSIL2RGIN2[4322453] - 11436: AF085451
Homo sapiens interleukin-2 receptor gamma chain (IL2RG) gene, intron 4, partial
sequence
gi|4322452|gb|AF085451.1|HSIL2RGIN1[4322452] - 11437: AF065213
Homo sapiens advanced glycosylation end product-specific receptor (RAGE) gene,
intron 3, partial sequence
gi|4321945|gb|AF065213.1|AF065213[4321945] - 11438: AF065212
Homo sapiens patient M1 advanced glycosylation end product-specific receptor (RAGE) gene, exon 3 and partial cds
gi|4321943|gb|AF065212.1|AF065212[4321943] - 11439: AF065211
Homo sapiens patient M21 advanced glycosylation end product-specific receptor (RAGE) gene, exon 3 and partial cds
gi|4321941|gb|AF065211.1|AF065211[4321941] - 11440: AF065210
Homo sapiens patient M20 advanced glycosylation end product-specific receptor (RAGE) gene, exon 3 and partial cds
gi|4321939|gb|AF0652101.1|AF065210[4321939] - 11441: AF051305
Homo sapiens beta chemokine receptor (CCR1) gene, promoter region and exon 1
gi|4321648|gb|AF051305.1|AF051305[4321648] - 11442: U87223
Homo sapiens contactin associated protein (Caspr) mRNA, complete cds
gi|1857707|gb|U87223.1|HSU87223[1857707] - 11443: AF022386
Homo sapiens p53-regulated DNA damage-inducible cell death receptor (killer) mRNA, complete cds
gi|2460427|gb|AF022386.1|AF022386[2460427] - 11444: AF011368
Homo sapiens CEV14 mRNA, partial cds
gi|2618824|gb|AF011368.1|AF011368[2618824] - 11445: AF016267
Homo sapiens TRAIL receptor 3 mRNA, complete cds
gi|2529564|gb|AF016267.1|AF016267[2529564] - 11446: AF020502
Homo sapiens cytotoxic TRAIL receptor-3 (TRAIL-R3) mRNA, complete cds
gi|2443819|gb|AF020502.1|AF020502[2443819] - 11447: AF020501
Homo sapiens cytotoxic TRAIL receptor-2 (DR5) mRNA, complete cds
gi|2443817|gb|AF020501.1|AF020501[2443817] - 11454: AF075460
Homo sapiens type 1-like ryanodine receptor mRNA, partial cds
gi|3328200|gb|AF075460.1|AF075460[3328200] - 11455: AF054830
Homo sapiens interleukin-1 type I receptor mRNA, partial sequence
gi|3003026|gb|AF054830.1|AF054830[3003026] - 11456: AF099082
Homo sapiens xenotropic and polytropic murine retrovirus receptor (XPR1) mRNA,
complete cds
gi|4176765|gb|AF099082.1|AF099082[4176765] - 11501: AF089744
Homo sapiens xenotropic and polytropic murine leukemia virus receptor (X3) mRNA,
complete cds
gi|4154282|gb|AF089744.1|AF089744[4154282] - 11502: AF001095
Homo sapiens receptor for advanced glycation end products (RAGE) gene, promoter
region and exon 1
gi|3093415|gb|AF001095.1|AF001095[3093415] - 11503: AF101784
Homo sapiens b-TRCP variant E3RS-IkappaB mRNA, partial cds
gi|4165135|gb|AF101784.1|AF101784[4165135] - 11504: AF080586
Homo sapiens galanin receptor type 2 (GALR2) mRNA, complete cds
gi|4165080|gb|AF080586.1|AF080586[4165080] - 11505: U71374
Homo sapiens HsPex13p mRNA, complete cds
gi|3738269|gb|U71374.1|HSU71374[3738269] - 11506: AF111116
Homo sapiens silencer of death domains (SODD) mRNA, complete cds
gi|4160013|gb|AF111116.1|AF111116[4160013] - 11507: AF110314
Homo sapiens herpesvirus immunoglobulin-like receptor HIgR mRNA, complete cds
gi|4154345|gb|AF110314.1|AF110314[4154345] - 11518: AF069543
Homo sapiens IL-3/IL-5/GM-CSFR receptor beta chain promoter and exon 1 sequence
gi|4071316|gb|AF069543.1|AF069543[4071316] - 11519: U81262
Homo sapiens LERK5 (LERK5) mRNA, complete cds
gi|1809333|gb|U81262.1|HSU81262[1809333] - 11520: AF097358
Homo sapiens mast cell function-associated antigen homolog (MAFA) mRNA, complete
cds
gi|4139191|gb|AF097358.1|AF097358[4139191] - 11521: AF029761
Homo sapiens decoy receptor 2 mRNA, complete cds
gi|4106963|gb|AF029761.1|AF029761[4106963] - 11522: AF074483
Homo sapiens GABA-B receptor 2 mRNA, complete cds
gi|4107511|gb|AF074483.1|AF074483[4107511] - 11523: AC006293
Homo sapiens chromosome 19, cosmid F15658, complete sequence
gi|4106979|gb|AC006293.1|AC006293[4106979] - 11524: AF104419
Homo sapiens decoy receptor 3 (DcR3) mRNA, complete cds
gi|4106877|gb|AF104419.1|AF104419[4106877] - 11525: AF046059
Homo sapiens cytokine receptor related protein 4 (CYTOR4) mRNA, complete cds
gi|4105471|gb|AF046059.1|AF046059[4105471] - 11526: AF041262
Homo sapiens immunoglobulin-like transcript 8 mRNA, complete cds
gi|4104892|gb|AF041262.1|AF041262[4104892] - 11527: AF041261
Homo sapiens immunoglobulin-like transcript 7 mRNA, complete cds
gi|4104890|gb|AF041261.1|AF041261[4104890] - 11528: AH007196
Homo sapiens transforming growth factor-beta type I receptor gene, exon 6
gi|4104446|gb|AH007196.1|SEG_HSTGFRBI[4104446] - 11529: AF035670
Homo sapiens transforming growth factor-beta type I receptor gene, exon 9, and
complete cds
gi|4104445|gb|AF035670.1|HSTGFRBI9[4104445] - 11530: AF035669
Homo sapiens transforming growth factor-beta type I receptor gene, exon 8
gi|4104444|gb|AF035669.1|HSTGFRBI8[4104444] - 11531: AF035668
Homo sapiens transforming growth factor-beta type I receptor gene, exon 7
gi|4104443|gb|AF035668.1|HSTGFRBI7[4104443] - 11532: AF035667
Homo sapiens transforming growth factor-beta type I receptor gene, exon 6
gi|4104442|gb|AF035667.1|HSTGFRBI6[4104442] - 11533: AF035666
Homo sapiens transforming growth factor-beta type I receptor gene, exon 5
gi|4104441|gb|AF035666.1|HSTGFRBI5[4104441] - 11534: AF035665
Homo sapiens transforming growth factor-beta type I receptor gene, exon 4
gi|4104440|gb|AF035665.1|HSTGFRBI4[4104440] - 11535: AF035664
Homo sapiens transforming growth factor-beta type I receptor gene, exon 3
gi|4104439|gb|AF035664.1|HSTGFRBI3[4104439] - 11536: AF035663
Homo sapiens transforming growth factor-beta type I receptor gene, exon 2
gi|4104438|gb|AF035663.1|HSTGFRBI2[4104438] - 11537: AF035662
Homo sapiens transforming growth factor-beta type I receptor gene, exon 1
gi|4104437|gb|AF035662.1|HSTGFRBI1[4104437] - 11538: AF037332
Homo sapiens Eph-like receptor tyrosine kinase hEphB1b (EphB1) mRNA, complete cds
gi|4104412|gb|AF037332.1|AF037332[4104412] - 11539: AF037331
Homo sapiens Eph-like receptor tyrosine kinase hEphB1 (EphB1) mRNA, complete cds
gi|4104410|gb|AF037331.1|AF037331[4104410] - 11543: AH007119
Homo sapiens killer cell inhibitory receptor KIRC1 gene, complete cds
gi|3776473|gb|AH007119.1|SEG_HSKIRCI[3776473] - 11544: AF072410
Homo sapiens killer cell inhibitory receptor KIRC1 gene, exons 6, 7 and 8 and complete cds
gi|3776472|gb|AF072410.1|HSKIRCI4[3776472] - 11545: AF072409
Homo sapiens killer cell inhibitory receptor KIRCI gene, exon 5
gi|3776471|gb|AF072409.1|HSKIRCI3[3776471] - 11546: AF072408
Homo sapiens killer cell inhibitor receptor KIRCI gene, exons 2, 3, and 4
gi|3776470|gb|AF072408.1|HSKIRCI2[3776470] - 11547: AF072407
Homo sapiens killer cell inhibitory receptor KIRCI gene, exon 1
gi|3776469|gb|AF072407.1|HSKIRCI1[3776469] - 11548: AH007118
Homo sapiens immunoglobulin-like transcript 10 protein gene, complete cds
gi|3776467|gb|AH007118.1|SEG_HSILTX[3776467] - 11549: AF072101
Homo sapiens immunoglobulin-like transcript 10 protein gene, exons 7 and 8
and
complete cds
gi|3776466|gb|AF072101.1|HSILTX2[3776466] - 11550: AF072100
Homo sapiens immunoglobulin-like transcript 10 protein gene, exons 1 through
gi|3776465|gb|AF072100.1|HSILTX1[3776465] - 11551: AF072099
Homo sapiens immunoglobulin-like transcript 3 protein variant 1 gene, complete
cds
gi|3776463|gb|AF072099.1|AF072099[3776463] - 11553: AF106941
Homo sapiens beta-arrestin 2 mRNA, complete cds
gi|4092782|gb|AF106941.1|AF106941[4092782] - 11554: AF104304
Homo sapiens Smad anchor for receptor activation (SARA) mRNA, complete cds
gi|4092766|gb|AF104304.1|AF104304[4092766] - 11555: AF034780
Homo sapiens lysosphingolipid receptor Edg5 mRNA, complete cds
gi|4090955|gb|AF034780.1|AF034780[4090955] - 11556: AF109401
Homo sapiens neurotrophic factor artemin precursor (ARTN) mRNA, complete cds
gi|4071352|gb|AF109401.1|AF109401[4071352] - 11557: AF099148
Homo sapiens GABA-B1a receptor mRNA, complete cds
gi|4063891|gb|AF099148.1|AF099148[4063891] - 11558: AF095448
Homo sapiens putative G protein-coupled receptor (RAIG1) mRNA, complete cds
gi|4063889|gb|AF095448.1|AF095448[4063889] - 11559: L34689
Homo sapiens somatostatin receptor isoform 2 (SSTR2) gene, partial cds
gi|598233|gb|L34689.1|HUMSOREC2X[598233] - 11560: AF100161
Homo sapiens folate receptor type gamma′ gene, partial cds
gi|4063392|gb|AF100161.1|AF100161[4063392] - 11561: AF082076
Homo sapiens luteinizing hormone receptor (LHR) gene, partial cds
gi|4063365|gb|AF082076.1|AF082076[4063365] - 11562: AC006132
Homo sapiens chromosome 19, cosmid R28204, complete sequence
gi|3970930|gb|AC006132.1|AC006132[3970930] - 11563: AH007081
Homo sapiens lectin-type oxidized LDL receptor (OLR1) gene, complete cds
gi|4050003|gb|AH007081.1|SEG_HSOLR[4050003] - 11564: AF079167
Homo sapiens lectin-type oxidized LDL receptor (OLR1) gene, exons 4, 5, and 6, and complete cds
gi|4050002|gb|AF079167.1|HSOLR4[4050002] - 11565: AF079166
Homo sapiens lectin-type oxidized LDL receptor (OLR1) gene, exon 3
gi|4050001|gb|AF079166.1|HSOLR3[4050001] - 11566: AF079165
Homo sapiens lectin-type oxidized LDL receptor (OLR1) gene, exon 2
gi|4050000|gb|AF079165.1|HSOLR2[4050000] - 11567: AF079164
Homo sapiens lectin-type oxidized LDL receptor (OLR1) gene, exon 1
gi|4049999|gb|AF079164.1|HSOLR1[4049999] - 11568: AF099083
Homo sapiens growth hormone secretagogue receptor gene, 5′ flanking region and
partial cds
gi|4039145|gb|AF099083.1|AF099083[4039145] - 11569: AF058390
Homo sapiens neurotrophin 3 receptor truncated isoform (NTRK3) mRNA, partial cds
gi|4027932|gb|AF058390.1|AF058390[4027932] - 11570: AF058389
Homo sapiens neurotrophin 3 receptor (NTRK3) mRNA, partial cds
gi|4027930|gb|AF058389.1|AF058389[4027930] - 11877: AF029839
Homo sapiens alpha 7 neuronal nicotinic receptor mRNA sequence
gi|3757794|gb|AF029839.1|AF029839[3757794] - 11878: AF029838
Homo sapiens alpha 7 neuronal nicotinic receptor mRNA sequence
gi|3757793|gb|AF029838.1|AF029838[3757793] - 11880: AH007062
Homo sapiens galanin receptor (GALNR), complete cds
gi|3064074|gb|AH007062.1|SEG_HSGALNRS[3064074] - 11881: U90660
Homo sapiens galanin receptor (GALNR) gene, exon 3 and complete cds
gi|3064073|gb|U90660.1|HSGALNRS3[3064073] - 11882: U90659
Homo sapiens galanin receptor (GALNR) gene, exon 2
gi|3064072|gb|U90659.1|HSGALNRS2[3064072] - 11883: U90658
Homo sapiens galanin receptor (GALNR) gene, exon 1
gi|3064071|gb|U90658.1|HSGALNRS1[3064071] - 11884: AF041474
Homo sapiens BAF53a (BAF53a) mRNA, complete cds
gi|4001802|gb|AF041474.1|AF041474[4001802] - 11886: AF097942
Homo sapiens monocyte antigen CD14 precursor (CD14) mRNA, complete cds
gi|3983126|gb|AF097942.1|AF097942[3983126] - 11887: AH007044
Homo sapiens growth factor receptor (GRB10) gene, alternative splice products,
complete cds
gi|3982774|gb|AH007044.1|SEG_HSGRB[3982774] - 11904: AF084941
Homo sapiens pre-T cell receptor alpha chain 1 precursor, gene, complete cds
gi|3978459|gb|AF084941.1|AF084941[3978459] - 11905: AH007043
Homo sapiens interleukin-7 receptor precursor (IL7R), complete cds
gi|3978161|gb|AH007043.1|SEG_HSIL7R[3978161] - 11906: AF043129
Homo sapiens interleukin-7 receptor precursor (IL7R) gene, exons 7 and 8 and complete cds
gi|3978160|gb|AF043129.1|HSIL7R7[3978160] - 11907: AF043128
Homo sapiens interleukin-7 receptor precursor (IL7R) gene, exon 6
gi|3978159|gb|AF043128.1|HSIL7R6[3978159] - 11908: AF043127
Homo sapiens interleukin-7 receptor precursor (IL7R) gene, exon 5
gi|3978158|gb|AF043127.1|HSIL7R5[3978158] - 11909: AF043126
Homo sapiens interleukin-7 receptor precursor (IL7R) gene, exon 4
gi|3978157|gb|AF043126.1|HSIL7R4[3978157] - 11910: AF043125
Homo sapiens interleukin-7 receptor precursor (IL7R) gene, exon 3
gi|3978156|gb|AF043125.1|HSIL7R3[3978156] - 11911: AF043124
Homo sapiens interleukin-7 receptor precursor (IL7R) gene, exon 2
gi|3978155|gb|AF043124.1|HSIL7R2[3978155] - 11912: AF043123
Homo sapiens interleukin-7 receptor precursor (IL7R) gene, exon 1
gi|3978154|gb|AF043123.1|HSIL7R1[3978154] - 11913: AH007033
Homo sapiens prostanoid FP receptor (PTGFR), partial cds
gi|3941539|gb|AH007033.1|SEG_HSPTF2AGR[3941539] - 11914: AF068679
Homo sapiens prostanoid FF receptor gene, exon and partial cds
gi|3941538|gb|AF068679.1|HSPTF2AGR4[3941538] - 11915: AF068678
Homo sapiens prostanoid FP receptor (PTGFR) gene, exon
gi|3941537|gb|AF068678.1|HSPTF2AGR3[3941537] - 11916: AF068677
Homo sapiens prostanoid FP receptor (PTGFR) gene, exon and partial 5′UTR
gi|3941536|gb|AF068677.1|HSPTF2AGR2[3941536] - 11917: AF068676
Homo sapiens prostanoid FP receptor (PTGFR) gene, exon
gi|3941535|gb|AF068676.1|HSPTF2AGR1[3941535] - 11918: AF035776
Homo sapiens oxidized low-density lipoprotein receptor mRNA, complete cds
gi|3941299|gb|AF035776.1|AF035776[3941299] - 11920: AF091501
Homo sapiens receptor protein patched 2 (PTCH2) mRNA, complete cds
gi|3929234|gb|AF091501.1|AF091501[3929234] - 11953: X98174
H. sapiens mRNA for MACH-alpha-3 protein
gi|3928273|emb|X98174.1|HSMACHA3[3928273] - 11955: X68990
Homo sapiens CR2 mRNA for complement receptor
gi|3928195|emb|X68990.1|HSCR2AA[3928195] - 11956: X63128
H. sapiens mRNA for activin receptor
gi|3928172|emb|X63128.1|HSACTREC[3928172] - 11958: AF074397
Homo sapiens anti-mullerian hormone type II receptor (AMHR2) gene, promoter region and partial cds
gi|3916231|gb|AF074397.1|AF074397[3916231] - 11959: U72648
Homo sapiens alpha2-C4-adrenergic receptor gene, complete cds
gi|3914602|gb|U72648.1|HSU72648[3914602] - 11960: Y10148
H. sapiens mRNA for NTR2 receptor
gi|3901027|emb|Y10148.1|HSNTR2REC[3901027] - 11961: Y12476
Homo sapiens putative GPR37 gene (exon 1 and joined CDS)
gi|2570029|emb|Y12476.1|HSY12476[2570029] - 11962: AJ000479
Homo sapiens mRNA for putative G-protein coupled receptor, EDG6
gi|3805931|emb|AJ000479.1|HSEDG4[3805931] - 11963: Y12477
Homo sapiens putative GPR37 gene, exon 2
gi|2570031|emb|Y12477.1|HSY12477[2570031] - 11964: X04329
Homo sapiens mRNA fragment for receptor-like furin
gi|31479|emb|X04329.1|HSFUR1[31479] - 11965: AH007002
Homo sapiens chromosome 1 map 1q12-q13
gi|3892221|gb|AH007002.1|SEG_HSM1MUSR[3892221] - 11966: AF091493
Homo sapiens M1 muscarinic receptor gene, exons 2 and 3
gi|3892220|gb|AF091493.1|HSM1MUSR2[3892220] - 11967: AF091492
Homo sapiens M1 muscarinic receptor gene, promoter region and exon 1
gi|3892219|gb|AF091492.1|HSM1MUSR1[3892219] - 12129: AF077820
Homo sapiens LDL receptor member LR3 mRNA, complete cds
gi|3831747|gb|AF077820.1|AF077820[3831747] - 12130: AF055992
Homo sapiens Duffy antigen/chemokine receptor (FY) gene, FY*X allele,
complete cds
gi|3659623|gb|AF055992.1|AF055992[3659623] - 12131: U58675
Homo sapiens Chromosome 17 p13 Cosmid Clone cos39, complete sequence
gi|3849817|gb|U58675.1|U58675[3849817] - 12132: AF077346
Homo sapiens interleukin-18 receptor accessory protein-like mRNA, complete cds
gi|3851059|gb|AF077346.1|AF077346[3851059] - 12136: Z17227
Homo sapiens mRNA for transmebrane receptor protein
gi|393378|emb|Z17227.1|HSTRECP[393378] - 12137: AF082742
Homo sapiens CC chemokine receptor 5 (CCR5) gene, promoter region and partial sequence
gi|3561057|gb|AF082742.1|AF082742[3561057] - 12139: Z34897
H. sapiens mRNA for H1 histamine receptor
gi|510295|emb|Z34897.1|HSHISTR1[510295] - 12140: X76786
H. sapiens histamine H1 receptor gene
gi|442517|emb|X76786.1|HSHISH1[442517] - 12141: AC005933
Homo sapiens chromosome 19, cosmid F15472, complete sequence
gi|3845348|gb|AC005933.1|AC005933[3845348] - 12142: AF094755
Homo sapiens glycine receptor beta subunit precursor (GLRB), variant B mRNA, complete cds
gi|3834636|gb|AF094755.1|AF094755[3834636] - 12143: AF094754
Homo sapiens glycine receptor beta subunit precursor (GLRB), variant A mRNA, complete cds
gi|3834634|gb|AF094754.1|AF094754[3834634] - 12144: AF091512
Homo sapiens familial Mediterranean fever locus genomic sequence
gi|3834584|gb|AF091512.1|AF091512[3834584] - 12145: AF065876
Homo sapiens olfactory receptor (OR2D2) gene, partial cds
gi|3831618|gb|AF065876.1|AF065876[3831618] - 12147: AF065874
Homo sapiens olfactory receptor (OR10A1) gene, partial cds
gi|3831615|gb|AF065874.1|AF065874[3831615] - 12151: AF065870
Homo sapiens olfactory receptor (OR6A1) gene, complete cds
gi|38316100gb|AF065870.1|AF065870[3831610] - 12158: AF065863
Homo sapiens olfactory receptor (OR5F1) gene, partial cds
gi|3831602|gb|AF065863.1|AF065863[3831602] - 12160: AF065861
Homo sapiens olfactory receptor (OR5D4) gene, partial cds
gi|3831599|gb|AF065861.1|AF06S861[3831599] - 12161: AF065860
Homo sapiens olfactory receptor (OR5D3) gene, partial cds
gi|3831597|gb|AF065860.1|AF065860[3831597] - 12170: AH006968
Homo sapiens
gi|2828129|gb|AH006968.1|SEG_HSCRFR[2828129] - 12171: AF039523
Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 14 and complete cds
gi|2828128|gb|AF039523.1|HSCRFR14[2828128] - 12172: AF039522
Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 13
gi|2828127|gb|AF039522.1|HSCRFR13[2828127] - 12173: AF039521
Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 12
gi|2828126|gb|AF039521.1|HSCRFR12[2828126] - 12174: AF039520
Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 11
gi|2828125|gb|AF039520.1|HSCRFR11[2828125] - 12175: AF039519
Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 10
gi|2828124|gb|AF039519.1|HSCRFR10[2828124] - 12176: AF039518
Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 9
gi|2828123|gb|AF039518.1|HSCRFR09[2828123] - 12177: AF039517
Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 8
gi|2828122|gb|AF039517.1|HSCRFR08[2828122] - 12178: AF039516
Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 7
gi|2828121|gb|AF039516.1|HSCRFR07[2828121] - 12179: AF039515
Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 6
gi|28281201gb|AF039515.1|HSCRFR06[2828120] - 12180: AF039514
Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 5
gi|2828119|gb|AF039514.1|HSCRFR05[2828119] - 12181: AF039513
Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 4
gi|2828118|gb|AF039513.1|HSCRFR04[2828118] - 12182: AF039512
Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 3
gi|2828117|gb|AF039512.1|HSCRFR03[2828117] - 12183: AF039511
Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 2
gi|2828116|gb|AF039511.1|HSCRFR02[2828116] - 12184: AF039510
Homo sapiens corticotropin-releasing factor type 1 receptor gene, exon 1
gi|2828115|gb|AF039510.1|HSCRFR01[2828115] - 12185: AF030186
Homo sapiens glypican-4 (GPC4) mRNA, complete cds
gi|3831546|gb|AF030186.1|AF030186[3831546] - 12206: AJ006353
Homo sapiens mRNA for ephrin-A4 protein, soluble form
gi|3821236|emb|AJ006353.1|HSA6353[3821236] - 12212: AF055634
Homo sapiens transmembrane receptor UNC5C (UNC5C) mRNA, complete cds
gi|3789764|gb|AF055634.1|AF055634[3789764] - 12227: AH006936
Homo sapiens activin receptor type IIB (ACVR2B), complete cds
gi|3769442|gb|AH006936.1|SEG_HSACVR2B[3769442] - 12228: AF060202
Homo sapiens activin receptor type IIB (ACVR2B) gene, exon 11 and complete cds
gi|3769441|gb|AF060202.1|HSACVR2B4[3769441] - 12229: AF060201
Homo sapiens activin receptor type IIB (ACVR2B) gene, exons 8, 9, and 10
gi|3769440|gb|AF060201.1|HSACVR2B3[3769440] - 12230: AF060200
Homo sapiens activin receptor type IIB (ACVR2B) gene, exons 2 through 7
gi|3769439|gb|AF060200.1|HSACVR2B2[3769439] - 12231: AF060199
Homo sapiens activin receptor type IIB (ACVR2B) gene, exon 1
gi|3769438|gb|AF060199.1|HSACVR2B[3769438] - 12232: AF037646
Homo sapiens alpha-7 neuronal nicotinic acetylcholine receptor precursor RNA, partial sequence
gi|3757808|gb|AF037646.1|AF037646[3757808] - 12233: AF036903
Homo sapiens alpha-7 neuronal nicotinic acetylcholine receptor mRNA, alternatively spliced, partial sequence
gi|3757807|gb|AF036903.1|AF036903[3757807] - 12234: AH006931
Homo sapiens lipoprotein receptor-related protein (LRP1) gene, complete cds
gi|3493575|gb|AH006931.1|SEG_HSLRPSS[3493575] - 12235: AF058427
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 80 through 89 and complete cds
gi|3493574|gb|AF058427.1|HSLRPSS61[3493574] - 12236: AF058426
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 78 and 79
gi|3493573|gb|AF058426.1|HSLRPSS59[3493573] - 12237: AF058425
Homo sapiens lipoprotein receptor-related protein (LRP1), exon 77
gi|3493572|gb|AF058425.1|HSLRPSS57[3493572] - 12238: AF058424
Homo sapiens lipoprotein receptor-related protein (LRP1), exon 76
gi|3493571|gb|AF058424.1|HSLRPSS55[3493571]
- 12239: AF058423
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 71 through 75
gi|3493570|gb|AF058423.1|HSLRPSS53[3493570] - 12240: AF058422
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 61 through 70
gi|3493569|gb|AF058422.1|HSLRPSS51[3493569] - 12241: AF058421
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 59 and 60
gi|3493568|gb|AF058421.1|HSLRPSS49[3493568] - 12242: AF058420
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 56, 57, and
gi|3493567|gb|AF058420.1|HSLRPSS47[3493567] - 12243: AF058419
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 45 through 55
gi|3493566|gb|AF058419.1|HSLRPSS45[3493566] - 12244: AF058418
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 43 and 44
gi|3493565|gb|AF058418.1|HSLRPSS43[3493565] - 12245: AF058417
Homo sapiens lipoprotein receptor-related protein (LRP1), exon 42
gi|3493564|gb|AF058417.1|HSLRPSS41[3493564] - 12246: AF058416
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 39, 40, and
gi|3493563|gb|AF058416.1|HSLRPSS39[3493563] - 12247: AF058415
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 36, 37, and
gi|3493562|gb|AF058415.1|HSLRPSS37[3493562] - 12248: AF058414
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 27 through 34
gi|3493561|gb|AF058414.1|HSLRPSS35[3493561] - 12249: AF058413
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 25 and 26
gi|3493560|gb|AF058413.1|HSLRPSS33[3493560] - 12250: AF058412
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 23 and 24
gi|3493559|gb|AF058412.1|HSLRPSS31[3493559] - 12251: AF058411
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 21 and 22
gi|3493558|gb|AF058411.1|HSLRPSS29[3493558] - 12252: AF058410
Homo sapiens lipoprotein receptor-related protein (LRP1), exon 20
gi|3493557|gb|AF058410.1|HSLRPSS27[3493557] - 12253: AF058409
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 18 and 19
gi|3493556|gb|AF058409.1|HSLRPSS25[3493556] - 12254: AF058408
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 16 and 17
gi|3493555|gb|AF058408.1|HSLRPSS23[3493555] - 12255: AF058407
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 14 and 15
gi|3493554|gb|AF058407.1|HSLRPSS21[3493554] - 12256: AF058406
Homo sapiens lipoprotein receptor-related protein (LRP1), exon 13
gi|3493553|gb|AF058406.1|HSLRPSS19[3493553] - 12257: AF058405
Homo sapiens lipoprotein receptor-related protein (LRP1), exon 12
gi|3493552|gb|AF058405.1|HSLRPSS17[3493552] - 12258: AF058404
Homo sapiens lipoprotein receptor-related protein (LRP1), exon 11
gi|3493551|gb|AF058404.1|HSLRPSS15[3493551] - 12259: AF058403
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 9 and 10
gi|3493550|gb|AF058403.1|HSLRPSS13[3493550] - 12260: AF058402
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 7 and 8
gi|493549|gb|AF058402.1|HSLRPSS11[3493549r - 12261: AF058401
Homo sapiens lipoprotein receptor-related protein (LRP1), exons 5 and 6
gi|3493548|gb|AF058401.1|HSLRPSS09[3493548] - 12262: AF058400
Homo sapiens lipoprotein receptor-related protein (LRP1), exon 4
gi|3493547|gb|AF058400.1|HSLRPSS07[3493547] - 12263: AF058399
Homo sapiens lipoprotein receptor-related protein (LRP1), exon 3
gi|3493546|gb|AF058399.1|HSLRPSS05[3493546] - 12264: AF058398
Homo sapiens lipoprotein receptor-related protein (LRP1), exon 2
gi|3493545|gb|AF058398.1|HSLRPSS03[3493545] - 12265: AF058397
Homo sapiens lipoprotein receptor-related protein (LRP1), exon 1
gi|3493544|gb|AF058397.1|HSLRPSS01[3493544] - 12267: Y11044
Homo sapiens mRNA for GABA-BR1a (hGB1a) receptor
gi|2826760|emb|Y11044.1|HSGTHLA1[2826760] - 12277: AF073019
Homo sapiens clone 21 T cell signal transduction molecule SAP mRNA, complete cds
gi|3695070|gb|AF073019.1|AF073019[3695070] - 12278: AF072930
Homo sapiens clone 14 T cell signal transduction molecule SAP mRNA, complete cds
gi|3695068|gb|AF072930.1|AF072930[3695068] - 12279: Y12670
Homo sapiens mRNA for leptin receptor gene-related protein
gi|2266637|emb|Y12670.1|HSOBRGRP[2266637] - 12280: AF091890
Homo sapiens G-protein coupled receptor RE2 mRNA, complete cds
gi|3659902|gb|AF091890.1|AF091890[3659902] - 12281: Y09586
Homo sapiens mRNA for serotonin 4 receptor (h5-HT4(a)), splice variant
gi|2584764|emb|Y09586.1|HS5HT4SAR[2584764] - 12282: X77777
H. sapiens intestinal VIP receptor related protein mRNA
gi|456352|emb|X77777.1|HSVIPRRP[456352] - 12283: AJ001383
Homo sapiens activating NK-receptor (NK-p46) mRNA
gi|3647278|emb|AJ001383.1|HSJ001383[3647278] - 12284: AJ224901
Homo sapiens mRNA for ZNF198 protein
gi|3647276|emb|AJ224901.1|HSAJ4901[3647276] - 12285: AJ006123
Homo sapiens mRNA for NK receptor (NKp46), isoform d
gi|3647272|emb|AJ006123.1|HSA6123[3647272] - 12286: AJ006122
Homo sapiens mRNA for NK receptor (NKp46) isoform c
gi|3647270|emb|AJ006122.1|HSA6122[3647270] - 12287: AJ006121
Homo sapiens mRNA for NK receptor (NKp46), isoform b
gi|3647268|emb|AJ006121.1|HSA6121[3647268] - 12289: X99906
Homo sapiens mRNA for alpha endosulfine
gi|2764973|emb|X99906.1|HSALPEND[2764973] - 12292: U52064
Kaposi's sarcoma-associated herpes-like virus ORF73 homolog gene, complete cds
gi|1633571|gb|U52064.1|KSU52064[1633571] - 12293: U29343
Homo sapiens hyaluronan receptor (RHAMM) mRNA, complete cds
gi|2959555|gb|U29343.1|HSU29343[2959555] - 12294: AF035771
Homo sapiens Na+/H+ exchanger regulatory factor 2 (NHERF-2) mRNA, complete cds
gi|2665825|gb|AF035771.1|AF035771[2665825] - 12296: AF023849
Homo sapiens TNF receptor-related receptor for TRAIL mRNA, complete cds
gi|2653844|gb|AF023849.1|AF023849[2653844] - 12297: AH006710
Homo sapiens interferon-gamma receptor alpha chain (interferon-gamma receptor alpha chain gene), complete cds
gi|2078444|gb|AH006710.1|SEG_HSINFGRA[2078444] - 12298: U19247
Homo sapiens interferon-gamma receptor alpha chain gene, exon 7 and complete cds
gi|632541|gb|U19247.1|HSINFGRA7[632541] - 12299: U19246
Homo sapiens interferon-gamma receptor alpha chain gene, exon 6
gi|632540|gb|U19246.1|HSINFGRA6[632540] - 12300: U19245
Homo sapiens interferon-gamma receptor alpha chain gene, exon 5
gi|632539|gb|U19245.1|HSINFGRA5[632539] - 12301: U19244
Homo sapiens interferon-gamma receptor alpha chain gene, exon 4
gi|632538|gb|U19244.1|HSINFGRA4[632538] - 12302: U19243
Homo sapiens interferon-gamma receptor alpha chain gene, exon 3
gi|632537|gb|U19243.1|HSINFGRA3[632537] - 12303: U19242
Homo sapiens interferon-gamma receptor alpha chain gene, exon 2
gi|632536|gb|U19242.1|HSINFGRA2[632536] - 12304: U19241
Homo sapiens interferon-gamma receptor alpha chain gene, exon 1
gi|632535|gb|U19241.1|HSINFGRA1[632535] - 12305: AF027957
Homo sapiens G protein-coupled receptor (GPR35) gene, complete cds
gi|2739108|gb|AF027957.1|AF027957[2739108] - 12306: AF027956
Homo sapiens G protein-coupled receptor (GPR30) gene, complete cds
gi|2739106|gb|AF027956.1|AF027956[2739106] - 12307: AF016709
Homo sapiens ATP receptor subunit (P2X5) mRNA, complete cds
gi|2731560|gb|AF016709.1|AF016709[2731560] - 12308: AF035824
Homo sapiens vesicle soluble NSF attachment protein receptor (VTI1) mRNA, complete cds
gi|2687399|gb|AF035824.1|AF035824[2687399] - 12309: U96845
Homo sapiens natual killer cell group 2-F (NKG2-F) mRNA, complete cds
gi|2673988|gb|U96845.1|HSU96845[2673988] - 12310: AF022139
Homo sapiens lysosphingolipid receptor (EDG3) mRNA, partial cds
gi|2668611|gb|AF022139.1|AF022139[2668611] - 12311: AF022137
Homo sapiens G protein-coupled receptor (EDG1) mRNA, partial cds
gi|2668607|gb|AF022137.1|AF022137[2668607] - 12312: AF031556
Homo sapiens clone 17.30 immunoglobulin-like transcript 5 mRNA, complete cds
gi|2665646|gb|AF031556.1|AF031556[2665646] - 12313: AF031555
Homo sapiens clone 17.23 immunoglobulin-like transcript 5 mRNA, complete cds
gi|2665644|gb|AF031555.1|AF031555[2665644] - 12314: AF031554
Homo sapiens clone 17.18 immunoglobulin-like transcript 5 mRNA, complete cds
gi|2665642|gb|AF031554.1|AF031554[2665642] - 12315: AF031553
Homo sapiens clone DC.1 immunoglobulin-like transcript 5 mRNA, complete cds
gi|2665640|gb|AF031553.1|AF031553[2665640] - 12316: AF009644
Homo sapiens clone 41 immunoglobulin-like transcript 5 protein mRNA, complete cds
gi|2662447|gb|AF009644.1|AF009644[2662447] - 12317: AF009643
Homo sapiens clone 6 immunoglobulin-like transcript 5 protein mRNA, complete cds
gi|2662445|gb|AF009643.1|AF009643[2662445] - 12318: AF009642
Homo sapiens clone 40 immunoglobulin-like transcript 5 protein mRNA, complete cds
gi|2662443|gb|AF009642.1|AF009642[2662443] - 12319: AF009641
Homo sapiens clone 36 immunoglobulin-like transcript 5 protein mRNA, complete cds
gi|2662441|gb|AF009641.1|AF009641[2662441] - 12320: AF009640
Homo sapiens clone 33 immunoglobulin-like transcript 5 protein mRNA, complete cds
gi|2662439|gb|AF009640.1|AF009640[2662439] - 12321: AF009639
Homo sapiens clone 31 immunoglobulin-like transcript 5 protein mRNA, complete cds
gi|2662437|gb|AF009639.1|AF009639[2662437] - 12322: AF009638
Homo sapiens clone 22 immunoglobulin-like transcript 5 protein mRNA, complete cds
gi|2662435|gb|AF009638.1|AF009638[2662435] - 12323: AF009637
Homo sapiens clone 19 immunoglobulin-like transcript 5 protein mRNA, complete cds
gi|2662433|gb|AF009637.1|AF009637[2662433] - 12324: AF009636
Homo sapiens clone 17.8 immunoglobulin-like transcript 5 protein mRNA, complete
cds
gi|2662431|gb|AF009636.1|AF009636[2662431] - 12325: AF009635
Homo sapiens clone 17.7 immunoglobulin-like transcript 5 protein mRNA, complete
cds
gi|2662429|gb|AF009635.1|AF009635[2662429] - 12326: AF009634
Homo sapiens clone 17.6 immunoglobulin-like transcript 5 protein mRNA, complete
cds
gi|2662427|gb|AF009634.1|AF009634[2662427] - 12327: AF009633
Homo sapiens clone 17.11 immunoglobulin-like transcript 5 protein mRNA, complete
cds
gi|2662425|gb|AF009633.1|AF009633[2662425] - 12328: AF009632
Homo sapiens clone 17.10 immunoglobulin-like transcript 5 protein mRNA, complete
cds
gi|2662423|gb|AF009632.1|AF009632[2662423] - 12329: AF014924
Homo sapiens immunoglobulin-like transcript 6a (ILT6a) mRNA, complete cds
gi|2661224|gb|AF014924.1|AF014924[2661224] - 12330: AF014923
Homo sapiens immunoglobulin-like transcript 6 (ILT6) mRNA, complete cds
gi|2661222|gb|AF014923.1|AF014923[2661222] - 12331: AF011566
Homo sapiens clone 17 immunoglobulin-like transcript 4 mRNA, complete cds
gi|2660709|gb|AF011566.1|AF011566[2660709] - 12332: AF011565
Homo sapiens clone 26 immunoglobulin-like transcript 4 mRNA, complete cds
gi|2660707|gb|AF011565.1|AF011565[2660707] - 12333: AF009007
Homo sapiens immunoglobulin-like transcript 2c mRNA, complete cds
gi|2660705|gb|AF009007.1|AF009007[2660705] - 12334: AF009006
Homo sapiens immunoglobulin-like transcript 2b mRNA, complete cds
gi|2660703|gb|AF009006.1|AF009006[2660703] - 12335: AF009005
Homo sapiens immunoglobulin-like transcript 2a mRNA, complete cds
gi|2660701|gb|AF009005.1|AF009005[2660701] - 12336: AH006705
Homo sapiens mu opioid receptor (OPRM1) and mu opioid receptor (OPRM1)s, partial
cds
gi|2655104|gb|AH006705.1|SEG_HSOPRMI[2655104] - 12338: AF024516
Homo sapiens mu opioid receptor (OPRM1) gene, partial cds, exons 2 and 3, complete IVS2
gi|2655102|gb|AF024516.1|HSOPRMI2[2655102] - 12339: AF024515
Homo sapiens mu opioid receptor (OPRM1) gene, partial cds, exon 1
gi|2655101|gb|AF024515.1|HSOPRMI1[2655101] - 12410: AF030625
Homo sapiens SCCL vasopressin subtype 1a receptor mRNA, complete cds
gi|2623229|gb|AF030625.1|AF030625[2623229] - 12411: AF002986
Homo sapiens platelet activating receptor homolog (H963) mRNA, complete cds
gi|2580587|gb|AF002986.1|AF002986[2580587] - 12412: AF023614
Homo sapiens transmembrane activator and CAML interactor (TACI) mRNA, complete
cds
gi|2554947|gb|AF023614.1|AF023614[2554947] - 12413: AF022860
Homo sapiens neuropilin-2(a17) mRNA, complete cds
gi|2547131|gb|AF022860.1|AF022860[2547131] - 12414: AF022859
Homo sapiens neuropilin-2(a0) mRNA, complete cds
gi|2547129|gb|AF022859.1|AF022859[2547129] - 12415: AF016849
Homo sapiens apoptosis inducing receptor TRAIL-R2 (TRAILR2) mRNA, complete cds
gi|2465585|gb|AF016849.1|AF016849[2465585] - 12416: AF013171
Homo sapiens TNF-related ligand TRANCE mRNA, partial cds
gi|2411499|gb|AF013171.1|AF013171[2411499] - 12417: AF018956
Homo sapiens neuropilin mRNA, complete cds
gi|2407640|gb|AF018956.1|AF018956[2407640] - 12419: AF015257
Homo sapiens flow-induced endothelial G protein-coupled receptor (FEG-1) mRNA,
complete cds
gi|2353152|gb|AF015257.1|AF015257[2353152] - 12420: U75285
Homo sapiens apoptosis inhibitor survivin gene, complete cds
gi|2315862|gb|U75285.1|HSU75285[2315862] - 12421: AF012270
Homo sapiens visual pigment-like receptor peropsin (Rrh) mRNA, complete cds
gi|2387009|gb|AF012270.1|AF012270[2307009] - 12422: AH006692
Homo sapiens chromosome 19 clone PAC clone 72N6 map 19q13.42
gi|2290633|gb|AH006692.1|SEG_HSNKAT2A[2290633] - 12423: U97180
Homo sapiens NKAT-2a like protein (KIR) gene, exons 8 and 9 and complete cds
gi|2290632|gb|U97180.1|HSNKAT2A8[2290632] - 12424: U97179
Homo sapiens NKAT-2a like protein (KIR) gene, exon 7
gi|2290631|gb|U97179.1|HSNKAT2A7[2290631] - 12425: U97178
Homo sapiens NKAT-2a like protein (KIR) gene, exon 6
gi|2290630|gb|U97178.1|HSNKAT2A6[2290630] - 12426: U97177
KIR Homo sapiens NKAT-2a like protein (KIR) gene, exon 5
gi|2290629|gb|U97177.1|HSNKAT2A5[2290629] - 12427: U97176
Homo sapiens NKAT-2a like protein (KIR) gene, exon 4
gi|2290628|gb|U97176.1|HSNKAT2A4[2290628] - 12429: U97174
KIR Homo sapiens NKAT-2a like protein (KIR) gene, exon 2
gi|2290626|gb|U97174.1|HSNKAT2A2[2290626] - 12430: U97173
Homo sapiens NKAT-2a like protein (KIR) gene, exon 1
gi|2290625|gb|U97173.1|HSNKAT2A1[2290625] - 12431: U97075
Homo sapiens FLICE-like inhibitory protein short form mRNA, complete cds
gi|2253680|gb|U97075.1|U97075[2253680] - 12432: U97074
Homo sapiens FLICE-like inhibitory protein long form mRNA, complete cds
gi|2253678|gb|U97074.1|U97074[2253678] - 12688: L76380
Homo sapiens (clone HSNME29) CGRP type 1 receptor mRNA, complete cds
gi|1321593|gb|L76380.1|HUMCGRPB[1321593] - 12689: L49241
Homo sapiens fibroblast growth factor 2 (FGFR2) Ser354Cys mutant gene, exon IIIc
gi|1129116|gb|L49241.1|HUMFGF354C[1129116] - 12690: L49240
Homo sapiens fibroblast growth factor 2 (FGFR2) Ala344Gly mutant gene, exon IIIc
gi|1129114|gb|L49240.1|HUMFGF344G[1129114] - 12691: L49239
Homo sapiens fibroblast growth factor 2 (FGFR2) Cys342Tyr mutant gene, exon IIIc
gi|1129112|gb|L49239.1|HUMFGF342Y[1129112] - 12692: L49238
Homo sapiens fibroblast growth factor 2 (FGFR2) Cys342Ser mutant gene, exon IIIc
gi|1129110|gb|L49238.1|HUMFGF342S[1129110] - 12693: L49242
Homo sapiens fibroblast growth factor 2 (FGFR2) Gly338Arg mutant gene, exon IIIc
gi|1129108|gb|L49242.1|HUMFGF338R[1129108] - 12694: L49237
Homo sapiens fibroblast growth factor 2 (FGFR2) Gln289Pro mutant gene, exon IIIu
gi|1129106|gb|L49237.1|HUMFGF289P[1129106] - 12842: L38734
Homo sapiens hepatoma transmembrane kinase ligand (HTK ligand) mRNA, complete cds
gi|769675|gb|L38734.1|HUMHTK[769675] - 12843: L40764
Homo sapiens vasoactive intestinal polypeptide receptor 2 (VIPR2) mRNA, complete
cds
gi|712836|gb|L40764.1|HUMVIPR2A[712836] - 12844: AF068181
Homo sapiens B cell linker protein BLNK-s mRNA, alternatively spliced, complete
cds
gi|3406750|gb|AF068181.1|AF068181[3406750] - 12845: AF068180
Homo sapiens B cell linker protein BLNK mRNA, alternatively spliced, complete cds
gi|3406748|gb|AF068180.1|AF068180[3406748] - 12846: AF064801
Homo sapiens multiple membrane spanning receptor TRC8 (TRC8) mRNA, complete cds
gi|3395786|gb|AF064801.1|AF064801[3395786] - 12847: AH006513
Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene
gi|3342791|gb|AH006513.1|SEG_HSGLRA3S[3342791] - 12848: AF017724
Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 10n, and complete cds
gi|3342790|gb|AF017724.1|HSGLRA3S10[3342790] - 12849: AF017723
Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 9n
gi|3342789|gb|AF017723.1|HSGLRA3S09[3342789] - 12850: AF017722
Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 8
gi|3342788|gb|AF017722.1|HSGLRA3S08[3342788] - 12851: AF017721
Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 7
gi|3342787|gb|AF017721.1|HSGLRA3S07[3342787] - 12852: AF017720
Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 6
gi|3342786|gb|AF017720.1|HSGLRA3S06[3342786] - 12853: AF017719
Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 5
gi|3342785|gb|AF017719.1|HSGLRA3S05[3342785] - 12854: AF017718
Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 4
gi|3342784|gb|AF017718.1|HSGLRA3S04[3342784] - 12855: AF017717
Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 3
gi|3342783|gb|AF017717.1|HSGLRA3S03[3342783] - 12856: AF017716
Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 2
gi|3342782|gb|AF017716.1|HSGLRA3S02[3342782] - 12857: AF017715
Homo sapiens glycine receptor alpha 3 subunit (GLRA3) gene, exon 1
gi|3342781|gb|AF017715.1|HSGLRA3S01[3342781] - 12858: AF018157
Homo sapiens glycine receptor alpha 3 subunit (GLRA3) mRNA, alternatively spliced, partial cds
gi|3342237|gb|AF018157.1|AF018157[3342237] - 12861: AF045764
Homo sapiens orphan G protein-coupled receptor (GPR32) gene, complete cds
gi|3282838|gb|AF045764.1|AF045764[3282838] - 12864: AF053004
Homo sapiens class I cytokine receptor (WSX1) mRNA, complete cds
gi|31532400gb|AF053004.1|AF053004[3153240] - 12865: AF055872
Homo sapiens Apo3/DR3 ligand (APO3L) mRNA, complete cds
gi|3108230|gb|AF055872.1|AF055872[3108230] - 12866: AF057140
Homo sapiens cargo selection protein TIP47 (TIP47) mRNA, complete cds
gi|3095185|gb|AF057140.1|AF057140[3095185] - 12870: AF028785
Homo sapiens phosphatidylinositol 3-kinase p55 gamma regulatory subunit mRNA, complete cds
gi|3046405|gb|AF028785.1|AF028785[3046405] - 12872: AF027826
Homo sapiens putative seven pass transmembrane protein (TM7SF1) mRNA, complete
cds
gi|2992627|gb|AF027826.1|AF027826[2992627] - 12883: AF040630
Homo sapiens galanin receptor GalR2 mRNA, complete cds
gi|2921759|gb|AF040630.1|AF040630[2921759] - 12904: U86281
Homo sapiens olfactory receptor (OR7-141) gene, partial cds
gi|2921715|gb|U86281.1|U86281[2921715] - 12905: U86280
Homo sapiens olfactory receptor (OR7-140) gene, partial cds
gi|2921713|gb|U86280.1|U86280[2921713] - 12906: U86279
Homo sapiens olfactory receptor (OR7-139) gene, partial cds
gi|2921711|gb|U86279.1|U86279[2921711] - 12907: U86278
Homo sapiens olfactory receptor (OR7-138) gene, partial cds
gi|2921709|gb|U86278.1|U86278[2921709] - 12911: U86274
Homo sapiens olfactory receptor (OR5-85) gene, partial cds
gi|2921704|gb|U86274.1|U86274[2921704] - 12915: U86270
Homo sapiens olfactory receptor (OR5-40) gene, partial cds
gi|2921699|gb|U86270.1|U86270[2921699] - 12921: U86264
Homo sapiens olfactory receptor (OR3-145) gene, partial cds
gi|2921692|gb|U86264.1|U86264[2921692] - 12927: AH006491
Homo sapiens GPI-linked anchor protein (GFRA1), complete cds
gi|2921544|gb|AH006491.1|SEG_HSGFRA1G[2921544] - 12928: AF038420
Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 11 and complete cds
gi|2921543|gb|AF038420.1|HSGFRA1G11[2921543] - 12929: AF038419
Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 10
gi|2921542|gb|AF038419.1|HSGFRA1G1002921542] - 12930: AF038418
Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 9
gi|2921541|gb|AF038418.1|HSGFRA1G 9[2921541] - 12931: AF038417
Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 8
gi|2921540|gb|AF038417.1|HSGFRA1G 8[2921540] - 12932: AF038416
Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 7
gi|2921539|gb|AF038416.1|HSGFRA1G 7[2921539] - 12933: AF038415
Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 6
gi|2921538|gb|AF038415.1|HSGFRA1G 6[2921538] - 12934: AF038414
Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 5
gi|2921537|gb|AF038414.1|HSGFRA1G 5[2921537] - 12935: AF038413
Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 4
gi|2921536|gb|AF038413.1|HSGFRA1G 4[2921536] - 12936: AF038412
Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 3
gi|2921535|gb|AF038412.1|HSGFRA1G 3[2921535] - 12937: AF038411
Homo sapiens GPI-linked anchor protein (GFRA1) gene, exon 2
gi|2921534|gb|AF038411.1|HSGFRA1G 2[2921534] - 12938: AF036906
Homo sapiens linker for activation of T cells (LAT) mRNA, alternatively spliced
form, complete cds
gi|2828025|gb|AF036906.1|AF036906[2828025] - 12939: AF036905
Homo sapiens linker for activation of T cells (LAT) mRNA, complete cds
gi|2828023|gb|AF036905.1|AF036905[2828023] - 12940: AF043724
Homo sapiens hepatitis A virus cellular receptor 1 (hHAVcr-1) mRNA, complete cds
gi|2827453|gb|AF043724.1|AF043724[2827453] - 12954: U86239
Homo sapiens olfactory receptor (OR16-90) gene, partial cds
gi|2921659|gb|U86239.1|U86239[2921659] - 12955: U86238
Homo sapiens olfactory receptor (OR16-89) gene, partial cds
gi|2921657|gb|U86238.1|U86238[2921657] - 12956: U86237
Homo sapiens olfactory receptor (OR16-88) gene, partial cds
gi|2921655|gb|U86237.1U86237[2921655] - 12957: U86236
Homo sapiens olfactory receptor (OR16-37) gene, partial cds
gi|2921653|gb|U86236.1|U86236[2921653] - 12958: U86235
Homo sapiens olfactory receptor (OR16-36) gene, partial cds
gi|2921651|gb|U86235.1|U86235[2921651] - 12959: U86234
Homo sapiens olfactory receptor (OR16-35) gene, partial cds
gi|2921649|gb|U86234.1|U86234[2921649]
- 12971: U86222
Homo sapiens olfactory receptor (OR13-66) gene, partial cds
gi|2921636|gb|U86222.1|U86222[2921636] - 12977: U86216
Homo sapiens olfactory receptor (OR1-26) gene, partial cds
gi|2921629|gb|U86216.1U86216[2921629] - 12978: U86215
Homo sapiens olfactory receptor (OR1-25) gene, partial cds
gi|2921627|gb|U86215.1|U86215[2921627] - 12979: AF016261
Homo sapiens interleukin-1 receptor accessory protein (IL1RAP) gene, partial cds
gi|2911297|gb|AF016261.1|AF016261[2911297] - 12980: AF041245
Homo sapiens orexin receptor-2 mRNA, complete cds
gi|2897127|gb|AF041245.1|AF041245[2897127] - 12981: AF041243
Homo sapiens orexin receptor-1 mRNA, complete cds
gi|2897123|gb|AF041243.1|AF041243[2897123] - 12982: U97123
Homo sapiens chemokine receptor mRNA, complete cds
gi|2897070|gb|U97123.1|HSU97123[2897070] - 12983: AF009014
Homo sapiens glutamate receptor delta-2 subunit (GLURD2) mRNA, complete cds
gi|2853314|gb|AF009014.1|AF009014[2853314] - 12984: AF036581
Homo sapiens tumor necrosis factor superfamily member LIGHT mRNA, complete cds
gi|2815623|gb|AF036581.1|AF036581[2815623] - 12985: AF040991
Homo sapiens roundabout 2 (robo2) mRNA, partial cds
gi|2804785|gb|AF040991.1|AF040991[2804785] - 12986: AF040990
Homo sapiens roundabout 1 (robo1) mRNA, complete cds
gi|2804783|gb|AF040990.1|AF040990[2804783] - 12987: AF026070
Homo sapiens death receptor 3 beta (DR3) mRNA, complete cds
gi|2570830|gb|AF026070.1|AF026070[2570830] - 12988: AF021818
Homo sapiens putative neurotransmitter receptor mRNA, complete cds
gi|2465431|gb|AF021818.1|AF021818[2465431] - 12990: L48211
Homo Sapiens angiotensin II receptor gene, complete cds
gi|1160612|gb|L48211.1|HUMAIR[1160612] - 12992: L47169
Homo sapiens neuropeptide Y receptor gene, exon, promoter C
gi|976208|gb|L47169.1|HUMNPYAC[976208] - 12993: L47168
Homo sapiens neuropeptide Y receptor gene, exon, promoter B
gi|976207|gb|L47168.1|HUMNPYAB[976207] - 12994: L47167
Homo sapiens neuropeptide Y receptor gene, exon, promoter A
gi|976206|gb|L47167.1|HUMNPYAA[976206] - 12995: L37086
Homo sapiens FK-506 binding protein (fkbp12.6) gene, complete cds
gi|965467|gb|L37086.1|HUMFK506B[965467] - 12996: L36566
Human helodermin-preferring VIP receptor (VIP2/PACAP receptor) mRNA, complete cds
gi|550477|gb|L36566.1|HUMHVP[550477] - 12997: L25647
Homo sapiens fibroblast growth factor receptor gene (located in the central MHC)
signal peptide and consecutive exon
gi|457233|gb|L25647.1|HUMFGFRZ[457233] - 12998: M85247
H. sapiens dopamine D1A receptor gene, complete exon 1, and exon 2, 5′ end
gi|181652|gb|M85247.1|HUMDOPAM[181652] - 12999: L21195
Human serotonin 5-HT7 receptor mRNA, complete cds
gi|413865|gb|L21195.1|HLJMSHTR[413865] - 13000: L22647
Human prostaglandin receptor ep1 subtype mRNA, complete cds
gi|410208|gb|L22647.1|HUMG[410208] - 13001: L10822
Human gastrin receptor gene, complete cds
gi|406075|gb|L10822.1|HUMGARE[406075] - 13002: L19546
Human (IL2RG) gene, complete cds with repeats
gi|349631|gb|L19546.1|HUMIL2RGA[349631] - 13003: M95667
Homo sapiens c-erb B2/neu protein (ERBB2) gene, partial cds
gi|182168|gb|M95667.1|HUMERBB2[182168] - 13004: AF087138
Homo sapiens sulfonylurea receptor 1 (SUR1) mRNA, complete cds
gi|3643189|gb|AF087138.1|AF087138[3643189] - 13005: AF042782
Homo sapiens galanin receptor type. 2 (GALR2) gene, complete cds
gi|3642913|gb|AF042782.1|AF042782[3642913] - 13007: AF064548
Homo sapiens low-density lipoprotein receptor-related protein 5 (LRP5) mRNA,
complete cds
gi|3641526|gb|AF064548.1|AF064548[3641526] - 13008: AF073799
Homo sapiens galanin receptor GALR3 mRNA, complete cds
gi|3608409|gb|AF073799.1|AF073799[3608409] - 13009: D10202
Homo sapiens mRNA for platelet-activating factor receptor, complete cds
gi|219975|dbj|D10202.1|HUMPAFRE[219975] - 13010: AB017498
Homo sapiens LRP5 mRNA for Lipoprotein Receptor Related Protein 5, complete cds
gi|3582144|dbj|AB017498.1|AB017498[3582144] - 13011: AJ011041
Homo sapiens CHRM2 gene, satellite
gi|3581973|emb|AJ011041.1|HSA011041[3581973] - 13012: AH006427
Homo sapiens chromosome 12 map 12q13-14
gi|3561040|gb|AH006427.1|SEG_HOMOVDR[3561040] - 13013: AF080456
Homo sapiens vitamin D receptor gene, exon if
gi|3561039|gb|AF080456.1|HOMOVDR3[3561039] - 13014: AF080455
Homo sapiens vitamin D receptor gene, exon le
gi|3561038|gb|AF080455.1|HOMOVDR2[3561038] - 13015: AF080454
Homo sapiens vitamin D receptor gene, exon id
gi|3561037|gb|AF080454.1|HOMOVDR1[3561037] - 13025: AJ001689
Homo sapiens NKG2D gene, exon 10
gi|2980867|emb|AJ001689.1|HSAJ1689[2980867] - 13026: AJ001688
Homo sapiens NKG2D gene, exons 6-9
gi|2980866|emb|AJ001688.1|HSAJ1688[2980866] - 13027: AJ001687
Homo sapiens NKG2D gene, exons 2-5 and joined mRNA and CDS
gi|2980864|emb|AJ001687.1|HSAJ1687[2980864] - 13028: AJ001686
Homo sapiens NKG2F gene
gi|2980862|emb|AJ001686.1|HSAJ1686[2980862] - 13029: AJ001685
Homo sapiens NKG2E gene
gi|2980860|emb|AJ001685.1|HSAJ1685[2980860] - 13030: AJ001684
Homo sapiens NKG2C gene
gi|2980858|emb|AJ001684.1|HSAJ1684[2980858] - 13031: AJ001683
Homo sapiens NKG2F mRNA
gi|2980856|emb|AJ001683.1|HSAJ1683[2980856] - 13032: Y12546
H. sapiens mRNA for P2Y-like G-protein coupled receptor
gi|2687818|emb|Y12546.1|HSP2YLG[2687818] - 13033: AF015525
Homo sapiens putative chemokine receptor (CRAM-B) mRNA, complete cds
gi|3550069|gb|AF015525.1|AF015525[3550069] - 13034: AF015524
Homo sapiens putative chemokine receptor (CRAM-A) mRNA, complete cds
gi|3550066|gb|AF015524.1|AF015524[3550066] - 13035: AF068868
Homo sapiens TNFR-related death receptor-6 (DR6) mRNA, complete cds
gi|3549262|gb|AF068868.1|AF068868[3549262] - 13036: AF052572
Homo sapiens chemokine receptor CXCR4 gene, promoter region and complete cds
gi|3549254|gb|AF052572.1|AF052572[3549254] - 13037: AC005625
Homo sapiens chromosome 19, cosmid R27328, complete sequence
gi|3549153|gb|AC005625.1|AC005625[3549153] - 13038: AF051152
Homo sapiens Toll/interleukin-1 receptor-like protein 4 (TIL4) mRNA, complete cds
gi|3132527|gb|AF051152.1|AF051152[3132527] - 13039: AF051151
Homo sapiens Toll/interleukin-1 receptor-like protein 3 (TIL3) mRNA, complete cds
gi|3132525|gb|AF051151.1|AF051151[3132525] - 13040: AC005601
Homo sapiens chromosome 5, BAC clone 343g16 (LBNL H180), complete sequence
gi|3522917|gb|AC005601.1|AC005601[3522917] - 13042: U88540
Homo sapiens Toll-like receptor 1 (TLR1) mRNA, complete cds
gi|2459617|gb|U88540.1|HSU88540[2459617] - 13066: Z94155
H. sapiens mRNA for P2Y-like G-protein coupled receptor (partial)
gi|2695875|emb|Z94155.1|HSZ94155[2695875] - 13067: Z94154
H. sapiens mRNA for P2Y-like G-protein coupled receptor
gi|2695873|emb|Z94154.1|HSZ94154[2695873] - 13068: AF074264
Homo sapiens LDL receptor-related protein 6 (LRP6) mRNA, complete cds
gi|3462526|gb|AF074264.1|AF074264[3462526] - 13069: AF021233
Homo sapiens TRAIL-R4-B (TRAIL-R4) mRNA, complete cds
gi|3452184|gb|AF021233.1|AF021233[3452184] - 13070: AF021232
Homo sapiens TRAIL-R4-A (TRAIL-R4) mRNA, complete cds
gi|3452182|gb|AF021232.1|AF021232[3452182] - 13072: X98765
H. sapiens gene encoding secretory component of polymeric immunoglobulin receptor
gi|2546984|emb|X98765.1|HSSC[2546984] - 13103: U50062
Homo sapiens RIP protein kinase mRNA, complete cds
gi|3426026|gb|U50062.1|HSU50062[3426026] - 13104: AF078925
Homo sapiens P2X1 receptor gene, partial cds
gi|3421366|gb|AF078925.1|AF078925[3421366] - 13106: AF061785
Homo sapiens gamma-aminobutyric acid receptor A5 subunit (GABRA5) gene, three alternative first exons and exons 2-3, partial cds
gi|3420025|gb|AF061785.1|AF061785[3420025] - 13110: AB009462
Homo sapiens hLRp105 mRNA for LDL receptor related protein 105, complete cds
gi|3413957|dbj|AB009462.1|AB009462[3413957] - 13111: AF075590
Homo sapiens MCF-7 peripheral-type benzodiazepine receptor (PBR) mRNA, partial
cds
gi|3411164|gb|AF075590.1|AF075590[3411164] - 13112: AF075589
Homo sapiens MDA-MB-231 peripheral-type benzodiazepine receptor (PBR) mRNA, partial cds
gi|3411162|gb|AF075589.1|AF075589[3411162] - 13113: L39064
Homo sapiens interleukin 9 receptor precursor (IL9R) gene, complete cds
gi|632992|gb|L39064.1|HUMIL9RA[632992] - 13114: AJ224878
Homo sapiens mRNA for T-cell receptor interacting molecule (TRIM) protein
gi|3402215|emb|AJ224878.1|HSAJ4878[3402215] - 13115: AF080214
Homo sapiens protease-activated receptor 4 mRNA, complete cds
gi|3396080|gb|AF080214.1|AF080214[3396080] - 13116: AF075005
Homo sapiens full length insert cDNA YH98E06
gi|3377544|gb|AF075005.1|HUMYH98E06[3377544] - 13133: AF062006
Homo sapiens orphan G protein-coupled receptor HG38 mRNA, complete cds
gi|3366801|gb|AF062006.1|AF062006[3366801] - 13134: Y12815
H. sapiens mRNA for chemokine receptor D6
gi|2204204|emb|Y12815.1|HSY12815[2204204] - 13135: AC005338
Homo sapiens chromosome 19, cosmid R31646, complete sequence
gi|3355457|gb|AC005338.1|AC005338[3355457] - 13137: AF078530
Homo sapiens receptor interacting protein 2 (RIP2) mRNA, complete cds
gi|3342909|gb|AF078530.1|AF078530[3342909] - 13138: AF077526
Homo sapiens parathyroid hormone-related protein receptor gene, partial cds
gi|3342553|gb|AF077526.1|AF077526[3342553] - 13139: AH006311
Homo sapiens chromosome 11 gastrin\cholecystokinin brain receptor (CCKBR), partial cds
gi|3342089|gb|AH006311.1|SEG_HSCCKBR[3342089] - 13140: AF074029
Homo sapiens gastrincholecystokinin brain receptor (CCKBR) gene, exons 4 and and partial cds
gi|3342088|gb|AF074029.1|HSCCKBR2[3342088] - 13141: AF074035
Homo sapiens gastrincholecystokinin brain receptor (CCKBR) gene, exons 2 and 3
gi|3342087|gb|AF074035.1|HSCCKBR1[3342087] - 13142: U44132
Homo sapiens lung cancer suppressor region LCR11.1 satellite DNA
gi|1174163|gb|U44132.1|HSU44132[1174163] - 13143: Y14930
Homo sapiens TCRAV28 gene, allele A4, partial
gi|2664276|emb|Y14930.1|HSY14930[2664276] - 13144: Y14931
Homo sapiens TCRAV28 gene, allele A5, partial
gi|2661832|emb|Y14931.1|HSY14931[2661832] - 13145: Y14929
Homo sapiens TCRAV28 gene, allele A3, partial
gi|2661828|emb|Y14929.1|HSY14929[2661828] - 13146: AF074087
Homo sapiens killer cell inhibitory receptor short form (KIR2D52) mRNA, alternatively spliced, partial cds
gi|3328178|gb|AF074087.1|AF074087[3328178] - 13147: Y12507
H. sapiens mRNA for serotonin receptor 5-HT4D, splice variant
gi|3326990|emb|Y12507.1|HSY12507[3326990] - 13148: Y12506
H. sapiens mRNA for serotonin receptor 5-HT4C, splice variant
gi|3326988|emb|Y12506.1|HSY12506[3326988] - 13151: D85242
Homo sapiens mRNA for NOR-1 3′-variant, partial cds
gi|3168581|dbj|D85242.1D85242[3168581] - 13152: D85241
Homo sapiens mRNA for NOR-1beta, partial cds
gi|3168579|dbj|D85241.1|D85241[3168579] - 13153: AF034633
Homo sapiens orphan G protein-coupled receptor (GPR39) mRNA, complete cds
gi|2654160|gb|AF034633.1|AF034633[2654160] - 13154: AF034632
Homo sapiens orphan G protein-coupled receptor (GPR38) gene, complete cds
gi|2654158|gb|AF034632.1|AF034632[2654158] - 13155: AF054633
Homo sapiens thrombin receptor gene, exon 1 and partial cds
gi|3309036|gb|AF054633.1|AF054633[3309036] - 13156: AF073792
Homo sapiens CGRP-receptor component protein mRNA, complete cds
gi|3300101|gb|AF073792.1|AF073792[3300101] - 13157: AF007575
Homo sapiens ES/130-related protein mRNA, partial cds - 13158: AF055917
Homo sapiens protease-activated receptor 4 mRNA, complete cds
gi|329332|gb|AF055917.1|AF055917[3293321] - 13160: AC005255
Homo sapiens chromosome 19, CIT-HSP-146e8, complete sequence
gi|3289998|gb|AC005255.1|AC005255[3289998] - 13165: AB012724
Homo sapiens gene for endothelin-A receptor, cis_element region
gi|3273319|dbj|AB012724.1|AB012724[3273319] - 13166: AB015745
Homo sapiens mRNA for human prolactin-releasing peptide receptor, complete cds
gi|3273224|dbj|AB015745.1|AB015745[3273224] - 13167: AF020498
Homo sapiens P2X1 purinoceptor (P2X) mRNA, complete cds
gi|3258622|gb|AF020498.1|AF020498[3258622] - 13170: AF051767
Homo sapiens GDNF family receptor alpha 3 (GFRA3) mRNA, complete cds
gi|2961631|gb|AF051767.1|AF051767[2961631] - 13171: AH006188
Homo sapiens GABA-A receptor pi subunit (GABRP), partial cds
gi|3252851|gb|AH006188.1|SEG_HSGABRP[3252851] - 13172: AF009702
Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 10 and complete cds
gi|3252850|gb|AF009702.1|HSGABRP10[3252850] - 13173: AF009701
Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 9
gi|3252849|gb|AF009701.1|HSGABRP09[3252849] - 13174: AF009700
Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 8
gi|3252848|gb|AF009700.1|HSGABRP08[3252848] - 13175: AF009699
Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 7
gi|3252847|gb|AF009699.1|HSGABRP07[3252847]
- 13176: AF009698
Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 6
gi|3252846|gb|AF009698.1|HSGABRP06[3252846] - 13177: AF009697
Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 5
gi|3252845|gb|AF009697.1|HSGABRP05[3252845] - 13178: AF009696
Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 4
gi|3252844|gb|AF009696.1|HSGABRP04[3252844] - 13179: AF009695
Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 3
gi|3252843|gb|AF009695.1|HSGABRP03[3252843] - 13180: AF009694
Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 2
gi|3252842|gb|AF009694.1|HSGABRP02[3252842] - 13181: AF009693
Homo sapiens GABA-A receptor pi subunit gene (GABRP), exon 1
gi|3252841|gb|AF009693.1|HSGABRP01[3252841] - 13182: E13909
cDNA encoding human MCP-1 receptor protein
gi|3252676|dbj|E13909.1|E13909[3252676] - 13183: E13892
cDNA encoding human novel G protein-coupling receptor protein
gi|3252659|dbj|E13892.1|E13892[3252659] - 13184: E13385
cDNA encoding human MIP-1 alpha/RANTES receptor
gi|13252190|dbj|E13385.1|E13385[3252190] - 13185: E13006
cDNA encoding human G-protein coupling receptor protein
gi|3251830|dbj|E13006.1|E13006[3251830] - 13186: E13005
cDNA encoding human G-protein-coupling receptor protein
gi|3251829|dbj|E13005.1|E13005[3251829] - 13187: E12979
cDNA encoding human interleukin-6 receptor
gi|3251803|dbj|E12979.1|E12979[3251803] - 13188: E12916
Human cDNA encoding a denatured low-density lipoprotein receptor
gi|3251747|dbj|E12916.1|E12916[3251747] - 13189: E12845
cDNA encoding melatonin receptor
gi|3251677|dbj|E12845.1|E12845[3251677] - 13190: E12752
A novel human Corticotropin Releasing Factor 2 (CRF2) receptor mRNA, complete cds
gi|3251584|dbj|E12752.1|E12752[3251584] - 13191: E12750
A novel human Corticotropin Releasing Factor 2 (CRF2) receptor mRNA, complete cds
gi|3251582|dbj|E12750.1|E12750[3251582] - 13192: E12703
cDNA encoding asialoglycoprotein receptor L-H2, AGPR L-H2
gi|3251535|dbj|E12703.1|E12703[3251535] - 13193: E12702
cDNA encoding asialoglycoprotein receptor H1, AGPR H1
gi|3251534|dbj|E12702.1|E12702[3251534] - 13197: E12658
cDNA encoding galanin receptor
gi|3251490|dbj|E12658.1|E12658[3251490] - 13198: E12487
Human cDNA encoding a G protein-coupled receptor
gi|3251320|dbj|E12487.1|E12487[3251320] - 13199: E12484
Human cDNA encoding a G protein-coupled receptor
gi|3251317|dbj|E12484.1|E12484[3251317] - 13200: E12354
cDNA encoding receptor of luteinizing hormone-releasing hormone, LH-RH receptor
gi|3251188|dbj|E12354.1|E12354[3251188] - 13201: E12281
cDNA encoding human growth hormone-releasing hormone receptor
gi|3251115|dbj|E12281.1|E12281[3251115] - 13202: E12186
A novel ligand for receptor type tyrosine kinase
gi|3251020|dbj|E12186.1|E12186[3251020] - 13203: E12185
cDNA encoding a receptor type tyrosine kinase
gi|3251019|dbj|E12185.1|E12185[3251019] - 13204: AF009962
Homo sapiens CC-chemokine receptor (CCR-5) gene, delta-32 allele, complete cds
gi|3243092|gb|AF009962.1|AF009962[3243092] - 13205: AF050525
Homo sapiens proteinase activated receptor-3 (PAR-3) gene, 5′ regulatory sequence
gi|3241996|gb|AF050525.1|AF050525[3241996] - 13206: U33328
Homo sapiens killer cell Ig-like receptor variant (KIR3DL1) mRNA, complete cds
gi|995756|gb|U33328.1|HSU33328[995756] - 13207: U31416
Homo sapiens killer cell Ig-like receptor (KIR3DL1) mRNA, complete cds
gi|973405|gb|U31416.1|HSU31416[973405] - 13208: U50748
Homo sapiens leptin receptor short form (db) mRNA, complete cds
gi|3236285|gb|U50748.1|HSU50748[3236285] - 13215: Y14838
Homo sapiens ChemR23 gene
gi|3219597|emb|Y14838.1|HSCHEMR23[3219597] - 13216: Y12505
H. sapiens mRNA for serotonin receptor 5-HT4B, splice variant
gi|2661756|emb|Y12505.1|HSY12505[2661756] - 13217: Y08756
H. sapiens mRNA for serotonin receptor 5-HT4
gi|2661732|emb|Y08756.1|HS5HT4AR[2661732] - 13218: X85785
H. sapiens DARC gene
gi|929624|emb|X85785.1|HSDARC[929624] - 13219: AH006173
Homo sapiens Type II integral membrane protein (NKG2-F), complete cds
gi|2674028|gb|AH006173.1|SEG_HSNKG2F0[2674028] - 13220: AF001298
Homo sapiens type II integral membrane protein (NKG2-D) gene, exons 9-13
gi|2674027|gb|AF001298.1|HSNKG2F02[2674027] - 13221: AF001297
Homo sapiens type II integral membrane protein (NKG2-D) gene, exons 5-8
gi|2674026|gb|AF001297.1|HSNKG2F01[2674026] - 13222: AF048704
Homo sapiens lamin B receptor homolog TM7SF2 gene, complete cds
gi|3211743|gb|AF048704.1|AF048704[3211743] - 13223: AF023676
Homo sapiens lamin B receptor homolog TM7SF2 (TM7SF2) mRNA, complete cds
gi|3211721|gb|AF023676.1|AF023676[3211721] - 13224: AJ001016
Homo sapiens mRNA encoding RAMP3
gi|3171913|emb|AJ001016.1|HSRAMP3[3171913] - 13236: Y13584
Homo sapiens mRNA for serotin receptor 4, short splice variant
gi|3183985|emb|Y13584.1|HSY13584[3183985] - 13237: AF030339
Homo sapiens receptor for viral semaphorin protein (VESPR) mRNA, complete cds
gi|3176761|gb|AF030339.1|AF030339[3176761] - 13239: AC004782
Homo sapiens chromosome 5, BAC clone 205e20 (LBNL H170), complete sequence
gi|3172145|gb|AC004782.1|AC004782[3172145] - 13240: AF009662
Homo sapiens T cell receptor beta locus, TCRBV13S1 to TCRBV6S9 region
gi|2275573|gb|AF009662.1|HSTCRBB27[2275573] - 13241: AJ001015
Homo sapiens mRNA encoding RAMP2
gi|3171911|emb|AJ001015.1|HSRAMP2[3171911] - 13242: AJ001014
Homo sapiens mRNA encoding RAMP1
gi|3171909|emb|AJ001014.1|HSRAMP1[3171909] - 13243: AF011333
Homo sapiens DEC-205 mRNA, complete cds
gi|3165456|gb|AF011333.1|AF011333[3165456] - 13244: AJ001902
Homo sapiens mRNA for TRIP6 (thyroid receptor interacting protein)
gi|2558591|emb|AJ001902.1|HSTRIP6[2558591] - 13245: AF002216
AF002216 AP20 melanoma mRNA Homo sapiens cDNA, mRNA sequence
gi|2895065|gb|AF002216.1|AF002216[2895065] - 13246: AF002215
AF002215 AP20 melanoma mRNA Homo sapiens cDNA, mRNA sequence
gi|2895064|gb|AF002215.1|AF002215[2895064] - 13247: AF002214
AF002214 AP20 melanoma mRNA Homo sapiens cDNA, mRNA sequence
gi|2895063|gb|AF002214.1|AF002214[2895063] - 13248: AC002411
Arabidopsis thaliana chromosome 1 BAC F20D22 sequence, complete sequence
gi|2570223|gb|AC002411.1|F20D22[2570223] - 13249: AF058927
Homo sapiens clone hvRNA92 vRNA sequence
gi|3138979|gb|AF058927.1|AF058927[3138979] - 13250: AF058926
Homo sapiens clone hvRNA82 vRNA sequence
gi|3138978|gb|AF058926.1|AF058926[3138978] - 13252: AC004699
Homo sapiens chromosome 19, cosmid R31973, complete sequence
gi|3138892|gb|AC004699.1|AC004699[3138892] - 13253: Y13472
Homo sapiens mRNA for FIM protein
gi|3135791|emb|Y13472.1|HSRIMP[3135791] - 13254: AF015452
Homo sapiens Usurpin-gamma mRNA, complete cds
gi|3133284|gb|AF015452.1|AF015452[3133284] - 13255: AF015451
Homo sapiens Usurpin-beta mRNA, complete cds
gi|3133282|gb|AF015451.1|AF015451[3133282] - 13256: AF015450
Homo sapiens Usurpin-alpha mRNA, complete cds
gi|3133280|gb|AF015450.1|AF015450[3133280] - 13257: AF063658
Homo sapiens vascular endothelial growth factor receptor 2 (KDR) mRNA, complete
cds
gi|3132832|gb|AF063658.1|AF063658[3132832] - 13258: AJ224869
Homo sapiens CXCR4 gene encoding receptor CXCR4
gi|3059119|emb|AJ224869.1|HSA224869[3059119] - 13259: AH006106
Homo sapiens apoptosis signaling receptor FAS (FAS) and apoptosis signaling receptor FAS (FAS)s, partial cds
gi|3128402|gb|AH006106.1|SEG_HSASRFAS[3128402] - 13260: AF061979
Homo sapiens apoptosis signaling receptor FAS (FAS) gene, exon 7 and partial cds
gi|3128401|gb|AF061979.1|HSASRFAS2[3128401] - 13261: AF061978
Homo sapiens apoptosis signaling receptor FAS (FAS) gene, exons 6 and 7 and partial cds
gi|3128400|gb|AF061978.1|HSASRFAS1[3128400] - 13262: AH006105
Homo sapiens sulfonylurea receptor type (SUR2) gene, alternative splice products, complete cds
gi|3127174|gb|AH006105.1|SEG_HSSUR2G[3127174] - 13263: AF061324
Homo sapiens sulfonylurea receptor 2B (SUR2) gene, alternatively spliced product, exon 38b and complete cds
gi|3127173|gb|AF061324.1|HSSUR2G71[3127173] - 13264: AF061323
Homo sapiens sulfonylurea receptor 2A (SUR2) gene, alternatively spliced product, exon 38a and complete cds
gi|3127172|gb|AF061323.1|HSSUR2G69[3127172] - 13265: AF061322
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 37
gi|3127171|gb|AF061322.1|HSSUR2G67[3127171] - 13266: AF061321
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 36
gi|3127170|gb|AF061321.1HSSUR2G65[3127170] - 13267: AF061320
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 35
gi|3127169|gb|AF061320.1|HSSUR2G63[3127169] - 13268: AF061319
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 34
gi|3127168|gb|AF061319.1|HSSUR2G61[3127168] - 13269: AF061318
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 33
gi|3127167|gb|AF061318.1|HSSUR2G59[3127167] - 13270: AF061317
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 32
gi|3127166|gb|AF061317.1|HSSUR2G57[3127166] - 13271: AF061316
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 31
gi|3127165|gb|AF061316.1|HSSUR2G55[3127165] - 13272: AF061315
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 30
gi|3127164|gb|AF061315.1|HSSUR2G53[3127164] - 13273: AF061314
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 29
gi|3127163|gb|AF061314.1|HSSUR2G51[3127163] - 13274: AF061313
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 28
gi|3127162|gb|AF061313.1|HSSUR2G49[3127162] - 13275: AF061312
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 27
gi|3127161|gb|AF061312.1|HSSUR2G47[3127161] - 13276: AF061311
Homo sapiens sulfonylurea receptor (SUR2) gene, exons 25 and 26
gi|3127160|gb|AF061311.1|HSSUR2G45[3127160] - 13277: AF061310
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 24
gi|3127159|gb|AF061310.1|HSSUR2G43[3127159] - 13278: AF061309
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 23
gi|3127158|gb|AF061309.1|HSSUR2G41[3127158] - 13279: AF061308
Homo sapiens sulfonylurea receptor (SUR2) gene, exons 21 and 22
gi|3127157|gb|AF061308.1|HSSUR2G39[3127157] - 13280: AF061307
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 20
gi|3127156|gb|AF061307.1|HSSUR2G37[3127156] - 13281: AF061306
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 19
gi|3127155|gb|AF061306.1|HSSUR2G35[3127155] - 13282: AF061305
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 18
gi|3127154|gb|AF061305.1|HSSUR2G33[3127154] - 13283: AF061304
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 17
gi|3127153|gb|AF061304.1|HSSUR2G31[3127153] - 13284: AF061303
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 16
gi|3127152|gb|AF061303.1|HSSUR2G29[3127152] - 13285: AF061302
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 15
gi|3127151|gb|AF061302.1|HSSUR2G27[3127151] - 13286: AF061301
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 14
gi|3127150|gb|AF061301.1|HSSUR2G25[3127150] - 13287: AF061300
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 13
gi|3127149|gb|AF061300.1|HSSUR2G23[3127149] - 13288: AF061299
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 12
gi|3127148|gb|AF061299.1|HSSUR2G21[3127148] - 13289: AF061298
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 11
gi|3127147|gb|AF061298.1|HSSUR2G19[3127147] - 13290: AF061297
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 10
gi|3127146|gb|AF061297.1|HSSUR2G17[3127146] - 13291: AF061296
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 9
gi|3127145|gb|AF061296.1|HSSUR2G15[3127145] - 13292: AF061295
Homo sapiens sulfonylurea receptor (SUR2) gene, exons 7 and 8
gi|3127144|gb|AF061295.1|HSSUR2G13[3127144] - 13293: AF061294
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 6
gi|3127143|gb|AF061294.1|HSSUR2G11[3127143] - 13294: AF061293
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 5
gi|3127142|gb|AF061293.1|HSSUR2G09[3127142] - 13295: AF061292
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 4
gi|3127141|gb|AF061292.1|HSSUR2G07[3127141] - 13296: AF061291
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 3
gi|3127140|gb|AF061291.1|HSSUR2G05[3127140] - 13297: AF061290
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 2
gi|3127139|gb|AF061290.1|HSSUR2G03[3127139] - 13298: AF061289
Homo sapiens sulfonylurea receptor (SUR2) gene, exon 1
gi|3127138|gb|AF061289.1|HSSUR2G01[3127138] - 13299: U77783
Homo sapiens N-methyl-D-aspartate receptor 2D subunit precursor (NMDAR2D) mRNA,
complete cds
gi|2444025|gb|U77783.1|HSU77783[2444025] - 13300: AJ001515
Homo sapiens mRNA for ryanodine receptor 3, complete CDS
gi|3123583|emb|AJ001515.1|HSRYR3[3123583] - 13302: AJ002512
Homo sapiens mRNA for ryanodine receptor 3, partial
gi|2582750|emb|AJ002512.1|HSAJ2512[2582750] - 13303: AJ002511
Homo sapiens mRNA for ryanodine receptor 2, partial
gi|2582748|emb|AJ002511.1HSAJ2511[2582748] - 13315: Z81148
H. sapiens mRNA for gonadotropin-releasing hormone receptor, splice variant
gi|1628389|emb|Z81148.1|HSGTRHSV[1628389] - 13316: U71092
Homo sapiens somatostatin receptor-like protein (GPR24) gene, complete cds
gi|1737178|gb|U71092.1|HSU71092[1737178] - 13317: AH006056
Homo sapiens chromosome 10 clone BAC 73106 map 10q25-q26
gi|3068782|gb|AH006056.1|SEG_HSGFRA1H[3068782] - 13318: AF058999
Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
gene, exon 11 and complete cds
gi|3068781|gb|AF058999.1|HSGFRA1H10[3068781] - 13319: AF058998
Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
gene, exon 10
gi|3068780|gb|AF058998.1|HSGFRA1H09[3068780] - 13320: AF058997
Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
gene, exon 9
gi|3068779|gb|AF058997.1|HSGFRA1H08[3068779] - 13321: AF058996
Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
gene, exon 8
gi|3068778|gb|AF058996.1|HSGFRA1H07[3068778] - 13322: AF058995
Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
gene, exon 7
gi|3068777|gb|AF058995.1|HSGFRA1H06[3068777] - 13323: AF058994
Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
gene, exon 6
gi|3068776|gb|AF058994.1|HSGFRA1H05[3068776] - 13324: AF058993
Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
gene, exon 5
gi|3068775|gb|AF058993.1|HSGFRA1H04[3068775] - 13325: AF058992
Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
gene, exon 4
gi|3068774|gb|AF058992.1|HSGFRA1H03[3068774] - 13326: AF058991
Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
gene, exon 3
gi|3068773|gb|AF058991.1|HSGFRA1H02[3068773] - 13327: AF058990
Homo sapiens glial cell line-derived neurotrophic factor receptor alpha (GFRA1)
gene, exon 2
gi|3068772|gb|AF058990.1|HSGFRA1H01[3068772] - 13328: AF044197
Homo sapiens B lymphocyte chemoattractant BLC mRNA, complete cds
gi|2911375|gb|AF044197.1|AF044197[2911375] - 13329: Y16280
Homo sapiens mRNA for G protein-coupled receptor ETBR-LP-2
gi|3059117|emb|Y16280.1|HSETBRLP2[3059117] - 13330: U16260
Neisseria gonorrheae lactoferrin receptor precursor (lbpA) gene, complete cds
gi|915277|gb|U16260.1|NGU16260[915277] - 13331: AF057177
Homo sapiens T-cell receptor gamma V1 gene region
gi|3047019|gb|AF057177.1|AF057177[3047019] - 13333: AF057168
Homo sapiens type II interleukin-1 receptor antagonist (IL-1ra3) gene, partial
cds
gi|3046605|gb|AF057168.1|AF057168[3046605] - 13334: L06155
Homo sapiens melanocortin receptor gene, complete cds
gi|188673|gb|L06155.1|HUMMR[188673] - 13335: L27490
Homo sapiens prostanoid EP3-I receptor mRNA, complete cds
gi|440313|gb|L27490.1|HUMPEIRB[440313] - 13336: L27489
Homo sapiens prostanoid EP3-III receptor mRNA, complete cds
gi|44031|gb|L27489.1|HUMPEIRA[440311] - 13337: L27488
Homo sapiens prostanoid EP3-II receptor mRNA, complete cds
gi|440309|gb|L27488.1|HUMPEIR[440309] - 13338: AF009664
Homo sapiens T cell receptor beta locus, 3′ trypsinogen repeats
gi|2275594|gb|AF009664.1|HSTCRB1H[2275594] - 13339: AF009660
Homo sapiens T cell receptor beta locus, TCRBV7S3A2 to TCRBV12S2 region
gi|2275560|gb|AF009660.1|HSTCRBK17[2275560] - 13340: AB006537
Homo sapiens mRNA for interleukin 1 receptor accessory protein, complete cds
gi|3041772|dbj|AB006537.1|AB006537[3041772] - 13341: AF016098
Homo sapiens vascular endothelial cell growth factor 165 receptor 2 (VEGF165R2)
mRNA, complete cds
gi|2978561|gb|AF016098.1|AF016098[2978561] - 13342: AF016050
Homo sapiens vascular endothelial cell growth factor 165 receptor/neuropilin (VEGF165) mRNA, complete cds
gi|2978559|gb|AF016050.1|AF016050[2978559] - 13343: U90941
Homo sapiens cell-type natural killer cells Fc gamma receptor RIIc4 (Fc-gammaRIIC) mRNA, complete cds
gi|214963|gb|U90941.1|HSU90941[2149631] - 13344: U90940
Homo sapiens cell-type natural killer cells Fc gamma receptor IIc3 (Fc-gammaRIIC) mRNA, complete cds
gi|2149629|gb|U90940.1|HSU90940[2149629] - 13345: U90939
Homo sapiens cell-type natural killer cells Fc gamma receptor IIc2 (Fc-gammaRIIC) mRNA, complete cds
gi|2149627|gb|U90939.1|HSU90939[2149627] - 13346: U90938
Homo sapiens cell-type natural killer cells Fc gamma receptor IIc1 (Fc-gammaRIIC) mRNA, complete cds
gi|2149625|gb|U90938.1|HSU90938[2149625] - 13348: Y14739
Homo sapiens CXCR4 gene
gi|3021393|emb|Y14739.1|HSCXCR4[3021393] - 13349: Y07683
H. sapiens mRNA for P2X3 purinoceptor
gi|2370146|emb|Y07683.1|HSP2X3PC[2370146] - 13350: AF027390
Homo sapiens 7q telomere, complete sequence
gi|3004858|gb|AF027390.1|AF027390[3004858] - 13351: U04357
Homo sapiens arginine vasopressin receptor type 11, V2 antidiuretic hormone receptor (AVPR2) gene, complete cds
gi|3004498|gb|U04357.1|HSU04357[3004498] - 13352: AH006005
Homo sapiens TGF-beta type I receptor (TGFBR1), complete cds
gi|3003037|gb|AH006005.1|SEG_HSTGFBR1G[3003037] - 13353: AF054598
Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 9 and complete cds
gi|3003036|gb|AF054598.1|HSTGFBR1G9[3003036] - 13354: AF054597
Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 8
gi|3003035|gb|AF054597.1|HSTGFBR1G8[3003035] - 13355: AF054596
Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 7
gi|3003034|gb|AF054596.1|HSTGFBR1G7[3003034] - 13356: AF054595
Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 6
gi|3003033|gb|AF054595.1|HSTGFBR1G6[3003033] - 13357: AF054594
Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 5
gi|3003032|gb|AF054594.1|HSTGFBR1G5[3003032] - 13358: AF054593
Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 4
gi|3003031|gb|AF054593.1|HSTGFBR1G4[3003031] - 13359: AF054592
Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 3
gi|3003030|gb|AF054592.1|HSTGFBR1G3[3003030] - 13360: AF054591
Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 2
gi|3003029|gb|AF054591.1|HSTGFBR1G2[3003029] - 13361: AF054590
Homo sapiens TGF-beta type I receptor (TGFBR1) gene, exon 1
gi|3003028|gb|AF054590.1|HSTGFBR1G1[3003028] - 13362: L12406
Homo sapiens chemoattractant receptor (fMLP) gene sequence
gi|348164|gb|L12406.1|HUMCR[348164] - 13363: AC004510
Homo sapiens chromosome 19, cosmid R30385, complete sequence
gi|12996651|gb|AC004510.1|AC004510[29969551] - 13364: U84721
Homo sapiens interferon gamma receptor 1 gene, microsatellite sequence
gi|2982188|gb|U84721.1|HSU84721[2982188] - 13365: AF013261
Homo sapiens alpha 1A adrenergic receptor isoform 4 mRNA, complete cds
gi|2978555|gb|AF013261.1|AF013261[2978555] - 13369: AF014794
Homo sapiens TNF related TRAIL receptor (TRAIL-R3) mRNA, complete cds
gi|2957263|gb|AF014794.1|AF014794[2957263] - 13372: AC003658
Homo sapiens Xp22 BAC GS-607H18 (Genome Systems Human BAC library) complete sequence
gi|2935592|gb|AC003658.1|AC003658[2935592] - 13375: AH005897
Homo sapiens type I sigma receptor, complete cds
gi|2914739|gb|AH005897.1|SEG_HSTIRG[2914739] - 13376: AF001977
Homo sapiens type I sigma receptor gene, exon 4 and complete cds
gi|2914738|gb|AF001977.1|HSTIRG3[2914738] - 13377: AF001976
Homo sapiens type I sigma receptor gene, exons 1, 2 and 3
gi|2914737|gb|AF001976.1|HSTIRG2[2914737] - 13486: U78192
Homo sapiens Edg-2 receptor mRNA, complete cds
gi|1688304|gb|U78192.1|HSU78192[1688304] - 13488: AF044492
Homo sapiens olfactory receptor-like protein (OLFR42A) gene, allele 9092.1, partial cds
gi|2828698|gb|AF044492.1|AF044492[2828698] - 13489: AF044491
Homo sapiens olfactory receptor-like protein (OLFR42A) gene, allele 9004.14, partial cds
gi|2828696|gb|AF044491.1|AF044491[2828696] - 13490: AF042078
Homo sapiens olfactory receptor-like protein (OLFR42A) gene, OLFR42A-9026.2 allele, partial cds
gi|282868|gb|AF042078.1|AF042078[2828681] - 13491: AB010710
Homo sapiens mRNA for lectin-like oxidized LDL receptor, complete cds
gi|2828355|dbj|AB010710.1|AB010710[2828355] - 13492: AF041462
Homo sapiens I-FLICE isoform 5 mRNA, complete cds
gi|2827297|gb|AF041462.1|AF041462[2827297] - 13493: AF041461
Homo sapiens I-FLICE isoform 4 mRNA, complete cds
gi|2827295|gb|AF041461.1|AF041461[2827295] - 13494: AF041460
Homo sapiens I-FLICE isoform 3 mRNA, complete cds
gi|2827293|gb|AF041460.1|AF041460[2827293] - 13495: AF041459
Homo sapiens I-FLICE isoform 2 mRNA, complete cds
gi|2827291|gb|AF041459.1|AF041459[2827291] - 13496: AF041458
Homo sapiens I-FLICE mRNA, complete cds
gi|2827289|gb|AF041458.1|AF041458[2827289] - 13497: Z73157
H. sapiens mRNA for C3a anaphylatoxin receptor
gi|2826756|emb|Z73157.1|HSC3AAREC[2826756] - 13498: U58917
Homo sapiens IL-17 receptor mRNA, complete cds
gi|2826475|gb|U58917.1|HSU58917[2826475] - 13524: Y16282
Homo sapiens mRNA for nicotinic acetylcholine receptor alpha6 subunit precursor
gi|2815224|emb|Y16282.1|HSY16282[2815224] - 13525: Y16281
Homo sapiens mRNA for nicotinic acetylcholine receptor alpha2 subunit precursor
gi|2815222|emb|Y16281.1|HSY16281[2815222] - 13526: X98858
H. sapiens mRNA for HLA-C specific activatory NK receptor
gi|1419593|emb|X98858.1|HSNKREC[1419593] - 13527: M76676
Homo sapiens leukocyte platelet-activating factor receptor mRNA, complete cds
gi|2810988|gb|M76676.1|HUMNPIIY20[2810988] - 13528: Y08420
H. sapiens mRNA for nicotinic acetylcholine receptor alpha7 subunit precursor
gi|2808623|emb|Y08420.1|HSNACHRA7[2808623] - 13529: Y08419
H. sapiens mRNA for nicotinic acetylcholine receptor alpha5 subunit precursor
gi|1702913|emb|Y08419.1|HSNACHRA5[1702913] - 13530: Y08421
H. sapiens mRNA for nicotinic acetylcholine receptor alpha4 subunit precursor
gi|1702911|emb|Y08421.1|HSNACHRA4[1702911] - 13531: Y08417
H. sapiens mRNA for nicotinic acetylcholine receptor beta3 subunit precursor
gi|1702909|emb|Y08417.1|HSNACHR3B[1702909] - 13532: Y08416
H. sapiens mRNA for nicotinic acetylcholine receptor beta4 subunit precursor
gi|1702919|emb|Y08416.1|HSNACHRB4[1702919] - 13533: Y08415
H. sapiens mRNA for nicotinic acetylcholine receptor beta2 subunit precursor
gi|1702917|emb|Y08415.1|HSNACHRB2[1702917] - 13534: Y08418
H. sapiens mRNA for nicotinic acetylcholine receptor alpha3 subunit precursor
gi|1702907|emb|Y08418.1|HSNACHR3A[1702907] - 13536: AF042077
Homo sapiens olfactory receptor-like protein (OLFR 42B) gene, OLFR 42B-9079.6 allele, partial cds
gi|2801710|gb|AF042077.1|AF042077[2801710] - 13537: AF042076
Homo sapiens olfactory receptor-like protein (OLFR 42B) gene, OLFR 42B-9108.1 allele, partial cds
gi|2801708|gb|AF042076.1|AF042076[2801708] - 13538: AF042075
Homo sapiens olfactory receptor-like protein (OLFR 428) gene, OLFR 42B-9110 allele, partial cds
gi|2801706|gb|AF042075.1|AF042075[2801706] - 13539: AF042074
Homo sapiens olfactory receptor-like protein (OLFR 42A) gene, OLFR 42A-9079.3 allele, partial cds
gi|2801704|gb|AF042074.1|AF042074[2801704] - 13540: AF042073
Homo sapiens olfactory receptor-like protein (OLFR 42A) gene, OLFR 42A-9049 allele, partial cds
gi|2801702|gb|AF042073.1|AF042073[2801702] - 13600: Y10530
H. sapiens gene encoding putative olfactory receptor (clone htpcr2)
gi|2792017|emb|Y10530.1|HSHTPCR2[2792017] - 13601: Y10529
H. sapiens mRNA for putative olfactory receptor (clone ht2)
gi|2792015|emb|Y10529.1|HSHT2[2792015] - 13614: Z26876
H. sapiens gene for ribosomal protein L38
gi|407422|emb|Z26876.1|HSRPL38[407422] - 13615: Z50150
H. sapiens mRNA for tyrosine kinase activator protein 1 (TKA-1)
gi|1246762|emb|Z50150.1|HSTKA1MR[1246762] - 13616: Y13055
Homo sapiens mRNA for NKG2-CII activating NK receptor
gi|2765292|emb|Y13055.1|HSNKG2CII[2765292] - 13617: Y13054
Homo sapiens mRNA for NK receptor, clone GR #29
gi|2765290|emb|Y13054.1|HSNKREC29[2765290] - 13618: Y10437
H. sapiens mRNA for serotonin receptor 4
gi|2765076|emb|Y10437.1|HSSERR4[2765076] - 13619: AJ002105
Homo sapiens mRNA for NK receptor, clone library TG14#13
gi|2764706|emb|AJ002105.1|HSAJ2105[2764706] - 13620: AJ002104
Homo sapiens mRNA for NK receptor, clone library TG14#6
gi|2764704|emb|AJ002104.1|HSAJ2104[2764704] - 13621: AJ002103
Homo sapiens mRNA for NK receptor, clone library TG14#35
gi|2764702|emb|AJ002103.1|HSAJ2103[2764702] - 13622: AJ002102
Homo sapiens mRNA for NK receptor, clone library TG14#8
gi|2764700|emb|AJ002102.1|HSAJ2102[2764700] - 13623: AJ000001
Homo sapiens mRNA for CD94-B NK receptor
gi|2764393|emb|AJ000001.1|HSCD94B[2764393] - 13624: Y10141
H. sapiens DAT1 gene, partial, VNTR
gi|1752665|emb|Y10141.1|HSDAT1[1752665] - 13625: Z97213
Homo sapiens mRNA for T-cell receptor
gi|2239129|emb|Z97213.1|HSTCRBV2S[2239129] - 13627: AF026263
Homo sapiens muscarinic receptor (CHRM5) mRNA, complete cds
gi|2605721|gb|AF026263.1|AF026263[2605721] - 13628: AF026261
Homo sapiens histamine H1 receptor mRNA, complete cds
gi|2605717|gb|AF026261.1|AF026261[2605717] - 13629: AF026260
Homo sapiens vitamin D receptor (VDR) mRNA, complete cds
gi|2605715|gb|AF026260.1|AF026260[2605715] - 13630: AH005786
Homo sapiens CC chemokine receptor 5 (CCR5) gene, complete cds
gi|2739498|gb|AH005786.1|SEG_HSCCR5AB[2739498] - 13631: AF031237
Homo sapiens CC chemokine receptor 5 (CCR5) gene, complete cds
gi|2739497|gb|AF031237.1|HSCCR5AB3[2739497] - 13633: AH005782
Homo sapiens chromosome X map Xq28
gi|2735348|gb|AH005782.1|SEG_HSGABRE[2735348] - 13634: AF037334
Homo sapiens Eph-like receptor tyrosine kinase hEphB1d (EphB1) mRNA, complete cds
gi|2739209|gb|AF037334.1|AF037334[2739209] - 13635: AF037333
Homo sapiens Eph-like receptor tyrosine kinase hEphB1c (EphB1) mRNA, complete cds
gi|2739207|gb|AF037333.1|AF037333[2739207] - 13636: AF011406
Homo sapiens corticotropin releasing hormone receptor type 2 beta isoform (CRH2R) mRNA, complete cds
gi|2738557|gb|AF011406.1|AF011406[2738557] - 13637: U59632
Homo sapiens H5 mRNA, partial cds; and platelet glycoprotein Ib beta chain mRNA,
complete cds
gi|1809264|gb|U59632.1|HSU59632[1809264] - 13638: D86864
Homo sapiens mRNA for acetyl LDL receptor, complete cds
gi|2723468|dbj|D586864.1|D86864[2723468] - 13639: AF027208
Homo sapiens AC133 antigen mRNA, complete cds
gi|2688948|gb|AF027208.1|AF027208[2688948] - 13640: AB001025
Homo sapiens mRNA for brain ryanodine receptor, complete cds
gi|2696014|dbj|AB001025.1|AB001025[2696014] - 13641: D00017
Homo sapiens mRNA for lipocortin II, complete cds
gi|219909|dbj|D00017.1|HUMLIC[219909] - 13642: Y08236
H. sapiens LRP gene, polymorphisms in intron 24
gi|2125808|emb|Y08236.1|HSLRPIN24[2125808] - 13644: AF025998
Homo sapiens atrial natriuretic peptide clearance receptor (ANPRC) mRNA, complete cds
gi|2570851|gb|AF025998.1|AF025998[2570851] - 13645: AD000671
Homo sapiens DNA from chromosome 19-cosmid f24109 containing HRX2, genomic sequence
gi|1905893|gb|AD000671.1|AD000671[1905893] - 13646: Z49119
H. sapiens mRNA for serotonin 6 receptor (5-HT6; partial)
gi|984128|emb|Z49119.1|HS5HT6[984128] - 13647: Z48150
H. sapiens 5-HT4 mRNA for serotonin 4 receptor (5-HT4)
gi|984126|emb|Z48150.1|HS5HT4[984126] - 13648: Y15743
Homo sapiens RET proto-oncogene, exon 13 containing two mutations
gi|2665353|emb|Y15743.1|HSRET13[2665353] - 13649: AF000575
Homo sapiens clone 16 immunoglobulin-like transcript 5 mRNA, complete cds
gi|2264428|gb|AF000575.1|AF000575[2264428] - 13650: AF000574
Homo sapiens clone 1 immunoglobulin-like transcript 4 mRNA, complete cds
gi|2264426|gb|AF000574.1|AF000574[2264426] - 13651: Z26652
H. sapiens FLT3 mRNA for FLT3 receptor tyrosine kinase
gi|406322|emb|Z26652.1|HSFLT3RTK[406322]
- 13653: X82208
H. sapiens mRNA for beta-centractin (ATCC# HHCPJ76)
gi|563887|emb|X82208.1|HSBCENTR[563887] - 13654: AF035261
Homo sapiens thyroid stimulating hormone receptor (TSHR) mRNA, partial cds
gi|2654195|gb|AF035261.1|HSTSHR[2654195] - 13655: AF032388
Homo sapiens vasopressin receptor type 2 mRNA, alternatively spliced, complete
cds
gi|2654030|gb|AF032388.1|AF032388[2654030] - 13656: AF025534
Homo sapiens leucocyte immunoglobulin-like receptor-8 (LIR-8) mRNA, complete cds
gi|2653874|gb|AF025534.1|AF025534[2653874] - 13657: AF025533
Homo sapiens leucocyte immunoglobulin-like receptor-3 (LIR-3) mRNA, complete cds
gi|2653872|gb|AF025533.1|AF025533[2653872] - 13658: AF025532
Homo sapiens leucocyte immunoglobulin-like receptor-5 (LIR-5) mRNA, complete cds
gi|2653870|gb|AF025532.1|AF025532[2653870] - 13659: AF025531
Homo sapiens leucocyte immunoglobulin-like receptor-7 (LIR-7) mRNA, complete cds
gi|2653868|gb|AF025531.1|AF025531[2653868] - 13660: AF025530
Homo sapiens leucocyte immunoglobulin-like receptor-6a (LIR-6) mRNA, complete cds
gi|2653866|gb|AF025530.1|AF025530[2653866] - 13661: AF025529
Homo sapiens leucocyte immunoglobulin-like receptor-6b (LIR-6) mRNA, complete cds
gi|2653864|gb|AF025529.1|AF025529[2653864] - 13662: AF025528
Homo sapiens leucocyte immunoglobulin-like receptor-2 (LIR-2) mRNA, complete cds
gi|2653862|gb|AF025528.1|AF025528[2653862] - 13663: AF025527
Homo sapiens leucocyte immunoglobulin-like receptor-4 (LIR-4) mRNA, complete cds
gi|2653860|gb|AF025527.1|AF025527[2653860] - 13664: Y13583
Homo sapiens mRNA for G-protein coupled receptor
gi|2652933|emb|Y13583.1|HSGPCP[2652933] - 13665: Y13367
H. sapiens mRNA for phosphoinositide 3-kinase
gi|2143259|emb|Y13367.1|HSPHOSI3K[2143259] - 13666: X82207
H. sapiens mRNA for beta-centractin (PC3)
gi|563885|emb|X82207.1|HSBCENT[563885] - 13667: AF033854
Homo sapiens lymphocyte inhibitor of TRAIL (LIT) mRNA, complete cds
gi|2645841|gb|AF033854.1|AF033854[2645841] - 13668: X81882
H. sapiens mRNA for for vasopressin activated calcium mobilizing receptor-like protein
gi|1628414|emb|X81882.1|HSVACM1[1628414] - 13669: AF024690
Homo sapiens putative G protein-coupled receptor (GPR43) gene, complete cds
gi|2612951|gb|AF024690.1|AF024690[2612951] - 13670: AF024689
Homo sapiens putative G protein-coupled receptor (GPR42) gene, complete cds
gi|2612949|gb|AF024689.1|AF024689[2612949] - 13671: AF024688
Homo sapiens putative G protein-coupled receptor (GPR41) gene, complete cds
gi|2612947|gb|AF024688.1|AF024688[2612947] - 13672: AF024687
Homo sapiens putative G protein-coupled receptor (GPR40) gene, complete cds
gi|2612945|gb|AF024687.1|AF024687[2612945] - 13673: D87513
Homo sapiens mRNA for Grb7 protein, partial cds
gi|1526534|dbj|D587513.1|D87513[1526534] - 13674: D49919
Homo sapiens mRNA for C-C chemokine receptor type 2, complete cds
gi|2626807|dbj|D549919.1|D49919[2626807] - 13675: AF030512
Homo sapiens small cell vasopressin subtype 1b receptor mRNA, complete cds
gi|2613124|gb|AF030512.1|AF030512[2613124] - 13676: Y12852
Homo sapiens P2X7 gene, exon 2 and 3
gi|2612788|emb|Y12852.1|HSP2X7E23[2612788] - 13677: Y12851
Homo sapiens P2X7 gene, exon 1 and joined CDS
gi|2597926|emb|Y12851.1|HSP2X7EX1[2597926] - 13678: Y12854
Homo sapiens P2X7 gene, exon 9-11
gi|2612787|emb|Y12854.1|HSP2X7911[2612787] - 13679: Y12853
Homo sapiens P2X7 gene, exon 4-8
gi|2612786|emb|Y12853.1|HSP2X748[2612786] - 13680: Y12855
Homo sapiens P2X7 gene, exon 12 and 13
gi|2612785|emb|Y12855.1|HSP2X7123[2612785] - 13681: AB005520
Homo sapiens ppar gamma2 gene for peroxisome proliferator activated-receptor gamma, partial cds and 5′ flanking
gi|2605488|dbj|AB005520.1|AB005520[2605488] - 13682: Y09765
Homo sapiens mRNA for putative GABA receptor epsilon subunit
gi|2285960|emb|Y09765.1|HSY09765[2285960] - 13683: Y09764
Homo sapiens GABRE gene, exon 2-8
gi|2285959|emb|Y09764.1|HSY09764[2285959] - 13684: Y09763
Homo sapiens GABRE gene, exon 1 (and joined CDS)
gi|2285957|emb|Y09763.1|HSY09763[2285957] - 13685: AF026535
Homo sapiens chemokine receptor (CCR3) mRNA, complete cds
gi|2582565|gb|AF026535.1|AF026535[2582565] - 13686: AF026071
Homo sapiens soluble death receptor 3 beta (DR3) mRNA, complete cds
gi|2570832|gb|AF026071.1|AF026071[2570832] - 13687: AF022956
Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
gi|2570532|gb|AF022956.1|AF022956[2570532] - 13688: AF022955
Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
gi|2570530|gb|AF022955.1|AF022955[2570530] - 13689: AF022954
Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
gi|2570528|gb|AF022954.1|AF022954[2570528] - 13690: AF022953
Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
gi|2570526|gb|AF022953.1|AF022953[2570526] - 13691: AF014958
Homo sapiens chemokine receptor X (CKRX) mRNA, complete cds
gi|2305263|gb|AF014958.1|AF014958[2305263] - 13692: AB000712
Homo sapiens hCPE-R mRNA for CPE-receptor, complete cds
gi|2570124|dbj|AB000712.1|AB000712[2570124] - 13693: X94609
H. sapiens mRNA for activatory NK receptor/KKA3 p50.3
gi|1495414|emb|X94609.1HSANKRMR[1495414] - 13694: AF025375
Homo sapiens chemokine receptor-4 (CXCR4) mRNA, complete cds
gi|2565335|gb|AF025375.1|AF025375[2565335] - 13695: AF000380
Homo sapiens folate binding protein mRNA, complete cds
gi|2565193|gb|AF000380.1|HSAF000380[2565193] - 13696: U35875
Homo sapiens B2 bradykinin receptor mRNA, 5′ sequence
gi|1353391|gb|U35875.1|HSU35875[1353391] - 13697: AF010193
Homo sapiens MAD-related gene SMAD7 (SMAD7) mRNA, complete cds
gi|2252821|gb|AF010193.1|AF010193[2252821] - 13698: X94634
H. sapiens CD97 gene exon 7
gi|1165087|emb|X94634.1|HSX94634[1165087] - 13699: X94633
H. sapiens CD97 gene exon 4
gi|1165086|emb|X94633.1|HSX94633[1165086] - 13700: X94632
H. sapiens CD97 gene exon 3
gi|1165085|emb|X94632.1|HSX94632[1165085] - 13702: AF007892
Homo sapiens P2Y6 receptor, long splice variant mRNA, complete cds
gi|2258421|gb|AF007892.1|[2258421] - 13703: AF007891
Homo sapiens P2Y6 receptor, short splice variant mRNA, complete cds
gi|2258419|gb|AF007891.1|[2258419] - 13704: AF022383
Homo sapiens complexin I mRNA, complete cds
gi|2465458|gb|AF022383.1|AF022383[2465458] - 13709: X89860
H. sapiens mRNA for T-cell receptor alpha chain
gi|927420|emb|X89860.1|HSNP7TCR2[927420] - 13710: Y08456
H. sapiens ChemR1 gene
gi|2465081|emb|Y08456.1|HSCHEMR1[2465081] - 13711: U95025
Homo sapiens metabotropic glutamate receptor 8 (GRM8) mRNA, complete cds
gi|2435409|gb|U95025.1|HSU95025[2435409] - 13712: AF021799
Homo sapiens interleukin 17 receptor-like mRNA sequence
gi|2460201|gb|AF021799.1|AF021799[2460201] - 13714: U73443
Homo sapiens 5HT3 serotonin receptor gene, partial cds
gi|2459549|gb|U73443.1|MMU73443[2459549] - 13715: AB000520
Homo sapiens mRNA for APS, complete cds
gi|2447035|dbj|AB000520.1|AB000520[2447035] - 13716: X98172
H. sapiens mRNA for MACH-alpha-1 protein
gi|1403318|emb|X98172.1|HSMACHA1[1403318] - 13728: AH005567
Homo sapiens chromosome 4 map 4q13
gi|2290767|gb|AH005567.1|SEG_HSGNRHR[2290767] - 13729: AF001952
Homo sapiens gonadotropin releasing hormone receptor (GNRHR) gene, exon 3 and complete cds
gi|2290766|gb|AF001952.1|HSGNRHR3[2290766] - 13730: AF001951
Homo sapiens gonadotropin releasing hormone receptor (GNRHR) gene, exon 2
gi|2290765|gb|AF001951.1|HSGNRHR2[2290765] - 13731: AF001950
Homo sapiens gonadotropin releasing hormone receptor (GNRHR) gene, exon 1
gi|2290764|gb|AF001950.1|HSGNRHR1[2290764] - 13733: AF020201
Homo sapiens Jagged 2 mRNA, complete cds
gi|2432001|gb|AF020201.1|AF020201([2432001] - 13734: Y14442
Homo sapiens mRNA for olfactory receptor protein, partial
gi|2370144|emb|Y14442.1|HSOLFMF[2370144] - 13736: AF017061
Homo sapiens vasopressin-activated calcium mobilizing putative receptor protein
(VACM-1) mRNA, complete cds
gi|2394273|gb|AF017061.1|AF017061[2394273] - 13737: AF017262
Homo sapiens putative G protein-coupled receptor mRNA, complete cds
gi|2388705|gb|AF017262.1|AF017262[2388705] - 13738: AF016917
Homo sapiens GABA-A receptor delta subunit (GABRD) mRNA, complete cds
gi|2388692|gb|AF016917.1|AF016917[2388692] - 13739: Y13248
Homo sapiens mRNA for orphan chemokine receptor TYMSTR
gi|2370179|emb|Y13248.1|HSY13248[2370179] - 13740: D83492
Homo sapiens mRNA for Eph-family protein, complete cds
gi|2281007|dbj|D83492.1|D83492[2281007] - 13741: AB002058
Homo sapiens mRNA for HUMAN P2XM, complete cds
gi|2350846|dbj|AB002058.1|AB002058[2350846] - 13742: AF015251
Homo sapiens breast cancer-related unknown protein mRNA, partial cds
gi|2345090|gb|AF015251.1|AF015251[2345090] - 13743: AF004231
Homo sapiens monocyte/macrophage Ig-related receptor MIR-10 (MIR cl-10) mRNA, complete cds
gi|2343110|gb|AF004231.1|AF004231[2343110] - 13744: AF004230
Homo sapiens monocyte/macrophage Ig-related receptor MIR-7 (MIR cl-7) mRNA, complete cds
gi|2343108|gb|AF004230.1|AF004230[2343108] - 13745: X90563
H. sapiens mRNA for peroxisome proliferactor activated receptor gamma
gi|1480099|emb|X90563.1|HSPPARGAM[1480099] - 13746: AF012629
Homo sapiens antagonist decoy receptor for TRAIL/Apo-2L (TRID) mRNA, complete cds
gi|2338430|gb|AF012629.1|AF012629[2338430] - 13747: AF012628
Homo sapiens death domain containing receptor for TRAIL/Apo-2L (DR5) mRNA, complete cds
gi|2338428|gb|AF012628.1|AF012628[2338428] - 13748: AF012536
Homo sapiens decoy receptor 1 (DcR1) mRNA, complete cds
gi|2338421|gb|AF012536.1|AF012536[2338421] - 13749: AF012535
Homo sapiens death receptor 5 (DR5) mRNA, complete cds
gi|2338419|gb|AF012535.1|AF012535[2338419] - 13750: AF012903
Homo sapiens P2X4 ATP-gated cation channel protein mRNA, partial cds
gi|2331043|gb|AF012903.1|AF012903[2331043] - 13751: X69316
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 21
gi|34105|emb|X69316.1|HSKITPO16[34105] - 13752: X69315
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exons 18, 19, 20
gi|34104|emb|X69315.1|HSKITPO15[34104] - 13753: X69314
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 17
gi|34103|emb|X69314.1|HSKITPO14[34103] - 13754: X69313
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 16
gi|34102|emb|X69313.1|HSKITPO13[34102] - 13755: X69312
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 15
gi|34101|emb|X69312.1|HSKITPO12[34101] - 13756: X69311
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 14
gi|34100|emb|X69311.1|HSKITPO11[34100] - 13757: X69310
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exons 10, 11, 12, 13
gi|34099|emb|X69310.1|HSKITPO10[34099] - 13758: X69309
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 9
gi|34098|emb|X69309.1|HSKITPO09[34098] - 13759: X69308
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 8
gi|34097|emb|X69308.1|HSKITPO08[34097] - 13760: X69307
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 7
gi|34096|emb|X69307.1|HSKITPO07[34096] - 13761: X69306
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 6
gi|34095|emboX69306.1|HSKITPO06[34095] - 13762: X69305
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 5
gi|34094|emb|X69305.1|HSKITPO05[34094] - 13763: AF005419
Homo sapiens P2Y5-like receptor gene, complete cds
gi|2240034|gb|AF005419.1|AF005419[2240034] - 13764: L42324
Homo sapiens (clone GPCR W) G protein-linked receptor gene (GPCR) gene, 5′ end
of cds
gi|066730|gb|L42324.1|HUMFRCG[1066730] - 13766: AF015910
Homo sapiens unknown protein mRNA, partial cds
gi|2286201|gb|AF015910.1|AF015910[2286201] - 13767: X99250
H. sapiens mRNA for endothelin-B receptor splice variant
gi|2285955|emb|X99250.1|HSX99250[2285955] - 13768: AF007545
Homo sapiens SIV/HIV receptor Bonzo (Bonzo) mRNA, complete cds
gi|225342|gb|AF007545.1|AF007545[2253421] - 13769: Z79783
H. sapiens G protein-coupled receptor CKR-L2
gi|2281709|emb|Z79783.1|HSCKRL2[2281709] - 13778: Z49994
H. sapiens partial gene for proteinase-activated receptor 2 (1289 BP)
gi|1008086|emb|Z49994.1|HSPAR2B[1008086] - 13779: AF007555
Homo sapiens IAR/receptor-like protein-tyrosine phosphatase precursor mRNA, complete cds
gi|2262074|gb|AF007555.1|AF007555[2262074] - 13780: AF008556
Homo sapiens interleukin-2 receptor mRNA, alternatively spliced, partial cds
gi|2266932|gb|AF008556.1|AF008556[2266932] - 13891: Y10152
H. sapiens mRNA for CRF2 receptor, beta isoform, aberrantly spliced, (94 bp deletion)
gi|1785640|emb|Y10152.1|HSCRF294[1785640] - 13892: Y10153
H. sapiens mRNA for CRF2 receptor, beta isoform, aberrantly spliced, (227 bp insertion)
gi|1785639|emb|Y10153.1|HSCRF2227[1785639] - 13893: Y10151
H. sapiens mRNA for CRF2 receptor, beta isoform, partial
gi|1785637|emb|Y10151.1|HSCRF2[1785637] - 13894: M17325
Homo sapiens T-cell receptor gamma-chain constant region (TCRGC1) mRNA, partial
cds
gi|2072752|gb|M17325.1|HUMTCGCJ[2072752] - 13895: M17324
Homo sapiens T-cell receptor gamma-chain constant region (TCRGC2) mRNA, partial
cds
gi|207275|gb|M17324.1|HUMTCGCI[2072751] - 13896: M17323
Homo sapiens T-cell receptor gamma-chain constant region (TCRGC2) mRNA, partial
cds
gi|2072750|gb|M17323.1|HUMTCGCH[2072750] - 13897: AF004327
Homo sapiens angiopoietin-2 mRNA, complete cds
gi|2257932|gb|AF004327.1|AF004327[2257932] - 13898: AF004021
Homo sapiens prostaglandin F2 alpha receptor mRNA, complete cds
gi|2257849|gb|AF004021.1|AF004021[2257849] - 13899: AF006464
Homo sapiens muscle specific tyrosine kinase receptor (MUSK) mRNA, complete cds
gi|225331|gb|AF006464.1|AF006464[2253311] - 13900: AF005637
Homo sapiens endothelin A receptor gene, 5′ flanking region and exon 1
gi|2253289|gb|AF005637.1|AF005637[2253289] - 13902: Z24461
H. sapiens MTCP-1 gene
gi|406866|emb|Z24461.1|HSMTCP1I[406866] - 13903: Z24463
H. sapiens MTCP-1 gene
gi|406865|emb|Z24463.1|HSMTCP1H[406865] - 13904: Z24457
H. sapiens of TCRA gene MTCP-1 gene
gi|406860|emb|Z24457.1|HSMTCP1D[406860] - 13905: Z24456
H. sapiens of MTCP-1 gene MTCP-1 gene
gi|406859|emb|Z24456.1|HSMTCP1C[406859] - 13906: U45984
Homo sapiens CCR6 chemokine receptor (CMKBR6) gene, complete cds
gi|2246432|gb|U45984.1|HSU45984[2246432] - 13908: AF005900
Homo sapiens alpha2B-adrenergic receptor (alpha2C2AR) gene, complete cds
gi|2245627|gb|AF005900.1|AF005900[2245627] - 13909: AF005210
Homo sapiens CC chemokine receptor CCR8 (CMKBR8) mRNA, partial cds
gi|2245579|gb|AF005210.1|AF005210[2245579] - 13524: Y16282
Homo sapiens mRNA for nicotinic acetylcholine receptor alpha6 subunit precursor
gi|2815224|emb|Y16282.1|HSY16282[2815224] - 13525: Y16281
Homo sapiens mRNA for nicotinic acetylcholine receptor alpha2 subunit precursor
gi|2815222|emb|Y16281.1|HSY16281[2815222] - 13526: X98858
H. sapiens mRNA for HLA-C specific activatory NK receptor
gi|1419593|emb|X98858.1|HSNKREC[1419593] - 13527: M76676
Homo sapiens leukocyte platelet-activating factor receptor mRNA, complete cds
gi|2810988|gb|M76676.1|HUMNPIIY20[2810988] - 13528: Y08420
H. sapiens mRNA for nicotinic acetylcholine receptor alpha7 subunit precursor
gi|2808623|emb|Y08420.1|HSNACHRA7[2808623] - 13529: Y08419
H. sapiens mRNA for nicotinic acetylcholine receptor alpha5 subunit precursor
gi|1702913|emb|Y08419.1|HSNACHRA5[1702913] - 13530: Y08421
H. sapiens mRNA for nicotinic acetylcholine receptor alpha4 subunit precursor
gi|1702911|emb|Y08421.1|HSNACHRA4[1702911] - 13531: Y08417
H. sapiens mRNA for nicotinic acetylcholine receptor beta3 subunit precursor
gi|1702909|emb|Y08417.1|HSNACHR3B[1702909] - 13532: Y08416
H. sapiens mRNA for nicotinic acetylcholine receptor beta4 subunit precursor
gi|1702919|emb|Y08416.1|HSNACHRB4[1702919] - 13533: Y08415
H. sapiens mRNA for nicotinic acetylcholine receptor beta2 subunit precursor
gi|1702917|emb|Y08415.1|HSNACHRB2[1702917] - 13534: Y08418
H. sapiens mRNA for nicotinic acetylcholine receptor alpha3 subunit precursor
gi|1702907|emb|Y08418.1|HSNACHR3A[1702907] - 13535: AF001985
Homo sapiens CD38 gene, 5′ upstream sequence
gi|2804672|gb|AF001985.1|AF001985[2804672] - 13536: AF042077
Homo sapiens olfactory receptor-like protein (OLFR 42B) gene, OLFR 42B-9079.6 allele, partial cds
gi|2801710|gb|AF042077.1|AF042077[2801710] - 13537: AF042076
Homo sapiens olfactory receptor-like protein (OLFR 42B) gene, OLFR 42B-9108.1 allele, partial cds
gi|2801708|gb|AF042076.1|AF042076[2801708] - 13538: AF042075
Homo sapiens olfactory receptor-like protein (OLFR 42B) gene, OLFR 42B-9110 allele, partial cds
gi|2801706|gb|AF042075.1|AF042075[2801706] - 13539: AF042074
Homo sapiens olfactory receptor-like protein (OLFR 42A) gene, OLFR 42A-9079.3 allele, partial cds
gi|2801704|gb|AF042074.1|AF042074[2801704] - 13540: AF042073
Homo sapiens olfactory receptor-like protein (OLFR 42A) gene, OLFR 42A-9049 allele, partial cds
gi|2801702|gb|AF042073.1|AF042073[2801702] - 13600: Y10530
H. sapiens gene encoding putative olfactory receptor (clone htpcr2)
gi|2792017|emb|Y10530.1|HSHTPCR2[2792017] - 13601: Y10529
H. sapiens mRNA for putative olfactory receptor (clone ht2)
gi|2792015|emb|Y10529.1|HSHT2[2792015] - 13614: Z26876
H. sapiens gene for ribosomal protein L38
gi|407422|emb|Z26876.1|HSRPL38[407422] - 13615: Z50150
H. sapiens mRNA for tyrosine kinase activator protein 1 (TKA-1)
gi|1246762|emb|Z50150.1|HSTKA1MR[1246762] - 13616: Y13055
Homo sapiens mRNA for NKG2-CII activating NK receptor
gi|2765292|emb|Y13055.1|HSNKG2CII[2765292] - 13617: Y13054
Homo sapiens mRNA for NK receptor, clone GR #29
gi|2765290|emb|Y13054.1|HSNKREC29[2765290] - 13618: Y10437
H. sapiens mRNA for serotonin receptor 4
gi|2765076|emb|Y10437.1|HSSERR4[2765076] - 13619: AJ002105
Homo sapiens mRNA for NK receptor, clone library TG14#13
gi|2764706|emb|AJ002105.1|HSAJ2105[2764706] - 13620: AJ002104
Homo sapiens mRNA for NK receptor, clone library TG14#6
gi|2764704|emb|AJ002104.1|HSAJ2104[2764704] - 13621: AJ002103
Homo sapiens mRNA for NK receptor, clone library TG14#35
gi|2764702|emb|AJ002103.1|HSAJ2103[2764702] - 13622: AJ002102
Homo sapiens mRNA for NK receptor, clone library TG14#8
gi|2764700|emb|AJ002102.1|HSAJ2102[2764700] - 13623: AJ000001
Homo sapiens mRNA for CD94-B NK receptor
gi|2764393|emb|AJ000001.1|HSCD94B[2764393] - 13624: Y10141
H. sapiens DAT1 gene, partial, VNTR
gi|1752665|emb|Y10141.1|HSDAT1[1752665] - 13625: Z97213
Homo sapiens mRNA for T-cell receptor
gi|2239129|emb|Z97213.1|HSTCRBV2S[2239129] - 13627: AF026263
Homo sapiens muscarinic receptor (CHRM5) mRNA, complete cds
gi|2605721|gb|AF026263.1|AF026263[2605721] - 13628: AF026261
Homo sapiens histamine H1 receptor mRNA, complete cds
gi|2605717|gb|AF026261.1|AF026261[2605717] - 13629: AF026260
Homo sapiens vitamin D receptor (VDR) mRNA, complete cds
gi|2605715|gb|AF026260.1|AF026260[2605715] - 13630: AH005786
Homo sapiens CC chemokine receptor 5 (CCR5) gene, complete cds
gi|2739498|gb|AH005786.1|SEG_HSCCR5AB[2739498] - 13631: AF031237
Homo sapiens CC chemokine receptor 5 (CCR5) gene, complete cds
gi|2739497|gb|AF031237.1|HSCCR5AB3[2739497] - 13633: AH005782
Homo sapiens chromosome X map Xq28
gi|2735348|gb|AH005782.1|SEG_HSGABRE[2735348] - 13634: AF037334
Homo sapiens Eph-like receptor tyrosine kinase hEphB1d (EphB1) mRNA, complete cds
gi|2739209|gb|AF037334.1|AF037334[2739209] - 13635: AF037333
Homo sapiens Eph-like receptor tyrosine kinase hEphB1c (EphB1) mRNA, complete cds
gi|2739207|gb|AF037333.1|AF037333[2739207] - 13636: AF011406
Homo sapiens corticotropin releasing hormone receptor type 2 beta isoform (CRH2R) mRNA, complete cds
gi|2738557|gb|AF011406.1|AF011406[2738557] - 13637: U59632
Homo sapiens H5 mRNA, partial cds; and platelet glycoprotein Ib beta chain mRNA,
complete cds
gi|1809264|gb|U59632.1|HSU59632[1809264] - 13638: D86864
Homo sapiens mRNA for acetyl LDL receptor, complete cds
gi|2723468|dbj|D86864.1|D86864[2723468] - 13639: AF027208
Homo sapiens AC133 antigen mRNA, complete cds
gi|2688948|gb|AF027208.1|AF027208[2688948] - 13640: AB001025
Homo sapiens mRNA for brain ryanodine receptor, complete cds
gi|2696014|dbj|AB001025.1|AB001025[2696014] - 13641: D00017
Homo sapiens mRNA for lipocortin II, complete cds
gi|219909|dbj|D00017.1|HUMLIC[219909] - 13644: AF025998
Homo sapiens atrial natriuretic peptide clearance receptor (ANPRC) mRNA, complete cds
gi|257085|gb|AF025998.1|AF025998[2570851] - 13645: AD000671
Homo sapiens DNA from chromosome 19-cosmid f24109 containing HRX2, genomic sequence
gi|1905893|gb|AD000671.1|AD000671[1905893] - 13646: Z49119
H. sapiens mRNA for serotonin 6 receptor (5-HT6; partial)
gi|984128|emb|Z49119.1|HS5HT6[984128] - 13647: Z48150
H. sapiens 5-HT4 mRNA for serotonin 4 receptor (5-HT4)
gi|984126|emb|Z48150.1|HS5HT4[984126] - 13648: Y15743
Homo sapiens RET proto-oncogene, exon 13 containing two mutations
gi|2665353|emb|Y15743.1|HSRET13[2665353] - 13649: AF000575
Homo sapiens clone 16 immunoglobulin-like transcript 5 mRNA, complete cds
gi|2264428|gb|AF000575.1|AF000575[2264428] - 13650: AF000574
Homo sapiens clone 1 immunoglobulin-like transcript 4 mRNA, complete cds
gi|2264426|gb|AF000574.1|AF000574[2264426] - 13651: Z26652
H. sapiens FLT3 mRNA for FLT3 receptor tyrosine kinase
gi|406322|emb|Z26652.1|HSFLT3RTK[406322] - 13653: X82208
H. sapiens mRNA for beta-centractin (ATCC# HHCPJ76)
gi|563887|emb|X82208.1|HSBCENTR[563887] - 13654: AF035261
Homo sapiens thyroid stimulating hormone receptor (TSHR) mRNA, partial cds
gi|2654195|gb|AF035261.1|HSTSHR[2654195] - 13655: AF032388
Homo sapiens vasopressin receptor type 2 mRNA, alternatively spliced, complete
cds
gi|2654030|gb|AF032388.1|AF032388[2654030] - 13656: AF025534
Homo sapiens leucocyte immunoglobulin-like receptor-8 (LIR-8) mRNA, complete cds
gi|2653874|gb|AF025534.1|AF025534[2653874] - 13657: AF025533
Homo sapiens leucocyte immunoglobulin-like receptor-3 (LIR-3) mRNA, complete cds
gi|2653872|gb|AF025533.1|AF025533[2653872] - 13658: AF025532
Homo sapiens leucocyte immunoglobulin-like receptor-5 (LIR-5) mRNA, complete cds
gi|2653870|gb|AF025532.1|AF025532[2653870] - 13659: AF025531
Homo sapiens leucocyte immunoglobulin-like receptor-7 (LIR-7) mRNA, complete cds
gi|2653868|gb|AF025531.1|AF025531[2653868] - 13660: AF025530
Homo sapiens leucocyte immunoglobulin-like receptor-6a (LIR-6) mRNA, complete cds
gi|2653866|gb|AF025530.1|AF025530[2653866] - 13661: AF025529
Homo sapiens leucocyte immunoglobulin-like receptor-6b (LIR-6) mRNA, complete cds
gi|2653864|gb|AF025529.1|AF025529[2653864] - 13662: AF025528
Homo sapiens leucocyte immunoglobulin-like receptor-2 (LIR-2) mRNA, complete cds
gi|2653862|gb|AF025528.1|AF025528[2653862] - 13663: AF025527
Homo sapiens leucocyte immunoglobulin-like receptor-4 (LIR-4) mRNA, complete cds
gi|2653860|gb|AF025527.1|AF025527[2653860] - 13664: Y13583
Homo sapiens mRNA for G-protein coupled receptor
gi|255233|emb|Y13583.1|HSGPCP[2652933] - 13665: Y13367
H. sapiens mRNA for phosphoinositide 3-kinase
gi|2143259|emb|Y13367.1|HSPHOSI3K[2143259] - 13666: X82207
H. sapiens mRNA for beta-centractin (PC3)
gi|563885|emb|X82207.1|HSBCENT[563885] - 13667: AF033854
Homo sapiens lymphocyte inhibitor of TRAIL (LIT) mRNA, complete cds
gi|2645841|gb|AF033854.1|AF033854[2645841] - 13668: X81882
H. sapiens mRNA for for vasopressin activated calcium mobilizing receptor-like protein
gi|1628414|emb|X81882.1|HSVACM1[1628414] - 13669: AF024690
Homo sapiens putative G protein-coupled receptor (GPR43) gene, complete cds
gi|2612951|gb|AF024690.1|AF024690[2612951] - 13670: AF024689
Homo sapiens putative G protein-coupled receptor (GPR42) gene, complete cds
gi|2612949|gb|AF024689.1|AF024689[2612949] - 13671: AF024688
Homo sapiens putative G protein-coupled receptor (GPR41) gene, complete cds
gi|2612947|gb|AF024688.1|AF024688[2612947] - 13672: AF024687
Homo sapiens putative G protein-coupled receptor (GPR40) gene, complete cds
gi|2612945|gb|AF024687.1|AF024687[2612945] - 13673: D87513
Homo sapiens mRNA for Grb7 protein, partial cds
gi|1526534|dbj|D87513.1|D87513[1526534] - 13674: D49919
Homo sapiens mRNA for C-C chemokine receptor type 2, complete cds
gi|2626807|dbj|D49919.1|D49919[2626807] - 13675: AF030512
Homo sapiens small cell vasopressin subtype 1b receptor mRNA, complete cds
gi|2613124|gb|AF030512.1|AF030512[2613124] - 13676: Y12852
Homo sapiens P2X7 gene, exon 2 and 3
gi|2612788|emb|Y12852.1|HSP2X7E23[2612788] - 13677: Y12851
Homo sapiens P2X7 gene, exon 1 and joined CDS
gi|2597926|emb|Y12851.1|HSP2X7EX1[2597926] - 13678: Y12854
Homo sapiens P2X7 gene, exon 9-11
gi|2612787|emb|Y12854.1|HSP2X7911[2612787] - 13679: Y12853
Homo sapiens P2X7 gene, exon 4-8
gi|2612786|emb|Y12853.1|HSP2X748[2612786] - 13680: Y12855
Homo sapiens P2X7 gene, exon 12 and 13
gi|2612785|emb|Y112855.1|HSP2X7123[2612785] - 13681: AB005520
Homo sapiens ppar gamma2 gene for peroxisome proliferator activated-receptor gamma, partial cds and 5′ flanking
gi|2605488|dbj|AB005520.1|AB005520[2605488] - 13682: Y09765
Homo sapiens mRNA for putative GABA receptor epsilon subunit
gi|2285960|emb|Y09765.1|HSY09765[2285960] - 13683: Y09764
Homo sapiens GABRE gene, exon 2-8
gi|2285959|emb|Y09764.1|HSY09764[2285959] - 13684: Y09763
Homo sapiens GABRE gene, exon 1 (and joined CDS)
gi|2285957|emb|Y09763.1|HSY09763[2285957] - 13685: AF026535
Homo sapiens chemokine receptor (CCR3) mRNA, complete cds
gi|2582565|gb|AF026535.1|AF026535[2582565] - 13686: AF026071
Homo sapiens soluble death receptor 3 beta (DR3) mRNA, complete cds
gi|2570832|gb|AF026071.1|AF026071[2570832] - 13687: AF022956
Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
gi|2570532|gb|AF022956.1|AF022956[2570532] - 13688: AF022955
Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
gi|2570530|gb|AF022955.1|AF022955[2570530] - 13689: AF022954
Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
gi|2570528|gb|AF022954.1|AF022954[2570528] - 13690: AF022953
Homo sapiens beta2-adrenergic receptor (ADRB2) gene, complete cds
gi|2570526|gb|AF022953.1|AF022953[2570526] - 13691: AF014958
Homo sapiens chemokine receptor X (CKRX) mRNA, complete cds
gi|2305263|gb|AF014958.1|AF014958[2305263] - 13692: AB000712
Homo sapiens hCPE-R mRNA for CPE-receptor, complete cds
gi|2570124|dbj|AB000712.1|AB000712[2570124] - 13693: X94609
H. sapiens mRNA for activatory NK receptor/KKA3 p50.3
gi|1495414|emb|X94609.1|HSANKRMR[1495414] - 13694: AF025375
Homo sapiens chemokine receptor-4 (CXCR4) mRNA, complete cds
gi|2565335|gb|AF025375.1|AF025375[2565335] - 13695: AF000380
Homo sapiens folate binding protein mRNA, complete cds
gi|2565193|gb|AF000380.1|HSAF000380[2565193] - 13696: U35875
Homo sapiens B2 bradykinin receptor mRNA, 5′ sequence
gi|135339|gb|U35875.1|HSU35875[1353391] - 13697: AF010193
Homo sapiens MAD-related gene SMAD7 (SMAD7) mRNA, complete cds
gi|225282|gb|AF010193.1|AF010193[2252821] - 13698: X94634
H. sapiens CD97 gene exon 7
gi|1165087|emb|X94634.1|HSX94634[1165087] - 13699: X94633
H. sapiens CD97 gene exon 4
gi|1165086|emb|X94633.1|HSX94633[1165086] - 13700: X94632
H. sapiens CD97 gene exon 3
gi|1165085|emb|X94632.1|HSX94632[1165085] - 13702: AF007892
Homo sapiens P2Y6 receptor, long splice variant mRNA, complete cds
gi|225842|gb|AF007892.1|[2258421] - 13703: AF007891
Homo sapiens P2Y6 receptor, short splice variant mRNA, complete cds
gi|2258419|gb|AF007891.1|[2258419] - 13704: AF022383
Homo sapiens complexin I mRNA, complete cds
gi|2465458|gb|AF022383.1|AF022383[2465458] - 13709: X89860
H. sapiens mRNA for T-cell receptor alpha chain
gi|927420|emb|X89860.1|HSNP7TCR2[927420] - 13710: Y08456
H. sapiens ChemR1 gene
gi|2465081|emb|Y08456.1|HSCHEMR1[2465081] - 13711: U95025
Homo sapiens metabotropic glutamate receptor 8 (GRM8) mRNA, complete cds
gi|2435409|gb|U95025.1|HsU95025[2435409] - 13712: AF021799
Homo sapiens interleukin 17 receptor-like mRNA sequence
gi|2460201|gb|AF021799.1|AF021799[2460201] - 13714: U73443
Homo sapiens 5HT3 serotonin receptor gene, partial cds
gi|2459549|gb|U73443.1|MMU73443[2459549] - 13715: AB000520
Homo sapiens mRNA for APS, complete cds
gi|2447035|dbj|AB3000520.1|AB3000520[2447035] - 13716: X98172
H. sapiens mRNA for MACH-alpha-1 protein
gi|1403318|emb|X98172.1|HSMACHA1[1403318] - 13727: X92883
H. sapiens mRNA for T cell receptor alpha (clone XPHC46IV)
gi|1061141|emb|X92883.1|HSPHC46A1[1061141] - 13728: AH005567
Homo sapiens chromosome 4 map 4q13
gi|2290767|gb|AH005567.1|SEG_HSGNRHR[2290767] - 13729: AF001952
Homo sapiens gonadotropin releasing hormone receptor (GNRHR) gene, exon 3 and complete cds
gi|2290766|gb|AF001952.1|HSGNRHR3[2290766] - 13730: AF001951
Homo sapiens gonadotropin releasing hormone receptor (GNRHR) gene, exon 2
gi|2290765|gb|AF001951.1|HSGNRHR2[2290765] - 13731: AF001950
Homo sapiens gonadotropin releasing hormone receptor (GNRHR) gene, exon 1
gi|2290764|gb|AF001951.1|HSGNRHR1[2290764] - 13732: AF017263
Homo sapiens putative G protein-coupled receptor gene, partial intron sequence
gi|2435439|gb|AF017263.1|AF017263[2435439] - 13733: AF020201
Homo sapiens Jagged 2 mRNA, complete cds
gi|2432001|gb|AF020201.1|AF020201[2432001] - 13734: Y14442
Homo sapiens mRNA for olfactory receptor protein, partial
gi|2370144|emb|Y14442.1|HSOLFMF[2370144] - 13735: AF017264
Homo sapiens putative G protein-coupled receptor gene, intronic sequence
gi|2407224|gb|AF017264.1|AF017264[2407224] - 13736: AF017061
Homo sapiens vasopressin-activated calcium mobilizing putative receptor protein
(VACM-1) mRNA, complete cds
gi|2394273|gb|AF01706.1|AF017061[2394273] - 13737: AF017262
Homo sapiens putative G protein-coupled receptor mRNA, complete cds
gi|2388705|gb|AF017262.1|AF017262[2388705] - 13738: AF016917
Homo sapiens GABA-A receptor delta subunit (GABRD) mRNA, complete cds
gi|2388692|gb|AF016917.1|AF016917[2388692] - 13739: Y13248
Homo sapiens mRNA for orphan chemokine receptor TYMSTR
gi|2370179|emb|Y13248.1|HSY13248[2370179] - 13740: D83492
Homo sapiens mRNA for Eph-family protein, complete cds
gi|2281007|dbj|D83492.1|D83492[2281007] - 13741: AB002058
Homo sapiens mRNA for HUMAN P2XM, complete cds
gi|2350846|dbj|AB002058.1|AB002058[2350846] - 13742: AF015251
Homo sapiens breast cancer-related unknown protein mRNA, partial cds
gi|2345090|gb|AF015251.1|AF015251[2345090] - 13743: AF004231
Homo sapiens monocyte/macrophage Ig-related receptor MIR-10 (MIR cl-10) mRNA, complete cds
gi|2343110|gb|AF004231.1|AF004231[2343110] - 13744: AF004230
Homo sapiens monocyte/macrophage Ig-related receptor MIR-7 (MIR cl-7) mRNA, complete cds
gi|2343108|gb|AF004230.1|AF004230[2343108] - 13745: X90563
H. sapiens mRNA for peroxisome proliferactor activated receptor gamma
gi|1480099|emb|X90563.1|HSPPARGAM[1480099] - 13746: AF012629
Homo sapiens antagonist decoy receptor for TRAIL/Apo-2L (TRID) mRNA, complete cds
gi|2338430|gb|AF012629.1|AF012629[2338430] - 13747: AF012628
Homo sapiens death domain containing receptor for TRAIL/Apo-2L (DR5) mRNA, complete cds
gi|2338428|gb|AF012628.1|AF012628[2338428] - 13748: AF012536
Homo sapiens decoy receptor 1 (DcR1) mRNA, complete cds
gi|2338421|gb|AF012536.1|AF012536[2338421] - 13749: AF012535
Homo sapiens death receptor 5 (DR5) mRNA, complete cds
gi|2338419|gb|AF012535.1|AF012535[2338419] - 13750: AF012903
Homo sapiens P2X4 ATP-gated cation channel protein mRNA, partial cds
gi|2331043|gb|AF012903.1|AF012903[2331043] - 13751: X69316
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 21
gi|34105|emb|X69316.1|HSKITPO16[34105] - 13752: X69315
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exons 18, 19, 20
gi|34104|emb|X69315.1|HSKITPO15[34104] - 13753: X69314
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 17
gi|34103|emb|X69314.1|HSKITPO14[34103] - 13754: X69313
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 16
gi|34102|emb|X69313.1|HSKITPO13[34102] - 13755: X69312
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 15
gi|34101|emb|X69312.1|HSKITPO12[34101] - 13756: X69311
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 14
gi|34100|emb|X69311.1|HSKITPO11[34100] - 13757: X69310
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exons 10, 11, 12, 13
gi|34099|emb|X69310.1|HSKITPO10[34099] - 13758: X69309
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 9
gi|34098|emb|X69309.1|HSKITPO09[34098] - 13759: X69308
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 9
gi|34097|emb|X69308.1|HSKITPO08[34097] - 13760: X69307
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 8
gi|34096|emb|X69307.1|HSKITPO07[34096] - 13761: X69306
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 7
gi|34095|emb|X69306.1|HSKITPO06[34095] - 13762: X69305
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 5
gi|34094|emb|X69305.1|HSKITPO05[34094] - 13763: AF005419
Homo sapiens P2Y5-like receptor gene, complete cds
gi|2240034|gb|AF005419.1|AF005419[2240034] - 13764: L42324
Homo sapiens (clone GPCR W) G protein-linked receptor gene (GPCR) gene, 5′ end
of cds
gi|1066730|gb|L42324.1|HUMFRCG[1066730] - 13766: AF015910
Homo sapiens unknown protein mRNA, partial cds
gi|2286201|gb|AF015910.1|AF015910[2286201] - 13767: X99250
H. sapiens mRNA for endothelin-B receptor splice variant
gi|2285955|emb|X99250.1|HSX99250[2285955] - 13768: AF007545
Homo sapiens SIV/HIV receptor Bonzo (Bonzo) mRNA, complete cds
gi|225342|gb|AF007545.1|AF007545[2253421] - 13769: Z79783
H. sapiens G protein-coupled receptor CKR-L2
gi|2281709|emb|Z79783.1|HSCKRL2[2281709] - 13778: Z49994
H. sapiens partial gene for proteinase-activated receptor 2 (1289 BP)
gi|1008086|emb|Z49994.1|HSPAR2B[1008086] - 13779: AF007555
Homo sapiens IAR/receptor-like protein-tyrosine phosphatase precursor mRNA, complete cds
gi|2262074|gb|AF007555.1|AF007555[2262074] - 13780: AF008556
Homo sapiens interleukin-2 receptor mRNA, alternatively spliced, partial cds
gi|2266932|gb|AF008556.1|AF008556[2266932] - 13891: Y10152
H. sapiens mRNA for CRF2 receptor, beta isoform, aberrantly spliced, (94 bp deletion)
gi|1785640|emb|Y10152.1|HSCRF294[1785640] - 13892: Y10153
H. sapiens mRNA for CRF2 receptor, beta isoform, aberrantly spliced, (227 bp insertion)
gi|1785639|emb|Y10153.1|HSCRF2227[1785639] - 13893: Y10151
H. sapiens mRNA for CRF2 receptor, beta isoform, partial
gi|1785637|emb|Y10151.1|HSCRF2[1785637] - 13894: M17325
Homo sapiens T-cell receptor gamma-chain constant region (TCRGC1) mRNA, partial
cds
gi|2072752|gb|M17325.1|HUMTCGCJ[2072752] - 13895: M17324
Homo sapiens T-cell receptor gamma-chain constant region (TCRGC2) mRNA, partial
cds
gi|2072751|gb|M17324.1|HUMTCGCI[2072751] - 13896: M17323
Homo sapiens T-cell receptor gamma-chain constant region (TCRGC2) mRNA, partial
cds
gi|2072750|gb|M17323.1|HUMTCGCH[2072750] - 13897: AF004327
Homo sapiens angiopoietin-2 mRNA, complete cds
gi|2257932|gb|AF004327.1|AF004327[2257932] - 13898: AF004021
Homo sapiens prostaglandin F2 alpha receptor mRNA, complete cds
gi|2257849|gb|AF004021.1|AF004021[2257849] - 13899: AF006464
Homo sapiens muscle specific tyrosine kinase receptor (MUSK) mRNA, complete cds
gi|2253311|gb|AF006464.1|AF006464[2253311] - 13900: AF005637
Homo sapiens endothelin A receptor gene, 5′ flanking region and exon 1
gi|2253289|gb|AF005637.1|AF005637[2253289] - 13902: Z24461
H. sapiens MTCP-1 gene
gi|406866|emb|Z24461.1|HSMTCP1I[406866] - 13903: Z24463
H. sapiens MTCP-1 gene
gi|406865|emb|Z24463.1|HSMTCP1H[406865] - 13904: Z24457
H. sapiens of TCRA gene MTCP-1 gene
gi|406860|emb|Z24457.1|HSMTCP1D[406860] - 13905: Z24456
H. sapiens of MTCP-1 gene MTCP-1 gene
gi|406859|emb|Z24456.1|HSMTCP1C[406859] - 13906: U45984
Homo sapiens CCR6 chemokine receptor (CMKBR6) gene, complete cds
gi|2246432|gb|U45984.1|HSU45984[2246432] - 13908: AF005900
Homo sapiens alpha2B-adrenergic receptor (alpha2C2AR) gene, complete cds
gi|2245627|gb|AF005900.1|AF005900[2245627] - 13909: AF005210
Homo sapiens CC chemokine receptor CCR8 (CMKBR8) mRNA, partial cds
gi|2245579|gb|AF005210.1|AF005210[2245579] - 14010: Y13758
Homo sapiens mRNA for transient receptor potential related channel 3 protein
gi|2225936|emb|Y13758.1|HSY13758[2225936] - 14012: AF000546
Homo sapiens purinergic receptor P2Y5 mRNA, complete cds
gi|2232068|gb|AF000546.1|HSAF000546[2232068] - 14013: U45983
Homo sapiens CCR8 chemokine receptor (CMKBR8) gene, complete cds
gi|2231165|gb|U45983.1|HSU45983[2231165] - 14015: X63819
H. sapiens mRNA for Lipoxin A4 receptor
gi|31460|emb|X63819.1|HSLIPA4R[31460] - 14016: X15274
H. sapiens TRGV9 gene, allele V9*A2
gi|1848091|emb|X15274.1|HSTRGV9F[1848091] - 14020: X80282
H. sapiens gene for oxytocin receptor
gi|609014|emb|X80282.1|HSOXYTOC[609014] - 14021: X81086
H. sapiens PCaR1 gene
gi|599819|emb|X81086.1|HSPCAR1[599819] - 14023: X65857
H. sapiens HGMP07E gene for olfactory receptor
gi|425220|emb|X65857.1|HSHGM07EG[425220] - 14024: X65858
H. sapiens gene for high affinity IL-8 receptor
gi|312046|emb|X65858.1|HSHAIL8G[312046] - 14026: Z69640
H. sapiens fgfr2 gene (exon 5)
gi|200062|emb|Z69640.1|HSFGFR2UB[1200062] - 14027: Z69641
H. sapiens fgfr2 gene
gi|1120006|emb|Z69641.1|HSFGFR2UA[1200061] - 14029: Z70243
H. sapiens enhancer region for interleukin-2 receptor alpha chain
gi|1769435|emb|Z70243.1|HSENHREG1[1769435] - 14030: Z38109
H. sapiens DNA for CD69, exon 1
gi|793837|emb|Z38109.1|HSCD69X1[793837] - 14031: AC002306
Homo sapiens DNA from chromosome 19-cosmid R33799, genomic sequence, complete sequence
gi|2213634|gb|AC002306.1|AC002306[2213634] - 14032: AF002256
Homo sapiens killer cell inhibitory receptor homolog cl-9 mRNA, complete cds
gi|2197058|gb|AF002256.1|AF002256[2197058] - 14033: AF002255
Homo sapiens killer cell inhibitory receptor cl-17 mRNA, complete cds
gi|2197056|gb|AF002255.1|AF002255[2197056] - 14034: D89079
Homo sapiens mRNA for leukotriene b4 receptor, complete cds
gi|2196450|dbj|D589079.1|D89079[2196450] - 14035: D89078
Homo sapiens mRNA for leukotriene b4 receptor, complete cds
gi|2196448|dbj|D89078.1|D89078[2196448] - 14036: AB004662
Homo sapiens mRNA for adenosine A1-receptor, complete cds
gi|2196442|dbj|AB004662.1|AB004662[2196442] - 14037: Y07909
H. sapiens mRNA for Progression Associated Protein
gi|1542882|emb|Y07909.1|HSPAPR[1542882] - 14038: L17411
Human complement receptor type 1 (alleles S and F) gene, exon 40
gi|1199855|gb|L17411.1|HUMCR1SF34[1199855] - 14039: L17425
Human complement receptor type 1 (allele S) gene, exon 11
gi|451301|gb|L17425.1|HUMCR1SF10[451301] - 14040: L17418
Human complement receptor type 1 (alleles S and F) gene, exon 47 and complete cds's
gi|306678|gb|L17418.1|HUMCR1SF41[306678] - 14041: L17417
Human complement receptor type 1 (alleles S and F) gene, exon 46
gi|306677|gb|L17417.1|HUMCR1SF40[306677] - 14042: L17416
Human complement receptor type 1 (alleles S and F) gene, exon 45
gi|306676|gb|L17416.1|HUMCR1SF39[306676] - 14043: L17415
Human complement receptor type 1 (alleles S and F) gene, exon 44
gi|306675|gb|L17415.1|HUMCR1SF38[306675] - 14044: L17414
Human complement receptor type 1 (alleles S and F) gene, exon 43
gi|306674|gb|L17414.1|HUMCR1SF37[306674] - 14045: L17413
Human complement receptor type 1 (alleles S and F) gene, exon 42
gi|306673|gb|L17413.1|HUMCR1SF36[306673] - 14046: L17412
Human complement receptor type 1 (alleles S and F) gene, exon 41
gi|306672|gb|L17412.1|HUMCR1SF35[306672] - 14047: L17410
Human complement receptor type 1 (alleles S and F) gene, exons 38 and 39
gi|306670|gb|L17410.1|HUMCR1SF33[306670] - 14048: L17408
Human complement receptor type 1 (alleles S and F) gene, exon 37
gi|306669|gb|L17408.1|HUMCR1SF32[306669] - 14049: L17407
Human complement receptor type 1 (alleles S and F) gene, exon 36
gi|306668|gb|L17407.1|HUMCR1SF31[306668] - 14050: L17406
Human complement receptor type 1 (alleles S and F) gene, exon 35
gi|306667|gb|L17406.1|HUMCR1SF30[306667] - 14051: L17405
Human complement receptor type 1 (alleles S and F) gene, exon 34
gi|306666|gb|L17405.1|HUMCR1SF29[306666] - 14052: L17404
Human complement receptor type 1 (alleles S and F) gene, exon 33
gi|306665|gb|L17404.1|HUMCR1SF28[306665] - 14053: L17403
Human complement receptor type 1 (alleles S and F) gene, exon 32
gi|306664|gb|L17403.1|HUMCR1SF27[306664] - 14054: L17402
Human complement receptor type 1 (alleles S and F) gene, exons 30 and 31
gi|306663|gb|L17402.1|HUMCR1SF26[306663] - 14055: L17401
Human complement receptor type 1 (alleles S and F) gene, exon 29
gi|306662|gb|L17401.1|HUMCR1SF25[306662] - 14056: L17400
Human complement receptor type 1 (alleles S and F) gene, exon 28
gi|306661|gb|L17400.1|HUMCR1SF24[306661]
- 14057: L17398
Human complement receptor type 1 (alleles S and F) gene, exons 26 and 27
gi|306660|gb|L17398.1|HUMCR1SF23[306660] - 14058: L17397
Human complement receptor type 1 (alleles S and F) gene, exon 25
gi|306659|gb|L17397.1|HUMCR1SF22[306659] - 14059: L17396
Human complement receptor type 1 (alleles S and F) gene, exon 24
gi|306658|gb|L17396.1|HUMCR1SF21[306658] - 14060: L17395
Human complement receptor type 1 (alleles S and F) gene, exons 22 and 23
gi|306657|gb|L17395.1|HUMCR1SF20[306657] - 14061: L17394
Human complement receptor type 1 (alleles S and F) gene, exon 21
gi|306656|gb|L17394.1|HUMCR1SF19[306656] - 14062: L17393
Human complement receptor type 1 (alleles S and F) gene, exon 20
gi|306655|gb|L17393.1|HUMCR1SF18[306655] - 14063: L17392
Human complement receptor type 1 (alleles S and F) gene, exon 19
gi|306654|gb|L17392.1|HUMCR1SF17[306654] - 14064: L17391
Human complement receptor type 1 (alleles S and F) gene, exon 18
gi|306653|gb|L17391.1|HUMCR1SF16[306653] - 14065: L17430
Human complement receptor type 1 (allele S) gene, exon 17
gi|306652|gb|L17430.1|HUMCR1SF15[306652] - 14066: L17429
Human complement receptor type 1 (allele S) gene, exon 16
gi|306651|gb|L17429.1|HUMCR1SF14[306651] - 14067: L17428
Human complement receptor type 1 (allele S) gene, exons 14 and 15
gi|306650|gb|L17428.1|HUMCR1SF13[306650] - 14068: L17427
Human complement receptor type 1 (allele S) gene, exon 13
gi|306649|gb|L17427.1|HUMCR1SF12[306649] - 14069: L17426
Human complement receptor type 1 (allele S) gene, exon 12
gi|306648|gb|L17426.1|HUMCR1SF11[306648] - 14070: L17424
Human complement receptor type 1 (allele S) gene, exon 10
gi|306646|gb|L17424.1|HUMCR1SF09[306646] - 14071: L17423
Human complement receptor type 1 (alleles S and F) gene, exon 9
gi|306645|gb|L17423.1|HUMCR1SF08[306645] - 14072: L17422
Human complement receptor type 1 (alleles S and F) gene, exon 8
gi|306644|gb|L17422.1|HUMCR1SF07[306644] - 14073: L17421
Human complement receptor type 1 (alleles S and F) gene, exons 6 and 7
gi|306643|gb|L17421.1|HUMCR1SF06[306643] - 14074: L17420
Human complement receptor type 1 (alleles S and F) gene, exon 5
gi|306642|gb|L17420.1|HUMCR1SF05[306642] - 14075: L17419
Human complement receptor type 1 (alleles S and F) gene, exon 4
gi|306641|gb|L17419.1|HUMCR1SF04[306641] - 14076: L17409
Human complement receptor type 1 (alleles S and F) gene, exon 3
gi|306640|gb|L17409.1|HUMCR1SF03[306640] - 14077: L17399
Human complement receptor type 1 (alleles S and F) gene, exon 2
gi|306639|gb|L17399.1|HUMCR1SF02[306639] - 14078: L17390
Human complement receptor type 1 (alleles S and F) gene, enhancer and exon 1
gi|306638|gb|L17390.1|HUMCR1SF01[306638] - 14081: M14764
Human nerve growth factor receptor mRNA, complete cds
gi|189204|gb|M14764.1|HUMNGFR[189204] - 14082: M11025
Human asialoglycoprotein receptor H2 mRNA, complete cds
gi|179080|gb|M11025.1|HUMASGPR2[179080] - 14083: L31772
Human alpha-1a/d adrenergic receptor mRNA, complete cds
gi|666894|gb|L31772.1|HUMA1DA[666894] - 14084: L31774
Human alpha-1c-adrenergic receptor mRNA, complete cds
gi|666892|gb|L31774.1|HUMA1ARA[666892] - 14085: L31773
Human alpha-1B-adrenergic receptor mRNA, complete cds
gi|666890|gb|L31773.1|HUMA1AR[666890] - 14093: L07868
Homo sapiens receptor tyrosine kinase (ERBB4) gene, complete cds
gi|337359|gb|L07868.1|HUMRETYKIN[337359] - 14094: L19593
Homo sapiens interleukin 8 receptor beta (IL8RB) mRNA, complete cds
gi|559053|gb|L19593.1|HUMIL8RB[559053] - 14095: L19591
Homo sapiens interleukin 8 receptor alpha (IL8RA) mRNA, complete cds
gi|559049|gb|L19591.1|HUMIL8RAA[559049] - 14096: M69229
Human insulin-like growth factor I receptor gene, promoter region and 5′ end
gi|184837|gb|M69229.1|HUMIGFR1PR[184837] - 14097: L03840
Human fibroblast growth factor receptor 4 (FGFR4) mRNA, complete cds
gi|182570|gb|L03840.1|HUMFGFR4X[182570] - 14098: L13268
Homo sapiens N-methyl-d-aspartate receptor (NR1-3) mRNA, 3′ end
gi|292286|gb|L13268.1|HUMMARB[292286] - 14099: L13266
Homo sapiens N-methyl-d-aspartate receptor (NR1-1) mRNA, complete cds
gi|292282|gb|L13266.1|HUMMAR[292282] - 14100: Y13426
Homo sapiens TCRDV2 gene, partial
gi|2181879|emb|Y13426.1|HSTCRDV2[2181879] - 14101: Y08768
H. sapiens mRNA for IL-13 receptor
gi|1877211|emb|Y08768.1|HSIL13[1877211] - 14102: Y08110
H. sapiens mRNA for mosaic protein LR11
gi|1552323|emb|Y08110.1|HSLR11[1552323] - 14103: E08844
Histamine H1 receptor gene
gi|2176948|dbj|E08844.1|E08844[2176948] - 14104: E08843
cDNA encoding Histamine H1 receptor
gi|2176947|dbj|E08843.1|E08843[2176947] - 14106: E07873
cDNA encoding cholecystokinin B/gastrin receptor
gi|2176006|dbj|E07873.1|E07873[2176006] - 14107: E07650
cDNA encoding endothelin receptor, ETB-receptor
gi|2175785|dbj|E07650.1|E07650[2175785] - 14108: E07649
cDNA encoding endothelin receptor, ETA-receptor
gi|2175784|dbj|E07649.1|E07649[2175784] - 14109: E07358
cDNA encoding adrenaline alpha2CII receptor
gi|2175498|dbj|E07358.1|E07358[2175498] - 14110: E07278
cDNA encoding human cholecystokinin (CCK) receptor
gi|2175419|dbj|E07278.1|E07278[2175419] - 14111: E06799
DNA encoding human Interleukin-5 receptor
gi|2174981|dbj|E06799.1|E06799[2174981] - 14112: E06798
DNA encoding human Interleukin-5 receptor
gi|2174980|dbj|E06798.1|E06798[2174980] - 14113: E06797
DNA encoding human Interleukin-5 receptor
gi|2174979|dbj|E06797.1|E06797[2174979] - 14114: E06796
DNA encoding human Interleukin-5 receptor
gi|2174978|dbj|E06796.1|E06796[2174978] - 14115: E05678
cDNA encoding human LH-hCG (luteinizing hormone-human choriogonadotropic hormone) receptor
gi|2173865|dbj|E05678.1|E05678[2173865] - 14116: E05211
DNA encoding human scavenger receptor II
gi|2173401|dbj|E05211.1|E05211[2173401] - 14117: E05210
DNA encoding human scavenger receptor I
gi|2173400|dbj|E05210.1|E05210[2173400] - 14118: E05109
cDNA encoding human oxytocin receptor
gi|2173303|dbj|E05109.1|E05109[2173303] - 14189: E04823
cDNA encoding interleukin 6 receptor
gi|2173019|dbj|E04823.1|E04823[2173019] - 14190: E03879
cDNA encoding platelet activating factor receptor
gi|2172093|dbj|E03879.1|E03879[2172093] - 14191: E03829
cDNA encoding human thromboxane receptor
gi|2172043|dbj|E03829.1|E03829[2172043] - 14192: E03378
DNA encoding N-terminal fragment of human growth hormone receptor
gi|2171595|dbj|E03378.1|E03378[2171595] - 14193: E03377
DNA encoding C-terminal fragment of human growth hormone receptor
gi|2171594|dbj|E03377.1|E03377[2171594] - 14194: E03335
Human b-FGF receptor gene
gi|2171552|dbj|E03335.1|E03335[2171552] - 14195: E03268
cDNA sequence coding for human scavenger receptor, type II
gi|2171485|dbj|E03268.1|E03268[2171485] - 14196: E03267
cDNA sequence coding for human scavenger receptor, type I
gi|2171484|dbj|E03267.1|E03267[2171484] - 14197: E02673
cDNA encoding human B cell stimulating factor 2 receptor protein
gi|2170901|dbj|E02673.1|E02673[2170901] - 14198: E02541
cDNA encoding human Interleukin-2 receptor L chain
gi|2170771|dbj|E02541.1|E02541[2170771] - 14199: E02151
Terminal sequence of constant region of T cell receptor beta chain (c beta-1)
gi|2170389|dbj|E02151.1|E02151[2170389] - 14200: E01646
cDNA encoding Fc epsilon receptor
gi|2169899|dbj|E01646.1|E01646[2169899] - 14201: E01052
DNA encoding human mature TNF
gi|2169311|dbj|E01052.1|E01052[2169311] - 14202: E00999
cDNA encoding human insulin receptor
gi|2169258|dbj|E00999.1|E00999[2169258] - 14203: E00990
cDNA encoding alpha chain of T-cell receptor
gi|2169251|dbj|E00990.1|E00990[2169251] - 14204: E00727
cDNA encoding human IL-2 receptor
gi|2169004|dbj|E00727.1|E00727[2169004] - 14205: E00723
cDNA encoding human interleukin-2 receptor
gi|2169000|dbj|E00723.1|E00723[2169000] - 14206: E00685
cDNA encoding human T-cell antigen receptor protein
gi|2168964|dbj|E00685.1|E00685[2168964] - 14207: D31833
Human mRNA for vasopressin V1b receptor, complete cds
gi|563981|dbj|D31833.1|HUMVV1BR[563981] - 14208: D16845
Human mRNA for thyrotropin-releasing hormone receptor, complete cds
gi|577631|dbj|D16845.1|HUMTRHR1[577631] - 14209: D28131
Human mRNA for TGF-beta receptor type IIB, partial sequence
gi|456708|dbj|D28131.1|HUMTGFBRII[456708] - 14211: D17517
Human sky mRNA for Sky, complete cds
gi|624880|dbj|D17517.1|HUMSKY[624880] - 14214: D30780
Human mRNA for phospholipase A2 receptor, partial cds
gi|565645|dbj|D30780.1|HUMPLA21R[565645] - 14215: D38299
Homo sapiens mRNA for prostaglandin E receotor EP3 subtype 2 isoform, complete
cds
gi|1389574|dbj|D38299.1|HUMPEREFC[1389574] - 14216: D38298
Homo sapiens mRNA for prostaglandin E receotor EP3 subtype 1b isoform, complete
cds
gi|1389573|dbj|D38298.1|HUMPEREEB[1389573] - 14217: D38301
Homo sapiens mRNA for prostaglandin E receptor EP3 subtype 3 isoform, complete
cds
gi|1389572|dbj|D38301.1|HUMPERECE[1389572] - 14218: D38300
Homo sapiens mRNA for prostaglandin E receotor EP3 subtype 4 isoform, complete
cds
gi|1389571|dbj|D38300.1|HUMPEREBD[1389571] - 14219: D38297
Homo sapiens mRNA for prostaglandin E receotor EP3 subtype 1a isoform, complete
cds
gi|1389570|dbj|D38297.1|HUMPEREA[1389570] - 14220: D28538
Human mRNA for metabotropic glutamate receptor subtype 5a, complete cds
gi|1140805|dbj|D28538.1|HUMMGRS5A[1408051] - 14221: D14872
Human DNA for fibroblast growth factor receptor 2 (K-sam-II) exon C3, partial sequence
gi|511927|dbj|D14872.1|HUMKSAMC3[511927] - 14222: D50582
Human gene for inward rectifier K channel, complete cds
gi|1088444|dbj|D50582.1|HUMIRKCB[1088444] - 14223: D26070
Human mRNA for type 1 inositol 1,4,5-trisphosphate receptor, complete cds
gi|559322|dbj|D26070.1|HUMINSP3R1[559322] - 14232: D26156
Human mRNA for transcriptional activator hSNF2b, complete cds
gi|505087|dbj|D26156.1|HUMHSNF2B[505087] - 14233: D26155
Human mRNA for transcriptional activator hSNF2a, complete cds
gi|505086|dbj|D26155.1|HUMHSNF2A[505086] - 14234: D26351
Human mRNA for type 3 inositol 1,4,5-trisphosphate receptor, complete cds
gi|450470|dbj|D26351.1|HUMHT3I[450470] - 14235: D26350
Human mRNA for type 2 inositol 1,4,5-trisphosphate receptor, complete cds
gi|450468|dbj|D26350.1|HUMHT2I[450468] - 14236: D25418
Human mRNA for prostacyclin receptor, complete cds
gi|467509|dbj|D25418.1|HUMHPR[467509] - 14237: D10924
Human mRNA for HM89
gi|219868|dbj|D10924.1|HUMHM89[219868] - 14238: D10923
Human mRNA for HM74
gi|219866|dbj|D10923.1|HUMHM74[219866] - 14239: D10922
Human mRNA for FMLP-related receptor (HM63)
gi|219864|dbj|D10922.1|HUMHM63[219864] - 14240: D10925
Human mRNA for HM145
gi|219862|dbj|D10925.1|HUMHM145[219862] - 14241: D28481
Human mRNA for histamine H1 receptor, complete cds
gi|457654|dbj|D28481.1|HUMHH1R[457654] - 14242: D10995
Human gene for serotonin 1B receptor, complete cds
gi|219678|dbj|D10995.1|HUMHGCR[219678] - 14243: D38449
Human mRNA for G protein-coupled receptor, complete cds
gi|556519|dbj|D30449.1|HUMGPCRAA[556519] - 14243: D38449
- 14245: D37827
Homo sapiens mRNA for large erk/cek5 tyrosine kinase, partial cds
gi|1060894|dbj|D37827.1|HUMERK1P[1060894] - 14246: D13305
Human mRNA for brain cholecystokinin receptor
gi|436039|dbj|D13305.1|HUMBRACHRE[436039] - 14247: D32201
Human mRNA for alpha 1C adrenergic receptor isoform 3, complete cds
gi|927210|dbj|D32201.1|HUMAICAR3[927210] - 14248: D16354
Human mRNA for Ah receptor, complete cds
gi|464179|dbj|D16354.1|HUMAHRE[464179] - 14249: D25235
Human mRNA for alpha1C adrenergic receptor, complete cds
gi|433200|dbj|D25235.1|HUMACAR[433200] - 14250: D13538
Human alpha2CII-adrenergic receptor gene, complete cds
gi|219405|dbj|D13538.1|HUMA2CIIA[219405] - 14251: D32202
Human mRNA for alpha 1C adrenergic receptor isoform 2, complete cds
gi|927208|dbj|D32202.1|HUMA1CAR2[927208] - 14253: D86519
Human mRNA for neuropeptide y/peptide YY Y6 receptor, complete cds
gi|1731789|dbj|D86519.1|D86519[1731789] - 14254: D50683
Homo sapiens mRNA for TGF-betaIIR alpha, complete cds
gi|1827474|dbj|D50683.1|D50683[1827474] - 14255: D50682
Homo sapiens mRNA for TGF-betaIIR beta, partial cds
gi|1827472|dbj|D50682.1|D50682[1827472] - 14256: D28472
Human mRNA for prostaglandin E receptor EP4 subtype, complete cds
gi|1486234|dbj|D28472.1|D28472[1486234] - 14257: D29634
Human lung mRNA for receptor for prostacyclin, complete cds
gi|577629|dbj|D29634.1|D29634[577629] - 14258: D28539
Human mRNA for metabotropic glutamate receptor subtype 5b, complete cds
gi|1408053|dbj|D28539.1|HUMMGRS5B[1408053] - 14259: Y09479
H. sapiens mRNA for G protein-coupled receptor Edg-2
gi|1679601|emb|Y09479.1|HSEDG2[1679601] - 14260: U97197
Homo sapiens asialoglycoprotein receptor (ASGPR) mRNA, complete cds
gi|2121249|gb|U97197.1|HSU97197[2121249] - 14261: X81892
H. sapiens mA for HE6 Tm7 receptor
gi|2117160|emb|X81892.1|HSHE6[2117160] - 14262: Y07619
H. sapiens mRNA for peroxisome proliferator-activated receptor alpha
gi|1514594|emb|Y07619.1|HSPPARAGE[1514594] - 14263: D16815
Homo sapiens mRNA for EAR-1r, complete cds
gi|2116671|dbj|D16815.1|D16815[2116671] - 14264: X95876
H. sapiens mRNA for G-protein coupled receptor
gi|1552845|emb|X95876.1|HSGPCRIN8[1552845] - 14265: AF000545
Homo sapiens putative purinergic receptor P2Y10 gene, complete cds
gi|2104786|gb|AF000545.1|HSAF000545[2104786] - 14267: U95626
Homo sapiens ccr2b (ccr2), ccr2a (ccr2), ccr5 (ccr5) and ccr6 (ccr6) genes, complete cds, and lactoferrin (lactoferrin) gene, partial cds, complete sequence
gi|2104517|gb|U95626.1|HSU95626[2104517] - 14268: U77352
Homo sapiens MAP kinase-activating death domain protein (MADD) mRNA, complete cds
gi|2102697|gb|U77352.1|HSU77352[2102697] - 14269: D86098
Homo sapiens mRNA for prostaglandin EP3 receptor subtype isoform, complete cds
gi|2102646|dbj|D86098.1|D86098[2102646] - 14270: D86097
Homo sapiens mRNA for prostaglandin EP3 receptor subtype isoform, complete cds
gi|2102644|dbj|D86097.1|D86097[2102644] - 14271: X98510
H. sapiens mRNA for G protein-coupled receptor
gi|1894788|emb|X98510.1|HSX98510[1894788] - 14272: D89675
Homo sapiens mRNA for bone morphogenetic protein type IB receptor, complete cds
gi|2055308|dbj|D89675.1|D89675[2055308] - 14273: D43772
Human squamous cell carcinoma of esophagus mRNA for GRB-7 SH2 domain protein, complete cds
gi|601890|dbj|D43772.1|HUMGRB7[601890] - 14274: X89677
H. sapiens RA for TPCR92 protein
gi|902337|emb|X89677.1|HSTPCR92P[902337] - 14275: X89676
H. sapiens mRNA for TPCR86 protein
gi|902335|emb|X89676.1|HSTPCR86P[902335] - 14276: X89675
H. sapiens mRNA for TPCR85 protein
gi|902333|emb|X89675.1|HSTPCR85P[902333] - 14277: X89674
H. sapiens mRNA for TPCR27 protein
gi|902331|emb|X89674.1|HSTPCR27P[902331] - 14278: X89673
H. sapiens mRNA for TPCR26 protein
gi|902329|emb|X89673.1|HSTPCR26P[902329] - 14279: X89672
H. sapiens mRNA for TPCR25 protein
gi|902327|emb|X89672.1|HSTPCR25P[902327] - 14280: X89671
H. sapiens mRNA for TPCR24 protein
gi|902325|emb|X89671.1|HSTPCR24P[902325] - 14281: X89670
H. sapiens mRNA for TPCR16 protein
gi|902323|emb|X89670.1|HSTPCR16P[902323] - 14282: X89669
H. sapiens mRNA for TPCR120 protein
gi|902321|emb|X89669.1|HSTPCR120[902321] - 14283: X89668
H. sapiens mRNA for TPCR110 protein
gi|902319|emb|X89668.1|HSTPCR110[902319] - 14284: X89667
H. sapiens mRNA for TPCR106 protein
gi|902317|emb|X89667.1|HSTPCR106[902317] - 14285: X89666
H. sapiens mRNA for TPCR100 protein
gi|902315|emb|X89666.1|HSTPCR100[902315] - 14291: X73617
H. sapiens mRNA for T-cell receptor delta
gi|402624|emb|X73617.1|HSTCRDE[402624] - 14292: Z79612
H. sapiens DNA for muscle nicotinic acetylcholine receptor gene promotor, clone
DBLambda20
gi|1922318|emb|Z79612.1|HSMNAR3[1922318] - 14293: Z79611
H. sapiens DNA for muscle nicotinic acetylcholine receptor gene promotor, clone
DBLambda23
gi|1922317|emb|Z79611.1|HSMNAR2[1922317] - 14294: Z79610
H. sapiens DNA for muscle nicotinic acetylcholine receptor gene promotor, clone
ICRFc105F02104
gi|1922316|emb|Z79610.1|HSMNAR1[1922316] - 14295: Y09852
H. sapiens FGFR3 gene, partial
gi|1922307|emb|Y09852.1|HSFGFR312[1922307] - 14309: Z46223
H. sapiens DNA for immunoglobulin G Fc receptor IIIB
gi|559446|emb|Z46223.1|HSIGGRE3B[559446] - 14310: Z46222
H. sapiens DNA for immunoglobulin G Fc receptor 111A
gi|559445|emb|Z46222.1|HSIGGRE3A[559445] - 14311: Y09561
H. sapiens mRNA for P2X7 receptor
gi|1854511|emb|Y09561.1|HSP2X7[1854511] - 14312: Y09328
H. sapiens mRNA for IL13 receptor alpha-1 chain
gi|1885307|emb|Y09328.1|HSIL13RA1[1885307] - 14313: Y07593
H. sapiens mRNA for 46 kDa coxsackievirus and adenovirus receptor (CAR) protein
gi|1881446|emb|Y07593.1|HS46 KDA[1881446] - 14314: X07205
H. sapiens TRGV9 gene, allele V9*A1
gi|1848089|emb|X07205.1|HSTRGV9[1848089] - 14315: X15272
H. sapiens TRGV4F gene
gi|1841921|emb|X15272.1|HSTRGV4F[1841921] - 14316: Y11227
H. sapiens TRGV11 gene
gi|1848086|emb|Y11227.1|HSTRGV11G[1848086] - 14317: X74798
H. sapiens TRGV10 gene, allele V10*A2
gi|1848083|emb|X74798.1|HSTRGV[1848083] - 14321: X80878
H. sapiens R kappa B mRNA
gi|695578|emb|X80878.1|HSTRGV[695578] - 14324: X70070
H. sapiens mRNA for neurotensin receptor
gi|35020|emb|X70070.1|HSNEURA[35020] - 14325: X94552
H. sapiens mRNA for metabotropic glutamate receptor type 7
gi|1370110|emb|X94552.1|HSMGLU7[1370110] - 14326: X89105
H. sapiens krag-like mRNA
gi|939922|emb|X89105.1|HSKRAGGEN[939922] - 14327: X92562
H. sapiens mRNA for myeloid IgA Fc receptor, CD89 (539 bp)
gi|1296655|emb|X92562.1|HSIGAFCR5[1296655] - 14328: X92561
H. sapiens mRNA for myeloid IgA Fc receptor, CD89 (585 bp)
gi|1296654|emb|X92561.1|HSIGAFCR4[1296654] - 14329: X92560
H. sapiens mRNA for myeloid IgA Fc receptor, CD89 (807 bp)
gi|1296653|emb|X92560.1|HSIGAFCR3[1296653] - 14330: X92559
H. sapiens mRNA for myeloid IgA Fc receptor, CD89 (771 bp)
gi|1296652|emb|X92559.1|HSIGAFCR2[1296652] - 14331: X92558
H. sapiens mRNA for myeloid IgA Fc receptor, CD89 (837 bp)
gi|1296651|emb|X92558.1|HSIGAFCR1[1296651] - 14332: Z50197
H. sapiens FGFR2, Bek gene (partial; mutation C)
gi|929635|emb|Z50197.1|HSFGFR2XC[929635] - 14333: Z50196
H. sapiens FGFR2, Bek gene (partial; mutation B)
gi|929634|emb|Z50196.1|HSFGFR2XB[929634] - 14334: Z50201
H. sapiens FGFR2 gene (partial; mutation A)
gi|929633|emb|Z50201.1|HSFGFR2XA[929633] - 14335: X72304
H. sapiens mRNA for corticotrophin releasing factor receptor
gi|436118|emb|X72304.1|HSCRFA[436118] - 14336: X86169
H. sapiens B2-bradykinin receptor gene, exon 2, C allele
gi|1220165|emb|X86169.1|HSB2BRX2C[1220165] - 14342: X03131
H. sapiens interleukin 2 receptor gene 5′ flanking region and exon 1 (and joined
CDS)
gi|33818|emb|X03131.1|HSIL2RG1[33818] - 14343: X57740
H. sapiens rearranged T-cell receptor gamma chain gene, V3RS-J1 (hybrid joint)
gi|505478|emb|X57740.1|HSTCRHJD[505478] - 14344: X01719
H. sapiens gene fragment for the acetylcholine receptor gamma subunit (exon 7 and
8)
gi|28278|emb|X01719.1|HSACHG5[28278] - 14345: X01715
H. sapiens gene fragment for the acetylcholine receptor gamma subunit precursor
(exons 1 and 2)
gi|28268|emb|X01715.1|HSACHG1[28268] - 14535: Z30429
H. sapiens gene for early lymphocyte activation antigen CD69, exon 4
gi|534947|emb|Z30429.1|HSLACD694[534947] - 14536: X89744
H. sapiens mRNA for neuronal acetylcholine receptor alpha-4 subunit, exon 4
gi|1279462|emb|X89744.1|HSCHRNA44[1279462] - 14537: X87765
H. sapiens CD89 gene, exon TM/C
gi|963045|emb|X87765.1|HSCD89EX5[963045] - 14538: X87766
H. sapiens CD89 gene, exon EC2
gi|963044|emb|X87766.1|HSCD89EX4[963044] - 14539: X87769
H. sapiens CD89 gene, exon EC1
gi|963043|emb|X87769.1|HSCD89EX3[963043] - 14540: X87768
H. sapiens CD89 gene, exon S2
gi|963042|emb|X87768.1|HSCD89EX2[963042] - 14541: X87767
H. sapiens CD89 gene, exon S1
gi|963041|emb|X87767.1|HSCD89EX1[963041] - 14542: AH004970
Homo sapiens (clone Q-20D3) interferon receptor (IFNAR2) gene
gi|995299|gb|AH004970.1|SEG_HUMIFNAMO[995299] - 14543: L42243
Homo sapiens (clone 51H8) alternatively spliced interferon receptor (IFNAR2) gene, exon 9 and complete cds's
gi|995298|gb|L42243.1|HUMIFNAM08[995298] - 14544: L41944
Homo sapiens interferon receptor ifnar2-1 (splice variant IFNAR2-1) mRNA, complete cds
gi|995296|gb|L41944.1|HUMIFNAL[995296] - 14545: L41943
Homo sapiens interferon receptor ifnar2-3 (splice variant IFNAR2-3) mRNA, complete cds
gi|995294|gb|L41943.1|HUMIFNAK[995294] - 14546: L41942
Homo sapiens interferon receptor ifnar2-2 (splice variant IFNAR2-2) mRNA, complete cds
gi|995292|gb|L41942.1|HUMIFNAJ[995292] - 14547: L42242
Homo sapiens (clone Q-20D3) interferon receptor (IFNAR2) gene, exon 8
gi|994722|gb|L42242.1|HUMIFNAM07[994722] - 14548: L42241
Homo sapiens (clone Q-20D3) interferon receptor (IFNAR2) gene, exon 7
gi|994721|gb|L42241.1|HUMIFNAM06[994721] - 14549: L42323
Homo sapiens (clone 20D3) interferon receptor (IFNAR2) gene, exon 6
gi|994720|gb|L42323.1|HUMIFNAM05[994720] - 14550: L42240
Homo sapiens (clone Q-20D3) interferon receptor (IFNAR2) gene, exon 5
gi|994719|gb|L42240.1|HUMIFNAM04[994719] - 14551: L42239
Homo sapiens (clone Q-20D3) interferon receptor (IFNAR2) gene, exons 3-4
gi|994718|gb|L42239.1|HUMIFNAM03[994718] - 14552: L42238
Homo sapiens (clone Q-20D3) interferon receptor (IFNAR2) gene, exon 2
gi|994717|gb|L42238.1|HUMIFNAM02[994717] - 14553: L42237
Homo sapiens (clone Q-20D3) interferon receptor (IFNAR2) gene, exon 1
gi|994716|gb|L42237.1|HUMIFNAM01[994716] - 14557: X94647
H. sapiens CD97 gene exon 20
gi|1165083|emb|X94647.1|HSX94647[1165083] - 14558: X94630
H. sapiens CD97 gene exon 1 (and joined CDS)
gi|1165073|emb|X94630.1|HSX94630[1165073] - 14560: X91747
H. sapiens gene for FSH receptor (exon 10)
gi|1009412|emb|X91747.1|HSFSHRX10[1009412] - 14561: X74979
H. sapiens TRK E mRNA
gi|400462|emb|X74979.1|HSTRKE[400462] - 14562: Y10100
H. sapiens ACTH receptor promoter & exon 1
gi|1743254|emb|Y10100.11HSACTHPRO[1743254] - 14563: Y09028
H. sapiens NTRK1 gene, exon 1 (and joined mRNA)
gi|1785644|emb|Y09028.1|HSNTRK11[1785644] - 14564: Y07684
H. sapiens mRNA for P2X4 purinoceptor
gi|1781008|emb|Y07684.1|HSP2X4PC[1781008] - 14565: X95712
H. sapiens mRNA for receptor protein tyrosine phosphatase
gi|1666422|emb|X95712.1|HSRPTYRPH[1666422] - 14568: X97232
H. sapiens mRNA for NK receptor, clone library D97.10
gi|1770483|emb|X97232.1|HSNKRD9[1770483] - 14569: X97233
H. sapiens mRNA for NK receptor, clone library C97.12#5
gi|1770481|emb|X97233.1|HSNKRC9[1770481] - 14570: X97231
H. sapiens mRNA for NK receptor, clone library 59C/K3
gi|1770479|emb|X97231.1|HSNKR59[1770479] - 14571: X97230
H. sapiens mRNA for NK receptor, clone library 4M1#6
gi|1770477|emb|X97230.1|HSNKR4M[1770477] - 14572: X97229
H. sapiens mRNA for NK receptor, clone library 15.212
gi|1770475|emb|X97229.1|HSNKR15[1770475] - 14573: X99481
H. sapiens mRNA for NK receptor, clone GR #19
gi|1770473|emb|X99481.1|HSNKGR19[1770473] - 14574: X99480
H. sapiens mRNA for NK receptor, clone NK3.3 #27
gi|1770471|emb|X99480.1|HSNK3327[1770471] - 14575: X99479
H. sapiens mRNA for NK receptor, clone 12.11C
gi|1770469|emb|X99479.1|HSNK1211C[1770469] - 14576: X98118
H. sapiens GRK4A gene
gi|1770421|emb|X98118.1|HSGRK4AGE[1770421] - 14589: X83864
H. sapiens EDG-3 gene
gi|1770395|emb|X83864.1|HSEDG3[1770395] - 14590: Z48923
H. sapiens mRNA for BMPR-II
gi|1009409|emb|Z48923.1|HSBMPRII[1009409] - 14592: X84939
H. sapiens mRNA for fibroblast growth factor receptor-3
gi|695548|emb|X84939.1|HSFGFR3EX[695548] - 14593: X89604
H. sapiens mRNA for metallothionein-III
gi|914850|emb|X89604.1|HSMTIII[914850] - 14594: Z70276
H. sapiens mRNA for fibroblast growth factor 12 (partial)
gi|1749790|emb|Z70276.1|HSFGF12CR[1749790] - 14595: Z70275
H. sapiens mRNA for fibroblast growth factor 11 (partial)
gi|1749788|emb|Z70275.1|HSFGF11CR[1749788] - 14596: Y09392
H. sapiens mRNA for WSL-LR, WSL-S1 and WSL-S2 proteins
gi|1669690|emb|Y09392.1|HSWSL1[1669690] - 14597: X99031
H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 14
gi|1480251|emb|X99031.1|HSDRTK14[1480251] - 14598: X99029
H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 11
gi|1480247|emb|X99029.1|HSDRTK11[1480247] - 14599: Y08162
H. sapiens mRNA for heptahelix receptor
gi|1707499|emb|Y08162.1|HSHHR[1707499] - 14600: X98194
H. sapiens gene encoding serotonin receptor, 5-HT7, exon 3
gi|1707470|emb|X98194.1|HS5HT73[1707470] - 14601: X99025
H. sapiens gene encoding discoidin receptor tyrosine kinase, exons 6 & 7
gi|1480257|emb|X99025.1|HSDRTK6[1480257] - 14615: X98147
H. sapiens gene encoding serotonin receptor, 5-HT7, exon 2
gi|1707469|emb|X98147.1|HS5HT72[1707469] - 14616: X98193
H. sapiens gene encoding serotonin receptor, 5-HT7, exon 1 (and joined CDS)
gi|1707467|emb|X98193.1|HS5HT71[1707467] - 14617: X90753
H. sapiens mRNA for alternatively spliced IgA Fc receptor (CD89)
gi|951268|emb|X90753.1|HSIGAFCGN[951268] - 14618: X70812
H. sapiens gene for beta 3 adrenergic receptor
gi|312398|emb|X70812.1|HSBARED[312398] - 14619: Z22971
H. sapiens mRNA for M130 antigen extracellular variant
gi|312147|emb|Z22971.1|HSM130AE[312147] - 14620: Z22970
H. sapiens mRNA for M130 antigen cytoplasmic variant 2
gi|312145|emb|Z22970.1|HSM130AC2[312145] - 14621: Z22969
H. sapiens mRNA for M130 antigen cytoplasmic variant 1
gi|312143|emb|Z22969.1|HSM130AC1[312143] - 14622: Z22968
H. sapiens mRNA for M130 antigen
gi|312141|emb|Z22968.1|HSM130A[312141] - 14623: X69680
H. sapiens mRNA for bradykinin receptor
gi|288798|emb|X69680.1|HSBKR[288798] - 14624: Z79784
H. sapiens G protein-coupled receptor CKR-L3
gi|1668737|emb|Z79784.1|HSCKRL3[1668737] - 14625: Z79782
H. sapiens G protein-coupled receptor CKR-L1
gi|1668735|emb|Z79782.1|HSCKRL1[1668735] - 14626: X94374
H. sapiens mRNA for HLA class I inhibitory NK receptor (AMC5)
gi|1495480|emb|X94374.1|HSNKRAMC5[1495480] - 14627: X94373
H. sapiens mRNA for HLA class I inhibitory NK receptor (1.1)
gi|1495478|emb|X94373.1|HSNKR11[1495478] - 14628: X93596
H. sapiens mRNA for HLA specific NK receptor
gi|1495476|emb|X93596.1|HSNKI8[1495476] - 14629: X93595
H. sapiens mRNA for NK receptor (clone 17.1C)
gi|1495474|emb|X93595.1|HSNKI7[1495474] - 14630: X94262
H. sapiens mRNA for HLA-Bw4 specific inhibitory NK cell receptor
gi|1495472|emb|X94262.1|HSNKCRMR[1495472] - 14631: X89772
H. sapiens mRNA for interferon alpha/beta receptor (long form)
gi|1620400|emb|X89772.1|HSRNAIABR[1620400] - 14632: X69516
H. sapiens gene for folate receptor
gi|288876|emb|X69516.1|HSFOLA[288876] - 14633: X97671
H. sapiens mRNA for erythropoietin receptor
gi|1310666|emb|X97671.1|HSERYTHR[1310666] - 14639: X97874
H. sapiens EP4 prostaglandin receptor gene, exon III
gi|1359732|emb|X97874.1|HSEP4EX3[1359732] - 14640: X97873
H. sapiens EP4 prostaglandin receptor gene, exons I & II (and joined CDS)
gi|1359730|emb|X97873.1|HSEP4EX12[1359730] - 14646: X99404
H. sapiens mRNA for early response gene, Berg36
gi|1480242|emb|X99404.1|HSBERG36[1480242] - 14647: Z49205
H. sapiens mRNA for purinergic receptor
gi|798835|emb|Z49205.1|HSATPRMR[798835] - 14650: X89066
H. sapiens mRNA for TRPC1 protein
gi|1370118|emb|X89066.1|HSTRPC1GN[1370118] - 14671: Y08218
H. sapiens mRNA for ryanodine receptor 2
gi|1561613|emb|Y08218.1|HSRYAN2[1561613] - 14678: X96586
H. sapiens mRNA for FAN protein
gi|1556398|emb|X96586.1|HSFAN[1556398] - 14679: Z48226
H. sapiens partial gene for receptor-type protein tyrosine phosphatase IA-2
gi|667014|emb|Z48226.1|HSPTPAIA2[667014] - 14680: X91665
H. sapiens B2-bradykinin receptor gene (allele BE-R33)
gi|121615|emb|X91665.1|HSB2BER33[1216151] - 14681: L05424
Human cell surface glycoprotein CD44 (CD44) gene, 3′ end of long tailed isoform
gi|337956|gb|L05424.1|HUMSCG19[337956] - 14682: L05423
Human cell surface glycoprotein CD44 (CD44) gene, exon 18, 3′ end of short tailed isoform
gi|337955|gb|L05423.1|HUMSCG18[337955] - 14683: L05422
Human cell surface glycoprotein CD44 (CD44) gene, exon 17
gi|337954|gb|L05422.1|HUMSCG17[337954] - 14684: L05421
Human cell surface glycoprotein CD44 (CD44) gene, exon 16
gi|337953|gb|L05421.1|HUMSCG16[337953] - 14685: L05420
Human cell surface glycoprotein CD44 (CD44) gene, exon 15
gi|337952|gb|L05420.1|HUMSCG1S[337952] - 14686: L05419
Human cell surface glycoprotein CD44 (CD44) gene, exon 14
gi|337951|gb|L05419.1|HUMSCG14[337951] - 14687: L05418
Human cell surface glycoprotein CD44 (CD44) gene, exon 13
gi|337950|gb|L05418.1|HUMSCG13[337950] - 14688: L05417
Human cell surface glycoprotein CD44 (CD44) gene, exon 12
gi|337949|gb|L05417.1|HUMSCG12[337949] - 14689: L05416
Human cell surface glycoprotein CD44 (CD44) gene, exon 11
gi|337948|gb|L05416.1|HUMSCG11[337948] - 14690: L05415
Human cell surface glycoprotein CD44 (CD44) gene, exon 10
gi|337947|gb|L05415.1|HUMSCG10[337947] - 14691: L05414
Human cell surface glycoprotein CD44 (CD44) gene, exon 9
gi|337946|gb|L05414.1|HUMSCG09[337946] - 14692: L05413
Human cell surface glycoprotein CD44 (CD44) gene, exon 8
gi|337945|gb|L05413.1|HUMSCG08[337945] - 14693: L05412
Human cell surface glycoprotein CD44 (CD44) gene, exon 7
gi|337944|gb|L05412.1|HUMSCG07[337944] - 14694: L05411
Human cell surface glycoprotein CD44 (CD44) gene, exon 6
gi|337943|gb|L05411.1|HUMSCG06[337943] - 14695: L05410
Human cell surface glycoprotein CD44 (CD44) gene, exon 5
gi|337942|gb|L05410.1|HUMSCG05[337942] - 14696: L05409
Human cell surface glycoprotein CD44 (CD44) gene, exon 4
gi|33794|gb|L05409.1|HUMSCG04[337941] - 14697: L05408
Human cell surface glycoprotein CD44 (CD44) gene, exon 3
gi|337940|gb|L05408.1|HUMSCG03[337940] - 14698: L05407
Human cell surface glycoprotein CD44 (CD44) gene, exon 2
gi|337939|gb|L05407.1|HUMSCG02[337939] - 14699: M69214
Human hyaluronate receptor (CD44) gene, exon 1
gi|180127|gb|M69215.1|HUMSCG01[180127] - 14700: X91492
H. sapiens ChemR13 gene
gi|1262810|emb|X91492.1|HSCCCKR4G[1262810] - 14701: X91742
H. sapiens gene for FSH receptor (exon 5)
gi|1051149|emb|X91742.1|HSFSHRX5[1051149] - 14702: X91746
H. sapiens gene for FSH receptor (exon 9)
gi|1009420|emb|X91746.1|HSFSHRX9[1009420] - 14703: X91745
H. sapiens gene for FSH receptor (exon 8)
gi|1009419|emb|X91745.1|HSFSHRX8[1009419] - 14704: X91744
H. sapiens gene for FSH receptor (exon 7)
gi|1009418|emb|X91744.1|HSFSHRX7[1009418] - 14705: X91743
H. sapiens gene for FSH receptor (exon 6)
gi|1009417|emb|X91743.1|HSFSHRX6[1009417] - 14706: X91741
H. sapiens gene for FSH receptor (exon 4)
gi|1009415|emb|X91741.1|HSFSHRX4[1009415] - 14707: X91740
H. sapiens gene for FSH receptor (exon 3)
gi|1009414|emb|X91740.1|HSFSHRX3[1009414] - 14708: X91739
H. sapiens gene for FSH receptor (exon 2)
gi|1009413|emb|X91739.1|HSFSHRX2[1009413] - 14709: X91738
H. sapiens gene for FSH receptor (exon 1)
gi|1009411|emb|X91738.1|HSFSHRX1[1009411] - 14710: A34990
H. sapiens TSH receptor
gi|1568335|emb|A34990.1|A34990[1568335] - 14729: A23337
H. sapiens mRNA for 5-HT2 receptor
gi|1566776|emb|A23337.1|A23337[1566776] - 14730: X95095
H. sapiens mRNA for PDGFRalpha protein
gi|1403334|emb|X95095.1|HSPDGFRAL[1403334] - 14731: X91875
H. sapiens IGF2R gene exon & intron 1
gi|1017421|emb|X91875.1|HSIGF2R1[1017421] - 14733: L40636
Homo sapiens (clone FBK III 16) protein tyrosine kinase (NET PTK) mRNA, complete
cds
gi|1100111|gb|L40636.1|HUMEPHT2R[1100111] - 14734: X55077
H. sapiens mRNA fragment for alpha-2 macroglobulin receptor
gi|24762|emb|X55077.1|HSA2MR[24762] - 14735: X98330
H. sapiens mRNA for ryanodine receptor 2
gi|1526977|emb|X98330.1|HSRR2[1526977] - 14737: X80038
H. sapiens PRR2 mRNA
gi|1524087|emb|X80038.1|HSPRR2[1524087] - 14738: Z15017
H. sapiens mRNA for glycoprotein 39 (gp39)
gi|38483|emb|Z15017.1|HSGP39MR[38483] - 14740: Z36748
H. sapiens mRNA for serotonin receptor
gi|558382|emb|Z36748.1|HSSERRC[558382] - 14741: X97198
H. sapiens mRNA for receptor phosphate PCP-2
gi|1502342|emb|X97198.1|HSRECPCP2[1502342] - 14742: X81870
H. sapiens DNA for macrophage stimulating protein receptor
gi|1491705|emb|X81870.1|HSDNAMSPR[1491705] - 14743: Z11168
H. sapiens 5HT1A receptor region
gi|1033027|emb|Z11168.1|HS5HT1A[1033027] - 14744: M75105
Human neurokinin-2 receptor (TAC2R) gene, exon 5
gi|189219|gb|M75105.1|HUMNK25[189219] - 14745: M75104
Human neurokinin-2 receptor (NK-2) gene, exon 4
gi|189218|gb|M75104.1|HUMNK24[189218] - 14746: M75103
Human neurokinin-2 receptor (NK-2) gene, exon 3
gi|189217|gb|M75103.1|HUMNK23[189217] - 14747: M75102
Human neurokinin-2 receptor (NK-2) gene, exon 2
gi|189216|gb|M75102.1|HUMNK22[189216] - 14748: M75101
Human neurokinin-2 receptor (TAC2R) gene, exon 1
gi|189215|gb|M75101.1|HUMNK21[189215] - 14750: X76981
H. sapiens mRNA for adenosin receptor A3
gi|440547|emb|X76981.1|HSRADRA3[440547] - 14751: X95302
H. sapiens mRNA for IL13 receptor
gi|1483349|emb|X95302.1|HSIL13REC[1483349] - 14752: X51469
H. sapiens cell receptor gamma-chain J1-C1 DNA fragment (Raji cell line)
gi|1480294|emb|X51469.1|HSRAJI[1480294] - 14753: X99027
H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 9
gi|1480259|emb|X99027.1|HSDRTK9[1480259] - 14754: X99026
H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 8
gi|1480258|emb|X99026.1|HSDRTK8[1480258] - 14755: X99024
H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 5
gi|1480256|emb|X99024.1|HSDRTK5[1480256] - 14756: X99023
H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 4
gi|1480255|emb|X99023.1|HSDRTK4[1480255] - 14757: X99034
H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 17
gi|1480254|emb|X99034.1|HSDRTK17[1480254] - 14758: X99033
H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 16
gi|1480253|emb|X99033.1|HSDRTK16[1480253] - 14759: X99032
H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 15
gi|1480252|emb|X99032.1|HSDRTK15[1480252] - 14760: X98208
H. sapiens gene encoding discoidin receptor tyrosine kinase, exons 1, 2, 3 and joined CDS
gi|1480249|emb|X98208.1|HSDRTK123[1480249] - 14761: X99030
H. sapiens gene encoding discoidin receptor tyrosine kinase, exons 12 & 13
gi|1480248|emb|X99030.1|HSDRTK12[1480248] - 14762: X99028
H. sapiens gene encoding discoidin receptor tyrosine kinase, exon 10
gi|1480246|emb|X99028.1|HSDRTK10[1480246] - 14763: X51470
H. sapiens T-cell receptor gamma-chain J1-C1 DNA fragment (D-PLL cell line)
gi|1480245|emb|X51470.1|HSDPLL[1480245] - 14764: L76631
Homo sapiens metabotropic glutamate receptor 1 beta (mGluR1beta) mRNA, complete
cds
gi|1477389|gb|L76631.1|HUMMGLUB[1477389] - 14765: L76627
Homo sapiens metabotropic glutamate receptor 1 alpha (mGluR1alpha) mRNA, complete cds
gi|1477387|gb|L76627.1|HUMMGLUB[1477387] - 14766: L57508
Homo sapiens Cak receptor kinase mRNA, complete cds
gi|1160924|gb|L57508.1|HUMCAKA[1160924] - 14767: L38019
Homo sapiens (clone HUM-IP3R1) inositol 1,4,5-trisphosphate receptor type 1 mRNA, complete cds
gi|1464750|gb|L38019.1|HUMITR[1464750] - 14768: X77748
H. sapiens mRNA for metabotropic glutamate receptor type 3
gi|1171563|emb|X77748.1|HSMGLUR3[1171563] - 14769: M26016
Human CR2/CD21/C3d/Epstein-Barr virus receptor gene, exon IC
gi|181935|gb|M26016.1|HUMEBUR13[181935] - 14770: X63717
H. sapiens mRNA for APO-1 cell surface antigen
gi|28741|emb|X63717.1|HSAPO1[28741] - 14771: L03718
Human G protein-coupled receptor (kinase-like) gene, complete cds
gi|183598|gb|L03718.1|HUMGPRKLG[183598] - 14773: X99269
H. sapiens NPYY1 gene
gi|1430810|emb|X99269.1|HSNPYY1[1430810] - 14774: X95536
H. sapiens earl gene
gi|418937|emb|X95536.1|HSREOR[1418937] - 14775: X63745
H. sapiens ERD2.2 mRNA for KDEL receptor
gi|31217|emb|X63745.1|HSERD22[31217] - 14777: X98133
H. sapiens gene encoding histamine H2 receptor
gi|1359758|emb|X98133.1|HSH2R[1359758] - 14778: X89893
H. sapiens mRNA for NK receptor (183 ActI)
gi|1103680|emb|X89893.1|HSNKRECT2[1103680] - 14779: X89892
H. sapiens mRNA for NK receptor (Eb6 ActI)
gi|1103678|emb|X89892.1|HSNKRECT1[1103678] - 14780: X98178
H. sapiens mRNA for MACH-beta-4 protein
gi|1403330|emb|X98178.1|HSMACHB4[1403330] - 14781: X98177
H. sapiens mRNA for MACH-beta-3 protein
gi|1403328|emb|X98177.1|HSMACHB3[1403328] - 14782: X98175
H. sapiens mRNA for MACH-beta-2 protein
gi|1403326|emb|X98175.1|HSMACHB2[1403326] - 14783: X98176
H. sapiens mRNA for MACH-beta-1 protein
gi|1403324|emb|X98176.1|HSMACHB1[1403324] - 14784: X98173
H. sapiens mRNA for MACH-alpha-2 protein
gi|1403320|emb|X98173.1|HSMACHA2[1403320] - 14785: X67594
H. sapiens mRNA for MSH receptor
gi|1405733|emb|X67594.1|HSMSHRECA[1405733] - 14786: X96597
H. sapiens gene encoding G protein coupled receptor
gi|1296631|emb|X96597.1|HSGPCRE[1296631] - 14789: M88714
Human bradykinin receptor (BK-2) mRNA, complete cds
gi|1387999|gb|M88714.1|HUMBK2A[1387999] - 14790: AH003589
Homo sapiens sulfonylurea receptor (SUR1) gene
gi|1374918|gb|AH003589.1|SEG_HUMSUR1G[1374918] - 14791: L78243
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 39
gi|1374917|gb|L78243.1|HUMSUR1G38[1374917] - 14792: L78242
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 38
gi|1374916|gb|L78242.1|HUMSUR1G37[1374916]
- 14793: L78241
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 37
gi|1374915|gb|L78241.1|HUMSUR1G36[1374915] - 14794: L78240
Homo sapiens sulfonylurea receptor (SUR1) gene, exons 34, 35, and 36
gi|1374914|gb|L78240.1|HUMSUR1G35[1374914] - 14795: L78239
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 33
gi|1374913|gb|L78239.1|HUMSUR1G34[1374913] - 14796: L78238
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 32
gi|1374912|gb|L78238.1|HUMSUR1G33[1374912] - 14797: L78237
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 31
gi|1374911|gb|L78237.1|HUSUR1G32[1374911] - 14798: L78236
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 30
gi|1374910|gb|L78236.1|HUMSUR1G31[1374910] - 14799: L78235
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 29
gi|1374909|gb|L78235.1|HUMSUR1G30[1374909] - 14800: L78234
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 28
gi|1374908|gb|L78234.1|HUMSUR1G29[1374908] - 14801: L78233
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 27
gi|1374907|gb|L78233.1|HUMSUR1G28[1374907] - 14802: L78232
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 26
gi|1374906|gb|L78232.1|HUMSUR1G27[1374906] - 14803: L78231
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 25
gi|1374905|gb|L78231.1|HUMSUR1G28[1374905] - 14804: L78230
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 24
gi|1374904|gb|L78230.1|HUMSUR1G25[1374904] - 14805: L78229
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 23
gi|1374903|gb|L78229.1|HUMSUR1G24[1374903] - 14806: L78228
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 22
gi|1374902|gb|L78228.1|HUMSUR1G23[1374902] - 14807: L78227
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 21
gi|1374901|gb|L78227.1|HUMSUR1G22[1374901] - 14808: L78226
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 20
gi|1374900|gb|L78226.1|HUMSUR1G21[1374900] - 14809: L78254
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 19
gi|1374899|gb|L78254.1|HUMSUR1G20[1374899] - 14810: L78225
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 18
gi|1374898|gb|L78225.1|HUMSUR1G19[1374898] - 14811: L78224
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 17 (alternative)
gi|1374897|gb|L78224.1|HUMSUR1G18[1374897] - 14812: L78223
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 17
gi|1374896|gb|L78223.1|HUMSUR1G17[1374896] - 14813: L78222
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 16
gi|1374895|gb|L78222.1|HUMSUR1G16[1374895] - 14814: L78221
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 15
gi|1374894|gb|L78221.1|HUMSUR1G15[1374894] - 14815: L78220
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 14
gi|1374893|gb|L78220.1|HUMSUR1G14[1374893] - 14816: L78219
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 13
gi|1374892|gb|L78219.1|HUMSUR1G13[1374892] - 14817: L78218
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 12
gi|1374891|gb|L78218.1|HUMSUR1G12[1374891] - 14818: L78217
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 11
gi|1374890|gb|L78217.1|HUMSUR1G11[1374890] - 14819: L78216
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 10
gi|1374889|gb|L78216.1|HUMSUR1G10[1374889] - 14820: L78215
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 9
gi|1374888|gb|L78215.1|HUMSUR1G09[1374888] - 14821: L78214
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 8
gi|1374887|gb|L78214.1|HUMSUR1G08[1374887] - 14822: L78213
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 7
gi|1374886|gb|L78213.1|HUMSUR1G07[1374886] - 14823: L78255
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 6
gi|1374885|gb|L78255.1|HUMSUR1G06[1374885] - 14824: L78212
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 5
gi|1374884|gb|L78212.1|HUMSUR1G05[1374884] - 14825: L78211
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 4
gi|1374883|gb|L78211.1|HUMSUR1G04[1374883] - 14826: L78210
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 3
gi|1374882|gb|L78210.1|HUMSUR1G03[1374882] - 14827: L78209
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 2
gi|137488|gb|L78209.1|HUMSUR1G02[1374881] - 14828: L78208
Homo sapiens sulfonylurea receptor (SUR1) gene, exon 1
gi|1374880|gb|L78208.1|HUMSUR1G01[1374880] - 14829: L78207
Homo sapiens sulfonylurea receptor (SUR1) mRNA, complete cds
gi|1374674|gb|L78207.1|HUMSUR1RNA[1374674] - 14830: X80818
H. sapiens mRNA for metabotropic glutamate receptor type 4
gi|1160182|emb|X80818.1|HSMGLUR4[1160182] - 14831: X89068
H. sapiens mRNA for TRPC3 protein
gi|1019789|emb|X89068.1|HSTRPC3GN[1019789] - 14832: X85740
H. sapiens mRNA for C-C chemokine receptor-4
gi|1370103|emb|X85740.1|HSCCCR3[1370103] - 14833: X72924
H. sapiens STS in the vicinity of the ADRA2C gene, sequence tagged site
gi|458814|emb|X72924.1|HSADRASTS[458814] - 14834: A27282
H. sapiens TGR-CL3C
gi|1247129|emb|A27282.1|A27282[1247129] - 14835: A27278
H. sapiens TGR-CL5
gi|1247127|emb|A27278.1|A27278[1247127] - 14836: A27276
H. sapiens TGR-CL1
gi|1247125|emb|A27276.1|A27276[1247125] - 14837: A27270
H. sapiens TGR-CL10C
gi|1247123|emb|A27270.1|A27270[1247123] - 14838: A10542
H. sapiens low affinity Fc-epsilon-receptor
gi|489152|emb|A10542.1|A10542[489152] - 14839: X84700
H. sapiens mRNA for leucocyte antigen CD97
gi|840770|emb|X84700.1|HSCD97[840770] - 14841: X56794
H. sapiens CD44R mRNA
gi|29798|emb|X56794.1|HSCD441[29798] - 14842: Z22924
H. sapiens of CD36 gene, partial CDS
gi|397604|emb|Z22924.1|HSCD36AA[397604] - 14843: X81121
H. sapiens mRNA for central cannabinoid receptor, short isoform
gi|736238|emb|X81121.1|HSCB1A[736238] - 14844: X74328
H. sapiens mRNA for CB2 (peripheral) cannabinoid receptor
gi|407806|emb|X74328.1|HSCB2CANR[407806] - 14852: X81120
H. sapiens mRNA for central cannabinoid receptor
gi|736236|emb|X81120.1|HSCANN6[736236] - 14853: X82466
H. sapiens mRNA for calcitonin receptor
gi|565026|emb|X82466.1|HSCALRECR[565026] - 14854: X69920
H. sapiens mRNA for calcitonin receptor
gi|474931|emb|X69920.1|HSCALRE[474931] - 14855: Z22672
H. sapiens cacnl1a3 gene encoding skeletal muscle dhp-receptor alpha 1 subunit
gi|297467|emb|Z22672.1|HSCACN1A[297467] - 14856: Z35761
H. sapiens TEL/ABL fusion protien
gi|601903|emb|Z35761.1|HSBREAKP3[601903] - 14862: X62515
H. sapiens mRNA for basement membrane heparan sulfate proteoglycan
gi|29469|emb|X62515.1|HSBMHSP[29469] - 14887: X70811
H. sapiens mRNA for beta 3 adrenergic receptor
gi|312396|emb|X70811.1|HSBARE[312396] - 14888: X69117
H. sapiens mRNA for beta-adrenergic kinase 2
gi|312394|emb|X69117.1|HSBADRK2[312394] - 14889: X61157
H. sapiens mRNA for beta-adrenergic receptor kinase
gi|288307|emb|X61157.1|HSBARK[288307] - 14891: X77584
H. sapiens mRNA for ATL-derived factor/thiredoxin
gi|453963|emb|X77584.1|HSATLRED[453963] - 14894: X70297
H. sapiens mRNA for neuronal nicotinic acetylcholine receptor alpha-7 subunit
gi|496606|emb|X70297.1|HSARA7A[496606] - 14901: Z11162
H. sapiens gene for angiotensin II
gi|28709|emb|Z11162.1|HSANTENII[28709] - 14902: X91162
H. sapiens anti-mullerian hormone type II receptor exon 9
gi|1107682|emb|X91162.1|HSAMREXO9[1107682] - 14903: X91164
H. sapiens anti-mullerian hormone type II receptor exon 11
gi|1107681|emb|X91164.1|HSAMREX11[1107681] - 14904: X91163
H. sapiens anti-mullerian hormone type II receptor exon 10
gi|1107680|emb|X91163.1|HSAMREX10[1107680] - 14905: X91161
H. sapiens anti-mullerian hormone type II receptor exon 8
gi|1107679|emb|X91161.1|HSAMREX08[1107679] - 14906: X91160
H. sapiens anti-mullerian hormone type II receptor exon 7
gi|1107678|emb|X91160.1|HSAMREX07[1107678] - 14907: X91159
H. sapiens anti-mullerian hormone type II receptor exon 6
gi|1107677|emb|X91159.1|HSAMREX06[1107677] - 14908: X91158
H. sapiens anti-mullerian hormone type II receptor exon 5
gi|1107676|emb|X91158.1|HSAMREX05[1107676] - 14909: X91157
H. sapiens anti-mullerian hormone type II receptor exon 4
gi|1107675|emb|X91157.1|HSAMREX04[1107675] - 14910: X91165
H. sapiens anti-mullerian hormone type II receptor exon 3
gi|1107674|emb|X91165.1|HSAMREX03[1107674] - 14911: X91166
H. sapiens anti-mullerian hormone type II receptor exon 2
gi|1107673|emb|X91166.1|HSAMREX02[1107673] - 14912: X65699
H. sapiens mRNA for angiotensin II receptor
gi|510983|emb|X65699.1|HSANGII[510983] - 14913: X91156
H. sapiens anti-mullerian hormone type II receptor exon 1
gi|1107671|emb|X91156.1|HSAMREX01[1107671] - 14914: Z22533
H. sapiens ALK-1 mRNA
gi|402196|emb|Z22533.1|HSALK1A[402196] - 14915: Z22536
Homo sapiens ALK-4 mRNA, complete CDS
gi|402188|emb|Z22536.1|HSALK4A[402188] - 14916: Z22535
H. sapiens ALK-3 mRNA
gi|402186|emb|Z22535.1|HSALK3A[402186] - 14917: Z22534
H. sapiens ALK-2 mRNA
gi|402184|emb|Z22534.1|HSALK2A[402184] - 14918: X59684
H. sapiens DNA for alpha2-1.8 adrenergic receptor gene
gi|28635|emb|X59684.1|HSALPH218[28635] - 14919: Z11687
H. sapiens mRNA for antidiuretic hormone receptor
gi|28417|emb|Z11687.1|HSADHRMR[28417] - 14920: X77533
H. sapiens mRNA for activin type II receptor
gi|825619|emb|X77533.1|HSACTIIRE[825619] - 14921: X62381
H. sapiens mRNA for activin receptor
gi|28347|emb|X62381.1|HSACTR[28347] - 14922: X65633
H. sapiens ACTH-R gene for adrenocorticotropic hormone receptor
gi|28343|emb|X65633.1|HSACTHR[28343] - 14923: X55019
H. sapiens mRNA for acetylcholine receptor delta subunit
gi|297401|emb|X55019.1|HSACHRG[297401] - 14924: X02508
H. sapiens gene fragment for acetylcholine receptor (AChR) alpha subunit exons 8,
9 and 3′ flanking region
gi|28306|emb|X02508.1|HSACHR8[28306] - 14925: X02507
H. sapiens gene fragment for acetylcholine receptor (AChR) alpha subunit exon 7
gi|28304|emb|X02507.1|HSACHR7[28304] - 14926: X02506
H. sapiens gene fragment for acetylcholine receptor (AChR) alpha-subunit exon 6
gi|28302|emb|X02506.1|HSACHR6[28302] - 14927: X83956
H. sapiens ACCA gene
gi|1061125|emb|X83956.1|HSACCAGEN[1061125] - 14928: X66403
H. sapiens mRNA for acetylcholine receptor (epsilon subunit)
gi|560152|emb|X66403.1|HSACETR[560152] - 14929: X02505
H. sapiens gene fragment for acetylcholine receptor (AChR) alpha subunit exon 5
gi|28300|emb|X02505.1|HSACHR5[28300] - 14930: X02504
H. sapiens gene fragment for acetylcholine receptor (AChR) alpha-subunit exon 4
gi|28298|emb|X02504.1|HSACHR4[28298] - 14931: X02503
H. sapiens gene fragment for acetylcholine receptor (AChR) alpha-subunit exons 2 and 3
gi|28293|emb|X02503.1|HSACHR2[28293] - 14932: X02502
H. sapiens gene fragment for acetylcholine receptor (AChR) alpha-subunit exon
gi|28291|emb|X02502.1|HSACHR[28291] - 14933: X04759
H. sapiens gene fragment for the acetylcholine receptor gamma subunit (exon 12)
gi|28288|emb|X04759.1|HSACHG8[28288] - 14934: X01721
H. sapiens gene fragment for the acetylcholine receptor gamma subunit (exons and 11)
gi|28286|emb|X01721.1|HSACHG7[28286] - 14935: X01720
H. sapiens gene fragment for the acetylcholine receptor gamma subunit (exon 9)
gi|28283|emb|X01720.1|HSACHG6[28283] - 14936: X01718
H. sapiens gene fragment for the acetylcholine receptor gamma subunit (exon 6)
gi|28276|emb|X01718.1|HSACHG4[28276] - 14937: X01717
H. sapiens gene fragment for the acetylcholine receptor gamma subunit (exon 5)
gi|28274|emb|X01717.1|HSACHG3[28274] - 14938: X01716
H. sapiens gene fragment for the acetylcholine receptor gamma subunit (exon 3 and
4)
gi|28271|emb|X01716.1|HSACHG2[28271] - 14939: X77018
H. sapiens mRNA for anti-acetylcholine receptor monoclonal autoantibody V lambda
region
gi|441251|emb|X77018.1|HSAARMA2[441251] - 14941: X68487
H. sapiens mRNA for A2b adenosine receptor
gi|400453|emb|X68487.1|HSA2BREC[400453] - 14942: X68486
H. sapiens mRNA for A2a adenosine receptor
gi|400451|emb|X68486.1|HSA2AREC[400451] - 14943: X68485
H. sapiens mRNA for A1 adenosine receptor
gi|400449|emb|X68485.1|HSA1ADREC[400449] - 14948: X87197
H. sapiens mRNA for 6.3 gene
gi|854083|emb|X87197.1|HS63MRNAG[854083] - 14949: X81412
H. sapiens DNA for 5-HT5A exon2
gi|541777|emb|X81412.1|HS5HT5A2[541777] - 14950: X81411
H. sapiens DNA for 5-HT5A exon1
gi|541776|emb|X81411.1|HS5HT5A1[541776] - 14952: X77307
H. sapiens mRNA for 5-HT2B serotonin receptor
gi|475197|emb|X77307.1|HS5HT2BSR[475197] - 14968: X75299
H. sapiens HIVR mRNA for vasoactive intestinal peptide (VIP) receptor
gi|407461|emb|X75299.1|HSVIPRE[407461] - 14969: X94216
H. sapiens mRNA for VEGF-C protein
gi|1177488|emb|X94216.1|HSVEGFC[1177488] - 14971: X67482
H. sapiens mRNA for 1,25-dihydroxyvitamin D-3 receptor
gi|37653|emb|X67482.1|HSVD3R[37653] - 14976: Z46797
H. sapiens gene for urokinase receptor (partial)
gi|732804|emb|Z46797.1|HSUPAR5[732804] - 14977: X74039
H. sapiens mRNA for urokinase plasminogen activator receptor
gi|456192|emb|X74039.1|HSUPAR[456192] - 14984: X51675
H. sapiens urokinase plasminogen activator surface receptor (UPAR) mRNA
gi|37604|emb|X51675.1|HSUPARAA[37604] - 14985: X76498
H. sapiens gene for uterine bombesin receptor
gi|468753|emb|X76498.1|HSUBR[468753] - 14986: X66029
H. sapiens mRNA for tyrosine kinase receptor
gi|37596|emb|X66029.1|HSUFOR[37596] - 14987: X66030
Homo sapiens partial ufo gene encoding tyrosine kinase receptor
gi|37594|emb|X66030.1|HSUFOD[37594] - 14998: X72089
H. sapiens mRNA for TRH receptor
gi|440155|emb|X72089.1|HSTRHREC[440155] - 15005: X72018
H. sapiens hTGR 1 mRNA
gi|1200088|emb|X72018.1|HSTGR1[1200088] - 15006: X69178
H. sapiens mRNA for thyrotropin receptor, partial
gi|288212|emb|X69178.1|HSTHREC[288212] - 15007: X69177
H. sapiens mRNA for thyrotropin receptor, partial
gi|288211|emb|X69177.1|HSTHRE[288211] - 15246: X65181
H. sapiens gene for substance P receptor (exon 5)
gi|36640|emb|X65181.1|HSSUBP5G[36640] - 15247: X65180
H. sapiens gene for substance P receptor (exon 4)
gi|36639|emb|X65180.1|HSSUBP4G[36639] - 15248: X65179
H. sapiens gene for substance P receptor (exon 3)
gi|36638|emb|X65179.1|HSSUBP3G[36638] - 15249: X65177
H. sapiens gene for substance P receptor (exon 1)
gi|36636|emb|X65177.1|HSSUBP1G[36636] - 15253: X62156
H. sapiens mRNA for soluble interleukin-5 receptor
gi|36465|emb|X62156.1|HSSILRS[36465] - 15254: X57830
H. sapiens serotonin 5-HT2 receptor mRNA
gi|36430|emb|X57830.1|HSSERR52[36430] - 15255: Z11166
H. sapiens S31 gene for serotonin receptor
gi|36264|emb|Z11166.1|HSS31G[36264] - 15256: X91869
H. sapiens mRNA for ryanodine receptor
gi|1022320|emb|X91869.1|HSRYR2[1022320] - 15257: X74269
H. sapiens RYR3 mRNA for ryanodine receptor type 3 (partial)
gi|405718|emb|X74269.1|HSRYR3MR[405718] - 15258: X74270
H. sapiens RYR3 gene for ryanodine receptor type 3 (partial)
gi|405716|emb|X74270.1|HSRYR3G[405716] - 15261: Z27409
H. sapiens mRNA for receptor tyrosine kinase eph (partial)
gi|482916|emb|Z27409.1|HSRTKEPH[482916] - 15262: X74764
H. sapiens mRNA for receptor protein tyrosine kinase
gi|433337|emb|X74764.1|HSRPTK[433337] - 15265: X59155
H. sapiens retroviral receptor mRNA
gi|36160|emb|X59155.1|HSRRMRNA[36160] - 15267: X70040
H. sapiens RON mRNA for tyrosine kinase
gi|36109|emb|X70040.1|HSRON[36109] - 15268: X75071
H. sapiens mRNA for human thyrotropin-releasing hormone receptor
gi|404157|emb|X75071.1|HSRNAHTRH[404157] - 15269: X86446
H. sapiens mRNA for 55.11 binding protein
gi|1008088|emb|X86446.1|HSRNA5511[1008088] - 15270: Z29093
H. sapiens EDDR1 gene for receptor tyrosine kinase
gi|732799|emb|Z29093.1|HSRETYK1[732799] - 15274: X64123
H. sapiens PVR gene for poliovirus receptor (exon 8)
gi|35819|emb|X64123.1|HSPVR8G[35819] - 15275: X64122
H. sapiens PVR gene for poliovirus receptor (exon 7)
gi|35818|emb|X64122.1|HSPVR7G[35818] - 15276: X64121
H. sapiens PVR gene for poliovirus receptor (exon 6)
gi|35817|emb|X64121.1|HSPVR6G[35817] - 15277: X64120
H. sapiens PVR gene for poliovirus receptor (exon 5)
gi|35816|emb|X64120.1|HSPVR5G[35816] - 15278: X64119
H. sapiens PVR gene for poliovirus receptor (exon 4)
gi|35815|emb|X64119.1|HSPVR4G[35815] - 15279: X64118
H. sapiens PVR gene for poliovirus receptor (exon 3)
gi|35814|emb|X64118.1|HSPVR3G[35814] - 15280: X64117
H. sapiens PVR gene for poliovirus receptor (exon 2)
gi|35813|emb|X64117.1|HSPVR2G[35813] - 15281: X64116
H. sapiens PVR gene for poliovirus receptor (exon 1)
gi|35809|emb|X64116.1|HSPVR1G[35809] - 15283: X75208
H. sapiens HEK2 mRNA for protein tyrosine kinase receptor
gi|406867|emb|X75208.1|HSPTKR[406867] - 15284: X65178
H. sapiens gene for substance P receptor (exon 2)
gi|35653|emb|X65178.1|HSPREC2G[35653] - 15285: X94226
H. sapiens poliovirus receptor gene
gi|1185121|emb|X94226.1|HSPOLR[1185121] - 15288: X73079
Homo sapiens encoding Polymeric immunoglobulin receptor
gi|456345|emb|X73079.1|HSPIR[456345] - 15291: X68596
H. sapiens mRNA for parathyroid hormone receptor
gi|396812|emb|X68596.1|HSPHR[396812] - 15302: X76079
H. sapiens mRNA for platelet derived growth factor alpha receptor
gi|433494|emb|X76079.1|HSPDGF[433494] - 15311: Z49993
H. sapiens partial gene for proteinase-activated receptor 2 (292 BP)
gi|1008084|emb|Z49993.1|HSPAR2A[1008084] - 15321: X80022
H. sapiens p75 TNF receptor, exon 2
gi|666045|emb|X80022.1|HSP75NFR2[666045] - 15322: X80021
H. sapiens p75 TNF receptor, exon 1
gi|666044|emb|X80021.1|HSP75NFR1[666044] - 15323: X69810
H. sapiens gene for p55 tumor necrosis factor receptor, exon 1
gi|288493|emb|X69810.1|HSP55TNF[288493] - 15324: X83688
H. sapiens mRNA for ATP receptor
gi|1166437|emb|X83688.1|HSP2XRCPR[1166437] - 15325: X77130
H. sapiens mRNA for ORL1 receptor
gi|471316|emb|X77130.1|HSORL1[471316] - 15327: X71635
H. sapiens mRNA for neuropeptide Y-like receptor
gi|297099|emb|X71635.1|HSNPYRLA[297099] - 15328: X71445
H. sapiens partial NTRK1 gene, involved in oncogenic rearrangements
gi|296536|emb|X71445.1|HSNTRK1[296536] - 15329: X66945
H. sapiens N-sam mRNA for fibroblast growth factor receptor
gi|35109|emb|X66945.1|HSNSAMTK[35109] - 15330: X75918
H. sapiens mRNA for NOT
gi|415822|emb|X75918.1|HSNOT[415822] - 15331: Z32774
H. sapiens gene for N-methyl-D-aspartate receptor R1 exons 6-21
gi|807894|emb|Z32774.1|HSNMDAR1C[807894] - 15332: Z32773
H. sapiens gene for N-methyl-D-aspartate receptor R1 exons 3, 4, 5
gi|807893|emb|Z32773.1|HSNMDAR1B[807893] - 15333: Z32772
H. sapiens gene for N-methyl-D-aspartate receptor R1, exon1, exon2
gi|807892|emb|Z32772.1|HSNMDAR1A[807892] - 15334: X68275
H. sapiens mRNA for nicotinic receptor beta 4 subunit
gi|35054|emb|X68275.1|HSNICRB[35054] - 15335: X65176
H. sapiens gene for neuromedin K receptor (exon 5)
gi|35027|emb|X65176.1|HSNEURK5[35027] - 15336: X65175
H. sapiens gene for neuromedin K receptor (exon 4)
gi|35026|emb|X65175.1|HSNEURK4[35026] - 15337: X65174
H. sapiens gene for neuromedin K receptor (exon 3)
gi|35025|emb|X65174.1|HSNEURK3[35025] - 15338: X65173
H. sapiens gene for neuromedin K receptor (exon 2)
gi|35024|emb|X65173.1|HSNEURK2[35024] - 15339: X65172
H. sapiens gene for neuromedin K receptor (exon 1)
gi|35022|emb|X65172.1|HSNEURK1[35022] - 15340: X87629
H. sapiens mRNA for nicotinic acetylcholine receptor alpha4 subunit
gi|854158|emb|X87629.1|HSNACRA4G[854158] - 15341: X70108
H. sapiens gene for nicotinic acetylcholine receptor alpha subunit, partial
gi|312470|emb|X70108.1|HSNACHRA[312470] - 15342: X67513
H. sapiens mRNA for neuronal nAChR beta-3 subunit
gi|34987|emb|X67513.1|HSNACHRB3[34987] - 15343: X53559
H. sapiens Hachr alpha-3 mRNA for mature neuronal nicotinic acetylcholine receptor alpha-3 subunit
gi|34985|emb|X53559.1|HSNACHRA3[34985] - 15344: X63131
H. sapiens My1 (PML) mRNA
gi|34813|emb|X63131.1|HSMY1[34813] - 15345: X65634
H. sapiens MSH-R gene for melanocyte stimulating hormone receptor
gi|34790|emb|X65634.1HSMSHR[34790] - 15346: X64878
H. sapiens mRNA for oxytocin receptor
gi|34764|emb|X64878.1|HSMRNAOXY[34764] - 15347: X84709
H. sapiens mRNA for mediator of receptor-induced toxicity
gi|791037|emb|X84709.1|HSMRINTX[791037] - 15348: X55635
H. sapiens mRNA for macrophage mannose receptor
gi|34702|emb|X55635.1|HSMMR[34702] - 15349: Z25470
H. sapiens melanocortin 5 receptor gene, complete CDS
gi|939924|emb|Z25470.1|HSMELRECA[939924] - 15350: X68829
H. sapiens mRNA for MDR15 protein
gi|840783|emb|X68829.1|HSMDCR[840783] - 15351: X61615
H. sapiens mRNA for leukemia inhibitory factor (LIF) receptor
gi|34365|emb|X61615.1|HSLIFR[34365] - 15374: X86128
H. sapiens mRNA for ood T lymphocyte
gi|1197254|emb|X86128.1|HSLAB2725[1197254] - 15375: Z30428
H. sapiens gene for early lymphocyte activation antigen CD69, exon 5
gi|536775|emb|Z30428.1|HSLACD695[536775] - 15376: Z30430
H. sapiens gene for early lymphocyte activation antigen CD69, exon 2
gi|535122|emb|Z30430.1|HSLACD692[535122] - 15398: X69304
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 4
gi|34093|emb|X69304.1HSKITPO04[34093] - 15399: X69303
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 3
gi|34092|emb|X69303.1|HSKITPO03[34092] - 15400: X69302
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 2
gi|34091|emb|X69302.1|HSKITPO02[34091] - 15401: X69301
H. sapiens KIT proto-oncogene for mast/stem cell growth factor receptor, exon 1
gi|34089|emb|X69301.1|HSKITPO01[34089] - 15405: X03138
H. sapiens interleukin 2 receptor gene exon 8 and 3′ untranslated region
gi|33830|emb|X03138.1|HSIL2RG8[33830] - 15406: X03137
H. sapiens interleukin 2 receptor gene exon 7
gi|33829|emb|X03137.1|HSIL2RG7[33829] - 15407: X03136
H. sapiens interleukin 2 receptor gene exon 6
gi|33827|emb|X03136.1|HSIL2RG6[33827] - 15408: X03135
H. sapiens interleukin 2 receptor gene exon 5
gi|33825|emb|X03135.1|HSIL2RG5[33825] - 15409: X03134
H. sapiens interleukin 2 receptor gene exon 4
gi|33823|emb|X03134.1|HSIL2RG4[33823] - 15410: X03133
H. sapiens interleukin 2 receptor gene exon 3
gi|33822|emb|X03133.1|HSIL2RG3[33822] - 15411: X03132
H. sapiens interleukin 2 receptor gene exon 2
gi|33820|emb|X03132.1|HSIL2RG2[33820] - 15412: X84348
H. sapiens mRNA for intracellular IL-1 receptor antagonist type II
gi|1008970|emb|X84348.1|HSIL1RAII[1008970] - 15413: Z46595
H. sapiens mRNA for interleukin 11 receptor isoform (incomplete)
gi|995655|emb|Z46595.1|HSIL11RR[995655] - 15414: Z38102
H. sapiens mRNA for interleukin-11 receptor
gi|995653|emb|Z38102.1|HSIL11RM[995653] - 15415: Z46596
H. sapiens gene for interleukin 11 receptor
gi|995652|emb|Z46596.1|HSIL11RGN[995652] - 15416: X59770
H. sapiens IL-1R2 mRNA for type II interleukin-1 receptor, (cell line CB23)
gi|33796|emb|X59770.1|HSIL1R211[33796] - 15421: X77722
H. sapiens mRNA for interferon alpha/beta receptor
gi|488363|emb|X77722.1|HSIFNABR[488363] - 15423: X53296
H. sapiens mRNA for IRAP
gi|32578|emb|X53296.1|HSI1RAP[32578] - 15424: X52015
H. sapiens mRNA for interleukin-1 receptor antagonist
gi|32576|emb|X52015.1|HSI1RA[32576] - 15425: X64993
H. sapiens mRNA HTPCRX19 for olfactory receptor
gi|32523|emb|X64993.1|HSHTPRX19[32523] - 15426: X64992
H. sapiens mRNA HTPCRX18 for olfactory receptor
gi|32522|emb|X64992.1|HSHTPRX18[32522] - 15427: X64991
H. sapiens mRNA HTPCRX17 for olfactory receptor
gi|32521|emb|X64991.1|HSHTPRX17[32521] - 15428: X64990
H. sapiens mRNA HTPCRX16 for olfactory receptor
gi|32520|emb|X64990.1|HSHTPRX16[32520] - 15429: X64989
H. sapiens mRNA HTPCRX15 for olfactory receptor
gi|32519|emb|X64989.1|HSHTPRX15[32519] - 15430: X64988
H. sapiens mRNA HTPCRX14 for olfactory receptor
gi|32518|emb|X64988.1|HSHTPRX14[32518] - 15431: X64987
H. sapiens mRNA HTPCRX13 for olfactory receptor
gi|32517|emb|X64987.1|HSHTPRX13[32517] - 15432: X64986
H. sapiens mRNA HTPCRX12 for olfactory receptor
gi|32516|emb|X64986.1|HSHTPRX12[32516] - 15433: X64985
H. sapiens mRNA HTPCRX11 for olfactory receptor
gi|32515|emb|X64985.1|HSHTPRX11[32515] - 15434: X64984
H. sapiens mRNA HTPCRX10 for olfactory receptor
gi|32514|emb|X64984.1|HSHTPRX10[32514] - 15435: X64983
H. sapiens mRNA HTPCRX09 for olfactory receptor
gi|32513|emb|X64983.1|HSHTPRX09[32513] - 15436: X64982
H. sapiens mRNA HTPCRX06 for olfactory receptor
gi|32512|emb|X64982.1|HSHTPRX06[32512] - 15437: X64981
H. sapiens mRNA HTPCRX03 for olfactory receptor
gi|32511|emb|X64981.1|HSHTPRX03[32511] - 15438: X64980
H. sapiens mRNA HTPCRX02 for olfactory receptor
gi|32510|emb|X64Y80.1|HSHTPRX02[32510] - 15439: X64979
H. sapiens mRNA HTPCRX01 for olfactory receptor
gi|32509|emb|X64979.1|HSHTPRX01[32509] - 15440: X64974
H. sapiens mRNA HTPCRH02 for olfactory receptor
gi|32508|emb|X64974.1|HSHTPRH02[32508] - 15441: X64978
H. sapiens mRNA HTPCRH07 for olfactory receptor
gi|32507|emb|X64978.1|HSHTPRH07[32507] - 15442: X64977
H. sapiens mRNA HTPCRH06 for olfactory receptor
gi|32506|emb|X64977.1|HSHTPRH06[32506] - 15443: X64976
H. sapiens mRNA HTPCRH04 for olfactory receptor
gi|32505|emb|X64976.1|HSHTPRH04[32505] - 15444: X64975
H. sapiens mRNA HTPCRH03 for olfactory receptor
gi|32504|emb|X64975.1|HSHTPRH03[32504] - 15445: X58288
H. sapiens hR-PTPu gene for protein tyrosine phosphatase
gi|32455|emb|X58288.1|HSHRPTPU[32455] - 15449: X64995
H. sapiens HGMP07J gene for olfactory receptor
gi|32092|emb|X64995.1|HSHGMP07J[32092] - 15450: X64994
H. sapiens HGMP07I gene for olfactory receptor
gi|32085|emb|X64994.1|HSHGM071[32085] - 15451: X17653
H. sapiens hFcRII-C isoform mRNA for IgG Fc receptor hFcRII
gi|32076|emb|X17653.1|HSHFCRIIC[32076] - 15452: X17652
H. sapiens hFcRII-B isoform mRNA for IgG Fc receptor hFcRII
gi|32073|emb|X17652.1|HSHFCRIIB[32073] - 15453: X53364
H. sapiens HePTP mRNA for tyrosine phosphatase
gi|32066|emb|X53364.1|HSHEPTP[32066] - 15454: X64830
H. sapiens mRNA for GLU-R2 glutamate receptor subunit, ‘flop’ exon
gi|31911|emb|X64830.1|HSGRSFLOP[31911] - 15455: X64829
H. sapiens mRNA for GLU-R2 glutamate receptor subunit, ‘flip’ exon
gi|31910|emb|X64829.1|HSGRSFLIP[31910] - 15456: X75897
H. sapiens mRNA for G-protein coupled kinase 4
gi|483764|emb|X75897.1|HSGRK4[483764] - 15460: X52009
H. sapiens alpha-1 strychnine binding subunit of inhibitory glycine receptor mRNA
gi|3185|emb|X52009.1|HSGLYRA2[31850] - 15461: X52008
H. sapiens alpha-2 strychnine binding subunit of inhibitory glycine receptor mRNA
gi|31848|emb|X52008.1|HSGLYRA1[31848] - 15462: X82068
H. sapiens mRNA for glutamate receptor subunit GluRC
gi|558587|emb|X82068.1|HSGLURC[558587] - 15463: X58633
H. sapiens mRNA for glutamate receptor GLUR1
gi|414892|emb|X58633.1|HSGLUR1[414892] - 15464: X81832
H. sapiens mRNA for glucose-dependant insulinotropic polypeptide receptor gene
gi|11030050 emb|X81832.1|HSGDIPR[1030050] - 15465: X61656
H. sapiens mRNA for growth factor receptor tyrosine kinase
gi|31717|emb|X61656.1|HSGFRTK[31717] - 15466: X55037
H. sapiens GATA-3 mRNA
gi|31661|emb|X55037.1|HSGATA3[31661] - 15467: X63670
H. sapiens DNA sequence for polymorphism at the GABA receptor B3
gi|31638|emb|X63670.1|HSGABRB3[31638] - 15472: Z34260
H. sapiens DNA for follicle stimulating hormone (FSH) receptor
gi|1052701|emb|Z34260.1|HSFSHX1[1052701] - 15473: X68044
H. sapiens mRNA for follicle-stimulating hormone receptor
gi|31473|emb|X68044.1|HSFSTHR[31473] - 15474: Z46619
H. sapiens mRNA for immunoglobulin kappa chain (fsa10)
gi|575235|emb|Z46619.1|HSFSA10KA[575235] - 15475: Z46615
H. sapiens DNA for immunoglobulin kappa chain (fsa10glk)
gi|575234|emb|Z46615.1|HSFSA10GL[575234] - 15476: Z32633
H. sapiens FRGAMMA′ mRNA for folate receptor (817 bp)
gi|474060|emb|Z32633.1|HSFRGAM2[474060] - 15477: Z32564
H. sapiens FRGAMMA mRNA (819 bp) for folate receptor
gi|473235|emb|Z32564.1|HSFRGAM1[473235] - 15478: X69878
H. sapiens Flt4 mRNA for transmembrane tyrosine kinase
gi|297049|emb|X69878.1|HSFLT4X[297049] - 15479: X68203
H. sapiens mRNA for FLT4, class III receptor tyrosine kinase
gi|31433|emb|X68203.1|HSFLT4[31433] - 15480: X62573
H. sapiens RNA for Fc receptor, TC9
gi|31339|emb|X62573.1|HSFCTC6[31339] - 15481: X66187
H. sapiens FceRI mRNA, partial CDS
gi|396463|emb|X66187.1|HSFCERIGB[396463] - 15482: X62572
H. sapiens RNA for Fc receptor, PC23
gi|31328|emb|X62572.1|HSFCPC23[31328] - 15483: Z46618
H. sapiens mRNA for immunoglobulin lambda chain (f29)
gi|575230|emb|Z46618.1|HSF29LAM[575230] - 15484: Z46634
H. sapiens mRNA for immunoglobulin kappa chain (f29)
gi|575228|emb|Z46634.1|HSF29KAP[575228] - 15485: X61950
H. sapiens mRNA for endothelin-1 receptor
gi|288312|emb|X61950.1|HSET1R[288312] - 15486: X83863
H. sapiens mRNA for prostaglandin E receptor (EP3f)
gi|633219|emb|X83863.1|HSEP3F[633219] - 15487: X83862
H. sapiens mRNA for prostaglandin E receptor (EP3e)
gi|633217|emb|X83862.1|HSEP3E[633217] - 15488: X83861
H. sapiens mRNA for prostaglandin E receptor (EP3d)
gi|633215|emb|X83861.1|HSEP3D[633215] - 15489: X83860
H. sapiens mRNA for prostaglandin E receptor (EP3c)
gi|633213|emb|X83860.1|HSEP3C[633213] - 15490: X83859
H. sapiens mRNA for prostaglandin E receptor (EP3b)
gi|633211|emb|X83859.1|HSEP3B[633211] - 15491: X83858
H. sapiens mRNA for prostaglandin E receptor (EP3a2)
gi|633209|emb|X83858.1|HSEP3A2[633209] - 15492: X83857
H. sapiens mRNA for prostaglandin E receptor (EP3a1)
gi|633207|emb|X83857.1HSEP3A1[633207] - 15493: X83868
H. sapiens mRNA for EP2 prostaglandin receptor
gi|633205|emb|X83868.1|HSEP2PR[633205] - 15494: X81479
H. sapiens mRNA for EMR1 hormone receptor
gi|784993|emb|X81479.1|HSEMR1[784993] - 15518: Z28613
H. sapiens (dhpa215) cacnl2a gene for dihydropyridine receptor alpha-2 subunit
gi|472953|emb|Z28613.1|HSDPRA25[472953] - 15519: Z28609
H. sapiens (dhpa22hd) cacnl2a gene for dihydropyridine receptor alpha 2-subunit
gi|472952|emb|Z28609.1|HSDPRA24[472952] - 15520: Z28605
H. sapiens (dhpa23) cacnl2a gene for dihydropyridine receptor alpha2 subunit
gi|472951|emb|Z28605.1|HSDPRA23[472951] - 15521: Z28602
H. sapiens (dhpa21hb) cacnl2a gene for dihydropyridine receptor alpha 2-subunit
gi|472950|emb|Z28602.1|HSDPRA22[472950] - 15522: Z28599
H. sapiens (a225eh) cacnl2a gene for dihydropyridine receptor alpha2 subunit
gi|472949|emb|Z28599.1|HSDPRA21[472949] - 15526: X55758
H. sapiens dopamine D1 receptor gene
gi|288931|emb|X55758.1|HSDOPD1[288931] - 15529: Z23025
H. sapiens cacnl1a3 gene encoding skeletal muscle DHP-receptor alpha 1 subunit (exon)
gi|312285|emb|Z23025.1|HSDHPRA1S[312285] - 15530: X84076
H. sapiens mRNA for DGCR2
gi|80902|emb|X84076.1|HSDGCR2[809021] - 15532: X63523
H. sapiens mRNA DAUD16 3′-region
gi|30449|emb|X63523.1|HSDAUDI63[30449] - 15533: X66171
H. sapiens CMRF35 mRNA, complete CDS
gi|396169|emb|X66171.1|HSCMRF35A[396169] - 15534: Z23141
H. sapiens CHRNA7 mRNA, 3′ end
gi|457736|emb|Z23141.1|HSCHRNA7A[457736] - 15550: X56777
H. sapiens mRNA for ZP3 gene
gi|297790|emb|X56777.1|HSZP3G[297790] - 15551: X77155
H. sapiens genomic DNA (YAC end 63 with high affinity Fc-receptor for IgG)
gi|450533|emb|X77155.1|HSYACFC[450533] - 15582: M31165
Human tumor necrosis factor-inducible (TSG-6) mRNA fragment, adhesion receptor
CD44 putative CDS
gi|339994|gb|M31165.1|HUMTSG6A[339994] - 15594: A31613
H. sapiens beta-adrenergic receptor gene
gi|1247565|emb|A31613.1|A31613[1247565] - 15595: A29216
H. sapiens DNA for bFGF receptor from patent WO9111459
gi|1247528|emb|A29216.1|A29216[1247528] - 15596: A29103
H. sapiens mRNA for TNF-binding polypeptide from patent EP0393438
gi|1247517|emb|A29103.1|A29103[1247517] - 15597: A28489
H. sapiens mRNA for IL-2R-beta-chain from patent EP0395853
gi|1247509|emb|A28489.1|A28489[1247509] - 15598: A28003
H. sapiens HEK gene
gi|1247486|emb|A28003.1|A28003[1247486] - 15599: A27284
H. sapiens TGR-CLH
gi|1247482|emb|A27284.1|A27284[1247482] - 15600: A27280
H. sapiens TGR-CL3
gi|1247480|emb|A27280.1|A27280[1247480] - 15601: A27274
H. sapiens TGR-CL11/TGR-C15
gi|1247478|emb|A27274.1|A27274[1247478] - 15602: A27272
H. sapiens TGR-CL11
gi|1247476|emb|A27272.1|A27272[1247476] - 15603: A27268
H. sapiens TGR-CL10
gi|1247474|emb|A27268.1|A27268[1247474] - 15604: A27266
H. sapiens TGR-CL7
gi|1247472|emb|A27266.1|A27266[1247472] - 15605: A27264
H. sapiens TGR-CL6
gi|1247470|emb|A27264.1|A27264[1247470] - 15606: A27262
H. sapiens TGR-CL5bis
gi|1247468|emb|A27262.1|A27262[1247468] - 15607: A27260
H. sapiens TGR-CL4
gi|1247466|emb|A27260.1|A27260[1247466] - 15608: A27258
H. sapiens TGR-CL1bis
gi|1247464|emb|A27258.1|A27258[1247464] - 15609: A19671
H. sapiens DNA for D3 receptor fragment
gi|579581|emb|A19671.1|A19671[579581] - 15610: A19670
H. sapiens DNA for D3 receptor fragment
gi|579580|emb|A19670.1|A19670[579580] - 15611: A19667
H. sapiens gene for dopaminergic receptor D-3
gi|579578|emb|A19667.1|A19667[579578] - 15612: A09781
H. sapiens (clone 18-4-3) mRNA interferon-gamma receptor segment
gi|412192|emb|A09781.1|A09781[412192] - 15613: A09779
H. sapiens (clone 15-21-1) mRNA for interferon-gamma receptor segment binding interferon-gamma
gi|412190|emb|A09779.1|A09779[412190] - 15614: A07799
H. sapiens IL-2R-beta mRNA for interleukin-2 beta-chain
gi|1247399|emb|A07799.1|A07799[1247399] - 15615: A07801
H. sapiens IL-2R-beta mRNA for interleukin-2 beta-chain
gi|490067|emb|A07801.1|A07801[490067] - 15616: A07795
H. sapiens IL-2R-beta mRNA for interleukin-2 receptor beta-chain
gi|412175|emb|A07795.1|A07795[412175] - 15617: L11573
Human surfactant protein B mRNA, complete cds
gi|1220354|gb|L11573.1|HUMPSPBQ[1220354] - 15618: L40625
Homo sapiens sulfonylurea receptor (SUR) mRNA, 3′ end of cds
gi|784881|gb|L40625.1|HUMSUR[784881] - 15620: L34579
Homo sapiens (clone HCl) angiotensin II type-2 receptor (AGTR2) gene, complete
cds
gi|510700|gb|L34579.1|HUMAIRS[510700] - 15621: X97058
H. sapiens mRNA for P2Y6 receptor
gi|1296659|emb|X97058.1|HSP2Y6[1296659] - 15622: X96588
H. sapiens mRNA for H-RYK receptor tyrosine kinase
gi|1296649|emb|X96588.1|HSHRYKG[1296649] - 15623: X80391
H. sapiens OR17-40 gene
gi|516319|emb|X80391.1|HSOR1740[516319] - 15624: L41690
Homo sapiens TNF receptor-1 associated protein (TRADD) mRNA, 3′ end of cds
gi|808914|gb|L41690.1|HUMTRADD[808914] - 15630: X89746
H. sapiens mRNA for neuronal acetylcholine receptor alpha-4 subunit, exon 6
gi|1279464|emb|X89746.1|HSCHRNA46[1279464] - 15631: X89745
H. sapiens mRNA for neuronal acetylcholine receptor alpha-4 subunit, exon 5
gi|1279463|emb|X89745.1|HSCHRNA45[1279463] - 15632: X89743
H. sapiens mRNA for neuronal acetylcholine receptor alpha-4 subunit, exon 3
gi|1279461|emb|X89743.1|HSCHRNA43[1279461] - 15633: X89742
H. sapiens mRNA for neuronal acetylcholine receptor alpha-4 subunit, exon 2
gi|1279460|emb|X89742.1|HSCHRNA42[1279460] - 15634: X89741
H. sapiens mRNA for neuronal acetylcholine receptor alpha-4 subunit, exon 1
gi|1279458|emb|X89741.1|HSCHRNA41[1279458] - 15644: M21574
Human platelet-derived growth factor receptor alpha (PDGFRA) mRNA, complete cds
gi|189733|gb|M21574.1|HUMPDGFRAA[189733] - 15645: X94635
H. sapiens CD97 gene exon 8
gi|4379070|emb|X94635.1|HSX94635[4379070] - 15646: X94638
H. sapiens CD97 gene exon 11
gi|165091|emb|X94638.1|HSX94638[1165091] - 15647: X94637
H. sapiens CD97 gene exon 10
gi|1165090|emb|X94637.1|HSX94637[1165090] - 15648: X94636
H. sapiens CD97 gene exon 9
gi|1165089|emb|X94636.1|HSX94636[1165089] - 15649: X94631
H. sapiens CD97 gene exon 2
gi|1165084|emb|X94631.1|HSX94631[1165084] - 15650: X94646
H. sapiens CD97 gene exon 19
gi|1165082|emb|X94646.1|HSX94646[1165082] - 15651: X94645
H. sapiens CD97 gene exon 18
gi|1165081|emb|X94645.1|HSX94645[1165081] - 15652: X94644
H. sapiens CD97 gene exon 17
gi|1165080|emb|X94644.1|HSX94644[1165080] - 15653: X94643
H. sapiens CD97 gene exon 16
gi|1165079|emb|X94643.1|HSX94643[1165079] - 15654: X94642
H. sapiens CD97 gene exon 15
gi|1165078|emb|X94642.1|HSX94642[1165078] - 15655: X94641
H. sapiens CD97 gene exon 14
gi|1165077|emb|X94641.1|HSX94641[1165077] - 15656: X94640
H. sapiens CD97 gene exon 13
gi|1165076|emb|X94640.1|HSX94640[1165076] - 15657: X94639
H. sapiens CD97 gene exon 12
gi|1165075|emb|X94639.1|HSX94639[1165075] - 15658: L40949
Homo sapiens (clone AT7-5eu) opioid-receptor-like protein mRNA, 5′ end
gi|725265|gb|L40949.1|HUMOPRLP[725265] - 15659: X57282
H. sapiens mRNA for soluble erythropoietin receptor
gi|36426|emb|X57282.1|HSSER[36426] - 15660: Z66526
H. sapiens pancreatic polypeptide receptor PP1 gene
gi|1107699|emb|Z66526.1|HSPP1GN[1107699] - 15661: X89013
H. sapiens gene for anti-mullerian hormone type II receptor
gi|1212943|emb|X89013.1|HSDNAAMHI[1212943]
- 15662: X86163
H. sapiens mRNA for B2-bradykinin receptor, 3′
gi|1220163|emb|X86163.1|HSB2BRRNA[1220163] - 15663: X86165
H. sapiens mRNA for B2-bradykinin receptor, R14 allele
gi|1220160|emb|X86165.1|HSB2BRR14[1220160] - 15664: X86164
H. sapiens mRNA for B2-bradykinin receptor, C14 allele
gi|1220155|emb|X86164.1|HSB2BRC14[1220155] - 15665: L08187
Human cytokine receptor (EBI3) mRNA, complete cds
gi|632973|gb|L08187.1|HUMEBI3X[632973] - 15666: L41147
Homo sapiens 5-HT6 serotonin receptor mRNA, complete cds
gi|1162923|gb|L41147.1|HUM5HSR[1162923] - 15698: X84755
H. sapiens LHCGR gene, exon 3
gi|1225986|emb|X84755.1|HSLHCGRX3[1225986] - 15699: L25829
Human platelet-derived growth factor alpha-receptor (PDGFRA) mRNA, exons 13-gi|1220351|gb|L25829.1|HUMPDGFRAX[1220351] - 15700: L07746
Human cholecystokinin B receptor (CCK-B) mRNA, complete cds
gi|1220298|gb|L07746.1|HUMCCKBR[1220298] - 15701: X86172
H. sapiens B2-bradykinin receptor gene, exon 3, allele R48
gi|220162|emb|X86172.1|HSB2BRR48[1220162] - 15702: X86180
H. sapiens B2-bradykinin receptor gene, promoter region and exon 1
gi|1220159|emb|X86180.1|HSB2BRPX1[1220159] - 15703: X86173
H. sapiens B2-bradykinin receptor gene, promotor region and exon 1
gi|220158|emb|X86173.1|HSB2BREX11[1220158] - 15704: X86162
H. sapiens B2-bradykinin receptor gene, 3′
gi|1220157|emb|X86162.1|HSB2BRDNA[1220157] - 15705: X86171
H. sapiens B2-bradykinin receptor gene, exon 3, BE3-R43 allele
gi|1220154|emb|X86171.1|HSB2BRBE3[1220154] - 15706: X86170
H. sapiens B2-bradykinin receptor gene, exon 2, T allele
gi|1220153|emb|X86170.1|HSB2BRAXT[1220153] - 15707: X86168
H. sapiens B2-bradykinin receptor gene, exon 1, 3T allele
gi|1220152|emb|X86168.1|HSB2BR3T[1220152] - 15708: X86167
H. sapiens B2-bradykinin receptor gene, exon 1, 3G allele
gi|1220151|emb|X86167.1|HSB2BR3G[1220151] - 15709: X86166
H. sapiens B2-bradykinin receptor gene, exon 1, 2G allele
gi|1220150|emb|X86166.1|HSB2BR2G[1220150] - 15710: Z69891
H. sapiens mRNA (clone ICRFp507G10101)
gi|1213610|emb|Z69891.1|HSBRN3B2[1213610] - 15711: L18983
Homo sapiens tyrosine phosphatase (IA-2/PTP) mRNA, complete cds
gi|662362|gb|L18983.1|HUMTYROPHO[662362] - 15712: L76224
Homo sapiens NMDA receptor mRNA, complete cds
gi|1196448|gb|L76224.1|HUMNMRE[1196448] - 15715: M73481
Human gastrin releasing peptide receptor (GRPR) mRNA, complete cds
gi|183649|gb|M73481.1|HUMGRPR[183649] - 15717: M30625
Human dopamine D2 receptor, mRNA, complete cds
gi|181431|gb|M30625.1|HUMD2A[181431] - 15718: J02960
Human beta-2-adrenergic receptor gene, complete cds
gi|178203|gb|J02960.1|HUMADRBRA[178203] - 15719: M15169
Human beta-2-adrenergic receptor mRNA, complete cds - 15720: L18973
Human acetylcholine receptor mRNA, partial cds
gi|441143|gb|L18973.1|HUMACETYL[441143] - 15723: M73969
Human interleukin-8 receptor type B (IL8RB) mRNA, complete cds
gi|186516|gb|M73969.1|HUMINTLEU8[186516] - 15752: L35233
Homo sapiens autocrine motility factor receptor (AMFR) mRNA, complete cds
gi|521220|gb|L35233.1|HUMNGP78A[521220] - 15754: U35399
Human G protein-coupled receptor mRNA, complete cds
gi|1015420|gb|U35399.1|HSU35399[1015420] - 15755: L35318
Human rearranged metabotropic glutamate receptor type II (GLUR2) mRNA, complete
cds
gi|999415|gb|L35318.1|HUMGLUR2A[999415] - 15756: M11730
Human tyrosine kinase-type receptor (HER2) mRNA, complete cds
gi|183986|gb|M11730.1|HUMHER2A[183986] - 15759: U33017
Human signaling lymphocytic activation molecule (SLAM) mRNA, complete cds
gi|984968|gb|U33017.1|HSU33017[984968] - 15761: L47220
Homo sapiens inositol triphosphate receptor type 1 gene fragment
gi|976275|gb|L47220.1|HUMITRT1F[976275] - 15762: M37722
Human shorter form basic fibroblast growth factor (bFGF) receptor mRNA, complete
cds
gi|179413|gb|M37722.1|HUMBFGFS[179413] - 15765: L09753
Homo sapiens CD30 ligand mRNA, complete cds
gi|349277|gb|L09753.1|HUMCD30[349277] - 15767: L36645
Homo sapiens receptor protein-tyrosine kinase (HEK8) mRNA, complete cds
gi|551613|gb|L36645.1|HUMRPTKC[551613] - 15768: L36644
Homo sapiens receptor protein-tyrosine kinase (HEK7) mRNA, 3′ end
gi|551611|gb|L36644.1|HUMRPTKB[551611] - 15769: L36643
Homo sapiens receptor protein-tyrosine kinase (HEK5) mRNA, 3′ end
gi|551609|gb|L36643.1|HUMRPTKA[551609] - 15770: L36642
Homo sapiens receptor protein-tyrosine kinase (HEK11) mRNA, complete cds
gi|551607|gb|L36642.1|HUMRPTK[551607] - 15771: L31581
Human G protein-coupled receptor (EBI 1) mRNA, complete cds
gi|468319|gb|L31581.1|HUMEBI1CDN[468319] - 15772: L29301
Homo sapiens opioid receptor mRNA, complete cds
gi|459831|gb|L29301.1|HUMOPIOIDA[459831] - 15773: L32831
Homo sapiens G protein-coupled receptor (GPR3) gene, complete cds
gi|602311|gb|L32831.1|HUMGPCRD[602311] - 15774: L32830
Homo sapiens G protein-coupled receptor (GPR3) gene, exon
gi|602310|gb|L32830.1|HUMGPCRC[602310] - 15775: M88461
Human neuropeptide Y peptide YY receptor mRNA, complete cds
gi|189155|gb|M88461.1|HUMNEYPEPY[189155] - 15779: M73747
Homo sapiens thyroid stimulating hormone receptor (TSHR) mRNA, complete cds
gi|903759|gb|M73747.1|HUMTSHR[903759] - 15780: M73746
Homo sapiens lutropin/choriogonadotropin receptor (LHCGR) mRNA, complete cds
gi|903745|gb|M73746.1|HUMLHCGR[903745] - 15781: M90103
Human (clones 18, 23, 27, 24) c-myeloproliferative leukemia virus type K (c-mpl-K) mRNA, complete cds
gi|184262|gb|M90103.1|HSHMPLK[184262] - 15782: M90102
Human (clones 15, 39, 41) c-myeloproliferative leukemia virus type P (c-mpl-P)
mRNA, complete cds
gi|184260|gb|M90102.1|HSHMPLP[184260] - 15796: M98512
Human NFG genomic fragment
gi|292359|gb|M98512.1|HUMNF1FRAG[292359] - 15797: M98511
Human NFE genomic fragment
gi|292358|gb|M98511.1|HUMNF1FRAE[292358] - 15798: M98510
Human NFC genomic fragment
gi|292357|gb|M98510.1|HUMNF1FRAC[292357] - 15799: M98508
Human NFA genomic fragment
gi|292355|gb|M98508.1|HUMNF1FRAA[292355] - 15801: L32662
Human prostaglandin E2 receptor EP3 subtype isoform IV mRNA, complete cds
gi|484163|gb|L32662.1|HUMEP3IV[484163] - 15802: L32661
Human prostaglandin E2 receptor EP3 subtype isoform III mRNA, 3′ end
gi|48416|gb|L32661.1|HUMEP3III[484161] - 15803: L32660
Human prostaglandin E2 receptor EP3 subtype isoform II mRNA, partial cds
gi|484159|gb|L32660.1|HUMEP3II[484159] - 15822: L07594
Human transforming growth factor-beta type III receptor (TGF-beta) mRNA, complete cds
gi|818001|gb|L07594.1|HUMTGFB3C[818001] - 15823: M83181
Human serotonin receptor gene, complete cds
gi|8080000gb|M83181.1|HUMHTRB[808000] - 15824: M33602
Human T-cell leukemia t(10:14) (q24:q11) chromosomal translocation
gi|339907|gb|M33602.1|HUMTRANSX[339907] - 15828: L37112
Homo sapiens vasopressin V3 receptor mRNA, complete cds
gi|791151|gb|L37112.1|HUMVVR[791151] - 15829: L35901
Human nicotinic acetylcholine receptor alpha 4 subunit (nAChR) mRNA, complete cds
gi|755647|gb|L35901.1|HUMNACHR4A[755647] - 15830: U13666
Human G protein-coupled receptor (GPR1) gene, complete cds
gi|577412|gb|U13666.1|HSU13666[577412] - 15831: L35903
Human dopamine D3 receptor gene, exon 6
gi|532478|gb|L35903.1|UMDOPD30S2[532478] - 15832: L35902
Human dopamine D3 receptor gene, exon 5
gi|532477|gb|L35902.1|UMDOPD30S1[532477] - 15833: L37362
Homo sapiens (clone d2-115) kappa opioid receptor (OPRK1) mRNA, complete cds
gi|722617|gb|L37362.1|HUMOPRK1B[722617] - 15834: L35545
Homo sapiens endothelial cell protein C/APC receptor (EPCR) mRNA, complete cds
gi|565267|gb|L35545.1|HUMECPC[565267] - 15835: L36130
Homo sapiens kappa opiate receptor mRNA, partial cds
gi|598184|gb|L36130.1|HUMKOR[598184] - 15836: L36150
Homo sapiens G protein-coupled receptor (GPR6) gene, complete cds
gi|598156|gb|L361500.1HUMGPR6A[598156] - 15837: L36148
Homo sapiens G protein-coupled receptor (GPR4) gene, complete cds
gi|598152|gb|L36148.1|HUMGPR4A[598152] - 15839: L36149
Homo sapiens G protein-coupled receptor (GPR5) gene, complete cds
gi|598154|gb|L36149.1|HUMGPR5A[598154] - 15840: M64749
Human homologue of the canine orphan receptor (RDC1) mRNA, 5′ end
gi|292418|gb|M64749.1|HUMRDC1A[292418] - 15841: L35848
Homo sapiens IgE receptor beta chain (HTm4) mRNA, complete cds
gi|561638|gb|L35848.1|HUMIERB[561638] - 16011: L22431
Human very low density lipoprotein receptor, complete cds
gi|437386|gb|L22431.1|HUMVLDLRX[437386] - 16012: M90366
Human zona pellucida glycoprotein 2 (ZP2) mRNA, complete cds
gi|292939|gb|M90366.1|HUMZP2GP[292939] - 16015: M76125
Human tyrosine kinase receptor (axl) mRNA, complete cds
gi|292869|gb|M76125.1|HUMTYRKINR[292869] - 16016: L04489
Homo sapiens (clone NCD18) tumor necrosis factor receptor related protein mRNA,
complete exon and repeat region
gi|340022|gb|L04489.1|HUMTUMNEC[340022] - 16017: M31163
Human tumor necrosis factor-inducible (TSG-12) mRNA fragment
gi|339990|gb|M31163.1|HUMTSG12A[339990] - 16019: M75866
Human tumor necrosis factor receptor 1 (TNFR1) gene, complete cds
gi|339748|gb|M75866.1|HUMTNFR103[339748] - 16020: M75865
Human tumor necrosis factor receptor 1 (TNFR1) gene, exons 2-5
gi|339747|gb|M75865.1|HUMTNFR102[339747] - 16021: M75864
Human tumor necrosis factor receptor 1 (TNFR1) gene, exon 1
gi|339746|gb|M75864.1|HUMTNFR101[339746] - 16026: M85079
Human TGF-beta type II receptor mRNA, complete cds
gi|339569|gb|M85079.1|HUMTGFBIIR[339569] - 16027: L06139
Homo sapiens receptor protein-tyrosine kinase (TEK) mRNA, complete cds
gi|292823|gb|L06139.1|HUMTEKRPTK[292823] - 16204: L29349
Homo sapiens granulocyte-macrophage colony-stimulating factor receptor alpha-subunit 3 (GM-CSF-RA3) mRNA, complete cds
gi|460284|gb|L29349.1|HUMGMCSA[460284] - 16205: L29348
Homo sapiens granulocyte-macrophage colony-stimulating factor receptor alpha-subunit soluble isoform 2 (GM-CSF-RAS2) mRNA, complete cds
gi|460282|gb|L29348.1|HUMGMCS[460282] - 16270: M74290
Human substance P receptor protein mRNA
gi|338612|gb|M74290.1|HUMSUBPRA[338612] - 16271: M96738
Human somatostatin receptor subtype 3 (SSTR3) gene, complete cds
gi|338498|gb|M96738.1|HUMSSTR3X[338498] - 16272: L13033
Homo sapiens somatostatin receptor isoform 2 gene, alternatively spliced exon
gi|292515|gb|L13033.1|HUMSSTR23X[292515] - 16273: L07833
Homo sapiens somatostatin receptor (SSTR4) gene, complete cds
gi|307429|gb|L07833.1|HUMSOMATA[307429] - 16274: L10126
Human serine/threonine kinase receptor-2-3 (SKR2-3) mRNA, complete cds
gi|558102|gb|L10126.1|HUMSKR23A[558102] - 16275: L10125
Human serine/threonine kinase receptor-2-2 (SKR2-2) mRNA, complete cds
gi|558101|gb|L10125.1|HUMSKR22A[558101] - 16276: J04132
Human T cell receptor zeta-chain mRNA, complete cds
gi|623041|gb|J04132.1|HUMTCRZCN[623041] - 16277: M93221
Human macrophage mannose receptor (MRC1) gene, exon 30
gi|187332|gb|M93221.1|HUMMANR30[187332] - 16278: M93220
Human macrophage mannose receptor (MRC1) gene, exon 29
gi|187331|gb|M93220.1|HUMMANR29[187331] - 16279: M93219
Human macrophage mannose receptor (MRC1) gene, exon 28
gi|187330|gb|M93219.1|HUMMANR28[187330] - 16280: M93218
Human macrophage mannose receptor (MRC1) gene, exon 27
gi|187329|gb|M93218.1|HUMMANR27[187329] - 16281: M93217
Human macrophage mannose receptor (MRC1) gene, exon 26
gi|187328|gb|M93217.1|HUMMANR26[187328] - 16282: M93216
Human macrophage mannose receptor (MRC1) gene, exon 25
gi|187327|gb|M93216.1|HUMMANR25[187327] - 16283: M93215
Human macrophage mannose receptor (MRC1) gene, exon 24
gi|187326|gb|M93215.1|HUMMANR24[187326] - 16284: M93214
Human macrophage mannose receptor (MRC1) gene, exon 23
gi|187325|gb|M93214.1|HUMMANR23[187325] - 16285: M93213
Human macrophage mannose receptor (MRC1) gene, exon 22
gi|187324|gb|M93213.1|HUMMANR22[187324] - 16286: M93212
Human macrophage mannose receptor (MRC1) gene, exon 21
gi|187323|gb|M93212.1|HUMMANR21[187323] - 16287: M93211
Human macrophage mannose receptor (MRC1) gene, exon 20
gi|187322|gb|M93211.1|HUMMANR20[187322] - 16288: M93210
Human macrophage mannose receptor (MRC1) gene, exon 19
gi|187321|gb|M93210.1|HUMMANR19[187321] - 16289: M93209
Human macrophage mannose receptor (MRC1) gene, exon 18
gi|187320|gb|M93209.1|HUMMANR18[187320] - 16290: M93208
Human macrophage mannose receptor (MRC1) gene, exon 17
gi|187319|gb|M93208.1|HUMMANR17[187319] - 16291: M93207
Human macrophage mannose receptor (MRC1) gene, exon 16
gi|187318|gb|M93207.1|HUMMANR16[187318] - 16292: M93206
Human macrophage mannose receptor (MRC1) gene, exon 15
gi|187317|gb|M93206.1|HUMMANR15[187317] - 16293: M93205
Human macrophage mannose receptor (MRC1) gene, exon 14
gi|187316|gb|M93205.1|HUMMANR14[187316] - 16294: M93204
Human macrophage mannose receptor (MRC1) gene, exon 13
gi|187315|gb|M93204.1|HUMMANR13[187315] - 16295: M93203
Human macrophage mannose receptor (MRC1) gene, exon 12
gi|187314|gb|M93203.1|HUMMANR12[187314] - 16296: M93202
Human macrophage mannose receptor (MRC1) gene, exon 11
gi|187313|gb|M93202.1|HUMMANR11[187313] - 16297: M93201
Human macrophage mannose receptor (MRC1) gene, exon 10
gi|187312|gb|M93201.1|HUMMANR10[187312] - 16298: M93200
Human macrophage mannose receptor (MRC1) gene, exon 9
gi|187311|gb|M93200.1|HUMMANR09[187311] - 16299: M93199
Human macrophage mannose receptor (MRC1) gene, exon 8
gi|187310|gb|M93199.1|HUMMANR08[187310] - 16300: M93198
Human macrophage mannose receptor (MRC1) gene, exon 7
gi|187309|gb|M93198.1|HUMMANR07[187309] - 16301: M93197
Human macrophage mannose receptor (MRC1) gene, exon 6
gi|187308|gb|M93197.1|HUMMANR06[187308] - 16302: M93196
Human macrophage mannose receptor (MRC1) gene, exon 5
gi|187307|gb|M93196.1|HUMMANR05[187307] - 16303: M93195
Human macrophage mannose receptor (MRC1) gene, exon 4
gi|187306|gb|M93195.1|HUMMANR04[187306] - 16304: M93194
Human macrophage mannose receptor (MRC1) gene, exon 3
gi|187305|gb|M93194.1HUMMANR03[187305] - 16305: M93193
Human macrophage mannose receptor (MRC1) gene, exon 2
gi|187304|gb|M93193.1HUMMANR02[187304] - 16306: M93192
Human macrophage mannose receptor (MRC1) gene, exon 1
gi|87303|gb|M93192.1|HUMMANR01[187303] - 16307: L05198
Homo sapiens insulin receptor substrate 1 (IRS1) gene, repeat polymorphism
gi|307396|gb|L05198.1|HUMIRS1RPT[307396] - 16308: M15365
Human low density lipoprotein receptor mutant gene recombination site
gi|187107|gb|M15365.1|HUMLDLRM[187107] - 16309: M80637
Human keratinocyte growth factor receptor gene, exon K
gi|186758|gb|M80637.1|HUMKKGFRA[186758] - 16310: M81778
Human serotonin 5-HT1C receptor mRNA, complete cds
gi|338027|gb|M81778.1|HUMSER5R[338027] - 16311: M81590
Homo sapiens serotonin 1D receptor (5-HT1D-) mRNA, complete cds
gi|338025|gb|M81590.1|HUMSER1DRB[338025] - 16312: M81589
Homo sapiens serotonin 1D receptor (5-HT1D) mRNA, complete cds
gi|338023|gb|M81589.1|HUMSER1DRA[338023] - 16313: M91455
Human ryanodine receptor (RYR1) gene, exons 17 and 18
gi|337723|gb|M91455.1|HUMRYR1[337723] - 16316: M97639
Human transmembrane receptor (ror2) mRNA, complete cds
gi|337466|gb|M97639.1|HUMROR2A[337466] - 16317: M97675
Human transmembrane receptor (ror1) mRNA, complete cds
gi|337464|gb|M97675.1|HUMROR1A[337464] - 16318: M74721
Human B-cell antigen receptor (MB-1) mRNA, complete cds
gi|337419|gb|M74721.1|HUMRIGMAMB[337419] - 16319: M89796
Human high affinity IgE receptor beta chain gene, complete cds
gi|337417|gb|M89796.1|HUMRIGBCHA[337417] - 16329: L09247
Human receptor-type protein tyrosine phosphatase gamma (PTPRG) mRNA, complete cds
gi|292410|gb|L09247.1|HUMPTPRG[292410] - 16330: M93426
Human protein tyrosine phosphatase zeta-polypeptide (PTPRZ) mRNA, complete cds
gi|190743|gb|M93426.1|HUMPTPRZ[190743] - 16331: M88177
Human platelet activating factor receptor (PTAFR) gene, complete cds
gi|190697|gb|M88177.1|HUMPTAFR[190697] - 16332: L16862
Homo sapiens G protein-coupled receptor kinase (GRK6) mRNA, complete cds
gi|388766|gb|L16862.1|HUMPROCRKI[388766] - 16333: M86528
Human neurotrophin-4 (NT-4) gene, complete cds
gi|190264|gb|M86528.1|HUMPPNT4P[190264] - 16334: L07334
Human platelet-activating factor receptor mRNA, complete cds
gi|1190014gb|L07334.1|HUMPLACTFR[190014] - 16335: L26976
Human prostalandin receptor (PGE-2) mRNA, complete cds
gi|473428|gb|L26976.1|HUMPGE2REP[473428] - 16336: M88107
Human formyl peptide receptor (FPR2) mRNA, complete cds
gi|189862|gb|M88107.1|HUMPFPR2A[189862] - 16337: M76674
Human platelet activating factor receptor (PAFR) mRNA, complete cds
gi|456293|gb|M76674.1|HUMPAFRX[456293] - 16338: M80436
Human platelet activating factor receptor mRNA, complete cds
gi|189537|gb|M80436.1|HUMPAFR[189537] - 16339: L26079
Homo sapiens (clone hSR4-1) kappa opioid receptor (OPRK1) gene, complete exon
gi|416143|gb|L26079.1|HUMOPRK1A[416143] - 16340: L07615
Human neuropeptide Y receptor Y1 (NPYY1) mRNA, exon 2-3 and complete cds
gi|189284|gb|L07615.1|HUMNPYY1A2[189284] - 16341: L07614
Human neuropeptide Y receptor Y1 (NPYY1) mA, exon 1
gi|189283|gb|L07614.1|PYY1A1[189283] - 16342: M37981
Human alpha-3 neuronal nicotinic acetylcholine receptor subunit mRNA, complete
cds
gi|189252|gb|M37981.1|HUMNNAR[189252] - 16343: M73482
Human neuromedin B receptor (NMB-R) mRNA, complete cds
gi|18924|gb|M73482.1|HUMNMBR[189241] - 16344: M76675
Human neurokinin 1 receptor (NKIR) mRNA, complete cds
gi|189231|gb|M76675.1|HUMNKIRX[189231] - 16345: M81797
Human NK-1 receptor mRNA, complete cds
gi|189213|gb|M81797.1|HUMNK1A[189213] - 16346: M32315
Human tumor necrosis factor receptor mRNA, complete cds- Human tumor necrosis factor receptor mRNA, complete cds
gi|189185|gb|M32315.1|HUMNFR[189185]
- Human tumor necrosis factor receptor mRNA, complete cds
- 16347: M84755
Human neuropeptide y receptor mRNA, complete cds
gi|189153|gb|M84755.1|HUMNEUYREC[189153] - 16348: M83246
Human monocyte activation antigen (Mo3) mRNA, complete cds
gi|188623|gb|M83246.1|HUMMO3A[188623] - 16350: L27080
Human melanocortin 5 receptor (MC5R) gene, complete cds
gi|435599|gb|L27080.1|HUMMC5R[435599] - 16351: M28219
Homo sapiens low density lipoprotein receptor (FH 10 mutant causing familial hypercholesterolemia) mRNA, 3′ end
gi|619785|gb|M28219.1|HUMLDLRFMT[619785] - 16352: M12626
Human low density lipoprotein receptor gene, FH381 (deletion mutant) allele
gi|187103|gb|M12626.1|HUMLDLRFH[187103] - 16353: M93189
Human acetylated low density lipoprotein (ACLDL) receptor (LDLR) gene, promoter
and exon 1
gi|187100|gb|M93189.1|HUMLDLRAC[187100] - 16354: M87772
Human secreted fibroblast growth factor receptor (K-sam-IV) mRNA, complete cds
gi|186783|gb|M87772.1|HUMKSAMIV[186783] - 16355: M87771
Human secreted fibroblast growth factor receptor (K-sam-III) mRNA, complete cds - 16356: M87770
Human fibroblast growth factor receptor (K-sam) mRNA, complete cds
gi|186779|gb|M87770.1|HUMKSAMI[186779] - 16357: L04947
Homo sapiens (clones BT3.081.8, BT3.129.5 and BT4.169) receptor tyrosine kinase
(KDR) mRNA, 31 end cds
gi|186674|gb|L04947.1|HUMKDRZ[186674] - 16358: M32972
Human insulin receptor (INSR) gene, exon 22, clones lambda-hINSR-(1-13)
gi|186462|gb|M32972.1|HUMINSR22[186462] - 16359: M32842
Human insulin receptor (INSR) gene, exon 21, clones lambda-hINSR-(1-13)
gi|8646|gb|M32842.1|HUMINSR21[186461] - 16360: M32841
Human insulin receptor (INSR) gene, exon 20, clones lambda-hINSR-(1-13)
gi|186460|gb|M32841.1|HUMINSR20[186460] - 16361: M32840
Human insulin receptor (INSR) gene, exon 19, clones lambda-hINSR-(1-13)
gi|186459|gb|M32840.1|HUMINSR19[186459] - 16362: M32839
Human insulin receptor (INSR) gene, exon 18, clones lambda-hINSR-(1-13)
gi|186458|gb|M32839.1|HUMINSR18[186458] - 16363: M32838
Human insulin receptor (hINSR) gene, exon 17, clones lambda-hINSR-(1-13)
gi|186457|gb|M32838.1|HUMINSR17[186457] - 16364: M32837
Human insulin receptor (INSR) gene, exon 16, clones lambda-hINSR-(1-13)
gi|186456|gb|M32837.1|HUMINSR16[186456] - 16365: M32836
Human insulin receptor (INSR) gene, exon 15, clones lambda-hINSR-(1-13)
gi|186455|gb|M32836.1|HUMINSR15[186455] - 16366: M32835
Human insulin receptor (INSR) gene, exon 14, clones lambda-hINSR-(1-13)
gi|186454|gb|M32835.1|HUMINSR14[186454] - 16367: M32834
Human insulin receptor (INSR) gene, exon 13, clones lambda-hINSR-(1-13)
gi|186453|gb|M32834.1|HUMINSR13[186453] - 16368: M32833
Human insulin receptor (INSR) gene, exon 12, clones lambda-hINSR-(1-13)
gi|186452|gb|M32833.1|HUMINSR12[186452] - 16369: M32832
Human insulin receptor (INSR) gene, exon 11, clones lambda-hINSR-(1-13)
gi|186451|gb|M32832.1|HUMINSR11[186451] - 16370: M32831
Human insulin receptor (INSR) gene, exon 10, clones lambda-hINSR-(1-13)
gi|186450|gb|M32831.1|HUMINSR10[186450] - 16371: M32830
Human insulin receptor (hINSR) gene, exon 9, clones lambda-hINSR-(1-13)
gi|186449|gb|M32830.1|HUMINSR09[186449] - 16372: M32829
Human insulin receptor (INSR) gene, exon 8, clones lambda-hINSR-(1-13)
gi|186448|gb|M32829.1|HUMINSR08[186448] - 16373: M32828
Human insulin receptor (INSR) gene, exon 7, clones lambda-hINSR-(1-13)
gi|186447|gb|M32828.1|HUMINSR07[186447] - 16374: M32827
Human insulin receptor (INSR) gene, exon 6, clones lambda-hINSR-(1-13)
gi|186446|gb|M32827.1|HUMINSR06[186446] - 16375: M32826
Human insulin receptor (INSR) gene, exon 5, clones lambda-hINSR-(1-13)
gi|186445|gb|M32826.1|HUMINSR05[186445] - 16376: M32825
Human insulin receptor (INSR) gene, exon 4, clones lambda-hINSR-(1-13)
gi|186444|gb|M32825.1|HUMINSR04[186444] - 16377: M32824
Human insulin receptor (INSR) gene, exon 3, clones lambda-hINSR-(1-13)
gi|186443|gb|M32824.1|HUMINSR03[186443] - 16378: M32823
Human insulin receptor (INSR) gene, exon 2, clones lambda-hINSR-(1-13)
gi|186442|gb|M32823.1|HUMINSR02[186442] - 16379: M23100
Human insulin receptor (INSR) gene, exon 1, clones lambda-hINSR-(1-13)
gi|186441|gb|M23100.1|HUMINSR01[186441] - 16380: J05043
Human insulin receptor (1R) gene, exon 1
gi|186556|gb|J05043.1|HUMIRSRE[186556] - 16381: M24555
Human insulin receptor (INSR) mRNA, partial cds
gi|186480|gb|M24555.1|HUMINSRZ[186480] - 16382: L07782
Human insulin receptor gene, last exon
gi|186475|gb|L07782.1|HUMINSRE[186475] - 16383: J03466
Human insulin receptor gene, exon 1, clone p-lambda EA2
gi|186469|gb|J03466.1|HUMINSRB[186469] - 16384: L19592
Homo sapiens interleukin 8 receptor alpha (IL8RA) gene, complete cds
gi|559051|gb|L19592.1|HUMIL8RAB[559051] - 16385: M15864
Human interleukin-2 receptor alpha (IL2R-alpha) gene, exon 1 and promoter region
gi|186375|gb|M15864.1|HUMILA2R1A[186375] - 16387: M68932
Human IL-8 receptor mRNA, complete cds
gi|186369|gb|M68932.1|HUMIL8RA[186369] - 16388: L12183
Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 8 and complete cds
gi|307056|gb|L12183.1|HUMIL2RG08[307056] - 16389: L12182
Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 7
gi|307055|gb|L12182.1|HUMIL2RG07[3070155] - 16390: L12181
Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 6
gi|307054|gb|L12181.1|HUMIL2RG06[307054] - 16391: L12180
Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 5
gi|307053|gb|L12180.1|HUMIL2RG05[307053] - 16392: L12179
Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 4
gi|307052|gb|L12179.1|HUMIL2RG04[307052] - 16393: L12177
Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 3
gi|307051|gb|L12177.1|HUMIL2RG03[307051] - 16394: L12176
Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 2
gi|307050|gb|L12176.1|HUMIL2RG02[307050] - 16395: L12178
Human interleukin 2 receptor gamma chain (IL2RG) gene, exon 1 and promoter region
gi|307049|gb|L12178.1|HUMIL2RG01[307049] - 16396: M96652
Human interleukin 5 receptor alpha-subunit (IL5R) mRNA, complete cds
gi|186344|gb|M96652.1|HUMILSRB[186344] - 16397: M96651
Human interleukin 5 receptor alpha-subunit (IL5R) mRNA, complete cds
gi|186342|gb|M96651.1|HUMIL5RA[186342] - 16398: M74782
Human interleukin 3 receptor (hIL-3Ra) mRNA, complete cds
gi|186330|gb|M74782.1|HUMIL3B[186330] - 16405: M84967
Human acrosin-trypsin inhibitor (HUSI-II) gene
gi|553347|gb|M84967.1|HUMHUSIIIA[553347] - 16406: M84747
Human interleukin 9 receptor mRNA, complete cds
gi|184508|gb|M84747.1|HUMI9R[184508] - 16407: M75128
Human serotonin 1Db receptor (HTR1D) gene, complete cds
gi|184459|gb|M75128.1|HUMHTR1DB[184459] - 16408: M64799
Human histamine H2 receptor gene, complete cds
gi|184087|gb|M64799.1|HUMHISH2R[184087] - 16409: M83941
Human receptor tyrosine kinase (HEK) mRNA, complete cds
gi|183931|gb|M83941.1|HUMHEK[183931] - 16410: L20814
Human glutamate receptor 2 (HBGR2) mRNA, complete cds
gi|493133|gb|L20814.1|HUMHBGR2A[493133] - 16412: L09237
growth hormone releasing hormone receptor, human, G-protein coupled receptor, secretin family
gi|337134|gb|L09237.1|HUMGRFREC1[337134] - 16413: L15388
Human G protein-coupled receptor kinase (GRK5) mRNA, complete cds
gi|306804|gb|L15388.1|HUMGRK5A[306804] - 16415: L08176
Human Epstein-Barr virus induced G-protein coupled receptor mRNA, complete cds
gi|183484|gb|L08176.1|HUMGPCRA[183484] - 16416: M64752
Human glutamate receptor subunit (GluH1) mRNA, complete cds
gi|183280|gb|M64752.1|HUMGLURS[183280] - 16417: L34075
Human FKBP-rapamycin associated protein (FRAP) mRNA, complete cds
gi|508481|gb|L34075.1|HUMFRAPX[508481] - 16418: L08485
Human GABA-benzodiazepine receptor alpha-5-subunit (GABRA5) mRNA, complete cds
gi|182915|gb|L08485.1|HUMGABRA5Y[182915] - 16419: M93435
Human gamma-aminobutyric acid receptor A5 subunit (GABRA5) gene
gi|182914|gb|M93435.1|HUMGABRASX[182914] - 16421: M76673
Human RMLP-related receptor I (RMLP R I) mRNA, complete cds
gi|182668|gb|M76673.1|HUMFMLPY[182668] - 16422: M76672
Human FMLP-related receptor II (FMLP R II) mRNA, complete cds
gi|182666|gb|M76672.1|HUMFMLPX[182666] - 16423: M64347
Human novel growth factor receptor mRNA, 3′ cds
gi|182564|gb|M64347.1|HUMFGFLR[182564] - 16424: M74921
Human endothelin receptor mRNA, complete cds
gi|182275|gb|M74921.1|HUMETSR[182275] - 16427: M96995
Homo sapiens epidermal growth factor receptor-binding protein GRB2 (EGFRBP-GRB2) mRNA sequence
gi|181975|gb|M96995.1|HUMEGFGRBA[181975] - 16428: L06622
Homo sapiens endothelin receptor type A (EDNRA) mRNA, complete cds
gi|181956|gb|L06622.1|HUMEDNRA[181956] - 16434: M26317
Homo sapiens (clone lambda-6.11) complement receptor 2 (CR2) allele, mRNA fragment
gi|541647|gb|M26317.1|HUMCR2ALLE[541647] - 16435: M25785
Homo sapiens transmembrane glycoprotein (c-fms) gene, exon 1, and platelet-derived growth factor receptor (PDGF) gene, 3′UTR
gi|349453|gb|M25785.1|HUMCFMS01[349453] - 16436: M91555
Human Fc gamma receptor type I (CD64) gene, exon 6
gi|180160|gb|M91555.1|HUMCD6406[180160] - 16437: M91554
Human Fc gamma receptor type I (CD64) gene, exon 5
gi|180159|gb|M91554.1|HUMCD6405[180159] - 16438: M91553
Human Fc gamma receptor type I (CD64) gene, exon 4
gi|180158|gb|M91553.1|HUMCD6404[180158] - 16439: M91552
Human Fc gamma receptor type I (CD64) gene, exon 3
gi|180157|gb|M91552.1|HUMCD6403[180157] - 16440: M91551
Human Fc gamma receptor type I (CD64) gene, exon 2
gi|180156|gb|M91551.1|HUMCD6402[180156] - 16441: M91550
Human Fc gamma receptor type I (CD64) gene, exon 1
gi|180155|gb|M91550.1|HUMCD6401[180155] - 16442: M63928
Homo sapiens T cell activation antigen (CD27) mRNA, complete cds
gi|180084|gb|M63928.1|HUMCD27A[180084] - 16443: M95293
Homo sapiens integrin beta subunit (CD18) gene, exon 1
gi|180022|gb|M95293.1|HUMCD18EX[180022] - 16444: M76724
Human leukocyte adhesion receptor alpha subunit (CD11b) gene, 5′ end
gi|180018|gb|M76724.1|HUMCD11B[180018] - 16447: L09230
Human C-C chemokine receptor type 1 (C-C CKR-1) mRNA, complete cds
gi|179984|gb|L09230.1|HUMCCCKR1A[179984] - 16448: M81886
Human glutamate receptor type 1 (HBGR1) mRNA, complete cds
gi|17944|gb|M81886.1|HUMBGR1A[179441] - 16449: M80776
Human beta-adrenergic receptor kinase 1 mRNA, complete cds
gi|179334|gb|M80776.1|HUMBARK1A[179334] - 16450: L25259
Human CTLA4 counter-receptor (B7-2) mRNA, complete cds
gi|416368|gb|L25259.1|HUMB72A[416368] - 16451: M93394
Human angiotensin 11 type-1 receptor (AT1) mRNA, complete cds
gi|178680|gb|M93394.1|HUMANTIIR[178680] - 16452: M83712
H. sapiens nicotinic receptor alpha 5 subunit mRNA, complete cds
gi|177925|gb|M83712.1|HUMA5NICRC[177925] - 16453: M97370
Human adenosine receptor (A2) gene, complete cds
gi|177891|gb|M97370.1|HUMA2XXX[177891] - 16454: M92826
Human serotonin receptor (5-HTR1E) gene, complete cds
gi|177777|gb|M92826.1|HUM5HTR1E[177777] - 16455: M86841
Human serotonin receptor type 2 (5HT2) mRNA, complete cds
gi|177775|gb|M86841.1|HUM5HT2A[177775] - 16456: M91467
Human serotonin receptor (5HT1E) mRNA, complete cds
gi|177773|gb|M91467.1|HUM5HT1E[177773] - 16457: M81830
Human somatostatin receptor isoform 2 (SSTR2) gene, complete cds
gi|307435|gb|M81830.1|HUMSRI2A[307435] - 16458: M81829
Human somatostatin receptor isoform 1 gene, complete cds
gi|307433|gb|M81829.1|HUMSRI1A[307433] - 16463: L20470
Human very low density lipoprotein receptor mRNA, complete cds
gi|409425|gb|L20470.1|HUMVLDLR[409425] - 16464: L20316
Human glucagon receptor mRNA, complete cds
gi|405189|gb|L20316.1|HUMGLUCREC[405189] - 16465: M24853
Homo sapiens (clone H12) low affinity IgG receptor CD16 (FcGRIII) mRNA, 3′ end
gi|184849|gb|M24853.1|HUMIGGRLA[184849] - 16466: M80635
Human fibroblast growth factor receptor-2 (FGFR2) gene, exon B
gi|182572|gb|M80635.1|HUMFGFRA[182572] - 16467: L31848
Homo sapiens serine/threonine kinase receptor 2 (SKR2) gene, 3 alternative splices, 3′ ends
gi|576680|gb|L31848.1|HUMSKR2[576680] - 16472: M29066
Human dopamine D2 receptor (DRD2) mRNA, complete cds
gi|181828|gb|M29066.1|HUMDRD2A[181828] - 16473: M85289
Human heparan sulfate proteoglycan (HSPG2) mRNA, complete cds
gi|184426|gb|M85289.1|HUMHSPG2B[184426] - 16474: L02931
Human hepatocyte growth factor heavy chain (HGF) gene mRNA, complete cds
gi|184033|gb|L02931.1|HUMHGFX[184033] - 16475: L19058
Human glutamate receptor (GLUR5) mRNA, complete cds
gi|455447|gb|L19058.1|HUMGLUR5X[455447] - 16476: L20859
Human leukemia virus receptor 1 (GLVR1) mRNA, complete cds
gi|306769|gb|L20859.1|HUMGLVR1X[306769] - 16477: M82919
Human gamma amino butyric acid (GABAA) receptor beta-3 subunit mRNA, complete cds
gi|182924|gb|M82919.1|HUMGABRB3A[182924] - 16478: M86868
Human gamma amino butyric acid (GABA rho2) gene mRNA, complete cds
gi|182912|gb|M86868.1|HUMGABARHO[182912] - 16479: L14061
Human N-formyl receptor-like 2 protein (FPRL2) gene, complete cds
gi|292034|gb|L14061.1|HUMFRPL2[292034] - 16480: M95489
H. sapiens follicle stimulating hormone receptor mRNA, complete cds
gi|182772|gb|M95489.1|HUMFSHREC[182772] - 16481: M84562
Human formyl peptide receptor-like receptor (FPRL1) mRNA, complete cds
gi|182741|gb|M84562.1|HUMFPRL1A[182741] - 16482: M97193
Homo sapiens fibroblast growth factor receptor 2 IIIb (FGFR2) mRNA, complete cds
gi|182566|gb|M97193.1|HUMFGFR2A[182566] - 16483: M23562
Human IgE Fc-epsilon-RIIa gene, exon 2, and Fc-epsilon-RIIb gene, exon 1
gi|182444|gb|M23562.1|HUMFCEIIA[182444] - 16484: M76595
Human erythropoietin receptor mRNA sequence derived from DNA, 5′ end
gi|182147|gb|M76595.1|HUMEPR[182147] - 16485: M77244
H. sapiens erythropoietin receptor (EPOR) gene, 5′ end
gi|182133|gb|M77244.1|HUMEPOR[182133] - 16486: M24736
Human endothelial leukocyte adhesion molecule 1 (ELAM-1) mRNA, complete cds
gi|537523|gb|M24736.1|HUMELAM1A[537523] - 16487: L37361
Homo sapiens (clone hELK-L) ELK receptor tyrosine kinase ligand (EFL-3) mRNA, complete cds
gi|567005|gb|L37361.1|HUMEFL3[567005] - 16488: L37360
Homo sapiens (clone hEHK1-L) EHK1 receptor tyrosine kinase ligand (EFL-2) mRNA,
complete cds
gi|567003|gb|L37360.1|HUMEFL2[567003] - 16489: K03193
Human aberrant (short) epidermal growth factor receptor mRNA, complete cds
gi|181984|gb|K03193.1|HUMEGFRS[181984] - 16490: M11234
Human epidermal growth factor receptor (EGFR) gene, exon 1
gi|181981|gb|M11234.1|HUMEGFRG[181981] - 16491: L06623
Homo sapiens endothelin receptor type B (EDNRB) mRNA, complete cds
gi|9181958|gb|L06623.1|HUMEDNRB[181958] - 16494: M67439
Human D5 dopamine receptor (DRD5) gene, complete cds
gi|181830|gb|M67439.1|HUMDRD5A[181830] - 16495: M77250
Human dopamine D2 receptor gene, intron 6/exon 7 boundary
gi|181825|gb|M77250.1|HUMDRD24[181825] - 16496: M77249
Human dopamine D2 receptor gene; exon 3
gi|181824|gb|M77249.1|HUMDRD23[181824] - 16497: M77247
Human dopamine D2 receptor gene, exon 2
gi|181823|gb|M77247.1|HUMDRD22[181823] - 16498: M77248
Human dopamine D2 receptor gene, exon 1
gi|181822|gb|M77248.1|HUMDRD21[181822] - 16499: M33210
Human colony stimulating factor 1 receptor (CSF1R) gene, exon 5
gi|532591|gb|M33210.1|HUMCSF1R03[532591] - 16500: M33209
Human colony stimulating factor 1 receptor (CSF1R) gene, exon 4
gi|532590|gb|M33209.1|HUMCSF1R02[532590] - 16501: M33208
Human colony stimulating factor 1 receptor (CSF1R) gene, exon 2
gi|532589|gb|M33208.1|HUMCSF1R01[532589] - 16502: M83328
Human cell surface glycoprotein CD44 mRNA, (variant F) exons 1, 2, 3, and 5
gi|180135|gb|M83328.1|HUMCD44J[180135] - 16503: M83327
Human cell surface glycoprotein CD44 mRNA, (variant E) exons 1, 2, 3, and 4
gi|180134|gb|M83327.1|HUMCD441[180134] - 16504: M83326
Human cell surface glycoprotein CD44 mRNA, (variant D) exon 1, 2, and 3
gi|180133|gb|M83326.1|HUMCD44H[180133] - 16505: M83325
Human cell surface glycoprotein CD44 mRNA, (variant C) exons 1 and 2
gi|180132|gb|M83325.1|HUMCD44G[180132] - 16506: M83324
Human cell surface glycoprotein CD44 mRNA, (variant B) exon 1
gi|180131|gb|M83324.1|HUMCD44F[180131] - 16507: M83554
H. sapiens lymphocyte activation antigen CD30 mRNA, complete cds
gi|180095|gb|M83554.1|HUMCD30A[180095] - 16512: M97759
Human adenosine A2b receptor (ADORA2) mRNA, complete cds
gi|178149|gb|M97759.1|HUMADORA1[178149] - 16513: M80333
Human m5 muscarinic acetylcholine receptor gene, complete cds
gi|177987|gb|M80333.1|HUMACHRM[177987] - 16527: L34339
Human galanin receptor mRNA, complete cds
gi|559047|gb|L34339.1|HUMGALAREC[559047] - 16528: L17033
Human heparin-binding epidermal growth factor gene sequence
gi|348176|gb|L17033.1|HUMHBEGFF[348176] - 16529: L17032
Human heparin-binding epidermal growth factor gene sequence
gi|348175|gb|L17032.1|HUMHBEGFE[348175] - 16530: L17031
Human heparin-binding epidermal growth factor gene, 3′ end
gi|348173|gb|L17031.1|HUMHBEGFD[348173] - 16531: L17030
Human heparin-binding epidermal growth factor gene, partial cds
gi|348171|gb|L17030.1|HUMHBEGFC[348171] - 16532: L17029
Human heparin-binding epidermal growth factor gene, partial cds
gi|348169|gb|L17029.1|HUMHBEGFB[348169] - 16533: L17028
Human heparin-binding epidermal growth factor gene, 5′ end
gi|348168|gb|L17028.1|HUMHBEGFA[348168] - 16534: L13288
Human vasoactive intestial peptide receptor mRNA, complete cds
gi|292903|gb|L13288.1|HUMVIPR[292903] - 16545: M31164
Human tumor necrosis factor-inducible (TSG-37) mRNA fragment
gi|339993|gb|M31164.1|HUMTSG37A[339993] - 16547: L04270
Homo sapiens (clone CD18) tumor necrosis factor receptor 2 related protein mRNA,
complete cds
gi|339761|gb|L04270.1|HUMTNFRRP[339761] - 16548: M58286
Homo sapiens tumor necrosis factor receptor mRNA, complete cds
gi|339753|gb|M58286.1|HUMTNFRB[339753] - 16562: L07062
Human somatostatin receptor 3 (SSTR3) gene
gi|348713|gb|L07062.1|HUMSSTR3Y[348713] - 16563: L07061
Human somatostatin receptor 4 (SSTR4) gene
gi|348712|gb|L07061.1|HUMSSTR4Z[348712] - 16564: M73489
Human heat-stable enterotoxin receptor mRNA, complete cds
gi|338501|gb|M73489.1|HUMSTAR[338501] - 16565: L04962
Homo sapiens serotonin receptor (HTR1F) gene, complete cds
gi|338464|gb|L04962.1|HUMSRCPT1F[338464] - 16566: M84426
Homo sapiens substance P receptor (short form) mRNA, complete cds
gi|338435|gb|M84426.1|HUMSPRSHOR[338435] - 16567: M84425
Homo sapiens substance P receptor (long form) mRNA, complete cds
gi|338427|gb|M84425.1|HUMSPRLONG[338427] - 16568: M97190
Human Sp2 protein mRNA, complete cds
gi|338300|gb|M97190.1|HUMSP2A[338300] - 16569: L05521
Human somatostatin receptor subtype 2 gene related dinucleotide repeat
gi|292502|gb|L05521.1|HUMSOMREPB[292502] - 16570: L05520
Human somatostatin receptor subtype 1 gene related dinucleotide repeat
gi|292501|gb|L05520.1|HUMSOMREPA[292501] - 16570: L14856
Human somatostatin receptor gene, complete cds
gi|292499|gb|L14856.1|HUMSOMAT[292499] - 16572: L02911
Human novel serine kinase receptor mRNA, complete cds
gi|338218|gb|L02911.1|HUMSKRN[338218] - 16573: L05597
Human serotonin receptor gene, complete cds
gi|307419|gb|L05597.1|HUMSEROTON[307419] - 16576: L10918
Homo sapiens macrophage inflammatory protein-1-alpha/RANTES receptor mRNA, complete cds
gi|292416|gb|L10918.1|HUMRANTES[292416] - 16577: L28824
Homo sapiens protein tyrosine kinase (Syk) mRNA, complete cds
gi|479012|gb|L28824.1|HUMPTK[479012] - 16578: L04308
Human parathyroid hormone receptor mRNA, complete cds
gi|190721|gb|L04308.1|HUMPTHR[190721] - 16579: L02932
Human peroxisome proliferator activated receptor mRNA, complete cds
gi|307340|gb|L02932.1|HUMPPAR[307340] - 16580: L07592
Human peroxisome proliferator activated receptor mRNA, complete cds
gi|190229|gb|L07592.1|HUMPPARA[190229] - 16581: L29016
Homo sapiens prostanoid IP receptor, complete cds
gi|495042|gb|L29016.1|HUMPIR[495042] - 16582: L25124
Homo sapiens prostaglandin E2 receptor mRNA, complete cds
gi|435049|gb|L25124.1|HUMPGE2R[435049] - 16583: L28175
Homo sapiens prostaglandin E2 receptor EP2 subtype mRNA, complete cds
gi|452495|gb|L28175.1|HUMPERE[452495] - 16584: M84986
Human DNA sequence from 5-hydroxytryptamine 1B receptor region
gi|189401|gb|M84986.1|HUMORFZ[189401] - 16585: M84605
Human putative opioid receptor mRNA, complete cds
gi|189391|gb|M84605.1|HUMOPIODRE[189391] - 16587: M89473
Human neurokinin 3 receptor (NK3R) mRNA, complete cds
gi|189223|gb|M89473.1|HUMNK3R[189223] - 16588: L12214
Human N-formyl receptor gene
gi|189182|gb|L12214.1|HUMNFORECB[189182] - 16589: L12213
Human N-formyl receptor gene
gi|189181|gb|L12213.1|HUMNFORECA[189181] - 16590: L13267
Homo sapiens N-methyl-d-aspartate receptor (NR1-2) mRNA, 3′ end
gi|292284|gb|L13267.1|HUMMARA[292284] - 16591: M80634
Human keratinocyte growth factor receptor mRNA, complete cds
gi|186740|gb|M80634.1|HUMKGFRA[186740] - 16592: M80638
Human keratinocyte growth factor receptor and fibroblast growth factor receptor-2 gene, exon
gi|186737|gb|M80638.1|HUMKFGFRB[186737] - 16593: M80636
Human keratinocyte growth factor receptor and fibroblast growth factor receptor-2 gene, exon
gi|186736|gb|M80636.1|HUMKFGFRA[186736] - 16594: M59911
Human integrin alpha-3 chain mRNA, complete cds
gi|186496|gb|M59911.1|HUMINTA3A[186496] - 16595: M75914
Human interleukin 5 receptor alpha mRNA, complete cds
gi|186387|gb|M75914.1|HUMILSRAA[186387] - 16596: M73724
Human insulin-like growth factor-I receptor gene, exon 1
gi|186383|gb|M73724.1|HUMILGFIR[186383] - 16597: M94582
Human interleukin 8 receptor B mRNA, complete cds
gi|186377|gb|M94582.1|HUMILEU8R[186377] - 16599: M24559
Human poly-Ig receptor transmembrane secretory component mRNA, 3′ end
gi|514365|gb|M24559.1|HUMIGRPOLY[514365] - 16600: L03418
Human Fc-gamma receptor I A1 mRNA, complete cds
gi|184840|gb|L03418.1|HUMIGGFCIA[184840] - 16601: M73780
Human integrin beta-8 subunit mRNA, complete cds
gi|184520|gb|M73780.1|HUMIBBSUA[184520] - 16602: L09732
Homo sapiens 5-hydroxytryptamine 1D receptor gene, complete cds
gi|184467|gb|L09732.1|HUMHTRD1A[184467] - 16603: M83180
Human serotonin receptor gene, complete cds
gi|184463|gb|M83180.1|HUMHTRA[184463] - 16605: M63889
Human heparin-binding growth factor receptor (HBGF-R-alpha-a3) mRNA, complete cds
gi|183882|gb|M63889.1|HUMHBGFC[183882]
- 16606: L22607
Homo sapiens A3 adenosine receptor mRNA, complete cds
gi|413863|gb|L22607.1|HUMHAAR[413863] - 16607: M82819
Human DNA sequence
gi|183778|gb|M82819.1|HUMHAIGGR[183778] - 16608: L13436
Homo sapiens guanylate cyclase mRNA, complete mature peptide
gi|292071|gb|L13436.1|HUMGUANCYC[292071] - 16609: L08177
Human EBV induced G-protein coupled receptor (EBI2) mRNA, complete cds
gi|292056|gb|L08177.1|HUMGPCRB[292056] - 16610: L07949
Homo sapiens GnRH receptor mRNA, complete cds
gi|292052|gb|L07949.1|HUMGNRHR[292052] - 16611: L03380
Human gonadotropin-releasing hormone receptor mRNA, complete cds
gi|18342|gb|L03380.1|HUMGNRHREC[183421] - 16612: M73832
Human GM-CSF receptor (GM-CSF receptor) mRNA, complete cds
gi|306773|gb|M73832.1|HUMGMCSFRA[306773] - 16613: M64445
Human GM-CSF receptor mRNA, complete cds
gi|183361|gb|M64445.1|HUMGMCSF[183361] - 16614: L24751
Homo sapiens glucagon receptor gene, partial cds
gi|404723|gb|L24751.1|HUMGLCGNR[404723] - 16615: L01406
Human growth hormone-releasing hormone receptor mRNA, complete cds
gi|183172|gb|L01406.1|HUMGHRHREC[183172] - 16616: L08109
Human low-affinity Fc-gamma receptor IIC gene, exons 4-7
gi|183090|gb|L08109.1|HUMGFCIIC[183090] - 16617: L08108
Human low-affinity Fc-receptor IIB gene, exons 4-7
gi|183089|gb|L08108.1|HUMGFCIIB[183089] - 16618: L08107
Human low-affinity Fc-gamma receptor IIA gene, exons 4-7
gi|183088|gb|L08107.1|HUMGFCIIA[183088] - 16619: M69106
Human Gata3 enhancer-binding protein mRNA, complete cds
gi|182999|gb|M69106.1|HUMGATA3BP[182999] - 16620: M59216
Human gamma-aminobutyric acid-A (GABA-A) receptor beta-1 subunit, exon 9
gi|182921|gb|M59216.1|HUMGABRB15[182921] - 16621: M59215
Human gamma-aminobutyric acid-A (GABA-A) receptor beta-1 subunit, exons 6, 7 and
8
gi|182920|gb|M59215.1|HUMGABRB14[182920] - 16622: M59214
Human gamma-aminobutyric acid-A (GABA-A) receptor beta-1 subunit, exon 5
gi|182919|gb|M59214.1|HUMGABRB13[182919] - 16623: M59213
Human gamma-aminobutyric acid-A (GABA-A) receptor beta-1 subunit, exon 4
gi|182918|gb|M5923.13|HUMGABRB12[182918] - 16624: M59212
Human gamma-aminobutyric acid-A (GABA-A) receptor beta-1 subunit, exons 1, 2 and
3
gi|182917|gb|M59212.1|HUMGABRB11[182917] - 16625: M11067
Human c-fms proto-oncogene, exon 2, partial cds
gi|182674|gb|M11067.1|HUMFMSB[182674] - 16626: M91647
Human high-affinity Fc IgG receptor gamma polypeptide (FcgammaRI) gene
gi|182486|gb|M91647.1|HUMFCIGGHC[182486] - 16627: M91646
Human high-affinity Fc IgG receptor gamma polypeptide (FcgammaRI) gene
gi|182485(gb|M91646.1|HUMFCIGGHB[182485] - 16628: M91645
Human high-affinity Fc IgG receptor gamma polypeptide (FcgammaRI) gene
gi|182484|gb|M91645.1|HUMFCIGGHA[182484] - 16629: L03420
Human Fc-gamma receptor I B2 mRNA, complete cds
gi|182461|gb|L03420.1|HUMFCGR1BB[182461] - 16630: L03419
Human Fc-gamma receptor I B1 mRNA, complete cds
gi|182460|gb|L03419.1|HUMFCGR1B[182460] - 16632: L08603
Human melanocortin 4 receptor gene, complete cds
gi|291977|gb|L08603.1|HUMEL4REC[182460] - 16633: M93111
Human endothelial cell-derived thrombin receptor cDNA, 5′ additional sequence
gi|181945 gb|M93111.1|HUMECTR[181945] - 16635: M94915
Human dinucleotide repeat polymorphism gene
gi|181836|gb|M94915.1|HUMDRP[181836] - 16636: L12116
Homo sapiens dinucleotide polymorphism in the G-protein coupled receptor gene (d20s32e)
gi|181631|gb|L12116.1|HUMDNP[181631] - 16637: M25945
Human DNA sequence, C-beta locus
gi|181627|gb|M25945.1|HUMDNAZ[181627] - 16639: L22303
Human dopamine receptor D2 gene, repeat polymorphism
gi|441061|gb|L22303.1|HUMD2RP[441061] - 16640: L23333
Human corticotropin releasing factor receptor mRNA, complete cds
gi|408691|gb|L23333.1|HUMCRFRB[408691] - 16641: L23332
Human corticotropin releasing factor receptor mRNA, complete cds
gi|408689|gb|L23332.1|HUMCRFRA[408689] - 16642: M73238
Human ciliary neurotrophic factor receptor (CNTFR) mRNA, complete cds
gi|180710|gb|M73238.1|HUMCNTFR[180710] - 16643: M63835
Human IgG Fc receptor I gene, exon 6 and complete cds
gi|80277|gb|M63835.1|HUMCFCGRI6[180277] - 16644: M63834
Human IgG Fc receptor I gene, exon 5
gi|180276|gb|M63834.1|HUMCFCGRI5[180276] - 16645: M63833
Human IgG Fc receptor I gene, exon 4
gi|180275|gb|M63833.1|HUMCFCGRI4[180275] - 16646: M63832
Human IgG Fc receptor I gene, exon 3
gi|180274|gb|M63832.1|HUMCFCGRI3[180274] - 16647: M63831
Human IgG Fc receptor I gene, exon 2
gi|180273|gb|M63831.1|HUMCFCGRI2[180273] - 16648: M63830
Human IgG Fc receptor I gene, exon 1
gi|180272|gb|M63830.1|HUMCFCGRI1[180272] - 16649: L13605
Human cholecystokinin A receptor mRNA, complete cds
gi|306490|gb|L13605.1|HUMCCKAR[306490] - 16650: L08112
Human brain cholecystokinin-B/gastrin receptor mRNA, complete cds
gi|306488|gb|L08112.1|HUMCCBGR[306488] - 16651: L04473
Human cholecystokinin receptor mRNA, complete cds
gi|179997|gb|L04473.1|HUMCCKR[179997] - 16652: L00587
Human calcitonin receptor mRNA, complete cds
gi|179879|gb|L00587.1|HUMCALREC[179879] - 16653: L08893
Human bombesin receptor subtype-3 mRNA, complete cds
gi|291876|gb|L08893.1|HUMBOMB3S[291876] - 16654: L27594
Homo sapiens bradykinin B2 receptor gene sequence
gi|508475|gb|L27594.1|HUMBB2R[508475] - 16656: M28639
Human autoimmune thyroid disease-related antigen mRNA
gi|291864|gb|M28639.1|HUMATDRAGA[291864] - 16657: M91464
Human angiotensinogen II type-1A receptor gene, complete cds
gi|179121|gb|M91464.1|HUMAT1A[179121] - 16658: M87290
Human angiotensin II type 1 receptor mRNA, complete cds
gi|178682|gb|M87290.1|HUMANTIR[178682] - 16659: M26228
Human anti-angiotensinogen mRNA, partial cds
gi|178641|gb|M26228.1|HUMANGA[178641] - 16661: M99590
Homo sapiens (clone pmt2-huma1b) alpha-1B adrenergic receptor gene sequence
gi|17821|gb|M99590.1|HUMADRENB[178211] - 16663: M93415
Human activin type II receptor mRNA, complete cds
gi|178049|gb|M93415.1|HUMACTIIA[178049] - 16664: M74954
Human alpha-5-beta-1 fibronectin receptor
gi|177940|gb|M74954.1|HUMABFIREC[177940] - 16665: L25827
Human a7 nicotinic acetylcholine receptor mRNA
gi|438616|gb|L25827.1|HUMA7NAR[438616] - 16666: M76446
Human alpha-A1-adrenergic receptor mRNA, complete cds
gi|177806|gb|M76446.1|HUMA1AADR[177806] - 16667: M89955
Human 5-HT1D-type serotonin receptor gene, complete cds
gi|177771|gb|M89955.1|HUM5HT1DA[177771] - 16668: M89478
Human 5-HT1B serotonin receptor gene
gi|177770|gb|M89478.1|HUM5HT1BSR[177770] - 16669: L36162
Homo sapiens (clone TH3L) receptor tyrosine kinase tire ITT (DTD) mRNA
gi|537326|gb|L36162.1|HUM3RTK[537326] - 16670: L05666
Homo sapiens NMDA receptor subunit (NR1) mRNA, complete cds
gi|307302|gb|L05666.1|HUMNMDAREC[307302] - 16671: L14865
Human somatostatin receptor (SST) gene, complete cds
gi|431094|gb|L14865.1|HUMSST28A[431094] - 16672: L24894
Human myelin protein zero (PO) gene, exon 1
gi|454413|gb|L24894.1|HUMAAC01[454413] - 16673: L24893
Human myelin protein zero (PO) gene, exons 2, 3, 4, 5, and 6
gi|454412|gb|L24893.1|HUMAAC02[454412] - 16674: L25119
Human Mu opiate receptor (MOR1) mRNA, complete cds
gi|452072|gb|L25119.1|HUMMOR1X[452072] - 16676: L24804
Human (p23) mRNA, complete cds
gi|438651|gb|L24804.1|HUMPRA[438651] - 16677: L21954
Human peripheral benzodiazepine receptor gene, exon 4
gi|483405|gb|L21954.1|HSPBR4[483405] - 16678: L21953
Human peripheral benzodiazepine receptor gene, exon 3
gi|483404|gb|L21953.1|HSPBR3[483404] - 16679: L21952
Human peripheral benzodiazepine receptor gene, exon 2
gi|483403|gb|L21952.1|HSPBR2[483403] - 16680: L21951
Human peripheral benzodiazepine receptor gene, exon 1
gi|483402|gb|L21951.1|HSPBR1[483402] - 16681: L21950
Human peripheral benzodiazepine receptor related mRNA sequence
gi|483401|gb|L21950.1|HUMBENZA[483401] - 16682: L20817
Homo sapiens tyrosine protein kinase (CAK) gene, complete cds
gi|306474|gb|L20817.1|HUMCAK[306474] - 16683: L20852
Human leukemia virus receptor 2 (GLVR2) mRNA, complete cds
gi|306771|gb|L20852.1|HUMGLVR2X[306771] - 16684: L24470
Homo sapiens prostanoid FP receptor mRNA, complete cds
gi|456563|gb|L24470.1|HUMPF2AR[456563] - 16685: L22214
Human adenosine A1 receptor (ADORA1) mRNA exons 1-6, complete cds
gi|347520|gb|L22214.1|HUMADORA1X[347520] - 16687: L23503
Human glucagon-like peptide-1 receptor (GLP-1) mRNA, complete cds
gi|402480|gb|L23503.1|HUMGLP1R[402480] - 16689: L10820
Human N-formyl peptide receptor (FPR1) gene, complete cds and Alu repeats
gi|182739|gb|L10820.1|HUMFPR1A[182739] - 16690: M99293
Homo sapiens seven transmembrane segment receptor mRNA, complete cds
gi|292516|gb|M99293.1|HUMSTSR[292516] - 16691: L01639
Human (clone HSY3RR) neuropeptide Y receptor (NPYR) mRNA, complete cds
gi|189313|gb|L01639.1|HUMNYRECA[189313] - 16692: L20463
Human A3 adenosine receptor mRNA, complete cds
gi|349448|gb|L20463.1|HUMA3ADENR[349448] - 16693: L19872
Human AH-receptor mRNA, complete cds
gi|41614|gb|L19872.1|HUMAHREC[416141] - 16694: L17075
Human TGF-b superfamily receptor type I mRNA, complete cds
gi|425147|gb|L17075.1|HUMTGFBRS[425147] - 16695: L14075
Homo sapiens immunoglobulin receptor alpha chain gene, complete cds
gi|410211|gb|L14075.1|HUMIGERA[410211] - 16696: L11695
Human activin receptor-like kinase (ALK-5) mRNA, complete cds
gi|431034|gb|L11695.1|HUMALK5A[431034] - 16697: L22206
Human vasopressin receptor V2 gene, complete cds
gi|347522|gb|L22206.1|HUMV2R[347522]
- 16698: M91211
Human receptor for advanced glycosylation end products (RAGE) mRNA, partial cds
gi|190845|gb|M91211.1|HUMRAGE[190845] - 16699: L20469
Human truncated dopamine D3 receptor mRNA, complete cds
gi|306688|gb|L20469.1|HUMD3DR[306688] - 16701: L11315
Homo sapiens receptor tyrosine kinase mRNA, complete cds
gi|403386|gb|L11315.1|HUMRTK[403386] - 16702: L19315
Human cholecystokinin A receptor mRNA, complete cds
gi|306595|gb|L19315.1|HUMCHOLREC[306595] - 16724: L15310
Homo sapiens glucagon-like peptide-1 receptor gene
gi|292051|gb|L15310.1|HUMGLP1RGA[292051] - 16725: M99624
Human epidermal growth factor receptor-related gene, 5′ end
gi|178251|gb|M99624.1|HUMAGGCRB[178251]-892-Appendix II - 1: NM—017882
Homo sapiens ceroid-lipofuscinosis, neuronal 6, late infantile, variant (CLN6),
mRNA
gi|8923531|ref|NM—017882.1|[8923531] - 2: BI480800
H2RPE-0436 Human Retinal Pigment Epithelium (2) Homo sapiens cDNA 5′ similar to
glycoprotein (transmembrane) nmb (GPNMB), mRNA sequence
gi|18998609|gb|BI480800.1|BI480800[18998609] - 4: AC096780
Tcc118, complete sequence
gi|18958727|gb|AC096780.1|[18958727] - 5: AC113243
Tcc1a22, complete sequence
gi|18958719|gb|AC113243.1|[18958719] - 6: AF347029
Homo sapiens transmembrane protein (C60RF33) mRNA, complete cds
gi|18873730|gb|AF347029.1|[18873730] - 8: NM—001183
Homo sapiens ATPase, H+ transporting, lysosomal (vacuolar proton pump), subunit
1 (ATP6S1), mRNA
gi|17136147|ref|NM—001183.2|[17136147] - 13: NM—005765
Homo sapiens ATPase, H+ transporting, lysosomal (vacuolar proton pump) membrane
sector associated protein M8-9 (ATP6M8-9), mRNA
gi|15011917|ref|NM—005765.2|[15011917] - 14: AB028140
Homo sapiens mRNA for spinesin, complete cds
gi|12248916|dbj|AB028140.1|[12248916] - 15: NM—002846
Homo sapiens protein tyrosine phosphatase, receptor type, N (PTPRN), mRNA
gi|18860905|ref|NM—002846.2|[18860905] - 16: NM—002845
Homo sapiens protein tyrosine phosphatase, receptor type, M (PTPRM), mRNA
gi|18860903|ref|NM—002845.2|[18860903] - 17: NM—002844
Homo sapiens protein tyrosine phosphatase, receptor type, K (PTPRK), mRNA
gi|18860901|ref|NM—002844.2|[18860901] - 18: NM—002843
Homo sapiens protein tyrosine phosphatase, receptor type, J (PTPRJ), mRNA
gi|18860899|ref|NM—002843.2|[18860899] - 19: NM—002841
Homo sapiens protein tyrosine phosphatase, receptor type, G (PTPRG), mRNA
gi|18860897|ref|NM—002841.2|[18860897] - 20: NM—130440
Homo sapiens protein tyrosine phosphatase, receptor type, F (PTPRF), transcript
variant 2, mRNA
gi|18860895|ref|NM—130440.1|[18860895] - 21: NM—130393
Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
variant 4, mRNA
gi|18860893|ref|NM—130393.1|[18860893] - 22: NM—130392
Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
variant 3, mRNA
gi|18860891|ref|NM—130392.1|[18860891] - 23: NM—130391
Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
variant 2, mRNA
gi|18860889|ref|NM—130391.1|[18860889] - 24: NM—002840
Homo sapiens protein tyrosine phosphatase, receptor type, F (PTPRF), transcript
variant 1, mRNA
gi|18860871|ref|NM—002840.2|[18860871] - 25: NM—006504
Homo sapiens protein tyrosine phosphatase, receptor type, E (PTPRE), transcript
variant 1, mRNA
gi|18860860|ref|NM—006504.2|[18860860] - 26: NM—130435
Homo sapiens protein tyrosine phosphatase, receptor type, E (PTPRE), transcript
variant 2, mRNA
gi|18860858|ref|NM—130435.1|[18860858] - 27: NM—002842
Homo sapiens protein tyrosine phosphatase, receptor type, H (PTPRH), mRNA
gi|4506312|ref|NM—002842.1|[4506312] - 28: NM—002839
Homo sapiens protein tyrosine phosphatase, receptor type, D (PTPRD), transcript
variant 1, mRNA
gi|4506308|ref|NM—002839.1|[4506308] - 29: BC024191
Homo sapiens, Similar to transmembrane protein HTMP10, clone IMAGE:4799785, mRNA
gi|18848306|gb|BC024191.1[18848306] - 30: NM—023068
Homo sapiens sialoadhesin (SN), mRNA
gi|18765743|ref|NM—023068.2|[18765743] - 31: NM—032646
Homo sapiens tweety homolog 2 (Drosophila) (TTYH2), mRNA
gi|17939343|ref|NM—032646.4|[17939343] - 32: NM—022006
Homo sapiens FXYD domain-containing ion transport regulator 7 (FXYD7), mRNA
gi|11612658|ref|NM—022006.1|[11612658] - 33: NM—022003
Homo sapiens FXYD domain-containing ion transport regulator 6 (FXYD6), mRNA
gi|11612654|ref|NM—022003.1|[11612654] - 34: NM—002127
Homo sapiens HLA-G histocompatibility antigen, class I, G (HLA-G), mRNA
gi|18765718|ref|NM—002127.2|[18765718] - 35: NM—005516
Homo sapiens major histocompatibility complex, class I, E (HLA-E), mRNA
gi|18765717|ref|NM—005516.2|[18765717] - 36: NM—002121
Homo sapiens major histocompatibility complex, class II, DP beta 1 (HLA-DPB1),
mRNA
gi|18765716|ref|NM—002121.3|[18765716] - 37: NM—006120
Homo sapiens major histocompatibility complex, class II, DM alpha (HLA-DMA), mRNA
gi|18765714|ref|NM—006120.2|[18765714] - 38: NM—002116
Homo sapiens major histocompatibility complex, class I, A (HLA-A), mRNA
gi|18765713|ref|NM—002116.3|[18765713] - 39: NM—130797
Homo sapiens dipeptidylpeptidase VI (DPP6), transcript variant 1, mRNA
gi|18765697|ref|NM—130797.1|[18765697] - 40: NM—001936
Homo sapiens dipeptidylpeptidase VI (DPP6), transcript variant 2, mRNA
gi|18765695|ref|NM—001936.2|[18765695] - 41: NM—018593
Homo sapiens solute carrier family 16 (monocarboxylic acid transporters), member
10 (SLC16A10), mRNA
gi|18699729|ref|NM—018593.2|[18699729] - 42: BM510040
ig97b09.x1 HR85 islet Homo sapiens cDNA clone IMAGE: 3′ similar to TR:O60478 O60478 PUTATIVE SEVEN PASS TRANSMEMBRANE PROTEIN.;, mRNA sequence
gi|18681183|gb|BM510040.1|BM510040[18681183] - 43: BM509858
ig94h01.y1 HR85 islet Homo sapiens cDNA clone IMAGE: 5′ similar to SW:MTRP_HUMAN
Q15012 GOLGI 4-TRANSMEMBRANE SPANNING TRANSPORTER MTP; mRNA sequence
gi|18681001|gb|BM509858.1|BM509858[18681001] - 44: BM509717
ig93b05.y1 HR85 islet Homo sapiens cDNA clone IMAGE: 5′ similar to SW:MTRP_HUMAN
Q15012 GOLGI 4-TRANSMEMBRANE SPANNING TRANSPORTER MTP;, mRNA sequence
gi|18680860|gb|BM509717.1|BM509717[18680860] - 45: BM508064
ij38f06.x1 Human insulinoma Homo sapiens cDNA clone IMAGE:5633410 3′ similar to
TR:P97544 P97544 ER TRANSMEMBRANE PROTEIN.;, mRNA sequence
gi|18679207|gb|BM508064.1|BM508064[18679207] - 46: NM—033543
Homo sapiens hypothetical protein R29124—1 (R29124—1), mRNA
gi|16117774|ref|NM—033543.1|[16117774] - 47: NM—032732
Homo sapiens hypothetical protein MGC10763 (IL17RL), mRNA
gi|14249349|ref|NM—032732.1|[14249349] - 48: NM—018676
Homo sapiens TMTSP for transmembrane molecule with thrombospondin module (LOC55901), mRNA
gi|8923893|ref|NM—018676.1|[8923893] - 49: NM—016372
Homo sapiens seven transmembrane domain orphan receptor (TPRA40), mRNA
gi|7705964|ref|NM—016372.1|[7705964] - 50: L47337
Homo sapiens transmembrane protein (TMC) mRNA, complete cds
gi|18654193|gb|L47337.1|HUMTMC[18654193] - 56: Y13567
Homo sapiens HLA-B*07022 gene exon 1-5
gi|4007617|emb|Y13567.1|HSY13567[4007617] - 57: NM—032027
Homo sapiens beta-amyloid binding protein precursor (BBP), mRNA
gi|17738309|ref|NM—032027.2|[17738309] - 58: NM—030913
Homo sapiens sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C (SEMA6C), mRNA
gi|16306551|ref|NM—030913.2|[16306551] - 59: NM—021203
Homo sapiens APMCF1 protein (APMCF1), mRNA
gi|14917112|ref|NM—021203.2|[14917112] - 60: NM—006854
Homo sapiens KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 (KDELR2), mRNA
gi|8051609|ref|NM—006854.21[8051609] - 61: NM—014394
Homo sapiens growth hormone inducible transmembrane protein (GHITM), mRNA
gi|7657479|ref|NM—014394.1|[7657479] - 62: NM—014399
Homo sapiens tetraspan NET-6 protein (NET-6), mRNA
gi|7657372|ref|NM—014399.1|[7657372] - 63: NM—014478
Homo sapiens calcitonin gene-related peptide-receptor component protein (CGRP-RCP), mRNA
gi|7656976|ref|NM—014478.1|[7656976] - 64: NM—007324
Homo sapiens MAD, mothers against decapentaplegic homolog (Drosophila) interacting protein, receptor activation anchor (MADHIP), transcript variant 1,
mRNA
gi|6552338|ref|NM—007324.1|[6552338] - 65: NM—007323
Homo sapiens MAD, mothers against decapentaplegic homolog (Drosophila) interacting protein, receptor activation anchor (MADHIP), transcript variant 2,
mRNA
gi|6552336|ref|NM—007323.1|[6552336] - 66: NM—006876
Homo sapiens UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (B3GNT6), mRNA
gi|5802983|ref|NM—006876.1|[5802983] - 67: NM—006675
Homo sapiens tetraspan transmembrane 4 super family (NET-5), mRNA
gi|5729940|ref|NM—006675.1|[5729940] - 68: NM—006405
Homo sapiens transmembrane 9 superfamily member 1 (TM9SF1), mRNA
gi|5453741|ref|NM—006405.1|[5453741] - 69: NM—005761
Homo sapiens plexin C1 (PLXNC1), mRNA
gi|5032222|ref|NM—005761.1|[5032222] - 70: NM—005814
Homo sapiens glycoprotein A33 (transmembrane) (GPA33), mRNA
gi|5031560|ref|NM—005814.1|[5031560] - 71: NM—004799
Homo sapiens MAD, mothers against decapentaplegic homolog (Drosophila) interacting protein, receptor activation anchor (MADHIP), transcript variant 3,
mRNA
gi|4759059|ref|NM—004799.1|[4759059] - 72: NM—003764
Homo sapiens syntaxin 11 (STX11), mRNA
gi|4507286|ref|NM—003764.1|[4507286] - 73: NM—003622
Homo sapiens PTPRF interacting protein, binding protein 1 (liprin beta 1) (PPFIBP1), mRNA
gi|4505986|ref|NM—003622.1|[4505986] - 74: NM—003626
Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF),
interacting protein (liprin), alpha 1 (PPFIA1), mRNA
gi|4505982|ref|NM—003626.1|[4505982] - 75: NM—033266
Homo sapiens ER to nucleus signalling 2 (ERN2), mRNA
gi|15149481|ref|NM—033266.1|[15149481] - 76: NM—030780
Homo sapiens folate transporter/carrier (LOC81034), mRNA
gi|13540550|ref|NM—030780.1|[13540550] - 77: NM—025179
Homo sapiens plexin A2 (PLXNA2), mRNA
gi|13378152|ref|NM—025179.1|[13378152] - 78: NM—022097
Homo sapiens hepatocellular carcinoma antigen gene 520 (LOC63928), mRNA
gi|11545810|ref|NM—022097.1|[11545810] - 79: NM—019111
Homo sapiens major histocompatibility complex, class II, DR alpha (HLA-DRA), mRNA
gi|18641378|ref|NM—019111.2|[18641378] - 80: NM—002120
Homo sapiens major histocompatibility complex, class II, DO beta (HLA-DOB), mRNA
gi|18641377|ref|NM—002120.2|[18641377] - 81: NM—002118
Homo sapiens major histocompatibility complex, class II, DM beta (HLA-DMB), mRNA
gi|18641376|ref|NM—002118.3|[18641376] - 82: NM—002125
Homo sapiens major histocompatibility complex, class II, DR beta 5 (HLA-DRB5),
mRNA
gi|18641374|ref|NM—002125.2|[18641374] - 83: NM—021983
Homo sapiens major histocompatibility complex, class II, DR beta 4 (HLA-DRB4),
mRNA
gi|18641372|ref|NM—021983.3|[18641372] - 84: NM—022555
Homo sapiens major histocompatibility complex, class II, DR beta 3 (HLA-DRB3),
mRNA
gi|18641371|ref|NM—022555.3|[18641371] - 85: NM—080923
Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
variant 4, mRNA
gi|18641365|ref|NM—080923.1|[18641365] - 86: NM—080922
Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
variant 3, mRNA
gi|18641363|ref|NM—080922.1|[18641363] - 87: NM—080921
Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
variant 2, mRNA
gi|18641361|ref|NM—080921.1|[18641361] - 88: NM—130778
Homo sapiens collagen, type XVII, alpha 1 (COL17A1), transcript variant short,
mRNA
gi|18641355|ref|NM—130778.1|[18641355] - 89: NM—000494
Homo sapiens collagen, type XVII, alpha 1 (COL17A1), transcript variant long, mRNA
gi|18641353|ref|NM—000494.2|[18641353] - 90: NM—002838
Homo sapiens protein tyrosine phosphatase, receptor type, C (PTPRC), transcript
variant 1, mRNA
gi|18641346|ref|NM—002838.2|[18641346] - 91: NM—030950
Homo sapiens ret finger protein (RFP), transcript variant beta, mRNA
gi|18641280|ref|NM—030950.2[18641280] - 92: NM—130785
Homo sapiens TPTE and PTEN homologous inositol lipid phosphatase (TPIP), mRNA
gi|18640755|ref|NM—130785.1|[18640755] - 93: AB057445
Homo sapiens hTAT1 mRNA for aromatic amino acid transporter, complete cds
gi|18640046|dbj|AB057445.1|[18640046] - 94: NM—006510
Homo sapiens ret finger protein (RFP), transcript variant alpha, mRNA
gi|17105396|ref|NM—006510.3|[17105396] - 95: NM—033554
Homo sapiens major histocompatibility complex, class II, DP alpha 1 (HLA-DPA1),
mRNA
gi|15809045|ref|NM—033554.1|[15809045] - 96: NM—005608
Homo sapiens protein tyrosine phosphatase, receptor type, C-associated protein
(PTPRCAP), mRNA
gi|5032004|ref|NM—005608.1|[5032004] - 97: BM491907
pgp2n.pk007.m20 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
Gallus gallus cDNA clone pgp2n.pk007.m20 5′ similar to gb|AAH17476.1|AAH17476 (BC017476) sema domain, immunoglobulin domain (Ig), transmembrane domain TM) and
short cytoplasmic domain, (semaphorin) 4C [Homo sapiens], mRNA sequence
gi|18612838|gb|BM491907.1|BM491907[18612838] - 98: BM491823
pgp2n.pk007.i6 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
Gallus gallus cDNA clone pgp2n.pk007.i6 5′ similar to ref|NP—055070.1 (NM—014255) transmembrane protein 4; putative type II membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens], mRNA sequence
gi|18612754|gb|BM491823.1|BM491823[18612754] - 99: BM491746
pgp2n.pk107.f14 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
Gallus gallus cDNA clone pgp2n.pk007.f14 5′ similar to ref|XP—044533.2 (XM—044533) sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
and short cytoplasmic domain, (semaphorin) 4B [Homo sapiens], mRNA sequence
gi|18612677|gb|BM491746.1|BM491746[18612677] - 100: BM491722
pgp2n.pk007.d9 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
Gallus gallus cDNA clone pgp2n.pk007.d9 5′ similar to ref|XP—032285.1 (XM—032285) similar to putative transmembrane protein; homolog of yeast Golgi membrane protein Yif1p (Yip1p-interacting factor) [Homo sapiens], mRNA sequence
gi|18612653|gb|BM491722.1|BM491722[18612653] - 101: BM491453
pgp2n.pk006.h11 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
Gallus gallus cDNA clone pgp2n.pk006.h11 5′ similar to ref|XP 058189.1 (XM—058189) similar to Similar to transmembrane 4 superfamily member 1 (H. sapiens) [Homo sapiens] gb|AAH14339.1|AAH14339 (BC014339) Similar to transmembrane 4 superfamily member 1 [Homo sapiens], mRNA sequence
gi|18612384|gb|BM491453.1|BM491453[18612384] - 102: BM490974
pgp2n.pk005.a11 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
Gallus gallus cDNA clone pgp2n.pk005.a11 5′ similar to ref|XP—008022.1 (XM—008022) chromosome 16 open reading frame 5 [Homo sapiens]
gi|AAG35583.1|AF195661—1 (AF195661) transmembrane protein I1 [Homo sapiens]
gi|AAH02882.1|AAH02882 (BC002882) chromosome 16 open reading frame 5 [Homo sapiens], mRNA sequence
gi|18611905|gb|BM490974.1|BM490974[18611905] - 103: BM490515
pgp2n.pk003.k2 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
Gallus gallus cDNA clone pgp2n.pk003.k2 5′ similar to ref|NP—055070.1 (NM—014255) transmembrane protein 4; putative type II membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens], mRNA sequence
gi|18611446|gb|BM490515.1|BM490515[18611446] - 104: BM490496
pgp2n.pk003.j21 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
Gallus gallus cDNA clone pgp2n.pk003.j21 5′ similar to ref|XP—015557.1 (XM—015557) transmembrane gamma-carboxyglutamic acid protein 3 [Homo sapiens],
mRNA sequence
gi|18611427|gb|BM490496.1|BM490496[18611427] - 105: BM490381
pgp2n.pk003.e10 Normalized Chicken Pituitary/Hypothalamus/Pineal Library (pgp2n)
Gallus gallus cDNA clone pgp2n.pk003.e10 5′ similar to ref|NP—057641.1 (NM—016557) orphan seven-transmembrane receptor, chemokine related [Homo sapiens] ref|XP—016022.11 (XM—016022) orphan seven-transmembrane receptor, chemokine related [Homo sapiens] sp|Q9NPB9|CKRB_HUMAN C-C CHEMOKINE RECEPTOR TYPE, mRNA sequence
gi|18611312|gb|BM490381.1|BM490381[18611312] - 106: BM489618
pgm2n.pk011.h5 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk011.h5 5′ similar to ref|NP—114131.1 (NM—031925) transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens] gb|AAK16442.1|AF327923—1 (AF327923) transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens], mRNA sequence
gi|18610549|gb|BM489618.1|BM489618[18610549] - 107: BM489501
pgm2n.pk011.b24 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk011.b24 5′ similar to ref|NP—055070.1 (NM—014255) transmembrane protein 4; putative type II
membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens], mRNA sequence
gi|18610432|gb|BM489501.1|BM489501[18610432] - 108: BM489487
pgm2n.pk011.a8 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk011.a8 5′ similar to gb|AAC64943.1 (AF084481) transmembrane protein [Homo sapiens], mRNA
sequence
gi|18610418|gb|BM489487.1|BM489487[18610418] - 109: BM489466
pgm2n.pk010.p5 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk010.p5 5′ similar to dbj|AK056595.1|AK056595 Homo sapiens cDNA FLJ32033 fis, clone NTONG2000265, weakly similar to Probable transmembrane protein of fission yeast,
mRNA sequence
gi|18610397|gb|BM489466.1|BM489466[18610397] - 110: BM489443
pgm2n.pk010.o4 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk010.o4 5′ similar to ref|XP—008022.1 (XM—008022) chromosome 16 open reading frame 5 [Homo sapiens] gb|AAG35583.1|AF195661—1 (AF195661) transmembrane protein I1 [Homo sapiens] gb|AAH02882.1|AAH02882 (BC002882) chromosome 16 open reading frame 5 [Homo sapiens], mRNA sequence
gi|18610374|gb|BM489443.1|BM489443[18610374] - 111: BM489432
pgm2n.pk010.o15 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk010.o15 5′ similar to ref|NP—055070.1 (NM—014255) transmembrane protein 4; putative type II
membrane protein [Homo sapiens] dbj|BAA76498.11 (AB015631) type II membrane protein [Homo sapiens], mRNA sequence
gi|18610363|gb|BM489432.1|BM489432[18610363] - 112: BM489389
pgm2n.pk010.m15 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk010.m15 5′ similar to ref|XP—028438.1 (XM—028438) CGI-101 protein [Homo sapiens]
gi|AAF99603.1|AF242523—1 (AF242523) hypothetical transmembrane protein SBB153 [Homo sapiens] gb|AAG43049.1|AF132289—1 (AF132289) F-LAN-1 [Homo sapiens]
gi|AAH10890.1|AAH10890 (BC010890), mRNA sequence
gi|18610320|gb|BM489389.1|BM489389[18610320] - 113: BM489272
pgm2n.pk010.g4 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk010.g4 5′ similar to ref|NP—055070.1 (NM—014255) transmembrane protein 4; putative type II
membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens], mRNA sequence
gi|18610203|gb|BM489272.1|BM489272[18610203] - 114: BM489267
pgm2n.pk010.g2 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk010.g2 5′ similar to ref|NP—055070.1 (NM—014255) transmembrane protein 4; putative type II
membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens), mRNA sequence
gi|18610198|gb|BM489267.1|BM489267[18610198] - 115: BM488196
pgm2n.pk006.n2 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk006.n2 5′ similar to ref|NP—114434.1 (NM—032045) kringle-containing transmembrane protein;
kringle-coding gene marking the eye and the nose [Homo sapiens] dbj|BAB40969.11
(AB059618) kringle-containing transmembrane protein [Homo sapiens), mRNA sequence
gi|18609127|gb|BM488196.1|BM488196[18609127] - 116: BM488072
pgm2n.pk006.h15 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk006.h15 5′ similar to ref|XP—044533.2 (XM—044533) sema domain, immunoglobulin domain (Ig),
transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B [Homo sapiens], mRNA sequence
gi|18609003|gb|BM488072.1|BM488072[18609003] - 117: BM487945
pgm2n.pk006.h16 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk006.b16 5′ similar to ref|NP—055070.1 (NM—014255) transmembrane protein 4; putative type II
membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens], mRNA sequence
gi|18608876|gb|BM487945.1|BM487945[18608876] - 118: BM487175
pgm2n.pk003.m18 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk003.m18 5′ similar to ref|NP—055070.1 (NM—014255) transmembrane protein 4; putative type II
membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens], mRNA sequence
gi|18608105|gb|BM487175.1|BM487175[18608105] - 119: BM487035
pgm2n.pk003.f7 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk003.f7 5′ similar to emb|CAC88191.1 (AL136141) bA138E2.2 (novel protein (lung seven transmembrane receptor 1 (LUSTR1), KIAA1623, FLJ22591, MGC15440)) [Homo sapiens), mRNA sequence
gi|18607965|gb|BM487035.1|BM487035[18607965] - 120: BM486914
pgm2n.pk003.a11 Normalized Chicken Breast Muscle, Leg Muscle, and Epiphyseal Growth Plate cDNA library (pgm2n) Gallus gallus cDNA clone pgm2n.pk003.a11 5′ similar to ref|NP—055070.1 (NM—014255) transmembrane protein 4; putative type II
membrane protein [Homo sapiens] dbj|BAA76498.11 (AB015631) type II membrane protein [Homo sapiens], mRNA sequence
gi|18607844|gb|BM486914.1|BM486914[18607844] - 121: NT—009151
Homo sapiens chromosome 11 working draft sequence segment
gi|18604868|ref|NT—009151.8|Hs11—9308[18604868] - 122: NT—010823
Homo sapiens chromosome 17 working draft sequence segment
gi|18604211|ref|NT—010823.8|Hs17—10980[18604211] - 123: XM—008517
Homo sapiens similar to transmembrane 4 superfamily member 5 (H. sapiens) (LOC147059), mRNA
gi|18604159|ref|XM—008517.4|[18604159] - 124: NT—009482
Homo sapiens chromosome 12 working draft sequence segment
gi|18601829|ref|NT—009482.8|Hs129639[18601829] - 125: NT—009458
Homo sapiens chromosome 12 working draft sequence segment
gi|18601539|ref|NT—009458.7|Hs12—9615[18601539] - 126: NT—005428
Homo sapiens chromosome 2 working draft sequence segment
gi|18600405|ref|NT—005428.7|Hs25585[18600405] - 127: XM—087234
Homo sapiens sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
and short cytoplasmic domain, (semaphorin) 4F (SEMA4F), mRNA
gi|18600294|ref|XM—087234.1|[18600294] - 128: NT—030593
Homo sapiens chromosome 2 working draft sequence segment
gi|18599598|ref|NT—030593.2|Hs2—30849[18599598] - 129: XM—092364
Homo sapiens similar to seven transmembrane receptor (LOC165082), mRNA
gi|18599578|ref|XM—092364.1|[18599578] - 130: NT—025667
Homo sapiens chromosome 3 working draft sequence segment
gi|18599563|ref|NT—025667.2|Hs325823[18599563] - 131: NT—010478
Homo sapiens chromosome 16 working draft sequence segment
gi|18598685|ref|NT—010478.8|Hs16—10635[18598685] - 132: NT—010422
Homo sapiens chromosome 16 working draft sequence segment
gi|18598469|ref|NT—010422.8|Hs16—10579[18598469] - 133: NT—030136
Homo sapiens chromosome 14 working draft sequence segment
gi|18597657|ref|NT—030136.3|Hs1430391[18597657] - 134: XM—090902
Homo sapiens similar to transmembrane 9 superfamily member 1 (H. sapiens) (LOC161426), mRNA
gi|18597655|ref|XM—090902.1|[18597655] - 135: XM—085169
Homo sapiens similar to seven transmembrane receptor BLTR2; leukotriene B4 receptor BLT2 (H. sapiens) (LOC145549), mRNA
gi|18597626|ref|XM—085169.1|[18597626] - 136: NT—026437
Homo sapiens chromosome 14 working draft sequence segment
gi|18597566|ref|NT—026437.6|Hs14—26604[18597566] - 137: XM—085149
Homo sapiens similar to fibronectin leucine rich transmembrane protein 2 (H. sapiens) (LOC145535), mRNA
gi|18597448|ref|XM—085149.1|[18597448] - 138: NT—025892
Homo sapiens chromosome 14 working draft sequence segment
gi|18597282|ref|NT—025892.7|Hs14—26048[18597282] - 139: NT—019583
Homo sapiens chromosome 14 working draft sequence segment
gi|18596851|ref|NT—019583.8|Hs14—19739[18596851] - 140: XM—093204
Homo sapiens similar to G protein-coupled receptor 64; G protein-coupled receptor, epididymis-specific (seven transmembrane family) (LOC170247), mRNA
gi|18596481|ref|XM—093204.1|[18596481] - 141: NT—025319
Homo sapiens chromosome X working draft sequence segment
gi|18596220|ref|NT—025319.8|HsX—25475[18596220] - 142: NT—011719
Homo sapiens chromosome X working draft sequence segment
gi|18595448|ref|NT—011719.6|HsX—11876[18595448] - 143: XM—093073
Homo sapiens similar to TRANSMEMBRANE 9 SUPERFAMILY PROTEIN MEMBER 2 PRECURSOR
(LOC170048), mRNA
gi|18595444|ref|XM—093073.1|[18595444] - 144: XM—060026
Homo sapiens similar to transmembrane 9 superfamily member 2; 76 kDa membrane protein; transmembrane protein 9 superfamily member 2 (LOC139375), mRNA
gi|18595426|ref|XM—060026.2|[18595426] - 145: NT—011687
Homo sapiens chromosome X working draft sequence segment
gi|18595291|ref|NT—011687.8|HsX—11844[18595291] - 146: NT—011657
Homo sapiens chromosome X working draft sequence segment
gi|18595178|ref|NT—011657.8|HsX—11814[18595178] - 147: XM—032382
Homo sapiens transmembrane 4 superfamily member 2 (TM4SF2), mRNA
gi|18595108|ref|XM—032382.3|[18595108] - 148: XM—055073
Homo sapiens similar to transmembrane phosphatase with tensin homology (H. sapiens) (LOC150132), mRNA
gi|18593511|ref|XM—055073.3|[18593511] - 149: XM—009671
Homo sapiens transmembrane, prostate androgen induced RNA (TMEPAI), mRNA
gi|18591987|ref|XM—009671.7|[18591987] - 150: NT—011296
Homo sapiens chromosome 19 working draft sequence segment
gi|18591133|ref|NT—011296.8|Hs19—11453[18591133] - 151: NT—011295
Homo sapiens chromosome 19 working draft sequence segment
gi|18591086|ref|NT—011295.5|Hs19—11452[18591086] - 152: NT—011294
Homo sapiens chromosome 19 working draft sequence segment
gi|18591029|ref|NT—011294.7|Hs19—11451[18591029] - 153: NT—011255
Homo sapiens chromosome 19 working draft sequence segment
gi|18590680|ref|NT—011255.8|HS19 11412[18590680] - 154: NT—011233
Homo sapiens chromosome 19 working draft sequence segment
gi|18590500|ref|NT—011233.8|Hs19—11390[18590500] - 155: XM—032285
Homo sapiens similar to putative transmembrane protein; homolog of yeast Golgi
membrane protein Yif1p (Yip1p-interacting factor) (LOC90522), mRNA
gi|18590452|ref|XM—032285.2|[18590452] - 156: NT—011151
Homo sapiens chromosome 19 working draft sequence segment
gi|18590324|ref|NT—011151.8|Hs19—11308[18590324] - 157: NT—011109
Homo sapiens chromosome 19 working draft sequence segment
gi|18589940|ref|NT—011109.8|Hs19—11266[18589940] - 158: NT—030157
Homo sapiens chromosome 17 working draft sequence segment
gi|18588299|ref|NT—030157.3|Hs1730412[18588299] - 159: XM—096100
Homo sapiens transmembrane activator and CAML interactor (TACI), mRNA
gi|18588295|ref|XM—096100.1|[18588295] - 160: NT—010672
Homo sapiens chromosome 17 working draft sequence segment
gi|18586808|ref|NT—010672.8|Hs17—10829[18586808] - 161: NT—024776
Homo sapiens chromosome 16 working draft sequence segment
gi|8585964|ref|NT—024776.4|Hs16—24932[18585964] - 162: NT—015360
Homo sapiens chromosome 16 working draft sequence segment
gi|18585813|ref|NT—015360.8|Hs16—15516[18585813] - 163: NT—010552
Homo sapiens chromosome 16 working draft sequence segment
gi|18585429|ref|NT—010552.8|Hs16—10709[18585429] - 164: NT—010356
Homo sapiens chromosome 15 working draft sequence segment
gi|18584698|ref|NT—010356.8|Hs15—10513[18584698] - 165: NT—010351
Homo sapiens chromosome 15 working draft sequence segment
gi|18584556|ref|NT—010351.8|Hs15—10508[18584556] - 166: NT—010224
Homo sapiens chromosome 15 working draft sequence segment
gi|18583998|ref|NT—010224.7|Hs15—10381[18583998] - 167: XM—083914
Homo sapiens transmembrane 6 superfamily member 1 (TM6SF1), mRNA
gi|18583986|ref|XM—083914.1|[18583986] - 168: XM—083903
Homo sapiens transmembrane 9 superfamily member 1 (TM9SF1), mRNA
gi|18583350|ref|XM—083903.1|[18583350] - 169: NT—010036
Homo sapiens chromosome 14 working draft sequence segment
gi|18583080|ref|NT—010036.8|Hs14—10193[18583080] - 170: XM—028295
Homo sapiens calponin like transmembrane domain protein (calmin), mRNA
gi|18582992|ref|XM—028295.3|[18582992] - 171: NT—029430
Homo sapiens chromosome 13 working draft sequence segment
gi|18582622|ref|NT—029430.4|Hs13—29589[18582622] - 172: NT—009967
Homo sapiens chromosome 13 working draft sequence segment
gi|18582005|ref|NT—009967.8|Hs13—10124[18582005] - 173: NT—009952
Homo sapiens chromosome 13 working draft sequence segment
gi|18581926|ref|NT—009952.8|Hs13—10109[18581926] - 174: NT—009917
Homo sapiens chromosome 13 working draft sequence segment
gi|18581517(ref|NT—009917.8|Hs13—10074[18581517] - 175: XM—084974
Homo sapiens transmembrane phosphatase with tensin homology (TPTE), mRNA
gi|18581435|ref|XM—084974.1|[18581435] - 176: NT—009910
Homo sapiens chromosome 13 working draft sequence segment
gi|18581383|ref|NT—009910.8|Hs13—10067[18581383] - 177: NT—009711
Homo sapiens chromosome 12 working draft sequence segment
gi|18580591|ref|NT—009711.8|Hs12—9868[18580591] - 178: NT—009540
Homo sapiens chromosome 12 working draft sequence segment
gi|18579972|ref|NT—009540.8|Hs129697[18579972] - 179: NT—009487
Homo sapiens chromosome 12 working draft sequence segment
gi|18579817|ref|NT—009487.8|Hs12—9644[18579817] - 180: XM—084852
Homo sapiens similar to transmembrane protein induced by tumor necrosis factor
alpha (LOC144404), mRNA
gi|18579801|ref|XM—084852.1|[18579801] - 181: NT—009471
Homo sapiens chromosome 12 working draft sequence segment
gi|18579778|ref|NT—009471.8|Hs12—9628[18579778] - 182: XM—084845
Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U) (LOC144383), mRNA
gi|18579688|ref|XM—084845.1|[18579688] - 183: XM—006748
Homo sapiens seven transmembrane protein TM7SF3 (TM7SF3), mRNA
gi|18579647|ref|XM—006748.5|[18579647] - 184: NT—030809
Homo sapiens chromosome 12 working draft sequence segment
gi|18579377|ref|NT—030809.2|Hs12—31065[18579377] - 185: NT—024394
Homo sapiens chromosome 12 working draft sequence segment
gi|18579035|ref|NT—024394.7|Hs12—24550[18579035] - 186: NT—009237
Homo sapiens chromosome 11 working draft sequence segment
gi|18578641|ref|NT—009237.8|Hs11—9394[18578641] - 187: NT—009215
Homo sapiens chromosome 11 working draft sequence segment
gi|18578584|ref|NT—009215.8|Hs11—9372[18578584] - 188: NT—008992
Homo sapiens chromosome 11 working draft sequence segment
gi|18578338|ref|NT—008992.7|Hs11—9149[18578338] - 189: XM—055266
Homo sapiens putative transmembrane protein; homolog of yeast Golgi membrane protein Yif1p (Yip1p-interacting factor) (54TM), mRNA
gi|18578177|ref|XM—055266.2|[18578177] - 190: XM—045525
Homo sapiens transmembrane 7 superfamily member 2 (TM7SF2), mRNA
gi|18578063|ref|XM—045525.4|[18578063] - 191: XM—006111
Homo sapiens fibronectin leucine rich transmembrane protein 1 (FLRT1), mRNA
gi|18578050|ref|XM—006111.5|[18578050] - 192: NT—008804
Homo sapiens chromosome 10 working draft sequence segment
gi|18576536|ref|NT—008804.8|Hs10—8961[18576536] - 193: XM—084484
Homo sapiens similar to sema domain, immunoglobulin domain (Ig), transmembrane
domain (TM) and short cytoplasmic domain, (semaphorin) 4G; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, 4G (LOC143288), mRNA
gi|18576428|ref|XM—084484.1|[18576428] - 194: NT—008609
Homo sapiens chromosome 10 working draft sequence segment
gi|18575857|ref|NT—008609.8|Hs10—8766[18575857] - 195: NT—029394
Homo sapiens chromosome 10 working draft sequence segment
gi|185745771 ref|NT029394.3|Hs10—29553[18574577] - 196: NT—024089
Homo sapiens chromosome 10 working draft sequence segment
gi|8574182|ref|NT—024089.8|Hs10—24245[18574182] - 197: NT—024064
Homo sapiens chromosome 10 working draft sequence segment
gi|18574077|ref|NT—024064.8|Hs10—24220[18574077] - 198: XM—084331
Homo sapiens similar to growth hormone inducible transmembrane protein (H. sapiens) (LOC170427), mRNA
gi|18574063|ref|XM—084331.1|[18574063] - 199: XM—043589
Homo sapiens growth hormone inducible transmembrane protein (GHITM), mRNA
gi|8574061|ref|XM—043589.3|[18574061] - 200: NT—008554
Homo sapiens chromosome 9 working draft sequence segment
gi|8573734|ref|NT—008554.8|HS9—8711[18573734] - 201: XM—071188
Homo sapiens similar to mucin 1, transmembrane (LOC138940), mRNA
gi|18573702|ref|XM—071188.2|[18573702] - 202: NT—008476
Homo sapiens chromosome 9 working draft sequence segment
gi|18573649|ref|NT—008476.8|HS9—8633[18573649] - 203: NT—008421
Homo sapiens chromosome 9 working draft sequence segment
gi|18573390|ref|NT—008421.8|Hs9—8578[18573390] - 204: NT—031831
Homo sapiens chromosome 9 working draft sequence segment
gi|18572946|ref|NT—031831.1|Hs9—32002[18572946] - 205: NT—031830
Homo sapiens chromosome 9 working draft sequence segment
gi|18572933|ref|NT—031830.1|HS9—32001[18572933] - 206: NT—029366
Homo sapiens chromosome 9 working draft sequence segment
gi|18572447|ref|NT—029366.4|Hs9—29525[18572447] - 207: NT—027082
Homo sapiens chromosome 9 working draft sequence segment
gi|18572282|ref|NT—027082.5|Hs9—27242[18572282] - 208: NT—024010
Homo sapiens chromosome 9 working draft sequence segment
gi|18572162|ref|NT—024010.7|Hs9—24166[18572162] - 209: XM—108898
Homo sapiens sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
and short cytoplasmic domain, (semaphorin) 4D (SEMA4D), mRNA
gi|18572160|ref|XM—108898.1|[18572160] - 210: NT—023967
Homo sapiens chromosome 9 working draft sequence segment
gi|18571929|ref|NT—023967.8|Hs924123[18571929] - 211: XM—095756
Homo sapiens similar to transmembrane protein 2 (H. sapiens) (LOC169529), mRNA
gi|18571901|ref|XM—095756.1|[18571901] - 212: NT—008253
Homo sapiens chromosome 8 working draft sequence segment
gi|18571429|ref|NT—008253.8|Hs88410[18571429] - 213: NT—008079
Homo sapiens chromosome 8 working draft sequence segment
gi|18570812|ref|NT—008079.8|Hs8—8236[18570812] - 214: NT—007997
Homo sapiens chromosome 8 working draft sequence segment
gi|8570417|ref|NT—007997.8|Hs88154[18570417] - 215: XM—095564
Homo sapiens similar to transmembrane trafficking protein (LOC169193), mRNA
gi|18570401|ref|XM—095564.1|[18570401] - 216: NT—007978
Homo sapiens chromosome 8 working draft sequence segment
gi|18570256|ref|NT—007978.8|Hs8—8135[18570256] - 217: NT—030735
Homo sapiens chromosome 8 working draft sequence segment
gi|18569963|ref|NT—030735.2|Hs8—30991[18569963] - 218: NT—007905
Homo sapiens chromosome 7 working draft sequence segment
gi|18568542|ref|NT—007905.8Hs7—8062[18568542] - 219: NT—007902
Homo sapiens chromosome 7 working draft sequence segment
gi|18568515|ref|NT—007902.8|Hs78059[18568515] - 220: AF132746
Homo sapiens transmembrane protein mRNA, complete cds
gi|18568116|gb|AF132746.1|[18568116] - 221: NT—007867
Homo sapiens chromosome 7 working draft sequence segment
gi|18568101|ref|NT—007867.8|Hs78024[18568101] - 222: NT—007751
Homo sapiens chromosome 7 working draft sequence segment
gi|18567173|ref|NT—007751.8|Hs7—7908[18567173] - 223: NT—031815
Homo sapiens chromosome 7 working draft sequence segment
gi|18566709|ref|NT—031815.1|Hs731986[18566709] - 224: NT—031811
Homo sapiens chromosome 7 working draft sequence segment
gi|18566667|ref|NT—031811.1Hs731982[18566667] - 225: XM—095132
Homo sapiens similar to dM538M10.1 (novel 7 transmembrane receptor (rhodopsin family) (olfactory receptor like) protein similar to human HS6M1-21) (LOC154958), mRNA
gi|18566661|ref|XM—095132.1|[18566661] - 226: NT—031807
Homo sapiens chromosome 7 working draft sequence segment
gi|18566613|ref|NT—031807.1|Hs7—31978[18566613] - 227: NT—030004
Homo sapiens chromosome 7 working draft sequence segment
gi|18566403|ref|NT—030004.3|Hs7—30259[18566403] - 228: NT—027064
Homo sapiens chromosome 7 working draft sequence segment
gi|18566143|ref|NT—027064.5|Hs7—27224[18566143] - 229: NT—017168
Homo sapiens chromosome 7 working draft sequence segment
gi|18565551|ref|NT—017168.8|Hs7—17324[18565551] - 230: NT—007592
Homo sapiens chromosome 6 working draft sequence segment
gi|18565438|ref|NT—007592.8|Hs6—7749[18565438] - 231: XM—094938
Homo sapiens similar to 573K1.2 (mm17M1-3 (novel 7 transmembrane receptor (rhodopsin family) (olfactory receptor LIKE) protein)) (LOC168233), mRNA
gi|18565395|ref|XM—094938.1|[18565395] - 232: XM—094903
Homo sapiens similar to 573K1.15 (mm17M1-6 (novel 7 transmembrane receptor (rhodopsin family) (olfactory receptor LIKE) protein)) (LOC168189), mRNA
gi|18565249|ref|XM—094903.1|[18565249] - 233: XM—094939
Homo sapiens similar to dM538M10.7 (novel 7 transmembrane receptor (rhodopsin family) (olfactory receptor like) protein) (LOC154634), mRNA
gi|18565093|ref|XM—094939.1|[18565093]
- 234: NT—007402
Homo sapiens chromosome 6 working draft sequence segment
gi|18564193|ref|NT—007402.8|Hs6—7559[18564193] - 235: XM—069322
Homo sapiens similar to transmembrane protein 2 (LOC135381), mRNA
gi|18564165|ref|XM—069322.2|[18564165] - 236: XM—087914
Homo sapiens similar to dJ402H5.1 (novel 7 transmembrane receptor of the rhodopsin family) (LOC154354), mRNA
gi|18564052|ref|XM—087914.1|[18564052] - 237: XM—087917
Homo sapiens similar to embryonic seven-span transmembrane protein-like protein
(LOC154344), mRNA
gi|18564031|ref|XM—087917.1|[18564031] - 238: XM—094741
Homo sapiens similar to 573K1.15 (mm17M1-6 (novel 7 transmembrane receptor (rhodopsin family) (olfactory receptor LIKE) protein)) (LOC167905), mRNA
gi|18563541|ref|XM—094741.1|[18563541] - 239: NT—025741
Homo sapiens chromosome 6 working draft sequence segment
gi|18563240|ref|NT—025741.7|Hs6—25897[18563240] - 240: NT—023451
Homo sapiens chromosome 6 working draft sequence segment
gi|18563080|ref|NT—023451.8|Hs623607[18563080] - 241: XM—069021
Homo sapiens similar to putative transmembrane protein PTG (L1C134801) mRNA
gi|18563039|ref|XM—069021.2|[18563039] - 242: NT—006725
Homo sapiens chromosome 5 working draft sequence segment
gi|18561712|ref|NT—006725.8|Hs56882[18561712] - 243: XM—094515
Homo sapiens similar to transmembrane receptor Unc5H1 (LOC167476), mRNA
gi|18561698|ref|XM—094515.1|[18561698] - 244: NT—006576
Homo sapiens chromosome 5 working draft sequence segment
gi|18561313|ref|NT—006576.8|Hs56733[18561313] - 245: XM—004042
Homo sapiens sema domain, seven thrombospondin repeats (type 1 and type 1-like),
transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A (SEMA5A), mRNA
gi|18561264|ref|XM—004042.7|[18561264] - 246: XM—087665
Homo sapiens similar to semaphorin 6A1; sema domain, transmembrane domain (TM),
and cytoplasmic domain, 6A; semaphorin 6A-1 (LOC153420), mRNA
gi|18560683|ref|XM—087665.1|[18560683] - 247: NT—006169
Homo sapiens chromosome 4 working draft sequence segment
gi|18558377|ref|NT—006169.8|Hs4—6326[18558377] - 248: NT—022836
Homo sapiens chromosome 4 working draft sequence segment
gi|18557125|ref|NT—022836.7|Hs4—22992[18557125] - 249: XM—093891
Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U) (LOC166482), mRNA
gi|18557119|ref|XM—093891.1|[18557119] - 250: AF456925
Homo sapiens USH3 region, partial sequence
gi|17901944|gb|AF456925.1|AF411849S2[17901944] - 251: AF411849
Homo sapiens USH3 region, partial sequence
gi|17901943|gb|AF411849.1|AF411849S1]17901943] - 252: AH011260
Homo sapiens
gi|17901942|gb|AH011260.1|SEG_AF411849S[17901942] - 253: XM—064062
Homo sapiens similar to putative transmembrane receptor (LOC124274), mRNA
gi|17488065|ref|XM—064062.1|[17488065] - 254: XM—063875
Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U) (LOC123862), mRNA
gi|17487213|ref|XM—063875.1|[17487213] - 255: XM—066655
Homo sapiens similar to G protein-coupled receptor 64; G protein-coupled receptor, epididymis-specific (seven transmembrane family) (LOC139378), mRNA
gi|17485715|ref|XM—066655.1|[17485715] - 256: NT—011519
Homo sapiens chromosome 22 working draft sequence segment
gi|17484914|ref|NT—011519.9|Hs22—11676[17484914] - 257: NT—011362
Homo sapiens chromosome 20 working draft sequence segment
gi|17484369|ref|NT—011362.7|Hs20—11519[17484369] - 258: XM—063355
Homo sapiens similar to transmembrane 7 superfamily member 1 (upregulated in kidney); transmembrane 7 superfamily member 1 (upregulated in (LOC122791), mRNA
gi|17476790|ref|XM—063355.1|[17476790] - 259: XM—062544
Homo sapiens similar to transmembrane protein 4; putative secreted protein ZSIG9 (LOC121255), mRNA
gi|17474559|ref|XM—062544.1|[17474559] - 260: XM—062443
Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U) (LOC121062), mRNA
gi|17474137|ref|XM—062443.1|[17474137] - 261: XM—070446
Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U) (LOC137474), mRNA
gi|17466780|ref|XM—070446.1|[17466780] - 262: XM—070130
Homo sapiens similar to transmembrane protein 4; putative secreted protein ZSIG9
(LOC136903), mRNA
gi|17465836|ref|XM—070130.1|[17465836] - 263: XM—069635
Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U) (LOC135982), mRNA
gi|17465065|ref|XM—069635.1|[17465065] - 264: XM—069633
Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U); interferon-inducible (LOC135976), mRNA
gi|17465055|ref|XM—069633.1|[17465055] - 265: XM—069470
Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U) (LOC135637), mRNA
gi|17464370|ref|XM—069470.1|[17464370] - 266: XM—069460
Homo sapiens similar to dM538M10.7 (novel 7 transmembrane receptor (rhodopsin family) (olfactory receptor like) protein) (LOC135626), mRNA
gi|17464346|ref|XM—069460.1|[17464346] - 267: XM—064220
Homo sapiens similar to putative transmembrane receptor (LOC124601), mRNA
gi|17457972|ref|XM—064220.1|[17457972] - 268: XM—063652
Homo sapiens similar to leucine zipper-EF-hand containing transmembrane protein
1; leucine zipper-EF-hand containing transmembrane protein 1 (LOC123430), mRNA
gi|17456715|ref|XM—063652.1|[17456715] - 269: XM—062703
Homo sapiens similar to tetraspan transmembrane 4 super family (LOC121590), mRNA
gi|17456679|ref|XM—062703.1|[17456679] - 270: XM—051362
Homo sapiens transmembrane 6 superfamily member 2 (TM6SF2), mRNA
gi|17456138|ref|XM—051362.2|[17456138] - 271: NT—011288
Homo sapiens chromosome 19 working draft sequence segment
gi|17455923|ref|NT—011288.7|HS19—11445[17455923] - 272: XM—031933
Homo sapiens transmembrane protein vezatin (VEZATIN), mRNA
gi|17454769|ref|XM—031933.3|[17454769] - 273: XM—068785
Homo sapiens similar to transmembrane receptor Unc5H1 (LOC13430i), mRNA
gi|17446928|ref|XM—068785.1|[17446928] - 274: NT—030685
Homo sapiens chromosome 5 working draft sequence segment
gi|17443457|ref|NT—030685.1Hs5—30941[17443457] - 275: NT—011387
Homo sapiens chromosome 20 working draft sequence segment
gi|16195112|ref|NT—011387.6|Hs20—11544[16195112] - 276: NT—011512
Homo sapiens chromosome 21 working draft sequence segment
gi|16170824|ref|NT—011512.4|Hs21—11669[16170824] - 277: XM—049793
Homo sapiens transmembrane protease, serine 2 (TMPRSS2), mRNA
gi|16170797|ref|XM—049793.2|[16170797] - 278: NT—011520
Homo sapiens chromosome 22 working draft sequence segment
gi|16168698|ref|NT—011520.8|Hs22—11677[16168698] - 279: NT—030188
Homo sapiens chromosome 21 working draft sequence segment
gi|16166749|ref|NT—030188.1|Hs21—30443[16166749] - 280: NT—029490
Homo sapiens chromosome 21 working draft sequence segment
gi|16166567|ref|NT—029490.2|Hs21—29649[16166567] - 281: NT—011515
Homo sapiens chromosome 21 working draft sequence segment
gi|16166537|ref|NT—011515.6|Hs21—11672[16166537] - 282: XM—009794
Homo sapiens transmembrane protein 1 (TMEM1), mRNA
gi|16166381|ref|XM—009794.4|[16166381] - 283: NT—009407
Homo sapiens chromosome 11 working draft sequence segment
gi|16164445|ref|NT—009407.5|Hs11—9564[16164445] - 284: NT—027220
Homo sapiens chromosome X working draft sequence segment
gi|16163830|ref|NT—027220.2|HsX—27380[16163830] - 285: XM—055222
Homo sapiens region containing sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G; mitochondrial ribosomal protein L32 (LOC143289), mRNA
gi|16156787|ref|XM—055222.1|[16156787] - 286: XM—008123
Homo sapiens tryptase gamma 1 (TPSG1), mRNA
gi|15317318|ref|XM—008123.5|[15317318] - 287: NT—009738
Homo sapiens chromosome 12 working draft sequence segment
gi|15307319|ref|NT—009738.5|HS12—9895[15307319] - 288: XM—006991
Homo sapiens tetraspan transmembrane 4 super family (NET-5), mRNA
gi|15307297|ref|XM—006991.5|[15307297] - 289: NT—009513
Homo sapiens chromosome 12 working draft sequence segment
gi|15303938|ref|NT—009513.5|Hs12—9670[15303938] - 290: NT—029317
Homo sapiens chromosome 6 working draft sequence segment
gi|15300889|ref|NT—029317.1|Hs6—29476[15300889] - 291: XM—040419
Homo sapiens transmembrane trafficking protein (TMP21), mRNA
gi|14784589|ref|XM—040419.1|[14784589] - 292: XM—030300
Homo sapiens similar to transmembrane receptor Unc5H1 (LOC90249), mRNA
gi|14781377|ref|XM—030300.1|[14781377] - 293: XM—036570
Homo sapiens type I transmembrane protein Fn14 (FN14), mRNA
gi|14777984|ref|XM—036570.1|[14777984] - 294: XM—027469
Homo sapiens transmembrane protein 8 (five membrane-spanning domains) (TMEM8),
mRNA
gi|14777199|ref|XM—027469.1|[14777199] - 295: XM—009839
Homo sapiens claudin 5 (transmembrane protein deleted in velocardiofacial syndrome) (CLDN5), mRNA
gi|14777026|ref|XM—009839.4|[14777026] - 296: NT—025911
Homo sapiens chromosome 17 working draft sequence segment
gi|14776336|ref|NT—025911.3|Hs17—26067[14776336] - 297: XM—041427
Homo sapiens transmembrane protease, serine 5 (spinesin) (TMPRSS5), mRNA
gi|14770562|ref|XM—041427.1|[14770562] - 298: XM—006940
Homo sapiens cytoskeleton-associated protein 4 (CKAP4), mRNA
gi|14766392|ref|XM—006940.4|[14766392] - 299: NT—011598
Homo sapiens chromosome X working draft sequence segment
gi|14759313|ref|NT—011598.4|HsX—11755[14759313] - 300: XM—033157
Homo sapiens transmembrane 4 superfamily member 6 (TM4SF6), mRNA
gi|14757314|ref|XM—033157.1|[14757314] - 301: XM—044358
Homo sapiens similar to cleft lip and palate associated transmembrane protein (LOC92330), mRNA
gi|14755905|ref|XM—044358.1|[14755905] - 302: XM—004980
Homo sapiens cystic fibrosis transmembrane conductance regulator, ATP-binding cassette (sub-family C, member 7) (CFTR), mRNA
gi|14753226|ref|XM—004980.4|[14753226] - 303: XM—002838
Homo sapiens similar to orphan seven-transmembrane receptor, chemokine related
(H. sapiens) (LOC154103), mRNA
gi|14750021|ref|XM—002838.6|[14750021] - 304: XM—005949
Homo sapiens sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
and short cytoplasmic domain, (semaphorin) 4G (SEMA4G), mRNA
gi|14747317|ref|XM—005949.4|[14747317] - 305: XM—035329
Homo sapiens similar to transmembrane trafficking protein (LOC90981), mRNA
gi|14744677|ref|XM—035329.1|[14744677] - 306: XM—038156
Homo sapiens transmembrane protein 2 (TMEM2), mRNA
gi|14743733|ref|XM—038156.1|[14743733] - 307: XM—005346
Homo sapiens transmembrane protein with EGF-like and two follistatin-like domains 1 (TMEFF1), mRNA
gi|14738782|ref|XM—005346.4|[14738782] - 308: XM—045505
Homo sapiens transmembrane 4 superfamily member (tetraspan NET-7) (NET-7), mRNA
gi|14738519|ref|XM—045505.1|[14738519] - 311: NT—026472
Homo sapiens chromosome 17 working draft sequence segment
gi|13654226|ref|NT—026472.1|Hs17—26639[13654226] - 312: XM—012718
Homo sapiens secreted and transmembrane 1 (SECTM1), mRNA
gi|13654161|ref|XM—012718.2|[13654161] - 313: XM—016506
Homo sapiens fibronectin leucine rich transmembrane protein 2 (FLRT2), mRNA
gi|13648109|ref|XM—016506.1|[13648109] - 314: XM—005187
Homo sapiens ankyrin-like with transmembrane domains 1 (ANKTM1), mRNA
gi|13645787|ref|XM—005187.3|[13645787] - 315: NT—025803
Homo sapiens chromosome 8 working draft sequence segment
gi|13642635|ref|NT—025803.2|Hs8—25959[13642635] - 316: XM—017003
Homo sapiens interferon induced transmembrane protein 3 (1-8U) (IFITM3), mRNA
gi|13642630|ref|XM—017003.1|[13642630] - 317: NT—022761
Homo sapiens chromosome 4 working draft sequence segment
gi|18556805|ref|NT—022761.8|Hs4—22917[18556805] - 318: XM—093853
Homo sapiens similar to transmembrane tryptase (LOC166415), mRNA
gi|18556799|ref|XM—093853.1|[18556799] - 319: NT—005997
Homo sapiens chromosome 3 working draft sequence segment
gi|18556520|ref|NT—005997.8|Hs3—6154[18556520] - 320: XM—087464
Homo sapiens similar to transmembrane protein 7 (LOC152408), mRNA
gi|18556483|ref|XM—087464.1|[18556483] - 321: NT—005986
Homo sapiens chromosome 3 working draft sequence segment
gi|18556440|ref|NT—005986.8|Hs3—6143[18556440] - 322: NT—005678
Homo sapiens chromosome 3 working draft sequence segment
gi|18555423|ref|NT—005678.7|Hs3—5835[18555423] - 323: XM—093638
Homo sapiens similar to orphan seven transmembrane receptor (LOC166071), mRNA
gi|18555421|ref|XM—093638.1|[18555421] - 324: XM—093637
Homo sapiens similar to orphan seven transmembrane receptor (LOC166070), mRNA
gi|18555419|ref|XM—093637.1|[18555419] - 325: NT—005654
Homo sapiens chromosome 3 working draft sequence segment
gi|18555355|ref|NT—005654.8|Hs3—5811[18555355] - 326: NT—005616
Homo sapiens chromosome 3 working draft sequence segment
gi|18555281|ref|NT—005616.8|Hs3—5773[18555281] - 327: NT—005543
Homo sapiens chromosome 3 working draft sequence segment
gi|18555061|ref|NT—005543.7|Hs35700[18555061] - 328: XM—098155
Homo sapiens similar to seven transmembrane domain orphan receptor (H. sapiens)
(LOC152010), mRNA
gi|18555022|ref|XM—098155.1|[18555022] - 329: NT—022531
Homo sapiens chromosome 3 working draft sequence segment
gi|18554079|ref|NT—022531.4|Hs3—22687[18554079] - 330: XM—096181
Homo sapiens transmembrane 4 superfamily member 4 (TM4SF4), mRNA
gi|18554072|ref|XM—096181.1|[18554072] - 331: NT—022412
Homo sapiens chromosome 3 working draft sequence segment
gi|18553606|ref NT—022412.6|Hs322568[18553606] - 332: NT —022393
Homo sapiens chromosome 3 working draft sequence segment
gi|18553572|ref|NT—022393.7|Hs322549[18553572] - 333: NT—005423
Homo sapiens chromosome 2 working draft sequence segment
gi|18553407|ref|NT—005423.8|Hs2—5580[18553407] - 334: NT—005387
Homo sapiens chromosome 2 working draft sequence segment
gi|18553071|ref|NT—005387.8|Hs2—5544[18553071] - 335: NT—005289
Homo sapiens chromosome 2 working draft sequence segment
gi|18552655|ref|NT—005289.8|Hs25446[18552655] - 336: NT—005214
Homo sapiens chromosome 2 working draft sequence segment
gi|18552351|ref|NT—005214.8|Hs25371[18552351] - 337: NT—005138
Homo sapiens chromosome 2 working draft sequence segment
gi|18552129|ref|NT—005138.8|Hs25295[18552129] - 338: NT —022180
Homo sapiens chromosome 2 working draft sequence segment
gi|18550124|ref|NT—022180.8|Hs222336[18550124] - 339: NT—004858
Homo sapiens chromosome 1 working draft sequence segment
gi|18549451|ref|NT—004858.8|Hs1—5015[18549451] - 340: XM—053256
Homo sapiens mucin 1, transmembrane (MUC1), mRNA
gi|18549380|ref|XM—053256.4|[18549380] - 341: NT—004836
Homo sapiens chromosome 1 working draft sequence segment
gi|18549182|ref|NT—004836.8|Hs1—4993[18549182] - 342: NT—004811
Homo sapiens chromosome 1 working draft sequence segment
gi|18549145|ref|NT—004811.8|Hs14968[18549145] - 343: XM—041879
Homo sapiens similar to AF1Q protein; transmembrane protein (LOC149430), mRNA
gi|18549121|ref|XM—041879.2|[18549121] - 344: NT—004668
Homo sapiens chromosome 1 working draft sequence segment
gi|18548894|ref|NT—004668.8|Hs14825[18548894] - 345: NT—004441
Homo sapiens chromosome 1 working draft sequence segment
gi|18547758|ref|NT—004441.8|Hs1—4598[18547758] - 346: NT—004434
Homo sapiens chromosome 1 working draft sequence segment
gi|18547724|ref|NT—004434.8|Hs14591[18547724] - 347: NT—004391
Homo sapiens chromosome 1 working draft sequence segment
gi|18547557|ref|NT—004391.8|Hs14548[18547557] - 348: NT—021907
Homo sapiens chromosome 1 working draft sequence segment
gi|18544452|ref|NT—021907.8|Hs1—22063[18544452] - 349: XM—053163
Homo sapiens sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C (SEMA6C), mRNA
gi|18544383|ref|XM—053163.4|[18544383] - 350: NM—016155
Homo sapiens matrix metalloproteinase 17 (membrane-inserted) (MMP17), mRNA
gi|18543372|ref|NM—016155.2|[18543372] - 351: XM—060507
Homo sapiens similar to putative integral membrane transporter; lysosomal associated transmembrane protein 4 beta (LOC127480), mRNA
gi|17443784|ref|XM—060507.1|[17443784] - 352: XM—060501
Homo sapiens similar to bM332P19.3 (novel 7 transmembrane receptor (rhodopsin family) (olfactory receptor like) protein (mm17M1-14)) (LOC127469), mRNA
gi|17443690|ref|XM—060501.1|[17443690] - 353: XM—060442
Homo sapiens similar to interferon induced transmembrane protein 3 (1-8U); interferon-inducible (LOC127360), mRNA
gi|17441370|ref|XM—060442.1|[17441370] - 354: XM—065294
Homo sapiens similar to Transmembrane protease, serine 3 (Serine protease TADG-12) (Tumor associated differentially-expressed gene-12 protein) (LOC129566), mRNA
gi|17439790|ref|XM—065294.1|[17439790] - 355: XM—032249
Homo sapiens sema domain, seven thrombospondin repeats (type 1 and type 1-like),
transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B (SEMA5B), mRNA
gi|17438489|ref|XM—032249.3|[17438489] - 356: XM—058189
Homo sapiens similar to TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 1 (TUMOR-ASSOCIATED
ANTIGEN L6) (MEMBRANE COMPONENT, SURFACE MARKER 1) (M3S1) (LOC116441), mRNA
gi|17437690|ref|XM—058189.2|[17437690] - 357: NT—011903
Homo sapiens chromosome Y working draft sequence segment
gi|17433681|ref|NT—011903.8|HsY—12060[17433681] - 358: XM—034757
Homo sapiens similar to transmembrane phosphatase with tensin homology (H. sapiens) (LOC159185), mRNA
gi|16164045|ref|XM—034757.2|[16164045] - 359: XM—003025
Homo sapiens mucin 13, epithelial transmembrane (MUC13), mRNA
gi|16159511|ref|XM—003025.5|[16159511] - 360: NT—015169
Homo sapiens chromosome 4 working draft sequence segment
gi|16156888|ref|NT—015169.5|Hs4—15325[16156888] - 361: NM—002837
Homo sapiens protein tyrosine phosphatase, receptor type, B (PTPRB), mRNA
gi|18491009|ref|NM—002837.2|[18491009] - 362: BC022439
Homo sapiens, interferon induced transmembrane protein 3 (1-8U), clone MGC:24755
IMAGE:4282809, mRNA, complete cds
gi|18490258|gb|BC022439.1|[18490258] - 363: NM—005031
Homo sapiens FXYD domain containing ion transport regulator 1 (phospholemman) (FXYD1), transcript variant a, mRNA
gi|11612671|ref|NM—005031.2|[11612671] - 364: NM—021902
Homo sapiens FXYD domain containing ion transport regulator 1 (phospholemman) (FXYD1), transcript variant b, mRNA
gi|11612669|ref|NM—021902.1|[11612669] - 365: NM—014164
Homo sapiens FXYD domain-containing ion transport regulator 5 (FXYD5), mRNA
gi|11612664|ref|NM—014164.2|[11612664] - 366: NM—020399
Homo sapiens PDZ/coiled-coil domain binding partner for the rho-family GTPase TC10 (PIST), mRNA
gi|9966876|ref|NM—020399.1|[9966876] - 367: BM439879
pgr1n.pk001.i17 Normalized Chicken Reproductive Tract cDNA Library (pgr1n) Gallus gallus cDNA clone pgr1n.pk001.i17 5′ similar to gi|7657373 ref|NP—055214.11 tetraspan NET-6 protein; transmembrane 4 superfamily protein [Homo sapiens] gi|13628481 ref|XP—004793.31 tetraspan NET-6 protein [Homo sapiens] gi|14747013 ref|XP—049585.11 tetraspan NET-6 protein [Homo sapiens]
gi|14, mRNA sequence
gi|18470654|gb|BM439879.1|BM439879[18470654] - 368: BM439852
pgr1n.pk001.h13 Normalized Chicken Reproductive Tract cDNA Library (pgr1n) Gallus gallus cDNA clone pgr1n.pk001.h13 5′ similar to gi|7657176 ref|NP—055070.1|transmembrane protein 4; putative type II membrane protein [Homo sapiens] dbj|BAA76498.1|(AB015631) type II membrane protein [Homo sapiens], mRNA sequence
gi|18470627|gb|BM439852.1|BM439852[18470627] - 369: BM439375
pgr1c.pk001.a9 Primary Chicken Reproductive Tract cDNA Library (pgr1c) Gallus gallus cDNA clone pgr1c.pk001.a9 5′ similar to gi|13994300 ref|NP—114131.1] transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens] gi|AAK16442.1|AF327923—1 (AF327923) transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens], mRNA sequence
gi|18470150|gb|BM439375.1|BM439375[18470150] - 370: NM—080841
Homo sapiens protein tyrosine phosphatase, receptor type, A (PTPRA), transcript
variant 3, mRNA
gi|18450370|ref|NM—080841.1|[18450370] - 371: NM—080840
Homo sapiens protein tyrosine phosphatase, receptor type, A (PTPRA), transcript
variant 2, mRNA
gi|18450368|ref|NM—080840.1|[18450368] - 372: NM—002836
Homo sapiens protein tyrosine phosphatase, receptor type, A (PTPRA), transcript
variant 1, mRNA
gi|18450367|ref|NM—002836.2|[18450367] - 373: NM—018490
Homo sapiens G protein-coupled receptor 48 (GPR48), mRNA
gi|8923700|ref|NM—018490.1|[8923700] - 374: NM—006065
Homo sapiens signal-regulatory protein beta 1 (SIRPB1), mRNA
gi|5174678|ref|NM—006065.1|[5174678] - 375: NM—004648
Homo sapiens protein tyrosine phosphatase, non-receptor type substrate 1 (PTPNS1), mRNA
gi|4758977|ref|NM—004648.1|[4758977] - 376: NM—003667
Homo sapiens G protein-coupled receptor 49 (GPR49), mRNA
gi|4504378|ref|NM—003667.1|[4504378] - 377: BM427439
pgf2n.pk006.m15 Normalized Chicken Abdominal Fat Library (pgf2n) Gallus gallus
cDNA clone pgf2n.pk006.m15 5′ similar to gi|13994300 ref|NP—114131.11 transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens] gi|AAK16442.1|AF327923—1 (AF327923) transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens], mRNA sequence
gi|18432616|gb|BM427439.1|BM427439[18432616] - 378: BM427410
pgf2n.pk006.k5 Normalized Chicken Abdominal Fat Library (pgf2n) Gallus gallus cDNA clone pgf2n.pk006.k5 5′ similar to gi|13994300 ref|NP—114131.1|transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens] gi|AAK16442.1|AF327923—1 (AF327923) transmembrane protein induced by tumor necrosis factor alpha [Homo sapiens], mRNA sequence
gi|18432562|gb|BM427410.1|BM427410[18432562] - 379: BM427358
pgf2n.pk006.i13 Normalized Chicken Abdominal Fat Library (pgf2n) Gallus gallus
cDNA clone pgf2n.pk006.i13 5′ similar to gi|7705965 ref|NP—057456.11 seven transmembrane domain orphan receptor [Homo sapiens] dbj|BAA89782.1|(AB037108)
seven transmembrane domain orphan receptor [Homo sapiens], mRNA sequence
gi|18432475|gb|BM427358.1|BM427358[18432475] - 380: NM—002122
Homo sapiens major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1),
mRNA
gi|18426974|ref|NM—002122.2|[18426974] - 381: NM—080815
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 19, mRNA
gi|18426960|ref|NM—080815.1|[18426960] - 382: NM—080814
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 18, mRNA
gi|18426958|ref|NM—080814.1|[18426958] - 383: NM—080813
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 17, mRNA
gi|18426956|ref|NM—080813.1|[18426956] - 384: NM—080812
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 16, mRNA
gi|18426954|ref|NM—080812.1|[18426954] - 385: NM—080811
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 15, mRNA
gi|18426952|ref|NM—080811.1|[18426952] - 386: NM—080810
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 14, mRNA
gi|18426950|ref|NM—080810.1|[18426950] - 387: NM—080809
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 13, mRNA
gi|18426948|ref|NM—080809.1|[18426948] - 388: NM—080808
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 12, mRNA
gi|18426946|ref|NM—080808.1|[18426946] - 389: NM—080807
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 11, mRNA
gi|18426944|ref|NM—080807.1|[18426944] - 390: NM—080806
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 10, mRNA
gi|18426942|ref|NM—080806.1|[18426942] - 391: NM—080805
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 9, mRNA
gi|18426940|ref|NM—080805.1|[18426940] - 392: NM—080804
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 8, mRNA
gi|18426938|ref|NM—080804.1|[18426938] - 393: NM—080803
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 7, mRNA
gi|18426936|ref|NM—080803.1|[18426936] - 394: NM—080802
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 6, mRNA
gi|18426934|ref|NM—080802.1|[18426934] - 395: NM—080801
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 5, mRNA
gi|18426932|ref|NM—080801.1|[18426932] - 396: NM—080800
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 4, mRNA
gi|18426930|ref|NM—080800.1|[18426930] - 397: NM—080799
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 3, mRNA
gi|18426928|ref|NM—080799.1|[18426928] - 398: NM—080798
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 2, mRNA
gi|18426926|ref|NM—080798.1|[18426926] - 399: NM—005203
Homo sapiens collagen, type XIII, alpha 1 (COL13A1), transcript variant 1, mRNA
gi|18426924|ref|NM—005203.2|[18426924] - 400: NM—080792
Homo sapiens brain-immunoglobulin-like molecule with tyrosine-based activation
motifs (BIT), mRNA
gi|18426910|ref|NM—080792.1|[8426910] - 401: NM—080816
Homo sapiens signal-regulatory protein beta 2 (SIRPB2), transcript variant 2, mRNA
gi|18426908|ref|NM—080816.1|[18426908] - 402: NM—018556
Homo sapiens signal-regulatory protein beta 2 (SIRPB2), transcript variant 1, mRNA
gi|18426907|ref|NM—018556.2|[18426907] - 406: AF367761
Homo sapiens transmembrane protein HTMP10 (HTMP10) mRNA, complete cds
gi|16356924|gb|AF367761.2|[16356924] - 409: NM—002124
Homo sapiens major histocompatibility complex, class II, DR beta 1 (HLA-DRB1),
mRNA
gi|4504410|ref|NM—002124.1|[4504410] - 411: NM—016235
Homo sapiens G protein-coupled receptor, family C, group 1, member B (GPRC5B),
mRNA
gi|7706450|ref|NM—016235.1|[7706450] - 412: NM—003105
Homo sapiens sortilin-related receptor, L(DLR class) A repeats-containing (SORL1), mRNA
gi|18379347|ref|NM—003105.3|[18379347] - 413: NM—004843
Homo sapiens class I cytokine receptor (WSX1), mRNA
gi|18379338|ref|NM—004843.2|[18379338] - 414: AF450008
Homo sapiens CFTR-associated ligand (CAL) mRNA, complete cds
gi|17865153|gb|AF450008.1|AF450008[17865153] - 415: NM—033056
Homo sapiens protocadherin 15 (PCDH15), mRNA
gi|16933554|ref|NM—033056.2|[16933554] - 416: NM—022349
Homo sapiens membrane-spanning 4-domains, subfamily A, member 6A (MS4A6A), mRNA
gi|11641258|ref|NM—022349.1|[11641258] - 417: NM—005438
Homo sapiens FOS-like antigen 1 (FOSL1), mRNA
gi|4885242|ref|NM—005438.1|[4885242] - 418: BC021208
Homo sapiens, leucine zipper-EF-hand containing transmembrane protein 1, clone
MGC:12631 IMAGE:4126510, mRNA, complete cds
gi|18204588|gb|BC021208.1|BC021208[18204588] - 419: BC021557
Homo sapiens, transmembrane protein 8 (five membrane-spanning domains), clone MGC:31822 IMAGE:4899167, mRNA, complete cds
gi|18204291|gb|BC021557.1|BC021557[18204291] - 420: BC020870
Homo sapiens, fibronectin leucine rich transmembrane protein 3, clone MGC:24073
IMAGE: A 6065852, mRNA, complete cds
gi|18088787|gb|BC020870.1|BC020870[18088787] - 421: BC020960
Homo sapiens, sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
and short cytoplasmic domain, (semaphorin) 4G, clone MGC:8849 IMAGE:3851526, mRNA, complete cds
gi|18088075|gb|BC020960.1|BC020960[18088075] - 422: AF444779
Homo sapiens myocyte inner nuclear membrane protein (MYNE1) mRNA, complete cds
gi|17227153|gb|AF444779.1|AF444779[17227153] - 423: AF329637
Homo sapiens mitofusin 1 mRNA, nuclear gene for mitochondrial protein, complete
cds
gi|12744895|gb|AF329637.1|AF329637[12744895] - 424: NM—019074
Homo sapiens delta-like 4 (Drosophila) (DLL4), mRNA
gi|9506544|ref|NM—019074.1|[9506544] - 425: NM—017789
Homo sapiens sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
and short cytoplasmic domain, (semaphorin) 4C (SEMA4C), mRNA
gi|8923345|ref|NM—017789.1|[8923345] - 426: NM—003836
Homo sapiens delta-like 1 homolog (Drosophila) (DLK1), mRNA
gi|4503338|ref|NM—003836.1|[4503338] - 427: NM—024021
Homo sapiens membrane-spanning 4-domains, subfamily A, member 4 (MS4A4A), mRNA
gi|13430865|ref|NM—024021.1|[13430865] - 432: NM—021950
Homo sapiens membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of
IgE, high affinity I, receptor for; beta polypeptide) (MS4A1), mRNA
gi|11386186|ref|NM—021950.1|[11386186] - 433: AY046529
Homo sapiens melanocortin 1 receptor mutant V122M (MC1R) gene, complete cds
gi|18138241|gb|AY046529.1|[18138241] - 434: AY046528
Homo sapiens melanocortin 1 receptor mutant 140T (MC1R) gene, complete cds
gi|18138239|gb|AY046528.1|[18138239] - 436: AY028261
Homo sapiens delta transmembrane LIGHT mRNA, complete cds, alternatively spliced
gi|14278834|gb|AY028261.1|[14278834] - 437: AF296875
Gallus gallus fas ligand receptor soluble form mRNA, partial cds
gi|993164|gb|AF296875.1|AF296875[9931641] - 439: BM315073
ig43b07.y1 HR85 islet Homo sapiens cDNA 5′ similar to SW:MTRP_HUMAN Q15012 GOLGI
4-TRANSMEMBRANE SPANNING TRANSPORTER MTP;, mRNA sequence
gi|18049418|gb|BM315073.1|BM315073[18049418] - 440: BM314493
ig51c05.y1 HR85 islet Homo sapiens cDNA 5′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
gi|18048838|gb|BM314493.1|BM314493[18048838] - 441: BM313985
ih05d09.y1 Human insulinoma Homo sapiens cDNA 5′ similar to SW:MTRP_HUMAN
Q15012 GOLGI 4-TRANSMEMBRANE SPANNING TRANSPORTER MTP;, mRNA sequence
gi|18048330|gb|BM313985.1|BM313985[18048330] - 442: AF267740
Homo sapiens transmembrane protein H4 mRNA, complete cds
gi|18032260|gb|AF267740.1|AF267740[18032260] - 443: AF350504
Homo sapiens four-span transmembrane protein 4 (4SPAN4) mRNA, complete cds
gi|18028935|gb|AF350504.1|AF350504[18028935] - 444: AF350503
Homo sapiens four-span transmembrane protein 3.2 (4SPAN3) mRNA, complete cds
gi|18028933|gb|AF350503.1|AF350503[18028933] - 445: AF350502
Homo sapiens four-span transmembrane protein 3.1 (4SPAN3) mRNA, complete cds
gi|1802893|gb|AF350502.1|AF350502[18028931] - 446: AF350501
Homo sapiens four-span transmembrane protein 2 (4SPAN2) mRNA, complete cds
gi|18028929|gb|AF350501.1|AF350501[18028929] - 447: AF350500
Homo sapiens four-span transmembrane protein 1 (4SPAN1) mRNA, complete cds
gi|18028927|gb|AF350500.1|AF350500[18028927] - 448: NM—078470
Homo sapiens COX15 homolog, cytochrome c oxidase assembly protein (yeast) (COX15), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA
gi|17921984|ref|NM—078470.1|[17921984] - 449: NM—004375
Homo sapiens COX11 homolog, cytochrome c oxidase assembly protein (yeast) (COX11), nuclear gene encoding mitochondrial protein, mRNA
gi|17921983|ref|NM—004375.2|[17921983] - 450: NM—001303
Homo sapiens COX10 homolog, cytochrome c oxidase assembly protein, heme A: farnesyltransferase (yeast) (COX10), nuclear gene encoding mitochondrial protein, mRNA
gi|17921981|ref|NM—001303.2|[17921981] - 451: NM—031999
Mus musculus transmembrane 7 superfamily member 1 (Tm7sf1), mRNA
gi|14269573|ref|NM—031999.1|[14269573] - 452: NM—020659
Homo sapiens tweety homolog 1 (Drosophila) (TTYH1), mRNA
gi|10257436|ref|NM—020659.1|[10257436] - 453: NM—052945
Homo sapiens BAFF receptor (BAFFR), mRNA
gi|17978517|ref|NM—052945.2|[17978517] - 454: NM—078481
Homo sapiens CD97 antigen (CD97), transcript variant 1, mRNA
gi|17978490|ref|NM—078481.1|[17978490] - 455: NM—001784
Homo sapiens CD97 antigen (CD97), transcript variant 2, mRNA
gi|17978488|ref|NM—001784.2|[17978488] - 456: NM—1004444
Homo sapiens EphB4 (EPHB4), mRNA
gi|17975769|ref|NM—004444.2|[17975769] - 457: NM—004443
Homo sapiens EphB3 (EPHB3), mRNA
gi|17975767|ref|NM—004443.2|[17975767] - 458: NM—004442
Homo sapiens EphB2 (EPHB2), transcript variant 1, mRNA
gi|17975766|ref|NM—004442.2|[17975766] - 459: NM—017449
Homo sapiens EphB2 (EPHB2), transcript variant 2, mRNA
gi|17975764|ref|NM—017449.1|[17975764] - 460: BM273281
if28f09.y1 Melton Normalized Human Islet 4 N4-HIS 1 Homo sapiens cDNA 5′ similar
to TR:Q9Z112 Q9Z112 SEVEN TRANSMEMBRANE DOMAIN ORPHAN RECEPTOR.;, mRNA sequence
gi|17966574|gb|BM273281.1|BM273281[17966574] - 461: BM271899
ig36e08.y1 HR85 islet Homo sapiens cDNA 5′ similar to SW:MTRP_HUMAN Q15012 GOLGI
4-TRANSMEMBRANE SPANNING TRANSPORTER MTP;, mRNA sequence
gi|17965175|gb|BM271899.1|BM271899[17965175] - 462: BM271817
ig35e06.y1 HR85 islet Homo sapiens cDNA 5′ similar to SW:MTRP_HUMAN Q15012 GOLGI
4-TRANSMEMBRANE SPANNING TRANSPORTER MTP;, mRNA sequence
gi|1796509|gb|BM271817.1|BM271817[17965091] - 463: BM271771
ig38h09.x1 HR85 islet Homo sapiens cDNA 3′ similar to TR:O08721 O08721 TRANSMEMBRANE RECEPTOR UNC5H1.;, mRNA sequence
gi|17965045|gb|BM271771.1|BM271771[17965045] - 464: BC019314
Homo sapiens, transmembrane 4 superfamily member 7, clone MGC:4337 IMAGE:2821236, mRNA, complete cds
gi|17939509|gb|BC019314.1|BC019314[17939509] - 465: BM263743
ig29h12.y1 HR85 islet Homo sapiens cDNA 5′ similar to SW:NMB_HUMAN Q14956 PUTATIVE TRANSMEMBRANE PROTEIN NMB PRECURSOR.;, mRNA sequence
gi|17926783|gb|BM263743.1|BM263743[17926783] - 466: NM—004376
Homo sapiens COX15 homolog, cytochrome c oxidase assembly protein (yeast) (COX15), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA
gi|17921986|ref|NM—004376.2|[17921986] - 467: AY062295
Homo sapiens prolactin receptor (PRLR) mRNA, partial cds; alternatively spliced
gi|17887307|gb|AY062295.1|[17887307] - 468: NM—078474
Homo sapiens BBP-like protein 2 (BLP2), transcript variant 1, mRNA
gi|17865799|ref|NM—078474.1|[17865799] - 469: NM—025141
Homo sapiens BBP-like protein 2 (BLP2), transcript variant 2, mRNA
gi|17865798|ref|NM—025141.2|[17865798] - 470: NM—078473
Homo sapiens BBP-like protein 1 (BLP1), transcript variant 1, mRNA
gi|17865796|ref|NM—078473.1|[17865796] - 471: NM—031940
Homo sapiens BBP-like protein 1 (BLP1), transcript variant 2, mRNA
gi|17865794|ref|NM—031940.2|[17865794] - 472: NM—003728
Homo sapiens unc-5 homolog B (C. elegans) (UNC5C), mRNA
gi|16933524|ref|NM—003728.2|[16933524] - 473: NM—054027
Homo sapiens ankylosis, progressive homolog (mouse) (ANKH), transcript variant
2, mRNA
gi|16905506|ref|NM—054027.1|[16905506] - 474: NM—019847
Homo sapiens ankylosis, progressive homolog (mouse) (ANKH), transcript variant
1, mRNA
gi|16905505|ref|NM—019847.3|[16905505] - 475: NM—018440
Homo sapiens phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), mRNA
gi|16753228|ref|NM—018440.2|[16753228] - 478: NM—019894
Homo sapiens transmembrane protease, serine 4 (TMPRSS4), mRNA
gi|15451939|ref|NM—019894.1|[15451939] - 479: NM—006577
Homo sapiens UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1), transcript variant 1, mRNA
gi|15451893|ref|NM—006577.3|[15451893] - 480: NM—033252
Homo sapiens UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1), transcript variant 2, mRNA
gi|15451863|ref|NM—033252.1|[15451863] - 481: NM—014302
Homo sapiens Sec61 gamma (SEC61G), mRNA
gi|14591933|ref|NM—014302.2|[14591933] - 482: NM—014459
Homo sapiens protocadherin 17 (PCDH17), mRNA
gi|14589926|ref|NM—014459.2|[14589926] - 483: NM—032961
Homo sapiens protocadherin 10 (PCDH10), transcript variant 1, mRNA
gi|14589915|ref|NM—032961.1|[14589915] - 484: NM—020815
Homo sapiens protocadherin 10 (PCDH10), transcript variant 2, mRNA
gi|14589913|ref|NM—020815.1|[14589913] - 485: NM—032966
Homo sapiens Burkitt lymphoma receptor 1, GTP binding protein (BLR1), transcript
variant 2, mRNA
gi|14589868|ref|NM—032966.1|[14589868] - 486: NM—001716
Homo sapiens Burkitt lymphoma receptor 1, GTP binding protein (BLR1), transcript
variant 1, mRNA
gi|14589867|ref|NM—001716.2|[14589867] - 487: NM—031866
Homo sapiens trizzled homolog 8 (Drosophila) (FZD8), mRNA
gi|13994189|ref|NM—031866.1|[13994189] - 488: NM—030770
Homo sapiens transmembrane protease, serine 5 (spinesin) (TMPRSS5), mRNA
gi|13540534|ref|NM—030770.1|[13540534] - 489: NM—001407
Homo sapiens cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog,
Drosophila) (CELSR3), mRNA
gi|13325065|ref|NM—001407.1|[13325065] - 490: NM—001408
Homo sapiens cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog,
Drosophila) (CELSR2), mRNA
gi|13325063|ref|NM—001408.1|[13325063] - 491: NM—005971
Homo sapiens FXYD domain-containing ion transport regulator 3 (FXYD3), transcript variant 1, mRNA
gi|11612675|ref|NM—005971.2|[11612675] - 492: NM—021910
Homo sapiens FXYD domain-containing ion transport regulator 3 (FXYD3), transcript variant 2, mRNA
gi|11612673|ref|NM—021910.1|[11612673] - 493: NM—021778
Homo sapiens a disintegrin and metalloproteinase domain 28 (ADAM28), transcript
variant 2, mRNA
gi|11496995|ref|NM—021778.1|[11496995] - 494: NM—021777
Homo sapiens a disintegrin and metalloproteinase domain 28 (ADAM28), transcript
variant 3, mRNA
gi|11496993|ref|NM—021777.1|[11496993] - 495: NM—021783
Homo sapiens ectodysplasin A2 isoform receptor (XEDAR), mRNA
gi|11140822|ref|NM—021783.1|[11140822] - 496: NM—020182
Homo sapiens transmembrane, prostate androgen induced RNA (TMEPAI), mRNA
gi|9910497|ref|NM—020182.1|[9910497] - 497: NM—003857
Homo sapiens galanin receptor 2 (GALR2), mRNA
gi|8051600|ref|NM—003857.21[8051600] - 498: NM—015727
Homo sapiens tachykinin receptor 1 (TACR1), transcript variant short, mRNA
gi|7669545|ref|NM—015727.1|[7669545] - 499: NM—001058
Homo sapiens tachykinin receptor 1 (TACR1), transcript variant long, mRNA
gi|7669544|ref|NM—001058.2|[7669544] - 501: NM—014246
Homo sapiens cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog,
Drosophila) (CELSR1), mRNA
gi|7656966|ref|NM—014246.1|[7656966] - 502: NM—014265
Homo sapiens a disintegrin and metalloproteinase domain 28 (ADAM28), transcript
variant 1, mRNA
gi|7656862|ref|NM—014265.1|[7656862] - 503: NM—007264
Homo sapiens adrenomedullin receptor (ADMR), mRNA
gi|6466448|ref|NM—007264.2|[6466448] - 504: NM—004733
Homo sapiens acetyl-Coenzyme A transporter (ACATN), mRNA
gi|6042194|ref|NM—004733.2|[6042194] - 505: NM—003801
Homo sapiens GPAA1P anchor attachment protein 1 homolog (yeast) (GPAA1), mRNA
gi|6031166|ref|NM—003801.2|[6031166] - 506: NM—007197
Homo sapiens frizzled homolog 10 (Drosophila) (FZD10), mRNA
gi|6005761|ref|NM—007197.1|[6005761] - 507: NM—001466
Homo sapiens frizzled homolog 2 (Drosophila) (FZD2), mRNA
gi|5922012|ref|NM—001466.21[5922012] - 508: NM—006579
Homo sapiens emopamil binding protein (sterol isomerase) (EBP), mRNA
gi|5729809|ref|NM—006579.1|[5729809] - 509: NM—006017
Homo sapiens prominin-like 1 (mouse) (PROML1), mRNA
gi|5174386|ref|NM—006017.1|[5174386] - 510: NM—005228
Homo sapiens epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) (EGFR), mRNA
gi|4885198|ref|NM—005228.1|[4885198] - 511: NM—004617
Homo sapiens transmembrane 4 superfamily member 4 (TM4SF4), mRNA
gi|4759239|ref|NM—004617.1|[4759239] - 512: NM—004787
Homo sapiens slit homolog 2 (Drosophila) (SLIT2), mRNA
gi|4759145|ref|NM—004787.1|[4759145] - 513: NM—004445
Homo sapiens EphB6 (EPHB6), mRNA
gi|4758291|ref|NM—004445.1|[4758291] - 514: NM—004338
Homo sapiens chromosome 18 open reading frame 1 (C18orf1), mRNA
gi|4757883|ref|NM—004338.1|[4757883] - 515: NM—002982
Homo sapiens small inducible cytokine A2 (monocyte chemotactic protein 1) (SCYA2), mRNA
gi|4506840|ref|NM—002982.1|[4506840] - 516: NM—002944
Homo sapiens v-ros UR2 sarcoma virus oncogene homolog 1 (avian) (ROS1), mRNA
gi|4506578|ref|NM—002944.1|[4506578] - 517: NM—000264
Homo sapiens patched homolog (Drosophila) (PTCH), mRNA
gi|4506246|ref|NM—000264.1|[4506246] - 518: NM—003508
Homo sapiens frizzled homolog 9 (Drosophila) (FZD9), mRNA
gi|4503834|ref|NM—003508.1|[4503834] - 519: NM—003507
Homo sapiens frizzled homolog 7 (Drosophila) (FZD7), mRNA
gi|4503832|ref|NM—003507.1|[4503832] - 520: NM—003506
Homo sapiens frizzled homolog 6 (Drosophila) (FZD6), mRNA
gi|4503830|ref|NM—003506.1|[4503830] - 521: NM—003468
Homo sapiens frizzled homolog 5 (Drosophila) (FZD5), mRNA
gi|4503828|ref|NM—003468.1|[4503828] - 522: NM—003505
Homo sapiens frizzled homolog 1 (Drosophila) (FZD1), mRNA
gi|4503824|ref|NM—003505.1|[4503824] - 523: NM—001982
Homo sapiens v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
(ERBB3), mRNA
gi|4503596|ref|NM—001982.1|[4503596] - 524: NM—003859
Homo sapiens dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit (DPM1), mRNA
gi|4503362|ref|NM—003859.1|[4503362] - 525: NM—003915
Homo sapiens copine I (CPNE1), mRNA
gi|4503012|ref|NM—003915.1|[4503012] - 527: NM—052959
Homo sapiens pannexin 3 (PANX3), mRNA
gi|16418452|ref|NM—052959.1|[16418452] - 528: NM—052859
Homo sapiens putative endoplasmic reticulum multispan transmembrane protein (RFT1), mRNA
gi|16418360|ref|NM—052859.1|[16418360] - 531: NM—032108
Homo sapiens sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B (SEMA6B), mRNA
gi|14165267|ref|NM—032108.1|[14165267] - 532: NM—031925
Homo sapiens transmembrane protein induced by tumor necrosis factor alpha (TMPIT), mRNA
gi|13994299|ref|NM—031925.1|[13994299] - 533: NM—030960
Homo sapiens sperm acrosome associated 1 (SPACA1), mRNA
gi|13569933|ref|NM—030960.1|[13569933] - 534: NM—030755
Homo sapiens thioredoxin domain-containing (TXNDC), mRNA
gi|13559515|ref|NM—030755.1|[13559515] - 535: NM—024734
Homo sapiens calponin like transmembrane domain protein (calmin), mRNA
gi|13376053|ref|NM—024734.1|[13376053] - 536: NM—023003
Homo sapiens transmembrane 6 superfamily member 1 (TM6SF1), mRNA
gi|13194198|ref|NM—023003.1|[13194198] - 537: NM—021034
Homo sapiens interferon induced transmembrane protein 3 (1-8U) (IFITM3), mRNA
gi|11995467|ref|NM—021034.1|[11995467] - 538: NM—006435
Homo sapiens interferon induced transmembrane protein 2 (1-8D) (IFITM2), mRNA
gi|10835237|ref|NM—006435.1|[0835237] - 539: NM—016326
Homo sapiens chemokine-like factor 1 (CKLF1), mRNA
gi|10092611|ref|NM—016326.2|[10092611] - 540: NM—016951
Homo sapiens chemokine-like factor 1 (CKLF1), mRNA
gi|10092593|ref|NM—016951.2|[10092593] - 541: NM—000888
Homo sapiens integrin, beta 6 (ITGB6), mRNA
gi|9966771|ref|NM—000888.3|[9966771] - 542: NM—020241
Homo sapiens sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B (SEMA6B), mRNA
gi|9910379|ref|NM—020241.1|[9910379] - 543: NM—018407
Homo sapiens putative integral membrane transporter (LC27), mRNA
gi|8923827|ref|NM—018407.1|[8923827] - 544: NM—017514
Homo sapiens SEX gene (HSSEXGENE), mRNA
gi|8923792|ref|NM—017514.1|[8923792] - 545: NM—017893
Homo sapiens sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
and short cytoplasmic domain, (semaphorin) 4G (SEMA4G), mRNA
gi|8923550|ref|NM—017893.1|[8923550] - 546: NM—017599
Homo sapiens transmembrane protein vezatin (VEZATIN), mRNA
gi|8922162|ref|NM—017599.1|[8922162] - 547: NM—014254
Homo sapiens transmembrane protein 5 (TMEM5), mRNA
gi|7657177|ref|NM—014254.1|[7657177] - 548: NM—012339
Homo sapiens transmembrane 4 superfamily member (tetraspan NET-7) (NET-7), mRNA
gi|6912529|ref|NM—012339.1|[6912529] - 549: NM—012338
Homo sapiens transmembrane 4 superfamily member (tetraspan NET-2) (NET-2), mRNA
gi|6912527|ref|NM—012338.1|[6912527] - 550: NM—002673
Homo sapiens plexin B1 (PLXNB1), mRNA
gi|6631105|ref|NM—002673.1|[6631105] - 551: NM—006825
Homo sapiens cytoskeleton-associated protein 4 (CKAP4), mRNA
gi|5803112|ref|NM—006825.1|[5803112] - 552: NM—004785
Homo sapiens solute carrier family 9 (sodium/hydrogen exchanger), isoform 3 regulatory factor 2 (SLC9A3R2), mRNA
gi|4759141|ref|NM—004785.1|[4759141] - 553: NM—004263
Homo sapiens sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
and short cytoplasmic domain, (semaphorin) 4F (SEMA4F), mRNA
gi|4759093|ref|NM—004263.1|[4759093] - 554: NM—004800
Homo sapiens transmembrane 9 superfamily member 2 (TM9SF2), mRNA
gi|4758873|ref|NM—004800.1|[4758873] - 555: NM—000950
Homo sapiens proline-rich Gla (G-carboxyglutamic acid) polypeptide 1 (PRRG1), mRNA
gi|4506134|ref|NM—000950.1|[4506134] - 556: NM—003625
Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF),
interacting protein (liprin), alpha 2 (PPFIA2), mRNA
gi|4505984|ref|NM—003625.1|[4505984] - 558: NM—032518
Homo sapiens collagen-like Alzheimer amyloid plaque component precursor (LOC84570), mRNA
gi|14210525|ref|NM—032518.1|[14210525] - 559: NM—023945
Homo sapiens membrane-spanning 4-domains, subfamily A, member 5 (MS4A5), mRNA
gi|12965204|ref|NM—023945.1|[12965204] - 560: NM—016158
Homo sapiens erythrocyte transmembrane protein (LOC51145), % T
gi|7705856|ref|NM—016158.1|[7705856] - 561: AK056649
Homo sapiens cDNA FLJ32087 fis, clone OCBBF2000467, highly similar to Fibronectin leucine rich transmembrane protein 2
gi|16552109|dbj|AK056649.1|AK056649[16552109] - 562: AK056595
Homo sapiens cDNA FLJ32033 fis, clone NTONG2000265, weakly similar to Probable
transmembrane protein of fission yeast
gi|16552042|dbj|AK056595.1|AK056595[16552042] - 563: AK055648
Homo sapiens cDNA FLJ31086 fis, clone IMR321000044, highly similar to Human transmembrane receptor precursor (PTK7) mRNA
gi|16550428|dbj|AK055648.1|AK055648[16550428] - 564: AK055208
Homo sapiens cDNA FLJ30646 fis, clone CTONG2004716, weakly similar to Rattus norvegicus mRNA for seven transmembrane receptor
gi|16549884|dbj|AK055208.1|AK055208[16549884] - 565: AK054712
Homo sapiens cDNA FLJ30150 fis, clone BRACE2000300, highly similar to TRANSMEMBRANE PROTEIN PFT27
gi|16549313|dbj|AK054712.1|AK054712[16549313] - 566: AK054646
Homo sapiens cDNA FLJ30084 fis, clone BGGI12001682, highly similar to Homo sapiens transmembrane protein TENB2 (TENB2) mRNA
gi|16549231|dbj|AK054646.1|AK054646[16549231] - 567: NM—019035
Homo sapiens protocadherin 18 (PCDH18), mRNA
gi|14589928|ref|NM—019035.1|[14589928] - 568: NM—030943
Homo sapiens amnionless protein (AMN), mRNA
gi|13569914|ref|NM—030943.1|[13569914] - 570: BC018361
Homo sapiens, sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)
and short cytoplasmic domain, (semaphorin) 4F, clone MGC:21849 IMAGE:4215248, mRNA, complete cds
gi|17390842|gb|BC018361.1|BC018361[17390842] - 571: AF214006
Homo sapiens TDC1 (TDC1) mRNA, complete cds
gi|17221828|gb|AF214006.1|AF214006[17221828]
- 572: NM—021201
Homo sapiens membrane-spanning 4-domains, subfamily A, member 7 (MS4A7), mRNA
gi|11139298|ref|NM—021201.1|[11139298] - 573: AF289028
Homo sapiens transmembrane protein B7-H2 ICOS ligand mRNA, complete cds
gi|9858866|gb|AF289028.1|AF289028[9858866] - 574: NM—016941
Homo sapiens delta-like 3 (Drosophila) (DLL3), mRNA
gi|8393263|ref|NM—016941.1|[8393263] - 575: NM—014450
Homo sapiens SHP2 interacting transmembrane adaptor (SIT), mRNA
gi|7657576|ref|NM—014450.1|[7657576] - 576: NM—021259
Homo sapiens transmembrane protein 8 (five membrane-spanning domains) (TMEM8),
mRNA
gi|10864068|ref|NM—021259.1|[10864068] - 577: NM—002959
Homo sapiens sortilin 1 (SORT1), mRNA
gi|17149833|ref|NM—002959.3|[17149833] - 578: NM—000675
Homo sapiens adenosine A2a receptor (ADORA2A), mRNA
gi|17136146|ref|NM—000675.3|[17136146] - 579: BM128846
if17e06.x1 Melton Normalized Human Islet 4 N4-HIS 1 Homo sapiens cDNA 3′ similar
to SW:PF27_MOUSE P52875 TRANSMEMBRANE PROTEIN PFT27. [1];, mRNA sequence
gi|17123398|gb|BM128846.1|BM128846[17123398] - 580: BM127423
ie95b07.y1 Melton Normalized Human Islet 4 N4-HIS 1 Homo sapiens cDNA 5′ similar
to TR:O60639 O60639 PUTATIVE TRANSMEMBRANE GTPASE;, mRNA sequence
gi|17121975|gb|BM127423.1|BM127423[17121975] - 581: AY016020
Gallus gallus alpha globin gene cluster, complete sequence
gi|17104478|gb|AY016020.1|[17104478] - 582: M86631
Homo sapiens (clone ST-18-5(9/16)) cystic fibrosis transmembrane conductance regulator (CFTR) gene, 3′ end intron 17B; complete exon 18; complete intron
gi|180296|gb|M86631.1|HUMCFTR[180296] - 584: BC017476
Homo sapiens, sema domain, immunoglobulin domain (Ig), transmembrane domain TM)
and short cytoplasmic domain, (semaphorin) 4C, clone MGC:15189 IMAGE:3528227, mRNA, complete cds
gi|17028345|gb|BC017476.1|BC017476[17028345] - 585: NM—000420
Homo sapiens Kell blood group (KEL), mRNA
gi|17025233|ref|NM—000420.2|[17025233] - 586: BM090614
ig16b09.y1 Human Fetal Pancreas 1A Homo sapiens cDNA 5′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
gi|17019580|gb|BM090614.1|BM090614[17019580] - 587: AF217288
Homo sapiens protocadherin-S mRNA, complete cds, alternatively spliced
gi|15054520|gb|AF217288.1|AF217288[15054520] - 588: AF206516
Homo sapiens protocadherin-S mRNA, complete cds
gi|15054518 gb|AF206516.1|AF206516[15054518] - 589: NM—021153
Homo sapiens cadherin 19, type 2 (CDH19), mRNA
gi|16306535|ref|NM—021153.2|[16306535] - 590: AY048509
Homo sapiens pannexin 1 (PANX1) gene, partial cds
gi|15808666|gb|AY048509.1|[15808666] - 591: NG—000012
Homo sapiens genomic protocadherin gamma cluster (PCDHG@) on chromosome 5
gi|14861871|ref|NG—000012.1|[14861871] - 592: AE006466
Homo sapiens 16p13.3 sequence section 5 of 8
gi|14336735|gb|AE006466.1|AE006466[14336735] - 593: AF376725
Homo sapiens lung seven transmembrane receptor 1 (LUSTR1) mRNA, complete cds
gi|14248996|gb|AF376725.1|AF376725[14248996] - 594: NM—004776
Homo sapiens UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5
(B4GALT5), mRNA
gi|13929470|ref|NM—004776.2|[13929470] - 595: NM—030587
Homo sapiens UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 2
(B4GALT2), transcript variant 1, mRNA
gi|13929464|ref|NM—030587.1|[13929464] - 596: NM—003780
Homo sapiens UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 2
(B4GALT2), transcript variant 2, mRNA
gi|13929463|ref|NM—003780.2|[13929463] - 597: NM—002590
Homo sapiens protocadherin 8 (PCDH8), transcript variant 1, mRNA
gi|6631101|ref|NM—002590.2|[6631101] - 598: L42572
Homo sapiens transmembrane protein (p87/89) mRNA, complete cds
gi|1160962|gb|L42572.1|HUMP8789R[1160962] - 599: AF106202
Homo sapiens endothelial cell protein C receptor precursor (EPCR) gene, promoter
region and complete cds
gi|16950557|gb|AF106202.2|AF106202[16950557] - 600: NM—033207
Homo sapiens transmembrane protein HTMP10 (HTMP10), mRNA
gi|16945967|ref|NM—033207.2|[16945967] - 601: AF153440
Mus musculus Nma (Nma) mRNA, complete cds
gi|14328906|gb|AF153440.1|AF153440[14328906] - 604: NM—005086
Homo sapiens sarcospan (Kras oncogene-associated gene) (SSPN), mRNA
gi|16933560|ref|NM—005086.3|[16933560] - 605: NM—018153
Homo sapiens tumor endothelial marker 8 (TEM8), transcript variant 3, mRNA
gi|16933552|ref|NM—018153.2|[16933552] - 606: NM—053034
Homo sapiens tumor endothelial marker 8 (TEM8), transcript variant 2, mRNA
gi|16933550|ref|NM—053034.1|[16933550] - 607: NM—032208
Homo sapiens tumor endothelial marker 8 (TEM8), transcript variant 1, mRNA
gi|14149903|ref|NM—032208.1|[14149903] - 608: AV225853
AV225853 RIKEN full-length enriched, 18 days pregnant, placenta and extra embryonic tissue Mus musculus cDNA clone 3830432D01 3′ similar to X69910
H. sapiens p63 mRNA for transmembrane protein, mRNA sequence
gi|6177168|dbj|AV225853.1|AV225853[6177168] - 609: AV222771
AV222771 RIKEN full-length enriched, 18 days pregnant, placenta and extra embryonic tissue Mus musculus cDNA clone 3830404C12 3′ similar to X69910
H. sapiens p63 mRNA for transmembrane protein, mRNA sequence
gi|6171948|dbj|AV222771.1|AV222771[6171948] - 611: BC017058
Homo sapiens, Similar to seven transmembrane domain orphan receptor, clone MGC:9442 IMAGE:3904719, mRNA, complete cds
gi|16877618|gb|BC017058.1|BC017058[16877618] - 612: BM055437
ie94h04.y1 Melton Normalized Human Islet 4 N4-HIS 1 Homo sapiens cDNA 5′ similar
to SW:CFTR_HUMAN P13569 CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;, mRNA sequence
gi|16813328|gb|BM055437.1|BM055437[16813328] - 614: AF328788
Homo sapiens amnionless mRNA, complete cds
gi|13507258|gb|AF328788.1|AF328788[13507258] - 615: NM—052836
Homo sapiens cadherin related 23 (CDH23), transcript variant 2, mRNA
gi|16507963|ref|NM—052836.1|[16507963] - 616: NM—022124
Homo sapiens cadherin related 23 (CDH23), transcript variant 1, mRNA
gi|16507961|ref|NM—022124.2|[16507961] - 617: NM—004063
Homo sapiens cadherin 17, LI cadherin (liver-intestine) (CDH17), mRNA
gi|16507959|ref|NM—004063.2|[16507959] - 618: NM—004062
Homo sapiens cadherin 16, KSP-cadherin (CDH16), mRNA
gi|16507958|ref|NM—004062.2|[16507958] - 619: NM—004933
Homo sapiens cadherin 15, M-cadherin (myotubule) (CDH15), mRNA
gi|16507957|ref|NM—004933.2|[16507957] - 620: NM—001257
Homo sapiens cadherin 13, H-cadherin (heart) (CDH13), mRNA
gi|16507956|ref|NM—001257.2|[16507956] - 621: BC009704
Homo sapiens, transmembrane 4 superfamily member 9, clone MGC:9300 IMAGE:3895933, mRNA, complete cds
gi|16307230|gb|BC009704.1|BC009704[16307230] - 622: BC001496
Homo sapiens, transmembrane trafficking protein, clone MGC:1979
IMAGE:2959718, mRNA, complete cds
gi|16306639|gb|BC001496.1|BC001496[16306639] - 623: BC013577
Homo sapiens, claudin 11 (oligodendrocyte transmembrane protein), clone MGC:9232
IMAGE:3895040, mRNA, complete cds
gi|15488893|gb|BC013577.1|BC013577[15488893] - 624: NM—053002
Homo sapiens no opposite paired repeat protein (NOPAR), mRNA
gi|16506292|ref|NM—053002.1|[16506292] - 625: NM—052995
Homo sapiens Usher syndrome 3A (USH3A), mRNA
gi|16506280|ref|NM—052995.1|[16506280] - 639: NM—014879
Homo sapiens G protein-coupled receptor 105 (GPR105), mRNA
gi|7661847|ref|NM—014879.1|[7661847] - 640: NM—052891
Homo sapiens peptidoglycan recognition protein-1-alpha precursor (PGLYRPIalpha),
mRNA
gi|16418404|ref|NM—052891.1|[16418404] - 642: B1964203
ie66b09.y1 Melton Normalized Human Islet 4 N4-HIS 1 Homo sapiens cDNA 5′ similar
to TR:Q99989 Q99989 TRANSMEMBRANE CHLORIDE CONDUCTOR PROTEIN;, mRNA sequence
gi|16338608|gb|BI964203.1|BI964203[16338608] - 643: B1963913
ie66e08.x1 Melton Normalized Human Islet 4 N4-HIS 1 Homo sapiens cDNA 3′ similar
to SW:PF27_MOUSE P52875 TRANSMEMBRANE PROTEIN PFT27. [1];, mRNA sequence
gi|16338318|gb|BI963913.1|BI963913[16338318] - 644: AF293372
Pan troglodytes sialic acid-binding lectin Siglec-L1 mRNA, complete cds
gi|15824309|gb|AF293372.1|AF293372[15824309] - 645: BC009696
Homo sapiens, interferon induced transmembrane protein 2 (1-8D), clone MGC:9196
IMAGE:3876542, mRNA, complete cds
gi|16307214|gb|BC009696.1|BC009696[16307214] - 646: NM—031891
Homo sapiens cadherin 20, type 2 (CDH20), mRNA
gi|16306536|ref|NM—031891.2|[16306536] - 647: NM—004361
Homo sapiens cadherin 7, type 2 (CDH7), transcript variant b, mRNA
gi|16306488|ref|NM—004361.2|[16306488] - 648: NM—033646
Homo sapiens cadherin 7, type 2 (CDH7), transcript variant a, mRNA
gi|16306486|ref|NM—033646.1|[16306486] - 649: AF319952
Homo sapiens tweety-like protein 2 mRNA, complete cds
gi|16303747|gb|AF319952.1|AF319952[16303747] - 651: NM—005756
Homo sapiens G protein-coupled receptor 64 (GPR64), mRNA
gi|5031732|ref|NM—005756.1|[5031732] - 652: AF416903
Homo sapiens SH2 domain-containing phosphatase anchor protein 2c mRNA, complete
cds, alternatively spliced
gi|16033593|gb|AF416903.1|AF416903[16033593] - 653: AF416902
Homo sapiens SH2 domain-containing phosphatase anchor protein 2b mRNA, complete
cds, alternatively spliced
gi|16033590|gb|AF416902.1|AF416902[16033590] - 654: AF416901
Homo sapiens SH2 domain-containing phosphatase anchor protein 2a mRNA, complete
cds, alternatively spliced
gi|16033587|gb|AF416901.1|AF416901[16033587] - 655: AF264740
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*015 allele,
exon 6 and partial cds
gi|16032983|gb|AF264740.1|AF264738S3[16032983] - 656: AF264739
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*015 allele,
exons 4 and 5
gi|16032982|gb|AF264739.1|AF264738S2[16032982] - 657: AF264738
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*015 allele,
exons 2 and 3
gi|16032981|gb|AF264738.1|AF264738S1[16032981] - 658: AH011143
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*015 allele,
partial cds
gi|16032980|gb|AH011143.1|SEG_AF264738S[16032980] - 659: NM—033467
Homo sapiens membrane metallo-endopeptidase-like 2 (MMEL2), mRNA
gi|15991812|ref|NM—033467.1|[15991812] - 660: AF378755
Homo sapiens tumor endothelial marker 5 precursor (TEM5) mRNA, complete cds
gi|15987490|gb|AF378755.1|AF378755[15987490] - 661: NM—016227
Homo sapiens chromosome 1 open reading frame 9 (C1orf9), mRNA
gi|7705321|ref|NM—016227.1|[7705321] - 662: NM—014283
Homo sapiens chromosome 1 open reading frame 9 (C1orf9), mRNA
gi|7656939|ref|NM—014283.1|[7656939] - 663: NM—018475
Homo sapiens TPA regulated locus (TPARL), mRNA
gi|8923860|ref|NM—018475.1|[8923860] - 664: D83783
Human mRNA for KIAA0192 gene, partial cds
gi|1663693|dbj|D83783.1D83783[1663693] - 665: D79997
Human mRNA for KIAA0175 gene, complete cds
gi|1136409|dbj|D79997.1|D79997[1136409] - 666: D13626
Human mRNA for KIAA0001 gene, complete cds
gi|285994|dbj|D13626.1|HUMRSC338[285994] - 679: B1793175
ie48h08.y1 Melton Normalized Human Islet 4 N4-HIS 1 Homo sapiens cDNA 5′ similar
to SW:NMB_HUMAN Q14956 PUTATIVE TRANSMEMBRANE PROTEIN NMB PRECURSOR.;, mRNA sequence
gi|15820900|gb|BI793175.1|BI793175[15820900] - 680: U40271
Homo sapiens transmembrane receptor precursor (PTK7) mRNA, complete cds
gi|15808058|gb|U40271.2|HSU40271[15808058] - 681: BC014554
Homo sapiens, calponin like transmembrane domain protein, clone IMAGE:3837453,
mRNA
gi|15778950|gb|BC014554.1|BC014554[15778950] - 682: NM—018916
Homo sapiens protocadherin gamma subfamily A, 3 (PCDHGA3), transcript variant 1,
mRNA
gi|14589879|ref|NM—018916.3|[14589879] - 683: NM—032407
Homo sapiens protocadherin gamma subfamily C, 5 (PCDHGC5), transcript variant 2,
mRNA
gi|14277684|ref|NM—032407.1|[14277684] - 684: NM—018929
Homo sapiens protocadherin gamma subfamily C, 5 (PCDHGC5), transcript variant 1,
mRNA
gi|14277683|ref|NM—018929.2|[14277683] - 685: NM—032406
Homo sapiens protocadherin gamma subfamily C, 4 (PCDHGC4), transcript variant 2,
mRNA
gi|14277681|ref|NM—032406.1|[14277681] - 686: NM—018928
Homo sapiens protocadherin gamma subfamily C, 4 (PCDHGC4), transcript variant 1,
mRNA
gi|14277680|ref|NM—018928.2|[14277680] - 687: NM—032101
Homo sapiens protocadherin gamma subfamily B, 7 (PCDHGB7), transcript variant 2,
mRNA
gi|14270507|ref|NM—032101.1|[14270507] - 688: NM—018927
Homo sapiens protocadherin gamma subfamily B, 7 (PCDHGB7), transcript variant 1,
gi|14270506|ref|NM—018927.2|[14270506] - 689: NM—032099
Homo sapiens protocadherin gamma subfamily B, 5 (PCDHGB5), transcript variant 2,
mRNA
gi|14270504|ref|NM—032099.1|[14270504] - 690: NM—018925
Homo sapiens protocadherin gamma subfamily B, 5 (PCDHGB5), transcript variant 1,
mRNA
gi|14270503|ref|NM—018925.2|[14270503] - 691: NM—032100
Homo sapiens protocadherin gamma subfamily B, 6 (PCDHGB6), transcript variant 2,
mRNA
gi|14270501|ref|NM—032100.2|[14270501] - 692: NM—018926
Homo sapiens protocadherin gamma subfamily B, 6 (PCDHGB6), transcript variant 1,
mRNA
gi|14270500|ref|NM—018926.2|[14270500] - 693: NM—032097
Homo sapiens protocadherin gamma subfamily B, 3 (PCDHGB3), transcript variant 2,
mRNA
gi|14270495|ref|NM—032097.1|[14270495] - 694: NM—018924
Homo sapiens protocadherin gamma subfamily B, 3 (PCDHGB3), transcript variant 1,
mRNA
gi|14270494|ref|NM—018924.2|[14270494] - 695: NM—032096
Homo sapiens protocadherin gamma subfamily B, 2 (PCDHGB2), transcript variant 2,
mRNA
gi|14270492|ref|NM—032096.1|[14270492] - 696: NM—018923
Homo sapiens protocadherin gamma subfamily B, 2 (PCDHGB2), transcript variant 1,
mRNA
gi|14270491|ref|NM—018923.2|[14270491] - 697: NM—032095
Homo sapiens protocadherin gamma subfamily B, 1 (PCDHGB1), transcript variant 2,
mRNA
gi|14270489|ref|NM—032095.1|[14270489] - 698: NM—018922
Homo sapiens protocadherin gamma subfamily B, 1 (PCDHGB1), transcript variant 1,
mRNA
gi|14270488|ref|NM—018922.2|[14270488] - 699: NM—032089
Homo sapiens protocadherin gamma subfamily A, 9 (PCDHGA9), transcript variant 2,
mRNA
gi|14270486|ref|NM—032089.1|[14270486] - 700: NM—018921
Homo sapiens protocadherin gamma subfamily A, 9 (PCDHGA9), transcript variant 1,
mRNA
gi|14270485|ref|NM—018921.2|[14270485] - 701: NM—032088
Homo sapiens protocadherin gamma subfamily A, 8 (PCDHGA8), transcript variant 1,
mRNA
gi|14270483|ref|NM—032088.1|[14270483] - 702: NM—014004
Homo sapiens protocadherin gamma subfamily A, 8 (PCDHGA8), transcript variant 2,
mRNA
gi|14270482|ref|NM—014004.2|[14270482] - 703: NM—032087
Homo sapiens protocadherin gamma subfamily A, 7 (PCDHGA7), transcript variant 2,
mRNA
gi|14196476|ref|NM—032087.1|[14196476] - 704: NM—018920
Homo sapiens protocadherin gamma subfamily A, 7 (PCDHGA7), transcript variant 1,
mRNA
gi|14196475|ref|NM—018920.2|[14196475] - 705: NM—032086
Homo sapiens protocadherin gamma subfamily A, 6 (PCDHGA6), transcript variant 2,
mRNA
gi|14196473|ref|NM—032086.1|[14196473] - 706: NM—018919
Homo sapiens protocadherin gamma subfamily A, 6 (PCDHGA6), transcript variant 1,
mRNA
gi|14196472|ref|NM—018919.2|[14196472] - 707: NM—032054
Homo sapiens protocadherin gamma subfamily A, 5 (PCDHGA5), transcript variant 2,
mRNA
gi|14196470|ref|NM—032054.1|[14196470] - 708: NM—018918
Homo sapiens protocadherin gamma subfamily A, 5 (PCDHGA5), transcript variant 1,
mRNA
gi|14196469|ref|NM—018918.2|[14196469] - 709: NM—032053
Homo sapiens protocadherin gamma subfamily A, 4 (PCDHGA4), transcript variant 2,
mRNA
gi|14196467|ref|NM—032053.1|[14196467] - 710: NM—018917
Homo sapiens protocadherin gamma subfamily A, 4 (PCDHGA4), transcript variant 1,
mRNA
gi|14196466|ref|NM—018917.2|[14196466] - 711: NM—032011
Homo sapiens protocadherin gamma subfamily A, 3 (PCDHGA3), transcript variant 2,
mRNA
gi|14196464|ref|NM—032011.1|[14196464] - 712: NM—032009
Homo sapiens protocadherin gamma subfamily A, 2 (PCDHGA2), transcript variant 2,
mRNA
gi|14196461|ref|NM—032009.1|[14196461] - 713: NM—018915
Homo sapiens protocadherin gamma subfamily A, 2 (PCDHGA2), transcript variant 1,
mRNA
gi|14196460|ref|NM—018915.2|[14196460] - 714: NM—031993
Homo sapiens protocadherin gamma subfamily A, 1 (PCDHGA1), transcript variant 2,
mRNA
gi|14196458|ref|NM—031993.1|[14196458] - 715: NM—032092
Homo sapiens protocadherin gamma subfamily A, 11 (PCDHGA11), transcript variant
3, mRNA
gi|14196454|ref|NM—032092.1|[14196454] - 716: NM—018912
Homo sapiens protocadherin gamma subfamily A, 1 (PCDHGA1), transcript variant mRNA
gi|14196453|ref|NM—018912.2|[14196453] - 717: NM—032091
Homo sapiens protocadherin gamma subfamily A, 11 (PCDHGA11), transcript variant
2, mRNA
gi|14196450|ref|NM—032091.1|[14196450] - 718: NM—018914
Homo sapiens protocadherin gamma subfamily A, 11 (PCDHGA11), transcript variant
1, mRNA
gi|14196449|ref|NM—018914.2|[14196449] - 719: NM—032090
Homo sapiens protocadherin gamma subfamily A, 10 (PCDHGA10), transcript variant
2, mRNA
gi|14196447|ref|NM—032090.1|[14196447] - 720: NM—018913
Homo sapiens protocadherin gamma subfamily A, 10 (PCDHGA10), transcript variant
1, mRNA
gi|14196446|ref|NM—018913.2|[14196446] - 721: NM—031411
Homo sapiens protocadherin alpha 1 (PCDHA1), transcript variant 3, mRNA
gi|14165401|ref|NM—031411.1|[14165401] - 722: NM—031849
Homo sapiens protocadherin alpha 6 (PCDHA6), transcript variant 3, mRNA
gi|14165393|ref|NM—031849.1|[14165393] - 723: NM—031860
Homo sapiens protocadherin alpha 10 (PCDHA10), transcript variant 3, mRNA
gi|14165382|ref|NM—031860.1|[14165382] - 724: NM—031442
Homo sapiens brain cell membrane protein 1 (BCMP1), mRNA
gi|13899272|ref|NM—031442.1|[13899272] - 725: NM—007000
Homo sapiens uroplakin 1A (UPK1A), mRNA
gi|5902147|ref|NM—007000.1|[5902147] - 726: NM—003332
Homo sapiens TYRO protein tyrosine kinase binding protein (TYROBP), mRNA
gi|4507754|ref|NM—003332.1|[4507754] - 727: AF264747
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*00901 allele,
exon 6 and partial cds
gi|14279228|gb|AF264747.1|AF264744S3[14279228] - 728: AF264746
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*00901 allele,
exons 4 and 5
gi|14279227|gb|AF264746.1|AF264744S2[14279227] - 729: AF264744
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*00901 allele,
exons 2 and 3
gi|14279226|gb|AF264744.1|AF264744S1[14279226] - 730: AH010821
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*00901 allele,
partial cds
gi|14279225|gb|AH010821.1|SEG_AF264744S[14279225] - 731: AF264743
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*048 allele,
exon 6 and partial cds
gi|14279223|gb|AF264743.1|AF264741S3[14279223] - 732: AF264742
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*048 allele,
exons 4 and 5
gi|14279222|gb|AF264742.1|AF264741S2[14279222] - 733: AF264741
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*048 allele,
exons 2 and 3
gi|14279221|gb|AF264741.1|AF264741S1[14279221] - 734: AH010820
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*048 allele,
partial cds
gi|14279220|gb|AH010820.1|SEG_AF264741S[14279220] - 735: AF264737
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*017 allele,
exon 6 and partial cds
gi|14279218|gb|AF264737.1|AF264735S3[14279218] - 736: AF264736
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*017 allele,
exons 4 and 5
gi|14279217|gb|AF264736.1|AF264735S2[14279217] - 737: AF264735
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*017 allele,
exons 2 and 3
gi|14279216|gb|AF264735.1|AF264735S1[14279216] - 738: AH010819
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*017 allele,
partial cds
gi|14279215|gb|AH010819.1|SEG_AF264735S[14279215] - 739: AF336080
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*019 allele,
exon 6 and partial cds
gi|13469855|gb|AF336080.1|AF336079S2[13469855] - 740: AF336079
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*019 allele,
exons 2 through 5
gi|13469854|gb|AF336079.1|AF336079S1[13469854] - 741: AH010587
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*019 allele,
partial cds
gi|13469853|gb|AH010587.1|SEG_AF336079S[13469853] - 742: AF336086
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*001 allele,
exon 6 and partial cds
gi|13445651|gb|AF336086.1|AF336085S2[13445651] - 743: AF336085
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*001 allele,
exons 2 through 5
gi|13445650 gb|AF336085.1|AF336085S1[13445650] - 744: AH010572
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*001 allele,
partial cds
gi|13445649|gb|AH010572.1|SEG_AF336085S[13445649] - 745: AF336084
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*002 allele,
exon 6 and partial cds
gi|13445647|gb|AF336084.1|AF336083S2[13445647] - 746: AF336083
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*002 allele,
exons 2 through 5
gi|13445646|gb|AF336083.1|AF336083S1[13445646] - 747: AH010571
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*002 allele,
partial cds
gi|13445645|gb|AH010571.1|SEG_AF336083S[13445645] - 748: AF336070
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*009 allele,
exon 6 and partial cds
gi|13430213|gb|AF336070.1|AF336069S2[13430213] - 749: AF336069
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*009 allele,
exons 2 through 5
gi|3430212|gb|AF336069.1|AF336069S1[13430212] - 750: AH010569
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*009 allele,
partial cds
gi|13430211|gb|AH010569.1|SEG_AF336069S[13430211] - 751: AF336068
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*008 allele,
exon 6
gi|13430209|gb|AF336068.1|AF336067S2[13430209] - 752: AF336067
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*008 allele,
exons 2 through 5 and partial cds
gi|13430208|gb|AF336067.1|AF336067S1[13430208] - 753: AH010568
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*008 allele,
partial cds
gi|13430207|gb|AH010568.1|SEG_AF336067S[13430207] - 754: AF336082
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*012 allele,
exon 6 and partial cds
gi|13378046|gb|AF336082.1|AF336081S2[13378046] - 755: AF336081
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*012 allele,
exons 2 through 5
gi|13378045|gb|AF336081.1|AF336081S1[13378045] - 756: AH010562
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*012 allele,
partial cds
gi|13378044|gb|AH010562.1|SEG_AF336081S[13378044] - 757: AF336078
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*018 allele,
exon 6 and partial cds
gi|13378042|gb|AF336078.1|AF336077S2[13378042] - 758: AF336077
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*018 allele,
exons 2 through 5
gi|13378041|gb|AF336077.1|AF336077S1[13378041] - 759: AH010561
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*018 allele,
partial cds
gi|13378040|gb|AH010561.1|SEG_AF336077S[13378040] - 760: AF336076
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*016 allele,
exon 6 and partial cds
gi|13378038|gb|AF336076.1|AF336075S2[13378038] - 761: AF336075
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*016 allele,
exons 2 through 5
gi|13378037|gb|AF336075.1|AF336075S1[13378037] - 762: AH010560
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*016 allele,
partial cds
gi|13378036|gb|AH010560.1|SEG_AF336075S[13378036] - 763: AF336074
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*011 allele,
exon 6 and partial cds
gi|13346205|gb|AF336074.1|AF336073S2[13346205] - 764: AF336073
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*011 allele,
exons 2 through 5
gi|13346204|gb|AF336073.1|AF336073S1[13346204] - 765: AH010546
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*011 allele,
partial cds
gi|13346203|gb|AH010546.1|SEG_AF336073S[13346203] - 766: AF336064
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*002 allele,
exon 6 and partial cds
gi|13346201|gb|AF336064.1|AF336063S2[13346201] - 767: AF336063
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*002 allele,
exons 2 through 5
gi|13346200|gb|AF336063.1|AF336063S1[13346200] - 768: AH010545
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*002 allele,
partial cds
gi|13346199|gb|AH010545.1|SEG_AF336063S[13346199] - 769: AF336072
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*010 allele,
exon 6 and partial cds
gi|13310419|gb|AF336072.1|AF336071S2[13310419] - 770: AF336071
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*010 allele,
exons 2 through 5
gi|13310418|gb|AF336071.1|AF336071S1[13310418] - 771: AH010532
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*010 allele,
partial cds
gi|13310417|gb|AH010532.1|SEG_AF336071S[13310417] - 772: AF336066
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*006 allele,
exon 6 and partial cds
gi|13274608|gb|AF336066.1|AF336065S2[13274608] - 773: AF336065
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*006 allele,
exons 2 through 5
gi|13274607|gb|AF336065.1|AF336065S1[13274607] - 774: AH010526
Homo sapiens MHC class I chain-related protein A (MICA) gene, MICA*006 allele,
partial cds
gi|13274606|gb|AH010526.1|SEG_AF336065S[13274606] - 775: NM—022059
Homo sapiens chemokine (C-X-C motif) ligand 16 (CXCL16), mRNA
gi|11545764|ref|NM—022059.1|[11545764] - 776: NM—000024
Homo sapiens adrenergic, beta-2-, receptor, surface (ADRB2), mRNA
gi|15718673|ref|NM—000024.3|[15718673] - 777: AF257472
Homo sapiens transmembrane protein MT75 mRNA, complete cds
gi|15718477|gb|AF257472.1|AF257472[15718477] - 778: AJ301609
Homo sapiens partial mRNA for GluR6 kainate receptor (GRIK2 gene), exons 10, and 13
gi|15485589|emb|AJ301609.1|HSA301609[15485589] - 779: AJ301608
Homo sapiens partial mRNA for GluR6 kainate receptor (GRIK2 gene), exons 11, and 14
gi|15485587|emb|AJ301608.1|HSA301608[15485587] - 780: B1713761
ie03f09.y1 HR85 islet Homo sapiens cDNA 5′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
gi|15689456|gb|BI713761.1|BI713761[15689456] - 781: B1713497
ie03f09.x1 HR85 islet Homo sapiens cDNA 3′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
gi|15689192|gb|BI713497.1|BI713497[15689192] - 782: B1712829
ie09g03.y1 HR85 islet Homo sapiens cDNA 5′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
gi|15688524|gb|BI712829.1|BI712829[15688524] - 783: B1712748
ie08g08.y1 HR85 islet Homo sapiens cDNA 5′ similar to SW:TM21_RAT Q63584 TRANSMEMBRANE PROTEIN TMP21 PRECURSOR;, mRNA sequence
gi|15688524|gb|BI712829.1|BI712829[15688524] - 784: B1711750
id97b10.y1 Human insulinoma Homo sapiens cDNA 5′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
gi|15687445|gb|BI711750.1|BI711750[15687445] - 785: B1711468
id97b10.x1 Human insulinoma Homo sapiens cDNA 3′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
gi|15687163|gb|BI711468.1|BI711468[15687163] - 786: B1711211
id93c12.x1 Human insulinoma Homo sapiens cDNA 3′ similar to TR:P97544 P97544 ER
TRANSMEMBRANE PROTEIN.;, mRNA sequence
gi|15686906|gb|BI711211.1|BI711211[15686906] - 787: B1710795
id92a02.y1 Human insulinoma Homo sapiens cDNA 5′ similar to SW:NMB_HUMAN Q14956
PUTATIVE TRANSMEMBRANE PROTEIN NMB PRECURSOR.;, mRNA sequence
gi|15686490|gb|BI710795.1|BI710795[15686490] - 788: BC014500
Homo sapiens, Similar to leucine zipper-EF-hand containing transmembrane protein
1, clone MGC:23613 IMAGE:4860194, mRNA, complete cds
gi|15680274|gb|BC014500.1|BC014500[15680274] - 789: BC014443
Homo sapiens, Similar to transmembrane protein vezatin, clone IMAGE:4851150, mRNA
gi|15680188|gb|BC014443.1|BC014443[15680188] - 790: BC014339
Homo sapiens, Similar to transmembrane 4 superfamily member 1, clone MGC:23935
IMAGE:3828466, mRNA, complete cds
gi|15680043|gb|BC014339.1|BC014339[15680043] - 791: NM—032405
Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant D,
mRNA
gi|14602456|ref|NM—032405.1|[14602456] - 792: NM—032404
Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant C,
mRNA
gi|14602454|ref|NM—032404.1|[14602454] - 793: NM—032401
Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant B,
mRNA
gi|14602452|ref|NM—032401.1|[14602452] - 794: NM—024022
Homo sapiens transmembrane protease, serine 3 (TMPRSS3), transcript variant A,
mRNA
gi|13173470|ref|NM—024022.1|[13173470] - 795: AF325418
Ovis aries cystic fibrosis transmembrane conductance regulator (CFTR) gene, intron 21
gi|15637182|gb|AF325418.1|F325416S08[15637182] - 796: AF325419
Ovis aries cystic fibrosis transmembrane conductance regulator (CFTR) gene, intron 10
gi|15637180|gb|AF325419.1|F325416S06[15637180] - 797: AH011064
Ovis aries
gi|15637174|gb|AH011064.1|SEG_F325416S[15637174] - 798: NM—022570
Homo sapiens C-type (calcium dependent, carbohydrate-recognition domain) lectin,
superfamily member 12 (CLECSF12), mRNA
gi|13384603|ref|NM—022570.2|[13384603] - 799: AF360695
Homo sapiens keratinocyte growth factor receptor 2 (FGFR2) gene, exons 3 through
22 and complete cds, alternatively spliced
gi|15620559|gb|AF360695.3|AF410480S2[15620559] - 800: AH010989
Homo sapiens keratinocyte growth factor receptor 2 (FGFR2) gene, complete cds,
alternatively spliced
gi|15620558|gb|AH010989.3|SEG_AF410480S[15620558] - 801: AY035377
Homo sapiens peptidoglycan recognition protein-1-beta precursor (PGLYRPIbeta) mRNA, complete cds
gi|15590685|gb|AY035377.1|[15590685] - 802: AY035376
Homo sapiens peptidoglycan recognition protein-1-alpha precursor (PGLYRPIalpha)
mRNA, complete cds
gi|15590683|gb|AY035376.1|[15590683] - 803: NM—013317
Homo sapiens lung type-I cell membrane-associated glycoprotein (T1A-2), transcript variant 1, mRNA
gi|7019416|ref|NM—013317.1|[7019416] - 804: AJ318099
Homo sapiens mRNA for putative endoplasmic reticulum multispan transmembrane protein (RFT1 gene)
gi|15558857|emb|AJ318099.1|HSA318099[15558857] - 807: NM—021808
Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) (GALNT9), mRNA
gi|11141878|ref|NM—021808.1|[11141878] - 808: AF275150
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 20 and complete cds
gi|9652146|gb|AF275150.1|F275131S20[9652146] - 809: AF275149
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 19
gi|9652145|gb|AF275149.1|F275131S19[9652145] - 810: AF275148
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 18
gi|9652144|gb|AF275148.1|F275131S18[9652144] - 811: AF275147
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 17
gi|9652143|gb|AF275147.1|F275131S17[9652143] - 812: AF275146
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 16
gi|9652142|gb|AF275146.1|F275131S16[9652142] - 813: AF275145
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 15
gi|9652141|gb|AF275145.1|F275131S15[9652141] - 814: AF275144
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 14
gi|9652140|gb|AF275144.1|F275131S14[9652140] - 815: AF275143
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 13
gi|9652139|gb|AF275143.1|F275131S13[9652139] - 816: AF275142
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 12
gi|9652138|gb|AF275142.1|F275131S12[9652138] - 817: AF275141
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 11
gi|9652137|gb|AF275141.1|F275131S11[9652137] - 818: AF275140
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 10
gi|9652136|gb|AF275140.1|F275131S10[9652136] - 819: AF275139
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 9
gi|9652135|gb|AF275139.1|F275131S09[9652135] - 820: AF275138
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 8
gi|9652134|gb|AF275138.1|F275131S08[9652134] - 821: AF275137
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 7
gi|9652133|gb|AF275137.1|F275131S07[9652133] - 822: AF275136
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 6
gi|9652132|gb|AF275136.1|F275131S06[9652132] - 823: AF275135
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 5
gi|9652131|gb|AF275135.1|F275131S05[9652131] - 824: AF275134
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 4
gi|9652130|gb|AF275134.1F275131S04[9652130] - 825: AF275133
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 3
gi|9652129|gb|AF275133.1F275131S03[9652129] - 826: AF275132
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 2
gi|9652128|gb|AF275132.1|F275131S02[9652128] - 827: AF275131
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, exon 1
gi|9652127|gb|AF275131.1|F275131S01[9652127] - 828: AH009676
Homo sapiens transmembrane-type protein tyrosine phosphatase H (PTPRH) gene, complete cds
gi|9652126|gb|AH009676.1|SEG_F275131S[9652126] - 829: NM—017417
Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 8 (GalNAc-T8) (GALNT8), mRNA
gi|8393411|ref|NM—017417.1|[8393411] - 830: NM—033346
Homo sapiens bone morphogenetic protein receptor, type II (serine/threonine kinase) (BMPR2), transcript variant 2, mRNA
gi|15451917|ref|NM—033346.1|[15451917] - 831: NM—001204
Homo sapiens bone morphogenetic protein receptor, type II (serine/threonine kinase) (BMPR2), transcript variant 1, mRNA
gi|15451915|ref|NM—001204.3|[15451915] - 832: NM—003933
Homo sapiens BAI1-associated protein 3 (BAIAP3), mRNA
gi|15451913|ref|NM—003933.3|[15451913] - 833: NM—014256
Homo sapiens UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 (B3GNT3), mRNA
gi|15451894|ref|NM—014256.2|[15451894]-834: NM—033274
Homo sapiens a disintegrin and metalloproteinase domain 19 (meltrin beta) (ADAM19), transcript variant 2, mRNA
gi|15451843|ref|NM—033274.1|[15451843] - 835: NM—023038
Homo sapiens a disintegrin and metalloproteinase domain 19 (meltrin beta) (ADAM19), transcript variant 1, mRNA
gi|15451841|ref|NM—023038.2|[15451841] - 836: NM—030765
Homo sapiens UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 (B3GNT4), mRNA
gi|13540526|ref|NM—030765.1|[13540526] - 837: AB048207
Homo sapiens mRNA for TIGA1, complete cds
gi|15425668|dbj|AB048207.1|AB048207[15425668] - 838: NM—006005
Homo sapiens Wolfram syndrome 1 (wolframin) (WFS1), mRNA
gi|13376995|ref|NM—006005.2|[13376995] - 839: NM—015722
Homo sapiens calcyon; D1 dopamine receptor-interacting protein (CALCYON),
gi|9257200|ref|NM—015722.2|[9257200] - 840: AY038990
Homo sapiens ER-localized type I transmembrane adaptor precursor (CAPER) mRNA,
complete cds
gi|15418959|gb|AY038990.1|[15418959] - 841: BB226825
BB226825 RIKEN full-length enriched, adult male aorta and vein Mus musculus cDNA
clone A530098L04 3′ similar to AF169676 Homo sapiens leucine-rich repeat transmembrane protein FLRT2 (FLRT2) mRNA, mRNA sequence
gi|15410201|dbj|BB226825.2|BB226825[15410201] - 843: AF059274
Homo sapiens neuroglycan C mRNA, complete cds
gi|3820499|gb|AF059274.1|AF059274[3820499] - 844: BC013152
Homo sapiens, Similar to transmembrane protein 5, clone MGC:17085 IMAGE:3919181, mRNA, complete cds
gi|15341928|gb|BC013152.1|BC013152[15341928] - 845: AH011005
Homo sapiens
gi|15341629|gb|AH011005.1|SEG_L11671S[15341629] - 846: AF406650
Homo sapiens putative gap junction protein pannexin 3 (PANX3) mRNA, complete cds
gi|1534153|gb|AF406650.1|AF406650[15341531] - 847: L11671
Homo sapiens transmembrane glycoprotein (CD53) gene, exon 1
gi|291896|gb|L11671.1|L11671S1[291896] - 848: L11670
Homo sapiens transmembrane glycoprotein (CD53) gene, exons 2 through 8
gi|180145|gb|L11670.1|L11671S2[180145] - 849: B1468287
id87a04.y1 Human insulinoma Homo sapiens cDNA 5′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
gi|15284396|gb|BI468287.1|BI468287[15284396] - 850: B1468286
id87a04.x1 Human insulinoma Homo sapiens cDNA 3′ similar to TR:Q9Y287 Q9Y287 TRANSMEMBRANE PROTEIN BRI.;, mRNA sequence
gi|15284395|gb|BI468286.1|BI468286[15284395]
Claims
1. A method of modulating an immune response in an animal comprising the step of administering to said animal a composition comprising
- an antigen bearing target and further comprising a multifunctional molecule which comprises a first amino acid sequence which can bind to a carbohydrate and a second amino acid sequence comprising a ligand for a cell surface polypeptide, wherein said ligand is chosen from the group: a ligand for a cytokine receptor, a ligand for CD40, a ligand for an adhesion molecule, a ligand for a defensin receptor, a ligand for a heat shock protein receptor, a ligand for a T cell costimulatory molecule, a ligand for a counterreceptor for a T cell costimulatory molecule.
2. The method of claim 1, wherein said animal is a mammal.
3. The method of claim 2, wherein said mammal is a human.
4. The method of claim 1, wherein said antigen bearing target comprises at least one of the following: a tumor antigen, a viral antigen, a bacterial antigen, a fungal antigen, a parasite antigen, a prion antigen, an antigen of an autoimmune disease.
5. The method of claim 1 wherein said antigen bearing target is a cell.
6. The method of claim 1, wherein said antigen bearing target is chosen from the group: a tumor cell, a virus, a bacterial cell, a fungal cell, a cell of a parasite, a prion, a mammalian cell, an insect cell, a polypeptide free of other cell-derived material.
7. The method of claim 5, wherein said antigen bearing target is pathogenic.
8. The method of claim 7, wherein said antigen bearing target is attenuated.
9. The method of claim 1, wherein said antigen bearing target is a cell which is substantially unable to divide.
10. The method of claim 1, wherein said multifunctional molecule is a fusion polypeptide.
11. The method of claim 10, wherein said first amino acid sequence is N-terminal to said second amino acid sequence.
12. The method of claim 10, wherein said first amino acid sequence is C-terminal to said second amino acid sequence.
13. The method of claim 5, wherein said multifunctional molecule is exogenous to said cell.
14. The method of claim 5, wherein said multifunctional molecule is endogenous to said cell and is encoded by a nucleic acid sequence comprised by the cell.
15. The method of claim 1, wherein said first amino acid sequence can bind to a sialic acid on a glycoprotein.
16. The method of claim 15, wherein said sialic acid comprises at least one of the following carbohydrate structures: N-acetylneuraminic acid, alpha-NeuNAc-[2->6]-Gal, alpha-NeuNAc-[2->6]-GalNAc, alpha-NeuNAc-[2->3]-Gal.
17. The method of claim 1, wherein said first amino acid sequence comprises a carbohydrate-binding domain of a naturally occuring lectin.
18. The method of claim 1, wherein said first amino acid sequence comprises at least about 10 contiguous amino acids of a hemagglutinin.
19. The method of claim 18, wherein said hemagglutinin is an influenza virus hemagglutinin.
20. The method of claim 19, wherein said contiguous amino acids of an influenza hemagglutinin are contiguous amino acids of an influenza hemagglutinin HA1 domain.
21. The method of claim 19, wherein said influenza virus is an influenza A virus.
22. The method of claim 21, wherein said influenza virus is of a subtype that infects humans.
23. The method of claim 21, wherein said influenza virus is of an H1 subtype.
24. The method of claim 23, wherein said influenza virus is from the strain A/PR/8/34.
25. The method of claim 24, wherein said influenza virus is of an H2 or H3 subtype.
26. The method of claim 19, wherein said influenza virus is of a subtype that does not infect humans.
27. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a mammalian cell surface polypeptide.
28. The method of claim 27, wherein said ligand for a cell surface polypeptide is a ligand for a mouse cell surface polypeptide.
29. The method of claim 27, wherein said ligand for a cell surface polypeptide is a ligand for a human cell surface polypeptide.
30. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a cell surface polypeptide of a leukocyte.
31. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a cell surface polypeptide of an antigen presenting cell.
32. The method of claim 31, wherein said ligand for a cell surface polypeptide is a ligand for a cell surface polypeptide of a professional antigen presenting cell.
33. The method of claim 30, wherein said ligand for a cell surface polypeptide is a ligand for a cell surface polypeptide of a dendritic cell.
34. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a mouse GM-CSF receptor.
35. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises at least about five contiguous amino acids of a mouse GM-CSF.
36. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises a mouse GM-CSF.
37. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a human GM-CSF receptor.
38. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises at least about five contiguous amino acids of a human GM-CSF.
39. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises a human GM-CSF.
40. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for an interleukin.
41. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for a mouse interleukin.
42. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for a human interleukin.
43. The method of claim 40, wherein said interleukin is chosen from the group: IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-14, IL-15, IL-16, IL-17, IL-18, IL-19, IL-20, IL-21, IL-22, IL-23, IL-24, IL-25.
44. The method of claim 40, wherein said ligand for a cell surface polypeptide comprises at least about 5 contiguous amino acids of an interleukin.
45. The method of claim 44, wherein said interleukin is chosen from the group: IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-14, IL-15, IL-16, IL-17, IL-18, IL-19, IL-20, IL-21, IL-22, IL-23, IL-24, IL-25.
46. The method of claim 40, wherein said ligand for a cell surface polypeptide comprises an interleukin.
47. The method of claim 46, wherein said interleukin is chosen from the group: IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-14, IL-15, IL-16, IL-17, IL-18, IL-19, IL-20, IL-21, IL-22, IL-23, IL-24, IL-25.
48. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for a chemokine.
49. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for a mouse chemokine.
50. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for a human chemokine.
51. The method of claim 48, wherein said chemokine is a C-C cytokine.
52. The method of claim 48, wherein said chemokine is a C-X-C cytokine.
53. The method of claim 48, wherein said cell surface polypeptide is chosen from the group: CXCR-1, CXCR-2, CXCR-3, CXCR-4, CCR-1, CCR-2, CCR-3, CCR-4, CCR-5, CCR-6, CCR-7, CCR-8.
54. The method of claim 48, wherein said chemokine is chosen from the group: 9E3, AMCF, beta-thromboglobulin, ENA-78, eotaxin, eotaxin-2, IP-10, KC, LIX, mig, MGSA, mob-1, NAP-2, NAP-3, NAP-4, PBSF, MGSA, mouse KC, MIP-2, MIP-1 alpha, NAP-2, ENA-78, GCP-2, ACT-2, C10, CCF18, DC-CK1, ELC, Exodus, FIC, GDCF, GDCF-2, HC-21, HCC-1, 1-309, JE, LAG-1, MARC, MCAF, MCP-1, MCP-2, MCP-3, MCP-4, MCP-5, MRP-2, RANTES SDF, TARC, ATAC, Ltn, SCM-1, neurotactin.
55. The method of claim 48, wherein said ligand for a cell surface polypeptide comprises at least about 5 contiguous amino acids of a chemokine.
56. The method of claim 55 wherein said chemokine is chosen from the group: 9E3, AMCF, beta-thromboglobulin, ENA-78, eotaxin, eotaxin-2, IP-10, KC, LIX, mig, MGSA, mob-1, NAP-2, NAP-3, NAP4, PBSF, MGSA, mouse KC, MIP-2, MIP-1 alpha, NAP-2, ENA-78, GCP-2, ACT-2, C10, CCF18, DC-CK1, ELC, Exodus, FIC, GDCF, GDCF-2, HC-21, HCC-1, 1-309, JE, LAG-1, MARC, MCAF, MCP-1, MCP-2, MCP-3, MCP-4, MCP-5, MRP-2, RANTES SDF, TARC, ATAC, Ltn, SCM-1, neurotactin.
57. The method of claim 48, wherein said ligand for a cell surface polypeptide comprises a chemokine.
58. The method of claim 57, wherein said chemokine is chosen from the group: 9E3, AMCF, beta-thromboglobulin, ENA-78, eotaxin, eotaxin-2, IP-10, KC, LIX, mig, MGSA, mob-1, NAP-2, NAP-3, NAP-4, PBSF, MGSA, mouse KC, MIP-2, MIP-1 alpha, NAP-2, ENA-78, GCP-2, ACT-2, C10, CCF18, DC-CK1, ELC, Exodus, FIC, GDCF, GDCF-2, HC-21, HCC-1, I-309, JE, LAG-1, MARC, MCAF, MCP-1, MCP-2, MCP-3, MCP-4, MCP-5, MRP-2, RANTES SDF, TARC, ATAC, Ltn, SCM-1, neurotactin.
59. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for an interferon.
60. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for a mouse interferon.
61. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a receptor for a human interferon.
62. The method of claim 59, wherein said interferon is chosen from the group: an interferon-alpha, an interferon-beta, an interferon gamma.
63. The method of claim 59, wherein said ligand for a cell surface polypeptide comprises at least about 5 contiguous amino acids of an interferon.
64. The method of claim 63, wherein said interferon is chosen from the group: an interferon-alpha, an interferon-beta, an interferon gamma.
65. The method of claim 59, wherein said ligand for a cell surface polypeptide comprises an interferon.
66. The method of claim 65, wherein said interferon is chosen from the group: an interferon-alpha, an interferon-beta, an interferon gamma.
67. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a mouse TNF-alpha receptor.
68. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises at least about five contiguous amino acids of a mouse TNF-alpha.
69. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises a mouse TNF-alpha.
70. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a human TNF-alpha receptor.
71. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises at least about five contiguous amino acids of a human TNF-alpha.
72. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises a human TNF-alpha.
73. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a mouse flt-3 receptor.
74. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises at least about five contiguous amino acids of a mouse flt-3.
75. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises a mouse flt-3.
76. The method of claim 1, wherein said ligand for a cell surface polypeptide is a ligand for a human flt-3 receptor.
77. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises at least about five contiguous amino acids of a human flt-3.
78. The method of claim 1, wherein said ligand for a cell surface polypeptide comprises a human flt-3.
79. The method of claim 10, wherein said fusion polypeptide further comprises a linker interposed between said first and second amino acid sequences.
80. The method of claim 79, wherein said linker has the formula (GlyxSer)n, wherein n is an integer between 1 and 15, and x is an integer between 1 and 10.
81. The method of claim 1, wherein said composition comprises said multifunctional molecule bound to a carbohydrate on said antigen bearing target.
82. The method of claim 1, in which at least some of said multifunctional molecule is not bound to said antigen bearing target.
Type: Application
Filed: Sep 19, 2003
Publication Date: Mar 24, 2005
Applicant:
Inventors: Andrew Segal (Boston, MA), Elihu Young (Sharon, MA)
Application Number: 10/668,073
